PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	EY	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Strazzulli, A; Fusco, S; Cobucci-Ponzano, B; Moracci, M; Contursi, P				Strazzulli, Andrea; Fusco, Salvatore; Cobucci-Ponzano, Beatrice; Moracci, Marco; Contursi, Patrizia			Metagenomics of microbial and viral life in terrestrial geothermal environments	REVIEWS IN ENVIRONMENTAL SCIENCE AND BIO-TECHNOLOGY			English	Review						Hyperthermophiles; Geothermal environments; Microbial and viral metagenomics; CRISPR; Enzyme discovery	YELLOWSTONE-NATIONAL-PARK; 16S RIBOSOMAL-RNA; SPINDLE-SHAPED VIRUS; HOT-SPRINGS; ARCHAEAL VIRUSES; YUNNAN PROVINCE; NEW-ZEALAND; SULFOLOBUS-ISLANDICUS; COMMUNITY ANALYSIS; BETA-GLYCOSIDASE	Geothermally heated regions of Earth, such as terrestrial volcanic areas (fumaroles, hot springs, and geysers) and deep-sea hydrothermal vents, represent a variety of different environments populated by extremophilic archaeal and bacterial microorganisms. Since most of these microbes thriving in such harsh biotopes, they are often recalcitrant to cultivation; therefore, ecological, physiological and phylogenetic studies of these microbial populations have been hampered for a long time. More recently, culture-independent methodologies coupled with the fast development of next generation sequencing technologies as well as with the continuous advances in computational biology, have allowed the production of large amounts of metagenomic data. Specifically, these approaches have assessed the phylogenetic composition and functional potential of microbial consortia thriving within these habitats, shedding light on how extreme physico-chemical conditions and biological interactions have shaped such microbial communities. Metagenomics allowed to better understand that the exposure to an extreme range of selective pressures in such severe environments, accounts for genomic flexibility and metabolic versatility of microbial and viral communities, and makes extreme-and hyper-thermophiles suitable for bioprospecting purposes, representing an interesting source for novel thermostable proteins that can be potentially used in several industrial processes.	[Strazzulli, Andrea; Moracci, Marco; Contursi, Patrizia] Univ Napoli Federico II, Complesso Univ Monte S Angelo, Dipartimento Biol, Via Cinthia, I-80126 Naples, Italy; [Strazzulli, Andrea; Cobucci-Ponzano, Beatrice; Moracci, Marco] Natl Res Council Italy, Inst Biosci & Bioresources, Via P Castellino 111, I-80131 Naples, Italy; [Fusco, Salvatore] Chalmers, Dept Biol & Biol Engn, Div Ind Biotechnol, Gothenburg, Sweden	Contursi, P (reprint author), Univ Napoli Federico II, Complesso Univ Monte S Angelo, Dipartimento Biol, Via Cinthia, I-80126 Naples, Italy.	contursi@unina.it		Fusco, Salvatore/0000-0003-2928-3609; Strazzulli, Andrea/0000-0002-9690-149X	Italian Space Agency [BIOPOLIS: PON03PE_00107_1 CUP: E48C14000030005, 2014-026-R.0]	This work was supported by a Grant from BIOPOLIS: PON03PE_00107_1 CUP: E48C14000030005 and by the project "Esobiologia e ambienti estremi: dalla Chimica delle Molecole alla Biologia degli Estremofili-ECMB'' No. 2014-026-R.0 of the Italian Space Agency.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Allgaier M, 2010, PLOS ONE, V5, P9; AMANN RI, 1995, MICROBIOL REV, V59, P143; Angelov A, 2009, SYST APPL MICROBIOL, V32, P177, DOI 10.1016/j.syapm.2008.01.003; Aulitto M, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0638-4; Ausili A, 2004, BIOCHEM J, V384, P69, DOI 10.1042/BJ20040646; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bartolucci S, 2013, FRONT BIOSCI-LANDMRK, V18, P165, DOI 10.2741/4094; Beam JP, 2014, ISME J, V8, P938, DOI 10.1038/ismej.2013.193; Bhaya D, 2007, ISME J, V1, P703, DOI 10.1038/ismej.2007.46; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Bize A, 2008, RES MICROBIOL, V159, P358, DOI 10.1016/j.resmic.2008.04.009; Blainey PC, 2014, NAT METHODS, V11, P19, DOI 10.1038/nmeth.2783; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bolduc B, 2015, ISME J, V9, P2162, DOI 10.1038/ismej.2015.28; Bolduc B, 2012, J VIROL, V86, P5562, DOI 10.1128/JVI.07196-11; Briggs BR, 2014, ENVIRON MICROBIOL, V16, P1579, DOI 10.1111/1462-2920.12311; Brito EMS, 2014, EXTREMOPHILES, V18, P385, DOI 10.1007/s00792-013-0624-7; BROCK T D, 1967, Internationale Revue der Gesamten Hydrobiologie, V52, P545, DOI 10.1002/iroh.19670520405; Brock TD, 2001, THERMOPHILES: BIODIVERSITY, ECOLOGY, AND EVOLUTION, P1; BROCK TD, 1971, J BACTERIOL, V107, P303; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Castiglia D, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0569-z; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chan CS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00177; Cheng JJ, 2014, J MICROBIOL METH, V99, P27, DOI 10.1016/j.mimet.2014.01.015; Chernyh NA, 2015, EXTREMOPHILES, V19, P1157, DOI 10.1007/s00792-015-0787-5; Clingenpeel S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00274; Clooney AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148028; Cobucci-Ponzano B, 2006, NUCLEIC ACIDS RES, V34, P4258, DOI 10.1093/nar/gkl574; Cobucci-Ponzano B, 2015, ENZYME MICROB TECH, V78, P63, DOI 10.1016/j.enzmictec.2015.06.014; Cobucci-Ponzano B, 2010, BIOCHIMIE, V92, P1895, DOI 10.1016/j.biochi.2010.07.016; Cobucci-Ponzano B, 2010, J BIOL CHEM, V285, P20691, DOI 10.1074/jbc.M109.086470; Cobucci-Ponzano B, 2013, LIGNOCELLULOSE CONVE, P111, DOI 10.1007/978-3-642-37861-4; Contursi P, 2014, NUCLEIC ACIDS RES, V42, P5993, DOI 10.1093/nar/gku215; Contursi P, 2014, EXTREMOPHILES, V18, P473, DOI 10.1007/s00792-014-0634-0; Contursi P, 2010, EXTREMOPHILES, V14, P453, DOI 10.1007/s00792-010-0325-4; Cowan DA, 2015, CURR OPIN MICROBIOL, V25, P97, DOI 10.1016/j.mib.2015.05.005; DeCastro ME, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01521; Dellas N, 2014, ANNU REV VIROL, V1, P399, DOI 10.1146/annurev-virology-031413-085357; Delmont TO, 2011, J MICROBIOL METH, V86, P397, DOI 10.1016/j.mimet.2011.06.013; Diemer GS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-13; Dougherty MJ, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-38; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicrol163; Eloe-Fadrosh EA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10476; Eme L, 2013, RES MICROBIOL, V164, P425, DOI 10.1016/j.resmic.2013.02.006; Faurez F, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-60; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fusco S, 2015, BIOCHIMIE, V118, P322, DOI 10.1016/j.biochi.2015.04.006; Fusco S, 2015, EXTREMOPHILES, V19, P539, DOI 10.1007/s00792-014-0717-y; Gabor EM, 2004, ENVIRON MICROBIOL, V6, P879, DOI 10.1111/j.1462-2920.2004.00640.x; Garrett RA, 2010, ENVIRON MICROBIOL, V12, P2918, DOI 10.1111/j.1462-2920.2010.02266.x; Gladden JM, 2011, APPL ENVIRON MICROB, V77, P5804, DOI 10.1128/AEM.00032-11; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Graham JE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1373; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Gudbergsdottir SR, 2016, ENVIRON MICROBIOL, V18, P863, DOI 10.1111/1462-2920.13079; Ha SH, 2011, BIORESOURCE TECHNOL, V102, P1214, DOI 10.1016/j.biortech.2010.07.108; Haring M, 2005, J VIROL, V79, P9904, DOI 10.1128/JVI.79.15.9904-9911.2005; Haring M, 2004, VIROLOGY, V323, P233, DOI 10.1016/j.virol.2004.03.002; HEDENQUIST JW, 1985, ECON GEOL, V80, P1640, DOI 10.2113/gsecongeo.80.6.1640                                                     ; Hirner AV, 1998, ORG GEOCHEM, V29, P1765, DOI 10.1016/S0146-6380(98)00153-3                                                   ; Hou WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053350; Huber R, 2000, FEMS MICROBIOL REV, V24, P615, DOI 10.1111/j.1574-6976.2000.tb00562.x                                              ; Hug K, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00569; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huson DH, 2013, METHOD ENZYMOL, V531, P465, DOI 10.1016/B978-0-12-407863-5.00021-6; Iacono R, 2016, CHEM TODAY, V34, P34; Inskeep WP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00095; Inskeep WP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00067; Inskeep WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009773; Isaia R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040513; Jiang HC, 2010, APPL ENVIRON MICROB, V76, P4538, DOI 10.1128/AEM.00143-10; Jiang XB, 2017, EXTREMOPHILES, V21, P135, DOI 10.1007/s00792-016-0889-8; John SG, 2011, ENV MICROBIOL REP, V3, P195, DOI 10.1111/j.1758-2229.2010.00208.x; Jones B, 2001, J GEOL SOC LONDON, V158, P895, DOI 10.1144/0016-764900-131                                                         ; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Katayama H, 2002, APPL ENVIRON MICROB, V68, P1033, DOI 10.1128/AEM.68.3.1033-1039.2002; Kim YM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00209; Kozubal MA, 2013, ISME J, V7, P622, DOI 10.1038/ismej.2012.132; Krupovic M, 2011, MICROBIOL MOL BIOL R, V75, P610, DOI 10.1128/MMBR.00011-11; Lakay FM, 2007, J APPL MICROBIOL, V102, P265, DOI 10.1111/j.1365-2672.2006.03052.x; Lasken RS, 2012, NAT REV MICROBIOL, V10, P631, DOI 10.1038/nrmicro2857; Leis B, 2015, FRONT MICROBIOL, V6, DOI [10.3389/frricb.2015.00275, 10.3389/fmicb.2015.00275]; Liang YN, 2010, APPL BIOCHEM BIOTECH, V161, P147, DOI 10.1007/s12010-009-8780-z; Lipps G, 2006, EXTREMOPHILES, V10, P17, DOI 10.1007/s00792-005-0492-x; Lopez-Lopez O, 2014, CURR PROTEIN PEPT SC, V15, P445, DOI 10.2174/1389203715666140228153801                                               ; Lopez-Lopez O, 2013, HOT SPRING METAGENOM, DOI [10.3390/life3020308, DOI 10.3390/LIFE3020308]; Lorenz P, 2002, CURR OPIN BIOTECH, V13, P572, DOI 10.1016/S0958-1669(02)00345-2; Luo CW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030087, 10.1371/journal.pone.0036568]; Macur RE, 2013, GEOBIOLOGY, V11, P86, DOI 10.1111/gbi.12015; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Martinez-Garcia M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5542; Menzel P, 2015, MICROB ECOL, V70, P411, DOI 10.1007/s00248-015-0576-9; Merkel AY, 2017, EXTREMOPHILES, V21, P307, DOI 10.1007/s00792-016-0903-1; Meyer-Dombard DR, 2005, GEOBIOLOGY, V3, P211, DOI 10.1111/j.1472-4669.2005.00052.x; Mountain BW, 2003, CAN J EARTH SCI, V40, P1643, DOI 10.1139/E03-068; Munson-McGee JH, 2015, APPL ENVIRON MICROB, V81, P7860, DOI 10.1128/AEM.01539-15; NEUMANN H, 1989, MOL GEN GENET, V217, P105, DOI 10.1007/BF00330948; Orsi G, 1996, J VOLCANOL GEOTH RES, V74, P179, DOI 10.1016/S0377-0273(96)00063-7                                                   ; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Peng X, 2012, SCI CHINA LIFE SCI, V55, P422, DOI 10.1007/s11427-012-4325-8; Petrosino S, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC004030; Pinkert A, 2009, CHEM REV, V109, P6712, DOI 10.1021/cr9001947; Poretsky R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093827; Prangishvili D, 2005, TRENDS MICROBIOL, V13, P535, DOI 10.1016/j.tim.2005.08.013; Prangishvili D, 2004, BIOCHEM SOC T, V32, P204, DOI 10.1042/BST0320204; Prangishvili D, 2001, TRENDS MICROBIOL, V9, P39, DOI 10.1016/S0966-842X(00)01910-7                                                   ; Prangishvili D, 2006, NAT REV MICROBIOL, V4, P837, DOI 10.1038/nrmicro1527; Prangishvili D, 2013, ANNU REV MICROBIOL, V67, P565, DOI 10.1146/annurev-micro-092412-155633; Prato S, 2008, FEBS J, V275, P4389, DOI 10.1111/j.1742-4658.2008.06585.x; Pride DT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-420; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/nmeth.1361, 10.1038/NMETH.1361]; Rampelli S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2446-3; Rath D, 2015, BIOCHIMIE, V117, P119, DOI 10.1016/j.biochi.2015.03.025; REYSENBACH AL, 1994, APPL ENVIRON MICROB, V60, P2113; Rice G, 2004, P NATL ACAD SCI USA, V101, P7716, DOI 10.1073/pnas.0401773101; Rice G, 2001, P NATL ACAD SCI USA, V98, P13341, DOI 10.1073/pnas.231170198; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Romano C, 2013, APPL ENVIRON MICROB, V79, P2932, DOI 10.1128/AEM.03591-12; Rosi M., 1984, B VOLCANOL, V47, P359; Rousseau C, 2009, BIOINFORMATICS, V25, P3317, DOI 10.1093/bioinformatics/btp586; Roux S, 2015, ELIFE, V4, DOI 10.7554/eLife.08490; Roux S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-76; Sahm K, 2013, EXTREMOPHILES, V17, P649, DOI 10.1007/s00792-013-0548-2; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; Servin-Garciduenas LE, 2013, GENOME ANNOUNC, V1, DOI 10.1128/genomeA.00164-13; Servin-Garciduenas LE, 2013, GENOME ANNOUNC, V1; Sharma A, 2012, EXTREMOPHILES, V16, P1, DOI 10.1007/s00792-011-0402-3; Short SM, 2008, AQUAT MICROB ECOL, V51, P13, DOI 10.3354/ame01183; Simon C, 2009, APPL ENVIRON MICROB, V75, P7519, DOI 10.1128/AEM.00946-09; Skennerton CT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt183; Snyder JC, 2015, VIROLOGY, V479, P369, DOI 10.1016/j.virol.2015.03.031; Snyder JC, 2013, BIOCHEM SOC T, V41, P309, DOI 10.1042/BST20120326; Snyder JC, 2011, J VIROL, V85, P6287, DOI 10.1128/JVI.00379-11; Snyder JC, 2010, APPL ENVIRON MICROB, V76, P7251, DOI 10.1128/AEM.01109-10; Urbieta MS, 2014, SYST APPL MICROBIOL, V37, P429, DOI 10.1016/j.syapm.2014.05.012; Song ZQ, 2010, EXTREMOPHILES, V14, P287, DOI 10.1007/s00792-010-0307-6; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447; STAHL DA, 1984, SCIENCE, V224, P409, DOI 10.1126/science.224.4647.409; Stauder S, 2005, ENVIRON SCI TECHNOL, V39, P5933, DOI 10.1021/es048034k; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Sun CL, 2016, ISME J, V10, P858, DOI 10.1038/ismej.2015.162; Sun GW, 2014, METHODSX, V1, P197, DOI 10.1016/j.mex.2014.09.001; Takacs-Vesbach C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00084; TEBBE CC, 1993, APPL ENVIRON MICROB, V59, P2657; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Uldahl KB, 2016, J VIROL, V90, P5693, DOI 10.1128/JVI.00075-16; Vale PF, 2010, P ROY SOC B-BIOL SCI, V277, P2097, DOI 10.1098/rspb.2010.0055; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Walker A, 2014, NAT REV MICROBIOL, V12, P78, DOI 10.1038/nrmicro3203; Wang HN, 2015, MICROBIOL MOL BIOL R, V79, P117, DOI 10.1128/MMBR.00042-14; Wang HM, 2015, DIVERSITY PUTATIVE A, DOI [10.1186/S40064-015-0973-Z, DOI 10.1186/S40064-015-0973-Z]; Wang LX, 2009, CHEM BIOL, V16, P1026, DOI 10.1016/j.chembiol.2009.10.003; Wang M., 2015, CLADISTICS, V2015, P1, DOI DOI 10.1007/S10648-015-9319-1; Wang S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07479; Wemheuer B, 2013, ARCHAEA, DOI 10.1155/2013/136714; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wolfenden R, 1998, J AM CHEM SOC, V120, P6814, DOI 10.1021/ja9813055                                                               ; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu YW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-26; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zhao C, 2017, BIOTECHNOL LETT, V39, P123, DOI 10.1007/s10529-016-2224-y; Zillig W, 1996, FEMS MICROBIOL REV, V18, P225, DOI 10.1111/j.1574-6976.1996.tb00239.x; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	169	1	1	22	22	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-1705	1572-9826		REV ENVIRON SCI BIO	Rev. Environ. Sci. Bio-Technol.	SEP	2017	16	3					425	454		10.1007/s11157-017-9435-0				30	Biotechnology & Applied Microbiology; Environmental Sciences	Biotechnology & Applied Microbiology; Environmental Sciences & Ecology	FE1EN	WOS:000407961300003		gold			2018-01-05	
J	Wasels, F; Jean-Marie, J; Collas, F; Lopez-Contreras, AM; Ferreira, NL				Wasels, Francois; Jean-Marie, Jennifer; Collas, Florent; Lopez-Contreras, Ana M.; Ferreira, Nicolas Lopes			A two-plasmid inducible CRISPR/Cas9 genome editing tool for Clostridium acetobutylicum	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						Clostridium acetobutylicum; CRISPR/Cas9; Genome engineering; Metabolic engineering	GENE; SYSTEM; BEIJERINCKII; PLASMIDS; ATCC-824; SEQUENCE; VECTOR	CRISPR/Cas-based genetic engineering has revolutionised molecular biology in both eukaryotes and prokaryotes. Several tools dedicated to the genomic transformation of the Clostridium genus of Gram-positive bacteria have been described in the literature; however, the integration of large DNA fragments still remains relatively limited. In this study, a CRISPR/Cas9 genome editing tool using a two-plasmid strategy was developed for the solventogenic strain Clostridium acetobutylicum ATCC 824. Codon-optimised cas9 from Streptococcus pyogenes was placed under the control of an anhydrotetracycline-inducible promoter on one plasmid, while the gRNA expression cassettes and editing templates were located on a second plasmid. Through the sequential introduction of these vectors into the cell, we achieved highly accurate genome modifications, including nucleotide substitution, gene deletion and cassette insertion up to 3.6 kb. To demonstrate its potential, this genome editing tool was used to generate a marker-free mutant of ATCC 824 that produced an isopropanol-butanol-ethanol mixture. Whole-genome sequencing confirmed that no off-target modifications were present in the mutants. Such a tool is a prerequisite for efficient metabolic engineering in this solventogenic strain and provides an alternative editing strategy that might be applicable to other Clostridium strains.	[Wasels, Francois; Jean-Marie, Jennifer; Ferreira, Nicolas Lopes] IFP Energies Nouvelles, Dept Biotechnol, 1&4 Ave Bois Preau, F-92852 Rueil Malmaison, France; [Collas, Florent; Lopez-Contreras, Ana M.] Wageningen Food & Biobased Res, Bornse Weilanden 9, NL-6709 WG Wageningen, Netherlands	Wasels, F (reprint author), IFP Energies Nouvelles, Dept Biotechnol, 1&4 Ave Bois Preau, F-92852 Rueil Malmaison, France.	francois.wasels@ifpen.fr	IFPEN, Publications/A-8028-2008; Physico chimie, Direction Physico/C-1380-2013		European Union [654010]	Work at Wageningen Food and Biobased Research was supported by European Union's Horizon 2020 Macrofuels project (contract number 654010).	Collas F., 2012, AMB EXPRESS; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornillot E, 1997, J BACTERIOL, V179, P5442, DOI 10.1128/jb.179.17.5442-5447.1997                                                ; Croux C., 2016, BIOTECHNOL BIOFUELS; Dong HJ, 2012, METAB ENG, V14, P59, DOI 10.1016/j.ymben.2011.10.004; Ehsaan M., 2016, BIOTECHNOL BIOFUELS; Gapes JR, 1996, APPL ENVIRON MICROB, V62, P3210; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1321; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Huang H, 2016, ACS SYNTH BIOL; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lee J, 2012, APPL ENVIRON MICROB, V78, P1416, DOI 10.1128/AEM.06382-11; Li Q., 2016, BIOTECHNOL J; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MERMELSTEIN LD, 1993, APPL ENVIRON MICROB, V59, P1077; Metzger MJ, 2011, NUCLEIC ACIDS RES, V39, P926, DOI 10.1093/nar/gkq826; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; OULTRAM JD, 1988, FEMS MICROBIOL LETT, V56, P83, DOI 10.1016/0378-1097(88)90131-0; Poehlein A, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0742-z; Pyne ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep25666; Sabathe F, 2002, FEMS MICROBIOL LETT, V210, P93, DOI 10.1111/j.1574-6968.2002.tb11165.x; Shao L, 2007, CELL RES, V17, P963, DOI 10.1038/cr.2007.91; Wang Y., 2016, ACS SYNTH BIOL; Wang Y, 2015, J BIOTECHNOL, V200, P1, DOI 10.1016/j.jbiotec.2015.02.005; Xu T, 2015, APPL ENVIRON MICROB, V81, P4423, DOI 10.1128/AEM.00873-15; Collas F., 2014, U. S. Patent Application No, Patent No. [14/350,923, 14350923]	30	0	0	15	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	SEP	2017	140						5	11		10.1016/j.mimet.2017.06.010				7	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	FE1MK	WOS:000407982100002	28610973	gold			2018-01-05	
J	Ren, JT; Zhao, YB				Ren, Jiangtao; Zhao, Yangbing			Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9	PROTEIN & CELL			English	Review						CRISPR/Cas9; chimeric antigen receptor; T lymphocytes; adoptive immunotherapy; gene therapy	ZINC-FINGER NUCLEASES; HIV-1 INFECTION; GUIDE RNAS; DNA; SPECIFICITY; CAS9; ACTIVATION; ZEBRAFISH; MULTIPLEX; SYSTEM	The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 (CRISPR/Cas9) system, an RNA-guided DNA targeting technology, is triggering a revolution in the field of biology. CRISPR/Cas9 has demonstrated great potential for genetic manipulation. In this review, we discuss the current development of CRISPR/Cas9 technologies for therapeutic applications, especially chimeric antigen receptor (CAR) T cell-based adoptive immunotherapy. Different methods used to facilitate efficient CRISPR delivery and gene editing in T cells are compared. The potential of genetic manipulation using CRISPR/Cas9 system to generate universal CAR T cells and potent T cells that are resistant to exhaustion and inhibition is explored. We also address the safety concerns associated with the use of CRISPR/Cas9 gene editing and provide potential solutions and future directions of CRISPR application in the field of CAR T cell immunotherapy. As an integration-free gene insertion method, CRISPR/Cas9 holds great promise as an efficient gene knock-in platform. Given the tremendous progress that has been made in the past few years, we believe that the CRISPR/Cas9 technology holds immense promise for advancing immunotherapy.	[Ren, Jiangtao; Zhao, Yangbing] Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USA	Zhao, YB (reprint author), Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USA.	Yangbing@upenn.edu			US National Institutes of Health (NIH) [2R01CA120409]	This work was supported by a US National Institutes of Health (NIH) Grants YZ (2R01CA120409).	Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Chi S., 2016, BIOMED RES INT, V2016; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Cyranoski D, 2016, NATURE, V539, P479, DOI 10.1038/nature.2016.20988; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; GROSS G, 1989, P NATL ACAD SCI USA, V86, P10024, DOI 10.1073/pnas.86.24.10024; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hoos A, 2016, NAT REV DRUG DISCOV, V15, P235, DOI 10.1038/nrd.2015.35; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Li CX, 2015, ELIFE, V4, DOI 10.7554/eLife.05378; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Liu XJ, 2017, CELL RES, V27, P154, DOI 10.1038/cr.2016.142; Lloyd A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00221; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]	51	0	0	41	41	HIGHER EDUCATION PRESS	BEIJING	NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA	1674-800X	1674-8018		PROTEIN CELL	Protein Cell	SEP	2017	8	9					634	643		10.1007/s13238-017-0410-x				10	Cell Biology	Cell Biology	FE1EY	WOS:000407962400002	28434148	gold			2018-01-05	
J	Li, WL; Yang, B				Li, Wanlong; Yang, Bing			Translational genomics of grain size regulation in wheat	THEORETICAL AND APPLIED GENETICS			English	Review							NATURAL VARIATION; SEED SIZE; AEGILOPS-TAUSCHII; DRAFT GENOME; COMMON WHEAT; BREAD WHEAT; RICE; GENE; WEIGHT; YIELD	Grain size (GS) or grain weight is believed to be a major driving force for further improvement of wheat yield. Although the large, polyploid genome of wheat poses an obstacle to identifying GS determinants using map-based cloning, a translational genomics approach using GS regulators identified in the model plants rice and Arabidopsis as candidate genes appears to be effective and supports a hypothesis that a conserved genetic network regulates GS in rice and wheat. In this review, we summarize the progress in the studies on GS in the model plants and wheat and identify 45 GS candidate loci in the wheat genome. In silico mapping of these GS loci in the diploid wheat and barley genomes showed (1) several gene families amplified in the wheat lineage, (2) a significant number of the GS genes located in the proximal regions surrounding the centromeres, and (3) more than half of candidate genes to be negative regulators, or their expression negatively related by microRNAs. Identifying and mapping the wheat GS gene homologs will not only facilitate candidate gene analysis, but also open the door to improving wheat yield using reverse genetics approaches by mining desired alleles in landraces and wild ancestors and to developing novel germplasm by TILLING and genome editing technologies.	[Li, Wanlong] South Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Yang, Bing] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA	Li, WL (reprint author), South Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA.	Wanlong.li@sdstate.edu			USDA NIFA-IWYP project [2016-06712]	This work is supported by a USDA NIFA-IWYP project (2016-06712).	Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cermak T, 2011, NUCLEIC ACIDS RES, V39, pe28; CHE RH, 2016, NAT PLANTS, V2; Clasen BM, 2016, PLANT BIOTECHNOL J, V14, P169, DOI 10.1111/pbi.12370; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Duan PG, 2017, MOL PLANT, V10, P685, DOI 10.1016/j.molp.2017.03.009; Fischer RA, 2008, FIELD CROP RES, V105, P15, DOI 10.1016/j.fcr.2007.04.002; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Griffiths S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118847; Hanif M, 2016, TATGW6 A1 ORTHOLOG R, V36, P1; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Heang D, 2012, BREEDING SCI, V62, P133, DOI 10.1270/jsbbs.62.133; Hong YT, 2014, FUNCT INTEGR GENOMIC, V14, P341, DOI 10.1007/s10142-014-0380-5; Hu J, 2015, MOL PLANT, V8, P1455, DOI 10.1016/j.molp.2015.07.002; Hu MJ, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0449-z; International Wheat Genome Sequencing C, 2014, SCIENCE, V345, DOI DOI 10.1126/SCIENCE.1251788; Jaiswal V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129400; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Krasileva KV, 2017, P NATL ACAD SCI USA, V114, pE913, DOI 10.1073/pnas.1619268114; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034231; Li N, 2015, J EXP BOT, V66, P1087, DOI 10.1093/jxb/eru549; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Li WL, 2004, PLANT J, V40, P500, DOI 10.1111/j.1365-313X.2004.02228.x; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu JF, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.43; Lu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144765; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; Ma L, 2016, PLANT BIOTECHNOL J, V14, P1269, DOI 10.1111/pbi.12492; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; NARANJO T, 1987, GENOME, V29, P873, DOI 10.1139/g87-149                                                                 ; Orozco-Arroyo G, 2015, PLANT REPROD, V28, P17, DOI 10.1007/s00497-015-0255-5; Qin L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-107; Segami S, 2012, RICE, V5, DOI 10.1186/1939-8433-5-4; Shan QW, 2015, PLANT BIOTECHNOL J, V13, P791, DOI 10.1111/pbi.12312; Si LZ, 2016, NAT GENET, V48, P447, DOI 10.1038/ng.3518; Simmonds J, 2016, THEOR APPL GENET, V129, P1099, DOI 10.1007/s00122-016-2686-2; Simmonds J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0191-9; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang SK, 2015, NAT GENET, V47, P949, DOI 10.1038/ng.3352; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; WANG SS, 2015, FRONT PLANT SCI, V6; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Weeks DP, 2016, PLANT BIOTECHNOL J, V14, P483, DOI 10.1111/pbi.12448; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Yu F, 2014, MOL PLANT, V7, P920, DOI 10.1093/mp/ssu010; Zhang L, 2012, NEW PHYTOL, V195, P574, DOI 10.1111/j.1469-8137.2012.04194.x; Zhang YJ, 2014, MOL BREEDING, V34, P1097, DOI 10.1007/s11032-014-0102-7; Zhou JH, 2015, PLANT J, V82, P632, DOI 10.1111/tpj.12838; Zuo JR, 2014, ANNU REV GENET, V48, P99, DOI 10.1146/annurev-genet-120213-092138	60	0	0	25	25	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0040-5752	1432-2242		THEOR APPL GENET	Theor. Appl. Genet.	SEP	2017	130	9					1765	1771		10.1007/s00122-017-2953-x				7	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	FE3MU	WOS:000408120800001	28765985				2018-01-05	
J	Rubio, M; Martinez-Gomez, P; Marais, A; Sanchez-Navarro, JA; Pallas, V; Candresse, T				Rubio, M.; Martinez-Gomez, P.; Marais, A.; Sanchez-Navarro, J. A.; Pallas, V.; Candresse, T.			Recent advances and prospects in Prunus virology	ANNALS OF APPLIED BIOLOGY			English	Review						Ampelovirus; Avsunviroidae; breeding; Capillovirus; characterisation; Cheravirus; control; detection; Foveavirus; Ilarvirus; Nepovirus; new generation sequencing; Ourmiavirus; Pospiviroidae; Potyvirus; Prunus; resistance; Tombusvirus; transmission; Trichovirus	PLUM-POX-VIRUS; PITTING-ASSOCIATED-VIRUS; FRUIT-TREES; SWEET CHERRY; SOUR CHERRY; MOLECULAR CHARACTERIZATION; FAMILY BETAFLEXIVIRIDAE; NICOTIANA-BENTHAMIANA; DIDERON ISOLATE; DETECTION ASSAY	The stone fruit genus Prunus, within the family Rosaceae, comprises more than 230 species, some of which have great importance or value as ornamental or fruit crops. Prunus are affected by numerous viruses and viroids linked to the vegetative propagation practices in many of the cultivated species. To date, 44 viruses and three viroids have been described in the 9 main cultivated Prunus species. Seven of these viruses and one viroid have been identified in Prunus hosts within the last 5 years. This work addresses recent advances and prospects in the study of viruses and viroids affecting Prunus species, mostly concerning the detection and characterisation of the agents involved, pathogenesis analysis and the search for new control tools. New sequencing technologies are quickly reshaping the way we can identify and characterise new plant viruses and isolates. Specific efforts aimed at virus identification or data mining of high-throughput sequencing data generated for plant genomics-oriented purposes can efficiently reveal the presence of known or novel viruses. These technologies have also been used to gain a deeper knowledge of the pathogenesis mechanisms at the gene and miRNA expression level that underlie the interactions between Prunus spp. and their main viruses and viroids. New biotechnological control tools include the transfer of resistance by grafting, the use of new sources of resistance and the development of gene silencing strategies using genetic transformation. In addition, the application of next generation sequencing and genome editing techniques will contribute to improving our knowledge of virus-host interactions and the mechanisms of resistance. This should be of great interest in the search to obtain new Prunus cultivars capable of dealing both with known viruses and viroids and with those that are yet to be discovered in the uncertain scenario of climate change.	[Rubio, M.; Martinez-Gomez, P.] CEBAS CSIC, Dept Plant Breeding, Murcia, Spain; [Marais, A.; Candresse, T.] Univ Bordeaux, INRA, UMR BFP 1332, Villenave Dornon, France; [Sanchez-Navarro, J. A.; Pallas, V.] IBMCP CSIC UPV, Dept Mol & Evolut Plant Virol, Valencia, Spain	Martinez-Gomez, P (reprint author), CEBAS CSIC, POB 164, Murcia 30100, Espinardo, Spain.	pmartinez@cebas.csic.es	Rubio, Manuel/E-8607-2010	Rubio, Manuel/0000-0003-4605-8227	Spanish Ministry of Economy and Competitiveness [RYC-2013-12563]; Spanish Ministry of Economy and Competiveness [AGL2015-68021-R]; Seneca Foundation of the Region of Murcia [19879/GERM/15]	The authors offer grateful thanks to Spanish Ministry of Economy and Competitiveness for the Ramon y Cajal contract (RYC-2013-12563) of Dr. Manuel Rubio. This study has been supported by the projects 'Molecular and Genetic bases of multiple resistance to Plum pox virus (PPV) and Apple chlorotic leaf spot virus (ACLSV) in apricot' (AGL2015-68021-R) from the Spanish Ministry of Economy and Competiveness and 'Breeding stone fruit species assisted by molecular tools' from the Seneca Foundation of the Region of Murcia (19879/GERM/15).	Angelova L., 2017, P SPIE 10226 19 INT; Garcia JA, 2015, CURR OPIN VIROL, V11, P21, DOI 10.1016/j.coviro.2015.01.001; Garcia JA, 2014, MOL PLANT PATHOL, V15, P226, DOI 10.1111/mpp.12083; Babu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-325; Bag S, 2015, PHYTOPATHOLOGY, V105, P840, DOI 10.1094/PHYTO-09-14-0262-R; Barba M, 2015, ADV VIRUS RES, V91, P47, DOI 10.1016/bs.aivir.2014.11.001; Barba M, 2014, VIRUSES-BASEL, V6, P106, DOI 10.3390/v6010106; Boonham N, 2014, VIRUS RES, V186, P20, DOI 10.1016/j.virusres.2013.12.007; Cambra M., 2006, Bulletin OEPP, V36, P202; Candresse T., 2015, 23 INT C VIR OTH GRA; Candresse T, 2013, PHYTOPATHOLOGY, V103, P293, DOI 10.1094/PHYTO-10-12-0275-R; Herranz MC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-164; Chirkov S, 2017, VIROLOGY, V502, P56, DOI 10.1016/j.virol.2016.12.016; Chirkov S, 2013, ARCH VIROL, V158, P1383, DOI 10.1007/s00705-013-1630-x; Clemente-Moreno MJ, 2015, J EXP BOT, V66, P25, DOI 10.1093/jxb/eru428; Cui HG, 2017, PLANT BIOTECHNOL J, V15, P344, DOI 10.1111/pbi.12629; Cui HG, 2013, MOL PLANT MICROBE IN, V26, P515, DOI 10.1094/MPMI-12-12-0282-R; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Elbeaino T, 2014, VIRUS RES, V181, P1, DOI 10.1016/j.virusres.2013.12.030; Garcia-Ibarra A, 2012, EUR J PLANT PATHOL, V133, P857, DOI 10.1007/s10658-012-0009-2; Glasa M, 2013, PHYTOPATHOLOGY, V103, P972, DOI 10.1094/PHYTO-11-12-0285-R; Hadidi A., 2011, VIRUS VIRUS LIKE DIS, P429; Hadidi A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01325; Ilardi V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00379; James D, 2014, ARCH VIROL, V159, P2463, DOI 10.1007/s00705-014-2075-6; Jung S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-76; Lenz O, 2017, ARCH VIROL, V162, P587, DOI 10.1007/s00705-016-3125-z; Lin LM, 2013, EUR J PLANT PATHOL, V137, P797, DOI 10.1007/s10658-013-0289-1; Marais A, 2016, PLANT DIS, V100, P2544, DOI 10.1094/PDIS-06-16-0915-PDN; Marais A, 2012, PLANT PATHOL, V61, P195, DOI 10.1111/j.1365-3059.2011.02488.x; Marais A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129469; Marais A, 2015, PHYTOPATHOLOGY, V105, P135, DOI 10.1094/PHYTO-04-14-0125-R; Marais A, 2014, PHYTOPATHOLOGY, V104, P660, DOI 10.1094/PHYTO-08-13-0229-R; Mariette S, 2016, NEW PHYTOL, V209, P773, DOI 10.1111/nph.13627; Martinelli F, 2015, AGRON SUSTAIN DEV, V35, P1, DOI 10.1007/s13593-014-0246-1; Martinez G, 2010, MOL PLANT PATHOL, V11, P347, DOI [10.1111/j.1364-3703.2009.00608.x, 10.1111/J.1364-3703.2009.00608.X]; Martinez-Gomez P, 2004, J AM SOC HORTIC SCI, V129, P544; Martinez-Gomez P, 2003, EUPHYTICA, V131, P313, DOI 10.1023/A:1024028518263; Martinez-Gomez P, 2011, GENETICA, V139, P755, DOI 10.1007/s10709-011-9580-2; Massart S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00045; Massart S, 2014, VIRUS RES, V188, P90, DOI 10.1016/j.virusres.2014.03.029; Matic S, 2009, VIRUS RES, V143, P61, DOI 10.1016/j.virusres.2009.03.005; Navarro B, 2012, PLANT J, V70, P991, DOI 10.1111/j.1365-313X.2012.04940.x; Osman F, 2014, J PLANT PATHOL, V96, P577; Pallas V, 2012, PHYTOPATHOLOGY, V102, P1108, DOI 10.1094/PHYTO-02-12-0023-RVW; Pallas V, 2013, ADV VIRUS RES, V87, P139, DOI 10.1016/B978-0-12-407698-3.00005-3; Peiro A, 2012, EUR J PLANT PATHOL, V132, P469, DOI 10.1007/s10658-011-9893-0; Postnikova OA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-101; Potter D, 2013, GENET GENOM BREED CR, P1; Ravelonandro M., 2011, ACTA HORTIC, V465, P185; Revers F, 2015, ADV VIRUS RES, V92, P101, DOI 10.1016/bs.aivir.2014.11.006; Rodamilans B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100477; Rubio M, 2013, ANN APPL BIOL, V163, P466, DOI 10.1111/aab.12069; Rubio M, 2011, PLANT BREEDING, V130, P283, DOI 10.1111/j.1439-0523.2010.01813.x; Rubio M, 2016, J PHYTOPATHOL, V164, P193, DOI 10.1111/jph.12407; Rubio M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144670; Rubio M, 2015, MOL PLANT PATHOL, V16, P164, DOI 10.1111/mpp.12169; Rubio M, 2012, SCI HORTIC-AMSTERDAM, V144, P81, DOI 10.1016/j.scienta.2012.06.038; Rubio M, 2010, TREE GENET GENOMES, V6, P291, DOI 10.1007/s11295-009-0249-2; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Scorza R, 2001, TRANSGENIC RES, V10, P201, DOI 10.1023/A:1016644823203; Scorza R, 2016, HORTSCIENCE, V51, P601; Shulaev V, 2008, PLANT PHYSIOL, V147, P985, DOI 10.1104/pp.107.115618; Song GQ, 2013, PLANT BIOTECHNOL J, V11, P702, DOI 10.1111/pbi.12060; Torre-Almaraz R., 2015, PLANT DIS, V99, P899; Velasco D, 2016, G3-GENES GENOM GENET, V6, P3985, DOI 10.1534/g3.116.032672; Villamor DEV, 2017, ARCH VIROL, V162, P811, DOI 10.1007/s00705-016-3141-z; Villamor DEV, 2016, PHYTOPATHOLOGY, V106, P519, DOI 10.1094/PHYTO-07-15-0168-R; Villamor DEV, 2015, PHYTOPATHOLOGY, V105, P399, DOI 10.1094/PHYTO-03-14-0066-R; Villamor DEV, 2013, PHYTOPATHOLOGY, V103, P1287, DOI 10.1094/PHYTO-05-13-0140-R; Walia Y, 2012, FOREST PATHOL, V42, P84, DOI 10.1111/j.1439-0329.2011.00723.x; Wang A, 2015, ACTA HORTIC, V1063, P77; Wang AM, 2015, ANNU REV PHYTOPATHOL, V53, P45, DOI 10.1146/annurev-phyto-080614-120001; Wang XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050627; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Yu Y, 2013, J PLANT PATHOL, V95, P603; Zhao DY, 2014, PLANT BIOTECHNOL J, V12, P1319, DOI 10.1111/pbi.12243; Zuriaga E, 2013, MOL PLANT PATHOL, V14, P663, DOI 10.1111/mpp.12037	79	0	0	14	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-4746	1744-7348		ANN APPL BIOL	Ann. Appl. Biol.	SEP	2017	171	2					125	138		10.1111/aab.12371				14	Agriculture, Multidisciplinary	Agriculture	FE0JW	WOS:000407907600001					2018-01-05	
J	Vega, JF; Ramos, J; Cruz, VL; Vicente-Alique, E; Sanchez-Sanchez, E; Sanchez-Fernandez, A; Wang, Y; Hu, P; Cortes, J; Martinez-Salazar, J				Vega, J. F.; Ramos, J.; Cruz, V. L.; Vicente-Alique, E.; Sanchez-Sanchez, E.; Sanchez-Fernandez, A.; Wang, Y.; Hu, P.; Cortes, J.; Martinez-Salazar, J.			Molecular and hydrodynamic properties of human epidermal growth factor receptor HER2 extracellular domain and its homodimer: Experiments and multi-scale simulations	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						HER2 homodimer; Hydrodynamic properties; Molecular dynamics; Hydrodynamic modeling; Conformational fluctuations	X-RAY-SCATTERING; INTRINSIC-VISCOSITY; ANALYTICAL ULTRACENTRIFUGATION; BIOLOGICAL MACROMOLECULES; TRANSPORT-PROPERTIES; ERBB2 ECTODOMAIN; ANTIBODY; CONFORMATION; COMPLEX; CRYSTALLOHYDRODYNAMICS	Background: In a broad range of human carcinomas gene amplification leads to HER2 overexpression, which has been proposed to cause spontaneous dimerization and activation in the absence of ligand. This makes HER2 attractive as a therapeutic target. However, the HER2 homodimerization mechanism remains unexplored. It has been suggested that the "back-to-back" homodimer does not form in solution. Notwithstanding, very recently the crystal structure of the HER2 extracellular domain homodimer formed with a "back-to-head" interaction has been resolved. We intend to explore the existence of such interactions. Methods: A combination of experiments, molecular dynamics and hydrodynamic modeling were used to monitor the transport properties of HER2 in solution. Results & conclusions: We have detected the HER2 extracellular domain homodimer in solution. The results show a high degree of molecular flexibility, which ultimately leads to quite higher values of the intrinsic viscosity and lower values of diffusion coefficient than those corresponding to globular proteins. This flexibility obeys to the open conformation of the receptor and to the large fluctuations of the different domains. We also report that for obtaining the correct hydrodynamic constants from the modeling one must consider the glycosylation of the systems. General significance: Conformational features of epidermal growth factor receptors regulate their hydrodynamic properties and control their activity. It is essential to understand the dynamics of these systems and the role of the specific domains involved. To find biophysical correlations between dynamics and macroscopic transport properties is of general interest for researches working in this area. This article is part of a Special Issue entitled "Biochemistry of Synthetic Biology - Recent Developments" Guest Editor: Dr. Ilka Heinemann and Dr. Patrick O'Donoghue.	[Vega, J. F.; Ramos, J.; Cruz, V. L.; Vicente-Alique, E.; Sanchez-Sanchez, E.; Sanchez-Fernandez, A.; Martinez-Salazar, J.] CSIC, IEM, Dept Macromol Phys, BIOPHYM, C Serrano 113 Bis, Madrid 28006, Spain; [Cortes, J.] Ramon & Cajal Univ Hosp, Ctra Colmenar Viejo,Km 9, Madrid 28034, Spain; [Cortes, J.] VHIO, Paseo Vail Hebron 119-129, Barcelona 08035, Spain; [Wang, Y.; Hu, P.] Sino Biol Inc, Beijing, Peoples R China	Vega, JF (reprint author), CSIC, IEM, Dept Macromol Phys, BIOPHYM, C Serrano 113 Bis, Madrid 28006, Spain.	jf.vega@csic.es	Ramos, Javier/G-3861-2011	Ramos, Javier/0000-0003-3556-7632	Spanish Ministry of Economy and Competitiveness (MINECO, Spain) [MAT2012-36341-FEDER]; CSIC (Spain) [PIE201360E097]; Ramon y Cajal program (MINECO, Spain) [RYC-2011-09585]	This research work was supported by Spanish Ministry of Economy and Competitiveness (MINECO, Spain) - Project MAT2012-36341-FEDER and by the CSIC (Spain) - Project PIE201360E097. J. Ramos acknowledges financial support through the Ramon y Cajal program (MINECO, Spain) - Contract RYC-2011-09585. We acknowledge Prof. Sergio R. Aragon (San Francisco State University, USA) for kindly providing us the BEST software to compute the transport properties of biomacromolecules. We also acknowledge Maurizio Scaltriti (Memorial Sloan Kettering Cancer Center, New York, USA) for helpful discussions.	Abdel-Azeim S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S5-S1; AHMAD F, 1980, INT J BIOCHEM, V11, P91, DOI 10.1016/0020-711X(80)90240-2; Amoros D, 2010, EUR BIOPHYS J BIOPHY, V39, P361, DOI 10.1007/s00249-008-0388-7; Aragon S, 2004, J COMPUT CHEM, V25, P1191, DOI 10.1002/jcc.20045; Aragon SR, 2011, METHODS, V54, P101, DOI 10.1016/j.ymeth.2010.10.005; Aragon S.R., 2016, ANAL ULTRACENTRIFUGA, P219; Arkhipov A, 2013, ELIFE, V2, DOI 10.7554/eLife.00708; Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Badache A, 2004, CANCER CELL, V5, P299, DOI 10.1016/S1535-6108(04)00088-1; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118                                                                ; Berne B.J., 2000, DYNAMIC LIGHT SCATTE; Boehm MK, 1999, J MOL BIOL, V286, P1421, DOI 10.1006/jmbi.1998.2556; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Brandt JP, 2010, BIOPHYS J, V99, P905, DOI 10.1016/j.bpj.2010.05.003; Brennan PJ, 2000, ONCOGENE, V19, P6093, DOI 10.1038/sj.onc.1203967; Brookes E, 2010, MACROMOL BIOSCI, V10, P746, DOI 10.1002/mabi.200900474; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2                                                   ; Case V.B.D.A., 2014, AMBER 14; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; CONNOLLY ML, 1993, J MOL GRAPHICS, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Garcia de la Torre J., 2013, BIOPHYS REV, V5, P195; Eigenbrot C, 2010, P NATL ACAD SCI USA, V107, P15039, DOI 10.1073/pnas.1005025107; Franco-Gonzalez JF, 2013, J MOL MODEL, V19, P1227, DOI 10.1007/s00894-012-1661-3; Franco-Gonzalez JF, 2013, J MOL MODEL, V19, P931, DOI 10.1007/s00894-012-1613-y; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2                                                   ; Furtado PB, 2004, J MOL BIOL, V338, P921, DOI 10.1016/j.jmb.2004.03.007; de la Torre JG, 2010, MACROMOL BIOSCI, V10, P721, DOI 10.1002/mabi.200900464; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; HAGERMAN PJ, 1981, BIOPOLYMERS, V20, P1481, DOI 10.1002/bip.1981.360200709; Hahn DK, 2006, J CHEM THEORY COMPUT, V2, P1416, DOI 10.1021/ct600062y; Harding SE, 1997, PROG BIOPHYS MOL BIO, V68, P207, DOI 10.1016/S0079-6107(97)00027-8                                                   ; Hu S, 2015, ONCOTARGET, V6, P1695, DOI 10.18632/oncotarget.2713                                                        ; INIESTA A, 1988, BIOPHYS J, V54, P269, DOI 10.1016/S0006-3495(88)82956-4                                                   ; Irani M.A., 2017, PROTEINS; Karunagaran D, 1996, EMBO J, V15, P254; Klapper LN, 1999, P NATL ACAD SCI USA, V96, P4995, DOI 10.1073/pnas.96.9.4995; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Lobner E, 2017, STRUCTURE, V25, P878, DOI 10.1016/j.str.2017.04.014; Longman E, 2003, EUR BIOPHYS J BIOPHY, V32, P503, DOI 10.1007/s00249-002-0314-y; Lu YL, 2007, BIOPHYS J, V93, P3733, DOI 10.1529/biophysj.107.108993; Lu YL, 2006, BIOPHYS J, V91, P1688, DOI 10.1529/biophysj.106.083469; Mie G, 1908, ANN PHYS-BERLIN, V25, P377; Ortega A, 2007, BIOMACROMOLECULES, V8, P2464, DOI 10.1021/bm700473f; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Rocco M., 2014, FUTURE DYNAMIC STRUC, P189; Silverman BD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-77; Silverman BD, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-20; Smith KD, 1996, GROWTH FACTORS, V13, P121, DOI 10.3109/08977199609034572                                                       ; Stetefeld Jorg, 2016, Biophys Rev, V8, P409, DOI 10.1007/s12551-016-0218-6; Sun Z, 2005, J MOL BIOL, V353, P155, DOI 10.1016/j.jmb.2005.07.072; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Watanabe M, 2013, ANAL BIOANAL CHEM, V405, P4289, DOI 10.1007/s00216-013-6771-y; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; Zhen YJ, 2003, BIOCHEMISTRY-US, V42, P5478, DOI 10.1021/bi027101p	58	0	0	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	SEP	2017	1861	9					2406	2416		10.1016/j.bbagen.2017.06.012				11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FE2UH	WOS:000408071800025	28642126				2018-01-05	
J	Mete, O; Lopes, MB				Mete, Ozgur; Lopes, M. Beatriz			Overview of the 2017 WHO Classification of Pituitary Tumors	ENDOCRINE PATHOLOGY			English	Review						Pituitary adenoma; Pituitary neuroendocrine tumor; Null cell adenoma; Silent subtype III adenoma; Immunohistochemistry; Pituicytoma	ENDOCRINE NEOPLASIA TYPE-1; MCCUNE-ALBRIGHT SYNDROME; SILENT CORTICOTROPH ADENOMAS; P53 GENE-MUTATIONS; OF-THE-LITERATURE; CUSHINGS-SYNDROME; CLINICOPATHOLOGICAL ANALYSIS; STEREOTACTIC RADIOSURGERY; THERAPEUTIC IMPLICATIONS; CLINICAL CHARACTERISTICS	This review focuses on discussing the main changes on the upcoming fourth edition of the WHO Classification of Tumors of the Pituitary Gland emphasizing histopathological and molecular genetics aspects of pituitary neuroendocrine (i.e., pituitary adenomas) and some of the non-neuroendocrine tumors involving the pituitary gland. Instead of a formal review, we introduced the highlights of the new WHO classification by answering select questions relevant to practising pathologists. The revised classification of pituitary adenomas, in addition to hormone immunohistochemistry, recognizes the role of other immunohistochemical markers including but not limited to pituitary transcription factors. Recognizing this novel approach, the fourth edition of the WHO classification has abandoned the concept of "a hormone-producing pituitary adenoma" and adopted a pituitary adenohypophyseal cell lineage designation of the adenomas with subsequent categorization of histological variants according to hormone content and specific histological and immunohistochemical features. This new classification does not require a routine ultrastructural examination of these tumors. The new definition of the Null cell adenoma requires the demonstration of immunonegativity for pituitary transcription factors and adenohypophyseal hormones Moreover, the term of atypical pituitary adenoma is no longer recommended. In addition to the accurate tumor subtyping, assessment of the tumor proliferative potential by mitotic count and Ki-67 index, and other clinical parameters such as tumor invasion, is strongly recommended in individual cases for consideration of clinically aggressive adenomas. This classification also recognizes some subtypes of pituitary neuroendocrine tumors as "high-risk pituitary adenomas" due to the clinical aggressive behavior; these include the sparsely granulated somatotroph adenoma, the lactotroph adenoma in men, the Crooke's cell adenoma, the silent corticotroph adenoma, and the newly introduced plurihormonal Pit-1-positive adenoma (previously known as silent subtype III pituitary adenoma). An additional novel aspect of the new WHO classification was also the definition of the spectrum of thyroid transcription factor-1 expressing pituitary tumors of the posterior lobe as representing a morphological spectrum of a single nosological entity. These tumors include the pituicytoma, the spindle cell oncocytoma, the granular cell tumor of the neurohypophysis, and the sellar ependymoma.	[Mete, Ozgur] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mete, Ozgur] Univ Hlth Network, Dept Pathol, 200 Elizabeth St,11th Floor, Toronto, ON M5G 2C4, Canada; [Mete, Ozgur] Princess Margaret Canc Ctr, Endocrine Oncol Site Grp, Toronto, ON, Canada; [Lopes, M. Beatriz] Univ Virginia Hlth Syst, Dept Pathol & Neurol Surg, Charlottesville, VA USA	Mete, O (reprint author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Mete, O (reprint author), Univ Hlth Network, Dept Pathol, 200 Elizabeth St,11th Floor, Toronto, ON M5G 2C4, Canada.; Mete, O (reprint author), Princess Margaret Canc Ctr, Endocrine Oncol Site Grp, Toronto, ON, Canada.	ozgur.mete2@uhn.ca		Mete, Ozgur/0000-0003-0469-2801			Al-Dahmani K, 2016, CAN J NEUROL SCI, V43, P291, DOI 10.1017/cjn.2015.301; Alahmadi H, 2012, ACTA NEUROCHIR, V154, P1493, DOI 10.1007/s00701-012-1378-1; Alband N, 2014, HAND CLINIC, V124, P339, DOI 10.1016/B978-0-444-59602-4.00023-X; Annamalai AK, 2012, PITUITARY, V15, P276, DOI 10.1007/s11102-011-0363-7; Asa SL, 2017, ENDOCR-RELAT CANCER, V24, pC5, DOI 10.1530/ERC-17-0004; ASA SL, 1993, J CLIN ENDOCR METAB, V77, P1275, DOI 10.1210/jc.77.5.1275; Asa SL, 1996, J CLIN ENDOCR METAB, V81, P2165, DOI 10.1210/jc.81.6.2165; Asa SL, 2017, HISTOPATHOL IN PRESS; Asa SL, 2011, TUMORS PITUITARY G 4; Asa SL, 2017, ENDOCR-RELAT CANCER, V24; Asa SL, 2009, ANNU REV PATHOL-MECH, V4, P97, DOI 10.1146/annurev.pathol.4.110807.092259; Balogun JA, 2015, ENDOCR PATHOL, V26, P63, DOI 10.1007/s12022-014-9347-2; Bayraktar F, 2006, EXP CLIN ENDOCR DIAB, V114, P444, DOI 10.1055/s-2006-924154; Beckers A, 2015, ENDOCR-RELAT CANCER, V22, P353, DOI 10.1530/ERC-15-0038; Boari N, 2016, ACTA NEUROCHIR WIEN, V148, P1311; Boari N, 2016, ACTA NEUROCHIR WIEN, V148, P1314; Carroll PV, 2016, ENDOTEXT; Chatzellis E, 2015, NEUROENDOCRINOLOGY, V101, P87, DOI 10.1159/000371806; Chiloiro S, 2015, NEUROENDOCRINOLOGY, V101, P143, DOI 10.1159/000375448; Colao A, 2010, FRONT HORM RES, V38, P94, DOI 10.1159/000318499; Cooper O, 2015, PITUITARY, V18, P225, DOI 10.1007/s11102-014-0624-3; Covington MF, 2011, AM J NEURORADIOL, V32, P2067, DOI 10.3174/ajnr.A2717; Cuny T, 2013, EUR J ENDOCRINOL, V168, P533, DOI 10.1530/EJE-12-0763; Dahia PLM, 1998, ONCOGENE, V16, P69, DOI 10.1038/sj.onc.1201516                                                          ; Daly, 2009, HORM RES, V71, P297, DOI 10.1159/000210885; Daly AF, 2006, J CLIN ENDOCR METAB, V91, P4769, DOI 10.1210/jc.2006-1668; Daly AF, 2009, HORM RES, V71, P105, DOI 10.1159/000178050; De Caro MD, 2017, NEUROSURG REV, V40, P105, DOI 10.1007/s10143-016-0740-9; de Kock L, 2014, ACTA NEUROPATHOL, V128, P111, DOI 10.1007/s00401-014-1285-z; De Lellis RA, 2004, WHO CLASSIFICATION T, P9; Denes J, 2015, J CLIN ENDOCR METAB, V100, pE531, DOI 10.1210/jc.2014-3399; Domingue ME, 2015, PITUITARY, V18, P738, DOI 10.1007/s11102-014-0595-4; Duan K, 2017, AJSP REV RE IN PRESS; Duan K, 2016, CANCER CYTOPATHOL, V124, P871, DOI 10.1002/cncy.21765; Dupuy M, 2012, ANN ENDOCRINOL-PARIS, V73, P216, DOI 10.1016/j.ando.2012.02.001; Erickson D, 2009, CLIN ENDOCRINOL, V71, P92, DOI 10.1111/j.1365-2265.2008.03514.x; Fan SY, 2013, CLIN NEUROL NEUROSUR, V115, P2543, DOI 10.1016/j.clineuro.2013.09.040; Fealey ME, 2010, ENDOCR PATHOL, V21, P161, DOI 10.1007/s12022-010-9120-0; Fountas A, 2015, ENDOCR PATHOL, V26, P239, DOI 10.1007/s12022-015-9384-5; FRIEND KE, 1993, J CLIN ENDOCR METAB, V77, P1281, DOI 10.1210/jc.77.5.1281; Gomez-Hernandez Karen, 2015, Turk Patoloji Derg, V31 Suppl 1, P4, DOI 10.5146/tjpath.2015.01311; Hayashi K, 2016, EUR J ENDOCRINOL, V174, P213, DOI 10.1530/EJE-15-0689; Hayashi T, 2014, DIAGN HISTOPATHOL, V20, P316; Heck A, 2012, CLIN ENDOCRINOL, V77, P72, DOI 10.1111/j.1365-2265.2011.04286.x; Hernandez-Ramirez LC, 2015, J CLIN ENDOCR METAB, V100, pE1242, DOI 10.1210/jc.2015-1869; HORVATH E, 1980, AM J PATHOL, V98, P617; HORVATH E, 1981, CANCER, V47, P761, DOI 10.1002/1097-0142(19810215)47:4<761::AID-CNCR2820470422>3.0.CO;2-L; Horvath E, 2005, ULTRASTRUCT PATHOL, V29, P511, DOI 10.1080/01913120500323514; HORVATH E, 1988, J CLIN ENDOCR METAB, V66, P1111, DOI 10.1210/jcem-66-6-1111                                                          ; Howlett TA, 2013, CLIN ENDOCRINOL, V79, P689, DOI 10.1111/cen.12207; Iacovazzo D, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0328-1; Kamil ZS, 2014, ENDOCR PATHOL, V25, P436, DOI 10.1007/s12022-013-9279-2; Komatsubara K, 2001, ENDOCR PATHOL, V12, P181, DOI 10.1385/EP:12:2:181                                                             ; KOVACS K, 1980, J GERONTOL, V35, P16, DOI 10.1093/geronj/35.1.16                                                          ; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Lania A, 2003, EXP BIOL MED, V228, P1004; Lee CC, 2015, PITUITARY, V18, P326, DOI 10.1007/s11102-014-0578-5; Lee EB, 2009, J NEUROPATH EXP NEUR, V68, P482, DOI 10.1097/NEN.0b013e3181a13fca; LEVY A, 1994, CLIN ENDOCRINOL, V41, P809, DOI 10.1111/j.1365-2265.1994.tb02797.x; Lim JS, 2010, ENDOCRINE, V38, P1, DOI 10.1007/s12020-010-9341-5; Liu W, 2002, BRAIN PATHOL, V12, P412; Lloyd RV, 1997, MICROSC RES TECHNIQ, V39, P168, DOI 10.1002/(SICI)1097-0029(19971015)39:2<168::AID-JEMT8>3.0.CO;2-H; Lodish MB, 2016, CURR OPIN ENDOCRINOL, V23, P72, DOI 10.1097/MED.0000000000000212; Lopes M Beatriz S, 2005, Endocrine, V28, P115, DOI 10.1385/ENDO:28:1:115; Louis DN, 2016, WHO CLASSIFICATION T; Ma ZY, 2015, CELL RES, V25, P306, DOI 10.1038/cr.2015.20; Mete O, 2016, MODERN PATHOL, V29, P131, DOI 10.1038/modpathol.2015.151; Mete O, 2013, SEMIN DIAGN PATHOL, V30, P158, DOI 10.1053/j.semdp.2013.06.002; Mete O, 2013, AM J SURG PATHOL, V37, P1694, DOI 10.1097/PAS.0b013e31829723e7; Mete O, 2013, PATHOLOGY, V45, P316, DOI 10.1097/PAT.0b013e32835f45c5; Mete O, 2012, J MOL ENDOCRINOL, V49, pR69, DOI 10.1530/JME-12-0113; Mete O, 2012, BRAIN PATHOL, V22, P443, DOI 10.1111/j.1750-3639.2012.00599.x; Miermeister CP, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0229-8; Nishioka H, 2015, ENDOCR PATHOL, V26, P349, DOI 10.1007/s12022-015-9398-z; Obari A, 2008, ENDOCR PATHOL, V19, P82, DOI 10.1007/s12022-008-9029-z; OBRIEN T, 1992, CLIN ENDOCRINOL, V37, P460, DOI 10.1111/j.1365-2265.1992.tb02359.x; Peng P, 2015, BIOMED REP, V3, P301, DOI 10.3892/br.2015.430; Perez-Rivas LG, 2015, J CLIN ENDOCR METAB, V100, pE997, DOI 10.1210/jc.2015-1453; Pernicone PJ, 1997, CANCER, V79, P804, DOI 10.1002/(SICI)1097-0142(19970215)79:4<804::AID-CNCR18>3.0.CO;2-3; Potorac I, 2015, ENDOCR-RELAT CANCER, V22, P169, DOI 10.1530/ERC-14-0305; Preda V, 2014, EUR J ENDOCRINOL, V171, P659, DOI 10.1530/EJE-14-0426; PUCHNER MJA, 1995, EXP CLIN ENDOCR DIAB, V103, P129, DOI 10.1055/s-0029-1211342                                                          ; Ragel Brian T, 2004, Neurosurg Focus, V16, pE7; Raverot G, 2015, ENDOCRIN METAB CLIN, V44, P11, DOI 10.1016/j.ecl.2014.10.001; Reincke M, 2015, NAT GENET, V47, P31, DOI 10.1038/ng.3166; Rostomyan L, 2015, ENDOCR-RELAT CANCER, V22, P745, DOI 10.1530/ERC-15-0320; Sahakitrungruang T, 2014, J CLIN ENDOCR METAB, V99, pE1487, DOI 10.1210/jc.2014-1016; Salehi F, 2010, ENDOCR PATHOL, V21, P227, DOI 10.1007/s12022-010-9138-3; Salenave S, 2014, J CLIN ENDOCR METAB, V99, P1955, DOI 10.1210/jc.2013-3826; Salpea P, 2014, MOL CELL ENDOCRINOL, V386, P85, DOI 10.1016/j.mce.2013.08.022; Schalin-Jantti C, 2013, ENDOCR PATHOL, V24, P25, DOI 10.1007/s12022-012-9228-5; Scheithauer BW, 2008, ACTA NEUROPATHOL, V116, P657, DOI 10.1007/s00401-008-0388-9; Scheithauer BW, 2012, PITUITARY, V15, P365, DOI 10.1007/s11102-011-0328-x; Scheithauer BW, 2000, NEUROSURGERY, V47, P723, DOI 10.1097/00006123-200009000-00039                                                ; Seltzer J, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2014.10.FOCUS14683; Stratakis CA, 2010, CLIN GENET, V78, P457, DOI 10.1111/j.1399-0004.2010.01406.x; Suhardja A, 2001, J NEURO-ONCOL, V52, P195, DOI 10.1023/A:1010655419332                                                         ; TAKEI Y, 1980, CELL TISSUE RES, V205, P273; Tani Y, 2011, ENDOCR J, V58, P297, DOI 10.1507/endocrj.K10E-389; Tanizaki Y, 2007, ENDOCR PATHOL, V18, P217, DOI 10.1007/s12022-007-9006-y; Thakker RV, 2014, MOL CELL ENDOCRINOL, V386, P2, DOI 10.1016/j.mce.2013.08.002; Tjornstrand A, 2014, EUR J ENDOCRINOL, V171, P519, DOI 10.1530/EJE-14-0144; Toledo RA, 2017, NAT REV ENDOCRINOL, V13, P233, DOI 10.1038/nrendo.2016.185; Trivellin G, 2014, NEW ENGL J MED, V371, P2363, DOI 10.1056/NEJMoa1408028; Trouillas J, 2008, AM J SURG PATHOL, V32, P534, DOI 10.1097/PAS.0b013e31815ade45; Vasiljevic A, 2016, MINERVA ENDOCRINOL, V41, P377; Verges B, 2002, J CLIN ENDOCR METAB, V87, P457, DOI 10.1210/jc.87.2.457; Verloes A, 1999, Pituitary, V1, P273, DOI 10.1023/A:1009958510378; Villa C, 2011, ENDOCR-RELAT CANCER, V18, P347, DOI 10.1530/ERC-11-0059; Vortmeyer AO, 2012, J CLIN ENDOCR METAB, V97, P2404, DOI 10.1210/jc.2012-1274; Wang EL, 2009, ENDOCR PATHOL, V20, P209, DOI 10.1007/s12022-009-9094-y; Winters SJ, 2015, AM J MED SCI, V349, P526, DOI 10.1097/MAJ.0000000000000305; Xekouki P, 2012, ENDOCR-RELAT CANCER, V19, pC33, DOI 10.1530/ERC-12-0118; Xu ZY, 2014, INT J RADIAT ONCOL, V90, P903, DOI 10.1016/j.ijrobp.2014.07.013; Yamada S, 2007, NEUROSURGERY, V61, P580, DOI 10.1227/01.NEU.0000280049.93275.3C; Yildirim AE, 2013, TURK NEUROSURG, V23, P226, DOI 10.5137/1019-5149.JTN.6828-12.1; Young WF, 1996, MAYO CLIN PROC, V71, P649; Yu R, 2001, BRAIN PATHOL, V11, P328; Zada G, 2011, J NEUROSURG, V114, P336, DOI 10.3171/2010.8.JNS10290; Zaidi HA, 2016, J CLIN NEUROSCI, V34, P246, DOI 10.1016/j.jocn.2016.09.014	120	2	2	3	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1046-3976	1559-0097		ENDOCR PATHOL	Endocr. Pathol.	SEP	2017	28	3					228	243		10.1007/s12022-017-9498-z				16	Endocrinology & Metabolism; Pathology	Endocrinology & Metabolism; Pathology	FD3UX	WOS:000407459000005	28766057				2018-01-05	
J	Keegan, L; Khan, A; Vukic, D; O'Connell, M				Keegan, Liam; Khan, Anzer; Vukic, Dragana; O'Connell, Mary			ADAR RNA editing below the backbone	RNA			English	Review						ADAR; Drosophila melanogaster; RNA editing; dsRNA; RNA modification; epitranscriptome	DOUBLE-STRANDED-RNA; ADENOSINE-DEAMINASE; DROSOPHILA-MELANOGASTER; ENZYME ADAR1; UNWINDING ACTIVITY; SEX DETERMINATION; BINDING DOMAINS; GENE FAMILY; PROTEIN; EVOLUTION	ADAR RNA editing enzymes (adenosine deaminases acting on RNA) that convert adenosine bases to inosines were first identified biochemically 30 years ago. Since then, studies on ADARs in genetic model organisms, and evolutionary comparisons between them, continue to reveal a surprising range of pleiotropic biological effects of ADARs. This review focuses on Drosophila melanogaster, which has a single Adar gene encoding a homolog of vertebrate ADAR2 that site-specifically edits hundreds of transcripts to change individual codons in ion channel subunits and membrane and cytoskeletal proteins. Drosophila ADAR is involved in the control of neuronal excitability and neurodegeneration and, intriguingly, in the control of neuronal plasticity and sleep. Drosophila ADAR also interacts strongly with RNA interference, a key antiviral defense mechanism in invertebrates. Recent crystal structures of human ADAR2 deaminase domain-RNA complexes help to interpret available information on Drosophila ADAR isoforms and on the evolution of ADARs from tRNA deaminase ADAT proteins. ADAR RNA editing is a paradigm for the now rapidly expanding range of RNA modifications in mRNAs and ncRNAs. Even with recent progress, much remains to be understood about these groundbreaking ADAR RNA modification systems.	[Keegan, Liam; Khan, Anzer; Vukic, Dragana; O'Connell, Mary] Masaryk Univ Brno, CEITEC, Pavilion A35, CZ-62500 Brno, Czech Republic	Keegan, L (reprint author), Masaryk Univ Brno, CEITEC, Pavilion A35, CZ-62500 Brno, Czech Republic.	Liam.Keegan@ceitec.muni.cz	OConnell, Mary Anne/G-4740-2015; Keegan, Liam/F-1106-2017	OConnell, Mary Anne/0000-0003-3844-6174; Keegan, Liam/0000-0001-7915-5790	European Union's Seventh Framework Programme for Research, Technological Development and Demonstration [621368]	This project has received funding from the European Union's Seventh Framework Programme for Research, Technological Development and Demonstration under grant agreement no. 621368.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bhogal B, 2011, NAT NEUROSCI, V14, P1517, DOI 10.1038/nn.2950; Carpenter JA, 2007, MOL ECOL, V16, P3947, DOI 10.1111/j.1365-294X.2007.03460.x; Carpenter JA, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-75; Catanese DJ, 2011, BIOCHEM BIOPH RES CO, V414, P506, DOI 10.1016/j.bbrc.2011.09.096; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170                                                       ; Connolly CM, 2005, DEV BIOL, V278, P13, DOI 10.1016/j.ydbio.2004.10.009; DeSousa D, 2003, J BIOL CHEM, V278, P38040, DOI 10.1074/jbc.M303512200; Diegelmann S, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-76; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Eifler T, 2013, BIOCHEMISTRY-US, V52, P7857, DOI 10.1021/bi4006539; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Galeano F, 2012, SEMIN CELL DEV BIOL, V23, P244, DOI 10.1016/j.semcdb.2011.09.003; Gallo A, 2012, BIOL REV, V87, P95, DOI 10.1111/j.1469-185X.2011.00186.x; Garrett S, 2012, SCIENCE, V335, P848, DOI 10.1126/science.1212795; Gerber AP, 2001, TRENDS BIOCHEM SCI, V26, P376, DOI 10.1016/S0968-0004(01)01827-8; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grice LF, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0279-3; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Haussmann IU, 2016, NATURE, V540, P301, DOI 10.1038/nature20577; Heale BSE, 2009, EMBO J, V28, P3145, DOI [10.1038/sj.emboj.2009.244, 10.1038/emboj.2009.244]; Hideyama T, 2010, J NEUROSCI, V30, P11917, DOI 10.1523/JNEUROSCI.2021-10.2010; Higuchi M, 2000, NATURE, V406, P78; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Hogg M, 2011, ADV GENET, V73, P87, DOI 10.1016/B978-0-12-380860-8.00003-3; Irvine RF, 2005, J PHYSIOL-LONDON, V566, P295, DOI 10.1113/jphysiol.2005.087387; Jepson JEC, 2011, J BIOL CHEM, V286, P8325, DOI 10.1074/jbc.M110.186817; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Keegan LP, 2011, NUCLEIC ACIDS RES, V39, P7249, DOI 10.1093/nar/gkr423; Keegan LP, 2005, EMBO J, V24, P2183, DOI 10.1038/sj.emboj.7600691; Keegan LP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-209; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584                                                                ; Kohn AB, 2015, INTEGR COMP BIOL, V55, P1111, DOI 10.1093/icb/icv065; Lence T, 2016, NATURE, V540, P242, DOI 10.1038/nature20568; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li XH, 2014, NUCLEIC ACIDS RES, V42, P1139, DOI 10.1093/nar/gkt909; Liscovitch-Brauer N, 2017, CELL, V169, P191, DOI 10.1016/j.cell.2017.03.025; Liu Y, 1996, J VIROL, V70, P1961; Liu Y, 2000, P NATL ACAD SCI USA, V97, P12541, DOI 10.1073/pnas.97.23.12541; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Maldonado C, 2013, MOL CELL NEUROSCI, V52, P173, DOI 10.1016/j.mcn.2012.10.009; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Marlow H, 2014, CURR BIOL, V24, pR757, DOI 10.1016/j.cub.2014.06.057; Matthews MM, 2016, NAT STRUCT MOL BIOL, V23, P426, DOI 10.1038/nsmb.3203; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795                                                        ; O'Connell MA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005687; OCONNELL MA, 1995, MOL CELL BIOL, V15, P1389; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Palladino MJ, 2000, RNA, V6, P1004, DOI 10.1017/S1355838200000248; Pan BC, 1998, NUCLEIC ACIDS RES, V26, P5699, DOI 10.1093/nar/26.24.5699                                                          ; Paz-Yaacov N., 2015, RNA, V13, P267; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reenan RA, 2000, NEURON, V25, P139, DOI 10.1016/S0896-6273(00)80878-8; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Robinson JE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10512; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Savva YA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3745; Savva YA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1789; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; Scadden ADJ, 2001, EMBO REP, V2, P1107, DOI 10.1093/embo-reports/kve244; Serra MJ, 2004, NUCLEIC ACIDS RES, V32, P1824, DOI 10.1093/nar/gkh501; Stefl R, 2010, CELL, V143, P225, DOI 10.1016/j.cell.2010.09.026; Thomas JM, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600187; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Wang CF, 2016, RNA BIOL, V13, P940, DOI 10.1080/15476286.2016.1215796; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765                                                   ; Watson PJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11262; Wong SK, 2001, RNA, V7, P846, DOI 10.1017/S135583820101007X                                                       ; Wood JG, 2016, P NATL ACAD SCI USA, V113, P11277, DOI 10.1073/pnas.1604621113; Wood Jason G., 2013, Frontiers in Genetics, V4, P274, DOI 10.3389/fgene.2013.00274; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zhang Q, 2015, BIOCHEM BIOPH RES CO, V460, P222, DOI 10.1016/j.bbrc.2015.03.013	80	1	1	7	7	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1355-8382	1469-9001		RNA	RNA	SEP	2017	23	9					1317	1328		10.1261/rna.060921				12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FD9NW	WOS:000407850200001	28559490				2018-01-05	
J	Pegoraro, G; Misteli, T				Pegoraro, Gianluca; Misteli, Tom			High-Throughput Imaging for the Discovery of Cellular Mechanisms of Disease	TRENDS IN GENETICS			English	Review							HUTCHINSON-GILFORD-PROGERIA; PLURIPOTENT STEM-CELLS; GENOME-WIDE RNAI; GENETIC SCREENS; IN-VITRO; AUTOMATED MICROSCOPY; CRISPR-CAS9 SYSTEM; SMALL MOLECULES; DRUG DISCOVERY; INFECTION	High-throughput imaging (HTI) is a powerful tool in the discovery of cellular disease mechanisms. While traditional approaches to identify disease pathways often rely on knowledge of the causative genetic defect, HTI-based screens offer an unbiased discovery approach based on any morphological or functional defects of disease cells or tissues. In this review, we provide an overview of the use of HTI for the study of human disease mechanisms. We discuss key technical aspects of HTI and highlight representative examples of its practical applications forthe discovery of molecular mechanisms of disease, focusing on infectious diseases and host pathogen interactions, cancer, and rare genetic diseases. We also present some of the current challenges and possible solutions offered by novel cell culture systems and genome engineering approaches.	[Pegoraro, Gianluca] NCI, High Throughput Imaging Facil, Bethesda, MD 20892 USA; [Pegoraro, Gianluca; Misteli, Tom] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Pegoraro, G (reprint author), NCI, High Throughput Imaging Facil, Bethesda, MD 20892 USA.; Pegoraro, G; Misteli, T (reprint author), NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	pegorarog@mail.nih.gov; mistelit@mail.nih.gov			Intramural Research Program of the National Institutes of Health (NIH); National Cancer Institute; Center for Cancer Research	The NCI High-Throughput Imaging Facility (HiTIF) and the Misteli lab are supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, the Center for Cancer Research. We thank Prabhakar Gudla (HiTIF) for assistance with Figure 1.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27; Bickle M, 2010, ANAL BIOANAL CHEM, V398, P219, DOI 10.1007/s00216-010-3788-3; Blondel S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.374; Boutros M, 2015, CELL, V163, P1314, DOI 10.1016/j.cell.2015.11.007; Bray MA, 2016, NAT PROTOC, V11, P1757, DOI 10.1038/nprot.2016.105; Breinig M, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156400; Brodin P, 2011, CURR OPIN CHEM BIOL, V15, P534, DOI 10.1016/j.cbpa.2011.05.023; Burkhardt MF, 2013, MOL CELL NEUROSCI, V56, P355, DOI 10.1016/j.mcn.2013.07.007; Burman B, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0718-x; Burman B, 2015, GENE DEV, V29, P1393, DOI 10.1101/gad.262170.115; Caicedo JC, 2016, CURR OPIN BIOTECH, V39, P134, DOI 10.1016/j.copbio.2016.04.003; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Conrad C, 2010, J CELL BIOL, V188, P453, DOI 10.1083/jcb.200910105; Cuylen S, 2016, NATURE, V535, P308, DOI 10.1038/nature18610; Danovi D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077053; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; Gibson CC, 2015, CIRCULATION, V131, P289, DOI 10.1161/CIRCULATIONAHA.114.010403; Gordon LB, 2012, P NATL ACAD SCI USA, V109, P16666, DOI 10.1073/pnas.1202529109; Green VA, 2016, CELL HOST MICROBE, V20, P107, DOI 10.1016/j.chom.2016.06.005; Gustafsdottir SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080999; Haggarty SJ, 2000, CHEM BIOL, V7, P275, DOI 10.1016/S1074-5521(00)00101-0; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Hoing S, 2012, CELL STEM CELL, V11, P620, DOI 10.1016/j.stem.2012.07.005; Horvath P, 2016, NAT REV DRUG DISCOV, V15, P751, DOI 10.1038/nrd.2016.175; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kamiyama D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11046; Kaufmann M, 2015, J BIOMOL SCREEN, V20, P1101, DOI 10.1177/1087057115588287; Kubben N, 2016, CELL, V165, P1361, DOI 10.1016/j.cell.2016.05.017; Kubben N, 2016, METHODS, V96, P46, DOI 10.1016/j.ymeth.2015.08.024; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Leonetti MD, 2016, P NATL ACAD SCI USA, V113, pE3501, DOI 10.1073/pnas.1606731113; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Ljosa V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000603; Lo Cicero A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34798; Lo SC, 2006, MOL CELL BIOL, V26, P1235, DOI 10.1128/MCB.26.4.1235-1244.2006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; McKnight NC, 2012, EMBO J, V31, P1931, DOI 10.1038/emboj.2012.36; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; O'Connell BC, 2010, MOL CELL, V40, P645, DOI 10.1016/j.molcel.2010.10.022; Oppermann S, 2016, BLOOD, V128, P934, DOI 10.1182/blood-2015-12-687814; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Pegoraro G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031684; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Ramage H, 2015, ANNU REV VIROL, V2, P497, DOI 10.1146/annurev-virology-100114-055238; Ranga A, 2014, ADV DRUG DELIVER REV, V69, P19, DOI 10.1016/j.addr.2014.02.006; Reisen F, 2015, ASSAY DRUG DEV TECHN, V13, P415, DOI 10.1089/adt.2015.656; Roberts B, 2017, BIORXIV; Rohban MH, 2017, ELIFE, V6, DOI 10.7554/eLife.24060; Roukos V, 2014, HISTOCHEM CELL BIOL, V142, P125, DOI 10.1007/s00418-014-1239-5; Roukos V, 2013, SCIENCE, V341, P660, DOI 10.1126/science.1237150; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Shachar S, 2015, CELL, V162, P911, DOI 10.1016/j.cell.2015.07.035; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Singh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131370; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Sundaramurthy V, 2013, CELL HOST MICROBE, V13, P129, DOI 10.1016/j.chom.2013.01.008; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Tan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168968; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Verissimo CS, 2016, ELIFE, V5, DOI 10.7554/eLife.18489; Veschi V, 2017, CANCER CELL, V31, P50, DOI 10.1016/j.ccell.2016.12.002; Wade M, 2015, J BIOMOL SCREEN, V20, P1027, DOI 10.1177/1087057115587916; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wawer MJ, 2014, P NATL ACAD SCI USA, V111, P10911, DOI [10.1073/pnas.1410933111/-/DCSupplemental, 10.1073/pnas.1410933111]; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114	85	0	0	11	11	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0168-9525	1362-4555		TRENDS GENET	Trends Genet.	SEP	2017	33	9					604	615		10.1016/j.tig.2017.06.005				12	Genetics & Heredity	Genetics & Heredity	FE0AQ	WOS:000407883600005	28732598				2018-01-05	
J	Shi, XW; Hanson, MR; Bentolila, S				Shi, Xiaowen; Hanson, Maureen R.; Bentolila, Stephane			Functional diversity of Arabidopsis organelle-localized RNA-recognition motif-containing proteins	WILEY INTERDISCIPLINARY REVIEWS-RNA			English	Review							PENTATRICOPEPTIDE REPEAT PROTEINS; CHLOROPLAST MESSENGER-RNAS; ABIOTIC STRESS CONDITIONS; COLD ADAPTATION PROCESS; BINDING PROTEINS; PLANT DEVELOPMENT; CHAPERONE ACTIVITY; THALIANA; GENE; DOMAIN	RNA-Binding Proteins (RBPs) play key roles in plant gene expression and regulation. RBPs contain a variety of RNA-binding motifs, the most abundant and most widespread one in eukaryotes is the RNA recognition motif (RRM). Many nucleus-encoded RRM-containing proteins are transported into chloroplasts and/or mitochondria, and participate in various RNA-related processes in plant organelles. Loss of these proteins can have a detrimental effect on some critical processes such as photosynthesis and respiration, sometimes leading to lethality. Progress has been made in the last few years in understanding the function of particular organelle-localized RRM-containing proteins. Members of the Organelle RRM protein (ORRM, some also characterized as Glycine-Rich RNA-Binding Proteins) family and the Chloroplast RiboNucleoProtein (cpRNP) family, are involved in various types of RNA metabolism, including RNA editing, RNA stability and RNA processing. Organelle-localized RRM proteins also function in plant development and stress responses, in some conditions acting as protein or RNA chaperones. There has been recent progress in characterizing the function of organelle-localized RRM proteins in RNA-related processes and how RRM proteins contribute to the normal growth and development of plants. (C) 2017 Wiley Periodicals, Inc.	[Shi, Xiaowen] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Shi, Xiaowen; Hanson, Maureen R.; Bentolila, Stephane] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Hanson, MR (reprint author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	mrh5@cornell.edu			National Science Foundation, Division of Molecular and Cellular Biosciences, Genes and Genome Systems [MCB-1615393, MCB-1330294]	Our recent work on RNA editing in plant organelles has been supported by the National Science Foundation, Division of Molecular and Cellular Biosciences, Genes and Genome Systems (grant MCB-1615393 to S.B. and M.R.H. and grant MCB-1330294 to M.R.H. and S.B.)	ADAM SA, 1986, MOL CELL BIOL, V6, P2932, DOI 10.1128/MCB.6.8.2932                                                            ; Ahlert D, 2003, P NATL ACAD SCI USA, V100, P15730, DOI 10.1073/pnas.2533668100; Amme S, 2006, J EXP BOT, V57, P1537, DOI 10.1093/jxb/erj129; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511                                                         ; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; CHENG SH, 1994, PLANT PHYSIOL, V106, P303, DOI 10.1104/pp.106.1.303; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; COE EH, 1988, AM J BOT, V75, P634, DOI 10.2307/2444197; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; DREYFUSS G, 1988, TRENDS BIOCHEM SCI, V13, P86, DOI 10.1016/0968-0004(88)90046-1; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fu ZQ, 2007, NATURE, V447, P284, DOI 10.1038/nature05737; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Gray MW, 2012, BIOCHEMISTRY-US, V51, P5235, DOI 10.1021/bi300419r; Hackett JB, 2017, PLANT PHYSL; Han JH, 2013, PROTEIN J, V32, P449, DOI 10.1007/s10930-013-9504-3; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Kim JY, 2007, PLANT J, V50, P439, DOI 10.1111/j.1365-313X.2007.03057.x; Kode V, 2005, PLANT J, V44, P237, DOI 10.1111/j.1365-313X.2005.02533.x; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Kupsch C, 2012, PLANT CELL, V24, P4266, DOI 10.1105/tpc.112.103002; Kuroda H, 2003, NATURE, V425, P86, DOI 10.1038/nature01909; Kwak KJ, 2005, J EXP BOT, V56, P3007, DOI 10.1093/jxb/eri298; Kwak KJ, 2011, J EXP BOT, V62, P4003, DOI 10.1093/jxb/err101; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lasko P, 2000, J CELL BIOL, V150, pF51, DOI 10.1083/jcb.150.2.F51; Lee SY, 2014, PLANT CELL REP, V33, P837, DOI 10.1007/s00299-013-1560-9; LI YQ, 1990, EMBO J, V9, P3059; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Mangeon A, 2010, PLANT SIGNAL BEHAV, V5, P99, DOI 10.4161/psb.5.2.10336; Mangeon A, 2009, PLANTA, V230, P253, DOI 10.1007/s00425-009-0940-4; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Maruyama K, 1999, NUCLEIC ACIDS RES, V27, P2029, DOI 10.1093/nar/27.9.2029; Melamed D, 2013, RNA, V19, P1537, DOI 10.1261/rna.040709.113; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Nakamura T, 2004, BIOCHEM SOC T, V32, P571, DOI 10.1042/BST0320571                                                              ; OHTA M, 1995, PLANT MOL BIOL, V27, P529, DOI 10.1007/BF00019319; Okuda K, 2014, PLANT J, V80, P870, DOI 10.1111/tpj.12687; Olinares PDB, 2011, BBA-BIOENERGETICS, V1807, P999, DOI 10.1016/j.bbabio.2010.12.003; Ruwe H, 2011, J PLANT PHYSIOL, V168, P1361, DOI 10.1016/j.jplph.2011.01.012; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Shi X, J EXP BOT IN PRESS; Shi X, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2015.1062196; Shi XW, 2016, PLANT PHYSIOL, V170, P294, DOI 10.1104/pp.15.01280; Shi XW, 2015, NUCLEIC ACIDS RES, V43, P3814, DOI 10.1093/nar/gkv245; Smith HC, 1997, RNA, V3, P1105; Spahr H, 2016, NUCLEIC ACIDS RES, V44, P6868, DOI 10.1093/nar/gkw575; Stern DB, 2004, TRENDS PLANT SCI, V9, P293, DOI 10.1016/j.tplants.2004.04.001; Sun T, 2016, TRENDS PLANT SCI, V21, P962, DOI 10.1016/j.tplants.2016.07.005; Sun T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005028; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Teubner M, 2017, PLANT J, V89, P472, DOI 10.1111/tpj.13396; Tiller N, 2012, PLANT J, V69, P302, DOI 10.1111/j.1365-313X.2011.04791.x; Tillich M, 2010, RNA BIOL, V7, P172, DOI 10.4161/rna.7.2.11090                                                           ; Tillich M, 2009, P NATL ACAD SCI USA, V106, P6002, DOI 10.1073/pnas.0808529106; Vermel M, 2002, P NATL ACAD SCI USA, V99, P5866, DOI 10.1073/pnas.092019599; Wang SY, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/3159805; WELLBURN FAM, 1979, PLANTA, V147, P178, DOI 10.1007/BF00389522; Xu T, 2013, PLANT PHYSIOL BIOCH, V73, P405, DOI 10.1016/j.plaphy.2013.10.027; Yang DH, 2014, PLANT SCI, V214, P106, DOI 10.1016/j.plantsci.2013.10.006; Yaniv K, 2002, GENE, V287, P49, DOI 10.1016/S0378-1119(01)00866-6                                                   ; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; Yin TZ, 2012, PLANTA, V235, P907, DOI 10.1007/s00425-011-1547-0; Zhang F, 2014, P NATL ACAD SCI USA, V111, P2023, DOI 10.1073/pnas.1316183111; Zubko MK, 1998, PLANT J, V15, P265, DOI 10.1046/j.1365-313X.1998.00195.x; Zubko MK, 2002, MOL GENET GENOMICS, V267, P27, DOI 10.1007/s00438-001-0627-4	75	0	0	8	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-7004	1757-7012		WIRES RNA	Wiley Interdiscip. Rev.-RNA	SEP-OCT	2017	8	5							e1420	10.1002/wrna.1420				14	Cell Biology	Cell Biology	FE0LX	WOS:000407912900004					2018-01-05	
J	Capriotti, E; Martelli, PL; Fariselli, P; Casadio, R				Capriotti, Emidio; Martelli, Pier Luigi; Fariselli, Piero; Casadio, Rita			Blind prediction of deleterious amino acid variations with SNPs&GO	HUMAN MUTATION			English	Article						disease-related variation; gene ontology; genome interpretation; machine learning; protein function; single amino acid variation; variant annotation	PERSONALIZED MEDICINE; DISEASE; GENOME; BIOINFORMATICS; SUBSTITUTIONS; MUTATIONS	SNPs&GO is a machine learning method for predicting the association of single amino acid variations (SAVs) to disease, considering protein functional annotation. The method is a binary classifier that implements a support vector machine algorithm to discriminate between disease-related and neutral SAVs. SNPs&GO combines information from protein sequence with functional annotation encoded by gene ontology (GO) terms. Tested in sequence mode on more than 38,000 SAVs from the SwissVar dataset, our method reached 81% overall accuracy and an area under the receiving operating characteristic curve of 0.88 with low false-positive rate. In almost all the editions of the Critical Assessment of Genome Interpretation (CAGI) experiments, SNPs&GO ranked among the most accurate algorithms for predicting the effect of SAVs. In this paper, we summarize the best results obtained by SNPs&GO on disease-related variations of four CAGI challenges relative to the following genes: CHEK2 (CAGI 2010), RAD50 (CAGI 2011), p16-INK (CAGI 2013), and NAGLU (CAGI 2016). Result evaluation provides insights about the accuracy of our algorithm and the relevance of GO terms in annotating the effect of the variants. It also helps to define good practices for the detection of deleterious SAVs.	[Capriotti, Emidio; Martelli, Pier Luigi; Casadio, Rita] Univ Bologna, BiGeA Giorgio Prodi Interdept Ctr Canc Res, Biocomp Grp, Bologna, Italy; [Fariselli, Piero] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy	Capriotti, E (reprint author), Univ Bologna, Dept Biol Geol & Environm Sci BiGeA, BioFolD Unit, Via F Selmi 3, I-40126 Bologna, Italy.	emidio.capriotti@unibo.it	Martelli, Pier Luigi/I-8824-2012; Casadio, Rita/K-3747-2017; Capriotti, Emidio/D-9318-2011	Martelli, Pier Luigi/0000-0002-0274-5669; Capriotti, Emidio/0000-0002-2323-0963	Italian MIUR (PRIN) [20108XYHJS]; European Union RTD Framework Program (COST BMBS Action) [TD1101, BM1405]; Italian MIUR (PON) [PON01_02249, PAN Lab PONa3_00166]; FARB UNIBO	Contract grant sponsors: Italian MIUR (PRIN 2010-2011, project 20108XYHJS); European Union RTD Framework Program (COST BMBS Action TD1101, Action BM1405); Italian MIUR (PON projects PON01_02249, PAN Lab PONa3_00166); FARB UNIBO 2012.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bromberg Y, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2721-3; Brownstein CA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r53; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Weinstein J.N., 2013, NAT GENET, V45, P1113, DOI DOI 10.1038/NG.2764; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S6; Capriotti E, 2012, BRIEF BIOINFORM, V13, P495, DOI 10.1093/bib/bbr070; Capriotti E, 2011, GENOMICS, V98, P310, DOI 10.1016/j.ygeno.2011.06.010; Carraro M., 2017, HUMAN MUTATION MINOR; Damiola F, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3669; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fernald GH, 2011, BIOINFORMATICS, V27, P1741, DOI 10.1093/bioinformatics/btr295; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; LesCalvez-Kelm F., 2011, BREAST CANC RES BCR, V13, pR6; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; Mottaz A, 2010, BIOINFORMATICS, V26, P851, DOI 10.1093/bioinformatics/btq028; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Niroula A, 2016, HUM MUTAT, V37, P579, DOI 10.1002/humu.22987; Oetting WS, 2011, HUM MUTAT, V32, P486, DOI 10.1002/humu.21443; Saez-Rodriguez J, 2016, NAT REV GENET, V17, P470, DOI 10.1038/nrg.2016.69; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Vihinen M, 2013, HUM MUTAT, V34, P275, DOI 10.1002/humu.22253; Vihinen M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S2; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	30	1	1	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-7794	1098-1004		HUM MUTAT	Hum. Mutat.	SEP	2017	38	9			SI		1064	1071		10.1002/humu.23179				8	Genetics & Heredity	Genetics & Heredity	FD9RZ	WOS:000407861100004	28102005	green_accepted			2018-01-05	
J	Giollo, M; Jones, DT; Carraro, M; Leonardi, E; Ferrari, C; Tosatto, SCE				Giollo, Manuel; Jones, David T.; Carraro, Marco; Leonardi, Emanuela; Ferrari, Carlo; Tosatto, Silvio C. E.			Crohn disease risk predictionBest practices and pitfalls with exome data	HUMAN MUTATION			English	Article						Crohn disease; disease risk prediction; exome data; genetic analysis; linear models; machine learning; methods comparison; next-generation sequencing; SNV evaluation; variants prioritization	GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; SUSCEPTIBILITY LOCI; GENETIC-VARIANTS; SEQUENCING DATA; BIOINFORMATICS; BIOCONDUCTOR; ANNOTATION; PROTEINS; PACKAGE	The Critical Assessment of Genome Interpretation (CAGI) experiment is the first attempt to evaluate the state-of-the-art in genetic data interpretation. Among the proposed challenges, Crohn disease (CD) risk prediction has become the most classic problem spanning three editions. The scientific question is very hard: can anybody assess the risk to develop CD given the exome data alone? This is one of the ultimate goals of genetic analysis, which motivated most CAGI participants to look for powerful new methods. In the 2016 CD challenge, we implemented all the best methods proposed in the past editions. This resulted in 10 algorithms, which were evaluated fairly by CAGI organizers. We also used all the data available from CAGI 11 and 13 to maximize the amount of training samples. The most effective algorithms used known genes associated with CD from the literature. No method could evaluate effectively the importance of unannotated variants by using heuristics. As a downside, all CD datasets were strongly affected by sample stratification. This affected the performance reported by assessors. Therefore, we expect that future datasets will be normalized in order to remove population effects. This will improve methods comparison and promote algorithms focused on causal variants discovery.	[Giollo, Manuel; Jones, David T.] UCL, Inst Struct & Mol Biol, London, England; [Carraro, Marco] Univ Padua, Dept Biomed Sci, Padua, Italy; [Leonardi, Emanuela; Tosatto, Silvio C. E.] Univ Padua, Dept Woman & Child Hlth, Padua, Italy; [Ferrari, Carlo] Univ Padua, Dept Informat Engn, Padua, Italy; [Tosatto, Silvio C. E.] CNR, Inst Neurosci, Padua, Italy	Giollo, M (reprint author), UCL, Inst Struct & Mol Biol, London, England.	manuel.giollo@gmail.com		Tosatto, Silvio/0000-0003-4525-7793; Leonardi, Emanuela/0000-0001-8486-8461	NIH [U41HG007346, R13 HG006650]; Italian Ministry of Health [GR-2011-02347754, GR-2011-02346845]	Contract grant sponsors: NIH (U41HG007346 and R13 HG006650); Italian Ministry of Health (GR-2011-02347754 and GR-2011-02346845).	1000GP Consortium, 2012, NATURE, V491, P56, DOI DOI 10.1038/NATURE11632; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Beck T, 2014, EUR J HUM GENET, V22, P949, DOI 10.1038/ejhg.2013.274; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2                                                   ; Chapelle O., 2009, IEEE T NEURAL NETWOR, V20, P542; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; EASTON DF, 1993, AM J HUM GENET, V52, P678; Efron B., 1992, BREAKTHROUGHS STAT, P569, DOI DOI 10.1007/978-1-4612-4380-9_41; Ellinghaus D, 2013, GASTROENTEROLOGY, V145, P339, DOI 10.1053/j.gastro.2013.04.040; Friedman JH, 1997, DATA MIN KNOWL DISC, V1, P55, DOI 10.1023/A:1009778005914; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giollo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124579; Giollo M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S4-S7; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Molodecky Natalie A, 2010, Gastroenterol Hepatol (N Y), V6, P339; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; Ningappa M, 2011, AM J GASTROENTEROL, V106, P157, DOI 10.1038/ajg.2010.322; Obenchain V, 2014, BIOINFORMATICS, V30, P2076, DOI 10.1093/bioinformatics/btu168; Ramos EM, 2014, EUR J HUM GENET, V22, P144, DOI 10.1038/ejhg.2013.96; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shivananda S, 1996, GUT, V39, P690, DOI 10.1136/gut.39.5.690; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; WANG K, 2010, NUCLEIC ACIDS RES, V38, DOI DOI 10.1093/NAR/GKQ603; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wei Z, 2013, AM J HUM GENET, V92, P1008, DOI 10.1016/j.ajhg.2013.05.002; Wellcome Trust Case Control Consortium, 2007, NATURE, V447, P661, DOI DOI 10.1038/NATURE05911; Yu W, 2010, BIOINFORMATICS, V26, P145, DOI 10.1093/bioinformatics/btp618	36	1	1	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-7794	1098-1004		HUM MUTAT	Hum. Mutat.	SEP	2017	38	9			SI		1193	1200		10.1002/humu.23177				8	Genetics & Heredity	Genetics & Heredity	FD9RZ	WOS:000407861100015	28087895				2018-01-05	
J	Menschaert, G; Fenyo, D				Menschaert, Gerben; Fenyo, David			PROTEOGENOMICS FROM A BIOINFORMATICS ANGLE: A GROWING FIELD	MASS SPECTROMETRY REVIEWS			English	Review						proteogenomics; bioinformatics; mass spectrometry; next-generation sequencing; proteoform; gene annotation; ribosome profiling	TANDEM MASS-SPECTRA; ALTERNATIVE TRANSLATION INITIATION; INTEGRATIVE GENOMICS VIEWER; GENERATION SEQUENCING DATA; SHOTGUN PROTEOMICS DATA; PROTEIN-CODING GENES; DATABASE SEARCH TOOL; RNA EDITING SITES; CONE SNAIL VENOM; PROJECT C-HPP	Proteogenomics is a research area that combines areas as proteomics and genomics in a multi-omics setup using both mass spectrometry and high-throughput sequencing technologies. Currently, the main goals of the field are to aid genome annotation or to unravel the proteome complexity. Mass spectrometry based identifications of matching or homologues peptides can further refine gene models. Also, the identification of novel proteoforms is also made possible based on detection of novel translation initiation sites (cognate or near-cognate), novel transcript isoforms, sequence variation or novel (small) open reading frames in intergenic or un-translated genic regions by analyzing high-throughput sequencing data from RNAseq or ribosome profiling experiments. Other proteogenomics studies using a combination of proteomics and genomics techniques focus on antibody sequencing, the identification of immunogenic peptides or venom peptides. Over the years, a growing amount of bioinformatics tools and databases became available to help streamlining these cross-omics studies. Some of these solutions only help in specific steps of the proteogenomics studies, e.g. building custom sequence databases (based on next generation sequencing output) for mass spectrometry fragmentation spectrum matching. Over the last few years a handful integrative tools also became available that can execute complete proteogenomics analyses. Some of these are presented as stand-alone solutions, whereas others are implemented in a web-based framework such as Galaxy. In this review we aimed at sketching a comprehensive overview of all the bioinformatics solutions that are available for this growing research area. (C) 2015 Wiley Periodicals, Inc.	[Menschaert, Gerben] Univ Ghent, Fac Biosci Engn, Dept Math Modeling Stat & Bioinformat, Lab Bioinformat & Computat Genom, Ghent, Belgium; [Fenyo, David] NYU, Sch Med, Dept Biochem & Mol Pharmacol, Ctr Hlth Informat & Bioinformat, New York, NY USA	Menschaert, G (reprint author), Univ Ghent, Fac Biosci Engn, Dept Math Modeling Stat & Bioinformat, Lab Bioinformat & Computat Genom, Ghent, Belgium.	gerben.menschaert@ugent.be		Fenyo, David/0000-0001-5049-3825	Research Foundation-Flanders (FWO-Vlaanderen); Ghent University; National Cancer Institute (NCI) CPTAC award [U24CA160035]; CPTAC contract from Leidos Biomedical Research, Inc. [13XS068]	Research Foundation-Flanders (FWO-Vlaanderen) and Ghent University. This work was supported by National Cancer Institute (NCI) CPTAC award U24CA160035, and by CPTAC contract 13XS068 from Leidos Biomedical Research, Inc.	Alfaro JA, 2014, NAT METHODS, V11, P1107, DOI [10.1038/NMETH.3138, 10.1038/nmeth.3138]; Aman JW, 2015, P NATL ACAD SCI USA, V112, P5087, DOI 10.1073/pnas.1424435112; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Armengaud J, 2014, J PROTEOMICS, V105, P5, DOI 10.1016/j.jprot.2014.01.007; Armengaud J, 2013, PROTEOMICS, V13, P2731, DOI 10.1002/pmic.201200576; Aspden JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03528; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Bassani-Sternberg M, 2015, MOL CELL PROTEOMICS, V14, P658, DOI 10.1074/mcp.M114.042812; Bazzini AA, 2014, EMBO J, V33, P981, DOI 10.1002/embj.201488411; Biass D, 2015, J PROTEOME RES, V14, P628, DOI 10.1021/pr500583u; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Boekel J, 2015, NAT BIOTECHNOL, V33, P137, DOI 10.1038/nbt.3134; Brahma RK, 2015, TOXICON, V93, P1, DOI 10.1016/j.toxicon.2014.10.022; Branca RMM, 2014, NAT METHODS, V11, P59, DOI [10.1038/NMETH.2732, 10.1038/nmeth.2732]; Brosch M, 2011, GENOME RES, V21, P756, DOI 10.1101/gr.114272.110; Brouwer RWW, 2009, BIOINFORMATICS, V25, P139, DOI 10.1093/bioinformatics/btn588; Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300; Capriotti AL, 2013, ANAL BIOANAL CHEM, V405, P9301, DOI 10.1007/s00216-013-7382-3; Caron E, 2015, ELIFE, V4, DOI 10.7554/eLife.07661; Castellana NE, 2014, MOL CELL PROTEOMICS, V13, P157, DOI 10.1074/mcp.M113.031260; Castellana NE, 2010, MOL CELL PROTEOMICS, V9, P1260, DOI 10.1074/mcp.M900504-MCP200; Castellana NE, 2008, P NATL ACAD SCI USA, V105, P21034, DOI 10.1073/pnas.0811066106; Chaiyarit S, 2014, J PROTEOME RES, V13, P3160, DOI 10.1021/pr500009j; Choudhary JS, 2001, PROTEOMICS, V1, P651, DOI 10.1002/1615-9861(200104)1:5<651::AID-PROT651>3.0.CO;2-N; Conlon KP, 2013, MOL CELL PROTEOMICS, V12, P2714, DOI 10.1074/mcp.M113.029926; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Crappe J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1283; Crappe J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-648; Dasari S, 2010, J PROTEOME RES, V9, P1716, DOI 10.1021/pr900850m; de Souza GA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002527; de Souza GA, 2010, BIOINFORMATICS, V26, P698, DOI 10.1093/bioinformatics/btq004; Degroeve S, 2013, BIOINFORMATICS, V29, P3199, DOI 10.1093/bioinformatics/btt544; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Diament BJ, 2011, J PROTEOME RES, V10, P3871, DOI 10.1021/pr101196n; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dutertre S, 2013, MOL CELL PROTEOMICS, V12, P312, DOI 10.1074/mcp.M112.021469; Edwards NJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100142; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Evans VC, 2012, NAT METHODS, V9, P1207, DOI [10.1038/NMETH.2227, 10.1038/nmeth.2227]; Fermin D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r35; Ferro M, 2008, J PROTEOME RES, V7, P1873, DOI 10.1021/pr070415k; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Frank A, 2005, ANAL CHEM, V77, P964, DOI 10.1021/ac048788h; Frenkel-Morgenstern M, 2015, NUCLEIC ACIDS RES, V43, pD68, DOI 10.1093/nar/gku1199; FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; Gao XW, 2015, NAT METHODS, V12, P147, DOI 10.1038/nmeth.3208; Gawron D, 2014, PROTEOMICS, V14, P2647, DOI 10.1002/pmic.201400165; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Ghali F, 2014, PROTEOMICS, V14, P2731, DOI 10.1002/pmic.201400265; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gonnelli G, 2015, J PROTEOME RES, V14, P1792, DOI 10.1021/pr501164r; Goode RJA, 2013, J PROTEOME RES, V12, P172, DOI 10.1021/pr3010056; Granados DP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4600; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Gubin MM, 2015, J CLIN INVEST, V125, P3413, DOI 10.1172/JCI80008; Han Yonghua, 2005, Journal of Bioinformatics and Computational Biology, V3, P697; Hartmann EM, 2014, PROTEOMICS, V14, P2637, DOI 10.1002/pmic.201400157; Hartmann EM, 2014, MAR GENOM, V17, P35, DOI 10.1016/j.margen.2014.04.003; He T, 2007, NUCLEIC ACIDS RES, V35, pD141, DOI 10.1093/nar/gkl815; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunter AA, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-1; Immel F, 2012, J PROTEOMICS, V75, P1129, DOI 10.1016/j.jprot.2011.10.026; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jaffe JD, 2004, PROTEOMICS, V4, P59, DOI 10.1002/pmic.200300511; Jagtap P, 2013, PROTEOMICS, V13, P1352, DOI 10.1002/pmic.201200352; Jagtap P, 2012, PROTEOMICS, V12, P1726, DOI 10.1002/pmic.201100097; Jagtap PD, 2014, J PROTEOME RES, V13, P5898, DOI 10.1021/pr500812t; Jeong K, 2013, BIOINFORMATICS, V29, P1953, DOI 10.1093/bioinformatics/btt338; Jeong SK, 2013, J PROTEOME RES, V12, P106, DOI 10.1021/pr3009447; Junqueira M, 2008, J PROTEOMICS, V71, P346, DOI 10.1016/j.jprot.2008.07.003; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kayser J P, 2004, J Biomol Tech, V15, P285; Khatun J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-141; Kim P, 2010, NUCLEIC ACIDS RES, V38, pD81, DOI 10.1093/nar/gkp982; Kim S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6277; Kiran AM, 2013, NUCLEIC ACIDS RES, V41, pD258, DOI 10.1093/nar/gks961; Koch A, 2014, PROTEOMICS, V14, P2688, DOI 10.1002/pmic.201400180; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Kong FL, 2011, NUCLEIC ACIDS RES, V39, pD895, DOI 10.1093/nar/gkq1038; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuhring M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050246; Kumar D, 2013, MOL CELL PROTEOMICS, V12, P3388, DOI 10.1074/mcp.M112.027169; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li HD, 2014, PROTEOMICS, V14, P2709, DOI 10.1002/pmic.201400170; Li J, 2010, HUM MUTAT, V31, P219, DOI 10.1002/humu.21176; Lindenbaum P, 2011, BIOINFORMATICS, V27, P3200, DOI 10.1093/bioinformatics/btr554; Liska AJ, 2005, PROTEOMICS, V5, P4118, DOI 10.1002/pmic.200401262; Liu SL, 2013, J PROTEOME RES, V12, P45, DOI 10.1021/pr300985j; Luge T, 2014, PROTEOMICS, V14, P1882, DOI 10.1002/pmic.201300551; Ma J, 2014, J PROTEOME RES, V13, P1757, DOI 10.1021/pr401280w; Ma K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S1; Margres MJ, 2014, J PROTEOMICS, V96, P145, DOI 10.1016/j.jprot.2013.11.001; Mason ME, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-2; Menschaert G, 2013, MOL CELL PROTEOMICS, V12, P1780, DOI 10.1074/mcp.M113.027540; Menschaert G, 2010, J PROTEOME RES, V9, P990, DOI 10.1021/pr900885k; Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970; Muth T, 2014, J PROTEOME RES, V13, P1143, DOI 10.1021/pr4008078; Nagaraj SH, 2015, J PROTEOME RES, V14, P2255, DOI 10.1021/acs.jproteome.5b00029; Nesvizhskii AI, 2006, MOL CELL PROTEOMICS, V5, P652, DOI 10.1074/mcp.M500319-MCP200; Nesvizhskii AI, 2014, NAT METHODS, V11, P1114, DOI [10.1038/nmeth.3144, 10.1038/NMETH.3144]; Olexiouk V, 2016, NUCLEIC ACIDS RES, V44, pD324, DOI 10.1093/nar/gkv1175; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Pandey A, 2014, PROTEOMICS, V14, P2631, DOI 10.1002/pmic.201470173; Park H, 2014, PROTEOMICS, V14, P2742, DOI 10.1002/pmic.201400225; Pawar H, 2014, GENOMICS, V104, P554, DOI 10.1016/j.ygeno.2014.09.008; Peterson ES, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-131; Picardi E, 2015, CURRENT PROTOCOLS BI, P49; Pineda SS, 2014, FUTURE MED CHEM, V6, P1699, DOI [10.4155/FMC.14.103, 10.4155/fmc.14.103]; Pinto SM, 2014, J PROTEOME RES, V13, P2749, DOI 10.1021/pr401169d; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Risk BA, 2013, J PROTEOME RES, V12, P3019, DOI 10.1021/pr400208w; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Safavi-Hemami H, 2015, P NATL ACAD SCI USA, V112, P1743, DOI 10.1073/pnas.1423857112; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/NMETH.2212, 10.1038/nmeth.2212]; Sanders WS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-115; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Shanmugam AK, 2014, J PROTEOME RES, V13, P4113, DOI 10.1021/pr500496p; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shevchenko Anna, 2003, Methods Mol Biol, V211, P221; Sheynkman GM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-703; Silvester N, 2015, NUCLEIC ACIDS RES, V43, pD23, DOI 10.1093/nar/gku1129; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Spivak M, 2009, J PROTEOME RES, V8, P3737, DOI 10.1021/pr801109k; Staes A, 2011, NAT PROTOC, V6, P1130, DOI 10.1038/nprot.2011.355; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/NMETH.2714, 10.1038/nmeth.2714]; Sun H, 2014, PROTEOMICS, V14, P2760, DOI 10.1002/pmic.201400174; Tabb DL, 2008, J PROTEOME RES, V7, P3838, DOI 10.1021/pr800154p; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Tanner S, 2007, GENOME RES, V17, P231, DOI 10.1101/gr.5646507; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tovchigrechko A, 2014, BIOINFORMATICS, V30, P1469, DOI 10.1093/bioinformatics/btu051; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ucciferri N, 2014, METHODS MOL BIOL, V1167, P187, DOI 10.1007/978-1-4939-0835-6_12; Ueberheide BM, 2009, P NATL ACAD SCI USA, V106, P6910, DOI 10.1073/pnas.0900745106; Uszkoreit J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S9-S19; Van Damme P, 2014, MOL CELL PROTEOMICS, V13, P1245, DOI 10.1074/mcp.M113.036442; Vanderperre B, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas025; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; Vaudel M, 2011, PROTEOMICS, V11, P996, DOI 10.1002/pmic.201000595; Volders PJ, 2015, NUCLEIC ACIDS RES, V43, pD174, DOI 10.1093/nar/gku1060; Volkening JD, 2012, MOL CELL PROTEOMICS, V11, P933, DOI 10.1074/mcp.M112.019471; Wan J, 2014, NUCLEIC ACIDS RES, V42, pD845, DOI 10.1093/nar/gkt1085; Wang XJ, 2014, PROTEOMICS, V14, P2676, DOI 10.1002/pmic.201400184; Wang XJ, 2013, BIOINFORMATICS, V29, P3235, DOI 10.1093/bioinformatics/btt543; Wen B, 2014, BIOINFORMATICS, V30, P3136, DOI 10.1093/bioinformatics/btu397; Wethmar K, 2014, NUCLEIC ACIDS RES, V42, pD60, DOI 10.1093/nar/gkt952; Wolstencroft K, 2013, NUCLEIC ACIDS RES, V41, pW557, DOI 10.1093/nar/gkt328; Woo S, 2014, PROTEOMICS, V14, P2719, DOI 10.1002/pmic.201400206; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Yang S, 2015, J PROTEOME RES, V14, P3720, DOI 10.1021/pr501335w; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; [张成普 Zhang Chengpu], 2014, [生物工程学报, Chinese Journal of Biotechnology], V30, P1026; Zhang Q, 2015, NAT METHODS, V12, P347, DOI [10.1038/NMETH.3314, 10.1038/nmeth.3314]	170	10	10	15	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-7037	1098-2787		MASS SPECTROM REV	Mass Spectrom. Rev.	SEP-OCT	2017	36	5					584	599		10.1002/mas.21483				16	Spectroscopy	Spectroscopy	FE0SW	WOS:000407931000002	26670565				2018-01-05	
J	Benes, D; Rodriguez-Paton, A; Sosik, P				Benes, David; Rodriguez-Paton, Alfonso; Sosik, Petr			Directed evolution of biocircuits using conjugative plasmids and CRISPR-Cas9: design and in silico experiments	NATURAL COMPUTING			English	Article						Directed evolution; Programmed evolution; Evolutionary search; Genetic circuit; Biocircuit; Conjugative plasmid; CRISPR-Cas9	ESCHERICHIA-COLI; NETWORKS; BIOLOGY; SYSTEM	Recent links between computer science and synthetic biology allow for construction of many kinds of algorithmic processes within cells, obtained either by a direct engineered design or by an evolutionary search. In the latter case, horizontal gene transfer and especially transfer of plasmids by conjugation is generally respected as a crucial source of genetic diversity in bacteria. While some previous studies focused on mutations as the crucial principle to obtain diversity for engineered evolution, here we consider conjugation itself as a tool to generate diversity from a pre-determined library of biocircuits basic components. The recent development of CRISPR-Cas9 and its programmable DNA cutting ability makes it a powerful selection tool able to remove nonfunctional biocircuits from a cell population. In this paper, we describe a framework for controlled bacterial evolution of biocircuits based on conjugation and on CRISPR-Cas9, resulting in a direct biological implementation of an evolutionary algorithm. In silico experiments provide data to estimate the computational/search capability of plasmid-based engineered evolution.	[Benes, David; Sosik, Petr] Silesian Univ Opava, Fac Philosophy & Sci, Ctr Excellence IT4Innovat, Res Inst, Opava 74601, Czech Republic; [Rodriguez-Paton, Alfonso] Univ Politecn Madrid, Dept Inteligencia Artificial, Campus Montegancedo S-N, E-28660 Madrid, Spain	Sosik, P (reprint author), Silesian Univ Opava, Fac Philosophy & Sci, Ctr Excellence IT4Innovat, Res Inst, Opava 74601, Czech Republic.	petr.sosik@fpf.slu.cz		Rodriguez-Paton, Alfonso/0000-0001-7289-2114	European Union [248919/FP7-ICT-2009-4, 612146/FP7-ICT-FET-Proactive, 610730/FP7-ICT-FET-Proactive]; National Programme of Sustainability (NPU II) of the Czech Republic [LQ1602]; Silesian University in Opava [SGS/13/2016];  [TIN2012-36992];  [TIN2016-81079-R]	This work was supported by the European Union projects BACTOCOM (248919/FP7-ICT-2009-4), PLAS-WIRES (612146/FP7-ICT-FET-Proactive) and EVOPROG (610730/FP7-ICT-FET-Proactive), by the National Programme of Sustainability (NPU II) of the Czech Republic, project IT4Innovations Excellence in Science-LQ1602, by the Silesian University in Opava under the Student Funding Scheme, project SGS/13/2016, and by Spanish projects TIN2012-36992 and TIN2016-81079-R.	Amos M, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0218; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Benes D, 2015, ARTIF LIFE, V21, P247, DOI 10.1162/ARTL_a_00160; Cameron DE, 2014, NAT REV MICROBIOL, V12, P381, DOI 10.1038/nrmicro3239; del Campo I, 2012, PLASMID, V67, P174, DOI 10.1016/j.plasmid.2012.01.008; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Esvelt KM, 2012, MOL SYST BIOL, V9, P641; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Prestes Garcia A, 2015, PAAMS, V2015, P275; Prestes Garcia A, 2015, PACBB, V2015, P1; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131                                                                ; Goni-Moreno A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065986; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407                                                         ; Harvey I, 2010, P ART LIF 12 12 INT, P370; Kreft JU, 2001, MICROBIOL-SGM, V147, P2897, DOI 10.1099/00221287-147-11-2897                                                    ; Krone SM, 2007, MICROBIOL-SGM, V153, P2803, DOI 10.1099/mic.0.2006/004531-0; LEVIN BR, 1980, GENETICS, V94, P425; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x                                                ; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mozhayskiy V, 2013, INTEGR BIOL-UK, V5, P262, DOI 10.1039/c2ib20095c; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; Packer MS, 2015, NAT REV GENET, V16, P379, DOI 10.1038/nrg3927; Rodrigo G, 2007, BIOINFORMATICS, V23, P1857, DOI 10.1093/bioinformatics/btm237; Rodrigo Guillermo, 2007, Syst Synth Biol, V1, P167, DOI 10.1007/s11693-008-9013-4; Seoane J, 2011, FEMS MICROBIOL ECOL, V75, P17, DOI 10.1111/j.1574-6941.2010.00994.x; SIMONSEN L, 1990, J GEN MICROBIOL, V136, P2319, DOI 10.1099/00221287-136-11-2319                                                    ; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Tomko N, 2013, UNCONSTRAIN POPULATI, P117; Yokobayashi Yohei, 2005, Natural Computing, V4, P245, DOI 10.1007/s11047-004-7442-x	31	0	0	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-7818	1572-9796		NAT COMPUT	Nat. Comput.	SEP	2017	16	3	1		SI		497	505		10.1007/s11047-016-9595-9				9	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods	Computer Science	FD9EA	WOS:000407824400010					2018-01-05	
J	Zhou, SJ; Deng, YL; Liang, HF; Jaoude, JC; Liu, FY				Zhou, Shao-jun; Deng, Yue-ling; Liang, Hui-fang; Jaoude, Jonathan C.; Liu, Fu-yao			Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and Notch signaling in hepatocellular carcinoma	CELL DEATH AND DIFFERENTIATION			English	Article							LIVER-CANCER; FAMILY-HISTORY; MICRORNAS; RISK; TAIWAN	Familiar clustering of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) has been frequently reported. However, limited information is available about the underlying molecular mechanisms in HBV-related HCC patients with family history of HCC. In our previous study, Agilent miRNA Base 16.0 microarray showed miRNA profiles of the plasma of HBV-related HCC patients who had a family history of HCC. This study aims to explore the expression, function, and mechanisms of miR-3188 in HCC that might provide novel insights into the role of family history on the risk of HCC. The expression levels of miR-3188 were markedly overexpressed in HCC tissues, HBV transgenic mice, and HepG2.215 cells. We knocked out miR-3188 in HCC cell lines using the CRISPR/Cas9 system, and demonstrated that miR-3188 knockout (KO) suppressed cell growth, migration, and invasion, and inhibited xenografts tumor growth in nude mice. Next, we determined that miR-3188 KO exerts antitumor functions by directly repressing ZHX2. It has been reported that HBV X protein (HBx) plays a critical role in HBV-related HCC, promoting CREB-mediated activation of miR-3188 and activation of Notch signaling through repressing ZHX2. Finally, we verified that ZHX2 functions as a transcriptional repressor to Notch1 via interaction with NF-YA. Our data demonstrate that the HBx-miR-3188-ZHX2-Notch1 signaling pathway plays an important role in the pathogenesis and progression of HBV-related HCC with family history of HCC. These findings have important implications for identifying new therapeutic targets in HBV-related HCC.	[Zhou, Shao-jun] Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan, Shandong, Peoples R China; [Deng, Yue-ling] Huazhong Univ Sci & Technol, Wuhan Cent Hosp, Tongji Med Coll, Dept Gastroenterol, Wuhan, Hubei, Peoples R China; [Liang, Hui-fang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Hepatol Surg, Wuhan, Hubei, Peoples R China; [Jaoude, Jonathan C.; Liu, Fu-yao] Univ Texas MD Anderson Canc Ctr, Dept GI Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA	Liu, FY (reprint author), Univ Texas MD Anderson Canc Ctr, Dept GI Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	FLiu3@mdanderson.org			National Natural Science Foundation of China [81202300]	We thank all the authors for discussing the project. This work was supported by the National Natural Science Foundation of China (81202300 to Hui-Fang Liang).	BEASLEY RP, 1981, LANCET, V2, P1129; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Callegari E, 2015, CELL DEATH DIFFER, V22, P46, DOI 10.1038/cdd.2014.136; CHANG H, 2016, SCI REP UK, V6; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Diao JY, 2001, CYTOKINE GROWTH F R, V12, P189, DOI 10.1016/S1359-6101(00)00034-4; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Gao P, 2011, J HEPATOL, V54, P1177, DOI 10.1016/j.jhep.2010.09.023; Hassan MM, 2009, J HEPATOL, V50, P334, DOI 10.1016/j.jhep.2008.08.016; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang YT, 2011, J CLIN ONCOL, V29, P3643, DOI 10.1200/JCO.2011.36.2335; Jing W, 2015, BIOMED RES INT, V2015; Kongkavitoon P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146696; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Liu FY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.46; Loomba R, 2013, CLIN GASTROENTEROL H, V11, P1636, DOI 10.1016/j.cgh.2013.04.043; Ma HX, 2015, ONCOTARGET, V6, P1049, DOI 10.18632/oncotarget.2832                                                        ; Morford LA, 2007, HEPATOLOGY, V46, P1541, DOI 10.1002/hep.21825; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Volk ML, 2009, J HEPATOL, V50, P247, DOI 10.1016/j.jhep.2008.11.009; Wang Y, 2010, J HEPATOL, V53, P57, DOI 10.1016/j.jhep.2009.12.043; Xie KL, 2014, THERANOSTICS, V4, P1176, DOI 10.7150/thno.8715; Xu XJ, 2013, J CLIN INVEST, V123, P630, DOI 10.1172/JCI64265; Yu MW, 2002, INT J EPIDEMIOL, V31, P1008, DOI 10.1093/ije/31.5.1008; Yue XT, 2012, GASTROENTEROLOGY, V142, P1559, DOI 10.1053/j.gastro.2012.02.049; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	27	1	1	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1350-9047	1476-5403		CELL DEATH DIFFER	Cell Death Differ.	SEP	2017	24	9					1577	1587		10.1038/cdd.2017.87				11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FD4MZ	WOS:000407506500012	28574502	green_published			2018-01-05	
J	Lim, MCC; Maubach, G; Sokolova, O; Feige, MH; Diezko, R; Buchbinder, J; Backert, S; Schluter, D; Lavrik, IN; Naumann, M				Lim, Michelle C. C.; Maubach, Gunter; Sokolova, Olga; Feige, Michael H.; Diezko, Rolf; Buchbinder, Joern; Backert, Steffen; Schlueter, Dirk; Lavrik, Inna N.; Naumann, Michael			Pathogen-induced ubiquitin-editing enzyme A20 bifunctionally shuts off NF-kappa B and caspase-8-dependent apoptotic cell death	CELL DEATH AND DIFFERENTIATION			English	Article							HELICOBACTER-PYLORI INFECTION; GASTRIC-CANCER; BINDING-PROTEIN; ACTIVATION; PATHWAY; COMPLEX; CAGA; P62; POLYUBIQUITINATION; MITOCHONDRIA	The human pathogen Helicobacter pylori infects more than half of the world's population and is a paradigm for persistent yet asymptomatic infection but increases the risk for chronic gastritis and gastric adenocarcinoma. For successful colonization, H. pylori needs to subvert the host cell death response, which serves to confine pathogen infection by killing infected cells and preventing malignant transformation. Infection of gastric epithelial cells by H. pylori provokes direct and fast activation of the proinflammatory and survival factor NF-kappa B, which regulates target genes, such as CXCL8, BIRC3 and TNFAIP3. However, it is not known how H. pylori exploits NF-kappa B activation and suppresses the inflammatory response and host apoptotic cell death, in order to avert the innate immune response and avoid cell loss, and thereby enhance colonization to establish long-term infection. Here we assign for the first time that H. pylori and also Campylobacter jejuni-induced ubiquitin-editing enzyme A20 bifunctionally terminates NF-kappa B activity and negatively regulates apoptotic cell death. Mechanistically, we show that the deubiquitinylase activity of A20 counteracts cullin3-mediated K63-linked ubiquitinylation of procaspase-8, therefore restricting the activity of caspase-8. Interestingly, another inducible NF-kappa B target gene, the scaffold protein p62, ameliorates the interaction of A20 with procaspase-8. In conclusion, pathogen-induced de novo synthesis of A20 regulates the shut-off of the survival factor NF-kappa B but, on the other hand, also impedes caspase-8-dependent apoptotic cell death so as to promote the persistence of pathogens.	[Lim, Michelle C. C.; Maubach, Gunter; Sokolova, Olga; Feige, Michael H.; Diezko, Rolf; Naumann, Michael] Otto von Guericke Univ, Inst Expt Internal Med, Leipziger Str 44, D-39120 Magdeburg, Germany; [Buchbinder, Joern; Lavrik, Inna N.] Otto von Guericke Univ, Inst Expt Internal Med, Res Grp Translat Inflammat Res, D-39106 Magdeburg, Germany; [Backert, Steffen] Friedrich Alexander Univ Erlangen Nuremberg, Div Microbiol, Dept Biol, D-91058 Erlangen, Germany; [Schlueter, Dirk] Otto von Guericke Univ, Inst Med Microbiol & Hosp Hyg, D-39120 Magdeburg, Germany; [Schlueter, Dirk] Helmholtz Ctr Infect Res, Organ Specif Immune Regulat, D-38124 Braunschweig, Germany	Naumann, M (reprint author), Otto von Guericke Univ, Inst Expt Internal Med, Leipziger Str 44, D-39120 Magdeburg, Germany.	Naumann@med.ovgu.de	Naumann, Michael/B-5285-2011; Lavrik, Inna/C-1700-2009; Sokolova, Olga/G-2123-2013	Naumann, Michael/0000-0002-8060-2313; Lavrik, Inna/0000-0002-9324-309X; Sokolova, Olga/0000-0003-1070-504X	German Research Foundation [CRC 854 A04, CRC 854 A05, CRC 1181 A04]; Medical Faculty of the Otto von Guericke University	The work was supported by grants of the German Research Foundation to M.N. (CRC 854 A04), D.S. (CRC 854 A05) and S.B. (CRC 1181 A04) and by stipends from the Medical Faculty of the Otto von Guericke University to M.C.C.L. and M.H.F.	Backert S, 2011, HELICOBACTER, V16, P19, DOI 10.1111/j.1523-5378.2011.00876.x; Bellail AC, 2012, CANCER DISCOV, V2, P140, DOI 10.1158/2159-8290.CD-11-0172; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI 10.1172/JCI200420925; Cover TL, 2003, CANCER RES, V63, P951; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Fox JG, 2003, CANCER RES, V63, P942; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gao LL, 2011, J BIOL CHEM, V286, P36592, DOI 10.1074/jbc.M111.283762; Geetha T, 2002, FEBS LETT, V512, P19, DOI 10.1016/S0014-5793(02)02286-X                                                   ; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Jones NL, 1999, INFECT IMMUN, V67, P4237; Kim KM, 2007, BIOCHEM BIOPH RES CO, V355, P562, DOI 10.1016/j.bbrc.2007.02.021; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lai TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073153; Lee GJ, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw015; Martin JH, 2004, HELICOBACTER, V9, P371, DOI 10.1111/j.1083-4389.2004.00269.x; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Oldani A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000603; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Schweitzer K, 2010, EMBO REP, V11, P10, DOI 10.1038/embor.2009.263; Shanks AM, 2009, J DIG DIS, V10, P157, DOI 10.1111/j.1751-2980.2009.00380.x; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Shibayama K, 2001, INFECT IMMUN, V69, P3181, DOI 10.1128/IAI.69.5.3181-3189.2001                                                 ; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Sokolova O, 2014, BBA-MOL CELL RES, V1843, P715, DOI 10.1016/j.bbamcr.2014.01.006; Sokolova O, 2013, INT J MED MICROBIOL, V303, P548, DOI 10.1016/j.ijmm.2013.07.008; Soutto M, 2011, J CLIN INVEST, V121, P1753, DOI 10.1172/JCI43922; Srivastav S, 2012, J IMMUNOL, V189, P924, DOI 10.4049/jimmunol.1102845; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Tiruppathi C, 2014, NAT IMMUNOL, V15, P239, DOI 10.1038/ni.2823; Vadlamudi RK, 1998, FEBS LETT, V435, P138, DOI 10.1016/S0014-5793(98)01021-7                                                   ; Yanai A, 2003, J INFECT DIS, V188, P1741, DOI 10.1086/379629; Yokota SI, 2008, FASEB J, V22, P74, DOI 10.1096/fj.07-8976com; Zhang H, 2007, J GASTROEN HEPATOL, V22, P1051, DOI 10.1111/j.1440-1746.2007.04959.x; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057; Zotti T, 2014, MOL IMMUNOL, V58, P27, DOI 10.1016/j.molimm.2013.10.015	44	1	1	9	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1350-9047	1476-5403		CELL DEATH DIFFER	Cell Death Differ.	SEP	2017	24	9					1621	1631		10.1038/cdd.2017.89				11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FD4MZ	WOS:000407506500016	28574503	green_published			2018-01-05	
J	Yan, HHN; Lai, JCW; Ho, SL; Leung, WK; Law, WL; Lee, JFY; Chan, AKW; Tsui, WY; Chan, ASY; Lee, BCH; Yue, SSK; Man, AHY; Clevers, H; Yuen, ST; Leung, SY				Yan, Helen H. N.; Lai, Jeffrey C. W.; Ho, Siu Lun; Leung, Wai Keung; Law, Wai Lun; Lee, Janet F. Y.; Chan, Anthony K. W.; Tsui, Wai Yin; Chan, Annie S. Y.; Lee, Bernard C. H.; Yue, Sarah S. K.; Man, Alice H. Y.; Clevers, Hans; Yuen, Siu Tsan; Leung, Suet Yi			RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation	GUT			English	Article							MISMATCH REPAIR DEFICIENCY; COLORECTAL-CANCER PATIENTS; HYPERPLASTIC POLYPOSIS; ENDOMETRIAL CANCERS; GENETIC PATHWAYS; BETA-CATENIN; COLON-CANCER; ADENOMAS; ADENOCARCINOMA; EXPRESSION	Objective Serrated polyps (hyperplastic polyps, sessile or traditional serrated adenomas), which can arise in a sporadic or polyposis setting, predispose to colorectal cancer (CRC), especially those with microsatellite instability (MSI) due to MLH1 promoter methylation (MLH1(me+)). We investigate genetic alterations in the serrated polyposis pathway. Design We used a combination of exome sequencing and target gene Sanger sequencing to study serrated polyposis families, sporadic serrated polyps and CRCs, with validation by analysis of The Cancer Genome Atlas (TCGA) cohort, followed by organoid-based functional studies. Results In one out of four serrated polyposis families, we identified a germline RNF43 mutation that displayed autosomal dominant cosegregation with the serrated polyposis phenotype, along with second-hit inactivation through loss of heterozygosity or somatic mutations in all serrated polyps (16), adenomas (5) and cancer (1) examined, as well as coincidental BRAF mutation in 62.5% of the serrated polyps. Concurrently, somatic RNF43 mutations were identified in 34% of sporadic sessile/traditional serrated adenomas, but 0% of hyperplastic polyps (p=0.013). Lastly, in MSI CRCs, we found significantly more frequent RNF43 mutations in the MLH1(me+) (85%) versus MLH1(me-) (33.3%) group (p< 0.001). These findings were validated in the TCGA MSI CRCs (p=0.005), which further delineated a significant differential involvement of three Wnt pathway genes between these two groups (RNF43 in MLH1(me+); APC and CTNNB1 in MLH1(me-)); and identified significant co-occurrence of BRAF and RNF43 mutations in the MSI (p< 0.001), microsatellite stable (MSS) (p=0.002) and MLH1(me+) MSI CRCs (p=0.042). Functionally, organoid culture of serrated adenoma or mouse colon with CRISPR-induced RNF43 mutations had reduced dependency on R-spondin1. Conclusions These results illustrate the importance of RNF43, along with BRAF mutation in the serrated neoplasia pathway (both the sporadic and familial forms), inform genetic diagnosis protocol and raise therapeutic opportunities through Wnt inhibition in different stages of evolution of serrated polyps.	[Yan, Helen H. N.; Lai, Jeffrey C. W.; Ho, Siu Lun; Chan, Anthony K. W.; Tsui, Wai Yin; Chan, Annie S. Y.; Lee, Bernard C. H.; Yue, Sarah S. K.; Man, Alice H. Y.; Yuen, Siu Tsan; Leung, Suet Yi] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hereditary Gastrointestinal Canc Genet Diag Lab, Pokfulam, Hong Kong, Peoples R China; [Leung, Wai Keung] Univ Hong Kong, Queen Mary Hosp, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Law, Wai Lun] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Pokfulam, Hong Kong, Peoples R China; [Lee, Janet F. Y.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China; [Clevers, Hans] Univ Med Ctr Utrecht, Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands	Leung, SY (reprint author), Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Pokfulam, Hong Kong, Peoples R China.; Yuen, ST (reprint author), St Pauls Hosp, Dept Pathol, Causeway Bay, Hong Kong, Peoples R China.	styuen@hku.hk			YW Kan Endowed Professorship	This work was supported by a donation from Mr S T Pan, the Hong Kong Cancer Fund, and the YW Kan Endowed Professorship established through a donation from the Croucher Foundation. The funders did not participate in the study design, collection, analysis and interpretation of data.	Akiyama Y, 2000, CANCER LETT, V157, P185, DOI 10.1016/S0304-3835(00)00486-9                                                   ; Bish R, 2014, MOL CELLS, V37, P357, DOI 10.14348/molcells.2014.0008; Burnett-Hartman AN, 2013, CANCER RES, V73, P2863, DOI 10.1158/0008-5472.CAN-12-3462; Carvajal-Carmona LG, 2007, J PATHOL, V212, P378, DOI 10.1002/path.2187; Chan TL, 2003, CANCER RES, V63, P4878; Chino A, 2016, INT J COLORECTAL DIS, V31, P343, DOI 10.1007/s00384-015-2416-2; De Jong AE, 2004, GASTROENTEROLOGY, V126, P42, DOI 10.1053/j.gastro.2003.10.043; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; Gala MK, 2014, GASTROENTEROLOGY, V146, P520, DOI 10.1053/j.gastro.2013.10.045; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Haraldsdottir S, 2014, GASTROENTEROLOGY, V147, P1308, DOI 10.1053/j.gastro.2014.08.041; Hiraoka S, 2010, GASTROENTEROLOGY, V139, P1503, DOI 10.1053/j.gastro.2010.07.011; IJspeert JEG, 2017, GUT, V66, P278, DOI 10.1136/gutjnl-2015-310630; Jass JR, 2000, GUT, V47, P43, DOI 10.1136/gut.47.1.43; Jiang X, MOL CELL; Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110; Konishi M, 1996, GASTROENTEROLOGY, V111, P307, DOI 10.1053/gast.1996.v111.pm8690195; Koo BK, 2015, P NATL ACAD SCI USA, V112, P7548, DOI 10.1073/pnas.1508113112; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Lash RH, 2010, J CLIN PATHOL, V63, P681, DOI 10.1136/jcp.2010.075507; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620                                                                ; OgierDenis E, 1997, J BIOL CHEM, V272, P24599, DOI 10.1074/jbc.272.39.24599; Olschwang S, 1997, P NATL ACAD SCI USA, V94, P12122, DOI 10.1073/pnas.94.22.12122; Rashid A, 2000, GASTROENTEROLOGY, V119, P323, DOI 10.1053/gast.2000.9361                                                          ; Riemer P, 2015, ONCOGENE, V34, P3164, DOI 10.1038/onc.2014.247; Rosty C, 2011, PATHOLOG RES INT, V2011, DOI DOI 10.4061/2011/157073; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Sekine S, 2016, J PATHOL, V239, P133, DOI 10.1002/path.4709; Smith CG, 2013, HUM MUTAT, V34, P1026, DOI 10.1002/humu.22333; Snover D, 2010, WHO CLASSIFICATION T; Taupin Douglas, 2015, Hum Genome Var, V2, P15013, DOI 10.1038/hgv.2015.13; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wang L, 2003, CANCER RES, V63, P5209; Yuen ST, 2002, ONCOGENE, V21, P7585, DOI 10.1038/sj.onc.1205968	38	6	6	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	SEP	2017	66	9					1645	1656		10.1136/gutjnl-2016-311849				12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	FD1AS	WOS:000407270400014	27329244				2018-01-05	
J	Gaulton, KJ				Gaulton, Kyle J.			Mechanisms of Type 2 Diabetes Risk Loci	CURRENT DIABETES REPORTS			English	Review						Human genetics; GWAS; Physiology; Epigenomics; Gene regulation	GENOME-WIDE ASSOCIATION; HUMAN PANCREATIC-ISLETS; BODY-MASS INDEX; OF-FUNCTION MUTATIONS; SUSCEPTIBILITY LOCI; GLUCOSE-HOMEOSTASIS; COMMON VARIANTS; OPEN CHROMATIN; HUMAN-DISEASE; DNA-BINDING	Purpose of Review Deciphering the mechanisms of type 2 diabetes (T2DM) risk loci can greatly inform on disease pathology. This review discusses current knowledge of mechanisms through which genetic variants influence T2DM risk and considerations for future studies. Recent Findings Over 100 T2DM risk loci to date have been identified. Candidate causal variants at risk loci map predominantly to non-coding sequence. Physiological, epigenomic and gene expression data suggest that variants at many known T2DM risk loci affect pancreatic islet regulation, although variants at other loci also affect protein function and regulatory processes in adipose, pre-adipose, liver, skeletal muscle and brain. The effects of T2DM variants on regulatory activity in these tissues appear largely, but not exclusively, due to altered transcription factor binding. Putative target genes of T2DM variants have been defined at an increasing number of loci and some, such as FTO, may entail several genes and multiple tissues. Gene networks in islets and adipocytes have been implicated in T2DM risk, although the molecular pathways of risk genes remain largely undefined. Summary Efforts to fully define the mechanisms of T2DM risk loci are just beginning. Continued identification of risk mechanisms will benefit from combining genetic fine-mapping with detailed phenotypic association data, high-throughput epigenomics data from diabetes-relevant tissue, functional screening of candidate genes and genome editing of cellular and animal models.	[Gaulton, Kyle J.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92093 USA	Gaulton, KJ (reprint author), Univ Calif San Diego, Dept Pediat, San Diego, CA 92093 USA.	kgaulton@ucsd.edu					Ackermann AM, 2016, MOL METAB, V5, P233, DOI 10.1016/j.molmet.2016.01.002; Alfa RW, 2016, DIS MODEL MECH, V9, P365, DOI 10.1242/dmm.023887; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Butler AA, 2003, ANN NY ACAD SCI, V994, P240, DOI 10.1111/j.1749-6632.2003.tb03186.x                                              ; Carrat GR, 2017, AM J HUM GENET, V100, P238, DOI 10.1016/j.ajhg.2017.01.011; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Claussnitzer M, 2016, NEW ENGL J MED, V374, P192, DOI 10.1056/NEJMc1513316; Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058; Cook JP, 2016, EUR J HUM GENET, V24, P1175, DOI 10.1038/ejhg.2016.17; Dimas AS, 2014, DIABETES, V63, P2158, DOI 10.2337/db13-0949; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5                                                   ; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Elliott HR, 2017, DIABETES, V66, P1713, DOI 10.2337/db16-0874; Fadista J, 2014, P NATL ACAD SCI USA, V111, P13924, DOI 10.1073/pnas.1402665111; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Fogarty MP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004633; Fogarty MP, 2013, DIABETES, V62, P1756, DOI 10.2337/db12-0972; Frayling TM, 2008, DIABETOLOGIA, V51, P1757, DOI 10.1007/s00125-008-1114-9; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Grotz AK, 2017, CURR DIABET IN PRESS; Grubert F, 2015, CELL, V162, P1051, DOI 10.1016/j.cell.2015.07.048; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Hebbring SJ, 2014, IMMUNOLOGY, V141, P157, DOI 10.1111/imm.12195; Horikoshi M, 2016, HUM MOL GENET, V25, P2070, DOI 10.1093/hmg/ddw048; Horikoshi M, 2016, NATURE, V538, P248, DOI 10.1038/nature19806; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kichaev G, 2015, AM J HUM GENET, V97, P260, DOI 10.1016/j.ajhg.2015.06.007; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kulzer JR, 2014, AM J HUM GENET, V94, P186, DOI 10.1016/j.ajhg.2013.12.011; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lawlor N, 2017, GENOME RES, V27, P208, DOI 10.1101/gr.212720.116; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Li YI, 2016, SCIENCE, V352, P600, DOI 10.1126/science.aad9417; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Locke JM, 2015, DIABETES, V64, P1484, DOI 10.2337/db14-0957; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JC130706; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Majithia AR, 2014, P NATL ACAD SCI USA, V111, P13127, DOI 10.1073/pnas.1410428111; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Mathelier A, 2015, TRENDS GENET, V31, P67, DOI 10.1016/j.tig.2014.12.003; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Pal A, 2016, DIABETES, V65, P527, DOI 10.2337/db15-0602; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Prokopenko I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004235; Rees MG, 2012, DIABETOLOGIA, V55, P114, DOI 10.1007/s00125-011-2348-5; Riley TR, 2014, METHODS MOL BIOL, V1196, P255, DOI 10.1007/978-1-4939-1242-1_16; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11764; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Stancakova A, 2011, DIABETES, V60, P1608, DOI 10.2337/db10-1655; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; Stitzel ML, 2010, CELL METAB, V12, P443, DOI 10.1016/j.cmet.2010.09.012; Stratigopoulos G, 2014, CELL METAB, V19, P767, DOI 10.1016/j.cmet.2014.04.009; Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thomsen SK, 2016, DIABETES, V65, P3805, DOI 10.2337/db16-0361; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; van de Bunt MV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005694; van de Bunt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055272; Varshney A, 2017, P NATL ACAD SCI USA, V114, P2301, DOI 10.1073/pnas.1621192114; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang A, 2015, CELL STEM CELL, V16, P386, DOI 10.1016/j.stem.2015.02.013; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Xavier GD, 2012, DIABETOLOGIA, V55, P2667, DOI 10.1007/s00125-012-2600-7; Xavier GD, 2013, J DIABETES RES, DOI 10.1155/2013/906590; Xia QH, 2016, DIABETOLOGIA, V59, P2360, DOI 10.1007/s00125-016-4077-2; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081	102	0	0	18	18	CURRENT MEDICINE GROUP	PHILADELPHIA	400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA	1534-4827	1539-0829		CURR DIABETES REP	Curr. Diabetes Rep.	SEP	2017	17	9							72	10.1007/s11892-017-0908-x				10	Endocrinology & Metabolism	Endocrinology & Metabolism	FD3QM	WOS:000407447500007	28741265				2018-01-05	
J	De Smet, J; Hendrix, H; Blasdel, BG; Danis-Wlodarczyk, K; Lavigne, R				De Smet, Jeroen; Hendrix, Hanne; Blasdel, Bob G.; Danis-Wlodarczyk, Katarzyna; Lavigne, Rob			Pseudomonas predators: understanding and exploiting phage-host interactions	NATURE REVIEWS MICROBIOLOGY			English	Review							CYSTIC-FIBROSIS PATIENTS; SEQUENCE-SPECIFIC ANTIMICROBIALS; BACTERIAL MUTATION-RATES; CHRONIC LUNG INFECTIONS; BACTERIOPHAGE PHI-KZ; ANTI-CRISPR PROTEINS; NS FAMILY-MEMBERS; IMMUNE-SYSTEM; IN-VIVO; AERUGINOSA BACTERIOPHAGES	Species in the genus Pseudomonas thrive in a diverse set of ecological niches and include crucial pathogens, such as the human pathogen Pseudomonas aeruginosa and the plant pathogen Pseudomonas syringae. The bacteriophages that infect Pseudomonas spp. mirror the widespread and diverse nature of their hosts. Therefore, Pseudomonas spp. and their phages are an ideal system to study the molecular mechanisms that govern virus-host interactions. Furthermore, phages are principal catalysts of host evolution and diversity, which directly affects the ecological roles of environmental and pathogenic Pseudomonas spp. Understanding these interactions not only provides novel insights into phage biology but also advances the development of phage therapy, phage-derived antimicrobial strategies and innovative biotechnological tools that may be derived from phage-bacteria interactions.	[De Smet, Jeroen; Hendrix, Hanne; Blasdel, Bob G.; Danis-Wlodarczyk, Katarzyna; Lavigne, Rob] Katholieke Univ Leuven, Dept Biosyst, Lab Gene Technol, Kasteelpk Arenberg 21,Box 2462, B-3001 Heverlee, Belgium	Lavigne, R (reprint author), Katholieke Univ Leuven, Dept Biosyst, Lab Gene Technol, Kasteelpk Arenberg 21,Box 2462, B-3001 Heverlee, Belgium.	Rob.Lavigne@kuleuven.be			GOA grant 'Phage biosystems' from KU Leuven [GOA/15/006]	The Laboratory of Gene Technology is supported by a GOA grant 'Phage biosystems' (GOA/15/006) from KU Leuven. J.D.S., K.D-.W. and B.G.B. hold a post-doctoral mandate (PDM) from KU Leuven.	Abdallah K, 2016, MOL MICROBIOL, V102, P1062, DOI 10.1111/mmi.13536; Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Adriaenssens EM, 2012, VIROLOGY, V434, P265, DOI 10.1016/j.virol.2012.09.018; Ali SS, 2012, CURR OPIN MICROBIOL, V15, P175, DOI 10.1016/j.mib.2011.12.014; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Aylett CHS, 2013, J MOL BIOL, V425, P2164, DOI 10.1016/j.jmb.2013.03.019; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beeton ML, 2015, INT J ANTIMICROB AG, V46, P196, DOI 10.1016/j.ijantimicag.2015.04.005; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2016, ISME J, V10, P2854, DOI 10.1038/ismej.2016.79; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Breitbart M, 2007, OCEANOGRAPHY, V20, P135, DOI 10.5670/oceanog.2007.58                                                         ; Briers Y, 2014, MBIO, V5, DOI 10.1128/mBio.01379-14; Briers Y, 2014, ANTIMICROB AGENTS CH, V58, P3774, DOI 10.1128/AAC.02668-14; Brockhurst Michael A., 2006, BMC Ecology, V6, P19, DOI 10.1186/1472-6785-6-19; Brussaard CPD, 2008, ISME J, V2, P575, DOI 10.1038/ismej.2008.31; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Budynek P, 2010, ARCH MICROBIOL, V192, P315, DOI 10.1007/s00203-010-0559-7; Budzik JM, 2004, J BACTERIOL, V186, P3270, DOI 10.1128/JB.186.10.3270-3273.2004; Cady KC, 2012, J BACTERIOL, V194, P5728, DOI 10.1128/JB.01184-12; Castang S, 2012, J BACTERIOL, V194, P5101, DOI 10.1128/JB.00932-12; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Cazares A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1146; Cenens W, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005770; Cenens W, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003269; Ceyssens PJ, 2008, J BACTERIOL, V190, P1429, DOI 10.1128/JB.01441-07; Ceyssens PJ, 2014, J VIROL, V88, P10501, DOI 10.1128/JVI.01347-14; Ceyssens PJ, 2010, FUTURE MICROBIOL, V5, P1041, DOI [10.2217/fmb.10.66, 10.2217/FMB.10.66]; Ceyssens PJ, 2009, ENVIRON MICROBIOL, V11, P1303, DOI 10.1111/j.1462-2920.2008.01862.x; Chabas H, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0721; Chan BK, 2016, SCI REP-UK, V6, DOI 10.1038/srep26717; Chevallereau A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006134; Chung IY, 2014, P NATL ACAD SCI USA, V111, P11503, DOI 10.1073/pnas.1403537111; Cisek AA, 2017, CURR MICROBIOL, V74, P277, DOI 10.1007/s00284-016-1166-x; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; Citorik RJ, 2014, CURR OPIN MICROBIOL, V19, P59, DOI 10.1016/j.mib.2014.05.022; Conter A, 1996, J BACTERIOL, V178, P5100, DOI 10.1128/jb.178.17.5100-5104.1996                                                ; Cooper CJ, 2014, LETT APPL MICROBIOL, V58, P118, DOI 10.1111/lam.12161; Cornelissen A, 2012, VIROLOGY, V434, P251, DOI 10.1016/j.virol.2012.09.030; Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597; Czaplewski L, 2016, LANCET INFECT DIS, V16, P239, DOI 10.1016/S1473-3099(15)00466-1; Danis-Wlodarczyk K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28115; Davies EV, 2016, ISME J, V10, P2553, DOI 10.1038/ismej.2016.51; Davies EV, 2016, P NATL ACAD SCI USA, V113, P8266, DOI 10.1073/pnas.1520056113; De Smet J, 2016, ISME J, V10, P1823, DOI 10.1038/ismej.2016.3; Defraine V, 2016, ANTIMICROB AGENTS CH, V60, P3480, DOI 10.1128/AAC.00285-16; Dendooven T, 2017, RNA BIOL, V14, P6, DOI 10.1080/15476286.2016.1251003; Erb ML, 2014, ELIFE, V3, DOI 10.7554/eLife.03197; Feiner R, 2015, NAT REV MICROBIOL, V13, P641, DOI 10.1038/nrmicro3527; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Fortier LC, 2013, VIRULENCE, V4, P354, DOI 10.4161/viru.24498; Frank JA, 2013, ISME J, V7, P1150, DOI 10.1038/ismej.2013.4; Freschi L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01036; Friman VP, 2014, ISME J, V8, P1820, DOI 10.1038/ismej.2014.40; Friman VP, 2013, ECOL LETT, V16, P39, DOI 10.1111/ele.12010; Furusawa T, 2016, APPL ENVIRON MICROB, V82, P5332, DOI 10.1128/AEM.01166-16; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gerstmans H, 2016, BIOCHEM SOC T, V44, P123, DOI 10.1042/BST20150192; Gloag ES, 2013, P NATL ACAD SCI USA, V110, P11541, DOI 10.1073/pnas.1218898110; Glonti T, 2010, J APPL MICROBIOL, V108, P695, DOI 10.1111/j.1365-2672.2009.04469.x; Gomez P, 2013, ISME J, V7, P2242, DOI 10.1038/ismej.2013.105; Gomez P, 2011, SCIENCE, V332, P106, DOI 10.1126/science.1198767; Gorski A, 2006, FEMS IMMUNOL MED MIC, V46, P313, DOI 10.1111/j.1574-695X.2006.00044.x; Gorski A, 2005, CELL MOL LIFE SCI, V62, P511, DOI 10.1007/s00018-004-4403-6; Gorski A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01515; Gorski A, 2012, ADV VIRUS RES, V83, P41, DOI 10.1016/B978-0-12-394438-2.00002-5; Gorter FA, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0879; Hall AR, 2011, ECOL LETT, V14, P635, DOI 10.1111/j.1461-0248.2011.01624.x; Hatfull GF, 2015, J VIROL, V89, P8107, DOI 10.1128/JVI.01340-15; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Hawkins C, 2010, VET MICROBIOL, V146, P309, DOI 10.1016/j.vetmic.2010.05.014; Henry M, 2013, ANTIMICROB AGENTS CH, V57, P5961, DOI 10.1128/AAC.01596-13; Hodyra-Stefaniak K, 2015, SCI REP-UK, V5, DOI 10.1038/srep14802; Hosseinidoust Z, 2013, APPL ENVIRON MICROB, V79, P6110, DOI 10.1128/AEM.01421-13; Hosseinidoust Z, 2013, BIOFOULING, V29, P457, DOI 10.1080/08927014.2013.779370; Hui JGK, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00654; James CE, 2015, ISME J, V9, P1391, DOI 10.1038/ismej.2014.223; Khairnar K, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-264; Klimuk E, 2013, VIROLOGY, V436, P67, DOI 10.1016/j.virol.2012.10.021; Koskella B, 2014, FEMS MICROBIOL REV, V38, P916, DOI 10.1111/1574-6976.12072; Kraemer JA, 2012, CELL, V149, P1488, DOI 10.1016/j.cell.2012.04.034; Kramberger P, 2015, HUM VACC IMMUNOTHER, V11, P1010, DOI 10.1080/21645515.2015.1009817; Kung VL, 2010, MICROBIOL MOL BIOL R, V74, P621, DOI 10.1128/MMBR.00027-10; Kutateladze M, 2008, MED MALADIES INFECT, V38, P426, DOI 10.1016/j.medmal.2008.06.023; Kutateladze M, 2010, TRENDS BIOTECHNOL, V28, P591, DOI 10.1016/j.tibtech.2010.08.001; Kwan T, 2006, J BACTERIOL, V188, P1184, DOI 10.1128/JB.188.3.1184-1187.2006; Latino L, 2016, MICROBIOL-SGM, V162, P748, DOI 10.1099/mic.0.000263; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Lavigne R, 2013, MBIO, V4, DOI 10.1128/mBio.00061-13; Lavigne R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-224; Le S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04738; Le S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068562; Lemieux AA, 2016, J INFECT DIS, V213, P395, DOI 10.1093/infdis/jiv415; Leung SSY, 2016, PHARM RES-DORDR, V33, P1486, DOI 10.1007/s11095-016-1892-6; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Liu J, 2004, NAT BIOTECHNOL, V22, P185, DOI 10.1038/nbt932; Loc-Carrillo C., 2014, BACTERIOPHAGE, V1, P111; Lusiak-Szelachowska M, 2014, VIRAL IMMUNOL, V27, P295, DOI 10.1089/vim.2013.0128; Markoishvili K, 2002, INT J DERMATOL, V41, P453, DOI 10.1046/j.1365-4362.2002.01451.x                                                ; Martinez-Garcia E, 2015, ENVIRON MICROBIOL, V17, P76, DOI 10.1111/1462-2920.12492; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P1340, DOI 10.1111/j.1462-2920.2009.01860.x; Marza JAS, 2006, BURNS, V32, P644, DOI 10.1016/j.burns.2006.02.012; Maynard ND, 2010, BIOTECHNOL J, V5, P686, DOI 10.1002/biot.201000080; Mcvay CS, 2007, ANTIMICROB AGENTS CH, V51, P1934, DOI 10.1128/AAC.01028-06; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Monson R, 2011, MICROBIOL-SGM, V157, P859, DOI 10.1099/mic.0.044701-0; Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963; Nakayama K, 1999, MOL MICROBIOL, V31, P399, DOI 10.1046/j.1365-2958.1999.01158.x; Olszak T, 2015, APPL MICROBIOL BIOT, V99, P6021, DOI 10.1007/s00253-015-6492-6; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; Park SC, 2003, DIS AQUAT ORGAN, V53, P33, DOI 10.3354/dao053033; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Penner JC, 2016, MICROBIOL-SGM, V162, P1583, DOI 10.1099/mic.0.000344; Petrova OE, 2011, MOL MICROBIOL, V81, P767, DOI 10.1111/j.1365-2958.2011.07733.x; Pires DP, 2016, MICROBIOL MOL BIOL R, V80, P523, DOI 10.1128/MMBR.00069-15; Pirnay JP, 2015, PHARM RES-DORDR, V32, P2173, DOI 10.1007/s11095-014-1617-7; Pirnay JP, 2011, PHARM RES-DORDR, V28, P934, DOI 10.1007/s11095-010-0313-5; Qimron U, 2008, MOL MICROBIOL, V67, P448, DOI 10.1111/j.1365-2958.2007.06058.x; Ravantti JJ, 2008, J VIROL, V82, P2324, DOI 10.1128/JVI.01930-07; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; Rohwer F, 2011, NAT REV MICROBIOL, V9, P308, DOI 10.1038/nrmicro2572; Rombouts S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00279; Rose T, 2014, INT J BURNS TRAUMA, V4, P66; Roucourt B, 2009, ENVIRON MICROBIOL, V11, P2789, DOI 10.1111/j.1462-2920.2009.02029.x; Ryan EM, 2011, J PHARM PHARMACOL, V63, P1253, DOI 10.1111/j.2042-7158.2011.01324.x; Sahota JS, 2015, J AEROSOL MED PULM D, V28, P353, DOI 10.1089/jamp.2014.1172; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Saussereau E, 2014, CLIN MICROBIOL INFEC, V20, pO983, DOI 10.1111/1469-0691.12712; Scanlan PD, 2015, MOL BIOL EVOL, V32, P1425, DOI 10.1093/molbev/msv032; Scanlan PD, 2011, MOL ECOL, V20, P981, DOI 10.1111/j.1365-294X.2010.04903.x; Scanlan PD, 2012, ISME J, V6, P1148, DOI 10.1038/ismej.2011.174; Secor PR, 2015, CELL HOST MICROBE, V18, P549, DOI 10.1016/j.chom.2015.10.013; Sepulveda-Robles O, 2012, APPL ENVIRON MICROB, V78, P4510, DOI 10.1128/AEM.00065-12; Sharon I, 2011, ISME J, V5, P1178, DOI 10.1038/ismej.2011.2; Sheppard C, 2013, RNA BIOL, V10, P495, DOI 10.4161/rna.24283; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Simmonds P, 2017, NAT REV MICROBIOL, V15, P161, DOI 10.1038/nrmicro.2016.177; Singla S, 2016, J VIROL METHODS, V236, P68, DOI 10.1016/j.jviromet.2016.07.002; Sonkar K, 2012, ANAL CHEM, V84, P4063, DOI 10.1021/ac300096j; Stover CK, 2000, NATURE, V406, P959; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Summers WC, 2001, ANNU REV MICROBIOL, V55, P437, DOI 10.1146/annurev.micro.55.1.437; Taylor TB, 2013, J EVOLUTION BIOL, V26, P2154, DOI 10.1111/jeb.12214; Taylor VL, 2013, J BACTERIOL, V195, P4735, DOI 10.1128/JB.00903-13; Thompson LR, 2011, P NATL ACAD SCI USA, V108, pE757, DOI 10.1073/pnas.1102164108; Tummler B., 2014, F1000PRIME REP, V6, P9; Turnbull L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11220; van Belkum A, 2015, MBIO, V6, DOI 10.1128/mBio.01796-15; Van den Bossche A, 2016, ELIFE, V5, DOI 10.7554/eLife.16413; Van den Bossche A, 2014, J PROTEOME RES, V13, P4446, DOI 10.1021/pr500796n; Vandenheuvel D, 2014, INT J PHARMACEUT, V472, P202, DOI 10.1016/j.ijpharm.2014.06.026; Vandenheuvel D, 2013, EUR J PHARM BIOPHARM, V84, P578, DOI 10.1016/j.ejpb.2012.12.022; Vogwill T, 2011, BIOL LETTERS, V7, P578, DOI 10.1098/rsbl.2011.0071; Wagemans J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01242; Wagemans J, 2014, CELL MICROBIOL, V16, P1822, DOI 10.1111/cmi.12330; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910                                                   ; Wang XX, 2016, DRUG RESIST UPDATE, V27, P30, DOI 10.1016/j.drup.2016.06.001; Weber-Dabrowska B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01177; Weigele P, 2016, CHEM REV, V116, P12655, DOI 10.1021/acs.chemrev.6b00114; Westra ER, 2015, CURR BIOL, V25, P1043, DOI 10.1016/j.cub.2015.01.065; Woolston BM, 2013, ANNU REV CHEM BIOMOL, V4, P259, DOI 10.1146/annurev-chembioeng-061312-103312; Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x; Yakunina M, 2015, NUCLEIC ACIDS RES, V43, P10411, DOI 10.1093/nar/gkv1095; Yano ST, 2011, MOL MICROBIOL, V79, P1325, DOI 10.1111/j.1365-2958.2010.07526.x; Yin YB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-24; Zhang QG, 2012, EVOL APPL, V5, P575, DOI 10.1111/j.1752-4571.2011.00236.x	172	2	2	32	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1740-1526	1740-1534		NAT REV MICROBIOL	Nat. Rev. Microbiol.	SEP	2017	15	9					517	530		10.1038/nrmicro.2017.61				14	Microbiology	Microbiology	FD4NK	WOS:000407507600007	28649138				2018-01-05	
J	Park, S; Zhang, XW; Li, C; Yin, CH; Li, JW; Fallon, JT; Huang, WH; Xu, DZ				Park, Soyoung; Zhang, Xiaowen; Li, Cen; Yin, Changhong; Li, Jiangwei; Fallon, John T.; Huang, Weihua; Xu, Dazhong			Single-cell RNA sequencing reveals an altered gene expression pattern as a result of CRISPR/cas9-mediated deletion of Gene 33/Mig6 and chronic exposure to hexavalent chromium in human lung epithelial cells	TOXICOLOGY AND APPLIED PHARMACOLOGY			English	Article						Gene 33/Mig6; RNA-seq; Single cell; Carcinogenesis; Lung; Chromium	C-TERMINAL HYDROLASE-L1; MEG3 NONCODING RNA; INDUCED DNA-DAMAGE; EGF RECEPTOR; TUMOR-SUPPRESSOR; MESENCHYMAL TRANSITION; ENDOGENOUS INHIBITOR; BREAST-CANCER; KINASE DOMAIN; UCH-L1	Gene 33 (Mig6, ERRFI1) is an adaptor protein with multiple cellular functions. We recently reported that depletion of this protein promotes lung epithelial cell transformation induced by hexavalent chromium [Cr(VI)]. However, the early molecular events that mediate this process are not clear. In the present study, we used single-cell RNA sequencing to compare gene expression profiles between BEAS-2B lung epithelial cells chronically exposed to a sublethal dose of Cr(VI) with or without CRISPR/cas9-mediated deletion of Gene 33. Our data reveal 83 differentially expressed genes. The most notable changes are genes associated with cell adhesion, oxidative stresses, protein ubiquitination, epithelial-mesenchymal transition/metastasis, and WNT signaling. Up-regulation of some neuro-specific genes is also evident, particularly ubiquitin carboxyl-terminal hydrolase L1 (UCHL1), a deubiquitinase and potential biomarker for lung cancer. Gene 33 deletion and/or Cr(VI) exposure did not cause discernable changes in cell morphology. However, Gene 33 deletion led to a modest but significant reduction of cells in the G2/M phase of the cell cycle regardless of Cr(VI) exposure. Gene 33 deletion also significantly reduced cell proliferation. Interestingly, Cr(VI) exposure eliminated the difference in cell proliferation between the two genotypes. Gene 33 deletion also significantly elevated cell migration. Our data indicate that combined Gene 33 deletion and chronic Cr(VI) exposure produces a gene expression pattern and a phenotype resemble those of the transformed lung epithelial cells. Given the known association of UCHL1 with lung cancer, we propose that UCHL1 is an important player in the early stage of lung epithelial cell transformation and tumorigenesis. (C) 2017 Elsevier Inc. All rights reserved.	[Park, Soyoung; Zhang, Xiaowen; Li, Cen; Yin, Changhong; Li, Jiangwei; Fallon, John T.; Huang, Weihua; Xu, Dazhong] New York Med Coll, Dept Pathol, Sch Med, 15 Dana Rd, Valhalla, NY 10595 USA	Xu, DZ (reprint author), New York Med Coll, Dept Pathol, Sch Med, 15 Dana Rd, Valhalla, NY 10595 USA.	Dazhong_xu@nymc.edu			National Institutes of Health [R21ES023862]; startup fund from NYMC; funds from the NYMC Castle-Krob Research Endowment Fund under the College's Intramural Research Support Program; Philips Research North America	This work was supported in part by National Institutes of Health Grant R21ES023862 (DX), a startup fund from NYMC (DX), funds from the NYMC Castle-Krob Research Endowment Fund under the College's Intramural Research Support Program (DX), and Philips Research North America (JTF).	Anastasi S, 2007, ONCOGENE, V26, P7833, DOI 10.1038/sj.onc.1210590; Anastasi S, 2003, ONCOGENE, V22, P4221, DOI 10.1038/sj.onc.1206516; BERENDSEN HH, 1989, J CLIN ONCOL, V7, P1614, DOI 10.1200/JCO.1989.7.11.1614                                                      ; Bheda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005955; BRAVER ER, 1985, TERATOGEN CARCIN MUT, V5, P365, DOI 10.1002/tcm.1770050507; Brennan DJ, 2012, ONCOGENE, V31, P3483, DOI 10.1038/onc.2011.519; Brinkmann K, 2013, CELL REP, V3, P881, DOI 10.1016/j.celrep.2013.02.014; Caballero OL, 2002, ONCOGENE, V21, P3003, DOI 10.1038/sj/onc/1205390; Cano CE, 2011, J CELL PHYSIOL, V226, P1439, DOI 10.1002/jcp.22324; Carnaghi C, 2001, ANN ONCOL, V12, pS119, DOI 10.1093/annonc/12.suppl_2.S119                                                  ; Carolan BJ, 2006, CANCER RES, V66, P10729, DOI 10.1158/0008-5472.CAN-06-2224; Cartularo L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155002; Chen DQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157317; Cheng L, 1998, ENVIRON HEALTH PERSP, V106, P1027, DOI 10.2307/3434147                                                                 ; Cheng Lei, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P239; Chiu A, 2010, J ENVIRON SCI HEAL C, V28, P188, DOI 10.1080/10590501.2010.504980; Costa AN, 2010, MOL CARCINOGEN, V49, P582, DOI 10.1002/mc.20624; Costa M, 2006, CRIT REV TOXICOL, V36, P155, DOI 10.1080/10408440500534032; Ding M, 2002, MOL CELL BIOCHEM, V234, P293, DOI 10.1023/A:1015975218920; Emma MR, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.175; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Fiorentino L, 2000, MOL CELL BIOL, V20, P7735, DOI 10.1128/MCB.20.20.7735-7750.2000; Gibb HJ, 2000, AM J IND MED, V38, P115, DOI 10.1002/1097-0274(200008)38:2<115::AID-AJIM1>3.3.CO;2-P; Gironella M, 2009, J CELL PHYSIOL, V221, P594, DOI 10.1002/jcp.21889; Goruppi S, 2010, J BIOL CHEM, V285, P1577, DOI 10.1074/jbc.R109.080887; Goto Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7153; Grasso D, 2015, SCI REP-UK, V5, DOI 10.1038/srep17549; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Ha N, 2003, J BIOL CHEM, V278, P17885, DOI 10.1074/jbc.M210560200; Halasova E, 2009, NEUROENDOCRINOL LETT, V30, P182; Hibi K, 1999, AM J PATHOL, V155, P711, DOI 10.1016/S0002-9440(10)65169-3                                                   ; Hibi K, 1998, CANCER RES, V58, P5690; Holmes AL, 2008, INDIAN J MED RES, V128, P353; Hopkins S, 2012, DEV CELL, V23, P547, DOI 10.1016/j.devcel.2012.08.001; Hu LY, 2011, CELL CYCLE, V10, P2373, DOI 10.4161/cc.10.14.16310; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Hurst-Kennedy J., 2012, BIOCH RES INT, V2012, DOI DOI 10.1155/2012/123706; Hussain S, 2010, LEUKEMIA, V24, P1641, DOI 10.1038/leu.2010.138; Imbeault M, 2017, NATURE, V543, P550, DOI 10.1038/nature21683; Jiang XN, 2016, ONCOTARGET, V7, P49180, DOI 10.18632/oncotarget.10205; Jin YT, 2015, INT J CLIN EXP PATHO, V8, P12500; Kabuta T, 2013, J BIOL CHEM, V288, P12615, DOI 10.1074/jbc.M112.435701; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim HJ, 2009, ONCOGENE, V28, P117, DOI 10.1038/onc.2008.364; Kim HJ, 2015, ONCOTARGET, V6, P16287, DOI 10.18632/oncotarget.3843                                                        ; Li LL, 2010, CLIN CANCER RES, V16, P2949, DOI 10.1158/1078-0432.CCR-09-3178; Li ZX, 2012, MOL CARCINOGEN, V51, P522, DOI 10.1002/mc.20815; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Luchansky SJ, 2006, BIOCHEMISTRY-US, V45, P14717, DOI 10.1021/bi061406c; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Orr KS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-79; Pante G, 2005, J CELL BIOL, V171, P337, DOI 10.1083/jcb.200502013; Park RM, 2004, RISK ANAL, V24, P1099, DOI 10.1111/j.0272-4332.2004.00512.x                                                ; Park S, 2016, ONCOTARGET, V7, P8916, DOI 10.18632/oncotarget.6866; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pratheeshkumar P, 2016, ONCOTARGET, V7, P51193, DOI 10.18632/oncotarget.9967; Stewart DJ, 2014, JNCI-J NATL CANCER I, P106, DOI DOI 10.1093/JNCI/DJT356; SULZER D, 1995, J NEUROSCI, V15, P4102; Tramutola A, 2016, OXID MED CELL LONGEV, DOI 10.1155/2016/2756068; Tseng RC, 2005, INT J CANCER, V117, P241, DOI 10.1002/ijc.21178; Tsunoda T, 2002, CANCER RES, V62, P5668; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Xie BS, 2013, BIOL CELL, V105, P488, DOI 10.1111/boc.201200052; Xu DZ, 2006, MOL CELL BIOL, V26, P5043, DOI 10.1128/MCB.02387-05; Xu DZ, 2005, J BIOL CHEM, V280, P2924, DOI 10.1074/jbc.M408907200; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835                                                          ; Zhang X, 2003, J CLIN ENDOCR METAB, V88, P5119, DOI 10.1210/jc.2003-030222; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhang YW, 2007, ONCOGENE, V26, P269, DOI 10.1038/sj.onc.1209790; Zhang YW, 2007, CELL CYCLE, V6, P507, DOI 10.4161/cc.6.5.3928; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008; Zhu JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139790	74	0	0	12	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0041-008X	1096-0333		TOXICOL APPL PHARM	Toxicol. Appl. Pharmacol.	SEP 1	2017	330						30	39		10.1016/j.taap.2017.07.003				10	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	FD6UE	WOS:000407662600004	28688920				2018-01-05	
J	Hanania, U; Ariel, T; Tekoah, Y; Fux, L; Sheva, M; Gubbay, Y; Weiss, M; Oz, D; Azulay, Y; Turbovski, A; Forster, Y; Shaaltiel, Y				Hanania, Uri; Ariel, Tami; Tekoah, Yoram; Fux, Liat; Sheva, Maor; Gubbay, Yehuda; Weiss, Mara; Oz, Dina; Azulay, Yaniv; Turbovski, Albina; Forster, Yehava; Shaaltiel, Yoseph			Establishment of a tobacco BY2 cell line devoid of plant-specific xylose and fucose as a platform for the production of biotherapeutic proteins	PLANT BIOTECHNOLOGY JOURNAL			English	Article						glyco-engineering; biopharming; DNaseI; plant glycans; CRISPR/Cas9; gene editing	ENGINEERED NICOTIANA-BENTHAMIANA; COMPLEX N-GLYCANS; MONOCLONAL-ANTIBODY; GENERATION; ARABIDOPSIS; GLYCOSYLATION; ENDONUCLEASE; CAS9	Plant-produced glycoproteins contain N-linked glycans with plant-specific residues of beta(1,2)-xylose and core alpha(1,3)-fucose, which do not exist in mammalian-derived proteins. Although our experience with two enzymes that are used for enzyme replacement therapy does not indicate that the plant sugar residues have deleterious effects, we made a conscious decision to eliminate these moieties from plant-expressed proteins. We knocked out the beta(1,2)-xylosyltranferase (XylT) and the alpha(1,3)-fucosyltransferase (FucT) genes, using CRISPR/Cas9 genome editing, in Nicotiana tabacum L. cv Bright Yellow 2 (BY2) cell suspension. In total, we knocked out 14 loci. The knocked-out lines were stable, viable and exhibited a typical BY2 growing rate. Glycan analysis of the endogenous proteins of these lines exhibited N-linked glycans lacking beta(1,2)-xylose and/or alpha(1,3)-fucose. The knocked-out lines were further transformed successfully with recombinant DNaseI. The expression level and the activity of the recombinant protein were similar to that of the protein produced in the wild-type BY2 cells. The recombinant DNaseI was shown to be totally free from any xylose and/or fucose residues. The glyco-engineered BY2 lines provide a valuable platform for producing potent biopharmaceutical products. Furthermore, these results demonstrate the power of the CRISPR/Cas9 technology for multiplex gene editing in BY2 cells.	[Hanania, Uri; Ariel, Tami; Tekoah, Yoram; Fux, Liat; Sheva, Maor; Gubbay, Yehuda; Weiss, Mara; Oz, Dina; Azulay, Yaniv; Turbovski, Albina; Forster, Yehava; Shaaltiel, Yoseph] Protalix Biotherapeut, Carmiel, Israel	Tekoah, Y (reprint author), Protalix Biotherapeut, Carmiel, Israel.	yoram.tekoah@protalix.com			Protalix Biotherapeutics	All of the authors are or were employees of Protalix Biotherapeutics, the sponsor of this study, and as such have vested commercial interests.	AN GH, 1985, PLANT PHYSIOL, V79, P568, DOI 10.1104/pp.79.2.568                                                             ; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Castilho A, 2011, GLYCOBIOLOGY, V21, P813, DOI 10.1093/glycob/cwr009; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Fox JL, 2012, NAT BIOTECHNOL, V30, P478, DOI 10.1038/nbt0612-478c; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gorbunova V, 1999, TRENDS PLANT SCI, V4, P263, DOI 10.1016/S1360-1385(99)01430-2                                                   ; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiang WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099225; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kumar S, 2006, TRENDS PLANT SCI, V11, P159, DOI 10.1016/j.tplants.2006.02.002; Li J, 2016, PLANT BIOTECHNOL J, V14, P533, DOI 10.1111/pbi.12403; Limkul J, 2016, PLANT BIOTECHNOL J, V14, P1682, DOI 10.1111/pbi.12529; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsuo K, 2011, PLANT BIOTECHNOL J, V9, P264, DOI 10.1111/j.1467-7652.2010.00553.x; Mercx S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00040; Nagata T., 2004, TOBACCO BY 2 CELLS, P1; Nagata Toshiyuki, 1999, Methods in Cell Science, V21, P123, DOI 10.1023/A:1009832822096; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Santos RB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00297; Schiml S, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0103-0; Shaaltiel Y, 2016, NAT BIOTECHNOL, V34, P706, DOI 10.1038/nbt.3556; SINICROPI D, 1994, ANAL BIOCHEM, V222, P351, DOI 10.1006/abio.1994.1502; Strasser R, 2004, FEBS LETT, V561, P132, DOI 10.1016/S0014-5793(04)00150-4; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Tekoah Y, 2004, ARCH BIOCHEM BIOPHYS, V426, P266, DOI 10.1016/j.abb.2004.02.034; Tekoah Y, 2015, PLANT BIOTECHNOL J, V13, P1199, DOI 10.1111/pbi.12428; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wenderoth I, 2000, PLANT PHYSIOL, V123, P1097, DOI 10.1104/pp.123.3.1097; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Yin BJ, 2011, PROTEIN CELL, V2, P41, DOI 10.1007/s13238-011-1007-4; Weterings K., 2013, Icon Genetic Gmbh. Patent, Patent No. [2013050155 A1, 2013050155]	36	3	3	12	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1467-7644	1467-7652		PLANT BIOTECHNOL J	Plant Biotechnol. J.	SEP	2017	15	9					1120	1129		10.1111/pbi.12702				10	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	FD2PU	WOS:000407378100004	28160363	gold			2018-01-05	
J	Blednov, YA; Borghese, CM; Ruiz, CI; Cullins, MA; Da Costa, A; Osterndorff-Kahanek, EA; Homanics, GE; Harris, RA				Blednov, Yuri A.; Borghese, Cecilia M.; Ruiz, Carlos I.; Cullins, Madeline A.; Da Costa, Adriana; Osterndorff-Kahanek, Elizabeth A.; Homanics, Gregg E.; Harris, R. Adron			Mutation of the inhibitory ethanol site in GABA(A) rho 1 receptors promotes tolerance to ethanol-induced motor incoordination	NEUROPHARMACOLOGY			English	Article						GABA(A) rhol receptor; p1 Knockin and knockout mice; Ethanol-induced motor impairment; Acute functional tolerance; Xenopus oocytes	ACUTE FUNCTIONAL TOLERANCE; CONDITIONED TASTE-AVERSION; ALCOHOL-CONSUMPTION; USE DISORDERS; MUTANT MICE; SUBUNITS; IDENTIFICATION; SPECIFICITY; SENSITIVITY; DEPENDENCE	Genes encoding the rho 1/2 subunits of GABA(A) receptors have been associated with alcohol (ethanol) dependence in humans, and rho 1 was also shown to regulate some of the behavioral effects of ethanol in animal models. Ethanol inhibits GABA-mediated responses in wild-type (WT) rho 1, but not rho 1 (T6'Y) mutant receptors expressed in Xenopus laevis oocytes, indicating the presence of an inhibitory site for ethanol in the second transmembrane helix. In this study, we found that rho 1(T6'Y) receptors expressed in oocytes display overall normal responses to GABA, the endogenous GABA modulator (zinc), and partial agonists (beta-alanine and taurine). We generated rho 1 (T6'Y) knockin (KI) mice using CRISPR/Cas9 to test the behavioral importance of the inhibitory actions of ethanol on this receptor. Both rho 1 KI and knockout (KO) mice showed faster recovery from acute ethanol-induced motor incoordination compared to WT mice. Both KI and KO mutant strains also showed increased tolerance to motor impairment produced by ethanol. The KI mice did not differ from WT mice in other behavioral actions, including ethanol intake and preference, conditioned taste aversion to ethanol, and duration of ethanol-induced loss of righting reflex. WT and KI mice did not differ in levels of rho 1 or rho 2 mRNA in cerebellum or in ethanol clearance. Our findings indicate that the inhibitory site for ethanol in GABA(A) rho 1 receptors regulates acute functional tolerance to moderate ethanol intoxication. We note that low sensitivity to alcohol intoxication has been linked to risk for development of alcohol dependence in humans. (C) 2017 Elsevier Ltd. All rights reserved.	[Blednov, Yuri A.; Borghese, Cecilia M.; Ruiz, Carlos I.; Cullins, Madeline A.; Da Costa, Adriana; Osterndorff-Kahanek, Elizabeth A.; Harris, R. Adron] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, 2500 Speedway, Austin, TX 78712 USA; [Homanics, Gregg E.] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Homanics, Gregg E.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15261 USA; [Homanics, Gregg E.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Harris, RA (reprint author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, 2500 Speedway, Austin, TX 78712 USA.	harris@austin.utexas.edu		Homanics, Gregg/0000-0003-3641-8153; harris, robert/0000-0001-8870-5950; Borghese, Cecilia/0000-0002-1028-8277	National Institutes of Health [AA006399, AA013520, AA010422, AA020889]	The authors thank Carolyn Ferguson, Olga Ponomareva, and Courtney Bridges for expert technical assistance and Jody Mayfield for help writing and editing the manuscript and preparing figures. This research was supported by the National Institutes of Health grants AA006399 (RAH), AA013520 (YAB and RAH), AA010422 and AA020889 (GEH).	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Blednov YA, 2013, NEUROPHARMACOLOGY, V67, P46, DOI 10.1016/j.neuropharm.2012.10.016; Blednov YA, 2011, J PHARMACOL EXP THER, V336, P145, DOI 10.1124/jpet.110.171645; Blednov YA, 2003, J PHARMACOL EXP THER, V305, P854, DOI 10.1124/jpet.103.049478; Blednov YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085525; Boehm SL, 2004, BIOCHEM PHARMACOL, V68, P1581, DOI 10.1016/j.bcp.2004.07.023; Borghese CM, 2016, ACS CHEM NEUROSCI, V7, P100, DOI [10.1021/acs.chemneuro.5b00246, 10.1021/acschemneuro.5b00246]; Boue-Grabot E, 1998, J NEUROCHEM, V70, P899; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CUTTING GR, 1992, GENOMICS, V12, P801, DOI 10.1016/0888-7543(92)90312-G; CUTTING GR, 1991, P NATL ACAD SCI USA, V88, P2673, DOI 10.1073/pnas.88.7.2673; Demarest K, 2001, BEHAV GENET, V31, P79, DOI 10.1023/A:1010261909853; Erwin VG, 1996, J PHARMACOL EXP THER, V279, P1310; Erwin VG, 2000, J PHARMACOL EXP THER, V293, P188; Fritz BM, 2013, GENES BRAIN BEHAV, V12, P78, DOI 10.1111/j.1601-183X.2012.00830.x; Fritz BM, 2014, ALCOHOL CLIN EXP RES, V38, P1284, DOI 10.1111/acer.12385; Gill K, 1996, ALCOHOL CLIN EXP RES, V20, P185, DOI 10.1111/j.1530-0277.1996.tb01063.x; Guo DY, 2015, J INTEGR BIOINFORMAT, V12, DOI 10.2390/biecoll-jib-2015-283; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Johnston Graham A. R., 2002, Current Topics in Medicinal Chemistry, V2, P903, DOI 10.2174/1568026023393453; Kendler KS, 2011, TWIN RES HUM GENET, V14, P1, DOI 10.1375/twin.14.1.1; Kumar S, 2009, PSYCHOPHARMACOLOGY, V205, P529, DOI 10.1007/s00213-009-1562-z; Lobo IA, 2008, PHARMACOL BIOCHEM BE, V90, P90, DOI 10.1016/j.pbb.2008.03.006; Merikangas KR, 1998, ARCH GEN PSYCHIAT, V55, P973, DOI 10.1001/archpsyc.55.11.973                                                      ; Mihic SJ, 1996, J PHARMACOL EXP THER, V277, P411; Naffaa MM, 2017, BRIT J PHARMACOL, V174, P1881, DOI 10.1111/bph.13768; NEWLIN DB, 1991, ALCOHOL CLIN EXP RES, V15, P399, DOI 10.1111/j.1530-0277.1991.tb00537.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SCHUCKIT MA, 1985, ARCH GEN PSYCHIAT, V42, P375; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Shram MJ, 2004, ALCOHOL CLIN EXP RES, V28, P1814, DOI 10.1097/01.ALC.0000148105.79934.14; Wallace MJ, 2007, NEUROPSYCHOPHARMACOL, V32, P127, DOI 10.1038/sj.npp.1301059; Werner DF, 2009, ALCOHOL CLIN EXP RES, V33, P289, DOI 10.1111/j.1530-0277.2008.00832.x; Xuei XL, 2010, AM J MED GENET B, V153B, P418, DOI 10.1002/ajmg.b.30995; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134	35	0	0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	SEP 1	2017	123						201	209		10.1016/j.neuropharm.2017.06.013				9	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	FC6YJ	WOS:000406987300018	28623169				2018-01-05	
J	Chandrasekaran, AP; Song, M; Ramakrishna, S				Chandrasekaran, Arun Pandian; Song, Minjung; Ramakrishna, Suresh			Genome editing: a robust technology for human stem cells	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Review						Induced pluripotent stem cells; Embryonic stem cells; Zinc finger nucleases; Transcription activator-like effector nucleases; Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated system	ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAKS; HUMAN HEMATOPOIETIC STEM; TAL EFFECTOR NUCLEASES; DNA-BINDING SPECIFICITY; GENE CORRECTION; HOMOLOGOUS RECOMBINATION; CRISPR-CAS9 NUCLEASES; LENTIVIRAL VECTOR; HUMAN BLASTOCYSTS	Human pluripotent stem cells comprise induced pluripotent and embryonic stem cells, which have tremendous potential for biological and therapeutic applications. The development of efficient technologies for the targeted genome alteration of stem cells in disease models is a prerequisite for utilizing stem cells to their full potential. Genome editing of stem cells is possible with the help of synthetic nucleases that facilitate site-specific modification of a gene of interest. Recent advances in genome editing techniques have improved the efficiency and speed of the development of stem cells for human disease models. Zinc finger nucleases, transcription activator- like effector nucleases, and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated system are powerful tools for editing DNA at specific loci. Here, we discuss recent technological advances in genome editing with site-specific nucleases in human stem cells.	[Chandrasekaran, Arun Pandian; Ramakrishna, Suresh] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul, South Korea; [Song, Minjung] Silla Univ, Div Bioind, Dept Food Biotechnol, Coll Med & Life Sci, Seoul, South Korea; [Ramakrishna, Suresh] Hanyang Univ, Coll Med, Seoul, South Korea	Ramakrishna, S (reprint author), Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul, South Korea.; Song, M (reprint author), Silla Univ, Div Bioind, Dept Food Biotechnol, Coll Med & Life Sci, Seoul, South Korea.; Ramakrishna, S (reprint author), Hanyang Univ, Coll Med, Seoul, South Korea.	songmj@silla.ac.kr; suri28@hanyang.ac.kr		Ramakrishna, Suresh/0000-0002-4038-1085	National Research Foundation of Korea [2015R1C1A1A01054482, 2013R1A1A1075992]	We would like to thank all of Suri's laboratory members for their helpful discussions. Our work is supported by the National Research Foundation of Korea (2015R1C1A1A01054482 and 2013R1A1A1075992).	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; An MC, 2014, PLOS CURR, V6, DOI [10.1371/currents.hd.0242d2e7ad72225efa72f6964589369a, DOI 10.1371/CURRENTS.HD.0242D2E7AD72225EFA72F6964589369A]; Asuri P, 2012, MOL THER, V20, P329, DOI 10.1038/mt.2011.255; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassuk AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19969; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Boettcher M, 2015, MOL CELL, V58, P575, DOI 10.1016/j.molcel.2015.04.028; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Boudes PF, 2014, EUR J INTERN MED, V25, P31, DOI 10.1016/j.ejim.2013.09.009; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Capecchi MR, 2001, NAT MED, V7, P1086, DOI 10.1038/nm1001-1086                                                             ; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cerbini T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116032; Chandrasegaran S, 1999, BIOL CHEM, V380, P841, DOI 10.1515/BC.1999.103                                                             ; Chen YJ, 2015, CELL STEM CELL, V17, P233, DOI 10.1016/j.stem.2015.06.001; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Choi SM, 2013, HEPATOLOGY, V57, P2458, DOI 10.1002/hep.26237; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cohen-Tannoudji M, 1998, MOL CELL BIOL, V18, P1444, DOI 10.1128/MCB.18.3.1444                                                           ; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330                                                            ; Davis L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023981; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deng D, 2012, CELL RES, V22, P1502, DOI 10.1038/cr.2012.127; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Di Domenico AI, 2008, CLONING STEM CELLS, V10, P217, DOI 10.1089/clo.2008.0016; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Ehrlich SD, 2005, MICROBIOLOGY, V151, P2551, DOI [10.1099/mic.0.28048-0, DOI 10.1099/MIC.0.28048-0]; Firth AL, 2015, CELL REP, V12, P1385, DOI 10.1016/j.celrep.2015.07.062; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Giani FC, 2016, CELL STEM CELL, V18, P73, DOI 10.1016/j.stem.2015.09.015; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616                                                            ; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hiroyuki S, 1981, GENE, V16, P73, DOI DOI 10.1016/0378-1119(81)90062-7; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hofer U, 2013, J INFECT DIS, V208, pS160, DOI 10.1093/infdis/jit382; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Ibraheem D, 2014, INT J PHARMACEUT, V459, P70, DOI 10.1016/j.ijpharm.2013.11.041; Jiang J, 2013, NATURE, V500, P296, DOI 10.1038/nature12394; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kandavelou K, 2005, NAT BIOTECHNOL, V23, P686, DOI 10.1038/nbt0605-686; Kazuki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06136; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Lee SH, 2017, NAT BIOTECHNOL, V35, P17, DOI 10.1038/nbt.3753; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Ma N, 2013, J BIOL CHEM, V288, P34671, DOI 10.1074/jbc.M113.496174; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Martinez RA, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv164; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; McConnell SA, 2009, P NATL ACAD SCI USA, V106, P5099; Metzger MJ, 2011, NUCLEIC ACIDS RES, V39, P926, DOI 10.1093/nar/gkq826; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mock U, 2015, NUCLEIC ACIDS RES, V43, P5560, DOI 10.1093/nar/gkv469; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Park CY, 2014, P NATL ACAD SCI USA, V111, P9253, DOI 10.1073/pnas.1323941111; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064                                                         ; Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73; Saleh-Gohari N, 2004, NUCLEIC ACIDS RES, V32, P3683, DOI 10.1093/nar/gkh703; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smih F, 1995, NUCLEIC ACIDS RES, V23, P5012, DOI 10.1093/nar/23.24.5012; Smith J, 1999, NUCLEIC ACIDS RES, V27, P674, DOI 10.1093/nar/27.2.674; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Suzuki K, 2008, P NATL ACAD SCI USA, V105, P13781, DOI 10.1073/pnas.0806976105; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tiyaboonchai A, 2014, STEM CELL RES, V12, P630, DOI 10.1016/j.scr.2014.02.004; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang HY, 2016, SCI BULL, V61, P1074, DOI 10.1007/s11434-016-1117-8; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Wyvekens N, 2015, HUM GENE THER, V26, P425, DOI 10.1089/hum.2015.084; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang PW, 2016, GLIA, V64, P63, DOI 10.1002/glia.22903; Zou JZ, 2011, BLOOD, V117, P5561, DOI 10.1182/blood-2010-12-328161; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	132	1	1	26	26	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	SEP	2017	74	18					3335	3346		10.1007/s00018-017-2522-0				12	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FC6GM	WOS:000406938400006	28405721				2018-01-05	
J	Niccheri, F; Pecori, R; Conticello, SG				Niccheri, Francesca; Pecori, Riccardo; Conticello, Silvestro G.			An efficient method to enrich for knock-out and knock-in cellular clones using the CRISPR/Cas9 system	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						Surrogate reporter; Genome editing; Mutagenesis; Activation-induced deaminase; Class switch recombination	ACTIVATION-INDUCED DEAMINASE; TAL EFFECTOR NUCLEASES; TARGETED GENE KNOCKOUT; ZINC-FINGER NUCLEASES; MAMMALIAN-CELLS; STEP GENERATION; HIGH-FREQUENCY; DNA CLEAVAGE; CAS SYSTEM; RNA	Clustered Regularly Interspaced Short Palin-dromic Repeats-associated protein 9 nuclease (CRISPR/Cas9) and Transcription Activator-Like Effector Nucleases (TALENs) are versatile tools for genome editing. Here we report a method to increase the frequency of Cas9-targeted cellular clones. Our method is based on a chimeric construct with a Blasticidin S Resistance gene (bsr) placed out-of-frame by a surrogate target sequence. End joining of the CRISPR/Cas9-induced double-strand break on the surrogate target can place the bsr in frame, thus providing temporary resistance to Blasticidin S: this is used to enrich for cells where Cas9 is active. By this approach, in a real experimental setting, we disrupted the Aicda gene in similar to 70% of clones from CH12F3 lymphoma cells (> 40% biallelically). With the same approach we knocked in a single nucleotide to reconstruct the frame of Aicda in these null cells, restoring the function in similar to 37% of the clones (less than 10% by the standard approach). Targeting of single nucleotide changes in other genes yielded analogous results. These results support our enrichment method as an efficient tool in genome editing.	[Niccheri, Francesca; Pecori, Riccardo; Conticello, Silvestro G.] Ist Toscano Tumori, Core Res Lab, I-50139 Florence, Italy; [Conticello, Silvestro G.] Univ Careggi, Azienda Osped, Dept Oncol, I-50139 Florence, Italy	Conticello, SG (reprint author), Ist Toscano Tumori, Core Res Lab, I-50139 Florence, Italy.; Conticello, SG (reprint author), Univ Careggi, Azienda Osped, Dept Oncol, I-50139 Florence, Italy.	silvo.conticello@ittumori.it			Istituto Toscano Tumori; Italian Ministry of Health [GR-2008-1141464, PE-2013-02357669]	This work was supported by an institutional grant of the Istituto Toscano Tumori, and by the Italian Ministry of Health [GR-2008-1141464; PE-2013-02357669]. Funding for open access charge: Istituto Toscano Tumori.	Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Flemr M, 2015, CELL REP, V12, P709, DOI 10.1016/j.celrep.2015.06.051; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056476; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193                                                          ; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Petrini I, 2014, NAT GENET, V46, P844, DOI 10.1038/ng.3016; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Qiu P, 2004, BIOTECHNIQUES, V36, P702; Ramakrishna S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4378; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren CH, 2015, CELL MOL LIFE SCI, V72, P2763, DOI 10.1007/s00018-015-1874-6; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Sernandez IV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003927; Severi F, 2015, RNA BIOL, V12, P389, DOI 10.1080/15476286.2015.1026033; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sun N, 2014, BIOTECHNOL BIOENG, V111, P683, DOI 10.1002/bit.25154; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Xu K, 2015, CELL MOL LIFE SCI, V72, P383, DOI 10.1007/s00018-014-1679-z; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yasuda H, 2016, J GENET GENOMICS, V43, P705, DOI 10.1016/j.jgg.2016.10.006; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang CF, 2015, BIOTECHNOL LETT, V37, P299, DOI 10.1007/s10529-014-1690-3; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhou Y, 2016, CELL MOL LIFE SCI, V73, P2543, DOI 10.1007/s00018-015-2128-3	53	0	0	16	16	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	SEP	2017	74	18					3413	3423		10.1007/s00018-017-2524-y				11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FC6GM	WOS:000406938400011	28421278	gold			2018-01-05	
J	Tornqvist, CE; Vaillancourt, B; Kim, J; Buell, CR; Kaeppler, SM; Casler, MD				Tornqvist, Carl-Erik; Vaillancourt, Brieanne; Kim, Jeongwoon; Buell, C. Robin; Kaeppler, Shawn M.; Casler, Michael D.			Transcriptional Analysis of Flowering Time in Switchgrass	BIOENERGY RESEARCH			English	Article						Switchgrass; Biomass; Flowering time; RNAseq; Differential expression	PHOTOPERIOD SENSITIVITY; RNA-SEQ; ARABIDOPSIS; PROTEIN; FT; GRASSES; ENCODES; SIGNALS; SORGHUM; GENE	Over the past two decades, switchgrass (Panicum virgatum) has emerged as a priority biofuel feedstock. The bulk of switchgrass biomass is in the vegetative portion of the plant; therefore, increasing the length of vegetative growth will lead to an increase in overall biomass yield. The goal of this study was to gain insight into the control of flowering time in switchgrass that would assist in development of cultivars with longer vegetative phases through delayed flowering. RNA sequencing was used to assess genome-wide expression profiles across a developmental series between switchgrass genotypes belonging to the two main ecotypes: upland, typically early flowering, and lowland, typically late flowering. Leaf blades and tissues enriched for the shoot apical meristem (SAM) were collected in a developmental series from emergence through anthesis for RNA extraction. RNA from samples that flanked the SAM transition stage was sequenced for expression analyses. The analyses revealed differential expression patterns between early-and late-flowering genotypes for known flowering time orthologs. Namely, genes shown to play roles in photoperiod response and the circadian clock in other species were identified as potential candidates for regulating flowering time in the switchgrass genotypes analyzed. Based on their expression patterns, many of the differentially expressed genes could also be classified as putative promoters or repressors of flowering. The candidate genes presented here may be used to guide switchgrass improvement through marker-assisted breeding and/or transgenic or gene editing approaches.	[Tornqvist, Carl-Erik; Kaeppler, Shawn M.; Casler, Michael D.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Tornqvist, Carl-Erik; Kaeppler, Shawn M.; Casler, Michael D.] Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Vaillancourt, Brieanne; Kim, Jeongwoon; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Vaillancourt, Brieanne; Kim, Jeongwoon; Buell, C. Robin] Michigan State Univ, DOE Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Kim, Jeongwoon] Monsanto Co, Chesterfield, MO 63017 USA; [Casler, Michael D.] USDA, Dairy Forage Res Ctr, Madison, WI 53706 USA	Tornqvist, CE (reprint author), Univ Wisconsin, Dept Agron, Madison, WI 53706 USA.; Tornqvist, CE (reprint author), Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA.	citornqvist@wisc.edu			US Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; US DOE Office of Science [DE-AC02-05CH11231]	This work was funded by the US Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494) and by the US DOE Office of Science DE-AC02-05CH11231.	Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Casler MD, 2012, SWITCHGRASS VALUABLE, P29, DOI DOI 10.1007/978-1-4471-2903-5_2; Casler MD, 2011, PLANT GENOME-US, V4, P273, DOI 10.3835/plantgenome2011.10.0026; Childs KL, 1997, PLANT PHYSIOL, V113, P611, DOI 10.1104/pp.113.2.611; Clouse SD, 2008, P NATL ACAD SCI USA, V105, P7345, DOI 10.1073/pnas.0803552105; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Grabowski PP, 2017, NEW PHYTOL, V213, P154, DOI 10.1111/nph.14101; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Jiang JJ, 2015, PLANT CELL, V27, P361, DOI 10.1105/tpc.114.133678; Johansson M, 2015, J EXP BOT, V66, P719, DOI 10.1093/jxb/eru441; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Lazakis CM, 2011, J EXP BOT, V62, P4833, DOI 10.1093/jxb/err129; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200; Martins Polyana Kelly, 2015, Biotechnol Rep (Amst), V6, P61, DOI 10.1016/j.btre.2015.02.006; McGarry RC, 2017, PLANT PHYSIOL, V173, P47, DOI 10.1104/pp.16.01336; MCMILLAN C, 1965, AM J BOT, V52, P55, DOI 10.2307/2439975                                                                 ; MCMILLAN C, 1959, ECOL MONOGR, V29, P285, DOI 10.2307/1942132; Meng X, 2011, PLANT CELL, V23, P942, DOI 10.1105/tpc.110.081406; MOORE KJ, 1991, AGRON J, V83, P1073, DOI 10.2134/agronj1991.00021962008300060027x                                        ; Murphy RL, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.11.0040; Murphy RL, 2011, P NATL ACAD SCI USA, V108, P16469, DOI 10.1073/pnas.1106212108; Niu LF, 2016, PLANT CELL ENVIRON, V39, P2158, DOI 10.1111/pce.12769; Nunez FDB, 2017, AGRONOMY-BASEL, V7, DOI 10.3390/agronomy7010017; R Core Team, 2014, R LANG ENV STAT COMP; Song YH, 2014, P NATL ACAD SCI USA, V111, P17672, DOI 10.1073/pnas.1415375111; Taliaferro C. M., 2002, BREEDING SELECTION N; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsuji H, 2011, CURR OPIN PLANT BIOL, V14, P45, DOI 10.1016/j.pbi.2010.08.016; Vogel KP, 2002, AGRON J, V94, P413, DOI 10.2134/agronj2002.0413                                                         ; Wolabu TW, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1261232; Wolabu TW, 2016, NEW PHYTOL, V210, P946, DOI 10.1111/nph.13834; Woods DP, 2014, GENETICS, V198, P397, DOI 10.1534/genetics.114.166785; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009	40	0	0	13	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1939-1234	1939-1242		BIOENERG RES	BioEnergy Res.	SEP	2017	10	3					700	713		10.1007/s12155-017-9832-9				14	Energy & Fuels; Environmental Sciences	Energy & Fuels; Environmental Sciences & Ecology	FC3MP	WOS:000406743700009		gold			2018-01-05	
J	Chen, LY; Morris, DL; Vyse, TJ				Chen, Lingyan; Morris, David L.; Vyse, Timothy J.			Genetic advances in systemic lupus erythematosus: an update	CURRENT OPINION IN RHEUMATOLOGY			English	Review						causal variants; epigenome; expression quantitative trait loci; genome-wide association studies; systemic lupus erythematosus	GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; ALLELE-SPECIFIC EXPRESSION; SUSCEPTIBILITY VARIANTS; COMPLEX DISEASES; IMMUNE CELLS; RISK-FACTORS; HLA ALLELES; LOCI; BINDING	Purpose of review More than 80 susceptibility loci are now reported to show robust genetic association with systemic lupus erythematosus (SLE). The differential functional effects of the risk alleles for the majority of these loci remain to be defined. Here, we review current SLE association findings and the recent progress in the annotation of noncoding regions of the human genome as well as the new technologies and statistical methods that can be applied to further the understanding of SLE genetics. Recent findings Genome-wide association studies (GWAS) have markedly expanded the catalogue of genetic signals contributing to SLE development; we can now explain more than 50% of the disease's heritability. Expression quantitative trait loci mapping with colocalization analysis of GWAS results help to identify the underlying causal genes. The Encyclopedia of DNA elements, Roadmap Epigenome, and the Blueprint Epigenome projects have jointly annotated more than 80% of the noncoding genome, providing a wealth of information (from healthy individuals) to define the functional elements within the risk loci. Technologies, such as next-generation sequencing, chromatin structure determination, and genome editing, will help elucidate the actual mechanisms that underpin SLE risk alleles. Summary Gene expression and epigenetic databases provide a valuable resource to interpret genetic association in SLE. Expansion of such resources to include disease status and multiple ancestries will further aid the exploration of the biology underlying the genetics.	[Chen, Lingyan; Morris, David L.; Vyse, Timothy J.] Kings Coll London, Guys Hosp, Div Genet & Mol Med, London, England; [Vyse, Timothy J.] Kings Coll London, Guys Hosp, Div Immunol Infect & Inflammatory Dis, London, England	Vyse, TJ (reprint author), Kings Coll London, Guys Hosp, Div Immunol Infect & Inflammatory Dis, Mol Med, London, England.; Vyse, TJ (reprint author), Guys & St Thomas NHS Trust, Rheumatol, London, England.	tim.vyse@kcl.ac.uk			China Scholarship Council (CSC) [201406380127]; Medical Research Council (MRC) [MR/L002604/01]	The study was supported by China Scholarship Council (CSC), no. 201406380127 and Medical Research Council (MRC), no. MR/L002604/01.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Alarcon-Riquelme ME, 2016, ARTHRITIS RHEUMATOL, V68, P932, DOI 10.1002/art.39504; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; BLOCK SR, 1975, AM J MED, V59, P533, DOI 10.1016/0002-9343(75)90261-2                                                    ; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Chen L, 2016, CELL, V167, P1398, DOI 10.1016/j.cell.2016.10.026; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Consortium RE, 2015, NATURE, V518, P317; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Demirci FY, 2016, ARTHRITIS RHEUMATOL, V68, P174, DOI 10.1002/art.39403; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Feldman CH, 2013, ARTHRITIS RHEUM-US, V65, P753, DOI 10.1002/art.37795; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley B., 2009, GENES IMMUN, V10, P373; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Jacquemin C, 2015, IMMUNITY, V42, P1159, DOI 10.1016/j.immuni.2015.05.012; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Kaiser R, 2013, ARTHRITIS RHEUM-US, V65, P211, DOI 10.1002/art.37751; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Kuo CF, 2015, JAMA INTERN MED, V175, P1518, DOI 10.1001/jamainternmed.2015.3528; Langefeld CD, 2017, NAT COMMUN IN PRESS; LAWRENCE JS, 1987, J RHEUMATOL, V14, P913; Lee HS, 2014, ANN RHEUM DIS, V73, P1240, DOI 10.1136/annrheumdis-2012-202675; Lessard CJ, 2016, ARTHRITIS RHEUMATOL, V68, P1197, DOI 10.1002/art.39548; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meyer CA, 2014, NAT REV GENET, V15, P709, DOI 10.1038/nrg3788; Molineros JE, 2017, HUM MOL GENET, V26, P1205, DOI 10.1093/hmg/ddx026; Morris DL, 2016, NAT GENET, V48, P940, DOI 10.1038/ng.3603; Morris DL, 2012, AM J HUM GENET, V91, P778, DOI 10.1016/j.ajhg.2012.08.026; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Odhams CA, 2017, HUM MOL GENET, V26, P1003, DOI 10.1093/hmg/ddw417; Okada Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002455; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Roberts AL, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4566; Royer-Bertrand B, 2015, CELL MOL LIFE SCI, V72, P1463, DOI 10.1007/s00018-014-1807-9; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Hannenhalli Sridhar, 2014, Genomics & Informatics, V12, P2, DOI 10.5808/GI.2014.12.1.2; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Sun C, 2016, NAT GENET, V48, P323, DOI 10.1038/ng.3496; Teruel M, 2016, J AUTOIMMUN, V74, P161, DOI 10.1016/j.jaut.2016.08.001; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Zhang J, 2015, ARTHRITIS RHEUMATOL, V67, P2966, DOI 10.1002/art.39275; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zoledziewska M, 2009, GENES IMMUN, V10, P15, DOI 10.1038/gene.2008.84	67	3	3	10	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-8711	1531-6963		CURR OPIN RHEUMATOL	Curr. Opin. Rheumatol.	SEP	2017	29	5					423	433		10.1097/BOR.0000000000000411				11	Rheumatology	Rheumatology	FB8TN	WOS:000406412300001	28509669				2018-01-05	
J	Cong, L				Cong, Le			CRISPR: Groundbreaking technology for RNA-guided genome engineering	ANALYTICAL BIOCHEMISTRY			English	Article						Microbial immunity; CRISPR; Cas9; Cpfl; C2c2; Genome engineering; Gene editing; Programmable DNA -Binding protein; Biotechnology		Years of advances in high-throughput biotechnologies exemplified by nucleic acid sequencing and single molecular imaging have led to our increasing capacity to interrogate genomes down to nucleotide accuracy with single-cell or even subcellular resolution, thereby gaining high-dimensional information on the genetic variants and epigenetic states associated with physiological and pathological processes. To achieve a causal understanding of the exquisite biology encoded in our genome, researchers in the past decades have sought to develop companion genome engineering tools. The ability to manipulate genetic information at similar resolution and genome-scale holds the promise to reveal fundamental insights into genomics research and has wide applications across many different fields. Technologies evolved from the naturally occurring Clustered Regularly Interspaced Palindromic Repeats (CRISPRs) have emerged as a versatile platform to enable this goal through RNA-guided genome engineering. Here, researchers in the CRISPR genome-editing field have presented forward-looking reviews on different modalities and applications of this groundbreaking technology, with implications for basic biology, translational medicine, and beyond. (C) 2017 Elsevier Inc. All rights reserved.	[Cong, Le] MIT & Harvard, Broad Inst, 415 Main St, Cambridge, MA 02142 USA; [Cong, Le] Tsinghua Univ, Beijing 100084, Peoples R China	Cong, L (reprint author), MIT & Harvard, Broad Inst, 415 Main St, Cambridge, MA 02142 USA.	conglab@biomed.tsinghua.edu.cn						0	0	0	65	65	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697	1096-0309		ANAL BIOCHEM	Anal. Biochem.	SEP 1	2017	532						87	89		10.1016/j.ab.2017.05.005				3	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	FB2MX	WOS:000405979000014	28479380				2018-01-05	
J	Ran, FA				Ran, F. Ann			Adaptation of CRISPR nucleases for eukaryotic applications	ANALYTICAL BIOCHEMISTRY			English	Article						CRISPR; Genome editing; Cas9; Cpf1; C2cx	RNA-GUIDED ENDONUCLEASE; STAPHYLOCOCCUS-AUREUS CAS9; STREPTOCOCCUS-THERMOPHILUS; ADAPTIVE IMMUNITY; NEISSERIA-MENINGITIDIS; BACTERIAL IMMUNITY; CRYSTAL-STRUCTURE; HUMAN-CELLS; STEM-CELLS; TARGET DNA		[Ran, F. Ann] MIT & Harvard, Broad Inst, 75 Ames St, Cambridge, MA 02142 USA; [Ran, F. Ann] Harvard Soc Fellows, 75 Mt Auburn St, Cambridge, MA 02138 USA	Ran, FA (reprint author), MIT & Harvard, Broad Inst, 75 Ames St, Cambridge, MA 02142 USA.	ran@fas.harvard.edu					Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Koonin EV, 2013, RNA BIOL, V10, P679, DOI 10.4161/rna.24022; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Schunder E, 2013, INT J MED MICROBIOL, V303, P51, DOI 10.1016/j.ijmm.2012.11.004; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	67	0	0	27	27	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697	1096-0309		ANAL BIOCHEM	Anal. Biochem.	SEP 1	2017	532						90	94		10.1016/j.ab.2016.10.018				5	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	FB2MX	WOS:000405979000015	27984015				2018-01-05	
J	Sanjana, NE				Sanjana, Neville E.			Genome-scale CRISPR pooled screens	ANALYTICAL BIOCHEMISTRY			English	Article						Genome engineering; Genetic screens; CRISPR; Cas9; Noncoding; Cancer	ESSENTIAL GENES; CANCER-CELLS; ACTIVATION; RESISTANCE; ELEMENTS; REPEATS; IDENTIFICATION; DNA	Genome editing technologies such as clustered regularly interspaced short palindromic repeats (CRISPR) systems have ushered in a new era of targeted DNA manipulation. The easy programmability of CRISPR using short oligonucleotides enables rapid synthesis of large-scale libraries for functional genetic screens. Here we present fundamental concepts and methods for pooled CRISPR screens and review biological results from recent genome-scale loss-of-function and gain-of-function screens. We also discuss new frontiers in pooled screens, including novel effector domains for functional screens and applications in the noncoding genome. (C) 2016 Elsevier Inc. All rights reserved.	[Sanjana, Neville E.] New York Genome Ctr, New York, NY 10013 USA; [Sanjana, Neville E.] NYU, Ctr Genom & Syst Biol, Dept Biol, New York, NY 10012 USA	Sanjana, NE (reprint author), New York Genome Ctr, New York, NY 10013 USA.; Sanjana, NE (reprint author), NYU, Ctr Genom & Syst Biol, Dept Biol, New York, NY 10012 USA.	nsanjana@nygenome.org			National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI) [R00-HG008171]	R. Macrae provided several helpful comments on an early draft. N.E.S. is supported by National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI) award R00-HG008171.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Consortium GT, 2015, SCIENCE, V348, P648, DOI DOI 10.1126/SCIENCE.1262110; Das Thakur M, 2013, CANCER RES, V73, P6106, DOI 10.1158/0008-5472.CAN-13-1633; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Evers B., 2016, NAT BIOTECHNOL; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Singh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131370; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Toledo CM, 2015, CELL REP, V13, P2425, DOI 10.1016/j.celrep.2015.11.021; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Whittaker SR, 2013, CANCER DISCOV, V3, P350, DOI 10.1158/2159-8290.CD-12-0470	36	1	1	13	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697	1096-0309		ANAL BIOCHEM	Anal. Biochem.	SEP 1	2017	532						95	99		10.1016/j.ab.2016.05.014				5	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	FB2MX	WOS:000405979000016	27261176				2018-01-05	
J	Piotto, S; Sessa, L; Iannelli, P; Concilio, S				Piotto, Stefano; Sessa, Lucia; Iannelli, Pio; Concilio, Simona			Computational study on human sphingomyelin synthase 1 (hSMS1)	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						hSMS1; Homology; 2OHOA; Molecular dynamics	STRUCTURAL-PROPERTIES; ACID; MEMBRANES; CELL; SPHINGOLIPIDS; APOPTOSIS; AUTOPHAGY; CERAMIDE; DOCKING; PEPTIDE	Human sphingomyelin synthase 1 (hSMS1) is the last enzyme for sphingomyelin (SM) biosynthesis. It has been discovered that in different human tumor tissues the SM levels are lower compared to normal tissues and the. activation of hSMS1, to restore the normal levels of SM, inhibits cell cycle proliferation of cancer cells..Since the importance of SM and other lipid metabolism genes in the malignant transformation, we decided to explore the hSMS1 mechanism of action. Enzymes capable to regulate the formation of lipids are therefore of paramount importance. Here we present a computational study on sphingomyelin synthases hSMS1. The full structure of the enzyme was obtained by means of homology and ab initio techniques. Further molecular dynamics and docking studies permitted to identify putative binding sites and to identify the key residues for binding. This article is part of a Special Issue entitled: Membrane Lipid Therapy: Drugs Targeting Biomembranes edited by Pablo V. Escriba. (C) 2017 Elsevier B.V. All rights reserved.	[Piotto, Stefano; Sessa, Lucia; Iannelli, Pio] Univ Salerno, Dept Pharm, Via Giovanni Paolo 2,132, I-84084 Fisciano, SA, Italy; [Concilio, Simona] Univ Salerno, Dept Ind Engn, Via Giovanni Paolo 2,132, I-84084 Fisciano, SA, Italy	Piotto, S (reprint author), Univ Salerno, Dept Pharm, Via Giovanni Paolo 2,132, I-84084 Fisciano, SA, Italy.	piotto@unisa.it		Sessa, Lucia/0000-0002-5343-2777; Piotto, Stefano/0000-0002-3102-1918			Barcelo F, 2004, MOL MEMBR BIOL, V21, P261, DOI 10.1080/09687680410001716835; Beard H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082849; Concilio S, 2014, THIN SOLID FILMS, V556, P419, DOI 10.1016/j.tsf.2014.01.011; Copeland RA., 2005, EVALUATION ENZYME IN, P178; Di Biasi L, 2016, COMM COM INF SC, V587, P65, DOI 10.1007/978-3-319-32695-5_6; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199                                                ; Funari SS, 2003, J LIPID RES, V44, P567, DOI 10.1194/jlr.M200356-JLR200; Guo D, 2012, BRIT J PHARMACOL, V166, P1846, DOI 10.1111/j.1476-5381.2012.01897.x; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hendrich AB, 2003, CURR DRUG TARGETS, V4, P23, DOI 10.2174/1389450033347172                                                        ; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Ibarguren M, 2013, BBA-BIOMEMBRANES, V1828, P2553, DOI 10.1016/j.bbamem.2013.06.014; JECKEL D, 1990, FEBS LETT, V261, P155, DOI 10.1016/0014-5793(90)80659-7; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Lopez DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072052; MARGGRAF WD, 1984, BIOCHIM BIOPHYS ACTA, V793, P346, DOI 10.1016/0005-2760(84)90248-0; MOREAU P, 1994, BBA-REV BIOMEMBRANES, V1197, P257; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Piotto S., 2016, J COMPUT AID MOL DES, P1; Piotto S, 2014, BBA-BIOMEMBRANES, V1838, P1628, DOI 10.1016/j.bbamem.2013.12.023; Piotto S, 2014, BBA-BIOMEMBRANES, V1838, P1509, DOI 10.1016/j.bbamem.2014.01.014; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Scrima M, 2014, BBA-BIOMEMBRANES, V1838, P1010, DOI 10.1016/j.bbamem.2013.12.010; Sessa L, 2015, IT WORKSH ART LIF EV, P117; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038                                                             ; Taniguchi M, 2014, BBA-MOL CELL BIOL L, V1841, P692, DOI 10.1016/j.bbalip.2013.12.003; Teres S, 2012, P NATL ACAD SCI USA, V109, P8489, DOI 10.1073/pnas.1118349109; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yeang C, 2008, BBA-MOL CELL BIOL L, V1781, P610, DOI 10.1016/j.bbalip.2008.07.002; Yeang C, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-89; Young MM, 2013, J LIPID RES, V54, P5, DOI 10.1194/jlr.R031278	34	1	1	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736	0006-3002		BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	SEP	2017	1859	9	B		SI		1517	1525		10.1016/j.bbamem.2017.04.004				9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FB2LD	WOS:000405974400003	28411172				2018-01-05	
J	Ellwanger, JH; Veit, TD; Chies, JAB				Ellwanger, Joel Henrique; Veit, Tiago Degani; Bogo Chies, Jose Artur			Exosomes in HIV infection: A review and critical look	INFECTION GENETICS AND EVOLUTION			English	Review						AIDS; Exosomes; Immune system; HIV; microRNA; HIV therapy	CELL-DERIVED EXOSOMES; PLASMA-MEMBRANE; CRISPR/CAS9 SYSTEM; DENDRITIC CELLS; T-CELLS; INFLAMMATORY CYTOKINES; TRANSFERRIN RECEPTOR; ENGINEERED EXOSOMES; CONTAINS EXOSOMES; HUMAN MACROPHAGES	Exosomes are nanovesicles released into the extracellular medium by different cell types. These vesicles carry a variety of protein and RNA cargos, and have a central role in cellular signaling and regulation. A PubMed search using the term "exosomes" finds 67 articles published in 2006. Ten years later, the same search returns approximately 1200 results for 2016 alone. The growing interest in exosomes within the scientific community reflects the different roles exerted by extracellular vesicles in biological systems and diseases. However, the increase in academic production addressing the biological function of exosomes causes much confusion, especially where the focus is on the role of exosomes in pathological situations. In this review, we critically interpret the current state of the research on exosomes and HIV infection. It is plausible to assume that exosomes influence the pathogenesis of HIV infection through their biological cargo (primarily membrane proteins and microRNAs). On the other hand, evidence for a usurpation of the exosomal budding and trafficking machinery by HIV during infection is limited, although such amechanism cannot be ruled out. This review also discusses several biological aspects of exosomal function in the immune system. Finally, the limitations of current exosome research are pointed out. (C) 2017 Elsevier B.V. All rights reserved.	[Ellwanger, Joel Henrique; Veit, Tiago Degani; Bogo Chies, Jose Artur] Univ Fed Rio Grande do Sul, Dept Genet, Lab Imunobiol & Imunogenet, Porto Alegre, RS, Brazil; [Veit, Tiago Degani] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil	Chies, JAB (reprint author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, Lab Imunobiol Imunogenet Predio 43323,Lab 212, Av Bento Goncalves,9500,Campus Vale, Porto Alegre, RS, Brazil.	jose.chies@pq.cnpq.br		Chies, Jose/0000-0001-7025-0660			Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969                                                     ; Ali SA, 2010, AIDS RES HUM RETROV, V26, P173, DOI 10.1089/aid.2009.0068; ALLAN D, 1980, BIOCHEM J, V188, P881, DOI 10.1042/bj1880881                                                               ; Aqil M, 2015, BIOMED RES INT, DOI 10.1155/2015/492395; Aqil M, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23129; Aqil M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074472; Arenaccio C., 2015, LATENT HIV 1 IS ACTI, V12, P87, DOI DOI 10.1186/S12977-015-0216-Y; Arenaccio C, 2014, J VIROL, V88, P11529, DOI 10.1128/JVI.01712-14; Arenaccio C, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-46; Baranyai T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145686; Barouch DH, 2014, SCIENCE, V345, P169, DOI 10.1126/science.1255512; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014                                                           ; Bretz NP, 2013, J BIOL CHEM, V288, P36691, DOI 10.1074/jbc.M113.512806; Cabezas SC, 2013, CELL MICROBIOL, V15, P412, DOI 10.1111/cmi.12046; Campbell Tamika D, 2008, Ethn Dis, V18, pS2; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Caskey M, 2017, NAT MED, V23, P185, DOI [10.1038/nm4268, 10.1038/nm.4268]; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; CHENGMAYER C, 1989, SCIENCE, V246, P1629, DOI 10.1126/science.2531920; Godinho RMD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099887; de Carvalho JV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113691; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Di Bonito P, 2015, VIRUSES-BASEL, V7, P1079, DOI 10.3390/v7031079; Dimov Irena, 2009, ScientificWorldJournal, V9, P1107, DOI 10.1100/tsw.2009.128; Dominy SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089366; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Gardner MR, 2015, NATURE, V519, P87, DOI 10.1038/nature14264; Genneback N, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20167; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.183143100; GUY B, 1990, VIROLOGY, V176, P413, DOI 10.1016/0042-6822(90)90011-F; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Hiemstra TF, 2014, J AM SOC NEPHROL, V25, P2017, DOI 10.1681/ASN.2013101066; Hu G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.114; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kadiu I, 2012, J IMMUNOL, V189, P744, DOI 10.4049/jimmunol.1102244; Khan MB, 2016, J NEUROVIROL, V22, P179, DOI 10.1007/s13365-015-0383-6; Khatua AK, 2009, J VIROL, V83, P512, DOI 10.1128/JVI.01658-08; Konadu KA, 2015, J INFECT DIS, V211, P1712, DOI 10.1093/infdis/jiu676; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Kramer B, 2005, BLOOD CELL MOL DIS, V35, P136, DOI 10.1016/j.bcmd.2005.06.006; Lattanzi L, 2012, VACCINE, V30, P7229, DOI 10.1016/j.vaccine.2012.10.010; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Levanen B, 2013, J ALLERGY CLIN IMMUN, V131, P894, DOI 10.1016/j.jaci.2012.11.039; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Luo XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124436; Machida T, 2015, INT J MOL SCI, V16, P21294, DOI 10.3390/ijms160921294; Madison MN, 2015, VIRUSES-BASEL, V7, P4093, DOI 10.3390/v7072810; Madison MN, 2015, VIROLOGY, V482, P189, DOI 10.1016/j.virol.2015.03.040; Madison MN, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0102-z; Mathias Rommel A., 2009, V528, P227, DOI 10.1007/978-1-60327-310-7_16; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Mincheva-Nilsson L, 2010, AM J REPROD IMMUNOL, V63, P520, DOI 10.1111/j.1600-0897.2010.00822.x; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895; Naslund TI, 2014, AIDS, V28, P171, DOI 10.1097/QAD.0000000000000159; Nazimek K, 2015, IMMUNOLOGY, V146, P23, DOI 10.1111/imm.12466; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Nkwe DO, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0272-3; Olson AD, 2014, JAIDS-J ACQ IMM DEF, V67, P15, DOI 10.1097/QAI.0000000000000240; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Poropatich K, 2011, J GEN VIROL, V92, P247, DOI 10.1099/vir.0.027102-0; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161                                                          ; Raymond AD, 2016, J NEUROVIROL, V22, P129, DOI 10.1007/s13365-015-0397-0; Raymond AD, 2011, AIDS RES HUM RETROV, V27, P167, DOI 10.1089/aid.2009.0170; Robbins P. D., 2014, IMMUNOLOGY, V14, P195, DOI DOI 10.1038/NRI3622.REVIEW; Rong L, 2016, ONCOL LETT, V11, P500, DOI 10.3892/ol.2015.3841; Roth W. W., 2016, INT J ENV RES PUB HE, V13, P32; Sampey GC, 2016, J BIOL CHEM, V291, P1251, DOI 10.1074/jbc.M115.662171; Shelton MN, 2012, J VIROL, V86, P406, DOI 10.1128/JVI.05720-11; Skriner K, 2006, ARTHRITIS RHEUM, V54, P3809, DOI 10.1002/art.22276; Smith JA, 2016, AIDS, V30, P2611, DOI 10.1097/QAD.0000000000001236; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; Thali M, 2009, CURR TOP MICROBIOL, V339, P85, DOI 10.1007/978-3-642-02175-6_5; Thery C., 2006, CURR PROTOC CELL BIO, V3, P3, DOI DOI 10.1002/0471143030.CB0322S30; TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5; Tumne A, 2009, J VIROL, V83, P4354, DOI 10.1128/JVI.02629-08; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Zhou JH, 2015, CHEM BIOL, V22, P379, DOI 10.1016/j.chembiol.2015.01.005; Zhu WJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0150-z; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594; Zlotogorski-Hurvitz A, 2015, J HISTOCHEM CYTOCHEM, V63, P181, DOI 10.1369/0022155414564219	83	0	0	22	22	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	SEP	2017	53						146	154		10.1016/j.meegid.2017.05.021				9	Infectious Diseases	Infectious Diseases	EZ2SD	WOS:000404559400019	28546080				2018-01-05	
J	Zago, M; Orru, L; Rossetti, L; Lamontanara, A; Fornasari, ME; Bonvini, B; Meucci, A; Carminati, D; Cattivelli, L; Giraffa, G				Zago, Miriam; Orru, Luigi; Rossetti, Lia; Lamontanara, Antonella; Fornasari, Maria Emanuela; Bonvini, Barbara; Meucci, Aurora; Carminati, Domenico; Cattivelli, Luigi; Giraffa, Giorgio			Survey on the phage resistance mechanisms displayed by a dairy Lactobacillus helveticus strain	FOOD MICROBIOLOGY			English	Article						Lactobacillus helveticus; Phage resistance; Restriction/modification systems; Dairy products	LACTIC-ACID BACTERIA; RESTRICTION-MODIFICATION SYSTEMS; HARD CHEESE PRODUCTION; STREPTOCOCCUS-THERMOPHILUS; DEFENSE SYSTEMS; IDENTIFICATION; BACTERIOPHAGES; STARTER; MUTANTS; PCR	In this study the presence and functionality of phage defence mechanisms in Lactobacillus helveticus ATCC 10386, a strain of dairy origin which is sensitive to Phi Lh56, were investigated. After exposure of ATCC 10386 to (Phi Lh56, the whole-genome sequences of ATCC 10386 and of a phage-resistant derivative (LhM3) were compared. LhM3 showed deletions in the S-layer protein and a higher expression of the genes involved in the restriction/modification (R/M) system. Genetic data were substantiated by measurements of bacteriophage adsorption rates, efficiency of plaguing, cell wall protein size and by gene expression analysis. In LhM3 two phage resistance mechanisms, the inhibition of phage adsorption and the upregulation of Type I R/M genes, take place and explain its resistance to Phi Lh56. Although present in both ATCC 10386 and LhM3 genomes, the CRISPR machinery did not seem to play a role in the phage resistance of LhM3. Overall, the natural selection of phage resistant strains resulted successful in detecting variants carrying multiple phage defence mechanisms in L helveticus. The concurrent presence of multiple phage-resistance systems should provide starter strains with increased fitness and robustness in dairy ecosystems. (C) 2017 Elsevier Ltd. All rights reserved.	[Zago, Miriam; Rossetti, Lia; Fornasari, Maria Emanuela; Bonvini, Barbara; Meucci, Aurora; Carminati, Domenico; Giraffa, Giorgio] Consiglio Ric Agr & Anal Econ Agr, Ctr Ric Prod Foraggere & Lattiero Casearie CREA F, Lodi, Italy; [Orru, Luigi; Lamontanara, Antonella; Cattivelli, Luigi] Consiglio Ric Agr & Anal Econ Agr, Ctr Ric Genom Vegetale CREA GPG, Fiorenzuola Darda, Italy	Giraffa, G (reprint author), CREA FLC, Via Lombardo 11, I-26900 Lodi, Italy.	giorgio.giraffa@crea.gov.it					Allison GE, 1998, INT DAIRY J, V8, P207, DOI 10.1016/S0958-6946(98)00043-0; Barrangou R, 2011, FOOD MICROBIOL FOOD, P459, DOI 10.1007/978-0-387-92771-8_19; Binetti AG, 2008, INT J FOOD MICROBIOL, V124, P147, DOI 10.1016/j.ijfoodmicro.2008.03.00; Carminati D., 2011, BACTERIOPHAGES DAIRY, P79; Chopin MC, 2005, CURR OPIN MICROBIOL, V8, P473, DOI 10.1016/j.mib.2005.06.006; DELOSREYESGAVILAN CG, 1990, APPL ENVIRON MICROB, V56, P3412; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5818, DOI 10.1128/AEM.70.10.5818-5824.2004; Dupuis ME, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3087; Erkus O, 2013, ISME J, V7, P2126, DOI 10.1038/ismej.2013.108; Forde A, 1999, ANTON LEEUW INT J G, V76, P89, DOI 10.1023/A:1002027321171                                                         ; Gatti M, 1997, LETT APPL MICROBIOL, V25, P345, DOI 10.1046/j.1472-765X.1997.00235.x; Giraffa G, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00338; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; HUEY B, 1989, J BACTERIOL, V171, P2528, DOI 10.1128/jb.171.5.2528-2532.1989                                                 ; LARBI D, 1992, J DAIRY RES, V59, P349, DOI 10.1017/S0022029900030624                                                       ; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Mahony J, 2012, VIROLOGY, V434, P143, DOI 10.1016/j.virol.2012.10.008; Mills S, 2010, J APPL MICROBIOL, V108, P945, DOI 10.1111/j.1365-2672.2009.04486.x; NEVIANI E, 1992, J DAIRY SCI, V75, P905, DOI 10.3168/jds.S0022-0302(92)77830-8                                               ; NYENGAARD N, 1995, GENE, V157, P13, DOI 10.1016/0378-1119(95)91235-R; O'Sullivan D, 1998, APPL ENVIRON MICROB, V64, P4618; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quiberoni A, 1998, INT DAIRY J, V8, P941, DOI 10.1016/S0958-6946(98)00126-5; Quiberoni A, 1998, FOOD RES INT, V31, P537, DOI 10.1016/S0963-9969(99)00020-4; Reinheimer J. A., 1993, Microbiologie, Aliments, Nutrition, V11, P235; Reinheimer JA, 1996, INT DAIRY J, V6, P869, DOI 10.1016/0958-6946(96)00014-3; Rossetti L, 2005, J MICROBIOL METH, V63, P135, DOI 10.1016/j.mimet.2005.03.001; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; SECHAUD L, 1992, APPL ENVIRON MICROB, V58, P1011; Selle K, 2015, J FOOD SCI, V80, pR2367, DOI 10.1111/1750-3841.13094; Slattery L, 2010, J DAIRY SCI, V93, P4435, DOI 10.3168/jds.2010-3327; Sturino JM, 2004, ADV APPL MICROBIOL, V56, P331, DOI 10.1016/S0065-2164(04)56011-2; Suarez V, 2009, J DAIRY RES, V76, P433, DOI 10.1017/S0022029909990112; Suarez VB, 2008, INT J FOOD MICROBIOL, V128, P401, DOI 10.1016/j.ijfoodmicro.2008.09.007; Svensson U, 1991, B INT DAIRY FEDERATI, V1991, P29; Ventura M, 1999, ANN MICROBIOL ENZIM, V49, P45	38	0	0	19	22	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0740-0020	1095-9998		FOOD MICROBIOL	Food Microbiol.	SEP	2017	66						110	116		10.1016/j.fm.2017.04.014				7	Biotechnology & Applied Microbiology; Food Science & Technology; Microbiology	Biotechnology & Applied Microbiology; Food Science & Technology; Microbiology	EY3IL	WOS:000403864700014	28576359				2018-01-05	
J	Adams, FF; Heckl, D; Hoffmann, T; Talbot, SR; Kloos, A; Thol, F; Heuser, M; Zuber, J; Schambach, A; Schwarzer, A				Adams, Felix F.; Heckl, Dirk; Hoffmann, Thomas; Talbot, Steven R.; Kloos, Arnold; Thol, Felicitas; Heuser, Michael; Zuber, Johannes; Schambach, Axel; Schwarzer, Adrian			An optimized lentiviral vector system for conditional RNAi and efficient cloning of microRNA embedded short hairpin RNA libraries	BIOMATERIALS			English	Article						RNAi; Knockdown; shRNA; miR-30; Lentiviral vector; Tet-regulation	MAMMALIAN-CELLS; GENE-EXPRESSION; SHRNA LIBRARIES; IN-VIVO; INTERFERENCE; MOUSE; SIRNA; GENERATION; ADDICTION; LEUKEMIA	RNA interference (RNAi) and CRISPR-Cas9-based screening systems have emerged as powerful and complementary tools to unravel genetic dependencies through systematic gain-and loss-of-function studies. In recent years, a series of technical advances helped to enhance the performance of virally delivered RNAi. For instance, the incorporation of short hairpin RNAs (shRNAs) into endogenous microRNA contexts (shRNAmiRs) allows the use of Tet-regulated promoters for synchronous onset of gene knockdown and precise interrogation of gene dosage effects. However, remaining challenges include lack of efficient cloning strategies, inconsistent knockdown potencies and leaky expression. Here, we present a simple, one-step cloning approach for rapid and efficient cloning of miR-30 shRNAmiR libraries. We combined a human miR-30 backbone retaining native flanking sequences with an optimized all-in-one lentiviral vector system for conditional RNAi to generate a versatile toolbox characterized by higher doxycycline sensitivity, reduced leakiness and enhanced titer. Furthermore, refinement of existing shRNA design rules resulted in substantially improved prediction of powerful shRNAs. Our approach was validated by accurate quantification of the knockdown potency of over 250 single shRNAmiRs. To facilitate access and use by the scientific community, an online tool was developed for the automated design of refined shRNA-coding oligonucleotides ready for cloning into our system. (C) 2017 Elsevier Ltd. All rights reserved.	[Adams, Felix F.; Schambach, Axel; Schwarzer, Adrian] Hannover Med Sch, Inst Expt Hematol, D-30625 Hannover, Germany; [Heckl, Dirk] Hannover Med Sch, Pediat Hematol & Oncol, D-30625 Hannover, Germany; [Hoffmann, Thomas; Zuber, Johannes] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Talbot, Steven R.] Hannover Med Sch, Inst Physiol Chem, D-30625 Hannover, Germany; [Kloos, Arnold; Thol, Felicitas; Heuser, Michael; Schwarzer, Adrian] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, D-30625 Hannover, Germany; [Schambach, Axel] Harvard Med Sch, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA	Schwarzer, A (reprint author), Hannover Med Sch, Inst Expt Hematol, D-30625 Hannover, Germany.	schwarzer.adrian@mh-hannover.de	Heuser, Michael/S-2363-2017	Adams, Felix F./0000-0002-6748-982X	DFG [SFB738, HE 5240/5-1, HE 5240/6-1]; DFG [REBIRTH Cluster of Excellence] [EXC62/1]; EU [PERSIST]; EU [CELL-PID]; EU [SCIDNET]; Hannover Medical School [HiLF and Young Academy-Grants]; Deutsche Krebshilfe [110284, 110287, 110292, 111267, 111743]	This work was supported by DFG [SFB738, REBIRTH Cluster of Excellence EXC62/1, HE 5240/5-1, HE 5240/6-1], EU [PERSIST, CELL-PID, SCIDNET], Hannover Medical School [HiLF and Young Academy-Grants to AdS]; and Deutsche Krebshilfe [110284, 110287, 110292 and 111267, 111743].	Aleman LM, 2007, RNA, V13, P385, DOI 10.1261/rna.352507; Andrews S., 2010, FASTQC QUALITY CONTR; Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Bassik MC, 2009, NAT METHODS, V6, P443, DOI [10.1038/NMETH.1330, 10.1038/nmeth.1330]; Boudreau RL, 2008, RNA, V14, P1834, DOI 10.1261/rna.1062908; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999                                                         ; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Dahlgren C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn190; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Efron B, 2004, ANN STAT, V32, P407; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Heinz N, 2011, HUM GENE THER, V22, P166, DOI 10.1089/hum.2010.099; Kampmann M, 2015, P NATL ACAD SCI USA, V112, pE3384, DOI 10.1073/pnas.1508821112; Knott SRV, 2014, MOL CELL, V56, P796, DOI 10.1016/j.molcel.2014.10.025; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Maetzig T, 2014, BIOMATERIALS, V35, P4345, DOI 10.1016/j.biomaterials.2014.01.057; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; Mohr SE, 2012, WIRES RNA, V3, P145, DOI 10.1002/wrna.110; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Nielsen TT, 2009, J GENE MED, V11, P559, DOI 10.1002/jgm.1333; Ohyashiki K., 1986, CANC RES, V46; Osorio L, 2014, J BIOTECHNOL, V169, P71, DOI 10.1016/j.jbiotec.2013.11.004; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; R Core Team, 2016, R LANG ENV STAT COMP; Raab David, 2010, Syst Synth Biol, V4, P215, DOI 10.1007/s11693-010-9062-3; RStudio, 2013, EAS WEB APPL R; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097                                                          ; Schwarzer A, 2015, ONCOGENE, V34, P3593, DOI 10.1038/onc.2014.290; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Sims D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r104; Stahlhut M, 2015, BIOMATERIALS, V63, P189, DOI 10.1016/j.biomaterials.2015.06.022; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Watanabe C, 2016, RNA BIOL, V13, P25, DOI 10.1080/15476286.2015.1128062; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780; Zuber J, 2011, GENE DEV, V25, P1628, DOI 10.1101/gad.17269211; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	47	0	0	18	21	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	SEP	2017	139						102	115		10.1016/j.biomaterials.2017.05.032				14	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	EX9GE	WOS:000403564300009	28599149				2018-01-05	
J	Kim, YW; Kim, A				Kim, Yea Woon; Kim, AeRi			Deletion of transcription factor binding motifs using the CRISPR/spCas9 system in the beta-globin LCR	BIOSCIENCE REPORTS			English	Article							ONE-STEP GENERATION; HUMAN-CELLS; GENE-EXPRESSION; PROMOTER; CAS9; RNA; ENDONUCLEASE; ELEMENTS; MUTATIONS; IMMUNITY	Transcription factors play roles in gene transcription through direct binding to their motifs in genome, and inhibiting this binding provides an effective strategy for studying their roles. Here, we applied the CRISPR (clustered, regularly interspaced, short palindromic repeat)/spCas9 (CRISPR-associated protein 9) system to mutate the binding motifs of transcription factors. Binding motifs for erythroid-specific transcription factors were mutated in the locus control region (LCR) hypersensitive sites (HSs) of the human beta-globin locus. Guide RNAs targetting binding motifs were cloned into lentiviral CRISPR vector containing the spCas9 gene, and transduced into MEL/ch11 cells carrying human chromosome 11. DNA mutations in clonal cells were initially screened by quantitative PCR (qPCR) in genomic DNA and then clarified by sequencing. Mutations in binding motifs reduced occupancy by transcription factors in a chromatin environment. Characterization ofmutations revealed that the CRISPR/spCas9 system mainly induced deletions in short regions of <20 bp and preferentially deleted nucleotides around the fifth nucleotide upstream of Protospacer adjacent motifs (PAMs). These results indicate that the CRISPR/Cas9 system is suitable for mutating the binding motifs of transcription factors, and, consequently, would contribute to elucidate the direct roles of transcription factors.	[Kim, Yea Woon; Kim, AeRi] Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Busan 46241, South Korea	Kim, A (reprint author), Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Busan 46241, South Korea.	kimaeri@pusan.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2014R1A2A1A11051702]; Ministry of Education [NRF-2014R1A1A2009565]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning [grant number NRF-2014R1A2A1A11051702]; and the Ministry of Education [grant number NRF-2014R1A1A2009565].	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Anderson KP, 2000, BLOOD, V95, P1652; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim S, 2012, INT J BIOCHEM CELL B, V44, P505, DOI 10.1016/j.biocel.2011.12.001; Kim YW, 2011, NUCLEIC ACIDS RES, V39, P6944, DOI 10.1093/nar/gkr253; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X                                                    ; Li D, 2012, GENE, V511, P18, DOI 10.1016/j.gene.2012.08.047; Liang S, 2008, J CELL BIOCHEM, V105, P9, DOI 10.1002/jcb.21820; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; MAIRE P, 1989, SCIENCE, V244, P343, DOI 10.1126/science.2711183                                                         ; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Rudge TL, 2002, EXP CELL RES, V274, P45, DOI 10.1006/excr.2001.5451; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Stewart AJ, 2012, GENETICS, V192, P973, DOI 10.1534/genetics.112.143370; Tanimura N, 2016, EMBO REP, V17, P249, DOI 10.15252/embr.201541465; Wakabayashi A, 2016, P NATL ACAD SCI USA, V113, P4434, DOI 10.1073/pnas.1521754113; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003	32	0	0	3	3	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0144-8463	1573-4935		BIOSCIENCE REP	Biosci. Rep.	AUG 31	2017	37		4						BSR20170976	10.1042/BSR20170976				10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FH6WU	WOS:000411322000062		gold			2018-01-05	
J	Benamar, S; Khalil, JYB; Blanc-Tailleur, C; Bilen, M; Barrassi, L; La Scola, B				Benamar, Samia; Khalil, Jacques Y. Bou; Blanc-Tailleur, Caroline; Bilen, Melhem; Barrassi, Lina; La Scola, Bernard			Developmental Cycle and Genome Analysis of Protochlamydia massiliensis sp nov a New Species in the Parachlamydiacae Family	FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY			English	Article						Chlamydiae; Vermamoeba vermiformis; co-culture; CRISPR; Protochlamydia massiliensis	STREPTOCOCCUS-THERMOPHILUS; VERMAMOEBA-VERMIFORMIS; ORDER CHLAMYDIALES; HOSPITAL WATER; IDENTIFICATION; ALIGNMENTS; RESISTANCE; EVOLUTION; HISTORY; GENE	Amoeba-associated microorganisms (AAMs) are frequently isolated from water networks. In this paper, we report the isolation and characterization of Protochlamydia massiliensis, an obligate intracellular Gram-negative bacterium belonging to the Parachlamydiaceae family in the Chlamydiales order, from a cooling water tower. This bacterium was isolated on Vermamoeba vermiformis. It has a multiple range of hosts among amoeba and is characterized by a typical replication cycle of Chlamydiae with a particularity, recently shown in some chlamydia, which is the absence of inclusion vacuoles in the V. vermiformis host, adding by this a new member of Chlamydiae undergoing developmental cycle changes in the newly adapted host V. vermiformis. Draft genome sequencing revealed a chromosome of 2.86 Mb consisting of four contigs and a plasmid of 92 Kb.	[Benamar, Samia; Khalil, Jacques Y. Bou; Blanc-Tailleur, Caroline; Bilen, Melhem; Barrassi, Lina; La Scola, Bernard] Inst Hosp Univ Mediterranee Infect, INSERM, U1095, UM63,Ctr Natl Rech Sci 7278,IRD 198,Unite Rech Ma, Marseille, France	La Scola, B (reprint author), Inst Hosp Univ Mediterranee Infect, INSERM, U1095, UM63,Ctr Natl Rech Sci 7278,IRD 198,Unite Rech Ma, Marseille, France.	bernard.la-scola@univ-amu.fr			Foundation Mediterranee Infection	SB was supported by the Foundation Mediterranee Infection.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bertelli C, 2016, GENOME BIOL EVOL, V8, P2376, DOI 10.1093/gbe/evw138; Camacho C., 2008, BMC BIOINFORMATICS, V10, P421, DOI [10.1186/1471-2105-10-421, DOI 10.1186/1471-2105-10-421]; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415                                                       ; Gimenez G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-542; Greub G, 2003, APPL ENVIRON MICROB, V69, P5530, DOI 10.1128/AEM.69.9.5530-5535.2003; Griffiths E, 2005, MICROBIOL-SGM, V151, P2647, DOI 10.1099/mic.0.28057-0; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Horn M, 2000, MICROBIOL-UK, V146, P1231, DOI 10.1099/00221287-146-5-1231                                                     ; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; KAHANE S, 1993, FEMS MICROBIOL LETT, V109, P329, DOI 10.1111/j.1574-6968.1993.tb06189.x; Khalil JYB, 2017, MICROBES INFECT, V19, P343, DOI 10.1016/j.micinf.2017.02.003; Khalil JYB, 2016, FRONT CELL INFECT MI, V6, DOI [10.3389/fcimb.2016.00031, 10.3389/fcimb.2016.00202]; La Scola B, 2000, FEMS MICROBIOL ECOL, V34, P129, DOI 10.1016/S0168-6496(00)00084-2                                                   ; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lo CI, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0019-8; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Pagnier I, 2015, MICROB PATHOGENESIS, V80, P14, DOI 10.1016/j.micpath.2015.02.006; Pillonel T, 2015, INT J SYST EVOL MICR, V65, P1381, DOI 10.1099/ijs.0.000090; Rossi-Tamisier M, 2015, INT J SYST EVOL MICR, V65, P1929, DOI 10.1099/ijs.0.000161; Talavera G, 2007, SYSTEMATIC BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121	32	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	2235-2988			FRONT CELL INFECT MI	Front. Cell. Infect. Microbiol.	AUG 31	2017	7								385	10.3389/fcimb.2017.00385				7	Immunology; Microbiology	Immunology; Microbiology	FF5XT	WOS:000409075300001	28913180	gold			2018-01-05	
J	Patel, SJ; Sanjana, NE; Kishton, RJ; Eidizadeh, A; Vodnala, SK; Cam, M; Gartner, JJ; Jia, L; Steinberg, SM; Yamamoto, TN; Merchant, AS; Mehta, GU; Chichura, A; Shalem, O; Tran, E; Eil, R; Sukumar, M; Guijarro, EP; Day, CP; Robbins, P; Feldman, S; Merlino, G; Zhang, F; Restifo, NP				Patel, Shashank J.; Sanjana, Neville E.; Kishton, Rigel J.; Eidizadeh, Arash; Vodnala, Suman K.; Cam, Maggie; Gartner, Jared J.; Jia, Li; Steinberg, Seth M.; Yamamoto, Tori N.; Merchant, Anand S.; Mehta, Gautam U.; Chichura, Anna; Shalem, Ophir; Tran, Eric; Eil, Robert; Sukumar, Madhusudhanan; Guijarro, Eva Perez; Day, Chi-Ping; Robbins, Paul; Feldman, Steve; Merlino, Glenn; Zhang, Feng; Restifo, Nicholas P.			Identification of essential genes for cancer immunotherapy	NATURE			English	Article							CELL LUNG-CANCER; METASTATIC MELANOMA; DIFFERENTIAL GENE; ENDOTHELIAL-CELLS; CTLA-4 BLOCKADE; PD-1 BLOCKADE; T-CELLS; GENOME; RECEPTOR; LYMPHOCYTES	Somatic gene mutations can alter the vulnerability of cancer cells to T-cell-based immunotherapies. Here we perturbed genes in human melanoma cells to mimic loss-of-function mutations involved in resistance to these therapies, by using a genome-scale CRISPR-Cas9 library that consisted of around 123,000 single-guide RNAs, and profiled genes whose loss in tumour cells impaired the effector function of CD8(+) T cells. The genes that were most enriched in the screen have key roles in antigen presentation and interferon-gamma signalling, and correlate with cytolytic activity in patient tumours from The Cancer Genome Atlas. Among the genes validated using different cancer cell lines and antigens, we identified multiple loss-of-function mutations in APLNR, encoding the apelin receptor, in patient tumours that were refractory to immunotherapy. We show that APLNR interacts with JAK1, modulating interferon-gamma responses in tumours, and that its functional loss reduces the efficacy of adoptive cell transfer and checkpoint blockade immunotherapies in mouse models. Our results link the loss of essential genes for the effector function of CD8(+) T cells with the resistance or non-responsiveness of cancer to immunotherapies.	[Patel, Shashank J.; Kishton, Rigel J.; Eidizadeh, Arash; Vodnala, Suman K.; Cam, Maggie; Gartner, Jared J.; Jia, Li; Steinberg, Seth M.; Yamamoto, Tori N.; Merchant, Anand S.; Mehta, Gautam U.; Chichura, Anna; Tran, Eric; Eil, Robert; Sukumar, Madhusudhanan; Guijarro, Eva Perez; Day, Chi-Ping; Robbins, Paul; Feldman, Steve; Merlino, Glenn; Restifo, Nicholas P.] NCI, NIH, Bethesda, MD 20892 USA; [Patel, Shashank J.] Georgetown Univ, Sch Med, NIH Georgetown Univ Grad Partnership Program, Washington, DC 20057 USA; [Sanjana, Neville E.] New York Genome Ctr, New York, NY 10013 USA; [Sanjana, Neville E.] NYU, Dept Biol, 550 1St Ave, New York, NY 10012 USA; [Yamamoto, Tori N.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Shalem, Ophir] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Shalem, Ophir] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Restifo, Nicholas P.] NIH, Ctr Cell Based Therapy, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA	Patel, SJ; Restifo, NP (reprint author), NCI, NIH, Bethesda, MD 20892 USA.; Patel, SJ (reprint author), Georgetown Univ, Sch Med, NIH Georgetown Univ Grad Partnership Program, Washington, DC 20057 USA.; Sanjana, NE (reprint author), New York Genome Ctr, New York, NY 10013 USA.; Sanjana, NE (reprint author), NYU, Dept Biol, 550 1St Ave, New York, NY 10012 USA.; Restifo, NP (reprint author), NIH, Ctr Cell Based Therapy, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA.	patelsj@mail.nih.gov; nsanjana@nygenome.org; restifon@mail.nih.gov		Restifo, Nicholas P./0000-0003-4229-4580	Intramural Research Program of the NCI; Cancer Moonshot program for the Center for Cell-based Therapy at the NCI, NIH; Milstein Family Foundation; NIH through NHGRI [R00-HG008171]; Sidney Kimmel Scholar Award	The research was supported by the Intramural Research Program of the NCI, and by the Cancer Moonshot program for the Center for Cell-based Therapy at the NCI, NIH. The work was also supported by the Milstein Family Foundation. We thank S.A. Rosenberg, K. Hanada, A. Wellstein, C. Hurley and L. M. Weiner for their valuable discussions and intellectual input, M. Kruhlak, Z. Yu, C. Subramaniam, C. Kariya, A. J. Leonardi, N. Ha, H. Xu, M. A. Black and H. Chinnasamy for technical assistance in this project. This work used the computational resources of the NIH HPC Biowulf cluster (http://hpc.nih.gov). The results here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/. This study was done in partial fulfilment of a PhD in Tumor Biology to S.J.P. N.E.S. is supported by the NIH through NHGRI (R00-HG008171) and a Sidney Kimmel Scholar Award.	Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan TA, 2015, NEW ENGL J MED, V373, P1984, DOI 10.1056/NEJMc1508163; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122                                                     ; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548                                                     ; Kammertoens T, 2017, NATURE, V545, P98, DOI 10.1038/nature22311; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kidoya H, 2012, ONCOGENE, V31, P3254, DOI 10.1038/onc.2011.489; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le D. T., 2017, SCI AAN, V6733; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; MARRERO MB, 1995, NATURE, V375, P247, DOI 10.1038/375247a0; Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200; Nathanson T, 2017, CANCER IMMUNOL RES, V5, P84, DOI 10.1158/2326-6066.CIR-16-0019; Noonan FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1893; O'Carroll AM, 2013, J ENDOCRINOL, V219, pR13, DOI 10.1530/JOE-13-0227; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116                                                     ; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Roh W., 2017, SCI TRANSL MED, V9; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Wan YW, 2016, BIOINFORMATICS, V32, P952, DOI 10.1093/bioinformatics/btv677; Wang LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062924; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wrangle J, 2013, ONCOTARGET, V4, P2067, DOI 10.18632/oncotarget.1542                                                        ; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	49	5	5	53	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					537	+		10.1038/nature23477				19	Multidisciplinary Sciences	Science & Technology - Other Topics	FF2BO	WOS:000408703100028	28783722				2018-01-05	
J	Niewoehner, O; Garcia-Doval, C; Rostol, JT; Berk, C; Schwede, F; Bigler, L; Hall, J; Marraffini, LA; Jinek, M				Niewoehner, Ole; Garcia-Doval, Carmela; Rostol, Jakob T.; Berk, Christian; Schwede, Frank; Bigler, Laurent; Hall, Jonathan; Marraffini, Luciano A.; Jinek, Martin			Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers	NATURE			English	Article							EFFECTOR COMPLEX; THERMUS-THERMOPHILUS; DNA CLEAVAGE; PROTEIN; IMMUNITY; RECOGNITION; ENDORIBONUCLEASE; CLASSIFICATION; DEGRADATION; BACTERIA	In many prokaryotes, type III clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR-associated (Cas) systems detect and degrade invasive genetic elements by an RNA-guided, RNA-targeting multisubunit interference complex. The CRISPR-associated protein Csm6 additionally contributes to interference by functioning as a standalone RNase that degrades invader RNA transcripts, but the mechanism linking invader sensing to Csm6 activity is not understood. Here we show that Csm6 proteins are activated through a second messenger generated by the type III interference complex. Upon target RNA binding by the interference complex, its Cas10 subunit converts ATP into a cyclic oligoadenylate product, which allosterically activates Csm6 by binding to its CRISPR-associated Rossmann fold (CARF) domain. CARF domain mutations that abolish allosteric activation inhibit Csm6 activity in vivo, and mutations in the Cas10 Palm domain phenocopy loss of Csm6. Together, these results point to an unprecedented mechanism for regulation of CRISPR interference that bears striking conceptual similarity to oligoadenylate signalling in mammalian innate immunity.	[Niewoehner, Ole; Garcia-Doval, Carmela; Jinek, Martin] Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Rostol, Jakob T.; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, 1230 York Ave, New York, NY 10065 USA; [Berk, Christian; Hall, Jonathan] Inst Pharmaceut Sci, Dept Chem & Appl Biosci, Vladimir Prelog Weg 1-5-10, CH-8093 Zurich, Switzerland; [Schwede, Frank] BIOLOG Life Sci Inst GmbH, Flughafendamm 9a, D-28199 Bremen, Germany; [Bigler, Laurent] Univ Zurich, Dept Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland	Jinek, M (reprint author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jinek@bioc.uzh.ch		Jinek, Martin/0000-0002-7601-210X; Garcia Doval, Carmela/0000-0002-3422-9490	Swiss National Science Foundation [SNSF 31003A_149393]; Swiss National Competence Center for Research (NCCR) 'RNA Disease'; European Molecular Biology Organization; Boehringer Ingelheim Fonds PhD fellowship; Rita Allen Scholars Program; Burroughs Wellcome Fund PATH award; National Institutes of Health Director's New Innovator Award [1DP2AI104556-01]; Howard Hughes Medical Institute-Simons Faculty Scholar Award	We thank members of the Jinek and Marraffini laboratories for discussions and comments on the manuscript. We thank D. Swarts and P. Sledz for technical assistance and sharing reagents. We thank U. Manzau for technical assistance during A4>P synthesis and purification. We thank the Service for Mass Spectrometry of ETH Zurich for support with MS analysis. This study was supported by a Swiss National Science Foundation project grant to M.J. (SNSF 31003A_149393) and by funding from the Swiss National Competence Center for Research (NCCR) 'RNA & Disease' (to M.J. and J.H.). M.J. is an International Research Scholar of the Howard Hughes Medical Institute and Vallee Scholar of the Bert L & N Kuggie Vallee Foundation. C.G.-D. was supported by a Long-Term Fellowship from the European Molecular Biology Organization. J.T.R. was supported by a Boehringer Ingelheim Fonds PhD fellowship. L.A.M. is supported by the Rita Allen Scholars Program, a Burroughs Wellcome Fund PATH award, a National Institutes of Health Director's New Innovator Award (1DP2AI104556-01), and a Howard Hughes Medical Institute-Simons Faculty Scholar Award.	Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Burroughs A Maxwell, 2015, Nucleic Acids Res, V43, P10633, DOI 10.1093/nar/gkv1267; Carroll SS, 1997, J BIOL CHEM, V272, P19193, DOI 10.1074/jbc.272.31.19193; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Geertsma ER, 2014, METHODS MOL BIOL, V1116, P153, DOI 10.1007/978-1-62703-764-8_11; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305                                                 ; Hale CR, 2014, GENE DEV, V28, P2432, DOI 10.1101/gad.250712.114; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Hatoum-Aslan A, 2013, J BIOL CHEM, V288, P27888, DOI 10.1074/jbc.M113.499244; He F, 2017, NUCLEIC ACIDS RES, V45, P1902, DOI 10.1093/nar/gkw1265; Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0                                                                ; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lintner NG, 2011, J MOL BIOL, V405, P939, DOI 10.1016/j.jmb.2010.11.019; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00102; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115; Osawa T, 2013, J MOL BIOL, V425, P3811, DOI 10.1016/j.jmb.2013.03.042; Prischi F., 2014, NAT COMMUN, V5, P3554; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sheppard NF, 2016, RNA, V22, P216, DOI 10.1261/rna.039842.113; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Tamulaitis G, 2017, TRENDS MICROBIOL, V25, P49, DOI 10.1016/j.tim.2016.09.012; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Topuzlu E, 2016, RNA BIOL, V13, P254, DOI 10.1080/15476286.2015.1130209; Yan XF, 2015, RNA BIOL, V12, P749, DOI 10.1080/15476286.2015.1051300	41	5	5	12	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					543	+		10.1038/nature23467				18	Multidisciplinary Sciences	Science & Technology - Other Topics	FF2BO	WOS:000408703100029	28722012				2018-01-05	
J	Petit, J; Bres, C; Mauxion, JP; Bakan, B; Rothan, C				Petit, Johann; Bres, Cecile; Mauxion, Jean-Philippe; Bakan, Benedicte; Rothan, Christophe			Breeding for cuticle-associated traits in crop species: traits, targets, and strategies	JOURNAL OF EXPERIMENTAL BOTANY			English	Review						Breeding; CRISPR/Cas9; crop; cuticle; genetic diversity; mapping; mutant; TILLING; trait	TRANSPIRATION BARRIER PROPERTIES; PLANT BIOPOLYESTER CUTIN; POSTHARVEST WATER-LOSS; GRAPE BERRY CUTICLE; TOMATO FRUIT; TRANSCRIPTION FACTOR; SOLANUM-PENNELLII; LIPID-COMPOSITION; INDUCED MUTATIONS; BOTRYTIS-CINEREA	Improving crop productivity and quality while promoting sustainable agriculture have become major goals in plant breeding. The cuticle is a natural film covering the aerial organs of plants and consists of lipid polyesters covered and embedded with wax. The cuticle protects plants against water loss and pathogens and affects traits with strong impacts on crop quality such as, for horticultural crops, fruit brightness, cracking, russeting, netting, and shelf life. Here we provide an overview of the most important cuticle-associated traits that can be targeted for crop improvement. To date, most studies on cuticle-associated traits aimed at crop breeding have been done on fleshy fruits. Less information is available for staple crops such as rice, wheat or maize. Here we present new insights into cuticle formation and properties resulting from the study of genetic resources available for the various crop species. Our review also covers the current strategies and tools aimed at exploiting available natural and artificially induced genetic diversity and the technologies used to transfer the beneficial alleles affecting cuticle-associated traits to commercial varieties.	[Petit, Johann; Bres, Cecile; Mauxion, Jean-Philippe; Rothan, Christophe] Univ Bordeaux, INRA, UMR BFP 1332, F-33140 Villenave Dornon, France; [Bakan, Benedicte] INRA, UR BIA 1268, F-44316 Nantes, France	Rothan, C (reprint author), Univ Bordeaux, INRA, UMR BFP 1332, F-33140 Villenave Dornon, France.	christophe.rothan@inra.fr		ROTHAN, Christophe/0000-0002-6831-2823			Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Adato A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000777; Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Agudelo-Romero P, 2015, J EXP BOT, V66, P1769, DOI 10.1093/jxb/eru517; Al-Abdallat AM, 2014, INT J MOL SCI, V15, P19499, DOI 10.3390/ijms151119499; Alkan Noam, 2015, Front Plant Sci, V6, P889, DOI 10.3389/fpls.2015.00889; Alkan N, 2015, NEW PHYTOL, V205, P801, DOI 10.1111/nph.13087; Alseekh S, 2013, TRENDS PLANT SCI, V18, P536, DOI 10.1016/j.tplants.2013.08.003; Altangerel N, 2017, P NATL ACAD SCI USA, V114, P3393, DOI 10.1073/pnas.1701328114; Ando K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142133; Argyris JM, 2015, PHYSIOL PLANTARUM, V155, P4, DOI 10.1111/ppl.12323; Ballester AR, 2010, PLANT PHYSIOL, V152, P71, DOI 10.1104/pp.109.147322; Bauchet G, 2017, THEOR APPL GENET, V130, P875, DOI 10.1007/s00122-017-2857-9; Bazakos C, 2017, ANNU REV PLANT BIOL, V68, P435, DOI 10.1146/annurev-arplant-042916-040820; Bemer M, 2012, PLANT CELL, V24, P4437, DOI 10.1105/tpc.112.103283; Beniitez JJ, 2004, BBA-GEN SUBJECTS, V1674, P1, DOI 10.1016/j.bbagen.2004.06.012; Benitez JJ, 2004, J STRUCT BIOL, V147, P179, DOI 10.1016/j.jsb.2004.03.006; Bernard A, 2013, PROG LIPID RES, V52, P110, DOI 10.1016/j.plipres.2012.10.002; Bi HH, 2016, J EXP BOT, V67, P5363, DOI 10.1093/jxb/erw298; Bolger A, 2014, NAT GENET, V46, P1034, DOI 10.1038/ng.3046; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Bruggenwirth M, 2017, PLANTA, V245, P765, DOI 10.1007/s00425-016-2639-7; Buda GJ, 2009, PLANT J, V60, P378, DOI 10.1111/j.1365-313X.2009.03960.x; Buschhaus C, 2011, J EXP BOT, V62, P841, DOI 10.1093/jxb/erq366; Buxdorf K, 2014, PLANT MOL BIOL, V84, P37, DOI 10.1007/s11103-013-0117-1; Causse M, 2016, COMPEND PL GENOME, P23, DOI 10.1007/978-3-662-53389-5_3; Cermak T, 2017, PLANT CELL, V29, P1196, DOI 10.1105/tpc.16.00922; Chatterjee S, 2016, BIOMACROMOLECULES, V17, P215, DOI 10.1021/acs.biomac.5b01321; Chaudhari SA, 2015, INT J BIOL MACROMOL, V79, P398, DOI 10.1016/j.ijbiomac.2015.05.006; Chen GX, 2011, P NATL ACAD SCI USA, V108, P12354, DOI 10.1073/pnas.1108444108; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Commenil P, 1997, J EXP BOT, V48, P1599, DOI 10.1093/jexbot/48.313.1599; Curvers K, 2010, PLANT PHYSIOL, V154, P847, DOI 10.1104/pp.110.158972; Dominguez E, 2012, PHYSIOL PLANTARUM, V146, P473, DOI 10.1111/j.1399-3054.2012.01647.x; Druka A, 2011, PLANT PHYSIOL, V155, P617, DOI 10.1104/pp.110.166249; Fernandez AI, 2009, PLANT PHYSIOL, V151, P1729, DOI 10.1104/pp.109.147546; Fernandez V, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00427; Fernandez-Moreno JP, 2017, J EXP BOT, V68, P2703, DOI 10.1093/jxb/erx134; Fernandez-Moreno JP, 2016, PLANT PHYSIOL, V171, P1821, DOI 10.1104/pp.16.00282; Fich EA, 2016, ANNU REV PLANT BIOL, V67, P207, DOI 10.1146/annurev-arplant-043015-111929; Filippis I, 2013, PLANT J, V75, P1039, DOI 10.1111/tpj.12250; Gady ALF, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-13; Garcia V, 2016, NAT PROTOC, V11, P2401, DOI 10.1038/nprot.2016.143; Gimenez E, 2015, PLANT PHYSIOL, V168, P1036, DOI 10.1104/pp.15.00469; Girard AL, 2012, PLANT CELL, V24, P3119, DOI 10.1105/tpc.112.101055; Greene EA, 2003, GENETICS, V164, P731; Guillet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036795; Hazard B, 2014, J PLANT REGIST, V8, P334, DOI 10.3198/jpr2014.02.0007crg; Hen-Avivi S, 2016, PLANT CELL, V28, P1440, DOI 10.1105/tpc.16.00197; Hen-Avivi S, 2014, J EXP BOT, V65, P4653, DOI 10.1093/jxb/eru225; Henry IM, 2014, PLANT CELL, V26, P1382, DOI 10.1105/tpc.113.121590; Herzog K, 2015, SENSORS-BASEL, V15, P12498, DOI 10.3390/s150612498; Hovav R, 2007, PLANT J, V52, P627, DOI 10.1111/j.1365-313X.2007.03265.x; Isaacson T, 2009, PLANT J, V60, P363, DOI 10.1111/j.1365-313X.2009.03969.x; Javelle M, 2010, PLANT PHYSIOL, V154, P273, DOI 10.1104/pp.109.150540; Jetter R, 2008, PLANT J, V54, P670, DOI 10.1111/j.1365-313X.2008.03467.x; Jetter R, 2016, PLANT PHYSIOL, V170, P921, DOI 10.1104/pp.15.01699; Just D, 2013, PLANT BIOTECHNOL-NAR, V30, P225, DOI 10.5511/plantbiotechnology.13.0622a; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kharkwal MC, 2009, ROLE INDUCED MUTATIO; Kimbara J, 2013, PLANT CELL PHYSIOL, V54, P1535, DOI 10.1093/pcp/pct100; Kosma DK, 2010, PHYSIOL PLANTARUM, V139, P107, DOI 10.1111/j.1399-3054.2009.01342.x; Krasileva KV, 2017, P NATL ACAD SCI USA, V114, pE913, DOI 10.1073/pnas.1619268114; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Lara I, 2015, J AGR FOOD CHEM, V63, P4005, DOI 10.1021/acs.jafc.5b00013; Lashbrooke J, 2016, PLANT CELL, V28, P2097, DOI 10.1105/tpc.16.00490; Lashbrooke J, 2015, PLANT PHYSIOL, V169, P2553, DOI 10.1104/pp.15.01145; Lashbrooke J, 2015, J EXP BOT, V66, P6579, DOI 10.1093/jxb/erv366; Lee H, 2014, SENSORS-BASEL, V14, P18837, DOI 10.3390/s141018837; Legay S, 2016, NEW PHYTOL, V212, P977, DOI 10.1111/nph.14170; Legay S, 2015, PLANT MOL BIOL, V88, P21, DOI 10.1007/s11103-015-0303-4; Leide J, 2007, PLANT PHYSIOL, V144, P1667, DOI 10.1104/pp.107.099481; Li F, 2011, BIOTECH HISTOCHEM, V86, P394, DOI 10.3109/10520295.2010.516685; Li GT, 2017, PLANT CELL, V29, P1218, DOI 10.1105/tpc.17.00154; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082333; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Littlejohn GR, 2015, PLANT PHYSIOL, V168, P18, DOI 10.1104/pp.15.00119; Lo SF, 2016, PLANT CELL ENVIRON, V39, P998, DOI 10.1111/pce.12632; LUNDQVIST U, 1988, HEREDITAS, V108, P1, DOI 10.1111/j.1601-5223.1988.tb00676.x                                              ; Martin LBB, 2014, J EXP BOT, V65, P4639, DOI 10.1093/jxb/eru301; Mascher M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r78; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Mazurek S, 2013, PLANT J, V74, P880, DOI 10.1111/tpj.12164; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Mikami M, 2016, PLANT CELL PHYSIOL, V57, P1058, DOI 10.1093/pcp/pcw049; Mintz-Oron S, 2008, PLANT PHYSIOL, V147, P823, DOI 10.1104/pp.108.116004; Monneveux P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00429; Musseau C, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00988; Nadakuduti SS, 2012, PLANT PHYSIOL, V159, P945, DOI 10.1104/pp.112.198374; Ofner I, 2016, PLANT J, V87, P151, DOI 10.1111/tpj.13194; Okabe Y, 2011, PLANT CELL PHYSIOL, V52, P1994, DOI 10.1093/pcp/pcr134; Pan CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep24765; Park JJ, 2010, PLANT MOL BIOL, V74, P91, DOI 10.1007/s11103-010-9656-x; Park SJ, 2014, NAT GENET, V46, P1337, DOI 10.1038/ng.3131; Parsons EP, 2013, PHYSIOL PLANTARUM, V149, P160, DOI 10.1111/ppl.12035; Parsons EP, 2012, PHYSIOL PLANTARUM, V146, P15, DOI 10.1111/j.1399-3054.2012.01592.x; Pascual L, 2015, PLANT BIOTECHNOL J, V13, P565, DOI 10.1111/pbi.12282; Petit J, 2016, PLANT PHYSIOL, V171, P894, DOI 10.1104/pp.16.00409; Petit J, 2014, PLANT PHYSIOL, V164, P888, DOI 10.1104/pp.113.232645; Philippe G, 2016, PLANT PHYSIOL, V170, P807, DOI 10.1104/pp.15.01620; Popovsky-Sarid S, 2017, THEOR APPL GENET, V130, P445, DOI 10.1007/s00122-016-2825-9; Puchta H, 2017, CURR OPIN PLANT BIOL, V36, P1, DOI 10.1016/j.pbi.2016.11.011; Reina-Pinto JJ, 2009, PLANT PHYSIOL BIOCH, V47, P540, DOI 10.1016/j.plaphy.2009.01.004; Riederer M, 2015, PLANTA, V242, P1207, DOI 10.1007/s00425-015-2360-y; Saito T, 2011, PLANT CELL PHYSIOL, V52, P283, DOI 10.1093/pcp/pcr004; Saladie M, 2007, PLANT PHYSIOL, V144, P1012, DOI 10.1104/pp.107.097477; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Schneeberger K, 2014, NAT REV GENET, V15, P662, DOI 10.1038/nrg3745; Schneider LM, 2016, J EXP BOT, V67, P2715, DOI 10.1093/jxb/erw105; Shi JX, 2013, NEW PHYTOL, V197, P468, DOI 10.1111/nph.12032; Shimatani Z, 2017, NAT BIOTECHNOL, V35, P441, DOI 10.1038/nbt.3833; Shirasawa K, 2016, PLANT BIOTECHNOL J, V14, P51, DOI 10.1111/pbi.12348; Sikora P, 2011, INT J PLANT GENOM, V2011, DOI DOI 10.1155/2011/314829; Sonawane PD, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.205; Song GY, 2016, CROP J, V4, P75, DOI 10.1016/j.cj.2015.12.002; Sun C, 2017, NUCLEIC ACIDS RES, V45, P597, DOI 10.1093/nar/gkw958; Tanaka T, 2004, PLANT J, V37, P139, DOI 10.1046/j.1365-313X.2003.01946.x; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tieman D, 2017, SCIENCE, V355, P391, DOI 10.1126/science.aal1556; Tsai H, 2011, PLANT PHYSIOL, V156, P1257, DOI 10.1104/pp.110.169748; Velickovic D, 2014, PLANT J, V80, P926, DOI 10.1111/tpj.12689; Vishwanath SJ, 2015, PLANT CELL REP, V34, P573, DOI 10.1007/s00299-014-1727-z; Vogg G, 2004, J EXP BOT, V55, P1401, DOI 10.1093/jxb/erh149; Vrkoslav V, 2010, J AM SOC MASS SPECTR, V21, P220, DOI 10.1016/j.jasms.2009.10.003; WALTON TJ, 1972, BIOCHEMISTRY-US, V11, P1885, DOI 10.1021/bi00760a025                                                             ; Waltz E, 2016, NATURE, V532, P293, DOI 10.1038/nature.2016.19754; Wang YH, 2016, BOT STUD, V57, DOI 10.1186/s40529-016-0130-1; Weidenbach D, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2014.1003752; Wu RH, 2011, PLANT CELL, V23, P3392, DOI 10.1105/tpc.111.088625; Xu Y, 2017, CROP J, V5, P175, DOI 10.1016/j.cj.2016.06.003; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; Yeats TH, 2012, NAT CHEM BIOL, V8, P609, DOI [10.1038/nchembio.960, 10.1038/NCHEMBIO.960]; Yeats TH, 2012, PLANT J, V69, P655, DOI 10.1111/j.1365-313X.2011.04820.x; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811; Rose J, 2012, U. S. Patent, Patent No. 20120054907	137	1	1	12	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	AUG 30	2017	68	19			SI		5369	5387		10.1093/jxb/erx341				19	Plant Sciences	Plant Sciences	FM5NV	WOS:000415083600011	29036305				2018-01-05	
J	Ma, L; Liu, GZ; Liu, J; Li, MZ; Zhang, H; Tang, D; Liu, Q				Ma, Lei; Liu, Gongzhen; Liu, Jing; Li, Muzi; Zhang, Heng; Tang, Di; Liu, Qun			Neospora caninum ROP16 play an important role in the pathogenicity by phosphorylating host cell STAT3	VETERINARY PARASITOLOGY			English	Article						Neospora caninum; Rhoptry protein 16; Virulence factor; Apoptosis; STAT3	TOXOPLASMA-GONDII; CRISPR/CAS9; MECHANISMS; ANTIBODIES; INFECTION; APOPTOSIS; INVASION; ANTIGEN	Neospora caninum is a common cause of abortions in cattle and nervous system dysfunctions in dogs. Our analysis shows that NcROP16 and TgROP16 have similar structures and may have similar functions. To our surprise, we found that similar to the T. gondii RH strain, the N. caninum Nc-1 strain could phosphorylate STAT3(Y705), but in contrast to T. gondii, N. caninum Nc-1 could not phosphorylate STAT6(Y641). We constructed a gene-knockout plasmid and screened ANcROP16 strains at the gene, protein and transcription levels. Plaque assays, invasion assays and intracellular proliferation tests indicated that the ANcROP16 strain phenotypes had changed, resulting in smaller plaques and slower intracellular growth. A virulence analysis showed that the cerebral loads of the parasite in mice infected with the ANcROP16 strain were significantly reduced compared to the loads in mice infected with the Nc-1 strain. In contrast, the overexpression of ROP16 led to the largest number of parasites observed in the mouse brains. Similarly, the overexpression of ROP16 caused the most powerful virulence in mice. In addition, NcROP16 takes part in the STAT3 signaling pathway in different host cells. This occurs by the secretion of NcROP16 into the host cell, where it phosphorylates STAT3, and phosphorylated STAT3 then migrates to the cell nucleus. NcROP16 can enter the host nucleus and continuously phosphorylate STAT3, resulting in the induction of host cell apoptosis. The parasites engineered to over express the NcROP16 induce the increased transcription of apoptotic-related genes, such as Fas, FasL and Bax and enhanced ANA1 cell apoptosis. The results show that NcROP16 is a key virulence factor in N. caninum, promoting the host cell apoptosis and enhancing the pathogenicity of the parasites for the host by phosphorylating STAT3.	[Ma, Lei; Liu, Gongzhen; Liu, Jing; Li, Muzi; Zhang, Heng; Tang, Di; Liu, Qun] China Agr Univ, Coll Vet Med, Natl Anim Protozoa Lab, 2 Yuanmingyuanxi Rd, Beijing 100193, Peoples R China; [Liu, Gongzhen] Shandong Acad Med Sci, Shandong Inst Parasit Dis, Jinan, Shandong, Peoples R China	Liu, Q (reprint author), China Agr Univ, Coll Vet Med, Natl Anim Protozoa Lab, 2 Yuanmingyuanxi Rd, Beijing 100193, Peoples R China.	qunliu@cau.edu.cn			National Key Basic Research Program (973 program) of China [2015CB150300]; Beijing Municipal Natural Science Foundation [6131001]; National Natural Science Foundation of China [31302075]; Beijing Natural Science Foundation [6172023]; Earmarked fund for Modern Agro-industry Technology Research System [CARS-37]	This study was supported by the National Key Basic Research Program (973 program) of China (No. 2015CB150300), Beijing Municipal Natural Science Foundation (Grant No. 6131001), National Natural Science Foundation of China (31302075), Beijing Natural Science Foundation (6172023) and Earmarked fund for Modern Agro-industry Technology Research System (< CARS-37). We are grateful to Professor Silvia N. J. Moreno (University of Georgia, USA) for kindly providing the pTCY vector. We thank Professor Xuenan Xuan (Obihiro University of Agriculture and Veterinary Medicine, Japan) for kindly providing the Nc-GFP strain.	Abreu J. A., 2016, REV BRASILEIRA PARAS, V25; Butcher BA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002236; Chang S, 2015, INT J BIOL SCI, V11, P1215, DOI 10.7150/ijbs.10516; Cobadiova A, 2013, VET PARASITOL, V197, P346, DOI 10.1016/j.vetpar.2013.05.005; Debache K, 2008, INT J PARASITOL, V38, P1455, DOI 10.1016/j.ijpara.2008.04.001; Du L, 2015, VET PARASITOL, V214, P171, DOI 10.1016/j.vetpar.2015.09.005; Dubey JP, 2007, CLIN MICROBIOL REV, V20, P323, DOI 10.1128/CMR.00031-06; Dubey JP, 2014, VET PARASITOL, V201, P150, DOI 10.1016/j.vetpar.2013.12.032; Dubey JP, 1999, VET PARASITOL, V84, P349, DOI 10.1016/S0304-4017(99)00044-8; El Hajj H, 2007, PLOS PATHOG, V3, P200, DOI 10.1371/journal.ppat.0030014; Fujii K, 2007, J VET MED SCI, V69, P393, DOI 10.1292/jvms.69.393; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Gharekhani J., 2014, J ADV VET ANIM RES, V1; Gondim LFP, 2002, J PARASITOL, V88, P1159, DOI 10.1645/0022-3395(2002)088[1159:IPONCO]2.0.CO;2; Hammoudi PM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005211; Han FJ, 2016, J WILDLIFE DIS, V52, P387, DOI 10.7589/2015-07-193; Hui W., 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.0111993; Koyama T, 2001, J PARASITOL, V87, P1486, DOI 10.2307/3285327; Lee AH, 2014, MICROBIOL MOL BIOL R, V78, P469, DOI 10.1128/MMBR.00059-13; Li M., 2016, FRONT MICROBIOL, V6; Luder CGK, 2005, CURR TOP MICROBIOL, V289, P219; Machacova T, 2016, VET PARASITOL, V223, P88, DOI 10.1016/j.vetpar.2016.04.018; Mohan CD, 2014, J BIOL CHEM, V289, P34296, DOI 10.1074/jbc.M114.601104; Moreno-Torres K, 2016, ECOL EVOL, V6, P2216, DOI 10.1002/ece3.2050; Mota CM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01456; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Rozovski U, 2016, J IMMUNOL, V196, P4400, DOI 10.4049/jimmunol.1402108; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Sayari M., 2016, J PARASITIC DIS, V40, P1; Schille C., 2016, VET PARASITOL REG ST, V1-2, P35; Shen B., 2017, METHODS MOL BIOL, V1498; Shen B., 2014, MBIO, V5, P1114, DOI DOI 10.1128/MBI0.01114-14; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Soares H. S., 2016, BRAZ J VET RES ANIM, V53; Sugi T, 2016, PARASITOL INT, V65, P558, DOI 10.1016/j.parint.2016.05.002; Suvorova ES, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002093; Tao L., 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.0099744; Walzer KA, 2014, EUKARYOT CELL, V13, P1507, DOI 10.1128/EC.00215-14; Wiengcharoen J, 2012, THAI J VET MED, V42, P235; Williams MJ, 2015, MBIO, V6, DOI 10.1128/mBio.00845-15; [吴亮 Wu Liang], 2014, [中国寄生虫学与寄生虫病杂志, Chinese Journal of Parasitology & Parasitic Diseases], V32, P264; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Yan H, 2016, BIOCHEM BIOPH RES CO, V470, P947, DOI 10.1016/j.bbrc.2016.01.131; Zhang HS, 2007, MOL BIOCHEM PARASIT, V151, P205, DOI 10.1016/j.molbiopara.2006.11.005; Zheng J, 2015, INT J PARASITOL, V45, P141, DOI 10.1016/j.ijpara.2014.09.003	46	0	0	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4017	1873-2550		VET PARASITOL	Vet. Parasitol.	AUG 30	2017	243						135	147		10.1016/j.vetpar.2017.04.020				13	Parasitology; Veterinary Sciences	Parasitology; Veterinary Sciences	FF8SK	WOS:000409287900025	28807283				2018-01-05	
J	Moffett, HF; Coon, ME; Radtke, S; Stephan, SB; McKnight, L; Lambert, A; Stoddard, BL; Kiem, HP; Stephan, MT				Moffett, H. F.; Coon, M. E.; Radtke, S.; Stephan, S. B.; McKnight, L.; Lambert, A.; Stoddard, B. L.; Kiem, H. P.; Stephan, M. T.			Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers	NATURE COMMUNICATIONS			English	Article							CHIMERIC-ANTIGEN-RECEPTOR; HEMATOPOIETIC STEM-CELLS; CD8(+) T-CELLS; GENE DISRUPTION; IN-VIVO; MEMORY; EXPRESSION; IMMUNOTHERAPY; GENERATION; LYMPHOCYTES	Therapies based on immune cells have been applied for diseases ranging from cancer to diabetes. However, the viral and electroporation methods used to create cytoreagents are complex and expensive. Consequently, we develop targeted mRNA nanocarriers that are simply mixed with cells to reprogram them via transient expression. Here, we describe three examples to establish that the approach is simple and generalizable. First, we demonstrate that nanocarriers delivering mRNA encoding a genome-editing agent can efficiently knockout selected genes in anti-cancer T-cells. Second, we imprint a long-lived phenotype exhibiting improved antitumor activities into T-cells by transfecting them with mRNAs that encode a key transcription factor of memory formation. Third, we show how mRNA nanocarriers can program hematopoietic stem cells with improved self-renewal properties. The simplicity of the approach contrasts with the complex protocols currently used to program therapeutic cells, so our methods will likely facilitate manufacturing of cytoreagents.	[Moffett, H. F.; Coon, M. E.; Radtke, S.; Stephan, S. B.; McKnight, L.; Kiem, H. P.; Stephan, M. T.] Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA 98109 USA; [Lambert, A.; Stoddard, B. L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Kiem, H. P.; Stephan, M. T.] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98109 USA; [Stephan, M. T.] Univ Washington, Dept Bioengn & Mol Engn, Seattle, WA 98105 USA; [Stephan, M. T.] Univ Washington, Sci Inst, Seattle, WA 98105 USA	Stephan, MT (reprint author), Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA 98109 USA.; Stephan, MT (reprint author), Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98109 USA.; Stephan, MT (reprint author), Univ Washington, Dept Bioengn & Mol Engn, Seattle, WA 98105 USA.; Stephan, MT (reprint author), Univ Washington, Sci Inst, Seattle, WA 98105 USA.	mstephan@fredhutch.org		Stephan, Matthias/0000-0001-8310-0100	Fred Hutchinson Cancer Research Center's Immunotherapy Initiative; Bezos Family, a FHCRC/UW Cancer Consortium Cancer Center Support Grant of the National Institutes of Health [P30 CA015704]; Prostate Cancer Research Program - Synergistic Idea Development Award from Department of Defense [PC140519P1]; National Science Foundation [1452492, 1644363]; American Cancer Society [RSG-16-110-01-LIB]	We thank Dr Liu and Dr Riddell for the gift of cell lines and StrepTagII antibody. We thank the Fred Hutchinson Genomics Core staff for assistance in the preparation and analysis of RNAseq data. This work was supported in part by the Fred Hutchinson Cancer Research Center's Immunotherapy Initiative with funds provided by the Bezos Family, a FHCRC/UW Cancer Consortium Cancer Center Support Grant of the National Institutes of Health under Award Number P30 CA015704, a Prostate Cancer Research Program - Synergistic Idea Development Award from the Department of Defense (PC140519P1), and by the National Science Foundation (CAREER Award # 1452492 and EAGER Award # 1644363). M. Stephan was also supported by a Research Scholar Grant, RSG-16-110-01-LIB, from the American Cancer Society.	Arasaratnam RJ, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.10.12; Bai Y, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.40; Boesteanu AC, 2009, SEMIN IMMUNOL, V21, P69, DOI 10.1016/j.smim.2009.02.005; Boissel S, 2015, METHODS MOL BIOL, V1239, P171, DOI 10.1007/978-1-4939-1862-1_9; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Burga RA, 2016, CYTOTHERAPY, V18, P1410, DOI 10.1016/j.jcyt.2016.05.018; Certo MT, 2012, NAT METHODS, V9, P973, DOI [10.1038/NMETH.2177, 10.1038/nmeth.2177]; Copolovici DM, 2014, ACS NANO, V8, P1972, DOI 10.1021/nn4057269; Costa A, 2015, DEVELOPMENT, V142, P1948, DOI 10.1242/dev.119149; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Cribbs AP, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-98; Darcy PK, 2015, IMMUNOTHERAPY-UK, V7, P469, DOI [10.2217/IMT.15.37, 10.2217/imt.15.37]; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Ellebrecht CT, 2016, SCIENCE, V353, P179, DOI 10.1126/science.aaf6756; Fesnak AD, 2016, NAT REV CANCER, V16, P566, DOI 10.1038/nrc.2016.97; Freitag J, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1085-9; Gratwohl A, 2015, LANCET HAEMATOL, V2, pE91, DOI 10.1016/S2352-3026(15)00028-9; Jain K. K., 2017, CELL THERAPY TECHNOL, P1; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kays SK, 2015, STEM CELLS DEV, V24, P714, DOI 10.1089/scd.2014.0455; Kim MV, 2013, IMMUNITY, V39, P286, DOI 10.1016/j.immuni.2013.07.013; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931.7940.2004; Koh S, 2013, NUCL ACIDS, V2, pe114, DOI DOI 10.1038/MTNA.2013.43; Lee J, 2013, BLOOD, V121, P4082, DOI 10.1182/blood-2012-09-455204; Liu J, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.6; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085755; Liu LF, 2016, NAT BIOTECHNOL, V34, P430, DOI 10.1038/nbt.3461; Liu XJ, 2015, CANCER RES, V75, P3596, DOI 10.1158/0008-5472.CAN-15-0159; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Mangraviti A, 2015, ACS NANO, V9, P1236, DOI 10.1021/nn504905q; Mao AS, 2015, P NATL ACAD SCI USA, V112, P14452, DOI 10.1073/pnas.1508520112; Menger L, 2016, CANCER RES, V76, P2087, DOI 10.1158/0008-5472.CAN-15-3352; Negre O, 2015, CURR GENE THER, V15, P64; Nightingale SJ, 2006, MOL THER, V13, P1121, DOI 10.1016/j.ymthe.2006.01.008; Pierelli L, 2000, BRIT J HAEMATOL, V108, P610, DOI 10.1046/j.1365-2141.2000.01869.x; Pierelli L, 2001, LEUKEMIA LYMPHOMA, V42, P1195, DOI 10.3109/10428190109097744                                                       ; Pineault N, 2015, EXP HEMATOL, V43, P498, DOI 10.1016/j.exphem.2015.04.011; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Quabius ES, 2015, NEW BIOTECHNOL, V32, P229, DOI 10.1016/j.nbt.2014.04.008; Rentas S, 2016, NATURE, V532, P508, DOI 10.1038/nature17665; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; Sadelain M, 2015, J CLIN INVEST, V125, P3392, DOI 10.1172/JCI80010; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Sommermeyer D, 2016, LEUKEMIA, V30, P492, DOI 10.1038/leu.2015.247; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tejera MM, 2013, J IMMUNOL, V191, P187, DOI 10.4049/jimmunol.1300331; Terakura S, 2012, BLOOD, V119, P72, DOI 10.1182/blood-2011-07-366419; Themeli M, 2013, NAT BIOTECHNOL, V31, P928, DOI 10.1038/nbt.2678; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; Wang JB, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1121; Wang XL, 2012, J IMMUNOTHER, V35, P689, DOI 10.1097/CJI.0b013e318270dec7; Wurm M, 2014, EXP HEMATOL, V42, P114, DOI 10.1016/j.exphem.2013.10.004; Zhang LY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8639; Zhang XB, 2008, J CLIN INVEST, V118, P1502, DOI 10.1172/JCI34371	60	1	1	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG 30	2017	8								389	10.1038/s41467-017-00505-8				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FF1YM	WOS:000408695100006	28855514	gold			2018-01-05	
J	D'Erchia, AM; Gallo, A; Manzari, C; Raho, S; Horner, DS; Chiara, M; Valletti, A; Aiello, I; Mastropasqua, F; Ciaccia, L; Locatelli, F; Pisani, F; Nicchia, GP; Svelto, M; Pesole, G; Picardi, E				D'Erchia, Anna Maria; Gallo, Angela; Manzari, Caterina; Raho, Susanna; Horner, David S.; Chiara, Matteo; Valletti, Alessio; Aiello, Italia; Mastropasqua, Francesca; Ciaccia, Loredana; Locatelli, Franco; Pisani, Francesco; Nicchia, Grazia Paola; Svelto, Maria; Pesole, Graziano; Picardi, Ernesto			Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS	SCIENTIFIC REPORTS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SPORADIC ALS; MOUSE MODEL; BRAIN; EXPRESSION; PROTEINS; DISEASE; MICE; DIFFERENTIATION; IDENTIFICATION	ALS is a devastating and debilitating human disease characterized by the progressive death of upper and lower motor neurons. Although much effort has been made to elucidate molecular determinants underlying the onset and progression of the disorder, the causes of ALS remain largely unknown. In the present work, we have deeply sequenced whole transcriptome from spinal cord ventral horns of post-mortem ALS human donors affected by the sporadic form of the disease (which comprises similar to 90% of the cases but which is less investigated than the inherited form of the disease). We observe 1160 deregulated genes including 18 miRNAs and show that down regulated genes are mainly of neuronal derivation while up regulated genes have glial origin and tend to be involved in neuroinflammation or cell death. Remarkably, we find strong deregulation of SNAP25 and STX1B at both mRNA and protein levels suggesting impaired synaptic function through SNAP25 reduction as a possible cause of calcium elevation and glutamate excitotoxicity. We also note aberrant alternative splicing but not disrupted RNA editing.	[D'Erchia, Anna Maria; Mastropasqua, Francesca; Ciaccia, Loredana; Pisani, Francesco; Nicchia, Grazia Paola; Svelto, Maria; Pesole, Graziano; Picardi, Ernesto] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70126 Bari, Italy; [D'Erchia, Anna Maria; Manzari, Caterina; Chiara, Matteo; Valletti, Alessio; Aiello, Italia; Pesole, Graziano; Picardi, Ernesto] CNR, Inst Biomembranes Bioenerget & Mol Biotechnol IBI, Via Amendola 165-A, I-70126 Bari, Italy; [Gallo, Angela; Raho, Susanna; Locatelli, Franco] IRCCS, Bambino Gesu Childrens Hosp, Dept Pediat Oncohaematol, Piazza S Onofrio 4, I-00165 Rome, Italy; [Svelto, Maria; Pesole, Graziano; Picardi, Ernesto] Natl Inst Biostruct & Biosystems INBB, Viale Medaglie Doro 305, I-00136 Rome, Italy; [Horner, David S.] Univ Milan, Dept Biosci, Via Celoria 26, I-20133 Milan, Italy; [Svelto, Maria; Pesole, Graziano] Univ Bari, Ctr Excellence Comparat Genom, Piazza Umberto I, I-70121 Bari, Italy	Pesole, G; Picardi, E (reprint author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70126 Bari, Italy.; Pesole, G; Picardi, E (reprint author), CNR, Inst Biomembranes Bioenerget & Mol Biotechnol IBI, Via Amendola 165-A, I-70126 Bari, Italy.; Pesole, G; Picardi, E (reprint author), Natl Inst Biostruct & Biosystems INBB, Viale Medaglie Doro 305, I-00136 Rome, Italy.; Pesole, G (reprint author), Univ Bari, Ctr Excellence Comparat Genom, Piazza Umberto I, I-70121 Bari, Italy.	graziano.pesole@uniba.it; ernesto.picardi@uniba.it		Valletti, Alessio/0000-0002-6772-1211	Agency for Research on Amyotrophic Lateral Sclerosis (AriSLA); Italian Ministero dell'Istruzione, Universita e Ricerca (MIUR): PRIN; Consiglio Nazionale delle Ricerche: Flagship Project Epigen; Consiglio Nazionale delle Ricerche: Medicina Personalizzata; Consiglio Nazionale delle Ricerche: Aging Program; Consiglio Nazionale delle Ricerche: Interomics	We kindly thank J. Cottrell at NICHD Brain Bank for assistance with spinal cord tissues. Authors are grateful to the NICHD Brain & Tissue Bank for Developmental Disorders (University of Maryland - USA) and the Human Brain and Spinal Fluid Resource Center (Los Angeles, CA) for providing lumbar spinal cord tissues used in this study. This work was supported by the Agency for Research on Amyotrophic Lateral Sclerosis (AriSLA); Italian Ministero dell'Istruzione, Universita e Ricerca (MIUR): PRIN 2009 and 2010; Consiglio Nazionale delle Ricerche: Flagship Project Epigen, Medicina Personalizzata, Aging Program 2012-2014 and Interomics.	Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; Alon S, 2012, GENOME RES, V22, P1533, DOI 10.1101/gr.131573.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antonucci F, 2013, EMBO REP, V14, P645, DOI 10.1038/embor.2013.75; Appel SH, 2001, AMYOTROPH LATERAL SC, V2, pS47; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Brohawn DG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160520; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Campos-Melo D, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-26; Chen JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062082; Chen LC, 2012, INT J BIOCHEM CELL B, V44, P1711, DOI 10.1016/j.biocel.2012.06.027; Cohen JE, 2011, P NATL ACAD SCI USA, V108, P11650, DOI 10.1073/pnas.1017576108; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Condliffe SB, 2010, J BIOL CHEM, V285, P24968, DOI 10.1074/jbc.M110.145813; Cooper-Knock J, 2012, NAT REV NEUROL, V8, P518, DOI 10.1038/nrneurol.2012.156; Day WA, 2005, NEUROBIOL DIS, V19, P323, DOI 10.1016/j.nbd.2005.01.010; Dhahbi JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-298; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Fujioka Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02388; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Heath PR, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00259; Hideyama T, 2010, J NEUROSCI, V30, P11917, DOI 10.1523/JNEUROSCI.2021-10.2010; Hudish LI, 2013, DEV CELL, V27, P387, DOI [10.1016/j.devce1.2013.10.015, 10.1016/j.devcel.2013.10.015]; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Ikemoto A, 2002, ACTA NEUROPATHOL, V103, P179, DOI 10.1007/s004010100449                                                           ; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Korkmaz OT, 2014, NEUROSCI LETT, V566, P286, DOI 10.1016/j.neulet.2014.02.058; Koval ED, 2013, HUM MOL GENET, V22, P4127, DOI 10.1093/hmg/ddt261; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin L, 2016, HUM MOL GENET, V25, P3454, DOI 10.1093/hmg/ddw187; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Mishima T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090004; Mola MG, 2016, GLIA, V64, P139, DOI 10.1002/glia.22921; Morcuende S, 2013, NEUROSCIENCE, V250, P31, DOI 10.1016/j.neuroscience.2013.06.050; Nakamura M, 2013, NEURODEGENER DIS, V11, P182, DOI 10.1159/000338151; Neo WH, 2014, J BIOL CHEM, V289, P20788, DOI 10.1074/jbc.M113.525493; Parisi C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.491; Peviani M, 2014, MOL NEUROBIOL, V49, P136, DOI 10.1007/s12035-013-8507-6; Phatnani HP, 2013, P NATL ACAD SCI USA, V110, pE756, DOI 10.1073/pnas.1222361110; Picardi E., 2016, NUCLEIC ACIDS RES, DOI 10.1093/nar/gkw767; Picardi E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14941; Picardi E, 2013, BIOINFORMATICS, V29, P1813, DOI 10.1093/bioinformatics/btt287; Pisani F, 2014, J BIOL CHEM, V289, P30578, DOI 10.1074/jbc.M114.582221; Prudencio M, 2015, NAT NEUROSCI, V18, P1175, DOI 10.1038/nn.4065; Pusic AD, 2014, GLIA, V62, P284, DOI 10.1002/glia.22606; Rabin SJ, 2010, HUM MOL GENET, V19, P313, DOI 10.1093/hmg/ddp498; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Saris CGJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-405; Schmidt ERE, 2009, PROG NEUROBIOL, V88, P286, DOI 10.1016/j.pneurobio.2009.05.004; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3                                                   ; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Tan WZ, 2014, BBA-MOL BASIS DIS, V1842, P1295, DOI 10.1016/j.bbadis.2014.02.009; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vance JE, 2012, DIS MODEL MECH, V5, P746, DOI 10.1242/dmm.010124; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wagner F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143196; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wu XF, 2010, BIOCHEM BIOPH RES CO, V393, P514, DOI 10.1016/j.bbrc.2010.02.038; Yang Y, 2012, FEBS LETT, V586, P3608, DOI 10.1016/j.febslet.2012.08.003; Zhou P, 2013, EMBO J, V32, P159, DOI 10.1038/emboj.2012.307	71	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 30	2017	7								10046	10.1038/s41598-017-10488-7				20	Multidisciplinary Sciences	Science & Technology - Other Topics	FF0WS	WOS:000408622400140	28855684	gold			2018-01-05	
J	Meccariello, A; Monti, SM; Romanelli, A; Colonna, R; Primo, P; Inghilterra, MG; Del Corsano, G; Ramaglia, A; Iazzetti, G; Chiarore, A; Patti, F; Heinze, SD; Salvemini, M; Lindsay, H; Chiavacci, E; Burger, A; Robinson, MD; Mosimann, C; Bopp, D; Saccone, G				Meccariello, Angela; Monti, Simona Maria; Romanelli, Alessandra; Colonna, Rita; Primo, Pasquale; Inghilterra, Maria Grazia; Del Corsano, Giuseppe; Ramaglia, Antonio; Iazzetti, Giovanni; Chiarore, Antonia; Patti, Francesco; Heinze, Svenia D.; Salvemini, Marco; Lindsay, Helen; Chiavacci, Elena; Burger, Alexa; Robinson, Mark D.; Mosimann, Christian; Bopp, Daniel; Saccone, Giuseppe			Highly efficient DNA-free gene disruption in the agricultural pest Ceratitis capitata by CRISPR-Cas9 ribonucleoprotein complexes	SCIENTIFIC REPORTS			English	Article							MEDITERRANEAN FRUIT-FLY; DROSOPHILA-MELANOGASTER; CARBONIC-ANHYDRASE; SEX DETERMINATION; AEDES-AEGYPTI; CRISPR/CAS9; MUTAGENESIS; SYSTEM; CAS9; INSECTS	The Mediterranean fruitfly Ceratitis capitata (medfly) is an invasive agricultural pest of high economic impact and has become an emerging model for developing new genetic control strategies as an alternative to insecticides. Here, we report the successful adaptation of CRISPR-Cas9-based gene disruption in the medfly by injecting in vitro pre-assembled, solubilized Cas9 ribonucleoprotein complexes (RNPs) loaded with gene-specific single guide RNAs (sgRNA) into early embryos. When targeting the eye pigmentation gene white eye (we), a high rate of somatic mosaicism in surviving G0 adults was observed. Germline transmission rate of mutated we alleles by G0 animals was on average above 52%, with individual cases achieving nearly 100%. We further recovered large deletions in the we gene when two sites were simultaneously targeted by two sgRNAs. CRISPR-Cas9 targeting of the Ceratitis ortholog of the Drosophila segmentation paired gene (Ccprd) caused segmental malformations in late embryos and in hatched larvae. Mutant phenotypes correlate with repair by non-homologous end-joining (NHEJ) lesions in the two targeted genes. This simple and highly effective Cas9 RNP-based gene editing to introduce mutations in C. capitata will significantly advance the design and development of new effective strategies for pest control management.	[Meccariello, Angela; Colonna, Rita; Primo, Pasquale; Inghilterra, Maria Grazia; Del Corsano, Giuseppe; Iazzetti, Giovanni; Salvemini, Marco; Saccone, Giuseppe] Univ Naples Federico II, Dept Biol, I-80126 Naples, Italy; [Monti, Simona Maria] CNR, IBB, I-80134 Naples, Italy; [Romanelli, Alessandra] Univ Naples Federico II, Dept Pharm, I-80134 Naples, Italy; [Ramaglia, Antonio] Univ Naples Federico II, Dept Phys E Pancini, I-80126 Naples, Italy; [Chiarore, Antonia; Patti, Francesco] Ctr Villa Dohrn Benth Ecol, Stn Zool Anton Dohrn, I-80077 Punta San Pietro, Ischia, Italy; [Heinze, Svenia D.; Lindsay, Helen; Chiavacci, Elena; Burger, Alexa; Robinson, Mark D.; Mosimann, Christian; Bopp, Daniel] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Lindsay, Helen; Robinson, Mark D.] Univ Zurich, Swiss Inst Bioinformat, CH-8057 Zurich, Switzerland	Saccone, G (reprint author), Univ Naples Federico II, Dept Biol, I-80126 Naples, Italy.	giuseppe.saccone@unina.it		SALVEMINI, Marco/0000-0003-2297-9267; saccone, giuseppe/0000-0002-9835-3693; ROMANELLI, Alessandra/0000-0002-7609-4061; Chiavacci, Elena/0000-0003-3924-3635; MONTI, SIMONA MARIA/0000-0001-9647-7089	Ricerca Dipartimentale; Legge 5/Regione Campania; BIP/POR Campania FESR; Biology Department (University of Naples Federico II); Canton of Zurich; Swiss National Science Foundation (SNSF) professorship [PP00P3_139093]; Marie Curie Career Integration Grant from the European Commission [CIG PCIG14-GA-2013-631984]; UZH URPP "Translational Cancer Research" grant; Swiss Heart Foundation	We wish to thank Jin-Soo Kim (Seoul National University, South Korea), Kate O'Connor-Gilles (University of Wisconsin-Madison, USA) and Andrew R. Bassett (University of Oxford, UK) for sharing information and reagents. We thank David O'Brochta (Univ, Maryland, USA), Max Scott (NC State Univ, USA) and William Reid (Univ, Maryland, USA) for invaluable help and advice and Tessa G. Montague (Harvard University, USA) for including the Medfly genome in the CHOPCHOP application. We wish to thank Claudia Brunner (University of Zurich, CH) for technical assistance and Domenica Ippolito (University of Zurich, CH) for embryos microinjections tutoring. We thank Marcelo Jacobs-Lorena (John Hopkins BSPH, USA), Serena Aceto (University of Naples, IT) and Philippos Papathanos (University of Perugia, IT) for critical reading of the manuscript. We wish to acknowledge the participation of AM in a practical course for application of the CRISPR-Cas9 technology in insects organized by Insect Genetic Technology Research Coordination Network (http://igtrcn.org; 17-21 August 2015). This project was supported by "Ricerca Dipartimentale" grants (2015, 2016), by "Legge 5/Regione Campania" grant (2008) and by a "BIP/POR Campania FESR 2007/2013" grant to GS; AM was supported with a PhD fellowship by Biology Department (University of Naples Federico II); CM received support from the Canton of Zurich, a Swiss National Science Foundation (SNSF) professorship [PP00P3_139093], and a Marie Curie Career Integration Grant from the European Commission [CIG PCIG14-GA-2013-631984]; AB was supported by an UZH URPP "Translational Cancer Research" grant; EC was supported by a project grant from the Swiss Heart Foundation.	Adelman ZN, 2016, TRENDS PARASITOL, V32, P219, DOI 10.1016/j.pt.2015.12.003; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112; BELOTE JM, 1982, P NATL ACAD SCI-BIOL, V79, P1568, DOI 10.1073/pnas.79.5.1568; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; Burger A, 2016, DEVELOPMENT, V143, P2025, DOI 10.1242/dev.134809; Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864; Chen Lei, 2016, [Zoological Research, 动物学研究], V37, P220, DOI 10.13918/j.issn.2095-8137.2016.4.220; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Courtier-Orgogozo V, 2017, EMBO REP, V18, P878, DOI 10.15252/embr.201744205; Dafa'alla TH, 2006, NAT BIOTECHNOL, V24, P820, DOI 10.1038/nbt1221; Dathan NA, 2014, J ENZYM INHIB MED CH, V29, P500, DOI 10.3109/14756366.2013.813942; Dyck V. A., 2005, STERILE INSECT TECHN, P1; Fu GL, 2007, NAT BIOTECHNOL, V25, P353, DOI 10.1038/nbt1283; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Galizi R., SCI REP, V6, P31139; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Gomulski LM, 2001, GENETICS, V157, P1245; Gong P, 2005, NAT BIOTECHNOL, V23, P453, DOI 10.1038/nbt1071; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Heinze Svenia D, 2017, Sci Rep, V7, P4582, DOI 10.1038/s41598-017-04686-6; Hille F., 2016, PHILOS T R SOC LON B, V371, P1707; HOLMES DS, 1973, BIOCHEMISTRY-US, V12, P2330, DOI 10.1021/bi00736a023                                                             ; Housden B. E., 2016, COLD SPRING HARB PRO, V9, P747; Isasawin S, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S2; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Koutroumpa, 2016, SCI REP, V6, P29620; Lee JS, 2014, G3-GENES GENOM GENET, V4, P1291, DOI 10.1534/g3.114.012179; Li M., 2017, BIORXIV; Lindsay H, 2016, NAT BIOTECHNOL, V34, P701, DOI 10.1038/nbt.3628; Liquido N. J., 1991, MISCELLANEOUS PUBLIC, V77, P1; Liu GQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128892; Lopez R. J., 2016, NATURE NEWS; LOUKERIS TG, 1995, SCIENCE, V270, P2002, DOI 10.1126/science.270.5244.2002; Ma SY, 2014, SCI REP-UK, V4, DOI 10.1038/srep04489; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Morrison NI, 2010, ASPAC J MOL BIOL BIO, V18, P275; Nusslein-Volhard C., 1980, NATURE, V287; Ogaugwu CE, 2013, INSECT BIOCHEM MOLEC, V43, P1, DOI 10.1016/j.ibmb.2012.10.010; Pane A, 2002, DEVELOPMENT, V129, P3715; Papanicolaou A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1049-2; Peel AD, 2005, NAT REV GENET, V6, P905, DOI 10.1038/nrg1724; Perry M, 2016, NATURE, V535, P280, DOI 10.1038/nature18616; Reid W, 2016, CURR OPIN INSECT SCI, V13, P43, DOI 10.1016/j.cois.2015.11.001; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Saccone G., 2007, AREA WIDE CONTROL IN; Salvemini M, 2006, INSECT MOL BIOL, V15, P341, DOI 10.1111/j.1365-2583.2006.00651.x; Salvemini M, 2009, INT J DEV BIOL, V53, P109, DOI 10.1387/ijdb.082681ms; Schetelig MF, 2012, INSECT BIOCHEM MOLEC, V42, P51, DOI 10.1016/j.ibmb.2011.10.007; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; Schetelig MF, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-4; Scolari F, 2008, NEW BIOTECHNOL, V25, P76, DOI 10.1016/j.nbt.2008.02.001; Sebo Z. L., 2013, FLY AUSTIN, V8, P52; Sharma A, 2017, SCIENCE, V356, P642, DOI 10.1126/science.aam5498; Taning CNT, 2017, J INSECT PHYSIOL, V98, P245, DOI 10.1016/j.jinsphys.2017.01.007; Truppo E, 2012, BIOORG MED CHEM LETT, V22, P1560, DOI 10.1016/j.bmcl.2011.12.134; Wang, 2013, CELL RES, V12, P1414; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhang L., 2017, BIORXIV; ZHANG LL, 2016, NAT COMMUN, V7; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37; ZWIEBEL LJ, 1995, SCIENCE, V270, P2005, DOI 10.1126/science.270.5244.2005	67	0	0	15	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 30	2017	7								10061	10.1038/s41598-017-10347-5				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FF0WS	WOS:000408622400155	28855635	gold			2018-01-05	
J	Watanabe, K; Kobayashi, A; Endo, M; Sage-Ono, K; Toki, S; Ono, M				Watanabe, Kenta; Kobayashi, Anna; Endo, Masaki; Sage-Ono, Kimiyo; Toki, Seiichi; Ono, Michiyuki			CRISPR/Cas9-mediated mutagenesis of the dihydroflavonol-4-reductase-B (DFR-B) locus in the Japanese morning glory Ipomoea (Pharbitis) nil	SCIENTIFIC REPORTS			English	Article							TRANSPOSABLE ELEMENT; FLOWER PIGMENTATION; PERICLINAL CHIMERAS; GUIDE RNA; GENE; PLANTS; EXPRESSION; SYSTEM; BIOSYNTHESIS; ARABIDOPSIS	CRISPR/Cas9 technology is a versatile tool for targeted mutagenesis in many organisms, including plants. However, this technique has not been applied to the Japanese morning glory (Ipomoea [Pharbitis] nil), a traditional garden plant chosen for the National BioResource Project in Japan. We selected dihydroflavonol-4-reductase-B (DFR-B) of I. nil, encoding an anthocyanin biosynthesis enzyme, as the target gene, and changes in the stem colour were observed during the early stages of plant tissue culture by Rhizobium [Agrobacterium]-mediated transformation. Twenty-four of the 32 (75%) transgenic plants bore anthocyanin-less white flowers with bi-allelic mutations at the Cas9 cleavage site in DFR-B, exhibiting a single base insertion or deletions of more than two bases. Thus, these results demonstrate that CRISPR/Cas9 technology enables the exploration of gene functions in this model horticultural plant. To our knowledge, this report is the first concerning flower colour changes in higher plants using CRISPR/Cas9 technology.	[Watanabe, Kenta; Ono, Michiyuki] Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan; [Kobayashi, Anna; Ono, Michiyuki] Univ Tsukuba, Sch Life & Environm Sci, Coll Biol Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan; [Endo, Masaki; Toki, Seiichi] Natl Agr & Food Res Org NARO, Inst Agrobiol Sci, Plant Genome Engn Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan; [Sage-Ono, Kimiyo; Ono, Michiyuki] Univ Tsukuba, Gene Res Ctr, T PIRC, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan; [Toki, Seiichi] Yokohama City Univ, Grad Sch Nanobiosci, Kanazawa Ku, 22-2 Seto, Yokohama, Kanagawa 2360027, Japan; [Toki, Seiichi] Yokohama City Univ, Kihara Inst Biol Res, 641-12 Maioka Cho, Yokohama, Kanagawa 2440813, Japan	Ono, M (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.; Ono, M (reprint author), Univ Tsukuba, Sch Life & Environm Sci, Coll Biol Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.; Ono, M (reprint author), Univ Tsukuba, Gene Res Ctr, T PIRC, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	ono.michiyuki.fm@u.tsukuba.ac.jp			Agency for Medical Research and Development (AMED) Japan; Cooperative Research Grant of the Plant Transgenic Design Initiative (PTraD), Gene Research Center, the University of Tsukuba; Cabinet Office, Government of Japan; Cross Ministerial Strategic Innovation Promotion Program (SIP)	We thank Drs H. Puchta, F. Fauser and S. Schiml at the Karlsruhe Institute of Technology for providing the FFCas9 construct used in this study. We are grateful to the National BioResource Project (NBRP) "Morning glory," which is supported by the Agency for Medical Research and Development (AMED) Japan, for supplying information on the DNA sequence of I. nil. This work was partially financially supported by a Cooperative Research Grant of the Plant Transgenic Design Initiative (PTraD), Gene Research Center, the University of Tsukuba, and by the Cabinet Office, Government of Japan, Cross Ministerial Strategic Innovation Promotion Program (SIP). We are grateful to the late Prof. Hiroshi Kamada for advice on genome editing research and express our condolences.	Aida R, 2016, PLANT BIOTECHNOL-NAR, V33, P45, DOI 10.5511/plantbiotechnology.15.1127a; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; Araki M, 2015, TRENDS PLANT SCI, V20, P145, DOI 10.1016/j.tplants.2015.01.010; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Des Marais DL, 2008, NATURE, V454, P762, DOI 10.1038/nature07092; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; DOONER HK, 1991, ANNU REV GENET, V25, P173, DOI 10.1146/annurev.ge.25.120191.001133; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Fits L., 2000, PLANT MOL BIOL, V43, P495; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fukada-Tanaka S, 2000, NATURE, V407, P581, DOI 10.1038/35036683; Hayama R, 2007, PLANT CELL, V19, P2988, DOI 10.1105/tpc.107.052480; Higuchi Y, 2011, PLANT CELL PHYSIOL, V52, P638, DOI 10.1093/pcp/pcr023; Hoshino A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13295; HUALA E, 1993, PLANT CELL, V5, P1157; Iida S, 1999, ANN NY ACAD SCI, V870, P265, DOI 10.1111/j.1749-6632.1999.tb08887.x                                              ; Imai Y, 1931, J GENET, V24, P203, DOI 10.1007/BF02983854; Imai Y., 1938, JAP J GENET, V14, P91; Imamura S., 1967, PHYSL FLOWERING PHAR, P15; Inagaki Y, 1996, THEOR APPL GENET, V92, P499, DOI 10.1007/BF00224550; Inagaki Y, 1999, GENE, V226, P181, DOI 10.1016/S0378-1119(98)00571-X; INAGAKI Y, 1994, PLANT CELL, V6, P375; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; Iwasaki M, 2006, PLANT MOL BIOL, V62, P913, DOI 10.1007/s11103-006-9066-2; KAWALLECK P, 1993, PLANT MOL BIOL, V21, P673, DOI 10.1007/BF00014550; Kikuchi R., 2005, PLANT BIOTECHNOL, V22, P295; Kitazawa D, 2005, P NATL ACAD SCI USA, V102, P18742, DOI 10.1073/pnas.0504617102; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li X, 2007, J INTEGR PLANT BIOL, V49, P222, DOI 10.1111/j.1672-9072.2007.00393.x; Liu JY, 2001, PLANT PHYSIOL, V125, P1821, DOI 10.1104/pp.125.4.1821; Ly T, 2012, BREEDING SCI, V62, P99, DOI 10.1270/jsbbs.62.99; Mikami M, 2015, PLANT MOL BIOL, V88, P561, DOI 10.1007/s11103-015-0342-x; Morita Y, 2014, PLANT J, V78, P294, DOI 10.1111/tpj.12469; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nitasaka E, 2003, PLANT J, V36, P522, DOI 10.1046/j.1365-313X.2003.01896.x; Ono M, 2000, PLANT BIOTECHNOL, V17, P211; Puchta H, 2017, CURR OPIN PLANT BIOL, V36, P1, DOI 10.1016/j.pbi.2016.11.011; Puchta H, 2014, PLANT J, V78, P727, DOI 10.1111/tpj.12338; Sage-Ono K, 1998, PLANT PHYSIOL, V116, P1479, DOI 10.1104/pp.116.4.1479; Satina S, 1940, AM J BOT, V27, P895, DOI 10.2307/2436558; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shibuya K, 2014, PLANT J, V79, P1044, DOI 10.1111/tpj.12605; SPARVOLI F, 1994, PLANT MOL BIOL, V24, P743, DOI 10.1007/BF00029856; Sprink T, 2016, PLANT CELL REP, V35, P1493, DOI 10.1007/s00299-016-1990-2; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Suzuki Y, 2003, PLANT J, V36, P401, DOI 10.1046/j.1365-313X.2003.01887.x; Takeno K, 2016, J EXP BOT, V67, P4925, DOI 10.1093/jxb/erw272; Trabelsi N, 2008, ACTA CRYSTALLOGR D, V64, P883, DOI 10.1107/S0907444908017769; WAIBEL F, 1990, NATURE, V346, P199, DOI 10.1038/346199a0; Yamazaki Y., 2009, NUCLEIC ACIDS RES, V38, pD26; Zhang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep20315; Zhang DD, 2016, J GENET GENOMICS, V43, P251, DOI 10.1016/j.jgg.2016.03.001; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200	56	0	0	19	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 30	2017	7								10028	10.1038/s41598-017-10715-1				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FF0WS	WOS:000408622400122	28855641	gold			2018-01-05	
J	Razin, SV; Ulianov, SV				Razin, Sergey V.; Ulianov, Sergey V.			Gene functioning and storage within a folded genome	CELLULAR & MOLECULAR BIOLOGY LETTERS			English	Review						Active chromatin; TADs; Hi-C; Self-organization; Epigenetic regulatory mechanisms; Enhancers	TOPOLOGICALLY ASSOCIATING DOMAINS; HI-C REVEALS; NUCLEOSOME CORE PARTICLE; LONG-RANGE INTERACTIONS; CHROMATIN DOMAINS; ARCHITECTURAL PROTEINS; HUMAN-CELLS; 3-DIMENSIONAL ORGANIZATION; CRYOELECTRON MICROSCOPY; CHROMOSOME TERRITORIES	In mammals, genomic DNA that is roughly 2 m long is folded to fit the size of the cell nucleus that has a diameter of about 10 mu m. The folding of genomic DNA is mediated via assembly of DNA-protein complex, chromatin. In addition to the reduction of genomic DNA linear dimensions, the assembly of chromatin allows to discriminate and to mark active (transcribed) and repressed (non-transcribed) genes. Consequently, epigenetic regulation of gene expression occurs at the level of DNA packaging in chromatin. Taking into account the increasing attention of scientific community toward epigenetic systems of gene regulation, it is very important to understand how DNA folding in chromatin is related to gene activity. For many years the hierarchical model of DNA folding was the most popular. It was assumed that nucleosome fiber (10-nm fiber) is folded into 30-nm fiber and further on into chromatin loops attached to a nuclear/chromosome scaffold. Recent studies have demonstrated that there is much less regularity in chromatin folding within the cell nucleus. The very existence of 30-nm chromatin fibers in living cells was questioned. On the other hand, it was found that chromosomes are partitioned into self-interacting spatial domains that restrict the area of enhancers action. Thus, TADs can be considered as structural-functional domains of the chromosomes. Here we discuss the modern view of DNA packaging within the cell nucleus in relation to the regulation of gene expression. Special attention is paid to the possible mechanisms of the chromatin fiber self-assembly into TADs. We discuss the model postulating that partitioning of the chromosome into TADs is determined by the distribution of active and inactive chromatin segments along the chromosome. This article was specially invited by the editors and represents work by leading researchers.	[Razin, Sergey V.; Ulianov, Sergey V.] Russian Acad Sci, Inst Gene Biol, Vavilov St 34-5, Moscow 119334, Russia; [Razin, Sergey V.; Ulianov, Sergey V.] Lomonosov Moscow State Univ, Biol Fac, Leninskie Gory 1,Bldg 12, Moscow 119192, Russia	Razin, SV (reprint author), Russian Acad Sci, Inst Gene Biol, Vavilov St 34-5, Moscow 119334, Russia.; Razin, SV (reprint author), Lomonosov Moscow State Univ, Biol Fac, Leninskie Gory 1,Bldg 12, Moscow 119192, Russia.	sergey.v.razin@usa.net	Razin, Sergey/M-6701-2015	Razin, Sergey/0000-0003-1976-8661	Russian Science Foundation (RSF) [14-24-00022]	This work was supported by the Russian Science Foundation (RSF) [grant number 14-24-00022].	Ali T, 2016, CURR OPIN GENET DEV, V37, P17, DOI 10.1016/j.gde.2015.11.009; Alipour E, 2012, NUCLEIC ACIDS RES, V40, P11202, DOI 10.1093/nar/gks925; Allahverdi A, 2011, NUCLEIC ACIDS RES, V39, P1680, DOI 10.1093/nar/gkq900; Barbieri M, 2013, NUCLEUS-AUSTIN, V4, P267, DOI 10.4161/nucl.25432; Barbieri M, 2012, P NATL ACAD SCI USA, V109, P16173, DOI 10.1073/pnas.1204799109; Battulin N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0642-0; Bazett-Jones DP, 2008, CHROMOSOME RES, V16, P397, DOI 10.1007/s10577-008-1237-3; BEDNAR J, 1995, J CELL BIOL, V131, P1365, DOI 10.1083/jcb.131.6.1365; BODNAR JW, 1988, J THEOR BIOL, V132, P479, DOI 10.1016/S0022-5193(88)80086-9; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; COOK PR, 1976, J CELL SCI, V22, P303; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075                                                                ; CREMER T, 1993, COLD SPRING HARB SYM, V58, P777, DOI 10.1101/SQB.1993.058.01.085                                                     ; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Cubenas-Potts C, 2015, NUCLEUS-PHILA, V6, P430, DOI 10.1080/19491034.2015.1096467; Cubenas-Potts C, 2015, FEBS LETT, V589, P2923, DOI 10.1016/j.febslet.2015.05.025; CULLEN KE, 1993, SCIENCE, V261, P203, DOI 10.1126/science.8327891                                                         ; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; de Wit E, 2015, MOL CELL, V60, P676, DOI 10.1016/j.molcel.2015.09.023; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019356; Dekker J, 2015, FEBS LETT, V589, P2877, DOI 10.1016/j.febslet.2015.08.044; Dileep V, 2015, GENOME RES, V25, P1104, DOI 10.1101/gr.183699.114; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Even-Faitelson L, 2013, METHODS MOL BIOL, V1042, P181, DOI 10.1007/978-1-62703-526-2_13; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Feng SH, 2014, MOL CELL, V55, P694, DOI 10.1016/j.molcel.2014.07.008; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897                                                          ; Flyamer IM, 2017, NATURE, V544, P110, DOI 10.1038/nature21711; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; Fragkos M, 2015, NAT REV MOL CELL BIO, V16, P360, DOI 10.1038/nrm4002; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Fraser J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156492; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Fussner E, 2012, EMBO REP, V13, P992, DOI 10.1038/embor.2012.139; Gan L, 2013, CHROMOSOMA, V122, P377, DOI 10.1007/s00412-013-0423-z; Gavrilov AA, 2016, NUCLEUS-PHILA, V7, P319, DOI 10.1080/19491034.2016.1190896; GETZENBERG RH, 1991, J CELL BIOCHEM, V47, P289, DOI 10.1002/jcb.240470402                                                           ; Ghirlando R, 2012, BBA-GENE REGUL MECH, V1819, P644, DOI 10.1016/j.bbagrm.2012.01.016; GOLDMAN MA, 1988, BIOESSAYS, V9, P50, DOI 10.1002/bies.950090204; Gomez-Diaz E, 2014, TRENDS CELL BIOL, V24, P703, DOI 10.1016/j.tcb.2014.08.003; Gothard LQ, 1996, MOL ENDOCRINOL, V10, P185, DOI 10.1210/me.10.2.185; Grigoryev SA, 2012, EXP CELL RES, V318, P1448, DOI 10.1016/j.yexcr.2012.02.014; Grigoryev SA, 2009, P NATL ACAD SCI USA, V106, P13317, DOI 10.1073/pnas.0903280106; Gurudatta B. V., 2009, Briefings in Functional Genomics & Proteomics, V8, P276, DOI 10.1093/bfgp/elp032; HANCOCK R, 1982, BIOL CELL, V44, P201; Hancock R, 2008, EUR BIOPHYS J BIOPHY, V37, P1059, DOI 10.1007/s00249-008-0276-1; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Hsieh THS, 2015, CELL, V162, P108, DOI 10.1016/j.cell.2015.05.048; Iarovaia OV, 2004, NUCLEIC ACIDS RES, V32, P2079, DOI 10.1093/nar/gkh532; Jensen TH, 2013, MOL CELL, V52, P473, DOI 10.1016/j.molcel.2013.10.032; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Jost D, 2014, NUCLEIC ACIDS RES, V42, P9553, DOI 10.1093/nar/gku698; Kalashnikova AA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1022; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424                                                           ; Kolbl AC, 2012, CHROMOSOME RES, V20, P735, DOI 10.1007/s10577-012-9309-9; Kyrchanova O, 2014, FEBS LETT, V588, P8, DOI 10.1016/j.febslet.2013.10.039; Le TBK, 2013, SCIENCE, V342, P731, DOI 10.1126/science.1242059; Li L, 2015, MOL CELL, V58, P216, DOI 10.1016/j.molcel.2015.02.023; Li Xiaomin, 2015, [Biophysics Reports, 生物物理学报], V1, P51; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lucas JS, 2014, CELL, V158, P339, DOI 10.1016/j.cell.2014.05.036; Luger K, 1997, NATURE, V389, P251; Lupianez DG, 2016, TRENDS GENET, V32, P225, DOI 10.1016/j.tig.2016.01.003; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Maeshima K, 2016, EMBO J, V8; Maeshima K, 2014, METHODS, V70, P154, DOI 10.1016/j.ymeth.2014.08.008; Maeshima K, 2014, CHROMOSOMA, V123, P225, DOI 10.1007/s00412-014-0460-2; Markaki Y, 2010, Cold Spring Harb Symp Quant Biol, V75, P475, DOI 10.1101/sqb.2010.75.042; Mechali M, 2013, CURR OPIN GENET DEV, V23, P124, DOI 10.1016/j.gde.2013.02.010; Merkenschlager M, 2016, ANNU REV GENOM HUM G, V17, P17, DOI 10.1146/annurev-genom-083115-022339; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Moindrot B, 2012, NUCLEIC ACIDS RES, V40, P9470, DOI 10.1093/nar/gks736; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Nora EP, 2013, BIOESSAYS, V35, P818, DOI 10.1002/bies.201300040; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Pepenella S, 2014, CHROMOSOMA, V123, P3, DOI 10.1007/s00412-013-0435-8; Pombo A, 2014, TRANSCRIPTION, V5; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Razin SV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1409, DOI 10.1134/S0006297912130019; Razin SV, 2007, J MOL BIOL, V369, P597, DOI 10.1016/j.jmb.2007.04.003; Razin SV, 2017, CHROMOSOMA, V126, P59, DOI 10.1007/s00412-016-0604-7; Razin SV, 2016, TRANSCR-AUSTIN, V7, P84, DOI 10.1080/21541264.2016.1181489; Razin SV, 2013, FEBS LETT, V587, P1840, DOI 10.1016/j.febslet.2013.04.027; Razin SV, 2003, INT REV CYTOL, V226, P63, DOI 10.1016/S0074-7696(03)01002-7; Razin SV, 1995, INT REV CYTOL, V162B, P405; Razin SV, 2001, CELL MOL BIOL LETT, V6, P59; Recillas-Targa F, 2001, CRIT REV EUKAR GENE, V11, P227; Rhind N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010132; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; SCHERRER K, 1989, BIOSCIENCE REP, V9, P157, DOI 10.1007/BF01115994; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sinha D, 2010, J BIOL CHEM, V285, P16572, DOI 10.1074/jbc.M109.091298; Smeets D, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-8; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tiana G, 2016, BIOPHYS J, V110, P1234, DOI 10.1016/j.bpj.2016.02.003; Ulianov SV, 2016, GENOME RES, V26, P70, DOI 10.1101/gr.196006.115; Valton AL, 2016, CURR OPIN GENET DEV, V36, P34, DOI 10.1016/j.gde.2016.03.008; Van Bortle K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r82; Vasquez PA, 2016, NUCLEIC ACIDS RES, V44, P5540, DOI 10.1093/nar/gkw510; Vernimmen D, 2015, TRENDS GENET, V31, P696, DOI 10.1016/j.tig.2015.10.004; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wang CM, 2015, GENOME RES, V25, P246, DOI 10.1101/gr.170332.113; Weinreb C, 2016, BIOINFORMATICS, V32, P1601, DOI 10.1093/bioinformatics/btv485; Woodcock CL, 2006, CURR OPIN STRUC BIOL, V16, P213, DOI 10.1016/j.sbi.2006.02.005; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; Yang JP, 2012, CURR OPIN GENET DEV, V22, P86, DOI 10.1016/j.gde.2011.12.007; Yang JP, 2011, ADV CANCER RES, V110, P43, DOI 10.1016/B978-0-12-386469-7.00003-7; Zhan YX, 2017, GENOME RES, V27, P479, DOI 10.1101/gr.212803.116; Zlatanova J, 2009, CELL MOL LIFE SCI, V66, P1647, DOI 10.1007/s00018-009-8647-z; Zolotarev N, 2016, NUCLEIC ACIDS RES, V44, P7228, DOI 10.1093/nar/gkw371; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	127	0	0	7	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1425-8153	1689-1392		CELL MOL BIOL LETT	Cell. Mol. Biol. Lett.	AUG 29	2017	22								18	10.1186/s11658-017-0050-4				15	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FF8VV	WOS:000409296800002	28861108	green_published			2018-01-05	
J	Toms, A; Barrangou, R				Toms, Alice; Barrangou, Rodolphe			On the global CRISPR array behavior in class I systems	BIOLOGY DIRECT			English	Article							CAS SYSTEMS; IMMUNE-SYSTEMS; DNA; EVOLUTION; CLASSIFICATION; DISTRIBUTIONS; PROKARYOTES; PACKAGE	Background: Much effort is underway to build and upgrade databases and tools related to occurrence, diversity, and characterization of CRISPR-Cas systems. As microbial communities and their genome complements are unearthed, much emphasis has been placed on details of individual strains and model systems within the CRISPR-Cas classification, and that collection of information as a whole affords the opportunity to analyze CRISPR-Cas systems from a quantitative perspective to gain insight into distribution of CRISPR array sizes across the different classes, types and subtypes. CRISPR diversity, nomenclature, occurrence, and biological functions have generated a plethora of data that created a need to understand the size and distribution of these various systems to appreciate their features and complexity. Results: By utilizing a statistical framework and visual analytic techniques, we have been able to test several hypotheses about CRISPR loci in bacterial class I systems. Quantitatively, though CRISPR loci can expand to hundreds of spacers, the mean and median sizes are 40 and 25, respectively, reflecting rather modest acquisition and/ or retention overall. Histograms uncovered that CRISPR array size displayed a parametric distribution, which was confirmed by a goodness-of fit test. Mapping the frequency of CRISPR loci on a standardized chromosome plot revealed that CRISPRs have a higher probability of occurring at clustered locations along the positive or negative strand. Lastly, when multiple arrays occur in a particular system, the size of a particular CRISPR array varies with its distance from the cas operon, reflecting acquisition and expansion biases. Conclusions: This study establishes that bacterial Class I CRISPR array size tends to follow a geometric distribution; these CRISPRs are not randomly distributed along the chromosome; and the CRISPR array closest to the cas genes is typically larger than loci in trans. Overall, we provide an analytical framework to understand the features and behavior of CRISPRCas systems through a quantitative lens.	[Toms, Alice] North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Toms, Alice] North Carolina State Univ, Dept Entomol & Plant Pathol, Ctr Integrated Fungal Res, Raleigh, NC 27695 USA; [Barrangou, Rodolphe] North Carolina State Univ, Dept Food Bioproc & Nutr Sci, 400 Dan Allen Dr,Schaub Hall,Campus Box 7624, Raleigh, NC 27695 USA	Toms, A (reprint author), North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA.; Toms, A (reprint author), North Carolina State Univ, Dept Entomol & Plant Pathol, Ctr Integrated Fungal Res, Raleigh, NC 27695 USA.; Barrangou, R (reprint author), North Carolina State Univ, Dept Food Bioproc & Nutr Sci, 400 Dan Allen Dr,Schaub Hall,Campus Box 7624, Raleigh, NC 27695 USA.	artoms@ncsu.edu; rbarran@ncsu.edu		Barrangou, Rodolphe/0000-0002-0648-3504	Genomics Fellowship from the Genomic Sciences graduate program at North Carolina State University	This work has been supported by the Genomics Fellowship from the Genomic Sciences graduate program at North Carolina State University.	Arnold TB, 2011, R J, V3, P34; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Barrangou R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0816-9; Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI 10.1093/nar/gks1195; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koonin EV, 2015, NAT REV GENET, V16, P184, DOI 10.1038/nrg3859; Krupovic M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-36; Lemon J., 2006, R NEWS, V6, P8; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Makarova KS, 2017, CELL, V168, P946, DOI 10.1016/j.cell.2017.02.018; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Makarova KS, 2013, BIOCHEM SOC T, V41, P1392, DOI 10.1042/BST20130038; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Myers JL, 2003, WELL AD RES DESIGN S, P508; R Core Team, 2016, R LANG ENV STAT COMP; Rice J., 2006, MATH STAT DATA ANAL; Scholz FW, 1985, ENCY STAT SCI; Wickham H., 2016, READXL READ EXCEL FI; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1; Wickham H, 2007, J STAT SOFTW, V21, P1	32	0	0	2	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1745-6150			BIOL DIRECT	Biol. Direct	AUG 29	2017	12								20	10.1186/s13062-017-0193-2				12	Biology	Life Sciences & Biomedicine - Other Topics	FF6CX	WOS:000409092500001	28851439	gold			2018-01-05	
J	Liu, XY; Fu, YM; Yang, H; Mavlyutov, T; Li, J; McCurdy, CR; Guo, LW; Pattnaik, BR				Liu, Xinying; Fu, Yingmei; Yang, Huan; Mavlyutov, Timur; Li, Jun; McCurdy, Christopher R.; Guo, Lian-Wang; Pattnaik, Bikash R.			Potential independent action of sigma receptor ligands through inhibition of the Kv2.1 channel	ONCOTARGET			English	Article						Kv2.1 channel; CRISPR/Cas9; sigma receptor ligands; patch-clamp; electroretinogram	GATED POTASSIUM CHANNELS; GANGLION-CELL DEATH; FREE CALCIUM LEVELS; THERAPEUTIC TARGETS; BINDING-SITES; MICE; LOCALIZATION; MODULATION; IDENTIFICATION; PROGESTERONE	The sigma-1 receptor (s1-R) and sigma-2 receptor (s2-R) are potential drug targets for treatment of cancer, pain, depression, retinal degeneration and other neuronal diseases. Previous reports show that sigma-1 receptor modulates the activities of multiple channels. We are interested in possible sigma receptor modulation of Kv2.1, a K+ channel abundant in retinal photoreceptors. We tested the effect of established sigma receptor ligands on Kv2.1 channels which were stably expressed in HEK293 cells. Surprisingly, s1-R antagonists inhibited Kv2.1 currents in both wild type and s1-R knockout HEK293 cells that we engineered using the CRISPR/Cas9 technology. Moreover, PB28, a s1-R antagonist and also s2-R agonist, inhibited Kv2.1 in s1-R knockout cells, but this action was not blocked by the s2-R antagonists that did not have an effect on Kv2.1. We also observed inhibition of electroretinogram by PB28 in wild type as well as s1-R knockout mice. Thus, the results in this study indicate that the Kv2.1-inhibiting function of the sigma ligands is not sigma receptor dependent, suggesting a direct effect of these ligands on the Kv2.1 channel.	[Liu, Xinying] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA; [Fu, Yingmei; Yang, Huan; Mavlyutov, Timur; Li, Jun; Guo, Lian-Wang] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, 600 Highland Ave, Madison, WI 53706 USA; [Fu, Yingmei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai, Peoples R China; [Mavlyutov, Timur] Univ Wisconsin, Sch Med & Publ Hlth, Dept Anesthesiol, Madison, WI USA; [Li, Jun] Third Peoples Hosp Dalian, Dept Ophthalmol, Dalian, Peoples R China; [McCurdy, Christopher R.] Univ Florida, Coll Pharm, Dept Med Chem, Gainesville, FL USA; [Guo, Lian-Wang; Pattnaik, Bikash R.] Univ Wisconsin, McPherson Eye Res Inst, Madison, WI 53706 USA; [Guo, Lian-Wang] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Guo, Lian-Wang] Ohio State Univ, Dept Physiol & Cell Biol, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Pattnaik, Bikash R.] Univ Wisconsin, Dept Pediat, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA	Guo, LW (reprint author), Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, 600 Highland Ave, Madison, WI 53706 USA.; Guo, LW; Pattnaik, BR (reprint author), Univ Wisconsin, McPherson Eye Res Inst, Madison, WI 53706 USA.; Guo, LW (reprint author), Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.; Guo, LW (reprint author), Ohio State Univ, Dept Physiol & Cell Biol, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.; Pattnaik, BR (reprint author), Univ Wisconsin, Dept Pediat, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA.	Lianwang.Guo@osumc.edu; bikashp@pediatrics.wisc.edu			National Institute of Health [EY024995, EY022678, DA023205, EY016665]; Retina Research Foundation M. D. Matthews Research Professorship; Morgridge Institute for Research & the James Christenson Estate Macular Degeneration Research Award; Shanghai Key Laboratory of Psychotic Disorders [13dz2260500]; Shanghai Health Talent Professional Project [XYQ2013114]; Shanghai Municipal Commission of Health and Family Planning [20124106]; National Natural Science Foundation of China [81371491]	This work is supported by the National Institute of Health grants; EY024995 (BRP), EY022678 (L-WG), DA023205(CRM), and EY016665 (to the University of Wisconsin Vision Core); the Retina Research Foundation M. D. Matthews Research Professorship (to BRP), Morgridge Institute for Research & the James Christenson Estate Macular Degeneration Research Award (to L-WG). Grant support also received from the Shanghai Key Laboratory of Psychotic Disorders (13dz2260500), Shanghai Health Talent Professional Project (XYQ2013114), Shanghai Municipal Commission of Health and Family Planning (20124106) and the National Natural Science Foundation of China (81371491) to YFu.	Abate C, 2010, CHEMMEDCHEM, V5, P268, DOI 10.1002/cmdc.200900402; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Azzariti A, 2006, MOL CANCER THER, V5, P1807, DOI 10.1158/1535-7163.MCT-05-0402; Brent PJ, 1996, BIOCHEM BIOPH RES CO, V219, P219, DOI 10.1006/bbrc.1996.0208; Brent PJ, 1996, NEUROSCI LETT, V211, P138, DOI 10.1016/0304-3940(96)12711-7; Cheng ZX, 2008, EXP NEUROL, V210, P128, DOI 10.1016/j.expneurol.2007.10.004; Chu UB, 2015, EBIOMEDICINE, V2, P1806, DOI 10.1016/j.ebiom.2015.10.017; Czirjak G, 2007, J NEUROPHYSIOL, V98, P1213, DOI 10.1152/jn.00493.2007; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Ha YJ, 2011, INVEST OPHTH VIS SCI, V52, P7749, DOI 10.1167/iovs.11-8169; Hayashi T, 2000, J PHARMACOL EXP THER, V293, P788; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; He YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041303; Holter P, 2012, INVEST OPHTH VIS SCI, V53, P6947, DOI 10.1167/iovs.12-10234; Johannessen M, 2011, AM J PHYSIOL-CELL PH, V300, pC328, DOI 10.1152/ajpcell.00383.2010; Kinoshita M, 2012, BRAIN RES, V1452, P1, DOI 10.1016/j.brainres.2012.02.070; KLUMPP DJ, 1995, VISUAL NEUROSCI, V12, P1177, DOI 10.1017/S0952523800006805                                                       ; Kourrich S, 2013, CELL, V152, P236, DOI 10.1016/j.cell.2012.12.004; Kourrich S, 2012, TRENDS NEUROSCI, V35, P762, DOI 10.1016/j.tins.2012.09.007; Li J, 2017, MOL VIS, V23, P149; Nguyen L, 2015, J PHARMACOL SCI, V127, P17, DOI 10.1016/j.jphs.2014.12.005; Mach RH, 1999, LIFE SCI, V64, pPL131, DOI 10.1016/S0024-3205(99)00014-4                                                   ; Matsumoto RR, 2014, ADV PHARMACOL, V69, P323, DOI 10.1016/B978-0-12-420118-7.00009-3; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Mavlyutov TA, 2013, NEUROSCIENCE, V240, P129, DOI 10.1016/j.neuroscience.2013.02.035; Mavlyutov TA, 2017, ADV EXP MED BIOL, V964, P285, DOI 10.1007/978-3-319-50174-1_19; Mavlyutov TA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10689; Mavlyutov TA, 2011, MOL VIS, V17, P1034; O'Connell KMS, 2010, P NATL ACAD SCI USA, V107, P12351, DOI 10.1073/pnas.1003028107; QUIRION R, 1992, TRENDS PHARMACOL SCI, V13, P85, DOI 10.1016/0165-6147(92)90030-A; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SU TP, 1991, J PHARMACOL EXP THER, V259, P543; Su TP, 2016, TRENDS PHARMACOL SCI, V37, P262, DOI 10.1016/j.tips.2016.01.003; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Tchedre KT, 2008, INVEST OPHTH VIS SCI, V49, P4993, DOI 10.1167/iovs.08-1867; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Vilner BJ, 2000, J PHARMACOL EXP THER, V292, P900; Wang J, 2016, P NATL ACAD SCI USA, V113, pE3764, DOI 10.1073/pnas.1521749113; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386; Yuan H, 2011, EUR J PHARMACOL, V657, P76, DOI 10.1016/j.ejphar.2011.01.054; Zhang H, 2009, INT J PHYSL PATH PHA, V2, P1; Zhao L, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0775-4; Zhao L, 2017, J CONTROL RELEASE, V247, P153, DOI 10.1016/j.jconrel.2016.12.038; Zhou TT, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.119	45	0	0	1	1	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	AUG 29	2017	8	35					59345	59358		10.18632/oncotarget.19581				14	Oncology; Cell Biology	Oncology; Cell Biology	FF4RD	WOS:000408941900116	28938641	green_published			2018-01-05	
J	Zhang, Y; Zhou, L; Leng, Y; Dai, Y; Orlowski, RZ; Grant, S				Zhang, Yu; Zhou, Liang; Leng, Yun; Dai, Yun; Orlowski, Robert Z.; Grant, Steven			Positive transcription elongation factor b (P-TEFb) is a therapeutic target in human multiple myeloma	ONCOTARGET			English	Article						P-TEFb; bortezomib resistance; myeloma; MCL-1; CDK inhibitors	DEPENDENT KINASE INHIBITOR; CHRONIC LYMPHOCYTIC-LEUKEMIA; SINGLE-AGENT ACTIVITY; BREAST-CANCER; INDUCED APOPTOSIS; DOWN-REGULATION; CDK INHIBITOR; BCL-2 FAMILY; CELL-DEATH; CYCLIN D1	The role of the positive RNA Pol II regulator, P-TEFb (positive transcription elongation factor b), in maintenance of the anti-apoptotic protein Mcl-1 and bortezomib (btz) resistance was investigated in human multiple myeloma (MM) cells. Mcl-1 was up-regulated in all MM lines tested, including bortezomib-resistant lines, human MM xenograft mouse models, and primary CD138(+) MM cells. Mcl-1 over-expression significantly reduced bortezomib lethality, indicating a functional role for Mcl-1 in bortezomib resistance. MM cell lines, primary MM specimens, and murine xenografts exhibited constitutive P-TEFb activation, manifested by high CTD (carboxy-terminal domain) S2 phosphorylation, associated with a) P-TEFb subunit up-regulation i.e., CDK9 (42 and 55 kDa isoforms) and cyclin T1; and b) marked CDK9 (42 kDa) T186 phosphorylation. In marked contrast, normal hematopoietic cells failed to exhibit up-regulation of p-CTD, CDK9, cyclin T1, or Mcl-1. CDK9 or cyclin T1 shRNA knock-down dramatically inhibited CTD S2 phosphorylation and down-regulated Mcl-1. Moreover, CRISPR-Cas CDK9 knock-out triggered apoptosis in MM cells and dramatically diminished cell growth. Pan-CDK e.g., dinaciclib or alvocidib and selective CDK9 inhibitors (CDK9i) recapitulated the effects of genetic P-TEFb disruption. CDK9 shRNA or CDK9 inhibitors significantly potentiated the susceptibility of MM cells, including bortezomib-resistant cells, to proteasome inhibitors. Analogously, CDK9 or cyclin T1 knock-down or CDK9 inhibitors markedly increased BH3-mimetic lethality in bortezomib-resistant cells. Finally, pan-CDK inhibition reduced human drug-naive or bortezomib-resistant CD138+ cells and restored bone marrow architecture in vivo. Collectively, these findings implicate constitutive P-TEFb activation in high Mcl-1 maintenance in MM, and validate targeting the P-TEFb complex to circumvent bortezomib-resistance.	[Zhang, Yu; Zhou, Liang; Leng, Yun; Grant, Steven] Virginia Commonwealth Univ, Dept Med, Div Hematol Oncol, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Zhang, Yu; Zhou, Liang; Leng, Yun; Grant, Steven] Massey Canc Ctr, Richmond, VA 23298 USA; [Leng, Yun] Capital Med Univ, Beijing Chaoyang Hosp, Dept Hematol, Beijing, Peoples R China; [Dai, Yun] Jilin Univ, Hosp 1, Canc Ctr, Changchun, Jilin, Peoples R China; [Orlowski, Robert Z.] Univ Texas MD Anderson Canc Ctr, Dept Myeloma & Lymphoma, Houston, TX 77030 USA; [Grant, Steven] Virginia Commonwealth Univ, Virginia Inst Mol Med, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Grant, Steven] Virginia Commonwealth Univ, Dept Biochem, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Grant, Steven] Virginia Commonwealth Univ, Dept Pharmacol, Med Coll Virginia Campus, Richmond, VA 23298 USA	Grant, S (reprint author), Virginia Commonwealth Univ, Dept Med, Div Hematol Oncol, Med Coll Virginia Campus, Richmond, VA 23298 USA.; Grant, S (reprint author), Massey Canc Ctr, Richmond, VA 23298 USA.; Grant, S (reprint author), Virginia Commonwealth Univ, Virginia Inst Mol Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.; Grant, S (reprint author), Virginia Commonwealth Univ, Dept Biochem, Med Coll Virginia Campus, Richmond, VA 23298 USA.; Grant, S (reprint author), Virginia Commonwealth Univ, Dept Pharmacol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	steven.grant@vcuhealth.org			Leukemia and Lymphoma Society of America [P50 CA142509-01, CA100866, CA205607, CA167708, 6472-15]; National Institutes of Health [UH2TR001373]; NIH-NCI Cancer Center Core Grant [5P30CA016059-29]	This work was supported by awards P50 CA142509-01 to SG, RZO, and YD, and CA100866, CA205607, CA167708, and award #6472-15 from the Leukemia and Lymphoma Society of America to SG. UH2TR001373 to SG from the National Institutes of Health; Plasmid preparation was performed at the VCU Macromolecule Core Facility, supported, in part, with funding from NIH-NCI Cancer Center Core Grant 5P30CA016059-29. We also want to thank Lora Kramer and Elisa Hawkins for help in preparing the manuscript.	Alagpulinsa DA, 2016, MOL CANCER THER, V15, P241, DOI 10.1158/1535-7163.MCT-15-0660; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Baker A, 2016, CANCER RES, V76, P1158, DOI 10.1158/0008-5472.CAN-15-1070; Booher RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108371; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Canduri F, 2008, MED CHEM, V4, P210, DOI 10.2174/157340608784325205                                                      ; Chen SA, 2014, MOL CELL BIOL, V34, P3435, DOI 10.1128/MCB.01383-13; Chen S, 2012, CANCER RES, V72, P4225, DOI 10.1158/0008-5472.CAN-12-1118; Chen ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29090; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Conery AR, 2016, ELIFE, V5, DOI 10.7554/eLife.10483; Criscitiello C, 2014, EXPERT OPIN INV DRUG, V23, P1305, DOI 10.1517/13543784.2014.948152; Dai Y, 2003, ONCOGENE, V22, P7108, DOI 10.1038/sj.onc.1206863; Dai Y, 2002, BLOOD, V100, P3333, DOI 10.1182/blood-2002-03-0940; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Dolloff NG, 2012, MOL CANCER THER, V11, P2321, DOI 10.1158/1535-7163.MCT-12-0578; Gojo I, 2002, CLIN CANCER RES, V8, P3527; Gomez-Bougie P, 2004, EUR J IMMUNOL, V34, P3156, DOI 10.1002/eji.200424981; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Hole AJ, 2013, J MED CHEM, V56, P660, DOI 10.1021/jm301495v; Kawabata S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.87; Kelland LR, 2000, EXPERT OPIN INV DRUG, V9, P2903, DOI 10.1517/13543784.9.12.2903                                                      ; Kohoutek J, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-19; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Kumar SK, 2015, BLOOD, V125, P443, DOI 10.1182/blood-2014-05-573741; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Li L, 2015, LEUKEMIA, V29, P1702, DOI 10.1038/leu.2015.99; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Menu E, 2008, CANCER RES, V68, P5519, DOI 10.1158/0008-5472.CAN-07-6404; Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633; Mitchell C, 2010, CANCER BIOL THER, V10, P907, DOI 10.4161/cbt.10.9.13273; Moreau P, 2016, LANCET, V388, P111, DOI 10.1016/S0140-6736(16)30954-0; Nencioni A, 2005, BLOOD, V105, P3255, DOI 10.1182/blood-2004-10-3984; Nguyen TK, 2014, MOL CANCER THER, V13, P662, DOI 10.1158/1535-7163.MCT-13-0714; Paiva C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143685; Pearl LH, 2015, NAT REV CANCER, V15, P166, DOI 10.1038/nrc3891; Podar K, 2008, ONCOGENE, V27, P721, DOI 10.1038/sj.onc.1210679; Ponder KG, 2016, CANCER BIOL THER, V17, P769, DOI 10.1080/15384047.2016.1192086; Pruneri G, 2000, AM J PATHOL, V156, P1505, DOI 10.1016/S0002-9440(10)65022-5; Rajan AM, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.53; Sedlacek HH, 1996, INT J ONCOL, V9, P1143; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Spets H, 2002, EUR J HAEMATOL, V69, P76, DOI 10.1034/j.1600-0609.2002.01549.x; Tong WG, 2010, J CLIN ONCOL, V28, P3015, DOI 10.1200/JCO.2009.26.1347; Tromp JM, 2012, CLIN CANCER RES, V18, P487, DOI 10.1158/1078-0432.CCR-11-1440; Vandenberg CJ, 2013, BLOOD, V121, P2285, DOI 10.1182/blood-2013-01-475855; Wang YB, 2015, CELL, V163, P174, DOI 10.1016/j.cell.2015.08.063; Whittaker SR, 2004, CANCER RES, V64, P262, DOI 10.1158/0008-5472.CAN-03-0110; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; Yin TG, 2014, MOL CANCER THER, V13, P1442, DOI 10.1158/1535-7163.MCT-13-0849; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zhou L, 2015, LEUKEMIA, V29, P807, DOI 10.1038/leu.2014.296	53	0	0	0	0	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	AUG 29	2017	8	35					59476	59491		10.18632/oncotarget.19761				16	Oncology; Cell Biology	Oncology; Cell Biology	FF4RD	WOS:000408941900126	28938651	green_published			2018-01-05	
J	Capps, B; Chadwick, R; Joly, Y; Mulvihill, JJ; Lysaght, T; Zwart, H				Capps, Benjamin; Chadwick, Ruth; Joly, Yann; Mulvihill, John J.; Lysaght, Tamra; Zwart, Hub			Falling giants and the rise of gene editing: ethics, private interests and the public good	HUMAN GENOMICS			English	Article						Public good; Public interest; CRISPR; Solidarity; Benefit sharing; Ethics in genomic research; Human genome project; Biobank	HUMAN-GENOME; CRISPR; INNOVATION; SEQUENCE; BIOBANKS; LIFE; ERA	This paper considers the tensions created in genomic research by public and private for-profit ideals. Our intent is to strengthen the public good at a time when doing science is strongly motivated by market possibilities and opportunities. Focusing on the emergence of gene editing, and in particular CRISPR, we consider how commercialisation encourages hype and hope- a sense that only promise and idealism can achieve progress. At this rate, genomic research reinforces structures that promote, above all else, private interests, but that may attenuate conditions for the public good of science. In the first part, we situate genomics using the aphorism that `on the shoulders of giants we see farther'; these giants are infrastructures and research cultures rather than individual `heroes' of science. In this respect, private initiatives are not the only pivot for successful discovery, and indeed, fascination in those could impinge upon the fundamental role of public-supported discovery. To redress these circumstances, we define the extent to which progress presupposes research strategies that are for the public good. In the second part, we use a `falling giant' narrative to illustrate the risks of over-indulging for-profit initiatives. We therefore offer a counterpoint to commercialised science, using three identifiable `giants'-scientists, publics and cultures-to illustrate how the public good contributes to genomic discovery.	[Capps, Benjamin] Dalhousie Univ, Dept Bioeth, Fac Med, Halifax, NS, Canada; [Chadwick, Ruth] Univ Manchester, Sch Law, Manchester, Lancs, England; [Joly, Yann] McGill Univ, Dept Human Genet, Ctr Genom & Policy, Quebec City, PQ, Canada; [Mulvihill, John J.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Norman, OK 73019 USA; [Lysaght, Tamra] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Biomed Eth, Singapore, Singapore; [Zwart, Hub] Radboud Univ Nijmegen, Dept Philosophy & Sci Studies, Fac Sci, Nijmegen, Netherlands	Capps, B (reprint author), Dalhousie Univ, Dept Bioeth, Fac Med, Halifax, NS, Canada.	benjamin.capps@dal.ca					Braude P, 2005, BRIT MED J, V330, P1159, DOI 10.1136/bmj.330.7501.1159; Brinegar K, 2017, CRIT REV BIOTECHNOL, V37, P924, DOI 10.1080/07388551.2016.1271768; Capps B., 2014, FUTURE BIOETHICS INT, P235; Capps B, 2013, LAW INNOVATION TECH, V5, P113; Capps B., 2016, ETHICAL RATIONALISM, P149; Capps B, 2016, BRIT MED BULL, V118, P5, DOI 10.1093/bmb/ldw014; Capps B, 2015, MONASH BIOETH REV, V33, P238, DOI 10.1007/s40592-015-0042-y; Caulfield T, 2000, NAT REV GENET, V1, P227, DOI 10.1038/35042087; Chadwick R, 2013, LIFE SCI SOC POLICY; Chalmers D, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0124-2; Collins F, 2010, NATURE, V464, P674, DOI 10.1038/464674a; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Comfort N, 2017, NATURE, V546, P30, DOI 10.1038/546030a; Committee on a Framework for Developing a New Taxonomy of Disease, 2011, BOARD LIF SCI DIV EA; Teilhard de Chardin P, 1955, THE HUMAN PHENOMENON; Egelie KJ, 2016, NAT BIOTECHNOL, V34, P1025, DOI 10.1038/nbt.3692; Fox EJ, 2014, NEXT GENER SEQ APPL, V1; Hayden EC, 2010, NATURE, V464, P664, DOI 10.1038/464664a; Heath J, 2006, PHILOS PUBLIC AFF, V34, P313, DOI 10.1111/j.1088-4963.2006.00073.x                                                ; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698                                                    ; Hoeyer K, 2005, ARCH INTERN MED, V165, P97, DOI 10.1001/archinte.165.1.97                                                       ; Kaebnick GE, 2013, BASIC BIOETH, P1, DOI 10.7551/mitpress/9780262019392.001.0001; Knoppers B, 1999, COMMERCIALIZATION GE, P1; Lander ES, 2016, CELL, V164, P18, DOI 10.1016/j.cell.2015.12.041; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a; Lipworth W, 2009, J LAW MED, V17, P119; Lundh A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000033.pub3; Lysaght T, 2017, J BIOETHIC INQ, V14, P261, DOI 10.1007/s11673-017-9776-y; Merton R., 1965, SHOULDERS GIANTS SHA; Meyer M., 2004, HARVARD LAW REV, V118, P810; Mirowski Philip, 2011, SCI MART PRIVATIZING; Mulvihill J, 2017, BR MED B, V122, P109; Musgrave Richard M., 1959, THEORY PUBLIC FINANC; Olson MV, 2002, J MOL BIOL, V319, P931, DOI 10.1016/S0022-2836(02)00333-9; OLSON MV, 1995, SCIENCE, V270, P394, DOI 10.1126/science.270.5235.394; Ratner H, 2016, COLD SPRING HARB PRO, DOI [10.1101/pdb.top088849, DOI 10.1101/PDB.TOP088849]; Samuelson PA, 1954, REV ECON STAT, V36, P387, DOI 10.2307/1925895                                                                 ; Shreeve J., 2005, GENOME WAR CRAIG VEN; Sterckx S, 2013, GENET MED, V15, P382, DOI 10.1038/gim.2012.143; Venter JC, 2010, NATURE, V464, P676, DOI 10.1038/464676a; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Winickoff DE, 2007, J LAW MED ETHICS, V35, P440, DOI 10.1111/j.1748-720X.2007.00166.x                                                ; Winickoff D. E., 2006, INNOVATIONS, P80; Zwart H., 2011, GENOMICS SOC POLICY, V6, P67; Zwart HAE, 2016, NEW GENET SOC, V35, P69, DOI 10.1080/14636778.2016.1143770; Zwart H, 2010, J BIOETHIC INQ, V7, P299, DOI 10.1007/s11673-010-9248-0	47	0	0	20	20	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1473-9542	1479-7364		HUM GENOMICS	Hum. Genomics	AUG 29	2017	11								20	10.1186/s40246-017-0116-4				10	Genetics & Heredity	Genetics & Heredity	FF2SK	WOS:000408746900001	28851444	gold			2018-01-05	
J	Ewen-Campen, B; Yang-Zhou, DH; Fernandes, VR; Gonzalez, DP; Liu, LP; Tao, R; Ren, XJ; Sun, J; Hu, YH; Zirin, J; Mohr, SE; Ni, JQ; Perrimon, N				Ewen-Campen, Ben; Yang-Zhou, Donghui; Fernandes, Vitoria R.; Gonzalez, Delfina P.; Liu, Lu-Ping; Tao, Rong; Ren, Xingjie; Sun, Jin; Hu, Yanhui; Zirin, Jonathan; Mohr, Stephanie E.; Ni, Jian-Quan; Perrimon, Norbert			Optimized strategy for in vivo Cas9-activation in Drosophila	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						CRISPR/Cas9; Cas9-activators; gain-of-function; CRISPR mutagenesis; CRISPRa	TRANSCRIPTIONAL ACTIVATION; TRANSGENIC RNAI; GENE-EXPRESSION; TNF SUPERFAMILY; Q-SYSTEM; COMPLEX; MECHANISMS; REAGENTS; PATHWAY; EMBRYOS	While several large-scale resources are available for in vivo loss-of-function studies in Drosophila, an analogous resource for overexpressing genes from their endogenous loci does not exist. We describe a strategy for generating such a resource using Cas9 transcriptional activators (CRISPRa). First, we compare a panel of CRISPRa approaches and demonstrate that, for in vivo studies, dCas9-VPR is the most optimal activator. Next, we demonstrate that this approach is scalable and has a high success rate, as >75% of the lines tested activate their target gene. We show that CRISPRa leads to physiologically relevant levels of target gene expression capable of generating strong gain-of-function (GOF) phenotypes in multiple tissues and thus serves as a useful platform for genetic screening. Based on the success of this CRISRPa approach, we are generating a genome-wide collection of flies expressing single-guide RNAs (sgRNAs) for CRISPRa. We also present a collection of more than 30 Gal4 > UAS:dCas9-VPR lines to aid in using these sgRNA lines for GOF studies in vivo.	[Ewen-Campen, Ben; Yang-Zhou, Donghui; Fernandes, Vitoria R.; Gonzalez, Delfina P.; Liu, Lu-Ping; Tao, Rong; Hu, Yanhui; Zirin, Jonathan; Mohr, Stephanie E.; Perrimon, Norbert] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Fernandes, Vitoria R.] Univ Fed Sao Joao del Rei, BR-36301 Divinopolis, MG, Brazil; [Gonzalez, Delfina P.] Pomona Coll, Claremont, CA 91711 USA; [Liu, Lu-Ping; Tao, Rong; Hu, Yanhui; Zirin, Jonathan; Mohr, Stephanie E.] Harvard Med Sch, Dept Genet, Drosophila RNAi Screening Ctr, Boston, MA 02115 USA; [Liu, Lu-Ping; Perrimon, Norbert] Howard Hughes Med Inst, Boston, MA 02115 USA; [Ren, Xingjie; Sun, Jin; Ni, Jian-Quan] Tsinghua Univ, Sch Med, Gene Regulatory Lab, Beijing 100084, Peoples R China	Perrimon, N (reprint author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Perrimon, N (reprint author), Howard Hughes Med Inst, Boston, MA 02115 USA.; Ni, JQ (reprint author), Tsinghua Univ, Sch Med, Gene Regulatory Lab, Beijing 100084, Peoples R China.	nijq@mail.tsinghua.edu.cn; perrimon@receptor.med.harvard.edu		Mohr, Stephanie/0000-0001-9639-7708	NIH [R01GM084947, R24OD021997]; NIH under Ruth L. Kirschstein National Research Service Award from the NIH General Medical Sciences Division [F32GM113395]; Howard Hughes Medical Institute (HHMI) Exceptional Research Opportunities Program; Brazil Scientific Mobility Program; NIH National Center Institute Cancer Center Support Grant [5 P30 CA06516]; National Key Technology Research and Development Program of the Ministry of Science and Technology of the People's Republic of China [2015BAI09B03, 2016YFE0113700]; National Basic Research Program (973 Program) [2013CB35102]; National Natural Science Foundation of China [31571320]	We thank F. Port and S. Bullock for sharing the UASt-sgRNA plasmid (pCFD6) prior to publication, H.-W. Tang for assistance generating FLP-out CRISPRa stocks, and R. Binari for expertise and assistance with fly work. This work was supported by NIH Grants R01GM084947 and R24OD021997 (to the N.P. laboratory). B.E.-C. received NIH funding under Ruth L. Kirschstein National Research Service Award F32GM113395 from the NIH General Medical Sciences Division. D.P.G. received funding from the Howard Hughes Medical Institute (HHMI) Exceptional Research Opportunities Program. V.R.F. received funding from the Brazil Scientific Mobility Program. S.E.M. is supported in part by NIH National Center Institute Cancer Center Support Grant 5 P30 CA06516 to the Dana Farber/Harvard Cancer Center. The J.-Q.N. laboratory was supported in part by National Key Technology Research and Development Program of the Ministry of Science and Technology of the People's Republic of China Grants 2015BAI09B03; 2016YFE0113700, National Basic Research Program (973 Program) Grant 2013CB35102, and National Natural Science Foundation of China Grant 31571320. N.P. is an investigator of the HHMI.	Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bischof J, 2013, DEVELOPMENT, V140, P2434, DOI 10.1242/dev.088757; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; deCelis JF, 1997, DEVELOPMENT, V124, P1007; Gesualdi SC, 2007, FLY, V1, P212, DOI 10.4161/fly.5116                                                                ; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Housden BE, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3729; Hu YH, 2013, G3-GENES GENOM GENET, V3, P1607, DOI 10.1534/g3.113.007021; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306                                                            ; Jensen PA, 2009, MECH DEVELOP, V126, P950, DOI 10.1016/j.mod.2009.09.003; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lin SL, 2015, GENETICS, V201, P433, DOI 10.1534/genetics.115.181065; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Mohr SE, 2014, METHODS, V68, P82, DOI 10.1016/j.ymeth.2014.02.018; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Ng M, 1996, NATURE, V381, P316, DOI 10.1038/381316a0; Nguyen M, 1998, CELL, V95, P495, DOI 10.1016/S0092-8674(00)81617-7; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; Perkins LA, 2015, GENETICS, V201, P843, DOI 10.1534/genetics.115.180208; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Port F, 2016, NAT METHODS, V13, P852, DOI 10.1038/nmeth.3972; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Riabinina O, 2015, NAT METHODS, V12, P219, DOI [10.1038/NMETH.3250, 10.1038/nmeth.3250]; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Schnepp B, 1998, GENE DEV, V12, P908, DOI 10.1101/gad.12.7.908; Sopko R, 2014, DEV CELL, V31, P114, DOI 10.1016/j.devcel.2014.07.027; Staudt N, 2005, PLOS GENET, V1, P499, DOI 10.1371/journal.pgen.0010055; Tang HW, 2011, EMBO J, V30, P636, DOI 10.1038/emboj.2010.338; Wessells RJ, 1999, DEV BIOL, V216, P243, DOI 10.1006/dbio.1999.9459; Wisniewski J, 1996, NUCLEIC ACIDS RES, V24, P367, DOI 10.1093/nar/24.2.367; Zhong J, 2009, GENET RES, V91, P243, DOI 10.1017/S0016672309990152	40	2	2	2	2	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	AUG 29	2017	114	35					9409	9414		10.1073/pnas.1707635114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FE9PQ	WOS:000408536000055	28808002				2018-01-05	
J	Kodama, M; Kodama, T; Newberg, JY; Katayama, H; Kobayashi, M; Hanash, SM; Yoshihara, K; Wei, ZB; Tien, JC; Rangel, R; Hashimoto, K; Mabuchi, S; Sawada, K; Kimura, T; Copeland, NG; Jenkins, NA				Kodama, Michiko; Kodama, Takahiro; Newberg, Justin Y.; Katayama, Hiroyuki; Kobayashi, Makoto; Hanash, Samir M.; Yoshihara, Kosuke; Wei, Zhubo; Tien, Jean C.; Rangel, Roberto; Hashimoto, Kae; Mabuchi, Seiji; Sawada, Kenjiro; Kimura, Tadashi; Copeland, Neal G.; Jenkins, Nancy A.			In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						ovarian cancer; KPNB1; loss-of-function screen; CRISPR/Cas; RNAi	ANAPHASE-PROMOTING COMPLEX; GROWTH-FACTOR RECEPTOR; RANDOMIZED PHASE-III; RESISTANT OVARIAN; BREAST-CANCER; TUMOR-GROWTH; LUNG-CANCER; HUMAN-CELLS; INHIBITOR; CARCINOMA	Epithelial ovarian cancer (EOC) is a deadly cancer, and its prognosis has not been changed significantly during several decades. To seek new therapeutic targets for EOC, we performed an in vivo dropout screen in human tumor xenografts using a pooled shRNA library targeting thousands of druggable genes. Then, in follow-up studies, we performed a second screen using a genome-wide CRISPR/Cas9 library. These screens identified 10 high-confidence drug targets that included well-known oncogenes such as ERBB2 and RAF1, and novel oncogenes, notably KPNB1, which we investigated further. Genetic and pharmacological inhibition showed that KPNB1 exerts its antitumor effects through multiphase cell cycle arrest and apoptosis induction. Mechanistically, proteomic studies revealed that KPNB1 acts as a master regulator of cell cycle-related proteins, including p21, p27, and APC/C. Clinically, EOC patients with higher expression levels of KPNB1 showed earlier recurrence and worse prognosis than those with lower expression levels of KPNB1. Interestingly, ivermectin, a Food and Drug Administration-approved antiparasitic drug, showed KPNB1-dependent antitumor effects on EOC, serving as an alternative therapeutic toward EOC patients through drug repositioning. Last, we found that the combination of ivermectin and paclitaxel produces a stronger antitumor effect on EOC both in vitro and in vivo than either drug alone. Our studies have thus identified a combinatorial therapy for EOC, in addition to a plethora of potential drug targets.	[Kodama, Michiko; Kodama, Takahiro; Newberg, Justin Y.; Wei, Zhubo; Tien, Jean C.; Rangel, Roberto; Copeland, Neal G.; Jenkins, Nancy A.] Houston Methodist Res Inst, Canc Res Program, Houston, TX 77030 USA; [Kodama, Michiko; Hashimoto, Kae; Mabuchi, Seiji; Sawada, Kenjiro; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Osaka 5650871, Japan; [Kodama, Takahiro] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Osaka 5650871, Japan; [Newberg, Justin Y.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Katayama, Hiroyuki; Kobayashi, Makoto; Hanash, Samir M.] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Yoshihara, Kosuke] Niigata Univ, Grad Sch Med & Dent Sci, Dept Obstet & Gynecol, Niigata 9518510, Japan; [Tien, Jean C.] Univ Michigan, Michigan Ctr Translat Pathol, Dept Pathol, Ann Arbor, MI 48109 USA; [Rangel, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Copeland, Neal G.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	Kodama, T; Jenkins, NA (reprint author), Houston Methodist Res Inst, Canc Res Program, Houston, TX 77030 USA.	t-kodama@gh.med.osaka-u.ac.jp; njenkins1@mdanderson.org		Kodama, Takahiro/0000-0002-6250-1324	Cancer Prevention Research Institute of Texas (CPRIT) [R1112, R1113]	We thank E. Freiter and H. Lee for monitoring the mice and animal technical assistance, David L. Haviland for technical assistance and discussion about flow cytometry experiments, and Ayako Okamura for the experiments for revision. The Cancer Prevention Research Institute of Texas (CPRIT) supported this research [Grants R1112 (N.G.C.) and R1113 (N.A.J.)]. N.G.C. and N.A.J. are both CPRIT Scholars in Cancer Research.	Arora S, 2010, GYNECOL ONCOL, V118, P220, DOI 10.1016/j.ygyno.2010.05.006; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Blagden SP, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00149; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Brabender J, 2001, CLIN CANCER RES, V7, P1850; Bressenot A, 2009, J HISTOCHEM CYTOCHEM, V57, P289, DOI 10.1369/jhc.2008.952044; Cancer Genome Atlas Research Network, 2011, NATURE, V474, P609, DOI DOI 10.1038/NATURE10166; Cancer Genome Atlas Research Network, 2014, NATURE, V507, P315, DOI DOI 10.1038/NATURE12965; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Gordon AN, 2005, INT J GYNECOL CANCER, V15, P785, DOI 10.1111/j.1525-1438.2005.00137.x                                                ; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Group US Cancer Statistics Working Group, 2016, US CANC STAT 1999 20; Guzzo CA, 2002, J CLIN PHARMACOL, V42, P1122, DOI 10.1177/009127002237994; Howlader N., 2016, SEER CANC STAT REV 1; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; JAEHNE J, 1992, J CANCER RES CLIN, V118, P474, DOI 10.1007/BF01629433; Kodama T, 2016, P NATL ACAD SCI USA, V113, pE3384, DOI 10.1073/pnas.1606876113; Kurzeder C, 2016, J CLIN ONCOL, V34, P2516, DOI 10.1200/JCO.2015.66.0787; Lu T, 2016, BIOCHEM BIOPH RES CO, V478, P1189, DOI 10.1016/j.bbrc.2016.08.093; Markman M, 2006, GYNECOL ONCOL, V101, P436, DOI 10.1016/j.ygyno.2005.10.036; Maurer G, 2011, ONCOGENE, V30, P3477, DOI 10.1038/onc.2011.160; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Omura S, 2004, NAT REV MICROBIOL, V2, P984, DOI 10.1038/nrmicro1048; Rauh-Hain Jose A, 2011, Rev Obstet Gynecol, V4, P15; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schliekelman MJ, 2015, CANCER RES, V75, P1789, DOI 10.1158/0008-5472.CAN-14-2535; Schroeder RL, 2014, MOLECULES, V19, P15196, DOI 10.3390/molecules190915196; Sethi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047086; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Sivakumar S, 2015, NAT REV MOL CELL BIO, V16, P82, DOI 10.1038/nrm3934; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Soderholm JF, 2011, ACS CHEM BIOL, V6, P700, DOI 10.1021/cb2000296; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Takeda H, 2015, NAT GENET, V47, P142, DOI 10.1038/ng.3175; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; TUBIANA M, 1989, ACTA ONCOL, V28, P113, DOI 10.3109/02841868909111193                                                       ; Turner NC, 2015, NEW ENGL J MED, V373, P1672, DOI 10.1056/NEJMc1510345; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146; Vergote IB, 2014, J CLIN ONCOL, V32, P320, DOI 10.1200/JCO.2013.50.5669; Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Yang L., 2015, APPL RES COMPUT, V32, P1; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7                                                    	50	0	0	2	2	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	AUG 29	2017	114	35					E7301	E7310		10.1073/pnas.1705441114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FE9PQ	WOS:000408536000012	28811376				2018-01-05	
J	Peters, JE; Makarova, KS; Shmakov, S; Koonin, EV				Peters, Joseph E.; Makarova, Kira S.; Shmakov, Sergey; Koonin, Eugene V.			Recruitment of CRISPR-Cas systems by Tn7-like transposons	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						CRISPR-Cas systems; Tn7 transposon; transposition strategy; crRNA guide; target-site selection	MULTIPLE SEQUENCE ALIGNMENT; GROUP-II INTRON; TN7 TRANSPOSITION; THERMUS-THERMOPHILUS; EFFECTOR COMPLEXES; DNA RECOMBINATION; PROTEIN; RECOGNITION; ADAPTATION; TARGETS	A survey of bacterial and archaeal genomes shows that many Tn7-like transposons contain minimal type I-F CRISPR-Cas systems that consist of fused cas8f and cas5f, cas7f, and cas6f genes and a short CRISPR array. Several small groups of Tn7-like transposons encompass similarly truncated type I-B CRISPR-Cas. This minimal gene complement of the transposon-associated CRISPR-Cas systems implies that they are competent for pre-CRISPR RNA (precrRNA) processing yielding mature crRNAs and target binding but not target cleavage that is required for interference. Phylogenetic analysis demonstrates that evolution of the CRISPR-Cas-containing transposons included a single, ancestral capture of a type I-F locus and two independent instances of type I-B loci capture. We show that the transposon-associated CRISPR arrays contain spacers homologous to plasmid and temperate phage sequences and, in some cases, chromosomal sequences adjacent to the transposon. We hypothesize that the transposon-encoded CRISPR-Cas systems generate displacement (R-loops) in the cognate DNA sites, targeting the transposon to these sites and thus facilitating their spread via plasmids and phages. These findings suggest the existence of RNA-guided transposition and fit the guns-for-hire conceptwhereby mobile genetic elements capture host defense systems and repurpose them for different stages in the life cycle of the element.	[Peters, Joseph E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Makarova, Kira S.; Shmakov, Sergey; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Shmakov, Sergey] Skolkovo Inst Sci & Technol, Skolkovo 143025, Russia	Peters, JE (reprint author), Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.; Koonin, EV (reprint author), NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA.	joe.peters@cornell.edu; koonin@ncbi.nlm.nih.gov		Peters, Joseph/0000-0001-8309-3297	US Department of Agriculture National Institute of Food and Agriculture Hatch Project [NYC-189438]; intramural program of the US Department of Health and Human Services	J.E.P. was supported by US Department of Agriculture National Institute of Food and Agriculture Hatch Project NYC-189438. K.S.M., S.S., and E.V.K. are supported by the intramural program of the US Department of Health and Human Services (to the National Library of Medicine).	Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; ARCISZEWSKA LK, 1991, NUCLEIC ACIDS RES, V19, P5021, DOI 10.1093/nar/19.18.5021; BAINTON RJ, 1993, CELL, V72, P931, DOI 10.1016/0092-8674(93)90581-A; Barrangou R, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.92; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Biery MC, 2000, NUCLEIC ACIDS RES, V28, P1067, DOI 10.1093/nar/28.5.1067                                                           ; Bleichert F, 2017, SCIENCE, V355, P811, DOI 10.1126/science.aah6317; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Burton ZF, 2016, TRANSCR-AUSTIN, V7, P1, DOI 10.1080/21541264.2015.1128518; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Choi KY, 2013, P NATL ACAD SCI USA, V110, pE2038, DOI 10.1073/pnas.1305716110; Cousineau B, 1998, CELL, V94, P451, DOI 10.1016/S0092-8674(00)81586-X; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-18; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Finn JA, 2007, J BACTERIOL, V189, P9122, DOI 10.1128/JB.01451-07; Gary PA, 1996, J MOL BIOL, V257, P301; Gleditzsch D, 2016, NUCLEIC ACIDS RES, V44, P5872, DOI 10.1093/nar/gkw469; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hamidian M, 2011, J ANTIMICROB CHEMOTH, V66, P2484, DOI 10.1093/jac/dkr356; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hickman AB, 2000, MOL CELL, V5, P1025, DOI 10.1016/S1097-2765(00)80267-1; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Holder JW, 2010, J MOL BIOL, V401, P167, DOI 10.1016/j.jmb.2010.06.003; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Hur JK, 2014, TRENDS BIOCHEM SCI, V39, P257, DOI 10.1016/j.tibs.2014.04.006; Ichiyanagi K, 2002, MOL MICROBIOL, V46, P1259, DOI 10.1046/j.1365-2958.2002.03226.x; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jackson SA, 2017, SCIENCE, V356, P40, DOI 10.1126/science.aal5056; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Koonin EV, 2015, SCIENTIST, V29, P46; KOONIN EV, 2017, BIOL DIRECT, V12; Krupovic M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-36; Kuduvalli PN, 2001, EMBO J, V20, P924, DOI 10.1093/emboj/20.4.924                                                          ; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Majumdar S, 2015, RNA, V21, P1147, DOI 10.1261/rna.049130.114; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; May EW, 1996, SCIENCE, V272, P401, DOI 10.1126/science.272.5260.401; MCKOWN RL, 1988, J BACTERIOL, V170, P352, DOI 10.1128/jb.170.1.352-358.1988                                                   ; Minakhina S, 1999, MOL MICROBIOL, V33, P1059, DOI 10.1046/j.1365-2958.1999.01548.x                                                ; Mitra R, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-18; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Parker SCJ, 2011, CURR OPIN STRUC BIOL, V21, P342, DOI 10.1016/j.sbi.2011.03.002; Parks AR, 2009, CELL, V138, P685, DOI 10.1016/j.cell.2009.06.011; Peters JE, 2001, GENE DEV, V15, P737, DOI 10.1101/gad.870201; Peters J. E., 2014, MICROBIOL SPECTR, V2, P1; Peters JE, 2014, MOL MICROBIOL, V93, P1084, DOI 10.1111/mmi.12740; Pingoud A, 2014, NUCLEIC ACIDS RES, V42, P7489, DOI 10.1093/nar/gku447; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rao JE, 2000, P NATL ACAD SCI USA, V97, P3936, DOI 10.1073/pnas.080061497; Rao JE, 2001, J MOL BIOL, V307, P1161, DOI 10.1006/jmbi.2001.4553; Rose A, 2010, BIOSCI HORIZONS, V3, P40; Rutkauskas M, 2015, CELL REP, V10, P1534, DOI 10.1016/j.celrep.2015.01.067; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shah SA, 2009, BIOCHEM SOC T, V37, P23, DOI 10.1042/BST0370023; Shi Qiaojuan, 2015, Nucleic Acids Res, V43, P10734, DOI 10.1093/nar/gkv913; Shmakov SA, 2017, CRISPR SPACER SPACE; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Stellwagen AE, 1997, GENETICS, V145, P573; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Sugiyama T, 2008, J BACTERIOL, V190, P1835, DOI 10.1128/JB.01293-07; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; TRIFONOV EN, 1989, B MATH BIOL, V51, P417, DOI 10.1007/BF02460081; Tsui TKM, 2015, ANNU REV BIOPHYS, V44, P229, DOI 10.1146/annurev-biophys-060414-033939; Vorontsova D, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1261; WADDELL CS, 1988, GENE DEV, V2, P137, DOI 10.1101/gad.2.2.137; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Wolkow CA, 1996, GENE DEV, V10, P2145, DOI 10.1101/gad.10.17.2145; Zhang J, 2016, NUCLEIC ACIDS RES, V44, P1789, DOI 10.1093/nar/gkw020	85	0	0	9	9	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	AUG 29	2017	114	35					E7358	E7366		10.1073/pnas.1709035114				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FE9PQ	WOS:000408536000018	28811374	green_published			2018-01-05	
J	Kage, F; Steffen, A; Ellinger, A; Ranftler, C; Gehre, C; Brakebusch, C; Pavelka, M; Stradal, T; Rottner, K				Kage, Frieda; Steffen, Anika; Ellinger, Adolf; Ranftler, Carmen; Gehre, Christian; Brakebusch, Cord; Pavelka, Margit; Stradal, Theresia; Rottner, Klemens			FMNL2 and-3 regulate Golgi architecture and anterograde transport downstream of Cdc42	SCIENTIFIC REPORTS			English	Article							FORMIN-INDUCED NUCLEATION; LIVING CELLS; PLASMA-MEMBRANE; ACTIN POLYMERIZATION; HOMOLOGY-2 DOMAIN; CATHEPSIN-D; TRAFFICKING; ORGANIZATION; APPARATUS; NETWORK	The Rho-family small GTPase Cdc42 localizes at plasma membrane and Golgi complex and aside from protrusion and migration operates in vesicle trafficking, endo- and exocytosis as well as establishment and/or maintenance of cell polarity. The formin family members FMNL2 and -3 are actin assembly factors established to regulate cell edge protrusion during migration and invasion. Here we report these formins to additionally accumulate and function at the Golgi apparatus. As opposed to lamellipodia, Golgi targeting of these proteins required both their N-terminal myristoylation and the interaction with Cdc42. Moreover, Golgi association of FMNL2 or -3 induced a phalloidin-detectable actin meshwork around the Golgi. Importantly, functional interference with FMNL2/3 formins by RNAi or CRISPR/Cas9-mediated gene deletion invariably induced Golgi fragmentation in different cell lines. Furthermore, absence of these proteins led to enlargement of endosomes as well as defective maturation and/or sorting into late endosomes and lysosomes. In line with Cdc42 - recently established to regulate anterograde transport through the Golgi by cargo sorting and carrier formation - FMNL2/3 depletion also affected anterograde trafficking of VSV-G from the Golgi to the plasma membrane. Our data thus link FMNL2/3 formins to actin assembly-dependent functions of Cdc42 in anterograde transport through the Golgi apparatus.	[Kage, Frieda; Gehre, Christian; Rottner, Klemens] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Mol Cell Biol Div, Spielmannstr 7, D-38106 Braunschweig, Germany; [Kage, Frieda; Steffen, Anika; Gehre, Christian; Stradal, Theresia; Rottner, Klemens] Helmholtz Ctr Infect Res, Dept Cell Biol, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Ellinger, Adolf; Ranftler, Carmen; Pavelka, Margit] Med Univ Vienna, Ctr Anat & Cell Biol, Schwarzspanierstr 17, A-1090 Vienna, Austria; [Brakebusch, Cord] Univ Copenhagen, Inst Biomed, BRIC, DK-2200 Copenhagen, Denmark	Rottner, K (reprint author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Mol Cell Biol Div, Spielmannstr 7, D-38106 Braunschweig, Germany.; Rottner, K (reprint author), Helmholtz Ctr Infect Res, Dept Cell Biol, Inhoffenstr 7, D-38124 Braunschweig, Germany.	rottner@tu-braunschweig.de		Rottner, Klemens/0000-0003-4244-4198	Deutsche Forschungsgemeinschaft (DFG) [RO2414/3-2]	This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG), grant RO2414/3-2 (to K.R.) We also thank Pontus Aspenstrom, Matthias Geyer, Stefan Honing and Laura Machesky for reagents, and Gerd Landsberg, Brigitte Denker, Ivanna Federenko and Ulrich Kaindl for excellent technical assistance.	Bhattacharya K, 2016, SCI REP-UK, V6, DOI 10.1038/srep25411; Block J, 2012, CURR BIOL, V22, P1005, DOI 10.1016/j.cub.2012.03.064; Breitsprecher D, 2013, J CELL SCI, V126, P1, DOI 10.1242/jcs.107250; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467                                                            ; Chen JL, 2004, FEBS LETT, V566, P281, DOI 10.1016/j.febslet.2004.04.061; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Colon-Franco JM, 2011, J CELL SCI, V124, P3118, DOI 10.1242/jcs.083725; Czuchra A, 2005, MOL BIOL CELL, V16, P4473, DOI 10.1091/mbc.E05-01-0061; Dimchev G, 2017, MOL BIOL CELL, V28, P1311, DOI 10.1091/mbc.E16-05-0334; Egea G, 2014, CURR BIOL, V24, pR741, DOI 10.1016/j.cub.2014.07.002; Egea G, 2013, HISTOCHEM CELL BIOL, V140, P347, DOI 10.1007/s00418-013-1115-8; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850                                                        ; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Farhan H, 2016, TRENDS CELL BIOL, V26, P241, DOI 10.1016/j.tcb.2015.11.003; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Friesland A, 2013, P NATL ACAD SCI USA, V110, P1261, DOI 10.1073/pnas.1116051110; Gauvin TJ, 2015, MOL BIOL CELL, V26, P467, DOI 10.1091/mbc.E14-07-1247; GIESELMANN V, 1985, J BIOL CHEM, V260, P3215; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Guet D, 2014, CURR BIOL, V24, P1700, DOI 10.1016/j.cub.2014.06.048; Gurel PS, 2014, CURR BIOL, V24, pR660, DOI 10.1016/j.cub.2014.05.033; Harris ES, 2010, CYTOSKELETON, V67, P755, DOI 10.1002/cm.20485; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kage F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14832; Kirkbride KC, 2012, CYTOSKELETON, V69, P625, DOI 10.1002/cm.21051; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kroschewski R, 1999, NAT CELL BIOL, V1, P8; Kuhn S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8088; Kuhn S., 2014, SMALL GTPASES, V5, DOI DOI 10.4161/SGTP.29513; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1                                                   ; LOMBARDI D, 1993, EMBO J, V12, P677; Matas OB, 2004, TRAFFIC, V5, P838, DOI 10.1111/j.1600-0854.2004.00225.x; MERESSE S, 1995, J CELL SCI, V108, P3349; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Ohashi E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019942; Ozaki-Kuroda K, 2001, MOL CELL BIOL, V21, P827, DOI 10.1128/MCB.21.3.827-839.2001; Park SY, 2015, NATURE, V521, P529, DOI 10.1038/nature14457; Presley JF, 1997, NATURE, V389, P81; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Ramabhadran V, 2012, J BIOL CHEM, V287, P34234, DOI 10.1074/jbc.M112.365122; Ramabhadran V, 2011, MOL BIOL CELL, V22, P4822, DOI 10.1091/mbc.E11-05-0457; Rizk A, 2014, NAT PROTOC, V9, P586, DOI 10.1038/nprot.2014.037; SAMAREL AM, 1989, AM J PHYSIOL, V257, pC1069; Sutterlin C, 2010, J CELL BIOL, V188, P621, DOI 10.1083/jcb.200910001; Tanabe Kenji, 2011, Commun Integr Biol, V4, P742; Thompson ME, 2013, NAT STRUCT MOL BIOL, V20, P111, DOI 10.1038/nsmb.2462; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Toomre D, 1999, J CELL SCI, V112, P21; Vaillant DC, 2008, J BIOL CHEM, V283, P33750, DOI 10.1074/jbc.M803156200; Wang Y, 2015, DEV CELL, V34, P475, DOI 10.1016/j.devcel.2015.06.015; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x; Yang JS, 2011, NAT CELL BIOL, V13, P996, DOI 10.1038/ncb2273; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019; Zilberman Y, 2011, MOL BIOL CELL, V22, P2900, DOI 10.1091/mbc.E11-01-0007	62	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 29	2017	7								9791	10.1038/s41598-017-09952-1				17	Multidisciplinary Sciences	Science & Technology - Other Topics	FE9QL	WOS:000408538100033	28852060	gold			2018-01-05	
J	Dwivedi, SL; Scheben, A; Edwards, D; Spillane, C; Ortiz, R				Dwivedi, Sangam L.; Scheben, Armin; Edwards, David; Spillane, Charles; Ortiz, Rodomiro			Assessing and Exploiting Functional Diversity in Germplasm Pools to Enhance Abiotic Stress Adaptation and Yield in Cereals and Food Legumes	FRONTIERS IN PLANT SCIENCE			English	Review						crop improvement; epigenetic variation; florigen pathways; functional diversity; genome editing; genomic estimated breeding value; haplotypes; TILLING	GENOME-WIDE ASSOCIATION; FLOWERING-LOCUS-T; SNP GENOTYPING ARRAY; PHOSPHORUS-DEFICIENCY-TOLERANCE; DNA METHYLATION VARIATION; NATURAL GENETIC-VARIATION; QUANTITATIVE TRAIT LOCUS; HEXAPLOID BREAD WHEAT; WILD-RICE GERMPLASM; CICER-ARIETINUM L.	There is a need to accelerate crop improvement by introducing alleles conferring host plant resistance, abiotic stress adaptation, and high yield potential. Elite cultivars, landraces and wild relatives harbor useful genetic variation that needs to be more easily utilized in plant breeding. We review genome-wide approaches for assessing and identifying alleles associated with desirable agronomic traits in diverse germplasm pools of cereals and legumes. Major quantitative trait loci and single nucleotide polymorphisms (SNPs) associated with desirable agronomic traits have been deployed to enhance crop productivity and resilience. These include alleles associated with variation conferring enhanced photoperiod and flowering traits. Genetic variants in the florigen pathway can provide both environmental flexibility and improved yields. SNPs associated with length of growing season and tolerance to abiotic stresses (precipitation, high temperature) are valuable resources for accelerating breeding for drought-prone environments. Both genomic selection and genome editing can also harness allelic diversity and increase productivity by improving multiple traits, including phenology, plant architecture, yield potential and adaptation to abiotic stresses. Discovering rare alleles and useful haplotypes also provides opportunities to enhance abiotic stress adaptation, while epigenetic variation has potential to enhance abiotic stress adaptation and productivity in crops. By reviewing current knowledge on specific traits and their genetic basis, we highlight recent developments in the understanding of crop functional diversity and identify potential candidate genes for future use. The storage and integration of genetic, genomic and phenotypic information will play an important role in ensuring broad and rapid application of novel genetic discoveries by the plant breeding community. Exploiting alleles for yield-related traits would allow improvement of selection efficiency and overall genetic gain of multigenic traits. An integrated approach involving multiple stakeholders specializing in management and utilization of genetic resources, crop breeding, molecular biology and genomics, agronomy, stress tolerance, and reproductive/seed biology will help to address the global challenge of ensuring food security in the face of growing resource demands and climate change induced stresses.	[Scheben, Armin; Edwards, David] Univ Western Australia, Inst Agr, Sch Biol Sci, Perth, WA, Australia; [Spillane, Charles] Natl Univ Ireland Galway, Ryan Inst, Plant & AgriBiosci Res Ctr, Galway, Ireland; [Ortiz, Rodomiro] Swedish Univ Agr Sci, Dept Plant Breeding, Alnarp, Sweden	Ortiz, R (reprint author), Swedish Univ Agr Sci, Dept Plant Breeding, Alnarp, Sweden.	rodomiro.ortiz@slu.se			Science Foundation Ireland; Irish Department of Food, Agriculture; Green Development and Demonstration Program, (GUDP, Denmark); Innovationsfonden (Denmark); Vetenskapsradet (VR, Sweden) Development Research	SLD acknowledges the contribution of Ramesh Kotnana of Knowledge Sharing and Innovation Program of ICRISAT for arranging reprints on functional diversity as valuable literature resources for drafting this manuscript. CS acknowledges funding support from Science Foundation Ireland, and the Irish Department of Food, Agriculture and the Marine, while grants provided during the writing of this manuscript from PlantePigment and Annato - projects led by Chr. Hansen A/S with grants from Green Development and Demonstration Program, (GUDP, Denmark) and Innovationsfonden (Denmark), respectively- and Utveckling av ett molekylart foradlingsprogram for durum-vete i Senegal: Kapacitetsuppbyggnad for att mota den globala uppvarmningen - a project with funding from Vetenskapsradet (VR, Sweden) Development Research, are acknowledged by RO. The sketch used for drawing Figure 1 was kindly shared by Dr. Sandeep Kumar Kushwaha (SLU, VF, Alnarp. Sweden). We are grateful to the three reviewers for helpful suggestions on improving the manuscript.	Abberton M, 2016, PLANT BIOTECHNOL J, V14, P1095, DOI 10.1111/pbi.12467; Abebe TD, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00813; Akond M., 2013, J PLANT GENOME SCI, V1, P80, DOI 10.5147/jpgs.2013.0090; Anderson JE, 2016, G3-GENES GENOM GENET, V6, P835, DOI 10.1534/g3.116.026914; Ariani A, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0512-9; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Aslan S, 2015, CROP SCI, V55, P2766, DOI 10.2135/cropsci2015.02.0119; Auger DL, 2004, THEOR APPL GENET, V108, P1017, DOI 10.1007/s00122-003-1521-8; Ayling S. C., 2016, TECHNICAL APPRAISAL; Azmach G, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-227; Bailey-Serres J, 2010, RICE, V3, P138, DOI 10.1007/s12284-010-9048-5; Bajaj D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12468; Batley J, 2009, BIOTECHNIQUES, V46, P333, DOI 10.2144/000113134; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bedada G, 2014, HEREDITY, V112, P646, DOI 10.1038/hdy.2014.2; Bennetzen JL, 2014, ANNU REV PLANT BIOL, V65, P505, DOI 10.1146/annurev-arplant-050213-035811; Benson DA, 2012, NUCLEIC ACIDS RES, V40, pD48, DOI 10.1093/nar/gkr1202; Birchler JA, 2010, PLANT CELL, V22, P2105, DOI 10.1105/tpc.110.076133; Biscarini F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155425; Blake VC, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2014.12.0099; Blomstedt CK, 2012, PLANT BIOTECHNOL J, V10, P54, DOI 10.1111/j.1467-7652.2011.00646.x; Bouchet S, 2017, HEREDITY, V118, P249, DOI 10.1038/hdy.2016.88; Boutet G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2447-2; Boyles RE, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.09.0091; Bray E. A., 2000, RESPONSES ABIOTIC ST; BRINK RA, 1958, COLD SPRING HARB SYM, V23, P379, DOI 10.1101/SQB.1958.023.01.036                                                     ; Brown PJ, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.154, 10.1038/NPLANTS.2016.154]; Burstin J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1266-1; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Casas AM, 2011, THEOR APPL GENET, V122, P1293, DOI 10.1007/s00122-011-1531-x; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chen HD, 2014, MOL PLANT, V7, P541, DOI 10.1093/mp/sst135; Chen JP, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2016.09.0091; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041570; Chen WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep09192; Chin JH, 2011, PLANT PHYSIOL, V156, P1202, DOI 10.1104/pp.111.175471; Chung WH, 2014, DNA RES, V21, P153, DOI 10.1093/dnares/dst047; Clevenger J, 2017, MOL PLANT, V10, P309, DOI 10.1016/j.molp.2016.11.015; Close T. J., 2015, DEV 60K ISELECT FACI; Cobb JN, 2013, THEOR APPL GENET, V126, P867, DOI 10.1007/s00122-013-2066-0; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Cortijo S, 2014, SCIENCE, V343, P1145, DOI 10.1126/science.1248127; Crossa J, 2016, G3-GENES GENOM GENET, V6, P1819, DOI 10.1534/g3.116.029637; Crowell S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10527; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Cuevas HE, 2016, MOL BIOL EVOL, V33, P2417, DOI 10.1093/molbev/msw120; Dapp M, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.92, 10.1038/nplants.2015.92]; Dar MH, 2013, SCI REP-UK, V3, DOI 10.1038/srep03315; Deng YW, 2017, SCIENCE, V355, P962, DOI 10.1126/science.aai8898; Deryng D, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034011; Dhanapal AP, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0861-x; Dhanapal AP, 2015, THEOR APPL GENET, V128, P73, DOI 10.1007/s00122-014-2413-9; Di Fenza M, 2017, PEERJ, V5, DOI 10.7717/peerj.2839; Doddamani D, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav078; Duszynska D, 2013, NEW PHYTOL, V198, P71, DOI 10.1111/nph.12147; Duvick DN, 2001, NAT REV GENET, V2, P69, DOI 10.1038/35047587; Dwivedi SL, 2008, PL BRED RE, V30, P179; Dwivedi SL, 2017, TRENDS PLANT SCI, V22, P842, DOI 10.1016/j.tplants.2017.06.011; Dwivedi SL, 2016, TRENDS PLANT SCI, V21, P31, DOI 10.1016/j.tplants.2015.10.012; Dwivedi S.L., 2010, PLANT BREED REV, V33, P31, DOI DOI 10.1002/9780470535486.CH2; Eichten SR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002372; Eichten SR, 2013, PLANT CELL, V25, P2783, DOI 10.1105/tpc.113.114793; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fang Z, 2014, G3-GENES GENOM GENET, V4, P1193, DOI 10.1534/g3.114.010561; Farfan IDB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117737; Finnegan EJ, 2002, CURR OPIN PLANT BIOL, V5, P101, DOI 10.1016/S1369-5266(02)00233-9; Fleury D, 2010, J EXP BOT, V61, P3211, DOI 10.1093/jxb/erq152; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fort A, 2016, NEW PHYTOL, V209, P590, DOI 10.1111/nph.13650; Foucher F, 2003, PLANT CELL, V15, P2742, DOI 10.1105/tpc.015701; Franckowiak J. D., 2012, Barley Genetics Newsletter, V42, P36; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Fu CY, 2016, GENOME, V59, P197, DOI 10.1139/gen-2015-0101; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fu YB, 2015, THEOR APPL GENET, V128, P2131, DOI 10.1007/s00122-015-2585-y; Fujita D, 2013, P NATL ACAD SCI USA, V110, P20431, DOI 10.1073/pnas.1310790110; Fukao T, 2009, ANN BOT-LONDON, V103, P143, DOI 10.1093/aob/mcn172; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; Gallusci P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00807; GAMON JA, 1992, REMOTE SENS ENVIRON, V41, P35, DOI 10.1016/0034-4257(92)90059-S; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Garnier O, 2008, EPIGENETICS-US, V3, P14, DOI 10.4161/epi.3.1.5554                                                            ; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilchrist EJ, 2005, CURR OPIN PLANT BIOL, V8, P211, DOI 10.1016/j.pbi.2005.01.004; Golicz AA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13390; Gonzalez AM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01940; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gorjanc G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2345-z; Gottwald Sven, 2009, BMC Res Notes, V2, P258, DOI 10.1186/1756-0500-2-258; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Greaves IK, 2015, PLANT PHYSIOL, V168, P1197, DOI 10.1104/pp.15.00231; Greaves IK, 2014, P NATL ACAD SCI USA, V111, P2017, DOI 10.1073/pnas.1323656111; Groszmann M, 2013, TRENDS GENET, V29, P684, DOI 10.1016/j.tig.2013.07.004; Groszmann M, 2011, P NATL ACAD SCI USA, V108, P2617, DOI 10.1073/pnas.1019217108; Gujaria-Verma N, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2499-3; Guo ZF, 2017, NEW PHYTOL, V214, P257, DOI 10.1111/nph.14342; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Hagmann J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004920; Haile JK, 2013, GENET RESOUR CROP EV, V60, P853, DOI 10.1007/s10722-012-9880-0; Hao DR, 2012, THEOR APPL GENET, V124, P447, DOI 10.1007/s00122-011-1719-0; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; HARTWIG EE, 1979, FIELD CROP RES, V2, P145, DOI 10.1016/0378-4290(79)90017-0                                                    ; Hauben M, 2009, P NATL ACAD SCI USA, V106, P20109, DOI 10.1073/pnas.0908755106; Hays DB, 2007, PLANT SCI, V172, P1113, DOI 10.1016/j.plantsci.2007.03.004; Henry IM, 2014, PLANT CELL, V26, P1382, DOI 10.1105/tpc.113.121590; Herritt M, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.08.0072; Heslot N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074612; Hirsch CD, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.12.0042; Hollick JB, 2017, NAT REV GENET, V18, P5, DOI 10.1038/nrg.2016.115; Hu ZB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2255-0; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huq MA, 2016, J PLANT BIOTECHNOL, V43, P1, DOI DOI 10.5010/JPB.2016.43.1.1; Huynh BL, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0005; Ingvarsson PK, 2011, NEW PHYTOL, V189, P909, DOI 10.1111/j.1469-8137.2010.03593.x; Ingvordsen CH, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0283-8; Jannink Jean-Luc, 2002, P59; Jarquin D, 2016, G3-GENES GENOM GENET, V6, P2329, DOI [10.1534/g3.116.031443/-/DC1, 10.1534/g3.116.031443]; Jia JZ, 2017, CROP J, V5, P166, DOI 10.1016/j.cj.2016.10.006; Jiang K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004043; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Jonas E, 2013, TRENDS BIOTECHNOL, V31, P497, DOI [10.1016/j.tibtech.2013.06, 10.1016/j.tibtech.2013.06.003]; Jordan KW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0606-4; Joshi T, 2014, NUCLEIC ACIDS RES, V42, pD1245, DOI 10.1093/nar/gkt905; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Kale SM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15296; Kamfwa K, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.09.0059; Kanz C, 2005, NUCLEIC ACIDS RES, V33, pD29, DOI 10.1093/nar/gki098; Karlgren A, 2011, PLANT PHYSIOL, V156, P1967, DOI 10.1104/pp.111.176206; Kawakatsu T, 2016, CELL, V166, P492, DOI 10.1016/j.cell.2016.06.044; Kawanabe T, 2016, P NATL ACAD SCI USA, V113, pE6704, DOI 10.1073/pnas.1613372113; Kilian B, 2012, BRIEF FUNCT GENOMICS, V11, P38, DOI 10.1093/bfgp/elr046; King GJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00968; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; Klein RR, 2016, J PLANT REGIST, V10, P57, DOI 10.3198/jpr2015.05.0034crg; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kole C, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00563; Kong FJ, 2014, CROP SCI, V54, P2529, DOI 10.2135/cropsci2014.03.0228; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Koo BH, 2013, MOL PLANT, V6, P1877, DOI 10.1093/mp/sst088; Kooke R, 2015, PLANT CELL, V27, P337, DOI 10.1105/tpc.114.133025; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213                                                              ; Kujur A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11166; Kumar APK, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0620-1; Kumar A, 2014, J EXP BOT, V65, P6265, DOI 10.1093/jxb/eru363; Kumar V, 2016, PLANT BIOTECHNOL J, V14, P1673, DOI 10.1111/pbi.12528; Kumar V, 2015, DNA RES, V22, P133, DOI 10.1093/dnares/dsu046; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lai KT, 2015, PLANT BIOTECHNOL J, V13, P97, DOI 10.1111/pbi.12240; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lasky JR, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400218; Lawrence CJ, 2004, NUCLEIC ACIDS RES, V32, pD393, DOI 10.1093/nar/gkh011; Leamy LJ, 2016, ECOL EVOL, V6, P6332, DOI 10.1002/ece3.2351; Lee HC, 2012, BRIEF FUNCT GENOMICS, V11, P12, DOI 10.1093/bfgp/elr037; Lee YG, 2015, PLANT J, V81, P625, DOI 10.1111/tpj.12755; Leiser WL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0206-6; Lesk C, 2016, NATURE, V529, P84, DOI 10.1038/nature16467; Li MR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00377; Li Q, 2014, GENETICS, V196, P667, DOI 10.1534/genetics.113.158980; Li XP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00833; Li XM, 2015, NAT GENET, V47, P827, DOI 10.1038/ng.3305; Li YH, 2014, NAT BIOTECHNOL, V32, P1045, DOI 10.1038/nbt.2979; Li YH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-579; Li Z, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01477; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Lin K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-250; Liu E, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00596; Liu HM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00667; Liu RE, 2015, P NATL ACAD SCI USA, V112, P10804, DOI 10.1073/pnas.1503362112; Liu YX, 2015, THEOR APPL GENET, V128, P2203, DOI 10.1007/s00122-015-2578-x; Lombardi M, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0150-3; Longin CFH, 2014, TRENDS PLANT SCI, V19, P631, DOI 10.1016/j.tplants.2014.06.012; Lu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034021; Lu SJ, 2017, NAT GENET, V49, P773, DOI 10.1038/ng.3819; Lu YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024861; Lu YL, 2010, P NATL ACAD SCI USA, V107, P19585, DOI 10.1073/pnas.1006105107; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; Ma Y, 2015, CELL, V160, P1209, DOI 10.1016/j.cell.2015.01.046; Mace ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3320; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Mackill DJ, 2012, ADV AGRON, V115, P299, DOI 10.1016/B978-0-12-394276-0.00006-8; Madduri RK, 2014, CONCURR COMP-PRACT E, V26, P2266, DOI 10.1002/cpe.3274; Makumburage GB, 2013, G3-GENES GENOM GENET, V3, P2195, DOI 10.1534/g3.113.008573; dos Santos JVM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2431-x; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Mashima J, 2016, NUCLEIC ACIDS RES, V44, pD51, DOI 10.1093/nar/gkv1105; Maurer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1459-7; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; McKeown PC, 2013, TRENDS BIOTECHNOL, V31, P549, DOI 10.1016/j.tibtech.2013.06.008; Mejlhede N, 2006, PLANT BREEDING, V125, P461, DOI 10.1111/j.1439-0523.2006.01226.x; Meng DZ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006141; Michael TP, 2015, CURR OPIN PLANT BIOL, V24, P71, DOI 10.1016/j.pbi.2015.02.002; Millet EJ, 2016, PLANT PHYSIOL, V172, P749, DOI 10.1104/pp.16.00621; Mir RR, 2014, THEOR APPL GENET, V127, P2663, DOI 10.1007/s00122-014-2406-8; Mishra S, 2016, PLANT CELL REP, V35, P2295, DOI 10.1007/s00299-016-2035-6; Mishra S, 2016, RICE, V9, DOI 10.1186/s12284-016-0083-8; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Montenegro JD, 2017, PLANT J, V90, P1007, DOI 10.1111/tpj.13515; Morris GP, 2013, P NATL ACAD SCI USA, V110, P453, DOI 10.1073/pnas.1215985110; Multani DS, 2003, SCIENCE, V302, P81, DOI 10.1126/science.1086072; Muraya MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132120; Murphy RL, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.11.0040; Murphy RL, 2011, P NATL ACAD SCI USA, V108, P16469, DOI 10.1073/pnas.1106212108; Naranjo L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-101; Nelson MN, 2017, NEW PHYTOL, V213, P220, DOI 10.1111/nph.14094; Neumaier N., 1993, FOOD LEGUME NEWSLETT, V8, P12; Nevo E, 2012, P NATL ACAD SCI USA, V109, P3412, DOI 10.1073/pnas.1121411109; Niemenmaa M, 2012, BIOINFORMATICS, V28, P876, DOI 10.1093/bioinformatics/bts054; Ning LH, 2016, BREEDING SCI, V66, P191, DOI 10.1270/jsbbs.66.191; Nordberg H, 2013, BIOINFORMATICS, V29, P3014, DOI 10.1093/bioinformatics/btt528; O'Driscoll A, 2013, J BIOMED INFORM, V46, P774, DOI 10.1016/j.jbi.2013.07.001; Oakey H, 2016, G3-GENES GENOM GENET, V6, P1313, DOI 10.1534/g3.116.027524; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Offermann S, 2014, CURR OPIN PLANT BIOL, V19, P105, DOI 10.1016/j.pbi.2014.05.010; Ogiso-Tanaka E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075959; Ong-Abdullah M, 2015, NATURE, V525, P533, DOI 10.1038/nature15365; Ortiz R., 2013, TARGET TRAITS, V2, P203, DOI [10.1007/978-3-642-37048-9_5, DOI 10.1007/978-3-642-37048-9_5]; Ortiz R., 2015, PLANT BREEDING OMICS, V249, DOI [10.1007/978-3-319-20532-8, DOI 10.1007/978-3-319-20532-8]; Ousseini IS, 2017, HEREDITY, V119, P88, DOI 10.1038/hdy.2017.13; Park M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1046-5; Park SJ, 2014, NAT GENET, V46, P1337, DOI 10.1038/ng.3131; Pasam RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116164; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Perez-Enciso M, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0117-5; Periyannan S, 2013, SCIENCE, V341, P786, DOI 10.1126/science.1239028; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pikaard CS, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019315; Poets AM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0712-3; Prins R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00973; Pyhajarvi T, 2013, GENOME BIOL EVOL, V5, P1594, DOI 10.1093/gbe/evt109; Qi XP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5340; Qin P, 2016, GENET MOL BIOL, V39, P398, DOI 10.1590/1678-4685-GMB-2015-0232; QUINBY JR, 1954, AGRON J, V46, P211, DOI 10.2134/agronj1954.00021962004600050007x                                        ; Raggi L, 2014, PLANT SCI, V215, P180, DOI 10.1016/j.plantsci.2013.11.001; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; RATHNAYAKE NRMKND, 2012, CEYLON J SCI BIO SCI, V41, P125; Rebolledo MC, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01384; Reinert S, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2015.01061, 10.3389/fpls.2016.01061]; Rhee SY, 2014, TRENDS PLANT SCI, V19, P212, DOI 10.1016/j.tplants.2013.10.006; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Roorkiwal M., 2016, HIGH THROUGHPUT SNP; Russell J, 2016, NAT GENET, V48, P1024, DOI 10.1038/ng.3612; Russo VE, 1996, EPIGENETIC MECH GENE; Ryder P, 2017, PLANT CELL REP, V36, P1005, DOI 10.1007/s00299-017-2125-0; Saidou AA, 2009, GENETICS, V182, P899, DOI 10.1534/genetics.109.102756; Sailer C, 2016, CURR BIOL, V26, P331, DOI 10.1016/j.cub.2015.12.045; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Samal R., 2014, Journal of Experimental Biology and Agricultural Sciences, V2, P315; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Schatz MC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0506-z; Scheben A, 2017, NEW PHYTOL, V216, P682, DOI 10.1111/nph.14702; Scheben A, 2017, SCIENCE, V355, P1122, DOI 10.1126/science.aal4680; Scheben A, 2017, PLANT BIOTECHNOL J, V15, P149, DOI 10.1111/pbi.12645; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schnable PS, 2013, ANNU REV PLANT BIOL, V64, P71, DOI 10.1146/annurev-arplant-042110-103827; Sehgal D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132112; Sehgal D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122165; Seymour DK, 2017, CURR OPIN PLANT BIOL, V36, P56, DOI 10.1016/j.pbi.2017.01.005; Shen HS, 2012, PLANT CELL, V24, P875, DOI 10.1105/tpc.111.094870; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Shi JR, 2017, PLANT BIOTECHNOL J, V15, P207, DOI 10.1111/pbi.12603; Shimatani Z, 2017, NAT BIOTECHNOL, V35, P441, DOI 10.1038/nbt.3833; Shivaprasad PV, 2012, EMBO J, V31, P257, DOI 10.1038/emboj.2011.458; Singh N, 2010, THEOR APPL GENET, V121, P1441, DOI 10.1007/s00122-010-1400-z; Singh N, 2015, SCI REP-UK, V5, DOI 10.1038/srep11600; Sobkowiak A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2453-4; Sonah H, 2015, PLANT BIOTECHNOL J, V13, P211, DOI 10.1111/pbi.12249; Song QJ, 2015, G3-GENES GENOM GENET, V5, P2285, DOI 10.1534/g3.115.020594; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Song SY, 2017, PLANT CELL, V29, P491, DOI 10.1105/tpc.16.00728; Song XJ, 2015, P NATL ACAD SCI USA, V112, P76, DOI 10.1073/pnas.1421127112; Song XW, 2017, CURR OPIN PLANT BIOL, V36, P111, DOI 10.1016/j.pbi.2017.02.004; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(00)00078-2; Soyk S, 2017, NAT GENET, V49, P162, DOI 10.1038/ng.3733; Sparla F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107779; Spillane C, 2004, NAT BIOTECHNOL, V22, P687, DOI 10.1038/nbt976; Spindel JE, 2016, HEREDITY, V116, P395, DOI 10.1038/hdy.2015.113; Spindel JE, 2016, NEW PHYTOL, V212, P814, DOI 10.1111/nph.14174; Steinert J, 2016, PLANT CELL REP, V35, P1429, DOI 10.1007/s00299-016-1981-3; STEPHENS JC, 1967, CROP SCI, V7, P396, DOI 10.2135/cropsci1967.0011183X000700040036x                                       ; Sun XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10342; Takeshima R, 2016, J EXP BOT, V67, P5247, DOI 10.1093/jxb/erw283; Talame V, 2008, PLANT BIOTECHNOL J, V6, P477, DOI 10.1111/j.1467-7652.2008.00341.x; Tamang Bishal Gole, 2011, Asian Journal of Plant Sciences, V10, P347, DOI 10.3923/ajps.2011.347.356; Tayeh N, 2015, PLANT J, V84, P1257, DOI 10.1111/tpj.13070; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Tello-Ruiz MK, 2016, NUCLEIC ACIDS RES, V44, pD1133, DOI 10.1093/nar/gkv1179; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Thirunavukkarasu N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-877; Thoen MPM, 2017, NEW PHYTOL, V213, P1346, DOI 10.1111/nph.14220; Thudi M, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-015-0690-3; Thurber CS, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r68; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Tian HL, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0335-0; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Trethowan R. M., 2007, Plant Breeding Reviews, V28, P39; Tsai H, 2011, PLANT PHYSIOL, V156, P1257, DOI 10.1104/pp.110.169748; Tsubokura Y, 2014, ANN BOT-LONDON, V113, P429, DOI 10.1093/aob/mct269; Tucker S, 2010, CURR OPIN CELL BIOL, V22, P351, DOI 10.1016/j.ceb.2010.03.009; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Unterseer S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1009-x; Unterseer S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-823; Valdisser PAMR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3805-4; Valliyodan B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23598; Valluru R, 2017, NEW PHYTOL, V214, P271, DOI 10.1111/nph.14367; Hintum TJL, 2000, IPGRI TECHNICAL B, V3, P48; Varshney RK, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.10.0035; Varshney RK, 2014, THEOR APPL GENET, V127, P445, DOI 10.1007/s00122-013-2230-6; Vigouroux Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019563; Vikram P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23092; Villordo-Pineda E, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00546; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Wang FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154027; Wang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20728; Wang L, 2015, P NATL ACAD SCI USA, V112, pE4959, DOI 10.1073/pnas.1514190112; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wang Y. F., 2015, MATH PROBL ENG, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0121893; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Westengen OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047832; Wissuwa M, 2002, THEOR APPL GENET, V105, P890, DOI 10.1007/s00122-002-1051-9; Wissuwa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124215; Xiong HZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160941; Xu C, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0622-z; Xu J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-83; Xu ML, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-91; Xu P, 2017, PLANT BIOTECHNOL J, V15, P547, DOI 10.1111/pbi.12639; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Xu YH, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-016-0964-4; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yamaguchi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28366; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yan WH, 2013, CELL RES, V23, P969, DOI 10.1038/cr.2013.43; Yang WN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6087; Yang XD, 2015, PLANT PHYSIOL, V168, P222, DOI 10.1104/pp.15.00075; Yu HH, 2014, PLANT BIOTECHNOL J, V12, P28, DOI 10.1111/pbi.12113; Yu LX, 2010, MOL BREEDING, V26, P667, DOI 10.1007/s11032-010-9403-7; YU XQ, 2016, NAT PLANTS, V2; Zhang D, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00372; Zhang HL, 2010, J EXP BOT, V61, P2549, DOI 10.1093/jxb/erq092; Zhang JP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1441-4; Zhang QZ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.27; Zhang QZ, 2016, P NATL ACAD SCI USA, V113, pE4248, DOI 10.1073/pnas.1607851113; Zhang XQ, 2015, PLANT PHYSIOL, V169, P2118, DOI 10.1104/pp.15.00836; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110; Zhang YF, 2015, RICE SCI, V22, P217, DOI 10.1016/j.rsci.2015.07.001; Zhang ZY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14788; Zhao C, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0704-9; Zhao JB, 2016, ACSR ADV COMPUT, V37, P9; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao MZ, 2016, BREEDING SCI, V66, P599, DOI 10.1270/jsbbs.16058; Zheng LY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r114; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811	369	0	0	20	20	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	AUG 29	2017	8								1461	10.3389/fpls.2017.01461				30	Plant Sciences	Plant Sciences	FF1KG	WOS:000408657800001	28900432	gold			2018-01-05	
J	Freyer, L; Hsu, CW; Nowotschin, S; Pauli, A; Ishida, J; Kuba, K; Fukamizu, A; Schier, AF; Hoodless, PA; Dickinson, ME; Hadjantonakis, AK				Freyer, Laina; Hsu, Chih-Wei; Nowotschin, Sonja; Pauli, Andrea; Ishida, Junji; Kuba, Keiji; Fukamizu, Akiyoshi; Schier, Alexander F.; Hoodless, Pamela A.; Dickinson, Mary E.; Hadjantonakis, Anna-Katerina			Loss of Apela Peptide in Mice Causes Low Penetrance Embryonic Lethality and Defects in Early Mesodermal Derivatives	CELL REPORTS			English	Article							LEFT-RIGHT ASYMMETRY; MOUSE YOLK-SAC; CARDIOVASCULAR DEVELOPMENT; MYELOID PROGENITORS; DEFINITIVE ENDODERM; HOMEOBOX GENE; STEM-CELLS; HEART; APJ; EXPRESSION	Apela (also known as Elabela, Ende, and Toddler) is a small signaling peptide that activates the G-proteincoupled receptor Aplnr to stimulate cell migration during zebrafish gastrulation. Here, using CRISPR/Cas9 to generate a null, reporter-expressing allele, we study the role of Apela in the developing mouse embryo. We found that loss of Apela results in low-penetrance cardiovascular defects that manifest after the onset of circulation. Three-dimensional micro- computed tomography revealed a higher penetrance of vascular remodeling defects, from which some mutants recover, and identified extraembryonic anomalies as the earliest morphological distinction in Apela mutant embryos. Transcriptomics at late gastrulation identified aberrant upregulation of erythroid and myeloid markers in mutant embryos prior to the appearance of physical malformations. Double-mutant analyses showed that loss of Apela signaling impacts early Aplnr-expressing mesodermal populations independently of the alternative ligand Apelin, leading to lethal cardiac defects in some Apela null embryos.	[Freyer, Laina; Nowotschin, Sonja; Hadjantonakis, Anna-Katerina] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Hsu, Chih-Wei; Dickinson, Mary E.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Pauli, Andrea] Vienna BioCtr, Res Inst Mol Pathol, A-1030 Vienna, Austria; [Ishida, Junji; Fukamizu, Akiyoshi] Univ Tsukuba, TARA, Life Sci Ctr, Tsukuba, Ibaraki 3058577, Japan; [Kuba, Keiji] Akita Univ, Dept Biochem & Metab Sci, Akita 0108543, Japan; [Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Hoodless, Pamela A.] BC Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Freyer, Laina] Inst Pasteur, Dept Dev & Stem Cell Biol, F-75015 Paris, France	Hadjantonakis, AK (reprint author), Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA.	hadj@mskcc.org			National Institutes of Health [F32GM115089, R01DK084391, P30CA008748, U54HG006348, R01HL128064]; Natural Sciences and Engineering Research Council of Canada [RGPIN418298-12]; Jackson Laboratory [030845]	We thank members of the Hadjantonakis lab and Nicolas Porchet for comments and suggestions on the manuscript; MSKCC's Mouse Genetics Core Facility for production of germline transmitting chimeras; Rockefeller University's Gene Targeting Facility for assistance in the generation of targeted embryonic stem cells (ESCs); the New York Genome Center for sequence data generation and analysis; and the Optical Imaging and Vital Microscopy core at BCM for microCT data. This work was supported by the National Institutes of Health (F32GM115089 to L.F.; R01DK084391 and P30CA008748 to A.-K.H.; and U54HG006348 and R01HL128064 to M.E.D.) and the Natural Sciences and Engineering Research Council of Canada (RGPIN418298-12 to P.A.H.). The Apela <SUP>H2B</SUP> <SUP>GFP</SUP> (Apela <SUP>em1.1Hadj/J</SUP>) strain of mice is available from the Jackson Laboratory Mouse Mutant Resource as JAX Stock No. 030845.	Arita Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5552; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Byrd N, 2002, DEVELOPMENT, V129, P361; Campione M, 1999, DEVELOPMENT, V126, P1225; Cortegano I, 2014, CELL DEATH DIFFER, V21, P1081, DOI 10.1038/cdd.2014.27; D'Aniello C, 2013, CARDIOVASC RES, V100, P95, DOI 10.1093/cvr/cvt166; Devic E, 1999, MECH DEVELOP, V84, P199, DOI 10.1016/S0925-4773(99)00081-7; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hassan AS, 2010, GENE EXPR PATTERNS, V10, P127, DOI 10.1016/j.gep.2010.02.001; Hazan AD, 2010, AM J PATHOL, V177, P1017, DOI 10.2353/ajpath.2010.091105; Helker CSM, 2015, ELIFE, V4, DOI 10.7554/eLife.06726; Ho L, 2017, SCIENCE; Ho LN, 2015, CELL STEM CELL, V17, DOI 10.1016/j.stem.2015.09.018; Hsu CW, 2016, DEV BIOL, V419, P229, DOI 10.1016/j.ydbio.2016.09.011; Huang CQ, 2003, DEVELOPMENT, V130, P6111, DOI 10.1242/dev.00831; Inui M, 2006, DEV BIOL, V298, P188, DOI 10.1016/j.ydbio.2006.06.028; Isern J, 2011, BLOOD, V117, P4924, DOI 10.1182/blood-2010-10-313676; Kang YJ, 2013, CIRC RES, V113, P22, DOI 10.1161/CIRCRESAHA.113.301324; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kasaai B, 2017, SCI REP-UK, V7, DOI 10.1038/srep43817; Kidoya H, 2015, DEV CELL, V33, P247, DOI 10.1016/j.devcel.2015.02.024; Koushik SV, 2001, FASEB J, V15, P1209; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Kwon GS, 2006, DEV DYNAM, V235, P2549, DOI 10.1002/dvdy.20843; Lang B, 2014, J CELL SCI, V127, P630, DOI 10.1242/jcs.137604; Li MM, 2015, CELL STEM CELL, V16, P669, DOI 10.1016/j.stem.2015.04.002; Liu ZP, 2001, DEV BIOL, V234, P497, DOI 10.1006/dbio.2001.0277; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; McGrath KE, 2003, BLOOD, V101, P1669, DOI 10.1182/blood-2002-08-2531; Palis J, 1999, DEVELOPMENT, V126, P5073; Paskaradevan S, 2012, BIOL OPEN, V1, P275, DOI 10.1242/bio.2012380; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Ryan AK, 1998, NATURE, V394, P545; Saga Y, 1999, DEVELOPMENT, V126, P3437; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Salaheldeen E, 2012, MOL REPROD DEV, V79, P843, DOI 10.1002/mrd.22123; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Tanaka Y, 2014, CELL REP, V8, P31, DOI 10.1016/j.celrep.2014.05.055; Ueyama T, 2003, J BIOL CHEM, V278, P28750, DOI 10.1074/jbc.M300014200; Venkatesh DA, 2008, CIRC RES, V103, P423, DOI 10.1161/CIRCRESAHA.108.177808; Xie J, 2009, AM J PATHOL, V175, P1315, DOI 10.2353/ajpath.2009.090094; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7	47	2	2	4	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	AUG 29	2017	20	9					2116	2130		10.1016/j.celrep.2017.08.014				15	Cell Biology	Cell Biology	FF0II	WOS:000408585000010	28854362	gold			2018-01-05	
J	Shinmyo, Y; Terashita, Y; Duong, TAD; Horiike, T; Kawasumi, M; Hosomichi, K; Tajima, A; Kawasaki, H				Shinmyo, Yohei; Terashita, Yukari; Duong, Tung Anh Dinh; Horiike, Toshihide; Kawasumi, Muneo; Hosomichi, Kazuyoshi; Tajima, Atsushi; Kawasaki, Hiroshi			Folding of the Cerebral Cortex Requires Cdk5 in Upper-Layer Neurons in Gyrencephalic Mammals	CELL REPORTS			English	Article							IN-UTERO ELECTROPORATION; LATERAL GENICULATE-NUCLEUS; CYCLIN-DEPENDENT KINASE-5; NEURAL STEM-CELLS; CORTICAL DEVELOPMENT; CEREBELLAR HYPOPLASIA; GENETIC MALFORMATIONS; SUBVENTRICULAR ZONE; FERRET CORTEX; MUTANT MICE	Folds in the cerebral cortex in mammals are believed to be key structures for accommodating increased cortical neurons in the cranial cavity. However, the mechanisms underlying cortical folding remain largely unknown, mainly because genetic manipulations for the gyrencephalic brain have been unavailable. By combining in utero electroporation and the CRISPR/Cas9 system, we succeeded in efficient gene knockout of Cdk5, which is mutated in some patients with classical lissencephaly, in the gyrencephalic brains of ferrets. We show that Cdk5 knockout in the ferret cerebral cortex markedly impaired cortical folding. Furthermore, the results obtained from the introduction of dominant-negative Cdk5 into specific cortical layers suggest that Cdk5 function in upper-layer neurons is more important for cortical folding than that in lower-layer neurons. Cdk5 inhibition induced severe migration defects in cortical neurons. Taken together, our findings suggest that the appropriate positioning of upper-layer neurons is critical for cortical folding.	[Shinmyo, Yohei; Terashita, Yukari; Duong, Tung Anh Dinh; Horiike, Toshihide; Kawasumi, Muneo; Kawasaki, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Med Neurosci, Kanazawa, Ishikawa 9208640, Japan; [Hosomichi, Kazuyoshi; Tajima, Atsushi] Kanazawa Univ, Grad Sch Adv Prevent Med Sci, Dept Bioinformat & Genom, Kanazawa, Ishikawa 9208640, Japan; [Kawasaki, Hiroshi] Kanazawa Univ, Brain Liver Interface Med Res Ctr, Kanazawa, Ishikawa 9208640, Japan	Kawasaki, H (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Med Neurosci, Kanazawa, Ishikawa 9208640, Japan.; Kawasaki, H (reprint author), Kanazawa Univ, Brain Liver Interface Med Res Ctr, Kanazawa, Ishikawa 9208640, Japan.	hiroshi-kawasaki@umin.ac.jp	Tajima, Atsushi/C-1053-2008	Tajima, Atsushi/0000-0001-6808-5491	Ministry of Education, Culture, Sports, Science and Technology-Japan; Japan Agency for Medical Research and Development; Takeda Science Foundation; Uehara Memorial Foundation; Inamori Foundation; Senri Life Science Foundation	We thank Dr. Takeshi Sakurai (Kanazawa University) for his technical support and Dr. Mikio Hoshino (National Center of Neurology and Psychiatry), Dr. Takeshi Kawauchi (Institute of Biomedical Research and Innovation), and Dr. Clifton W. Ragsdale (University of Chicago) for plasmids. We also thank Advanced Preventive Medical Sciences Research Center, Kanazawa University for the use of facilities, and Kawasaki lab members and Z. Blalock for critical discussions and comments on this manuscript. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology-Japan, Japan Agency for Medical Research and Development, the Takeda Science Foundation, the Uehara Memorial Foundation, Inamori Foundation, and the Senri Life Science Foundation.	Martinez-Martinez MA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11812; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Borrell V, 2014, CURR OPIN NEUROBIOL, V27, P39, DOI 10.1016/j.conb.2014.02.007; Boycott KM, 2005, AM J HUM GENET, V77, P477, DOI 10.1086/444400                                                                  ; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265                                                         ; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Francis F, 2006, EUR J NEUROSCI, V23, P877, DOI 10.1111/j.1460-9568.2006.04649.x; Fry AE, 2014, AM J MED GENET C, V166, P198, DOI 10.1002/ajmg.c.31402; Fujishiro T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06501; Gertz CC, 2015, J NEUROSCI, V35, P14307, DOI 10.1523/JNEUROSCI.2198-15.2015; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Guerrini R, 2006, EXP BRAIN RES, V173, P322, DOI 10.1007/s00221-006-0501-z; Hong SE, 2000, NAT GENET, V26, P93; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; Iwai L, 2009, NEUROSCIENCE, V159, P1326, DOI 10.1016/j.neuroscience.2009.02.010; Iwai L, 2013, CEREB CORTEX, V23, P2204, DOI 10.1093/cercor/bhs207; Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980; Kalebic N, 2016, EMBO REP, V17, P338, DOI 10.15252/embr.201541715; Kawasaki H, 2004, J NEUROSCI, V24, P9962, DOI 10.1523/JNEUROSCI.2165-04.2004; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kawasaki H, 2013, BIOL OPEN, V2, P95, DOI 10.1242/bio.20123160; Kawasaki H, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-24; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kerjan G, 2007, TRENDS GENET, V23, P623, DOI 10.1016/j.tig.2007.09.003; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Magen D, 2015, HUM GENET, V134, P305, DOI 10.1007/s00439-014-1522-5; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Masuda K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15370; Molnar Z, 2006, EUR J NEUROSCI, V23, P921, DOI 10.1111/j.1460-9568.2006.04611.x; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816                                                            ; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Pilz DT, 1998, HUM MOL GENET, V7, P2029, DOI 10.1093/hmg/7.13.2029; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Poluch S, 2015, CEREB CORTEX, V25, P346, DOI 10.1093/cercor/bht232; Pramparo T, 2010, J NEUROSCI, V30, P3002, DOI 10.1523/JNEUROSCI.4851-09.2010; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; RICHMAN DP, 1975, SCIENCE, V189, P18; Kelava I, 2013, EMBO J, V7, P16; Sharma P, 1999, P NATL ACAD SCI USA, V96, P11156, DOI 10.1073/pnas.96.20.11156; Shinmyo Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20611; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707; Sunagawa GA, 2016, CELL REP, V14, P662, DOI 10.1016/j.celrep.2015.12.052; Toda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep29578; Toda T, 2013, DEV CELL, V27, P32, DOI 10.1016/j.devcel.2013.09.002; TSAI LH, 1993, DEVELOPMENT, V119, P1029; Wakimoto M, 2015, CEREB CORTEX, V25, P3535, DOI 10.1093/cercor/bhu197; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7                                                   ; Ware ML, 1999, CEREB CORTEX, V9, P636, DOI 10.1093/cercor/9.6.636                                                          ; White LE, 1999, J NEUROSCI, V19, P7089; Wynshaw-Boris A, 2007, CLIN GENET, V72, P296, DOI 10.1111/j.1399-0004.2007.00888.x; Zecevic N, 2005, J COMP NEUROL, V491, P109, DOI 10.1002/cne.20714; Zilles K, 2013, TRENDS NEUROSCI, V36, P275, DOI 10.1016/j.tins.2013.01.006	62	1	1	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	AUG 29	2017	20	9					2131	2143		10.1016/j.celrep.2017.08.024				13	Cell Biology	Cell Biology	FF0II	WOS:000408585000011	28854363	gold			2018-01-05	
J	Roumeliotis, TI; Williams, SP; Goncalves, E; Alsinet, C; Velasco-Herrera, MD; Aben, N; Ghavidel, FZ; Michaut, M; Schubert, M; Price, S; Wright, JC; Yu, L; Yang, M; Dienstmann, R; Guinney, J; Beltrao, P; Brazma, A; Pardo, M; Stegle, O; Adams, DJ; Wessels, L; Saez-Rodriguez, J; McDermott, U; Choudhary, JS				Roumeliotis, Theodoros I.; Williams, Steven P.; Goncalves, Emanuel; Alsinet, Clara; Velasco-Herrera, Martin Del Castillo; Aben, Nanne; Ghavidel, Fatemeh Zamanzad; Michaut, Magali; Schubert, Michael; Price, Stacey; Wright, James C.; Yu, Lu; Yang, Mi; Dienstmann, Rodrigo; Guinney, Justin; Beltrao, Pedro; Brazma, Alvis; Pardo, Mercedes; Stegle, Oliver; Adams, David J.; Wessels, Lodewyk; Saez-Rodriguez, Julio; McDermott, Ultan; Choudhary, Jyoti S.			Genomic Determinants of Protein Abundance Variation in Colorectal Cancer Cells	CELL REPORTS			English	Article							PROTEOGENOMIC CHARACTERIZATION; MICROSATELLITE INSTABILITY; HUMAN INTERACTOME; DRUG-SENSITIVITY; GENE; EXPRESSION; NETWORKS; UPDATE; LINES; DIFFERENTIATION	Assessing the impact of genomic alterations on protein networks is fundamental in identifying the mechanisms that shape cancer heterogeneity. We have used isobaric labeling to characterize the proteomic landscapes of 50 colorectal cancer cell lines and to decipher the functional consequences of somatic genomic variants. The robust quantification of over 9,000 proteins and 11,000 phosphopeptides on average enabled the de novo construction of a functional protein correlation network, which ultimately exposed the collateral effects of mutations on protein complexes. CRISPR-cas9 deletion of key chromatin modifiers confirmed that the consequences of genomic alterations can propagate through protein interactions in a transcript-independent manner. Lastly, we leveraged the quantified proteome to perform unsupervised classification of the cell lines and to build predictive models of drug response in colorectal cancer. Overall, we provide a deep integrative view of the functional network and the molecular structure underlying the heterogeneity of colorectal cancer cells.	[Roumeliotis, Theodoros I.; Williams, Steven P.; Alsinet, Clara; Velasco-Herrera, Martin Del Castillo; Price, Stacey; Wright, James C.; Yu, Lu; Pardo, Mercedes; Adams, David J.; McDermott, Ultan; Choudhary, Jyoti S.] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Goncalves, Emanuel; Ghavidel, Fatemeh Zamanzad; Schubert, Michael; Beltrao, Pedro; Brazma, Alvis; Stegle, Oliver; Saez-Rodriguez, Julio] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Wellcome Genome Campus, Cambridge CB10 1SD, England; [Yang, Mi; Saez-Rodriguez, Julio] Rhein Westfal TH Aachen, Joint Res Ctr Computat Biomed, Fac Med, D-52057 Aachen, Germany; [Aben, Nanne; Michaut, Magali; Wessels, Lodewyk] Netherlands Canc Inst, Div Mol Carcinogenesis, Computat Canc Biol, NL-1066 Amsterdam, Netherlands; [Wessels, Lodewyk] Delft Univ Technol, Fac EEMCS, NL-2628 Delft, Netherlands; [Dienstmann, Rodrigo; Guinney, Justin] Fred Hutchinson Canc Res Ctr, Computat Oncol, Sage Bionetworks, Seattle, WA 98109 USA; [Dienstmann, Rodrigo] Vall dHebron Inst Oncol, Oncol Data Sci Grp, Barcelona 08035, Spain; [Choudhary, Jyoti S.] Inst Canc Res, Funct Prote Grp, Chester Beatty Labs, London SW3 6JB, England	Roumeliotis, TI; Choudhary, JS (reprint author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England.; Choudhary, JS (reprint author), Inst Canc Res, Funct Prote Grp, Chester Beatty Labs, London SW3 6JB, England.	tr6@sanger.ac.uk; jc4@sanger.ac.uk	Choudhary, Jyoti/S-1232-2017	Choudhary, Jyoti/0000-0003-0881-5477; Pardo, Mercedes/0000-0002-3477-9695; Saez-Rodriguez, Julio/0000-0002-8552-8976; Beltrao, Pedro/0000-0002-2724-7703; Williams, Steven/0000-0002-9382-4337	Wellcome Trust [098051]; European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC synergy grant [319661 COMBATCANCER]; Merck KGaA, Darmstadt, Germany	The work performed at the Sanger Institute was funded by a core grant from the Wellcome Trust (098051). S.P.W., C.A., D.J.A., N.A., M.M., and L.W. are funded by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC synergy grant agreement no. 319661 COMBATCANCER. The work of R.D. and J.G. was supported in part by the Merck KGaA, Darmstadt, Germany (Grant for Oncology Innovation 2015). We thank Christoph Schlaffner for generating the data file formats compatible with genomic browsers and the Expression Atlas team for making the proteomics data publicly available in Expression Atlas and ArrayExpress repositories. We would like to thank members of the Cancer Genome Project for helpful discussions and Sarah A. Teichmann for discussions and general suggestions about the manuscript.	Aken BL, 2017, NUCLEIC ACIDS RES, V45, pD635, DOI 10.1093/nar/gkw1104; Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Beltrao P, 2013, MOL SYST BIOL, V9, DOI 10.1002/msb.201304521; Bertorelle R, 1996, J CLIN PATHOL-CL MOL, V49, pM85; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI 10.1053/j.gastro.2009.12.064; Cairns BR, 2001, TRENDS CELL BIOL, V11, pS15, DOI 10.1016/S0962-8924(01)82074-2; Chan CWM, 2009, P NATL ACAD SCI USA, V106, P1936, DOI 10.1073/pnas.0812904106; Chen WH, 2017, NUCLEIC ACIDS RES, V45, pD940, DOI 10.1093/nar/gkw1013; Chen ZL, 2016, CANCER LETT, V370, P153, DOI 10.1016/j.canlet.2015.10.010; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Davis MA, 2013, GENE DEV, V27, P151, DOI 10.1101/gad.207720.112; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; DIX B, 1994, BRIT J CANCER, V70, P585, DOI 10.1038/bjc.1994.355; Forester CM, 2007, P NATL ACAD SCI USA, V104, P19867, DOI 10.1073/pnas.0709879104; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hodges C, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026930; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Jones MF, 2015, P NATL ACAD SCI USA, V112, pE1550, DOI 10.1073/pnas.1503370112; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lei M, 2001, J CELL SCI, V114, P1447; Li J, 2017, CANCER CELL, V31, P225, DOI 10.1016/j.ccell.2017.01.005; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Medico E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8002; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Ochoa D, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20167295; Ohta S, 2003, J BIOL CHEM, V278, P41535, DOI 10.1074/jbc.M307535200; Petryszak R, 2016, NUCLEIC ACIDS RES, V44, pD746, DOI 10.1093/nar/gkv1045; Petsalaki E, 2015, NUCLEIC ACIDS RES, V43, pW276, DOI 10.1093/nar/gkv459; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.186; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Stefely JA, 2016, NAT BIOTECHNOL, V34, P1191, DOI 10.1038/nbt.3683; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thompson M, 2009, BIOCHIMIE, V91, P309, DOI 10.1016/j.biochi.2008.10.019; Wang J, 2017, MOL CELL PROTEOMICS, V16, P121, DOI 10.1074/mcp.M116.060301; Wickramasinghe VO, 2015, NAT REV MOL CELL BIO, V16, P431, DOI 10.1038/nrm4010; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhang H, 2016, CELL, V166, P755, DOI 10.1016/j.cell.2016.05.069	54	0	0	7	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	AUG 29	2017	20	9					2201	2214		10.1016/j.celrep.2017.08.010				14	Cell Biology	Cell Biology	FF0II	WOS:000408585000016	28854368	gold			2018-01-05	
J	Fu, SZ; Hiley, L; Octavia, S; Tanaka, MM; Sintchenko, V; Lan, RT				Fu, Songzhe; Hiley, Lester; Octavia, Sophie; Tanaka, Mark M.; Sintchenko, Vitali; Lan, Ruiting			Comparative genomics of Australian and international isolates of Salmonella Typhimurium: correlation of core genome evolution with CRISPR and prophage profiles	SCIENTIFIC REPORTS			English	Article							ENTERICA SEROVAR TYPHIMURIUM; CAS SYSTEMS; PHAGE TYPES; VIRULENCE; GENES; SURVEILLANCE; ENTERITIDIS; OUTBREAK; EFFECTOR; MICE	Salmonella enterica subsp enterica serovar Typhimurium (S. Typhimurium) is a serovar with broad host range. To determine the genomic diversity of S. Typhimurium, we sequenced 39 isolates (37 Australian and 2 UK isolates) representing 14 Repeats Groups (RGs) determined primarily by clustered regularly interspaced short palindromic repeats (CRISPR). Analysis of single nucleotide polymorphisms (SNPs) among the 39 isolates yielded an average of 1,232 SNPs per isolate, ranging from 128 SNPs to 11,339 SNPs relative to the reference strain LT2. Phylogenetic analysis of the 39 isolates together with 66 publicly available genomes divided the 105 isolates into five clades and 19 lineages, with the majority of the isolates belonging to clades I and II. The composition of CRISPR profiles correlated well with the lineages, showing progressive deletion and occasional duplication of spacers. Prophage genes contributed nearly a quarter of the S. Typhimurium accessory genome. Prophage profiles were found to be correlated with lineages and CRISPR profiles. Three new variants of HP2-like P2 prophage, several new variants of P22 prophage and a plasmid-like genomic island StmGI_0323 were found. This study presents evidence of horizontal transfer from other serovars or species and provides a broader understanding of the global genomic diversity of S. Typhimurium.	[Fu, Songzhe; Octavia, Sophie; Tanaka, Mark M.; Lan, Ruiting] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Hiley, Lester] Forens & Sci Serv, Queensland Dept Hlth, Publ Hlth Microbiol Lab, Brisbane, Qld, Australia; [Sintchenko, Vitali] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Sintchenko, Vitali] Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Inst Clin Pathol & Med Res, Sydney, NSW, Australia	Lan, RT (reprint author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	r.lan@unsw.edu.au			National Health and Medical Research Council of Australia; UNSW Early Career Research grant; UNSW international postgraduate research award; Australian Research Council Future Fellowship	This work was supported by a grant from the National Health and Medical Research Council of Australia and a UNSW Early Career Research grant. SF was supported by a UNSW international postgraduate research award. MT was supported by an Australian Research Council Future Fellowship.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Allison GE, 2003, VIROLOGY, V308, P114, DOI 10.1016/S0042-6822(03)00198-3; ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187                                                       ; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Balbontin R, 2008, J BACTERIOL, V190, P4075, DOI 10.1128/JB.00220-08; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Brown NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017824; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Delcher A. L., 2003, CURR PROTOC BIOINFOR, V10; Deng XY, 2015, J CLIN MICROBIOL, V53, P212, DOI 10.1128/JCM.02332-14; Fabre L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036995; Figueroa-Bossi N, 1999, MOL MICROBIOL, V33, P167, DOI 10.1046/j.1365-2958.1999.01461.x; Fu SZ, 2015, J CLIN MICROBIOL, V53, P2530, DOI 10.1128/JCM.03407-14; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854                                                          ; Gao XF, 2013, CELL HOST MICROBE, V13, P87, DOI 10.1016/j.chom.2012.11.010; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hawkey J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-800; Hayden HS, 2016, MBIO, V7, DOI 10.1128/mBio.00154-16; Hiley L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086203; Liu FY, 2011, APPL ENVIRON MICROB, V77, P4520, DOI 10.1128/AEM.00468-11; Liu FY, 2011, APPL ENVIRON MICROB, V77, P1946, DOI 10.1128/AEM.02625-10; Lopez CA, 2012, MBIO, V3, DOI 10.1128/mBio.00143-12; Mather AE, 2016, APPL ENVIRON MICROB, V82, P6728, DOI 10.1128/AEM.01660-16; Mohammed Manal, 2015, BMC Res Notes, V8, P728, DOI 10.1186/s13104-015-1687-6; Octavia S, 2015, J CLIN MICROBIOL, V53, P1063, DOI 10.1128/JCM.03235-14; Octavia S, 2010, J CLIN MICROBIOL, V48, P3504, DOI 10.1128/JCM.00709-10; Pang S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-718; Pang S, 2012, J CLIN MICROBIOL, V50, P727, DOI 10.1128/JCM.01284-11; Pettengill JB, 2014, PEERJ, V2, DOI 10.7717/peerj.340; Saitoh M, 2005, MICROBIOL-SGM, V151, P3089, DOI 10.1099/mic.0.27933-0; Shariat N, 2015, MICROBIOL-SGM, V161, P374, DOI 10.1099/mic.0.000005; Switt AIM, 2015, METHODS MOL BIOL, V1225, P237, DOI 10.1007/978-1-4939-1625-2_15; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Villafane R, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-227; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Williams BJ, 2002, J BACTERIOL, V184, P6893, DOI 10.1128/JB.184.24.6893-6905.2002; Zeng HY, 2017, SCI REP-UK, V7, DOI 10.1038/srep40206; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	42	0	0	8	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 29	2017	7								9733	10.1038/s41598-017-06079-1				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FE9QJ	WOS:000408537900015	28851865	gold			2018-01-05	
J	Tian, YL; Yang, CJ; Shang, SJ; Cai, YJ; Deng, XF; Zhang, J; Shao, F; Zhu, DS; Liu, YB; Chen, GQ; Liang, J; Sun, Q; Qiu, ZL; Zhang, C				Tian, Yonglu; Yang, Chaojuan; Shang, Shujiang; Cai, Yijun; Deng, Xiaofei; Zhang, Jian; Shao, Feng; Zhu, Desheng; Liu, Yunbo; Chen, Guiquan; Liang, Jing; Sun, Qiang; Qiu, Zilong; Zhang, Chen			Loss of FMRP Impaired Hippocampal Long-Term Plasticity and Spatial Learning in Rats	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						FXS; hippocampus; long-term plasticity; spatial learning; intellectual disability	FRAGILE-X-SYNDROME; SPONTANEOUSLY HYPERTENSIVE-RAT; MENTAL-RETARDATION PROTEIN; KNOCKOUT MICE; MOUSE MODEL; SYNAPTIC PLASTICITY; SOCIAL-BEHAVIOR; POTENTIATION; GENE; EXPRESSION	Fragile X syndrome (FXS) is a neurodevelopmental disorder caused by mutations in the FMR1 gene that inactivate expression of the gene product, the fragile X mental retardation 1 protein (FMRP). In this study, we used clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) technology to generate Fmr1 knockout (KO) rats by disruption of the fourth exon of the Fmr1 gene. Western blotting analysis confirmed that the FMRP was absent from the brains of the Fmr1 KO rats (Fmr1(exon4-KO)). Electrophysiological analysis revealed that the theta-burst stimulation (TBS)-induced long-term potentiation (LTP) and the low-frequency stimulus (LFS)-induced long-term depression (LTD) were decreased in the hippocampal Schaffer collateral pathway of the Fmr1(exon4-KO) rats. Short-term plasticity, measured as the paired-pulse ratio, remained normal in the KO rats. The synaptic strength mediated by the a -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) was also impaired. Consistent with previous reports, the Fmr1(exon4-KO) rats demonstrated an enhanced 3,5-dihydroxyphenylglycine (DHPG)-induced LTD in the present study, and this enhancement is insensitive to protein translation. In addition, the Fmr1(exon4-KO) rats showed deficits in the probe trial in the Morris water maze test. These results demonstrate that deletion of the Fmr1 gene in rats specifically impairs long-term synaptic plasticity and hippocampus-dependent learning in a manner resembling the key symptoms of FXS. Furthermore, the Fmr1(exon4-KO) rats displayed impaired social interaction and macroorchidism, the results consistent with those observed in patients with FXS. Thus, Fmr1exon4 KO rats constitute a novel rat model of FXS that complements existing mouse models.	[Tian, Yonglu; Yang, Chaojuan; Shang, Shujiang; Zhang, Jian; Zhu, Desheng; Zhang, Chen] Peking Univ, State Key Lab Membrane Biol, Sch Life Sci, Peking Univ IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Tian, Yonglu] Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Cai, Yijun; Sun, Qiang; Qiu, Zilong] Chinese Acad Sci, Inst Neurosci, CAS Key Lab Primate Neurobiol, Shanghai, Peoples R China; [Deng, Xiaofei; Liang, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing, Peoples R China; [Shao, Feng] Peking Univ, Dept Psychol, Beijing, Peoples R China; [Liu, Yunbo] Chinese Acad Med Sci, Peking Union Med Coll, Inst Lab Anim Sci, Beijing, Peoples R China; [Chen, Guiquan] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China; [Zhang, Chen] Peking Univ, Key Lab Neurosci, Minist Educ, Natl Hlth & Family Planning Commiss, Beijing, Peoples R China	Zhang, C (reprint author), Peking Univ, State Key Lab Membrane Biol, Sch Life Sci, Peking Univ IDG McGovern Inst Brain Res, Beijing, Peoples R China.; Sun, Q; Qiu, ZL (reprint author), Chinese Acad Sci, Inst Neurosci, CAS Key Lab Primate Neurobiol, Shanghai, Peoples R China.; Liang, J (reprint author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing, Peoples R China.; Zhang, C (reprint author), Peking Univ, Key Lab Neurosci, Minist Educ, Natl Hlth & Family Planning Commiss, Beijing, Peoples R China.	liangj@psych.ac.cn; qsun@ion.ac.cn; zqiu@ion.ac.cn; ch.zhang@pku.edu.cn			National Key Research and Development Program of China [2017YFA0105201, 2012YQ03026004, 2014CB942804]; National Science Foundation of China [31670842]; Beijing Municipal Science and Technology Commission [Z161100002616021, Z161100000216154]; Seeding Grant for Medicine and Life Sciences of Peking University [2014-MB-11]	This work was supported by grants from the National Key Research and Development Program of China (2017YFA0105201, 2012YQ03026004 and 2014CB942804), the National Science Foundation of China (31670842), Beijing Municipal Science and Technology Commission (Z161100002616021, Z161100000216154), and the Seeding Grant for Medicine and Life Sciences of Peking University (Grant 2014-MB-11).	ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; Bailey EL, 2011, INT J STROKE, V6, P434, DOI 10.1111/j.1747-4949.2011.00659.x; Baker H., 1979, LAB RAT; Baker KB, 2010, GENES BRAIN BEHAV, V9, P562, DOI 10.1111/j.1601-183X.2010.00585.x; Bakker CE, 2000, EXP CELL RES, V258, P162, DOI 10.1006/excr.2000.4932; BAKKER CE, 1994, CELL, V78, P23; Berzhanskaya J, 2017, CEREB CORTEX, V27, P1386, DOI 10.1093/cercor/bhv331; Berzhanskaya J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30769; Bontekoe CJM, 2001, HUM MOL GENET, V10, P1693, DOI 10.1093/hmg/10.16.1693; Bostrom CA, 2015, CEREB CORTEX, V25, P271, DOI 10.1093/cercor/bht237; Chung W, 2015, NAT NEUROSCI, V18, P435, DOI [10.1038/n.3927, 10.1038/nn.3927]; Cohen D, 2005, J AUTISM DEV DISORD, V35, P103, DOI 10.1007/s10803-004-1038-2; Demark JL, 2003, AM J MENT RETARD, V108, P314, DOI 10.1352/0895-8017(2003)108<314:BRBAAF>2.0.CO;2; deVries BBA, 1997, AM J HUM GENET, V61, P660, DOI 10.1086/515496; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; DHooge R, 1997, NEUROSCIENCE, V76, P367, DOI 10.1016/S0306-4522(96)00224-2; Engineer CT, 2014, BRAIN RES, V1564, P72, DOI 10.1016/j.brainres.2014.03.049; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; Godfraind JM, 1996, AM J MED GENET, V64, P246; Hagerman R J, 1987, Curr Probl Pediatr, V17, P621; Hall SS, 2008, J ABNORM CHILD PSYCH, V36, P927, DOI 10.1007/s10802-008-9223-y; Hamilton SM, 2014, BEHAV NEUROSCI, V128, P103, DOI 10.1037/a0035988; Hatton DD, 2006, AM J MED GENET A, V140A, P1804, DOI 10.1002/ajmg.a.31286; Heitzer AM, 2013, J AUTISM DEV DISORD, V43, P1452, DOI 10.1007/s10803-012-1670-1; Hu HL, 2008, J NEUROSCI, V28, P7847, DOI 10.1523/JNEUROSCI.1496-08.2008; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Jia ZP, 2001, PHYSIOL BEHAV, V73, P793, DOI 10.1016/S0031-9384(01)00516-9; Kaufmann WE, 2002, MICROSC RES TECHNIQ, V57, P135, DOI 10.1002/jemt.10066; Kazdoba TM, 2014, INTRACTABLE RARE DIS, V3, P118, DOI 10.5582/irdr.2014.01024; Kerkerian-Le Goff L, 2009, BRAIN RES BULL, V78, P80, DOI 10.1016/j.brainresbull.2008.08.010; Koga K, 2015, J NEUROSCI, V35, P2033, DOI 10.1523/JNEUROSCI.2644-14.2015; Kooy RF, 1996, AM J MED GENET, V64, P241, DOI 10.1002/(SICI)1096-8628(19960809)64:2<241::AID-AJMG1>3.0.CO;2-X; Li JX, 2002, MOL CELL NEUROSCI, V19, P138, DOI 10.1006/mcne.2001.1085; Liao SJ, 2013, J NEUROL SCI, V334, P1, DOI 10.1016/j.jns.2013.07.2517; Liu ZH, 2009, NEUROSCI LETT, V454, P62, DOI 10.1016/j.neulet.2009.02.066; Lo SC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18335; Lozano R, 2016, INTRACTABLE RARE DIS, V5, P145, DOI 10.5582/irdr.2016.01048; Lu YM, 1997, J NEUROSCI, V17, P5196; Martin JR, 2008, CURR OPIN OBSTET GYN, V20, P216, DOI 10.1097/GCO.0b013e3282fe7254; McNaughton CH, 2008, BEHAV NEUROSCI, V122, P293, DOI 10.1037/0735-7044A22.2.293; Melani A, 2010, ANN NY ACAD SCI, V1207, P89, DOI 10.1111/j.1749-6632.2010.05732.x; Mientjes EJ, 2006, NEUROBIOL DIS, V21, P549, DOI 10.1016/j.nbd.2005.08.019; Mines MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009706; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Nabika T, 2012, HYPERTENS RES, V35, P477, DOI 10.1038/hr.2012.30; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; NostenBertrand M, 1996, NATURE, V379, P826, DOI 10.1038/379826a0; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Paradee W, 1999, NEUROSCIENCE, V94, P185, DOI 10.1016/S0306-4522(99)00285-7; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145                                                            ; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I                                                    ; Ruby K, 2015, NEUROSCIENCE, V303, P285, DOI 10.1016/j.neuroscience.2015.06.061; Russo E, 2013, NEUROPHARMACOLOGY, V64, P371, DOI 10.1016/j.neuropharm.2012.06.039; Saldarriaga W, 2014, COLOMB MEDICA, V45, P190; SCHENK F, 1985, EXP BRAIN RES, V58, P11; Shang YZ, 2009, J NEUROCHEM, V111, P635, DOI 10.1111/j.1471-4159.2009.06314.x; Sidorov MS, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-15; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U                                                    ; Skinner M, 2005, AM J MED GENET A, V132A, P25, DOI 10.1002/ajmg.a.30353; Spencer CA, 2008, BEHAV NEUROSCI, V122, P710, DOI 10.1037/0735-7044.122.3.710; Tayebati SK, 2012, J NEUROL SCI, V322, P241, DOI 10.1016/j.jns.2012.05.047; Terry AV, 2009, FRONT NEUROSCI, P267; Till SM, 2015, HUM MOL GENET, V24, P5977, DOI 10.1093/hmg/ddv299; Uutela M, 2012, GENES BRAIN BEHAV, V11, P513, DOI 10.1111/j.1601-183X.2012.00784.x; Wei MP, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00055; Wei MP, 2016, P NATL ACAD SCI USA, V113, pE2695, DOI 10.1073/pnas.1524589113; Xu XJ, 2015, PHYSIOL BEHAV, V138, P13, DOI 10.1016/j.physbeh.2014.09.014; Yan QJ, 2004, GENES BRAIN BEHAV, V3, P337, DOI 10.1111/j.1601-183X.2004.00087.x; Yun SH, 2011, J NEUROSCI RES, V89, P176, DOI 10.1002/jnr.22546; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhang DW, 2010, J NEUROCHEM, V115, P1215, DOI 10.1111/j.1471-4159.2010.07011.x; Zhang J, 2009, J NEUROPHYSIOL, V101, P2572, DOI 10.1152/jn.90558.2008	72	1	1	6	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	AUG 28	2017	10								269	10.3389/fnmol.2017.00269				14	Neurosciences	Neurosciences & Neurology	FF5UV	WOS:000409065700001	28894415	gold			2018-01-05	
J	Goetze, RW; Kim, DH; Schinazi, RF; Kim, B				Goetze, Russell W.; Kim, Dong-Hyun; Schinazi, Raymond F.; Kim, Baek			A CRISPR/Cas9 approach reveals that the polymerase activity of DNA polymerase is dispensable for HIV-1 infection in dividing and nondividing cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; DNA repair; human immunodeficiency virus (HIV); macrophage; nucleotide; DNA polymerase; integration	HUMAN-IMMUNODEFICIENCY-VIRUS; BASE-EXCISION-REPAIR; REVERSE TRANSCRIPTASES; INDUCED APOPTOSIS; LEUKEMIA-VIRUS; BETA; INTEGRATION; SAMHD1; TYPE-1; CYCLE	Retrovirus integration into the host genome relies on several host enzymes, potentially including DNA polymerase (Pol ). However, whether human Pol is essential for lentivirus replication in human cells is unclear. Here, we abolished DNA polymerase (Pol ) expression by targeting its DNA polymerase domain with CRISPR/Cas9 in human monocytic THP-1 cells to investigate the role of Pol in HIV-1 transduction in both dividing and nondividing macrophage stages of THP-1 cells. Pol -knock-out was confirmed by enhanced sensitivity to methyl methanesulfonate-induced DNA damage. Of note, nuclear extracts from Pol -knock-out THP-1 cells prepared from both dividing and nondividing stages displayed significantly reduced capability to repair the gapped HIV-1 integration intermediate DNA substrate in a biochemical simulation. However, nuclear extract from both dividing and nondividing stages of the Pol -KO cells had detectable gap repair activity, suggesting that other host DNA polymerases also repair gapped HIV-1 DNA, particularly in dividing cells. Next, when we compared transduction using HIV-1 and simian immunodeficiency virus in control and Pol -KO cells, the loss of the Pol expression did not affect transduction efficiency of these lentiviruses in both dividing and nondividing stages. Finally, the gap repair assay indicated that limited cellular dNTP pools, but not Pol expression, are a primary factor for HIV-1 DNA gap repair, particularly in nondividing cells. These data support the idea that Pol polymerase activity is dispensable for HIV-1 infection in both dividing and nondividing stages of human cells targeted by the virus.	[Goetze, Russell W.; Schinazi, Raymond F.; Kim, Baek] Emory Univ, Dept Pediat, Ctr Drug Discovery, Atlanta, GA 30322 USA; [Kim, Dong-Hyun; Kim, Baek] Kyung Hee Univ, Sch Pharm, Seoul 2447, South Korea; [Kim, Baek] Childrens Healthcare Atlanta, Atlanta, GA 30329 USA	Kim, B (reprint author), 1760 Haygood Dr, Atlanta, GA 30322 USA.	baek.kim@emory.edu			National Institutes of Health [GM104198, AI049781, MH100999, T32-GM008602]	This work was supported, in whole or in part, by National Institutes of Health Grants GM104198 (to B. K.), AI049781 (to B. K.), MH100999 (to R. F. S), and T32-GM008602 (to R. W. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abmayr S. M., 2006, CURR PROTOC MOL BIOL; Allinson SL, 2001, EMBO J, V20, P6919, DOI 10.1093/emboj/20.23.6919; Andersen JL, 2006, PLOS PATHOG, V2, P1106, DOI 10.1371/journal.ppat.0020127; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Bennett GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103164; Bonifati S, 2016, VIROLOGY, V495, P92, DOI 10.1016/j.virol.2016.05.002; Braithwaite EK, 2005, J BIOL CHEM, V280, P18469, DOI 10.1074/jbc.M411864200; Brin E, 2000, J BIOL CHEM, V275, P39287, DOI 10.1074/jbc.M006929200; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339                                                          ; Choi JY, 2006, J BIOL CHEM, V281, P12315, DOI 10.1074/jbc.M600112200; COFFIN JM, 1997, RETROVIRUSES; Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499; Dalal S, 2008, NUCLEIC ACIDS RES, V36, P411, DOI 10.1093/nar/gkm1053; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Espeseth AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017612; FORNACE AJ, 1989, MOL CELL BIOL, V9, P851, DOI 10.1128/MCB.9.2.851                                                             ; FUJIWARA T, 1988, CELL, V54, P497, DOI 10.1016/0092-8674(88)90071-2; Garcia-Diaz M, 2001, J BIOL CHEM, V276, P34659, DOI 10.1074/jbc.M106336200; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; HE JL, 1995, J VIROL, V69, P6705; HOTTIGER M, 1994, J BIOL CHEM, V269, P986; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; LEWIS PF, 1994, J VIROL, V68, P510; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; MENEGAZZI M, 1992, FEBS LETT, V310, P135, DOI 10.1016/0014-5793(92)81314-C                                                    ; Nishida M, 2008, FOOD CHEM, V108, P551, DOI 10.1016/j.foodchem.2007.11.007; Ochs K, 1999, CANCER RES, V59, P1544; Operario DJ, 2005, VIROLOGY, V335, P106, DOI 10.1016/j.virol.2005.02.010; Roe T, 1997, J VIROL, V71, P1334; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SCHINAZI RF, 1989, ANTIMICROB AGENTS CH, V33, P115, DOI 10.1128/AAC.33.1.115                                                            ; Schmitt MW, 2010, J BIOL CHEM, V285, P32264, DOI 10.1074/jbc.M110.147017; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Skasko M, 2005, J BIOL CHEM, V280, P12190, DOI 10.1074/jbc.M412859200; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; SUZUKI H, 1991, BIOCHEM BIOPH RES CO, V181, P623, DOI 10.1016/0006-291X(91)91236-6; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Tanaka H, 2000, NATURE, V404, P42; Van Cor-Hosmer SK, 2013, J BIOL CHEM, V288, P33253, DOI 10.1074/jbc.M113.486787; WANG LM, 1992, CANCER RES, V52, P4824; Wilkinson TA, 2009, J BIOL CHEM, V284, P7931, DOI 10.1074/jbc.M806241200; Yamtich J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003052; Yamtich J, 2010, BBA-PROTEINS PROTEOM, V1804, P1136, DOI 10.1016/j.bbapap.2009.07.008; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000                                              ; Yoder KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017862	52	0	0	9	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14016	14025		10.1074/jbc.M117.793661				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FE8FA	WOS:000408439800010	28684413				2018-01-05	
J	Majumdar, I; Ahuja, V; Paul, J				Majumdar, Ishani; Ahuja, Vineet; Paul, Jaishree			Altered expression of Tumor Necrosis Factor Alpha -Induced Protein 3 correlates with disease severity in Ulcerative Colitis	SCIENTIFIC REPORTS			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; EDITING ENZYME A20; COLORECTAL-CANCER; GENE-EXPRESSION; NITRIC-OXIDE; INTESTINAL INFLAMMATION; TRANSCRIPTION FACTOR; MESSENGER-RNA; E3 LIGASE	Ulcerative colitis (UC), an inflammatory disorder of the colon arises from dysregulated immune response towards gut microbes. Transcription factor NF kappa B is a major regulatory component influencing mucosal inflammation. We evaluated expression of Tumor Necrosis Factor Alpha Induced Protein3 (TNFAIP3), the inhibitor of NF kappa B activation and its associated partners ITCH, RNF11 and Tax1BP1 in inflamed mucosa of UC patients. We found highly significant up-regulated mRNA expression of TNFAIP3 that negatively correlated with disease activity in UC. mRNA levels of ITCH, RNF11 and Tax1BP1 were significantly down-regulated. Significant positive correlation with disease activity was noted for Tax1BP1. All four genes showed significant down-regulation at protein level. mRNA levels of inducers of TNFAIP3 expression, NF kappa B p65 subunit and MAST3 was determined. There was significant increase in p65 mRNA expression and down-regulated MAST3 expression. This suggested that increase in NF kappa B expression regulates TNFAIP3 levels. Deficiency of TNFAIP3 expression resulted in significant up-regulation of NF kappa B p65 sub-unit as well as its downstream genes such as iNOS, an inflammatory marker, inhibitors of apoptosis like cIAP2 and XIAP and mediators of anti-apoptotic signals TRAF1 and TRAF2. Taken together, decreased expression of TNFAIP3 and its partners contribute to inflammation and up-regulation of apoptosis inhibitors that may create microenvironment for colorectal cancer.	[Majumdar, Ishani; Paul, Jaishree] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi, India; [Ahuja, Vineet] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India	Paul, J (reprint author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi, India.	jpaul33@hotmail.com			Council of Scientific and Industrial Research, New Delhi; DST Purse II [(54)/SLS/JP/DST PURSE/2016-17]; UGC [05/59738-2]	We acknowledge the subjects who contributed biopsy samples for this study. IM is thankful to Council of Scientific and Industrial Research, New Delhi for research fellowship. The research was supported by the umbrella research grant from DST Purse II (File no. (54)/SLS/JP/DST PURSE/2016-17) and UGC Resource Networking Grant No. 05/59738-2.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Arsenescu R, 2008, MUCOSAL IMMUNOL, V1, P399, DOI 10.1038/mi.2008.32; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649                                                   ; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Chanudet E, 2010, LEUKEMIA, V24, P483, DOI 10.1038/leu.2009.234; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373                                                                ; Coskun M, 2013, WORLD J GASTROENTERO, V19, P4289, DOI 10.3748/wjg.v19.i27.4289; Dagenais M, 2016, MUCOSAL IMMUNOL, V9, P146, DOI 10.1038/mi.2015.46; Dignass A, 2012, J CROHNS COLITIS, V6, P991, DOI 10.1016/j.crohns.2012.09.002; Elsby LM, 2010, CLIN EXP RHEUMATOL, V28, P708; [Anonymous], 2007, NATURE, V447, P661, DOI DOI 10.1038/NATURE05911; Guo Z, 2012, P NATL ACAD SCI USA, V109, P5826, DOI 10.1073/pnas.1118118109; Hart LA, 1998, AM J RESP CRIT CARE, V158, P1585, DOI 10.1164/ajrccm.158.5.9706116                                                    ; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Ho E, 1999, P SOC EXP BIOL MED, V222, P205, DOI 10.1046/j.1525-1373.1999.d01-137.x; Huang TT, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0493-7; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Jaattela M, 1996, J IMMUNOL, V156, P1166; Jiang XB, 2012, CLIN VACCINE IMMUNOL, V19, P1938, DOI 10.1128/CVI.00500-12; Kawasaki A., 2010, J BIOMED BIOTECHNOL, V2010, DOI [10.1155/2010/207578, DOI 10.1155/2010/207578]; Kelly C, 2013, J CYST FIBROS, V12, P411, DOI 10.1016/j.jcf.2012.10.009; Kelly C, 2011, AM J RESP CELL MOL, V44, P743, DOI 10.1165/rcmb.2010-0339TR; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Kitching R, 2003, BBA-MOL BASIS DIS, V1639, P104, DOI 10.1016/j.nnadis.2003.07.001; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; Kolodziej LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026352; Labbe C, 2008, GENES IMMUN, V9, P602, DOI 10.1038/gene.2008.57; Labbe C, 2012, INFLAMM BOWEL DIS, V18, P1072, DOI 10.1002/ibd.21887; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodolce JP, 2010, J IMMUNOL, V184, P7001, DOI 10.4049/jimmunol.1000324; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Matesic LE, 2008, CURR TOP MICROBIOL, V321, P185; Mirza AH, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0162-2; Nakano S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073205; Nguyen D. H., 2013, CANC INCYTES, V2, P1; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4                                                   ; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Qiao YQ, 2013, J DIGEST DIS, V14, P244, DOI 10.1111/1751-2980.12044; Ray G, 2016, WORLD J GASTROENTERO, V22, P8123, DOI 10.3748/wjg.v22.i36.8123; Roda G, 2010, WORLD J GASTROENTERO, V16, P4264, DOI 10.3748/wjg.v16.i34.4264; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Schottelius AJG, 1999, INT J COLORECTAL DIS, V14, P18, DOI 10.1007/s003840050178; Schottelius AJ, 2006, CANC TREAT, V130, P67; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477                                                            ; Seidelin JB, 2007, VIRCHOWS ARCH, V451, P1031, DOI 10.1007/s00428-007-0517-1; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Sood A, 2003, GUT, V52, P1587, DOI 10.1136/gut.52.11.1587                                                          ; Speckmann C, 2014, GUT, V63, P1031, DOI 10.1136/gutjnl-2013-306474; Subramaniam V, 2003, BRIT J CANCER, V89, P1538, DOI 10.1038/sj.bjc.6601301; Suzuki R, 2001, AM J PATHOL, V159, P425, DOI 10.1016/S0002-9440(10)61713-0                                                   ; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Takeuchi H, 2005, CLIN CANCER RES, V11, P7621, DOI 10.1158/1078-0432.CCR-05-0479; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Verma R, 2013, EUR CYTOKINE NETW, V24, P130, DOI 10.1684/ecn.2013.0343; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; Walmsley RS, 1998, GUT, V43, P29, DOI 10.1136/gut.43.1.29                                                             ; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XF, 2004, ONCOGENE, V23, P1885, DOI 10.1038/sj.onc.1207312; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wong NACS, 2003, HUM PATHOL, V34, P580, DOI 10.1016/S0046-8177(03)000125-4; Yang CZ, 2012, FASEB J, V26, P4506, DOI 10.1096/fj.12-210146; Zafirellis K, 2010, APMIS, V118, P115, DOI 10.1111/j.1600-0463.2009.02569.x; Zheng Cui-Fang, 2011, Zhonghua Er Ke Za Zhi, V49, P261	68	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 25	2017	7								9420	10.1038/s41598-017-09796-9				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FE8IF	WOS:000408448100013	28842689	gold			2018-01-05	
J	Ghosh, P; Sowdhamini, R				Ghosh, Pritha; Sowdhamini, Ramanathan			Bioinformatics comparisons of RNA-binding proteins of pathogenic and non-pathogenic Escherichia coli strains reveal novel virulence factors	BMC GENOMICS			English	Article						Escherichia coli; RNA-binding proteins; Genome-wide survey; Pathogen; Virulence; Ribonuclease PH; PELOTA; Uncharacterised	CRISPR-CAS SYSTEMS; PSEUDOMONAS-AERUGINOSA; BACILLUS-SUBTILIS; MESSENGER-RNA; CRYSTAL-STRUCTURE; CHAPERONE HFQ; RSMA PLAYS; RECOGNITION; PH; FINO	Background: Pathogenic bacteria have evolved various strategies to counteract host defences. They are also exposed to environments that are undergoing constant changes. Hence, in order to survive, bacteria must adapt themselves to the changing environmental conditions by performing regulations at the transcriptional and/or post-transcriptional levels. Roles of RNA-binding proteins (RBPs) as virulence factors have been very well studied. Here, we have used a sequence search-based method to compare and contrast the proteomes of 16 pathogenic and three non-pathogenic E. coli strains as well as to obtain a global picture of the RBP landscape (RBPome) in E. coli. Results: Our results show that there are no significant differences in the percentage of RBPs encoded by the pathogenic and the non-pathogenic E. coli strains. The differences in the types of Pfam domains as well as Pfam RNA-binding domains, encoded by these two classes of E. coli strains, are also insignificant. The complete and distinct RBPome of E. coli has been established by studying all known E. coli strains till date. We have also identified RBPs that are exclusive to pathogenic strains, and most of them can be exploited as drug targets since they appear to be non-homologous to their human host proteins. Many of these pathogen-specific proteins were uncharacterised and their identities could be resolved on the basis of sequence homology searches with known proteins. Detailed structural modelling, molecular dynamics simulations and sequence comparisons have been pursued for selected examples to understand differences in stability and RNA-binding. Conclusions: The approach used in this paper to cross-compare proteomes of pathogenic and non-pathogenic strains may also be extended to other bacterial or even eukaryotic proteomes to understand interesting differences in their RBPomes. The pathogen-specific RBPs reported in this study, may also be taken up further for clinical trials and/or experimental validations.	[Ghosh, Pritha; Sowdhamini, Ramanathan] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bellary Rd, Bangalore 560065, Karnataka, India	Sowdhamini, R (reprint author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bellary Rd, Bangalore 560065, Karnataka, India.	mini@ncbs.res.in			University Grants Commission (UGC); NCBS	We thank University Grants Commission (UGC) and the NCBS Bridge Postdoctoral Fellowship for funding P.G.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427                                                           ; Anantharaman V, 2012, MOL BIOSYST, V8, P3142, DOI 10.1039/c2mb25239b; Arthur DC, 2011, NUCLEIC ACIDS RES, V39, P4450, DOI 10.1093/nar/gkr025; Arthur DC, 2003, EMBO J, V22, P6346, DOI 10.1093/emboj/cdg607; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Chao NX, 2008, MOL PLANT MICROBE IN, V21, P411, DOI 10.1094/MPMI-21-4-0411; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Chen Y, 2005, FEBS J, V272, P2088, DOI 10.1111/j.1742-4658.2005.04650.x; Choi JM, 2004, J BIOL CHEM, V279, P755, DOI 10.1074/jbc.M309628200; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.113355-3362.2004; Cusack S, 1999, CURR OPIN STRUC BIOL, V9, P66; De Lay N, 2013, J BIOL CHEM, V288, P7996, DOI 10.1074/jbc.R112.441386; DEUTSCHER MP, 1988, P NATL ACAD SCI USA, V85, P4710, DOI 10.1073/pnas.85.13.4710; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dong JS, 2005, MOL CELL BIOL, V25, P9859, DOI 10.1128/MCB.25.22.9859-9873.2005; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991                                                          ; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Fozo EM, 2008, MOL MICROBIOL, V70, P1076, DOI 10.1111/j.1365-2958.2008.06394.x; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Geissmann TA, 2004, EMBO J, V23, P396, DOI 10.1038/sj.emboj.7600058; Geng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006213; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Ghetu AF, 2000, NAT STRUCT BIOL, V7, P565; Ghosh P, 2016, MOL BIOSYST, V12, P532, DOI 10.1039/c5mb00638d; Glover JNM, 2015, PLASMID, V78, P79, DOI 10.1016/j.plasmid.2014.07.003; Goeders N, 2013, TOXINS, P304; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; HACKER J, 1990, MICROB PATHOGENESIS, V8, P213, DOI 10.1016/0882-4010(90)90048-U; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Hall KB, 2002, CURR OPIN STRUC BIOL, V12, P283, DOI 10.1016/S0959-440X(02)00323-8; Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harlow LS, 2004, PROTEIN SCI, V13, P668, DOI 10.1110/ps.03477004; Holmqvist E, 2013, GENE DEV, V27, P1073, DOI 10.1101/gad.220178.113; Huang L, 2013, RNA, V19, P1703, DOI 10.1261/rna.041517.113; Iyer LM, 2002, GENOME BIOL, V3; Iyer LM, 2006, BIOINFORMATICS, V22, P257, DOI 10.1093/bioinformatics/bti767; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993                                                ; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091                                                          ; Jones S, 2001, NUCLEIC ACIDS RES, V29, P943, DOI 10.1093/nar/29.4.943                                                            ; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kaushik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056449; KELLY KO, 1992, J BIOL CHEM, V267, P17153; Kendall MM, 2011, J BACTERIOL, V193, P6843, DOI 10.1128/JB.06141-11; Kim S-H, 1998, NATURE, V396, P703; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054; Kumar S, 2012, BIOINFORMATICS, V28, P2685, DOI 10.1093/bioinformatics/bts507; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944                                                       ; Liaw SJ, 2003, J MED MICROBIOL, V52, P19, DOI 10.1099/jmm.0.05024-0; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu JM, 2010, CURR OPIN MICROBIOL, V13, P18, DOI 10.1016/j.mib.2009.11.004; Louwen R, 2014, MICROBIOL MOL BIOL R, V78, P74, DOI 10.1128/MMBR.00039-13; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Menke M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040010; Mulcahy H, 2006, INFECT IMMUN, V74, P3012, DOI 10.1128/IAI.74.5.3012-3015.2006; Mulcahy H, 2008, INFECT IMMUN, V76, P632, DOI 10.1128/IAI.01132-07; Oliva G, 2015, FEMS MICROBIOL REV, V39, P331, DOI 10.1093/femsre/fuv022; Perez-Rueda Ernesto, 2012, Science Progress, V95, P315, DOI 10.3184/003685012X13420097673409; Pessi G, 2001, J BACTERIOL, V183, P6676, DOI 10.1128/JB.183.22.6676-6683.2001; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9                                                   ; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Pugalenthi G, 2006, NUCLEIC ACIDS RES, V34, pW231, DOI 10.1093/nar/gkl314; Rodnina MV, 2010, EMBO REP, V11, P143, DOI 10.1038/embor.2010.25; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samra N, 2015, BMC MOL BIOL, V16, DOI [10.1186/s12867-015-0045, 10.1186/s12867-015-0045-5]; Sauer E, 2012, P NATL ACAD SCI USA, V109, P9396, DOI 10.1073/pnas.1202521109; Schroeder R, 2004, NAT REV MOL CELL BIO, V5, P908, DOI 10.1038/nrm1497; Sharma AK, 2006, MOL MICROBIOL, V62, P469, DOI 10.1111/j.1365-2958.2006.05376.x; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Sukhwal A, 2015, BIOINFORM BIOL INSIG, V9, P141, DOI 10.4137/BBI.S25928; Tatusova T, 2015, NUCLEIC ACIDS RES, V43, pD599, DOI 10.1093/nar/gku1062; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; Van Assche E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00141; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Van Melderen L, 2009, PLOS GENET; Vercruysse M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004175; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wen TY, 2005, NUCLEIC ACIDS RES, V33, P3636, DOI 10.1093/nar/gki675; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wilf NM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-822; Windbichler N, 2008, RNA BIOL, V5, P30, DOI 10.4161/rna.5.1.5694                                                            ; Yamanaka Kunitoshi, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P193; Zeng Q, 2013, J BACTERIOL, V195, P1706, DOI 10.1128/JB.02056-12	102	0	0	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	AUG 24	2017	18								658	10.1186/s12864-017-4045-3				23	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FF3XS	WOS:000408859000002	28836963	gold			2018-01-05	
J	Kudumala, SR; Penserga, T; Borner, J; Slipchuk, O; Kakad, P; Lee, LH; Qureshi, A; Pielage, J; Godenschwege, TA				Kudumala, Sirisha R.; Penserga, Tyrone; Boerner, Jana; Slipchuk, Olesya; Kakad, Priyanka; Lee, LaTasha H.; Qureshi, Aater; Pielage, Jan; Godenschwege, Tanja A.			Lissencephaly-1 dependent axonal retrograde transport of L1-type CAM Neuroglian in the adult drosophila central nervous system	PLOS ONE			English	Article							ADHESION MOLECULE L1; LONG-TERM POTENTIATION; CENTRAL-SYNAPSE FORMATION; GIANT-FIBER SYSTEM; FLUORESCENT PROTEINS; ORGANELLE TRANSPORT; IN-VIVO; CHROMOPHORE MATURATION; NUCLEAR TRANSLOCATION; DYNACTIN INTERACTION	Here, we established the Drosophila Giant Fiber neurons (GF) as a novel model to study axonal trafficking of L1-type Cell Adhesion Molecules (CAM) Neuroglian (Nrg) in the adult CNS using live imaging. L1-type CAMs are well known for their importance in nervous system development and we previously demonstrated a role for Nrg in GF synapse formation. However, in the adult they have also been implicated in synaptic plasticity and regeneration. In addition, to its canonical role in organizing cytoskeletal elements at the plasma membrane, vertebrate L1CAM has also been shown to regulate transcription indirectly as well as directly via its import to the nucleus. Here, we intend to determine if the sole L1CAM homolog Nrg is retrogradley transported and thus has the potential to relay signals from the synapse to the soma. Live imaging of c-terminally tagged Nrg in the GF revealed that there are at least two populations of retrograde vesicles that differ in speed, and either move with consistent or varying velocity. To determine if endogenous Nrg is retrogradely transported, we inhibited two key regulators, Lissencephaly-1 (Lis1) and Dynactin, of the retrograde motor protein Dynein. Similar to previously described phenotypes for expression of poisonous sub-units of Dynactin, we found that developmental knock down of Lis1 disrupted GF synaptic terminal growth and that Nrg vesicles accumulated inside the stunted terminals in both mutant backgrounds. Moreover, post mitotic Lis1 knock down in mature GFs by either RNAi or Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) induced mutations, resulted in normal length terminals with fully functional GF synapses which also exhibited severe accumulation of endogenous Nrg vesicles. Thus, our data suggests that accumulation of Nrg vesicles is due to failure of retrograde transport rather than a failure of terminal development. Together with the finding that post mitotic knock down of Lis1 also disrupted retrograde transport of tagged Nrg vesicles in GF axons, it demonstrates that endogenous Nrg protein is transported from the synapse to the soma in the adult central nervous system in a Lis1-dependent manner.	[Kudumala, Sirisha R.; Penserga, Tyrone; Boerner, Jana; Slipchuk, Olesya; Kakad, Priyanka; Lee, LaTasha H.; Godenschwege, Tanja A.] Florida Atlantic Univ, Dept Biol Sci, Jupiter, FL 33458 USA; [Qureshi, Aater] Florida Atlantic Univ, Harriet L Wilkes Honors Coll, Jupiter, FL USA; [Pielage, Jan] Tech Univ Kaiserslautern, Div Zool Neurobiol, Dept Biol, Kaiserslautern, Germany	Godenschwege, TA (reprint author), Florida Atlantic Univ, Dept Biol Sci, Jupiter, FL 33458 USA.	godensch@fau.edu			National Institute for Neurological Disease and Stroke [R15NS090043]; National Institute of Child Health And Human Development [R01HD050725]; Jupiter Life Sciences Initiative; Division of Research- Florida Atlantic University; College of Science- Florida Atlantic University	This work was supported by the National Institute for Neurological Disease and Stroke, https://www.ninds.nih.gov/, (R15NS090043) to TAG; the National Institute of Child Health And Human Development, https://www.nichd.nih.gov/Pages/index.aspx, (R01HD050725) to TAG; Jupiter Life Sciences Initiative, http://www.fau.edu/jlsi/, TAG and SRK; Division of Research- Florida Atlantic University, http://www.fau.edu/research/, TAG; College of Science- Florida Atlantic University, http://www.science.fau.edu/, TAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2012, J BIOL CHEM, V287, P32312, DOI 10.1074/jbc.M112.374322; Allen MJ, 2006, SEMIN CELL DEV BIOL, V17, P31, DOI 10.1016/j.semcdb.2005.11.011; Allen MJ, 1999, J NEUROSCI, V19, P9374; Allen MJ, 1998, J COMP NEUROL, V397, P519, DOI 10.1002/(SICI)1096-9861(19980810)397:4<519::AID-CNE5>3.0.CO;2-4; Allen MJ, 2010, COLD SPRING HARBOR P, V2010; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x                                               ; Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054; Bliss T, 2000, CURR BIOL, V10, P1607, DOI 10.1016/S0960-9822(00)00865-4; BOERNER J, 2011, JOVE J VIS EXP JUN, P66880, DOI DOI 10.3791/3080; Boerner J, 2010, J NEUROGENET, V24, P158, DOI 10.3109/01677063.2010.489624; Chen QY, 2005, SCHIZOPHR RES, V73, P269, DOI 10.1016/j.schres.2004.06.001; Chen XQ, 2012, CELL RES, V22, P677, DOI 10.1038/cr.2011.197; Cheng L, 2011, EMBO J, V30, P800, DOI 10.1038/emboj.2011.10; Chiba K, 2014, MOL BIOL CELL, V25, P3569, DOI 10.1091/mbc.E14-06-1111; Clague MJ, 2016, CURR BIOL, V26, pR332, DOI 10.1016/j.cub.2016.03.001; Costantini LM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8670; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Dix CI, 2013, J CELL BIOL, V202, P479, DOI 10.1083/jcb.201211052; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Drerup CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003303; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Enneking EM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001537; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Garcia-Alonso L, 2000, NEURON, V28, P741, DOI 10.1016/S0896-6273(00)00150-1; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Godenschwege TA, 2009, J NEUROGENET, V23, P147, DOI 10.1080/01677060802441380; Gunawardena S, 2013, HUM MOL GENET, V22, P3828, DOI 10.1093/hmg/ddt237; Hebisch E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0                                                                ; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; Islam R, 2003, DEVELOPMENT, V130, P2051, DOI 10.1242/dev.00415; Itoh K, 2005, MOL CELL NEUROSCI, V29, P245, DOI 10.1016/j.mcn.2005.02.014; Jacobs K, 2000, DEVELOPMENT, V127, P5203; Janssens K, 2014, NEUROBIOL DIS, V65, P211, DOI 10.1016/j.nbd.2014.01.021; Kalinovsky A, 2004, CURR OPIN NEUROBIOL, V14, P272, DOI 10.1016/j.conb.2004.05.011; Kiefel H, 2011, TRENDS MOL MED, V17, P178, DOI 10.1016/j.molmed.2010.11.005; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Kristiansen LV, 2005, MOL CELL NEUROSCI, V28, P141, DOI 10.1016/j.mcn.2004.09.003; Kudumala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076974; Lee LH, 2015, MOL CELL NEUROSCI, V64, P24, DOI 10.1016/j.mcn.2014.11.002; Lei YD, 2000, DEV BIOL, V226, P57, DOI 10.1006/dbio.2000.9848; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Liu Z, 2000, NAT CELL BIOL, V2, P776; Liu Z, 1999, DEVELOPMENT, V126, P4477; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; Lorenzo DN, 2014, J CELL BIOL, V207, P735, DOI 10.1083/jcb.201407063; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Lutz D, 2013, J NEUROCHEMISTRY; Lutz D, 2012, J BIOL CHEM, V287, P17161, DOI 10.1074/jbc.M112.346759; Macdonald PJ, 2012, ANAL BIOCHEM, V421, P291, DOI 10.1016/j.ab.2011.10.040; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Medioni C, 2015, NAT PROTOC, V10, P574, DOI 10.1038/nprot.2015.034; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Moughamian AJ, 2013, J NEUROSCI, V33, P13190, DOI 10.1523/JNEUROSCI.0935-13.2013; Moughamian AJ, 2012, NEURON, V74, P331, DOI 10.1016/j.neuron.2012.02.025; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Nikonenko AG, 2006, EUR J NEUROSCI, V23, P1839, DOI 10.1111/j.1460-9568.2006.04710.x; Pandey JP, 2011, J NEUROSCI, V31, P17207, DOI 10.1523/JNEUROSCI.4108-11.2011; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Poltorak M, 1997, BRAIN RES, V751, P152, DOI 10.1016/S0006-8993(97)00023-1; Port F, 2015, G3-GENES GENOM GENET, V5, P1493, DOI 10.1534/g3.115.019083; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj/mp/4000973; Sakurai T, 2012, MOL CELL NEUROSCI, V49, P351, DOI 10.1016/j.mcn.2011.12.002; Salinas PC, 2005, BIOCHEM SOC T, V33, P1295, DOI 10.1042/BST0331295                                                              ; Sanyal S, 2004, NEURON, V41, P845, DOI 10.1016/S0896-6273(04)00152-7                                                   ; Sayama K, 2010, J BIOL CHEM, V285, P30042, DOI 10.1074/jbc.M110.106484; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Schmieg N, 2014, SEMIN CELL DEV BIOL, V27, P32, DOI 10.1016/j.semcdb.2013.10.004; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shao CY, 2013, TRAFFIC, V14, P785, DOI 10.1111/tra.12070; Siegenthaler D, 2015, J CELL BIOL, V208, P1003, DOI 10.1083/jcb.201407131; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Sinadinos C, 2009, NEUROBIOL DIS, V34, P389, DOI 10.1016/j.nbd.2009.02.012; Smith RB, 2012, J CELL SCI, V125, P3752, DOI 10.1242/jcs.094292; Soares L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06199; Uthaman SB, THE STICKY SYNAPSE, P247; Vallee RB, 2006, GENE DEV, V20, P1384, DOI 10.1101/gad.1417206; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; von Reyn CR, 2014, NAT NEUROSCI, V17, P962, DOI 10.1038/nn.3741; Wang SS, 2013, MOL BIOL CELL, V24, P3522, DOI 10.1091/mbc.E13-05-0283; White JA, 2015, HUM MOL GENET, V24, P7182, DOI 10.1093/hmg/ddv415; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yamasaki M, 1997, NEUROPEDIATRICS, V28, P175, DOI 10.1055/s-2007-973696; Yi JY, 2011, J CELL BIOL, V195, P193, DOI 10.1083/jcb.201104076; Zala D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060162; Zhou B, 2012, CELL REPORTS, V2, P42, DOI 10.1016/j.celrep.2012.06.010	95	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183605	10.1371/journal.pone.0183605				22	Multidisciplinary Sciences	Science & Technology - Other Topics	FE7CK	WOS:000408365000086	28837701	gold			2018-01-05	
J	Watanabe, T; Shibasaki, M; Maruyama, F; Sekizaki, T; Nakagawa, I				Watanabe, Takayasu; Shibasaki, Masaki; Maruyama, Fumito; Sekizaki, Tsutomu; Nakagawa, Ichiro			Investigation of potential targets of Porphyromonas CRISPRs among the genomes of Porphyromonas species	PLOS ONE			English	Article							CAS SYSTEMS; HOMOLOGOUS RECOMBINATION; HORIZONTAL TRANSFER; CONJUGAL TRANSFER; GENE-TRANSFER; STRAIN W83; SMALL RNA; COMB-NOV; CD-HIT; GINGIVALIS	The oral bacterial species Porphyromonas gingivalis, a periodontal pathogen, has plastic genomes that may be driven by homologous recombination with exogenous deoxyribonucleic acid (DNA) that is incorporated by natural transformation and conjugation. However, bacteriophages and plasmids, both of which are main resources of exogenous DNA, do not exist in the known P. gingivalis genomes. This could be associated with an adaptive immunity system conferred by clustered regularly interspaced short palindromic repeat (CRISPR) and CRISPR-associated (cas) genes in P. gingivalis as well as innate immune systems such as a restriction-modification system. In a previous study, few immune targets were predicted for P. gingivalis CRISPR/Cas. In this paper, we analyzed 51 P. gingivalis genomes, which were newly sequenced, and publicly available genomes of 13 P. gingivalis and 46 other Porphyromonas species. We detected 6 CRISPR/Cas types (classified by sequence similarity of repeat) in P. gingivalis and 12 other types in the remaining species. The Porphyromonas CRISPR spacers with potential targets in the genus Porphyromonas were approximately 23 times more abundant than those with potential targets in other genus taxa (1,720/6,896 spacers vs. 74/6,896 spacers). Porphyromonas CRISPR/Cas may be involved in genome plasticity by exhibiting selective interference against intra-and interspecies nucleic acids.	[Watanabe, Takayasu; Sekizaki, Tsutomu] Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Lab Food Borne Pathogen Microbiol,Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan; [Shibasaki, Masaki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Implantol & Regenerat Dent Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo, Japan; [Maruyama, Fumito; Nakagawa, Ichiro] Kyoto Univ, Grad Sch Med, Dept Microbiol, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan	Watanabe, T (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Lab Food Borne Pathogen Microbiol,Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan.	atakawat@mail.ecc.u-tokyo.ac.jp		Maruyama, Fumito/0000-0003-2347-616X	Japan Society for the Promotion of Science (Tokyo, Japan) KAKENHI Grant [JP12J05796, JP14J02840, JP26861544, JP16K08015]	This work was supported by the Japan Society for the Promotion of Science (Tokyo, Japan) KAKENHI Grant Numbers JP12J05796, JP14J02840, JP26861544, and JP16K08015 (to TW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklujkar M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-230; Alkhnbashi OS, 2014, BIOINFORMATICS, V30, pI489, DOI 10.1093/bioinformatics/btu459; Aronesty E, 2013, OPEN BIOINFORMATICS, V7, P1, DOI DOI 10.2174/1875036201307010001; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baltrus DA, 2009, GENOME DYNAM, V6, P75, DOI 10.1159/000235764; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burmistrz M, 2015, J BACTERIOL, V197, P2631, DOI 10.1128/JB.00261-15; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Chakraborty S, 2010, MOL PHYLOGENET EVOL, V56, P878, DOI 10.1016/j.ympev.2010.05.020; COYKENDALL AL, 1980, INT J SYST BACTERIOL, V30, P559, DOI 10.1099/00207713-30-3-559                                                       ; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cugini C, 2013, J ORAL MICROBIOL, P5, DOI DOI 10.3402/JOM.V5I0.19804; Darmon E, 2014, MICROBIOL MOL BIOL R, V78, P1, DOI 10.1128/MMBR.00035-13; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Didelot X, 2010, TRENDS MICROBIOL, V18, P315, DOI 10.1016/j.tim.2010.04.002; Dziarski R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146162; Eggerth AH, 1933, J BACTERIOL, V25, P389; Enersen M., 2011, J ORAL MICROBIOL, P3; Fournier D, 2001, INT J SYST EVOL MICR, V51, P1179, DOI 10.1099/00207713-51-3-1179                                                      ; Foxman EF, 2011, NAT REV MICROBIOL, V9, P254, DOI 10.1038/nrmicro2541; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Goessweiner-Mohr N, 2014, MICROBIOL SPECTR, V2, DOI DOI 10.1128/MICROBIOLSPEC.PLAS-0004-2013; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Jorth P, 2012, MBIO, V3, DOI 10.1128/mBio.00309-12; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Koehler A, 2003, MICROBIOL-SGM, V149, P2407, DOI 10.1099/mic.0.26267-0; Kong Y, 2013, GENOME BIOL EVOL, V5, P1611, DOI 10.1093/gbe/evt116; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244; Lange SJ, 2013, NUCLEIC ACIDS RES, V41, P8034, DOI 10.1093/nar/gkt606; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; McLean JS, 2013, GENOME RES, V23, P867, DOI 10.1101/gr.150433.112; Mell JC, 2014, J BACTERIOL, V196, P1471, DOI 10.1128/JB.01293-13; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Naito M, 2011, MICROBIOL-SGM, V157, P2022, DOI 10.1099/mic.0.047803-0; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ogier JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-568; Ohyama A, 2006, J COMPUT AIDED CHEM, V7, P102, DOI 10.2751/jcac.7.102; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Phillips P, 2014, FEMS MICROBIOL LETT, V351, P202, DOI 10.1111/1574-6968.12320; Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169; Sakamoto M, 2006, INT J SYST EVOL MICR, V56, P1599, DOI 10.1099/ijs.0.64192-0; Salmond GPC, 2015, NAT REV MICROBIOL, V13, P777, DOI [10.1038/nrmicro3564, 10.1038/nrmicr03564]; SALYERS AA, 1995, MICROBIOL REV, V59, P579; Samson JE, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.PLAS-0034-2014; Schoen C, 2009, VACCINE, V27, pB103, DOI 10.1016/j.vaccine.2009.04.064; Serbanescu MA, 2015, J BACTERIOL, V197, P749, DOI 10.1128/JB.02333-14; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Suominen I, 2003, INT J SYST EVOL MICR, V53, P1369, DOI 10.1099/ijs.0.02277-0; Tribble GD, 2007, J BACTERIOL, V189, P6382, DOI 10.1128/JB.00460-07; Tribble GD, 2013, FUTURE MICROBIOL, V8, P607, DOI [10.2217/fmb.13.30, 10.2217/FMB.13.30]; Tribble GD, 2012, MBIO, V3, DOI 10.1128/mBio.00231-11; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; Vos M, 2009, TRENDS MICROBIOL, V17, P226, DOI 10.1016/j.tim.2009.03.001; Watanabe T, 2013, GENOME BIOL EVOL, V5, P1099, DOI 10.1093/gbe/evt075; Watanabe T, 2011, J BACTERIOL, V193, P4259, DOI 10.1128/JB.05269-11; WYSS C, 1992, J CLIN MICROBIOL, V30, P2225; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zou SM, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0177-y	68	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183752	10.1371/journal.pone.0183752				18	Multidisciplinary Sciences	Science & Technology - Other Topics	FE7CK	WOS:000408365000110	28837670	gold			2018-01-05	
J	Batra, R; Nelles, DA; Pirie, E; Blue, SM; Marina, RJ; Wang, H; Chaim, IA; Thomas, JD; Zhang, N; Nguyen, V; Aigner, S; Markmiller, S; Xia, GB; Corbett, KD; Swanson, MS; Yeo, GW				Batra, Ranjan; Nelles, David A.; Pirie, Elaine; Blue, Steven M.; Marina, Ryan J.; Wang, Harrison; Chaim, Isaac A.; Thomas, James D.; Zhang, Nigel; Nguyen, Vu; Aigner, Stefan; Markmiller, Sebastian; Xia, Guangbin; Corbett, Kevin D.; Swanson, Maurice S.; Yeo, Gene W.			Elimination of Toxic Microsatellite Repeat Expansion RNA by RNA-Targeting Cas9	CELL			English	Article							MYOTONIC-DYSTROPHY TYPE-1; FRAGILE-X-SYNDROME; ALTERNATIVE POLYADENYLATION; HEXANUCLEOTIDE REPEAT; CRYSTAL-STRUCTURE; IN-VIVO; DISEASE; C9ORF72; ALS; DNA	Microsatellite repeat expansions in DNA produce pathogenic RNA species that cause dominantly inherited diseases such as myotonic dystrophy type 1 and 2 (DM1/2), Huntington's disease, and C9orf72-linked amyotrophic lateral sclerosis (C9-ALS). Means to target these repetitive RNAs are required for diagnostic and therapeutic purposes. Here, we describe the development of a programmable CRISPR system capable of specifically visualizing and eliminating these toxic RNAs. We observe specific targeting and efficient elimination of micro-satellite repeat expansion RNAs both when exogenously expressed and in patient cells. Importantly, RNA-targeting Cas9 (RCas9) reverses hallmark features of disease including elimination of RNA foci among all conditions studied (DM1, DM2, C9-ALS, polyglutamine diseases), reduction of polyglutamine protein products, relocalization of repeat-bound proteins to resemble healthy controls, and efficient reversal of DM1-associated splicing abnormalities in patient myotubes. Finally, we report a truncated RCas9 system compatible with adeno-associated viral packaging. This effort highlights the potential of RCas9 for human therapeutics.	[Batra, Ranjan; Nelles, David A.; Pirie, Elaine; Blue, Steven M.; Marina, Ryan J.; Wang, Harrison; Chaim, Isaac A.; Zhang, Nigel; Nguyen, Vu; Aigner, Stefan; Markmiller, Sebastian; Corbett, Kevin D.; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Batra, Ranjan; Nelles, David A.; Pirie, Elaine; Blue, Steven M.; Marina, Ryan J.; Wang, Harrison; Chaim, Isaac A.; Zhang, Nigel; Nguyen, Vu; Aigner, Stefan; Markmiller, Sebastian; Yeo, Gene W.] Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92093 USA; [Batra, Ranjan; Nelles, David A.; Pirie, Elaine; Blue, Steven M.; Marina, Ryan J.; Wang, Harrison; Chaim, Isaac A.; Zhang, Nigel; Nguyen, Vu; Aigner, Stefan; Markmiller, Sebastian; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Thomas, James D.] Univ Florida, Ctr NeuroGenet, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Xia, Guangbin] Univ Florida, Coll Med, Genet Inst, Gainesville, FL USA; [Corbett, Kevin D.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Corbett, Kevin D.] Ludwig Inst Canc Res, San Diego Branch, La Jolla, CA USA; [Yeo, Gene W.] Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; [Yeo, Gene W.] ASTAR, Mol Engn Lab, Singapore, Singapore; [Batra, Ranjan; Nelles, David A.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol, Singapore, Singapore	Yeo, GW (reprint author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Yeo, GW (reprint author), Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92093 USA.; Yeo, GW (reprint author), Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.; Yeo, GW (reprint author), Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA.; Yeo, GW (reprint author), ASTAR, Mol Engn Lab, Singapore, Singapore.	geneyeo@ucsd.edu		Corbett, Kevin/0000-0001-5854-2388; Aigner, Stefan/0000-0002-9511-3328	NIH [HG004659, NS075449]; start-up grant from the Stem Cell Program at UCSD; National Institute for General Medical Sciences [T32 GM008666]	We acknowledge members of the Yeo lab, particularly Kris Brannan and Frederick Tan for critical comments. We thank Dr. Thomas A. Cooper of Baylor College of Medicine for the gift of the tetracycline-inducible expression system for (CTG)<SUP>960</SUP> and Dr. Laura Ranum of the University of Florida for the gifts of the CCTG-300, GGGGCC-120, and CAG-80 vectors. Salary support for G.W.Y. was partially supported by grants from the NIH (HG004659 and NS075449). This work was funded by a start-up grant from the Stem Cell Program at UCSD (G.W.Y). Ranjan Batra is an MDF Postdoctoral Fellow. R.J.M. is supported in part by an institutional award to the UCSD Genetics Training Program from the National Institute for General Medical Sciences, T32 GM008666. D.A.N. and G.W.Y. are co-founders of Locana, Inc. G.W.Y. and M.S.S. are members of its scientific advisory board.	Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Banez-Coronel M, 2015, NEURON, V88, P667, DOI 10.1016/j.neuron.2015.10.038; Batra R, 2016, NAT STRUCT MOL BIOL, V23, P1101, DOI 10.1038/nsmb.3310; Batra R, 2015, RNA BIOL, V12, P597, DOI 10.1080/15476286.2015.1040974; Batra R, 2014, MOL CELL, V56, P311, DOI 10.1016/j.molcel.2014.08.027; Batra R, 2010, HUM MOL GENET, V19, pR77, DOI 10.1093/hmg/ddq132; Charizanis K, 2012, NEURON, V75, P437, DOI 10.1016/j.neuron.2012.05.029; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cooper-Knock J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127376; Daughters RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000600; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X                                                    ; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Gao YZ, 2016, MOL THER, V24, P1378, DOI 10.1038/mt.2016.97; Geary RS, 2015, ADV DRUG DELIVER REV, V87, P46, DOI 10.1016/j.addr.2015.01.008; Goodwin M, 2014, ADV EXP MED BIOL, V825, P353, DOI 10.1007/978-1-4939-1221-6_10; Holmes SE, 1999, NAT GENET, V23, P391; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; LASPADA AR, 1991, NATURE, V352, P77; Lee JE, 2012, P NATL ACAD SCI USA, V109, P4221, DOI 10.1073/pnas.1117019109; Lee KY, 2013, EMBO MOL MED, V5, P1887, DOI 10.1002/emmm.201303275; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125                                                         ; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911                                                                   ; Nakamori M, 2013, ANN NEUROL, V74, P862, DOI 10.1002/ana.23992; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X                                                   ; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; O'Rourke JR, 2009, J BIOL CHEM, V284, P7419, DOI 10.1074/jbc.R800025200; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Paulson HL, 2000, P NATL ACAD SCI USA, V97, P12957, DOI 10.1073/pnas.210395797                                                          ; Poulos M. G., 2011, COLD SPRING HARB PER, V3; Prudencio M, 2015, NAT NEUROSCI, V18, P1175, DOI 10.1038/nn.4065; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; The Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schaefer KA, 2017, NAT METHODS, V14, P547, DOI 10.1038/nmeth.4293; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Takeshita D, 2007, PROTEINS, V68, P980, DOI 10.1002/prot.21351; Timchenko NA, 2001, MOL CELL BIOL, V21, P6927, DOI 10.1128/MCB.21.20.6927-6938.2001; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261; van Agtmaal EL, 2017, MOL THER, V25, P24, DOI 10.1016/j.ymthe.2016.10.014; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H                                                    ; Wilburn B, 2011, NEURON, V70, P427, DOI 10.1016/j.neuron.2011.03.021; Wojciechowska M, 2011, HUM MOL GENET, V20, P3811, DOI 10.1093/hmg/ddr299; Wu J, 2013, NUCLEIC ACIDS RES, V41, P5149, DOI 10.1093/nar/gkt216; Xia GB, 2013, CELL REPROGRAM, V15, P166, DOI 10.1089/cell.2012.0086; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179; Yu WH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14716; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhang WJ, 2014, MOL THER, V22, P312, DOI 10.1038/mt.2013.251; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	56	4	4	11	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					899	+	912.e10	10.1016/j.cell.2017.07.010				24	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FE7FG	WOS:000408372400010	28803727				2018-01-05	
J	Liu, X; Zhang, YY; Chen, Y; Li, MS; Zhou, F; Li, KL; Cao, H; Ni, M; Liu, YX; Gu, ZM; Dickerson, KE; Xie, SQ; Hon, GC; Xuan, ZY; Zhang, MQ; Shao, Z; Xu, J				Liu, Xin; Zhang, Yuannyu; Chen, Yong; Li, Mushan; Zhou, Feng; Li, Kailong; Cao, Hui; Ni, Min; Liu, Yuxuan; Gu, Zhimin; Dickerson, Kathryn E.; Xie, Shiqi; Hon, Gary C.; Xuan, Zhenyu; Zhang, Michael Q.; Shao, Zhen; Xu, Jian			In Situ Capture of Chromatin Interactions by Biotinylated dCas9	CELL			English	Article							LOCUS-CONTROL REGION; BETA-GLOBIN LOCUS; EMBRYONIC STEM-CELLS; HUMAN GENOME; CHROMOSOME CONFORMATION; GENE-EXPRESSION; TRANSGENIC MICE; DNA INTERACTIONS; TRANSCRIPTION; PROTEINS	Cis-regulatory elements (CREs) are commonly recognized by correlative chromatin features, yet the molecular composition of the vast majority of CREs in chromatin remains unknown. Here, we describe a CRISPR affinity purification in situ of regulatory elements (CAPTURE) approach to unbiasedly identify locus-specific chromatin-regulating protein complexes and long-range DNA interactions. Using an in vivo biotinylated nuclease-deficient Cas9 protein and sequence-specific guide RNAs, we show high-resolution and selective isolation of chromatin interactions at a single-copy genomic locus. Purification of human telomeres using CAPTURE identifies known and new telomeric factors. In situ capture of individual constituents of the enhancer cluster controlling human beta-globin genes establishes evidence for composition-based hierarchical organization. Furthermore, unbiased analysis of chromatin interactions at disease-associated cis-elements and developmentally regulated super-enhancers reveals spatial features that causally control gene transcription. Thus, comprehensive and unbiased analysis of locus-specific regulatory composition provides mechanistic insight into genome structure and function in development and disease.	[Liu, Xin; Zhang, Yuannyu; Li, Kailong; Cao, Hui; Ni, Min; Liu, Yuxuan; Gu, Zhimin; Dickerson, Kathryn E.; Xu, Jian] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA; [Chen, Yong; Xuan, Zhenyu; Zhang, Michael Q.] Univ Texas Dallas, Dept Biol Sci, Ctr Syst Biol, Richardson, TX 75080 USA; [Li, Mushan; Shao, Zhen] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai 200031, Peoples R China; [Zhou, Feng] Fudan Univ, Minister Educ, Key Lab Carcinogenesis & Canc Invas, Liver Canc Inst,Zhongshan Hosp, Shanghai 200032, Peoples R China; [Zhou, Feng] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Xie, Shiqi; Hon, Gary C.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Zhang, Michael Q.] Tsinghua Univ, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Zhang, Michael Q.] Tsinghua Univ, Bioinformat Div, Beijing 100084, Peoples R China; [Zhang, Michael Q.] Tsinghua Univ, Ctr Synthet & Syst Biol, TNLIST, Beijing 100084, Peoples R China; [Zhang, Michael Q.] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China	Xu, J (reprint author), Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA.; Zhou, F (reprint author), Fudan Univ, Minister Educ, Key Lab Carcinogenesis & Canc Invas, Liver Canc Inst,Zhongshan Hosp, Shanghai 200032, Peoples R China.; Zhou, F (reprint author), Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China.	zhou_feng@fudan.edu.cn; jian.xu@utsouthwestern.edu		Shao, Zhen/0000-0002-4934-4360; Xie, Shiqi/0000-0002-0516-3621	NIH [R01MH102616]; Cecil H. and Ida Green Endowment; SKRDPC grant [2017YFA0505503]; NSFC [91519326, 31671384]; NSFC grant [31670836]; National Key R&D Program of China [2017YFA0505100]; Shanghai Institute of Higher Learning [TP2015003]; "100-Talent'' Program of Chinese Academy of Sciences [Y516C11851]; NIH grants [K01DK093543, R03DK101665, R01DK111430]; Cancer Prevention and Research Institute of Texas (CPRIT) New Investigator award [RR140025]; American Cancer Society award; Harold C. Simmons Comprehensive Cancer Center at UT Southwestern [IRG-02-196]; Welch Foundation grant [I-1942-20170325]; American Society of Hematology Scholar award	We thank B. Chen and B. Huang at UCSF for the CRISPR imaging reagents and discussion; L. Wang, Y. Du, and D. Trudgian at UTSW BioHPC for assistance; and S.T. Smale at UCLA for critical reading of the manuscript and discussion. This work was supported by the NIH grant R01MH102616, the Cecil H. and Ida Green Endowment, the SKR&DPC grant (2017YFA0505503), and the NSFC grants (91519326, 31671384) to M.Q.Z.; the NSFC grant (31670836), the National Key R&D Program of China (2017YFA0505100), and Shanghai Institute of Higher Learning (TP2015003) to F.Z.; the "100-Talent'' Program of Chinese Academy of Sciences (Y516C11851) to Z.S.; the NIH grants K01DK093543, R03DK101665, and R01DK111430, a Cancer Prevention and Research Institute of Texas (CPRIT) New Investigator award (RR140025), the American Cancer Society award and the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern (IRG-02-196), the Welch Foundation grant I-1942-20170325, and an American Society of Hematology Scholar award to J.X.	Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Consortium T. E. P., 2012, NATURE, V489, P57, DOI DOI 10.1038/NATURE11247; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106                                                             ; Fujita T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03171; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Hardison R, 1997, GENE, V205, P73, DOI 10.1016/S0378-1119(97)00474-5                                                   ; Huang JL, 2016, DEV CELL, V36, P9, DOI 10.1016/j.devcel.2015.12.014; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Ibarra A., 2016, NATURE, V30, P2253; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Kim SI, 2009, P NATL ACAD SCI USA, V106, P2259, DOI 10.1073/pnas.0806420106; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lewis KA, 2012, STRUCTURE, V20, P28, DOI 10.1016/j.str.2011.10.017; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ma WX, 2015, NAT METHODS, V12, P71, DOI [10.1038/NMETH.3205, 10.1038/nmeth.3205]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miccio A, 2010, MOL CELL BIOL, V30, P3460, DOI 10.1128/MCB.00001-10; MORLEY BJ, 1992, MOL CELL BIOL, V12, P2057, DOI 10.1128/MCB.12.5.2057                                                           ; Morley B. J., 1992, NATURE, V467, P430; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Navas PA, 1998, MOL CELL BIOL, V18, P4188, DOI 10.1128/MCB.18.7.4188                                                           ; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Peterson KR, 1998, HUM MOL GENET, V7, P2079, DOI 10.1093/hmg/7.13.2079; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138                                                            ; Schwartzman O, 2016, NAT METHODS, V13, P685, DOI 10.1038/nmeth.3922; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Stonestrom AJ, 2015, BLOOD, V125, P2825, DOI 10.1182/blood-2014-10-607309; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Waldrip ZJ, 2014, EPIGENETICS-US, V9, P1207, DOI 10.4161/epi.29919; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zhou F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3171	58	4	4	17	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					1028	+	1043.e19	10.1016/j.cell.2017.08.003				35	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FE7FG	WOS:000408372400019	28841410				2018-01-05	
J	Ma, H; Marti-Gutierrez, N; Park, SW; Wu, J; Lee, Y; Suzuki, K; Koski, A; Ji, DM; Hayama, T; Ahmed, R; Darby, H; Van Dyken, C; Li, Y; Kang, E; Park, AR; Kim, D; Kim, ST; Gong, JH; Gu, Y; Xu, X; Battaglia, D; Krieg, SA; Lee, DM; Wu, DH; Wolf, DP; Heitner, SB; Belmonte, JCI; Mato, PA; Kim, JS; Kaul, S; Mitalipov, S				Ma, Hong; Marti-Gutierrez, Nuria; Park, Sang-Wook; Wu, Jun; Lee, Yeonmi; Suzuki, Keiichiro; Koski, Amy; Ji, Dongmei; Hayama, Tomonari; Ahmed, Riffat; Darby, Hayley; Van Dyken, Crystal; Li, Ying; Kang, Eunju; Park, A. -Reum; Kim, Daesik; Kim, Sang-Tae; Gong, Jianhui; Gu, Ying; Xu, Xun; Battaglia, David; Krieg, Sacha A.; Lee, David M.; Wu, Diana H.; Wolf, Don P.; Heitner, Stephen B.; Belmonte, Juan Carlos Izpisua; Mato, Paula A.; Kim, Jin-Soo; Kaul, Sanjiv; Mitalipov, Shoukhrat			Correction of a pathogenic gene mutation in human embryos	NATURE			English	Article							RNA-GUIDED ENDONUCLEASES; HUMAN-CELLS; PRIMATE EMBRYOS; DIGENOME-SEQ; CAS9; CRISPR-CAS9; NUCLEASES; MOUSE; DNA; ZYGOTES	Genome editing has potential for the targeted correction of germline mutations. Here we describe the correction of the heterozygous MYBPC3 mutation in human preimplantation embryos with precise CRISPR-Cas9-based targeting accuracy and high homology-directed repair efficiency by activating an endogenous, germline-specific DNA repair response. Induced double-strand breaks (DSBs) at the mutant paternal allele were predominantly repaired using the homologous wild-type maternal gene instead of a synthetic DNA template. By modulating the cell cycle stage at which the DSB was induced, we were able to avoid mosaicism in cleaving embryos and achieve a high yield of homozygous embryos carrying the wild-type MYBPC3 gene without evidence of off-target mutations. The efficiency, accuracy and safety of the approach presented suggest that it has potential to be used for the correction of heritable mutations in human embryos by complementing preimplantation genetic diagnosis. However, much remains to be considered before clinical applications, including the reproducibility of the technique with other heterozygous mutations.	[Ma, Hong; Marti-Gutierrez, Nuria; Lee, Yeonmi; Koski, Amy; Ji, Dongmei; Hayama, Tomonari; Ahmed, Riffat; Darby, Hayley; Van Dyken, Crystal; Li, Ying; Kang, Eunju; Battaglia, David; Wolf, Don P.; Mato, Paula A.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, 3303 Southwest,Bond Ave, Portland, OR 97239 USA; [Park, Sang-Wook; Park, A. -Reum; Kim, Sang-Tae; Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, 70 Yuseong Daero 1689 Gil, Daejeon 34047, South Korea; [Wu, Jun; Suzuki, Keiichiro; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Kim, Daesik; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, 599 Gwanak Ro, Seoul 151747, South Korea; [Gong, Jianhui; Gu, Ying; Xu, Xun] BGI Shenzhen, Bldg 11, Shenzhen 518083, Peoples R China; [Gong, Jianhui; Gu, Ying; Xu, Xun] BGI Shenzhen, China Natl GeneBank, Jinsha Rd, Shenzhen 518210, Peoples R China; [Gong, Jianhui; Gu, Ying; Xu, Xun] BGI Qingdao, 2877 Tuanjie Rd,Sino German Ecopk, Qingdao 266000, Peoples R China; [Gong, Jianhui] BGI Shenzhen, Shenzhen Engn Lab Innovat Mol Diagnost, Bldg 11, Shenzhen 518083, Peoples R China; [Battaglia, David; Krieg, Sacha A.; Lee, David M.; Wu, Diana H.; Mato, Paula A.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, 3303 Southwest,Bond Ave, Portland, OR 97239 USA; [Heitner, Stephen B.; Kaul, Sanjiv; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, 3181 Southwest,Sam Jackson Pk Rd, Portland, OR 97239 USA	Mato, PA; Mitalipov, S (reprint author), Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, 3303 Southwest,Bond Ave, Portland, OR 97239 USA.; Kim, JS (reprint author), Inst for Basic Sci Korea, Ctr Genome Engn, 70 Yuseong Daero 1689 Gil, Daejeon 34047, South Korea.; Belmonte, JCI (reprint author), Salk Inst Biol Studies, Gene Express Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.; Kim, JS (reprint author), Seoul Natl Univ, Dept Chem, 599 Gwanak Ro, Seoul 151747, South Korea.; Mato, PA (reprint author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, 3303 Southwest,Bond Ave, Portland, OR 97239 USA.; Kaul, S; Mitalipov, S (reprint author), Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, 3181 Southwest,Sam Jackson Pk Rd, Portland, OR 97239 USA.	belmonte@salk.edu; amatop@ohsu.edu; jskim01@snu.ac.kr; kauls@ohsu.edu; mitalipo@ohsu.edu			OHSU institutional funds; Institute for Basic Science [IBS-R021-D1]; G. Harold and Leila Y. Mathers Charitable Foundation; Moxie Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Shenzhen Municipal Government of China [DRC-SZ [2016] 884]	We acknowledge the OHSU Institutional Review Board (IRB), Innovative Research Advisory Panel (IRAP), Scientific Review Committee (SRC) and Data Safety Monitoring Committee (DSMC) for oversight and guidance on this study. We thank all study participants for tissue donations; the Women's Health Research Unit staff, IVF laboratory staff, University Fertility Consultants and the Reproductive Endocrinology and Infertility Division in the Department of Obstetrics and Gynecology, OHSU for support and procurement of human gametes; S. Olson and Research Cytogenetics Laboratory at OHSU for cytogenetic analysis of ES cells; S. Cooper from the Wallace Division of Smiths Medical for donating ICSI and gamete manipulation micropipettes; Y. Wang, T. Wu and Y. Shen from BGI-Shenzhen for help with sample preparation, sequencing and data analyses; M. Ku from the H. A. and Mary K. Chapman Charitable Foundations Genomic Sequencing Core of the Salk Institute for next generation sequencing; and E. Aizawa and R. HernandezBenitez from the laboratory of JCIB for assistance. Studies conducted at OHSU were supported by OHSU institutional funds. Work in the laboratory of J.-S. K. was supported by the Institute for Basic Science (IBS-R021-D1). Work in the laboratory of J.C.I.B. was supported by the G. Harold and Leila Y. Mathers Charitable Foundation, the Moxie Foundation and the Leona M. and Harry B. Helmsley Charitable Trust. Work at BGI was supported by the Shenzhen Municipal Government of China (DRC-SZ [2016] 884).	Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033                                                                  ; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Capmany G, 1996, Mol Hum Reprod, V2, P299, DOI 10.1093/molehr/2.5.299; Carrier L, 2015, GENE, V573, P188, DOI 10.1016/j.gene.2015.09.008; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Guo XY, 2015, CELL RES, V25, P767, DOI 10.1038/cr.2015.64; Hashimoto M, 2016, DEV BIOL, V418, P1, DOI 10.1016/j.ydbio.2016.07.017; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005; Kang Y, 2015, HUM MOL GENET, V24, P7255, DOI 10.1093/hmg/ddv425; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4157; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Lange J, 2016, CELL, V167, P695, DOI 10.1016/j.cell.2016.09.035; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Luo Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004730; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MARON BJ, 1995, CIRCULATION, V92, P785; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Park J, 2017, BIOINFORMATICS, V33, P286, DOI 10.1093/bioinformatics/btw561; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schlossarek S, 2011, J MOL CELL CARDIOL, V50, P613, DOI 10.1016/j.yjmcc.2011.01.014; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097                                                          ; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Suzuki T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07621; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tang LC, 2017, MOL GENET GENOMICS, V292, P525, DOI 10.1007/s00438-017-1299-z; Tennakoon C, 2012, BIOINFORMATICS, V28, P2122, DOI 10.1093/bioinformatics/bts339; Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925; Tu ZC, 2017, SCI REP-UK, V7, DOI 10.1038/srep42081; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016	48	30	31	234	234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					413	+		10.1038/nature23305				24	Multidisciplinary Sciences	Science & Technology - Other Topics	FE5VI	WOS:000408279000030	28783728				2018-01-05	
J	Pei, WK; Feyerabend, TB; Rossler, J; Wang, X; Postrach, D; Busch, K; Rode, I; Klapproth, K; Dietlein, N; Quedenau, C; Chen, W; Sauer, S; Wolf, S; Hofer, T; Rodewald, HR				Pei, Weike; Feyerabend, Thorsten B.; Rossler, Jens; Wang, Xi; Postrach, Daniel; Busch, Katrin; Rode, Immanuel; Klapproth, Kay; Dietlein, Nikolaus; Quedenau, Claudia; Chen, Wei; Sauer, Sascha; Wolf, Stephan; Hoefer, Thomas; Rodewald, Hans-Reimer			Polylox barcoding reveals haematopoietic stem cell fates realized in vivo	NATURE			English	Article							SITE-SPECIFIC RECOMBINATION; LINEAGE COMMITMENT; CLONAL ANALYSIS; EXPRESSION; GENE; PROGENITORS; SYSTEM; DIFFERENTIATION; PRECURSORS; RESOURCES	Developmental deconvolution of complex organs and tissues at the level of individual cells remains challenging. Non-invasive genetic fate mapping(1) has been widely used, but the low number of distinct fluorescent marker proteins limits its resolution. Much higher numbers of cell markers have been generated using viral integration sites(2), viral barcodes(3), and strategies based on transposons(4) and CRISPR-Cas9 genome editing(5); however, temporal and tissue-specific induction of barcodes in situ has not been achieved. Here we report the development of an artificial DNA recombination locus (termed Polylox) that enables broadly applicable endogenous barcoding based on the Cre-loxP recombination system(6,7). Polylox recombination in situ reaches a practical diversity of several hundred thousand barcodes, allowing tagging of single cells. We have used this experimental system, combined with fate mapping, to assess haematopoietic stem cell (HSC) fates in vivo. Classical models of haematopoietic lineage specification assume a tree with few major branches. More recently, driven in part by the development of more efficient single-cell assays and improved transplantation efficiencies, different models have been proposed, in which unilineage priming may occur in mice and humans at the level of HSCs8-10. We have introduced barcodes into HSC progenitors in embryonic mice, and found that the adult HSC compartment is a mosaic of embryo-derived HSC clones, some of which are unexpectedly large. Most HSC clones gave rise to multilineage or oligolineage fates, arguing against unilineage priming, and suggesting coherent usage of the potential of cells in a clone. The spreading of barcodes, both after induction in embryos and in adult mice, revealed a basic split between common myeloid-erythroid development and common lymphocyte development, supporting the long-held but contested view of a tree-like haematopoietic structure.	[Pei, Weike; Feyerabend, Thorsten B.; Postrach, Daniel; Busch, Katrin; Rode, Immanuel; Klapproth, Kay; Dietlein, Nikolaus; Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany; [Rossler, Jens; Wang, Xi; Hoefer, Thomas] German Canc Res Ctr, Div Theoret Syst Biol, D-69120 Heidelberg, Germany; [Wang, Xi; Quedenau, Claudia; Chen, Wei; Sauer, Sascha] Max Delbruck Ctr, Sci Genom Platforms BIMSB BIH, D-13125 Berlin, Germany; [Wolf, Stephan] German Canc Res Ctr, Genom Facil, D-69120 Heidelberg, Germany; [Wolf, Stephan] German Canc Res Ctr, Prote Core Facil, D-69120 Heidelberg, Germany; [Hoefer, Thomas] Heidelberg Univ, Bioquant Ctr, D-69120 Heidelberg, Germany	Rodewald, HR (reprint author), German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany.; Hofer, T (reprint author), German Canc Res Ctr, Div Theoret Syst Biol, D-69120 Heidelberg, Germany.; Hofer, T (reprint author), Heidelberg Univ, Bioquant Ctr, D-69120 Heidelberg, Germany.	t.hoefer@dkfz.de; hr.rodewald@dkfz.de			CellNetworks; DKFZ; e:Bio BMBF project [FKZ 0316182B]; ERC [742883];  [Transregio 156-A07];  [SFB 873-B11]	We thank J. Muehling, S. Oh, C. Heiner, P. Lobb, R. Lleras and C. Koenig (Pacific Biosciences), E. Hobeika (Ulm), S. Schafer, T. Grunzinger (DKFZ), K. Reifenberg, M. Socher, A. Frenznick (Animal Facility DKFZ), F. v. der Hoeven, U. Kloz (Transgenic Service DKFZ), and N. Diessl, C. Previti and S. Wiemann (Genomics & Proteomics Core Facilities DKFZ) for help, and R. Hoess, H. Glimm and K. Rajewsky for discussions. T. H. is supported by CellNetworks, DKFZ core funding and e:Bio BMBF project FKZ 0316182B (SB-Epo); T.B.F. and H.-R.R. are supported by Transregio 156-A07; H.-R.R. is supported by SFB 873-B11, ERC Advanced Grant 742883, and DKFZ core funding.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1                                                   ; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; HOESS R, 1985, GENE, V40, P325, DOI 10.1016/0378-1119(85)90056-3; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Junker J. P., 2017, MASSIVELY PARALLEL C; Kawamoto H, 2010, IMMUNOL REV, V238, P23, DOI 10.1111/j.1600-065X.2010.00959.x; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Pei W., 2017, PROTOC EXCH; Perie L, 2015, CELL, V163, P1655, DOI 10.1016/j.cell.2015.11.059; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Rybtsov S, 2016, DEVELOPMENT, V143, P1284, DOI 10.1242/dev.131193; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Schoedel KB, 2016, BLOOD, V128, P2285, DOI 10.1182/blood-2016-03-706010; Sheikh BN, 2016, BLOOD, V128, P2307, DOI 10.1182/blood-2015-10-676072; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007                                                                    ; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Terszowski G, 2005, BLOOD, V105, P1937, DOI 10.1182/blood-2004-09-3459; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Weber TS, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0290-3; Weissman TA, 2015, GENETICS, V199, P293, DOI 10.1534/genetics.114.172510; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	33	1	1	8	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					456	+		10.1038/nature23653				24	Multidisciplinary Sciences	Science & Technology - Other Topics	FE5VI	WOS:000408279000039	28813413				2018-01-05	
J	Ishizu, T; Higo, S; Masumura, Y; Kohama, Y; Shiba, M; Higo, T; Shibamoto, M; Nakagawa, A; Morimoto, S; Takashima, S; Hikoso, S; Sakata, Y				Ishizu, Takamaru; Higo, Shuichiro; Masumura, Yuki; Kohama, Yasuaki; Shiba, Mikio; Higo, Tomoaki; Shibamoto, Masato; Nakagawa, Akito; Morimoto, Sachio; Takashima, Seiji; Hikoso, Shungo; Sakata, Yasushi			Targeted Genome Replacement via Homology-directed Repair in Non-dividing Cardiomyocytes	SCIENTIFIC REPORTS			English	Article							STRAND BREAK REPAIR; IN-VIVO; DILATED CARDIOMYOPATHY; MOUSE MODEL; CELL-CYCLE; MUSCULAR-DYSTROPHY; MAMMALIAN-CELLS; HIGH-THROUGHPUT; DNA; CRISPR-CAS9	Although high-throughput sequencing can elucidate the genetic basis of hereditary cardiomyopathy, direct interventions targeting pathological mutations have not been established. Furthermore, it remains uncertain whether homology-directed repair (HDR) is effective in non-dividing cardiomyocytes. Here, we demonstrate that HDR-mediated genome editing using CRISPR/Cas9 is effective in nondividing cardiomyocytes. Transduction of adeno-associated virus (AAV) containing sgRNA and repair template into cardiomyocytes constitutively expressing Cas9 efficiently introduced a fluorescent protein to the C-terminus of Myl2. Imaging-based sequential evaluation of endogenously tagged protein revealed that HDR occurs in cardiomyocytes, independently of DNA synthesis. We sought to repair a pathological mutation in Tnnt2 in cardiomyocytes of cardiomyopathy model mice. An sgRNA that avoided the mutated exon minimized deleterious effects on Tnnt2 expression, and AAV-mediated HDR achieved precise genome correction at a frequency of similar to 12.5%. Thus, targeted genome replacement via HDR is effective in non-dividing cardiomyocytes, and represents a potential therapeutic tool for targeting intractable cardiomyopathy.	[Ishizu, Takamaru; Higo, Shuichiro; Masumura, Yuki; Kohama, Yasuaki; Shiba, Mikio; Higo, Tomoaki; Shibamoto, Masato; Nakagawa, Akito; Hikoso, Shungo; Sakata, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Morimoto, Sachio] Int Univ Hlth & Welf, Dept Hlth & Med Care, Okawa, Fukuoka 8318501, Japan; [Takashima, Seiji] Osaka Univ, Grad Sch Med, Dept Med Biochem, Suita, Osaka 5650871, Japan; [Hikoso, Shungo] Osaka Univ, Grad Sch Med, Dept Med Therapeut Heart Failure, Suita, Osaka 5650871, Japan	Higo, S (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan.	higo-s@cardiology.med.osaka-u.ac.jp			JSPS KAKENHI [16K09500, 26461129]; Japanese Ministry of Health, Labor, and Welfare; Japan agency for medical research and development; Banyu Foundation; Novartis Pharma; Actelion Pharmaceuticals Japan; Center for Medical Research and Education, Graduate School of Medicine, Osaka University	This work was supported by JSPS KAKENHI Grant Numbers 16K09500, 26461129, grants-in-aid from the Japanese Ministry of Health, Labor, and Welfare, the Japan agency for medical research and development. This work was also supported by Banyu Foundation and Novartis Pharma. Department of Medical Therapeutics for Heart Failure is an endowment department, supported by Actelion Pharmaceuticals Japan. We thank M. Moriyasu for technical assistance. This study was supported by Center for Medical Research and Education, Graduate School of Medicine, Osaka University.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Allen LA, 2012, CIRCULATION, V125, P1928, DOI 10.1161/CIR.0b013e31824f2173; Carroll KJ, 2016, P NATL ACAD SCI USA, V113, P338, DOI 10.1073/pnas.1523918113; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Futakuchi A, 2016, EXP EYE RES, V149, P107, DOI 10.1016/j.exer.2016.07.001; Haas J, 2015, EUR HEART J, V36, P1123, DOI 10.1093/eurheartj/ehu301; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304                                                     ; Kan YN, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004251; KIMURA Y, 2015, SCI REP UK, V5; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Masumura Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep28592; Mikuni T, 2016, CELL, V165, P1803, DOI 10.1016/j.cell.2016.04.044; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Neuber C, 2014, J PHARMACOL EXP THER, V349, P39, DOI 10.1124/jpet.113.210898; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Poon SSS, 2008, CYTOM PART A, V73A, P904, DOI 10.1002/cyto.a.20624; Ratz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09592; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706.5715.2003; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sharma S, 2007, BRAIN RES BULL, V73, P48, DOI 10.1016/j.brainresbull.2007.02.011; Shintani Y, 2014, EMBO REP, V15, P438, DOI 10.1002/embr.201337945; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsukamoto O, 2013, CIRC J, V77, P2218, DOI 10.1253/circj.CJ-13-0627; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Ware JS, 2016, NEW ENGL J MED, V374, P233, DOI 10.1056/NEJMoa1505517; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	50	1	1	8	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 24	2017	7								9363	10.1038/s41598-017-09716-x				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FE8FS	WOS:000408441600087	28839205	gold			2018-01-05	
J	Takei, N; Yoneda, A; Sakai-Sawada, K; Kosaka, M; Minomi, K; Tamura, Y				Takei, Norio; Yoneda, Akihiro; Sakai-Sawada, Kaori; Kosaka, Marina; Minomi, Kenjiro; Tamura, Yasuaki			Hypoxia-inducible ERO1a alpha promotes cancer progression through modulation of integrin-beta 1 modification and signalling in HCT116 colorectal cancer cells	SCIENTIFIC REPORTS			English	Article							OXIDOREDUCTASE ERO1-ALPHA DRIVES; ENDOPLASMIC-RETICULUM; E-CADHERIN; DISULFIDE OXIDASE; TUMOR PROGRESSION; EXPRESSION; GLYCOSYLATION; BETA-1-INTEGRIN; ALPHA-5-BETA-1; ERO1-L-ALPHA	Endoplasmic reticulum disulphide oxidase 1 alpha (ERO1 alpha) is an oxidase localized in the endoplasmic reticulum that plays a role in the formation of disulphide bonds of secreted and cell-surface proteins. We previously showed that ERO1a is overexpressed in various types of cancer and we further identified ERO1 alpha expression as a novel factor related to poor prognosis in cancer. However, the biological functions of ERO1 alpha in cancer remain unclear. Here, we investigated the cell biological roles of ERO1 alpha in the human colon-cancer cell line HCT116. ERO1 alpha knockout (KO) by using CRISPR/Cas9 resulted in decreased tumourigenicity in vivo and reduced cell proliferation only under hypoxia in vitro, which suggested that ERO1 alpha promotes cancer progression specifically in a low-oxygen environment. Thus, we evaluated the function of ERO1 alpha in cell proliferation under hypoxia, and found that under hypoxic conditions, ERO1 alpha KO resulted in a contact-inhibited morphology and diminished motility of cells. We further showed that ERO1 alpha KO induced a change in integrin-beta 1 glycosylation and thus an attenuation of cell-surface integrin-beta 1 expression, which resulted in the aforementioned phenotype. Our study has established a previously unrecognized link between ERO1 alpha expression and integrin activation, and thus provides new evidence for the effectiveness of ERO1 alpha-targeted therapy for colorectal carcinoma.	[Takei, Norio; Yoneda, Akihiro; Sakai-Sawada, Kaori; Kosaka, Marina; Tamura, Yasuaki] Hokkaido Univ, Dept Mol Therapeut, Ctr Food & Med Innovat, Inst Promot Business Reg Collaborat,Kita Ku, Kita 21 Nishi 11, Sapporo, Hokkaido 0010021, Japan; [Kosaka, Marina; Minomi, Kenjiro] Nitto Denko Corp, Nucle Acid Med Business Div, Res & Dev Dept, Osaka, Japan	Takei, N (reprint author), Hokkaido Univ, Dept Mol Therapeut, Ctr Food & Med Innovat, Inst Promot Business Reg Collaborat,Kita Ku, Kita 21 Nishi 11, Sapporo, Hokkaido 0010021, Japan.	ntakei@fmi.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [16K20874]; Nitto Denko Corporation (Osaka, Japan)	This work was supported in part by a Grant-in-Aid for Scientific Research (16K20874 to N.T.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan. N.T. also acknowledges the support of Nitto Denko Corporation (Osaka, Japan). We give special thanks to Dr. Takayuki Sakurai (Shinshu University) for supplying materials and for technical advice and discussion related to gene editing. We are indebted to Dr. Mami Yamaguchi, Dr. Michitoshi Kimura, and Eriko Iwai for their technical support in the histological analysis.	Araki K, 2012, ANTIOXID REDOX SIGN, V16, P790, DOI 10.1089/ars.2011.4418; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Blandin AF, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00279; Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; DUNPHY WG, 1985, CELL, V40, P463, DOI 10.1016/0092-8674(85)90161-8; Geng F, 2004, CELL RES, V14, P423, DOI 10.1038/sj.cr.7290243; Gess B, 2003, EUR J BIOCHEM, V270, P2228, DOI 10.1046/j.1432-1033.2003.03590.x; Guo HB, 2009, J BIOL CHEM, V284, P34986, DOI 10.1074/jbc.M109.060806; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; HOU S, 2016, SCI REP UK, V6; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425                                             ; Huttenlocher A, 1998, J CELL BIOL, V141, P515, DOI 10.1083/jcb.141.2.515                                                           ; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kukita K, 2015, J IMMUNOL, V194, P4988, DOI 10.4049/jimmunol.1303228; Kutomi G, 2013, CANCER SCI, V104, P1091, DOI 10.1111/cas.12177; Lee SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067149; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; May D, 2005, ONCOGENE, V24, P1011, DOI 10.1038/sj.onc.1208325; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nita-Lazar M, 2010, EXP CELL RES, V316, P1871, DOI 10.1016/j.yexcr.2010.02.008; Pinho SS, 2011, CELL MOL LIFE SCI, V68, P1011, DOI 10.1007/s00018-010-0595-0; Rutkevich LA, 2010, MOL BIOL CELL, V21, P3093, DOI 10.1091/mbc.E10-04-0356; Sakurai T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20011; Sakurai T, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-69; Schulman S, 2010, P NATL ACAD SCI USA, V107, P15027, DOI 10.1073/pnas.1009972107; Song J, 2014, ONCOL REP, V32, P302, DOI 10.3892/or.2014.3168; Takei N, 2015, J BIOL CHEM, V290, P987, DOI 10.1074/jbc.M114.599852; Tanaka T, 2016, BRIT J CANCER, V114, P1227, DOI 10.1038/bjc.2016.105; Tanaka T, 2015, J IMMUNOL, V194, P2004, DOI 10.4049/jimmunol.1402538; Zheng KB, 2015, ONCOL REP, V34, P272, DOI 10.3892/or.2015.3983; Zito E, 2015, FREE RADICAL BIO MED, V83, P299, DOI 10.1016/j.freeradbiomed.2015.01.011; Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	39	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 24	2017	7								9389	10.1038/s41598-017-09976-7				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FE8FS	WOS:000408441600113	28839225	gold			2018-01-05	
J	Mandl, M; Depping, R				Mandl, Markus; Depping, Reinhard			ARNT is a potential direct HIF-1 target gene in human Hep3B hepatocellular carcinoma cells	CANCER CELL INTERNATIONAL			English	Article						Aryl hydrocarbon receptor nuclear translocator; Oxygen sensing; Hep3B; HIF-1b; Hypoxia	ARYL-HYDROCARBON RECEPTOR; INDUCIBLE FACTOR-I; NUCLEAR TRANSLOCATOR; TRANSCRIPTION FACTOR; BINDING-SITES; HYPOXIA; PROTEINS; CANCER; COMPETITION; INDUCTION	Background: The transcription factor aryl hydrocarbon receptor nuclear translocator (ARNT) participates in the hypoxia-inducible factor (HIF) pathway which senses a decline in cellular oxygen tension. In hypoxia, HIF-1 alpha and ARNT form the transcriptional active complex HIF-1 followed by the expression of target genes. ARNT is considered as constitutively expressed and unaffected by hypoxia. However, certain tumour cell lines derived from different entities are capable to elevate ARNT expression under hypoxic conditions which implies a survival benefit. It was demonstrated that high ARNT protein levels mediate radioresistance in tumour cells. Furthermore, a HIF-1 alpha-driven feed-forward loop leading to augmented HIF signalling was discovered in Hep3B cells. Herein HIF-1 alpha elevates the mRNA and protein expression of its binding partner ARNT in hypoxia. However, the detailed mechanism remained unclear. The objective of this study was to test whether HIF-1 alpha might directly regulate ARNT expression by recruitment to the ARNT promoter. Methods: Chromatin immunoprecipitation (ChIP), CRISPR/Cas9 genome editing, Western blotting, quantitative RTPCR and reporter gene assays were applied. The unpaired t test was used for statistical analysis. Results: ChIP assays revealed the binding of both HIF-1 alpha and ARNT to the ARNT promoter in hypoxia. The relevance of this particular region for hypoxic ARNT induction was confirmed by CRISPR/Cas9 genome editing. ARNT normoxic basal expression and hypoxic inducibility was reduced in genome-edited Hep3B cells. This phenotype was accompanied with impaired HIF signalling and was rescued by ARNT overexpression. Conclusions: The results indicate ARNT to be a putative HIF-1 target gene and a limiting factor in this model.	[Depping, Reinhard] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Physiol, Ratzeburger Allee 160, D-23562 Lubeck, Germany; [Mandl, Markus] Univ Innsbruck, Inst Biomed Aging Res, Div Cell Metab & Differentiat Res, Rennweg 10, A-6020 Innsbruck, Austria	Depping, R (reprint author), Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Physiol, Ratzeburger Allee 160, D-23562 Lubeck, Germany.	reinhard.depping@uni-luebeck.de					Bersten DC, 2013, NAT REV CANCER, V13, P827, DOI 10.1038/nrc3621; Charpentier E, 2015, EMBO MOL MED, V7, P363, DOI 10.15252/emmm.201504847; Chilov D, 1999, J CELL SCI, V112, P1203; Depping R, 2015, J MOL MED, V93, P599, DOI 10.1007/s00109-015-1276-0; Dreos R, 2015, NUCLEIC ACIDS RES, V43, pD92, DOI 10.1093/nar/gku1111; Gradin K, 1996, MOL CELL BIOL, V16, P5221; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hunter SR, 2017, DRUG METAB DISPOS, V45, P118, DOI 10.1124/dmd.116.073833; Jaeger C, 2016, ENVIRON HEALTH INSIG, V10, P133, DOI 10.4137/EHI.S38343; Lisy K, 2008, CELL DEATH DIFFER, V15, P642, DOI 10.1038/sj.cdd.4402315; Lo R, 2012, TOXICOL SCI, V130, P349, DOI 10.1093/toxsci/kfs253; Mandl M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.187; Mandl M, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0539-9; Mandl M, 2014, MOL MED, V20, P215, DOI 10.2119/molmed.2014.00032; Mandl M, 2013, BIOCHEM BIOPH RES CO, V434, P166, DOI 10.1016/j.bbrc.2013.03.051; Park J, 2015, BIOINFORMATICS, V31, P4014, DOI 10.1093/bioinformatics/btv537; Platt JL, 2016, EMBO REP, V17, P1410, DOI 10.15252/embr.201642198; Pollenz RS, 1999, MOL PHARMACOL, V56, P1127; Ramani V, 2016, GENOM PROTEOM BIOINF, V14, P7, DOI 10.1016/j.gpb.2016.01.002; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; SOGAWA K, 1995, P NATL ACAD SCI USA, V92, P1936, DOI 10.1073/pnas.92.6.1936; van Uden P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001285; Vorrink SU, 2014, CHEM-BIOL INTERACT, V218, P82, DOI 10.1016/j.cbi.2014.05.001; Vorrink SU, 2014, TOXICOL APPL PHARM, V274, P408, DOI 10.1016/j.taap.2013.12.002; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wolff M, 2013, CELL PHYSIOL BIOCHEM, V32, P849, DOI 10.1159/000354487; Wong N, 2000, HEPATOLOGY, V32, P1060, DOI 10.1053/jhep.2000.19349; Xia XB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r113; Zagorska A, 2004, ACTA BIOCHIM POL, V51, P563; Zhong H, 2001, BIOCHEM BIOPH RES CO, V284, P352, DOI 10.1006/bbrc.2001.4981	30	0	0	2	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2867			CANCER CELL INT	Cancer Cell Int.	AUG 24	2017	17								77	10.1186/s12935-017-0446-2				11	Oncology	Oncology	FE6MM	WOS:000408323600001	28855849	gold			2018-01-05	
J	Butt, H; Eid, A; Ali, Z; Atia, MAM; Mokhtar, MM; Hassan, N; Lee, CM; Bao, G; Mahfouz, MM				Butt, Haroon; Eid, Ayman; Ali, Zahir; Atia, Mohamed A. M.; Mokhtar, Morad M.; Hassan, Norhan; Lee, Ciaran M.; Bao, Gang; Mahfouz, Magdy M.			Efficient CRISPR/Cas9-Mediated Genome Editing Using a Chimeric Single-Guide RNA Molecule	FRONTIERS IN PLANT SCIENCE			English	Article						genome engineering; CRISPR/Cas9; HDR; RNA-templated repair; gene editing	DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; DNA-REPAIR; TARGETED MUTAGENESIS; GENE; SYSTEM; PLANTS; MULTIPLEX; CELLS; RICE	The CRISPR/Cas9 system has been applied in diverse eukaryotic organisms for targeted mutagenesis. However, targeted gene editing is inefficient and requires the simultaneous delivery of a DNA template for homology-directed repair (HDR). Here, we used CRISPR/Cas9 to generate targeted double-strand breaks and to deliver an RNA repair template for HDR in rice (Oryza sativa). We used chimeric single-guide RNA (cgRNA) molecules carrying both sequences for target site specificity (to generate the double-strand breaks) and repair template sequences (to direct HDR), flanked by regions of homology to the target. Gene editing was more efficient in rice protoplasts using repair templates complementary to the non-target DNA strand, rather than the target strand. We applied this cgRNA repair method to generate herbicide resistance in rice, which showed that this cgRNA repair method can be used for targeted gene editing in plants. Our findings will facilitate applications in functional genomics and targeted improvement of crop traits.	[Butt, Haroon; Eid, Ayman; Ali, Zahir; Hassan, Norhan; Mahfouz, Magdy M.] King Abdullah Univ Sci & Technol, Lab Genome Engn, Div Biol Sci, Thuwal, Saudi Arabia; [Atia, Mohamed A. M.; Mokhtar, Morad M.] Agr Res Ctr, Mol Genet & Genome Mapping Lab, Agr Genet Engn Res Inst, Giza, Egypt; [Lee, Ciaran M.; Bao, Gang] Rice Univ, Dept Bioengn, Houston, TX USA	Mahfouz, MM (reprint author), King Abdullah Univ Sci & Technol, Lab Genome Engn, Div Biol Sci, Thuwal, Saudi Arabia.	magdy.mahfouz@kaust.edu.sa	MAHFOUZ, MAGDY/O-1550-2016	Lee, Ciaran/0000-0002-0789-9149	King Abdullah University of Science and Technology	This study was supported by King Abdullah University of Science and Technology.	Ali Z, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1044191; Angeleska A, 2007, J THEOR BIOL, V248, P706, DOI 10.1016/j.jtbi.2007.06.007; Aouida M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133373; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Bi YW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004090; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Butt H, 2014, J EXP BOT, V65, P1217, DOI 10.1093/jxb/ert480; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chipman D, 1998, BBA-PROTEIN STRUCT M, V1385, P401, DOI 10.1016/S0167-4838(98)00083-1; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Donoho G, 1998, MOL CELL BIOL, V18, P4070, DOI 10.1128/MCB.18.7.4070                                                           ; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Endo M, 2007, PLANT J, V52, P157, DOI 10.1111/j.1365-313X.2007.03230.x; Fauser F, 2012, P NATL ACAD SCI USA, V109, P7535, DOI 10.1073/pnas.1202191109; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Keskin H, 2016, RNA BIOL, V13, P157, DOI 10.1080/15476286.2015.1116676; Keskin H, 2014, NATURE, V515, P436, DOI 10.1038/nature13682; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MAZUR BJ, 1987, PLANT PHYSIOL, V85, P1110, DOI 10.1104/pp.85.4.1110; Meers C, 2016, DNA REPAIR, V44, P17, DOI 10.1016/j.dnarep.2016.05.002; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Onozawa M, 2014, P NATL ACAD SCI USA, V111, P7729, DOI 10.1073/pnas.1321889111; Osakabe Y, 2015, PLANT CELL PHYSIOL, V56, P389, DOI 10.1093/pcp/pcu170; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Puchta H, 1996, P NATL ACAD SCI USA, V93, P5055, DOI 10.1073/pnas.93.10.5055; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Shimizu T., 2005, P ACS S SERIES, P255; Steinert J, 2016, PLANT CELL REP, V35, P1429, DOI 10.1007/s00299-016-1981-3; Storici F, 2007, NATURE, V447, P338, DOI 10.1038/nature05720; Sugano SS, 2014, PLANT CELL PHYSIOL, V55, P475, DOI 10.1093/pcp/pcu014; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Terada R, 2002, NAT BIOTECHNOL, V20, P1030, DOI 10.1038/nbt737; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Verma P, 2016, GENE DEV, V30, P1138, DOI 10.1101/gad.280545.116; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Wang AT, 2015, MOL CELL, V59, P478, DOI 10.1016/j.molcel.2015.07.009; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Yamanaka S, 2014, CELL RES, V24, P511, DOI 10.1038/cr.2014.45; Zaidi SSEA, 2016, TRENDS PLANT SCI, V21, P279, DOI 10.1016/j.tplants.2016.01.023; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052	51	0	0	27	27	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	AUG 24	2017	8								1441	10.3389/fpls.2017.01441				8	Plant Sciences	Plant Sciences	FE7FX	WOS:000408374100001	28883826	gold			2018-01-05	
J	Martinez-Martinez, E; Ibarrola, J; Lachen-Montes, M; Fernandez-Celis, A; Jaisser, F; Santamaria, E; Fernandez-Irigoyen, J; Lopez-Andres, N				Martinez-Martinez, Ernesto; Ibarrola, Jaime; Lachen-Montes, Mercedes; Fernandez-Celis, Amaya; Jaisser, Frederic; Santamaria, Enrique; Fernandez-Irigoyen, Joaquin; Lopez-Andres, Natalia			Differential proteomics reveals S100-A11 as a key factor in aldosterone-induced collagen expression in human cardiac fibroblasts	JOURNAL OF PROTEOMICS			English	Article						Aldosterone; Proteomics; Collagen; Fibrosis	HEART-FAILURE; ANGIOTENSIN-II; MYOCARDIAL-INFARCTION; SIGNALING PATHWAY; FIBROSIS; TURNOVER; PROLIFERATION; INSIGHTS; SURVIVAL	Aldosterone (Aldo) could induce cardiac fibrosis, a hallmark of heart disease. Aldo direct effects on collagen production in cardiac fibroblasts remain controversial. Our aim is to characterize changes in the proteome of adult human cardiac fibroblasts treated with Aldo to identify new proteins altered that might be new therapeutic targets in cardiovascular" diseases. Aldo increased collagens expressions in human cardiac fibroblasts. Complementary, using a quantitative proteomic approach, 30 proteins were found differentially expressed between control and Aldo-treated cardiac fibroblasts. Among these proteins, 7 were up-regulated and 23 were down-regulated by Aldo. From the up-regulated proteins, collagen type I, collagen type III, collagen type VI and 5100-A11 were verified by Western blot. Moreover, protein interaction networks revealed a functional link between a third of Aldo modulated proteome and specific survival routes. S100-A11 was identified as a possible link between Aldo and collagen. Interestingly, CRISPR/Cas9-mediated knock-down of 5100-A11 blocked Aldo-induced collagen production in human cardiac fibroblasts. In adult human cardiac fibroblasts treated with Aldo, proteomic analyses revealed an increase in collagen production. S100-A11 was identified as a new regulator of Aldo-induced collagen production in human cardiac fibroblasts. These data could identify new candidate proteins for the treatment of cardiac fibrosis in cardiovascular diseases. Significance: S100-All is identified by a proteomic approach as a novel regulator of Aldosterone-induced collagen production in human cardiac fibroblasts. Our data could identify new candidate proteins of interest for the treatment of cardiac fibrosis in cardiovascular diseases. (C) 2017 Published by Elsevier B.V.	[Martinez-Martinez, Ernesto; Ibarrola, Jaime; Fernandez-Celis, Amaya; Lopez-Andres, Natalia] Fdn Miguel Servet, Inst Invest Sanitana Navarra IdiSNA, Cardiovasc Translat Res, Navarrabiomed, Pamplona, Spain; [Lachen-Montes, Mercedes; Santamaria, Enrique; Fernandez-Irigoyen, Joaquin] Univ Publ Navarra, IdiSNA, Navarra Inst Hlth Res, Dept Salud,Navarrabiomed,Proteom Unit,Proteored I, Pamplona, Spain; [Jaisser, Frederic] Univ Paris 06, Ctr Rech Cordeliers, INSERM, UMRS Team 1 1138, Paris, France; [Jaisser, Frederic; Lopez-Andres, Natalia] Univ Lorraine, CHRU Nancy, UMR 1116, INSERM,Ctr Invest Clin Plurithemat 1433, Nancy, France	Lopez-Andres, N (reprint author), Miguel Servet Fdn, Navarrabiomed, Cardiovasc Translat Res, C Irunlarrea 3, Pamplona 31008, Spain.	natalia.lopez.andres@navarra.es	Jaisser, Frederic/P-4287-2017	Jaisser, Frederic/0000-0001-9051-1901; Martinez-Martinez, Ernesto/0000-0002-3011-2041	"Institute de Salud Carlos III-FEDER, a way to build Europe" [CP13/00221]; Fondo de Investigaciones Sanitarias [P115/02160]; FIBROTARGETS project [602904]; FP7 funded COST ADMIRE network [BM1301]; Public University of Navarra; PE I+D+I - ISCIII [PT13/0001]; PE I+D+I - FEDER [PT13/0001]	This work was supported by Miguel Servet contract CP13/00221 from the "Institute de Salud Carlos III-FEDER, a way to build Europe", Fondo de Investigaciones Sanitarias [P115/02160], FIBROTARGETS project (Grant agreement number FP7 #602904) and the FP7 funded COST ADMIRE network (BM1301). JI and ML are supported by predoctoral fellowships from the Public University of Navarra. The Proteomics Unit of Navarrabiomed is a member of Proteored, PRB2-ISCIII, and is supported by grant PT13/0001, of the PE I+D+I 2013-2016 funded by ISCIII and FEDER.	BRILLA CG, 1994, J MOL CELL CARDIOL, V26, P809, DOI 10.1006/jmcc.1994.1098                                                          ; Brilla CG, 2000, HERZ, V25, P299, DOI 10.1007/s000590050024                                                           ; Bunda S, 2009, J BIOL CHEM, V284, P16633, DOI 10.1074/jbc.M109.008748; FULLERTON MJ, 1994, CARDIOVASC RES, V28, P1863, DOI 10.1093/cvr/28.12.1863; Heba G, 2001, J VASC RES, V38, P288, DOI 10.1159/000051057; Hung CS, 2016, HYPERTENSION, V67, P1309, DOI 10.1161/HYPERTENSIONAHA.115.06768; Iraqi W, 2009, CIRCULATION, V119, P2471, DOI 10.1161/CIRCULATIONAHA.108.809194; Kim CH, 2002, CIRC RES, V90, pE25, DOI 10.1161/hh0202.104923; Kohler E, 1996, J VASC RES, V33, P315, DOI 10.1159/000159159; Kotlyar M, 2015, NAT METHODS, V12, P79, DOI [10.1038/nmeth.3178, 10.1038/NMETH.3178]; Lagares D, 2013, BIODRUGS, V27, P15, DOI 10.1007/s40259-012-0003-4; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Liu JC, 2017, INT J CARDIOL, V228, P388, DOI 10.1016/j.ijcard.2016.11.202; Lopez-Andres N, 2008, ENDOCRINOLOGY, V149, P4970, DOI 10.1210/en.2008-0120; MacFadyen RJ, 1997, CARDIOVASC RES, V35, P30, DOI 10.1016/S0008-6363(97)00091-6                                                   ; Malmstrom J, 2004, MOL CELL PROTEOMICS, V3, P466, DOI 10.1074/mcp.M300108-MCP200; Martinez-Martinez E, 2015, HYPERTENSION, V66, P767, DOI 10.1161/HYPERTENSIONAHA.115.05876; Michel F, 2004, CIRCULATION, V109, P1933, DOI 10.1161/01.CIR.0000127112.36796.9B; Rogerson FM, 2000, STEROIDS, V65, P61, DOI 10.1016/S0039-128X(99)00087-2; Rombouts K, 2001, BRIT J PHARMACOL, V134, P224, DOI 10.1038/sj.bjp.0704247; Sakaguchi M, 2000, J CELL BIOL, V149, P1193, DOI 10.1083/jcb.149.6.1193                                                          ; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Stockand JD, 2003, AM J PHYSIOL-HEART C, V284, pH176, DOI 10.1152/ajpheart.00421.2002; Toba H, 2016, AM J PHYSIOL-ENDOC M, V310, pE1027, DOI 10.1152/ajpendo.00040.2016; Unwin RD, 2010, NAT PROTOC, V5, P1574, DOI 10.1038/nprot.2010.123; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Walczak C, 2011, BBA-MOL CELL RES, V1813, P2125, DOI 10.1016/j.bbamcr.2011.07.010; Zannad F, 2000, CIRCULATION, V102, P2700; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zhou GP, 1996, MOL CELL BIOCHEM, V154, P171, DOI 10.1007/BF00226785	31	0	0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-3919	1876-7737		J PROTEOMICS	J. Proteomics	AUG 23	2017	166						93	100		10.1016/j.jprot.2017.07.011				8	Biochemical Research Methods	Biochemistry & Molecular Biology	FG6GN	WOS:000410470300010	28739510				2018-01-05	
J	Chen, TJ; Gao, D; Zhang, RS; Zeng, GH; Yan, H; Lim, EJ; Liang, FS				Chen, Tingjun; Gao, Dan; Zhang, Roushu; Zeng, Guihua; Yan, Hao; Lim, Eunju; Liang, Fu-Sen			Chemically Controlled Epigenome Editing through an Inducible dCas9 System	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							HISTONE MODIFICATIONS; OPTICAL CONTROL; CHROMATIN; TRANSCRIPTION; PROTEIN; HETEROCHROMATIN; CRISPR-CAS9; SPECIFICITY; MODULATION; ENHANCERS	Although histone modifications are associated with gene activities, studies of their causal relationships have been difficult. For this purpose, we developed an inducible system integrating dCas9-based targeting and chemically induced proximity technologies to allow small, molecule induced recruitment of P300 acetyltransferase and the acetylation of H3K27 at precise gene loci in cells. Employing the new technique, we elucidated the temporal order of histone acetylation and gene activation, as well as the stability of the installed histone modification.	[Chen, Tingjun; Gao, Dan; Zhang, Roushu; Zeng, Guihua; Yan, Hao; Lim, Eunju; Liang, Fu-Sen] Univ New Mexico, Dept Chem & Chem Biol, 300 Terrace St NE, Albuquerque, NM 87131 USA	Liang, FS (reprint author), Univ New Mexico, Dept Chem & Chem Biol, 300 Terrace St NE, Albuquerque, NM 87131 USA.	fsliang@unm.edu	Yan, Hao/B-2358-2017	Yan, Hao/0000-0002-5418-0516	National Institutes of Health [R21 HG008776]	This work was supported by the National Institutes of Health R21 HG008776.	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Dancy BM, 2015, CHEM REV, V115, P2419, DOI 10.1021/cr500452k; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Delvecchio M, 2013, NAT STRUCT MOL BIOL, V20, P1040, DOI 10.1038/nsmb.2642; Fegan A, 2010, CHEM REV, V110, P3315, DOI 10.1021/cr8002888; Gao YC, 2016, NAT METHODS, V13, P1043, DOI [10.1038/NMETH.4042, 10.1038/nmeth.4042]; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hemphill J, 2015, J AM CHEM SOC, V137, P5642, DOI 10.1021/ja512664v; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kadoch C, 2017, NAT GENET, V49, P213, DOI 10.1038/ng.3734; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Liang FS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001449; Liu KI, 2016, NAT CHEM BIOL, V12, P980, DOI 10.1038/nchembio.2179; Maji B, 2017, NAT CHEM BIOL, V13, P9, DOI 10.1038/nchembio.2224; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Qi L. S., 2013, CELL, V152, P1173; Polstein LR, 2015, GENOME RES, V25, P1158, DOI 10.1101/gr.179044.114; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Stanton BZ, 2017, NAT GENET, V49, P282, DOI 10.1038/ng.3735; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412                                                                   ; Wright CW, 2015, CHEMBIOCHEM, V16, P254, DOI 10.1002/cbic.201402576; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhou WY, 2016, ANGEW CHEM INT EDIT, V55, P5394, DOI 10.1002/anie.201511441	29	0	0	10	10	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	AUG 23	2017	139	33					11337	11340		10.1021/jacs.7b06555				4	Chemistry, Multidisciplinary	Chemistry	FE9JI	WOS:000408519600008	28787145				2018-01-05	
J	Wang, J; Li, W; Zhang, LC; Ban, L; Chen, P; Du, W; Feng, XJ; Liu, BF				Wang, Jie; Li, Wei; Zhang, Leicheng; Ban, Lin; Chen, Peng; Du, Wei; Feng, Xiaojun; Liu, Bi-Feng			Chemically Edited Exosomes with Dual Ligand Purified by Microfluidic Device for Active Targeted Drug Delivery to Tumor Cells	ACS APPLIED MATERIALS & INTERFACES			English	Article						exosome; microfluidic chip; scalable separation; dual ligands; tumor targeting; drug delivery	EXTRACELLULAR VESICLES; CANCER-THERAPY; GENE-THERAPY; NANOPARTICLES; BIOTIN; AVIDIN; MICROVESICLES; BLOOD; CHIP; RNA	Exosomes, which are lipid membrane-bound DSPE-PEG-Biotin nanovesicles (50-150 nm in diameter), have aroused extensive attention for their potential applications in invasive molecular and stand for a new therapeutic delivery system. However, they are limited by poor targeting ability and a lack of efficient isolation techniques. Here, we present a three-dimensional nanostructured microfluidic chip, in which arrays of micro pillars were functionalized with crisscrossed multiwall carbon nanotubes by chemical deposition, to capture,exosomes with high efficiency through a combination of a specific recognition molecule (CD63) and the unique topography of the nanormaterials. As is proven, this nanostructured interface substantially made the immuno, capturing of exosomes more efficient. A high percentage of intact vesicles < 150 nm were readily purified. As a further application, we added functionality to the exosomes by a chemical editing approach for targeted drug delivery. Donor cells were labeled chemically with dual ligands (biotin and avidin) in the phospholipid membrane and encapsulated drugs in,the cytosol. Though the engineered donor cells, secreted exosomes, the dual ligands, together with the drugs, were inherited by the exosomes, which were then isolated with the microfluidic chip. Then, the isolated,exosomes were used as drug delivery vehicles and showed strong targeting abilities to tumor cells and highly efficient receptor-mediated cellular uptake when exposed to recipient cells. Thus, the anticancer effect of chemotherapeutic drugs was improved significantly. It suggested. hat this platform could provide a useful tool for isolating intact exosomes with high efficiency and exploiting their natural carrier function. to deliver chemotherapeutic drugs to tumor Cells with increased efficacy and targeting capacity.	[Wang, Jie; Li, Wei; Zhang, Leicheng; Ban, Lin; Chen, Peng; Du, Wei; Feng, Xiaojun; Liu, Bi-Feng] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect,Dept Biomed Engn,Coll Li, Hubei Bioinformat & Mol Imaging Key Lab,Syst Biol, Wuhan 430074, Hubei, Peoples R China	Liu, BF (reprint author), Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect,Dept Biomed Engn,Coll Li, Hubei Bioinformat & Mol Imaging Key Lab,Syst Biol, Wuhan 430074, Hubei, Peoples R China.	bfliu@mail.hust.edu.cn			National Natural Science Foundation of China [21275060, 21475049, 31471257]; National Key R&D Program of China [2016YFF0100801]	We gratefully acknowledge the financial supports from National Natural Science Foundation of China (21275060, 21475049, and 31471257) and National Key R&D Program of China (2016YFF0100801).	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Barnard AS, 2006, NAT MATER, V5, P245, DOI 10.1038/nmat1625; Bu L, 2013, INT J PHARMACEUT, V452, P355, DOI 10.1016/j.ijpharm.2013.05.007; Chen C, 2010, LAB CHIP, V10, P505, DOI 10.1039/b916199f; Chen G, 2015, ANGEW CHEM INT EDIT, V54, P1036, DOI 10.1002/anie.201410223; Chen SY, 2010, BIOCONJUGATE CHEM, V21, P979, DOI 10.1021/bc9005656; Davies RT, 2012, LAB CHIP, V12, P5202, DOI 10.1039/c2lc41006k; Deregibus MC, 2016, INT J MOL MED, V38, P1359, DOI 10.3892/ijmm.2016.2759; Dolatmoradi A, 2017, LAB CHIP, V17, P1332, DOI 10.1039/c7lc00161d; Hama Y, 2007, CANCER RES, V67, P2791, DOI 10.1158/0008-5472.CAN-06-3315; Hama Y, 2006, BIOCHEM BIOPH RES CO, V348, P807, DOI 10.1016/j.bbrc.2006.07.169; Heo DN, 2012, BIOMATERIALS, V33, P856, DOI 10.1016/j.biomaterials.2011.09.064; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hu YL, 2010, INT J PHARMACEUT, V394, P115, DOI 10.1016/j.ijpharm.2010.04.026; Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005; Kibria G, 2011, J CONTROL RELEASE, V153, P141, DOI 10.1016/j.jconrel.2011.03.012; Kim H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15880; Lee K, 2015, ACS NANO, V9, P2321, DOI 10.1021/nn506538f; Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595; Li M, 2013, J MATER CHEM B, V1, P676, DOI 10.1039/c2tb00155a; Liga A, 2015, LAB CHIP, V15, P2388, DOI 10.1039/c5lc00240k; Mizutani K, 2014, ANTICANCER RES, V34, P3419; Muller L, 2014, J IMMUNOL METHODS, V411, P55, DOI 10.1016/j.jim.2014.06.007; Nguyen TT, 2012, ANAL CHEM, V84, P201, DOI 10.1021/ac202375n; Nie Y, 2011, J CONTROL RELEASE, V152, P127, DOI 10.1016/j.jconrel.2011.02.028; Osada-Oka M, 2017, HYPERTENS RES, V40, P353, DOI 10.1038/hr.2016.163; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Qi HZ, 2016, ACS NANO, V10, P3323, DOI 10.1021/acsnano.5b06939; Shao HL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7999; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sun TM, 2014, ANGEW CHEM INT EDIT, V53, P12320, DOI 10.1002/anie.201403036; Taller D, 2015, LAB CHIP, V15, P1656, DOI 10.1039/c5lc00036j; Tan A, 2013, ADV DRUG DELIVER REV, V65, P357, DOI 10.1016/j.addr.2012.06.014; Tang K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2282; Tian YH, 2014, BIOMATERIALS, V35, P2383, DOI 10.1016/j.biomaterials.2013.11.083; Tintut Y, 2015, CIRC RES, V116, P1281, DOI 10.1161/CIRCRESAHA.115.306324; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Vader P, 2016, ADV DRUG DELIVER REV, V106, P148, DOI 10.1016/j.addr.2016.02.006; Wang ZX, 2013, LAB CHIP, V13, P2879, DOI 10.1039/c3lc41343h; Weng YJ, 2016, ANALYST, V141, P4640, DOI 10.1039/c6an00892e; Woo HK, 2017, ACS NANO, V11, P1360, DOI 10.1021/acsnano.6b06131; Xitong D., 2016, GENE, V575, P377, DOI DOI 10.1016/J.GENE.2015.08.067; Xu R, 2015, METHODS, V87, P11, DOI 10.1016/j.ymeth.2015.04.008; Yamamoto T, 2016, SCI TECHNOL ADV MAT, V17, P677, DOI 10.1080/14686996.2016.1240006; Yang WJ, 2009, EUR J MED CHEM, V44, P862, DOI 10.1016/j.ejmech.2008.04.021; Yim N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12277; Zhang P, 2016, LAB CHIP, V16, P3033, DOI 10.1039/c6lc00279j; Zhao Z, 2016, LAB CHIP, V16, P489, DOI 10.1039/c5lc01117e	48	2	2	46	46	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1944-8244			ACS APPL MATER INTER	ACS Appl. Mater. Interfaces	AUG 23	2017	9	33					27441	27452		10.1021/acsami.7b06464				12	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	FE9JA	WOS:000408518800015	28762264				2018-01-05	
J	Zheng, YM; Lin, FL; Gao, H; Zou, G; Zhang, JW; Wang, GQ; Chen, GD; Zhou, ZH; Yao, XS; Hu, D				Zheng, Yan-Mei; Lin, Fu-Long; Gao, Hao; Zou, Gen; Zhang, Jiang-Wei; Wang, Gao-Qian; Chen, Guo-Dong; Zhou, Zhi-Hua; Yao, Xin-Sheng; Hu, Dan			Development of a versatile and conventional technique for gene disruption in filamentous fungi based on CRISPR-Cas9 technology	SCIENTIFIC REPORTS			English	Article							ASPERGILLUS-FUMIGATUS; MOLECULAR-BIOLOGY; NATURAL-PRODUCTS; NODULISPORIUM SP; CRISPR/CAS9; ENZYMES; SYSTEM	Filamentous fungi represent an invaluable source of pharmaceutically active compounds. The development of versatile methods to genetically manipulate filamentous fungi is of great value for improving the low yields of bioactive metabolites and expanding chemical diversity. The CRISPR-Cas9-based system has become a common platform for genome editing in a variety of organisms. However, recent application of this technology in filamentous fungi is limited to model strains, a versatile method for efficient gene disruption in different fungi is lacking. Here, we investigated the utility of the CRISPR-Cas9 system in a less-studied fungus Nodulisporium sp. (No. 65-12-7-1), and we have developed an efficient CRISPR-Cas9-based gene disruption strategy by simultaneous transformation of in vitro transcriptional gRNA and the linear maker gene cassette into the Cas9-expressing fungi. We found that the linear marker gene cassette could not only allow for selection of transformants, but also significantly enhance the gene disruption efficiency by inserting itself into the Cas9 cut site. Moreover, the above approach also demonstrated its efficiency in two other phylogenetically distinct strains Aspergillus oryzae NSAR1 and Sporormiella minima (No. 40-1-4-1) from two different classes of Ascomycota. These results suggested that a versatile CRISPR-Cas9-based gene disruption method in filamentous fungi was established.	[Zheng, Yan-Mei; Lin, Fu-Long; Gao, Hao; Zhang, Jiang-Wei; Wang, Gao-Qian; Chen, Guo-Dong; Yao, Xin-Sheng; Hu, Dan] Jinan Univ, Guangdong Prov Key Lab Pharmacodynam Constituents, Coll Pharm, Inst Tradit Chinese Med & Nat Prod, Guangzhou 510632, Guangdong, Peoples R China; [Zou, Gen; Zhou, Zhi-Hua] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, CAS Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Hu, Dan] Univ Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China	Gao, H; Hu, D (reprint author), Jinan Univ, Guangdong Prov Key Lab Pharmacodynam Constituents, Coll Pharm, Inst Tradit Chinese Med & Nat Prod, Guangzhou 510632, Guangdong, Peoples R China.; Hu, D (reprint author), Univ Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China.	tghao@jnu.edu.cn; thudan@jnu.edu.cn			National Natural Science Foundation of China [31670036, 81302673, 81373306, 81422054]; Natural Science Foundation of Guangdong Province [2014A030313389]; Guangdong Natural Science Funds for Distinguished Young Scholar [S2013050014287]; Guangdong Special Support Program [2016TX03R280]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; K.C. Wong Education Foundation	This work was mainly supported by grants from the National Natural Science Foundation of China (31670036, 81302673, 81373306, 81422054), Natural Science Foundation of Guangdong Province (2014A030313389), Guangdong Natural Science Funds for Distinguished Young Scholar (S2013050014287), Guangdong Special Support Program (2016TX03R280), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (Hao Gao, 2014), and K.C. Wong Education Foundation (Hao Gao, 2016). We are a grateful to Prof. Maruyam from the University of Tokyo for providing pUNAFNC9gwA1. Assistance with the proper usage of scientific English was provided by Dr. L.J. Sparvero from the University of Pittsburgh.	Alberti F, 2017, APPL MICROBIOL BIOT, V101, P493, DOI 10.1007/s00253-016-8034-2; Arazoe T, 2015, BIOTECHNOL BIOENG, V112, P2543, DOI 10.1002/bit.25662; Bachu R, 2015, BIOTECHNOL BIOENG, V112, P2154, DOI 10.1002/bit.25629; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; HAMLYN PF, 1981, ENZYME MICROB TECH, V3, P321, DOI 10.1016/0141-0229(81)90007-7; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Katayama T, 2016, BIOTECHNOL LETT, V38, P637, DOI 10.1007/s10529-015-2015-x; Kitamoto K, 2002, ADV APPL MICROBIOL, V51, P129, DOI 10.1016/S0065-2164(02)51004-2; Kuivanen J, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0613-5; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Liu TH, 2010, NEW BIOTECHNOL, V27, P64, DOI 10.1016/j.nbt.2009.08.009; Liu X, 2017, ACTA PHARM SIN B, V7, P292, DOI 10.1016/j.apsb.2017.01.002; MANN W, 1986, BIOSCIENCE REP, V6, P597, DOI 10.1007/BF01114753                                                              ; Matsu-Ura Toru, 2015, Fungal Biol Biotechnol, V2, P4, DOI 10.1186/s40694-015-0015-1; Ng H., 2017, mSphere, V2, pe00385, DOI 10.1128/msphere.00385-16; Nielsen ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169712; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schmidt-Dannert C, 2015, MICROB BIOTECHNOL, V8, P26, DOI 10.1111/1751-7915.12184; Schuster M, 2016, FUNGAL GENET BIOL, V89, P3, DOI 10.1016/j.fgb.2015.09.001; Wenderoth M, 2017, FUNGAL GENET BIOL, V101, P55, DOI 10.1016/j.fgb.2017.03.001; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Zhang C, 2016, FUNGAL GENET BIOL, V86, P47, DOI 10.1016/j.fgb.2015.12.007; Zhao Q, 2015, J NAT PROD, V78, P1221, DOI 10.1021/np500912t; Zheng QC, 2013, STEROIDS, V78, P896, DOI 10.1016/j.steroids.2013.05.007	28	0	0	25	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 23	2017	7								9250	10.1038/s41598-017-10052-3				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FE5OO	WOS:000408261000002	28835711	gold			2018-01-05	
J	Sattar, MN; Iqbal, Z; Tahir, MN; Shahid, MS; Khurshid, M; Al-Khateeb, AA; Al-Khateeb, SA				Sattar, Muhammad N.; Iqbal, Zafar; Tahir, Muhammad N.; Shahid, Muhammad S.; Khurshid, Muhammad; Al-Khateeb, Abdullatif A.; Al-Khateeb, Suliman A.			CRISPR/Cas9: A Practical Approach in Date Palm Genome Editing	FRONTIERS IN PLANT SCIENCE			English	Review						CRISPR/Cas9; date palm; genome editing; multiplexing; loss of and gain-of-functions	ZINC-FINGER NUCLEASES; TAL EFFECTOR NUCLEASES; TARGETED MUTAGENESIS; PHOENIX-DACTYLIFERA; ARABIDOPSIS-THALIANA; PAIRED NICKASES; PLANT GENOME; GUIDE-RNA; HOMOLOGOUS RECOMBINATION; CRISPR-CAS9 NUCLEASES	The genetic modifications through breeding of crop plants have long been used to improve the yield and quality. However, precise genome editing (GE) could be a very useful supplementary tool for improvement of crop plants by targeted genome modifications. Various GE techniques including ZFNs (zinc finger nucleases), TALENs (transcription activator-like effector nucleases), and most recently clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 (CRISPR-associated protein 9)based approaches have been successfully employed for various crop plants including fruit trees. CRISPR/Cas9-based approaches hold great potential in GE due to their simplicity, competency, and versatility over other GE techniques. However, to the best of our knowledge no such genetic improvement has ever been developed in date palm-an important fruit crop in Oasis agriculture. The applications of CRISPR/Cas9 can be a challenging task in date palm GE due to its large and complex genome, high rate of heterozygosity and outcrossing, in vitro regeneration and screening of mutants, high frequency of single-nucleotide polymorphism in the genome and ultimately genetic instability. In this review, we addressed the potential application of CRISPR/Cas9-based approaches in date palm GE to improve the sustainable date palm production. The availability of the date palm whole genome sequence has made it feasible to use CRISPR/Cas9 GE approach for genetic improvement in this species. Moreover, the future prospects of GE application in date palm are also addressed in this review.	[Sattar, Muhammad N.; Al-Khateeb, Suliman A.] King Faisal Univ, Fac Agr & Food Sci, Dept Environm & Nat Resources, Al Hasa, Saudi Arabia; [Iqbal, Zafar] Akhuwat Faisalabad Inst Res Sci & Technol, Faisalabad, Pakistan; [Tahir, Muhammad N.] Natl Inst Biotechnol & Genet Engn, Faisalabad, Pakistan; [Shahid, Muhammad S.] Sultan Qaboos Univ, Coll Agr & Marine Sci, Dept Crop Sci, Al Khoud, Oman; [Khurshid, Muhammad] Univ Punjab, Inst Biochem & Biotechnol, Lahore, Pakistan; [Al-Khateeb, Abdullatif A.] King Faisal Univ, Fac Agr & Food Sci, Plant Biotechnol Dept, Al Hasa, Saudi Arabia; [Al-Khateeb, Suliman A.] Minist Environm Water & Agr, Riyadh, Saudi Arabia	Sattar, MN (reprint author), King Faisal Univ, Fac Agr & Food Sci, Dept Environm & Nat Resources, Al Hasa, Saudi Arabia.	naeem.sattar1177@gmail.com					Ainley WM, 2013, PLANT BIOTECHNOL J, V11, P1126, DOI 10.1111/pbi.12107; Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Al-Mssallem IS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3274; Al-Sadi AM, 2012, CROP PROT, V37, P1, DOI 10.1016/j.cropro.2012.02.011; Ali Z, 2015, MOL PLANT, V8, P1288, DOI 10.1016/j.molp.2015.02.011; Al-Khayri JM, 2015, DATE PALM GENETIC RE; Arzani A, 2016, CRIT REV PLANT SCI, V35, P146, DOI 10.1080/07352689.2016.1245056; Bekheet SA, 2011, DATE PALM BIOTECHNOLOGY, P551, DOI 10.1007/978-94-007-1318-5_26; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Bourgis F, 2011, P NATL ACAD SCI USA, V108, P12527, DOI 10.1073/pnas.1106502108; Braatz J, 2017, PLANT PHYSIOL, V174, P935, DOI 10.1104/pp.17.00426; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Butler NM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01045; Char SN, 2017, PLANT BIOTECHNOL J, V15, P257, DOI 10.1111/pbi.12611; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Christian M, 2013, G3-GENES GENOM GENET, V3, P1697, DOI 10.1534/g3.113.007104; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Curtin SJ, 2013, METHODS MOL BIOL, V1069, P25, DOI 10.1007/978-1-62703-613-9_3; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Ding YD, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00703; Dong FP, 2017, BIOCHEM BIOPH RES CO, V482, P889, DOI 10.1016/j.bbrc.2016.11.129; El Rabey HA, 2015, INT J GENOMICS, DOI 10.1155/2015/407165; Fan D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12217; Fang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037164; Fang YF, 2016, MOL PLANT PATHOL, V17, P127, DOI 10.1111/mpp.12318; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Ferry M., 2002, Palms, V46, P172; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gao JP, 2015, PLANT MOL BIOL, V87, P99, DOI 10.1007/s11103-014-0263-0; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hazzouri KM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9824; Honda A, 2015, EXP ANIM TOKYO, V64, P31, DOI 10.1538/expanim.14-0034; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hua YF, 2017, J GENET GENOMICS, V44, P207, DOI 10.1016/j.jgg.2017.03.005; Iqbal Z, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00475; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jain SM, 2011, DATE PALM BIOTECHNOLOGY, P271, DOI 10.1007/978-94-007-1318-5_14; Jia HG, 2016, PLANT BIOTECHNOL J, V14, P1291, DOI 10.1111/pbi.12495; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jubrael JMS, 2005, J AM SOC HORTIC SCI, V130, P442; Kanchiswamy CN, 2016, PLANT CELL REP, V35, P1469, DOI 10.1007/s00299-016-1982-2; Kanda Y, 2017, BIOSCI BIOTECH BIOCH, V81, P1497, DOI 10.1080/09168451.2017.1325710; Khan A, 2012, PLANT MOL BIOL REP, V30, P666, DOI 10.1007/s11105-011-0373-7; Khan MS, 2005, TRENDS PLANT SCI, V10, P1, DOI 10.1016/j.tplants.2004.11.001; Khatodia S, 2017, BIOENGINEERED, V8, P274, DOI 10.1080/21655979.2017.1297347; Khatodia S, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2015.00506, 10.3389/fpls.2016.00506]; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lee CM, 2016, MOL THER, V24, P475, DOI 10.1038/mt.2016.1; Lee DW, 2008, PLANT CELL, V20, P1603, DOI 10.1105/tpc.108.060541; Lei S. Q., 2013, CELL, V152, P1173, DOI [10.1016/j.cell.2013.02.022, DOI 10.1016/J.CELL.2013.02.022]; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li R., 2017, PLANT BIOTECHNOL J, DOI [10.1111/pbi.12781, DOI 10.1111/PBI.12781]; Liu DF, 2012, J EXP BOT, V63, P3899, DOI 10.1093/jxb/ers079; Liu J, 2015, NAT PROTOC, V10, P1842, DOI 10.1038/nprot.2015.117; Lowder L. G., 2017, PLANT GENE REGULATOR, P167; Lu HP, 2017, PLANT BIOTECHNOL J, V15, P1371, DOI 10.1111/pbi.12788; Ma XL, 2016, MOL PLANT, V9, P961, DOI 10.1016/j.molp.2016.04.009; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mahmoudi H., 2008, Journal of Organic Systems, V3, P29; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Malnoy M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01904; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Mathew LS, 2015, G3-GENES GENOM GENET, V5, P1429, DOI 10.1534/g3.115.018341; Mercx S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00403; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Mikami M, 2016, PLANT CELL PHYSIOL, V57, P1058, DOI 10.1093/pcp/pcw049; Minkenberg B, 2017, PLANT J, V89, P636, DOI 10.1111/tpj.13399; Mokhtar MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159268; Mousavi M, 2014, MOL BIOL REP, V41, P8185, DOI 10.1007/s11033-014-3720-6; Nekrasov V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00578-x; Nishitani C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31481; Pater S., 2013, PLANT BIOTECHNOL J, V11, P510, DOI [10.1111/pbi.12040, DOI 10.1111/PBI.12040]; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Peng AH, 2017, PLANT BIOTECHNOL J, V15, P1509, DOI 10.1111/pbi.12733; Peterson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162169; Pintaud J. C., 2011, P 1 INT S DAT PALM A, P19; Qi WW, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0289-2; Qi YP, 2013, G3-GENES GENOM GENET, V3, P1707, DOI 10.1534/g3.113.006270; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rekik I, 2015, THEOR BIOL MED MODEL, V12, DOI 10.1186/s12976-015-0013-2; Sabir JSM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094158; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Sedra M., 2007, P 4 S DAT PALM; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shen L, 2017, SCI CHINA LIFE SCI, V60, P506, DOI 10.1007/s11427-017-9008-8; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Siebert R, 2002, PLANT CELL, V14, P1121, DOI 10.1105/tpc.001727; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Sun ZJ, 2013, J INTEGR PLANT BIOL, V55, P1092, DOI 10.1111/jipb.12091; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Tsai CJ, 2015, GM CROPS FOOD, V6, P206, DOI 10.1080/21645698.2015.1091553; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Wang FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154027; Wang MG, 2017, MOL PLANT, V10, P1011, DOI 10.1016/j.molp.2017.03.001; Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Xiao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071435; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xin CQ, 2015, GENOMICS, V105, P242, DOI 10.1016/j.ygeno.2015.01.004; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yaish MW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00946; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Yin YX, 2012, PLANT MOL BIOL, V78, P617, DOI 10.1007/s11103-012-9890-5; Zhang F, 2011, METHODS MOL BIOL, V701, P167, DOI 10.1007/978-1-61737-957-4_9; Zhang GY, 2012, PLANT MOL BIOL, V79, P521, DOI 10.1007/s11103-012-9924-z; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; ZHANG Y, 2016, NAT COMMUN, V7; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zhang YW, 2017, PLANT J, V91, P714, DOI 10.1111/tpj.13599; Zhang ZJ, 2016, PLANT CELL REP, V35, P1519, DOI 10.1007/s00299-015-1900-z; Zhao YL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-237; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zhou XH, 2015, NEW PHYTOL, V208, P298, DOI 10.1111/nph.13470	123	0	0	32	32	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	AUG 23	2017	8								1469	10.3389/fpls.2017.01469				16	Plant Sciences	Plant Sciences	FE4WA	WOS:000408212800004	28878801	gold			2018-01-05	
J	Fernandez-Cardenas, LP; Villanueva-Chimal, E; Salinas, LS; Jose-Nunez, C; Puyou, MTD; Navarro, RE				Fernandez-Cardenas, L. P.; Villanueva-Chimal, E.; Salinas, L. S.; Jose-Nunez, C.; de Gomez Puyou, M. Tuena; Navarro, R. E.			Caenorhabditis elegans ATPase inhibitor factor 1 (IF1) MAI-2 preserves the mitochondrial membrane potential (Delta Psi(m)) and is important to induce germ cell apoptosis	PLOS ONE			English	Article							C. ELEGANS; ADENOSINE-TRIPHOSPHATASE; TUMOR-SUPPRESSOR; PROTEIN IF1; DNA-DAMAGE; SYNTHASE; ATPIF1; DEATH; ELECTROPHORESIS; MECHANISMS	When the electrochemical proton gradient is disrupted in the mitochondria, IF1(Inhibitor Factor-1) inhibits the reverse hydrolytic activity of the F1Fo-ATP synthase, thereby allowing cells to conserve ATP at the expense of losing the mitochondrial membrane potential (Delta Psi(m)). The function of IF1 has been studied mainly in different cell lines, but these studies have generated contrasting results, which have not been helpful to understand the real role of this protein in a whole organism. In this work, we studied IF1 function in Caenorhabditis elegans to understand IF1's role in vivo. C. elegans has two inhibitor proteins of the F1Fo-ATPase, MAI-1 and MAI-2. To determine their protein localization in C. elegans, we generated translational reporters and found that MAI-2 is expressed ubiquitously in the mitochondria; conversely, MAI-1 was found in the cytoplasm and nuclei of certain tissues. By CRISPR/Cas9 genome editing, we generated mai-2 mutant alleles. Here, we showed that mai-2 mutant animals have normal progeny, embryonic development and lifespan. Contrasting with the results previously obtained in cell lines, we found no evident defects in the mitochondrial network, dimer/monomer ATP synthase ratio, ATP concentration or respiration. Our results suggest that some of the roles previously attributed to IF1 in cell lines could not reflect the function of this protein in a whole organism and could be attributed to specific cell lines or methods used to silence, knockout or overexpress this protein. However, we did observe that animals lacking IF1 had an enhanced Delta Psi(m) and lower physiological germ cell apoptosis. Importantly, we found that mai-2 mutant animals must be under stress to observe the role of IF1. Accordingly, we observed that mai-2 mutant animals were more sensitive to heat shock, oxidative stress and electron transport chain blockade. Furthermore, we observed that IF1 is important to induce germ cell apoptosis under certain types of stress. Here, we propose that MAI-2 might play a role in apoptosis by regulating Delta Psi(m). Additionally, we suggest that IF1 function is mainly observed under stress and that, under physiological conditions, this protein does not play an essential role.	[Fernandez-Cardenas, L. P.; Villanueva-Chimal, E.; Salinas, L. S.; Navarro, R. E.] Univ Nacl Autonoma Mexico, Dept Biol Celular & Desarrollo, Inst Fisiol Celular, Ciudad De Mexico, Mexico; [Jose-Nunez, C.; de Gomez Puyou, M. Tuena] Univ Nacl Autonoma Mexico, Dept Bioquim & Biol Estruct, Inst Fisiol Celular, Ciudad De Mexico, Mexico	Navarro, RE (reprint author), Univ Nacl Autonoma Mexico, Dept Biol Celular & Desarrollo, Inst Fisiol Celular, Ciudad De Mexico, Mexico.; Puyou, MTD (reprint author), Univ Nacl Autonoma Mexico, Dept Bioquim & Biol Estruct, Inst Fisiol Celular, Ciudad De Mexico, Mexico.	mtuena@ifc.unam.mx; rnavarro@ifc.unam.mx			Direccion General de Asuntos del Personal Academic PAPIIT-UNAM [IN207412, IN207415]; Consejo Nacional de Ciencia y Tecnologia-MEXICO [103856-Q, 220987]; CONACyT; PAPIIT-UNAM; NIH Office of Research Infrastructure Programs [P40 OD010440]	This work was supported by grants from Direccion General de Asuntos del Personal Academic PAPIIT-UNAM (IN207412 and IN207415) and Consejo Nacional de Ciencia y Tecnologia-MEXICO (103856-Q and 220987) to R. E.N. L.P.F.C. is a doctoral student from Programa de Doctorado en Ciencias Bioquimicas, Universidad Nacional Autonoma de Mexico (UNAM) and received fellowships from CONACyT and PAPIIT-UNAM. Fundacion Miguel Aleman/UNAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Some strains were provided by CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We thank WormBase release WS224 for gathering information and making it available. We also thank T. Keith Blackwell and members of the Navarro lab for their insightful comments on the development of this project as well to Salvador Uribe Carvajal, Emilio Espinoza and Alfredo Cabrera Orefice for kindly advising us and borrowing us the equipment and/or materials for respiratory experiments and ATP quantifications. We are grateful Erik M. Jorgensen, C. Frokjaer-Jensen for kindly providing reagents for MosSCI experiments. We thank Rachel Beltzhoover for reading and kindly editing our manuscript. L.P.F.C. is a doctoral student from Programa de Doctorado en Ciencias Bioquimicas, Universidad Nacional Autonoma de Mexico (UNAM) and received fellowships from CONACyT and PAPIIT-UNAM.	Andreux PA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05285; Arun P, 2005, ANAL BIOCHEM, V339, P282, DOI 10.1016/j.ab.2005.01.015; Barbato S, 2015, J BIOL CHEM, V290, P6338, DOI 10.1074/jbc.M114.631788; Bollag D, 1996, PROTEIN METHODS; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717                                                ; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; BRENNER S, 1974, GENETICS, V77, P71; Buzhynskyy N, 2007, BIOPHYS J, V93, P2870, DOI 10.1529/biophysj.107.109728; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Campanella M, 2009, BBA-BIOENERGETICS, V1787, P393, DOI 10.1016/j.bbabio.2009.02.023; Chen WW, 2014, CELL REP, V7, P27, DOI 10.1016/j.celrep.2014.02.046; Faccenda D, 2013, CELL DEATH DIFFER, V20, P686, DOI 10.1038/cdd.2012.163; Faccenda D, 2012, INT J CELL BIOL, V2012, P1; Faccenda D, 2017, CELL REP, V18, P1869, DOI 10.1016/j.celrep.2017.01.070; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865; Fujikawa M, 2012, J BIOL CHEM, V287, P18781, DOI 10.1074/jbc.M112.345793; Garcia JJ, 2006, BIOCHEMISTRY-US, V45, P12695, DOI 10.1021/bi060339j; Garcia-Bermudez J, 2016, BIOCH BIOPHYS ACTA; Carlos Giovanni SG, 2013, GENESIS, V51, P690; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Grad Leslie I, 2007, Methods Mol Biol, V372, P51, DOI 10.1007/978-1-59745-365-3_4; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Ichikawa N, 2006, J BIOENERG BIOMEMBR, V38, P93, DOI 10.1007/s10863-006-9009-2; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Jensen C, 2008, NAT GENET, V40, P1375; Labbadia J, 2015, MOL CELL, V59, P639, DOI 10.1016/j.molcel.2015.06.027; Lascarez-Lagunas LI, 2014, MOL CELL BIOL, V34, P2499, DOI 10.1128/MCB.01532-13; Lefebvre V, 2013, AUTOPHAGY, V9, P1770, DOI 10.4161/auto.25413; Liu X, 2009, CELL, V139, P623, DOI 10.1016/j.cell.2009.08.044; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762                                                         ; MADURO M, 1995, GENETICS, V141, P977; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Merritt C, 2008, REPORT 3 0 UTRS ARE, P1476; MITCHELL P, 1967, NATURE, V213, P137, DOI 10.1038/213137a0; Nakamura J, 2013, BIOSCIENCE REP, V33, P735, DOI 10.1042/BSR20130078; Paix A, 2014, GENETICS, V198, P1347, DOI 10.1534/genetics.114.170423; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Paz-Gomez D, 2014, PLOS ONE, V9; PETRONILLI V, 1993, J BIOL CHEM, V268, P21939; Praitis V, 2001, GENETICS, V157, P1217; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Rolland SG, 2014, METHOD ENZYMOL, V544, P75, DOI 10.1016/B978-0-12-417158-9.00004-2; Saldanha JN, 2013, TOXICOL SCI, V135, P156, DOI 10.1093/toxsci/kft138; Salinas LS, 2006, CELL DEATH DIFFER, V13, P2129, DOI 10.1038/sj.cdd.4401976; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schertel C, 2007, DEVELOPMENT, V134, P3691, DOI 10.1242/dev.004606; SCHLEYER M, 1982, EUR J BIOCHEM, V125, P109, DOI 10.1111/j.1432-1033.1982.tb06657.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Seervi M, 2015, MITOCHONDRIAL CELL D; Shah DI, 2012, NATURE, V491, P608, DOI 10.1038/nature11536; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; Sun AY, 1997, GENETICS, V147, P1077; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wilkinson DS, 2012, METHOD CELL BIOL, V107, P353, DOI 10.1016/B978-0-12-394620-1.00012-6; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055; YOSHIDA M, 1975, J BIOL CHEM, V250, P7910	66	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0181984	10.1371/journal.pone.0181984				25	Multidisciplinary Sciences	Science & Technology - Other Topics	FE2ZB	WOS:000408085100006	28829773	gold			2018-01-05	
J	Pomerantsev, AP; McCall, RM; Chahoud, M; Hepler, NK; Fattah, R; Leppla, SH				Pomerantsev, Andrei P.; McCall, Rita M.; Chahoud, Margaret; Hepler, Nathan K.; Fattah, Rasem; Leppla, Stephen H.			Genome engineering in Bacillus anthracis using tyrosine site-specific recombinases	PLOS ONE			English	Article							PROTECTIVE ANTIGEN GENE; PLASMID PXO1; TOXIN GENE; EXPRESSION; ATXA; MAINTENANCE; PROMOTERS; PROTEINS; CLEAVAGE; CLONING	Tyrosine site-specific recombinases (T-SSR) are polynucleotidyltransferases that catalyze cutting and joining reactions between short specific DNA sequences. We developed three systems for performing genetic modifications in Bacillus anthracis that use T-SSR and their cognate target sequences, namely Escherichia coli bacteriophage P1 Cre-loxP, Saccharomyces cerevisiae Flp-FRT, and a newly discovered IntXO-PSL system from B. anthracis plasmid pXO1. All three tyrosine recombinase systems were used for creation of a B. anthracis sporulation-deficient, plasmid-free strain deleted for ten proteases which had been identified by proteomic analysis as being present in the B. anthracis secretome. This strain was used successfully for production of various recombinant proteins, including several that are candidates for inclusion in improved anthrax vaccines. These genetic tools developed for DNA manipulation in B. anthracis were also used for construction of strains having chromosomal insertions of 1, 2, or 3 adjacent atxA genes. AtxA is a B. anthracis global transcriptional regulator required for the response of B. anthracis virulence factor genes to bicarbonate. We found a positive correlation between the atxA copy number and the expression level of the pagA gene encoding B. anthracis protective antigen, when strains were grown in a carbon dioxide atmosphere. These results demonstrate that the three T-SSR systems described here provide effective tools for B. anthracis genome editing. These T-SSR systems may also be applicable to other prokaryotes and to eukaryotes.	[Pomerantsev, Andrei P.; McCall, Rita M.; Chahoud, Margaret; Hepler, Nathan K.; Fattah, Rasem; Leppla, Stephen H.] NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Leppla, SH (reprint author), NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sleppla@niaid.nih.gov			National Institutes of Health Intramural Program [1 ZIA ZI001030-04]; National Institute of Allergy and Infectious Diseases, National Institutes of Health	This work was supported by the National Institutes of Health Intramural Program (1 ZIA ZI001030-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the intramural research program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. We thank Brian Martin for Nterminal sequencing of proteins and L. Renee Olano for proteomic analysis of secretomes (both at NIAID/NIH Research Technologies Branch) and Sergey Tarasov (Biophysics Resource in the Structural Biophysics Laboratory, NCI/NIH-Frederick) for LC-ESI-MS determination of protein exact masses.	Bertin M, 2010, RES MICROBIOL, V161, P249, DOI 10.1016/j.resmic.2010.03.003; Bongiorni C, 2008, J BACTERIOL, V190, P6483, DOI 10.1128/JB.00766-08; Buchholz F, 2009, CURR OPIN BIOTECH, V20, P383, DOI 10.1016/j.copbio.2009.07.005; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chitlaru T, 2011, MOL MICROBIOL, V81, P1542, DOI 10.1111/j.1365-2958.2011.07790.x; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Hoffmaster AR, 1997, INFECT IMMUN, V65, P3091; KOEHLER TM, 1994, J BACTERIOL, V176, P586, DOI 10.1128/jb.176.3.586-595.1994                                                   ; Krishnappa L, 2013, J PROTEOME RES, V12, P4101, DOI 10.1021/pr400433h; Liu SH, 2016, P NATL ACAD SCI USA, V113, pE4079, DOI 10.1073/pnas.1600982113; McKenzie AT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-229; Moayeri M, 2007, INFECT IMMUN, V75, P5175, DOI 10.1128/IAI.00719-07; Park SH, 2000, PARTICUL SCI TECHNOL, V18, P293, DOI 10.1006/prep.2000.1208; Pomerantsev AP, 2016, J BACTERIOL, V198, P1939, DOI 10.1128/JB.01004-15; Pomerantsev AP, 2014, J BACTERIOL, V196, P2921, DOI 10.1128/JB.01747-14; Pomerantsev AP, 2011, PROTEIN EXPRES PURIF, V80, P80, DOI 10.1016/j.pep.2011.05.016; Pomerantsev AP, 2009, J BACTERIOL, V191, P5134, DOI 10.1128/JB.00422-09; Pomerantsev AP, 2006, INFECT IMMUN, V74, P682, DOI 10.1128/IAI.74.1.682-693.2006; Sambrook J, 2001, MOL CLONING LAB MANU, V2001; SINGH Y, 1989, J BIOL CHEM, V264, P19103; UCHIDA I, 1993, J BACTERIOL, V175, P5329; VODKIN MH, 1983, CELL, V34, P693, DOI 10.1016/0092-8674(83)90402-6; Yen Ting L, 2014, MICROBIOL SPECTR, V2	23	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183346	10.1371/journal.pone.0183346				19	Multidisciplinary Sciences	Science & Technology - Other Topics	FE2ZB	WOS:000408085100040	28829806	gold			2018-01-05	
J	Mabashi-Asazuma, H; Jarvis, DL				Mabashi-Asazuma, Hideaki; Jarvis, Donald L.			CRISPR-Cas9 vectors for genome editing and host engineering in the baculovirus-insect cell system	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						CRISPR-Cas9; baculovirus; insect cells; genome editing; glycoengineering	BETA-N-ACETYLGLUCOSAMINIDASE; LOBES GENE ENCODES; EXPRESSION SYSTEMS; DROSOPHILA-MELANOGASTER; SPODOPTERA-FRUGIPERDA; GLYCOSYLATION PATHWAY; TRICHOPLUSIA-NI; S2 CELLS; IDENTIFICATION; PROTEINS	The baculovirus-insect cell system (BICS) has been widely used to produce many different recombinant proteins for basic research and is being used to produce several biologics approved for use in human or veterinary medicine. Early BICS were technically complex and constrained by the relatively primordial nature of insect cell protein glycosylation pathways. Since then, recombination has been used to modify baculovirus vectors-which has simplified the system-and transform insect cells, which has enhanced its protein glycosylation capabilities. Now, CRISPR-Cas9 tools for site-specific genome editing are needed to facilitate further improvements in the BICS. Thus, in this study, we used various insect U6 promoters to construct CRISPR-Cas9 vectors and assessed their utility for site-specific genome editing in two insect cell lines commonly used as hosts in the BICS. We demonstrate the use of CRISPR-Cas9 to edit an endogenous insect cell gene and alter protein glycosylation in the BICS.	[Mabashi-Asazuma, Hideaki; Jarvis, Donald L.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Jarvis, Donald L.] GlycoBac LLC, Laramie, WY 82072 USA; [Mabashi-Asazuma, Hideaki] Ochanomizu Univ, Grad Sch Humanities & Sci, Dept Nutr & Food Sci, Tokyo 1128610, Japan	Mabashi-Asazuma, H (reprint author), Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.; Mabashi-Asazuma, H (reprint author), Ochanomizu Univ, Grad Sch Humanities & Sci, Dept Nutr & Food Sci, Tokyo 1128610, Japan.	mabashi.hideaki@ocha.ac.jp		Mabashi-Asazuma, Hideaki/0000-0001-5302-6536	National Institute of General Medical Sciences, NIH [R43 GM102982]	We thank Dr. Kostas Iatrou of the Institute of Biosciences & Applications, National Center for Scientific Research "Demokritos," Greece, for providing BmN cells; and Leslie Armstrong-Lea, of the Research Cores Facilities Program, Colorado State University, for performing Moflo Flow Cytometry-based cell sorting services. This work was supported by Award R43 GM102982 from the National Institute of General Medical Sciences, NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the NIH.	ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344                                                        ; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Bassett AR, 2014, BIOL OPEN, V3, P42, DOI 10.1242/bio.20137120; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; DEVON RS, 1995, NUCLEIC ACIDS RES, V23, P1644, DOI 10.1093/nar/23.9.1644; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Felberbaum RS, 2015, BIOTECHNOL J, V10, P702, DOI 10.1002/biot.201400438; Fujita R, 2015, BIOCHEM BIOPH RES CO, V464, P1297, DOI 10.1016/j.bbrc.2015.07.126; Geisler C, 2009, POSTTRANSLATIONAL MO, P165; Geisler C, 2008, J BIOL CHEM, V283, P11330, DOI 10.1074/jbc.M710279200; Geisler C, 2015, METHODS MOL BIOL, V1321, P131, DOI 10.1007/978-1-4939-2760-9_10; Geisler C, 2015, J BIOTECHNOL, V193, P52, DOI 10.1016/j.jbiotec.2014.11.013; Geisler C, 2010, BIOTECHNOL PROGR, V26, P34, DOI 10.1002/btpr.298; Harrison RL, 2006, ADV VIRUS RES, V68, P159, DOI 10.1016/S0065-3527(06)68005-6; Harrison RL, 2016, METHODS MOL BIOL, V1350, P359, DOI 10.1007/978-1-4939-3043-2_18; Harrison RL, 2016, METHODS MOL BIOL, V1350, P329, DOI 10.1007/978-1-4939-3043-2_16; Hernandez G, 2007, NUCLEIC ACIDS RES, V35, P21, DOI 10.1093/nar/gkl982; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jarvis DL, 2009, METHOD ENZYMOL, V463, P191, DOI 10.1016/S0076-6879(09)63014-7; Kakumani PK, 2014, GENOMICS, V104, P134, DOI 10.1016/j.ygeno.2014.06.005; Kim NY, 2012, J MICROBIOL BIOTECHN, V22, P190, DOI 10.4014/jmb.1108.08045; Kim YK, 2009, GLYCOBIOLOGY, V19, P301, DOI 10.1093/glycob/cwn138; KITTS PA, 1990, NUCLEIC ACIDS RES, V18, P5667, DOI 10.1093/nar/18.19.5667                                                          ; KITTS PA, 1993, BIOTECHNIQUES, V14, P810; Koles K, 2004, J BIOL CHEM, V279, P4346, DOI 10.1074/jbc.M309912200; Koles K, 2007, GLYCOBIOLOGY, V17, P1388, DOI 10.1093/glycob/cwm097; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Liu YY, 2014, INSECT BIOCHEM MOLEC, V49, P35, DOI 10.1016/j.ibmb.2014.03.010; LUCKOW VA, 1993, J VIROL, V67, P4566; Mabashi-Asazuma H, 2015, INSECT BIOCHEM MOLEC, V65, P20, DOI 10.1016/j.ibmb.2015.07.004; Mabashi-Asazuma H, 2015, ACS CHEM BIOL, V10, P2199, DOI 10.1021/acschembio.5b00340; Maghodia AB, 2016, PROTEIN EXPRES PURIF, V122, P45, DOI 10.1016/j.pep.2016.02.014; Mansouri M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11529; Marchal I, 2001, BIOL CHEM, V382, P151, DOI 10.1515/BC.2001.023                                                             ; MARZ L, 1995, N COMP BIOC A, V29, P543; Nomura T, 2015, J BIOSCI BIOENG, V119, P131, DOI 10.1016/j.jbiosc.2014.07.012; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shi XZ, 2007, CURR DRUG TARGETS, V8, P1116, DOI 10.2174/138945007782151360; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156                                                           ; Sola RJ, 2010, BIODRUGS, V24, P9, DOI 10.2165/11530550-000000000-00000; SUMMERS MD, 1987, TEXAS AGR EXPT STATI, V1555, P1; WICKHAM TJ, 1992, BIOTECHNOL PROGR, V8, P391, DOI 10.1021/bp00017a003; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353	43	0	0	9	9	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	AUG 22	2017	114	34					9068	9073		10.1073/pnas.1705836114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FE3CZ	WOS:000408095300055	28784806				2018-01-05	
J	Krapivinsky, G; Krapivinsky, L; Renthal, NE; Santa-Cruz, A; Manasian, Y; Clapham, DE				Krapivinsky, Grigory; Krapivinsky, Luba; Renthal, Nora E.; Santa-Cruz, Ana; Manasian, Yunona; Clapham, David E.			Histone phosphorylation by TRPM6's cleaved kinase attenuates adjacent arginine methylation to regulate gene expression	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						TRPM6; TRPM7; kinase; ion channel; PRMT5	CRISPR-CAS9 NUCLEASES; EMBRYONIC-DEVELOPMENT; CHANNEL FUNCTIONS; PRMT5; PROTEIN; METHYLTRANSFERASE; CANCER; PICLN; DIFFERENTIATION; TRANSCRIPTION	TRPM6 and TRPM7 are members of the melastatin-related transient receptor potential (TRPM) subfamily of ion channels. Deletion of either gene in mice is embryonically lethal. TRPM6/7 are the only known examples of single polypeptides containing both an ion channel pore and a serine/threonine kinase (chanzyme). Here we show that the C-terminal kinase domain of TRPM6 is cleaved from the channel domain in a cell type-specific fashion and is active. Cleavage requires that the channel conductance is functional. The cleaved kinase translocates to the nucleus, where it is strictly localized and phosphorylates specific histone serine and threonine (S/T) residues. TRPM6-cleaved kinases (M6CKs) bind subunits of the protein arginine methyltransferase 5 (PRMT5) molecular complex that make important epigenetic modifications by methylating histone arginine residues. Histone phosphorylation by M6CK results in a dramatic decrease in methylation of arginines adjacent to M6CK-phosphorylated amino acids. Knockout of TRPM6 or inactivation of its kinase results in global changes in histone S/T phosphorylation and changes the transcription of hundreds of genes. We hypothesize that M6CK associates with the PRMT5 molecular complex in the nucleus, directing M6CK to a specific genomic location and providing site-specific histone phosphorylation. M6CK histone phosphorylation, in turn, regulates transcription by attenuating the effect of local arginine methylation.	[Krapivinsky, Grigory; Krapivinsky, Luba; Santa-Cruz, Ana; Manasian, Yunona; Clapham, David E.] Harvard Med Sch, Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Krapivinsky, Grigory; Krapivinsky, Luba; Santa-Cruz, Ana; Manasian, Yunona; Clapham, David E.] Harvard Med Sch, Dept Cardiol, Boston, MA 02115 USA; [Renthal, Nora E.] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Clapham, David E.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Clapham, David E.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA	Clapham, DE (reprint author), Harvard Med Sch, Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.; Clapham, DE (reprint author), Harvard Med Sch, Dept Cardiol, Boston, MA 02115 USA.; Clapham, DE (reprint author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.; Clapham, DE (reprint author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	claphamd@janelia.hhmi.org					Abiria SA, 2017, P NATL ACAD SCI USA, V114, pE6079, DOI 10.1073/pnas.1707380114; Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Astor MC, 2015, ENDOCR CONNECT, V4, P215, DOI 10.1530/EC-15-0066; Blanc R. S., 2017, CELL, V65, P8, DOI DOI 10.1016/J.M0LCEL.2016.11.003; Blanchard MG, 2016, J AM SOC NEPHROL, V27, P804, DOI 10.1681/ASN.2014121228; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Burgos ES, 2015, J BIOL CHEM, V290, P9674, DOI [10.1074/jbc.M114.636894, 10.1074/jbc.M115.636894]; Cai N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42739; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1                                                   ; Chen H, 2017, ONCOGENE, V36, P373, DOI 10.1038/onc.2016.205; Chittka A, 2012, J BIOL CHEM, V287, P42995, DOI 10.1074/jbc.M112.392746; Chubanov V, 2016, ELIFE, V5, DOI 10.7554/eLife.20914; Clark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001876; Coelho MB, 2015, EMBO J, V34, P653, DOI 10.15252/embj.201489852; Deng X, 2017, ONCOGENE, V36, P1223, DOI 10.1038/onc.2016.287; Duan Q, 2008, J BIOL CHEM, V283, P33585, DOI 10.1074/jbc.M803312200; Fuhrmann J, 2015, CHEM REV, V115, P5413, DOI 10.1021/acs.chemrev.5b00003; Gayatri S, 2014, BBA-GENE REGUL MECH, V1839, P702, DOI 10.1016/j.bbagrm.2014.02.015; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; Gu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044033; Ho MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057008; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kim S, 2014, MOL CELL, V56, P564, DOI 10.1016/j.molcel.2014.10.003; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komiya Y, 2015, INT J DEV BIOL, V59, P281, DOI 10.1387/ijdb.150196lr; Krapivinsky G, 1998, J BIOL CHEM, V273, P10811, DOI 10.1074/jbc.273.18.10811; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Krapivinsky G, 2014, CELL, V157, P1061, DOI 10.1016/j.cell.2014.03.046; Lammirato A, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0318-6; Lau PNI, 2011, P NATL ACAD SCI USA, V108, P2801, DOI 10.1073/pnas.1012798108; Leonetti MD, 2016, P NATL ACAD SCI USA, V113, pE3501, DOI 10.1073/pnas.1606731113; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li Y, 2015, CANCER DISCOV, V5, P288, DOI 10.1158/2159-8290.CD-14-0625; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Runnels LW, 2011, CURR PHARM BIOTECHNO, V12, P42; Saha K, 2016, J INVEST DERMATOL, V136, P214, DOI 10.1038/JID.2015.400; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Starokadomskyy P, 2014, METHODS MOL BIOL, V1177, P193, DOI 10.1007/978-1-4939-1034-2_15; Stopa N, 2015, CELL MOL LIFE SCI, V72, P2041, DOI 10.1007/s00018-015-1847-9; Tarighat SS, 2016, LEUKEMIA, V30, P789, DOI 10.1038/leu.2015.308; Thebault S, 2008, J BIOL CHEM, V283, P19999, DOI 10.1074/jbc.M800167200; Tsai WW, 2013, P NATL ACAD SCI USA, V110, P8870, DOI 10.1073/pnas.1304602110; Walder RY, 2009, HUM MOL GENET, V18, P4367, DOI 10.1093/hmg/ddp392; Woudenberg-Vrenken TE, 2011, NEPHRON PHYSIOL, V117, pP11, DOI 10.1159/000320580	52	0	0	5	5	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	AUG 22	2017	114	34					E7092	E7100		10.1073/pnas.1708427114				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FE3CZ	WOS:000408095300009	28784805				2018-01-05	
J	Wiese, KE; Amante, RJ; Vivanco, MD; Bentires-Alj, M; Iggo, RD				Wiese, Katrin E.; Amante, Romain J.; Vivanco, Maria dM.; Bentires-Alj, Mohamed; Iggo, Richard D.			The ninth ENBDC Weggis meeting: growth and in-depth characterisation of normal and neoplastic breast cells	BREAST CANCER RESEARCH			English	Article						Breast cancer; Oestrogen receptor; Proteomics; Organoid culture; CRISPR screen; European Network for Breast Development and Cancer	MAMMARY-GLAND; STEM-CELLS; CANCER; MICROENVIRONMENT; MULTIPOTENCY; RESISTANCE; PHENOTYPE; TUMORS	Mammary gland biologists gathered for the ninth annual workshop of the European Network for Breast Development and Cancer (ENBDC) at Weggis on the shores of Lake Lucerne in March 2017. The main themes were oestrogen receptor alpha signalling, new techniques for mammary cell culture, CRISPR screening and proteogenomics.	[Wiese, Katrin E.] Univ Amsterdam, Sect Mol Cytol, Swammerdam Inst Life Sci, NL-1098 XH Amsterdam, Netherlands; [Wiese, Katrin E.] Univ Amsterdam, Van Leeuwenhoek Ctr Adv Microscopy, Swammerdam Inst Life Sci, NL-1098 XH Amsterdam, Netherlands; [Amante, Romain J.; Bentires-Alj, Mohamed] Univ Basel, Univ Basel Hosp, Dept Biomed, Hebelstr 20, CH-4031 Basel, Switzerland; [Vivanco, Maria dM.] CIC bioGUNE, Technol Pk, Bizkaia 48160, Derio, Spain; [Iggo, Richard D.] Univ Bordeaux, Inst Bergonie, INSERM, U1218, 229 Cours Argonne, F-33076 Bordeaux, France	Iggo, RD (reprint author), Univ Bordeaux, Inst Bergonie, INSERM, U1218, 229 Cours Argonne, F-33076 Bordeaux, France.	R.Iggo@bordeaux.unicancer.fr			Roche; Novartis through Swiss Kontaktgruppe fur Forschungsfragen (KGF) programme; STEMCELL technologies; BD Life Sciences; Breast Cancer Research; EU Horizon (Marie Sklodowska-Curie) [706443]; Institute of Health Carlos III [PI14/01328]; Department of Surgery of the University Hospital of Basel; European Research Council; Swiss National Science Foundation; Krebsliga Beider Basel; Swiss Cancer League; Swiss Initiative for Systems Biology (SystemsX. ch); French Cancer League; Fondation pour la lutte contre le cancer et pour des recherches medico-biologiques;  [IDEX-FAC2014-INCa-DGOS-INSERM 6046 SIRIC BRIO]	Funding for the meeting was received from Roche and Novartis through the Swiss Kontaktgruppe fur Forschungsfragen (KGF) programme, from STEMCELL technologies, from BD Life Sciences and from Breast Cancer Research.; KEW received funding from EU Horizon 2020 (Marie Sklodowska-Curie grant 706443). MdMV received funding from the Institute of Health Carlos III (grant PI14/01328). RJA and MB-A received funding from Department of Surgery of the University Hospital of Basel, the European Research Council, the Swiss National Science Foundation, the Krebsliga Beider Basel, the Swiss Cancer League and the Swiss Initiative for Systems Biology (SystemsX. ch). RDI received funding from the French Cancer League, Fondation pour la lutte contre le cancer et pour des recherches medico-biologiques, and the IDEX-FAC2014-INCa-DGOS-INSERM 6046 SIRIC BRIO.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Alessandri K, 2013, P NATL ACAD SCI USA, V110, P14843, DOI 10.1073/pnas.1309482110; Annunziato S, 2016, GENE DEV, V30, P1470, DOI 10.1101/gad.279190.116; Branca RMM, 2014, NAT METHODS, V11, P59, DOI [10.1038/NMETH.2732, 10.1038/nmeth.2732]; Fridriksdottir AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9786; Johansson HJ, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9080-y; Koren S, 2015, NATURE, V525, P114, DOI 10.1038/nature14669; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; Richard E, 2016, J PATHOL, V240, P256, DOI 10.1002/path.4772; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Ruprecht B, 2017, CANCER RES, V77, P1842, DOI 10.1158/0008-5472.CAN-16-2976; Sachs N, 2014, CURR OPIN GENET DEV, V24, P68, DOI 10.1016/j.gde.2013.11.012; Santagata S, 2014, J CLIN INVEST, V124, P859, DOI 10.1172/JCI70941; Sflomos G, 2016, CANCER CELL, V29, P407, DOI 10.1016/j.ccell.2016.02.002; Van Keymeulen A, 2015, NATURE, V525, P119, DOI 10.1038/nature14665; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533	18	0	0	3	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1465-542X	1465-5411		BREAST CANCER RES	Breast Cancer Res.	AUG 22	2017	19								96	10.1186/s13058-017-0891-9				4	Oncology	Oncology	FE5QO	WOS:000408266200001	28830566	green_published			2018-01-05	
J	Aprile, FA; Kallstig, E; Limorenko, G; Vendruscolo, M; Ron, D; Hansen, C				Aprile, Francesco A.; Kallstig, Emma; Limorenko, Galina; Vendruscolo, Michele; Ron, David; Hansen, Christian			The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress alpha-synuclein aggregation	SCIENTIFIC REPORTS			English	Article							PARKINSONS-DISEASE; POLYGLUTAMINE PEPTIDES; LEWY BODIES; IN-VITRO; TOXICITY; BINDING; PROTEOSTASIS; INHIBITION; MUTATIONS; SUBSTRATE	A major hallmark of Parkinson's disease (PD) is the presence of Lewy bodies (LBs) in certain neuronal tissues. LBs are protein-rich inclusions, in which alpha-synuclein (alpha-syn) is the most abundant protein. Since these inclusions are not present in healthy individuals, despite the high concentration of alpha-syn in neurons, it is important to investigate whether natural control mechanisms are present to efficiently suppress alpha-syn aggregation. Here, we demonstrate that a CRISPR/Cas9-mediated knockout (KO) of a DnaJ protein, DNAJB6, in HEK293T cells expressing alpha-syn, causes a massive increase in alpha-syn aggregation. Upon DNAJB6 re-introduction into these DNAJB6-KO HEK293T-alpha-syn cells, aggregation is reduced to the level of the parental cells. We then show that the suppression of alpha-syn aggregation is dependent on the J-domain of DNAJB6, as the catalytically inactive protein, which carries the H31Q mutation, does not suppress aggregation, when re-introduced into DNAJB6-KO cells. We further demonstrate, that the suppression of alpha-syn aggregation is dependent on the molecular chaperone Hsp70, which is consistent with the well-known function of J-domains of transferring unfolded and misfolded proteins to Hsp70. These data identify a natural control strategy to suppress alpha-syn aggregation and suggest potential therapeutic approaches to prevent or treat PD and related disorders.	[Aprile, Francesco A.; Vendruscolo, Michele] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Ron, David; Hansen, Christian] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Kallstig, Emma; Limorenko, Galina; Hansen, Christian] Dept Expt Med Sci, Mol Neurobiol, BMC B11, S-22184 Lund, Sweden	Hansen, C (reprint author), Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England.; Hansen, C (reprint author), Dept Expt Med Sci, Mol Neurobiol, BMC B11, S-22184 Lund, Sweden.	Christian.hansen@med.lu.se			INCA grant; Marie Sklodowska Curie Actions FP7; Swedish Research Council; Swedish Parkinsons foundation; Crafoordska Stiftelsen; Wellcome Trust [Wellcome 200848/Z/16/Z, Wellcome 100140]; Alzheimer's Society, UK [317, AS-SF-16-003]	This study was supported by an INCA grant co-funded by the Marie Sklodowska Curie Actions FP7 and The Swedish Research Council, as well as it was funded by the Swedish Parkinsons foundation and Crafoordska Stiftelsen (C.H.). In addition, it was supported by grants from the Wellcome Trust (Wellcome 200848/Z/16/Z and a strategic award Wellcome 100140). D.R. is a Wellcome Trust Principal Research Fellow. FAA is supported by a Senior Research Fellowship award from the Alzheimer's Society, UK (Grant Number 317, AS-SF-16-003).	Aprile FA, 2017, BIOCHEMISTRY-US, V56, P1177, DOI 10.1021/acs.biochem.6b01178; Aprile FA, 2015, BIOCHEMISTRY-US, V54, P5103, DOI 10.1021/acs.biochem.5b00459; Aprile FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067961; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389                                                         ; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bonini NM, 2005, CELL, V123, P359, DOI 10.1016/j.cell.2005.10.017; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chuang JZ, 2002, J BIOL CHEM, V277, P19831, DOI 10.1074/jbc.M109613200; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Durrenberger PF, 2009, J NEUROSCI RES, V87, P238, DOI 10.1002/jnr.21819; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Gillis J, 2013, J BIOL CHEM, V288, P17225, DOI 10.1074/jbc.M112.421685; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Hansen C, 2012, TRENDS MOL MED, V18, P248, DOI 10.1016/j.molmed.2012.03.002; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Kakkar V, 2016, MOL CELL, V62, P272, DOI 10.1016/j.molcel.2016.03.017; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Mansson C, 2014, J BIOL CHEM, V289, P31066, DOI 10.1074/jbc.M114.595124; Mansson C, 2014, CELL STRESS CHAPERON, V19, P227, DOI 10.1007/s12192-013-0448-5; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Olgiati S, 2016, ANN NEUROL, V79, P244, DOI 10.1002/ana.24553; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347                                                         ; Vekrellis K, 2011, LANCET NEUROL, V10, P1015, DOI 10.1016/S1474-4422(11)70213-7; Vilarino-Guell C, 2014, HUM MOL GENET, V23, P1794, DOI 10.1093/hmg/ddt570; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013	30	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 22	2017	7								9039	10.1038/s41598-017-08324-z				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FE4AP	WOS:000408157100001	28831037	gold			2018-01-05	
J	Krivega, I; Dean, A				Krivega, Ivan; Dean, Ann			LDB1-mediated enhancer looping can be established independent of mediator and cohesin	NUCLEIC ACIDS RESEARCH			English	Article							GLOBIN LOCUS REQUIRES; CELL IDENTITY GENES; CHROMATIN ARCHITECTURE; TRANSCRIPTION FACTORS; ACTIVATE TRANSCRIPTION; REGULATORY LANDSCAPE; HYPERSENSITIVE SITES; SUPER-ENHANCERS; 3D GENOME; EXPRESSION	Mechanistic studies in erythroid cells indicate that LDB1, as part of a GATA1/TAL1/LMO2 complex, brings erythroid-expressed genes into proximity with enhancers for transcription activation. The role of co-activators in establishing this long-range interaction is poorly understood. Here we tested the contributions of the RNA Pol II pre-initiation complex (PIC), mediator and cohesin to establishment of locus control region (LCR)/beta-globin proximity. CRISPR/Cas9 editing of the beta-globin promoter to eliminate the RNA Pol II PIC by deleting the TATA-box resulted in loss of transcription, but enhancer-promoter interaction was unaffected. Additional deletion of the promoter GATA1 site eliminated LDB1 complex and mediator occupancy and resulted in loss of LCR/beta-globin proximity. To separate the roles of LDB1 and mediator in LCR looping, we expressed a looping-competent but transcription-activation deficient form of LDB1 in LDB1 knock down cells: LCR/beta-globin proximity was restored without mediator core occupancy. Further, Cas9-directed tethering of mutant LDB1 to the beta-globin promoter forced LCR loop formation in the absence of mediator or cohesin occupancy. Moreover, ENCODE data and our chromatin immunoprecipitation results indicate that cohesin is almost completely absent from validated and predicted LDB1-regulated erythroid enhancer-gene pairs. Thus, lineage specific factors largely mediate enhancer-promoter looping in erythroid cells independent of mediator and cohesin.	[Krivega, Ivan; Dean, Ann] NIDDK, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA	Dean, A (reprint author), NIDDK, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA.	anndean@helix.nih.gov			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Intramural Program; National Institutes of Health (NIH) [DK015508]; Intramural Program; NIDDK; NIH [DK015508]	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Intramural Program; National Institutes of Health (NIH) [DK015508 to A.D.]. Funding for open access charge: Intramural Program; NIDDK; NIH [DK015508].	Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; Barrow JJ, 2012, P NATL ACAD SCI USA, V109, P17948, DOI 10.1073/pnas.1207677109; Bender MA, 2012, BLOOD, V119, P3820, DOI 10.1182/blood-2011-09-380485; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; Cadiz-Rivera B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092947; Caputo L, 2015, CELL STEM CELL, V17, P287, DOI 10.1016/j.stem.2015.08.007; Carlsten JOP, 2013, TRENDS BIOCHEM SCI, V38, P531, DOI 10.1016/j.tibs.2013.08.007; Costello I, 2015, GENE DEV, V29, P2108, DOI 10.1101/gad.268979.115; Cuadrado A, 2015, NUCLEIC ACIDS RES, V43, P3056, DOI 10.1093/nar/gkv144; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; DeMare LE, 2013, GENOME RES, V23, P1224, DOI 10.1101/gr.156570.113; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; ENCODE Project Consortium, 2014, NATURE, V515, P355; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Faure AJ, 2012, GENOME RES, V22, P2163, DOI 10.1101/gr.136507.111; Frank CL, 2015, NAT NEUROSCI, V18, P647, DOI 10.1038/nn.3995; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Garcia-Gonzalez E, 2016, CELL MOL LIFE SCI, V73, P2897, DOI 10.1007/s00018-016-2184-3; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Hay D, 2016, NAT GENET, V48, P895, DOI 10.1038/ng.3605; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Iglesias-Platas I, 2014, HUM MOL GENET, V23, P6275, DOI 10.1093/hmg/ddu347; Ji X, 2016, CELL STEM CELL, V18, P262, DOI 10.1016/j.stem.2015.11.007; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim A, 2007, NUCLEIC ACIDS RES, V35, P5831, DOI 10.1093/nar/gkm620; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; Knuesel MT, 2009, MOL CELL BIOL, V29, P650, DOI 10.1128/MCB.00993-08; Krivega I, 2014, GENE DEV, V28, P1278, DOI 10.1101/gad.239749.114; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Landry JR, 2009, BLOOD, V113, P5783, DOI 10.1182/blood-2008-11-187757; Lavagnolli T, 2015, GENE DEV, V29, P23, DOI 10.1101/gad.251835.114; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Li LQ, 2013, BLOOD, V121, P4575, DOI 10.1182/blood-2013-01-479451; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Love PE, 2014, TRENDS GENET, V30, P1, DOI 10.1016/j.tig.2013.10.001; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Merkenschlager M, 2016, ANNU REV GENOM HUM G, V17, P17, DOI 10.1146/annurev-genom-083115-022339; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Nottingham WT, 2007, BLOOD, V110, P4188, DOI 10.1182/blood-2007-07-100883; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Palstra RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001661; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Plank JL, 2014, MOL CELL, V55, P5, DOI 10.1016/j.molcel.2014.06.015; Quinlan AR, 2014, CURR PROTOC BIOINFOR, V47, P11, DOI DOI 10.1002/0471250953.BI1112S47; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ren Bing, 2015, Cold Spring Harb Symp Quant Biol, V80, P17, DOI 10.1101/sqb.2015.80.027219; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schoenfelder S, 2015, GENOME RES, V25, P582, DOI 10.1101/gr.185272.114; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Stumpf M, 2006, P NATL ACAD SCI USA, V103, P18504, DOI 10.1073/pnas.0604494103; Stumpf M, 2010, P NATL ACAD SCI USA, V107, P21541, DOI 10.1073/pnas.1005794107; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wakabayashi A, 2016, P NATL ACAD SCI USA, V113, P4434, DOI 10.1073/pnas.1521754113; Wei YJ, 2016, NUCLEIC ACIDS RES, V44, pD172, DOI 10.1093/nar/gkv1243; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Yun WJ, 2014, NUCLEIC ACIDS RES, V42, P4283, DOI 10.1093/nar/gku072; Zhang F, 2015, P NATL ACAD SCI USA, V112, P1380, DOI 10.1073/pnas.1424228112	75	0	0	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	AUG 21	2017	45	14					8255	8268		10.1093/nar/gkx433				14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FE0NL	WOS:000407916900021	28520978	gold			2018-01-05	
J	Luo, WT; Galvan, DL; Woodard, LE; Dorset, D; Levy, S; Wilson, MH				Luo, Wentian; Galvan, Daniel L.; Woodard, Lauren E.; Dorset, Dan; Levy, Shawn; Wilson, Matthew H.			Comparative analysis of chimeric ZFP-, TALE- and Cas9-piggyBac transposases for integration into a single locus in human cells	NUCLEIC ACIDS RESEARCH			English	Article							ADENOASSOCIATED VIRUS VECTORS; RNA-GUIDED ENDONUCLEASE; PLURIPOTENT STEM-CELLS; ZINC-FINGER NUCLEASES; PIGGYBAC TRANSPOSON; IN-VIVO; T-CELLS; GENE DISRUPTION; SITE SELECTION; GENOME	Integrating DNA delivery systems hold promise for many applications including treatment of diseases; however, targeted integration is needed for improved safety. The piggyBac (PB) transposon system is a highly active non-viral gene delivery system capable of integrating defined DNA segments into host chromosomes without requiring homologous recombination. We systematically compared four different engineered zinc finger proteins (ZFP), four transcription activator-like effector proteins (TALE), CRISPR associated protein 9 (SpCas9) and the catalytically inactive dSpCas9 protein fused to the amino-terminus of the transposase enzyme designed to target the hypoxanthine phosphoribosyltransferase (HPRT) gene located on human chromosome X. Chimeric transposases were evaluated for expression, transposition activity, chromatin immunoprecipitation at the target loci, and targeted knockout of the HPRT gene in human cells. One ZFP-PB and one TALE-PB chimera demonstrated notable HPRT gene targeting. In contrast, Cas9/dCas9-PB chimeras did not result in gene targeting. Instead, the HPRT locus appeared to be protected from transposon integration. Supplied separately, PB permitted highly efficient isolation of Cas9-mediated knockout of HPRT, with zero transposon integrations in HPRT by deep sequencing. In summary, these tools may allow isolation of 'targeted-only' cells, be utilized to protect a genomic locus from transposon integration, and enrich for Cas9-mutated cells.	[Luo, Wentian; Woodard, Lauren E.; Wilson, Matthew H.] Dept Vet Affairs, Nashville, TN 37212 USA; [Luo, Wentian; Woodard, Lauren E.; Wilson, Matthew H.] Vanderbilt Univ, Med Ctr, Dept Med, Dept Pharmacol, Nashville, TN 37232 USA; [Galvan, Daniel L.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Dorset, Dan; Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA	Wilson, MH (reprint author), Dept Vet Affairs, Nashville, TN 37212 USA.; Wilson, MH (reprint author), Vanderbilt Univ, Med Ctr, Dept Med, Dept Pharmacol, Nashville, TN 37232 USA.	matthew.wilson@vanderbilt.edu			National Institutes of Health (NIH) [DK093660]; Department of Veterans Affairs [BX002190, BX002797]; Vanderbilt Center for Kidney Disease; NIH [DK093660, VA BX002190]	National Institutes of Health (NIH) [DK093660 to M.H.W.] (in part); Department of Veterans Affairs [BX002190 to M.H.W., BX002797 to L.E.W.]; Vanderbilt Center for Kidney Disease (to M.H.W.). Funding for open access charge: NIH [DK093660, VA BX002190].	Ammar I, 2012, NUCLEIC ACIDS RES, V40, P6693, DOI 10.1093/nar/gks317; Beumer KJ, 2013, G3-GENES GENOM GENET, V3, P1717, DOI 10.1534/g3.113.007260; Burnight ER, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.12; CASKEY CT, 1979, CELL, V16, P1, DOI 10.1016/0092-8674(79)90182-X; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0                                                                ; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gogol-Doring A, 2016, MOL THER, V24, P592, DOI 10.1038/mt.2016.11; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hirata R, 2002, NAT BIOTECHNOL, V20, P735, DOI 10.1038/nbt0702-735; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kettlun C, 2011, MOL THER, V19, P1636, DOI 10.1038/mt.2011.129; Khan IF, 2010, MOL THER, V18, P1192, DOI 10.1038/mt.2010.55; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Manuri PVR, 2010, HUM GENE THER, V21, P427, DOI 10.1089/hum.2009.114; Maragathavally KJ, 2006, FASEB J, V20, P1880, DOI 10.1096/fj.05-5485fje; Moriarity BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096114; Nakazawa Y, 2011, MOL THER, V19, P2133, DOI 10.1038/mt.2011.131; Nakazawa Y, 2009, J IMMUNOTHER, V32, P826, DOI 10.1097/CJI.0b013e3181ad762b; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Owens JB, 2013, NUCLEIC ACIDS RES, V41, P9197, DOI 10.1093/nar/gkt677; Owens JB, 2012, NUCLEIC ACIDS RES, V40, P6978, DOI 10.1093/nar/gks309; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Russell DW, 1998, NAT GENET, V18, P325, DOI 10.1038/ng0498-325                                                              ; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Trobridge G, 2005, HUM GENE THER, V16, P522, DOI 10.1089/hum.2005.16.522; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Woodard LE, 2015, TRENDS BIOTECHNOL, V33, P525, DOI 10.1016/j.tibtech.2015.06.009; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; YE LP, 2015, SCI REP UK, V5; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]	49	0	0	10	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	AUG 21	2017	45	14					8411	8422		10.1093/nar/gkx572				12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FE0NL	WOS:000407916900034	28666380	gold			2018-01-05	
J	Li, SY; Dong, FH; Wu, YX; Zhang, S; Zhang, C; Liu, X; Jiang, T; Zeng, JY				Li, Shuya; Dong, Fanghong; Wu, Yuexin; Zhang, Sai; Zhang, Chen; Liu, Xiao; Jiang, Tao; Zeng, Jianyang			A deep boosting based approach for capturing the sequence binding preferences of RNA-binding proteins from high-throughput CLIP-seq data	NUCLEIC ACIDS RESEARCH			English	Article							GENE-EXPRESSION; MESSENGER-RNAS; WIDE ANALYSIS; CANCER; IDENTIFICATION; RECOGNITION; INSIGHTS; MOTIF; SPECIFICITIES; CARCINOMA	Characterizing the binding behaviors of RNA-binding proteins (RBPs) is important for understanding their functional roles in gene expression regulation. However, current high-throughput experimental methods for identifying RBP targets, such as CLIP-seq and RNAcompete, usually suffer from the false negative issue. Here, we develop a deep boosting based machine learning approach, called DeBooster, to accurately model the binding sequence preferences and identify the corresponding binding targets of RBPs from CLIP-seq data. Comprehensive validation tests have shown that DeBooster can outperform other state-of-the-art approaches in RBP target prediction. In addition, we have demonstrated that DeBooster may provide new insights into understanding the regulatory functions of RBPs, including the binding effects of the RNA helicase MOV10 on mRNA degradation, the potentially different ADAR1 binding behaviors related to its editing activity, as well as the antagonizing effect of RBP binding on miRNA repression. Moreover, DeBooster may provide an effective index to investigate the effect of pathogenic mutations in RBP binding sites, especially those related to splicing events. We expect that DeBooster will be widely applied to analyze large-scale CLIP-seq experimental data and can provide a practically useful tool for novel biological discoveries in understanding the regulatory mechanisms of RBPs. The source code of DeBooster can be downloaded from http://github.com/dongfanghong/deepboost.	[Li, Shuya; Liu, Xiao] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Dong, Fanghong; Wu, Yuexin; Zhang, Sai; Zhang, Chen; Zeng, Jianyang] Tsinghua Univ, Inst Interdisciplinary Informat Sci, Beijing 100084, Peoples R China; [Wu, Yuexin] Carnegie Mellon Univ, Language Technol Inst, Pittsburgh, PA 15232 USA; [Jiang, Tao] Univ Calif Riverside, Dept Comp Sci & Engn, Riverside, CA 92521 USA; [Jiang, Tao] Tsinghua Univ, Dept Comp Sci & Technol, Beijing 100084, Peoples R China	Zeng, JY (reprint author), Tsinghua Univ, Inst Interdisciplinary Informat Sci, Beijing 100084, Peoples R China.	zengjy@gmail.com		Jiang, Tao/0000-0003-3833-4498	National Natural Science Foundation of China [61472205]; US National Science Foundation [DBI-1262107, IIS-1646333]; China's Youth 1000-Talent Program; Beijing Advanced Innovation Center for Structural Biology	National Natural Science Foundation of China [61472205]; US National Science Foundation [DBI-1262107, IIS-1646333]; China's Youth 1000-Talent Program; Beijing Advanced Innovation Center for Structural Biology. Funding for open access charge: China's Youth 1000-Talent Program.	Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Anczukow O, 2015, MOL CELL, V60, P105, DOI 10.1016/j.molcel.2015.09.005; Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bartlett P. L., 2003, Journal of Machine Learning Research, V3, P463, DOI 10.1162/153244303321897690; Bhardwaj A, 2013, NUCLEIC ACIDS RES, V41, P5062, DOI 10.1093/nar/gkt189; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; Bourgeois CF, 2016, NAT REV MOL CELL BIO, V17, P426, DOI 10.1038/nrm.2016.50; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Ciafre SA, 2013, RNA BIOL, V10, P935, DOI 10.4161/rna.24641; Cienikova Z, 2014, J AM CHEM SOC, V136, P14536, DOI 10.1021/ja507690d; Colombrita C, 2012, J BIOL CHEM, V287, P15635, DOI 10.1074/jbc.M111.333450; Cortes C., 2014, P 31 INT C MACH LEAR; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CZWORKOWSKI J, 1991, BIOCHEMISTRY-US, V30, P4821, DOI 10.1021/bi00233a026; DAHLBERG AE, 1969, J MOL BIOL, V41, P139, DOI 10.1016/0022-2836(69)90131-4; Delhommeau F, 2008, BLOOD, V112; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0                                                                ; Epis MR, 2011, J BIOL CHEM, V286, P41442, DOI 10.1074/jbc.M111.301481; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Foat B. C., 2006, NUCL ACIDS RES, V22, DOI 10.1093/bioinformatics/btl223; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Freund Y, 1995, DECISION THEORETIC G; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451                                                          ; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gregersen LH, 2014, MOL CELL, V54, P573, DOI 10.1016/j.molcel.2014.03.017; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hiller M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl544; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Hu B., 2016, NUCLEIC ACIDS RES, V45, pD104; Kazan H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000832; Klaue Y, 2003, RNA, V9, P839, DOI 10.1261/rna.2167603; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200                                                          ; Li JJ, 2014, GENOME RES, V24, P775, DOI 10.1101/gr.162230.113; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Maticzka D, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r17; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8                                                   ; Morgan SE, 1997, ADV CANCER RES, V71, P1, DOI 10.1016/S0065-230X(08)60095-0; Murr R, 2007, ONCOGENE, V26, P5358, DOI 10.1038/sj.onc.1210605; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; ODA T, 1994, P NATL ACAD SCI USA, V91, P1858, DOI 10.1073/pnas.91.5.1858                                                          ; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3                                                   ; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Raney BJ, 2014, BIOINFORMATICS, V30, P1003, DOI 10.1093/bioinformatics/btt637; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Reyesherrera P. H., 2014, BIOINFORMATICS BIOL, P199; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Schwarte-Waldhoff I, 2000, P NATL ACAD SCI USA, V97, P9624, DOI 10.1073/pnas.97.17.9624; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Takahama K, 2011, FEBS J, V278, P988, DOI 10.1111/j.1742-4658.2011.08020.x; Viskochil D, 2002, J CHILD NEUROL, V17, P562, DOI 10.1177/088307380201700804; WALKER SH, 1967, BIOMETRIKA, V54, P167, DOI 10.2307/2333860; Wang HC, 2004, BIOCHEM CELL BIOL, V82, P321, DOI 10.1139/004-003; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Zhang S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1025; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9                                                   	68	0	0	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	AUG 21	2017	45	14							e129	10.1093/nar/gkx492				15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FE0NL	WOS:000407916900002	28575488	gold			2018-01-05	
J	Li, GL; Zhang, XW; Zhong, CL; Mo, JX; Quan, R; Yang, J; Liu, DW; Li, ZC; Yang, HQ; Wu, ZF				Li, Guoling; Zhang, Xianwei; Zhong, Cuili; Mo, Jianxin; Quan, Rong; Yang, Jie; Liu, Dewu; Li, Zicong; Yang, Huaqiang; Wu, Zhenfang			Small molecules enhance CRISPR/Cas9-mediated homology-directed genome editing in primary cells	SCIENTIFIC REPORTS			English	Article							DOUBLE-STRAND BREAK; ONE-STEP GENERATION; MAMMALIAN-CELLS; REPAIR PATHWAY; RECOMBINATION; RESVERATROL; CRISPR-CAS9; EFFICIENCY; DNA	CRISPR/Cas9 is an efficient customizable nuclease to generate double-strand breaks (DSBs) in the genome. This process results in knockout of the targeted gene or knock-in of a specific DNA fragment at the targeted locus in the genome of various species. However, efficiency of knock-in mediated by homology-directed repair (HDR) pathway is substantially lower compared with the efficiency of knockout mediated by the nonhomologous end-joining (NHEJ) pathway. Suppressing NHEJ pathway or enhancing HDR pathway has been proven to enhance the nuclease-mediated knock-in efficiency in cultured cells and model organisms. We here investigated the effect of small molecules, Scr7, L755507 and resveratrol, on promoting HDR efficiency in porcine fetal fibroblasts. Results from eGFP reporter assay showed that these small molecules could increase the HDR efficiency by 2-3-fold in porcine fetal fibroblasts. When transfecting with the homologous template DNA and CRISPR/Cas9 plasmid and treating with small molecules, the rate of knock-in porcine fetal fibroblast cell lines with large DNA fragment integration could reach more than 50% of the screened cell colonies, compared with 26.1% knock-in cell lines in the DMSO-treated group. The application of small molecules offers a beneficial approach to improve the frequency of precise genetic modifications in primary somatic cells.	[Li, Guoling; Zhang, Xianwei; Zhong, Cuili; Mo, Jianxin; Quan, Rong; Yang, Jie; Liu, Dewu; Li, Zicong; Yang, Huaqiang; Wu, Zhenfang] South China Agr Univ, Coll Anim Sci, Natl Engn Res Ctr Breeding Swine Ind, Guangzhou 510642, Guangdong, Peoples R China; [Li, Guoling; Zhang, Xianwei; Zhong, Cuili; Mo, Jianxin; Quan, Rong; Yang, Jie; Liu, Dewu; Li, Zicong; Yang, Huaqiang; Wu, Zhenfang] South China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou 510642, Guangdong, Peoples R China	Yang, HQ; Wu, ZF (reprint author), South China Agr Univ, Coll Anim Sci, Natl Engn Res Ctr Breeding Swine Ind, Guangzhou 510642, Guangdong, Peoples R China.; Yang, HQ; Wu, ZF (reprint author), South China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou 510642, Guangdong, Peoples R China.	yangh@scau.edu.cn; wzfemail@163.com		Yang, Huaqiang/0000-0002-4287-0026	national science and technology major project for breeding of new transgenic organisms [2016ZX08006002]	This work was supported by the national science and technology major project for breeding of new transgenic organisms (Grant number: 2016ZX08006002).	Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bozas A, 2009, GENETICS, V182, P641, DOI 10.1534/genetics.109.101329; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Dexheimer T. S., 2013, DNA REPAIR CANC STEM, P19, DOI DOI 10.1007/978-94-007-4590-2_2; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; Jayathilaka K, 2008, P NATL ACAD SCI USA, V105, P15848, DOI 10.1073/pnas.0808046105; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398                                                        ; Li XP, 2014, CELL RES, V24, P501, DOI 10.1038/cr.2014.15; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Parmee ER, 1998, BIOORG MED CHEM LETT, V8, P1107, DOI 10.1016/S0960-894X(98)00170-X; Prather RS, 2008, BIOTECHNOL GENET ENG, V25, P245; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7	25	0	0	12	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 21	2017	7								8943	10.1038/s41598-017-09306-x				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FE3HM	WOS:000408107000077	28827551	gold			2018-01-05	
J	Nambu-Nishida, Y; Nishida, K; Hasunuma, T; Kondo, A				Nambu-Nishida, Yumiko; Nishida, Keiji; Hasunuma, Tomohisa; Kondo, Akihiko			Development of a comprehensive set of tools for genome engineering in a cold- and thermo-tolerant Kluyveromyces marxianus yeast strain	SCIENTIFIC REPORTS			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSFORMATION; HOMOLOG; GENES; DNA; KU	Kluyveromyces marxianus, a non-conventional thermotolerant yeast, is potentially useful for production of ethanol and other products. This species has a strong tendency to randomly integrate transforming DNA fragments, making necessary the development of more precise methods for gene targeting. In this study, we first demonstrated that K. marxianus NBRC1777 is cold-tolerant, and then established a highly efficient and precise technique for gene editing by introducing genes encoding deaminase-mediated targeted point mutagenesis (Target-AID) and clustered regularly interspaced short palindromic repeats (CRISPR) associated proteins (CRISPR-Cas9). We used Target-AID to introduce targeted point mutations that disrupted Nej1 or Dnl4, genes that are involved in non-homologous end-joining (NHEJ). Both of the resulting mutant strains showed enhanced proportions of homology-mediated integration compared to the wild-type parent. In combination with target cleavage by CRISPR-Cas9, markerless integration was performed using short (-50 bp) flanking homologous sequences. Together, these tools render this species fully tractable for gene manipulation, permitting targeted genetic changes in the cold- and thermo-tolerant yeast K. marxianus.	[Nambu-Nishida, Yumiko] Technol Res Assoc Highly Efficient Gene Design TR, Chuo Ku, 7-1-49 Minatojimaminamimachi, Kobe, Hyogo 6500047, Japan; [Nambu-Nishida, Yumiko; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan; [Nishida, Keiji; Hasunuma, Tomohisa; Kondo, Akihiko] Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai cho, Kobe, Hyogo 6578501, Japan; [Kondo, Akihiko] RIKEN, Biomass Engn Program, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan	Kondo, A (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.; Kondo, A (reprint author), Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai cho, Kobe, Hyogo 6578501, Japan.; Kondo, A (reprint author), RIKEN, Biomass Engn Program, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	akondo@kobe-u.ac.jp	Hasunuma, Tomohisa/A-1949-2015; Kondo, Akihiko/A-2130-2015	Hasunuma, Tomohisa/0000-0002-8382-2362; 	Project Focused on Developing Key Technology for Discovering and Manufacturing Drugs for Next-Generation Treatment and Diagnosis from the Japan Agency for Medical Research and Development (AMED), Japan	This research was supported by the Project Focused on Developing Key Technology for Discovering and Manufacturing Drugs for Next-Generation Treatment and Diagnosis from the Japan Agency for Medical Research and Development (AMED), Japan.	Abdel-Banat BMA, 2010, YEAST, V27, P29, DOI 10.1002/yea.1729; Da Silva NA, 2012, FEMS YEAST RES, V12, P197, DOI 10.1111/j.1567-1364.2011.00769.x; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; FELDMANN H, 1993, J BIOL CHEM, V268, P12895; Feldmann H, 1996, J BIOL CHEM, V271, P27765, DOI 10.1074/jbc.271.44.27765                                                        ; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hong J, 2007, J BIOTECHNOL, V130, P114, DOI 10.1016/j.jbiotec.2007.03.008; Hoshida H, 2014, YEAST, V31, P29, DOI 10.1002/yea.2993; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Inokuma K., 2015, YEAST, V3; Jakociunas T, 2016, METAB ENG, V34, P44, DOI 10.1016/j.ymben.2015.12.003; Jeong H, 2012, EUKARYOT CELL, V11, P1584, DOI 10.1128/EC.00260-12; Moore JK, 1996, MOL CELL BIOL, V16, P2164; Nishida K., 2016, SCIENCE, V353; Nonklang S, 2008, APPL ENVIRON MICROB, V74, P7514, DOI 10.1128/AEM.01854-08; Suzuki T., 2014, GENOME ANNOUNC, V2; Valencia M, 2001, NATURE, V414, P666, DOI 10.1038/414666a; Wagner JM, 2016, FUNGAL GENET BIOL, V89, P126, DOI [10.1010/j.fgb.2015.12.001, 10.1016/j.fgb.2015.12.001]; Yarimizu T, 2015, J BIOSCI BIOENG, V119, P251, DOI 10.1016/j.jbiosc.2014.08.006	20	0	0	14	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 21	2017	7								8993	10.1038/s41598-017-08356-5				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FE3HM	WOS:000408107000127	28827530	gold			2018-01-05	
J	Campos, NA; Panis, B; Carpentier, SC				Campos, Nydia A.; Panis, Bart; Carpentier, Sebastien C.			Somatic Embryogenesis in Coffee: The Evolution of Biotechnology and the Integration of Omics Technologies Offer Great Opportunities	FRONTIERS IN PLANT SCIENCE			English	Review						totipotency; somatic embryogenesis; Coffea arabica; tissue culture; molecular biology; coffee	CELL-SUSPENSION-CULTURES; ARABICA L.; PROTEOMIC ANALYSIS; EMBRYO DEVELOPMENT; VITIS-VINIFERA; MOLECULAR CHARACTERIZATION; SOMACLONAL VARIATION; PLANT-CELLS; SERK GENE; EXPRESSION	One of the most important crops cultivated around the world is coffee. There are two main cultivated species, Coffea arabica and C. canephora. Both species are difficult to improve through conventional breeding, taking at least 20 years to produce a new cultivar. Biotechnological tools such as genetic transformation, micropropagation and somatic embryogenesis (SE) have been extensively studied in order to provide practical results for coffee improvement. While genetic transformation got many attention in the past and is booming with the CRISPR technology, micropropagation and SE are still the major bottle neck and urgently need more attention. The methodologies to induce SE and the further development of the embryos are genotype-dependent, what leads to an almost empirical development of specific protocols for each cultivar or clone. This is a serious limitation and excludes a general comprehensive understanding of the process as a whole. The aim of this review is to provide an overview of which achievements and molecular insights have been gained in (coffee) somatic embryogenesis and encourage researchers to invest further in the in vitro technology and combine it with the latest omics techniques (genomics, transcriptomics, proteomics, metabolomics, and phenomics). We conclude that the evolution of biotechnology and the integration of omics technologies offer great opportunities to (i) optimize the production process of SE and the subsequent conversion into rooted plantlets and (ii) to screen for possible somaclonal variation. However, currently the usage of the latest biotechnology did not pass the stage beyond proof of potential and needs to further improve.	[Campos, Nydia A.; Carpentier, Sebastien C.] Katholieke Univ Leuven, Dept Biosyst, Leuven, Belgium; [Panis, Bart] Biovers Int, Leuven, Belgium; [Carpentier, Sebastien C.] Katholieke Univ Leuven, Facil Syst Biol Based Mass Spectrometry, Leuven, Belgium	Carpentier, SC (reprint author), Katholieke Univ Leuven, Dept Biosyst, Leuven, Belgium.; Panis, B (reprint author), Biovers Int, Leuven, Belgium.; Carpentier, SC (reprint author), Katholieke Univ Leuven, Facil Syst Biol Based Mass Spectrometry, Leuven, Belgium.	b.panis@cgiar.org; sebastien.carpentier@kuleuven.be			CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [249409/2013-5 PDE]	The authors are grateful to CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) through the process 249409/2013-5 PDE for the scholarship of NC.	Arroyo-Herrera A, 2008, PLANT CELL TISS ORG, V94, P171, DOI 10.1007/s11240-008-9401-1; Azma A., 2013, MALAYS APPL BIOL, V43, P1; Baba AI, 2008, PLANT SCI, V175, P717, DOI 10.1016/j.plantsci.2008.07.014; Barbon R, 2008, PLANT CELL TISS ORG, V95, P155, DOI 10.1007/s11240-008-9427-4; Baudino S, 2001, PLANTA, V213, P1, DOI 10.1007/s004250000471; Berthouly M, 1996, PLANT CELL TISS ORG, V44, P169, DOI 10.1007/BF00048196; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI [10.1105/tpc.001941, 10.1005/tpc.001941]; Braybrook SA, 2008, TRENDS PLANT SCI, V13, P624, DOI 10.1016/j.tplants.2008.09.008; Campos NA, 2016, PROTEOMICS, V16, P1001, DOI 10.1002/pmic.201500399; Carpentier SC, 2014, METHODS MOL BIOL, V1072, P333, DOI 10.1007/978-1-62703-631-3_24; Carpentier SC, 2008, PHYSIOL PLANTARUM, V133, P117, DOI 10.1111/j.1399-3054.2008.01069.x; Chung JP, 2006, PLANT CELL TISS ORG, V87, P305, DOI 10.1007/s11240-006-9168-1; Chung JP, 2016, PLANT CELL TISS ORG, V124, P241, DOI 10.1007/s11240-015-0888-y; Croce P, 2009, ACTA HORTIC, V827, P521; de Feria M, 2003, PLANT CELL TISS ORG, V72, P1, DOI 10.1023/A:1021202305692; Denoeud F, 2014, SCIENCE, V345, P1181, DOI 10.1126/science.1255274; de Oliveira SM, 2005, PLANT SCI, V168, P723; Dulloo ME, 2009, CROP SCI, V49, P2123, DOI 10.2135/cropsci2008.12.0736; Dussert S., 1997, CRYOLETT, V276, P269; Vieira Luiz Gonzaga Esteves, 2006, Braz. J. Plant Physiol., V18, P95, DOI 10.1590/S1677-04202006000100008; Etienne H, 2003, TREE PHYSIOL, V23, P419, DOI 10.1093/treephys/23.6.419                                                       ; Etienne H, 2002, IN VITRO CELL DEV-PL, V38, P129, DOI 10.1079/IVP2001273; Etienne H, 2001, TREE PHYSIOL, V21, P1031, DOI 10.1093/treephys/21.14.1031                                                     ; Etienne H., 2005, PROTOCOL SOMATIC EMB, P167, DOI [10.1007/1-4020-2985-3_14, DOI 10.1007/1-4020-2985-3_14]; Etienne H, 2016, HUM GENET EMBRYOL, V6, P1, DOI [10.4172/2161-0436.1000136, DOI 10.4172/2161-0436.1000136]; Etienne Hervé, 2006, Braz. J. Plant Physiol., V18, P45, DOI 10.1590/S1677-04202006000100005; Etienne H, 2013, TREE PHYSIOL, V33, P640, DOI 10.1093/treephys/tpt034; Etienne H, 2012, CAH AGRIC, V21, P115, DOI 10.1684/agr.2012.0553; Etienne-Barry D, 1999, PLANT CELL REP, V19, P111, DOI 10.1007/s002990050720; Faostat, 2014, FAOSTAT DAT; Feher A, 2003, PLANT CELL TISS ORG, V74, P201, DOI 10.1023/A:1024033216561; Feher A, 2015, BBA-GENE REGUL MECH, V1849, P385, DOI 10.1016/j.bbagrm.2014.07.005; Mukul-Lopez HG, 2012, J MEX CHEM SOC, V56, P72; Gatica-Arias A.M., 2008, ELECTRON J BIOTECHN, V11, P1, DOI DOI 10.2225/V0L11-ISSUE1-FULLTEXT-9; Georget F, 2017, SCI HORTIC-AMSTERDAM, V216, P177, DOI 10.1016/j.scienta.2016.12.017; Guzman-Garcia E, 2013, PROTEOMICS, V13, P3498, DOI 10.1002/pmic.201300148; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.127.3.803; Heringer AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127803; Ito Y, 2005, BBA-GENE STRUCT EXPR, V1730, P253, DOI 10.1016/j.bbaexp.2005.06.007; Jansen RC, 2002, NAT BIOTECHNOL, V20, P19, DOI 10.1038/nbt0102-19b                                                             ; Jimenez VM, 2005, PLANT GROWTH REGUL, V47, P91, DOI 10.1007/s10725-005-3478-x; Kobayashi T, 2000, PLANT CELL PHYSIOL, V41, P268; Kumar V, 2006, PLANT CELL TISS ORG, V87, P49, DOI 10.1007/s11240-006-9134-y; Landey RB, 2015, PLANT CELL TISS ORG, V122, P517, DOI 10.1007/s11240-015-0772-9; Landey RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056372; Lashermes P, 1999, MOL GEN GENET, V261, P259, DOI 10.1007/s004380050965                                                           ; Lashermes P, 2000, THEOR APPL GENET, V100, P139, DOI 10.1007/s001220050019; Li KM, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-10; Lippert D, 2005, PROTEOMICS, V5, P461, DOI 10.1002/pmic.200400986; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4                                                   ; Loyola-vargas V. M., 2016, SOMATIC EMBRYOGENESI, P297; Ma J, 2012, PLANT MOL BIOL REP, V30, P195, DOI 10.1007/s11105-011-0330-5; Marsoni M, 2008, PLANT CELL REP, V27, P347, DOI 10.1007/s00299-007-0438-0; Menendez-Yuffa A, 2010, PLANT CELL TISS ORG, V102, P297, DOI 10.1007/s11240-010-9734-4; Mira MM, 2016, J EXP BOT, V67, P2231, DOI 10.1093/jxb/erw022; Molina DM, 2002, PLANT CELL TISS ORG, V71, P117, DOI 10.1023/A:1019965621041; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nic-Can GI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072160; Noah AM, 2013, J PROTEOMICS, V78, P123, DOI 10.1016/j.jprot.2012.11.007; Padua MS, 2014, CIENC RURAL, V44, P660, DOI 10.1590/S0103-84782014000400014; Palma JM, 2011, J PROTEOMICS, V74, P1230, DOI 10.1016/j.jprot.2011.04.010; Papanastasiou I, 2008, PLANT CELL TISS ORG, V92, P215, DOI 10.1007/s11240-007-9326-0; Quiroz-Figueroa F, 2002, J PLANT PHYSIOL, V159, P1267, DOI 10.1078/0176-1617-00878                                                         ; Quiroz-Figueroa FR, 2006, PLANT CELL TISS ORG, V86, P285, DOI 10.1007/s11240-006-9139-6; Rezende J. C., 2011, CIENC RURAL, V41, P384, DOI [10.1590/S0103-84782011000500031, DOI 10.1590/S0103-84782011000500031]; Riechmann JL, 1998, BIOL CHEM, V379, P633; Rudus I, 2006, PLANT GROWTH REGUL, V48, P1, DOI 10.1007/s10725-005-5136-8; Santana N, 2004, IN VITRO CELL DEV-PL, V40, P95, DOI 10.1079/IVP2003486; Santana-Buzzy N, 2007, IN VITRO CELL DEV-PL, V43, P507, DOI 10.1007/s11627-007-9074-1; Schellenbaum P, 2008, PLANT CELL REP, V27, P1799, DOI 10.1007/s00299-008-0588-8; Schmidt EDL, 1997, DEVELOPMENT, V124, P2049; Shimada T, 2005, SCI HORTIC-AMSTERDAM, V103, P233, DOI 10.1016/j.scienta.2004.07.005; Silva AT, 2013, GENET MOL RES, V12, P1698, DOI 10.4238/2013.May.21.1; Silva AS, 2011, REV CIENC AGRON, V42, P921, DOI 10.1590/S1806-66902011000400014; Silva AT, 2015, IN VITRO CELL DEV-PL, V51, P93, DOI 10.1007/s11627-014-9643-z; Silva AT, 2014, PLANT MOL BIOL REP, V32, P176, DOI 10.1007/s11105-013-0632-x; Simoes-Costa MC, 2009, ACTA HORTIC, V812, P295; SONDAHL MR, 1977, Z PFLANZENPHYSIOL, V81, P395; STARITSKY G, 1970, ACTA BOT NEERL, V19, P509, DOI 10.1111/j.1438-8677.1970.tb00677.x                                              ; Teixeira JB, 2004, MULTIPLICACAO CLONAL; Thomas C, 2004, PLANT PHYSIOL BIOCH, V42, P35, DOI 10.1016/j.plaphy.2003.10.008; Tonietto A, 2012, PLANT MOL BIOL REP, V30, P1393, DOI 10.1007/s11105-012-0425-7; TOONEN MAJ, 1994, PLANTA, V194, P565, DOI 10.1007/BF00714471                                                              ; van der Vossen H, 2015, EUPHYTICA, V204, P243, DOI 10.1007/s10681-015-1398-z; vanBoxtel J, 1996, PLANT CELL TISS ORG, V44, P7, DOI 10.1007/BF00045907                                                              ; Varhanikova M, 2014, J PROTEOMICS, V104, P57, DOI 10.1016/j.jprot.2014.02.003; Yang XY, 2010, CRIT REV PLANT SCI, V29, P36, DOI 10.1080/07352680903436291; Yang Y, 2011, J EXP BOT, V62, P2079, DOI 10.1093/jxb/erq400; Zivy M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00448	89	0	0	36	36	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	AUG 21	2017	8								1460	10.3389/fpls.2017.01460				12	Plant Sciences	Plant Sciences	FE2CO	WOS:000408024100001	28871271	gold			2018-01-05	
J	Lee, CT; Bendriem, RM; Wu, WW; Shen, RF				Lee, Chun-Ting; Bendriem, Raphael M.; Wu, Wells W.; Shen, Rong-Fong			3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders	JOURNAL OF BIOMEDICAL SCIENCE			English	Review						3D brain organoids; Induced pluripotent stem cells; Brain development; Neocortex; Neurodevelopmental disorder; Neurodegenerative disorder; Microcephaly; Drugs; Autism; Alzheimer's disease	PRENATAL COCAINE EXPOSURE; AMYLOID PRECURSOR PROTEIN; ZIKA VIRUS-INFECTION; ALZHEIMERS-DISEASE; DIRECTED DIFFERENTIATION; CEREBRAL-CORTEX; HUMAN ES; NEURAL PROGENITORS; MICROGLIA; NEOCORTEX	Three-dimensional (3D) brain organoids derived from human pluripotent stem cells (hPSCs), including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), appear to recapitulate the brain's 3D cytoarchitectural arrangement and provide new opportunities to explore disease pathogenesis in the human brain. Human iPSC (hiPSC) reprogramming methods, combined with 3D brain organoid tools, may allow patient-derived organoids to serve as a preclinical platform to bridge the translational gap between animal models and human clinical trials. Studies using patient-derived brain organoids have already revealed novel insights into molecular and genetic mechanisms of certain complex human neurological disorders such as microcephaly, autism, and Alzheimer's disease. Furthermore, the combination of hiPSC technology and small-molecule high-throughput screening (HTS) facilitates the development of novel pharmacotherapeutic strategies, while transcriptome sequencing enables the transcriptional profiling of patient-derived brain organoids. Finally, the addition of CRISPR/Cas9 genome editing provides incredible potential for personalized cell replacement therapy with genetically corrected hiPSCs. This review describes the history and current state of 3D brain organoid differentiation strategies, a survey of applications of organoids towards studies of neurodevelopmental and neurodegenerative disorders, and the challenges associated with their use as in vitro models of neurological disorders.	[Lee, Chun-Ting; Wu, Wells W.; Shen, Rong-Fong] US FDA, Facil Biotechnol Resources, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Bendriem, Raphael M.] Weill Cornell Med, Ctr Neurogenet, Feil Family Brain & Mind Res Inst, New York, NY 10021 USA; [Lee, Chun-Ting] US FDA, Ctr Biol Evaluat & Res, Bldg 52,Rm 1121,10903 New Hampshire Ave, Silver Spring, MD 20993 USA	Lee, CT (reprint author), US FDA, Facil Biotechnol Resources, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.; Lee, CT (reprint author), US FDA, Ctr Biol Evaluat & Res, Bldg 52,Rm 1121,10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	Chun-Ting.Lee@fda.hhs.gov					Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Bandstra ES, 2004, SUBST USE MISUSE, V39, P25, DOI 10.1081/JA-120027765; Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Behnke M, 2013, PEDIATRICS, V131, pE1009, DOI 10.1542/peds.2012-3931; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7                                                   ; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Byron SA, 2016, NAT REV GENET, V17, P257, DOI 10.1038/nrg.2016.10; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Campion D, 1999, AM J HUM GENET, V65, P664, DOI 10.1086/302553                                                                  ; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen H, 2014, CELL STEM CELL, V14, P796, DOI 10.1016/j.stem.2014.02.004; Chiriboga CA, 1999, PEDIATRICS, V103, P79, DOI 10.1542/peds.103.1.79                                                           ; Chiriboga CA, 2007, NEUROTOXICOL TERATOL, V29, P323, DOI 10.1016/j.ntt.2006.12.002; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Cunningham CL, 2013, J NEUROSCI, V33, P4216, DOI 10.1523/JNEUROSCI.3441-12.2013; Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014; DelaneyBlack V, 1996, PEDIATRICS, V98, P735; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Ebert AD, 2010, NAT REV DRUG DISCOV, V9, P1, DOI 10.1038/nrd3000; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Engle SJ, 2014, J BIOL CHEM, V289, P4562, DOI 10.1074/jbc.R113.529156; Escott-Price V, 2015, BRAIN, V138, P3673, DOI 10.1093/brain/awv268; Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4; Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571; Franco SJ, 2013, NEURON, V77, P19, DOI 10.1016/j.neuron.2012.12.022; Frank DA, 1998, ANN NY ACAD SCI, V846, P40, DOI 10.1111/j.1749-6632.1998.tb09725.x; Gandal MJ, 2016, NAT NEUROSCI, V19, P1397, DOI 10.1038/nn.4409; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Gonzalez-Mantilla AJ, 2016, JAMA PSYCHIAT, V73, P275, DOI 10.1001/jamapsychiatry.2015.2692; Gratten J, 2014, NAT NEUROSCI, V17, P782, DOI 10.1038/nn.3708; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Hendriks WT, 2016, CELL STEM CELL, V18, P53, DOI 10.1016/j.stem.2015.12.002; Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2; Hibaoui Y, 2014, EMBO MOL MED, V6, P259, DOI 10.1002/emmm.201302848; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Hogberg HT, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt365; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Javaherian A, 2009, CEREB CORTEX, V19, pI70, DOI 10.1093/cercor/bhp029; Orqueda AJ, 2016, STEM CELLS INT, DOI 10.1155/2016/5934782; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Kim YH, 2015, NAT PROTOC, V10, P985, DOI 10.1038/nprot.2015.065; Kindberg AA, 2014, DIS MODEL MECH, V7, P1397, DOI 10.1242/dmm.017251; Krauer F, 2016, PLOS MED, V14; La Cognata V, 2017, HUM GENET, V136, P13, DOI 10.1007/s00439-016-1749-4; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lange C, 2016, EMBO J, V35, P924, DOI 10.15252/embj.201592372; Lee CT, 2017, NEUROPSYCHOPHARMACOL, V42, P774, DOI 10.1038/npp.2016.156; Lee CT, 2015, ONCOTARGET, V6, P18238, DOI 10.18632/oncotarget.4853                                                        ; Lee CT, 2015, RESTOR NEUROL NEUROS, V33, P347, DOI 10.3233/RNN-140488; Lee CT, 2015, CELL REP, V10, P616, DOI 10.1016/j.celrep.2014.12.050; Lee CT, 2011, SYNAPSE, V65, P21, DOI 10.1002/syn.20814; Lee CT, 2008, PLOS MED, V5, P987, DOI 10.1371/journal.pmed.0050117; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Marchetto MC, 2017, MOL PSYCHIATR, V22, P820, DOI 10.1038/mp.2016.95; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; McCarroll SA, 2013, NEURON, V80, P578, DOI 10.1016/j.neuron.2013.10.046; Megraw TL, 2011, TRENDS CELL BIOL, V21, P470, DOI 10.1016/j.tcb.2011.04.007; Merikangas AK, 2009, TRENDS GENET, V25, P536, DOI 10.1016/j.tig.2009.10.006; Minnes Sonia, 2011, Addict Sci Clin Pract, V6, P57; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; Nie J, 2017, EMBO REP, V18, P367, DOI 10.15252/embr.201643732; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831; Pandya H, 2017, NAT NEUROSCI, V20, P753, DOI 10.1038/nn.4534; Parikshak NN, 2015, NAT REV GENET, V16, P441, DOI 10.1038/nrg3934; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Pinto AM, 2016, EXPERT REV MOL DIAGN, V16, P1037, DOI 10.1080/14737159.2016.1224181; Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Rabbani B, 2016, MOL BIOSYST, V12, P1818, DOI 10.1039/c6mb00115g; Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rando K, 2013, BIOL PSYCHIAT, V74, P482, DOI 10.1016/j.biopsych.2013.04.030; Rivkin MJ, 2008, PEDIATRICS, V121, P741, DOI 10.1542/peds.2007-1399; Ryan SD, 2013, CELL, V155, P1351, DOI 10.1016/j.cell.2013.11.009; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Sarno M, 2016, PLOS NEGL TROP DIS, V10; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schwartz MP, 2015, P NATL ACAD SCI USA, V112, P12516, DOI 10.1073/pnas.1516645112; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Singer LT, 2002, JAMA-J AM MED ASSOC, V287, P1952, DOI 10.1001/jama.287.15.1952                                                        ; Smith C, 2016, COLD SPRING HARB PRO; Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491; Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009; Takebe T, 2015, CELL STEM CELL, V16, P556, DOI 10.1016/j.stem.2015.03.004; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Thompson BL, 2009, NAT REV NEUROSCI, V10, P303, DOI 10.1038/nrn2598; Tronick EZ, 1996, PEDIATRICS, V98, P76; Tay TL, 2017, J PHYSIOL-LONDON, V595, P1929, DOI 10.1113/JP272134; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Vasudevan A, 2008, NAT NEUROSCI, V11, P429, DOI 10.1038/nn2074; Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4; Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930                                                                  ; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zielinski BA, 2014, BRAIN, V137, P1799, DOI 10.1093/brain/awu083	121	0	0	39	39	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1021-7770	1423-0127		J BIOMED SCI	J. Biomed. Sci.	AUG 20	2017	24								59	10.1186/s12929-017-0362-8				12	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	FE0JM	WOS:000407906600001	28822354	gold			2018-01-05	
J	Gaytan-Cervantes, J; Gonzalez-Torres, C; Maldonado, V; Zampedri, C; Ceballos-Cancino, G; Melendez-Zajgla, J				Gaytan-Cervantes, Javier; Gonzalez-Torres, Carolina; Maldonado, Vilma; Zampedri, Cecilia; Ceballos-Cancino, Gisela; Melendez-Zajgla, Jorge			Protein Sam68 regulates the alternative splicing of survivin DEx3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; EXPRESSION; CANCER; CELL; DISEASE; PHOSPHORYLATION; VARIANTS; TARGET; DNA; SURVIVIN-DELTA-EX3	Messenger RNA alternative splicing (AS) regulates the expression of a variety of genes involved in both physiological and pathological processes. AS of the anti-apoptotic and proliferation-associated survivin (BIRC5) gene generates six isoforms, which regulate key aspects of cancer initiation and progression. One of the isoforms is survivin DEx3, in which the exclusion of exon 3 generates a unique carboxyl terminus with specific anti-apoptotic functions. This isoform is highly expressed in advanced stages of breast and cervical tumors. Therefore, understanding the mechanisms that regulate survivin DEx3 mRNA AS is clearly important. To this end, we designed a minigene (M), and in combination with a series of deletions and site-directed mutations, we determined that the first 22 bp of exon 3 contain cis-acting elements that enhance the exclusion of exon 3 to generate the survivin DEx3 mRNA isoform. Furthermore, using pulldown assays, we discovered that Sam68 is a possible trans-acting factor that binds to this region and regulates exon 3 splicing. This result was corroborated using a cell line in which the Sam68 binding site in the survivin gene was mutated with the CRISPR/Cas system. This work provides the first clues regarding the regulation of survivin DEx3 mRNA splicing.	[Gaytan-Cervantes, Javier; Zampedri, Cecilia; Ceballos-Cancino, Gisela; Melendez-Zajgla, Jorge] Natl Inst Genom Med INMEGEN, Lab Funct Genom, Mexico City 14610, DF, Mexico; [Gonzalez-Torres, Carolina; Maldonado, Vilma] Natl Inst Genom Med INMEGEN, Lab Epigenet, Mexico City 14610, DF, Mexico	Ceballos-Cancino, G; Melendez-Zajgla, J (reprint author), Natl Inst Genom Med INMEGEN, Lab Funct Genom, Mexico City 14610, DF, Mexico.	gceballos@inmegen.gob.mx; jmelendez@inmegen.gob.mx			Consejo Nacional de Ciencia y Tecnologia [132931]	This work was supported by Consejo Nacional de Ciencia y Tecnologia Grant 132931. The authors declare that they have no conflicts of interest with the contents of this article.	Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Bielli P, 2014, NUCLEIC ACIDS RES, V42, P12070, DOI 10.1093/nar/gku922; Bielli P, 2014, EMBO REP, V15, P419, DOI 10.1002/embr.201338241; Bonomi S, 2013, INT J CELL BIOL, V2013, DOI DOI 10.1155/2013/962038; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Carter BZ, 2012, BLOOD, V120, P173, DOI 10.1182/blood-2012-02-409888; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Cooper TA, 2005, METHODS, V37, P331, DOI 10.1016/j.ymeth.2005.07.015; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Necochea-Campion R, 2013, CANCER LETT, V339, P167, DOI 10.1016/j.canlet.2013.06.007; Douglas AGL, 2011, BRIEF FUNCT GENOMICS, V10, P151, DOI 10.1093/bfgp/elr020; Espinosa M, 2012, CANCER LETT, V318, P61, DOI 10.1016/j.canlet.2011.12.002; Ezponda T, 2010, CLIN CANCER RES, V16, P4113, DOI 10.1158/1078-0432.CCR-10-0076; Fredericks AM, 2015, BIOMOLECULES, V5, P893, DOI 10.3390/biom5020893; Frisone P, 2015, BIOMED RES INT, DOI 10.1155/2015/528954; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ishiyama M, 1996, BIOL PHARM BULL, V19, P1518; Kechris K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-551; Krieg A, 2002, BRIT J CANCER, V86, P737, DOI 10.1038/sj/bjc/6600153; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lopergolo A, 2012, CANCER RES, V72, P3251, DOI 10.1158/0008-5472.CAN-11-4035; Malcles MH, 2007, BRIT J CANCER, V96, P1659, DOI 10.1038/sj.bjc.6603768; MARTINEZCONTRERAS, 2007, ADV EXP MED BIOL, V623, P123; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nouraee N, 2009, UROL J, V6, P101; Pavlidou Anastasia, 2014, World J Clin Oncol, V5, P883, DOI 10.5306/wjco.v5.i5.883; Pavlidou A, 2011, WORLD J GASTROENTERO, V17, P1614, DOI [10.3748/wjg.v17.i12.1614, 10.3748/wjg.v17.i12. 1614]; Piva F, 2012, HUM MUTAT, V33, P81, DOI 10.1002/humu.21609; Rosenberger S, 2010, P NATL ACAD SCI USA, V107, P7006, DOI 10.1073/pnas.1002620107; Sanchez SE, 2011, RNA BIOL, V8, P954, DOI 10.4161/rna.8.6.17336; Siddharth S, 2016, CLIN EXP METASTAS, V33, P661, DOI 10.1007/s10585-016-9809-7; Spitali P, 2012, CELL, V148, P1085, DOI 10.1016/j.cell.2012.02.014; Talukdar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027869; Taubert H, 2005, ONCOGENE, V24, P5258, DOI 10.1038/sj.onc.1208702; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Valacca C, 2010, J CELL BIOL, V191, P87, DOI 10.1083/jcb.201001073; Waligorska-Stachura J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100534; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; WESTERFIELD M, 2000, ZEBRAFISH BOOK GUIDE, DOI DOI 10.1371/JOURNAL.PONE.0027869; WESTERFIELD M, 1993, ZEBRAFISH BOOK GUIDE; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109	50	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13745	13757		10.1074/jbc.M117.800318				13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FE0XG	WOS:000407942400006	28655776				2018-01-05	
J	Ha, S; Jeong, SH; Yi, K; Chung, KM; Hong, CJ; Kim, SW; Kim, EK; Yu, SW				Ha, Shinwon; Jeong, Seol-Hwa; Yi, Kyungrim; Chung, Kyung Min; Hong, Caroline Jeeyeon; Kim, Seong Who; Kim, Eun-Kyoung; Yu, Seong-Woon			Phosphorylation of p62 by AMP-activated protein kinase mediates autophagic cell death in adult hippocampal neural stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN WITHDRAWAL; MITOPHAGY; P62/SQSTM1; DEGRADATION; APOPTOSIS; PATHWAY; SURVIVAL; PROLIFERATION; MITOCHONDRIA; MECHANISMS	In the adult brain, programmed death of neural stem cells is considered to be critical for tissue homeostasis and cognitive function and is dysregulated in neurodegeneration. Previously, we have reported that adult rat hippocampal neural (HCN) stem cells undergo autophagic cell death (ACD) following insulin withdrawal. Because the apoptotic capability of the HCN cells was intact, our findings suggested activation of unique molecular mechanisms linking insulin withdrawal to ACD rather than apoptosis. Here, we report that phosphorylation of autophagy-associated protein p62 by AMP-activated protein kinase (AMPK) drives ACD and mitophagy in HCN cells. Pharmacological inhibition of AMPK or genetic ablation of the AMPK alpha 2 subunit by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 genome editing suppressed ACD, whereas AMPK activation promoted ACD in insulin-deprived HCN cells. We found that following insulin withdrawal AMPK phosphorylated p62 at a novel site, Ser-293/Ser-294 (in rat and human p62, respectively). Phosphorylated p62 translocated to mitochondria and induced mitophagy and ACD. Interestingly, p62 phosphorylation at Ser-293 was not required for staurosporine-induced apoptosis in HCN cells. To the best of our knowledge, this is the first report on the direct phosphorylation of p62 by AMPK. Our data suggest that AMPK-mediated p62 phosphorylation is an ACD-specific signaling event and provide novel mechanistic insight into the molecular mechanisms in ACD.	[Ha, Shinwon; Jeong, Seol-Hwa; Yi, Kyungrim; Chung, Kyung Min; Hong, Caroline Jeeyeon; Kim, Eun-Kyoung; Yu, Seong-Woon] Gyeongbuk Inst Sci & Technol, Dept Brain & Cognit Sci, Daegu 42988, South Korea; [Kim, Eun-Kyoung; Yu, Seong-Woon] Gyeongbuk Inst Sci & Technol, Neurometab Res Ctr, Daegu 42988, South Korea; [Kim, Seong Who] Univ Ulsan, Dept Biochem & Mol Biol, Asan Med Ctr, Coll Med, Seoul 05505, South Korea	Yu, SW (reprint author), DGIST, Dept Brain & Cognit Sci, 333 Techno Jungang Daero, Dalseong Gun 42988, Daegu, South Korea.	yusw@dgist.ac.kr			Bio and Medical Technology Development Program of the National Research Foundation of Korea [2012M3A9C6049935, 2013M3C7A1056099]; Korea Brain Research Institute Basic Research Program [17-BR-04]; Daegu Gyeongbuk Institute of Science and Technology Convergence Science Center Program of the Ministry of Science, ICT and Future Planning of Korea [17-BD-04]	This work was supported by Bio and Medical Technology Development Program of the National Research Foundation of Korea Grants (2012M3A9C6049935 and 2013M3C7A1056099), Korea Brain Research Institute Basic Research Program (17-BR-04), and Daegu Gyeongbuk Institute of Science and Technology Convergence Science Center Program (17-BD-04) of the Ministry of Science, ICT and Future Planning of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Baek SH, 2009, AUTOPHAGY, V5, P277, DOI 10.1634/stemcells.2008-0153; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chung KM, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00116; Chung KM, 2015, STEM CELLS, V33, P3052, DOI 10.1002/stem.2082; Chung KM, 2013, BMB REP, V46, P383, DOI 10.5483/BMBRep.2013.46.8.164; Clarke PGH, 2012, AUTOPHAGY, V8, P867, DOI 10.4161/auto.20380; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458                                                               ; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Elmore SP, 2001, FASEB J, V15, P2286; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Ha S, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0119-9; Han D, 2010, BIOCHEM J, V425, P541, DOI 10.1042/BJ20090429; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879                                                        ; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; Hong CJ, 2016, BRAIN RES, V1649, P166, DOI 10.1016/j.brainres.2016.02.048; Ichimura Y, 2000, NATURE, V408, P488; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826                                                               ; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.119; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim NY, 2014, ANIM CELLS SYST, V18, P183, DOI 10.1080/19768354.2014.923045; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451                                                               ; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lim J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004987; Linares JF, 2011, MOL CELL BIOL, V31, P105, DOI 10.1128/MCB.00620-10; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660                                                                 ; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mitani T, 2015, CELL SIGNAL, V27, P1994, DOI 10.1016/j.cellsig.2015.07.009; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Puyal J, 2013, PROG NEUROBIOL, V105, P24, DOI 10.1016/j.pneurobio.2013.03.002; Ryu JR, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0224-4; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; Shen HM, 2011, AUTOPHAGY, V7, P457, DOI 10.4161/auto.7.5.14226; Sinha RA, 2015, AUTOPHAGY, V11, P1341, DOI 10.1080/15548627.2015.1061849; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611                                                           ; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Wu XR, 2012, MOL CELL PROTEOMICS, V11, P1640, DOI 10.1074/mcp.M112.019091; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Yeo BK, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0212-8; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu SW, 2008, STEM CELLS, V26, P2602, DOI 10.1634/stemcells.2008-0153	68	0	0	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13795	13808		10.1074/jbc.M117.780874				14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FE0XG	WOS:000407942400008	28655770				2018-01-05	
J	Qin, S; Ingle, JN; Liu, M; Yu, J; Wickerham, L; Kubo, M; Weinshilboum, RM; Wang, LW				Qin, Sisi; Ingle, James N.; Liu, Mohan; Yu, Jia; Wickerham, Lawrence; Kubo, Michiaki; Weinshilboum, Richard M.; Wang, Liewei			Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion	BREAST CANCER RESEARCH			English	Article						ER alpha coregulator; Single nucleotide polymorphism; Estrogen; Selective estrogen receptor modulator treatment	SURGICAL ADJUVANT BREAST; STAR P-2 TRIAL; MYOSIN-X; BOWEL PROJECT; CANCER CELLS; TAMOXIFEN; FILOPODIA; BRCA1; LOCALIZATION; CHEMOTHERAPY	Background: We previously performed a case-control genome-wide association study in women treated with selective estrogen receptor modulators (SERMs) for breast cancer prevention and identified single nucleotide polymorphisms (SNPs) in ZNF423 as potential biomarkers for response to SERM therapy. The ZNF423rs9940645 SNP, which is approximately 200 bp away from the estrogen response elements, resulted in the SNP, estrogen, and SERM-dependent regulation of ZNF423 expression and, "downstream", that of BRCA1. Methods: Electrophoretic mobility shift assay-mass spectrometry was performed to identify proteins binding to the ZNF423 SNP and coordinating with estrogen receptor alpha (ERa). Clustered, regularly interspaced short palindromic repeats (CRISPR)/Cas9 genome editing was applied to generate ZR75-1 breast cancer cells with different ZNF423 SNP genotypes. Both cultured cells and mouse xenograft models with different ZNF423 SNP genotypes were used to study the cellular responses to SERMs and poly(ADP-ribose) polymerase (PARP) inhibitors. Results: We identified calmodulin-like protein 3 (CALML3) as a key sensor of this SNP and a coregulator of ERa, which contributes to differential gene transcription regulation in an estrogen and SERM-dependent fashion. Furthermore, using CRISPR/Cas9-engineered ZR75-1 breast cancer cells with different ZNF423 SNP genotypes, striking differences in cellular responses to SERMs and PARP inhibitors, alone or in combination, were observed not only in cells but also in a mouse xenograft model. Conclusions: Our results have demonstrated the mechanism by which the ZNF423 rs9940645 SNP might regulate gene expression and drug response as well as its potential role in achieving more highly individualized breast cancer therapy.	[Qin, Sisi; Liu, Mohan; Yu, Jia; Weinshilboum, Richard M.; Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Ingle, James N.] Mayo Clin, Dept Med Oncol, Rochester, MN USA; [Wickerham, Lawrence] Allegheny Hlth Network Canc Inst, Sect Canc Genet & Prevent, Pittsburgh, PA USA; [Wickerham, Lawrence] Natl Surg Adjuvant Breast & Bowel Project NRG Onc, Pittsburgh, PA USA; [Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan	Wang, LW (reprint author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA.	Wang.Liewei@mayo.edu			Breast Cancer Research Foundation; Nan Sawyer Breast Cancer Fund; George M. Eisenberg Foundation for Charities;  [P50CA116201];  [U19GM61388];  [R01 GM28157];  [R01 CA196648];  [NIH U10CA180868];  [UG1CA18967]	This work was supported by The Breast Cancer Research Foundation, The Nan Sawyer Breast Cancer Fund, George M. Eisenberg Foundation for Charities and grants P50CA116201 (Mayo Clinic Breast Cancer Specialized Program of Research excellence), U19GM61388 (The Pharmacogenomics Research Network), R01 GM28157, R01 CA196648, NIH U10CA180868 and UG1CA18967.	Addison WN, 2014, MOL CELL BIOL, V34, P3076, DOI 10.1128/MCB.00185-14; Annunziata CM, 2010, F1000 BIOL REP, V2, P10, DOI DOI 10.3410/B2-10; Armstrong K, 2006, ARCH INTERN MED, V166, P2260, DOI 10.1001/archinte.166.20.2260; Bennett RD, 2007, J BIOL CHEM, V282, P3205, DOI 10.1074/jbc.M607174200; Biswas DK, 1998, J BIOL CHEM, V273, P33817, DOI 10.1074/jbc.273.50.33817; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Caballero I, 2017, SCI REP-UK, V7, DOI 10.1038/srep40981; Dall G, 2015, J CANCER, V6, P1331, DOI 10.7150/jca.10890; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371                                                         ; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gallo D, 2008, MOL CELL ENDOCRINOL, V291, P20, DOI 10.1016/j.mce.2008.04.011; Harder L, 2014, MOL CELL ONCOL, V1, DOI 10.4161/23723548.2014.969655; Harder L, 2013, J EXP MED, V210, P2289, DOI 10.1084/jem.20130497; Ho MF, 2016, MOL ENDOCRINOL, V30, P382, DOI 10.1210/me.2015-1267; Ingle JN, 2013, CANCER DISCOV, V3, P812, DOI 10.1158/2159-8290.CD-13-0038; Lafarge S, 2001, ONCOGENE, V20, P6597, DOI 10.1038/sj.onc.1204812                                                          ; Li L, 2005, J BIOL CHEM, V280, P13097, DOI 10.1074/jbc.M410642200; Maniccia AW, 2009, J CELL PHYSIOL, V219, P634, DOI 10.1002/jcp.21708; Michalak EM, 2011, J MAMMARY GLAND BIOL, V16, P41, DOI 10.1007/s10911-011-9199-z; Niu NF, 2010, GENOME RES, V20, P1482, DOI 10.1101/gr.107672.110; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Quinn JE, 2003, CANCER RES, V63, P6221; Rogers Michael S., 1999, Neoplasia (New York), V1, P220, DOI 10.1038/sj.neo.7900029; Rogers MS, 2001, J BIOL CHEM, V276, P12182, DOI 10.1074/jbc.M010056200                                                          ; Ropka ME, 2010, J CLIN ONCOL, V28, P3090, DOI 10.1200/JCO.2009.27.8077; Rottenberg S, 2008, P NATL ACAD SCI USA, V105, P17079, DOI 10.1073/pnas.0806092105; Santen RJ, 2007, ENDOCR-RELAT CANCER, V14, P169, DOI 10.1677/ERC-06-0045; Scott CL, 2015, J CLIN ONCOL, V33, P1397, DOI 10.1200/JCO.2014.58.8848; Tassone P, 2003, BRIT J CANCER, V88, P1285, DOI 10.1038/sj.bjc.6600859; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074                                                    ; Vogel VG, 2010, CANCER PREV RES, V3, P696, DOI 10.1158/1940-6207.CAPR-10-0076; YASWEN P, 1992, CELL GROWTH DIFFER, V3, P335; YASWEN P, 1990, P NATL ACAD SCI USA, V87, P7360, DOI 10.1073/pnas.87.19.7360; Yonezawa S, 2003, DEV GROWTH DIFFER, V45, P175	36	0	0	3	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1465-542X	1465-5411		BREAST CANCER RES	Breast Cancer Res.	AUG 18	2017	19								95	10.1186/s13058-017-0890-x				14	Oncology	Oncology	FE0VT	WOS:000407938500002	28821270	green_published			2018-01-05	
J	Silas, S; Lucas-Elio, P; Jackson, SA; Aroca-Crevillen, A; Hansen, LL; Fineran, PC; Fire, AZ; Sanchez-Amat, A				Silas, Sukrit; Lucas-Elio, Patricia; Jackson, Simon A.; Aroca-Crevillen, Alejandra; Hansen, Loren L.; Fineran, Peter C.; Fire, Andrew Z.; Sanchez-Amat, Antonio			Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems	ELIFE			English	Article							MARINOMONAS-MEDITERRANEA; STREPTOCOCCUS-THERMOPHILUS; PSEUDOMONAS-AERUGINOSA; THERMUS-THERMOPHILUS; PYROCOCCUS-FURIOSUS; SPACER ACQUISITION; ADAPTIVE IMMUNITY; RNA CLEAVAGE; DNA; INTERFERENCE	CRISPR-Cas-mediated defense utilizes information stored as spacers in CRISPR arrays to defend against genetic invaders. We define the mode of target interference and role in antiviral defense for two CRISPR-Cas systems in Marinomonas mediterranea. One system (type I-F) targets DNA. A second system (type III-B) is broadly capable of acquiring spacers in either orientation from RNA and DNA, and exhibits transcription-dependent DNA interference. Examining resistance to phages isolated from Mediterranean seagrass meadows, we found that the type III-B machinery co-opts type I-F CRISPR-RNAs. Sequencing and infectivity assessments of related bacterial and phage strains suggests an arms race in which phage escape from the type I-F system can be overcome through use of type I-F spacers by a horizontally-acquired type III-B system. We propose that the phage-host arms race can drive selection for horizontal uptake and maintenance of promiscuous type III interference modules that supplement existing host type I CRISPR-Cas systems.	[Silas, Sukrit; Hansen, Loren L.; Fire, Andrew Z.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Silas, Sukrit] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Lucas-Elio, Patricia; Aroca-Crevillen, Alejandra; Sanchez-Amat, Antonio] Univ Murcia, Dept Genet & Microbiol, Murcia, Spain; [Fineran, Peter C.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [Fineran, Peter C.] Univ Otago, Bioprotect Res Ctr, Dunedin, New Zealand	Fire, AZ (reprint author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.; Sanchez-Amat, A (reprint author), Univ Murcia, Dept Genet & Microbiol, Murcia, Spain.	afire@stanford.edu; antonio@um.es		Sanchez-Amat, Antonio/0000-0001-8597-9235; Silas, Sukrit/0000-0003-3251-8579; Jackson, Simon/0000-0002-4512-3093; Fineran, Peter/0000-0002-4639-6704; Lucas-Elio, Patricia/0000-0001-7182-1189	National Institutes of Health [R01-GM37706]	National Institutes of Health R01-GM37706 Andrew Z Fire	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cady KC, 2012, J BACTERIOL, V194, P5728, DOI 10.1128/JB.01184-12; Campillo-Brocal JC, 2013, MICROBIOLOGYOPEN, V2, P684, DOI 10.1002/mbo3.107; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Elmore J, 2015, NUCLEIC ACIDS RES, V43, P10353, DOI 10.1093/nar/gkv1140; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Espinosa E, 2010, INT J SYST EVOL MICR, V60, P93, DOI 10.1099/ijs.0.008607-0; Fineran PC, 2013, GENOME ANOUNCEMENTS, V1; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; HALE CR, 2012, CELL, V45, P292, DOI DOI 10.1016/J.MOLCEL.2011.10.023; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Held NL, 2013, ENVIRON MICROBIOL, V15, P3065, DOI 10.1111/1462-2920.12146; Hochstrasser ML, 2015, TRENDS BIOCHEM SCI, V40, P58, DOI 10.1016/j.tibs.2014.10.007; Jackson SA, 2017, SCIENCE, V356, P40, DOI 10.1126/science.aal5056; Kang I, 2012, J VIROL, V86, P8909, DOI 10.1128/JVI.01328-12; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; KOTT Y, 1966, APPL MICROBIOL, V14, P141; Li Z, 2016, AQUACULTURE, V451, P345, DOI 10.1016/j.aquaculture.2015.09.024; Liu WT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-505; Lucas-Elio P, 2002, MICROBIOL-SGM, V148, P2457, DOI 10.1099/00221287-148-8-2457                                                     ; Majumdar S, 2015, RNA, V21, P1147, DOI 10.1261/rna.049130.114; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Patterson AG, 2016, MOL CELL, V64, P1102, DOI 10.1016/j.molcel.2016.11.012; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Plagens A, 2015, FEMS MICROBIOL REV, V39, P442, DOI 10.1093/femsre/fuv019; Przybilski R, 2011, RNA BIOL, V8, P517, DOI 10.4161/rna.8.3.15190; Rollins MF, 2015, NUCLEIC ACIDS RES, V43, P2216, DOI 10.1093/nar/gkv094; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Solano F, 1997, APPL ENVIRON MICROB, V63, P3499; Solano F, 2000, J BACTERIOL, V182, P3754, DOI 10.1128/JB.182.13.3754-3760.2000; Staals RHJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12853; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Suttle C., 1993, HDB METHODS AQUATIC; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	57	0	0	4	4	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	AUG 17	2017	6								e27601	10.7554/eLife.27601				27	Biology	Life Sciences & Biomedicine - Other Topics	FF1AK	WOS:000408632000001		gold			2018-01-05	
J	Pausch, P; Muller-Esparza, H; Gleditzsch, D; Altegoer, F; Randau, L; Bange, G				Pausch, Patrick; Mueller-Esparza, Hanna; Gleditzsch, Daniel; Altegoer, Florian; Randau, Lennart; Bange, Gert			Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance	MOLECULAR CELL			English	Article							BACTERIAL IMMUNE-SYSTEM; CAS SYSTEMS; ADAPTIVE IMMUNITY; CRYSTAL-STRUCTURE; BACTERIOPHAGE; EVOLUTION; COMPLEX; CASCADE; RECOGNITION; PROTEINS	CRISPR-Cas systems are prokaryotic immune systems against invading nucleic acids. Type I CRISPR-Cas systems employ highly diverse, multi-subunit surveillance Cascade complexes that facilitate duplex formation between crRNA and complementary target DNA for R-loop formation, retention, and DNA degradation by the subsequently recruited nuclease Cas3. Typically, the large subunit recognizes bona fide targets through the PAM (protospacer adjacent motif), and the small subunit guides the non-target DNA strand. Here, we present the Apo-and target-DNA-bound structures of the I-Fv (type I-F variant) Cascade lacking the small and large subunits. Large and small subunits are functionally replaced by the 50 terminal crRNA cap Cas5fv and the backbone protein Cas7fv, respectively. Cas5fv facilitates PAM recognition from the DNA major groove site, in contrast to all other described type I systems. Comparison of the type I-Fv Cascade with an anti-CRISPR protein-bound I-F Cascade reveals that the type I-Fv structure differs substantially at known anti-CRISPR protein target sites and might therefore be resistant to viral Cascade interception.	[Pausch, Patrick; Altegoer, Florian; Bange, Gert] Philipps Univ Marburg, LOEWE Ctr Synthet Microbiol Synmikro, Hans Meerwein Str C07, D-35043 Marburg, Germany; [Pausch, Patrick; Altegoer, Florian; Bange, Gert] Philipps Univ Marburg, Fac Chem, Hans Meerwein Str C07, D-35043 Marburg, Germany; [Mueller-Esparza, Hanna; Gleditzsch, Daniel; Randau, Lennart] Max Planck Inst Terr Microbiol, Prokaryot Small RNA Biol Grp, D-35043 Marburg, Germany	Bange, G (reprint author), Philipps Univ Marburg, LOEWE Ctr Synthet Microbiol Synmikro, Hans Meerwein Str C07, D-35043 Marburg, Germany.; Bange, G (reprint author), Philipps Univ Marburg, Fac Chem, Hans Meerwein Str C07, D-35043 Marburg, Germany.; Randau, L (reprint author), Max Planck Inst Terr Microbiol, Prokaryot Small RNA Biol Grp, D-35043 Marburg, Germany.	lennart.randau@mpi-marburg.mpg.de; gert.bange@synmikro.uni-marburg.de			International Max-Planck-Research School for Environmental, Cellular, and Molecular Microbiology (IMPRS-Mic); DFG [FOR1680]; LOEWE excellence initiative; European Synchrotron Radiation Facility (ESRF), Grenoble, France	P.P. and H.M.-E. are recipients of a fellowship of the International Max-Planck-Research School for Environmental, Cellular, and Molecular Microbiology (IMPRS-Mic). D.G. and L.R. are supported by DFG FOR1680. G.B. thanks the LOEWE excellence initiative for financial support. G.B., P.P., and F.A. acknowledge the always excellent support by the European Synchrotron Radiation Facility (ESRF), Grenoble, France. We thank B. Wiedenheft (Montana State University, USA) for sharing the coordinates of type I-F bound to AcrF1 and AcrF2 prior to publication.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bange G, 2010, P NATL ACAD SCI USA, V107, P11295, DOI 10.1073/pnas.1001383107; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Carpenter MR, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00842-16; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Dwarakanath S, 2015, NUCLEIC ACIDS RES, V43, P8913, DOI 10.1093/nar/gkv882; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gleditzsch D, 2016, NUCLEIC ACIDS RES, V44, P5872, DOI 10.1093/nar/gkw469; Grissa I, 2009, METHODS MOL BIOL, V551, P105, DOI 10.1007/978-1-60327-999-4_9; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Hochstrasser ML, 2016, MOL CELL, V63, P840, DOI 10.1016/j.molcel.2016.07.027; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koonin EV, 2015, MOL BIOSYST, V11, P20, DOI 10.1039/c4mb00438h; Labbate M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36891; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Pausch P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8494; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rollins MF, 2015, NUCLEIC ACIDS RES, V43, P2216, DOI 10.1093/nar/gkv094; Takeuchi N, 2012, J BACTERIOL, V194, P1216, DOI 10.1128/JB.06521-11; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Westra ER, 2016, ANNU REV ECOL EVOL S, V47, P307, DOI 10.1146/annurev-ecolsys-121415-032428; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	40	2	2	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	AUG 17	2017	67	4					622	+		10.1016/j.molcel.2017.06.036				15	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FE0UP	WOS:000407935500008	28781236				2018-01-05	
J	Yamano, T; Zetsche, B; Ishitani, R; Zhang, F; Nishimasu, H; Nureki, O				Yamano, Takashi; Zetsche, Bernd; Ishitani, Ryuichiro; Zhang, Feng; Nishimasu, Hiroshi; Nureki, Osamu			Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1	MOLECULAR CELL			English	Article							TARGET DNA RECOGNITION; STAPHYLOCOCCUS-AUREUS CAS9; CRYSTAL-STRUCTURE; HUMAN-CELLS; GUIDE RNA; DUAL-RNA; CPF1; SYSTEMS; ENDONUCLEASE; COMPLEX	The RNA-guided Cpf1 (also known as Cas12a) nuclease associates with a CRISPR RNA (crRNA) and cleaves the double-stranded DNA target complementary to the crRNA guide. The two Cpf1 orthologs from Acidaminococcus sp. (AsCpf1) and Lachnospiraceae bacterium (LbCpf1) have been harnessed for eukaryotic genome editing. Cpf1 requires a specific nucleotide sequence, called a protospacer adjacent motif (PAM), for target recognition. Besides the canonical TTTV PAM, Cpf1 recognizes suboptimal C-containing PAMs. Here, we report four crystal structures of LbCpf1 in complex with the crRNA and its target DNA containing either TTTA, TCTA, TCCA, or CCCA as the PAM. These structures revealed that, depending on the PAM sequences, LbCpf1 undergoes conformational changes to form altered interactions with the PAM-containing DNA duplexes, thereby achieving the relaxed PAM recognition. Collectively, the present structures advance our mechanistic understanding of the PAM-dependent, crRNA-guided DNA cleavage by the Cpf1 family nucleases.	[Yamano, Takashi; Ishitani, Ryuichiro; Nishimasu, Hiroshi; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan; [Zetsche, Bernd; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zetsche, Bernd; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zetsche, Bernd; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Zetsche, Bernd; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Nishimasu, H; Nureki, O (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	nisimasu@bs.s.u-tokyo.ac.jp; nureki@bs.s.u-tokyo.ac.jp			JST, PRESTO [JPMJPR13L8]; JSPS KAKENHI [26291010, 15H01463]; NIH through NIMH [5DP1-MH100706, 1R01-MH110049]; NIDDK [5R01DK097768-03]; New York Stem Cell, Simons, Paul G. Allen Family, Vallee Foundations; B. Metcalfe; Basic Science and Platform Technology Program for Innovative Biological Medicine from the Japan Agency for Medical Research and Development (AMED); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology	We thank Dr. Takanori Nakane for assistance with data processing and Masahiro Fukuda for assistance with model building. We thank the beamline scientists at PXI at the Swiss Light Source and BL41XU at SPring-8 for assistance with data collection. H.N. is supported by JST, PRESTO (JPMJPR13L8), and JSPS KAKENHI (grants 26291010 and 15H01463). F.Z. is supported by the NIH through NIMH (5DP1-MH100706 and 1R01-MH110049) and NIDDK (5R01DK097768-03), the New York Stem Cell, Simons, Paul G. Allen Family, Vallee Foundations, and B. Metcalfe. F.Z. is a New York Stem Cell Foundation Robertson Investigator, a founder of Editas Medicine, and a scientific advisor for Editas Medicine and Horizon Discovery. O.N. is supported by the Basic Science and Platform Technology Program for Innovative Biological Medicine from the Japan Agency for Medical Research and Development (AMED) and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Gao L., 2017, NAT BIOTECHNOL; Gao P, 2016, CELL RES, V26, P901, DOI 10.1038/cr.2016.88; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim HK, 2017, NAT METHODS, V14, P153, DOI [10.1038/NMETH.4104, 10.1038/nmeth.4104]; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Liu L, 2017, MOL CELL, V65, P310, DOI 10.1016/j.molcel.2016.11.040; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Nishimasu H, 2017, MOL CELL, V67, P139, DOI 10.1016/j.molcel.2017.04.019; Nishimasu H, 2017, CURR OPIN STRUC BIOL, V43, P68, DOI 10.1016/j.sbi.2016.11.013; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Swarts DC, 2017, MOL CELL, V66, P221, DOI 10.1016/j.molcel.2017.03.016; Tang X, 2017, NAT PLANTS, V3, DOI [10.1038/nplants.2017.56, 10.1038/nplants.2017.18]; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Waterman D. G., 2013, CCP4 NEWSL PROTEIN C, V49, P16; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yamada M, 2017, MOL CELL, V65, P1109, DOI 10.1016/j.molcel.2017.02.007; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yang H, 2016, CELL, V167, P1814, DOI 10.1016/j.cell.2016.11.053; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	45	2	2	10	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	AUG 17	2017	67	4					633	+		10.1016/j.molcel.2017.06.035				16	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FE0UP	WOS:000407935500009	28781234				2018-01-05	
J	Lataniotis, L; Albrecht, A; Kok, FO; Monfries, CAL; Benedetti, L; Lawson, ND; Hughes, SM; Steinhofel, K; Mayr, M; Zampetaki, A				Lataniotis, Lazaros; Albrecht, Andreas; Kok, Fatma O.; Monfries, Clinton A. L.; Benedetti, Lorena; Lawson, Nathan D.; Hughes, Simon M.; Steinhofel, Kathleen; Mayr, Manuel; Zampetaki, Anna			CRISPR/Cas9 editing reveals novel mechanisms of clustered microRNA regulation and function	SCIENTIFIC REPORTS			English	Article							HUMAN-DISEASE; IN-VIVO; CRISPR-CAS9; SYSTEM; FAMILY; CELLS; GENE; BIOGENESIS; KNOCKOUT; DETERMINANTS	MicroRNAs (miRNAs) are important regulators of diverse physiological and pathophysiological processes. MiRNA families and clusters are two key features in miRNA biology. Here we explore the use of CRISPR/Cas9 as a powerful tool to delineate the function and regulation of miRNA families and clusters. We focused on four miRNA clusters composed of miRNA members of the same family, homo-clusters or different families, hetero-clusters. Our results highlight different regulatory mechanisms in miRNA cluster expression. In the case of the miR-497 similar to 195 cluster, editing of miR-195 led to a significant decrease in the expression of the other miRNA in the cluster, miR-497a. Although no gene editing was detected in the miR-497a genomic locus, computational simulation revealed alteration in the three dimensional structure of the pri-miR-497 similar to 195 that may affect its processing. In cluster miR-143 similar to 145 our results imply a feed-forward regulation, although structural changes cannot be ruled out. Furthermore, in the miR-179 similar to and miR-106 similar to 25 clusters no interdependency in miRNA expression was observed. Our findings suggest that CRISPR/Cas9 is a powerful gene editing tool that can uncover novel mechanisms of clustered miRNA regulation and function.	[Lataniotis, Lazaros; Mayr, Manuel; Zampetaki, Anna] Kings Coll London, Kings British Heart Fdn Ctr, London, England; [Albrecht, Andreas] Middlesex Univ, Sch Sci & Technol, London, England; [Kok, Fatma O.; Lawson, Nathan D.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA USA; [Monfries, Clinton A. L.; Hughes, Simon M.] Kings Coll London, Randall Div, London, England; [Benedetti, Lorena] Kings Coll London, Div Canc Studies, London, England; [Steinhofel, Kathleen] Kings Coll London, Informat Dept, London, England	Zampetaki, A (reprint author), Kings Coll London, Kings British Heart Fdn Ctr, London, England.	anna.zampetaki@kcl.ac.uk		Mayr, Manuel/0000-0002-0597-829X	British Heart Foundation; King's Medical Research Trust Joint Research Committee; Medical Research Council [G1001029, MR/N021231/1]; Wellcome Trust [093389/Z/10/Z]	This work was funded by the British Heart Foundation. A. Zampetaki is an Intermediate Fellow of the British Heart Foundation. M. Mayr is a Senior Fellow of the British Heart Foundation. L. Lataniotis is a recipient of a studentship by the King's Medical Research Trust Joint Research Committee. SMH is a Medical Research Council Scientist with Programme Grant G1001029 and MR/N021231/1 support. CALM and the KCL Genome Editing Facility was funded by Wellcome Trust grant 093389/Z/10/Z to SMH, Corinne Houart, Jon Clarke, Robert Hindges and Uwe Drescher.	Abrahimi P, 2015, CIRC RES, V117, P121, DOI 10.1161/CIRCRESAHA.117.306290; Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Chakraborty S, 2012, RNA, V18, P1014, DOI 10.1261/rna.031039.111; Chang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22312; Chaulk SG, 2014, NUCLEIC ACIDS RES, V42, P5234, DOI 10.1093/nar/gku133; Chen J, 2016, ARTERIOSCL THROM VAS, V36, P2381, DOI 10.1161/ATVBAHA.116.308120; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Dawson WK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000905; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Fang WW, 2015, MOL CELL, V60, P131, DOI 10.1016/j.molcel.2015.08.015; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Golden RJ, 2017, NATURE, V542, P197, DOI 10.1038/nature21025; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Inoue K, 2017, CELL REP, V19, P949, DOI 10.1016/j.celrep.2017.04.018; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kwon SC, 2016, CELL, V164, P81, DOI 10.1016/j.cell.2015.12.019; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Mathelier A, 2013, NUCLEIC ACIDS RES, V41, P4392, DOI 10.1093/nar/gkt112; Mayr M, 2013, ARTERIOSCL THROM VAS, V33, P206, DOI 10.1161/ATVBAHA.112.300141; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Narayanan A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32386; Ounzain S, 2015, J MOL CELL CARDIOL, V89, P98, DOI 10.1016/j.yjmcc.2015.09.016; Popenda M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks339; Porrello ER, 2011, CIRC RES, V109, P670, DOI 10.1161/CIRCRESAHA.111.248880; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rissland OS, 2011, MOL CELL, V43, P993, DOI 10.1016/j.molcel.2011.08.021; Roden C, 2017, GENOME RES, V27, P374, DOI 10.1101/gr.208900.116; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Suzuki HI, 2017, CELL, V168, P1000, DOI 10.1016/j.cell.2017.02.015; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Treiber T, 2017, MOL CELL, V66, P270, DOI 10.1016/j.molcel.2017.03.014; Nguyen TA, 2015, CELL, V161, P1374, DOI 10.1016/j.cell.2015.05.010; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-199; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yoshino H, 2017, ONCOTARGET, V8, P20881, DOI 10.18632/oncotarget.14930; Zampetaki A, CIRCULATION, V121, P132; Zampetaki A, 2014, CIRC RES, V115, P857, DOI 10.1161/CIRCRESAHA.115.304361; Zampetaki A, 2012, CARDIOVASC RES, V93, P555, DOI 10.1093/cvr/cvr266; Zampetaki A, 2012, CIRC RES, V110, P508, DOI 10.1161/CIRCRESAHA.111.247445; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang YH, 2017, AM J TRANSL RES, V9, P355; Zhao YC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03943	55	0	0	8	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 17	2017	7								8585	10.1038/s41598-017-09268-0				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FD9TC	WOS:000407864000052	28819307	gold			2018-01-05	
J	Tanaka, T; Hirata, Y; Tominaga, Y; Furuta, H; Matsumura, S; Ikawa, Y				Tanaka, Takahiro; Hirata, Yusuke; Tominaga, Yuto; Furuta, Hiroyuki; Matsumura, Shigeyoshi; Ikawa, Yoshiya			Heterodimerization of GroupI Ribozymes Enabling Exon Recombination through Pairs of Cooperative trans-Splicing Reactions	CHEMBIOCHEM			English	Article						groupI introns; ribozymes; RNA modular engineering; synthetic biology; trans-splicing	GROUP-I INTRON; TETRAHYMENA RIBOZYME; MUTATIONAL ANALYSIS; SPLICING RIBOZYME; CRYSTAL-STRUCTURE; CATALYTIC CORE; MESSENGER-RNA; EVOLUTION; SELECTION; GENE	GroupI (GI) self-splicing ribozymes are attractive tools for biotechnology and synthetic biology. Several trans-splicing and related reactions based on GI ribozymes have been developed for the purpose of recombining their target mRNA sequences. By combining trans-splicing systems with rational modular engineering of GI ribozymes it was possible to achieve more complex editing of target RNA sequences. In this study we have developed a cooperative trans-splicing system through rational modular engineering with use of dimeric GI ribozymes derived from the Tetrahymena groupI intron ribozyme. The resulting pairs of ribozymes exhibited catalytic activity depending on their selective dimerization. Rational modular redesign as performed in this study would facilitate the development of sophisticated regulation of double or multiple trans-splicing reactions in a cooperative manner.	[Tanaka, Takahiro; Hirata, Yusuke; Furuta, Hiroyuki] Kyushu Univ, Grad Sch Engn, Dept Chem & Biochem, Nishi Ku, 744 Moto Oka, Fukuoka 8190395, Japan; [Hirata, Yusuke; Matsumura, Shigeyoshi; Ikawa, Yoshiya] Univ Toyama, Grad Sch Sci & Engn, Dept Chem, Gofuku 3190, Toyama 9308555, Japan	Ikawa, Y (reprint author), Univ Toyama, Grad Sch Sci & Engn, Dept Chem, Gofuku 3190, Toyama 9308555, Japan.	yikawa@sci.u-toyama.ac.jp	Furuta, Hiroyuki/B-9505-2008	Furuta, Hiroyuki/0000-0002-3881-8807; Ikawa, Yoshiya/0000-0002-6814-0443	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [23119005, 15K05561]; University of Toyama	This work was supported by Grants-in-Aid for Scientific Research on Innovative Area "Synthetic Biology" (no. 23119005 to Y.I.) and Scientific Research C (no. 15K05561 to Y.I.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. This work was also supported partly by University of Toyama Discretionary Funds of the President "Toyama RNA Research Alliance" (to Y.I. and S. M.).	Alexander RC, 2005, BIOCHEMISTRY-US, V44, P7796, DOI 10.1021/bi047284a; Ameta S, 2014, NUCLEIC ACIDS RES, V42, P1303, DOI 10.1093/nar/gkt949; Amini ZN, 2015, RNA, V21, P1480, DOI 10.1261/rna.051888.115; Amini ZN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101932; Baum DA, 2005, RNA, V11, P897, DOI 10.1261/rna.2050505; Bell MA, 2002, BIOCHEMISTRY-US, V41, P15327, DOI 10.1021/bi0267386; Byun J, 2003, RNA, V9, P1254, DOI 10.1261/rna.5450203; Campbell TB, 1996, BIOCHEMISTRY-US, V35, P11493, DOI 10.1021/bi960510z; CAPRARA MG, 1993, BIOCHEMISTRY-US, V32, P3604, DOI 10.1021/bi00065a011; Che AJ, 2010, NUCLEIC ACIDS RES, V38, P2748, DOI 10.1093/nar/gkq186; Chen AGY, 2011, RNA, V17, P1967, DOI 10.1261/rna.2757311; Costa M, 1997, EMBO J, V16, P3289, DOI 10.1093/emboj/16.11.3289; COUTURE S, 1990, J MOL BIOL, V215, P345, DOI 10.1016/S0022-2836(05)80356-0; Doherty EA, 1999, BIOCHEMISTRY-US, V38, P2982, DOI 10.1021/bi982113p; Engelhardt MA, 2000, BIOCHEMISTRY-US, V39, P2639, DOI 10.1021/bi992313g; Furukawa Airi, 2016, Biology-Basel, V5, P43, DOI 10.3390/biology5040043; Golden BL, 1998, SCIENCE, V282, P259, DOI 10.1126/science.282.5387.259; Guo F, 2006, RNA, V12, P387, DOI 10.1261/rna.2198206; Guo F, 2002, NAT STRUCT BIOL, V9, P855, DOI 10.1038/nsb850; Heilman-Miller SL, 2003, J MOL BIOL, V328, P385, DOI 10.1016/S0022-2836(03)00304-8; Hicks LD, 2011, J BACTERIOL, V193, P5292, DOI 10.1128/JB.05472-11; Ikawa Y, 1997, NUCLEIC ACIDS RES, V25, P1761, DOI 10.1093/nar/25.9.1761; Ikawa Y, 2008, ANAL BIOCHEM, V378, P166, DOI 10.1016/j.ab.2008.03.054; Jones JT, 1997, NAT BIOTECHNOL, V15, P902, DOI 10.1038/nbt0997-902; Kastanos E, 2004, BIOCHEM BIOPH RES CO, V322, P930, DOI 10.1016/j.bbrc.2004.07.203; Kobori S, 2016, ANGEW CHEM INT EDIT, V55, P10354, DOI 10.1002/anie.201605470; Kohler U, 1999, J MOL BIOL, V285, P1935, DOI 10.1006/jmbi.1998.2447; Landthaler M, 1999, P NATL ACAD SCI USA, V96, P7005, DOI 10.1073/pnas.96.12.7005                                                         ; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Matsumura S, 2016, SCIENCE, V354, P1293, DOI 10.1126/science.aag1582; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Oe Y, 2002, BIOCHEM BIOPH RES CO, V291, P1225, DOI 10.1006/bbrc.2002.6609; Oe Y, 2001, BIOCHEM BIOPH RES CO, V284, P948, DOI 10.1006/bbrc.2001.5072; Olson KE, 2012, RNA, V18, P581, DOI 10.1261/rna.028472.111; Paegel BM, 2010, CHEM BIOL, V17, P717, DOI 10.1016/j.chembiol.2010.05.021; Paegel BM, 2008, PLOS BIOL, V6, P900, DOI 10.1371/journal.pbio.0060085; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Pereira MJB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012953; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; PYLE AM, 1992, NATURE, V358, P123, DOI 10.1038/358123a0                                                                ; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Ryckelynck M, 2015, RNA, V21, P458, DOI 10.1261/rna.048033.114; Sclavi B, 1998, SCIENCE, V279, P1940, DOI 10.1126/science.279.5358.1940; Stahley MR, 2006, CURR OPIN STRUC BIOL, V16, P319, DOI 10.1016/j.sbi.2006.04.005; SULLENGER BA, 1994, NATURE, V371, P619, DOI 10.1038/371619a0                                                                ; Tanaka T, 2016, CHEMBIOCHEM, V17, P1448, DOI 10.1002/cbic.201600190; Vicens Q, 2006, TRENDS BIOCHEM SCI, V31, P41, DOI 10.1016/j.tibs.2005.11.008; Wan YQ, 2011, BIOCHEMISTRY-US, V50, P864, DOI 10.1021/bi101467q; WILLIAMSON CL, 1989, NUCLEIC ACIDS RES, V17, P675, DOI 10.1093/nar/17.2.675; [Anonymous], 2016, ANGEW CHEM, V128, P10510	51	0	0	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1439-4227	1439-7633		CHEMBIOCHEM	ChemBioChem	AUG 17	2017	18	16					1659	1667		10.1002/cbic.201700053				9	Biochemistry & Molecular Biology; Chemistry, Medicinal	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	FD9AK	WOS:000407815000017	28556398				2018-01-05	
J	Joung, J; Engreitz, JM; Konermann, S; Abudayyeh, OO; Verdine, VK; Aguet, F; Gootenberg, JS; Sanjana, NE; Wright, JB; Fulco, CP; Tseng, YY; Yoon, CH; Boehm, JS; Lander, ES; Zhang, F				Joung, Julia; Engreitz, Jesse M.; Konermann, Silvana; Abudayyeh, Omar O.; Verdine, Vanessa K.; Aguet, Francois; Gootenberg, Jonathan S.; Sanjana, Neville E.; Wright, Jason B.; Fulco, Charles P.; Tseng, Yuen-Yi; Yoon, Charles H.; Boehm, Jesse S.; Lander, Eric S.; Zhang, Feng			Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood	NATURE			English	Article							NONCODING RNAS; TRANSCRIPTIONAL ACTIVATION; CHROMATIN; REVEALS; EXPRESSION; INTERFERENCE; SENSITIVITY; SEQ; MAP	Mammalian genomes contain thousands of loci that transcribe long noncoding RNAs (lncRNAs)(1,2), some of which are known to carry out critical roles in diverse cellular processes through a variety of mechanisms(3-8). Although some lncRNA loci encode RNAs that act non-locally (in trans)(5), there is emerging evidence that many lncRNA loci act locally (in cis) to regulate the expression of nearby genes-for example, through functions of the lncRNA promoter, transcription, or transcript itself(3,6-8). Despite their potentially important roles, it remains challenging to identify functional lncRNA loci and distinguish among these and other mechanisms. Here, to address these challenges, we developed a genome-scale CRISPR-Cas9 activation screen that targets more than 10,000 lncRNA transcriptional start sites to identify noncoding loci that influence a phenotype of interest. We found 11 lncRNA loci that, upon recruitment of an activator, mediate resistance to BRAF inhibitors in human melanoma cells. Most candidate loci appear to regulate nearby genes. Detailed analysis of one candidate, termed EMICERI, revealed that its transcriptional activation resulted in dosage-dependent activation of four neighbouring protein-coding genes, one of which confers the resistance phenotype. Our screening and characterization approach provides a CRISPR toolkit with which to systematically discover the functions of noncoding loci and elucidate their diverse roles in gene regulation and cellular function.	[Joung, Julia; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Joung, Julia; Engreitz, Jesse M.; Konermann, Silvana; Abudayyeh, Omar O.; Verdine, Vanessa K.; Aguet, Francois; Gootenberg, Jonathan S.; Sanjana, Neville E.; Wright, Jason B.; Fulco, Charles P.; Tseng, Yuen-Yi; Boehm, Jesse S.; Lander, Eric S.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Joung, Julia; Konermann, Silvana; Abudayyeh, Omar O.; Verdine, Vanessa K.; Gootenberg, Jonathan S.; Sanjana, Neville E.; Wright, Jason B.; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Joung, Julia; Konermann, Silvana; Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Sanjana, Neville E.; Wright, Jason B.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Abudayyeh, Omar O.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.; Fulco, Charles P.; Lander, Eric S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Yoon, Charles H.] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Konermann, Silvana] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Sanjana, Neville E.] New York Genome Ctr, New York, NY USA; [Sanjana, Neville E.] NYU, Dept Biol, New York, NY 10003 USA	Zhang, F (reprint author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lander, ES; Zhang, F (reprint author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Zhang, F (reprint author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (reprint author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Lander, ES (reprint author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.; Lander, ES (reprint author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lander@broadinstitute.org; zhang@broadinstitute.org			Fannie and John Hertz Foundation; Paul and Daisy Soros Fellowship; National Defense Science and Engineering Fellowship; DOE Computational Science Graduate Fellowship; NIH through NHGRI [R00-HG008171]; NIH through NIDDK [F32-DK096822]; National Defense Science and Engineering Graduate Fellowship; Broad Institute; NIH through NIMH [5DP1-MH100706, 1R01-MH110049]; NSF; Howard Hughes Medical Institute; New York Stem Cell; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation;  [UM1HG008895]	We thank M. Guttman, C. M. Johannessen and M. Ghandi for helpful discussions and insights; A. Sayeed, R. Deasy, A. Rotem and B. Izar for generating the primary patient melanoma cell lines; and R. Belliveau, R. Macrae and the Zhang laboratory for support and advice. J.M.E. is supported by the Fannie and John Hertz Foundation. O.A.A. is supported by a Paul and Daisy Soros Fellowship and National Defense Science and Engineering Fellowship. J.S.G. is supported by a DOE Computational Science Graduate Fellowship. N.E.S. is supported by the NIH through NHGRI (R00-HG008171). J.B.W. is supported by the NIH through NIDDK (F32-DK096822). C.P.F. is supported by the National Defense Science and Engineering Graduate Fellowship. E.S.L. is supported by UM1HG008895 and funds from the Broad Institute. F.Z. is a New York Stem Cell Foundation-Robertson Investigator. F.Z. is supported by the NIH through NIMH (5DP1-MH100706 and 1R01-MH110049), NSF, Howard Hughes Medical Institute, the New York Stem Cell, Simons, Paul G. Allen Family, and Vallee Foundations; and James and Patricia Poitras, Robert Metcalfe, and David Cheng.	Anderson KM, 2016, NATURE, V539, P433, DOI 10.1038/nature20128; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575                                           ; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; O'Leary Nuala A, 2016, Nucleic Acids Res, V44, pD733, DOI 10.1093/nar/gkv1189; Paralkar VR, 2016, MOL CELL, V62, P104, DOI 10.1016/j.molcel.2016.02.029; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Skalska L, 2017, NAT REV MOL CELL BIO, V18, P1, DOI 10.1038/nrm.2017.12; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715	28	3	3	30	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					343	+		10.1038/nature23451				17	Multidisciplinary Sciences	Science & Technology - Other Topics	FD8AU	WOS:000407748400035	28792927				2018-01-05	
J	Khan, AO; Simms, VA; Pike, JA; Thomas, SG; Morgan, NV				Khan, Abdullah O.; Simms, Victoria A.; Pike, Jeremy A.; Thomas, Steven G.; Morgan, Neil V.			CRISPR-Cas9 Mediated Labelling Allows for Single Molecule Imaging and Resolution	SCIENTIFIC REPORTS			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; LOCALIZATION MICROSCOPY; LIVE-CELL; SUPERRESOLUTION MICROSCOPY; FLUORESCENCE MICROSCOPY; ENDOGENOUS PROTEIN; ESCHERICHIA-COLI; RNA-POLYMERASE; SOFI; FLUOROPHORES	Single molecule imaging approaches like dSTORM and PALM resolve structures at 10-20 nm, and allow for unique insights into protein stoichiometry and spatial relationships. However, key obstacles remain in developing highly accurate quantitative single molecule approaches. The genomic tagging of PALM fluorophores through CRISPR-Cas9 offers an excellent opportunity for generating stable cell lines expressing a defined single molecule probe at endogenous levels, without the biological disruption and variability inherent to transfection. A fundamental question is whether these comparatively low levels of expression can successfully satisfy the stringent labelling demands of super-resolution SMLM. Here we apply CRISPR-Cas9 gene editing to tag a cytoskeletal protein (alpha-tubulin) and demonstrate a relationship between expression level and the subsequent quality of PALM imaging, and that spatial resolutions comparable to dSTORM can be achieved with CRISPR-PALM. Our approach shows a relationship between choice of tag and the total expression of labelled protein, which has important implications for the development of future PALM tags. CRISPR-PALM allows for nanoscopic spatial resolution and the unique quantitative benefits of single molecule localization microscopy through endogenous expression, as well as the capacity for super-resolved live cell imaging.	[Khan, Abdullah O.; Simms, Victoria A.; Thomas, Steven G.; Morgan, Neil V.] Univ Birmingham, Inst Cardiovasc Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Pike, Jeremy A.; Thomas, Steven G.] Univ Birmingham, Ctr Membrane Prot & Receptors COMPARE, Midlands, England; [Pike, Jeremy A.; Thomas, Steven G.] Univ Nottingham, Ctr Membrane Prot & Receptors COMPARE, Midlands, England	Thomas, SG; Morgan, NV (reprint author), Univ Birmingham, Inst Cardiovasc Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England.; Thomas, SG (reprint author), Univ Birmingham, Ctr Membrane Prot & Receptors COMPARE, Midlands, England.; Thomas, SG (reprint author), Univ Nottingham, Ctr Membrane Prot & Receptors COMPARE, Midlands, England.	s.thomas@bham.ac.uk; n.v.morgan@bham.ac.uk	Morgan, Neil/A-5475-2009	Morgan, Neil/0000-0001-6433-5692	British Heart Foundation [IG/14/1/30652, PG/15/114/31945]; University of Birmingham College of Medical and Dental Sciences; COMPARE	We thank the British Heart Foundation (IG/14/1/30652) for funding for the N-STORM microscope. AOK is funded by the University of Birmingham College of Medical and Dental Sciences PhD studentship. VAS is funded by the British Heart Foundation (PG/15/114/31945). JAP is funded by COMPARE. The authors would like to thank Dr. Ian Hitchcock for the generous provision of TPO, and Professor Steve P Watson for his support.	Baddeley D, 2009, BIOPHYS J, V96, pL22, DOI 10.1016/j.bpj.2008.11.002; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Boraas LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145084; Chozinski TJ, 2014, FEBS LETT, V588, P3603, DOI 10.1016/j.febslet.2014.06.043; Cranfill PJ, 2016, NAT METHODS, V13, P557, DOI [10.1038/NMETH.3891, 10.1038/nmeth.3891]; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Dertinger T, 2013, Q REV BIOPHYS, V46, P210, DOI 10.1017/S0033583513000036; Dertinger T, 2012, ADV EXP MED BIOL, V733, P17, DOI 10.1007/978-94-007-2555-3_2; Deschout H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13693; Endesfelder U, 2013, BIOPHYS J, V105, P172, DOI 10.1016/j.bpj.2013.05.048; Fricke F, 2014, HISTOCHEM CELL BIOL, V142, P91, DOI 10.1007/s00418-014-1195-0; Gahlmann A, 2014, NAT REV MICROBIOL, V12, P9, DOI 10.1038/nrmicro3154; Gallagher SS, 2009, ACS CHEM BIOL, V4, P547, DOI 10.1021/cb900062k; Geissbuehler S, 2011, BIOMED OPT EXPRESS, V2, P408, DOI 10.1364/BOE.2.000408; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Gustafsson N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12471; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Jensen E, 2014, ANAT REC, V297, P2227, DOI 10.1002/ar.22960; Jing CR, 2011, ACCOUNTS CHEM RES, V44, P784, DOI 10.1021/ar200099f; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klein T, 2014, HISTOCHEM CELL BIOL, V141, P561, DOI 10.1007/s00418-014-1184-3; Lee SH, 2012, P NATL ACAD SCI USA, V109, P17436, DOI 10.1073/pnas.1215175109; Li D., 2015, SCIENCE, V349; Lidke KA, 2005, OPT EXPRESS, V13, P7052, DOI 10.1364/OPEX.13.007052                                                          ; Lindskog C, 2016, EXPERT REV PROTEOMIC, V13, P627, DOI 10.1080/14789450.2016.1199280; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Mikhaylova M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8933; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Nieuwenhuizen RPJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127989; Nieuwenhuizen RPJ, 2013, NAT METHODS, V10, P557, DOI [10.1038/NMETH.2448, 10.1038/nmeth.2448]; Ober RJ, 2015, IEEE SIGNAL PROC MAG, V32, P58, DOI 10.1109/MSP.2014.2353664; Qu XH, 2004, P NATL ACAD SCI USA, V101, P11298, DOI 10.1073/pnas.0402155101; Quan TW, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3505017; Ratz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09592; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shivanandan A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118767; Shroff H., 2008, CURR PROTOC CELL BIO, V4, P21; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Stracy M, 2015, P NATL ACAD SCI USA, V112, pE4390, DOI 10.1073/pnas.1507592112; Uemura T, 2016, SCI REP-UK, V6, DOI 10.1038/srep35861; Uhlen M, 2005, PROTEOMICS, V4, P1920, DOI DOI 10.1074/MCP.M500279-MCP200; van de Linde S, 2010, J BIOTECHNOL, V149, P260, DOI 10.1016/j.jbiotec.2010.02.010	47	0	0	21	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 16	2017	7								8450	10.1038/s41598-017-08493-x				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FD7AA	WOS:000407677800004	28814796	gold			2018-01-05	
J	Ye, ZF; Liu, XL; Han, Q; Liao, H; Dong, XT; Zhu, GH; Dong, SL				Ye, Zhan-Feng; Liu, Xiao-Long; Han, Qi; Liao, Hui; Dong, Xiao-Tong; Zhu, Guan-Heng; Dong, Shuang-Lin			Functional characterization of PBP1 gene in Helicoverpa armigera (Lepidoptera: Noctuidae) by using the CRISPR/Cas9 system	SCIENTIFIC REPORTS			English	Article							PHEROMONE-BINDING-PROTEINS; SPODOPTERA-EXIGUA HUBNER; FEMALE SEX-PHEROMONE; BOMBYX-MORI; MOLECULAR CHARACTERIZATION; TARGETED MUTAGENESIS; RNA INTERFERENCE; MATING-BEHAVIOR; BEET ARMYWORM; EXPRESSION	Pheromone binding proteins (PBPs) are thought to play crucial roles in perception of the sex pheromones particularly in noctuid moths, but this is rarely in vivo evidenced due to lacking an effective technique. Here, we reported an in vivo functional study of PBP1 in the important lepidopteran pest Helicoverpa armigera (HarmPBP1), by using the CRISPR/Cas9 system. Efficient and heritable mutagenesis was achieved by egg injection of mixture of Cas9-mRNA and HarmPBP1-sgRNA. The TA cloning and sequencing revealed various insertion and/or deletion (indel) mutations at the target site. Among those, one mutation resulted in a premature stop codon at the target site, which led to a highly truncated protein with only 10 amino acids. The HarmPBP1 with this mutation would completely loss its function, and thus was used to select the homozygous mutant insects for functional analysis. The electroantennogram recording showed that the mutant male adults displayed severely impaired responses to all three sex pheromone components (Z11-16: Ald, Z9-16: Ald and Z9-14: Ald). Our study provides the first in vivo evidence that HarmPBP1 plays important role in perception of female sex pheromones, and also an effective methodology for using CRISPR/Cas9 system in functional genetic study in H. armigera as well as other insects.	[Ye, Zhan-Feng; Liu, Xiao-Long; Han, Qi; Liao, Hui; Dong, Xiao-Tong; Zhu, Guan-Heng; Dong, Shuang-Lin] Nanjing Agr Univ, Coll Plant Protect, Key Lab Integrated Pest Management Crops Eastern, Minist Agr China, Nanjing 210095, Jiangsu, Peoples R China	Dong, SL (reprint author), Nanjing Agr Univ, Coll Plant Protect, Key Lab Integrated Pest Management Crops Eastern, Minist Agr China, Nanjing 210095, Jiangsu, Peoples R China.	sldong@njau.edu.cn			National Natural Science Foundation of China [31071978, 31372264]; Special Fund for Agro-scientific Research in the Public Interest [201203036]	This study was supported by the National Natural Science Foundation of China (31071978; 31372264) and the Special Fund for Agro-scientific Research in the Public Interest (201203036).	Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Awata H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15885; Barrangou R, 2014, SCIENCE, V344, P707, DOI 10.1126/science.1252964; Bassett A, 2014, METHODS, V69, P128, DOI 10.1016/j.ymeth.2014.02.019; Chen Lei, 2016, [Zoological Research, 动物学研究], V37, P220, DOI 10.13918/j.issn.2095-8137.2016.4.220; Chen L, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-24; DU GH, 1995, BIOCHEMISTRY-US, V34, P8726, DOI 10.1021/bi00027a023; Gong Y. M., 2009, BINDING MECH PHEROMO; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Guo F, 2012, INSECT BIOCHEM MOLEC, V42, P708, DOI 10.1016/j.ibmb.2012.06.004; Henriques A., 2012, BIOTECHNIQUES, V53; HIROOKA Y, 1986, J ETHOL, V4, P27, DOI 10.1007/BF02348250; Huang Y., 2016, MOL BIOL, V75, P98, DOI [10.1016/j.ibmb.2016.06.004, DOI 10.1016/J.IBMB.2016.06.004]; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; [焦晓国 Jiao Xiaoguo], 2006, [植物保护, Plant Protection], V32, P9; Jin JY, 2014, J INSECT PHYSIOL, V66, P71, DOI 10.1016/j.jinsphys.2014.05.013; Kirsch P., 1988, American Journal of Alternative Agriculture, V3, P83; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; Koutroumpa FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep29620; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Li XY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9212; Liu NY, 2013, COMP BIOCHEM PHYS A, V165, P254, DOI 10.1016/j.cbpa.2013.03.016; Liu YY, 2014, INSECT BIOCHEM MOLEC, V49, P35, DOI 10.1016/j.ibmb.2014.03.010; Ma SY, 2014, SCI REP-UK, V4, DOI 10.1038/srep04489; Mao A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34484; Markert MJ, 2016, G3-GENES GENOM GENET, V6, P905, DOI 10.1534/g3.116.027029; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Meyering-Vos M, 2007, J INSECT PHYSIOL, V53, P840, DOI 10.1016/j.jinsphys.2007.04.003; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; PICCARDI P, 1977, J INSECT PHYSIOL, V23, P1443, DOI 10.1016/0022-1910(77)90170-6; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; ROELOFS WL, 1977, ANNU REV ENTOMOL, V22, P377, DOI 10.1146/annurev.en.22.010177.002113; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Swevers L., 2012, PROGR BIOL CONTROL, V14, P177; Taning CNT, 2017, J INSECT PHYSIOL, V98, P245, DOI 10.1016/j.jinsphys.2017.01.007; Uddin MDK, 2016, PAK J ZOOL, V48, P1543; Vogt RG, 2015, INSECT BIOCHEM MOLEC, V62, P142, DOI 10.1016/j.ibmb.2015.03.003; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Wei W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101210; Xiao A, 2014, BIOINFORMATICS, V30, P1180, DOI 10.1093/bioinformatics/btt764; Xiu WM, 2008, J CHEM ECOL, V34, P487, DOI 10.1007/s10886-008-9452-0; Xiu WM, 2007, J CHEM ECOL, V33, P947, DOI 10.1007/s10886-007-9277-2; Xu Z, 2010, J CHEM ECOL, V36, P526, DOI 10.1007/s10886-010-9785-3; Yang B, 2016, INSECT BIOCHEM MOLEC, V70, P53, DOI 10.1016/j.ibmb.2015.12.003; Yang MW, 2009, J INSECT BEHAV, V22, P153, DOI 10.1007/s10905-008-9162-z; Yang YH, 2009, B ENTOMOL RES, V99, P175, DOI 10.1017/S0007485308006226; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117054; Zhang JP, 2012, J INSECT PHYSIOL, V58, P1209, DOI 10.1016/j.jinsphys.2012.05.018; Zhang SG, 2001, CHEM SENSES, V26, P885, DOI 10.1093/chemse/26.7.885; Zhang TT, 2012, J INSECT PHYSIOL, V58, P941, DOI 10.1016/j.jinsphys.2012.04.010; Zhang TT, 2017, BMC MOL BIOL, V18, DOI 10.1186/s12867-017-0079-y; Zhang TT, 2011, BIOCHEM BIOPH RES CO, V407, P393, DOI 10.1016/j.bbrc.2011.03.032; Zhang ZC, 2009, ENTOMOL EXP APPL, V133, P136, DOI 10.1111/j.1570-7458.2009.00917.x; Zhang ZJ, 2015, J INSECT PHYSIOL, V79, P73, DOI 10.1016/j.jinsphys.2015.06.004; Zhu GH, 2016, INSECT BIOCHEM MOLEC, V75, P1, DOI 10.1016/j.ibmb.2016.05.006	61	0	0	10	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 16	2017	7								8470	10.1038/s41598-017-08769-2				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FD7AA	WOS:000407677800024	28814748	gold			2018-01-05	
J	Yang, YJ; Wang, Y; Li, ZF; Gong, Y; Zhang, P; Hu, WC; Sheng, DH; Li, YZ				Yang, Ying-Jie; Wang, Ye; Li, Zhi-Feng; Gong, Ya; Zhang, Peng; Hu, Wen-Chao; Sheng, Duo-Hong; Li, Yue-Zhong			Increasing on-target cleavage efficiency for CRISPR/Cas9-induced large fragment deletion in Myxococcus xanthus	MICROBIAL CELL FACTORIES			English	Article						CRISPR/Cas9; On-target cleavage efficiency; Spacer sequence; Free energy; Deletion of large genome fragments; Biosynthetic gene clusters for secondary metabolites; Epothilones; Myxococcus xanthus	HETEROLOGOUS EXPRESSION; SYSTEM; GENOME; RNA; GENE; SEQUENCE; DNA; BIOSYNTHESIS; ENDONUCLEASE; MYXOBACTERIA	Background: The CRISPR/Cas9 system is a powerful tool for genome editing, in which the sgRNA binds and guides the Cas9 protein for the sequence-specific cleavage. The protocol is employable in different organisms, but is often limited by cell damage due to the endonuclease activity of the introduced Cas9 and the potential off-target DNA cleavage from incorrect guide by the 20 nt spacer. Results: In this study, after resolving some critical limits, we have established an efficient CRISPR/Cas9 system for the deletion of large genome fragments related to the biosynthesis of secondary metabolites in Myxococcus xanthus cells. We revealed that the high expression of a codon-optimized cas9 gene in M. xanthus was cytotoxic, and developed a temporally high expression strategy to reduce the cell damage from high expressions of Cas9. We optimized the deletion protocol by using the tRNA-sgRNA-tRNA chimeric structure to ensure correct sgRNA sequence. We found that, in addition to the position-dependent nucleotide preference, the free energy of a 20 nt spacer was a key factor for the deletion efficiency. Conclusions: By using the developed protocol, we achieved the CRISPR/Cas9-induced deletion of large biosynthetic gene clusters for secondary metabolites in M. xanthus DK1622 and its epothilone-producing mutant. The findings and the proposals described in this paper were suggested to be workable in other organisms, for example, other Gram negative bacteria with high GC content.	[Yang, Ying-Jie; Wang, Ye; Li, Zhi-Feng; Gong, Ya; Zhang, Peng; Hu, Wen-Chao; Sheng, Duo-Hong; Li, Yue-Zhong] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China	Li, YZ (reprint author), Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China.	lilab@sdu.edu.cn		Li, Yuezhong/0000-0001-8336-6638	National Natural Science Foundation of China (NSFC) [31471183, 31670076]; Key Program of Shandong Natural Science Foundation [ZR2016QZ002]; NSFC [31370123]	This work was financially supported by the National Natural Science Foundation of China (NSFC) (Nos. 31471183 and 31670076) and the Key Program of Shandong Natural Science Foundation (No. ZR2016QZ002) to YZL, and NSFC (No. 31370123) to ZFL.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bode HB, 2005, ANGEW CHEM INT EDIT, V44, P6828, DOI 10.1002/anie.200501080; Bode HB, 2007, CHEMBIOCHEM, V8, P2139, DOI 10.1002/cbic.200700401; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cencic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109213; Chen XY, 2016, 2016 IEEE OPTOELECTRONICS GLOBAL CONFERENCE (OGC), P11; Cleto S, 2016, ACS SYNTH BIOL, V5, P375, DOI 10.1021/acssynbio.5b00216; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fu J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn499; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Gomez-Santos N, 2012, APPL ENVIRON MICROB, V78, P2515, DOI 10.1128/AEM.07502-11; Huang H, 2016, ACS SYNTH BIOL, V5, P1355, DOI 10.1021/acssynbio.6b00044; Huang He, 2015, Acta Biochim Biophys Sin (Shanghai), V47, P231, DOI 10.1093/abbs/gmv007; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaiser D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000380; Krug D, 2008, APPL ENVIRON MICROB, V74, P3058, DOI 10.1128/AEM.02863-07; KUSPA A, 1989, J BACTERIOL, V171, P2762, DOI 10.1128/jb.171.5.2762-2772.1989                                                 ; Landwehr Wiebke, 2016, Curr Top Microbiol Immunol, V398, P273, DOI 10.1007/82_2016_503; Li ZF, 2011, J BACTERIOL, V193, P5015, DOI 10.1128/JB.05516-11; Liu XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep19675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Muller R, 2014, INT J MED MICROBIOL, V304, P3, DOI 10.1016/j.ijmm.2013.09.004; Muller S, 2013, GENOME ANNOUNC, V1; Munoz-Dorado J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00781; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; Reichenbach H, 2001, J IND MICROBIOL BIOT, V27, P149, DOI 10.1038/sj.jim.7000025; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Schley C, 2006, J PROTEOME RES, V5, P2760, DOI 10.1021/pr0602489; Shi SB, 2016, METAB ENG, V33, P19, DOI 10.1016/j.ymben.2015.10.011; Simunovic V, 2006, CHEMBIOCHEM, V7, P1206, DOI 10.1002/cbic.200600075; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Stevens DC, 2010, APPL ENVIRON MICROB, V76, P2681, DOI 10.1128/AEM.02841-09; Sun YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep22091; Thyme SB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11750; Tu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep21066; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang Y, 2016, ACS SYNTH BIOL, V5, P721, DOI 10.1021/acssynbio.6b00060; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Wenzel SC, 2006, ANGEW CHEM INT EDIT, V45, P2296, DOI 10.1002/anie.200503737; Wenzel SC, 2005, CURR OPIN BIOTECH, V16, P594, DOI 10.1016/j.copbio.2005.10.001; Wenzel SC, 2009, MOL BIOSYST, V5, P567, DOI 10.1039/b901287g; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Zeng H, 2015, APPL MICROBIOL BIOT, V99, P10575, DOI 10.1007/s00253-015-6931-4; Zhang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27943; ZHANG LL, 2016, NAT COMMUN, V7; Zhu LP, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0294-5	56	0	0	8	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2859			MICROB CELL FACT	Microb. Cell. Fact.	AUG 16	2017	16								142	10.1186/s12934-017-0758-x				15	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FE0LD	WOS:000407910900001	28814300	gold			2018-01-05	
J	Prowse, TAA; Cassey, P; Ross, JV; Pfitzner, C; Wittmann, TA; Thomas, P				Prowse, Thomas A. A.; Cassey, Phillip; Ross, Joshua V.; Pfitzner, Chandran; Wittmann, Talia A.; Thomas, Paul			Dodging silver bullets: good CRISPR gene-drive design is critical for eradicating exotic vertebrates	PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES			English	Article						gene drive; homing; non-homologous end joining; resistance allele; population eradication; island conservation	MUTAGENIC CHAIN-REACTION; Y-CHROMOSOME; NATURAL-POPULATIONS; INVASIVE PREDATORS; MICE; GENERATION; REPRODUCTION; CONSERVATION; ISLANDS; VECTOR	Self-replicating gene drives that can spread deleterious alleles through animal populations have been promoted as a much needed but controversial 'silver bullet' for controlling invasive alien species. Homing-based drives comprise an endonuclease and a guide RNA (gRNA) that are replicated during meiosis via homologous recombination. However, their efficacy for controlling wild populations is threatened by inherent polymorphic resistance and the creation of resistance alleles via non-homologous end-joining (NHEJ)-mediated DNA repair. We used stochastic individual-based models to identify realistic gene-drive strategies capable of eradicating vertebrate pest populations (mice, rats and rabbits) on islands. One popular strategy, a sex-reversing drive that converts heterozygous females into sterile males, failed to spread and required the ongoing deployment of gene-drive carriers to achieve eradication. Under alternative strategies, multiplexed gRNAs could overcome inherent polymorphic resistance and were required for eradication success even when the probability of NHEJ was low. Strategies causing homozygotic embryonic non-viability or homozygotic female sterility produced high probabilities of eradication and were robust to NHEJ-mediated deletion of the DNA sequence between multiplexed endonuclease recognition sites. The latter two strategies also purged the gene drive when eradication failed, therefore posing lower long-term risk should animals escape beyond target islands. Multiplexing gRNAs will be necessary if this technology is to be useful for insular extirpation attempts; however, precise knowledge of homing rates will be required to design low-risk gene drives with high probabilities of eradication success.	[Prowse, Thomas A. A.; Ross, Joshua V.] Univ Adelaide, Sch Math Sci, Adelaide, SA 5005, Australia; [Cassey, Phillip; Pfitzner, Chandran; Wittmann, Talia A.; Thomas, Paul] Univ Adelaide, Environm Inst, Adelaide, SA 5005, Australia; [Cassey, Phillip; Pfitzner, Chandran; Wittmann, Talia A.; Thomas, Paul] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia; [Thomas, Paul] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5005, Australia	Prowse, TAA (reprint author), Univ Adelaide, Sch Math Sci, Adelaide, SA 5005, Australia.	thomas.prowse@adelaide.edu.au		Pfitzner, Chandran/0000-0001-6151-5479	University of Adelaide's Environment Institute	We thank The University of Adelaide's Environment Institute for funding this work.	Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932; Backus GA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1589; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617                                                         ; BURGOYNE PS, 1987, DEVELOPMENT, V101, P133; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Campbell KJ, 2015, BIOL CONSERV, V185, P47, DOI 10.1016/j.biocon.2014.10.016; Caswell H, 2001, MATRIX POPULATION MO; Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34; Chan YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054130; Chu V, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0234-4; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; DiCarlo JE, 2015, NAT BIOTECHNOL, V33, P1250, DOI 10.1038/nbt.3412; Doherty TS, 2016, P NATL ACAD SCI USA, V113, P11261, DOI 10.1073/pnas.1602480113; Eckhoff PA, 2017, P NATL ACAD SCI USA, V114, pE255, DOI 10.1073/pnas.1611064114; Eroglu B, 2014, DEV BIOL, V386, P448, DOI 10.1016/j.ydbio.2013.12.038; Estoup A, 2016, ANNU REV ECOL EVOL S, V47, P51, DOI 10.1146/annurev-ecolsys-121415-032116; Esvelt K, 2016, NATURE, V534, P153, DOI 10.1038/534153a; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Fang KT, 2006, CH CRC COMP SCI DATA, P3; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Gilpin M.E., 1986, P19; Government of New Zealand, 2016, MILL DOLL MOUS ER MI; Gregory S. D., 2014, ERADICATIONS VERTEBR; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Harris DB, 2009, BIOL INVASIONS, V11, P1611, DOI 10.1007/s10530-008-9393-0; Huang YX, 2009, EVOL APPL, V2, P143, DOI 10.1111/j.1752-4571.2008.00049.x; Johnson JA, 2016, ANIM CONSERV, V19, P97, DOI 10.1111/acv.12273; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Lindholm AK, 2016, TRENDS ECOL EVOL, V31, P315, DOI 10.1016/j.tree.2016.02.001; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; McLeod Ross, 2004, COUNTING COST IMPACT; Mohun T, 2013, DIS MODEL MECH, V6, P562, DOI 10.1242/dmm.011957; Nagy A. G. M., 2003, MANIPULATING MOUSE E; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Noble C, 2016, BIORXIV, DOI [10.1101/057307, DOI 10.1101/057307]; Noble C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601964; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Port F, 2016, NAT METHODS, V13, P852, DOI 10.1038/nmeth.3972; Prowse TAA, 2017, DRYAD DIGITAL REPOSI; Prowse TAA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1238; R Development Core Team, 2015, R LANG ENV STAT COMP; Roelz R, 2010, EXP HEMATOL, V38, P792, DOI 10.1016/j.exphem.2010.05.005; Russell JC, 2016, CONSERV BIOL, V30, P670, DOI 10.1111/cobi.12666; Simoni A, 2014, NUCLEIC ACIDS RES, V42, P7461, DOI 10.1093/nar/gku387; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Stenseth NC, 2003, FRONT ECOL ENVIRON, V1, P367, DOI 10.2307/3868189; Sutton E, 2011, J CLIN INVEST, V121, P328, DOI 10.1172/JCI42580; Teem JL, 2014, BIOL INVASIONS, V16, P1231, DOI 10.1007/s10530-013-0476-1; Unckless RL, 2015, GENETICS, V201, P425, DOI 10.1534/genetics.115.177592; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Webber BL, 2015, P NATL ACAD SCI USA, V112, P10565, DOI 10.1073/pnas.1514258112; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Yamauchi Y, 2016, SCIENCE, V351, P514, DOI 10.1126/science.aad1795; Yamauchi Y, 2014, SCIENCE, V343, P69, DOI 10.1126/science.1242544; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	59	1	1	57	57	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	0962-8452	1471-2954		P ROY SOC B-BIOL SCI	Proc. R. Soc. B-Biol. Sci.	AUG 16	2017	284	1860							20170799	10.1098/rspb.2017.0799				10	Biology; Ecology; Evolutionary Biology	Life Sciences & Biomedicine - Other Topics; Environmental Sciences & Ecology; Evolutionary Biology	FD8WO	WOS:000407805000014					2018-01-05	
J	Nottle, MB; Salvaris, EJ; Fisicaro, N; McIlfatrick, S; Vassiliev, I; Hawthorne, WJ; O'Connell, PJ; Brady, JL; Lew, AM; Cowan, PJ				Nottle, Mark B.; Salvaris, Evelyn J.; Fisicaro, Nella; McIlfatrick, Stephen; Vassiliev, Ivan; Hawthorne, Wayne J.; O'Connell, Philip J.; Brady, Jamie L.; Lew, Andrew M.; Cowan, Peter J.			Targeted insertion of an anti-CD2 monoclonal antibody transgene into the GGTA1 locus in pigs using FokI-dCas9	SCIENTIFIC REPORTS			English	Article							KNOCKOUT PIGS; TO-HUMAN; EXPRESSION; NUCLEASES; BABOONS; TRANSPLANTATION; TRANSFERASE; XENOGRAFTS; IMPROVES; CELLS	Xenotransplantation from pigs has been advocated as a solution to the perennial shortage of donated human organs and tissues. CRISPR/Cas9 has facilitated the silencing of genes in donor pigs that contribute to xenograft rejection. However, the generation of modified pigs using second-generation nucleases with much lower off-target mutation rates than Cas9, such as FokI-dCas9, has not been reported. Furthermore, there have been no reports on the use of CRISPR to knock protective transgenes into detrimental porcine genes. In this study, we used FokI-dCas9 with two guide RNAs to integrate a 7.1 kilobase pair transgene into exon 9 of the GGTA1 gene in porcine fetal fibroblasts. The modified cells lacked expression of the alpha Gal xenoantigen, and secreted an anti-CD2 monoclonal antibody encoded by the transgene. PCR and sequencing revealed precise integration of the transgene into one allele of GGTA1, and a small deletion in the second allele. The cells were used for somatic cell nuclear transfer to generate healthy male knock-in piglets, which did not express aGal and which contained anti-CD2 in their serum. We have therefore developed a versatile high-fidelity system for knocking transgenes into the pig genome for xenotransplantation purposes.	[Nottle, Mark B.; McIlfatrick, Stephen; Vassiliev, Ivan] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Nottle, Mark B.; McIlfatrick, Stephen] Univ Adelaide, Adelaide Sch Med, Adelaide, SA, Australia; [Salvaris, Evelyn J.; Fisicaro, Nella; Cowan, Peter J.] St Vincents Hosp, Immunol Res Ctr, Melbourne, Vic, Australia; [Hawthorne, Wayne J.; O'Connell, Philip J.] Univ Sydney, Westmead Millennium Inst, Sydney, NSW, Australia; [Brady, Jamie L.; Lew, Andrew M.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Lew, Andrew M.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Cowan, Peter J.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia	Cowan, PJ (reprint author), St Vincents Hosp, Immunol Res Ctr, Melbourne, Vic, Australia.; Cowan, PJ (reprint author), Univ Melbourne, Dept Med, Melbourne, Vic, Australia.	peter.cowan@svha.org.au		Cowan, Peter/0000-0001-9016-4954	National Health & Medical Research Council of Australia (NHMRC) [1061868, 1037321, 1043414, 1080321, 1105209]; Juvenile Diabetes Research Foundation [3-SRA-2017-366-S-B]	These studies were supported by the National Health & Medical Research Council of Australia (NHMRC) (1061868, 1037321, 1043414, 1080321, 1105209) and the Juvenile Diabetes Research Foundation (3-SRA-2017-366-S-B). The authors thank Jessica Zemmentis for animal care.	Aouida M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133373; Beebe L, 2007, CLONING STEM CELLS, V9, P564, DOI 10.1089/clo.2007.0025; Beebe LFS, 2009, J REPROD DEVELOP, V55, P373, DOI 10.1262/jrd.20176                                                               ; Brady JL, 2013, XENOTRANSPLANTATION, V20, P100, DOI 10.1111/xen.12025; Brady JL, 2009, IMMUNOL CELL BIOL, V87, P413, DOI 10.1038/icb.2009.4; Butler JR, 2016, XENOTRANSPLANTATION, V23, P106, DOI 10.1111/xen.12217; Chen CG, 1996, XENOTRANSPLANTATION, V3, P69, DOI 10.1111/j.1399-3089.1996.tb00121.x; Cowan PJ, 2016, CURR OPIN ORGAN TRAN, V21, P461, DOI 10.1097/MOT.0000000000000347; Cowan PJ, 2000, TRANSPLANTATION, V69, P2504, DOI 10.1097/00007890-200006270-00008; Crikis S, 2010, AM J TRANSPLANT, V10, P242, DOI 10.1111/j.1600-6143.2009.02939.x; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Fisicaro N, 2011, XENOTRANSPLANTATION, V18, P121, DOI 10.1111/j.1399-3089.2011.00631.x; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hara S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11221; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Hawthorne WJ, 2014, AM J TRANSPLANT, V14, P1300, DOI 10.1111/ajt.12722; Kuwaki K, 2005, NAT MED, V11, P29, DOI 10.1038/nm1171; Lai SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146562; Li P, 2015, XENOTRANSPLANTATION, V22, P20, DOI 10.1111/xen.12131; Miyaoka Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23549; Mohiuddin MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11138; PENG J, 2015, SCI REP UK, V5; Petersen B, 2016, XENOTRANSPLANTATION, V23, P338, DOI 10.1111/xen.12258; Reyes LM, 2014, J IMMUNOL, V193, P5751, DOI 10.4049/jimmunol.1402059; Ruan JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep14253; Tena A, 2014, AM J TRANSPLANT, V14, P2713, DOI 10.1111/ajt.12918; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908	28	1	1	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 16	2017	7								8383	10.1038/s41598-017-09030-6				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FD6ZJ	WOS:000407676100002	28814758	gold			2018-01-05	
J	Capovilla, G; Symeonidi, E; Wu, R; Schmid, M				Capovilla, Giovanna; Symeonidi, Efthymia; Wu, Rui; Schmid, Markus			Contribution of major FLM isoforms to temperature-dependent flowering in Arabidopsis thaliana	JOURNAL OF EXPERIMENTAL BOTANY			English	Article						Arabidopsis thaliana; CRISPR/Cas9; FLOWERING LOCUS M (FLM); flowering time; splice isoforms; temperature-dependent alternative splicing	MESSENGER-RNA DECAY; VERNALIZATION; TRANSCRIPTION; TRANSLATION; POLYMERASE; IMMUNITY; MUTANTS; GENES	FLOWERING LOCUS M (FLM), a component of the thermosensory flowering time pathway in Arabidopsis thaliana, is regulated by temperature-dependent alternative splicing (AS). The main splicing variant, FLM-beta, is a well-documented floral repressor that is down-regulated in response to increasing ambient growth temperature. Two hypotheses have been formulated to explain how flowering time is modulated by AS of FLM. In the first model a second splice variant, FLM-delta, acts as a dominant negative isoform that competes with FLM-beta at elevated ambient temperatures, thereby indirectly promoting flowering. Alternatively, it has been suggested that the induction of flowering at elevated temperatures is caused only by reduced FLM-beta expression. To better understand the role of the two FLM splice forms, we employed CRISPR/Cas9 technology to specifically delete the exons that characterize each splice variant. Lines that produced repressive FLM-beta but were incapable of producing FLM-delta were late flowering. In contrast, FLM-beta knockout lines that still produced FLM-delta flowered early, but not earlier than the flm-3 loss of function mutant, as would be expected if FLM-delta had a dominant-negative effect on flowering. Our data support the role of FLM-beta as a flower repressor and provide evidence that a contribution of FLM-delta to the regulation of flowering time in wild-type A. thaliana seems unlikely.	[Capovilla, Giovanna; Symeonidi, Efthymia; Wu, Rui; Schmid, Markus] Max Planck Inst Dev Biol, Dept Mol Biol, Spemannstr 35, D-72076 Tubingen, Germany; [Schmid, Markus] Umea Univ, Umea Plant Sci Ctr, Dept Plant Physiol, SE-90187 Umea, Sweden	Schmid, M (reprint author), Max Planck Inst Dev Biol, Dept Mol Biol, Spemannstr 35, D-72076 Tubingen, Germany.; Schmid, M (reprint author), Umea Univ, Umea Plant Sci Ctr, Dept Plant Physiol, SE-90187 Umea, Sweden.	markus.schmid@umu.se		Schmid, Markus/0000-0002-0068-2967	Sonderforschungsbereich 1101 (Collaborative Research Centre 1101) [SFB1101/1-C04]	We thank Holger Puchta for sharing the Arabidopsis codon optimized Cas9 version, Joachim Forner and Jan Lohmann for sharing GreenGate vectors prior to publication, and Rebecca Schwab and other colleagues from the Department of Molecular Biology at the MPI for Developmental Biology for comments on the manuscript. Supported through the Sonderforschungsbereich 1101 (Collaborative Research Centre 1101), project SFB1101/1-C04, to MS.	Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Box MS, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-7; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Gao XH, 2016, PLANT PHYSIOL, V171, P1794, DOI 10.1104/pp.16.00663; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Lampropoulos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083043; Lee JH, 2013, SCIENCE, V342, P628, DOI 10.1126/science.1241097; LEE LG, 1993, NUCLEIC ACIDS RES, V21, P3761, DOI 10.1093/nar/21.16.3761; Lutz U, 2017, ELIFE, V6, DOI 10.7554/eLife.22114; Lutz U, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005588; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949                                                            ; Pose D, 2013, NATURE, V503, P414, DOI 10.1038/nature12633; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Staiger D., 2015, ADV IN BOT; Sureshkumar S, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.55, 10.1038/nplants.2016.55]; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001; WAIBEL F, 1990, NUCLEIC ACIDS RES, V18, P3451, DOI 10.1093/nar/18.12.3451; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0	26	1	1	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	AUG 15	2017	68	18					5117	5127		10.1093/jxb/erx328				11	Plant Sciences	Plant Sciences	FL6QS	WOS:000414371700011	29036339				2018-01-05	
J	Huang, P; Keller, CA; Giardine, B; Grevet, JD; Davies, JOJ; Hughes, JR; Kurita, R; Nakamura, Y; Hardison, RC; Blobel, GA				Huang, Peng; Keller, Cheryl A.; Giardine, Belinda; Grevet, Jeremy D.; Davies, James O. J.; Hughes, Jim R.; Kurita, Ryo; Nakamura, Yukio; Hardison, Ross C.; Blobel, Gerd A.			Comparative analysis of three-dimensional chromosomal architecture identifies a novel fetal hemoglobin regulatory element	GENES & DEVELOPMENT			English	Article						chromatin structure; transcription; globin switching; fetal hemoglobin	LONG-RANGE INTERACTIONS; BETA-GLOBIN LOCUS; GENE-EXPRESSION; GAMMA-GLOBIN; HUMAN GENOME; BCL11A; ENHANCER; DIFFERENTIATION; CONFORMATION; ORGANIZATION	Chromatin structure is tightly intertwined with transcription regulation. Here we compared the chromosomal architectures of fetal and adult human erythroblasts and found that, globally, chromatin structures and compartments A/B are highly similar at both developmental stages. At a finer scale, we detected distinct folding patterns at the developmentally controlled beta-globin locus. Specifically, new fetal stage-specific contacts were uncovered between a region separating the fetal (gamma) and adult (delta and beta) globin genes (encompassing the HBBP1 and BGLT3 noncoding genes) and two distal chromosomal sites (HS5 and 3'HS1) that flank the locus. In contrast, in adult cells, the HBBP1-BGLT3 region contacts the embryonic epsilon-globin gene, physically separating the fetal globin genes from the enhancer (locus control region [LCR]). Deletion of the HBBP1 region in adult cells alters contact landscapes in ways more closely resembling those of fetal cells, including increased LCR-gamma-globin contacts. These changes are accompanied by strong increases in gamma-globin transcription. Notably, the effects of HBBP1 removal on chromatin architecture and gene expression closely mimic those of deleting the fetal globin repressor BCL11A, implicating BCL11A in the function of the HBBP1 region. Our results uncover a new critical regulatory region as a potential target for therapeutic genome editing for hemoglobinopathies and highlight the power of chromosome conformation analysis in discovering new cis control elements.	[Huang, Peng; Grevet, Jeremy D.; Blobel, Gerd A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Keller, Cheryl A.; Giardine, Belinda; Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Grevet, Jeremy D.; Blobel, Gerd A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Davies, James O. J.; Hughes, Jim R.] Univ Oxford, Weatherall Inst Mol Med, MRC, Mol Hematol Unit, Oxford OX3 9DS, England; [Kurita, Ryo] Japanese Red Cross Soc, Blood Serv Headquarters, Cent Blood Inst, Res & Dev Dept,Koto Ku, Tokyo 1358521, Japan; [Nakamura, Yukio] RIKEN, BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki 3050074, Japan	Blobel, GA (reprint author), Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA.; Blobel, GA (reprint author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	blobel@email.chop.edu		Davies, James/0000-0002-4108-4357	National Institutes of Health [UO1HL129998A, R24 DK106766-01]; Children's Hospital of Philadelphia Center for Spatial and Functional Genomics	We thank Jeremy Rupon for the help with cell cultures, Elisabetta Manduchi for assistance with RNA-seq analysis, and Kai Tan, Changya Chen, Wenbao Yu, Andrew Wells, Struan Grant, and members of the laboratory for helpful discussions. This work was supported by the National Institutes of Health (grants UO1HL129998A to G.A.B., and R24 DK106766-01 to R.C.H. and G.A.B.) and the Children's Hospital of Philadelphia Center for Spatial and Functional Genomics (G.A.B.).	Bartman CR, 2016, MOL CELL, V62, P237, DOI 10.1016/j.molcel.2016.03.007; Chakalova L, 2005, BLOOD, V105, P2154, DOI 10.1182/blood-2003-11-4069; Chang KH, 2017, MOL THER-METH CLIN D, V4, P137, DOI 10.1016/j.omtm.2016.12.009; Chang KH, 2013, STEM CELL REV REP, V9, P397, DOI 10.1007/s12015-012-9355-x; Davies JOJ, 2016, NAT METHODS, V13, P74, DOI [10.1038/NMETH.3664, 10.1038/nmeth.3664]; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Durand NC, 2016, CELL SYST, V3, P99, DOI 10.1016/j.cels.2015.07.012; Forcato M, 2017, NAT METHODS, V14, P679, DOI 10.1038/nmeth.4325; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Hardison RC, 2013, SCIENCE, V342, P206, DOI 10.1126/science.1245813; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Hsu SC, 2017, MOL CELL, V66, P102, DOI 10.1016/j.molcel.2017.02.027; Huang JL, 2016, DEV CELL, V36, P9, DOI 10.1016/j.devcel.2015.12.014; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Jawaid K, 2010, BLOOD CELL MOL DIS, V45, P140, DOI 10.1016/j.bcmd.2010.05.006; Kang Y, 2017, BBA-GENE REGUL MECH, V1860, P416, DOI 10.1016/j.bbagrm.2017.01.013; Kiefer CM, 2011, BLOOD, V118, P6200, DOI 10.1182/blood-2011-06-363101; Krijger PHL, 2016, CELL STEM CELL, V18, P597, DOI 10.1016/j.stem.2016.01.007; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Lessard S, 2015, GENOME MED, V7, DOI 10.1186/s13073-014-0122-2; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Smith EC, 2016, HUM MOL GENET, V25, pR99, DOI 10.1093/hmg/ddw170; Smith EC, 2016, BLOOD, V128, P2338, DOI 10.1182/blood-2016-08-736249; Stonestrom AJ, 2015, BLOOD, V125, P2825, DOI 10.1182/blood-2014-10-607309; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; Xu J, 2012, DEV CELL, V23, P796, DOI 10.1016/j.devcel.2012.09.003; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Ye L, 2016, P NATL ACAD SCI USA, V113, P10661, DOI 10.1073/pnas.1612075113; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	43	0	0	4	4	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	0890-9369	1549-5477		GENE DEV	Genes Dev.	AUG 15	2017	31	16					1704	1713		10.1101/gad.303461.117				10	Cell Biology; Developmental Biology; Genetics & Heredity	Cell Biology; Developmental Biology; Genetics & Heredity	FI0PG	WOS:000411629600008	28916711				2018-01-05	
J	Ishizu, H; Sumiyoshi, T; Siomi, MC				Ishizu, Hirotsugu; Sumiyoshi, Tetsutaro; Siomi, Mikiko C.			Use of the CRISPR-Cas9 system for genome editing in cultured Drosophila ovarian somatic cells	METHODS			English	Article							HOMOLOGY-DIRECTED REPAIR; PRIMARY PIRNA BIOGENESIS; WIDE RNAI SCREEN; STEM-CELLS; PATHWAY; PIWI; GERMLINE; DEFENSE; MUTAGENESIS; NUCLEASES	The CRISPR-Cas9 system can be used for genome engineering in many organisms. PIWI-interacting RNAs (piRNAs) play a crucial role in repressing transposons to maintain genome integrity in Drosophila ovaries, and cultured ovarian somatic cells (OSCs) are widely used to elucidate the molecular mechanisms underlying the piRNA pathway. However, the germline-specific piRNA amplification system known as the ping-pong machinery does not occur in OSCs, making them unsuitable for elucidating the underlying mechanisms. Mutations in the lethal (3) malignant brain tumor gene (l(3)mbt) have been shown to cause ectopic expression of germline genes, including ping-pong factors. We therefore performed genome editing of Drosophila OSCs using the CRISPR-Cas9 system to achieve 1(3)mbt knockout, resulting in successful induction of the piRNA amplification machinery. Here, we describe the detailed procedures for generating knockout and knockin OSC cells. (C) 2017 Published by Elsevier Inc.	[Ishizu, Hirotsugu; Sumiyoshi, Tetsutaro; Siomi, Mikiko C.] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan	Siomi, MC (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	siomim@bs.s.u-tokyo.ac.jp			JSPS KAKENHI [17H03632, 16H01214, 26113004, 25221101]	Current studies in the authors' laboratory are supported in part by JSPS KAKENHI Grant Numbers 17H03632, 16H01214 to H.I. and 26113004, 25221101 to M.C.S.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bibikova M, 2002, GENETICS, V161, P1169; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iwasaki YW, 2015, ANNU REV BIOCHEM, V84, P405, DOI 10.1146/annurev-biochem-060614-034258; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Ma S, 2014, SCI REP, V4, P4489; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Muerdter F, 2013, MOL CELL, V50, P736, DOI 10.1016/j.molcel.2013.04.006; Niki Y, 2006, P NATL ACAD SCI USA, V103, P16325, DOI 10.1073/pnas.0607435103; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Saito K, 2014, METHODS MOL BIOL, V1093, P25, DOI 10.1007/978-1-62703-694-8_3; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Sumiyoshi T, 2016, GENE DEV, V30, P1617, DOI 10.1101/gad.283929.116; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vouillot L, 2015, POLLET G, P407	39	1	1	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	AUG 15	2017	126						186	192		10.1016/j.ymeth.2017.05.021				7	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FH1CR	WOS:000410877800021	28552546				2018-01-05	
J	Limera, C; Sabbadini, S; Sweet, JB; Mezzetti, B				Limera, Cecilia; Sabbadini, Silvia; Sweet, Jeremy B.; Mezzetti, Bruno			New Biotechnological Tools for the Genetic Improvement of Major Woody Fruit Species	FRONTIERS IN PLANT SCIENCE			English	Review						plant breeding; RNA interference (RNAi); trans-grafting; cisgenesis/intragenesis; Crispr/Cas9; genome editing; EU biosafety regulations	ZINC-FINGER NUCLEASES; COAT PROTEIN GENE; PLUM-POX-VIRUS; PLANT-BREEDING TECHNIQUES; SCAB RESISTANCE GENE; CRISPR-CAS SYSTEMS; PATHOGEN-DERIVED RESISTANCE; CROWN GALL TUMORIGENESIS; RNA SILENCING PATHWAYS; DOUBLE-STRANDED-RNA	The improvement of woody fruit species by traditional plant breeding techniques has several limitations mainly caused by their high degree of heterozygosity, the length of their juvenile phase and auto-incompatibility. The development of new biotechnological tools (NBTs), such as RNA interference (RNAi), trans-grafting, cisgenesis/intragenesis, and genome editing tools, like zinc-finger and CRISPR/Cas9, has introduced the possibility of more precise and faster genetic modifications of plants. This aspect is of particular importance for the introduction or modification of specific traits in woody fruit species while maintaining unchanged general characteristics of a selected cultivar. Moreover, some of these new tools give the possibility to obtain transgene-free modified fruit tree genomes, which should increase consumer's acceptance. Over the decades biotechnological tools have undergone rapid development and there is a continuous addition of new and valuable techniques for plant breeders. This makes it possible to create desirable woody fruit varieties in a fast and more efficient way to meet the demand for sustainable agricultural productivity. Although, NBTs have a common goal i.e., precise, fast, and efficient crop improvement, individually they are markedly different in approach and characteristics from each other. In this review we describe in detail their mechanisms and applications for the improvement of fruit trees and consider the relationship between these biotechnological tools and the EU biosafety regulations applied to the plants and products obtained through these techniques.	[Limera, Cecilia; Sabbadini, Silvia; Mezzetti, Bruno] Univ Politecn Marche, Dept Agr Food & Environm Sci, Ancona, Italy; [Sweet, Jeremy B.] JT Environm Consultants Ltd, Cambridge, England	Mezzetti, B (reprint author), Univ Politecn Marche, Dept Agr Food & Environm Sci, Ancona, Italy.	b.mezzetti@univpm.it		Mezzetti, Bruno/0000-0001-9307-812X	COST action CA15223 iPlanta project	Our studies described here were supported by COST action CA15223 iPlanta project.	ABEL PP, 1986, SCIENCE, V232, P738, DOI 10.1126/science.3457472; Almeida R, 2005, TRENDS CELL BIOL, V15, P251, DOI 10.1016/j.tcb.2005.03.006; Aloni B, 2010, SCI HORTIC-AMSTERDAM, V127, P119, DOI 10.1016/j.scienta.2010.09.003; Altpeter F, 2005, MOL BREEDING, V15, P305, DOI 10.1007/s11032-004-8001-y; An C. F., 2013, American Journal of Plant Sciences, V4, P2131, DOI 10.4236/ajps.2013.411265; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Reyes CA, 2011, J BIOTECHNOL, V151, P151, DOI 10.1016/j.jbiotec.2010.11.007; Atkinson RG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-129; Barrangou R, 2015, CURR OPIN IMMUNOL, V32, P36, DOI 10.1016/j.coi.2014.12.008; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5                                                   ; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baulcombe DC, 1996, PLANT CELL, V8, P1833; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bhullar NK, 2013, BIOTECHNOL ADV, V31, P50, DOI 10.1016/j.biotechadv.2012.02.001; Billmyre RB, 2013, CHROMOSOME RES, V21, P561, DOI 10.1007/s10577-013-9388-2; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Borges F, 2015, NAT REV MOL CELL BIO, V16, P727, DOI 10.1038/nrm4085; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brazelton VA, 2015, GM CROPS FOOD, V6, P266, DOI 10.1080/21645698.2015.1137690; Breyer Didier, 2009, Environmental Biosafety Research, V8, P57, DOI 10.1051/ebr/2009007; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Brosnan CA, 2011, CURR OPIN PLANT BIOL, V14, P580, DOI 10.1016/j.pbi.2011.07.011; Cambra M., 2006, Bulletin OEPP, V36, P202; Campbell TN, 2005, CURR ISSUES MOL BIOL, V7, P1; Carbonell A, 2015, CURR OPIN PLANT BIOL, V27, P111, DOI 10.1016/j.pbi.2015.06.013; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cervera M, 1998, TRANSGENIC RES, V7, P51; Cheng W, 2015, PLANT BIOTECHNOL J, V13, P1335, DOI 10.1111/pbi.12352; CHILTON MD, 1977, CELL, V11, P263, DOI 10.1016/0092-8674(77)90043-5                                                    ; Collinge DB, 2010, ANNU REV PHYTOPATHOL, V48, P269, DOI 10.1146/annurev-phyto-073009-114430; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conner AJ, 2007, EUPHYTICA, V154, P341, DOI 10.1007/s10681-006-9316-z; Curtin SJ, 2012, PLANT GENOME-US, V5, P42, DOI 10.3835/plantgenome2012.06.0008; Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981; Datta A., 2013, AGR FOOD SECURITY, V2, P15; de Alba AEM, 2013, BBA-GENE REGUL MECH, V1829, P1300, DOI 10.1016/j.bbagrm.2013.10.005; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Dhekney SA, 2011, IN VITRO CELL DEV-PL, V47, P458, DOI 10.1007/s11627-011-9358-3; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Dong CM, 2006, PLANT CELL REP, V25, P457, DOI 10.1007/s00299-005-0098-x; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Dutt M, 2007, ACTA HORTIC, P749, DOI 10.17660/ActaHortic.2007.738.99                                                 ; EFSA Panel of GMO, 2012, EFSA J, V10, P2561, DOI [DOI 10.2903/J.EFSA.2012.2561, 10.2903/j.efsa.2012.2561]; Elomaa P, 2003, PLANT PHYSIOL, V133, P1831, DOI 10.1104/pp.103.026039; English JJ, 1996, PLANT CELL, V8, P179; Escobar MA, 2001, P NATL ACAD SCI USA, V98, P13437, DOI 10.1073/pnas.241276898; Febres VJ, 2008, PLANT CELL REP, V27, P93, DOI 10.1007/s00299-007-0445-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Freiman A, 2012, PLANTA, V235, P1239, DOI 10.1007/s00425-011-1571-0; Frizzi A, 2010, PLANT BIOTECHNOL J, V8, P655, DOI 10.1111/j.1467-7652.2010.00505.x; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Gessler C, 2014, ACTA HORTIC, V1048, P43; Giuliano G, 2017, CURR OPIN BIOTECH, V44, P169, DOI 10.1016/j.copbio.2017.02.001; Gonsalves D., 2004, AgBioForum, V7, P36; Gonsalves D, 1998, ANNU REV PHYTOPATHOL, V36, P415, DOI 10.1146/annurev.phyto.36.1.415; Gonsalves D, 2006, ADV VIRUS RES, V67, P317, DOI 10.1016/S0065-3527(06)67009-7; Gottula J, 2009, ADV VIRUS RES, V75, P161, DOI 10.1016/S0065-3527(09)07505-8; Grens K., 2017, RNA INTERFERENCE BET; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Haroldsen VM, 2012, J BIOTECHNOL, V161, P349, DOI 10.1016/j.jbiotec.2012.06.017; Haroldsen VM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00039; Hartung F, 2014, PLANT J, V78, P742, DOI 10.1111/tpj.12413; Hily JM, 2007, J AM SOC HORTIC SCI, V132, P850; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hu Y, 2014, P NATL ACAD SCI USA, V111, pE521, DOI 10.1073/pnas.1313271111; Iida S, 2005, PLANT MOL BIOL, V59, P205, DOI 10.1007/s11103-005-2162-x; Ipsaro JJ, 2015, NAT STRUCT MOL BIOL, V22, P20, DOI 10.1038/nsmb.2931; Jacobsen E, 2007, TRENDS BIOTECHNOL, V25, P219, DOI 10.1016/j.tibtech.2007.03.008; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Jones HD, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2014.11, 10.1038/nplants.2014.11]; Joshi SG, 2011, PLANT MOL BIOL, V75, P579, DOI 10.1007/s11103-011-9749-1; Kandel R, 2016, PLANT CELL TISS ORG, V124, P599, DOI 10.1007/s11240-015-0918-9; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Khalid Annum, 2017, Front Microbiol, V8, P43, DOI 10.3389/fmicb.2017.00043; Klocko AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159421; Knip M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004602; Kost TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143980; Krens FA, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00286; LANG A, 1977, P NATL ACAD SCI USA, V74, P2412, DOI 10.1073/pnas.74.6.2412                                                          ; Lemgo GNY, 2013, TRANSGENIC RES, V22, P1073, DOI 10.1007/s11248-013-9728-1; Lombardo L, 2016, TRENDS BIOTECHNOL, V34, P49, DOI 10.1016/j.tibtech.2015.10.006; Lucas WJ, 2004, NAT REV MOL CELL BIO, V5, P712, DOI 10.1038/nrm1470; Lusser M., 2011, JRC SCI TECHNICAL RE; Lusser M, 2013, NEW BIOTECHNOL, V30, P437, DOI 10.1016/j.nbt.2013.02.004; Lusser M, 2012, NAT BIOTECHNOL, V30, P231, DOI 10.1038/nbt.2142; Mallory AC, 2003, PLANT J, V35, P82, DOI 10.1046/j.1365-313X.2003.01785.x; Malnoy M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01904; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; Matzke MA, 2014, NAT REV GENET, V15, P394, DOI 10.1038/nrg3683; McGarry RC, 2013, TRENDS PLANT SCI, V18, P198, DOI 10.1016/j.tplants.2013.01.004; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Melnyk CW, 2015, CURR BIOL, V25, pR183, DOI 10.1016/j.cub.2015.01.029; Melnyk CW, 2011, EMBO J, V30, P3553, DOI 10.1038/emboj.2011.274; Metzlaff M, 1997, CELL, V88, P845, DOI 10.1016/S0092-8674(00)81930-3; Mezzetti B, 2001, PLANT BIOSYST, V135, P63; Mezzetti Bruno, 2002, BMC Biotechnol, V2, P18, DOI 10.1186/1472-6750-2-18; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Molnar A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-215; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mudge K., 2009, Horticultural Reviews, V35, P437; Nagamangala K., 2015, TRENDS BIOTECHNOL, V33, P62, DOI [10.1016/j.tibtech.2014.07.003, DOI 10.1016/J.TIBTECH.2014.07.003]; Nakajima I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177966; Nakayashiki H, 2005, FEBS LETT, V579, P5950, DOI 10.1016/j.febslet.2005.08.016; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nazim U. M., 2013, WILEY INTERDISCIP RE, V4, P279, DOI [10.1002/wrna.1160, DOI 10.1002/WRNA.1160]; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nishitani C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31481; Omid A, 2007, J EXP BOT, V58, P3645, DOI 10.1093/jxb/erm214; Osakabe Y, 2015, PLANT CELL PHYSIOL, V56, P389, DOI 10.1093/pcp/pcu170; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313                                                ; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Parent JS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00179; Parisi C, 2016, NAT BIOTECHNOL, V34, P31, DOI 10.1038/nbt.3449; PATATOCHATT EM, 1988, J PLANT PHYSIOL, V133, P460, DOI 10.1016/S0176-1617(88)80037-3                                                   ; Peer R, 2015, PLANTA, V241, P941, DOI 10.1007/s00425-014-2224-x; Peil A, 2007, PLANT BREEDING, V126, P470, DOI 10.1111/j.1439-0523.2007.01408.x; Peng AH, 2017, PLANT BIOTECHNOL J, V15, P1509, DOI 10.1111/pbi.12733; Perez-Jimenez M, 2012, PLANT CELL TISS ORG, V108, P55, DOI 10.1007/s11240-011-0011-y; Perez-Massot E, 2013, GENES NUTR, V8, P29, DOI 10.1007/s12263-012-0315-5; Pessina S, 2016, PLANT BIOTECHNOL J, V14, P2033, DOI 10.1111/pbi.12562; Petolino JF, 2015, IN VITRO CELL DEV-PL, V51, P1, DOI 10.1007/s11627-015-9663-3; Petri C, 2005, TRANSGENIC RES, V14, P15, DOI 10.1007/s11248-004-2770-2; Podevin N, 2012, EMBO REP, V13, P1057, DOI 10.1038/embor.2012.168; Qaim M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064879; Qi YJ, 2005, FEBS LETT, V579, P5899, DOI 10.1016/j.feblset.2005.08.035; Rai MK, 2014, PLANT CELL TISS ORG, V116, P1, DOI 10.1007/s11240-013-0389-9; Ren C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32289; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Rommens CM, 2007, J AGR FOOD CHEM, V55, P4281, DOI 10.1021/jf0706631; Rommens CM, 2004, TRENDS PLANT SCI, V9, P457, DOI 10.1016/j.tplants.2004.07.001; Ruiter R, 2003, PLANT MOL BIOL, V53, P715, DOI 10.1023/B:PLAN.0000019111.96107.01                                              ; Sabbadini S, 2015, METHODS MOL BIOL, V1224, P205, DOI 10.1007/978-1-4939-1658-0_17; Salame TM, 2011, APPL MICROBIOL BIOT, V89, P501, DOI 10.1007/s00253-010-2928-1; SANFORD JC, 1985, J THEOR BIOL, V113, P395, DOI 10.1016/S0022-5193(85)80234-4; Gisbert C., 2017, VITIS J GRAPE RES, V55, P173, DOI [10.5073/vitis.2016.55.173-186, DOI 10.5073/VITIS.2016.55.173-186]; Sauer NJ, 2016, PLANT BIOTECHNOL J, V14, P496, DOI 10.1111/pbi.12496; Schaart JG, 2016, TRENDS PLANT SCI, V21, P438, DOI 10.1016/j.tplants.2015.11.006; Schaart J. G., 2009, 200902 COGEM; Schouten HJ, 2006, EMBO REP, V7, P750, DOI 10.1038/sj.embor.7400769; Schouten HJ, 2006, NAT BIOTECHNOL, V24, P753, DOI 10.1038/nbt0706-753; SCORZA R, 1994, PLANT CELL REP, V14, P18, DOI 10.1007/BF00233291; Scorza R, 2001, TRANSGENIC RES, V10, P201, DOI 10.1023/A:1016644823203; Scorza R, 2013, PLANT CELL TISS ORG, V115, P1, DOI 10.1007/s11240-013-0339-6; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Simon-Mateo C, 2011, BBA-GENE REGUL MECH, V1809, P722, DOI 10.1016/j.bbagrm.2011.05.011; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Smolka A, 2010, TRANSGENIC RES, V19, P933, DOI 10.1007/s11248-010-9370-0; Song GQ, 2013, PLANT BIOTECHNOL J, V11, P702, DOI 10.1111/pbi.12060; Sprink T, 2016, PLANT CELL REP, V35, P1493, DOI 10.1007/s00299-016-1990-2; Stegemann S, 2009, SCIENCE, V324, P649, DOI 10.1126/science.1170397; Stover E, 2014, HORTSCIENCE, V49, P4; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Tzfira T, 2006, CURR OPIN BIOTECH, V17, P147, DOI 10.1016/j.copbio.2006.01.009; Tzfira T, 2012, PLANT BIOTECHNOL J, V10, P373, DOI 10.1111/j.1467-7652.2011.00672.x; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Vanblaere T, 2014, PLANT BIOTECHNOL J, V12, P2, DOI 10.1111/pbi.12110; Vanblaere T, 2011, J BIOTECHNOL, V154, P304, DOI 10.1016/j.jbiotec.2011.05.013; VARDI A, 1990, PLANT SCI, V69, P199, DOI 10.1016/0168-9452(90)90118-8; Vaucheret H, 2001, TRENDS GENET, V17, P29, DOI 10.1016/S0168-9525(00)02166-1; Vaucheret H, 2001, J CELL SCI, V114, P3083; Viss WJ, 2003, MOL BREEDING, V12, P283, DOI 10.1023/B:MOLB.0000006805.76717.08; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Voinnet O, 2008, CURR OPIN PLANT BIOL, V11, P464, DOI 10.1016/j.pbi.2008.04.006; Waltz E, 2011, NAT BIOTECHNOL, V29, P677, DOI [10.1038/nbt0811-677b, DOI 10.1038/NBT0811-677B]; Waltz E, 2015, NAT BIOTECHNOL, V33, P326, DOI 10.1038/nbt0415-326c; Wang H, 2011, SCI HORTIC-AMSTERDAM, V128, P457, DOI 10.1016/j.scienta.2011.02.020; Welander M, 2000, ACTA HORTIC, P133, DOI 10.17660/ActaHortic.2000.521.14                                                 ; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Wurdig J, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0291-8; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhao DY, 2014, PLANT BIOTECHNOL J, V12, P1319, DOI 10.1111/pbi.12243; Zhao K, 2016, J AM SOC HORTIC SCI, V141, P242; Zhu CF, 2013, PLANT BIOTECHNOL J, V11, P129, DOI 10.1111/j.1467-7652.2012.00740.x; Zhu T, 2000, NAT BIOTECHNOL, V18, P555	188	0	0	25	25	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	AUG 15	2017	8								1418	10.3389/fpls.2017.01418				16	Plant Sciences	Plant Sciences	FD7LX	WOS:000407708700001	28861099	gold			2018-01-05	
J	Chen, HY; Wu, CT; Tang, CJC; Lin, YN; Wang, WJ; Tang, TK				Chen, Hsin-Yi; Wu, Chien-Ting; Tang, Chieh-Ju C.; Lin, Yi-Nan; Wang, Won-Jing; Tang, Tang K.			Human microcephaly protein RTTN interacts with STIL and is required to build full-length centrioles	NATURE COMMUNICATIONS			English	Article							CENTROSOME DUPLICATION CYCLE; HUMAN-CELLS; PROCENTRIOLE FORMATION; SINGLE PROCENTRIOLE; KINASE 4; CPAP; PLK4; ELONGATION; MUTATIONS; SCAFFOLD	Mutations in many centriolar protein-encoding genes cause primary microcephaly. Using super-resolution and electron microscopy, we find that the human microcephaly protein, RTTN, is recruited to the proximal end of the procentriole at early S phase, and is located at the inner luminal walls of centrioles. Further studies demonstrate that RTTN directly interacts with STIL and acts downstream of STIL-mediated centriole assembly. CRISPR/Cas9-mediated RTTN gene knockout in p53-deficient cells induce amplification of primitive procentriole bodies that lack the distal-half centriolar proteins, POC5 and POC1B. Additional analyses show that RTTN serves as an upstream effector of CEP295, which mediates the loading of POC1B and POC5 to the distal-half centrioles. Interestingly, the naturally occurring microcephaly-associated mutant, RTTN (A578P), shows a low affinity for STIL binding and blocks centriole assembly. These findings reveal that RTTN contributes to building full-length centrioles and illuminate the molecular mechanism through which the RTTN (A578P) mutation causes primary microcephaly.	[Chen, Hsin-Yi; Tang, Tang K.] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chen, Hsin-Yi; Wu, Chien-Ting; Tang, Chieh-Ju C.; Lin, Yi-Nan; Tang, Tang K.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Wu, Chien-Ting; Tang, Tang K.] Natl Yang Ming Univ, Taiwan Int Grad Program Interdisciplinary Neurosc, Taipei, Taiwan; [Wu, Chien-Ting; Tang, Tang K.] Acad Sinica, Taipei, Taiwan; [Wang, Won-Jing] Natl Yang Ming Univ, Coll Life Sci, Inst Biochem & Mol Biol, Taipei, Taiwan	Tang, TK (reprint author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Tang, TK (reprint author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.; Tang, TK (reprint author), Natl Yang Ming Univ, Taiwan Int Grad Program Interdisciplinary Neurosc, Taipei, Taiwan.; Tang, TK (reprint author), Acad Sinica, Taipei, Taiwan.	tktang@ibms.sinica.edu.tw		Tang, Tang/0000-0002-3660-0695	Ministry of Science and Technology, Taiwan, ROC [MOST 105-2321-B001-016]; Academia Sinica Investigator Award	We thank the sequencing core facility (IBMS), the confocal imaging core facilities (IBMS, SIC, ABRC, NPAS), and the EM core facilities (IMB, SIC) of Academia Sinica. We thank Ching-Wen Chang for helpful discussion and Shu-Chen Shen for technical assistance. This work was supported by grants from the Ministry of Science and Technology, Taiwan, ROC (MOST 105-2321-B001-016) and the Academia Sinica Investigator Award.	Arquint C, 2015, ELIFE, V4, DOI 10.7554/eLife.07888; Azimzadeh J, 2010, CURR BIOL, V20, pR816, DOI 10.1016/j.cub.2010.08.010; Azimzadeh J, 2009, J CELL BIOL, V185, P101, DOI 10.1083/jcb.200808082; Bazzi H, 2014, P NATL ACAD SCI USA, V111, pE1491, DOI 10.1073/pnas.1400568111; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Chang CW, 2016, J CELL SCI, V129, P2501, DOI 10.1242/jcs.186338; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Comartin D, 2013, CURR BIOL, V23, P1360, DOI 10.1016/j.cub.2013.06.002; Conduit PT, 2015, NAT REV MOL CELL BIO, V16, P611, DOI 10.1038/nrm4062; Dzhindzhev NS, 2014, CURR BIOL, V24, P2526, DOI 10.1016/j.cub.2014.08.061; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Faisst AM, 2002, MECH DEVELOP, V113, P15, DOI 10.1016/S0925-4773(02)00003-5                                                   ; Fu JY, 2016, NAT CELL BIOL, V18, P87, DOI 10.1038/ncb3274; Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373; Gudi R, 2011, J CELL BIOL, V193, P711, DOI 10.1083/jcb.201006135; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016; Insolera R, 2014, NAT NEUROSCI, V17, P1528, DOI 10.1038/nn.3831; Izquierdo D, 2014, CELL REP, V8, P957, DOI 10.1016/j.celrep.2014.07.022; Khan MA, 2014, HUM MOL GENET, V23, P5940, DOI 10.1093/hmg/ddu318; Kia SK, 2012, AM J HUM GENET, V91, P533, DOI 10.1016/j.ajhg.2012.07.008; Klebba JE, 2015, J CELL BIOL, V208, P401, DOI 10.1083/jcb.201410105; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Kratz AS, 2015, BIOL OPEN, V4, P370, DOI 10.1242/bio.201411023; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Lin YN, 2013, J CELL BIOL, V202, P211, DOI 10.1083/jcb.201212060; Lin YC, 2013, EMBO J, V32, P1141, DOI 10.1038/emboj.2013.56; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martin CA, 2014, NAT GENET, V46, P1283, DOI 10.1038/ng.3122; Moyer TC, 2015, J CELL BIOL, V209, P863, DOI 10.1083/jcb.201502088; Nigg EA, 2014, FEBS LETT, V588, P2366, DOI 10.1016/j.febslet.2014.06.030; Ohta M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6267; Saurya S, 2016, J CELL SCI, V129, P2514, DOI 10.1242/jcs.186460; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Shamseldin H, 2015, AM J HUM GENET, V97, P862, DOI 10.1016/j.ajhg.2015.10.012; Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971; Stevens NR, 2009, J CELL BIOL, V187, P355, DOI 10.1083/jcb.200905031; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Tang CJC, 2011, EMBO J, V30, P4790, DOI 10.1038/emboj.2011.378; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Tsuchiya Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12567; Venoux M, 2013, J CELL SCI, V126, P163, DOI 10.1242/jcs.111203; Vulprecht J, 2012, J CELL SCI, V125, P1353, DOI 10.1242/jcs.104109; Wang WJ, 2015, ELIFE, V4; Wong YL, 2015, SCIENCE, V348, P1155, DOI 10.1126/science.aaa5111	52	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG 15	2017	8								247	10.1038/s41467-017-00305-0				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FD5EN	WOS:000407553800005	28811500	gold			2018-01-05	
J	Zhang, XM; Li, WR; Liu, CX; Peng, XR; Lin, JP; He, SG; Li, XJ; Han, B; Zhang, N; Wu, YS; Chen, L; Wang, LQ; MaYila; Huang, JC; Liu, MJ				Zhang, Xuemei; Li, Wenrong; Liu, Chenxi; Peng, Xinrong; Lin, Jiapeng; He, Sangang; Li, Xuejiao; Han, Bing; Zhang, Ning; Wu, Yangsheng; Chen, Lei; Wang, Liqin; MaYila; Huang, Juncheng; Liu, Mingjun			Alteration of sheep coat color pattern by disruption of ASIP gene via CRISPR Cas9	SCIENTIFIC REPORTS			English	Article							HUMAN SKIN COLORATION; AGOUTI; RECEPTOR; WHITE	Coat color is an important characteristic and economic trait in domestic sheep. Aiming at alteration of Chinese merino sheep coat color by genome manipulation, we disrupted sheep agouti signaling protein gene by CRISPR/Cas9. A total of seven indels were identified in 5 of 6 born lambs. Each targeted lamb happened at least two kinds of modifications, and targeted lambs with multiple modifications displayed variety of coat color patterns. Three lambs with 4 bp deletion showed badgerface with black body coat color in two lambs, and brown coat color with light ventral pigmentation in another one. The black-white spotted color was observed in two lambs with 2 bp deletion. Further analysis unraveled that modifications happened in one or more than two copies of ASIP gene, and moreover, the additional spontaneous mutations of D-9 and/or D-5 preceding the targeting modification could also involve the formation of coat color patterns. Taken together, the entanglement of ASIP modifications by CRISPR/Cas9, spontaneous D-9/D-5 mutations, and ASIP gene duplications contributed to the variety of coat color patterns in targeted lambs.	[Zhang, Xuemei; Li, Wenrong; Liu, Chenxi; Peng, Xinrong; Lin, Jiapeng; He, Sangang; Li, Xuejiao; Han, Bing; Zhang, Ning; Wu, Yangsheng; Chen, Lei; Wang, Liqin; MaYila; Huang, Juncheng; Liu, Mingjun] Minist Agr MOA, Key Lab Anim Biotechnol Xinjiang, Key Lab Genet Breeding & Reprod Grass Feeding Liv, Urumqi 830026, Xinjiang, Peoples R China; [Zhang, Xuemei; Li, Wenrong; Liu, Chenxi; Peng, Xinrong; Lin, Jiapeng; He, Sangang; Li, Xuejiao; Han, Bing; Zhang, Ning; Wu, Yangsheng; Chen, Lei; Wang, Liqin; MaYila; Huang, Juncheng; Liu, Mingjun] Xinjiang Acad Anim Sci, Inst Anim Biotechnol, Urumqi 830026, Xinjiang, Peoples R China	Liu, MJ (reprint author), Minist Agr MOA, Key Lab Anim Biotechnol Xinjiang, Key Lab Genet Breeding & Reprod Grass Feeding Liv, Urumqi 830026, Xinjiang, Peoples R China.; Liu, MJ (reprint author), Xinjiang Acad Anim Sci, Inst Anim Biotechnol, Urumqi 830026, Xinjiang, Peoples R China.	xjlmj@hotmail.com			National Key Program of Animal Breeding by Transgenesis [2016ZX08010-004-009, 2016ZX08008-001]; Youth Science and technology innovation personnel training project of Xinjiang Uygur Autonomous Region [QN2016JQ0153]; Key Laboratory Research Grant of Xinjiang Province [2014KL007]	The authors would like to thank those who assisted in sheep feeding, breeding, lambing and manipulation work. This study was supported by the National Key Program of Animal Breeding by Transgenesis (2016ZX08010-004-009, 2016ZX08008-001), the Youth Science and technology innovation personnel training project of Xinjiang Uygur Autonomous Region (QN2016JQ0153) and the Key Laboratory Research Grant of Xinjiang Province (2014KL007).	Adalsteinsson S, 1970, J AGR RES ICELAND, V23; Armstrong GAB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150188; Carroll L, 2005, PEPTIDES, V26, P1871, DOI 10.1016/j.peptides.2004.12.031; Chaplin G, 2004, AM J PHYS ANTHROPOL, V125, P292, DOI 10.1002/ajpa.10263; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Gratten J, 2010, HEREDITY, V104, P206, DOI 10.1038/hdy.2009.105; Henry BA, 2003, J NEUROENDOCRINOL, V15, P697, DOI 10.1046/j.1365-2826.2003.01049.x; Horrell EMW, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00095; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403                                                          ; Jackson PJ, 2006, CHEM BIOL, V13, P1297, DOI 10.1016/j.chembiol.2006.10.006; Li MH, 2014, HEREDITY, V112, P122, DOI 10.1038/hdy.2013.83; LOOMIS WF, 1967, SCIENCE, V157, P501, DOI 10.1126/science.157.3788.501; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Miller KA, 1997, GENETICS, V146, P1407; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Smit MA, 2002, ANIM GENET, V33, P383, DOI 10.1046/j.1365-2052.2002.00896_5.x; Sponenberg D. P., 1997, GENETICS OF THE DOG, P61; Wang XP, 2015, SCI REP-UK, V5, DOI 10.1038/srep17945; WILSON BD, 1995, HUM MOL GENET, V4, P223, DOI 10.1093/hmg/4.2.223	20	0	0	15	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 15	2017	7								8149	10.1038/s41598-017-08636-0				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FD5KT	WOS:000407570000026	28811591	gold			2018-01-05	
J	Zhu, YX; Shi, CX; Bruins, LA; Jedlowski, P; Wang, XW; Kortum, KM; Luo, ML; Ahmann, JM; Braggio, E; Stewart, AK				Zhu, Yuan Xiao; Shi, Chang-Xin; Bruins, Laura A.; Jedlowski, Patrick; Wang, Xuewei; Kortum, K. Martin; Luo, Moulun; Ahmann, Jonathan M.; Braggio, Esteban; Stewart, A. Keith			Loss of FAM46C Promotes Cell Survival in Myeloma	CANCER RESEARCH			English	Article							UNFOLDED PROTEIN RESPONSE; MULTIPLE-MYELOMA; PANEL (MP)-P-3; AURORA KINASE; B-LYMPHOCYTES; ER STRESS; RNA-SEQ; IDENTIFICATION; SYSTEM; PERK	FAM46C is one of the most recurrently mutated genes in multiple myeloma; however its role in disease pathogenesis has not been determined. Here we demonstrate that wild-type (WT) FAM46C overexpression induces substantial cytotoxicity in multiple myeloma cells. In contrast, FAM46C mutations found in multiple myeloma patients abrogate this cytotoxicity, indicating a survival advantage conferred by the FAM46C mutant phenotype. WT FAM46C overexpression downregulated IRF4, CEBPB, and MYC and upregulated immunoglobulin (Ig) light chain and HSPA5/BIP. Furthermore, pathway analysis suggests that enforced FAM46C expression activated the unfolded protein response pathway and induced mitochondrial dysfunction. CRISPR-mediated depletion of endogenous FAM46C enhanced multiple myeloma cell growth, decreased Ig light chain and HSPA5/BIP expression, activated ERK and antiapoptotic signaling, and conferred relative resistance to dexamethasone and lenalidomide treatments. Genes altered in FAM46C-depleted cells were enriched for signaling pathways regulating estrogen, glucocorticoid, B-cell receptor signaling, and ATM signaling. Together these results implicate FAM46C in myeloma cell growth and survival and identify FAM46C mutation as a contributor to myeloma pathogenesis and disease progression via perturbation in plasma cell differentiation and endoplasmic reticulum homeostasis. (C)2017 AACR.	[Zhu, Yuan Xiao; Shi, Chang-Xin; Bruins, Laura A.; Jedlowski, Patrick; Kortum, K. Martin; Ahmann, Jonathan M.; Braggio, Esteban; Stewart, A. Keith] Mayo Clin Scottsdale, Div Hematol, Scottsdale, AZ USA; [Wang, Xuewei] Mayo Clin Rochester, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Luo, Moulun] Arizona State Univ, Ctr Metab & Vasc Biol, Tempe, AZ USA; [Stewart, A. Keith] Mayo Clin, Ctr Individualized Med, Rochester, MN USA	Stewart, AK (reprint author), Mayo Clin Arizona, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	stewart.keith@mayo.edu			Mayo Clinic; National Institutes of Health [RO1CA183968-01A]; Spore Award [CA186781-02A1P4A]	This work was supported by the Mayo Clinic (to A.K. Stewart), National Institutes of Health (grant no. RO1CA183968-01A to A.K. Stewart), and Spore Award (grant no. CA186781-02A1P4A to A.K. Stewart).	Adzhubei I, 2013, CURR PROTOC HUM GENE, V7, P20, DOI DOI 10.1002/0471142905.HG0720S76; Affer M, 2014, LEUKEMIA, V28, P1725, DOI 10.1038/leu.2014.70; Alcaide M, 2015, APPL ENVIRON MICROB, V81, P2125, DOI 10.1128/AEM.03387-14; Barbieri M, 2016, BRIT J HAEMATOL, V174, P642, DOI 10.1111/bjh.13793; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Boyd KD, 2011, CLIN CANCER RES, V17, P7776, DOI 10.1158/1078-0432.CCR-11-1791; Braggio E, 2009, CANCER RES, V69, P3579, DOI 10.1158/0008-5472.CAN-08-3701; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dutta-Simmons J, 2009, BLOOD, V114, P2699, DOI 10.1182/blood-2008-12-194290; Gass JN, 2008, MOL IMMUNOL, V45, P1035, DOI 10.1016/j.molimm.2007.07.029; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Kalari KR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-224; Kocher JPA, 2014, BIOINFORMATICS, V30, P1920, DOI 10.1093/bioinformatics/btu137; Kortum KM, 2015, ANN HEMATOL, V94, P1205, DOI 10.1007/s00277-015-2344-9; Kortum KM, 2015, BRIT J HAEMATOL, V168, P507, DOI 10.1111/bjh.13171; Kuchta K, 2016, NUCLEIC ACIDS RES, V44, P3534, DOI 10.1093/nar/gkw222; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; Leow CCY, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.1; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin KI, 2000, MOL CELL BIOL, V20, P8684, DOI 10.1128/MCB.20.23.8684-8695.2000; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Ma YJ, 2010, CELL STRESS CHAPERON, V15, P281, DOI 10.1007/s12192-009-0142-9; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pal R, 2009, BLOOD, V114, P3890, DOI 10.1182/blood-2009-01-201111; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Santo L, 2011, CLIN CANCER RES, V17, P3259, DOI 10.1158/1078-0432.CCR-10-3012; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Tiedemann RE, 2010, BLOOD, V115, P1594, DOI 10.1182/blood-2009-09-243980; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walker BA, 2015, J CLIN ONCOL, V33, P3911, DOI 10.1200/JCO.2014.59.1503; Walker BA, 2010, BLOOD, V116, pE56, DOI 10.1182/blood-2010-04-279596; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Zhang QY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00313-6; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	39	0	0	4	4	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	AUG 15	2017	77	16					4317	4327		10.1158/0008-5472.CAN-16-3011				11	Oncology	Oncology	FD6BK	WOS:000407613500011	28619709				2018-01-05	
J	Hou, PP; Wu, C; Wang, YC; Qi, R; Bhavanasi, D; Zuo, ZX; Dos Santos, C; Chen, SL; Chen, Y; Zheng, H; Wang, H; Perl, A; Guo, DY; Huang, J				Hou, Panpan; Wu, Chao; Wang, Yuchen; Qi, Rui; Bhavanasi, Dheeraj; Zuo, Zhixiang; Dos Santos, Cedric; Chen, Shuliang; Chen, Yu; Zheng, Hong; Wang, Hong; Perl, Alexander; Guo, Deyin; Huang, Jian			A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220	CANCER RESEARCH			English	Article							ACUTE MYELOID-LEUKEMIA; SIGNAL-TRANSDUCTION; RISK-STRATIFICATION; KINASE INHIBITORS; TARGETING FLT3; MUTATIONS; AML; DISCOVERY; SPROUTY; CELLS	Acute myeloid leukemia (AML) is a malignant hematopoietic disease and the most common type of acute leukemia in adults. The mechanisms underlying drug resistance in AML are poorly understood. Activating mutations in FMS-like tyrosine kinase 3 (FLT3) are the most common molecular abnormality in AML. Quizartinib (AC220) is a potent and selective second-generation inhibitor of FLT3. It is in clinical trials for the treatment of relapsed or refractory FLT3-ITD-positive and -negative AML patients and as maintenance therapy. To understand the mechanisms of drug resistance to AC220, we undertook an unbiased approach with a novel CRISPR-pooled library to screen new genes whose loss of function confers resistance to AC220. We identified SPRY3, an intracellular inhibitor of FGF signaling, and GSK3, a canonical Wnt signaling antagonist, and demonstrated reactivation of downstream FGF/Ras/ERK and Wnt signaling as major mechanisms of resistance to AC220. We confirmed these findings in primary AML patient samples. Expression of SPRY3 and GSK3A was dramatically reduced in AC220-resistant AML samples, and SPRY3-deleted primary AML cells were resistant to AC220. Intriguingly, expression of SPRY3 was greatly reduced in GSK3 knockout AML cells, which positioned SPRY3 downstream of GSK3 in the resistance pathway. Taken together, our study identified novel genes whose loss of function conferred resistance to a selective FLT3 inhibitor, providing new insight into signaling pathways that contribute to acquired resistance in AML. (C)2017 AACR.	[Hou, Panpan; Chen, Yu; Guo, Deyin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Hou, Panpan; Wu, Chao; Wang, Yuchen; Qi, Rui; Huang, Jian] Temple Univ, Dept Pathol & Lab Med, Lewis Katz Sch Med, Philadelphia, PA 19140 USA; [Wang, Yuchen] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Bhavanasi, Dheeraj; Perl, Alexander] Univ Penn, Sch Med, Dept Med Hematol Oncol, Philadelphia, PA 19104 USA; [Zuo, Zhixiang] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Dos Santos, Cedric] Amgen Inc, Clin Biomarkers Oncol, San Francisco, CA USA; [Chen, Shuliang] Wuhan Univ, Sch Basic Med Sci, Wuhan, Hubei, Peoples R China; [Zheng, Hong] Penn State Univ, Div Hematol Oncol, Penn State Hershey Canc Inst, Coll Med, Hershey, PA USA; [Wang, Hong] Temple Univ, Lewis Katz Sch Med, Ctr Metab Dis Res, Dept Pharmacol, Philadelphia, PA 19140 USA	Huang, J (reprint author), Temple Univ, Lewis Katz Sch Med, 3500 N Broad St,MERB 845B, Philadelphia, PA 19140 USA.	jianh@temple.edu		Guo, Deyin/0000-0002-8297-0814	NHLBI [R00 HL107747-04]; Temple University Lewis Katz School of Medicine	J. Huang has been awarded a grant from the NHLBI (R00 HL107747-04) and seed grant from Temple University Lewis Katz School of Medicine.	Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Engen CBN, 2014, J CLIN MED, V3, P1466, DOI 10.3390/jcm3041466; Estey EH, 2014, AM J HEMATOL, V89, P1063, DOI 10.1002/ajh.23834; Estey EH, 2013, AM J HEMATOL, V88, P317, DOI 10.1002/ajh.23404; Fathi A, 2011, CURR OPIN HEMATOL, V18, P71, DOI 10.1097/MOH.0b013e3283439a03; Fathi AT, 2011, AM J BLOOD RES, V1, P175; Felfly H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02277; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001                                                       ; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Gilliland DG, 2003, BEST PRACT RES CL HA, V16, P409, DOI 10.1053/ybeha.2003.274; Grafone T, 2012, ONCOL REV, V6, P64, DOI 10.4081/oncol.2012.e8; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Holgren C, 2010, ONCOGENE, V29, P5241, DOI 10.1038/onc.2010.264; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang Jingrui, 2010, Genes Cancer, V1, P164, DOI 10.1177/1947601910362446; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Kiyoi H, 2015, NAGOYA J MED SCI, V77, P7; Konig H, 2015, EXPERT OPIN THER TAR, V19, P37, DOI 10.1517/14728222.2014.960843; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Naoe T, 2004, CELL MOL LIFE SCI, V61, P2932, DOI 10.1007/s00018-004-4274-x; Parcells BW, 2006, STEM CELLS, V24, P1174, DOI 10.1634/stemcells.2005-0519; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Perl Alexander E, 2007, Curr Treat Options Oncol, V8, P265, DOI 10.1007/s11864-007-0043-z; Quentmeier H, 2003, LEUKEMIA, V17, P120, DOI 10.1038/sj.leu.2402740; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Scott E, 2010, CURR ONCOL REP, V12, P358, DOI 10.1007/s11912-010-0126-z; Shaffer BC, 2012, DRUG RESIST UPDATE, V15, P62, DOI 10.1016/j.drup.2012.02.001; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Small D, 2008, SEMIN HEMATOL, V45, pS17, DOI 10.1053/j.seminhematol.2008.07.007; Smith CC, 2013, AM SOC CLIN ONCOL ED, V2013, P313, DOI DOI 10.1200/EDB00K; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Sudhindra A, 2014, CURR HEMATOL MALIG R, V9, P174, DOI 10.1007/s11899-014-0203-8; Swords R, 2012, LEUKEMIA, V26, P2176, DOI 10.1038/leu.2012.114; Takahashi S, 2011, J HEMATOL ONCOL, V4, P13; Tickenbrock L, 2005, BLOOD, V105, P3699, DOI 10.1182/blood-2004-07-2924; Traer E, 2016, CANCER RES, V76, P6471, DOI 10.1158/0008-5472.CAN-15-3569; Wander SA, 2014, THER ADV HEMATOL, V5, P65, DOI 10.1177/2040620714532123; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Weisberg E, 2010, MOL CANCER THER, V9, P2468, DOI 10.1158/1535-7163.MCT-10-0232; Weisberg E, 2009, DRUG RESIST UPDATE, V12, P81, DOI 10.1016/j.drup.2009.04.001; Williams AB, 2013, LEUKEMIA, V27, P48, DOI 10.1038/leu.2012.191; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035	54	0	0	12	12	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	AUG 15	2017	77	16					4402	4413		10.1158/0008-5472.CAN-16-1627				12	Oncology	Oncology	FD6BK	WOS:000407613500018	28625976				2018-01-05	
J	Zarei, M; Lal, S; Parker, SJ; Nevler, A; Vaziri-Gohar, A; Dukleska, K; Mambelli-Lisboa, NC; Moffat, C; Blanco, FF; Chand, SN; Jimbo, M; Cozzitorto, JA; Jiang, W; Yeo, CJ; Londin, ER; Seifert, EL; Metallo, CM; Brody, JR; Winter, JM				Zarei, Mahsa; Lal, Shruti; Parker, Seth J.; Nevler, Avinoam; Vaziri-Gohar, Ali; Dukleska, Katerina; Mambelli-Lisboa, Nicole C.; Moffat, Cynthia; Blanco, Fernando F.; Chand, Saswati N.; Jimbo, Masaya; Cozzitorto, Joseph A.; Jiang, Wei; Yeo, Charles J.; Londin, Eric R.; Seifert, Erin L.; Metallo, Christian M.; Brody, Jonathan R.; Winter, Jordan M.			Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer Cells	CANCER RESEARCH			English	Article							DUCTAL ADENOCARCINOMA; OXIDATIVE STRESS; GEMCITABINE; TUMOR; CHEMOTHERAPY; PROTEIN; METABOLISM; GLIOBLASTOMA; DEPENDENCE; INCREASE	Cancer aggressiveness may result from the selective pressure of a harsh nutrient-deprived microenvironment. Here we illustrate how such conditions promote chemotherapy resistance in pancreatic ductal adenocarcinoma (PDAC). Glucose or glutamine withdrawal resulted in a 5- to 10-fold protective effect with chemotherapy treatment. PDAC xenografts were less sensitive to gemcitabine in hypoglycemic mice compared with hyperglycemic mice. Consistent with this observation, patients receiving adjuvant gemcitabine (n = 107) with elevated serum glucose levels (HgbA1C > 6.5%) exhibited improved survival. We identified enhanced antioxidant defense as a driver of chemoresistance in this setting. ROS levels were doubled in vitro by either nutrient withdrawal or gemcitabine treatment, but deprivingPDACcells of nutrients before gemcitabine treatment attenuated this effect. Mechanistic investigations based on RNAi or CRISPR approaches implicated the RNA binding protein HuR in preserving survival under nutrient withdrawal, with or without gemcitabine. Notably, RNA deep sequencing and functional analyses in HuR-deficient PDAC cell lines identified isocitrate dehydrogenase 1 (IDH1) as the sole antioxidant enzyme under HuR regulation. HuR-deficient PDAC cells lacked the ability to engraft successfully in immunocompromised mice, but IDH1 overexpression in these cells was sufficient to fully restore chemoresistance under low nutrient conditions. Overall, our findings highlight the HuRIDH1 regulatory axis as a critical, actionable therapeutic target in pancreatic cancer. (C)2017 AACR.	[Zarei, Mahsa; Lal, Shruti; Nevler, Avinoam; Vaziri-Gohar, Ali; Dukleska, Katerina; Mambelli-Lisboa, Nicole C.; Blanco, Fernando F.; Chand, Saswati N.; Jimbo, Masaya; Cozzitorto, Joseph A.; Yeo, Charles J.; Brody, Jonathan R.; Winter, Jordan M.] Thomas Jefferson Univ, Dept Surg, Div Surg Res, Jefferson Pancreas Biliary & Related Canc Ctr, Philadelphia, PA 19107 USA; [Parker, Seth J.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Moffat, Cynthia; Seifert, Erin L.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, MitoCare Ctr, Philadelphia, PA 19107 USA; [Moffat, Cynthia; Jiang, Wei; Seifert, Erin L.] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA; [Londin, Eric R.] Thomas Jefferson Univ, Computat Med Ctr, Philadelphia, PA 19107 USA; [Metallo, Christian M.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Winter, JM (reprint author), Thomas Jefferson Univ, Jefferson Med Coll, 1015 Walnut St, Philadelphia, PA 19107 USA.	jordan.winter@jefferson.edu		Nevler, Avinoam/0000-0002-5928-0559	American Cancer Society Mentored Research ScholarGrant [14-019-01-CDD]; Gail V. Coleman-Kenneth M. Bruntel Pancreatic Cancer Research Fund	This work was supported by American Cancer Society Mentored Research ScholarGrant-14-019-01-CDD (J.M. Winter) and Gail V. Coleman-Kenneth M. Bruntel Pancreatic Cancer Research Fund (J.M. Winter).	Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4; Ahmad IM, 2005, J BIOL CHEM, V280, P4254, DOI 10.1074/jbc.M411662200; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Benoit RM, 2010, J MOL BIOL, V397, P1231, DOI 10.1016/j.jmb.2010.02.043; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Blanco FF, 2016, ONCOGENE, V35, P2529, DOI 10.1038/onc.2015.325; Brody Jonathan R, 2016, Cancer Biol Ther, P0, DOI 10.1080/15384047.2016.1210743; Burkhart RA, 2013, RNA BIOL, V10, P1312, DOI 10.4161/rna.25274; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Costantino CL, 2009, CANCER RES, V69, P4567, DOI 10.1158/0008-5472.CAN-09-0371; Dong R, 2007, BIOCHEM BIOPH RES CO, V356, P318, DOI 10.1016/j.bbrc.2007.02.145; Florkowski Chris, 2013, Clin Biochem Rev, V34, P75; Grassian AR, 2014, CANCER RES, V74, P3317, DOI 10.1158/0008-5472.CAN-14-0772-T; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Itsumi M, 2015, CELL DEATH DIFFER, V22, P1837, DOI 10.1038/cdd.2015.38; Jiang L, 2016, NATURE, V532, P255, DOI 10.1038/nature17393; Jimbo M, 2015, ONCOTARGET, V6, P27312, DOI 10.18632/oncotarget.4743; Kamphorst JJ, 2015, CANCER RES, V75, P544, DOI 10.1158/0008-5472.CAN-14-2211; Lal S., 2017, MOL CANC RES; Lal S, 2014, CANCER RES, V74, P1128, DOI 10.1158/0008-5472.CAN-13-1915; Mehta M, 2016, ONCOTARGET, V7, P64820, DOI 10.18632/oncotarget.11706; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Morgan G, 2004, CLIN ONCOL-UK, V16, P549, DOI 10.1016/j.clon.2004.06.007; Mukherjee N, 2011, MOL CELL, V43, P327, DOI [10.1016/j.molcel.2011.06.007, 10.1016/j.molce1.2011.06.007]; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pawlik TM, 2007, SURGERY, V141, P610, DOI 10.1016/j.surg.2006.12.013; Peltz C, 2005, ADV EXP MED BIOL, V566, P343; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Reber HAH, 2006, J GASTROINTEST SURG, V10, P1210; Richards NG, 2010, ANN SURG, V252, P499, DOI 10.1097/SLA.0b013e3181f1fd44; Ros P R, 2001, JBR-BTR, V84, P239; SANGEETHA P, 1990, FREE RADICAL BIO MED, V8, P15, DOI 10.1016/0891-5849(90)90139-A; Schroeder T, 2005, CANCER RES, V65, P5163, DOI 10.1158/0008-5472.CAN-04-3900; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332; Sousa CM, 2016, NATURE, V536, P479, DOI 10.1038/nature19084; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Winter JM, 2016, ANN SURG, V263, P793, DOI 10.1097/SLA.0000000000001319	42	0	0	4	4	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	AUG 15	2017	77	16					4460	4471		10.1158/0008-5472.CAN-17-0015				12	Oncology	Oncology	FD6BK	WOS:000407613500023	28652247				2018-01-05	
J	Kono, N; Amin-Wetzel, N; Ron, D				Kono, Nozomu; Amin-Wetzel, Niko; Ron, David			Generic membrane-spanning features endow IRE1 alpha with responsiveness to membrane aberrancy	MOLECULAR BIOLOGY OF THE CELL			English	Article							UNFOLDED-PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; SATURATED FATTY-ACIDS; INDUCED ER STRESS; LIPID SATURATION; TRANSMEMBRANE DOMAINS; CRISPR-CAS9 SYSTEM; REVEALS; IRE1; SENSOR	Altered cellular lipid composition activates the endoplasmic reticulum unfolded protein response (UPR), and UPR signaling effects important changes in lipid metabolism. Secondary effects on protein folding homeostasis likely contribute to UPR activation, but deletion of the unfolded protein stress-sensing luminal domain of the UPR transducers PERK and IRE1 alpha does not abolish their responsiveness to lipid perturbation. This finding suggests that PERK and IRE1a also directly recognize the membrane aberrancy wrought by lipid perturbation. However, beyond the need for a transmembrane domain (TMD), little is known about the features involved. Regulation of the UPR transducers entails changes in their oligomeric state and is easily corrupted by overexpression. We used CRISPR/Cas9-mediated gene editing of the Ern1 locus to study the role of the TMD in the ability of the endogenous IRE1a protein to recognize membrane aberrancy in mammalian cells. Conducted in the background of a point mutation that isolated the response to membrane aberrancy induced by palmitate from unfolded protein stress, our analysis shows that generic membrane-spanning features of the TMD are sufficient for IRE1 alpha's responsiveness to membrane aberrancy. Our data suggest that IRE1 alpha's conserved TMD may have been selected for features imparting a relatively muted response to acyl-chain saturation.	[Kono, Nozomu; Amin-Wetzel, Niko; Ron, David] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Kono, Nozomu] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan	Kono, N; Ron, D (reprint author), Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England.; Kono, N (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan.	nozomu@mol.f.u-tokyo.ac.jp; dr360@medschl.cam.ac.uk			Wellcome Trust [Wellcome 200848/Z/16/Z, Wellcome 100140]; Medical Research Council [MR/K50127X/1]	We thank H. Sharpe (Cambridge Institute for Medical Research) for advice on construction of membrane-spanning mutants and insightful comments on the manuscript; R. Ernst and K. Halbleib (Goethe-University, Frankfurt, Germany) for discussing unpublished experimental observations and providing constructive critiques on the manuscript; R. Schulte and the Cambridge Institute for Medical Research flow cytometry team for assistance; and S. Preissler, C. Rato, and R. Saunders (Cambridge Institute for Medical Research) for advice and comments on the manuscript. This work was supported by grants from the Wellcome Trust (Wellcome 200848/Z/16/Z and strategic award Wellcome 100140) and a Medical Research Council studentship to N.A.-W. (MR/K50127X/1). D.R. is a Wellcome Trust Principal Research Fellow.	Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Avezov E, 2013, J CELL BIOL, V201, P337, DOI 10.1083/jcb.201211155; Bertolotti A, 2000, NAT CELL BIOL, V2, P326; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Covino R, 2016, MOL CELL, V63, P49, DOI 10.1016/j.molcel.2016.05.015; Cox JS, 1997, MOL BIOL CELL, V8, P1805; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cybulski LE, 2010, CURR BIOL, V20, P1539, DOI 10.1016/j.cub.2010.06.074; Deguil J, 2011, TRAFFIC, V12, P349, DOI 10.1111/j.1600-0854.2010.01150.x; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9                                                    ; Halbleib K, 2017, MOL CELL, V67, P1; Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Korennykh AV, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-48; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Le Gall S, 2004, MOL BIOL CELL, V15, P447, DOI 10.1091/mbc.E03-05-0325; Lee AG, 2011, BIOCHEM SOC T, V39, P761, DOI 10.1042/BST0390761; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011                                                          ; Pineau L, 2009, TRAFFIC, V10, P673, DOI 10.1111/j.1600-0854.2009.00903.x; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robblee MM, 2016, CELL REP, V14, P2611, DOI 10.1016/j.celrep.2016.02.053; Ronda C, 2014, BIOTECHNOL BIOENG, V111, P1604, DOI 10.1002/bit.25233; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sekine Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166278; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; SPECTOR AA, 1986, METHOD ENZYMOL, V128, P320; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sundaram A, 2017, ELIFE, V6, DOI 10.7554/eLife.27187; Surma MA, 2013, MOL CELL, V51, P519, DOI 10.1016/j.molcel.2013.06.014; Thibault G, 2012, MOL CELL, V48, P16, DOI 10.1016/j.molcel.2012.08.016; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1                                                   ; Volmer R, 2015, CURR OPIN CELL BIOL, V33, P67, DOI 10.1016/j.ceb.2014.12.002; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	50	0	0	2	2	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	AUG 15	2017	28	17					2318	2332		10.1091/mbc.E17-03-0144				15	Cell Biology	Cell Biology	FE3XQ	WOS:000408149400009	28615323				2018-01-05	
J	Sommerova, L; Ondrouskova, E; Vojtesek, B; Hrstka, R				Sommerova, Lucia; Ondrouskova, Eva; Vojtesek, Borivoj; Hrstka, Roman			Suppression of AGR2 in a TGF-beta-induced Smad regulatory pathway mediates epithelial-mesenchymal transition	BMC CANCER			English	Article						AGR2; EMT; TGF-beta; E-cadherin; Vimentin; Metastasis	PROTEIN ANTERIOR GRADIENT-2; BREAST-CANCER CELLS; PANCREATIC-CANCER; ESTROGEN-RECEPTOR; HUMAN HOMOLOG; GENE XAG-2; PROGRESSION; METASTASIS; PROMOTES; INDUCTION	Background: During cancer progression, epithelial cancer cells can be reprogrammed into mesenchymal-like cells with increased migratory potential through the process of epithelial-mesenchymal transition (EMT), representing an essential step of tumor progression towards metastatic state. AGR2 protein was shown to regulate several cancer-associated processes including cellular proliferation, survival and drug resistance. Methods: The expression of AGR2 was analyzed in cancer cell lines exposed to TGF-beta alone or to combined treatment with TGF-beta and the Erk1/2 inhibitor PD98059 or the TGF-beta receptor specific inhibitor SB431542. The impact of AGR2 silencing by specific siRNAs or CRISPR/Cas9 technology on EMT was investigated by western blot analysis, quantitative PCR, immunofluorescence analysis, real-time invasion assay and adhesion assay. Results: Induction of EMT was associated with decreased AGR2 along with changes in cellular morphology, actin reorganization, inhibition of E-cadherin and induction of the mesenchymal markers vimentin and N-cadherin in various cancer cell lines. Conversely, induction of AGR2 caused reversion of the mesenchymal phenotype back to the epithelial phenotype and re-acquisition of epithelial markers. Activated Smad and Erk signaling cascades were identified as mutually complementary pathways responsible for TGF-beta-mediated inhibition of AGR2. Conclusion: Taken together our results highlight a crucial role for AGR2 in maintaining the epithelial phenotype by preventing the activation of key factors involved in the process of EMT.	[Sommerova, Lucia; Ondrouskova, Eva; Vojtesek, Borivoj; Hrstka, Roman] Masaryk Mem Canc Inst, RECAMO, Zluty Kopec 7, Brno 65653, Czech Republic	Hrstka, R (reprint author), Masaryk Mem Canc Inst, RECAMO, Zluty Kopec 7, Brno 65653, Czech Republic.	hrstka@mou.cz			GACR [13-00956S]; MEYS-NPS [I-LO1413]; MH CZ-DRO (MMCI) [00209805]	The work was supported by GACR 13-00956S, MEYS-NPS I-LO1413 and MH CZ-DRO (MMCI, 00209805). The funding bodies were not involved in study design, data collection, analysis and interpretation of data or writing of the manuscript.	Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5                                                   ; Blanchette F, 2001, J BIOL CHEM, V276, P33986, DOI 10.1074/jbc.M100093200; Boye A, 2015, TUMOR BIOL, V36, P3643, DOI 10.1007/s13277-014-3002-x; Bu H, 2013, FEBS J, V280, P1249, DOI 10.1111/febs.12118; Chanda D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089940; Chevet E, 2013, ONCOGENE, V32, P2499, DOI 10.1038/onc.2012.346; Cormier K, 2014, ANTI-CANCER AGENT ME, V14, P35, DOI 10.2174/18715206113136660333; David JM, 2012, CANCER RES, V72, P2917, DOI 10.1158/0008-5472.CAN-11-3498; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117                                                              ; Dumartin L, 2011, CANCER RES, V71, P7091, DOI 10.1158/0008-5472.CAN-11-1367; Fessart D, 2016, ELIFE, V5, DOI 10.7554/eLife.13887; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; Heerboth S, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0048-3; Higa A, 2011, J BIOL CHEM, V286, P44855, DOI 10.1074/jbc.M111.275529; Hrstka R, 2010, ONCOGENE, V29, P4838, DOI 10.1038/onc.2010.228; Hrstka R, 2016, MOL ONCOL, V10, P652, DOI 10.1016/j.molonc.2015.12.003; Hrstka R, 2013, DIS MARKERS, P207, DOI 10.1155/2013/761537; Hrstka R, 2013, CANCER LETT, V333, P187, DOI 10.1016/j.canlet.2013.01.034; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Jiang YF, 2015, MOL CELL BIOCHEM, V406, P255, DOI 10.1007/s11010-015-2443-x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804                                                            ; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li H, 2013, AM J REPROD IMMUNOL, V70, P8; Li Z., 2015, STEM CELL INVEST, V2, P1; Liu D, 2005, CANCER RES, V65, P3796, DOI 10.1158/0008-5472.CAN-04-3823                                                   ; Liu J, 2014, MOL MED REP, V10, P1089, DOI 10.3892/mmr.2014.2279; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Mizuuchi Y, 2015, LAB INVEST, V95, P193, DOI 10.1038/labinvest.2014.138; Norris AM, 2013, ONCOGENE, V32, P3867, DOI 10.1038/onc.2012.394; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Patel P, 2013, J MOL BIOL, V425, P929, DOI 10.1016/j.jmb.2012.12.009; Persson S, 2005, MOL PHYLOGENET EVOL, V36, P734, DOI 10.1016/j.ympev.2005.04.002; Pohler E, 2004, MOL CELL PROTEOMICS, V3, P534, DOI 10.1074/mcp.M300089-MCP200; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Schroeder BW, 2012, AM J RESP CELL MOL, V47, P178, DOI 10.1165/rcmb.2011-0421OC; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Tsuji T, 2015, CANCER RES, V75, P356, DOI 10.1158/0008-5472.CAN-14-1693; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; Wright TM, 2014, MOL CANCER RES, V12, P1829, DOI 10.1158/1541-7786.MCR-14-0195; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yao DB, 2011, MOL CANCER RES, V9, P1608, DOI 10.1158/1541-7786.MCR-10-0568; Zhang Q, 2009, CANCER CELL, V16, P413, DOI 10.1016/j.ccr.2009.09.029; Zhang X, 2010, J CELL PHYSIOL, V224, P691, DOI 10.1002/jcp.22173; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zweitzig DR, 2007, MOL CELL BIOCHEM, V306, P255, DOI 10.1007/s11010-007-9562-y	51	0	0	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2407			BMC CANCER	BMC Cancer	AUG 15	2017	17								546	10.1186/s12885-017-3537-5				11	Oncology	Oncology	FE2FO	WOS:000408032200001	28810836	gold			2018-01-05	
J	Arikawa, K				Arikawa, Kentaro			The eyes and vision of butterflies	JOURNAL OF PHYSIOLOGY-LONDON			English	Article; Proceedings Paper	Symposium on Phototransduction and Synaptic Transmission at the Phototransduction UK Workshop	AUG 31-SEP 02, 2016	Sheffield, ENGLAND				COLOR-VISION; WAVELENGTH DISCRIMINATION; SPECTRAL SENSITIVITY; PAPILIO-XUTHUS; COMPOUND EYE; PHOTORECEPTOR; RETINA; HETEROGENEITY; CRISPR/CAS9; EVOLUTION	Butterflies use colour vision when searching for flowers. Unlike the trichromatic retinas of humans(blue, green and red cones; plus rods) and honeybees (ultraviolet, blue and green photoreceptors), butterfly retinas typically have six ormore photoreceptor classes with distinct spectral sensitivities. The eyes of the Japanese yellow swallowtail (Papilio xuthus) contain ultraviolet, violet, blue, green, red and broad-band receptors, with each ommatidium housing nine photoreceptor cells in one of three fixed combinations. The Papilio eye is thus a random patchwork of three types of spectrally heterogeneous ommatidia. To determine whether Papilio use all of their receptors to see colours, we measured their ability to discriminate monochromatic lights of slightly different wavelengths. We found that Papilio can detect differences as small as 1-2 nm in threewavelength regions, rivalling human performance. We then used mathematical modelling to infer which photoreceptors are involved in wavelength discrimination. Our simulation indicated that the Papilio vision is tetrachromatic, employing the ultraviolet, blue, green and red receptors. The random array of three ommatidial types is a common feature in butterflies. To address the question of how the spectrally complex eyes of butterflies evolved, we studied their developmental process. We have found that the development of butterfly eyes shares its molecular logic with that of Drosophila: the three-way stochastic expression pattern of the transcription factor Spineless determines the fate of ommatidia, creating the random array in Papilio.	[Arikawa, Kentaro] SOKENDAI Hayama, Kanagawa 2400193, Japan	Arikawa, K (reprint author), SOKENDAI Hayama, Kanagawa 2400193, Japan.	arikawa@soken.ac.jp			Japan Society for the Promotion of Science (JSPS) [26650117, 26251036]; National Agriculture and Food Research Organization (NARO)	This work is supported by research grants to the author from the Japan Society for the Promotion of Science (JSPS; nos 26650117 and 26251036) and from the National Agriculture and Food Research Organization (NARO) under the Cross-ministerial Strategic Innovation Promotion Program (SIP) 'Technologies for creating next generation agriculture, forestry, and fisheries' (not numbered).	Arikawa K, 2003, J COMP PHYSIOL A, V189, P791, DOI 10.1007/s00359-003-0454-7; AUTRUM H, 1964, Z VERGL PHYSIOL, V48, P357, DOI 10.1007/BF00299270                                                              ; Backhaus W. G., 1998, COLOR VISION PERSPEC; BERNARD GD, 1979, SCIENCE, V203, P1125, DOI 10.1126/science.203.4385.1125; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Briscoe AD, 2003, J COMP NEUROL, V458, P334, DOI 10.1002/cne.10582                                                               ; Chen Lei, 2016, [Zoological Research, 动物学研究], V37, P220, DOI 10.13918/j.issn.2095-8137.2016.4.220; Chen PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062240; Chen P-J, 2016, FRONT ECOL EVOL, V4, P1, DOI DOI 10.3389/FEV0.2016.00018); Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; de Ibarra NH, 2014, J COMP PHYSIOL A, V200, P411, DOI 10.1007/s00359-014-0915-1; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DEVALOIS RL, 1968, SCIENCE, V162, P533, DOI 10.1126/science.162.3853.533                                                    ; EGUCHI E, 1984, J INSECT PHYSIOL, V30, P607, DOI 10.1016/0022-1910(84)90044-1                                                    ; EMMERTON J, 1980, J COMP PHYSIOL, V141, P47, DOI 10.1007/BF00611877                                                              ; Friedrich M, 2011, J EXP ZOOL PART B, V316B, P484, DOI 10.1002/jez.b.21424; GOLDSMITH TH, 1981, J COMP PHYSIOL, V143, P103, DOI 10.1007/BF00606073                                                              ; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Telles FJ, 2014, J COMP PHYSIOL A, V200, P537, DOI 10.1007/s00359-014-0888-0; Kawasaki M, 2015, J COMP PHYSIOL A, V201, P1115, DOI 10.1007/s00359-015-1039-y; Kelber A, 1999, NATURWISSENSCHAFTEN, V86, P221, DOI 10.1007/s001140050601                                                           ; Kelber A, 1999, J EXP BIOL, V202, P2619; Kelber A, 2006, INVERTEBRATE VISION, P250; Kinoshita M, 2014, J COMP PHYSIOL A, V200, P513, DOI 10.1007/s00359-014-0903-5; Koshitaka H, 2008, P R SOC B, V275, P947, DOI 10.1098/rspb.2007.1614; Li XY, 2017, INSECT SCI, V24, P708, DOI 10.1111/1744-7917.12421; Li Xueyan, 2015, Nature Communications, V9, P8212; Markert MJ, 2016, G3-GENES GENOM GENET, V6, P905, DOI 10.1534/g3.116.027029; Marshall Justin, 2014, Curr Biol, V24, pR1150, DOI 10.1016/j.cub.2014.10.025; MATIC T, 1983, J COMP PHYSIOL, V152, P169, DOI 10.1007/BF00611182                                                              ; McCulloch KJ, 2016, J EXP BIOL, V219, P2377, DOI 10.1242/jeb.136523; Menzel R., 1989, P281; NEUMEYER C, 1986, J COMP PHYSIOL A, V158, P203, DOI 10.1007/BF01338563                                                              ; Ogawa Y, 2013, J EXP BIOL, V216, P1916, DOI 10.1242/jeb.083485; Perry M, 2016, NATURE, V535, P280, DOI 10.1038/nature18616; Stavenga DG, 2017, J COMP PHYSIOL A, V203, P23, DOI 10.1007/s00359-016-1131-y; Stavenga DG, 2002, J EXP BIOL, V205, P1077; Stavenga DG, 2001, NATURWISSENSCHAFTEN, V88, P477, DOI 10.1007/s001140100268; Stewart FJ, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0687; SWIHART SL, 1971, NATURE, V231, P126, DOI 10.1038/231126a0; Takemura SY, 2005, J COMP NEUROL, V483, P341, DOI 10.1002/cne.20446; Von Helverson O., 1972, Journal Comp Physiol, V80, P439; von Frisch K, 1914, ZOOLOGISCHE JB, V35, P1; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302                                                          ; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; WHITE RH, 1983, J COMP PHYSIOL, V153, P59, DOI 10.1007/BF00610343                                                              ; WRIGHT AA, 1972, VISION RES, V12, P1447, DOI 10.1016/0042-6989(72)90171-X; Zaccardi G, 2006, J EXP BIOL, V209, P1944, DOI 10.1242/jeb.02207	49	1	1	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751	1469-7793		J PHYSIOL-LONDON	J. Physiol.-London	AUG 15	2017	595	16					5457	5464		10.1113/JP273917				8	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	FD5UX	WOS:000407596400011	28332207				2018-01-05	
J	Heaton, BE; Kennedy, EM; Dumm, RE; Harding, AT; Sacco, MT; Sachs, D; Heaton, NS				Heaton, Brook E.; Kennedy, Edward M.; Dumm, Rebekah E.; Harding, Alfred T.; Sacco, Matthew T.; Sachs, David; Heaton, Nicholas S.			A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor	CELL REPORTS			English	Article							RECEPTOR-BINDING; PROTEIN; ENDOCYTOSIS; EXPRESSION; HEMAGGLUTININ; INFECTIONS; EVOLUTION; PATHOLOGY; B4GALNT2; COMPLEX	Influenza A virus (IAV) is a pathogen that poses significant risks to human health. It is therefore critical to develop strategies to prevent influenza disease. Many loss-of-function screens have been performed to identify the host proteins required for viral infection. However, there has been no systematic screen to identify the host factors that, when overexpressed, are sufficient to prevent infection. In this study, we used CRISPR/dCas9 activation technology to perform a genome-wide overexpression screen to identify IAV restriction factors. The major hit from our screen, B4GALNT2, showed inhibitory activity against influenza viruses with an alpha 2,3-linked sialic acid receptor preference. B4GALNT2 overexpression prevented the infection of every avian influenza virus strain tested, including the H5, H9, and H7 subtypes, which have previously caused disease in humans. Thus, we have used CRISPR/dCas9 activation technology to identify a factor that can abolish infection by avian influenza viruses.	[Heaton, Brook E.; Kennedy, Edward M.; Dumm, Rebekah E.; Harding, Alfred T.; Sacco, Matthew T.; Heaton, Nicholas S.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Sachs, David] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	Heaton, NS (reprint author), Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	nicholas.heaton@duke.edu			NIH [1K22AI116509, T32-CA009111, T32-GM007184-41]; Duke School of Medicine	We acknowledge assistance from Mike Cook and the Duke Cancer Institute Flow Cytometry Core, as well as assistance with pilot experiments from Dina Alzhanova. We thank Gregory Gray, Benjamin Anderson, and members of the Duke One Health Laboratory for the low-passage avian influenza strains and their support performing those experiments. We also acknowledge Bryan Cullen and Hal Bogerd for helpful discussions and reagents and Biswa Choudhury at the Glycotechnology Core Resource at the University of California, San Diego for performing the glycan analysis. The graphical abstract was designed by Griffin Haas. N.S.H. is a member of the Duke Cancer Institute. N.S.H. is partially supported by NIH 1K22AI116509 and the Duke School of Medicine Whitehead Scholarship. A.H. is supported by NIH training grant T32-CA009111. R.E.D. is supported by NIH training grant T32-GM007184-41.	Bogerd HP, 2015, P NATL ACAD SCI USA, V112, pE7249, DOI 10.1073/pnas.1516305112; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Capua I, 2006, EMERG INFECT DIS, V12, P1319, DOI 10.3201/eid1209.060430                                                          ; Chou Yu-Chi, 2015, J Clin Bioinforma, V5, P2, DOI 10.1186/s13336-015-0017-5; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; Dall'Olio F, 2014, BBA-GEN SUBJECTS, V1840, P443, DOI 10.1016/j.bbagen.2013.09.036; de Vries E, 2012, P NATL ACAD SCI USA, V109, P7457, DOI 10.1073/pnas.1200987109; Denison C, 1998, CHEM BIOL, V5, pR129, DOI 10.1016/S1074-5521(98)90167-3                                                   ; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gambaryan AS, 1999, VIROLOGY, V258, P232, DOI 10.1006/viro.1999.9732; Hamilton JR, 2016, P NATL ACAD SCI USA, V113, P3861, DOI 10.1073/pnas.1522376113; Harding AT, 2017, MBIO, V8, DOI 10.1128/mBio.00669-17; Heaton NS, 2014, J EXP MED, V211, P1707, DOI 10.1084/jem.20140488; Heaton NS, 2013, J VIROL, V87, P8272, DOI 10.1128/JVI.00969-13; Kimura T, 2006, J BIOL CHEM, V281, P10598, DOI 10.1074/jbc.M510531200; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lakadamyali M, 2004, MICROBES INFECT, V6, P929, DOI 10.1016/j.micinf.2004.05.002; Meng B, 2010, INFLUENZA OTHER RESP, V4, P147, DOI 10.1111/j.1750-2659.2010.00130.x; Montiel MD, 2003, BIOCHEM J, V373, P369, DOI 10.1042/BJ20021892; Morens D. M., 2013, MBIO, V4, P1; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; PAVLOVIC J, 1990, J VIROL, V64, P3370; Ramage H, 2015, ANNU REV VIROL, V2, P497, DOI 10.1146/annurev-virology-100114-055238; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Sandri C, 2012, CELL RES, V22, P1479, DOI 10.1038/cr.2012.110; Schimmoller F, 1998, GENE, V216, P311, DOI 10.1016/S0378-1119(98)00349-7; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Shaw M. L., 2013, FIELDS VIROLOGY, P1151; Stencel-Baerenwald JE, 2014, NAT REV MICROBIOL, V12, P739, DOI 10.1038/nrmicro3346; Stertz S, 2011, MICROBES INFECT, V13, P516, DOI 10.1016/j.micinf.2011.01.012; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI [10.1146/annurev.pathmechdis.3.121806.154316, 10.1146/annurev.pathol.3.121806.154316]; Thomas PJ, 2016, AM J PATHOL, V186, P2429, DOI 10.1016/j.ajpath.2016.05.021; van Duyne GD, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0014-2014; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Wilks S, 2012, VACCINE, V30, P4369, DOI 10.1016/j.vaccine.2012.02.076; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; Yoon SW, 2014, CURR TOP MICROBIOL, V385, P359, DOI 10.1007/82_2014_396	43	0	0	4	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	AUG 15	2017	20	7					1503	1512		10.1016/j.celrep.2017.07.060				10	Cell Biology	Cell Biology	FE0QH	WOS:000407924300001	28813663	gold			2018-01-05	
J	Guillaumot, D; Lopez-Obando, M; Baudry, K; Avon, A; Rigaill, G; de Longevialle, AF; Broche, B; Takenaka, M; Berthome, R; De Jaeger, G; Delannoy, E; Lurin, C				Guillaumot, Damien; Lopez-Obando, Mauricio; Baudry, Kevin; Avon, Alexandra; Rigaill, Guillem; de Longevialle, Andeol Falcon; Broche, Benjamin; Takenaka, Mizuki; Berthome, Richard; De Jaeger, Geert; Delannoy, Etienne; Lurin, Claire			Two interacting PPR proteins are major Arabidopsis editing factors in plastid and mitochondria	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						RNA editing; organelles; pentatricopeptide repeat	PENTATRICOPEPTIDE REPEAT PROTEINS; TANDEM AFFINITY PURIFICATION; MOTIF-CONTAINING PROTEIN; RNA RECOGNITION; PLANT ORGANELLES; STRUCTURAL BASIS; THALIANA; COMPLEXES; IDENTIFICATION; BIOGENESIS	RNA editing is converting hundreds of cytosines into uridines during organelle gene expression of land plants. The pentatricopeptide repeat (PPR) proteins are at the core of this posttranscriptional RNA modification. Even if a PPR protein defines the editing site, a DYW domain of the same or another PPR protein is believed to catalyze the deamination. To give insight into the organelle RNA editosome, we performed tandem affinity purification of the plastidial CHLOROPLAST BIOGENESIS 19 (CLB19) PPR editing factor. Two PPR proteins, dually targeted to mitochondria and chloroplasts, were identified as potential partners of CLB19. These two proteins, a P-type PPR and a member of a small PPR-DYW subfamily, were shown to interact in yeast. Insertional mutations resulted in embryo lethality that could be rescued by embryo-specific complementation. A transcriptome analysis of these complemented plants showed major editing defects in both organelles with a very high PPR type specificity, indicating that the two proteins are core members of E+-type PPR editosomes.	[Guillaumot, Damien; Lopez-Obando, Mauricio; Baudry, Kevin; Avon, Alexandra; Rigaill, Guillem; de Longevialle, Andeol Falcon; Broche, Benjamin; Berthome, Richard; Delannoy, Etienne; Lurin, Claire] Univ Paris Saclay, Univ Evry, Univ Paris Sud, INRA,CNRS,Inst Plant Sci Paris Saclay IPS2, F-91405 Orsay, France; [Guillaumot, Damien; Lopez-Obando, Mauricio; Baudry, Kevin; Avon, Alexandra; Rigaill, Guillem; de Longevialle, Andeol Falcon; Broche, Benjamin; Berthome, Richard; Delannoy, Etienne; Lurin, Claire] Paris Diderot, Sorbonne Paris Cite, Inst Plant Sci Paris Saclay IPS2, F-91405 Orsay, France; [Rigaill, Guillem] Univ Evry, Lab Math & Modelisat LaMME, F-91000 Evry, France; [Takenaka, Mizuki] Univ Ulm, Mol Bot, D-89069 Ulm, Germany; [De Jaeger, Geert] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [De Jaeger, Geert] VIB Ctr Plant Syst Biol, B-9052 Ghent, Belgium; [Lopez-Obando, Mauricio] Swedish Univ Agr Sci, Dept Plant Biol, Linnean Ctr Plant Biol Uppsala, SE-75007 Uppsala, Sweden; [de Longevialle, Andeol Falcon] GENOPOLE, Lab Plant Proc Innovat, F-91000 Evry, France; [Berthome, Richard] Univ Toulouse, LIPM, INRA, CNRS, F-31326 Castanet Tolosan, France	Lurin, C (reprint author), Univ Paris Saclay, Univ Evry, Univ Paris Sud, INRA,CNRS,Inst Plant Sci Paris Saclay IPS2, F-91405 Orsay, France.; Lurin, C (reprint author), Paris Diderot, Sorbonne Paris Cite, Inst Plant Sci Paris Saclay IPS2, F-91405 Orsay, France.	claire.lurin@inra.fr	Delannoy, Etienne/E-5077-2011	Delannoy, Etienne/0000-0002-0866-2063; Lopez-Obando, Mauricio/0000-0002-1380-0643	Ministere de la Recherche et de l'Enseignement Superieur; Labex Saclay Plant Sciences-SPS postdoctoral fellowship; DFG; Labex Saclay Plant Sciences-SPS [ANR-10-LABX-0040-SPS]	M.L.-O. and K.B.'s research was supported by French PhD fellowships from "Ministere de la Recherche et de l'Enseignement Superieur." D.G.'s research was supported by a Labex Saclay Plant Sciences-SPS postdoctoral fellowship. M.T. is a Heisenberg fellow, and his work is supported by grants from the DFG. The IPS2 benefits from the support of the Labex Saclay Plant Sciences-SPS (Grant ANR-10-LABX-0040-SPS).	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335                                                       ; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Andres-Colas N, 2017, P NATL ACAD SCI USA, V114, P8883, DOI 10.1073/pnas.1705815114; Arenas A, 2013, FEBS LETT, V587, P887, DOI 10.1016/j.febslet.2013.02.009; Aryamanesh N, 2017, PLANT PHYSIOL, V173, P1164, DOI 10.1104/pp.16.01840; AUGER IE, 1989, B MATH BIOL, V51, P39, DOI 10.1007/BF02458835; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Baudry JP, 2012, STAT COMPUT, V22, P455, DOI 10.1007/s11222-011-9236-1; Bayer-Csaszar E, 2017, BBA-GENE REGUL MECH, V1860, P813, DOI 10.1016/j.bbagrm.2017.05.004; Benjamini Y, 2001, ANN STAT, V29, P1165; Bentolila S, 2013, PLOS GENET; Bentolila S, 2013, RNA BIOL, V10, P1520, DOI 10.4161/rna.25297; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Blanc V, 2010, WIRES SYST BIOL MED, V2, P594, DOI 10.1002/wsbm.82; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boussardon C, 2014, NEW PHYTOL, V203, P1090, DOI 10.1111/nph.12928; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Brehme N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140680; Bryant N, 2011, PLANT PHYSIOL, V155, P1678, DOI 10.1104/pp.110.168120; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Castandet B, 2016, G3-GENES GENOM GENET, V6, P2817, DOI 10.1534/g3.116.030783; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chateigner-Boutin AL, 2010, RNA BIOL, V7, P213, DOI 10.4161/rna.7.2.11343                                                           ; Cheng SF, 2016, PLANT J, V85, P532, DOI 10.1111/tpj.13121; Cleynen A, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-6; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colcombet J, 2013, RNA BIOL, V10, P1557, DOI 10.4161/rna.26128; Dahan J, 2014, PLANT PHYSIOL, V166, P1788, DOI 10.1104/pp.114.248526; Delannoy E, 2007, BIOCHEM SOC T, V35, P1643, DOI 10.1042/BST0351643; Ding YH, 2006, PLANT CELL, V18, P815, DOI 10.1105/tpc.105.039495; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330                                                                 ; Goringer HU, 2012, ANNU REV MICROBIOL, V66, P65, DOI 10.1146/annurev-micro-092611-150150; Hartel B, 2013, RNA BIOL, V10, P1543, DOI 10.4161/rna.25484; He S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006553; Hu ZB, 2016, PLANT CELL, V28, P2276, DOI 10.1105/tpc.16.00540; Huang S, 2009, PLANT PHYSIOL, V149, P719, DOI 10.1104/pp.108.131300; Ichinose M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010005; Ito J, 2006, J PROTEOME RES, V5, P3459, DOI 10.1021/pr060403j; James P, 1996, GENETICS, V144, P1425; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Ke JY, 2013, NAT STRUCT MOL BIOL, V20, P1377, DOI 10.1038/nsmb.2710; Kleine T, 2016, BBA-BIOENERGETICS, V1857, P1313, DOI 10.1016/j.bbabio.2016.03.017; Klodmann J, 2011, PLANT PHYSIOL, V157, P587, DOI 10.1104/pp.111.182352; Kupsch C, 2012, PLANT CELL, V24, P4266, DOI 10.1105/tpc.112.103002; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leu KC, 2016, RNA BIOL, V13, P593, DOI 10.1080/15476286.2016.1184384; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Majeran W, 2012, PLANT PHYSIOL, V158, P156, DOI 10.1104/pp.111.188474; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Olinares PDB, 2010, MOL CELL PROTEOMICS, V9, P1594, DOI 10.1074/mcp.M000038-MCP201; Rigaill G, 2016, BRIEF BIOINFORM, DOI [10.1093/bib/bbw092, DOI 10.1093/BIB/BBW092]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rudinger M, 2012, J MOL EVOL, V74, P37, DOI 10.1007/s00239-012-9486-3; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Shi XW, 2016, PLANT PHYSIOL, V170, P294, DOI 10.1104/pp.15.01280; Shi XW, 2015, NUCLEIC ACIDS RES, V43, P3814, DOI 10.1093/nar/gkv245; Shikanai T, 2006, CELL MOL LIFE SCI, V63, P698, DOI 10.1007/s00018-005-5449-9; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun T, 2016, TRENDS PLANT SCI, V21, P962, DOI 10.1016/j.tplants.2016.07.005; Sun T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005028; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Tanz SK, 2013, NUCLEIC ACIDS RES, V41, pD1185, DOI 10.1093/nar/gks1151; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Van Leene J, 2008, TRENDS PLANT SCI, V13, P517, DOI 10.1016/j.tplants.2008.08.002; Van Leene J, 2007, MOL CELL PROTEOMICS, V6, P1226, DOI 10.1074/mcp.M700078-MCP200; Van Leene J, 2011, METHODS MOL BIOL, V754, P195, DOI 10.1007/978-1-61779-154-3_11; Van Leene J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.53; Verbitskiy D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397992; Wagoner JA, 2015, J BIOL CHEM, V290, P2957, DOI 10.1074/jbc.M114.622084; Weissenberger S, 2017, PLANT MOL BIOL, V93, P355, DOI 10.1007/s11103-016-0566-4; Xie TT, 2016, J EXP BOT, V67, P5687, DOI 10.1093/jxb/erw331; Xiu ZH, 2016, PLANT J, V85, P507, DOI 10.1111/tpj.13122; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; Zmudjak M, 2013, NEW PHYTOL, V199, P379, DOI 10.1111/nph.12282; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	83	2	2	16	16	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	AUG 15	2017	114	33					8877	8882		10.1073/pnas.1705780114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FD6AG	WOS:000407610400078	28760958				2018-01-05	
J	Hosur, V; Low, BE; Shultz, LD; Wiles, MV				Hosur, Vishnu; Low, Benjamin E.; Shultz, Leonard D.; Wiles, Michael V.			Genetic deletion of amphiregulin restores the normal skin phenotype in a mouse model of the human skin disease tylosis	BIOLOGY OPEN			English	Article						CRISPR/Cas9; EGFR; RHBDF2; Amphiregulin; Tylosis	PALMOPLANTAR KERATODERMA; RHBDF2 MUTATIONS	In humans, gain-of-function (GOF) mutations in RHBDF2 cause the skin disease tylosis. We generated a mouse model of human tylosis and show that GOF mutations in RHBDF2 cause tylosis by enhancing the amount of amphiregulin (AREG) secretion. Furthermore, we show that genetic disruption of AREG ameliorates skin pathology in mice carrying the human tylosis disease mutation. Collectively, our data suggest that RHBDF2 plays a critical role in regulating EGFR signaling and its downstream events, including development of tylosis, by facilitating enhanced secretion of AREG. Thus, targeting AREG could have therapeutic benefit in the treatment of tylosis.	[Hosur, Vishnu; Low, Benjamin E.; Shultz, Leonard D.; Wiles, Michael V.] Jackson Lab, Bar Harbor, ME 04609 USA	Hosur, V (reprint author), Jackson Lab, Bar Harbor, ME 04609 USA.	vishnu.hosur@jax.org			National Institutes of Health [CA034196, R21 OD023800-01]	This work was supported by the National Institutes of Health (CA034196 and R21 OD023800-01 to M.V.W.).	Almeida Jonas S, 2012, J Pathol Inform, V3, P25, DOI 10.4103/2153-3539.98813; Blaydon DC, 2012, AM J HUM GENET, V90, P340, DOI 10.1016/j.ajhg.2011.12.008; Brooke MA, 2014, HUM MOL GENET, V23, P4064, DOI 10.1093/hmg/ddu120; Field EA, 1997, ORAL ONCOL, V33B, P55, DOI 10.1016/S0964-1955(96)00052-8                                                   ; HENNIES HC, 1995, GENOMICS, V29, P537, DOI 10.1006/geno.1995.9971                                                          ; Hosur V, 2014, P NATL ACAD SCI USA, V111, pE2200, DOI 10.1073/pnas.1323908111; Johnson KR, 2003, GENOMICS, V81, P6, DOI 10.1016/S0888-7543(02)00013-7; Saarinen S, 2012, FAM CANCER, V11, P525, DOI 10.1007/s10689-012-9532-8; Siggs OM, 2014, BIOL OPEN, V3, P1151, DOI 10.1242/bio.201410116; Stevens HP, 1996, ARCH DERMATOL, V132, P640, DOI 10.1001/archderm.132.6.640	10	0	0	1	1	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	2046-6390			BIOL OPEN	Biol. Open	AUG 15	2017	6	8					1174	1179		10.1242/bio.026260				6	Biology	Life Sciences & Biomedicine - Other Topics	FD6ZS	WOS:000407677000007	28655741	gold			2018-01-05	
J	Servetnick, MD; Steinworth, B; Babonis, LS; Simmons, D; Salinas-Saavedra, M; Martindale, MQ				Servetnick, Marc D.; Steinworth, Bailey; Babonis, Leslie S.; Simmons, David; Salinas-Saavedra, Miguel; Martindale, Mark Q.			Cas9-mediated excision of Nematostella brachyury disrupts endoderm development, pharynx formation and oral-aboral patterning	DEVELOPMENT			English	Article						Nematostella; Cnidarian; Brachyury; Mesoderm; Endoderm; Pharynx	EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR BRACHYURY; NUCLEAR BETA-CATENIN; STARLET SEA-ANEMONE; GERM-LAYER; ANTHOZOAN CNIDARIAN; MESODERM FORMATION; ASCIDIAN EMBRYOS; VECTENSIS OCCURS; GENE-EXPRESSION	The mesoderm is a key novelty in animal evolution, although we understand little of how the mesoderm arose. brachyury, the founding member of the T-box gene family, is a key gene in chordate mesoderm development. However, the brachyury gene was present in the common ancestor of fungi and animals long before mesoderm appeared. To explore ancestral roles of brachyury prior to the evolution of definitive mesoderm, we excised the gene using CRISPR/Cas9 in the diploblastic cnidarian Nematostella vectensis. Nvbrachyury is normally expressed in precursors of the pharynx, which separates endoderm from ectoderm. In knockout embryos, the pharynx does not form, embryos fail to elongate, and endoderm organization, ectodermal cell polarity and patterning along the oral-aboral axis are disrupted. Expression of many genes both inside and outside the Nvbrachyury expression domain is affected, including downregulation of Wnt genes at the oral pole. Our results point to an ancient role for brachyury in morphogenesis, cell polarity and the patterning of both ectodermal and endodermal derivatives along the primary body axis.	[Servetnick, Marc D.] Univ Washington Bothell, Div Biol Sci, Bothell, WA 98011 USA; [Steinworth, Bailey; Babonis, Leslie S.; Simmons, David; Salinas-Saavedra, Miguel; Martindale, Mark Q.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL 32080 USA	Servetnick, MD (reprint author), Univ Washington Bothell, Div Biol Sci, Bothell, WA 98011 USA.	mds56@uw.edu		Servetnick, Marc/0000-0003-2130-1892	National Institutes of Health [GM093116]; National Science Foundation [IOS06-42273]; National Aeronautics and Space Administration [NNX14AG70G]; University of Washington	M.Q.M. thanks the National Institutes of Health (GM093116), the National Science Foundation (IOS06-42273) and the National Aeronautics and Space Administration (NNX14AG70G) for supporting this project. M.D.S. thanks the University of Washington for funding a sabbatical visit to M.Q.M.'s lab. Deposited in PMC for immediate release.	ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Babonis LS, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0683-3; Bielen H, 2007, DEVELOPMENT, V134, P4187, DOI 10.1242/dev.010173; Chen JY, 2002, DEV BIOL, V248, P182, DOI 10.1006/dbio.2002.0714; Chesley P, 1935, J EXP ZOOL, V70, P429, DOI 10.1002/jez.1400700306; Chiba S, 2009, DEVELOPMENT, V136, P35, DOI 10.1242/dev.030981; CUNLIFFE V, 1992, NATURE, V358, P427, DOI 10.1038/358427a0; Dal-Pra S, 2011, DEV BIOL, V350, P484, DOI 10.1016/j.ydbio.2010.12.018; Darras S, 2011, DEVELOPMENT, V138, P959, DOI 10.1242/dev.059493; Du R, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0105-6; Dunn CW, 2014, ANNU REV ECOL EVOL S, V45, P371, DOI 10.1146/annurev-ecolsys-120213-091627; Fernando RI, 2010, J CLIN INVEST, V120, P533, DOI 10.1172/JCI38379; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Fritzenwanker JH, 2004, DEV BIOL, V275, P389, DOI 10.1016/j.ydbio.2004.08.014; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gentsch GE, 2013, CELL REP, V4, P1185, DOI 10.1016/j.celrep.2013.08.012; Hayward DC, 2015, DEV BIOL, V399, P337, DOI 10.1016/j.ydbio.2015.01.006; Helm RR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-266; Henry JQ, 2000, DEV BIOL, V220, P285, DOI 10.1006/dbio.2000.9628; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hudson C, 2016, ELIFE, V5, DOI 10.7554/eLife.14692; Hudson C, 2013, CURR BIOL, V23, P491, DOI 10.1016/j.cub.2013.02.005; Ikmi A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6486; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kimelman D, 2000, CURR OPIN GENET DEV, V10, P350, DOI 10.1016/S0959-437X(00)00095-2                                                   ; Kraus Y, 2006, DEV GENES EVOL, V216, P119, DOI 10.1007/s00427-005-0038-3; Kraus Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11694; Layden MJ, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0282-1; Layden MJ, 2013, NAT PROTOC, V8, P924, DOI 10.1038/nprot.2013.009; Layden MJ, 2012, DEVELOPMENT, V139, P1013, DOI 10.1242/dev.073221; Leclere L, 2016, DEVELOPMENT, V143, P1766, DOI 10.1242/dev.120931; Lee PN, 2007, DEV BIOL, V310, P169, DOI 10.1016/j.ydbio.2007.05.040; Logan CY, 1999, DEVELOPMENT, V126, P345; Magie CR, 2007, DEV BIOL, V305, P483, DOI 10.1016/j.ydbio.2007.02.044; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; Martindale MQ, 2009, DEV CELL, V17, P162, DOI 10.1016/j.devcel.2009.07.024; Martindale MQ, 1999, DEV BIOL, V214, P243, DOI 10.1006/dbio.1999.9427                                                          ; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; Matus DQ, 2007, DEV GENES EVOL, V217, P137, DOI 10.1007/s00427-006-0122-3; Matus DQ, 2006, CURR BIOL, V16, P499, DOI 10.1016/j.cub.2006.01.052; McCauley BS, 2015, DEVELOPMENT, V142, P207, DOI 10.1242/dev.113043; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; OREILLY MAJ, 1995, DEVELOPMENT, V121, P1351; Palena C, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju054; Papaioannou VE, 2014, DEVELOPMENT, V141, P3819, DOI 10.1242/dev.104471; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Peres R, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-26; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Pinto F, 2014, CLIN CANCER RES, V20, P4949, DOI 10.1158/1078-0432.CCR-14-0421; Rentzsch F, 2008, DEVELOPMENT, V135, P1761, DOI 10.1242/dev.020784; Rentzsch F, 2016, CURR OPIN GENET DEV, V39, P63, DOI 10.1016/j.gde.2016.05.024; Rodaway A, 2001, CELL, V105, P169, DOI 10.1016/S0092-8674(01)00307-5; Rottinger E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003164; Roselli M, 2012, CLIN CANCER RES, V18, P3868, DOI 10.1158/1078-0432.CCR-11-3211; Saina M, 2009, P NATL ACAD SCI USA, V106, P18592, DOI 10.1073/pnas.0900151106; Salinas-Saavedra M, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0014-6; Satoh N, 2012, EVOL DEV, V14, P56, DOI 10.1111/j.1525-142X.2011.00522.x; Schneider SQ, 2013, CURR BIOL, V23, pR313, DOI 10.1016/j.cub.2013.03.011; Scholz CB, 2003, DEV GENES EVOL, V212, P563, DOI 10.1007/s00427-002-0272-x; Sebe-Pedros A, 2016, CELL, V165, P1224, DOI 10.1016/j.cell.2016.03.034; Sebe-Pedros A, 2013, P NATL ACAD SCI USA, V110, P16050, DOI 10.1073/pnas.1309748110; Sethi AJ, 2012, SCIENCE, V335, P590, DOI 10.1126/science.1212867; Shimauchi Y, 2001, INT J DEV BIOL, V45, P643; Shimoda M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-377; Singer JB, 1996, DEVELOPMENT, V122, P3707; Sinigaglia C, 2015, DEV BIOL, V398, P120, DOI 10.1016/j.ydbio.2014.11.019; Sinigaglia C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001488; Steinmetz PRH, 2012, NATURE, V487, P231, DOI 10.1038/nature11180; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Sun SR, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0076-4; Tamulonis C, 2011, DEV BIOL, V351, P217, DOI 10.1016/j.ydbio.2010.10.017; Technau U, 2001, BIOESSAYS, V23, P788, DOI 10.1002/bies.1114; Technau U, 2011, DEVELOPMENT, V138, P1447, DOI 10.1242/dev.048959; Tulin S, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-16; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Wijesena N, 2017, P NATL ACAD SCI USA, V114, pE5608, DOI 10.1073/pnas.1701607114; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; WILSON V, 1995, DEVELOPMENT, V121, P877; Wolenski FS, 2013, NAT PROTOC, V8, P900, DOI 10.1038/nprot.2013.014; Yamada A, 2010, DEV BIOL, V339, P212, DOI 10.1016/j.ydbio.2009.12.019; Yasuoka Y, 2016, CURR BIOL, V26, P2885, DOI 10.1016/j.cub.2016.08.011; Zenkert C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022725	83	0	0	10	10	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	AUG 15	2017	144	16					2951	2960		10.1242/dev.145839				10	Developmental Biology	Developmental Biology	FD5JR	WOS:000407567200010	28705897	gold			2018-01-05	
J	Imperatore, F; Maurizio, J; Aguilar, SV; Busch, CJ; Favret, J; Kowenz-Leutz, E; Cathou, W; Gentek, R; Perrin, P; Leutz, A; Berruyer, C; Sieweke, MH				Imperatore, Francesco; Maurizio, Julien; Aguilar, Stephanie Vargas; Busch, Clara J.; Favret, Jeremy; Kowenz-Leutz, Elisabeth; Cathou, Wilfried; Gentek, Rebecca; Perrin, Pierre; Leutz, Achim; Berruyer, Carole; Sieweke, Michael H.			SIRT1 regulates macrophage self-renewal	EMBO JOURNAL			English	Article						cell cycle regulation; macrophage; replicative life span; self-renewal; sirtuins	FORKHEAD TRANSCRIPTION FACTORS; TISSUE-RESIDENT MACROPHAGES; CNS MYELOID CELLS; EXTENDS LIFE-SPAN; STEM-CELLS; FOXO PROTEINS; C-MYC; HEMATOPOIETIC STEM; OXIDATIVE STRESS; FEEDBACK LOOP	Mature differentiated macrophages can self-maintain by local proliferation in tissues and can be extensively expanded in culture under specific conditions, but the mechanisms of this phenomenon remain only partially defined. Here, we show that SIRT1, an evolutionary conserved regulator of life span, positively affects macrophage self-renewal ability in vitro and in vivo. Overexpression of SIRT1 during bone marrow-derived macrophage differentiation increased their proliferative capacity. Conversely, decrease of SIRT1 expression by shRNA inactivation, CRISPR/Cas9 mediated deletion and pharmacological inhibition restricted macrophage self-renewal in culture. Furthermore, pharmacological SIRT1 inhibition in vivo reduced steady state and cytokine-induced proliferation of alveolar and peritoneal macrophages. Mechanistically, SIRT1 inhibition negatively regulated G1/S transition, cell cycle progression and a network of self-renewal genes. This included inhibition of E2F1 and Myc and concomitant activation of FoxO1, SIRT1 targets mediating cell cycle progression and stress response, respectively. Our findings indicate that SIRT1 is a key regulator of macrophage self-renewal that integrates cell cycle and longevity pathways. This suggests that macrophage self-renewal might be a relevant parameter of ageing.	[Imperatore, Francesco; Maurizio, Julien; Aguilar, Stephanie Vargas; Favret, Jeremy; Cathou, Wilfried; Gentek, Rebecca; Perrin, Pierre; Berruyer, Carole; Sieweke, Michael H.] Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; [Aguilar, Stephanie Vargas; Busch, Clara J.; Favret, Jeremy; Kowenz-Leutz, Elisabeth; Leutz, Achim; Sieweke, Michael H.] Max Delbruck Ctr Mol Med Helmholtzgemeinsch MDC, Berlin, Germany	Sieweke, MH (reprint author), Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France.; Sieweke, MH (reprint author), Max Delbruck Ctr Mol Med Helmholtzgemeinsch MDC, Berlin, Germany.	sieweke@ciml.univ-mrs.fr			French National Research Agency [ANR-10-INBS-04]; INSERM; CNRS; Aix-Marseille University; Volkswagen Stiftung [I/79 994-996]; Agence nationale de la Recherche [ANR-11-BSV3-0026]; Fondation pour la Recherche Medicale [DEQ. 20071210559, DEQ. 20110421320, FDT20111223609]; European Research Council (ERC) under the European Union [695093 MacAge]	We thank David Hume, The Roslin Institute, University of Edinburgh, for the CSF1-Fc reagent and Klaus Rajewsky, MDC, Berlin, for Rosa26-Cas9p2aGFP transgenic mice. We are thankful to Gregory Gimenez, Van Trung Chu and Robin Graf for technical advice and to Sandrine Sarrazin for mouse colony management. We thank the Centre d'Immunologie de Marseille-Luminy (CIML) mouse house and cytometry facilities and Gisele Froment, Didier Negre and Caroline Costa from the lentivectors production facility/SFR BioSciences Gerland-Lyon Sud (UMRS3444/US8). We acknowledge the PICSL imaging facility of the CIML (ImagImm), member of the national infrastructure France-BioImaging supported by the French National Research Agency (ANR-10-INBS-04). The work was supported by institutional grants from INSERM, CNRS and Aix-Marseille University to the CIML and grants to MHS from the Volkswagen Stiftung (I/79 994-996), "Agence nationale de la Recherche" (ANR-11-BSV3-0026), Fondation pour la Recherche Medicale (DEQ. 20071210559 and DEQ. 20110421320) and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement number 695093 MacAge). FI was supported by a fellowship from the Fondation pour la Recherche Medicale (FDT20111223609). MHS is a BIH-Einstein fellow and INSERM-Helmholtz group leader.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI [10.1172/JC172181, 10.1172/JCI72181]; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Boutant M, 2014, MOL METAB, V3, P5, DOI 10.1016/j.molmet.2013.10.006; Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Charitou P, 2013, ANTIOXID REDOX SIGN, V19, P1400, DOI 10.1089/ars.2012.4921; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; Ekblad T, 2016, CHEM BIOL DRUG DES, V87, P478, DOI 10.1111/cbdd.12680; FAGAN R, 1994, CELL, V78, P799, DOI 10.1016/S0092-8674(94)90522-3                                                   ; Feinberg MW, 2013, CIRC RES, V112, P978, DOI 10.1161/CIRCRESAHA.113.301159; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Gomez-Nicola D, 2016, METHODS MOL BIOL, V1303, P185, DOI 10.1007/978-1-4939-2627-5_10; Gow DJ, 2014, MOL THER, V22, P1580, DOI 10.1038/mt.2014.112; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Haw R, 2011, PROTEOMICS, V11, P3598, DOI 10.1002/pmic.201100066; Hill R, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0482-y; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249                                                   ; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570                                                          ; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2006.02.002; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Mao BB, 2011, INT J BIOCHEM CELL B, V43, P1573, DOI 10.1016/j.biocel.2011.07.006; Marshall GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002135; Martins R, 2016, AGING CELL, V15, P196, DOI 10.1111/acel.12427; MCEVOY RC, 1984, J CLIN INVEST, V74, P715, DOI 10.1172/JCI111487; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mildner A, 2013, ADV IMMUNOL, V120, P69, DOI 10.1016/B978-0-12-417028-5.00003-X; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Niu BW, 2016, REJUV RES, V19, P120, DOI 10.1089/rej.2015.1719; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224                                                         ; Nowak K, 2007, BBA-GENE STRUCT EXPR, V1769, P244, DOI 10.1016/j.bbaexp.2007.04.001; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Petrie TA, 2014, DEVELOPMENT, V141, P2581, DOI 10.1242/dev.098459; Pietrocola F, 2013, SEMIN CANCER BIOL, V23, P310, DOI 10.1016/j.semcancer.2013.05.008; Poulose N, 2015, BBA-MOL BASIS DIS, V1852, P2442, DOI 10.1016/j.bbadis.2015.08.017; Prinz M, 2017, NAT IMMUNOL, V18, P385, DOI 10.1038/ni.3703; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Rathbone CR, 2009, EUR J CELL BIOL, V88, P35, DOI 10.1016/j.ejcb.2008.08.003; Rimmele P, 2014, STEM CELL R IN PRESS, V3, P1, DOI DOI 10.1016/J.STEMCR.2014.04.015; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Ruckerl D, 2012, BLOOD, V120, P2307, DOI 10.1182/blood-2012-02-408252; Saldeen J, 2003, MOL CELL BIOCHEM, V243, P113, DOI 10.1023/A:1021651811345                                                         ; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176                                                           ; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi0349591; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sharma A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00040; SHERR CJ, 1995, P ASSOC AM PHYSICIAN, V107, P181; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Singh SK, 2013, J EXP MED, V210, P987, DOI 10.1084/jem.20121608; Smyth G. K., 2004, APPL GENET MOL BIOL, V3, DOI DOI 10.2202/1544-6115.1027; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; SPECTOR R, 1987, NEUROCHEM RES, V12, P27, DOI 10.1007/BF00971360; Spinelli L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2012-4; STANLEY ER, 1985, METHOD ENZYMOL, V116, P564; Stevens C, 2003, ARCH BIOCHEM BIOPHYS, V412, P157, DOI 10.1016/S0003-9861(03)00054-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsuchiya K, 2013, CIRC RES, V112, P992, DOI 10.1161/CIRCRESAHA.112.300749; Chu VT, 2016, P NATL ACAD SCI USA, V113, P12514, DOI 10.1073/pnas.1613884113; Venter G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097378; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796                                                             ; Waisman A, 2015, TRENDS IMMUNOL, V36, P625, DOI 10.1016/j.it.2015.08.005; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wong S, 2007, BIOCHEM J, V407, P451, DOI 10.1042/BJ20070151; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yuan HF, 2012, J MOL MED, V90, P389, DOI 10.1007/s00109-011-0825-4; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zhang Q., 2016, EURASIP J WIREL COMM, V2016, P1, DOI DOI 10.3171/2016.2.JNS152173; Zhang Q, 2012, EMBO MOL MED, V4, P298, DOI 10.1002/emmm.201100211; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010	121	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0261-4189	1460-2075		EMBO J	Embo J.	AUG 15	2017	36	16					2353	2372		10.15252/embj.201695737				20	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FD8PL	WOS:000407786500006	28701484				2018-01-05	
J	Rossi, CC; Souza-Silva, T; Araujo-Alves, AV; Giambiagi-deMarval, M				Rossi, Ciro C.; Souza-Silva, Thaysa; Araujo-Alves, Amanda V.; Giambiagi-deMarval, Marcia			CRISPR-Cas Systems Features and the Gene-Reservoir Role of Coagulase-Negative Staphylococci	FRONTIERS IN MICROBIOLOGY			English	Article						CRISPR; cas genes; CoNS; coagulase-negative staphylococci; horizontal gene transfer	UNCULTIVATED MICROBES; SEQUENCE; AUREUS; HAEMOLYTICUS; EPIDERMIDIS; RESISTANCE; REPEATS; IDENTIFICATION; INFECTIONS; INSIGHTS	The claimed role of gene reservoir of coagulase-negative staphylococci (CoNS) could be contradicted by estimates that CRISPR/Cas systems are found in the genomes of 40-50% of bacteria, as these systems interfere with plasmid uptake in staphylococci. To further correlate this role with presence of CRISPR, we analyzed, by computational methods, 122 genomes from 15 species of CoNS. Only 15% of them harbored CRISPR/Cas systems, and this proportion was much lower for S. epidermidis and S. haemolyticus, the CoNS most frequently associated with opportunistic infections in humans. These systems are of type II or III, and at least two of them are located within SCCmec, a mobile genetic element of Staphylococcus bacterial species. An analysis of the spacers of these CRISPRs, which come from exogenous origin, allowed us to track the transference of the SCCmec, which was exchanged between different strains, species and hosts. Some of the spacers are derived from plasmids described in Staphylococcus species that are different from those in which the CRISPR are found, evidencing the attempt (and failure) of plasmid transference between them. Based on the polymorphisms of the cas1 gene in CRISPRs of types II and III, we developed a multiplex polymerase chain reaction (PCR) suitable to screen and type CRISPR systems in CoNS. The PCR was tested in 59 S. haemolyticus strains, of which only two contained a type III cas1. This gene was shown to be expressed in the exponential growth, stationary phase and during biofilm formation. The low abundance of CRISPRs in CoNS is in accordance with their role as gene reservoirs, but when present, their spacers sequence evidence and give an insight on the dynamics of horizontal genetic transfer among staphylococci.	[Rossi, Ciro C.; Souza-Silva, Thaysa; Araujo-Alves, Amanda V.; Giambiagi-deMarval, Marcia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil	Rossi, CC; Giambiagi-deMarval, M (reprint author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.	ciro.rossi@hotmail.com; marciagm@micro.ufrj.br			FAPERJ [E-26/203.037/2016, E-26/202.799/2016, E-26/202.800/2016]; CNPq [304.506/2014-1]; CAPES-Proex [23038.003823/2014-79]	This work was supported by Brazilian grants, FAPERJ (grant E-26/203.037/2016), CNPq (grant 304.506/2014-1) and CAPES-Proex (grant 23038.003823/2014-79). CR is recipient of post-doctoral scholarship from FAPERJ (grants E-26/202.799/2016 and E-26/202.800/2016).	Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Asaad AM, 2016, INFECT DIS-NOR, V48, P356, DOI 10.3109/23744235.2015.1122833; Barbier F, 2010, J INFECT DIS, V202, P270, DOI 10.1086/653483; Barrangou R, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.92; Barros EM, 2012, J CLIN MICROBIOL, V50, P166, DOI 10.1128/JCM.05563-11; Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Burstein D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10613; Cao LY, 2016, INT J MED MICROBIOL, V306, P686, DOI 10.1016/j.ijmm.2016.08.005; Chen HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066880; Cloney R, 2017, NAT REV GENET, V18, P146, DOI 10.1038/nrg.2017.1; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Czekaj T, 2015, MICROBIOL-SGM, V161, P2061, DOI 10.1099/mic.0.000178; Drancourt M, 2002, J CLIN MICROBIOL, V40, P1333, DOI 10.1128/JCM.40.4.1333-1338.2002; Flemming HC, 2016, NAT REV MICROBIOL, V14, P563, DOI 10.1038/nrmicro.2016.94; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Golding GR, 2012, J BACTERIOL, V194, P6627, DOI 10.1128/JB.01680-12; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Lopatina A, 2016, CURR BIOL, V26, pR683, DOI 10.1016/j.cub.2016.05.034; Luo ML, 2016, BIOTECHNOL BIOENG, V113, P930, DOI 10.1002/bit.25851; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Misic A. M., 2015, GENOME ANNOUNC, V3, DOI [10.1128/genomeA.01011-15, DOI 10.1128/GENOMEA.01011-15]; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Otto M, 2013, BIOESSAYS, V35, P4, DOI 10.1002/bies.201200112; Perez-Rodriguez R, 2011, MOL MICROBIOL, V79, P584, DOI 10.1111/j.1365-2958.2010.07482.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rossi CC, 2016, LETT APPL MICROBIOL, V63, P215, DOI 10.1111/lam.12611; Rossi CC, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw121; Rossi CC, 2017, VET MICROBIOL, V201, P136, DOI 10.1016/j.vetmic.2017.01.029; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944                                                ; Sasaki T., 2015, GENOME ANNOUNC, V3, DOI [10.1128/genomeA.01268-15, DOI 10.1128/GENOMEA.01268-15]; Sievers F., 2014, CURR PROTOC BIOINFOR, V48, DOI 10.1002/0471250953.bi0313s48; Siguier P, 2012, Methods Mol Biol, V859, P91, DOI 10.1007/978-1-61779-603-6_5; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Viswanathan P, 2007, J BACTERIOL, V189, P3738, DOI 10.1128/JB.00187-07; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0                                                   	39	1	1	4	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	AUG 15	2017	8								1545	10.3389/fmicb.2017.01545				9	Microbiology	Microbiology	FD7XF	WOS:000407738600002	28861060	gold			2018-01-05	
J	Ayyathan, DM; Ilic, N; Gil-Henn, H; Blank, M				Ayyathan, Dhanoop Manikoth; Ilic, Nata; Gil-Henn, Hava; Blank, Michael			Generation of SMURF2 knockout human cells using the CRISPR/Cas9 system	ANALYTICAL BIOCHEMISTRY			English	Article						SMURF2; CRISPR/Cas9; Knockout; Human cells	E3 UBIQUITIN LIGASES; STABILITY; CANCER	The HECT domain E3 ubiquitin ligase SMURF2 regulates stability of several key protein targets involved in tumorigenesis, cell proliferation, migration, differentiation, and senescence. While altered levels and aberrant cellular distribution of SMURF2 were reported in different types of cancer, its role in tumorigenesis is far from understood. To elucidate the role of SMURF2 in cancer, appropriate human cancer cell models are needed. Here, we describe approaches that can be used to generate human normal and cancer cell strains knocked-out for SMURF2 using the clustered regularly interspaced short palindromic repeats (CRISPR/Cas9) gene-editing technology. (C) 2017 Elsevier Inc. All rights reserved.	[Ayyathan, Dhanoop Manikoth; Ilic, Nata; Blank, Michael] Bar Ilan Univ, Fac Med Galilee, Lab Mol & Cellular Canc Biol, Safed, Israel; [Gil-Henn, Hava] Bar Ilan Univ, Fac Med Galilee, Cell Migrat & Invas Lab, Safed, Israel	Blank, M (reprint author), Bar Ilan Univ, Fac Med Galilee, Lab Mol & Cellular Canc Biol, Safed, Israel.	michael.blank@biu.ac.il			ICRF [00636, 12-709-RCDA]; CIG [612816]; Israel Cancer Association [20160073, 20171153, 20141043]; Dayan Family Foundation; Israel Science Foundation [996/12]	This work was supported by the ICRF (grant number 00636), Marie-Curie FP-7 CIG (grant number 612816), the Israel Cancer Association (grant numbers 20160073 and 20171153), and Dayan Family Foundation (to M.B); and by the Israel Science Foundation (grant number 996/12), the Israel Cancer Association (grant number 20141043) and ICRF (grant number 12-709-RCDA) (to H.G.H.).	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Blank M, 2012, NAT MED, V18, P227, DOI 10.1038/nm.2596; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; David D, 2013, BBA-REV CANCER, V1835, P119, DOI 10.1016/j.bbcan.2012.11.003; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Ray D, 2011, NEOPLASIA, V13, P570, DOI 10.1593/neo.11632; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Zou X, 2015, BBA-REV CANCER, V1856, P91, DOI 10.1016/j.bbcan.2015.06.005	12	0	0	21	21	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697	1096-0309		ANAL BIOCHEM	Anal. Biochem.	AUG 15	2017	531						56	59		10.1016/j.ab.2017.05.024				4	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	EY6FG	WOS:000404077300009	28552759				2018-01-05	
J	Lombardi, L; Turner, SA; Zhao, F; Butler, G				Lombardi, Lisa; Turner, Siobhan A.; Zhao, Fang; Butler, Geraldine			Gene editing in clinical isolates of Candida parapsilosis using CRISPR/Cas9	SCIENTIFIC REPORTS			English	Article							HEALTH-CARE WORKERS; COMPARATIVE GENOMICS; PHENOTYPIC SWITCH; BIOFILM FORMATION; IN-VIVO; ALBICANS; YEAST; STRAINS; CRISPR-CAS9; DISRUPTION	Candida parapsilosis is one of the most common causes of candidiasis, particularly in the very young and the very old. Studies of gene function are limited by the lack of a sexual cycle, the diploid genome, and a paucity of molecular tools. We describe here the development of a plasmid-based CRISPR-Cas9 system for gene editing in C. parapsilosis. A major advantage of the system is that it can be used in any genetic background, which we showed by editing genes in 20 different isolates. Gene editing is carried out in a single transformation step. The CAS9 gene is expressed only when the plasmid is present, and it can be removed easily from transformed strains. There is theoretically no limit to the number of genes that can be edited in any strain. Gene editing is increased by homology-directed repair in the presence of a repair template. Editing by non-homologous end joining (NHEJ) also occurs in some genetic backgrounds. Finally, we used the system to introduce unique tags at edited sites.	[Lombardi, Lisa; Turner, Siobhan A.; Zhao, Fang; Butler, Geraldine] Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin 4, Ireland	Butler, G (reprint author), Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin 4, Ireland.	gbutler@ucd.ie		Butler, Geraldine/0000-0002-1770-5301	Science Foundation Ireland [12IA1343]; China Scholarship Scheme	We thank Attila Gacser (University of Szeged) for the gift of plasmid pGIZI, Paul Donovan (UCD) for bioinformatic support, and Ken Wolfe (UCD) for designing the codon-optimized Cas9. This work was supported by Science Foundation Ireland Grant 12IA1343 (GB) and the China Scholarship Scheme (FZ).	Bennett RJ, 2005, ANNU REV MICROBIOL, V59, P233, DOI 10.1146/annurev.micro.59.030804.121310; Bertini A, 2016, VIRULENCE, V7, P85, DOI 10.1080/21505594.2015.1112491; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Cao M, 2017, ACS SYNTH B IN PRESS, DOI [10.1021/acssynbio.7b00046, DOI 10.1021/ACSSYNBIO.7B00046(]; Daniel HM, 2014, ANTON LEEUW INT J G, V106, P67, DOI 10.1007/s10482-014-0170-z; Delfino D, 2014, CLIN MICROBIOL INFEC, V20, pO946, DOI 10.1111/1469-0691.12685; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Diekema DJ, 2002, J CLIN MICROBIOL, V40, P1298, DOI 10.1128/JCM.40.4.1298-1302.2002; Ding C, 2007, EUKARYOT CELL, V6, P1310, DOI 10.1128/EC.00136-07; Ding C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028151; Donovan P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146093; Dunkel N, 2013, EUKARYOT CELL, V12, P520, DOI 10.1128/EC.00008-13; Forche A, 2008, PLOS BIOL, V6, P1084, DOI 10.1371/journal.pbio.0060110; Gacser A, 2007, J CLIN INVEST, V117, P3049, DOI 10.1172/JCI32294; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grahl N, 2017, MSPHERE, V2, DOI [10.1128/msphere.00218-17, 10.1128/mSphere.00218-17]; Hittinger CT, 2015, CURR OPIN GENET DEV, V35, P100, DOI 10.1016/j.gde.2015.10.008; Holland LM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004365; Huang MNY, 2017, MSPHERE, V2, DOI [10.1128/msphere.00050-17, 10.1128/mSphere.00050-17]; Jacobs JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6344; JAMES SA, 1994, LETT APPL MICROBIOL, V19, P308, DOI 10.1111/j.1472-765X.1994.tb00462.x; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Koo T, 2015, MOL CELLS, V38, P475, DOI 10.14348/molcells.2015.0103; Levin AS, 1998, DIAGN MICR INFEC DIS, V30, P243, DOI 10.1016/S0732-8893(98)00006-6; Marck C, 2006, NUCLEIC ACIDS RES, V34, P1816, DOI 10.1093/nar/gkl085; Millerioux Y, 2011, FEMS YEAST RES, V11, P457, DOI 10.1111/j.1567-1364.2011.00731.x; Min K, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00130-16; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Morschhauser J, 1999, MOL MICROBIOL, V32, P547, DOI 10.1046/j.1365-2958.1999.01393.x; Ng H., 2017, mSphere, V2, pe00385, DOI 10.1128/msphere.00385-16; Nguyen N., 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00149-17, DOI 10.1128/MSPHEREDIRECT.00149-17]; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Norton EL, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00217-17, 10.1128/msphere.00217-17]; Nosek J, 2002, CURR GENET, V42, P27, DOI 10.1007/s00294-002-0326-7; Pande K, 2013, NAT GENET, V45, P1088, DOI 10.1038/ng.2710; Pannanusorn S, 2014, EUKARYOT CELL, V13, P438, DOI 10.1128/EC.00181-13; Papon N, 2012, MICROBIOL-SGM, V158, P585, DOI 10.1099/mic.0.055244-0; Peng D., 2015, MICROB GENOM, V1, DOI DOI 10.1099/MGEN.0.000033; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Porman AM, 2011, P NATL ACAD SCI USA, V108, P21158, DOI 10.1073/pnas.1112076109; Posteraro B, 2004, INFECT CONT HOSP EP, V25, P641, DOI 10.1086/502454; Pryszcz LP, 2013, GENOME BIOL EVOL, V5, P2382, DOI 10.1093/gbe/evt185; Pujol C, 2004, EUKARYOT CELL, V3, P1015, DOI 10.1128/EC.3.4.1015-1027.2004; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Riley R, 2016, P NATL ACAD SCI USA, V113, P9882, DOI 10.1073/pnas.1603941113; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Sai SX, 2011, EUKARYOT CELL, V10, P578, DOI 10.1128/EC.00276-10; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; Shen XX, 2016, G3-GENES GENOM GENET, V6, P3927, DOI 10.1534/g3.116.034744; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; van Asbeck EC, 2007, MYCOPATHOLOGIA, V164, P287, DOI 10.1007/s11046-007-9054-3; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; Wohlbach DJ, 2011, P NATL ACAD SCI USA, V108, P13212, DOI 10.1073/pnas.1103039108	58	0	0	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 14	2017	7								8051	10.1038/s41598-017-08500-1				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FD5GV	WOS:000407559800018	28808289	gold			2018-01-05	
J	Horii, T; Morita, S; Kimura, M; Terawaki, N; Shibutani, M; Hatada, I				Horii, Takuro; Morita, Sumiyo; Kimura, Mika; Terawaki, Naomi; Shibutani, Mihiro; Hatada, Izuho			Efficient generation of conditional knockout mice via sequential introduction of lox sites	SCIENTIFIC REPORTS			English	Article							ONE-STEP GENERATION; MOUSE ZYGOTES; GENOME; RNA; CAS9; ELECTROPORATION; CELLS; DNA; ENDONUCLEASE; RECOMBINASE	Conditional knockout using Cre/lox is essential for functional analysis of genes. CRISPR/Cas in combination with two sets of guide RNAs and a single-stranded oligonucleotide enables simultaneous insertion of two lox sequences. However, this method induces double-strand breaks at two sites on the same chromosome, which causes an undesirable chromosomal deletion and reduces the flanked lox (flox) rate. To solve this problem, we investigated a method that sequentially introduces each lox sequence at the 1-cell and 2-cell embryonic stages, respectively. The sequential method was applied to both microinjection and electroporation systems. Sequential electroporation improved the flox efficiency compared with ordinary simultaneous microinjection, leading to a high yield of offspring with floxed alleles. Finally, we directly produced Cre/lox mice containing both the Cre transgene and floxed allele via sequential electroporation using Cre zygotes, which accelerated the generation of conditional knockout mice compared with the ordinary method.	[Horii, Takuro; Morita, Sumiyo; Kimura, Mika; Terawaki, Naomi; Shibutani, Mihiro; Hatada, Izuho] Gunma Univ, Inst Mol & Cellular Regulat, Biosignal Genome Resource Ctr, Lab Genome Sci, 3-39-15 Showa Machi, Maebashi, Gunma 3718512, Japan	Hatada, I (reprint author), Gunma Univ, Inst Mol & Cellular Regulat, Biosignal Genome Resource Ctr, Lab Genome Sci, 3-39-15 Showa Machi, Maebashi, Gunma 3718512, Japan.	hatada@gunma-u.ac.jp			Basic Science and Platform Technology Program for Innovative Biological Medicine from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Agency for Medical Research and Development (AMED)	We thank Dr. Tsukasa Oda and Takayuki Yamashita (Gunma University) for discussion and support regarding the electroporation experiments. This work was supported by grants from the Basic Science and Platform Technology Program for Innovative Biological Medicine from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) and The Japan Agency for Medical Research and Development (AMED) to I. H.	ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x                                              ; Bishop KA, 2016, G3-GENES GENOM GENET, V6, P2051, DOI 10.1534/g3.116.030601; Chen S, 2016, J BIOL CHEM, V291, P14457, DOI 10.1074/jbc.M116.733154; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Hashimoto M, 2016, DEV BIOL, V418, P1, DOI 10.1016/j.ydbio.2016.07.017; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X                                                   ; Horii T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04513; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaneko T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142755; Kaneko T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06382; Ma XL, 2017, SCI REP-UK, V7, DOI 10.1038/srep42244; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nakagawa Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27857; Qin WN, 2015, GENETICS, V200, P423, DOI 10.1534/genetics.115.176594; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; SADOWSKI PD, 1995, PROG NUCLEIC ACID RE, V51, P53, DOI 10.1016/S0079-6603(08)60876-4; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Tanihara F, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600803; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang WB, 2016, J GENET GENOMICS, V43, P319, DOI 10.1016/j.jgg.2016.02.004; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017	29	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 11	2017	7								7891	10.1038/s41598-017-08496-8				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FD3OO	WOS:000407442500031	28801621	gold			2018-01-05	
J	Chen, ZG; Eggerman, TL; Bocharov, AV; Baranova, IN; Vishnyakova, TG; Kurlander, R; Patterson, AP				Chen, Zhigang; Eggerman, Thomas L.; Bocharov, Alexander V.; Baranova, Irina N.; Vishnyakova, Tatyana G.; Kurlander, Roger; Patterson, Amy P.			Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION-INDUCED DEAMINASE; MULTIPLE HUMAN CANCERS; MESSENGER-RNA; APOBEC-1 OVEREXPRESSION; RETROVIRAL RESTRICTION; BREAST-CANCER; HSP90; DNA; HYPERMUTATION; REPLICATION	Apolipoprotein B mRNA-editing enzyme catalytic subunit 3 (APOBEC-3) enzymes are cytidine deaminases that are broadly and constitutively expressed. They are often up-regulated during carcinogenesis and candidate genes for causing the major single-base substitution in cancer-associated DNA mutations. Moreover, APOBEC-3s are involved in host innate immunity against many viruses. However, how APOBEC-3 mutational activity is regulated in normal and pathological conditions remains largely unknown. Heat shock protein levels are often elevated in both carcinogenesis and viral infection and are associated with DNA mutations. Here, using mutational analyses of hepatitis B virus (HBV), we found that Hsp90 stimulates deamination activity of APOBEC-3G (A3G), A3B, and A3C during co-expression in human liver HepG2 cells. Hsp90 directly stimulated A3G deamination activity when the purified proteins were used in in vitro reactions. Hsp40, -60, and -70 also had variable stimulatory effects in the cellular assay, but not in vitro. Sequencing analyses further demonstrated that Hsp90 increased both A3G cytosine mutation efficiency on HBV DNA and total HBV mutation frequency. In addition, Hsp90 shifted A3G's cytosine region selection in HBV DNA and increased A3G's 5' nucleoside preference for deoxycytidine (5' -CC). Furthermore, the Hsp90 inhibitor 17-N-allylamino-17-demethoxygeldanamycin dose dependently inhibited A3G and A3B mutational activity on HBV viral DNA. Hsp90 knockdown by siRNA or by Hsp90 active-site mutation also decreased A3G activity. These results indicate that heat shock proteins, in particular Hsp90, stimulate APOBEC-3-mediated DNA deamination activity, suggesting a potential physiological role in carcinogenesis and viral innate immunity.	[Chen, Zhigang; Eggerman, Thomas L.; Bocharov, Alexander V.; Baranova, Irina N.; Vishnyakova, Tatyana G.; Kurlander, Roger; Patterson, Amy P.] NIDDK, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA; [Eggerman, Thomas L.] NIDDK, Div Diabet Endocrinol & Metab Dis, Bethesda, MD 20892 USA; [Patterson, Amy P.] NHLBI, NIH, 31 Ctr Dr, Bethesda, MD 20892 USA	Patterson, AP (reprint author), NHLBI, NIH, 31 Ctr Dr, Bethesda, MD 20892 USA.	amy.patterson@nih.gov					Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48                                                           ; Bonvin M, 2007, J GEN VIROL, V88, P3270, DOI 10.1099/vir.0.83149-0; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Caval V, 2015, NUCLEIC ACIDS RES, V43, P9340, DOI 10.1093/nar/gkv935; Cescon DW, 2015, P NATL ACAD SCI USA, V112, P2841, DOI 10.1073/pnas.1424869112; Chen ZG, 2012, J MOL BIOL, V418, P65, DOI 10.1016/j.jmb.2012.02.005; Chen ZG, 2010, RNA, V16, P1040, DOI 10.1261/rna.1863010; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1                                                               ; Demorest ZL, 2011, J BIOL CHEM, V286, P26568, DOI 10.1074/jbc.M111.235721; Fontaine SN, 2015, J BIOL CHEM, V290, P13115, DOI 10.1074/jbc.M115.637595; Glebe D, 2013, SEMIN LIVER DIS, V33, P103, DOI 10.1055/s-0033-1345717; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9                                                   ; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Henderson S, 2015, TRENDS MOL MED, V21, P274, DOI 10.1016/j.molmed.2015.02.007; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Jarosz D, 2016, ADV CANCER RES, V129, P225, DOI 10.1016/bs.acr.2015.11.001; Khurana N, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00100; Kock J, 2008, J GEN VIROL, V89, P1184, DOI 10.1099/vir.0.83507-0; Koito A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00028; Lada AG, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005217; Lada AG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003736; Lada AG, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-47; Leonard B, 2015, CANCER RES, V75, P4538, DOI 10.1158/0008-5472.CAN-15-2171-T; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Lianos GD, 2015, CANCER LETT, V360, P114, DOI 10.1016/j.canlet.2015.02.026; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; Masel J, 2010, TRENDS GENET, V26, P406, DOI 10.1016/j.tig.2010.06.002; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0                                                   ; Michels AA, 1999, J BIOL CHEM, V274, P36757, DOI 10.1074/jbc.274.51.36757                                                        ; Orthwein A, 2010, J EXP MED, V207, P2751, DOI 10.1084/jem.20101321; Pak V, 2011, J VIROL, V85, P8538, DOI 10.1128/JVI.02645-10; Patterson AP, 2003, J BIOL CHEM, V278, P7600, DOI 10.1074/jbc.M201601200; Pearl LH, 2016, BIOPOLYMERS, V105, P594, DOI 10.1002/bip.22835; Prodromou C, 2016, BIOCHEM J, V473, P2439, DOI 10.1042/BCJ20160005; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Sakofsky CJ, 2014, CELL REP, V7, P1640, DOI 10.1016/j.celrep.2014.04.053; Shinohara M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00806; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Vieira VC, 2014, MBIO, V5, DOI 10.1128/mBio.02234-14; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012	56	0	0	4	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13459	13479		10.1074/jbc.M116.760637				21	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FD3XI	WOS:000407465300030	28637869				2018-01-05	
J	Chen, YR; Zeng, SY; Hu, RK; Wang, XX; Huang, WL; Liu, JF; Wang, LY; Liu, GF; Cao, Y; Zhang, Y				Chen, Yunru; Zeng, Shiyang; Hu, Ruikun; Wang, Xiangxiu; Huang, Weilai; Liu, Jiangfang; Wang, Luying; Liu, Guifen; Cao, Ying; Zhang, Yong			Using local chromatin structure to improve CRISPR/Cas9 efficiency in zebrafish	PLOS ONE			English	Article							POSITIONS IN-VIVO; NUCLEOSOME ORGANIZATION; CAS9 ENDONUCLEASE; READ ALIGNMENT; GENOME; SYSTEM; BINDING; DESIGN; SGRNAS; CELLS	Although the CRISPR/Cas9 has been successfully applied in zebrafish, considerable variations in efficiency have been observed for different gRNAs. The workload and cost of zebrafish mutant screening is largely dependent on the mutation rate of injected embryos; therefore, selecting more effective gRNAs is especially important for zebrafish mutant construction. Besides the sequence features, local chromatin structures may have effects on CRISPR/Cas9 efficiency, which remain largely unexplored. In the only related study in zebrafish, nucleosome organization was not found to have an effect on CRISPR/Cas9 efficiency, which is inconsistent with recent studies in vitro and in mammalian cell lines. To understand the effects of local chromatin structure on CRISPR/Cas9 efficiency in zebrafish, we first determined that CRISPR/Cas9 introduced genome editing mainly before the dome stage. Based on this observation, we reanalyzed our published nucleosome organization profiles and generated chromatin accessibility profiles in the 256-cell and dome stages using ATAC-seq technology. Our study demonstrated that chromatin accessibility showed positive correlation with CRISPR/Cas9 efficiency, but we did not observe a clear correlation between nucleosome organization and CRISPR/Cas9 efficiency. We constructed an online database for zebrafish gRNA selection based on local chromatin structure features that could prove beneficial to zebrafish homozygous mutant construction via CRISPR/Cas9.	[Chen, Yunru; Zeng, Shiyang; Hu, Ruikun; Wang, Xiangxiu; Huang, Weilai; Liu, Jiangfang; Wang, Luying; Liu, Guifen; Cao, Ying; Zhang, Yong] Tongji Univ, Shanghai East Hosp, Sch Life Sci & Technol, Translat Med Ctr Stem Cell Therapy & Inst Regener, Shanghai, Peoples R China; [Chen, Yunru; Zeng, Shiyang; Wang, Xiangxiu; Wang, Luying; Liu, Guifen; Zhang, Yong] Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Shanghai, Peoples R China	Cao, Y; Zhang, Y (reprint author), Tongji Univ, Shanghai East Hosp, Sch Life Sci & Technol, Translat Med Ctr Stem Cell Therapy & Inst Regener, Shanghai, Peoples R China.; Zhang, Y (reprint author), Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Shanghai, Peoples R China.	yingcao@tongji.edu.cn; yzhang@tongji.edu.cn		Zhang, Yong/0000-0001-6316-2734	National Natural Science Foundation of China [31322031, 31571365, 31371288, 31601161, 31571515]; National Key Research and Development Program of China [2017YFA0102602, 2016YFA0100400]; Specialized Research Fund for the Doctoral Program of Higher Education [20130072110032]; Program of Shanghai Academic Research Leader [17XD1403600]; Exploration Program of Shanghai Natural Science Foundation [17ZR1449500]	This work was supported by National Natural Science Foundation of China (31322031, 31571365, 31371288, 31601161, 31571515), National Key Research and Development Program of China (2017YFA0102602, 2016YFA0100400), Specialized Research Fund for the Doctoral Program of Higher Education (20130072110032), Program of Shanghai Academic Research Leader (17XD1403600) and Exploration Program of Shanghai Natural Science Foundation (17ZR1449500).	Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Daer RM, 2016, BIORXIV, V6, P428; del Ama LF, 2016, ONCOTARGET, V7, P40348, DOI 10.18632/oncotarget.9613; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5                                                   ; DRIEVER W, 1994, TRENDS GENET, V10, P152, DOI 10.1016/0168-9525(94)90091-4; Hinz JM, 2015, BIOCHEMISTRY-US, V54, P7063, DOI 10.1021/acs.biochem.5b01108; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shah AN, 2015, NAT METHODS, V12, P535, DOI 10.1038/nmeth.3360; Stein A, 2010, NUCLEIC ACIDS RES, V38, P709, DOI 10.1093/nar/gkp1043; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Wager K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157365; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, P1; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Zhang Y, 2014, GENOME RES, V24, P260, DOI 10.1101/gr.157750.113; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	33	1	1	12	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182528	10.1371/journal.pone.0182528				19	Multidisciplinary Sciences	Science & Technology - Other Topics	FD3KL	WOS:000407431800021	28800611	gold			2018-01-05	
J	Cohen, JE; Wang, R; Shen, RF; Wu, WW; Keller, JE				Cohen, Jonathan E.; Wang, Rong; Shen, Rong-Fong; Wu, Wells W.; Keller, James E.			Comparative pathogenomics of Clostridium tetani	PLOS ONE			English	Article							NICOLAIERILLUS B TETANI; BOTULINUM NEUROTOXINS; SEARCH TOOL; DIVERSITY; SEQUENCE; PROTEIN; GLYCOSYLATION; PATHOGENICITY; ALIGNMENT; GENOMICS	Clostridium tetani and Clostridium botulinum produce two of the most potent neurotoxins known, tetanus neurotoxin and botulinum neurotoxin, respectively. Extensive biochemical and genetic investigation has been devoted to identifying and characterizing various C. botulinum strains. Less effort has been focused on studying C. tetani likely because recently sequenced strains of C. tetani show much less genetic diversity than C. botulinum strains and because widespread vaccination efforts have reduced the public health threat from tetanus. Our aim was to acquire genomic data on the U.S. vaccine strain of C. tetani to better understand its genetic relationship to previously published genomic data from European vaccine strains. We performed high throughput genomic sequence analysis on two wildtype and two vaccine C. tetani strains. Comparative genomic analysis was performed using these and previously published genomic data for seven other C. tetani strains. Our analysis focused on single nucleotide polymorphisms (SNP) and four distinct constituents of the mobile genome (mobilome): a hypervariable flagellar glycosylation island region, five conserved bacteriophage insertion regions, variations in three CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-associated) systems, and a single plasmid. Intact type IA and IB CRISPR/Cas systems were within 10 of 11 strains. A type IIIA CRISPR/Cas system was present in two strains. Phage infection histories derived from CRISPR-Cas sequences indicate C. tetani encounters phages common among commensal gut bacteria and soil-borne organisms consistent with C. tetani distribution in nature. All vaccine strains form a clade distinct from currently sequenced wild type strains when considering variations in these mobile elements. SNP, flagellar glycosylation island, prophage content and CRISPR/Cas phylogenic histories provide tentative evidence suggesting vaccine and wild type strains share a common ancestor.	[Cohen, Jonathan E.; Keller, James E.] US FDA, Lab Resp & Special Pathogens, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Wang, Rong; Shen, Rong-Fong; Wu, Wells W.] US FDA, Facil Biotechnol Resources, Ctr Biol Evaluat & Res, Silver Spring, MD USA	Keller, JE (reprint author), US FDA, Lab Resp & Special Pathogens, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	James.keller@fda.hhs.gov			FDA/CBER; Center for Biologics Evaluation and Research, Food and Drug Administration	FDA/CBER intramural funding supported this work; This work was supported by the intramural research program at the Center for Biologics Evaluation and Research, Food and Drug Administration. We thank Christina Egan, (Ph.D., NYDPH) for her help tracing the history of the Harvard strain and, Diana M. Oram, (Ph.D.) and Michael P. Schmitt (Ph.D.) for helpful discussions and comments on the manuscript.	Ackermann H.W., 2010, MANUAL AQUATIC VIRAL, P182, DOI DOI 10.4319/MAVE.2010.978-0-9845591-0-7.182; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bengtson IA, 1919, AM J PUBLIC HEALTH, V9, P427, DOI 10.2105/AJPH.9.6.427                                                            ; Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI 10.1093/nar/gks1195; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Bruggemann H, 2005, CURR OPIN MICROBIOL, V8, P601, DOI 10.1016/j.mib.2005.08.006; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Bruggemann H, 2015, RES MICROBIOL, V166, P326, DOI 10.1016/j.resmic.2015.01.002; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carter AT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-115; Collins MD, 1998, J APPL MICROBIOL, V84, P5, DOI 10.1046/j.1365-2672.1997.00313.x; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Das B, 2013, TRENDS MICROBIOL, V21, P23, DOI 10.1016/j.tim.2012.10.003; Duchene S, 2016, MICROBIAL GENOME, P2; Fildes P, 1927, BRIT J EXP PATHOL, V8, P219; Fournier P-E, 2014, New Microbes New Infect, V2, P25, DOI 10.1002/2052-2975.27; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gupta RS, 2009, INT J SYST EVOL MICR, V59, P285, DOI 10.1099/ijs.0.001792-0; Haraldsen JD, 2003, MOL MICROBIOL, V48, P811, DOI 10.1046/j.1365-2958.2003.03471.x; Heller HH, 1922, J INFECT DIS, V30, P33; Heller HH, 1922, J INFECT DIS, V30, P18; Hill KK, 2015, TOXICON, V107, P2, DOI 10.1016/j.toxicon.2015.09.011; Kim K-P, 2012, BACTERIOPHAGE, V2, P89, DOI DOI 10.4161/BACT.21363; LATHAM WC, 1962, APPL MICROBIOL, V10, P146; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Menard R, 2014, ANTIMICROB AGENTS CH, V58, P7430, DOI 10.1128/AAC.03858-14; Morrison MJ, 2014, BIOCHEMISTRY-US, V53, P624, DOI 10.1021/bi401546r; MUELLER JH, 1945, J IMMUNOL, V50, P377; Negahdaripour M, 2017, INFECT GENETICS EVOL; Oliveros J. C., 2007, VENNY INTERACTIVE TO; Olson ND, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00235; Parte AC, 2014, NUCLEIC ACIDS RES, V42, pD613, DOI 10.1093/nar/gkt1111; Popoff MR, 2014, ANAEROBE, V30, P220, DOI 10.1016/j.anaerobe.2014.05.014; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rossetto O, 2014, NAT REV MICROBIOL, V12, P535, DOI 10.1038/nrmicro3295; Rummel A, 2015, TOXICON, V107, P9, DOI 10.1016/j.toxicon.2015.09.009; SANADA I, 1965, J BACTERIOL, V89, P626; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Skarin H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-185; Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x                                                ; Smith TJ, 2015, RES MICROBIOL, V166, P290, DOI 10.1016/j.resmic.2014.09.007; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; STRAGIER P, 1989, SCIENCE, V243, P507, DOI 10.1126/science.2536191; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Tenbroeck C, 1922, J EXP MED, V36, P261, DOI 10.1084/jem.36.3.261; Tenbroeck C, 1923, J EXP MED, V37, P479, DOI 10.1084/jem.37.4.479; Twine SM, 2008, FEBS J, V275, P4428, DOI 10.1111/j.1742-4658.2008.06589.x; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	53	0	0	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182909	10.1371/journal.pone.0182909				24	Multidisciplinary Sciences	Science & Technology - Other Topics	FD3KL	WOS:000407431800034	28800585	gold			2018-01-05	
J	Voets, O; Tielen, F; Elstak, E; Benschop, J; Grimbergen, M; Stallen, J; Janssen, R; van Marle, A; Essrich, C				Voets, Olaf; Tielen, Frans; Elstak, Edo; Benschop, Julian; Grimbergen, Max; Stallen, Jan; Janssen, Richard; van Marle, Andre; Essrich, Christian			Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; CRISPR-CAS9 SYSTEM; TGF-BETA; GENOME; EXPRESSION; MICE; ENDONUCLEASE; REVEALS; CAS9; RNAI	Phenotypic assays using human primary cells are highly valuable tools for target discovery and validation in drug discovery. Expression knockdown (KD) of such targets in these assays allows the investigation of their role in models of disease processes. Therefore, efficient and fast modes of protein KD in phenotypic assays are required. The CRISPR/Cas9 system has been shown to be a versatile and efficient means of gene inactivation in immortalized cell lines. Here we describe the use of adenoviral (AdV) CRISPR/Cas9 vectors for efficient gene inactivation in two human primary cell types, normal human lung fibroblasts and human bronchial epithelial cells. The effects of gene inactivation were studied in the TGF-beta-induced fibroblast to myofibroblast transition assay (FMT) and the epithelial to mesenchymal transition assay (EMT), which are SMAD3 dependent and reflect pathogenic mechanisms observed in fibrosis. Co-transduction (co-TD) of AdV Cas9 with SMAD3-targeting guide RNAs (gRNAs) resulted in fast and efficient genome editing judged by insertion/deletion (indel) formation, as well as significant reduction of SMAD3 protein expression and nuclear translocation. This led to phenotypic changes downstream of SMAD3 inhibition, including substantially decreased alpha smooth muscle actin and fibronectin 1 expression, which are markers for FMT and EMT, respectively. A direct comparison between co-TD of separate Cas9 and gRNA AdV, versus TD with a single "all-in-one" Cas9/gRNA AdV, revealed that both methods achieve similar levels of indel formation. These data demonstrate that AdV CRISPR/Cas9 is a useful and efficient tool for protein KD in human primary cell phenotypic assays. The use of AdV CRISPR/Cas9 may offer significant advantages over the current existing tools and should enhance target discovery and validation opportunities.	[Voets, Olaf; Tielen, Frans; Elstak, Edo; Benschop, Julian; Grimbergen, Max; Stallen, Jan; Janssen, Richard; van Marle, Andre; Essrich, Christian] Galapagos BV, Cl Leiden, Netherlands	van Marle, A (reprint author), Galapagos BV, Cl Leiden, Netherlands.	richard.janssen@glpg.com					Abrahimi P, 2015, CIRC RES, V117, P121, DOI 10.1161/CIRCRESAHA.117.306290; Arts GJ, 2003, GENOME RES, V13, P2325, DOI 10.1101/gr.1332603; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bellec J, 2015, CURR GENE THER, V15, P447; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Chu HW, 2015, GENE THER, V22, P822, DOI 10.1038/gt.2015.53; Claussnitzer M, 2015, NEW ENGL J MED, V373; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Ghosh AK, 2000, ONCOGENE, V19, P3546, DOI 10.1038/sj.onc.1203693; Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/nmeth.3075, 10.1038/NMETH.3075]; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139; Maggio I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05105; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Michiels F, 2002, NAT BIOTECHNOL, V20, P1154, DOI 10.1038/nbt746; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Ohneda K, 2014, MOL CELL BIOL, V34, P1812, DOI [10.1128/MCB.01524, 10.1128/MCB.01524-13]; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Popp MW, 2016, CELL, V165, P1319, DOI 10.1016/j.cell.2016.05.053; Ratz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09592; Rippmann JF, 2009, J LIPID RES, V50, P22, DOI 10.1194/jlr.M700571-JLR200; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; van Es HHG, 2005, DRUG DISCOV TODAY, V10, P1385, DOI 10.1016/S1359-6446(05)03590-7                                                   ; Van Wetering S, 2000, AM J PHYSIOL-LUNG C, V278, pL51; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889	44	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182974	10.1371/journal.pone.0182974				20	Multidisciplinary Sciences	Science & Technology - Other Topics	FD3KL	WOS:000407431800040	28800587	gold			2018-01-05	
J	Hong, CP; Park, J; Lee, Y; Lee, M; Park, SG; Uhm, Y; Lee, J; Kim, CK				Hong, Chang Pyo; Park, Jihye; Lee, Yi; Lee, Minjee; Park, Sin Gi; Uhm, Yurry; Lee, Jungho; Kim, Chang-Kug			accD nuclear transfer of Platycodon grandiflorum and the plastid of early Campanulaceae	BMC GENOMICS			English	Article						accD; Campanulaceae; Genomic rearrangement; Intron loss; Nuclear gene transfer; Plastid	ACETYL-COA CARBOXYLASE; TRANSFER-RNA GENES; REARRANGED CHLOROPLAST GENOME; INVERTED REPEAT; HIGHER-PLANTS; TRACHELIUM-CAERULEUM; NUCLEOTIDE-SEQUENCES; MEDICAGO-TRUNCATULA; DNA-MOLECULES; EVOLUTION	Background: Campanulaceae species are known to have highly rearranged plastid genomes lacking the acetyl-CoA carboxylase (ACC) subunit D gene (accD), and instead have a nuclear (nr)-accD. Plastid genome information has been thought to depend on studies concerning Trachelium caeruleum and genome announcements for Adenophora remotiflora, Campanula takesimana, and Hanabusaya asiatica. RNA editing information for plastid genes is currently unavailable for Campanulaceae. To understand plastid genome evolution in Campanulaceae, we have sequenced and characterized the chloroplast (cp) genome and nr-accD of Platycodon grandiflorum, a basal member of Campanulaceae. Results: We sequenced the 171,818 bp cp genome containing a 79,061 bp large single-copy (LSC) region, a 42,433 bp inverted repeat (IR) and a 7840 bp small single-copy (SSC) region, which represents the cp genome with the largest IR among species of Campanulaceae. The genome contains 110 genes and 18 introns, comprising 77 protein-coding genes, four RNA genes, 29 tRNA genes, 17 group II introns, and one group I intron. RNA editing of genes was detected in 18 sites of 14 protein-coding genes. Platycodon has an IR containing a 3' rps12 operon, which occurs in the middle of the LSC region in four other species of Campanulaceae (T. caeruleum, A. remotiflora, C. takesimana, and H. asiatica), but lacks accD, clpP, infA, and rpl23, as has been found in these four species. Platycodon nr-accD contains about 3.2 kb intron between nr-accD. e1 and nr-accD. e2 at the same insertion point as in other Campanulaceae. The phylogenies of the plastid genomes and accD show that Platycodon is basal in the Campanulaceae clade, indicating that IR disruption in Campanulaceae occurred after the loss of accD, clpP, infA, and rpl23 in the cp genome, which occurred during plastid evolution in Campanulaceae. Conclusions: The plastid genome of P. grandiflorum lacks the rearrangement of the IR found in T. caeruleum, A. remotiflora, C. takesimana, and H. asiatica. The absence of accD, clpP, infA, and rpl23 in the plastid genome is a synapomorphic characteristic of Campanulaceae. The chloroplast genome phylogeny supports the hypothesis that chloroplast genomic arrangement occurred after accD nuclear transfer and loss of the four genes in the plastid of early Campanulaceae as a lineage of asterids.	[Hong, Chang Pyo; Park, Sin Gi] Theragen Etex Bio Inst, Bioinformat Team, Suwon 443270, South Korea; [Park, Jihye; Lee, Minjee; Lee, Jungho] Green Plant Inst, Heungdeok IT Valley, B-301, Yongin 446908, South Korea; [Lee, Yi] Chungbuk Natl Univ, Dept Ind Plant Sci & Technol, Cheongju 362763, South Korea; [Uhm, Yurry] Natl Inst Hort & Herbal Sci NIHH, Herbal Crop Res Div, RDA, Eumseong 369873, South Korea; [Kim, Chang-Kug] Natl Inst Agr Sci NAS, Genom Div, RDA, Jeonju 560500, South Korea	Lee, J (reprint author), Green Plant Inst, Heungdeok IT Valley, B-301, Yongin 446908, South Korea.; Kim, CK (reprint author), Natl Inst Agr Sci NAS, Genom Div, RDA, Jeonju 560500, South Korea.	jlee@greenplant.re.kr; chang@korea.kr			National Agricultural Genome Center, Rural Development Administration, Republic of Korea [PJ010351, PJ010456]	This work was supported by grants from the National Agricultural Genome Center (project No. PJ010351 & PJ010456), Rural Development Administration, Republic of Korea.	Bendich AJ, 2004, PLANT CELL, V16, P1661, DOI 10.1105/tpc.160771; Besendahl A, 2000, CURR GENET, V37, P12, DOI 10.1007/s002940050002                                                           ; Cai ZQ, 2008, J MOL EVOL, V67, P696, DOI 10.1007/s00239-008-9180-7; Cheon KS, 2014, MITOCHONDR DNA, V27, P2169; Cheon KS, 2014, MITOCHONDR DNA, V27, P1629; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Cosner ME, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-27; Cosner ME, 1997, CURR GENET, V31, P419, DOI 10.1007/s002940050225                                                           ; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Vries J, 2015, PLANT CELL, V27, P1827, DOI 10.1105/tpc.114.135541; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; FUKUZAWA H, 1988, J MOL BIOL, V203, P333, DOI 10.1016/0022-2836(88)90003-4; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Gornicki P, 1997, P NATL ACAD SCI USA, V94, P14179, DOI 10.1073/pnas.94.25.14179; Grewe F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-8; Guisinger MM, 2011, MOL BIOL EVOL, V28, P583, DOI 10.1093/molbev/msq229; Guisinger MM, 2008, P NATL ACAD SCI USA, V105, P18424, DOI 10.1073/pnas.0806759105; Guo WH, 2014, GENOME BIOL EVOL, V6, P580, DOI 10.1093/gbe/evu046; Haberle RC, 2006, PHYLOGENY COMP CHLOR; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Harris ME, 2013, PLANT MOL BIOL REP, V31, P21, DOI 10.1007/s11105-012-0461-3; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880                                                              ; Jansen R. K., 2012, GENOMICS CHLOROPLAST, P103, DOI [10.1007/978-94-007-2920-9_5, DOI 10.1007/978-94-007-2920-9_]; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jeong H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-286; Kim KA, 2016, MITOCHONDRIAL DNA A, V27, P2963, DOI 10.3109/19401736.2015.1060461; Knox EB, 1999, PLANT SYST EVOL, V214, P49, DOI 10.1007/BF00985731                                                              ; Kode V, 2005, PLANT J, V44, P237, DOI 10.1111/j.1365-313X.2005.02533.x; KOLODNER R, 1979, P NATL ACAD SCI USA, V76, P41, DOI 10.1073/pnas.76.1.41; KONISHI T, 1994, P NATL ACAD SCI USA, V91, P3598, DOI 10.1073/pnas.91.9.3598                                                          ; Konishi T, 1996, PLANT CELL PHYSIOL, V37, P117, DOI 10.1093/oxfordjournals.pcp.a028920                                              ; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Lee J. J., 1997, THESIS; Lee Jungho, 2002, Algae, V17, P53; Lee Jungho, 2002, Algae, V17, P59; Lilly JW, 2001, PLANT CELL, V13, P245, DOI 10.1105/tpc.13.2.245; Lin CP, 2012, GENOME BIOL EVOL, V4, P374, DOI 10.1093/gbe/evs021; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Magee AM, 2010, GENOME RES, V20, P1700, DOI 10.1101/gr.111955.110; Matsuo M, 2005, PLANT CELL, V17, P665, DOI 10.1105/tpc.104.027706; Michaud M, 2011, PLANT J, V66, P80, DOI 10.1111/j.1365-313X.2011.04490.x; MILLIGAN BG, 1989, MOL BIOL EVOL, V6, P355; Molina J, 2014, MOL BIOL EVOL, V31, P793, DOI 10.1093/molbev/msu051; Noutsos C, 2005, GENOME RES, V15, P616, DOI 10.1101/gr.9788705; Oldenburg DJ, 2004, J MOL BIOL, V344, P1311, DOI 10.1016/j.jmb.2004.10.001; Oldenburg DJ, 2004, J MOL BIOL, V335, P953, DOI 10.1016/j.jmb.2003.11.020; PALMER JD, 1988, CURR GENET, V14, P65, DOI 10.1007/BF00405856; PALMER JD, 1987, CURR GENET, V11, P275, DOI 10.1007/BF00355401; Perry AS, 2002, DNA RES, V9, P157, DOI 10.1093/dnares/9.5.157                                                          ; Rockenbach K, 2016, GENETICS, V204, P1507, DOI 10.1534/genetics.116.188268; Rogalski M, 2008, NAT STRUCT MOL BIOL, V15, P192, DOI 10.1038/nsmb.1370; Rousseau-Gueutin M, 2013, PLANT PHYSIOL, V161, P1918, DOI 10.1104/pp.113.214528; Shaver JM, 2008, PLANT PHYSIOL, V146, P1064, DOI 10.1104/pp.107.112946; Shaver JM, 2006, PLANTA, V224, P72, DOI 10.1007/s00425-005-0195-7; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; TSUDZUKI J, 1992, MOL GEN GENET, V232, P206; Wang MX, 2015, PLANT MOL BIOL REP, V33, P1526, DOI 10.1007/s11105-015-0853-2; Wu CS, 2011, GENOME BIOL EVOL, V3, P309, DOI 10.1093/gbe/evr026; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zhu AD, 2016, NEW PHYTOL, V209, P1747, DOI 10.1111/nph.13743	62	0	0	4	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	AUG 11	2017	18								607	10.1186/s12864-017-4014-x				13	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FE2GX	WOS:000408035900003	28800729	gold			2018-01-05	
J	Kazlauskiene, M; Kostiuk, G; Venclovas, C; Tamulaitis, G; Siksnys, V				Kazlauskiene, Migle; Kostiuk, Georgij; Venclovas, Ceslovas; Tamulaitis, Gintautas; Siksnys, Virginijus			A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems	SCIENCE			English	Article							CRYSTAL-STRUCTURE; EFFECTOR COMPLEX; DNA CLEAVAGE; RNA; IMMUNITY; PROTEIN; RECOGNITION; ENDORIBONUCLEASE; SUPERFAMILY; DEGRADATION	Type III CRISPR-Cas systems in prokaryotes provide immunity against invading nucleic acids through the coordinated degradation of transcriptionally active DNA and its transcripts by the Csm effector complex. The Cas10 subunit of the complex contains an HD nuclease domain that is responsible for DNA degradation and two Palm domains with elusive functions. In addition, Csm6, a ribonuclease that is not part of the complex, is also required to provide full immunity. We show here that target RNA binding by the Csm effector complex of Streptococcus thermophilus triggers Cas10 to synthesize cyclic oligoadenylates (cA(n); n = 2 to 6) by means of the Palm domains. Acting as signaling molecules, cyclic oligoadenylates bind Csm6 to activate its nonspecific RNA degradation. This cyclic oligoadenylate-based signaling pathway coordinates different components of CRISPR-Cas to prevent phage infection and propagation.	[Kazlauskiene, Migle; Kostiuk, Georgij; Venclovas, Ceslovas; Tamulaitis, Gintautas; Siksnys, Virginijus] Vilnius Univ, Inst Biotechnol, Sauletekio Ave 7, LT-10257 Vilnius, Lithuania	Tamulaitis, G; Siksnys, V (reprint author), Vilnius Univ, Inst Biotechnol, Sauletekio Ave 7, LT-10257 Vilnius, Lithuania.	tamulaitis@ibt.lt; siksnys@ibt.lt	Tamulaitis, Gintautas/U-9601-2017	Tamulaitis, Gintautas/0000-0002-2259-3033	Research Council of Lithuania [APP-3/2016]	We thank A. Ruksenaite and L. Taujenis (Thermofisher Scientific) for help with HPLC-MS experiments; A. Silanskas for HPLC purification of adenylates; P. Moller Martensen (Aarhus University) for a kind gift of pOAS1 and pPDE12 plasmids; P. Horvath (DuPont) for a kind gift of S. thermophilus DGCC8004 strain and discussions; and S. E. Halford for critical reading of the manuscript. G.T. acknowledges support from the Research Council of Lithuania (grant APP-3/2016). M.K., G.K., G.T., and V.S. are inventors on patent applications related to the work described in this manuscript: V.S., M.K., and G.T. on international patent application PCT/IB2015/056756 submitted by Vilnius University, which covers the StCsm complex and its use for directed RNA cleavage, and V.S., M.K., G.K., and G.T. on U.S. provisional patent application 62/512868 submitted by Vilnius University, which covers production of cyclic oligoadenylates and their use as allosteric regulators. Expression plasmids used in this work are available from G.T., M.K., or V.S. under a material transfer agreement with Vilnius University.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Burroughs A Maxwell, 2015, Nucleic Acids Res, V43, P10633, DOI 10.1093/nar/gkv1267; Cocozaki AI, 2012, STRUCTURE, V20, P545, DOI 10.1016/j.str.2012.01.018; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; FUJIMOTO M, 1974, AGR BIOL CHEM TOKYO, V38, P1555, DOI 10.1080/00021369.1974.10861384                                                  ; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Koonin EV, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600186; Lintner NG, 2011, J MOL BIOL, V405, P939, DOI 10.1016/j.jmb.2010.11.019; Liu TY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170552; Makarova KS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00102; Makarova KS, 2013, BIOCHEM SOC T, V41, P1392, DOI 10.1042/BST20130038; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115; Opoku-Temeng C, 2016, CHEM COMMUN, V52, P9327, DOI 10.1039/c6cc03439j; Osawa T, 2013, J MOL BIOL, V425, P3811, DOI 10.1016/j.jmb.2013.03.042; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; SCHMIDT A, 1979, P NATL ACAD SCI USA, V76, P4788, DOI 10.1073/pnas.76.10.4788; Sheppard NF, 2016, RNA, V22, P216, DOI 10.1261/rna.039842.113; Silverman RH, 2007, CYTOKINE GROWTH F R, V18, P381, DOI 10.1016/j.cytogfr.2007.06.012; Tamulaitis G, 2017, TRENDS MICROBIOL, V25, P49, DOI 10.1016/j.tim.2016.09.012; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Topuzlu E, 2016, RNA BIOL, V13, P254, DOI 10.1080/15476286.2015.1130209; Yan XF, 2015, RNA BIOL, V12, P749, DOI 10.1080/15476286.2015.1051300; Zhu X, 2012, FEBS LETT, V586, P939, DOI 10.1016/j.febslet.2012.02.036	28	6	6	12	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					605	+		10.1126/science.aao0100				5	Multidisciplinary Sciences	Science & Technology - Other Topics	FD1VM	WOS:000407324800044	28663439				2018-01-05	
J	Liu, L; Li, XY; Ma, J; Li, ZQ; You, LL; Wang, JY; Wang, M; Zhang, XZ; Wang, YL				Liu, Liang; Li, Xueyan; Ma, Jun; Li, Zongqiang; You, Lilan; Wang, Jiuyu; Wang, Min; Zhang, Xinzheng; Wang, Yanli			The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a	CELL			English	Article							TARGET DNA RECOGNITION; STRUCTURAL BASIS; CRYO-EM; CRISPR; SYSTEMS; COMPLEX; REVEALS; ENDONUCLEASE; PROKARYOTES; IMMUNITY	Cas13a, a type VI-A CRISPR-Cas RNA-guided RNA ribonuclease, degrades invasive RNAs targeted by CRISPR RNA (crRNA) and has potential applications in RNA technology. To understand how Cas13a is activated to cleave RNA, we have determined the crystal structure of Leptotrichia buccalis (Lbu) Cas13a bound to crRNA and its target RNA, as well as the cryo-EM structure of the LbuCas13a-crRNA complex. The crRNA-target RNA duplex binds in a positively charged central channel of the nuclease (NUC) lobe, and Cas13a protein and crRNA undergo a significant conformational change upon target RNA binding. The guide-target RNA duplex formation triggers HEPN1 domain to move toward HEPN2 domain, activating the HEPN catalytic site of Cas13a protein, which subsequently cleaves both single-stranded target and collateral RNAs in a non-specific manner. These findings reveal how Cas13a of type VI CRISPR-Cas systems defend against RNA phages and set the stage for its development as a tool for RNA manipulation.	[Liu, Liang; Li, Xueyan; Li, Zongqiang; You, Lilan; Wang, Jiuyu; Wang, Min; Wang, Yanli] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing 100101, Peoples R China; [Li, Xueyan; You, Lilan; Zhang, Xinzheng; Wang, Yanli] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Ma, Jun; Zhang, Xinzheng] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Zhang, Xinzheng] Chinese Acad Sci, Inst Biophys, Ctr Biol Imaging, CAS Ctr Excellence Biomacromol, Beijing 100101, Peoples R China; [Wang, Yanli] Collaborat Innovat Ctr Genet & Dev, Shanghai 200438, Peoples R China	Wang, YL (reprint author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing 100101, Peoples R China.; Zhang, XZ; Wang, YL (reprint author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Zhang, XZ (reprint author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Zhang, XZ (reprint author), Chinese Acad Sci, Inst Biophys, Ctr Biol Imaging, CAS Ctr Excellence Biomacromol, Beijing 100101, Peoples R China.; Wang, YL (reprint author), Collaborat Innovat Ctr Genet & Dev, Shanghai 200438, Peoples R China.	xzzhang@ibp.ac.cn; ylwang@ibp.ac.cn			Chinese Ministry of Science and Technology [2014CB910102]; Natural Science Foundation of China [91440201, 31571335, 31400640, 31570874]; Chinese Academy of Sciences [XDB08010203]; "National Thousand (Young) Talents Program" from the Office of Global Experts Recruitment in China	We thank the staff of the BL-17U1, BL-18U, and BL-19U1 beamlines at the National Center for Protein Sciences Shanghai (NCPSS) at SSRF. We thank X. Huang, G. Ji, Z. Guo, B. Zhu, D. Fan, F. Sun, and other staff members at the Center for Biological Imaging (IBP, CAS) for their support in cryo-EM data collection. This work was supported by grants from the Chinese Ministry of Science and Technology (2014CB910102), the Natural Science Foundation of China (91440201, 31571335, 31400640, 31570874), and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08010203). X.Z. received scholarships from the "National Thousand (Young) Talents Program" from the Office of Global Experts Recruitment in China. We thank Joy Fleming for critical reading of the manuscript and linguistic assistance.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brown A., 2015, CELL, V170, p[714, 725]; East-Seletsky A, 2017, MOL CELL, V66, P373, DOI 10.1016/j.molcel.2017.04.008; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gorski SA, 2017, NAT REV MOL CELL BIO, V18, P215, DOI 10.1038/nrm.2016.174; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Han YC, 2014, SCIENCE, V343, P1244, DOI 10.1126/science.1249845; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lewis KM, 2017, MOL CELL, V65, P377, DOI 10.1016/j.molcel.2017.01.024; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Makarova KS, 2017, CELL, V168, P946, DOI 10.1016/j.cell.2017.02.018; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plagens A, 2015, FEMS MICROBIOL REV, V39, P442, DOI 10.1093/femsre/fuv019; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B., 2015, CPF1 IS SINGLE RNA G; [Anonymous], ACTA CRYSTALLOGR D, V71, P136	42	4	4	19	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					714	+		10.1016/j.cell.2017.06.050				23	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FD3PU	WOS:000407445700012	28757251				2018-01-05	
J	Yan, H; Opachaloemphan, C; Mancini, G; Yang, H; Gallitto, M; Mlejnek, J; Leibholz, A; Haight, K; Ghaninia, M; Huo, L; Perry, M; Slone, J; Zhou, XF; Traficante, M; Penick, CA; Dolezal, K; Gokhale, K; Stevens, K; Fetter-Pruneda, I; Bonasio, R; Zwiebel, LJ; Berger, SL; Liebig, J; Reinberg, D; Desplan, C				Yan, Hua; Opachaloemphan, Comzit; Mancini, Giacomo; Yang, Huan; Gallitto, Matthew; Mlejnek, Jakub; Leibholz, Alexandra; Haight, Kevin; Ghaninia, Majid; Huo, Lucy; Perry, Michael; Slone, Jesse; Zhou, Xiaofan; Traficante, Maria; Penick, Clint A.; Dolezal, Kelly; Gokhale, Kaustubh; Stevens, Kelsey; Fetter-Pruneda, Ingrid; Bonasio, Roberto; Zwiebel, Laurence J.; Berger, Shelley L.; Liebig, Jurgen; Reinberg, Danny; Desplan, Claude			An Engineered orco Mutation Produces Aberrant Social Behavior and Defective Neural Development in Ants	CELL			English	Article							OLFACTORY SENSORY MAP; HARPEGNATHOS-SALTATOR; CUTICULAR HYDROCARBONS; CHEMOSENSORY RECEPTORS; CHEMICAL COMMUNICATION; CAMPONOTUS-FLORIDANUS; TARGETED MUTAGENESIS; ODORANT RECEPTORS; JUVENILE-HORMONE; DROSOPHILA	Ants exhibit cooperative behaviors and advanced forms of sociality that depend on pheromone-mediated communication. Odorant receptor neurons (ORNs) express specific odorant receptors (ORs) encoded by a dramatically expanded gene family in ants. In most eusocial insects, only the queen can transmit genetic information, restricting genetic studies. In contrast, workers in Harpegnathos saltator ants can be converted into gamergates (pseudoqueens) that can found entire colonies. This feature facilitated CRISPR-Cas9 generation of germline mutations in orco, the gene that encodes the obligate co-receptor of all ORs. orco mutations should significantly impact olfaction. We demonstrate striking functions of Orco in odorant perception, reproductive physiology, and social behavior plasticity. Surprisingly, unlike in other insects, loss of OR functionality also dramatically impairs development of the antennal lobe to which ORNs project. Therefore, the development of genetics in Harpegnathos establishes this ant species as a model organism to study the complexity of eusociality.	[Yan, Hua; Opachaloemphan, Comzit; Yang, Huan; Gallitto, Matthew; Reinberg, Danny] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Mancini, Giacomo; Mlejnek, Jakub; Leibholz, Alexandra; Huo, Lucy; Perry, Michael; Traficante, Maria; Stevens, Kelsey; Desplan, Claude] NYU, Dept Biol, New York, NY 10003 USA; [Haight, Kevin; Ghaninia, Majid; Penick, Clint A.; Dolezal, Kelly; Gokhale, Kaustubh; Liebig, Jurgen] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Slone, Jesse; Zhou, Xiaofan; Zwiebel, Laurence J.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Fetter-Pruneda, Ingrid] Rockefeller Univ, Lab Social Evolut & Behav, New York, NY 10065 USA; [Bonasio, Roberto; Berger, Shelley L.] Univ Penn, Perelman Sch Med, Penn Epigenet Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Bonasio, Roberto; Berger, Shelley L.] Univ Penn, Perelman Sch Med, Penn Epigenet Inst, Dept Genet, Philadelphia, PA 19104 USA; [Bonasio, Roberto; Berger, Shelley L.] Univ Penn, Perelman Sch Med, Penn Epigenet Inst, Dept Biol, Philadelphia, PA 19104 USA; [Yan, Hua; Reinberg, Danny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	Reinberg, D (reprint author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.; Desplan, C (reprint author), NYU, Dept Biol, New York, NY 10003 USA.; Liebig, J (reprint author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.; Berger, SL (reprint author), Univ Penn, Perelman Sch Med, Penn Epigenet Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.; Berger, SL (reprint author), Univ Penn, Perelman Sch Med, Penn Epigenet Inst, Dept Genet, Philadelphia, PA 19104 USA.; Berger, SL (reprint author), Univ Penn, Perelman Sch Med, Penn Epigenet Inst, Dept Biol, Philadelphia, PA 19104 USA.; Reinberg, D (reprint author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	bergers@mail.med.upenn.edu; juergen.liebig@asu.edu; danny.reinberg@nyumc.org; cd38@nyu.edu			Howard Hughes Medical Institute [2009005]; HCIA [2009005]; NIH [R21GM114457, EY13010, K99 EY027016, DP2MH107055]; Helen Hay Whitney Foundation	We appreciate the advice and assistance from Gregory Pask, Daniel Simola, and Takahiro Ohde in designing orco sgRNAs and improving reproduction of individually isolated ants; from Brittany Enzmann for embryo injections; from Christopher Albin-Brooks for behavioral responses to odorants; from Waring (Buck) Trible (Daniel Kronauer's lab) for deep sequencing to test somatic mutation efficiency; from Haiyan Zheng and Shengjiang Tu for mass spectrometry; and from Lynne Vales for helping in manuscript preparation. We also appreciate the assistance from Heike Pelka, Anika Paradkar, Nicholas Rogers, and Chen Dong in managing the ant room, maintaining ant colonies, or analyzing behavioral videos. This work was supported by a Howard Hughes Medical Institute Collaborative Innovation Award (CIA; #2009005) (to D.R., S.L.B., and J.L.), HCIA #2009005 (to D.R., S.L.B., J.L., C.D., and L.J.Z.), NIH grants (R21GM114457 to D.R.; EY13010 to C.D.). H. Yan was an NIH Ruth L. Kirschstein NRSA Postdoctoral Fellow (F32AG044971). M.P. was supported by NIH grant K99 EY027016. R.B. was supported by the Helen Hay Whitney Foundation and by an NIH New Innovator Award (DP2MH107055).	ALI MF, 1990, BIOL REV, V65, P227, DOI 10.1111/j.1469-185X.1990.tb01425.x; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Boroczky K, 2013, P NATL ACAD SCI USA, V110, P3615, DOI 10.1073/pnas.1212466110; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonasio R, 2012, ANN NY ACAD SCI, V1260, P14, DOI 10.1111/j.1749-6632.2011.06363.x; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Capinera JL, 2004, ENCY ENTOMOLOGY; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chiang A, 2009, DEVELOPMENT, V136, P1273, DOI 10.1242/dev.031377; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Depickere S, 2004, J INSECT BEHAV, V17, P81, DOI 10.1023/B:JOIR.0000025134.06111.be; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Ghaninia M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03964-7; Haight KL, 2012, J INSECT PHYSIOL, V58, P1568, DOI 10.1016/j.jinsphys.2012.09.011; Hassan BA, 2015, CELL, V163, P285, DOI 10.1016/j.cell.2015.09.031; Henderson D.S., 2004, DROSOPHILA CYTOGENET; Holldobler B., 2008, SUPERORGANISM BEAUTY; Holldobler B., 1990, ANTS; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Hou Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002716; Hoyer SC, 2005, ARTHROPOD STRUCT DEV, V34, P429, DOI 10.1016/j.asd.2005.03.003; HUBEL DH, 1979, SCI AM, V241, P150, DOI 10.1038/scientificamerican0979-150                                              ; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8                                                   ; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574                                                                ; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kather R, 2015, J CHEM ECOL, V41, P871, DOI 10.1007/s10886-015-0631-5; Khila A., 2009, COLD SPRING HARB PRO, V7; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; Koutroumpa FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep29620; Laissue PP, 2008, ADV EXP MED BIOL, V628, P102, DOI 10.1007/978-0-387-78261-4_7; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leonhardt SD, 2016, CELL, V164, P1277, DOI 10.1016/j.cell.2016.01.035; Li Y, 2016, INSECT BIOCHEM MOLEC, V79, P27, DOI 10.1016/j.ibmb.2016.10.003; Liebig J, 1998, NATURWISSENSCHAFTEN, V85, P133, DOI 10.1007/s001140050470; Liebig J, 2000, P NATL ACAD SCI USA, V97, P4124, DOI 10.1073/pnas.97.8.4124; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; McKenzie SK, 2016, P NATL ACAD SCI USA, V113, P14091, DOI 10.1073/pnas.1610800113; McKenzie SK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-718; Menuz K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004810; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Nakanishi A, 2009, CELL TISSUE RES, V338, P79, DOI 10.1007/s00441-009-0863-1; Oland LA, 1996, J NEUROBIOL, V30, P92; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Peeters C, 2000, INSECT SOC, V47, P325, DOI 10.1007/PL00001724; Penick CA, 2012, J INSECT PHYSIOL, V58, P1643, DOI 10.1016/j.jinsphys.2012.10.004; Perry M, 2016, NATURE, V535, P280, DOI 10.1038/nature18616; Petsakou A, 2015, CELL, V162, P823, DOI 10.1016/j.cell.2015.07.010; ROBINSON GE, 1987, BEHAV ECOL SOCIOBIOL, V20, P329, DOI 10.1007/BF00300679; Sakano H, 2010, NEURON, V67, P530, DOI 10.1016/j.neuron.2010.07.003; Sasaki T, 2016, AM NAT, V187, P765, DOI 10.1086/686259; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Van Oystaeyen A, 2014, SCIENCE, V343, P287, DOI 10.1126/science.1244899; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0                                                   ; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Watanabe T, 2014, METHODS, V69, P17, DOI 10.1016/j.ymeth.2014.05.006; Wicher D, 2015, PROG MOL BIOL TRANSL, V130, P37, DOI 10.1016/bs.pmbts.2014.11.002; Wilt F.H., 1967, METHODS DEV BIOL; Yan H, 2014, NAT REV GENET, V15, P677, DOI 10.1038/nrg3787; Yang B, 2016, INSECT BIOCHEM MOLEC, V70, P53, DOI 10.1016/j.ibmb.2015.12.003; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhao N, 2010, PLANT PHYSIOL BIOCH, V48, P279, DOI 10.1016/j.plaphy.2010.01.023; Zhou XF, 2015, GENOME BIOL EVOL, V7, P2407, DOI 10.1093/gbe/evv149; Zube C, 2008, ARTHROPOD STRUCT DEV, V37, P469, DOI 10.1016/j.asd.2008.05.004; [Anonymous], TITLE ERROR	74	1	1	27	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					736	+		10.1016/j.cell.2017.06.051				21	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FD3PU	WOS:000407445700014	28802043				2018-01-05	
J	Sechler, AJ; Tancos, MA; Schneider, DJ; King, JG; Fennessey, CM; Schroeder, BK; Murray, TD; Luster, DG; Schneider, WL; Rogers, EE				Sechler, Aaron J.; Tancos, Matthew A.; Schneider, David J.; King, Jonas G.; Fennessey, Christine M.; Schroeder, Brenda K.; Murray, Timothy D.; Luster, Douglas G.; Schneider, William L.; Rogers, Elizabeth E.			Whole genome sequence of two Rathayibacter toxicus strains reveals a tunicamycin biosynthetic cluster similar to Streptomyces chartreusis	PLOS ONE			English	Article							ANNUAL RYEGRASS TOXICITY; MICHIGANENSIS SUBSP MICHIGANENSIS; CORYNEBACTERIUM-RATHAYI; CLAVIBACTER-TOXICUS; ANGUINA-AGROSTIS; IDENTIFICATION; GENE; PATHOGENICITY; CORYNETOXINS; DIVERSITY	Rathayibacter toxicus is a forage grass associated Gram-positive bacterium of major concern to food safety and agriculture. This species is listed by USDA-APHIS as a plant pathogen select agent because it produces a tunicamycin-like toxin that is lethal to livestock and may be vectored by nematode species native to the U.S. The complete genomes of two strains of R. toxicus, including the type strain FH-79, were sequenced and analyzed in comparison with all available, complete R. toxicus genomes. Genome sizes ranged from 2,343,780 to 2,394,755 nucleotides, with 2079 to 2137 predicted open reading frames; all four strains showed remarkable synteny over nearly the entire genome, with only a small transposed region. A cluster of genes with similarity to the tunicamycin biosynthetic cluster from Streptomyces chartreusis was identified. The tunicamycin gene cluster (TGC) in R. toxicus contained 14 genes in two transcriptional units, with all of the functional elements for tunicamycin biosynthesis present. The TGC had a significantly lower GC content (52%) than the rest of the genome (61.5%), suggesting that the TGC may have originated from a horizontal transfer event. Further analysis indicated numerous remnants of other potential horizontal transfer events are present in the genome. In addition to the TGC, genes potentially associated with carotenoid and exopolysaccharide production, bacteriocins and secondary metabolites were identified. A CRISPR array is evident. There were relatively few plant-associated cell-wall hydrolyzing enzymes, but there were numerous secreted serine proteases that share sequence homology to the pathogenicity-associated protein Pat-1 of Clavibacter michiganensis. Overall, the genome provides clear insight into the possible mechanisms for toxin production in R. toxicus, providing a basis for future genetic approaches.	[Sechler, Aaron J.; Tancos, Matthew A.; King, Jonas G.; Fennessey, Christine M.; Luster, Douglas G.; Schneider, William L.; Rogers, Elizabeth E.] ARS, Foreign Disease Weed Sci Res Unit, USDA, Frederick, MD 21702 USA; [Schneider, David J.] ARS, Emerging Pests & Pathogens Res Unit, USDA, Ithaca, NY USA; [Schroeder, Brenda K.] Univ Idaho, Dept Entomol Plant Pathol & Nematol, Moscow, ID 83843 USA; [Murray, Timothy D.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Schneider, David J.] Univ Saskatchewan, Global Inst Food Secur, Saskatoon, SK, Canada; [Schneider, David J.] Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK, Canada; [King, Jonas G.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Fennessey, Christine M.] Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD USA; [Fennessey, Christine M.] Leidos Biomed Res Inc, Frederick, MD USA	Schneider, WL; Rogers, EE (reprint author), ARS, Foreign Disease Weed Sci Res Unit, USDA, Frederick, MD 21702 USA.	william.schneider@ars.usda.gov; elizabeth.rogers@ars.usda.gov		Schneider, David/0000-0002-2124-8385; Murray, Timothy/0000-0002-6772-202X	United States Department of Agriculture Agricultural Research Service appropriated project [8044-22000-040-00D]; Farm Bill grants [13-8130-0247-CA, 148130 -0367-CA]; United States Department of Agriculture (USDA) Agricultural Research Service appropriated project [8044-22000-040-00D]	Funding for this work was from the United States Department of Agriculture Agricultural Research Service appropriated project 8044-22000-040-00D to DGL, WLS, and EER. No grant website available. Funding was also received from two 2008 Farm Bill grants, Section 10201 administered through the United States Department of Agriculture, Animal and Plant Health Inspection Service: 13-8130-0247-CA and 148130 -0367-CA to BKS, TDM, DGL, and WLS. Grant website is http://www.aphis.usda.gov/aphis/resources/farm-bill/lut/p/z1/04 iIUDg4tKPAFJABpSA0fpReYllmemJJZn5eYk5-hH6kVF m8T7-; The authors would like to thank Dr. Ian Riley (University of Adelaide) for providing Rathayibacter toxicus strains and for considerable assistance over the years with R. toxicus. Funding for this work was from the United States Department of Agriculture (USDA) Agricultural Research Service appropriated project 8044-22000-040-00D and from two 2008 Farm Bill grants, Section 10201 administered through the United States Department of Agriculture, Animal and Plant Health Inspection Service (13-8130-0247-CA and 14-8130-0367-CA). Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. USDA is an equal opportunity provider and employer.	Agarkova IV, 2006, PHYTOPATHOLOGY, V96, P1270, DOI 10.1094/PHYTO-96-1270; Akerman B, 2002, ELECTROPHORESIS, V23, P2549, DOI 10.1002/1522-2683(200208)23:16<2549::AID-ELPS2549>3.0.CO;2-Q; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Arif M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156182; BIRD AF, 1984, INT J PARASITOL, V14, P503; BIRD AF, 1985, INT J PARASITOL, V15, P301, DOI 10.1016/0020-7519(85)90067-0                                                    ; Chatel D. L., 1979, Journal of Agriculture Western Australia, V20, P89; Chen WQ, 2010, PROTEIN CELL, V1, P1093, DOI 10.1007/s13238-010-0127-6; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DEBOER SH, 1980, AM POTATO J, V57, P457, DOI 10.1007/BF02854462                                                              ; EDGAR JA, 1982, J CHEM SOC CHEM COMM, P222, DOI 10.1039/c39820000222; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichenlaub R, 2011, ANNU REV PHYTOPATHOL, V49, P445, DOI 10.1146/annurev-phyto-072910-095258; Finnie JW, 2006, AUST VET J, V84, P271, DOI 10.1111/j.1751-0813.2006.00019.x; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gartemann KH, 2008, J BACTERIOL, V190, P2138, DOI 10.1128/JB.01595-07; Gomez-Escribano JP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1652-8; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Heider SAE, 2014, FEBS J, V281, P4906, DOI 10.1111/febs.13033; JAGO MV, 1983, CHEM-BIOL INTERACT, V45, P223, DOI 10.1016/0009-2797(83)90070-4; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275; Kessell D., 2010, ANN RYEGRASS TOXICIT, P1; Kirby R, 2011, FEMS MICROBIOL LETT, V319, P1, DOI 10.1111/j.1574-6968.2011.02242.x; Kowalski MC, 2007, AUST J EXP AGR, V47, P177, DOI 10.1071/EA05162; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054; Lian LH, 2007, LETT APPL MICROBIOL, V45, P262, DOI 10.1111/j.1472-765X.2007.02184.x; Liu YC, 2010, BIOINFORMATICS, V26, P1958, DOI 10.1093/bioinformatics/btq338; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; McTaggart LR, 2010, J CLIN MICROBIOL, V48, P4525, DOI 10.1128/JCM.00883-10; Meganathan R, 2009, ECOSAL PLUS, V3; Monteiro-Vitorello CB, 2004, MOL PLANT MICROBE IN, V17, P827, DOI 10.1094/MPMI.2004.17.8.827; Odom AR, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002323; Ophel K. M., 1993, MOL PLANT PATHOL, V83, P676; Peeters K, 2011, FEMS MICROBIOL LETT, V321, P130, DOI 10.1111/j.1574-6968.2011.02326.x; Riadi G, 2012, INT J GENOMICS, V2012; Riley IT, 2008, AUSTRALAS PLANT PATH, V37, P289, DOI 10.1071/AP08022; RILEY IT, 1992, INT J SYST BACTERIOL, V42, P64, DOI 10.1099/00207713-42-1-64                                                        ; Sasaki J, 1998, INT J SYST BACTERIOL, V48, P403, DOI 10.1099/00207713-48-2-403                                                       ; Schaad NW, 2004, SYST APPL MICROBIOL, V27, P763, DOI 10.1078/0723202042369848                                                        ; Schneider WL, 2017, GENOME ANNOUCE UNPUB; Shin SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068824; Stork I, 2008, MOL PLANT PATHOL, V9, P599, DOI [10.1111/j.1364-3703.2008.00484.x, 10.1111/J.1364-3703.2008.00484.X]; STYNES BA, 1983, AUST J AGR RES, V34, P653, DOI 10.1071/AR9830653; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569; Tian BY, 2009, J INVERTEBR PATHOL, V101, P143, DOI 10.1016/j.jip.2009.05.001; Trutko S M, 2005, Mikrobiologiia, V74, P335; van Heel AJ, 2013, NUCLEIC ACIDS RES, V41, pW448, DOI 10.1093/nar/gkt391; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Wyszynski FJ, 2010, CHEM SCI, V1, P581, DOI 10.1039/c0sc00325e	52	0	0	8	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0183005	10.1371/journal.pone.0183005				17	Multidisciplinary Sciences	Science & Technology - Other Topics	FD2WT	WOS:000407396200141	28796837	gold			2018-01-05	
J	Wienert, B; Martyn, GE; Kurita, R; Nakamura, Y; Quinlan, KGR; Crossley, M				Wienert, Beeke; Martyn, Gabriella E.; Kurita, Ryo; Nakamura, Yukio; Quinlan, Kate G. R.; Crossley, Merlin			KLF1 drives the expression of fetal hemoglobin in British HPFH	BLOOD			English	Article							TRANSCRIPTION FACTOR; ERYTHROID-CELLS; IN-VIVO; GLOBIN; ENHANCER; ERYTHROPOIESIS; DISSECTION; PROTEINS; PROMOTER; DISEASE	beta-Hemoglobinopathies are among the most common single-locus inherited diseases. In this condition, high fetal hemoglobin (HbF) levels have been found to be beneficial, and boosting HbF expression is seen as an attractive therapy. Naturally occurring mutations in the fetal globin promoter can result in high HbF persisting into adulthood in a benign condition known as hereditary persistence of fetal hemoglobin (HPFH). Individuals with one form of HPFH, British HPFH, carry a T to C substitution at position -198 of the fetal globin gene promoter. These individuals exhibit HbF levels of up to 20%, enough to ameliorate the symptoms of beta-hemoglobinopathies. Here, we use clustered regularly interspaced short palindromic repeat-mediated genome editing to introduce the -198 substitution into human erythroid HUDEP-2 cells and show that this mutation is sufficient to substantially elevate expression of HbF. We also examined the molecular mechanism underlying the increase in fetal globin expression. Through a combination of in vitro and in vivo studies, wedemonstrate that the mutation creates a de novo binding site for the important erythroid gene activator Kruppel-like factor 1 (KLF1/erythroid KLF). Our results indicate that introducing this single naturally occurring mutation leads to significantly boosted HbF levels.	[Wienert, Beeke; Martyn, Gabriella E.; Quinlan, Kate G. R.; Crossley, Merlin] Univ New South Wales UNSW Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Kurita, Ryo] Japanese Red Cross Soc, Blood Serv Headquarters, Cent Blood Inst, Res & Dev Dept, Tokyo, Japan; [Nakamura, Yukio] RIKEN, BioResource Ctr, Cell Engn Div, Ibaraki, Japan	Crossley, M (reprint author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	m.crossley@unsw.edu.au		Quinlan, Kate/0000-0002-5722-8183; Crossley, Merlin/0000-0003-2057-3642	Australian National Health and Medical Research Council [APP1098391]; University International Postgraduate Award; Australian Postgraduate Award	This work was supported by funding from the Australian National Health and Medical Research Council (APP1098391) (M.C.). B.W. was supported by a University International Postgraduate Award. G.E.M. was supported by an Australian Postgraduate Award.	Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Burdach J, 2014, NUCLEIC ACIDS RES, V42, P276, DOI 10.1093/nar/gkt895; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chong HK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-51; Crossley M, 1996, MOL CELL BIOL, V16, P1695; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Deplancke B, 2016, CELL, V166, P538, DOI 10.1016/j.cell.2016.07.012; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; FISCHER KD, 1990, NUCLEIC ACIDS RES, V18, P5685, DOI 10.1093/nar/18.19.5685                                                          ; Hay D, 2016, NAT GENET, V48, P895, DOI 10.1038/ng.3605; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776                                                           ; Norton LJ, 2017, BLOOD ADV, V1, P685, DOI 10.1182/bloodadvances.2016002303; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PERKINS AC, 1995, NATURE, V375, P318; Perkins A, 2016, BLOOD, V127, P1856, DOI 10.1182/blood-2016-01-694331; POWARS DR, 1984, BLOOD, V63, P921; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; RONCHI A, 1989, NUCLEIC ACIDS RES, V17, P10231, DOI 10.1093/nar/17.24.10231; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; WEATHERALL DJ, 1975, BRIT J HAEMATOL, V29, P205, DOI 10.1111/j.1365-2141.1975.tb01815.x                                              ; Wienert B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8085; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; WOOD WG, 1982, BRIT J HAEMATOL, V50, P401, DOI 10.1111/j.1365-2141.1982.tb01935.x; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053	27	2	2	2	2	AMER SOC HEMATOLOGY	WASHINGTON	2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA	0006-4971	1528-0020		BLOOD	Blood	AUG 10	2017	130	6					803	807		10.1182/blood-2017-02-767400				5	Hematology	Hematology	FD2VQ	WOS:000407393300013	28659276				2018-01-05	
J	Tang, YD; Liu, JT; Wang, TY; Sun, MX; Tian, ZJ; Cai, XH				Tang, Yan-Dong; Liu, Ji-Ting; Wang, Tong-Yun; Sun, Ming-Xia; Tian, Zhi-Jun; Cai, Xue-Hui			Comparison of Pathogenicity-Related Genes in the Current Pseudorabies Virus Outbreak in China	SCIENTIFIC REPORTS			English	Article							US3 PROTEIN-KINASE; THYMIDINE KINASE; GENOMIC CHARACTERIZATION; SIMULTANEOUS DELETION; ACTIN CYTOSKELETON; CRISPR/CAS9 SYSTEM; MEMBRANE-PROTEINS; DEFICIENT MUTANTS; GLYCOPROTEIN; INFECTION	There is currently a pandemic of pseudorabies virus (PRV) variant strains in China. Despite extensive research on PRV variant strains in the past two years, few studies have investigated PRV pathogenicity-related genes. To determine which gene(s) is/are linked to PRV virulence, ten putative virulence genes were knocked out using clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 technology. The pathogenicity of these mutants was evaluated in a mouse model. Our results demonstrated that of the ten tested genes, the thymidine kinase (TK) and glycoprotein M (gM) knockout mutants displayed significantly reduced virulence. However, mutants of other putative virulence genes, such as glycoprotein E (gE), glycoprotein I (gI), Us2, Us9, Us3, glycoprotein G (gG), glycoprotein N (gN) and early protein 0 (EP0), did not exhibit significantly reduced virulence compared to that of the wild-type PRV. To our knowledge, this study is the first to compare virulence genes from the current pandemic PRV variant strain. This study will provide a valuable reference for scientists to design effective live attenuated vaccines in the future.	[Tang, Yan-Dong; Liu, Ji-Ting; Wang, Tong-Yun; Sun, Ming-Xia; Tian, Zhi-Jun; Cai, Xue-Hui] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China; [Liu, Ji-Ting] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun 130018, Peoples R China	Cai, XH (reprint author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China.	cai139@hvri.ac.cn			National Program on Key Research Project [2016YFD0500100]	This study was supported by grants from the National Program on Key Research Project (2016YFD0500100). We thank professor Chang-Jiang Weng of Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences for providing the EP0 antibody.	An TQ, 2013, EMERG INFECT DIS, V19, P1749, DOI 10.3201/eid1911.130177; Boldogkoi Z, 2000, MICROBES INFECT, V2, P1321, DOI 10.1016/S1286-4579(00)01285-5                                                   ; Brack AR, 1999, J VIROL, V73, P5364; Brideau AD, 2000, J VIROL, V74, P834, DOI 10.1128/JVI.74.2.834-845.2000; CARD JP, 1992, J VIROL, V66, P3032; CHEUNG AK, 1994, AM J VET RES, V55, P1710; Clase AC, 2003, J VIROL, V77, P12285, DOI 10.1128/JVI.77.22.12285-12298.2003; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cong X, 2016, VET MICROBIOL, V182, P170, DOI 10.1016/j.vetmic.2015.11.022; Crump CM, 2004, J GEN VIROL, V85, P3517, DOI 10.1099/vir.0.80361-0; Deruelle MJ, 2010, J GEN VIROL, V91, P1127, DOI 10.1099/vir.0.015297-0; Deruelle MJ, 2009, VIROLOGY, V395, P172, DOI 10.1016/j.virol.2009.09.019; Dijkstra JM, 1997, J GEN VIROL, V78, P2147, DOI 10.1099/0022-1317-78-9-2147                                                     ; Geenen K, 2005, VIROLOGY, V331, P144, DOI 10.1016/j.virol.2004.10.027; Guo JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02110; Husak PJ, 2000, J VIROL, V74, P10975, DOI 10.1128/JVI.74.23.10975-10983.2000; Jacob T, 2015, J GEN VIROL, V96, P2328, DOI 10.1099/vir.0.000152; Jons A, 1998, J VIROL, V72, P550; Kang MH, 2010, J VIROL, V84, P8398, DOI 10.1128/JVI.00794-10; KIMMAN TG, 1994, VIROLOGY, V205, P511, DOI 10.1006/viro.1994.1672; KIT S, 1985, AM J VET RES, V46, P1359; Klupp BG, 2000, J VIROL, V74, P6760, DOI 10.1128/JVI.74.15.6760-6768.2000; Kopp M, 2004, J VIROL, V78, P3024, DOI 10.1128/JVI.78.6.3024-3034.2004; Kratchmarov R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058776; Liang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep19176; LOMNICZI B, 1987, J VIROL, V61, P796; Luo YZ, 2014, VET MICROBIOL, V174, P107, DOI 10.1016/j.vetmic.2014.09.003; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MCGREGOR S, 1985, AM J VET RES, V46, P1494; METTENLEITER TC, 1991, COMP IMMUNOL MICROB, V14, P151, DOI 10.1016/0147-9571(91)90128-Z; METTENLEITER TC, 1985, J VIROL, V56, P307; Olsen LM, 2006, J VIROL, V80, P6387, DOI 10.1128/JVI.00352-06; Pellagatti A, 2015, ARCH TOXICOL, V89, P1023, DOI 10.1007/s00204-015-1504-y; PETROVSKIS EA, 1986, J VIROL, V60, P1166; Pomeranz LE, 2005, MICROBIOL MOL BIOL R, V69, P462, DOI 10.1128/MMBR.69.3.462-500.2005; Sun Y, 2016, VET MICROBIOL, V183, P119, DOI 10.1016/j.vetmic.2015.12.008; Tang YD, 2016, VIRUS RES, V225, P33, DOI 10.1016/j.virusres.2016.09.004; Tang YD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040090; Tong W, 2015, VET MICROBIOL, V181, P236, DOI 10.1016/j.vetmic.2015.09.021; Van den Broeke C, 2009, VIROLOGY, V385, P155, DOI 10.1016/j.virol.2008.11.050; Viejo-Borbolla A, 2010, J GEN VIROL, V91, P23, DOI 10.1099/vir.0.011940-0; WATANABE S, 1995, J GEN VIROL, V76, P2881, DOI 10.1099/0022-1317-76-11-2881; Wesley RD, 1996, J VET DIAGN INVEST, V8, P21, DOI 10.1177/104063879600800104                                                      ; Xu AT, 2015, BIOTECHNOL LETT, V37, P1265, DOI 10.1007/s10529-015-1796-2; Ye C, 2015, VIROLOGY, V483, P32, DOI 10.1016/j.virol.2015.04.013; Yu XL, 2014, EMERG INFECT DIS, V20, P102, DOI 10.3201/eid2001.130531; Zhang CL, 2015, VACCINE, V33, P2432, DOI 10.1016/j.vaccine.2015.03.094	47	0	0	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 10	2017	7								7783	10.1038/s41598-017-08269-3				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FD2YK	WOS:000407400500015	28798304	gold			2018-01-05	
J	Shi, HJ; Enriquez, A; Rapadas, M; Martin, EMMA; Wang, R; Moreau, J; Lim, CK; Szot, JO; Ip, E; Hughes, JN; Sugimoto, K; Humphreys, DT; McInerney-Leo, AM; Leo, PJ; Maghzal, GJ; Halliday, J; Smith, J; Colley, A; Mark, PR; Collins, F; Sillence, DO; Winlaw, DS; Ho, JWK; Guillemin, GJ; Brown, MA; Kikuchi, K; Thomas, PQ; Stocker, R; Giannoulatou, E; Chapman, G; Duncan, EL; Sparrow, DB; Dunwoodie, SL				Shi, Hongjun; Enriquez, Annabelle; Rapadas, Melissa; Martin, Ella M. M. A.; Wang, Roni; Moreau, Julie; Lim, Chai K.; Szot, Justin O.; Ip, Eddie; Hughes, James N.; Sugimoto, Kotaro; Humphreys, David T.; McInerney-Leo, Aideen M.; Leo, Paul J.; Maghzal, Ghassan J.; Halliday, Jake; Smith, Janine; Colley, Alison; Mark, Paul R.; Collins, Felicity; Sillence, David O.; Winlaw, David S.; Ho, Joshua W. K.; Guillemin, Gilles J.; Brown, Matthew A.; Kikuchi, Kazu; Thomas, Paul Q.; Stocker, Roland; Giannoulatou, Eleni; Chapman, Gavin; Duncan, Emma L.; Sparrow, Duncan B.; Dunwoodie, Sally L.			NAD Deficiency, Congenital Malformations, and Niacin Supplementation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CAUSES SPONDYLOCOSTAL DYSOSTOSIS; METABOLISM; MUTATIONS; DEFECTS; HUMANS; ASSOCIATION; KYNURENINE; TRYPTOPHAN; VARIANTS; SIRTUINS	BACKGROUND Congenital malformations can be manifested as combinations of phenotypes that co-occur more often than expected by chance. In many such cases, it has proved difficult to identify a genetic cause. We sought the genetic cause of cardiac, vertebral, and renal defects, among others, in unrelated patients. METHODS We used genomic sequencing to identify potentially pathogenic gene variants in families in which a person had multiple congenital malformations. We tested the function of the variant by using assays of in vitro enzyme activity and by quantifying metabolites in patient plasma. We engineered mouse models with similar variants using the CRISPR (clustered regularly interspaced short palindromic repeats)-Cas9 system. RESULTS Variants were identified in two genes that encode enzymes of the kynurenine pathway, 3-hydroxyanthranilic acid 3,4-dioxygenase (HAAO) and kynureninase (KYNU). Three patients carried homozygous variants predicting loss-of-function changes in the HAAO or KYNU proteins (HAAO p.D162*, HAAO p.W186*, or KYNU p.V57Efs*21). Another patient carried heterozygous KYNU variants (p.Y156* and p.F349Kfs*4). The mutant enzymes had greatly reduced activity in vitro. Nicotinamide adenine dinucleotide (NAD) is synthesized de novo from tryptophan through the kynurenine pathway. The patients had reduced levels of circulating NAD. Defects similar to those in the patients developed in the embryos of Haao-null or Kynu-null mice owing to NAD deficiency. In null mice, the prevention of NAD deficiency during gestation averted defects. CONCLUSIONS Disruption of NAD synthesis caused a deficiency of NAD and congenital malformations in humans and mice. Niacin supplementation during gestation prevented the malformations in mice. (Funded by the National Health and Medical Research Council of Australia and others.)	[Shi, Hongjun; Enriquez, Annabelle; Rapadas, Melissa; Martin, Ella M. M. A.; Wang, Roni; Moreau, Julie; Szot, Justin O.; Ip, Eddie; Sugimoto, Kotaro; Halliday, Jake; Kikuchi, Kazu; Chapman, Gavin; Sparrow, Duncan B.; Dunwoodie, Sally L.] Victor Chang Cardiac Res Inst, Div Dev & Stem Cell Biol, Sydney, NSW, Australia; [Maghzal, Ghassan J.; Stocker, Roland] Victor Chang Cardiac Res Inst, Div Vasc Biol, Sydney, NSW, Australia; [Humphreys, David T.; Ho, Joshua W. K.; Giannoulatou, Eleni] Victor Chang Cardiac Res Inst, Div Mol Struct & Computat Biol, Sydney, NSW, Australia; [Shi, Hongjun; Enriquez, Annabelle; Szot, Justin O.; Ip, Eddie; Humphreys, David T.; Maghzal, Ghassan J.; Ho, Joshua W. K.; Kikuchi, Kazu; Stocker, Roland; Giannoulatou, Eleni; Chapman, Gavin; Sparrow, Duncan B.; Dunwoodie, Sally L.] Univ New South Wales, Fac Med, Sydney, NSW, Australia; [Shi, Hongjun; Enriquez, Annabelle; Szot, Justin O.; Ip, Eddie; Humphreys, David T.; Maghzal, Ghassan J.; Ho, Joshua W. K.; Kikuchi, Kazu; Stocker, Roland; Giannoulatou, Eleni; Chapman, Gavin; Sparrow, Duncan B.; Dunwoodie, Sally L.] Univ New South Wales, Fac Sci, Sydney, NSW, Australia; [Enriquez, Annabelle; Colley, Alison] Liverpool Hosp, Dept Clin Genet, Sydney, NSW, Australia; [Enriquez, Annabelle; Smith, Janine; Collins, Felicity; Sillence, David O.] Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW, Australia; [Winlaw, David S.] Childrens Hosp Westmead, Heart Ctr Children, Sydney, NSW, Australia; [Enriquez, Annabelle; Smith, Janine; Collins, Felicity; Sillence, David O.] Univ Sydney, Discipline Genet Med, Sydney, NSW, Australia; [Winlaw, David S.] Univ Sydney, Med Sch, Sydney, NSW, Australia; [Lim, Chai K.; Guillemin, Gilles J.] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia; [Hughes, James N.; Thomas, Paul Q.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [McInerney-Leo, Aideen M.; Leo, Paul J.; Brown, Matthew A.; Duncan, Emma L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [McInerney-Leo, Aideen M.; Leo, Paul J.; Brown, Matthew A.; Duncan, Emma L.] Royal Brisbane & Womens Hosp, Translat Res Inst, Brisbane, Qld, Australia; [Duncan, Emma L.] Royal Brisbane & Womens Hosp, Dept Endocrinol, Brisbane, Qld, Australia; [Duncan, Emma L.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Mark, Paul R.] Spectrum Hlth Med Grp, Med Genet, Grand Rapids, MI USA	Dunwoodie, SL (reprint author), Victor Chang Cardiac Res Inst, Lowy Packer Bldg,405 Liverpool St, Sydney, NSW 2010, Australia.	s.dunwoodie@victorchang.edu.au		Lim, Edwin/0000-0003-3526-8405; Sugimoto, Kotaro/0000-0002-5299-7610	National Health and Medical Research Council of Australia	Funded by the National Health and Medical Research Council of Australia and others.	Aasheim ET, 2008, AM J CLIN NUTR, V87, P362; Allegri G, 2003, ADV EXP MED BIOL, V527, P387; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Baker H, 2002, J AM COLL NUTR, V21, P33, DOI 10.1080/07315724.2002.10719191                                                  ; Blue GM, 2014, J AM COLL CARDIOL, V64, P2498, DOI 10.1016/j.jacc.2014.09.048; Bulman MP, 2000, NAT GENET, V24, P438; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chen YX, 2016, J MED GENET, V53, P431, DOI 10.1136/jmedgenet-2015-103554; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Christensen M, 2007, J INHERIT METAB DIS, V30, P248, DOI 10.1007/s10545-007-0396-2; Correia M, 2017, BBA-GEN SUBJECTS, V1861, P3444, DOI 10.1016/j.bbagen.2016.09.008; Dolk H, 2010, ADV EXP MED BIOL, V686, P349, DOI 10.1007/978-90-481-9485-8_20; HOLLIDAY MA, 1967, PEDIATR RES, V1, P185, DOI 10.1203/00006450-196705000-00005; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Jacobson EL, 1999, MOL CELL BIOCHEM, V193, P69, DOI 10.1023/A:1006960126369; Kirkland JB, 2012, MUTAT RES-FUND MOL M, V733, P14, DOI 10.1016/j.mrfmmm.2011.11.008; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Lovelace MD, 2017, NEUROPHARMACOLOGY, V112, P373, DOI 10.1016/j.neuropharm.2016.03.024; McInerney-Leo AM, 2015, HUM MOL GENET, V24, P1234, DOI 10.1093/hmg/ddu534; Mohamed JY, 2013, AM J HUM GENET, V92, P157, DOI 10.1016/j.ajhg.2012.11.016; Oxenkrug G, 2013, MOL NEUROBIOL, V48, P294, DOI 10.1007/s12035-013-8497-4; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rosa Rosana Cardoso M, 2013, Rev Paul Pediatr, V31, P243, DOI 10.1590/S0103-05822013000200017; Sasaki Y, 2015, J BIOL CHEM, V290, P17228, DOI 10.1074/jbc.M115.637850; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Solomon BD, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-56; Sparrow DB, 2006, AM J HUM GENET, V78, P28, DOI 10.1086/498879; Sparrow DB, 2008, HUM MOL GENET, V17, P3761, DOI 10.1093/hmg/ddn272; Sparrow DB, 2013, HUM MOL GENET, V22, P1625, DOI 10.1093/hmg/ddt012; Terakata M, 2012, J NUTR, V142, P2148, DOI 10.3945/jn.112.167569; Vinson RK, 2002, MUTAT RES-FUND MOL M, V509, P79, DOI 10.1016/S0027-5107(02)00223-3; Wan P, 2011, BRIT J DERMATOL, V164, P1188, DOI 10.1111/j.1365-2133.2010.10163.x; Whittock NV, 2004, AM J HUM GENET, V74, P1249, DOI 10.1086/421053	33	3	3	9	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2017	377	6					544	552		10.1056/NEJMoa1616361				9	Medicine, General & Internal	General & Internal Medicine	FD0EM	WOS:000407212600007	28792876				2018-01-05	
J	Wei, XR; Lai, YX; Li, BH; Qin, L; Xu, YD; Lin, SM; Wang, SN; Wu, QT; Liang, QB; Huang, GH; Deng, QH; Liu, PT; Wu, DH; Lai, LX; Yao, Y; Li, P				Wei, Xinru; Lai, Yunxin; Li, Baiheng; Qin, Le; Xu, Youdi; Lin, Simiao; Wang, Suna; Wu, Qiting; Liang, Qiubin; Huang, Guohua; Deng, Qiuhua; Liu, Pentao; Wu, Donghai; Lai, Liangxue; Yao, Yao; Li, Peng			CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg(-/-) Mice Results in Severe Immunodeficiency	SCIENTIFIC REPORTS			English	Article							HUMAN HEMATOPOIETIC STEM; T-CELL DEVELOPMENT; HUMANIZED MICE; MOUSE MODEL; HIGHER SUSCEPTIBILITY; BIOMEDICAL-RESEARCH; NUDE-MICE; GENE; LYMPHOCYTES; SYSTEM	Immunodeficient mice engrafted with either normal or cancerous human cells are widely used in basic and translational research. In particular, NOD/SCID/IL2rg(-/-)mice can support the growth of various types of human cancer cells. However, the hairs of these mice interfere with the observation and imaging of engrafted tissues. Therefore, novel hairless strains exhibiting comparable immunodeficiency would be beneficial. Recently, the CRISPR/Cas9 system has been used for efficient multiplexed genome editing. In the present study, we generated a novel strain of nude NOD/SCID/IL2rg-/-(NSIN) mice by knocking out Foxn1 from NOD/SCID/IL2rg(-/-)(NSI) mice using the CRISPR/Cas9 system. The NSIN mice were deficient in B, T, and NK cells and not only showed impaired T cell reconstitution and thymus regeneration after allogeneic bone marrow nucleated cell transplantation but also exhibited improved capacity to graft both leukemic and solid tumor cells compared with NSI, NOG, and NDG mice. Moreover, the NSIN mice facilitated the monitoring and in vivo imaging of both leukemia and solid tumors. Therefore, our NSIN mice provide a new platform for xenograft mouse models in basic and translational research.	[Wei, Xinru; Xu, Youdi] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Wei, Xinru; Lai, Yunxin; Li, Baiheng; Qin, Le; Xu, Youdi; Lin, Simiao; Wang, Suna; Wu, Qiting; Wu, Donghai; Lai, Liangxue; Yao, Yao; Li, Peng] Chinese Acad Sci, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China; [Wei, Xinru; Lai, Yunxin; Li, Baiheng; Qin, Le; Xu, Youdi; Lin, Simiao; Wang, Suna; Wu, Qiting; Wu, Donghai; Lai, Liangxue; Yao, Yao; Li, Peng] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Liang, Qiubin] Shenzhen InVivo Biomed Co Ltd, Shenzhen 518000, Peoples R China; [Huang, Guohua; Deng, Qiuhua] Southern Med Univ, Nanfang Hosp, Dept Resp Med, Guangzhou 510515, Guangdong, Peoples R China; [Liu, Pentao] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England	Yao, Y; Li, P (reprint author), Chinese Acad Sci, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China.; Yao, Y; Li, P (reprint author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China.	yao_yao@gibh.ac.cn; li_peng@gibh.ac.cn			National Natural Science Foundation of China [81522002]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19030205]; Natural Science Fund for Distinguished Young Scholars of Guangdong Province [2014A030306028]; Guangdong Provincial Applied Science and Technology Research& Development Program [2016B020237006]; Guangdong Provincial Outstanding Young Scholars Award [2014TQ01R068]; Frontier and key technology innovation special grant from the Department of Science and Technology of Guangdong province [2015B020227003, 2014B020225005, 2016B030229006]; Guangdong Provincial Research and Commercialization Program [2014B090901044]; Guangzhou Science Technology and Innovation Commission Project [201504010016]	This study was supported by National Natural Science Foundation of China (81522002), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB19030205), the Natural Science Fund for Distinguished Young Scholars of Guangdong Province (2014A030306028), the Guangdong Provincial Applied Science and Technology Research& Development Program (2016B020237006), the Guangdong Provincial Outstanding Young Scholars Award (2014TQ01R068), the Frontier and key technology innovation special grant from the Department of Science and Technology of Guangdong province, (2015B020227003, 2014B020225005, 2016B030229006), the Guangdong Provincial Research and Commercialization Program (Grant No. 2014B090901044), and the Guangzhou Science Technology and Innovation Commission Project (201504010016).	Agliano A, 2008, INT J CANCER, V123, P2222, DOI 10.1002/ijc.23772; Blais ME, 2006, IMMUNOL REV, V209, P103, DOI 10.1111/j.0105-2896.2006.00341.x; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Cheng LL, 2010, J BIOL CHEM, V285, P5836, DOI 10.1074/jbc.M109.072124; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Covassin L, 2013, CLIN EXP IMMUNOL, V174, P372, DOI 10.1111/cei.12180; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168                                                       ; Gawronska-Kozak B, 2006, WOUND REPAIR REGEN, V14, P265, DOI 10.1111/j.1743-6109.2006.00121.x; Gawronska-Kozak B, 2011, MATRIX BIOL, V30, P290, DOI 10.1016/j.matbio.2011.04.004; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Goto T, 2016, TRANSGENIC RES, V25, P533, DOI 10.1007/s11248-016-9941-9; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Hiroshima Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114310; Ishikawa F, 2002, EXP HEMATOL, V30, P488, DOI 10.1016/S0301-472X(02)00784-1; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jiang Zhiwu, 2016, Front Immunol, V7, P690, DOI 10.3389/fimmu.2016.00690; Jiang ZW, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0310-1; Kaestner KH, 2000, GENE DEV, V14, P142; Kanaji N, 2014, CANCER MANAG RES, V6, P431, DOI 10.2147/CMAR.S71185; Kiyuna T, 2017, J CELL BIOCHEM, V118, P361, DOI 10.1002/jcb.25643; Ma XL, 2017, SCI REP-UK, V7, DOI 10.1038/srep42244; Machida K, 2009, J TOXICOL SCI, V34, P123, DOI 10.2131/jts.34.123                                                              ; Manuel JA, 2006, MATRIX BIOL, V25, P505, DOI 10.1016/j.matbio.2006.07.008; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; Metildi CA, 2014, J SURG ONCOL, V109, P451, DOI 10.1002/jso.23507; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; PANTELOURIS EM, 1968, NATURE, V217, P370, DOI 10.1038/217370a0; Raveux A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42661; RYGAARD J, 1969, Acta Pathologica et Microbiologica Scandinavica, V77, P758; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477                                                    ; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Shultz LD, 2011, ANN NY ACAD SCI, V1245, P50, DOI 10.1111/j.1749-6632.2011.06310.x; TAKAHASHI Y, 1992, J EXP MED, V175, P873, DOI 10.1084/jem.175.3.873; Tu ZC, 2017, SCI REP-UK, V7, DOI 10.1038/srep42081; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Xiao YR, 2015, HAEMATOLOGICA, V100, P585, DOI 10.3324/haematol.2014.118612; Ye W, 2017, ONCOTARGET, V8, P87002, DOI 10.18632/oncotarget.10881; Ye W, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0156-y; Zuklys S, 2016, NAT IMMUNOL, V17, P1206, DOI 10.1038/ni.3537	43	0	0	13	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 10	2017	7								7720	10.1038/s41598-017-08337-8				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FD2YG	WOS:000407400100007	28798321	gold			2018-01-05	
J	Wang, HX; Li, M; Lee, CM; Chakraborty, S; Kim, HW; Bao, G; Leong, KW				Wang, Hong-Xia; Li, Mingqiang; Lee, Ciaran M.; Chakraborty, Syandan; Kim, Hae-Won; Bao, Gang; Leong, Kam W.			CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery	CHEMICAL REVIEWS			English	Review							RNA-GUIDED ENDONUCLEASE; ZINC-FINGER NUCLEASES; CRISPR-CAS SYSTEM; OFF-TARGET SITES; COMPACTED DNA NANOPARTICLES; DUCHENNE MUSCULAR-DYSTROPHY; STAPHYLOCOCCUS-AUREUS CAS9; PLURIPOTENT STEM-CELLS; MEDIATED GENE-TRANSFER; HEPATITIS-B-VIRUS	Genome editing offers promising solutions to genetic disorders by editing DNA sequences or modulating gene expression. The clustered regularly interspaced short palindromic repeats (CRISPR)/associated protein 9 (CRISPR/Cas9) technology can be used to edit single or multiple genes in a wide variety of cell types and organisms in vitro and in vivo. Herein, we review the rapidly developing CRISPR/Cas9-based technologies for disease modeling and gene correction and recent progress toward Cas9/guide RNA (gRNA) delivery based on viral and nonviral vectors. We discuss the relative merits of delivering the genome editing elements in the form of DNA, mRNA, or protein, and the opportunities of combining viral delivery of a transgene encoding Cas9 with nonviral delivery of gRNA. We highlight the lessons learned from nonviral gene delivery in the past three decades and consider their applicability for CRISPR/Cas9 delivery. We also include a discussion of bioinformatics tools for gRNA design and chemical modifications of gRNA. Finally, we consider the extracellular and intracellular barriers to nonviral CRISPR/Cas9 delivery and propose strategies that may overcome these barriers to realize the clinical potential of CRISPR/Cas9-based genome editing.	[Wang, Hong-Xia; Li, Mingqiang; Chakraborty, Syandan; Leong, Kam W.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Lee, Ciaran M.; Bao, Gang] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan 31116, South Korea; [Kim, Hae-Won] Dankook Univ, Dept Nanobiomed Sci, Cheonan 31116, South Korea; [Kim, Hae-Won] Dankook Univ, PLUS NBM Global Res Ctr Regenerat Med BK21, Cheonan 31116, South Korea	Leong, KW (reprint author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.	kam.leong@columbia.edu		Lee, Ciaran/0000-0002-0789-9149; Li, Mingqiang/0000-0002-5178-4138	NIH [HL109442, AI096305, UH3TR000505, GM110494]; Guangdong Innovative and Entrepreneurial Research Team Program, China [2013S086]; Global Research Laboratory Program, Korea [2015032163]; Cancer Prevention and Research Institute of Texas [RR140081]	This work is supported by the NIH (HL109442, AI096305, UH3TR000505, and GM110494), the Guangdong Innovative and Entrepreneurial Research Team Program, China (2013S086), and the Global Research Laboratory Program, Korea (2015032163), and the Cancer Prevention and Research Institute of Texas (RR140081).	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Ain Q.U., 2015, J CONTROL RELEASE, V205, P120, DOI DOI 10.1016/J.JCONREL.2014.12.036; Alconcel SNS, 2011, POLYM CHEM-UK, V2, P1442, DOI 10.1039/c1py00034a; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Anders C, 2016, MOL CELL, V61, P895, DOI 10.1016/j.molcel.2016.02.020; Antal CE, 2015, CELL, V160, P489, DOI 10.1016/j.cell.2015.01.001; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bates K, 2013, ADV DRUG DELIVER REV, V65, P2023, DOI 10.1016/j.addr.2013.10.003; Benner SA, 2012, ACCOUNTS CHEM RES, V45, P2025, DOI 10.1021/ar200332w; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Boissel S, 2014, NUCLEIC ACIDS RES, V42, P2591, DOI 10.1093/nar/gkt1224; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bolukbasi MF, 2015, NAT METHODS, V12, P1150, DOI 10.1038/nmeth.3624; Braasch DA, 2003, BIOCHEMISTRY-US, V42, P7967, DOI 10.1021/bi0343774; Bramsen JB, 2009, NUCLEIC ACIDS RES, V37, P2867, DOI 10.1093/nar/gkp106; Branden LJ, 1999, NAT BIOTECHNOL, V17, P784, DOI 10.1038/11726                                                                   ; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Buscail L, 2015, MOL THER, V23, P779, DOI 10.1038/mt.2015.1; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Campbell TA, 2013, NANO TODAY, V8, P119, DOI 10.1016/j.nantod.2012.12.002; CAPECCHI MR, 1980, CELL, V22, P479, DOI 10.1016/0092-8674(80)90358-X; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Cardenas-Bailon F., 2015, J MICROENCAPSUL, V32, P1; Carroll KJ, 2016, P NATL ACAD SCI USA, V113, P338, DOI 10.1073/pnas.1523918113; Chakraborty S, 2014, STEM CELL REP, V3, P940, DOI 10.1016/j.stemcr.2014.09.013; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Charpentier E., 2012, SCIENCE, V337, P816, DOI [10.1126/science.1225829, DOI 10.1126/SCIENCE.1225829]; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chen X, 2016, MOL THER, V24, P447, DOI 10.1038/mt.2015.164; Chen YC, 2015, HUM MOL GENET, V24, P3764, DOI 10.1093/hmg/ddv120; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Cyranoski D, 2016, NATURE, V535, P476, DOI 10.1038/nature.2016.20302; D'Astolfo DS, 2015, CELL, V161, P674, DOI 10.1016/j.cell.2015.03.028; Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Davis ME, 2009, MOL PHARMACEUT, V6, P659, DOI 10.1021/mp900015y; Deleavey GF, 2012, CHEM BIOL, V19, P937, DOI 10.1016/j.chembiol.2012.07.011; Dellinger DJ, 2003, J AM CHEM SOC, V125, P940, DOI 10.1021/ja027983f; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dunn SS, 2012, J AM CHEM SOC, V134, P7423, DOI 10.1021/ja300174v; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fink TL, 2006, GENE THER, V13, P1048, DOI 10.1038/sj.gt.3302761; Fotin-Mleczek M, 2011, J IMMUNOTHER, V34, P1, DOI 10.1097/CJI.0b013e3181f7dbe8; Francis SM, 2014, MOL THER, V22, P1643, DOI 10.1038/mt.2014.24; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gagnon KT, 2015, P NATL ACAD SCI USA, V112, P15536, DOI 10.1073/pnas.1521670112; Geall AJ, 2012, P NATL ACAD SCI USA, V109, P14604, DOI 10.1073/pnas.1209367109; Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q                 ; Goodwin T, 2014, ADV GENET, V88, P1, DOI 10.1016/B978-0-12-800148-6.00001-8; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; GRAESSMANN M, 1983, METHOD ENZYMOL, V101, P482; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Grigsby CL, 2013, SCI REP-UK, V3, DOI 10.1038/srep03155; Gu Z, 2011, CHEM SOC REV, V40, P3638, DOI 10.1039/c0cs00227e; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Han X, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500454; Hanna N, 2012, CANCER GENE THER, V19, P374, DOI 10.1038/cgt.2012.10; Hasan W, 2012, NANO LETT, V12, P287, DOI 10.1021/nl2035354; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hemmi H, 2000, NATURE, V408, P740; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hirano S, 2016, MOL CELL, V61, P886, DOI 10.1016/j.molcel.2016.02.018; Ho YP, 2011, NANO LETT, V11, P2178, DOI [10.1021/nl200862n, 10.1021/n1200862n]; Ho YP, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/9/095103; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Horii T, 2013, INT J MOL SCI, V14, P19774, DOI 10.3390/ijms141019774; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu JH, 2016, CELL CHEM BIOL, V23, P57, DOI 10.1016/j.chembiol.2015.12.009; Huang M, 2005, J CONTROL RELEASE, V106, P391, DOI 10.1016/j.cornel.2005.05.004; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Isalan M, 2012, NAT METHODS, V9, P32, DOI 10.1038/nmeth.1805; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; Kallen KJ, 2013, HUM VACC IMMUNOTHER, V9, P2263, DOI 10.4161/hv.25181; Kaminski R, 2016, GENE THER, V23, P690, DOI 10.1038/gt.2016.41; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kariko K, 2012, MOL THER, V20, P948, DOI 10.1038/mt.2012.7; Kauffman KJ, 2015, NANO LETT, V15, P7300, DOI 10.1021/acs.nanolett.5b02497; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Kennedy EM, 2014, J VIROL, V88, P11965, DOI 10.1128/JVI.01879-14; Kiang T, 2004, BIOMATERIALS, V25, P5293, DOI 10.1016/j.biomaterials.2003.12.036; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kim YH, 2001, BIOCONJUGATE CHEM, V12, P932, DOI 10.1021/bc015510c; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Kirchner M, 2015, ANGEW CHEM INT EDIT, V54, P13508, DOI 10.1002/anie.201504741; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672; Kogure K, 2004, J CONTROL RELEASE, V98, P317, DOI 10.1016/j.jconrel.2004.04.024; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Konstan MW, 2004, HUM GENE THER, V15, P1255, DOI 10.1089/hum.2004.15.1255                                                        ; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Kotterman MA, 2015, ANNU REV BIOMED ENG, V17, P63, DOI 10.1146/annurev-bioeng-071813-104938; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; LaFountaine JS, 2015, INT J PHARMACEUT, V494, P180, DOI 10.1016/j.ijpharm.2015.08.029; Lao YH, 2015, ACS NANO, V9, P2235, DOI 10.1021/nn507494p; Lennox KA, 2011, GENE THER, V18, P1111, DOI 10.1038/gt.2011.100; Li LJ, 2010, NANO TODAY, V5, P296, DOI 10.1016/j.nantod.2010.06.007; Li L, 2017, ACS NANO, V11, P95, DOI 10.1021/acsnano.6b04261; Li S, 1999, GENE THER, V6, P585, DOI 10.1038/sj.gt.3300865                                                           ; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lin CY, 2015, J CONTROL RELEASE, V212, P1, DOI 10.1016/j.jconrel.2015.06.010; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Liu YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6393; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Lu MQ, 2014, ACS NANO, V8, P332, DOI 10.1021/nn404193e; Lu Y, 2014, J CONTROL RELEASE, V194, P1, DOI 10.1016/j.jconrel.2014.08.015; Luo D, 2000, NAT BIOTECHNOL, V18, P893, DOI 10.1038/78523                                                                   ; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Maggio I, 2015, TRENDS BIOTECHNOL, V33, P280, DOI 10.1016/j.tibtech.2015.02.011; Mahiny AJ, 2015, NAT BIOTECHNOL, V33, P584, DOI 10.1038/nbt.3241; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Matrai J, 2010, MOL THER, V18, P477, DOI 10.1038/mt.2009.319; Maurisse R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-9; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; McManus JJ, 2004, J AM CHEM SOC, V126, P15966, DOI 10.1021/ja046105+; Meyers B. C., 2010, PLANT MICRORNAS METH, P137; Miller JB, 2017, ANGEW CHEM INT EDIT, V56, P1059, DOI 10.1002/anie.201610209; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mout R, 2017, ACS NANO, V11, P2452, DOI 10.1021/acsnano.6b07600; MULLARD A, 2015, NAT REV DRUG DISCOVE, V14, P82; Nakamura T, 2012, ACCOUNTS CHEM RES, V45, P1113, DOI 10.1021/ar200254s; Nelles DA, 2015, BIOESSAYS, V37, P732, DOI 10.1002/bies.201500001; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; O'Brien A, 2014, BIOINFORMATICS, V30, P2673, DOI 10.1093/bioinformatics/btu354; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; O'Geen H, 2015, NUCLEIC ACIDS RES, V43, P3389, DOI 10.1093/nar/gkv137; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Peacock H, 2011, J ORG CHEM, V76, P7295, DOI 10.1021/jo2012225; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Peng B, 2015, ADV DRUG DELIVER REV, V88, P108, DOI 10.1016/j.addr.2015.05.014; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Perry JL, 2011, ACCOUNTS CHEM RES, V44, P990, DOI 10.1021/ar2000315; Petros RA, 2008, J AM CHEM SOC, V130, P5008, DOI 10.1021/ja801436j; Phua KKL, 2013, J CONTROL RELEASE, V166, P227, DOI 10.1016/j.jconrel.2012.12.029; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Pollard C, 2013, MOL THER, V21, P251, DOI 10.1038/mt.2012.202; Pottier N, 2014, TRENDS PHARMACOL SCI, V35, P119, DOI 10.1016/j.tips.2014.01.003; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112; Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Randar M., 2015, P NATL ACAD SCI USA, V112, pE7110, DOI DOI 10.1073/PNAS.1520883112; Rejman J, 2010, J CONTROL RELEASE, V147, P385, DOI 10.1016/j.jconrel.2010.07.124; Roberts MJ, 2012, ADV DRUG DELIVER REV, V64, P116, DOI 10.1016/j.addr.2012.09.025; Rodriguez PL, 2013, SCIENCE, V339, P971, DOI 10.1126/science.1229568; Roehm PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23146; Rosen LE, 2006, NUCLEIC ACIDS RES, V34, P4791, DOI 10.1093/nar/gkl645; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature01058; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schaffer DV, 2000, BIOTECHNOL BIOENG, V67, P598, DOI 10.1002/(SICI)1097-0290(20000305)67:5<598::AID-BIT10>3.0.CO;2-G                 ; Scheule RK, 1997, HUM GENE THER, V8, P689, DOI 10.1089/hum.1997.8.6-689                                                        ; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Schratzberger P, 2002, MOL THER, V6, P576, DOI 10.1006/mthe.2002.0715; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Seligman LM, 2002, NUCLEIC ACIDS RES, V30, P3870, DOI 10.1093/nar/gkf495; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharei A, 2013, P NATL ACAD SCI USA, V110, P2082, DOI 10.1073/pnas.1218705110; Sharma VK, 2014, MEDCHEMCOMM, V5, P1454, DOI 10.1039/c4md00184b; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Siksnys V, 2016, MOL CELL, V61, P793, DOI 10.1016/j.molcel.2016.03.002; Singh A, 2016, CHEM SOC REV, V45, P6666, DOI 10.1039/c6cs00197a; Singh R., 2015, NUCLEIC ACIDS RES, V43, pe118; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Sun L, 2013, BIOMATERIALS, V34, P2107, DOI 10.1016/j.biomaterials.2012.11.041; Sun W, 2015, ANGEW CHEM, V127, P12197, DOI DOI 10.1002/ANIE.201506030; Sundaram P, 2013, EUR J PHARM SCI, V48, P259, DOI 10.1016/j.ejps.2012.10.014; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tekin E, 2008, SOFT MATTER, V4, P703, DOI 10.1039/b711984d; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Thess A, 2015, MOL THER, V23, P1456, DOI 10.1038/mt.2015.103; THIERRY A, 1992, NUCLEIC ACIDS RES, V20, P5625, DOI 10.1093/nar/20.21.5625; Tirlapur UK, 2002, NATURE, V418, P290, DOI 10.1038/418290a                                                                 ; Tlaxca JL, 2013, J CONTROL RELEASE, V165, P216, DOI 10.1016/j.jconrel.2012.10.021; Truong DJJ, 2015, NUCLEIC ACIDS RES, V43, P6450, DOI 10.1093/nar/gkv601; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Uzgun S, 2011, PHARM RES-DORDR, V28, P2223, DOI 10.1007/s11095-011-0464-z; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Valencia PM, 2012, NAT NANOTECHNOL, V7, P623, DOI 10.1038/nnano.2012.168; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Oliveira AVV, 2015, ACTA BIOMATER, V17, P89, DOI 10.1016/j.actbio.2015.01.013; Wagner E, 2013, BIOMATER SCI-UK, V1, P804, DOI 10.1039/c3bm60071h; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111; Wang M, 2017, GENE THER, V24, P144, DOI 10.1038/gt.2016.72; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Wang SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26857; Wang T, 2012, INT J PHARMACEUT, V427, P3, DOI 10.1016/j.ijpharm.2011.07.013; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Weide B, 2009, J IMMUNOTHER, V32, P498, DOI 10.1097/CJI.0b013e3181a00068; Wells DJ, 2004, GENE THER, V11, P1363, DOI 10.1038/sj.gt.3302337; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Wightman L, 2001, J GENE MED, V3, P362, DOI 10.1002/jgm.187                                                                 ; Williford JM, 2014, ANNU REV BIOMED ENG, V16, P347, DOI 10.1146/annurev-bioeng-071813-105119; Wisse E, 2008, GENE THER, V15, P1193, DOI 10.1038/gt.2008.60; Wong N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0784-0; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Wu YX, 2015, CELL RES, V25, P67, DOI 10.1038/cr.2014.160; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Xu J, 2013, MOL PHARMACEUT, V10, P3366, DOI 10.1021/mp400190z; Xu XM, 2008, J BIOMED MATER RES A, V84A, P1038, DOI 10.1002/jbm.a.31479; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang LH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6507; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688; Zuckermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8391; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	299	1	1	57	57	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0009-2665	1520-6890		CHEM REV	Chem. Rev.	AUG 9	2017	117	15					9874	9906		10.1021/acs.chemrev.6b00799				33	Chemistry, Multidisciplinary	Chemistry	FD4ZK	WOS:000407540500002	28640612				2018-01-05	
J	Zhang, Q; Zeng, LP; Zhou, P; Irving, AT; Li, S; Shi, ZL; Wang, LF				Zhang, Qian; Zeng, Lei-Ping; Zhou, Peng; Irving, Aaron T.; Li, Shang; Shi, Zheng-Li; Wang, Lin-Fa			IFNAR2-dependent gene expression profile induced by IFN-alpha in Pteropus alecto bat cells and impact of IFNAR2 knockout on virus infection	PLOS ONE			English	Article							EMERGING VIRUSES; DNA-DAMAGE; AUTOIMMUNE-DISEASES; HUMAN MACROPHAGES; INTERFERON; RESPONSES; RECEPTOR; RESERVOIRS; PATHWAY; MUTANT	Bats are important reservoirs of many viruses, which are capable of infecting the host without inducing obvious clinical diseases. Interferon and the downstream interferon regulated genes (IRGs) are known to act as the first line of defense against viral infections. Little is known about the transcriptional profile of genes being induced by interferon in bats and their role in controlling virus infection. In this study, we constructed IFNAR2 knockout bat cell lines using CRISPR technology and further characterized gene expression profiles induced by the most abundant IFN-alpha (IFN-alpha 3). Firstly, we demonstrated that the CRISPR/Cas9 system is applicable for bat cells as this represents the first CRIPSR knockout cell line for bats. Our results showed the pleiotropic effect of IFN-a3 on the bat kidney cell line, PaKiT03. As expected, we confirmed that IFNAR2 is indispensable for IFN-a signaling pathway and plays an important role in antiviral immunity. Unexpectedly, we also identified novel IFNAR2-dependent IRGs which are enriched in pathways related to cancer. To our knowledge, this seems to be bat-specific as no such observation has been reported for other mammalian species. This study expands our knowledge about bat immunology and the cell line established can provide a powerful tool for future study into virus-bat interaction and cancer biology.	[Zhang, Qian; Zeng, Lei-Ping; Zhou, Peng; Shi, Zheng-Li] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Special Pathogens, Wuhan, Hubei, Peoples R China; [Irving, Aaron T.; Wang, Lin-Fa] Duke Natl Univ Singapore Med Sch, Programme Emerging Infect Dis, Singapore, Singapore; [Li, Shang] Duke Natl Univ Singapore Med Sch, Programme Canc & Stem Cell Biol, Singapore, Singapore	Shi, ZL (reprint author), Chinese Acad Sci, Wuhan Inst Virol, Key Lab Special Pathogens, Wuhan, Hubei, Peoples R China.	zlshi@wh.iov.cn			National Natural Science Foundation of China [31621061]; National Research Foundation-Competitive Research Program (NRF-CRP) from National Research Foundation in Singapore [NRF2012NRF-CRP001-056)]	This study was supported in part by National Natural Science Foundation of China (31621061) (to Z-LS) and the National Research Foundation-Competitive Research Program (NRF-CRP) grant (NRF2012NRF-CRP001-056) from the National Research Foundation in Singapore (to L-FW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge and thank Muhammad Khairul RAMLEE and Jing WANG for technical help with CRISPR work. This study was supported in part by National Natural Science Foundation of China (31621061) (to Z-LS) and the NRF-CRP grant (NRF2012NRF-CRP001-056) from the National Research Foundation in Singapore (to L-FW).	Ahn M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21722; Anderson AC, 2006, CURR OPIN IMMUNOL, V18, P665, DOI 10.1016/j.coi.2006.09.009; Brook CE, 2015, TRENDS MICROBIOL, V23, P172, DOI 10.1016/j.tim.2014.12.004; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Conlan LA, 2004, ONCOGENE, V23, P307, DOI 10.1038/sj.onc.1207119; Cowled C, 2012, DEV COMP IMMUNOL, V36, P657, DOI 10.1016/j.dci.2011.11.008; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Curtiss ML, 2012, EUR J IMMUNOL, V42, P651, DOI 10.1002/eji.201141581; Dai SY, 2014, CELL IMMUNOL, V290, P72, DOI 10.1016/j.cellimm.2014.05.006; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122                                                     ; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711                                                     ; Krebs DL, 2000, J CELL SCI, V113, P2813; Lamken P, 2004, J MOL BIOL, V341, P303, DOI 10.1016/j.jmb.2004.05.059; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luheshi N, 2014, EUR J IMMUNOL, V44, P162, DOI 10.1002/eji.201343351; Minn AJ, 2015, TRENDS IMMUNOL, V36, P725, DOI 10.1016/j.it.2015.09.007; Ni W, 2014, PLOS ONE, V9; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; Ramlee MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15587; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romagnani S, 1997, IMMUNOL TODAY, V18, P263, DOI 10.1016/S0167-5699(97)80019-9; Sakai R, 2014, INT J MOL SCI, V15, P17256, DOI 10.3390/ijms151017256; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462; Schoggins JW, 2014, CURR OPIN VIROL, V6, P40, DOI 10.1016/j.coviro.2014.03.006; Schreiber G, 2015, TRENDS IMMUNOL, V36, P139, DOI 10.1016/j.it.2015.01.002; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Vinay DS, 2011, CLIN EXP IMMUNOL, V164, P145, DOI 10.1111/j.1365-2249.2011.04375.x; Wang LF, 2011, CURR OPIN VIROL, V1, P649, DOI 10.1016/j.coviro.2011.10.013; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep20620; Welsby I, 2012, BIOCHEM PHARMACOL, V84, P11, DOI 10.1016/j.bcp.2012.02.016; Yang XO, 2009, NAT IMMUNOL, V10, P1260, DOI 10.1038/ni.1821; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhou P, 2016, P NATL ACAD SCI USA, V113, P2696, DOI 10.1073/pnas.1518240113; Zhou P, 2013, DEV COMP IMMUNOL, V40, P240, DOI 10.1016/j.dci.2013.03.006	46	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182866	10.1371/journal.pone.0182866				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FC9YJ	WOS:000407196700075	28793350	gold			2018-01-05	
J	Tanaka, H; Stone, HA; Nelson, DR				Tanaka, Hidenori; Stone, Howard A.; Nelson, David R.			Spatial gene drives and pushed genetic waves	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						gene drive; Fisher wave; bistable wave	MUTAGENIC CHAIN-REACTION; NATURAL-POPULATIONS; PEST-MANAGEMENT; HYBRID ZONES; CRISPR-CAS; DYNAMICS; SYSTEMS; IMMUNITY; ADVANCE; VECTOR	Gene drives have the potential to rapidly replace a harmful wildtype allele with a gene drive allele engineered to have desired functionalities. However, an accidental or premature release of a gene drive construct to the natural environment could damage an ecosystem irreversibly. Thus, it is important to understand the spatiotemporal consequences of the super-Mendelian population genetics before potential applications. Here, we use a reaction-diffusion model for sexually reproducing diploid organisms to study how a locally introduced gene drive allele spreads to replace the wild-type allele, although it possesses a selective disadvantage s > 0. Using methods developed by Barton and collaborators, we show that socially responsible gene drives require 0.5 < s < 0.697, a rather narrow range. In this "pushed wave" regime, the spatial spreading of gene drives will be initiated only when the initial frequency distribution is above a threshold profile called "critical propagule," which acts as a safeguard against accidental release. We also study how the spatial spread of the pushed wave can be stopped by making gene drives uniquely vulnerable ("sensitizing drive") in a way that is harmless for a wildtype allele. Finally, we show that appropriately sensitized drives in two dimensions can be stopped, even by imperfect barriers perforated by a series of gaps.	[Tanaka, Hidenori; Nelson, David R.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Tanaka, Hidenori] Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA; [Stone, Howard A.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Nelson, David R.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Nelson, David R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Tanaka, H; Nelson, DR (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Tanaka, H (reprint author), Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA.; Nelson, DR (reprint author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Nelson, DR (reprint author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	tanaka@g.harvard.edu; drnelson@fas.harvard.edu			National Science Foundation [DMR1608501, MCB1344191, DMS1614907]; Harvard Materials Science Research and Engineering Center [DMR1435999]	We thank N. Barton, S. Block, S. Sawyer, T. Stearns, and M. Turelli for helpful discussions and two anonymous reviewers for useful suggestions. N. Barton also provided a critical reading of our manuscript. Work by H.T. and D.R.N. was supported by National Science Foundation Grant DMR1608501 and Harvard Materials Science Research and Engineering Center Grant DMR1435999. H.A.S. acknowledges support from National Science Foundation Grants MCB1344191 and DMS1614907.	Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932; Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002; Barton NH, 2011, AM NAT, V178, pE48, DOI 10.1086/661246; BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; BARTON NH, 1979, HEREDITY, V43, P341, DOI 10.1038/hdy.1979.87                                                             ; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Burt A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0432; Chan YS, 2011, GENETICS, V188, P33, DOI 10.1534/genetics.111.127506; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; DiCarlo JE, 2015, NAT BIOTECHNOL, V33, P1250, DOI 10.1038/nbt.3412; Eckhoff PA, 2017, P NATL ACAD SCI USA, V114, pE255, DOI 10.1073/pnas.1611064114; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x                                              ; FOSTER GG, 1972, SCIENCE, V176, P875, DOI 10.1126/science.176.4037.875; Frey E, 2010, PHYSICA A, V389, P4265, DOI 10.1016/j.physa.2010.02.047; Gandhi SR, 2016, P NATL ACAD SCI USA, V113, P6922, DOI 10.1073/pnas.1521056113; Gantz VM, 2016, BIOESSAYS, V38, P50, DOI 10.1002/bies.201500102; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Gould F, 2008, EVOLUTION, V62, P500, DOI 10.1111/j.1558-5646.2007.00298.x; Hallatschek O, 2007, P NATL ACAD SCI USA, V104, P19926, DOI 10.1073/pnas.0710150104; Hartl D. L., 1997, PRINCIPLES POPULATIO, V116; Henkel RD, 2012, APPL BIOSAFETY, V17, P171; Huang YX, 2011, EVOL APPL, V4, P415, DOI 10.1111/j.1752-4571.2010.00153.x; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kolmogorov A., 1937, B MGU A, V1, P1; Korolev KS, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.088103; Korolev KS, 2010, REV MOD PHYS, V82, P1691, DOI 10.1103/RevModPhys.82.1691; Lavrentovich MO, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.138102; LEWIS MA, 1993, THEOR POPUL BIOL, V43, P141, DOI 10.1006/tpbi.1993.1007; Lewis MA, 2016, P NATL ACAD SCI USA, V113, P6819, DOI 10.1073/pnas.1606665113; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Muller MJI, 2014, P NATL ACAD SCI USA, V111, P1037, DOI 10.1073/pnas.1313285111; Nelson P., 2004, BIOL PHYS; Noble C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601964; North A, 2013, J APPL ECOL, V50, P1216, DOI 10.1111/1365-2664.12133; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; STOKES AN, 1976, MATH BIOSCI, V31, P307, DOI 10.1016/0025-5564(76)90087-0; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Turelli M, 2017, THEOR POPUL BIOL, V115, P45, DOI 10.1016/j.tpb.2017.03.003; Unckless RL, 2015, GENETICS, V201, P425, DOI 10.1534/genetics.115.177592; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035	46	0	0	13	13	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	AUG 8	2017	114	32					8452	8457		10.1073/pnas.1705868114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FC8YZ	WOS:000407129000038	28743753				2018-01-05	
J	Li, N; Fu, HY; Hewitt, SM; Dimitrov, DS; Ho, M				Li, Nan; Fu, Haiying; Hewitt, Stephen M.; Dimitrov, Dimiter S.; Ho, Mitchell			Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						glypican; neuroblastoma; single-domain antibody; chimeric antigen receptor T-cell therapy; immunotoxin	HEPARAN-SULFATE PROTEOGLYCAN; LIVER-CANCER THERAPY; MODIFIED T-CELLS; HEPATOCELLULAR-CARCINOMA; WNT/BETA-CATENIN; NERVOUS-SYSTEM; PHASE-I; N-MYC; 13-CIS-RETINOIC ACID; FATE SPECIFICATION	Neuroblastoma is a childhood cancer that is fatal in almost half of patients despite intense multimodality treatment. This cancer is derived from neuroendocrine tissue located in the sympathetic nervous system. Glypican-2 (GPC2) is a cell surface heparan sulfate proteoglycan that is important for neuronal cell adhesion and neurite outgrowth. In this study, we find that GPC2 protein is highly expressed in about half of neuroblastoma cases and that high GPC2 expression correlates with poor overall survival compared with patients with low GPC2 expression. We demonstrate that silencing of GPC2 by CRISPR-Cas9 or siRNA results in the inhibition of neuroblastoma tumor cell growth. GPC2 silencing inactivates Wnt/beta-catenin signaling and reduces the expression of the target gene N-Myc, an oncogenic driver of neuroblastoma tumorigenesis. We have isolated human single-domain antibodies specific for GPC2 by phage display technology and found that the single-domain antibodies can inhibit active beta-catenin signaling by disrupting the interaction of GPC2 and Wnt3a. To explore GPC2 as a potential target in neuroblastoma, we have developed two forms of antibody therapeutics, immunotoxins and chimeric antigen receptor (CAR) T cells. Immunotoxin treatment was demonstrated to inhibit neuroblastoma growth in mice. CAR T cells targeting GPC2 eliminated tumors in a disseminated neuroblastoma mouse model where tumor metastasis had spread to multiple clinically relevant sites, including spine, skull, legs, and pelvis. This study suggests GPC2 as a promising therapeutic target in neuroblastoma.	[Li, Nan; Fu, Haiying; Ho, Mitchell] NCI, Lab Mol Biol, Ctr Canc Res, Bethesda, MD 20892 USA; [Fu, Haiying] Jilin Univ, Norman Bethune Coll Med, Dept Immunol, Changchun 130021, Peoples R China; [Hewitt, Stephen M.] NCI, Lab Pathol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Dimitrov, Dimiter S.] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA	Ho, M (reprint author), NCI, Lab Mol Biol, Ctr Canc Res, Bethesda, MD 20892 USA.	homi@mail.nih.gov			Intramural Research Program of NIH, NCI [Z01 BC010891, ZIA BC010891]; NCI; China Scholarship Council	We thank Dr. Javed Khan (NCI), Dr. Crystal Mackall (NCI; currently Stanford University), and Dr. Rimas J. Orentas (NCI; currently Lentigen Technology, Inc.) for providing the neuroblastoma cell lines used in the present study and for helpful discussions; Dr. Terry J. Fry (NCI) for providing a laboratory protocol of CAR T-cell activation; Dr. Carol J. Thiele (NCI) for critical reading of the manuscript; Dr. Diana Haines and colleagues in the Pathology/Histotechnology Laboratory (NCI) for pathological evaluation of the mice treated in the present study; and Dr. Bryan D. Fleming (NCI) and the NCI Editorial Board for editorial assistance. This research was supported by the Intramural Research Program of NIH, NCI (Z01 BC010891 and ZIA BC010891) (to M.H.). N.L. was a recipient of the NCI Director's Intramural Innovation Award/Career Development Award. H.F. was a recipient of a fellowship from the China Scholarship Council.	BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BRODEUR GM, 1986, CANCER GENET CYTOGEN, V19, P101, DOI 10.1016/0165-4608(86)90377-8; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Chen WZ, 2008, J MOL BIOL, V382, P779, DOI 10.1016/j.jmb.2008.07.054; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cheung NKV, 2012, J CLIN ONCOL, V30, P3264, DOI 10.1200/JCO.2011.41.3807; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Colombres M, 2008, J CELL PHYSIOL, V216, P805, DOI 10.1002/jcp.21465; Day CP, 2009, PIGM CELL MELANOMA R, V22, P283, DOI 10.1111/j.1755-148X.2009.00545.x; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Feng MQ, 2013, P NATL ACAD SCI USA, V110, pE1083, DOI 10.1073/pnas.1217868110; Feng MQ, 2011, J CANCER, V2, P123, DOI 10.7150/jca.2.123; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Gao W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7536; Gao W, 2014, HEPATOLOGY, V60, P576, DOI 10.1002/hep.26996; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; HANDGRETINGER R, 1995, EUR J CANCER, V31A, P261, DOI 10.1016/0959-8049(94)00413-Y; Hara H, 2016, BRIT J CANCER, V115, P66, DOI 10.1038/bjc.2016.183; Hassan R, 2014, CLIN CANCER RES, V20, P5927, DOI 10.1158/1078-0432.CCR-14-0804; Hassan R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006941; Herreros-Villanueva M, 2016, ANN TRANSL MED, V4, DOI 10.3978/j.issn.2305-5839.2015.10.39; Ho M, 2005, J BIOL CHEM, V280, P607, DOI 10.1074/jbc.M409783200; Ho Mitchell, 2009, V525, P293, DOI 10.1007/978-1-59745-554-1_15; Ivins JK, 1997, DEV BIOL, V184, P320, DOI 10.1006/dbio.1997.8532                                                          ; Kochenderfer JN, 2013, NAT REV CLIN ONCOL, V10, P267, DOI 10.1038/nrclinonc.2013.46; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kreitman RJ, 2011, CLIN CANCER RES, V17, P6398, DOI 10.1158/1078-0432.CCR-11-0487; Kreitman RJ, 2009, J CLIN ONCOL, V27, P2983, DOI 10.1200/JCO.2008.20.2630; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Li M, 1997, EXP CELL RES, V235, P3, DOI 10.1006/excr.1997.3629; LITWACK ED, 1994, J NEUROSCI, V14, P3713; Litwack ED, 1998, DEV DYNAM, V211, P72, DOI 10.1002/(SICI)1097-0177(199801)211:1<72::AID-AJA7>3.0.CO;2-4; Liu X, 2008, ONCOGENE, V27, P1478, DOI 10.1038/sj.onc.1210769; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0                                                   ; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Maus MV, 2016, CLIN CANCER RES, V22, P1875, DOI 10.1158/1078-0432.CCR-15-1433; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; Mazor R, 2016, IMMUNOL REV, V270, P152, DOI 10.1111/imr.12390; Orentas RJ, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00003; Pastan I, 2010, ANTIBODY ENG; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Saunders S, 1997, DEV BIOL, V190, P78, DOI 10.1006/dbio.1997.8690; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802                                                     ; Shirakawa H, 2009, CANCER SCI, V100, P1403, DOI 10.1111/j.1349-7006.2009.01206.x; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Sterman DH, 2007, CLIN CANCER RES, V13, P4456, DOI 10.1158/1078-0432.CCR-07-0403; STIPP CS, 1994, J CELL BIOL, V124, P149, DOI 10.1083/jcb.124.1.149; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Wai DH, 2002, INT J ONCOL, V20, P441; Wang CG, 2017, ONCOTARGET, V8, P32450, DOI 10.18632/oncotarget.10592; Xiao WK, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-104; Yu AL, 1998, J CLIN ONCOL, V16, P2169, DOI 10.1200/JCO.1998.16.6.2169                                                      ; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4	60	1	1	5	5	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	AUG 8	2017	114	32					E6623	E6631		10.1073/pnas.1706055114				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FC8YZ	WOS:000407129000018	28739923				2018-01-05	
J	Yu, SL; Parameswaran, N; Li, M; Wang, YW; Jackson, MW; Liu, HP; Xin, W; Zhou, L				Yu, Shuiliang; Parameswaran, Neetha; Li, Ming; Wang, Yiwei; Jackson, Mark W.; Liu, Huiping; Xin, Wei; Zhou, Lan			CRABP-II enhances pancreatic cancer cell migration and invasion by stabilizing interleukin 8 expression	ONCOTARGET			English	Article						pancreatic cancer; CRABP-II; IL-8; MMP-2/MMP-14; metastasis	BINDING-PROTEIN-II; TRANS-RETINOIC ACID; MESSENGER-RNA; INFLAMMATORY CYTOKINES; MECHANISTIC INSIGHTS; GENE-EXPRESSION; WILMS-TUMOR; HUR; CARCINOMA; GROWTH	Our previous study shows that cellular retinoic acid binding protein II (CRABP-II) is overexpressed in pancreatic ductal adenocarcinoma (PDAC) and pre-cancerous lesions, but not detected in normal pancreatic tissues. In this study, we show that deletion of CRABP-II in PDAC cells by CRISPR/Cas9 does not affect cancer cell proliferation, but decreases cell migration and invasion. Gene expression microarray analysis reveals that IL-8 is one of the top genes whose expression is down-regulated upon CRABP-II deletion, while expression of MMP-2 and MMP-14, two targets of IL-8 are also significantly down-regulated. Moreover, we found that CRABP-II is able to form a complex with HuR, which binds to the 3'UTR of IL-8 messenger RNA (mRNA) and enhances IL-8 mRNA stability. Ectopic expression of flag-CRABP-II in CRABP-II knockout cells is able to rescue the expression of IL-8, MMP-2/MMP-14 and recovers cell migration. Using the orthotopic xenograft model, we further demonstrate that CRABP-II deletion impairs tumor metastasis to nearby lymph nodes. Taken together, our results reveal a novel pathway linking CRABP-II expression to enhanced PDAC metastasis, and hence we propose CRABP-II may serve as a new PDAC therapeutic target.	[Yu, Shuiliang; Parameswaran, Neetha; Wang, Yiwei; Jackson, Mark W.; Liu, Huiping; Xin, Wei; Zhou, Lan] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Li, Ming] Case Western Reserve Univ, Sch Med, Biostat & Bioinformat Core Facil, Case Comprehens Canc Ctr, Cleveland, OH USA; [Xin, Wei; Zhou, Lan] Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA	Zhou, L (reprint author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.; Zhou, L (reprint author), Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA.	lan.zhou@case.edu			Department of Pathology Case Western Reserve University faculty	Part of the work was supported by Department of Pathology Case Western Reserve University faculty startup fund to W. X. and L. Z.	Baroni Timothy E., 2008, V419, P93, DOI 10.1007/978-1-59745-033-1_6; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Calmon MF, 2009, NEOPLASIA, V11, P1329, DOI 10.1593/neo.91110; Campos B, 2011, AM J PATHOL, V178, P1953, DOI 10.1016/j.ajpath.2011.01.051; Chen LY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05911; Chen Y, 2012, WORLD J GASTROENTERO, V18, P1123, DOI 10.3748/wjg.v18.i10.1123; Dai XJ, 2004, J INVEST DERMATOL, V123, P1078, DOI 10.1111/j.0022-202X.2004.23503.x; Dima SO, 2012, PANCREAS, V41, P1001, DOI 10.1097/MPA.0b013e3182546e13; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; Galvez BG, 2005, J BIOL CHEM, V280, P1292, DOI 10.1074/jbc.M408673200; Geiger T, 2012, CANCER RES, V72, P2428, DOI 10.1158/0008-5472.CAN-11-3711; Goelden U, 2005, UROL INT, V75, P269, DOI 10.1159/000087807; Gupta A, 2006, CANCER RES, V66, P8100, DOI 10.1158/0008-5472.CAN-05-4519; Gupta A, 2008, EXP CELL RES, V314, P3663, DOI 10.1016/j.yexcr.2008.09.029; Hathout Y, 2002, J PROTEOME RES, V1, P435, DOI 10.1021/pr020006i; Hessmann E, 2016, ONCOGENE, V35, P1609, DOI 10.1038/onc.2015.216; Hibbs K, 2004, AM J PATHOL, V165, P397, DOI 10.1016/S0002-9440(10)63306-8                                                   ; Hussain F, 2010, CYTOKINE, V49, P134, DOI 10.1016/j.cyto.2009.11.010; Jin BY, 2013, CHINESE MED J-PEKING, V126, P3787, DOI 10.3760/cma.j.issn.0366-6999.20130786; Korkola JE, 2003, CANCER RES, V63, P7167; Kuwada Y, 2003, INT J ONCOL, V22, P765; Li CY, 2009, J CLIN INVEST, V119, P2725, DOI 10.1172/JCI39542; Li CM, 2002, AM J PATHOL, V160, P2181, DOI 10.1016/S0002-9440(10)61166-2; Li WL, 2005, ONCOGENE, V24, P457, DOI 10.1038/sj.onc.1208228; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Lu M, 2005, ONCOGENE, V24, P4362, DOI 10.1038/sj.onc.1208661; McPherson LA, 2007, J SURG RES, V138, P71, DOI 10.1016/j.jss.2006.07.002; Ning Y, 2012, EXPERT OPIN THER TAR, V16, P491, DOI 10.1517/14728222.2012.677440; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Noy N, 2010, ANNU REV NUTR, V30, P201, DOI 10.1146/annurev.nutr.28.061807.155509; Okuducu AF, 2005, INT J ONCOL, V27, P1273; Palanisamy V, 2008, J DENT RES, V87, P772, DOI 10.1177/154405910808700803                                                      ; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roshani R, 2014, CANCER LETT, V345, P157, DOI 10.1016/j.canlet.2013.07.014; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332; Singh JK, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3436; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Suswam EA, 2005, INT J CANCER, V113, P911, DOI 10.1002/ijc.20675; Tsibris JCM, 2002, FERTIL STERIL, V78, P114, DOI 10.1016/S0015-0282(02)03191-6                                                   ; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Vo HP, 1998, ANTICANCER RES, V18, P217; Vreeland AC, 2014, MOL CELL BIOL, V34, P2135, DOI 10.1128/MCB.00281-14; [Anonymous], 2014, WORLD CANC REPORT; Wirth M, 2016, MOL CANCER THER, V15, P1792, DOI 10.1158/1535-7163.MCT-16-0050; Xiao WB, 2014, HUM PATHOL, V45, P1177, DOI 10.1016/j.humpath.2014.01.014; Zarogoulidis P, 2014, CANCER INVEST, V32, P197, DOI 10.3109/07357907.2014.898156; Zhou DC, 1998, CANCER RES, V58, P5770	52	0	0	2	2	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	AUG 8	2017	8	32					52432	52444		10.18632/oncotarget.14194				13	Oncology; Cell Biology	Oncology; Cell Biology	FC8XE	WOS:000407124100034	28881741	green_published			2018-01-05	
J	Silva-Oliveira, RJ; Melendez, M; Martinho, O; Zanon, MF; Viana, LD; Carvalho, AL; Reis, RM				Silva-Oliveira, Renato Jose; Melendez, Matias; Martinho, Olga; Zanon, Maicon F.; Viana, Luciano de Souza; Carvalho, Andre Lopes; Reis, Rui Manuel			AKT can modulate the in vitro response of HNSCC cells to irreversible EGFR inhibitors	ONCOTARGET			English	Article						HNSCC; anti-EGFR; anti-AKT; AKT1; resistance	GROWTH-FACTOR RECEPTOR; NECK-CANCER; COLORECTAL-CANCER; PLUS CETUXIMAB; COPY NUMBER; HEAD; CARCINOMA; MUTATIONS; THERAPY; MECHANISMS	Epidermal growth factor receptor (EGFR) is overexpressed in up to 90% of head and neck squamous cell carcinoma (HNSCC) tumors. Cetuximab is the first targeted (anti-EGFR) therapy approved for the treatment of HNSCC patients. However, its efficacy is limited due to primary and secondary resistance, and there is no predict biomarkers of response. New generation of EGFR inhibitors with pan HER targeting and irreversible action, such as afatinib and allitinib, represents a significant therapeutic promise. In this study, we intend to compare the potential cytotoxicity of two anti-EGFR inhibitors (afatinib and allitinib) with cetuximab and to identify potential predictive biomarkers of response in a panel of HNSCC cell lines. The mutational analysis in the eight HNSCC cell lines revealed an EGFR mutation (p.H773Y) and gene amplification in the HN13 cells. According to the growth inhibition score (GI), allitinib was the most cytotoxic drug, followed by afatinib and finally cetuximab. The higher AKT phosphorylation level was associated with resistance to anti-EGFR agents. Therefore, we further performed drug combinations with anti-AKT agent (MK2206) and AKT1 gene editing, which demonstrated afatinib and allitinib sensitivity restored. Additionally, in silico analysis of TCGA database showed that AKT1 overexpression was present in 14.7% (41/279) of HNSCC cases, and was associated with perineural invasion in advanced stage. In conclusion, allitinib presented a greater cytotoxic profile when compared to afatinib and cetuximab. AKT pathway constitutes a predictive marker of allitinib response and combination with AKT inhibitors could restore response and increase treatment success.	[Silva-Oliveira, Renato Jose; Melendez, Matias; Martinho, Olga; Zanon, Maicon F.; Viana, Luciano de Souza; Carvalho, Andre Lopes; Reis, Rui Manuel] Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, Brazil; [Martinho, Olga; Reis, Rui Manuel] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Martinho, Olga; Reis, Rui Manuel] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Viana, Luciano de Souza] Barretos Canc Hosp, Dept Med Oncol, Barretos, Brazil	Reis, RM (reprint author), Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, Brazil.; Reis, RM (reprint author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.; Reis, RM (reprint author), ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.	ruireis.hcb@gmail.com		Carvalho, Andre/0000-0001-7214-6402; Martinho, Olga/0000-0002-3221-0403	FINEP [MCTI/FINEP/MS/SCTIE/DECIT-01/2013 - FPXII-BIOPLAT]; Assistance Program and Incentive Research (PAIP), Barretos Cancer Hospital Sao Paulo, Brazil; National Counsel of Technological and Scientific Development (CNPq) scholarship; Portuguese Foundation for Science and Technology (FCT) scholarship [SFRH/BPD/108351/2015]	This study was partially supported by FINEP (MCTI/FINEP/MS/SCTIE/DECIT-01/2013 - FPXII-BIOPLAT) and the Assistance Program and Incentive Research (PAIP), Barretos Cancer Hospital Sao Paulo, Brazil. The authors would like to acknowledge the technical support of Gabriela Lamberti in the clonogenic assays. A.L.C and R.M.R are recipients of a National Counsel of Technological and Scientific Development (CNPq) scholarship and O.C.M is recipient of a Portuguese Foundation for Science and Technology (FCT) scholarship (SFRH/BPD/108351/2015).	Amornphimoltham P, 2004, CLIN CANCER RES, V10, P4029, DOI 10.1158/1078-0432.CCR-03-0249                                                   ; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477                                                   ; Blick SKA, 2007, DRUGS, V67, P2585, DOI 10.2165/00003495-200767170-00008                                                ; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Burtness B, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-469; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Cancer Genome Atlas Network, 2015, NATURE, V517, P576, DOI DOI 10.1038/NATURE14129; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Carracedo A, 2008, CELL CYCLE, V7, P3805, DOI 10.4161/cc.7.24.7244                                                            ; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; Cohen EEW, 2009, ORAL ONCOL, V45, pE155, DOI 10.1016/j.oraloncology.2009.05.637; Cohen MH, 2013, ONCOLOGIST, V18, P460, DOI 10.1634/theoncologist.2012-0458; Cooper JB, 2009, HEAD NECK-J SCI SPEC, V31, P1086, DOI 10.1002/hed.21109; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Fagan JJ, 1998, ARCH OTOLARYNGOL, V124, P637, DOI 10.1001/archotol.124.6.637                                                      ; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Freudlsperger C, 2015, INT J CANCER, V136, P2775, DOI 10.1002/ijc.29328; Goldberg RM, 2005, NAT REV DRUG DISCO S, pS10; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO2005.04.8306; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Konecny GE, 2009, BRIT J CANCER, V101, P1699, DOI 10.1038/sj.bjc.6605381; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Mazumdar T, 2014, MOL CANCER THER, V13, P2738, DOI 10.1158/1535-7163.MCT-13-1090; Mesia R, 2010, ANN ONCOL, V21, P1967, DOI 10.1093/annonc/mdq077; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Molife LR, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-1; Oliveira-Silva RJ, 2016, RECENT PAT ANTI-CANC, V11, P170, DOI 10.2174/1574892811666160309121238; Pedrero JMG, 2005, INT J CANCER, V114, P242, DOI 10.1002/ijc.20711; Perez CA, 2012, ORAL ONCOL, V48, P887, DOI 10.1016/j.oraloncology.2012.03.020; Reis JS, 2006, J PATHOL, V209, P445, DOI 10.1002/path.2004; Reis RM, 2000, AM J PATHOL, V156, P425, DOI 10.1016/S0002-9440(10)64746-3; Roh J, 2015, ORAL ONCOL, V51, P16, DOI 10.1016/j.oraloncology.2014.10.004; Schuetze C, 2007, STRAHLENTHER ONKOL, V183, P256, DOI 10.1007/s00066-007-1696-z; Segrelles C, 2002, ONCOGENE, V21, P53, DOI 10.1038/sj.onc.1205032                                                          ; Silva-Oliveira RJ, 2016, CELL ONCOL, V39, P253, DOI 10.1007/s13402-016-0270-z; Specenier P, 2013, BIOL-TARGETS THER, V7, P77, DOI 10.2147/BTT.S43628; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Svejda B, 2011, CANCER-AM CANCER SOC, V117, P4141, DOI 10.1002/cncr.26011; Temam S, 2007, J CLIN ONCOL, V25, P2164, DOI 10.1200/JCO.2006.06.6605; Thompson Lester, 2006, Ear Nose Throat J, V85, P74; Westra WH, 2008, CLIN CANCER RES, V14, P366, DOI 10.1158/1078-0432.CCR-07-1402; Xie H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021487; Yamane LS, 2014, ONCOL REP, V32, P1419, DOI 10.3892/or.2014.3338; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Zhang J, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-22	45	0	0	2	2	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	AUG 8	2017	8	32					53288	53301		10.18632/oncotarget.18395				14	Oncology; Cell Biology	Oncology; Cell Biology	FC8XE	WOS:000407124100104	28881811				2018-01-05	
J	Hu, JH; Guan, W; Liu, PJ; Dai, J; Tang, K; Xiao, HB; Qian, Y; Sharrow, AC; Ye, ZQ; Wu, L; Xu, H				Hu, Junhui; Guan, Wei; Liu, Peijun; Dai, Jin; Tang, Kun; Xiao, Haibing; Qian, Yuan; Sharrow, Allison C.; Ye, Zhangqun; Wu, Lily; Xu, Hua			Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in Renal Cancer Stem Cells	STEM CELL REPORTS			English	Article							KIDNEY CANCER; DNA DEMETHYLATION; PHASE-I; C-MYC; CARCINOMA; EXPRESSION; GROWTH; IDENTIFICATION; RESISTANT; THERAPY	Renal cell carcinoma (RCC) is a deadly malignancy due to its tendency to metastasize and resistance to chemotherapy. Stem-like tumor cells often confer these aggressive behaviors. We discovered an endoglin (CD105)-expressing subpopulation in human RCC xenografts and patient samples with a greater capability to form spheres in vitro and tumors in mice at low dilutions than parental cells. Knockdown of CD105 by short hairpin RNA and CRISPR/cas9 reduced stemness markers and sphere-formation ability while accelerating senescence in vitro. Importantly, downregulation of CD105 significantly decreased the tumorigenicity and gemcitabine resistance. This loss of stemlike properties can be rescued by CDA, MYC, or NANOG, and CDA might act as a demethylase maintaining MYC and NANOG. In this study, we showed that Endoglin (CD105) expression not only demarcates a cancer stem cell subpopulation but also confers self-renewal ability and contributes to chemoresistance in RCC.	[Hu, Junhui; Guan, Wei; Liu, Peijun; Tang, Kun; Xiao, Haibing; Ye, Zhangqun; Xu, Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dep Urol, Wuhan 430030, Hubei, Peoples R China; [Hu, Junhui; Guan, Wei; Liu, Peijun; Tang, Kun; Xiao, Haibing; Ye, Zhangqun; Xu, Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Urol, Wuhan 430030, Hubei, Peoples R China; [Hu, Junhui] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Pediat Surg, Wuhan 430030, Hubei, Peoples R China; [Dai, Jin] Yangtze Univ, Affiliated Hosp 1, Dept Urol, Jingzhou 434000, Peoples R China; [Hu, Junhui; Sharrow, Allison C.; Wu, Lily] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Wu, Lily] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Qian, Yuan] Huazhong Univ Sci & Technol, Dept Biomed Engn, MoE Key Lab Biomed Photon, Wuhan 430074, Hubei, Peoples R China	Xu, H (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dep Urol, Wuhan 430030, Hubei, Peoples R China.; Xu, H (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Urol, Wuhan 430030, Hubei, Peoples R China.; Wu, L (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.; Wu, L (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA.	lwu@mednet.ucla.edu; xuhua@mail.hust.edu.cn			National Natural Science Foundation of China [31372562, 81470935]; National Major Scientific and Technological Special Project for Significant New Drugs Development [2012ZX09303018]; Chenguang Program of Wuhan Science and Technology Bureau [2015070404010199]; National High Technology Research and Development Program 863 [2014AA020607]; Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology	This work was supported by the National Natural Science Foundation of China (31372562, 81470935), the National Major Scientific and Technological Special Project for Significant New Drugs Development (2012ZX09303018), the Chenguang Program of Wuhan Science and Technology Bureau (2015070404010199), and the National High Technology Research and Development Program 863 (2014AA020607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank all the donors who participated in this program and all our coworkers who contributed to the construction of the urologic tumor tissue bank sponsored by the Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. Also, the technical support in in vivo imaging from Dr. Qingming Luo and Dr. Zhihong Zhang from the Britton Chance Center for Biomedical Photonics in HUST and support in cell sorting from Mr. Peng Xu in YZY Bioscience Corp. in Wuhan are greatly appreciated.	Abdullah LN, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-3; Azzi S, 2011, J NATL CANCER I, V103, P1884, DOI 10.1093/jnci/djr451; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Beier D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-128; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Canino C, 2015, ONCOTARGET, V6, P12637, DOI 10.18632/oncotarget.3703                                                        ; Chen XJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07481; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Dales JP, 2003, AM J CLIN PATHOL, V119, P374, DOI 10.1309/1KF54L6RB625556W; Escudier B, 2008, BIOL-TARGETS THER, V2, P517; Fritz EL, 2010, GENE DEV, V24, P2107, DOI 10.1101/gad.1963010; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Henry LA, 2011, ONCOGENE, V30, P1046, DOI 10.1038/onc.2010.488; Hoffman AM, 2011, EPIGENOMICS-UK, V3, P19, DOI 10.2217/EPI.10.64; Huang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068293; Kamohara Y, 2008, SURGERY, V144, P119, DOI 10.1016/j.surg.2008.04.008; Kandyba E, 2014, STEM CELLS, V32, P534, DOI 10.1002/stem.1548; Karzai FH, 2015, BJU INT, V116, P546, DOI 10.1111/bju.12986; Khan MI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165718; Kim SH, 2015, STEM CELL REP, V4, P226, DOI 10.1016/j.stemcr.2014.12.006; Koleva RI, 2006, J BIOL CHEM, V281, P25110, DOI 10.1074/jbc.M601288200; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Larkin James Mg, 2006, Ther Clin Risk Manag, V2, P87; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Leonetti C, 1999, CLIN CANCER RES, V5, P2588; Li L, 2014, J NEUROSCI, V34, P16713, DOI 10.1523/JNEUROSCI.4590-13.2014; Linehan WM, 2012, UROL ONCOL-SEMIN ORI, V30, P948, DOI 10.1016/j.urolonc.2012.08.021; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luo HM, 2014, ACS NANO, V8, P4334, DOI 10.1021/nn405989n; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Mahfouz RZ, 2013, CLIN CANCER RES, V19, P938, DOI 10.1158/1078-0432.CCR-12-1722; Maugeri-Sacca M, 2012, MOL CANCER THER, V11, P1627, DOI 10.1158/1535-7163.MCT-11-1040; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/nchembio.1042, 10.1038/NCHEMBIO.1042]; NAITO S, 1989, CLIN EXP METASTAS, V7, P381, DOI 10.1007/BF01753659; Pal K, 2014, MOL CANCER THER, V13, P2264, DOI 10.1158/1535-7163.MCT-14-0291; Paldino E, 2014, BIOMED RES INT, V2014; Pantuck AJ, 2010, CANCER RES, V70, P752, DOI 10.1158/0008-5472.CAN-09-2211; Parodi B, 2002, BIOTECHNIQUES, V32, P432; Perez-Gomez E, 2005, ONCOGENE, V24, P4450, DOI 10.1038/sj.onc.1208644; Qian Y, 2016, BIOMATERIALS, V98, P171, DOI 10.1016/j.biomaterials.2016.05.008; Ramiro AR, 2015, TRENDS BIOCHEM SCI, V40, P172, DOI 10.1016/j.tibs.2015.01.006; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rosen LS, 2012, CLIN CANCER RES, V18, P4820, DOI 10.1158/1078-0432.CCR-12-0098; Sakaki-Yumoto M, 2013, J BIOL CHEM, V288, P18546, DOI 10.1074/jbc.M112.446591; Saroufim A, 2014, BRIT J CANCER, V110, P1778, DOI 10.1038/bjc.2014.71; Schokrpur S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29032; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sudarshan S, 2013, EUR UROL, V63, P244, DOI 10.1016/j.eururo.2012.09.054; Sussman RT, 2007, CANCER BIOL THER, V6, P1490, DOI 10.4161/cbt.6.9.4905                                                            ; Van Le Binh, 2009, Biochem Biophys Res Commun, V383, P386, DOI 10.1016/j.bbrc.2009.02.162; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; Velasco S, 2008, J CELL SCI, V121, P913, DOI 10.1242/jcs.023283; Whalley K, 2011, NAT REV NEUROSCI, V12, P489, DOI [10.1038/nrn3088, 10.1038/nrn3092]; Wong VCL, 2008, INT J CANCER, V123, P2816, DOI 10.1002/ijc.23882; Yang XQ, 2012, COMPUT MED IMAG GRAP, V36, P259, DOI 10.1016/j.compmedimag.2011.09.002; Zauri M, 2015, NATURE, V524, P114, DOI 10.1038/nature14948; Zhong Y, 2010, CANCER LETT, V299, P150, DOI 10.1016/j.canlet.2010.08.013	61	0	0	7	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	AUG 8	2017	9	2					464	477		10.1016/j.stemcr.2017.07.009				14	Cell & Tissue Engineering; Cell Biology	Cell Biology	FC8QE	WOS:000407105000006	28793246	gold			2018-01-05	
J	Ho, SM; Hartley, BJ; Flaherty, E; Rajarajan, P; Abdelaal, R; Obiorah, I; Barretto, N; Muhammad, H; Phatnani, HP; Akbarian, S; Brennand, KJ				Ho, Seok-Man; Hartley, Brigham J.; Flaherty, Erin; Rajarajan, Prashanth; Abdelaal, Rawan; Obiorah, Ifeanyi; Barretto, Natalie; Muhammad, Hamza; Phatnani, Hemali P.; Akbarian, Schahram; Brennand, Kristen J.			Evaluating Synthetic Activation and Repression of Neuropsychiatric-Related Genes in hiPSC-Derived NPCs, Neurons, and Astrocytes	STEM CELL REPORTS			English	Article							PLURIPOTENT STEM-CELLS; NEURAL PROGENITOR CELLS; DNA METHYLATION; SGRNA DESIGN; SCHIZOPHRENIA; CRISPR-CAS9; GENOME; CAS9; DIFFERENTIATION; IDENTIFICATION	Modulation of transcription, either synthetic activation or repression, via dCas9-fusion proteins is a relatively new methodology with the potential to facilitate high-throughput up-or down regulation studies of gene function. Genetic studies of neuro-developmental disorders have identified a growing list of risk variants, including both common single-nucleotide variants and rare copy-number variations, many of which are associated with genes having limited functional annotations. By applying a CRISPR-mediated gene-activation/repression platform to populations of human-induced pluripotent stem cell-derived neural progenitor cells, neurons, and astrocytes, we demonstrate that it is possible to manipulate endogenous expression levels of candidate neuropsychiatric risk genes across these three cell types. Although proof-of-concept studies using catalytically inactive Cas9-fusion proteins to modulate transcription have been reported, here we present a detailed survey of the reproducibility of gRNA positional effects across a variety of neuro-developmental disorder-relevant risk genes, donors, neural cell types, and dCas9 effectors.	[Ho, Seok-Man; Hartley, Brigham J.; Obiorah, Ifeanyi; Barretto, Natalie; Muhammad, Hamza; Akbarian, Schahram; Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Flaherty, Erin; Rajarajan, Prashanth; Barretto, Natalie; Muhammad, Hamza; Akbarian, Schahram; Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Ho, Seok-Man] Icahn Sch Med Mt Sinai, Dept Cell Dev & Regenerat Biol, New York, NY 10029 USA; [Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Dept Genet & Genom, New York, NY 10029 USA; [Ho, Seok-Man; Hartley, Brigham J.; Flaherty, Erin; Rajarajan, Prashanth; Obiorah, Ifeanyi; Barretto, Natalie; Muhammad, Hamza; Akbarian, Schahram; Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Abdelaal, Rawan; Phatnani, Hemali P.] New York Genome Ctr, Ctr Genom Neurodegenerat Dis, New York, NY 10013 USA; [Abdelaal, Rawan; Phatnani, Hemali P.] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Brennand, KJ (reprint author), Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA.; Brennand, KJ (reprint author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Brennand, KJ (reprint author), Icahn Sch Med Mt Sinai, Dept Genet & Genom, New York, NY 10029 USA.; Brennand, KJ (reprint author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.	kristen.brennand@mssm.edu			Brain and Behavior Young Investigator Grant, NIH [R01 MH101454, R01 MH106056]; New York Stem Cell Foundation	Kristen J. Brennand is a New York Stem Cell Foundation-Robertson Investigator. The Brennand Laboratory is supported by a Brain and Behavior Young Investigator Grant, NIH grants R01 MH101454 and R01 MH106056, and the New York Stem Cell Foundation. We thank the FACS core at Icahn School of Medicine at Mount Sinai.	Brennand K, 2015, MOL PSYCHIATR, V20, P361, DOI 10.1038/mp.2014.22; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Carcamo-Orive I, 2017, CELL STEM CELL, V20, P518, DOI 10.1016/j.stem.2016.11.005; Carlson-Stevermer J, 2016, STEM CELL REP, V6, P109, DOI 10.1016/j.stemcr.2015.11.014; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Ho SM, 2016, METHODS, V101, P113, DOI 10.1016/j.ymeth.2015.11.019; Horlbeck M. A., 2016, ELIFE, V5; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Jaaro-Peled H, 2010, SCHIZOPHRENIA BULL, V36, P301, DOI 10.1093/schbul/sbp133; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lin MY, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0366-0; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Maillard AM, 2015, MOL PSYCHIATR, V20, P140, DOI 10.1038/mp.2014.145; Marshall CR, 2017, NAT GENET, V49, P27, DOI 10.1038/ng.3725; McDonald JI, 2016, BIOL OPEN, V5, P866, DOI 10.1242/bio.019067; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Nishizawa M, 2016, CELL STEM CELL, V19, P341, DOI 10.1016/j.stem.2016.06.019; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Runkel F, 2013, J NEUROCHEM, V127, P36, DOI 10.1111/jnc.12372; Smith JD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0900-9; Srikanth P, 2015, CELL REP, V12, P1414, DOI 10.1016/j.celrep.2015.07.061; TCW J., 2017, BIORXIV; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Topol A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.118; Topol A, 2016, CELL REP, V15, P1024, DOI 10.1016/j.celrep.2016.03.090; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Wong AHC, 2003, NEUROSCI BIOBEHAV R, V27, P269, DOI 10.1016/S0149-7634(03)00035-6; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184; Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003; Yu DX, 2014, STEM CELL REP, V2, P295, DOI 10.1016/j.stemcr.2014.01.009; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zhao DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132387	57	1	1	4	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	AUG 8	2017	9	2					615	628		10.1016/j.stemcr.2017.06.012				14	Cell & Tissue Engineering; Cell Biology	Cell Biology	FC8QE	WOS:000407105000017	28757163	gold			2018-01-05	
J	Lettice, LA; Devenney, P; De Angelis, C; Hill, RE				Lettice, Laura A.; Devenney, Paul; De Angelis, Carlo; Hill, Robert E.			The Conserved Sonic Hedgehog Limb Enhancer Consists of Discrete Functional Elements that Regulate Precise Spatial Expression	CELL REPORTS			English	Article							SHH EXPRESSION; CIS-REGULATOR; MOUSE LIMB; EVOLUTION; POLARITY; DEFINE; FAMILY; GENES; BUD	Expression of sonic hedgehog (Shh) in the limb bud is regulated by an enhancer called the zone of polarizing activity regulatory sequence (ZRS), which, in evolution, belongs to an ancient group of highly conserved cis regulators found in all classes of vertebrates. Here, we examined the endogenous ZRS in mice, using genome editing to establish the relationship between enhancer composition and embryonic phenotype. We show that enhancer activity is a consolidation of distinct activity domains. Spatial restriction of Shh expression is mediated by a discrete repressor module, whereas levels of gene expression are controlled by large overlapping domains containing varying numbers of HOXD binding sites. The number of HOXD binding sites regulates expression levels incrementally. Substantial portions of conserved sequence are dispensable, indicating the presence of sequence redundancy. We propose a collective model for enhancer activity in which function is an integration of discrete expression activities and redundant components that drive robust expression.	[Lettice, Laura A.; Devenney, Paul; De Angelis, Carlo; Hill, Robert E.] Univ Edinburgh, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Hill, RE (reprint author), Univ Edinburgh, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	bob.hill@igmm.ed.ac.uk			MRC core program	We would like to thank Richard Mort for help with the statistical analysis and MRC Central Services for providing DNA sequence support. We would also like to thank the staff at the Evans Building for expert technical assistance. Invaluable advice on the manuscript was given by David Fitzpatrick, Nick Hastie, and Wendy Bickmore. This work was supported by an MRC core program grant.	Anderson E, 2012, TRENDS GENET, V28, P364, DOI 10.1016/j.tig.2012.03.012; Capellini TD, 2006, DEVELOPMENT, V133, P2263, DOI 10.1242/dev.02395; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Dow LE, 2015, TRENDS MOL MED, V21, P609, DOI 10.1016/j.molmed.2015.07.006; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gehrke AR, 2016, SEMIN CELL DEV BIOL, V57, P31, DOI 10.1016/j.semcdb.2016.01.015; Hayes C, 1998, DEVELOPMENT, V125, P351; Hecksher-Sorensen J, 1998, BIOTECHNIQUES, V24, P914; Kvon EZ, 2016, CELL, V167, P633, DOI 10.1016/j.cell.2016.09.028; Laurell T, 2012, HUM MUTAT, V33, P1063, DOI 10.1002/humu.22097; Leal F, 2016, CURR BIOL, V26, P2966, DOI 10.1016/j.cub.2016.09.020; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lettice LA, 2008, HUM MOL GENET, V17, P978, DOI 10.1093/hmg/ddm370; Lettice LA, 2014, DEVELOPMENT, V141, P1715, DOI 10.1242/dev.095430; Lettice LA, 2012, DEV CELL, V22, P459, DOI 10.1016/j.devcel.2011.12.010; Nagy A., 2009, COLD SPRING HARB PRO, V2009; Nagy A., 2009, COLD SPRING HARB PRO, V2009; Norbnop P, 2014, J HUM GENET, V59, P467, DOI 10.1038/jhg.2014.50; Osterwalder M, 2014, DEV CELL, V31, P345, DOI 10.1016/j.devcel.2014.09.018; Ovcharenko I, 2004, GENOMICS, V84, P890, DOI 10.1016/j.ygeno.2004.07.011; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; Tarchini B, 2006, NATURE, V443, P985, DOI 10.1038/nature05247; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wieczorek D, 2010, HUM MUTAT, V31, P81, DOI 10.1002/humu.21142; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049	31	0	0	4	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	AUG 8	2017	20	6					1396	1408		10.1016/j.celrep.2017.07.037				13	Cell Biology	Cell Biology	FC8ZM	WOS:000407130400014	28793263	gold			2018-01-05	
J	Yang, H; Wu, JJ; Tang, T; Liu, KD; Dai, C				Yang, Hong; Wu, Jia-Jing; Tang, Ting; Liu, Ke-De; Dai, Cheng			CRISPR/Cas9-mediated genome editing efficiently creates specific mutations at multiple loci using one sgRNA in Brassica napus	SCIENTIFIC REPORTS			English	Article							CRISPR-CAS SYSTEM; ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAKS; TARGETED MUTAGENESIS; ARABIDOPSIS-THALIANA; HOMOLOGOUS RECOMBINATION; GENE MODIFICATIONS; ORGAN SIZE; CANOLA OIL; GUIDE RNA	CRISPR/Cas9 is a valuable tool for both basic and applied research that has been widely applied to different plant species. Nonetheless, a systematical assessment of the efficiency of this method is not available for the allotetraploid Brassica napus-an important oilseed crop. In this study, we examined the mutation efficiency of the CRISPR/Cas9 method for 12 genes and also determined the pattern, specificity and heritability of these gene modifications in B. napus. The average mutation frequency for a single-gene targeted sgRNA in the T0 generation is 65.3%. For paralogous genes located in conserved regions that were targeted by sgRNAs, we observed mutation frequencies that ranged from 27.6% to 96.6%. Homozygotes were readily found in T0 plants. A total of 48.2% of the gene mutations, including homozygotes, bi-alleles, and heterozygotes were stably inherited as classic Mendelian alleles in the next generation (T1) without any new mutations or reversions. Moreover, no mutation was found in the putative off-target sites among the examined T0 plants. Collectively, our results demonstrate that CRISPR/Cas9 is an efficient tool for creating targeted genome modifications at multiple loci that are stable and inheritable in B. napus. These findings open many doors for biotechnological applications in oilseed crops.	[Yang, Hong; Wu, Jia-Jing; Tang, Ting; Dai, Cheng] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Hubei, Peoples R China; [Liu, Ke-De] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China	Dai, C (reprint author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Hubei, Peoples R China.; Liu, KD (reprint author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China.	kdliu@mail.hzau.edu.cn; cdai@mail.hzau.edu.cn			National Key Research and Development Program of China [2016YFD0101007]; Natural Science Foundation of Hubei Province [36116006]; Scientific & Technological Self-innovation Foundation of Huazhong Agricultural University [0900206305]	This study was supported by the National Key Research and Development Program of China (2016YFD0101007) to Dr. Ke-de Liu, the Natural Science Foundation of Hubei Province (36116006), and the Scientific & Technological Self-innovation Foundation of Huazhong Agricultural University (0900206305) to Dr. Cheng Dai. We are grateful to Dr. Qijun Chen for kindly providing pKSE401 and pCBC-DT1T2. We thank Dr. Chunying Kang, Dr. Robert M. Larkin and Dr. Liang Guo (Huazhong Agricultural University, China) for helpful discussion and critical reading of the manuscript.	Arntzen CJ, 2003, NAT REV GENET, V4, P839, DOI 10.1038/nrg1185; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bortesi L, 2016, PLANT BIOTECHNOL J, V14, P2203, DOI 10.1111/pbi.12634; Britt AB, 2003, TRENDS PLANT SCI, V8, P90, DOI 10.1016/S1360-1385(03)00002-5; Buckler ES, 2001, GENET RES, V77, P213; Butler NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144591; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen KL, 2014, PLANT CELL REP, V33, P575, DOI 10.1007/s00299-013-1539-6; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Du HY, 2016, J BIOTECHNOL, V217, P90, DOI 10.1016/j.jbiotec.2015.11.005; DUPONT J, 1989, J AM COLL NUTR, V8, P360; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao XZ, 2013, ANAL BIOCHEM, V437, P172, DOI 10.1016/j.ab.2013.02.028; Gao XH, 2016, PLANT PHYSIOL, V171, P1794, DOI 10.1104/pp.16.00663; Hyun Y, 2015, PLANTA, V241, P271, DOI 10.1007/s00425-014-2180-5; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khatodia S, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2015.00506, 10.3389/fpls.2016.00506]; Kim J, 2016, NAT BIOTECHNOL, V34, P1014, DOI 10.1038/nbt.3680; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li YH, 2008, GENE DEV, V22, P1331, DOI 10.1101/gad.463608; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Lin L, 2013, NUTR REV, V71, P370, DOI 10.1111/nure.12033; Liu L, 2014, PLANT MOL BIOL, V85, P209, DOI 10.1007/s11103-014-0188-7; Liu WZ, 2015, MOL PLANT, V8, P1431, DOI 10.1016/j.molp.2015.05.009; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mao YF, 2016, PLANT BIOTECHNOL J, V14, P519, DOI 10.1111/pbi.12468; Mason AS, 2016, PLANT BIOLOGY, V18, P883, DOI 10.1111/plb.12462; Melzer S, 2008, NAT GENET, V40, P1489, DOI 10.1038/ng.253; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Morineau C, 2017, PLANT BIOTECHNOL J, V15, P729, DOI 10.1111/pbi.12671; Muhlhausen A, 2013, PLANT J, V73, P824, DOI 10.1111/tpj.12079; Pan C., 2016, NAT SCI REP, V6, P24765, DOI DOI 10.1038/SREP24765; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Puchta H, 1996, P NATL ACAD SCI USA, V93, P5055, DOI 10.1073/pnas.93.10.5055; Roberts JA, 2002, ANNU REV PLANT BIOL, V53, P131, DOI 10.1146/annurev.arplant.53.092701.180236; Samanta MK, 2016, TRANSGENIC RES, V25, P561, DOI 10.1007/s11248-016-9953-5; Sauer NJ, 2016, PLANT PHYSIOL, V170, P1917, DOI 10.1104/pp.15.01696; Schouten Henk J, 2007, J Biomed Biotechnol, V2007, P82612, DOI 10.1155/2007/82612; Silverstone AL, 1997, GENETICS, V146, P1087; Smith JSC, 2008, MOL BREEDING, V22, P51, DOI 10.1007/s11032-007-9155-1; Sugano SS, 2014, PLANT CELL PHYSIOL, V55, P475, DOI 10.1093/pcp/pcu014; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Sun XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10342; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Xia T, 2013, PLANT CELL, V25, P3347, DOI 10.1105/tpc.113.115063; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004; Yan M, 2015, J INTEGR PLANT BIOL, V57, P613, DOI 10.1111/jipb.12295; Zhang B, 2015, NEW PHYTOL, V206, P1513, DOI 10.1111/nph.13335; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27943; ZHANG Y, 2016, NAT COMMUN, V7; Zhao B, 2017, THEOR APPL GENET, V130, P727, DOI 10.1007/s00122-016-2846-4	64	1	1	26	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 8	2017	7								7489	10.1038/s41598-017-07871-9				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FC9RW	WOS:000407179800007	28790350	gold			2018-01-05	
J	Lai, M; Realini, N; La Ferla, M; Passalacqua, I; Matteoli, G; Ganesan, A; Pistello, M; Mazzanti, CM; Piomelli, D				Lai, Michele; Realini, Natalia; La Ferla, Marco; Passalacqua, Ilaria; Matteoli, Giulia; Ganesan, Anand; Pistello, Mauro; Mazzanti, Chiara Maria; Piomelli, Daniele			Complete Acid Ceramidase ablation prevents cancer-initiating cell formation in melanoma cells	SCIENTIFIC REPORTS			English	Article							PROSTATE-CANCER; STEM-CELLS; WAARDENBURG-SYNDROME; DNA-DAMAGE; GENE; RESISTANCE; SPHINGOSINE; ACTIVATION; MECHANISMS; INHIBITION	Acid ceramidase (AC) is a lysosomal cysteine hydrolase that catalyzes the conversion of ceramide into fatty acid and sphingosine. This reaction lowers intracellular ceramide levels and concomitantly generates sphingosine used for sphingosine-1-phosphate (S1P) production. Since increases in ceramide and consequent decreases of S1P reduce proliferation of various cancers, AC might offer a new target for anti-tumor therapy. Here we used CrispR-Cas9-mediated gene editing to delete the gene encoding for AC, ASAH1, in human A375 melanoma cells. ASAH1-null clones show significantly greater accumulation of long-chain saturated ceramides that are substrate for AC. As seen with administration of exogenous ceramide, AC ablation blocks cell cycle progression and accelerates senescence. Importantly, ASAH1-null cells also lose the ability to form cancer-initiating cells and to undergo self-renewal, which is suggestive of a key role for AC in maintaining malignancy and self-renewal of invasive melanoma cells. The results suggest that AC inhibitors might find therapeutic use as adjuvant therapy for advanced melanoma.	[Lai, Michele; Realini, Natalia] Ist Italiano Tecnol, Drug Discovery & Dev, I-16163 Genoa, Italy; [Lai, Michele; La Ferla, Marco; Mazzanti, Chiara Maria] Pisa Sci Fdn, I-56121 Pisa, Italy; [Lai, Michele; Passalacqua, Ilaria; Matteoli, Giulia; Pistello, Mauro] Univ Pisa, Retrovirus Ctr, Pisa, Italy; [Lai, Michele; Passalacqua, Ilaria; Matteoli, Giulia; Pistello, Mauro] Univ Pisa, Virol Sect, Dept Translat Res, Pisa, Italy; [Lai, Michele; Piomelli, Daniele] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92617 USA; [Lai, Michele; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92617 USA; [Lai, Michele; Piomelli, Daniele] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92617 USA; [Ganesan, Anand] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92868 USA	Mazzanti, CM (reprint author), Pisa Sci Fdn, I-56121 Pisa, Italy.; Piomelli, D (reprint author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92617 USA.; Piomelli, D (reprint author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92617 USA.; Piomelli, D (reprint author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92617 USA.	c.mazzanti@fpscience.it; piomelli@uci.edu					Abuhusain HJ, 2013, J BIOL CHEM, V288, P37355, DOI 10.1074/jbc.M113.494740; Alphonse G, 2002, INT J RADIAT BIOL, V78, P821, DOI 10.1080/09553000210153943; Astarita G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116961; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Basit A, 2015, ANAL BIOANAL CHEM, V407, P5189, DOI 10.1007/s00216-015-8585-6; Beckham TH, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.14; Beckham TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076593; Bedia C, 2011, J BIOL CHEM, V286, P28200, DOI 10.1074/jbc.M110.216382; Berndt N, 2013, CELL CYCLE, V12, P2024, DOI 10.4161/cc.25043; Bieberich E, 2008, FUTURE LIPIDOL, V3, P273, DOI 10.2217/17460875.3.3.273; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Borghi A., 2016, BIOCH PHARM; Camacho L, 2013, J LIPID RES, V54, P1207, DOI 10.1194/jlr.M032375; Chen XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07581; Cheng JC, 2013, J CLIN INVEST, V123, P4344, DOI 10.1172/JCI64791; Dany M, 2015, BBA-MOL CELL RES, V1853, P2834, DOI [10.1016/j.bbamcr2014.12.039, 10.1016/j.bbamcr.2014.12.039]; Eliyahu E, 2007, FASEB J, V21, P1403, DOI 10.1096/fj.06-7016com; Elojeimy S, 2007, MOL THER, V15, P1259, DOI 10.1038/sj.mt.6300167; Feng HZ, 2014, J CLIN INVEST, V124, P3741, DOI [10.1172/JC173093, 10.1172/JCI73093]; Galadari S, 2015, APOPTOSIS, V20, P689, DOI 10.1007/s10495-015-1109-1; Giuliano S, 2010, CANCER RES, V70, P3813, DOI 10.1158/0008-5472.CAN-09-2913; Gouaze-Andersson V, 2011, PROSTATE, V71, P1064, DOI 10.1002/pros.21321; Hajj C, 2015, BIOL CHEM, V396, P669, DOI 10.1515/hsz-2014-0302; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heise T., 2016, ONCOTARGET; Kim R, 2001, INT J ONCOL, V18, P363; Lai M, 2016, J MED GENET, V53, P242, DOI 10.1136/jmedgenet-2015-103539; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lee N, 2014, LAB INVEST, V94, P13, DOI 10.1038/labinvest.2013.116; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li CM, 2002, GENOMICS, V79, P218, DOI 10.1006/geno.2002.6686; Luo YC, 2012, STEM CELLS, V30, P2100, DOI 10.1002/stem.1193; Mahdy AEM, 2009, MOL THER, V17, P430, DOI 10.1038/mt.2008.281; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Morales A, 2007, ONCOGENE, V26, P905, DOI 10.1038/sj.onc.1209834; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ozsvari B, 2016, AGING-US, V8, P567, DOI 10.18632/aging.100941; Park JH, 2006, BBA-BIOMEMBRANES, V1758, P2133, DOI 10.1016/j.bbamem.2006.08.019; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Realini N., 2015, J BIOL CHEM; Realini N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01035; Roh JL, 2016, EUR J CANCER, V52, P163, DOI 10.1016/j.ejca.2015.10.056; Saad AF, 2007, CANCER BIOL THER, V6, P1455; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Seelan RS, 2000, GENE CHROMOSOME CANC, V29, P137, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1018>3.0.CO;2-E; Shao CL, 2014, CLIN CANCER RES, V20, P4154, DOI 10.1158/1078-0432.CCR-13-3292; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Sultan I, 2006, BIOCHEM J, V393, P513, DOI 10.1042/BJ20051083; Teni Tanuja, 2002, Pathology and Oncology Research, V8, P109; Turner LS, 2011, PROSTATE CANCER P D, V14, P30, DOI 10.1038/pcan.2010.47; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Venable ME, 2009, CELL BIOCHEM FUNCT, V27, P547, DOI 10.1002/cbf.1605; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701                                                        ; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Zeidan YH, 2008, CURR DRUG TARGETS, V9, P653, DOI 10.2174/138945008785132358                                                      ; Zhang LQ, 2016, J CELL SCI, V129, P1455, DOI 10.1242/jcs.180554	59	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 7	2017	7								7411	10.1038/s41598-017-07606-w				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FC8GP	WOS:000407080100041	28785021	gold			2018-01-05	
J	Ong, SH; Li, Y; Koike-Yusa, H; Yusa, K				Ong, Swee Hoe; Li, Yilong; Koike-Yusa, Hiroko; Yusa, Kosuke			Optimised metrics for CRISPR-KO screens with second-generation gRNA libraries	SCIENTIFIC REPORTS			English	Article							HUMAN-CELLS; TARGET SITES; DNA CLEAVAGE; SGRNA DESIGN; HUMAN GENOME; RNA; CAS9; SYSTEM; GENES; VULNERABILITIES	Genome-wide CRISPR-based knockout (CRISPR-KO) screening is an emerging technique which enables systematic genetic analysis of a cellular or molecular phenotype in question. Continuous improvements, such as modifications to the guide RNA (gRNA) scaffold and the development of gRNA on-target prediction algorithms, have since been made to increase their screening performance. We compared the performance of three available second-generation human genome-wide CRISPR-KO libraries that included at least one of the improvements, and examined the effect of gRNA scaffold, number of gRNAs per gene and number of replicates on screen performance. We identified duplicated screens using a library with 6 gRNAs per gene as providing the best trade-off. Despite the improvements, we found that each improved library still has library-specific false negatives and, for the first time, estimated the false negative rates of CRISPR-KO screens, which are between 10% and 20%. Our newly-defined optimal screening parameters would be helpful in designing screens and constructing bespoke gRNA libraries.	[Ong, Swee Hoe; Li, Yilong; Koike-Yusa, Hiroko; Yusa, Kosuke] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Yusa, K (reprint author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	ky1@sanger.ac.uk		Ong, Swee Hoe/0000-0002-3629-5387	Wellcome Trust [WT077187]	This work was funded by the Wellcome Trust (WT077187).	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cross BCS, 2016, SCI REP-UK, V6, DOI 10.1038/srep31782; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Diaz AA, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1197; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hart T, 2017, G3-GENES GENOM GENET, V7, P2719, DOI 10.1534/g3.117.041277; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Park RJ, 2017, NAT GENET, V49, P193, DOI 10.1038/ng.3741; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Steinhart Z, 2017, NAT MED, V23, P60, DOI 10.1038/nm.4219; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Winter J, 2016, BIOINFORMATICS, V32, P632, DOI 10.1093/bioinformatics/btv617; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Yu JY, 2016, BIOINFORMATICS, V32, P260, DOI 10.1093/bioinformatics/btv556	53	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 7	2017	7								7384	10.1038/s41598-017-07827-z				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FC8GP	WOS:000407080100014	28785007	gold			2018-01-05	
J	Scott, T; Moyo, B; Nicholson, S; Maepa, MB; Watashi, K; Ely, A; Weinberg, MS; Arbuthnot, P				Scott, Tristan; Moyo, Buhle; Nicholson, Samantha; Maepa, Mohube Betty; Watashi, Koichi; Ely, Abdullah; Weinberg, Marc S.; Arbuthnot, Patrick			ssAAVs containing cassettes encoding SaCas9 and guides targeting hepatitis B virus inactivate replication of the virus in cultured cells	SCIENTIFIC REPORTS			English	Article							IN-VIVO; NUCLEASES; GENOME; CAS9; DNA; CRISPR/CAS9; ENDONUCLEASE; HEPATOCYTES; POLYPEPTIDE; SPECIFICITY	Management of infection with hepatitis B virus (HBV) remains a global health problem. Persistence of stable covalently closed circular DNA (cccDNA) during HBV replication is responsible for modest curative efficacy of currently licensed drugs. Novel gene editing technologies, such as those based on CRISPR/Cas9, provide the means for permanently disabling cccDNA. However, efficient delivery of antiviral sequences to infected hepatocytes is challenging. A limiting factor is the large size of sequences encoding Cas9 from Streptococcus pyogenes, and resultant incompatibility with the popular single stranded adeno-associated viral vectors (ssAAVs). We thus explored the utility of ssAAVs for delivery of engineered CRISPR/Cas9 of Staphylococcus aureus (Sa), which is encoded by shorter DNA sequences. Short guide RNAs (sgRNAs) were designed with cognates in the S open reading frame of HBV and incorporated into AAVs that also encoded SaCas9. Intended targeted mutation of HBV DNA was observed after transduction of cells with the all-in-one vectors. Efficacy against HBV-infected hNTCP-HepG2 cells indicated that inactivation of cccDNA was successful. Analysis of likely off-target mutagenesis revealed no unintended sequence changes. Use of ssAAVs to deliver all components required to disable cccDNA by SaCas9 is novel and the technology has curative potential for HBV infection.	[Scott, Tristan; Moyo, Buhle; Nicholson, Samantha; Maepa, Mohube Betty; Ely, Abdullah; Weinberg, Marc S.; Arbuthnot, Patrick] Univ Witwatersrand, Hlth Sci Fac, Wits SAMRC Antiviral Gene Therapy Res Unit, Johannesburg, South Africa; [Scott, Tristan] Univ Witwatersrand, HIV Pathogenesis Res Unit, Hlth Sci Fac, Johannesburg, South Africa; [Watashi, Koichi] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan	Arbuthnot, P (reprint author), Univ Witwatersrand, Hlth Sci Fac, Wits SAMRC Antiviral Gene Therapy Res Unit, Johannesburg, South Africa.	Patrick.Arbuthnot@wits.ac.za			South African National Research Foundation (NRF) [GUNs 81768, 81692, 68339, 85981, 77954]; Medical Research Council; Johnson & Johnson Innovation; Poliomyelitis Research Foundation [PRF-15/27]	Financial assistance for work carried out in the authors' laboratory, which was received from the South African National Research Foundation (NRF, GUNs 81768, 81692, 68339, 85981 & 77954), Medical Research Council, Johnson & Johnson Innovation and the Poliomyelitis Research Foundation (PRF-15/27) is gratefully acknowledged.	Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bhoola NH, 2014, J VIROL METHODS, V203, P54, DOI 10.1016/j.jviromet.2014.03.015; Bloom K., 2017, HEPATITIS B VIRUS ME, V1540, P85; Bloom K, 2013, MOL THER, V21, P1889, DOI 10.1038/mt.2013.170; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chamberlain K, 2016, HUM GENE THER METHOD, V27, P1, DOI 10.1089/hgtb.2015.140; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Cradick TJ, 2010, MOL THER, V18, P947, DOI 10.1038/mt.2010.20; Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015; Ely A, 2016, MOL THER, V24, P671, DOI 10.1038/mt.2016.43; Findlay SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153901; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Kattenhorn LM, 2016, HUM GENE THER, V27, P947, DOI 10.1089/hum.2016.160; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Lin Y., 2014, NUCL ACIDS RES; Liu X, 2015, J GEN VIROL, V96, P2252, DOI 10.1099/vir.0.000159; Morikawa K, 2016, HEPATOL RES, V46, P871, DOI 10.1111/hepr.12650; Moyo B, 2017, VIRUS RES; NASSAL M, 1992, J VIROL, V66, P4107; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Passman M, 2000, BIOCHEM BIOPH RES CO, V268, P728, DOI 10.1006/bbrc.2000.2209                                                          ; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Pliatsika V, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0035-z; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Sunbul M, 2014, WORLD J GASTROENTERO, V20, P5427, DOI 10.3748/wjg.v20.i18.5427; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Watashi K, 2014, HEPATOLOGY, V59, P1726, DOI 10.1002/hep.26982; Wu Xuebing, 2014, Quant Biol, V2, P59; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	40	0	0	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 7	2017	7								7401	10.1038/s41598-017-07642-6				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FC8GP	WOS:000407080100031	28785016	gold			2018-01-05	
J	Li, N; Shi, Y; Zhang, PP; Sang, J; Li, F; Deng, H; Lv, Y; Han, QY; Liu, ZW				Li, Na; Shi, Ying; Zhang, Pingping; Sang, Jiao; Li, Fang; Deng, Huan; Lv, Yi; Han, Qunying; Liu, Zhengwen			Association of the tandem polymorphisms (rs148314165, rs200820567) in TNFAIP3 with chronic hepatitis B virus infection in Chinese Han population	VIROLOGY JOURNAL			English	Article						Hepatitis B virus; TNFAIP3; Polymorphism; Susceptibility; Clinical disease	NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TUMOR-NECROSIS-FACTOR; LIVER-REGENERATION; A20; MICE; HEPATOCYTES; INHIBITION; ACTIVATION; EXPRESSION	Background: Chronic hepatitis B virus (HBV) infection remains an important public health issue. A20, a ubiquitin-editing protein encoded by tumor necrosis factor alpha-inducible protein 3 (TNFAIP3) gene, is complicated in HBV infection and liver injury. The tandem polymorphisms (rs148314165, rs200820567), deletion T followed by a T to A transversion and collectively referred to as TT > A in TNFAIP3, may attenuate A20 expression. Methods: The rs148314165 and rs200820567 polymorphisms were examined using PCR amplification followed by direct sequencing in 419 patients with chronic HBV infection, 77 HBV infection resolvers and 175 healthy controls of Chinese Han ethnicity. Results: The genotypes and alleles of rs148314165 and rs200820567 polymorphisms determined and the haplotypes constructed were consistently identical, confirming the reliable determination of the TT > A variant. The genotypes of rs148314165 and rs200820567 in HBV patients, HBV infection resolvers and healthy controls are in Hardy-Weinberg equilibrium (P > 0. 05). The patients with chronic HBV infection had higher frequency of TT > A variant than healthy controls (6.6% vs. 3.4%; OR, 1.979; 95% CI, 1.046-3.742; P = 0.033). The frequency of TT > A variant between patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma had no significant differences. Conclusions: The TT > A variant of TNFAIP3 may be associated with the susceptibility of chronic HBV infection but not the clinical diseases. Studies in large sample size of HBV patient and control populations are required to further clarify the role of this important variant in chronic HBV infection and the disease progression related to the infection.	[Li, Na; Zhang, Pingping; Sang, Jiao; Li, Fang; Deng, Huan; Han, Qunying; Liu, Zhengwen] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Infect Dis, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China; [Shi, Ying] Maternal & Children Hlth Hosp Tongchuan, Tongchuan 727000, Shaanxi, Peoples R China; [Lv, Yi] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710061, Shaanxi, Peoples R China; [Lv, Yi; Liu, Zhengwen] Xi An Jiao Tong Univ, Inst Adv Surg Technol & Engn, Xian 710061, Shaanxi, Peoples R China	Han, QY; Liu, ZW (reprint author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Infect Dis, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China.; Liu, ZW (reprint author), Xi An Jiao Tong Univ, Inst Adv Surg Technol & Engn, Xian 710061, Shaanxi, Peoples R China.	hanqunying@medmail.com.cn; liuzhengwen@medmail.com.cn			National Natural Science Foundation of China [81371798]	This work was supported in part by funding from the National Natural Science Foundation of China (Grant no. 81371798).	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Arguello M, 2014, ADV EXP MED BIOL, V809, P49; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Catrysse L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.154; Chen HY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0454-6; Clippinger AJ, 2009, J VIROL, V83, P4718, DOI 10.1128/JVI.02590-08; da Silva CG, 2013, HEPATOLOGY, V57, P2014, DOI 10.1002/hep.26197; Fan YC, 2016, ONCOTARGET, V7, P68821, DOI 10.18632/oncotarget.11993; Golsaz-Shirazi F, 2016, IMMUNOTHERAPY-UK, V8, P461, DOI 10.2217/imt.16.3; Guo YS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001501; Kawasaki A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/207578; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Pujari R, 2013, IMMUNOL RES, V57, P166, DOI 10.1007/s12026-013-8463-2; Satake S, 2007, HEPATOL RES, V37, P524, DOI 10.1111/j.1872-034X.2007.00083.x; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272                                                           ; Studer P, 2015, CELL DEATH DIFFER, V22, P2068, DOI 10.1038/cdd.2015.52; Valaydon Z, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.68; Wang SF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003750; Wang XT, 2016, ONCOTARGET, V7, P14742, DOI 10.18632/oncotarget.7521; Zhang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127329; Zhang PP, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0268-6; Zilberman-Rudenko J, 2016, P NATL ACAD SCI USA, V113, P1612, DOI 10.1073/pnas.1518163113	26	0	0	5	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1743-422X			VIROL J	Virol. J.	AUG 7	2017	14								148	10.1186/s12985-017-0814-5				7	Virology	Virology	FD0FK	WOS:000407215000001	28784141	gold			2018-01-05	
J	Cremer, M; Schmid, VJ; Kraus, F; Markaki, Y; Hellmann, I; Maiser, A; Leonhardt, H; John, S; Stamatoyannopoulos, J; Cremer, T				Cremer, Marion; Schmid, Volker J.; Kraus, Felix; Markaki, Yolanda; Hellmann, Ines; Maiser, Andreas; Leonhardt, Heinrich; John, Sam; Stamatoyannopoulos, John; Cremer, Thomas			Initial high-resolution microscopic mapping of active and inactive regulatory sequences proves non-random 3D arrangements in chromatin domain clusters	EPIGENETICS & CHROMATIN			English	Article						Transcription regulatory sequences; DNAse I hypersensitive sites; Super-resolution microscopy; Chromatin domain; Nuclear architecture; Active and inactive nuclear compartment; Chromatin compaction	I HYPERSENSITIVE SITES; HUMAN GENOME; NUCLEAR LANDSCAPE; MAMMALIAN-CELLS; SUPERRESOLUTION MICROSCOPY; FLUORESCENCE MICROSCOPY; CRISPR/CAS9 SYSTEM; XIST RNA; REVEALS; ORGANIZATION	Background: The association of active transcription regulatory elements (TREs) with DNAse I hypersensitivity (DHS[+]) and an 'open' local chromatin configuration has long been known. However, the 3D topography of TREs within the nuclear landscape of individual cells in relation to their active or inactive status has remained elusive. Here, we explored the 3D nuclear topography of active and inactive TREs in the context of a recently proposed model for a functionally defined nuclear architecture, where an active and an inactive nuclear compartment (ANC-INC) form two spatially co-aligned and functionally interacting networks. Results: Using 3D structured illumination microscopy, we performed 3D FISH with differently labeled DNA probe sets targeting either sites with DHS[+], apparently active TREs, or DHS[-] sites harboring inactive TREs. Using an in-house image analysis tool, DNA targets were quantitatively mapped on chromatin compaction shaped 3D nuclear landscapes. Our analyses present evidence for a radial 3D organization of chromatin domain clusters (CDCs) with layers of increasing chromatin compaction from the periphery to the CDC core. Segments harboring active TREs are significantly enriched at the decondensed periphery of CDCs with loops penetrating into interchromatin compartment channels, constituting the ANC. In contrast, segments lacking active TREs (DHS[-]) are enriched toward the compacted interior of CDCs (INC). Conclusions: Our results add further evidence in support of the ANC-INC network model. The different 3D topographies of DHS[+] and DHS[-] sites suggest positional changes of TREs between the ANC and INC depending on their functional state, which might provide additional protection against an inappropriate activation. Our finding of a structural organization of CDCs based on radially arranged layers of different chromatin compaction levels indicates a complex higher-order chromatin organization beyond a dichotomic classification of chromatin into an 'open,' active and 'closed,' inactive state.	[Cremer, Marion; Kraus, Felix; Markaki, Yolanda; Hellmann, Ines; Maiser, Andreas; Leonhardt, Heinrich; Cremer, Thomas] Ludwig Maximilians Univ LMU Munich, Dept Biol 2, LMU Bioctr, Grosshadernerstr 2, D-82152 Martinsried, Germany; [Schmid, Volker J.] Ludwig Maximilians Univ LMU Munich, Dept Stat, BioImaging Grp, Munich, Germany; [Kraus, Felix] Monash Univ, Dept Biochem & Mol Biol, Monash Biomed Discovery Inst, Melbourne, Vic 3800, Australia; [Markaki, Yolanda] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [John, Sam; Stamatoyannopoulos, John] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [John, Sam] NCI, Ctr Canc Res, Bethesda, MD 20892 USA	Cremer, M; Cremer, T (reprint author), Ludwig Maximilians Univ LMU Munich, Dept Biol 2, LMU Bioctr, Grosshadernerstr 2, D-82152 Martinsried, Germany.	Marion.cremer@lrz.uni-muenchen.de; Thomas.Cremer@lrz.uni-muenchen.de	Leonhardt, Heinrich/B-2791-2014	Kraus, Felix/0000-0002-3757-541X	Ludwig Maximilians-Universitat (LMU Munich)	This work was supported by funding of the Ludwig Maximilians-Universitat (LMU Munich) to TC.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Anton T, 2016, METHODS MOL BIOL, V1411, P407, DOI 10.1007/978-1-4939-3530-7_25; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Ay F, 2014, GENOME RES, V24, P999, DOI 10.1101/gr.160374.113; Ball G, 2015, SCI REP-UK, V5, DOI 10.1038/srep15915; Beliveau BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8147; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Boeger H, 2015, GENES-BASEL, V6, P469, DOI 10.3390/genes6030469; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Boulos RE, 2015, FEBS LETT, V589, P2944, DOI 10.1016/j.febslet.2015.04.015; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bronshtein I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9044; Bronshtein I, 2016, NUCLEUS-PHILA, V7, P27, DOI 10.1080/19491034.2016.1139272; Cerase A, 2014, P NATL ACAD SCI USA, V111, P2235, DOI 10.1073/pnas.1312951111; Cockerill PN, 2011, FEBS J, V278, P2182, DOI 10.1111/j.1742-4658.2011.08128.x; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075                                                                ; Cremer T, 2015, FEBS LETT, V589, P2931, DOI 10.1016/j.febslet.2015.05.037; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Demmerle J, 2015, METHODS, V88, P3, DOI 10.1016/j.ymeth.2015.07.001; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobbie Ian M, 2011, Cold Spring Harb Protoc, V2011, P899, DOI 10.1101/pdb.top121; Fraser J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156492; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Hihara S, 2012, CELL REP, V2, P1645, DOI 10.1016/j.celrep.2012.11.008; Hubner B, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0038-0; Hubner B, 2013, METHODS MOL BIOL, V1042, P299, DOI 10.1007/978-1-62703-526-2_21; Jin WF, 2015, NATURE, V528, P142, DOI 10.1038/nature15740; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kirmes I, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0802-2; Knoch TA, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0089-x; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Ma WX, 2015, NAT METHODS, V12, P71, DOI [10.1038/NMETH.3205, 10.1038/nmeth.3205]; Maeshima K, 2016, CURR OPIN GENET DEV, V37, P36, DOI 10.1016/j.gde.2015.11.006; Maeshima K, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/6/064116; Maeshima K, 2010, CURR OPIN CELL BIOL, V22, P291, DOI 10.1016/j.ceb.2010.03.001; Markaki Yolanda, 2013, Methods Mol Biol, V950, P43, DOI 10.1007/978-1-62703-137-0_4; Markaki Y, 2012, BIOESSAYS, V34, P412, DOI 10.1002/bies.201100176; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Mercer TR, 2013, NAT GENET, V45, P852, DOI 10.1038/ng.2677; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Neems DS, 2016, P NATL ACAD SCI USA, V113, pE1691, DOI 10.1073/pnas.1521826113; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Over RS, 2014, MOL PLANT, V7, P481, DOI 10.1093/mp/sst164; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Popken J, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0092-7; Popken J, 2014, NUCLEUS-PHILA, V5, P555, DOI 10.4161/19491034.2014.979712; Pundhir S, 2016, NUCLEIC ACIDS RES, V44, P4037, DOI 10.1093/nar/gkw250; R Core Team, 2013, LANG ENV STAT COMP; Ramani V, 2016, NAT PROTOC, V11, P59, DOI 10.1038/nprot.2016.126; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P4537, DOI 10.1073/pnas.0400678101; Sakabe NJ, 2010, WIRES SYST BIOL MED, V2, P422, DOI 10.1002/wsbm.70; Saksouk N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-3; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schmid VJ, 2017, METHODS, V123, P33, DOI 10.1016/j.ymeth.2017.03.013; Sexton T, 2015, CELL, V160, P1049, DOI 10.1016/j.cell.2015.02.040; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shao SP, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw066; Smeets D, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-8; Stevens TJ, 2017, NATURE, V544, P59, DOI 10.1038/nature21429; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Yang R, 2016, NUCLEIC ACIDS RES, V44, P3082, DOI 10.1093/nar/gkv1358; Zerbino DR, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0621-5	72	1	1	8	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-8935			EPIGENET CHROMATIN	Epigenetics Chromatin	AUG 7	2017	10								39	10.1186/s13072-017-0146-0				17	Genetics & Heredity	Genetics & Heredity	FC7FL	WOS:000407006500001	28784182	gold			2018-01-05	
J	Khalil, K; Elayat, M; Khalifa, E; Daghash, S; Elaswad, A; Miller, M; Abdelrahman, H; Ye, Z; Odin, R; Drescher, D; Vo, K; Gosh, K; Bugg, W; Robinson, D; Dunham, R				Khalil, Karim; Elayat, Medhat; Khalifa, Elsayed; Daghash, Samer; Elaswad, Ahmed; Miller, Michael; Abdelrahman, Hisham; Ye, Zhi; Odin, Ramjie; Drescher, David; Vo, Khoi; Gosh, Kamal; Bugg, William; Robinson, Dalton; Dunham, Rex			Generation of Myostatin Gene-Edited Channel Catfish (Ictalurus punctatus) via Zygote Injection of CRISPR/Cas9 System	SCIENTIFIC REPORTS			English	Article							ONE-STEP GENERATION; DIFFERENTIAL EXPRESSION; MUSCLE MASS; OOPLASMIC SEGREGATION; TRANSGENIC ZEBRAFISH; HYPERTROPHIC GROWTH; MOLECULAR-CLONING; BETA SUPERFAMILY; LATERAL MUSCLE; IMMUNE-SYSTEM	The myostatin (MSTN) gene is important because of its role in regulation of skeletal muscle growth in all vertebrates. In this study, CRISPR/Cas9 was utilized to successfully target the channel catfish, Ictalurus punctatus, muscle suppressor gene MSTN. CRISPR/Cas9 induced high rates (88-100%) of mutagenesis in the target protein-encoding sites of MSTN. MSTN-edited fry had more muscle cells (p < 0.001) than controls, and the mean body weight of gene-edited fry increased by 29.7%. The nucleic acid alignment of the mutated sequences against the wild-type sequence revealed multiple insertions and deletions. These results demonstrate that CRISPR/Cas9 is a highly efficient tool for editing the channel catfish genome, and opens ways for facilitating channel catfish genetic enhancement and functional genomics. This approach may produce growth-enhanced channel catfish and increase productivity.	[Khalil, Karim; Elaswad, Ahmed; Abdelrahman, Hisham; Ye, Zhi; Odin, Ramjie; Drescher, David; Vo, Khoi; Gosh, Kamal; Bugg, William; Robinson, Dalton; Dunham, Rex] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA; [Khalil, Karim; Elayat, Medhat; Khalifa, Elsayed; Daghash, Samer] Cairo Univ, Fac Vet Med, Anat & Embryol Dept, Giza 12211, Egypt; [Miller, Michael] Auburn Univ, Harrison Sch Pharm, Auburn, AL 36849 USA; [Elaswad, Ahmed] Suez Canal Univ, Fac Vet Med, Dept Anim Wealth Dev, Ismailia 41522, Egypt; [Abdelrahman, Hisham] Cairo Univ, Fac Vet Med, Dept Vet Hyg & Management, Giza 12211, Egypt	Khalil, K; Elaswad, A; Dunham, R (reprint author), Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA.; Khalil, K (reprint author), Cairo Univ, Fac Vet Med, Anat & Embryol Dept, Giza 12211, Egypt.; Elaswad, A (reprint author), Suez Canal Univ, Fac Vet Med, Dept Anim Wealth Dev, Ismailia 41522, Egypt.	Karim.Khalil@vet.cu.edu.eg; ahe0001@auburn.edu; dunhara@auburn.edu			Culture Affairs and Mission Sector, Ministry of Higher Education, Government of Egypt	This project was supported via PhD scholarship to Karim Khalil from Culture Affairs and Mission Sector, Ministry of Higher Education, Government of Egypt.	ABDELRAHMAN H, 2017, BMC GENOMICS, V18; ABRAHAM VC, 1993, BIOL BULL, V184, P115, DOI 10.2307/1542222; Acosta J, 2005, J BIOTECHNOL, V119, P324, DOI 10.1016/j.jbiotec.2005.04.023; Armstrong J., 1989, RAISING AXOLOTL CAPT, P220; Bart AN, 1996, THERIOGENOLOGY, V45, P673, DOI 10.1016/0093-691X(95)00413-3                                                    ; Biga PR, 2006, AM J PHYSIOL-REG I, V291, pR1327, DOI 10.1152/ajpregu.00905.2005; Carlson CJ, 1999, AM J PHYSIOL-REG I, V277, pR601; Chakrapani V, 2016, DEV COMP IMMUNOL, V61, P242, DOI 10.1016/j.dci.2016.04.009; Chiang YA, 2016, FISH SHELLFISH IMMUN, V48, P212, DOI 10.1016/j.fsi.2015.11.016; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; De Santis C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-82; Dong ZJ, 2014, ZEBRAFISH, V11, P265, DOI 10.1089/zeb.2014.0974; Dong ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028897; Dunner S, 1997, MAMM GENOME, V8, P430, DOI 10.1007/s003359900462; Edvardsen RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108622; Elaswad A., 2016, THESIS; Fujii W, 2014, J REPROD DEVELOP, V60, P324, DOI 10.1262/jrd.2013-139                                                            ; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Garikipati DK, 2007, ENDOCRINOLOGY, V148, P2106, DOI 10.1210/en.2006-1299; Gerard G., 2006, GENETIC VARIANCE DET, P95; Gregory DJ, 2004, ANIM GENET, V35, P425, DOI 10.1111/j.1365-2052.2004.01193.x; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Grobet L, 1998, MAMM GENOME, V9, P210, DOI 10.1007/s003359900727; Guo R., 2016, SCI REPORTS, V6; Hanson T., 2012, 2011 US CATFISH DATA; Hongbing H., 2014, FRONT AGR SCI ENG, V1, P2; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910                                                              ; Kanjanaworakul P, 2016, MOL BIOL REP, V43, P283, DOI 10.1007/s11033-016-3961-7; Kanjanaworakul P, 2015, FISH PHYSIOL BIOCHEM, V41, P177, DOI 10.1007/s10695-014-0015-8; Kerr T, 2005, EVOL DEV, V7, P390, DOI 10.1111/j.1525-142X.2005.05044.x; Kocabas AM, 2002, BBA-GENE STRUCT EXPR, V1575, P99, DOI 10.1016/S0167-4781(02)00289-0; Kurita K, 2004, P NATL ACAD SCI USA, V101, P1263, DOI 10.1073/pnas.0304265101; Lee CY, 2009, BIOCHEM BIOPH RES CO, V387, P766, DOI 10.1016/j.bbrc.2009.07.110; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098                                                          ; Leung CF, 2000, DEV GROWTH DIFFER, V42, P29; Li MH, 2014, GENETICS, V197, P591, DOI 10.1534/genetics.114.163667; Liu LS, 2012, MOL BIOL REP, V39, P9211, DOI 10.1007/s11033-012-1794-6; Liu Z., 2016, NATURE COMMUNICATION, V7; Lv Q., 2016, SCI REPORTS, V6; Lyons JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012928; Maccatrozzo L, 2001, MAR BIOTECHNOL, V3, P224, DOI 10.1007/s101260000064; Maccatrozzo L, 2001, FEBS LETT, V509, P36, DOI 10.1016/S0014-5793(01)03124-6; Maggio I, 2015, TRENDS BIOTECHNOL, V33, P280, DOI 10.1016/j.tibtech.2015.02.011; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Nelson J. S., 2016, FISHES WORLD; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ostbye TKK, 2007, GENE, V403, P159, DOI 10.1016/j.gene.2007.08.008; Pan JL, 2007, DNA SEQUENCE, V18, P279, DOI 10.1080/10425170701243492; Qin Z, 2015, THESIS; Qiu P, 2004, BIOTECHNIQUES, V36, P702; Radaelli G, 2003, CELL TISSUE RES, V311, P239, DOI 10.1007/s00441-002-0668-y; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Rescan PY, 2001, J EXP BIOL, V204, P3523; Rodgers BD, 2001, ENDOCRINOLOGY, V142, P1412, DOI 10.1210/endo.142.4.8097; Rodgers BD, 2007, AM J PHYSIOL-ENDOC M, V292, pE371, DOI 10.1152/ajpendo.00395.2006; Saksena V. P., 1961, PROG FISH CULT, V23, P156; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silva P, 2009, J FISH BIOL, V74, P37, DOI 10.1111/j.1095-8649.2008.02122.x; Singh NK, 2012, ANIM BIOTECHNOL, V23, P174, DOI 10.1080/10495398.2012.664598; Smith JA, 2000, ANIM GENET, V31, P306, DOI 10.1046/j.1365-2052.2000.00521.x; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; Steel R. G., 1980, PRINCIPLES PROCEDURE, V633; Tucker C. S., 1990, CHANNEL CATFISH FARM; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; VEGGETTI A, 1990, ANAT EMBRYOL, V182, P1; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang KK, 2015, SCI REP-UK, V5, DOI 10.1038/srep16623; Wang X., 2015, SCI REPORTS, V5; Wargelius A, 2016, SCI REPORTS, V6; Westerfield M, 2004, METHODS CELL BIOL GE; Xianghai Ye, 2007, Genetics, Selection, Evolution, V39, P73, DOI 10.1051/gse:2006029; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Ye HQ, 2007, MAR BIOTECHNOL, V9, P262, DOI 10.1007/s10126-006-6093-6; Zhang CY, 2012, MOL BIOL REP, V39, P3081, DOI 10.1007/s11033-011-1071-0; Zheng GD, 2015, GEN COMP ENDOCR, V214, P68, DOI 10.1016/j.ygcen.2015.03.008; Zhong Z., 2016, SCI REPORTS, V6	85	0	0	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 4	2017	7								7301	10.1038/s41598-017-07223-7				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FC6VW	WOS:000406980800040	28779173	gold			2018-01-05	
J	van Eijl, RAPM; van den Brand, T; Nguyen, LN; Mulder, KW				van Eijl, Roderick A. P. M.; van den Brand, Teun; Nguyen, Luan N.; Mulder, Klaas W.			Reactivity of human AGO2 monoclonal antibody 11A9 with the SWI/SNF complex: A case study for rigorously defining antibody selectivity	SCIENTIFIC REPORTS			English	Article							SMALL RNAS; HUMAN-CELLS; NONCODING TRANSCRIPT; ARGONAUTE PROTEINS; NUCLEAR RNAI; GENE; PROMOTER; GENOME; COMPLEMENTARY; PURIFICATION	In this study, we originally aimed to characterize the potential role of Argonaute 2 (AGO2) in the nucleus, a key protein of the miRNA machinery. We combined Chromatin Immunoprecipitation (ChIP) with high throughput sequencing (ChIP-seq) and quantitative mass spectrometry (ChIP-MS) using the broadly used AGO2 11A9 antibody to determine interactions with chromatin and nuclear proteins. We found a previously described interaction between AGO2 and SWI/SNF on chromatin with ChIP-MS and observed enrichment at enhancers and transcription start sites using ChIP-seq. However, antibody specificity issues can produce misleading results for ChIP, RNA-seq and Mass spectrometry. Therefore, we developed a CRISPR/Cas9 engineered AGO2(-/-)HEK293T cell line to validate our findings. ChIP-qPCR and immunoprecipitation combined with MS (IP-MS) showed that the 11A9 antibody associates with chromatin and SWI/SNF in the absence of AGO2. Furthermore, stoichiometry, IP-MS and co-IP analysis suggests a direct interaction of this antibody with SMARCC1, a component of the SWI/SNF complex. For this reason, particular care should be taken in performing and interpreting experiments in which the 11A9 antibody is used to study a nuclear role of AGO2.	[van Eijl, Roderick A. P. M.; van den Brand, Teun; Mulder, Klaas W.] Radboud Univ Nijmegen, Dept Mol Dev Biol, Nijmegen, Netherlands; [Nguyen, Luan N.] Radboud Inst Mol Life Sci, Mol Biol, Nijmegen, Netherlands	Mulder, KW (reprint author), Radboud Univ Nijmegen, Dept Mol Dev Biol, Nijmegen, Netherlands.	k.mulder@science.ru.nl			Radboud University; Dutch Organization for Scientific Research (NWO-VIDI); European Union (Marie-Curie Career Integration Grant)	We acknowledge the funding support from the Radboud University, the Dutch Organization for Scientific Research (NWO-VIDI) and the European Union (Marie-Curie Career Integration Grant).	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Ahlenstiel CL, 2012, NUCLEIC ACIDS RES, V40, P1579, DOI 10.1093/nar/gkr891; Allo M, 2014, P NATL ACAD SCI USA, V111, P15622, DOI 10.1073/pnas.1416858111; Ameyar-Zazoua M, 2012, NAT STRUCT MOL BIOL, V19, P998, DOI 10.1038/nsmb.2373; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Carissimi C, 2015, NUCLEIC ACIDS RES, V43, P1498, DOI 10.1093/nar/gku1387; Cho S, 2014, NUCLEIC ACIDS RES, V42, P13545, DOI 10.1093/nar/gku788; Chu YJ, 2010, NUCLEIC ACIDS RES, V38, P7736, DOI 10.1093/nar/gkq648; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gagnon KT, 2014, CELL REP, V6, P211, DOI 10.1016/j.celrep.2013.12.013; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Geiger T, 2012, MOL CELL PROTEOMICS, V11, pM111, DOI DOI 10.1074/MCP.M111.014050; Hawkins PG, 2009, NUCLEIC ACIDS RES, V37, P2984, DOI 10.1093/nar/gkp127; Kalantari R., 2016, STABLE ASS RNAI MACH, P1, DOI [10.1261/rna.056499.116, DOI 10.1261/RNA.056499.116]; Kalantari R, 2016, NUCLEIC ACIDS RES, V44, P524, DOI 10.1093/nar/gkv1305; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Matsui M, 2013, NUCLEIC ACIDS RES, V41, P10086, DOI 10.1093/nar/gkt777; Matsui M, 2010, CHEM BIOL, V17, P1344, DOI 10.1016/j.chembiol.2010.10.009; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Moshkovich N, 2011, GENE DEV, V25, P1686, DOI 10.1101/gad.16651211; Nishi K, 2013, RNA, V19, P17, DOI 10.1261/rna.034769.112; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsm.1444; Simonnet H, 2002, CARCINOGENESIS, V23, P759, DOI 10.1093/carcin/23.5.759                                                         ; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Tan GS, 2009, NUCLEIC ACIDS RES, V37, P7533, DOI 10.1093/nar/gkp812; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/nmeth.3995, 10.1038/NMETH.3995]; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Zamudio JR, 2014, CELL, V156, P920, DOI 10.1016/j.cell.2014.01.041; Zhang XZ, 2011, J BIOL CHEM, V286, P29443, DOI 10.1074/jbc.R111.276378; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	43	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 4	2017	7								7278	10.1038/s41598-017-07539-4				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FC6VW	WOS:000406980800017	28779093	gold			2018-01-05	
J	Tokuda, S; Hirai, T; Furuse, M				Tokuda, Shinsaku; Hirai, Toyohiro; Furuse, Mikio			Claudin-4 knockout by TALEN-mediated gene targeting in MDCK cells: Claudin-4 is dispensable for the permeability properties of tight junctions in wild-type MDCK cells	PLOS ONE			English	Article							ZONULAE-OCCLUDENTES; EPITHELIAL-CELLS; EXPRESSION; OCCLUDIN; CATION; CONDUCTANCE; SELECTIVITY; TRANSPORT; MEMBRANE; PROTEIN	Epithelia act as a barrier between the internal and external environments, and the movement of substances via the paracellular pathway is regulated by tight junctions (TJs). Claudins are major determinants of TJ permeability. Claudin-4 was the first claudin whose involvement in the TJ permeability in cultured cells was directly demonstrated, but the permeability properties of individual claudins including claudin-4 are still incompletely clarified. In this study, we established claudin-4 knockout cells using transcription activator-like effector nucleases (TALENs), a recently developed method for genome editing, and investigated the permeability property of claudin-4 in MDCK II cells. We found that claudin-4 knockout has no apparent effect on the localization of other claudins and electrophysiological properties in MDCK II cells. Therefore we further established claudin-2 and claudin-4 double knockout clones and investigated the effects on TJs. Claudin-4 knockout in addition to claudin-2 knockout slightly increased the localization of other claudins at TJs but showed no obvious effects on the electrophysiological properties in MDCK II cells. These results indicate that claudin-4 is dispensable for the barrier property of TJs in wild-type as well as claudin-2 knockout MDCK II cells. Our results suggest the need for further knockout analysis to reveal the permeability properties of individual claudins.	[Tokuda, Shinsaku; Hirai, Toyohiro] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Furuse, Mikio] Natl Inst Physiol Sci, Div Cell Struct, Okazaki, Aichi, Japan; [Furuse, Mikio] SOKENDAI, Dept Physiol Sci, Okazaki, Aichi, Japan	Tokuda, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan.	tokku@kuhp.kyotosu.ac.ju			Japan Society for the Promotion of Science [16K21101, 26291043]	This work was supported by the Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science, 16K21101, http://www.jsps.go.jp/, ST; and the Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science, 26291043, http://www.jsps.go.jp/, MF.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Grau J, 2013, BIOINFORMATICS, V29, P2931, DOI 10.1093/bioinformatics/btt501; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Hou JH, 2006, J BIOL CHEM, V281, P36117, DOI 10.1074/jbc.M608853200; ITOH M, 1991, J CELL BIOL, V115, P1449, DOI 10.1083/jcb.115.5.1449; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Larre I, 2010, P NATL ACAD SCI USA, V107, P11387, DOI 10.1073/pnas.1000500107; McCarthy KM, 2000, J CELL SCI, V113, P3387; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; NIWA H, 1991, GENE, V108, P193; POWELL DW, 1981, AM J PHYSIOL, V241, pG275; Reuss L., 2001, TIGHT JUNCTIONS, P61; Saitou M, 1997, EUR J CELL BIOL, V73, P222; STAEHELIN LA, 1973, J CELL SCI, V13, P763; Tokuda S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166904; Tokuda S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145522; Tokuda S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119869; Tokuda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104994; Tokuda S, 2010, BIOCHEM BIOPH RES CO, V393, P390, DOI 10.1016/j.bbrc.2010.02.002; Truett GE, 2000, BIOTECHNIQUES, V29, P52; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wu CJ, 2013, J BIOL CHEM, V288, P12253, DOI 10.1074/jbc.M113.457499; Yu ASL, 2010, J BIOL CHEM, V285, P37060, DOI 10.1074/jbc.M110.146621; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154	36	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182521	10.1371/journal.pone.0182521				19	Multidisciplinary Sciences	Science & Technology - Other Topics	FC6IS	WOS:000406944300038	28777806	gold			2018-01-05	
J	Pessino, V; Citron, YR; Feng, SY; Huang, B				Pessino, Veronica; Citron, Y. Rose; Feng, Siyu; Huang, Bo			Covalent Protein Labeling by SpyTag-SpyCatcher in Fixed Cells for Super-Resolution Microscopy	CHEMBIOCHEM			English	Article						epitope tags; fluorescence microscopy; fluorescent probes; SpyTag-SpyCatcher; super-resolution microscopy		Labeling proteins with high specificity and efficiency is a fundamental prerequisite for microscopic visualization of subcellular protein structures and interactions. Although the comparatively small size of epitope tags makes them less perturbative to fusion proteins, they require the use of large antibodies that often limit probe accessibility and effective resolution. Here we use the covalent SpyTag-SpyCatcher system as an epitope-like tag for fluorescent labeling of intracellular proteins in fixed cells for both conventional and super-resolution microscopy. We also applied this method to endogenous proteins by gene editing, demonstrating its high labeling efficiency and capability for isoform-specific labeling.	[Huang, Bo] Univ Calif San Francisco, Dept Pharmaceut Chem, 1700 4th St MC 2532, San Francisco, CA 94143 USA; [Huang, Bo] Univ Calif San Francisco, Dept Biochem & Biophys, 1700 4th St MC 2532, San Francisco, CA 94143 USA; [Pessino, Veronica; Citron, Y. Rose] Univ Calif San Francisco, Grad Program Biophys, 1700 4th St MC 2532, San Francisco, CA 94143 USA; [Feng, Siyu] Univ Calif San Francisco, UC Berkeley UCSF Grad Program Bioengn, 1700 4th St MC 2532, San Francisco, CA 94143 USA	Huang, B (reprint author), Univ Calif San Francisco, Dept Pharmaceut Chem, 1700 4th St MC 2532, San Francisco, CA 94143 USA.; Huang, B (reprint author), Univ Calif San Francisco, Dept Biochem & Biophys, 1700 4th St MC 2532, San Francisco, CA 94143 USA.	bo.huang@ucsf.edu			National Institutes of Health [DP2OD008479]; NIH [R21 EB022798]; American Heart Association; National Science Foundation	We thank the Charles Craik lab (University of California, San Francisco) for their gift of the SpyCatcher plasmid used for purification, the Joseph DeRisi lab (UCSF) for use of their electroporation equipment, and David Brown of the B.H. lab for general experimental advice. This work was supported by a National Institutes of Health Director's New Innovator Award DP2OD008479 (to B.H.) and an NIH R21 EB022798 (to B.H., S.F., and V.P.). V.P. was supported by a predoctoral fellowship from the American Heart Association. Y.R.C. acknowledges support from a National Science Foundation Graduate Research Fellowship. B.H. is a Chan Zuckerberg Biohub investigator.	Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bedbrook CN, 2015, CHEM BIOL, V22, P1108, DOI 10.1016/j.chembiol.2015.06.020; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Cole N. B., 2013, CURR PROTOC PROTEIN, V73; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Gilbert C, 2017, ACS SYNTH BIOL, V6, P957, DOI 10.1021/acssynbio.6b00292; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kamiyama D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11046; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Karathanasis C, 2017, CHEMPHYSCHEM, V18, P942, DOI 10.1002/cphc.201601425; Leonetti MD, 2016, P NATL ACAD SCI USA, V113, pE3501, DOI 10.1073/pnas.1606731113; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Los G V, 2008, ACS CHEM BIOL, V3, P373; Moon H, 2016, CHEM COMMUN, V52, P14051, DOI 10.1039/c6cc07363h; Opazo F, 2012, NAT METHODS, V9, P938, DOI 10.1038/nmeth.2179; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Szymborska A, 2013, SCIENCE, V341, P655, DOI 10.1126/science.1240672; Veggiani G, 2016, P NATL ACAD SCI USA, V113, P1202, DOI 10.1073/pnas.1519214113; Wieneke R., 2015, ANGEW CHEM, V127, P10354; Wieneke R, 2015, ANGEW CHEM INT EDIT, V54, P10216, DOI 10.1002/anie.201503215; Zakeri B, 2012, P NATL ACAD SCI USA, V109, pE690, DOI 10.1073/pnas.1115485109	21	2	2	17	17	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1439-4227	1439-7633		CHEMBIOCHEM	ChemBioChem	AUG 4	2017	18	15					1492	1495		10.1002/cbic.201700177				4	Biochemistry & Molecular Biology; Chemistry, Medicinal	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	FC6EI	WOS:000406932800006	28514494				2018-01-05	
J	Yue, JP; Gou, XW; Li, YY; Wicksteed, B; Wu, XY				Yue, Jiping; Gou, Xuewen; Li, Yuanyuan; Wicksteed, Barton; Wu, Xiaoyang			Engineered Epidermal Progenitor Cells Can Correct Diet-Induced Obesity and Diabetes	CELL STEM CELL			English	Article							GENE-THERAPY; STEM-CELLS; BETA-CELL; TGF-BETA; SKIN; KERATINOCYTES; EXPRESSION; MICE; HOMEOSTASIS; CARCINOMAS	Somatic gene therapy is a promising approach for treating otherwise terminal or debilitating diseases. The human skin is a promising conduit for genetic engineering, as it is the largest and most accessible organ, epidermal autografts and tissue-engineered skin equivalents have been successfully deployed in clinical applications, and skin epidermal stem/progenitor cells for generating such grafts are easy to obtain and expand in vitro. Here, we develop skin grafts from mouse and human epidermal progenitors that were engineered by CRISPR-mediated genome editing to controllably release GLP-1 (glucagon-like peptide 1), a critical incretin that regulates blood glucose homeostasis. GLP-1 induction from engineered mouse cells grafted onto immunocompetent hosts increased insulin secretion and reversed high-fat-diet-induced weight gain and insulin resistance. Taken together, these results highlight the clinical potential of developing long-lasting, safe, and versatile gene therapy approaches based on engineering epidermal progenitor cells.	[Yue, Jiping; Gou, Xuewen; Li, Yuanyuan; Wu, Xiaoyang] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Wicksteed, Barton] Univ Illinois, Dept Med, Div Endocrinol Diabet & Metab, Chicago, IL 60612 USA	Wu, XY (reprint author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	xiaoyangwu@uchicago.edu			National Institutes of Health [R01-AR063630, R01OD023700]; Research Scholar Grant from the American Cancer Society [RSG-13-198-01]; V scholar award from V foundation; National Institute of Health [DK-020595]	We are very grateful to Dr. Lev Becker at the University of Chicago, Dr. Markus Schober at New York University School of Medicine, and Dr. Elaine Fuchs at the Rockefeller University for sharing reagents and technical assistance. We thank Linda Degenstein at the transgenic core facility and Drs. Honggang Ye and Graeme Bell at the Diabetes Research Laboratory at University of Chicago for excellent technical assistance. The animal studies were carried out in the ALAAC-accredited animal research facility at the University of Chicago. This work was supported by grants R01-AR063630 and R01OD023700 from the National Institutes of Health, the Research Scholar Grant (RSG-13-198-01) from the American Cancer Society, the V scholar award from V foundation to X.W., and National Institute of Health grant DK-020595 to B.W.	Ahima RS, 2011, J CLIN INVEST, V121, P2076, DOI 10.1172/JCI58719; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Carsin H, 2000, BURNS, V26, P379, DOI 10.1016/S0305-4179(99)00143-6                                                   ; Centanni JM, 2011, ANN SURG, V253, P672, DOI 10.1097/SLA.0b013e318210f3bd; Christensen R, 2002, CELLS TISSUES ORGANS, V172, P96, DOI 10.1159/000065612; Collins M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3003; Del Rio M, 2004, GENE THER, V11, pS57, DOI 10.1038/sj.gt.3302370; Fakharzadeh SS, 2000, BLOOD, V95, P2799; FENJVES ES, 1989, P NATL ACAD SCI USA, V86, P8803, DOI 10.1073/pnas.86.22.8803; GERRARD AJ, 1993, NAT GENET, V3, P180, DOI 10.1038/ng0293-180                                                              ; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Guerra L, 2000, ARCH DERMATOL, V136, P1380, DOI 10.1001/archderm.136.11.1380                                                    ; Haniffa M, 2015, J DERMATOL SCI, V77, P85, DOI 10.1016/j.jdermsci.2014.08.012; HANSEN LS, 1984, ANAT REC, V210, P569, DOI 10.1002/ar.1092100404; Kotterman MA, 2015, ANNU REV BIOMED ENG, V17, P63, DOI 10.1146/annurev-bioeng-071813-104938; Kumar M, 2007, GENE THER, V14, P162, DOI 10.1038/sj.gt.3302836; Liu H, 2015, J BIOL CHEM, V290, P30771, DOI 10.1074/jbc.M115.671743; MORGAN JR, 1987, SCIENCE, V237, P1476; Prud'homme GJ, 2007, GENE THER, V14, P553, DOI 10.1038/sj.gt.3302907; Prunieras M., 1983, J INVEST DERMATOL S, V81, p28s; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rasmussen Cathy, 2013, Methods Mol Biol, V945, P161, DOI 10.1007/978-1-62703-125-7_11; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8                                                   ; Rowzee AM, 2011, EXP DIABETES RES, DOI 10.1155/2011/601047; Sandby-Moller J, 2003, ACTA DERM-VENEREOL, V83, P410, DOI 10.1080/00015550310015419; Sandoval DA, 2015, PHYSIOL REV, V95, P513, DOI 10.1152/physrev.00013.2014; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Sebastiano V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009540; Shinkuma S, 2014, ACTA DERM-VENEREOL, V94, P98, DOI 10.2340/00015555-1592; Sloan B, 2008, EXPERT OPIN DRUG SAF, V7, P571, DOI [10.1517/14740338.7.5.571 , 10.1517/14740330802333466]; Watt FM, 2014, SCIENCE, V346, P937, DOI 10.1126/science.1253734; WEINSTEIN GD, 1984, J INVEST DERMATOL, V82, P623, DOI 10.1111/1523-1747.ep12261462; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Xie M, 2016, SCIENCE, V354, P1296, DOI 10.1126/science.aaf4006; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; Yue JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11692; Zaulyanov L, 2007, CLIN INTERV AGING, V2, P93, DOI 10.2147/ciia.2007.2.1.93                                                        	41	1	1	15	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 3	2017	21	2					256	+		10.1016/j.stem.2017.06.016				12	Cell & Tissue Engineering; Cell Biology	Cell Biology	FC5EE	WOS:000406863800013	28777946				2018-01-05	
J	Gasperini, M; Findlay, GM; McKenna, A; Milbank, JH; Lee, C; Zhang, MD; Cusanovich, DA; Shendure, J				Gasperini, Molly; Findlay, Gregory M.; McKenna, Aaron; Milbank, Jennifer H.; Lee, Choli; Zhang, Melissa D.; Cusanovich, Darren A.; Shendure, Jay			CRISPR/Cas9-Mediated Scanning for Regulatory Elements Required for HPRT1 Expression via Thousands of Large, Programmed Genomic Deletions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LONG NONCODING RNAS; HUMAN-CELLS; MAMMALIAN-CELLS; GENETIC SCREENS; STEM-CELLS; CRISPR-CAS9; DNA; CHROMATIN; PROMOTER; VARIANTS	The extent to which non-coding mutations contribute to Mendelian disease is a major unknown in human genetics. Relatedly, the vast majority of candidate regulatory elements have yet to be functionally validated. Here, we describe a CRISPR-based system that uses pairs of guide RNAs (gRNAs) to program thousands of kilobase-scale deletions that deeply scan across a targeted region in a tiling fashion ("ScanDel''). We applied ScanDel to HPRT1, the housekeeping gene underlying Lesch-Nyhan syndrome, an X-linked recessive disorder. Altogether, we programmed 4,342 overlapping 1 and 2 kb deletions that tiled 206 kb centered on HPRT1 (including 87 kb upstream and 79 kb downstream) with median 27-fold redundancy per base. We functionally assayed programmed deletions in parallel by selecting for loss of HPRT function with 6-thioguanine. As expected, sequencing gRNA pairs before and after selection confirmed that all HPRT1 exons are needed. However, HPRT1 function was robust to deletion of any intergenic or deeply intronic non-coding region, indicating that proximal regulatory sequences are sufficient for HPRT1 expression. Although our screen did identify the disruption of exon-proximal non-coding sequences (e.g., the promoter) as functionally consequential, long-read sequencing revealed that this signal was driven by rare, imprecise deletions that extended into exons. Our results suggest that no singular distal regulatory element is required for HPRT1 expression and that distal mutations are unlikely to contribute substantially to Lesch-Nyhan syndrome burden. Further application of ScanDel could shed light on the role of regulatory mutations in disease at other loci while also facilitating a deeper understanding of endogenous gene regulation.	[Gasperini, Molly; Findlay, Gregory M.; McKenna, Aaron; Milbank, Jennifer H.; Lee, Choli; Zhang, Melissa D.; Cusanovich, Darren A.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Shendure, Jay] Howard Hughes Med Inst, Seattle, WA 98195 USA	Gasperini, M; Shendure, J (reprint author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Shendure, J (reprint author), Howard Hughes Med Inst, Seattle, WA 98195 USA.	gasperim@uw.edu; shendure@uw.edu			NIH [DP1HG007811]; National Human Genome Research Institute [1R01HG006768]; National Cancer Institute [1R01CA197139, F30CA213728]; NIH; National Heart, Lung, and Blood Institute (NHLBI) [T32HL007312]; NHLBI [T32HL007828]	For discussion and advice, the authors thank all members of the Shendure Lab, particularly Lea Starita, Andrew Hill, Ron Hause, Seungsoo Kim, Martin Kircher, and Beth Martin. We thank the University of Washington PacBio Sequencing Services core for their assistance. This work was supported by an NIH Director's Pioneer Award (DP1HG007811 to J.S.), the National Human Genome Research Institute (1R01HG006768 to J.S.), and the National Cancer Institute (1R01CA197139 to J.S. and F30CA213728 to G.M.F.). M.G. is a National Science Foundation Graduate Research Fellow. A.M. was supported by the NIH and National Heart, Lung, and Blood Institute (NHLBI; T32HL007312). D.A.C. was supported in part by the NHLBI (T32HL007828). J.S. is an investigator of the Howard Hughes Medical Institute.	Aguet F., 2016, LOCAL GENETIC EF FEC; Aparicio-Prat E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2086-z; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Byrne SM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1246; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Coetzee SG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks542; Diao YR, 2017, NAT METHODS, V14, P629, DOI [10.1038/nmeth.4264, 10.1038/NMETH.4264]; Diao YR, 2016, GENOME RES, V26, P397, DOI 10.1101/gr.197152.115; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doring A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-11; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Fu R, 2014, BRAIN, V137, P1282, DOI 10.1093/brain/awt202; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Horlbeck M. A., 2016, ELIFE, V5, P1; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jacobs L., 1984, HDB MUTAGENICITY TES, P321; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kumasaka N, 2016, NAT GENET, V48, P206, DOI 10.1038/ng.3467; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4                                                    ; Li MLJ, 2013, NUCLEIC ACIDS RES, V41, pW150, DOI 10.1093/nar/gkt456; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McKenna A., 2016, WHOLE ORGANISM LINEA, P353; Monnat R. J., 2009, PROTOCOL HPRT MUTAGE; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; REID LH, 1990, P NATL ACAD SCI USA, V87, P4299, DOI 10.1073/pnas.87.11.4299                                                         ; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2                                                   ; RINCONLIMAS DE, 1991, MOL CELL BIOL, V11, P4157, DOI 10.1128/MCB.11.8.4157                                                           ; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wakabayashi A, 2016, P NATL ACAD SCI USA, V113, P4434, DOI 10.1073/pnas.1521754113; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Weedon MN, 2014, NAT GENET, V46, P61, DOI 10.1038/ng.2826; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715	57	4	4	7	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 3	2017	101	2					192	205		10.1016/j.ajhg.2017.06.010				14	Genetics & Heredity	Genetics & Heredity	FC5BD	WOS:000406854800004	28712454				2018-01-05	
J	Mastaglio, S; Genovese, P; Magnani, Z; Ruggiero, E; Landoni, E; Camisa, B; Schiroli, G; Provasi, E; Lombardo, A; Reik, A; Cieri, N; Rocchi, M; Oliveira, G; Escobar, G; Casucci, M; Gentner, B; Spinelli, A; Mondino, A; Bondanza, A; Vago, L; Ponzoni, M; Ciceri, F; Holmes, MC; Naldini, L; Bonini, C				Mastaglio, Sara; Genovese, Pietro; Magnani, Zulma; Ruggiero, Eliana; Landoni, Elisa; Camisa, Barbara; Schiroli, Giulia; Provasi, Elena; Lombardo, Angelo; Reik, Andreas; Cieri, Nicoletta; Rocchi, Martina; Oliveira, Giacomo; Escobar, Giulia; Casucci, Monica; Gentner, Bernhard; Spinelli, Antonello; Mondino, Anna; Bondanza, Attilio; Vago, Luca; Ponzoni, Maurilio; Ciceri, Fabio; Holmes, Michael C.; Naldini, Luigi; Bonini, Chiara			NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease	BLOOD			English	Article							GENE-THERAPY; ANTITUMOR IMMUNITY; ADOPTIVE TRANSFER; LYMPHOCYTES; CANCER; IMMUNOTHERAPY; ANTIGEN; DIFFERENTIATION; EXPRESSION; TRANSPLANTATION	Transfer of T-cell receptors (TCRs) specific for tumor-associated antigens is a promising approach for cancer immunotherapy. We developed the TCR gene editing technology that is based on the knockout of the endogenous TCR alpha and beta genes, followed by the introduction of tumor-specific TCR genes, and that proved safer and more effective than conventional TCR gene transfer. Although successful, complete editing requires extensive cell manipulation and 4 transduction procedures. Here we propose a novel and clinically feasible TCR "single editing" (SE) approach, based on the disruption of the endogenous TCR alpha chain only, followed by the transfer of genes encoding for a tumor-specific TCR. We validated SE with the clinical grade HLA-A2 restricted NY-ESO-1(157-165)-specific TCR. SE allowed the rapid production of high numbers of tumor-specific T cells, with optimal TCR expression and preferential stem memory and central memory phenotype. Similarly to unedited T cells redirected by TCR gene transfer (TCR transferred [TR]), SE T cells efficiently killed NY-ESO-1(pos) targets; however, although TR cells proved highly alloreactive, SE cells showed a favorable safety profile. Accordingly, when infused in NSG mice previously engrafted with myeloma, SE cells mediated tumor rejection without inducing xenogeneic graft-versus-host disease, thus resulting in significantly higher survival than that observed in mice treated with TR cells. Overall, single TCR gene editing represents a clinically feasible approach that is able to increase the safety and efficacy of cancer adoptive immunotherapy.	[Mastaglio, Sara; Magnani, Zulma; Ruggiero, Eliana; Landoni, Elisa; Camisa, Barbara; Provasi, Elena; Cieri, Nicoletta; Oliveira, Giacomo; Bonini, Chiara] Osped San Raffaele Sci Inst, Expt Hematol Unit, Program Immunol & Bio Immunotherapy Canc, Div Immunol Transplantat & Infect Dis, Milan, Italy; [Mastaglio, Sara; Gentner, Bernhard; Bondanza, Attilio; Vago, Luca; Ciceri, Fabio] Osped San Raffaele Sci Inst, Hematol & Bone Marrow Transplantat Unit, Milan, Italy; [Genovese, Pietro; Schiroli, Giulia; Lombardo, Angelo; Escobar, Giulia; Gentner, Bernhard; Naldini, Luigi] Osped San Raffaele Sci Inst, Telethon Inst Gene Therapy, Milan, Italy; [Schiroli, Giulia; Lombardo, Angelo; Escobar, Giulia; Ponzoni, Maurilio; Ciceri, Fabio; Naldini, Luigi; Bonini, Chiara] Univ Vita Salute San Raffaele, Milan, Italy; [Reik, Andreas; Holmes, Michael C.] Sangamo BioSci, Richmond, CA USA; [Rocchi, Martina; Ponzoni, Maurilio] Osped San Raffaele Sci Inst, Pathol Unit, Milan, Italy; [Casucci, Monica; Bondanza, Attilio] Osped San Raffaele Sci Inst, Innovat Immunotherapies Unit, Div Immunol Transplantat & Infect Dis, Program Immunol & Bioimmunotherapy Canc, Milan, Italy; [Spinelli, Antonello] Osped San Raffaele Sci Inst, Med Phys Dept, Milan, Italy; [Spinelli, Antonello] Osped San Raffaele Sci Inst, Ctr Expt Imaging, Milan, Italy; [Mondino, Anna] Osped San Raffaele Sci Inst, Lymphocyte Activat Unit, Div Immunol Transplantat & Infect Dis, Milan, Italy; [Vago, Luca] Osped San Raffaele Sci Inst, Unit Immunogenet Leukemia Genom & Immunobiol, Div Regenerat Med Stem Cells & Gene Therapy, Milan, Italy; [Ponzoni, Maurilio] Osped San Raffaele Sci Inst, Leukemia Unit, Milan, Italy	Bonini, C (reprint author), Osped San Raffaele Sci Inst, Expt Hematol Unit, Via Olgettina 60, Milan, Italy.	bonini.chiara@hsr.it		Genovese, Pietro/0000-0001-9507-9003	European Union Seventh Framework Programme (SUPERSIST, ATTACK); Italian Association for Cancer Research, Italian Ministry of University and Research (MIUR); Associazione Italiana per la Ricerca sul Cancro - European Union	This work was supported by European Union Seventh Framework Programme (SUPERSIST, ATTACK) and by the Italian Association for Cancer Research, Italian Ministry of University and Research (MIUR). E.R. was supported by a fellowship by Associazione Italiana per la Ricerca sul Cancro cofunded by the European Union.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Bleakley M, 2012, EXPERT REV HEMATOL, V5, P409, DOI 10.1586/EHM.12.28; Bondanza A, 2006, BLOOD, V107, P1828, DOI 10.1182/blood-2005-09-3716; Bondanza A, 2011, BLOOD, V117, P6469, DOI 10.1182/blood-2010-11-320366; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chen JL, 2000, J IMMUNOL, V165, P948, DOI 10.4049/jimmunol.165.2.948                                                      ; Cieri N, 2014, IMMUNOL REV, V257, P165, DOI 10.1111/imr.12130; Cieri N, 2013, BLOOD, V121, P573, DOI 10.1182/blood-2012-05-431718; Dolton G, 2014, CLIN EXP IMMUNOL, V177, P47, DOI 10.1111/cei.12339; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Follenzi Antonia, 2002, Methods Mol Med, V69, P259; Fujita S, 2004, CLIN CANCER RES, V10, P6551, DOI 10.1158/1078-0432.CCR-04-0819                                                   ; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Gnjatic S, 2006, ADV CANCER RES, V95, P1, DOI 10.1016/S0065-230X(06)95001-5; Huang JP, 2005, J IMMUNOTHER, V28, P258, DOI 10.1097/01.cji.0000158855.92792.7a                                              ; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaneko S, 2009, BLOOD, V113, P1006, DOI 10.1182/blood-2008-05-156059; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Klippel ZK, 2014, GENE THER, V21, P337, DOI 10.1038/gt.2013.87; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Nilsson M, 2004, J GENE MED, V6, P631, DOI 10.1002/jgm.543; Nishikawa H, 2012, BLOOD, V119, P3097, DOI 10.1182/blood-2011-09-379982; Oliveira G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8265; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Rapoport AP, 2015, NAT MED, V21, P914, DOI 10.1038/nm.3910; RIDDELL SR, 1992, SCIENCE, V257, P238; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116                                                     ; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schmitt TM, 2013, BLOOD, V122, P348, DOI 10.1182/blood-2013-01-478164; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Stadmauer EA, 2016, P AM SOC HEMATALOGY; Torikai H, 2015, BLOOD, V126, P2527, DOI 10.1182/blood-2015-10-675991; Zeiser R, 2016, BLOOD, V127, P3117, DOI 10.1182/blood-2016-02-699082; Zhao YB, 2005, J IMMUNOL, V174, P4415, DOI 10.4049/jimmunol.174.7.4415                                                     	42	3	3	4	4	AMER SOC HEMATOLOGY	WASHINGTON	2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA	0006-4971	1528-0020		BLOOD	Blood	AUG 3	2017	130	5					606	618		10.1182/blood-2016-08-732636				13	Hematology	Hematology	FC5IP	WOS:000406875400009	28637663				2018-01-05	
J	Hu, ZL; Liu, Y; Huarng, MC; Menegatti, M; Reyon, D; Rost, MS; Norris, ZG; Richter, CE; Stapleton, AN; Chi, NC; Peyvandi, F; Joung, JK; Shavit, JA				Hu, Zhilian; Liu, Yang; Huarng, Michael C.; Menegatti, Marzia; Reyon, Deepak; Rost, Megan S.; Norris, Zachary G.; Richter, Catherine E.; Stapleton, Alexandra N.; Chi, Neil C.; Peyvandi, Flora; Joung, J. Keith; Shavit, Jordan A.			Genome editing of factor X in zebrafish reveals unexpected tolerance of severe defects in the common pathway	BLOOD			English	Article							BLOOD-COAGULATION; FACTOR-VII; PROTHROMBIN DEFICIENCY; EMBRYONIC-DEVELOPMENT; TARGETED MUTAGENESIS; VASCULAR DEVELOPMENT; TISSUE FACTOR; HEMOSTASIS; MICE; GENE	Deficiency of factor X (F10) in humans is a rare bleeding disorder with a heterogeneous phenotype and limited therapeutic options. Targeted disruption of F10 and other common pathway factors in mice results in embryonic/neonatal lethality with rapid resorption of homozygous mutants, hampering additional studies. Several of these mutants also display yolk sac vascular defects, suggesting a role for thrombin signaling in vessel development. The zebrafish is a vertebrate model that demonstrates conservation of the mammalian hemostatic and vascular systems. We have leveraged these advantages for in-depth study of the role of the coagulation cascade in the developmental regulation of hemostasis and vasculogenesis. In this article, we show that ablation of zebrafish f10 by using genome editing with transcription activator-like effector nucleases results in a major embryonic hemostatic defect. However, widespread hemorrhage and subsequent lethality does not occur until later stages, with absence of any detectable defect in vascular development. We also use f10(-/-) zebrafish to confirm 5 novel human F10 variants as causative mutations in affected patients, providing a rapid and reliable in vivo model for testing the severity of F10 variants. These findings as well as the prolonged survival of f10(-/-) mutants will enable us to expand our understanding of the molecular mechanisms of hemostasis, including a platform for screening variants of uncertain significance in patients with F10 deficiency and other coagulation disorders. Further study as to how fish tolerate what is an early lethal mutation in mammals could facilitate improvement of diagnostics and therapeutics for affected patients with bleeding disorders.	[Hu, Zhilian; Liu, Yang; Huarng, Michael C.; Rost, Megan S.; Norris, Zachary G.; Richter, Catherine E.; Stapleton, Alexandra N.; Shavit, Jordan A.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Menegatti, Marzia; Peyvandi, Flora] Fdn IRCCS, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Ca Granda Osped Maggiore Policlin, Milan, Italy; [Menegatti, Marzia] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Menegatti, Marzia] Fdn Luigi Villa, Milan, Italy; [Reyon, Deepak; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Mol Pathol Unit, Charlestown, MA USA; [Reyon, Deepak; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Reyon, Deepak; Joung, J. Keith] Harvard Med Sch, Dept Pathol, Boston, MA USA; [Chi, Neil C.] Univ Calif San Diego, Dept Med, Div Cardiol, San Diego, CA 92103 USA; [Liu, Yang] Mol Innovat Inc, Novi, MI USA; [Reyon, Deepak] Editas Med, Cambridge, MA USA	Shavit, JA (reprint author), Univ Michigan, Dept Pediat, Room 8301,Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA.	jshavit@umich.edu		HU, ZHILIAN/0000-0002-1632-6318; Menegatti, Marzia/0000-0002-8527-7556	National Institutes of Health (NIH), National Heart, Lung, and Blood Institute [R01-HL124232]; Hemophilia of Georgia Clinical Scientist Development Grant; National Hemophilia Foundation/Novo Nordisk Career Development Award; Bayer Hemophilia Awards Program; NIH, National Heart, Lung, and Blood Institute grant [T32-HL007622]; National Institutes of Health; NIH, National Institute of General Medical Sciences [R01-GM088040]	This work was supported by National Institutes of Health (NIH), National Heart, Lung, and Blood Institute grant R01-HL124232, a Hemophilia of Georgia Clinical Scientist Development Grant, a National Hemophilia Foundation/Novo Nordisk Career Development Award, the Bayer Hemophilia Awards Program (J.A.S.), NIH, National Heart, Lung, and Blood Institute grant T32-HL007622 (M.S.R.), National Institutes of Health (N.C.C.), and NIH, National Institute of General Medical Sciences grant R01-GM088040 (J.K.J.). J.K.J. is the Jim and Ann Orr Massachusetts General Hospital Research Scholar. J.A.S. is the Diane and Larry Johnson Family Scholar of Pediatrics and Communicable Diseases.	Aasrum M, 2002, BIOCHEMISTRY-MOSCOW+, V67, P25, DOI 10.1023/A:1013943912668                                                         ; Borensztajn KS, 2007, EXP CELL RES, V313, P2622, DOI 10.1016/j.yexcr.2007.04.014; Brown DL, 2008, HAEMOPHILIA, V14, P1176, DOI 10.1111/j.1365-2516.2008.01856.x; Buchner DA, 2007, P NATL ACAD SCI USA, V104, P13996, DOI 10.1073/pnas.0700947104; Bussmann J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000064.g001; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x                                                ; Cui J, 1996, NATURE, V384; Davidson CJ, 2003, J THROMB HAEMOST, V1, P1487, DOI 10.1046/j.1538-7836.2003.00334.x; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001                                                             ; Dewerchin M, 2000, THROMB HAEMOSTASIS, V83, P185; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P698, DOI 10.1021/bi00623a022                                                             ; Fish RJ, 2014, BLOOD, V123, P2278, DOI 10.1182/blood-2013-12-547182; Flood VH, 2010, J THROMB HAEMOST, V8, P1431, DOI 10.1111/j.1538-7836.2010.03869.x; Flood VH, 2009, J THROMB HAEMOST, V7, P1832, DOI 10.1111/j.1538-7836.2009.03594.x; Foley JE, 2009, NAT PROTOC, V4, P1855, DOI 10.1038/nprot.2009.209; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; FurutaniSeiki M, 1996, DEVELOPMENT, V123, P229; Ghosh A, 2012, ADV HEMATOL, V2012; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Gore AV, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006684; Guidugli L, 2014, HUM MUTAT, V35, P151, DOI 10.1002/humu.22478; Hanumanthaiah R, 2002, BLOOD CELL MOL DIS, V29, P57, DOI 10.1006/bcmd.2002.0534; Herrmann FH, 2006, HAEMOPHILIA, V12, P479, DOI 10.1111/j.1365-2516.2006.01303.x; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hu N, 2000, ANAT REC, V260, P148, DOI 10.1002/1097-0185(20001001)260:2<148::AID-AR50>3.0.CO;2-X; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Hu ZL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134299; Huarng MC, 2015, ZEBRAFISH, V12, P238, DOI 10.1089/zeb.2014.1079; Ishiwata T, 2003, CIRC RES, V93, P857, DOI 10.1161/01.RES.0000100389.57520.1A; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; IUCHI I, 1983, J EXP ZOOL, V226, P409, DOI 10.1002/jez.1402260311; Jagadeeswaran P, 1999, BLOOD CELL MOL DIS, V25, P239, DOI 10.1006/bcmd.1999.0249                                                          ; Jagadeeswaran P, 2005, J THROMB HAEMOST, V3, P46, DOI 10.1111/j.1538-7836.2004.00999.x                                                ; Jagadeeswaran P, 2011, METHOD CELL BIOL, V101, P197, DOI [10.1016/B978-0-12-387036-0.00009-8, 10.1016/B978-0-12-385464-3.00002-9]; Jin SW, 2007, DEV BIOL, V307, P29, DOI 10.1016/j.ydbio.2007.03.526; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Kretz Colin A, 2015, Curr Pathobiol Rep, V3, P155; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lawson ND, 2011, DEVELOPMENT, V128; Liu Y, 2014, BLOOD, V124, P142, DOI 10.1182/blood-2014-03-561027; Menegatti M, 2009, SEMIN THROMB HEMOST, V35, P407, DOI 10.1055/s-0029-1225763; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Negron JF, 2004, DEV DYNAM, V231, P161, DOI 10.1002/dvdy.20424; Paffett-Lugassy Noelle N, 2005, Methods Mol Med, V105, P171; Palencia-Desai S, 2015, DEVELOPMENT, V142, P2304, DOI 10.1242/dev.118687; Peyvandi F, 2002, BRIT J HAEMATOL, V117, P685, DOI 10.1046/j.1365-2141.2002.03486.x                                                ; RAO LVM, 1988, P NATL ACAD SCI USA, V85, P6687, DOI 10.1073/pnas.85.18.6687; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rosen ED, 2002, FRONT BIOSCI, V7, pD1915, DOI 10.2741/rosen; Rost MS, 2016, METHOD CELL BIOL, V134, P377, DOI 10.1016/bs.mcb.2016.01.003; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8; Shavit JA, 2013, EMERY RIMOINS PRINCI, P1; Sheehan J, 2001, P NATL ACAD SCI USA, V98, P8768, DOI 10.1073/pnas.131109398; Sood R, 2006, BLOOD, V107, P3173, DOI 10.1182/blood-2005-10-4111; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Sumanas S, 2005, BLOOD, V106, P534, DOI 10.1182/blood-2004-12-4653; Sumoy L, 1997, MECH DEVELOP, V63, P15, DOI 10.1016/S0925-4773(97)00671-0; Sun WY, 1998, P NATL ACAD SCI USA, V95, P7597, DOI 10.1073/pnas.95.13.7597                                                         ; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887                                                          ; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; Vo AH, 2013, PLOS ONE; Westerfield M., 2000, GUIDE LAB USE ZEBRAF; Weyand AC, 2014, CURR OPIN HEMATOL, V21, P418, DOI 10.1097/MOH.0000000000000075; Wilkinson RN, 2013, BIOTECHNIQUES, V55, P314, DOI 10.2144/000114116; Xue JC, 1998, P NATL ACAD SCI USA, V95, P7603, DOI 10.1073/pnas.95.13.7603; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	70	1	1	1	1	AMER SOC HEMATOLOGY	WASHINGTON	2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA	0006-4971	1528-0020		BLOOD	Blood	AUG 3	2017	130	5					666	676		10.1182/blood-2017-02-765206				11	Hematology	Hematology	FC5IP	WOS:000406875400015	28576875				2018-01-05	
J	Gao, W; Long, L; Tian, XQ; Xu, FC; Liu, J; Singh, PK; Botella, JR; Song, CP				Gao, Wei; Long, Lu; Tian, Xinquan; Xu, Fuchun; Liu, Ji; Singh, Prashant K.; Botella, Jose R.; Song, Chunpeng			Genome Editing in Cotton with the CRISPR/Cas9 System	FRONTIERS IN PLANT SCIENCE			English	Article						cotton; CRISPR/Cas9; deletion; genome editing; insertion; mutagenesis; transient transform	GOSSYPIUM-HIRSUTUM L.; TARGETED MUTAGENESIS; AGROBACTERIUM-TUMEFACIENS; STRESS TOLERANCE; 1ST GENERATION; ZINC-FINGER; ARABIDOPSIS; MULTIPLEX; RNA; EXPRESSION	Genome editing is an important tool for gene functional studies as well as crop improvement. The recent development of the CRISPR/Cas9 system using single guide RNA molecules (sgRNAs) to direct precise double strand breaks in the genome has the potential to revolutionize agriculture. Unfortunately, not all sgRNAs are equally efficient and it is difficult to predict their efficiency by bioinformatics. In crops such as cotton (Gossypium hirsutum L.), with labor-intensive and lengthy transformation procedures, it is essential to minimize the risk of using an ineffective sgRNA that could result in the production of transgenic plants without the desired CRISPR-induced mutations. In this study, we have developed a fast and efficient method to validate the functionality of sgRNAs in cotton using a transient expression system. We have used this method to validate target sites for three different genes GhPDS, GhCLA1, and GhEF1 and analyzed the nature of the CRISPR/Cas9-induced mutations. In our experiments, the most frequent type of mutations observed in cotton cotyledons were deletions (similar to 64%). We prove that the CRISPR/Cas9 system can effectively produce mutations in homeologous cotton genes, an important requisite in this allotetraploid crop. We also show that multiple gene targeting can be achieved in cotton with the simultaneous expression of several sgRNAs and have generated mutations in GhPDS and GhEF1 at two target sites. Additionally, we have used the CRISPR/Cas9 system to produce targeted gene fragment deletions in the GhPDS locus. Finally, we obtained transgenic cotton plants containing CRISPR/Cas9-induced gene editing mutations in the GhCLA1 gene. The mutation efficiency was very high, with 80.6% of the transgenic lines containing mutations in the GhCLA1 target site resulting in an intense albino phenotype due to interference with chloroplast biogenesis.	[Gao, Wei; Long, Lu; Tian, Xinquan; Xu, Fuchun; Singh, Prashant K.; Song, Chunpeng] Henan Univ, Sch Life Sci, Henan Key Lab Plant Stress Biol, State Key Lab Cotton Biol, Kaifeng, Peoples R China; [Liu, Ji] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Botella, Jose R.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia	Song, CP (reprint author), Henan Univ, Sch Life Sci, Henan Key Lab Plant Stress Biol, State Key Lab Cotton Biol, Kaifeng, Peoples R China.	songcp@henu.edu.cn			National Natural Science Foundation of China [31601344, 31430061]; Ministry of Agriculture of China [2016ZX08009-003]; 111 project of China	We are grateful to Prof. Y. G. Liu (South China Agricultural University, China) for generously providing the binary pYLCRISPR/Cas9 multiplex genome targeting vector system. The cotton seeds of G. hirsutum L. cv. 'YZ-1' used for stable transformation were kindly provided by Prof. X. L. Zhang (Huazhong Agricultural University, China). This work was financially supported by the National Natural Science Foundation of China (31601344), the Ministry of Agriculture of China (2016ZX08009-003), the National Natural Science Foundation of China (31430061), and 111 project of China.	Boettcher M, 2015, MOL CELL, V58, P575, DOI 10.1016/j.molcel.2015.04.028; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chen XG, 2017, SCI REP-UK, V7, DOI 10.1038/srep44304; Emonds-Alt B, 2017, PLANT J, V89, P141, DOI 10.1111/tpj.13352; Fan D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12217; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao JP, 2015, PLANT MOL BIOL, V87, P99, DOI 10.1007/s11103-014-0263-0; Gao W, 2016, MOL GENET GENOMICS, V291, P2199, DOI 10.1007/s00438-016-1252-6; Gao W, 2016, J INTEGR PLANT BIOL, V58, P503, DOI 10.1111/jipb.12432; Gao XQ, 2011, PLANT J, V66, P293, DOI 10.1111/j.1365-313X.2011.04491.x; Hilscher J, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600173; Janga MR, 2017, PLANT MOL BIOL, V94, P349, DOI 10.1007/s11103-017-0599-3; Jin LG, 2008, PLANT PHYSIOL BIOCH, V46, P46, DOI 10.1016/j.plaphy.2007.10.004; Jin SX, 2005, PLANT CELL TISS ORG, V81, P229, DOI 10.1007/s11240-004-5209-9; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43902; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li JF, 2014, METHOD ENZYMOL, V546, P459, DOI 10.1016/B978-0-12-801185-0.00022-2; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li P, 2017, PLANT J, V89, P85, DOI 10.1111/tpj.13324; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Long L, 2014, PLANT CELL TISS ORG, V116, P153, DOI 10.1007/s11240-013-0392-1; Ma XL, 2016, MOL PLANT, V9, P961, DOI 10.1016/j.molp.2016.04.009; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mao YF, 2016, PLANT BIOTECHNOL J, V14, P519, DOI 10.1111/pbi.12468; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Oliveira MAC, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038667; Pan Xiaoping, 2013, Methods Mol Biol, V958, P261, DOI 10.1007/978-1-62703-212-4_21; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Shi J, 2014, BIOPROC BIOSYST ENG, V37, P2463, DOI 10.1007/s00449-014-1224-3; Shi SL, 2016, PLANT PHYSIOL, V172, P1708, DOI 10.1104/pp.16.01332; Sun XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10342; Sun YW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01928; Taliercio E, 2010, MOL BIOL REP, V37, P3915, DOI 10.1007/s11033-010-0048-8; Thung L, 2012, J PLANT PHYSIOL, V169, P542, DOI 10.1016/j.jplph.2011.11.010; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang MG, 2017, MOL PLANT, V10, P1007, DOI 10.1016/j.molp.2017.03.002; Wang P., 2017, PLANT BIOTECHNOL J, DOI [10.1111/pbi.12755, DOI 10.1111/PBI.12755]; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang YL, 2017, SCI CHINA LIFE SCI, V60, P524, DOI 10.1007/s11427-017-9031-y; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu J, 2016, GENES-BASEL, V7, DOI 10.3390/genes7100088; Xu RF, 2014, RICE, V7, DOI 10.1186/s12284-014-0005-6; Zhang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep20315; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00177; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12617; Zhang ZJ, 2016, PLANT CELL REP, V35, P1519, DOI 10.1007/s00299-015-1900-z; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806	59	1	1	32	32	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	AUG 3	2017	8								1364	10.3389/fpls.2017.01364				12	Plant Sciences	Plant Sciences	FC5BY	WOS:000406857000001	28824692	gold			2018-01-05	
J	Liu, R; Chen, L; Jiang, YP; Zou, G; Zhou, ZH				Liu, Rui; Chen, Ling; Jiang, Yanping; Zou, Gen; Zhou, Zhihua			A novel transcription factor specifically regulates GH11 xylanase genes in Trichoderma reesei	BIOTECHNOLOGY FOR BIOFUELS			English	Article						Hemi-cellulase; Transcription factor; Xylanase; Glycoside hydrolase; Trichoderma reesei; CRISPR/Cas9	HYPOCREA-JECORINA; CELLULASE ACTIVITY; MASTER REGULATOR; RICE STRAW; EXPRESSION; REPRESSOR; HYDROLYSIS; METABOLISM; ACTIVATOR; REVEALS	Background: The filamentous fungus Trichoderma reesei is widely utilized in industry for cellulase production, but its xylanase activity must be improved to enhance the accessibility of lignocellulose to cellulases. Several transcription factors play important roles in this progress; however, nearly all the reported transcription factors typically target both cellulase and hemi-cellulase genes. Specific xylanase transcription factor would be useful to regulate xylanase activity directly. Results: In this study, a novel zinc binuclear cluster transcription factor (jgi|Trire2|123881) was found to repress xylanase activity, but not cellulase activity, and was designated as SxlR (specialized xylanase regulator). Further investigations using real-time PCR and an electrophoretic mobility shift assay demonstrated that SxlR might bind the promoters of GH11 xylanase genes (xyn1, xyn2, and xyn5), but not those of GH10 (xyn3) and GH30 (xyn4) xylanase genes, and thus regulate their transcription and expression directly. We also identified the binding consensus sequence of SxlR as 5'-CATCSGSWCWMSA-3'. The deletion of SxlR in T. reesei RUT-C30 to generate the mutant Delta sxlr strain resulted in higher xylanase activity as well as higher hydrolytic efficiency on pretreated rice straw. Conclusions: Our study characterizes a novel specific transcriptional repressor of GH11 xylanase genes, which adds to our understanding of the regulatory system for the synthesis and secretion of cellulase and hemi-cellulase in T. reesei. The deletion of SxlR may also help to improve the hydrolytic efficiency of T. reesei for lignocellulose degradation by increasing the xylanase-to-cellulase ratio.	[Liu, Rui; Chen, Ling; Jiang, Yanping; Zou, Gen; Zhou, Zhihua] Chinese Acad Sci, Inst Plant Physiol & Ecol, CAS Ctr Excellence Mol Plant Sci, CAS Key Lab Synthet Biol, Fenglin Rd 300, Shanghai 200032, Peoples R China; [Liu, Rui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Zou, G; Zhou, ZH (reprint author), Chinese Acad Sci, Inst Plant Physiol & Ecol, CAS Ctr Excellence Mol Plant Sci, CAS Key Lab Synthet Biol, Fenglin Rd 300, Shanghai 200032, Peoples R China.	zougen@sibs.ac.cn; zhouzhihua@sippe.ac.cn			High-tech Research and Development Program of China [863:2013AA102806]; National Natural Science Foundation of China [31470201, 31300073]	This work was financially supported by High-tech Research and Development Program of China (863:2013AA102806) and the National Natural Science Foundation of China (31470201, 31300073).	Aristidou A, 2000, CURR OPIN BIOTECH, V11, P187, DOI 10.1016/S0958-1669(00)00085-9; Aro N, 2003, APPL ENVIRON MICROB, V69, P56, DOI 10.1128/AEM.69.1.56-65.2003; Aro N, 2001, J BIOL CHEM, V276, P24309, DOI 10.1074/jbc.M003624200; Arvas M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-616; BAILEY MJ, 1992, J BIOTECHNOL, V23, P257, DOI 10.1016/0168-1656(92)90074-J                                                    ; Castro LD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00175; Chen L, 2014, FUNGAL GENET BIOL, V63, P42, DOI 10.1016/j.fgb.2013.12.001; Chuang YC, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0202-6; Derntl C, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0298-8; Derntl C, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-62; Druzhinina IS, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0488-z; Fekete E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-447; Hakkinen M, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-14; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Herold S, 2013, EUKARYOT CELL, V12, P390, DOI 10.1128/EC.00182-12; Hu JG, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-36; Ilmen M, 1996, MOL GEN GENET, V251, P451, DOI 10.1007/s004380050189; Jin SY, 2007, PROCESS BIOCHEM, V42, P188, DOI 10.1016/j.procbio.2006.07.030; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Liu T, 2008, ACTA BIOCH BIOPH SIN, V40, P158, DOI 10.1111/j.1745-7270.2008.00388.x; Ma L, 2011, ENZYME MICROB TECH, V49, P366, DOI 10.1016/j.enzmictec.2011.06.013; Marie-Nelly H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6695; Nitta M, 2012, FUNGAL GENET BIOL, V49, P388, DOI 10.1016/j.fgb.2012.02.009; Paes G, 2012, BIOTECHNOL ADV, V30, P564, DOI 10.1016/j.biotechadv.2011.10.003; Portnoy T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-269; Portnoy T, 2011, EUKARYOT CELL, V10, P262, DOI 10.1128/EC.00208-10; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Seiboth B, 2012, MOL MICROBIOL, V84, P1150, DOI 10.1111/j.1365-2958.2012.08083.x; Shawky BT, 2011, J GENETIC ENG BIOTEC, V9, P59; Singh A, 2015, BIOTECHNOL ADV, V33, P142, DOI 10.1016/j.biotechadv.2014.11.009; Steiger MG, 2010, J BIOTECHNOL, V145, P30, DOI 10.1016/j.jbiotec.2009.10.012; Stricker AR, 2008, FUNGAL GENET BIOL, V45, P436, DOI 10.1016/j.fgb.2007.08.005; Stricker AR, 2006, EUKARYOT CELL, V5, P2128, DOI 10.1128/EC.00211-06; Sumphanwanich J, 2008, ANN MICROBIOL, V58, P219, DOI 10.1007/BF03175320                                                              ; Tisch D, 2011, FUNGAL GENET BIOL, V48, P631, DOI 10.1016/j.fgb.2010.12.009; Wang SW, 2013, J IND MICROBIOL BIOT, V40, P633, DOI 10.1007/s10295-013-1253-y; Xiao ZZ, 2004, BIOTECHNOL BIOENG, V88, P832, DOI 10.1002/bit.20286; Zeilinger S, 2001, MOL GENET GENOMICS, V266, P56; Zhao YB, 2013, APPL MICROBIOL BIOT, V97, P5069, DOI 10.1007/s00253-013-4893-y	39	0	0	12	12	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1754-6834			BIOTECHNOL BIOFUELS	Biotechnol. Biofuels	AUG 3	2017	10								194	10.1186/s13068-017-0878-x				14	Biotechnology & Applied Microbiology; Energy & Fuels	Biotechnology & Applied Microbiology; Energy & Fuels	FC4HB	WOS:000406798800001	28785310	gold			2018-01-05	
J	Schaefer, SM; Segalada, C; Cheng, PF; Bonalli, M; Parfejevs, V; Levesque, MP; Dummer, R; Nicolis, SK; Sommer, L				Schaefer, S. M.; Segalada, C.; Cheng, P. F.; Bonalli, M.; Parfejevs, V.; Levesque, M. P.; Dummer, R.; Nicolis, S. K.; Sommer, L.			Sox2 is dispensable for primary melanoma and metastasis formation	ONCOGENE			English	Article							SQUAMOUS-CELL CARCINOMA; CANCER STEM-CELLS; INITIATING CELLS; TRANSCRIPTION FACTOR; CUTANEOUS MELANOMA; MOUSE MODEL; EXPRESSION; TUMORIGENICITY; NEUROGENESIS; MAINTENANCE	Tumor initiation and metastasis formation in many cancers have been associated with emergence of a gene expression program normally active in embryonic or organ-specific stem cells. In particular, the stem cell transcription factor Sox2 is not only expressed in a variety of tumors, but is also required for their formation. Melanoma, the most aggressive skin tumor, derives from melanocytes that during development originate from neural crest stem cells. While neural crest stem cells do not express Sox2, expression of this transcription factor has been reported in melanoma. However, the role of Sox2 in melanoma is controversial. To study the requirement of Sox2 for melanoma formation, we therefore performed CRISPR-Cas9-mediated gene inactivation in human melanoma cells. In addition, we conditionally inactivated Sox2 in a genetically engineered mouse model, in which melanoma spontaneously develops in the context of an intact stroma and immune system. Surprisingly, in both models, loss of Sox2 did neither affect melanoma initiation, nor growth, nor metastasis formation. The lack of a tumorigenic role of Sox2 in melanoma might reflect a distinct stem cell program active in neural crest stem cells and during melanoma formation.	[Schaefer, S. M.; Segalada, C.; Bonalli, M.; Parfejevs, V.; Sommer, L.] Univ Zurich, Inst Anat, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Cheng, P. F.; Levesque, M. P.; Dummer, R.] Univ Zurich Hosp, Dept Dermatol, Zurich, Switzerland; [Nicolis, S. K.] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy	Sommer, L (reprint author), Univ Zurich, Inst Anat, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	lukas.sommer@anatom.uzh.ch		Cheng, Phil/0000-0003-2940-006X	Swiss National Science Foundation (SNF); University Research Priority Program (URPP) 'Translational Cancer Research' Biobank; Swiss Cancer League; AIRC; Telethon	We thank Annika Klug for help with hematoxylin and eosin stainings and Jessica Hausel for assistance in histology. We would like to thank Daniel Zingg for his help with statistical analysis. Further, we acknowledge the advice by the Cancer Biology PhD program of the University of Zurich. This work was supported by the Swiss National Science Foundation (SNF), the University Research Priority Program (URPP) 'Translational Cancer Research' Biobank, and the Swiss Cancer League. Work in the Nicolis laboratory was supported by AIRC and Telethon.	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Basu-Roy U, 2010, CELL DEATH DIFFER, V17, P1345, DOI 10.1038/cdd.2010.57; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; BUTTNER P, 1995, CANCER, V75, P2499, DOI 10.1002/1097-0142(19950515)75:10<2499::AID-CNCR2820751016>3.0.CO;2-8; Buzaid AC, 1997, J CLIN ONCOL, V15, P1039, DOI 10.1200/JCO.1997.15.3.1039                                                      ; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Carrasco-Garcia E, 2016, AM J CANCER RES, V6, P701; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cesarini V, ONCOGENE; Chen PL, 2013, MODERN PATHOL, V26, P44, DOI 10.1038/modpathol.2012.132; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Favaro R, 2014, CANCER RES, V74, P1833, DOI 10.1158/0008-5472.CAN-13-1942; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferone G, 2016, CANCER CELL, V30, P519, DOI 10.1016/j.ccell.2016.09.001; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Girouard SD, 2012, LAB INVEST, V92, P362, DOI 10.1038/labinvest.2011.188; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Kareta MS, 2015, CELL STEM CELL, V16, P39, DOI 10.1016/j.stem.2014.10.019; Kaufman CK, 2016, SCIENCE, V351, DOI 10.1126/science.aad2197; Laga AC, 2011, EXP DERMATOL, V20, P339, DOI 10.1111/j.1600-0625.2011.01247.x; Laga AC, 2010, AM J PATHOL, V176, P903, DOI 10.2353/ajpath.2010.090495; Li H, 2012, CELL STEM CELL, V11, P845, DOI 10.1016/j.stem.2012.09.014; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Sarkar A, 2016, CELL REP, V16, P1929, DOI 10.1016/j.celrep.2016.07.034; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Shakhova O, 2013, CANCER LETT, V338, P74, DOI 10.1016/j.canlet.2012.10.009; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007                                                                    ; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Van Keymeulen A, 2015, NATURE, V525, P119, DOI 10.1038/nature14665; Vanner RJ, 2014, CANCER CELL, V26, P33, DOI 10.1016/j.ccr.2014.05.005; Wakamatsu Y, 2004, DEV DYNAM, V229, P74, DOI 10.1002/dvdy.10498; Weina K, 2016, PIGM CELL MELANOMA R, V29, P453, DOI 10.1111/pcmr.12483; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Zingg D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7051; Zipser MC, 2011, PIGM CELL MELANOMA R, V24, P326, DOI 10.1111/j.1755-148X.2010.00823.x	45	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 3	2017	36	31					4516	4524		10.1038/onc.2017.55				9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FC4JL	WOS:000406806000013	28368416				2018-01-05	
J	Zhang, XF; Lin, B; Luo, X; Zhao, WY; Jiang, J; Zhang, CX; Gao, M; Chen, XF; Dong, YZ				Zhang, Xinfu; Lin, Bin; Luo, Xiao; Zhao, Weiyu; Jiang, Justin; Zhang, Chengxiang; Gao, Min; Chen, Xiaofang; Dong, Yizhou			Biodegradable Amino-Ester Nanomaterials for Cas9 mRNA Delivery in Vitro and in Vivo	ACS APPLIED MATERIALS & INTERFACES			English	Article						biodegradable nanomaterials; lipidlike nanoparticles; CRISPR/Cas9; mRNA; genome editing	STAPHYLOCOCCUS-AUREUS CAS9; LIPID NANOPARTICLES; SIRNA DELIVERY; DRUG-DELIVERY; POTENT; MICE; THERAPEUTICS; OPTIMIZATION; CRISPR-CAS9; FORMULATION	Efficient and safe delivery of the CRISPR/Cas system is one of the key challenges for genome-editing applications in humans. Herein, we designed and synthesized a series of biodegradable lipidlike compounds containing ester groups for the delivery of mRNA-encoding Cas9. Two lead materials, termed N-methyl-1,3-propanediamine (MPA)-A and MPA-Ab, showed a tunable rate of biodegradation. MPA-A with linear ester chains was degraded dramatically faster than MPA-Ab with branched ester chains in the presence of esterase or in wild-type mice. Most importantly, MPA-A and MPA-Ab demonstrated efficient delivery of Cas9 mRNA both in Vitro and in vivo. Consequently, these biodegradable lipidlike nanomaterials merit further development as genome-editing delivery tools for biological and therapeutic applications.	[Zhang, Xinfu; Lin, Bin; Luo, Xiao; Zhao, Weiyu; Jiang, Justin; Zhang, Chengxiang; Chen, Xiaofang; Dong, Yizhou] Ohio State Univ, Div Pharmaceut & Pharmaceut Chem, Coll Pharm, Columbus, OH 43210 USA; [Dong, Yizhou] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Dong, Yizhou] Ohio State Univ, Ctr Clin & Translat Sci, Columbus, OH 43210 USA; [Dong, Yizhou] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Dong, Yizhou] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Dong, Yizhou] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Dong, Yizhou] Ohio State Univ, Dept Radiat Oncol, Columbus, OH 43210 USA; [Gao, Min] Kent State Univ, Liquid Crystal Inst, LCI Characterizat Facil, Kent, OH 44242 USA	Dong, YZ (reprint author), Ohio State Univ, Div Pharmaceut & Pharmaceut Chem, Coll Pharm, Columbus, OH 43210 USA.; Dong, YZ (reprint author), Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.; Dong, YZ (reprint author), Ohio State Univ, Ctr Clin & Translat Sci, Columbus, OH 43210 USA.; Dong, YZ (reprint author), Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA.; Dong, YZ (reprint author), Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA.; Dong, YZ (reprint author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.; Dong, YZ (reprint author), Ohio State Univ, Dept Radiat Oncol, Columbus, OH 43210 USA.	dong.525@osu.edu	Li, Bin/O-3224-2015	Li, Bin/0000-0002-6981-5676	NCI [P30 CA016058]; Early Career Investigator Award from the Bayer Hemophilia Awards Program; National PKU Alliance; AAPS Foundation; National Institute of General Medical Sciences [1R35GM119679]; College of Pharmacy at the Ohio State University	The cryo-TEM data were obtained at the Liquid Crystal Institute Characterization Facility, Kent State University. Histology slides were obtained at the Comparative Pathology and Mouse Phenotyping Shared Resource (CPMPSR), College of Veterinary Medicine at the Ohio State University, supported in part by NCI grant P30 CA016058. We thank Dr. Wen Xue for providing 293T cells that stably expressed eGFP and the corresponding eGFP guide RNA. This work was supported by the Early Career Investigator Award from the Bayer Hemophilia Awards Program, Research Awards from the National PKU Alliance, New Investigator Grant from the AAPS Foundation, Maximizing Investigators' Research Award 1R35GM119679 from the National Institute of General Medical Sciences, and the start-up fund from the College of Pharmacy at the Ohio State University.	Barros SA, 2012, ADV DRUG DELIVER REV, V64, P1730, DOI 10.1016/j.addr.2012.06.007; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen DL, 2012, J AM CHEM SOC, V134, P6948, DOI 10.1021/ja301621z; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dong YZ, 2016, NANO LETT, V16, P842, DOI 10.1021/acs.nanolett.5b02428; Dong YZ, 2014, ADV HEALTHC MATER, V3, P1392, DOI 10.1002/adhm.201400054; Dong YZ, 2014, P NATL ACAD SCI USA, V111, P3955, DOI 10.1073/pnas.1322937111; Du D, 2014, J CONTROL RELEASE, V182, P99, DOI 10.1016/j.jconrel.2014.03.006; Fenton OS, 2016, ADV MATER, V28, P2939, DOI 10.1002/adma.201505822; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gao M, 2014, MICROSC RES TECHNIQ, V77, P754, DOI 10.1002/jemt.22397; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kariko K, 2012, MOL THER, V20, P948, DOI 10.1038/mt.2012.7; Kauffman KJ, 2015, NANO LETT, V15, P7300, DOI 10.1021/acs.nanolett.5b02497; Li B, 2015, NANO LETT, V15, P8099, DOI 10.1021/acs.nanolett.5b03528; Li MH, 2014, J MATER CHEM B, V2, P1619, DOI 10.1039/c3tb21423k; Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106; LU Y, 2017, NAT REV MAT, V2; Maier MA, 2013, MOL THER, V21, P1570, DOI 10.1038/mt.2013.124; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JB, 2017, ANGEW CHEM INT EDIT, V56, P1059, DOI 10.1002/anie.201610209; Mitragotri S, 2014, NAT REV DRUG DISCOV, V13, P655, DOI 10.1038/nrd4363; ODA H, 1990, J LIPID RES, V31, P2209; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Rajabi M, 2014, SYNTHETIC COMMUN, V44, P1149, DOI 10.1080/00397911.2013.853800; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Nguyen TX, 2016, NANOMEDICINE-UK, V11, P1169, DOI 10.2217/nnm.16.9; Wang Q, 2015, ADV DRUG DELIVER REV, V91, P125, DOI 10.1016/j.addr.2014.12.003; Whitehead KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5277; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Woodcock SR, 2006, ORG LETT, V8, P3931, DOI 10.1021/ol0613463; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471	36	0	0	37	37	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1944-8244			ACS APPL MATER INTER	ACS Appl. Mater. Interfaces	AUG 2	2017	9	30					25481	25487		10.1021/acsami.7b08163				7	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	FC8KD	WOS:000407089300047	28685575				2018-01-05	
J	Lauritsen, I; Porse, A; Sommer, MOA; Norholm, MHH				Lauritsen, Ida; Porse, Andreas; Sommer, Morten O. A.; Norholm, Morten H. H.			A versatile one-step CRISPR-Cas9 based approach to plasmid-curing	MICROBIAL CELL FACTORIES			English	Article						CRISPR-Cas9; Plasmid-curing; pFREE; Replicon analysis; Pseudomonas putida; Genome engineering	ESCHERICHIA-COLI; BACTERIAL PLASMIDS; CLONING VEHICLES; DNA CLONING; IN-VITRO; REPLICATION; CONSTRUCTION; MUTATIONS; INCOMPATIBILITY; EXPRESSION	Background: Plasmids are widely used and essential tools in molecular biology. However, plasmids often impose a metabolic burden and are only temporarily useful for genetic engineering, bio-sensing and characterization purposes. While numerous techniques for genetic manipulation exist, a universal tool enabling rapid removal of plasmids from bacterial cells is lacking. Results: Based on replicon abundance and sequence conservation analysis, we show that the vast majority of bacterial cloning and expression vectors share sequence similarities that allow for broad CRISPR-Cas9 targeting. We have constructed a universal plasmid-curing system (pFREE) and developed a one-step protocol and PCR procedure that allow for identification of plasmid-free clones within 24 h. While the context of the targeted replicons affects efficiency, we obtained curing efficiencies between 40 and 100% for the plasmids most widely used for expression and engineering purposes. By virtue of the CRISPR-Cas9 targeting, our platform is highly expandable and can be applied in a broad host context. We exemplify the wide applicability of our system in Gram-negative bacteria by demonstrating the successful application in both Escherichia coli and the promising cell factory chassis Pseudomonas putida. Conclusion: As a fast and freely available plasmid-curing system, targeting virtually all vectors used for cloning and expression purposes, we believe that pFREE has the potential to eliminate the need for individualized vector suicide solutions in molecular biology. We envision the application of pFREE to be especially useful in methodologies involving multiple plasmids, used sequentially or simultaneously, which are becoming increasingly popular for genome editing or combinatorial pathway engineering.	[Lauritsen, Ida; Porse, Andreas; Sommer, Morten O. A.; Norholm, Morten H. H.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Kongens Lyngby, Denmark	Norholm, MHH (reprint author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Kongens Lyngby, Denmark.	morno@biosustain.dtu.dk			EU H [ERC-20104-STG LimitMDR, 638902]; Danish Council for Independent Research Sapere Aude programme [DFF-4004-00213]; Novo Nordisk Foundation	This work was supported by the EU H2020 ERC-20104-STG LimitMDR (638902) Grant, the Danish Council for Independent Research Sapere Aude programme DFF-4004-00213 and the Novo Nordisk Foundation.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2                                                    ; Cavaleiro AM, 2015, ACS SYNTH BIOL, V4, P1042, DOI 10.1021/acssynbio.5b00113; CHANG ACY, 1974, P NATL ACAD SCI USA, V71, P1030, DOI 10.1073/pnas.71.4.1030; CHANG ACY, 1978, J BACTERIOL, V134, P1141; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; Cohen SN, 2013, P NATL ACAD SCI USA, V110, P15521, DOI 10.1073/pnas.1313397110; CRAMERI R, 1986, J GEN MICROBIOL, V132, P819; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Ginesy M, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0211-y; Gregg CJ, 2014, NUCLEIC ACIDS RES, V42, P4779, DOI 10.1093/nar/gkt1374; Hale L, 2010, BIOTECHNIQUES, V48, P223, DOI 10.2144/000113366; HASHIMOTOGOTOH T, 1981, GENE, V16, P227, DOI 10.1016/0378-1119(81)90079-2; HAUGAN K, 1992, J BACTERIOL, V174, P7026; HERSHFIE.V, 1974, P NATL ACAD SCI USA, V71, P3455, DOI 10.1073/pnas.71.9.3455; Jain A, 2013, FEMS MICROBIOL LETT, V348, P87, DOI 10.1111/1574-6968.12241; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson TJ, 2007, APPL ENVIRON MICROB, V73, P1976, DOI 10.1128/AEM.02171-06; Kamens J, 2015, NUCLEIC ACIDS RES, V43, pD1152, DOI 10.1093/nar/gku893; Kamruzzaman M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172913; Karunakaran P, 1998, J BACTERIOL, V180, P3793; Kim JS, 2016, J MICROBIOL BIOTECHN, V26, P394, DOI 10.4014/jmb.1508.08080; Lee J, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0420-z; LENSKI RE, 1994, J BACTERIOL, V176, P3140, DOI 10.1128/jb.176.11.3140-3147.1994                                                ; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203                                                           ; Martinez-Garcia E, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-38; Nicoloff H, 2016, J ANTIMICROB CHEMOTH, V71, P100, DOI 10.1093/jac/dkv312; Nike PI, 2016, CURR OPIN CHEM BIOL, V34, P20, DOI 10.1016/j.cbpa.2016.05.011; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; NOVICK RP, 1987, MICROBIOL REV, V51, P381; Podolsky T, 1996, PLASMID, V36, P112, DOI 10.1006/plas.1996.0038; Raman S, 2014, P NATL ACAD SCI USA, V111, P17803, DOI 10.1073/pnas.1409523111; Reyrat JM, 1998, INFECT IMMUN, V66, P4011; Ronda C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19452; Rosano G.L., 2014, FRONT MICROBIOL, V5, P1, DOI DOI 10.3389/FMICB.2014.00172; Schaefer KA, 2017, NAT METHODS, V14, P547, DOI 10.1038/nmeth.4293; Schlegel S, 2015, CELL REP, V10, P1758, DOI 10.1016/j.celrep.2015.02.029; SELZER G, 1983, CELL, V32, P119, DOI 10.1016/0092-8674(83)90502-0                                                    ; Shintani M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00242; Silva-Rocha R, 2013, NUCLEIC ACIDS RES, V41, pD666, DOI 10.1093/nar/gks1119; Singh V, 2017, GENE, V599, P1, DOI 10.1016/j.gene.2016.11.008; STEARNS T, 1990, METHOD ENZYMOL, V185, P280; TREVORS JT, 1986, FEMS MICROBIOL LETT, V32, P149; TUCKER WT, 1984, CELL, V38, P191, DOI 10.1016/0092-8674(84)90540-3; Velappan N, 2007, PROTEIN ENG DES SEL, V20, P309, DOI 10.1093/protein/gzm005	48	0	0	13	13	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2859			MICROB CELL FACT	Microb. Cell. Fact.	AUG 2	2017	16								135	10.1186/s12934-017-0748-z				10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FC7ZH	WOS:000407060700001	28764701	gold			2018-01-05	
J	Xu, L; Yang, H; Gao, Y; Chen, ZY; Xie, LF; Liu, YL; Liu, Y; Wang, XB; Li, HW; Lai, WF; He, Y; Yao, AZ; Ma, LY; Shao, YM; Zhang, B; Wang, CY; Chen, H; Deng, HK				Xu, Lei; Yang, Huan; Gao, Yang; Chen, Zeyu; Xie, Liangfu; Liu, Yulin; Liu, Ying; Wang, Xiaobao; Li, Hanwei; Lai, Weifeng; He, Yuan; Yao, Anzhi; Ma, Liying; Shao, Yiming; Zhang, Bin; Wang, Chengyan; Chen, Hu; Deng, Hongkui			CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo	MOLECULAR THERAPY			English	Article							ZINC-FINGER NUCLEASES; STEM-CELLS; CORECEPTOR; GENE; INDIVIDUALS; SPECIFICITY; INFECTION	Transplantation of hematopoietic stem cells (HSCs) with a naturally occurring CCR5 mutation confers a loss of detectable HIV-1 in the patient, making ablation of the CCR5 gene in HSCs an ideal therapy for an HIV-1 cure. Although CCR5 disruption has been attempted in CD4(+) T cells and hematopoietic stem/progenitor cells (HSPCs), efficient gene editing with high specificity and long-term therapeutic potential remains a major challenge for clinical translation. Here, we established a CRISPR/Cas9 gene editing system in human CD34(+) HSPCs and achieved efficient CCR5 ablation evaluated in long-term reconstituted NOD/Prkdc(scid)/IL-2R gamma(null) mice. The CCR5 disruption efficiency in our system remained robust in secondary transplanted repopulating hematopoietic cells. More importantly, an HIV-1 resistance effect was observed as indicated by significant reduction of virus titration and enrichment of human CD4(+) T cells. Hence, we successfully established a CRISPR/Cas9 mediated CCR5 ablating system in long-term HSCs, which confers HIV-1 resistance in vivo. Our study provides evidence for translating CCR5 gene-edited HSC transplantation for an HIV cure to the clinic.	[Xu, Lei; Gao, Yang; Zhang, Bin; Chen, Hu] 307 Hosp PLA, Dept Hematopoiet Stem Cell Transplantat, Beijing 100071, Peoples R China; [Xu, Lei; Gao, Yang; Zhang, Bin; Chen, Hu] Acad Mil Med Sci, Cell & Gene Therapy Ctr, Beijing 100850, Peoples R China; [Yang, Huan; Chen, Zeyu; Xie, Liangfu; Liu, Yulin; Wang, Xiaobao; Li, Hanwei; Lai, Weifeng; He, Yuan; Yao, Anzhi; Wang, Chengyan; Deng, Hongkui] Peking Univ Stem Cell Res Ctr, Sch Basic Med Sci, Dept Cell Biol, Beijing, Peoples R China; [Yang, Huan; Chen, Zeyu; Xie, Liangfu; Liu, Yulin; Wang, Xiaobao; Li, Hanwei; Lai, Weifeng; He, Yuan; Yao, Anzhi; Wang, Chengyan; Deng, Hongkui] Peking Univ, Peking Univ Hlth Sci Ctr, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China; [Yang, Huan; Chen, Zeyu; Xie, Liangfu; Liu, Yulin; Wang, Xiaobao; Li, Hanwei; Lai, Weifeng; He, Yuan; Yao, Anzhi; Wang, Chengyan; Deng, Hongkui] Peking Univ, Peking Tsinghua Ctr Life Sci, Coll Life Sci, MOE Key Lab Cell Proliferat & Differentiat, Beijing 100191, Peoples R China; [Yang, Huan; Deng, Hongkui] Peking Univ, Shenzhen Grad Sch, Key Lab Chem Genom, Shenzhen Stem Cell Engn Lab, Shenzhen 518055, Peoples R China; [Gao, Yang] Guangzhou Gen Hosp Guangzhou Mil Command, Dept Hematol, Guangzhou 510010, Guangdong, Peoples R China; [Liu, Ying; Ma, Liying; Shao, Yiming] China CDC, Natl Ctr AIDS STD Control & Prevent, Beijing 102206, Peoples R China	Chen, H (reprint author), 307 Hosp PLA, Dept Hematopoiet Stem Cell Transplantat, Beijing 100071, Peoples R China.; Deng, HK (reprint author), Peking Univ Stem Cell Res Ctr, Sch Basic Med Sci, Dept Cell Biol, Beijing, Peoples R China.; Deng, HK (reprint author), Peking Univ, Peking Univ Hlth Sci Ctr, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China.	chenhu217@aliyun.com; hongkui_deng@pku.edu.cn		Yang, Huan/0000-0001-8345-9957	Beijing Science and Technology Major Project [D171100000517004]; National Natural Science Foundation of China [31521004]; National Science and Technology Support Project [2014BA102B01]; National High Technology Research and Development Program of China [2013ZX10001003003]; Guangdong Innovative and Entrepreneurial Research Team Program [2014ZT05S216]; Science and Technology Planning Project of Guangdong Province [2014B020226001]; Science and Technology Program of Guangzhou [2016B030232001]; Ministry of Education of China (111 Project); BeiHao Stem Cell and Regenerative Medicine Translational Research Institute	We thank Jing Zhang, Jingwen Niu, Lina Zhou, Li Liao, Weichao Du, Jingyun Li, and Daomin Zhuang for technical assistance. We thank Jun Xu, Xu Zhang, and Ting Zhao for assistance with the written manuscript. We thank the Core Facilities at School of Life Sciences, Peking University, for assistance. This work was supported by the Beijing Science and Technology Major Project (D171100000517004), the National Natural Science Foundation of China (31521004), the National Science and Technology Support Project (2014BA102B01), the National High Technology Research and Development Program of China (2013ZX10001003003), the Guangdong Innovative and Entrepreneurial Research Team Program (2014ZT05S216), the Science and Technology Planning Project of Guangdong Province (2014B020226001), the Science and Technology Program of Guangzhou (2016B030232001), and the Ministry of Education of China (111 Project). This work was supported in part by a grant from BeiHao Stem Cell and Regenerative Medicine Translational Research Institute.	Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DiGiusto DL, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.67; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Peterson CW, 2016, BLOOD, V127, P2416, DOI 10.1182/blood-2015-09-672337; Peterson CW, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.7; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004; Upadhyay SK, 2014, BIOMED RES INT, DOI 10.1155/2014/742482; Wagner JE, 2016, CELL STEM CELL, V18, P144, DOI 10.1016/j.stem.2015.10.004; ZHANG J, 2016, SCI REP UK, V6	22	4	4	20	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	AUG 2	2017	25	8					1782	1789		10.1016/j.ymthe.2017.04.027				8	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FC6ZH	WOS:000406989700010	28527722				2018-01-05	
J	Han, MKL; van der Krogt, GNM; de Rooij, J				Han, Mitchell K. L.; van der Krogt, Gerard N. M.; de Rooij, Johan			Zygotic vinculin is not essential for embryonic development in zebrafish	PLOS ONE			English	Article							ALPHA-E-CATENIN; FOCAL-ADHESION; F-ACTIN; DEPENDENT MANNER; BINDING-PROTEIN; CELL-ADHESION; GENOME; TALIN; PHOSPHORYLATION; FORCE	The formation of multicellular tissues during development is governed by mechanical forces that drive cell shape and tissue architecture. Protein complexes at sites of adhesion to the extracellular matrix (ECM) and cell neighbors, not only transmit these mechanical forces, but also allow cells to respond to changes in force by inducing biochemical feedback pathways. Such force-induced signaling processes are termed mechanotransduction. Vinculin is a central protein in mechanotransduction that in both integrin-mediated cell-ECM and cadherin-mediated cell-cell adhesions mediates force-induced cytoskeletal remodeling and adhesion strengthening. Vinculin was found to be important for the integrity and remodeling of epithelial tissues in cell culture models and could therefore be expected to be of broad importance in epithelial morphogenesis in vivo. Besides a function in mouse heart development, however, the importance of vinculin in morphogenesis of other vertebrate tissues has remained unclear. To investigate this further, we knocked out vinculin functioning in zebrafish, which contain two fully functional isoforms designated as vinculin A and vinculin B that both show high sequence conservation with higher vertebrates. Using TALEN and CRISPR-Cas gene editing technology we generated vinculin-deficient zebrafish. While single vinculin A mutants are viable and able to reproduce, additional loss of zygotic vinculin B was lethal after embryonic stages. Remarkably, vinculin-deficient embryos do not show major developmental defects, apart from mild pericardial edemas. These results lead to the conclusion that vinculin is not of broad importance for the development and morphogenesis of zebrafish tissues.	[Han, Mitchell K. L.; van der Krogt, Gerard N. M.; de Rooij, Johan] Univ Med Ctr Utrecht, Ctr Mol Med, Mol Canc Res, Utrecht, Netherlands	de Rooij, J (reprint author), Univ Med Ctr Utrecht, Ctr Mol Med, Mol Canc Res, Utrecht, Netherlands.	j.derooij-3@umcutrecht.nl					Alatortsev VE, 1997, FEBS LETT, V413, P197, DOI 10.1016/S0014-5793(97)00901-0; Armenti Stephen T, 2012, Subcell Biochem, V60, P279, DOI 10.1007/978-94-007-4186-7_12; Atherton P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10038; Auernheimer V, 2015, J CELL SCI, V128, P3435, DOI 10.1242/jcs.172031; Auernheimer V, 2014, BIOCHEM BIOPH RES CO, V450, P1095, DOI 10.1016/j.bbrc.2014.06.122; Baena-Lopez LA, 2013, DEVELOPMENT, V140, P4818, DOI 10.1242/dev.100933; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; BARSTEAD RJ, 1991, J CELL BIOL, V114, P715, DOI 10.1083/jcb.114.4.715; Bays JL, 2014, J CELL BIOL, V205, P251, DOI 10.1083/jcb.201309092; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bharadwaj R, 2013, DEVELOPMENT, V140, P627, DOI 10.1242/dev.085100; Brindle NPJ, 1996, BIOCHEM J, V318, P753, DOI 10.1042/bj3180753                                                               ; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Bruce AEE, 2016, DEV DYNAM, V245, P244, DOI 10.1002/dvdy.24353; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Camara-Pereira ES, 2009, HISTOL HISTOPATHOL, V24, P187, DOI 10.14670/HH-24.187; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Case LB, 2015, NAT CELL BIOL, V17, P880, DOI 10.1038/ncb3180; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Charvet B, 2013, DEVELOPMENT, V140, P4602, DOI 10.1242/dev.096024; Cheng F, 2016, DEVELOPMENT, V143, P3522, DOI 10.1242/dev.132936; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Golji J, 2011, BIOPHYS J, V100, P332, DOI 10.1016/j.bpj.2010.11.024; Gupta V, 2012, FASEB J, V26, P1892, DOI 10.1096/fj.11-194548; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002                                                   ; Han MKL, 2016, BIOL OPEN, V5, P1461, DOI 10.1242/bio.021378; Han MK, 2016, TRENDS CELL BIOL; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Huveneers S, 2013, J CELL SCI, V126, P403, DOI 10.1242/jcs.109447; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jacob AE, 2017, DEV BIOL, V425, P70, DOI 10.1016/j.ydbio.2017.03.012; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Kardash E, 2010, NAT CELL BIOL, V12, P47, DOI 10.1038/ncb2003; Kaushik G., 2015, SCI TRANSL MED, V7; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; KROEMKER M, 1994, FEBS LETT, V355, P259, DOI 10.1016/0014-5793(94)01216-4                                                    ; Lagendijk AK, 2014, CELL ADHES MIGR, V8, P136, DOI 10.4161/cam.28229; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Leerberg JM, 2014, CURR BIOL, V24, P1689, DOI 10.1016/j.cub.2014.06.028; Maartens AP, 2016, J CELL SCI, V129, P4354, DOI 10.1242/jcs.189878; Miller PW, 2013, J BIOL CHEM, V288, P22324, DOI 10.1074/jbc.M113.458406; Neu-Yilik G, 2011, RNA, V17, P843, DOI 10.1261/rna.2401811; ODELL G, 1980, J MATH BIOL, V9, P291, DOI 10.1007/BF00276030; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Peng X, 2010, J CELL SCI, V123, P567, DOI 10.1242/jcs.056432; Postel R, 2008, DEV BIOL, V318, P92, DOI 10.1016/j.ydbio.2008.03.024; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Shen K, 2011, J BIOL CHEM, V286, P45103, DOI 10.1074/jbc.M111.244293; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Thompson PM, 2014, STRUCTURE, V22, P697, DOI 10.1016/j.str.2014.03.002; Thompson PM, 2013, FEBS LETT, V587, P1220, DOI 10.1016/j.febslet.2013.02.042; Tolbert CE, 2014, BIOCHEMISTRY-US, V53, P5526, DOI 10.1021/bi500678x; Twiss F, 2013, CELL MOL LIFE SCI, V70, P4101, DOI 10.1007/s00018-013-1329-x; Twiss F, 2012, BIOL OPEN, V1, P1128, DOI 10.1242/bio.20122428; van Impel A, 2014, DEVELOPMENT, V141, P1228, DOI 10.1242/dev.105031; Vogel B, 2009, BIOCHEM BIOPH RES CO, V390, P516, DOI 10.1016/j.bbrc.2009.09.129; Wen WS, 2016, INT J CANCER, V138, P1328, DOI 10.1002/ijc.29626; Xu WM, 1998, DEVELOPMENT, V125, P327; Yan J, 2015, CELL MOL BIOENG, V8, P151, DOI 10.1007/s12195-014-0364-5; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yao MX, 2014, SCI REP-UK, V4, DOI 10.1038/srep04610; Zemljic-Harpf AE, 2004, AM J PATHOL, V165, P1033, DOI 10.1016/S0002-9440(10)63364-0                                                   ; Zemljic-Harpf A, 2009, J INVEST MED, V57, P849, DOI 10.2310/JIM.0b013e3181c5e074; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.0028-07	78	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182278	10.1371/journal.pone.0182278				22	Multidisciplinary Sciences	Science & Technology - Other Topics	FC3VT	WOS:000406768200063	28767718	gold			2018-01-05	
J	Rahman, MK; Rahman, MS				Rahman, Md. Khaledur; Rahman, M. Sohel			] CRISPRpred: A flexible and efficient tool for sgRNAs on-target activity prediction in CRISPR/Cas9 systems	PLOS ONE			English	Article							CAS9; DNA; CRISPR-CAS9; DESIGN; SPECIFICITY; PROKARYOTES; NUCLEASES	The CRISPR/Cas9-sgRNA system has recently become a popular tool for genome editing and a very hot topic in the field of medical research. In this system, Cas9 protein is directed to a desired location for gene engineering and cleaves target DNA sequence which is complementary to a 20-nucleotide guide sequence found within the sgRNA. A lot of experimental efforts, ranging from in vivo selection to in silico modeling, have been made for efficient designing of sgRNAs in CRISPR/Cas9 system. In this article, we present a novel tool, called CRISPRpred, for efficient in silico prediction of sgRNAs on-target activity which is based on the applications of Support Vector Machine (SVM) model. To conduct experiments, we have used a benchmark dataset of 17 genes and 5310 guide sequences where there are only 20% true values. CRISPRpred achieves Area Under Receiver Operating Characteristics Curve (AUROC-Curve), Area Under Precision Recall Curve (AUPR-Curve) and maximum Matthews Correlation Coefficient (MCC) as 0.85, 0.56 and 0.48, respectively. Our tool shows approximately 5% improvement in AUPR-Curve and after analyzing all evaluation metrics, we find that CRISPRpred is better than the current state-of-the-art. CRISPRpred is enough flexible to extract relevant features and use them in a learning algorithm.	[Rahman, Md. Khaledur; Rahman, M. Sohel] Bangladesh Univ Engn & Technol, AlEDA Grp, Dept Comp Sci & Engn, Dhaka, Bangladesh; [Rahman, Md. Khaledur] United Int Univ, Dept Comp Sci & Engn, Dhaka, Bangladesh	Rahman, MK; Rahman, MS (reprint author), Bangladesh Univ Engn & Technol, AlEDA Grp, Dept Comp Sci & Engn, Dhaka, Bangladesh.; Rahman, MK (reprint author), United Int Univ, Dept Comp Sci & Engn, Dhaka, Bangladesh.	khaledur@cse.uiu.ac.bd; msrahman@cse.buet.ac.bd		Rahman, Md. Khaledur/0000-0002-0166-2992	INSPIRE Strategic Partnership Award	This research work is part of an ongoing CASR research project of Bangladesh University of Engineering and Technology (BUET). It is also partially supported by an INSPIRE Strategic Partnership Award (M. Sohel Rahman), administered by British Council, Bangladesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research work is part of an ongoing CASR research project of Bangladesh University of Engineering and Technology (BUET). It is also partially supported by an INSPIRE Strategic Partnership Award (M. Sohel Rahman), administered by British Council, Bangladesh. Authors would like to thank Dr. Miguel and Dr. Jennifer Listgarten for providing supporting documents and directions.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Blin K, 2016, SYNTHETIC SYSTEMS BI; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis J., 2006, P 23 INT C MACH LEAR, V23, P233, DOI DOI 10.1145/1143844.1143874; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Ho TT, 2014, NUCLEIC ACIDS RES, V43, pe17, DOI DOI 10.1093/NAR/GKU1198; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kursa MB, J STAT SOFTWARE, V36; Liang G, 2016, SCI REPORTS, P6; Liu H, 2015, BIOINFORMATICS; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Montague TG, 2014, NUCL ACIDS RES; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wong N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0784-0; Xiao A, 2014, BIOINFORMATICS, V30, P1180, DOI 10.1093/bioinformatics/btt764; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424	34	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181943	10.1371/journal.pone.0181943				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FC3VT	WOS:000406768200040	28767689	gold			2018-01-05	
J	Slotta, C; Schluter, T; Ruiz-Perera, LM; Kadhim, HM; Tertel, T; Henkel, E; Hubner, W; Greiner, JFW; Huser, T; Kaltschmidt, B; Kaltschmidt, C				Slotta, Carsten; Schlueter, Thomas; Ruiz-Perera, Lucia M.; Kadhim, Hussamadin M.; Tertel, Tobias; Henkel, Elena; Huebner, Wolfgang; Greiner, Johannes F. W.; Huser, Thomas; Kaltschmidt, Barbara; Kaltschmidt, Christian			CRISPR/Cas9-mediated knockout of c-REL in HeLa cells results in profound defects of the cell cycle	PLOS ONE			English	Article							NF-KAPPA-B; CERVICAL-CANCER CELLS; BREAST-CANCER; HUMAN-PAPILLOMAVIRUS; TRANSCRIPTION FACTOR; HUMAN GENOME; LUNG-CANCER; V-REL; APOPTOSIS; EXPRESSION	Cervical cancer is the fourth common cancer in women resulting worldwide in 266,000 deaths per year. Belonging to the carcinomas, new insights into cervical cancer biology may also have great implications for finding new treatment strategies for other kinds of epithelial cancers. Although the transcription factor NF-kappa B is known as a key player in tumor formation, the relevance of its particular subunits is still underestimated. Here, we applied CRISPR/Cas9n-mediated genome editing to successfully knockout the NF-kappa B subunit c-REL in HeLa Kyoto cells as a model system for cervical cancers. We successfully generated a homozygous deletion in the c-REL gene, which we validated using sequencing, qPCR, immunocytochemistry, western blot analysis, EMSA and analysis of off-target effects. On the functional level, we observed the deletion of c-REL to result in a significantly decreased cell proliferation in comparison to wildtype (wt) without affecting apoptosis. The impaired proliferative behavior of c-REL-/- cells was accompanied by a strongly decreased amount of the H2B protein as well as a significant delay in the prometaphase of mitosis compared to c-REL+/+ HeLa Kyoto cells. c-REL-/- cells further showed significantly decreased expression levels of c-REL target genes in comparison to wt. In accordance to our proliferation data, we observed the c-REL knockout to result in a significantly increased resistance against the chemotherapeutic agents 5-Fluoro-2'-deoxyuridine (5-FUDR) and cisplatin. In summary, our findings emphasize the importance of c-REL signaling in a cellular model of cervical cancer with direct clinical implications for the development of new treatment strategies.	[Slotta, Carsten; Schlueter, Thomas; Kadhim, Hussamadin M.; Tertel, Tobias; Henkel, Elena; Greiner, Johannes F. W.; Kaltschmidt, Barbara; Kaltschmidt, Christian] Univ Bielefeld, Dept Cell Biol, Bielefeld, Germany; [Ruiz-Perera, Lucia M.; Kaltschmidt, Barbara] Univ Bielefeld, AG Mol Neurobiol, Bielefeld, Germany; [Huebner, Wolfgang; Huser, Thomas] Univ Bielefeld, Biomol Photon, Bielefeld, Germany	Kaltschmidt, C (reprint author), Univ Bielefeld, Dept Cell Biol, Bielefeld, Germany.	c.kaltschmidt@uni-bielefeld.de		Greiner, Johannes/0000-0002-0524-662X			Adli M, 2006, J BIOL CHEM, P281; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; De Siervi A, 2009, CELL CYCLE, V8, P2093, DOI 10.4161/cc.8.13.8926; Eddy SF, 2005, CANCER RES, V65, P11375, DOI 10.1158/0008-5472.CAN-05-1602; Forbes SA, 2014, CANC; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garland SM, 2002, PATHOLOGY, V34, P213, DOI [10.1080/00313020220131255, 10.1080/00313020212469]; Gilmore TD, 1999, ONCOGENE, V18, P6925, DOI 10.1038/sj.onc.1203222; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Gilmore TD, 2001, ONCOGENE, V20, P7098, DOI 10.1038/sj.onc.1204898                                                          ; Gilmore TD, NF KB TARGET GENES; Grey ST, 1999, J EXP MED, V190, P1135, DOI 10.1084/jem.190.8.1135; Grossmann M, 2000, EMBO J, V19, P6351, DOI 10.1093/emboj/19.23.6351; Grumont R, 2004, IMMUNITY, V21, P19, DOI 10.1016/j.immuni.2004.06.004; Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663                                                           ; Hamada K, 1996, CANCER RES, V56, P3047; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527                                                     ; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Houldsworth J, 2004, BLOOD, V103, P1862, DOI 10.1182/blood-2003-04-1359; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kaltschmidt B, 1999, ONCOGENE, V18, P3213, DOI 10.1038/sj.onc.1202657                                                          ; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Kang YJ, 2015, CANCER EPIDEMIOL, V39, P600, DOI 10.1016/j.canep.2015.04.009; Krappmann D, 1999, ONCOGENE, V18, P943, DOI 10.1038/sj.onc.1202351; Li QT, 2005, TRENDS IMMUNOL, V26, P318, DOI 10.1016/j.it.2005.04.003; Lorenz VN, 2014, J INVEST DERMATOL, V134, P415, DOI 10.1038/jid.2013.315; Lorusso D, 2014, GYNECOL ONCOL, V133, P117, DOI 10.1016/j.ygyno.2014.01.042; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Nair A, 2003, ONCOGENE, V22, P50, DOI 10.1038/sj.onc.1206043; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nishiyama M, 1999, CLIN CANCER RES, V5, P2620; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Peters GJ, 2002, BBA-MOL BASIS DIS, V1587, P194, DOI 10.1016/S0925-4439(02)00082-0; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(07)61416-0; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Shehata M, 2005, CELL BIOL INT, V29, P429, DOI 10.1016/j.cellbi.2004.12.014; Shehata M, 2004, CELL BIOL INT, V28, P895, DOI 10.1016/j.cellbi.2004.09.002; Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Stewart BW, 2014, WORLD CANC REPORT; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Tian WZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005028; Tokunaga S, 2014, ANAL BIOCHEM, V465, P70, DOI 10.1016/j.ab.2014.06.020; Vidya PR, 2010, EUR J PHARMACOL, V649, P84, DOI DOI 10.1016/J.EJPHAR.2010.09.020; Wang CY, 1999, NAT MED, V5, P412; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; WILHELMSEN KC, 1984, J VIROL, V52, P172; Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112; Yang LN, 2015, CANCER LETT, V357, P520, DOI 10.1016/j.canlet.2014.12.003; Zhao Y, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035001; [Anonymous], 2005, CELL INT, V5, P10	64	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182373	10.1371/journal.pone.0182373				19	Multidisciplinary Sciences	Science & Technology - Other Topics	FC3VT	WOS:000406768200073	28767691	gold			2018-01-05	
J	Sauvageau, E; McCormick, PJ; Lefrancois, S				Sauvageau, Etienne; McCormick, Peter J.; Lefrancois, Stephane			In vivo monitoring of the recruitment and activation of AP-1 by Arf1	SCIENTIFIC REPORTS			English	Article							RESONANCE ENERGY-TRANSFER; ADP-RIBOSYLATION FACTOR; LIVING CELLS; PROTEIN INTERACTIONS; TRANSFER BRET; GOLGI MEMBRANES; RECEPTOR; ADAPTERS; CARGO; ENDOSOMES	AP-1 is a clathrin adaptor recruited to the trans-Golgi Network where it can interact with specific signals found in the cytosolic tail of cargo proteins to incorporate them into clathrin-coated vesicles for trafficking. The small G protein Arf1 regulates the spatiotemporal recruitment of AP-1 and also drives a conformational change favoring an interaction with cargo proteins. A recent crystal structure and in vitro experiments highlighted potential residues mediating the AP-1/Arf1 interaction and the unlocking of the complex. We have used bioluminescence resonance energy transfer (BRET) to study the Arf1/AP-1 interaction and AP-1 conformational changes in vivo. We identified novel residues required for this interaction in addition to those predicted in the crystal structure. We also studied the conformational changes in AP-1 driven by Arf1 in live cells and found that opening of the complex is prerequisite for oligomerization. Using Arf1 knockout cells generated by CRISPR/Cas9, we demonstrated that residue 172 in Arf1 is necessary for AP-1 activation and is required for the efficient sorting of the lysosomal protein prosaposin. We have used BRET to study the in vivo activation of AP-1. The advantages of BRET include expressing full-length proteins in their native environment that have been fully posttranslationally modified.	[Sauvageau, Etienne; Lefrancois, Stephane] INRS, Inst Armand Frappier, Ctr INRS, Laval, PQ H7V 1B7, Canada; [McCormick, Peter J.] Univ Surrey, Sch Vet Med, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England; [Lefrancois, Stephane] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	Lefrancois, S (reprint author), INRS, Inst Armand Frappier, Ctr INRS, Laval, PQ H7V 1B7, Canada.; Lefrancois, S (reprint author), McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada.	stephane.lefrancois@iaf.inrs.ca			National Sciences and Engineering Research Council (NSERC); La Fondation du Grand defi Piere Lavoie; Fonds de recherche du Quebec-Sante	pcDNA3.1 Hygro (+) RlucII-GFP10-st2 and pcDNA3.1 Hygro (+) GFP10-RlucII-st2 plasmids were generous gifts from Dr. Michel Bouvier (IRIC, Universite de Montreal, Montreal, QC). Arf1-HA was a generous gift from Dr. Audrey Claing (Department of Pharmacology, Universite de Montreal). Funding for this work was provided by the National Sciences and Engineering Research Council (NSERC) and La Fondation du Grand defi Piere Lavoie to SL. SL is supported by a salary award from Fonds de recherche du Quebec-Sante.	Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Caster AH, 2013, J BIOL CHEM, V288, P14788, DOI 10.1074/jbc.M113.453621; Dacres H, 2011, BIOSENS BIOELECTRON, V29, P119, DOI 10.1016/j.bios.2011.08.004; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Haines E, 2015, CANCER BIOL THER, V16, P1535, DOI 10.1080/15384047.2015.1071737; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Honda A, 2005, J CELL BIOL, V168, P1039, DOI 10.1083/jcb.200409138; Jian XY, 2010, TRAFFIC, V11, P732, DOI 10.1111/j.1600-0854.2010.01054.x; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5                                                   ; Kondo Y, 2012, CELL STRUCT FUNCT, V37, P141, DOI 10.1247/csf.12015                                                               ; Lan TH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10166; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Meyer DM, 2005, MOL BIOL CELL, V16, P4745, DOI 10.1091/mbc.E05-06-0568; Nakai W, 2013, MOL BIOL CELL, V24, P2570, DOI 10.1091/mbc.E13-04-0197; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Rafiq NBM, 2017, J CELL BIOL, V216, P181, DOI 10.1083/jcb.201605104; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Robers MB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10091; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Shen QT, 2015, SCIENCE, V350, DOI 10.1126/science.aac5137; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Szalai B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109503; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Wang JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099768; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2                                                   ; Yu XC, 2012, CELL, V148, P530, DOI 10.1016/j.cell.2012.01.015; Zhao Q, 2000, J BIOL CHEM, V275, P24829, DOI 10.1074/jbc.M003497200; Zhou FG, 2015, CELL SIGNAL, V27, P2035, DOI 10.1016/j.cellsig.2015.06.007	39	0	0	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 2	2017	7								7148	10.1038/s41598-017-07493-1				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FC4NK	WOS:000406816300021	28769048	gold			2018-01-05	
J	Merino, D; Whittle, JR; Vaillant, F; Serrano, A; Gong, JN; Giner, G; Maragno, AL; Chanrion, M; Schneider, E; Pal, B; Li, X; Dewson, G; Grasel, J; Liu, K; Lalaoui, N; Segal, D; Herold, MJ; Huang, DCS; Smyth, GK; Geneste, O; Lessene, G; Visvader, JE; Lindeman, GJ				Merino, Delphine; Whittle, James R.; Vaillant, Francois; Serrano, Antonin; Gong, Jia-Nan; Giner, Goknur; Maragno, Ana Leticia; Chanrion, Maia; Schneider, Emilie; Pal, Bhupinder; Li, Xiang; Dewson, Grant; Grasel, Julius; Liu, Kevin; Lalaoui, Najoua; Segal, David; Herold, Marco J.; Huang, David C. S.; Smyth, Gordon K.; Geneste, Olivier; Lessene, Guillaume; Visvader, Jane E.; Lindeman, Geoffrey J.			Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer	SCIENCE TRANSLATIONAL MEDICINE			English	Article							SELECTIVE SMALL-MOLECULE; DIFFERENTIAL EXPRESSION ANALYSIS; CHRONIC LYMPHOCYTIC-LEUKEMIA; BH3 MIMETIC ABT-737; CELL-SURVIVAL; TARGETING BCL2; IN-VITRO; APOPTOSIS; SENSITIVITY; TUMORS	The development of BH3 mimetics, which antagonize prosurvival proteins of the BCL-2 family, represents a potential breakthrough in cancer therapy. Targeting the prosurvival member MCL-1 has been an area of intense interest because it is frequently deregulated in cancer. In breast cancer, MCL-1 is often amplified, and high expression predicts poor patient outcome. We tested the MCL-1 inhibitor S63845 in breast cancer cell lines and patient-derived xenografts with high expression of MCL-1. S63845 displayed synergistic activity with docetaxel in triple-negative breast cancer and with trastuzumab or lapatinib in HER2-amplified breast cancer. Using S63845-resistant cells combined with CRISPR (clustered regularly interspaced short palindromic repeats)-Cas9 (CRISPR-associated 9) technology, we identified deletion of BAK and up-regulation of prosurvival proteins as potential mechanisms that confer resistance to S63845 in breast cancer. Collectively, our findings provide a strong rationale for the clinical evaluation of MCL-1 inhibitors in breast cancer.	[Merino, Delphine; Whittle, James R.; Vaillant, Francois; Serrano, Antonin; Pal, Bhupinder; Grasel, Julius; Liu, Kevin; Visvader, Jane E.; Lindeman, Geoffrey J.] Walter & Eliza Hall Inst Med Res, ACRF Stem Cells & Canc Div, Parkville, Vic 3052, Australia; [Merino, Delphine; Whittle, James R.; Vaillant, Francois; Serrano, Antonin; Gong, Jia-Nan; Giner, Goknur; Pal, Bhupinder; Li, Xiang; Dewson, Grant; Grasel, Julius; Liu, Kevin; Lalaoui, Najoua; Segal, David; Herold, Marco J.; Huang, David C. S.; Lessene, Guillaume; Visvader, Jane E.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Whittle, James R.; Lindeman, Geoffrey J.] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic 3000, Australia; [Gong, Jia-Nan; Segal, David; Huang, David C. S.] Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Parkville, Vic 3052, Australia; [Giner, Goknur; Smyth, Gordon K.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Maragno, Ana Leticia; Chanrion, Maia; Schneider, Emilie; Geneste, Olivier] Inst Rech Servier Oncol, R&D Unit, F-78290 Croissy Sur Seine, France; [Li, Xiang; Dewson, Grant; Lalaoui, Najoua] Walter & Eliza Hall Inst Med Res, Cell Signalling & Cell Death Div, Parkville, Vic 3052, Australia; [Herold, Marco J.] Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Parkville, Vic 3052, Australia; [Smyth, Gordon K.] Univ Melbourne, Sch Math & Stat, Parkville, Vic 3010, Australia; [Lessene, Guillaume] Walter & Eliza Hall Inst Med Res, Chem Biol Div, Parkville, Vic 3052, Australia; [Lessene, Guillaume] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3010, Australia; [Lindeman, Geoffrey J.] Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia; [Lindeman, Geoffrey J.] Royal Melbourne Hosp, Parkville Familial Canc Ctr, Parkville, Vic 3050, Australia; [Lindeman, Geoffrey J.] Peter MacCallum Canc Ctr, Parkville, Vic 3050, Australia	Visvader, JE; Lindeman, GJ (reprint author), Walter & Eliza Hall Inst Med Res, ACRF Stem Cells & Canc Div, Parkville, Vic 3052, Australia.; Visvader, JE (reprint author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia.; Lindeman, GJ (reprint author), Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic 3000, Australia.; Lindeman, GJ (reprint author), Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia.; Lindeman, GJ (reprint author), Royal Melbourne Hosp, Parkville Familial Canc Ctr, Parkville, Vic 3050, Australia.; Lindeman, GJ (reprint author), Peter MacCallum Canc Ctr, Parkville, Vic 3050, Australia.	visvader@wehi.edu.au; lindeman@wehi.edu.au	dewson, grant/C-7646-2013; Herold, Marco/C-8039-2013	dewson, grant/0000-0003-4251-8898; Herold, Marco/0000-0001-7539-7581; Lindeman, Geoffrey/0000-0001-9386-2416	National Health and Medical Research Council, Australia (NHMRC) [1016701, 1040978, 1054618, 1086727, 1101378]; NHMRC Independent Research Institute Infrastructure Support Scheme; Victorian State Government through Victorian Cancer Agency funding [TRP13041]; Operational Infrastructure Support; Australian Cancer Research Foundation; National Breast Cancer Foundation (NBCF) [NT-13-06]; Servier; Qualtrough Cancer Research Fund; Joan Marshall Breast Cancer Research Fund; NBCF Early Career Fellowship; NHMRC [1101378, 1100807, 1037230, 1102742, 1043149, 1078730]; NHMRC/NCBF Research Fellowship; Royal Australasian College of Physicians; Victorian Cancer Agency Early Career Seed grant [13-035]; Worldwide Cancer Research grant [15-0042]	This work was supported by the National Health and Medical Research Council, Australia (NHMRC) (grants 1016701, 1040978, 1054618, 1086727, and 1101378); NHMRC Independent Research Institute Infrastructure Support Scheme; the Victorian State Government through Victorian Cancer Agency funding (TRP13041) and Operational Infrastructure Support; the Australian Cancer Research Foundation; the National Breast Cancer Foundation (NBCF) (NT-13-06); Servier; the Qualtrough Cancer Research Fund; and the Joan Marshall Breast Cancer Research Fund. D.M. was supported by an NBCF Early Career Fellowship and NHMRC Project grant (1101378); J.R.W. by an NHMRC/NCBF Research Fellowship and the Royal Australasian College of Physicians; B.P. by a Victorian Cancer Agency Early Career Seed grant (13-035) and NHMRC Project Grant (1100807); N.L. by a Worldwide Cancer Research grant (15-0042); J.E.V. by an NHMRC Australia Fellowship (1037230) and Research Fellowship (1102742); and D.C.S.H. and G.J.L. by NHMRC Research Fellowships (1043149 and 1078730, respectively).	Anderson GR, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aae0348; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Balko JM, 2014, CANCER DISCOV, V4, P232, DOI 10.1158/2159-8290.CD-13-0286; Bashari MH, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0686-4; Belmar J, 2015, PHARMACOL THERAPEUT, V145, P76, DOI 10.1016/j.pharmthera.2014.08.003; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Campone M., 2017, SCI TRANSL MED, V9; Chen J, 2011, MOL CANCER THER, V10, P2340, DOI 10.1158/1535-7163.MCT-11-0415; Cohen NA, 2012, CHEM BIOL, V19, P1175, DOI 10.1016/j.chembiol.2012.07.018; Cruickshanks N, 2012, MOL PHARMACOL, V81, P748, DOI 10.1124/mol.112.077586; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Dai HM, 2015, GENE DEV, V29, P2140, DOI 10.1101/gad.267997.115; Dawson SJ, 2010, BRIT J CANCER, V103, P668, DOI [10.1038/sj.bjc6605736, 10.1038/sj.bjc.6605736]; Delbridge ARD, 2016, NAT REV CANCER, V16, P99, DOI 10.1038/nrc.2015.17; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Friberg A, 2013, J MED CHEM, V56, P15, DOI 10.1021/jm301448p; Fu NY, 2015, NAT CELL BIOL, V17, P365, DOI 10.1038/ncb3117; Goodwin CM, 2015, CELL DEATH DIFFER, V22, P2098, DOI 10.1038/cdd.2015.73; Henson ES, 2006, CLIN CANCER RES, V12, P845, DOI 10.1158/1078-0432.CCR-05-0754; Juin P., 2011, MOL CANCER, V10, P110; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lessene G, 2013, NAT CHEM BIOL, V9, P390, DOI [10.1038/NCHEMBIO.1246, 10.1038/nchembio.1246]; Letai A, 2016, CANCER CELL, V30, P834, DOI 10.1016/j.ccell.2016.11.016; Leverson JD, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.561; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lim JJ, 2016, FEBS LETT, V590, P4402, DOI 10.1002/1873-3468.12447; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Merino D, 2016, ONCOGENE, V35, P1877, DOI 10.1038/onc.2015.287; Mitchell C, 2010, CANCER BIOL THER, V10, P907, DOI 10.4161/cbt.10.9.13273; O'Reilly LA, 2001, CELL DEATH DIFFER, V8, P486, DOI 10.1038/sj.cdd.4400835; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Perciavalle RM, 2013, TRENDS CELL BIOL, V23, P22, DOI 10.1016/j.tcb.2012.08.011; Perciavalle RM, 2012, NAT CELL BIOL, V14, P575, DOI 10.1038/ncb2488; Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920; Placzek WJ, 2010, CELL DEATH DIS, V6, pe40; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; PRICHARD MN, 1991, ANTIMICROB AGENTS CH, V35, P1060, DOI 10.1128/AAC.35.6.1060                                                           ; Rinkenberger JL, 2000, GENE DEV, V14, P23; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts AW, 2017, CLIN PHARMACOL THER, V101, P89, DOI 10.1002/cpt.553; Roberts AW, 2016, NEW ENGL J MED, V374, P311, DOI 10.1056/NEJMoa1513257; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarosiek KA, 2016, FEBS J, V283, P3523, DOI 10.1111/febs.13714; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Vaillant F, 2013, CANCER CELL, V24, P120, DOI 10.1016/j.ccr.2013.06.002; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wang X, 2013, GENE DEV, V27, P1351, DOI 10.1101/gad.215855.113; Wei SH, 2008, CANCER CHEMOTH PHARM, V62, P1055, DOI 10.1007/s00280-008-0697-7; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Xiao Y, 2015, MOL CANCER THER, V14, P1837, DOI 10.1158/1535-7163.MCT-14-0928; Xu Z, 2016, LEUKEMIA, V30, P1531, DOI 10.1038/leu.2016.52; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Young AIJ, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0781-6	67	0	0	6	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	1946-6234	1946-6242		SCI TRANSL MED	Sci. Transl. Med.	AUG 2	2017	9	401							eaam7049	10.1126/scitranslmed.aam7049				10	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	FC3XQ	WOS:000406773200003					2018-01-05	
J	Liu, X; Ji, Q; Zhang, CC; Liu, XW; Liu, YN; Liu, NN; Sui, H; Zhou, LH; Wang, S; Li, Q				Liu, Xuan; Ji, Qing; Zhang, Chengcheng; Liu, Xiaowei; Liu, Yanna; Liu, Ningning; Sui, Hua; Zhou, Lihong; Wang, Songpo; Li, Qi			miR-30a acts as a tumor suppressor by double-targeting COX-2 and BCL9 in H-pylori gastric cancer models	SCIENTIFIC REPORTS			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL LUNG-CANCER; BETA-CATENIN; SIGNALING PATHWAY; CYCLOOXYGENASE-2 EXPRESSION; HEPATOCELLULAR-CARCINOMA; ABERRANT ACTIVATION; COLORECTAL-CANCER; ANGIOGENESIS; PROLIFERATION	Helicobacter pylori (H. pylori) is one of the most important factors that affect the development of gastric cancer, and its mechanism remains un-elucidated. Our present study found that, miR-30a is crucial for regulating the growth and migration of H. pylori infected gastric cancer in vitro by targeting COX-2 and BCL9. In details, double-stranded miR-30a precursor produced two single-stranded and matured miRNAs including miR-30a-3p and miR-30a-5p, which played significant biological functions in two different manners. First, miR-30a-3p inhibited COX-2 expression and regulated nuclear translocation of beta-catenin, and second, miR-30a-5p targeted BCL9 to regulate TCF/LEF promoter activity followed by affecting beta-catenin downstream target gene expression. In vivo, miR-30a knockout mice were successfully achieved using CRISPR/Cas9 gene editing technology. Compared with H. pyloriinfected wild-type mice, H. pylori-infected miR-30a knockout mice showed increased incidence of chronic gastritis, chronic atrophic gastritis, atypical hyperplasia, and other precancerous lesions or adenocarcinoma manifestations in the antral or gastric mucosa of mice, as well as regulation of genes closely associated with tumor development. Taken together, miR-30a acts as a tumor suppressor by double-targeting COX-2 and BCL9, and significantly affects the development of H. pylori-induced gastric cancer, shedding new light on the mechanisms underlying H. pylori-associated gastric cancer.	[Liu, Xuan; Ji, Qing; Liu, Ningning; Sui, Hua; Zhou, Lihong; Li, Qi] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, Shanghai, Peoples R China; [Zhang, Chengcheng] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Med Oncol, Shanghai, Peoples R China; [Liu, Xiaowei] Shaanxi Prov Peoples Hosp, Dept Tradit Chinese Med, Xian, Shaanxi, Peoples R China; [Liu, Yanna] Zhejiang Univ Tradit Chinese Med, Huzhou Hosp Tradit Chinese Med, Dept Chinese Internal Med, Hangzhou, Zhejiang, Peoples R China; [Wang, Songpo] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Tradit Chinese Med, Shanghai, Peoples R China	Li, Q (reprint author), Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, Shanghai, Peoples R China.	Lzwf@hotmail.com			National Natural Science Foundation of China [81273958, 81673783]; Program of Shanghai Academic Research Leader [16XD1403600]; Shanghai Rising-Star Program [17QA1404100]; Program for Outstanding Medical Academic Leader; Chen Guang Project of Shanghai Municipal Education Commission [13CG47]; Chen Guang Project of Shanghai Education Development Foundation [13CG47]	The work was supported by the National Natural Science Foundation of China (81273958, 81673783), Program of Shanghai Academic Research Leader (16XD1403600), Program for Outstanding Medical Academic Leader and Chen Guang Project of Shanghai Municipal Education Commission and Shanghai Education Development Foundation (13CG47), Shanghai Rising-Star Program (17QA1404100).	Adachi S, 2004, CANCER RES, V64, P8496, DOI 10.1158/0008-5472.CAN-04-2254                                                   ; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chan KF, 2016, BIOTECHNOL J, V11, P399, DOI 10.1002/biot.201500331; Chen CB, 2015, ONCOTARGET, V6, P17570, DOI 10.18632/oncotarget.4100                                                        ; Chi F, 2016, ONCOTARGETS THER, V9, P2709, DOI 10.2147/OTT.S96197; Crowe SE, 2005, CURR OPIN GASTROEN, V21, P32; de la Roche M, 2014, CANCER RES, V74, P1495, DOI 10.1158/0008-5472.CAN-13-2682; Farrell P, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.38, 10.1038/nmicrobiol.2016.38]; Fu J, 2014, BIOCHEM BIOPH RES CO, V445, P314, DOI 10.1016/j.bbrc.2014.01.174; Gately S, 2000, CANCER METAST REV, V19, P19, DOI 10.1023/A:1026575610124                                                         ; Guan P, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-54; Han FJ, 2016, ONCOTARGET, V7, P38626, DOI 10.18632/oncotarget.9573; Huang Q, 2014, BIOCHEM BIOPH RES CO, V453, P160, DOI 10.1016/j.bbrc.2014.09.076; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Hyeon J, 2013, KOREAN J PATHOL, V47, P130, DOI 10.4132/KoreanJPathol.2013.47.2.130; Ji Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078700; Kawasaki T, 2007, NEOPLASIA, V9, P569, DOI 10.1593/neo.07334; Kim DH, 2003, ALIMENT PHARM THERAP, V18, P14, DOI 10.1046/j.1365-2036.18.s1.4.x                                                   ; Lazar D, 2008, ROM J MORPHOL EMBRYO, V49, P371; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Li Q, 2009, CANCER LETT, V278, P97, DOI 10.1016/j.canlet.2008.12.032; Liu KM, 2015, EUR J CELL BIOL, V94, P22, DOI 10.1016/j.ejcb.2014.10.006; Liu N, 2014, MOL MED REP, V9, P2166, DOI 10.3892/mmr.2014.2102; Liu NN, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2351-9; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mani M, 2009, CANCER RES, V69, P7577, DOI 10.1158/0008-5472.CAN-09-0773; Matono H, 2011, HISTOPATHOLOGY, V59, P368, DOI 10.1111/j.1365-2559.2011.03945.x; Nip H, 2016, ONCOTARGET, V7, P68371, DOI 10.18632/oncotarget.12031; Pandey R, 2010, ASIAN PAC J CANCER P, V11, P583; Prescott SM, 2000, BBA-REV CANCER, V1470, pM69, DOI 10.1016/S0304-419X(00)00006-8                                                   ; Sampietro J, 2006, MOL CELL, V24, P293, DOI 10.1016/j.molcel.2006.09.001; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stasinopoulos I, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00034; Tang HW, 2008, CANCER INVEST, V26, P60, DOI 10.1080/07357900701519279; Uefuji K, 2000, CLIN CANCER RES, V6, P135; Vidya PR, 2012, ORAL ONCOL, V48, P33, DOI [10.1016/j.oraloncology.2011.08.008, DOI 10.1016/J.ORALONCOLOGY.2011.08.008]; Wang W, 2014, EJSO-EUR J SURG ONC, V40, P1586, DOI 10.1016/j.ejso.2013.11.008; Wang X, 2003, APMIS, V111, P514, DOI 10.1034/j.1600-0463.2003.1110410.x; Yamanaka Y, 2016, METHODS MOL BIOL, V1458, P261, DOI 10.1007/978-1-4939-3801-8_19; Yu HG, 2003, CANCER LETT, V195, P43, DOI 10.1016/S0304-3835(03)00153-8; Zatula N, 2014, ONCOTARGET, V5, P6770, DOI 10.18632/oncotarget.2252                                                        ; Zhao JJ, 2014, CANCER RES, V74, P1801, DOI 10.1158/0008-5472.CAN-13-3311-T; Zimmerman AL, 2011, CANCER LETT, V300, P10, DOI 10.1016/j.canlet.2010.09.019	44	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 2	2017	7								7113	10.1038/s41598-017-07193-w				15	Multidisciplinary Sciences	Science & Technology - Other Topics	FC4ND	WOS:000406815600026	28769030	gold			2018-01-05	
J	Toro, N; Martinez-Abarca, F; Gonzalez-Delgado, A				Toro, Nicolas; Martinez-Abarca, Francisco; Gonzalez-Delgado, Alejandro			The Reverse Transcriptases Associated with CRISPR-Cas Systems	SCIENTIFIC REPORTS			English	Article							DEPENDENT DNA-POLYMERASE; GROUP-II INTRONS; ADAPTIVE IMMUNITY; ESCHERICHIA-COLI; RECOGNITION; DIVERSITY; CLASSIFICATION; PROKARYOTES; CLEAVAGE; BACTERIA	CRISPR (clustered regularly interspaced short palindromic repeats) and associated proteins (Cas) act as adaptive immune systems in bacteria and archaea. Some CRISPR-Cas systems have been found to be associated with putative reverse transcriptases (RT), and an RT-Cas1 fusion associated with a type III-B system has been shown to acquire RNA spacers in vivo. Nevertheless, the origin and evolutionary relationships of these RTs and associated CRISPR-Cas systems remain largely unknown. We performed a comprehensive phylogenetic analysis of these RTs and associated Cas1 proteins, and classified their CRISPR-Cas modules. These systems were found predominantly in bacteria, and their presence in archaea may be due to a horizontal gene transfer event. These RTs cluster into 12 major clades essentially restricted to particular phyla, suggesting host-dependent functioning. The RTs and associated Cas1 proteins may have largely coevolved. They are, therefore, subject to the same selection pressures, which may have led to coadaptation within particular protein complexes. Furthermore, our results indicate that the association of an RT with a CRISPR-Cas system has occurred on multiple occasions during evolution.	[Toro, Nicolas; Martinez-Abarca, Francisco; Gonzalez-Delgado, Alejandro] CSIC, Struct Dynam & Funct Rhizobacterial Genomes, Dept Soil Microbiol & Symbiot Syst, Grp Ecol Genet Rizosfera,Estac Expt Zaidin, C Profesor Albareda 1, E-18008 Granada, Spain	Toro, N (reprint author), CSIC, Struct Dynam & Funct Rhizobacterial Genomes, Dept Soil Microbiol & Symbiot Syst, Grp Ecol Genet Rizosfera,Estac Expt Zaidin, C Profesor Albareda 1, E-18008 Granada, Spain.	nicolas.toro@eez.csic.es	Toro, Nicolas/K-4909-2014	Toro, Nicolas/0000-0002-3614-807X	Ministerio de Economia y Competitividad [BIO2014-51953-P]; ERDF (European Regional Development Funds); FPU from the Ministerio de Economia y Competitividad	This work was supported by research grant BIO2014-51953-P from the Spanish Ministerio de Ciencia e Innovacion, now known as the Ministerio de Economia y Competitividad, including ERDF (European Regional Development Funds). A.G.-D. was supported by a FPU predoctoral fellowship from the Ministerio de Economia y Competitividad.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Alkhnbashi OS, 2014, BIOINFORMATICS, V30, pI489, DOI 10.1093/bioinformatics/btu459; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0                                                               ; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Biswas A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2627-0; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Candales MA, 2012, NUCLEIC ACIDS RES, V40, pD187, DOI 10.1093/nar/gkr1043; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Dai LX, 2003, RNA, V9, P14, DOI 10.1261/rna.212603; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eickbush TH, 2008, VIRUS RES, V134, P221, DOI 10.1016/j.virusres.2007.12.010; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Finnegan DJ, 2012, CURR BIOL, V22, pR432, DOI 10.1016/j.cub.2012.04.025; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kojima KK, 2008, MOL BIOL EVOL, V25, P1395, DOI 10.1093/molbev/msn081; LAMPSON BC, 1989, CELL, V56, P701, DOI 10.1016/0092-8674(89)90592-8                                                    ; LIM D, 1989, CELL, V56, P891, DOI 10.1016/0092-8674(89)90693-4; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Simon DM, 2008, NUCLEIC ACIDS RES, V36, P7219, DOI 10.1093/nar/gkn867; Tamulaitis G, 2017, TRENDS MICROBIOL, V25, P49, DOI 10.1016/j.tim.2016.09.012; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Toro N, 2003, ENVIRON MICROBIOL, V5, P143, DOI 10.1046/j.1462-2920.2003.00398.x; Toro N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114083; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	38	0	0	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 2	2017	7								7089	10.1038/s41598-017-07828-y				7	Multidisciplinary Sciences	Science & Technology - Other Topics	FC4ND	WOS:000406815600002	28769116	gold			2018-01-05	
J	Krupovic, M; Beguin, P; Koonin, EV				Krupovic, Mart; Beguin, Pierre; Koonin, Eugene V.			Casposons: mobile genetic elements that gave rise to the CRISPR-Cas adaptation machinery	CURRENT OPINION IN MICROBIOLOGY			English	Review							SELF-SYNTHESIZING TRANSPOSONS; ADAPTIVE IMMUNITY; SPACER ACQUISITION; DNA TRANSPOSONS; HOST FACTOR; SYSTEMS; EVOLUTION; EUKARYOTES; VIRUSES; PROTEIN	A casposon, a member of a distinct superfamily of archaeal and bacterial self-synthesizing transposons that employ a recombinase (casposase) homologous to the Cas1 endonuclease, appears to have given rise to the adaptation module of CRISPR-Cas systems as well as the CRISPR repeats themselves. Comparison of the mechanistic features of the reactions catalyzed by the casposase and the Cast-Cas2 heterohexamer, the CRISPR integrase, reveals close similarity but also important differences that explain the requirement of Cas2 for integration of short DNA fragments, the CRISPR spacers.	[Krupovic, Mart; Beguin, Pierre] Inst Pasteur, Unite Biol Mol Gene Chez Extremophiles, 25 Rue Docteur Roux, F-75015 Paris, France; [Koonin, Eugene V.] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA	Krupovic, M (reprint author), Inst Pasteur, Unite Biol Mol Gene Chez Extremophiles, 25 Rue Docteur Roux, F-75015 Paris, France.	krupovic@pasteur.fr			intramural funds of the US Department of Health and Human Services	EVK was supported by intramural funds of the US Department of Health and Human Services (to the National Library of Medicine).	Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Beguin P, 2016, NUCLEIC ACIDS RES, V44, P10367, DOI 10.1093/nar/gkw821; Brinkers S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3142699; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Craig NL, 2015, MOBILE DNA 3; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fischer MG, 2011, SCIENCE, V332, P231, DOI 10.1126/science.1199412; Hickman AB, 2015, NUCLEIC ACIDS RES, V43, P10576, DOI 10.1093/nar/gkv1180; Hickman AB, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0034-2014; Hickman AB, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-23; Hochstrasser ML, 2015, TRENDS BIOCHEM SCI, V40, P58, DOI 10.1016/j.tibs.2014.10.007; Kapitonov VV, 2006, P NATL ACAD SCI USA, V103, P4540, DOI 10.1073/pnas.0600833103; Kim TY, 2013, BIOCHEM BIOPH RES CO, V441, P720, DOI 10.1016/j.bbrc.2013.10.122; Koonin EV, 2015, VIROLOGY, V479, P2, DOI 10.1016/j.virol.2015.02.039; Koonin EV, 2015, NAT REV GENET, V16, P184, DOI 10.1038/nrg3859; Koonin EV, 2015, SCIENTIST, V29, P46; Krupovic M, 2016, CURR OPIN MICROBIOL, V31, P25, DOI 10.1016/j.mib.2016.01.006; Krupovic M, 2016, GENOME BIOL EVOL, V8, P375, DOI 10.1093/gbe/evw006; Krupovic M, 2015, NAT REV MICROBIOL, V13, P105, DOI 10.1038/nrmicro3389; Krupovic M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-36; Krupovic M, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-6; Kwon AR, 2012, NUCLEIC ACIDS RES, V40, P4216, DOI 10.1093/nar/gkr1305; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00354; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mitchell JS, 2017, J CHEM THEORY COMPUT, V13, P1539, DOI 10.1021/acs.jctc.6b00904; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Nowacki M, 2011, ANNU REV GENOM HUM G, V12, P367, DOI 10.1146/annurev-genom-082410-101420; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Plagens A, 2015, FEMS MICROBIOL REV, V39, P442, DOI 10.1093/femsre/fuv019; Plagens A, 2012, J BACTERIOL, V194, P2491, DOI 10.1128/JB.00206-12; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; Rollie C, 2015, ELIFE, V4, DOI 10.7554/eLife.08716.001; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Tsui TKM, 2015, ANNU REV BIOPHYS, V44, P229, DOI 10.1146/annurev-biophys-060414-033939; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Wilkinson ME, 2016, BIOCHEM J, V473, P1063, DOI 10.1042/BCJ20160078; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Yang W, 2008, NAT STRUCT MOL BIOL, V15, P1228, DOI 10.1038/nsmb.1502; Yoganand KNR, 2017, NUCLEIC ACIDS RES, V45, P367, DOI 10.1093/nar/gkw1151	52	7	7	1	2	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5274	1879-0364		CURR OPIN MICROBIOL	Curr. Opin. Microbiol.	AUG	2017	38						36	43		10.1016/j.mib.2017.04.004				8	Microbiology	Microbiology	FO9RO	WOS:000417229200008	28472712				2018-01-05	
J	Waller, MC; Bober, JR; Nair, NU; Beisel, CL				Waller, Matthew C.; Bober, Josef R.; Nair, Nikhil U.; Beisel, Chase L.			Toward a genetic tool development pipeline for host-associated bacteria	CURRENT OPINION IN MICROBIOLOGY			English	Review							CRISPR-CAS SYSTEMS; ESCHERICHIA-COLI; GUT MICROBIOTA; GENOME; EXPRESSION; CLOSTRIDIUM; REPRESSION; DIVERSITY; EVOLUTION; MODEL	Bacteria reside in externally accessible niches on and in multicellular organisms, often forming mutualistic relationships with their host. Recent studies have linked the composition of these microbial communities with alterations in the host's health, behavior, and development, yet the causative mediators of host-microbiota interactions remain poorly understood. Advances in understanding and engineering these interactions require the development of genetic tools to probe the molecular interactions driving the structure and function of microbial communities as well as their interactions with their host. This review discusses the current challenges to rendering culturable, non-model members of microbial communities genetically tractable - including overcoming barriers to DNA delivery, achieving predictable gene expression, and applying CRISPR-based tools - and details recent efforts to create generalized pipelines that simplify and expedite the tool development process. We use the bacteria present in the human gastrointestinal tract as representative microbiota to illustrate some of the recent achievements and future opportunities for genetic tool development.	[Waller, Matthew C.; Beisel, Chase L.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Bober, Josef R.; Nair, Nikhil U.] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA	Beisel, CL (reprint author), North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.	cbeisel@ncsu.edu			National Science Foundation [MCB-1452902]; National Institutes of Health [1DP2HD91798-01]	We thank Jennie Fagcn for providing critical feedback. This work was supported by funding from the National Science Foundation (MCB-1452902 to C.L.B.) and from the National Institutes of Health (1DP2HD91798-01 to N.U.N.).	Afroz T, 2014, MOL MICROBIOL, V93, P1093, DOI 10.1111/mmi.12695; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Barrangou R, 2016, CURR OPIN BIOTECH, V37, P61, DOI 10.1016/j.copbio.2015.10.003; Borujeni AE, 2017, NUCLEIC ACIDS RES, V45, P5437, DOI 10.1093/nar/gkx061; Borujeni AE, 2016, J AM CHEM SOC, V138, P7016, DOI 10.1021/jacs.6b01453; Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645; Cui L, 2016, NUCLEIC ACIDS RES, V44, P4243, DOI 10.1093/nar/gkw223; Dalia AB, 2014, P NATL ACAD SCI USA, V111, P8937, DOI 10.1073/pnas.1406478111; Garcia PA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21238; Garst AD, 2017, NAT BIOTECHNOL, V35, P48, DOI 10.1038/nbt.3718; Goldfarb T, 2015, EMBO J, V34, P169, DOI 10.15252/embj.201489455; Horn N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01080; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Krylov AA, 2014, J MICROBIOL METH, V105, P109, DOI 10.1016/j.mimet.2014.07.028; Kushwaha M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8832; Lee WC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1585-2; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Leonard MT, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00361; Lo Scrudato M, 2013, NUCLEIC ACIDS RES, V41, P3644, DOI 10.1093/nar/gkt041; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; Luo ML, 2016, BIOTECHNOL BIOENG, V113, P930, DOI 10.1002/bit.25851; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mimee M, 2015, CELL SYST, V1, P62, DOI 10.1016/j.cels.2015.06.001; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Motherway MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094875; Mougiakos I, 2017, ACS SYNTH BIOL, V6, P849, DOI 10.1021/acssynbio.6b00339; O'Callaghan A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1968-4; Oh J-H., 2015, NUCLEIC ACIDS RES, V42, pe131, DOI DOI 10.1093/NAR/GKU623; Perez-Arellano I, 2001, PLASMID, V46, P106, DOI 10.1006/plas.2001.1531; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pham VHT, 2012, TRENDS BIOTECHNOL, V30, P475, DOI 10.1016/j.tibtech.2012.05.007; Pyne ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep25666; Qi L, 2012, NAT BIOTECHNOL, V30, P1002, DOI 10.1038/nbt.2355; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quinn RA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00038-16; Rath D, 2015, NUCLEIC ACIDS RES, V43, P237, DOI 10.1093/nar/gku1257; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Rud I, 2006, MICROBIOL-SGM, V152, P1011, DOI 10.1099/mic.0.28599-0; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Schnupf P, 2015, NATURE, V520, P99, DOI 10.1038/nature14027; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Spath K, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-141; Stachler AE, 2016, J BIOL CHEM, V291, P15226, DOI [10.1074/jbc.M116/724062, 10.1074/jbc.M116.724062]; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Tian T, 2015, NUCLEIC ACIDS RES, V43, P7137, DOI 10.1093/nar/gkv635; Topp S, 2010, APPL ENVIRON MICROB, V76, P7881, DOI 10.1128/AEM.01537-10; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Houte S, 2016, MICROBIOL MOL BIOL R, V80, P745, DOI 10.1128/MMBR.00011-16; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Xu T, 2015, APPL ENVIRON MICROB, V81, P4423, DOI 10.1128/AEM.00873-15; Yang P, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0344-z; Zhang GQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002987	61	0	0	0	0	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5274	1879-0364		CURR OPIN MICROBIOL	Curr. Opin. Microbiol.	AUG	2017	38						156	164		10.1016/j.mib.2017.05.006				9	Microbiology	Microbiology	FO9RO	WOS:000417229200024	28624690				2018-01-05	
J	Siguier, P; Gourbeyre, E; Chandler, M				Siguier, Patricia; Gourbeyre, Edith; Chandler, Michael			Known knowns, known unknowns and unknown unknowns in prokaryotic transposition	CURRENT OPINION IN MICROBIOLOGY			English	Review							STREPTOMYCES-COELICOLOR A3(2); SINGLE-STRANDED-DNA; CRISPR-CAS SYSTEMS; PUTIDA STRAIN-H; INSERTION-SEQUENCE; ESCHERICHIA-COLI; IS1111 FAMILY; TARGET SITE; PSEUDOALTEROMONAS-ATLANTICA; STAPHYLOCOCCUS-AUREUS	Although the phenomenon of transposition has been known for over 60 years, its overarching importance in modifying and streamlining genomes took some time to recognize. In spite of a robust understanding of transposition of some TE, there remain a number of important TE groups with potential high genome impact and unknown transposition mechanisms and yet others, only recently identified by bioinformatics, yet to be formally confirmed as mobile. Here, we point to some areas of limited understanding concerning well established important TE groups with DDE Tpases, to address central gaps in our knowledge of characterised Tn with other types of Tpases and finally, to highlight new potentially mobile DNA species. It is not exhaustive. Examples have been chosen to provide encouragement in the continued exploration of the considerable prokaryotic mobilome especially in light of the current threat to public health posed by the spread of multiple Ab(R).	[Siguier, Patricia; Gourbeyre, Edith; Chandler, Michael] CNRS, Toulouse, France; [Chandler, Michael] Georgetown Univ, Med Ctr, Dept Biochem Mol & Cell Biol, 3900 Reservoir Rd, Washington, DC 20057 USA	Chandler, M (reprint author), CNRS, Toulouse, France.; Chandler, M (reprint author), Georgetown Univ, Med Ctr, Dept Biochem Mol & Cell Biol, 3900 Reservoir Rd, Washington, DC 20057 USA.	Mike.Chandler@ibcg.biotoul.fr					Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Bao WD, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-12; BARTLETT DH, 1989, J BACTERIOL, V171, P1763, DOI 10.1128/jb.171.3.1763-1766.1989                                                 ; Bastos MC, 1988, EMBO J, P7; Beguin P, 2016, NUCLEIC ACIDS RES, V44, P10367, DOI 10.1093/nar/gkw821; Bertels F, 2011, MOB GENET ELEMENTS, V1, P262; Boocock MR, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-24; BROWN AMC, 1984, J BACTERIOL, V159, P472; Buchner JM, 2005, J BACTERIOL, V187, P3431, DOI 10.1128/JB.187.10.3431-3437.2005; Chandler M, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0031-2014; Chandler M, 2013, NAT REV MICROBIOL, V11, P525, DOI 10.1038/nrmicro3067; Choi S, 2003, J BACTERIOL, V185, P4891, DOI 10.1128/JB.185.16.4891-4900.2003; COLONNA B, 1988, PLASMID, V20, P221, DOI 10.1016/0147-619X(88)90028-5; Craig NL, 2015, MOBILE DNA 3; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; FAYET O, 1990, MOL MICROBIOL, V4, P1771, DOI 10.1111/j.1365-2958.1990.tb00555.x                                              ; FIANDT M, 1972, MOL GEN GENET, V119, P223, DOI 10.1007/BF00333860; Furi L, 2016, FRONT MICROBIOL, V7, P1008; Garcillan-Barcia MD, 2001, MOL MICROBIOL, V39, P494; Garcillan-Barcia MP, 2002, MOBILE DNA, P891; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Grabundzija I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10716; Griffin TJ, 1999, NUCLEIC ACIDS RES, V27, P3859, DOI 10.1093/nar/27.19.3859; Harmer CJ, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00038-16; Harmer CJ, 2015, MBIO, V6, DOI 10.1128/mBio.01866-15; Harmer CJ, 2014, MBIO, V5, DOI 10.1128/mBio.01801-14; He S, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0039-2014; He SS, 2015, MBIO, V6, DOI 10.1128/mBio.00762-15; He SS, 2013, NUCLEIC ACIDS RES, V41, P3302, DOI 10.1093/nar/gkt014; HEDGES RW, 1974, MOL GEN GENET, V132, P31, DOI 10.1007/BF00268228; HENDERSON DJ, 1989, MOL MICROBIOL, V3, P1307, DOI 10.1111/j.1365-2958.1989.tb00112.x; Hickman AB, 2015, NUCLEIC ACIDS RES, V43, P10576, DOI 10.1093/nar/gkv1180; Hickman AB, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0034-2014; Hickman AB, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-23; Higgins BP, 2007, P NATL ACAD SCI USA, V104, P1901, DOI 10.1073/pnas.0608633104; Higgins BP, 2009, J BACTERIOL, V191, P6408, DOI 10.1128/JB.00771-09; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; IIDA S, 1984, MOL GEN GENET, V198, P84, DOI 10.1007/BF00328705; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kapitonov VV, 2016, J BACTERIOL, V198, P797, DOI 10.1128/JB.00783-15; Kersulyte D, 2000, J BACTERIOL, V182, P5300, DOI 10.1128/JB.182.19.5300-5308.2000; Kim TY, 2013, BIOCHEM BIOPH RES CO, V441, P720, DOI 10.1016/j.bbrc.2013.10.122; Koonin EV, 2015, NAT REV GENET, V16, P184, DOI 10.1038/nrg3859; Krupovic M, 2016, GENOME BIOL EVOL, V8, P375, DOI 10.1093/gbe/evw006; Krupovic M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-36; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331                                                           ; Lauf U, 1999, FEMS MICROBIOL LETT, V170, P407; Lesic B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002529; Liebert CA, 1999, MICROBIOL MOL BIOL R, V63, P507; Loot C, 2004, MOL MICROBIOL, V51, P385, DOI 10.1046/j.1365-2958.2003.03850.x; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; May EW, 1996, SCIENCE, V272, P401, DOI 10.1126/science.272.5260.401; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; MCCLINTOCK B, 1953, GENETICS, V38, P579; Misiura A, 2013, MOL MICROBIOL, V88, P1218, DOI 10.1111/mmi.12253; MIZUUCHI K, 1991, CELL, V66, P129, DOI 10.1016/0092-8674(91)90145-O; MOLLET B, 1983, NUCLEIC ACIDS RES, V11, P6319, DOI 10.1093/nar/11.18.6319                                                          ; Muller C, 2001, MOL GENET GENOMICS, V265, P1004, DOI 10.1007/s004380100495; MURPHY E, 1991, PLASMID, V26, P20, DOI 10.1016/0147-619X(91)90033-S                                                    ; Nicolas E, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0060-2014; Nunvar J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-44; Partridge SR, 2003, J BACTERIOL, V185, P6371, DOI 10.1128/JB.185.21.6371-6384.2003; Pasternak C, 2013, MOL MICROBIOL, V88, P443, DOI 10.1111/mmi.12194; Perkins-Balding D, 1999, J BACTERIOL, V181, P4937; POLZIN KM, 1987, J BACTERIOL, V169, P5481, DOI 10.1128/jb.169.12.5481-5488.1987                                                ; Post V, 2009, FEMS MICROBIOL LETT, V290, P182, DOI 10.1111/j.1574-6968.2008.01412.x; Prosseda G, 2006, J BACTERIOL, V188, P4681, DOI 10.1128/JB.00332-06; ROWLAND SJ, 1990, MOL MICROBIOL, V4, P961, DOI 10.1111/j.1365-2958.1990.tb00669.x; Schoeniger JS, 2016, NUCLEIC ACIDS RES, V44, P6830, DOI 10.1093/nar/gkw601; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Siguier P, 2014, FEMS MICROBIOL REV; SMOKVINA T, 1994, MOL MICROBIOL, V12, P459, DOI 10.1111/j.1365-2958.1994.tb01034.x; STARLINGER P, 1972, BIOCHIMIE, V54, P177, DOI 10.1016/S0300-9084(72)80102-0; Tavakoli NP, 2001, EMBO J, V20, P2923, DOI 10.1093/emboj/20.11.2923; Thomas J, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0049-2014; Tobiason DM, 2001, MOL MICROBIOL, V39, P641, DOI 10.1046/j.1365-2958.2001.02276.x; Tobiason DM, 1999, J BIOL CHEM, V274, P9698, DOI 10.1074/jbc.274.14.9698; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; TRIEUCUOT P, 1985, PLASMID, V14, P80, DOI 10.1016/0147-619X(85)90034-4                                                    ; TURLAN C, 1995, EMBO J, V14, P5410; Turlan C, 2004, MOL MICROBIOL, V53, P1021, DOI 10.1111/j.1365-2958.2004.04165.x; Van Houdt R, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-6; Van Houdt R, 2009, ANTON LEEUW INT J G, V96, P205, DOI 10.1007/s10482-009-9345-4; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	86	0	0	1	1	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5274	1879-0364		CURR OPIN MICROBIOL	Curr. Opin. Microbiol.	AUG	2017	38						171	180		10.1016/j.mib.2017.06.005				10	Microbiology	Microbiology	FO9RO	WOS:000417229200026	28683354				2018-01-05	
J	Tuberosa, R; Frascaroli, E; Salvi, S				Tuberosa, Roberto; Frascaroli, Elisabetta; Salvi, Silvio			Leveraging plant genomics for better and healthier food	CURRENT OPINION IN FOOD SCIENCE			English	Article							QUANTITATIVE TRAIT LOCI; DURUM-WHEAT GRAIN; QUALITY; BIOFORTIFICATION; NUTRITION; CROPS; IDENTIFICATION; IMPROVEMENT; ASSOCIATION; EFFICIENCY	Producing better and healthier food is an unprecedented challenge that the food-supply chain will face, particularly in view of the negative impact of climate change on food security and safety. Among the different options available to meet these challenges, the recent advances in genome sequencing provide unparalleled opportunities to identify beneficial alleles at the genes controlling food properties and leverage this information for tailoring the genetic make-up of the crops that feed mankind. Breeding programmes aiming at selecting more nutritious and safer crops increasingly benefit from the application of marker-assisted selection and genomic selection. Cloning the genes underscoring food quality paves the way for the targeted use of gene editing to fully harness the opportunities offered by native and artificially induced genetic variability.	[Tuberosa, Roberto; Frascaroli, Elisabetta; Salvi, Silvio] Univ Bologna, Dept Agr Sci, Bologna, Italy	Tuberosa, R (reprint author), Univ Bologna, Dept Agr Sci, Bologna, Italy.	roberto.tuberosa@unibo.it					Arruda MP, 2016, MOL BREED, V36; Ates D, 2016, PLOS ONE, V11, Patent No. 26978666; Avni R, 2017, SCIENCE, V357, P93, DOI 10.1126/science.aan0032; Balyan HS, 2013, PLANT BREEDING, V132, P446, DOI 10.1111/pbr.12047; Battilani P, 2016, WORLD MYCOTOXIN J, V9, P647, DOI 10.3920/WMJ2016.x004; Bernardo R, 2016, THEOR APPL GENET, V129, P2323, DOI 10.1007/s00122-016-2772-5; Bevan MW, 2017, NATURE, V543, P346, DOI 10.1038/nature22011; Blair Matthew Wohlgemuth, 2016, Front Plant Sci, V7, P219, DOI 10.3389/fpls.2016.00219; Bordoni A, 2014, CURR OPIN CLIN NUTR, V17, P418, DOI 10.1097/MCO.0000000000000089; Bouis HE, 2017, GLOB FOOD SECUR-AGR, V12, P49, DOI 10.1016/j.gfs.2017.01.009; Brul S, 2016, CURR OPIN FOOD SCI, V10; Campos KM, 2016, EUPHYTICA, V207, P109, DOI 10.1007/s10681-015-1541-x; Cardenas PD, 2015, PHYTOCHEMISTRY, V113, P24, DOI 10.1016/j.phytochem.2014.12.010; Clasen BM, 2016, PLANT BIOTECHNOL J, V14, P169, DOI 10.1111/pbi.12370; Colasuonno P, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3395-6; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Crespo-Herrera LA, 2016, ANN APPL BIOL, V169, P27, DOI 10.1111/aab.12276; Diaz-Gomez J, 2017, CURR OPIN BIOTECH, V44, P115, DOI 10.1016/j.copbio.2016.12.002; Dwivedi SL, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00763; Esuma W, 2016, EUPHYTICA, V212, P97, DOI 10.1007/s10681-016-1772-5; Farre G, 2015, CURR OPIN BIOTECH, V32, P54, DOI 10.1016/j.copbio.2014.11.004; Ficco DBM, 2014, J AGR FOOD CHEM, V62, P8686, DOI 10.1021/jf5003683; Ficco DBM, 2016, FOOD CHEM, V205, P187, DOI 10.1016/j.foodchem.2016.03.014; Francis D, 2017, CURR OPIN BIOTECH, V44, P124, DOI 10.1016/j.copbio.2016.11.009; Fu Z, 2016, SCI REP, V6; Gallo M, 2016, J CHROMATOGR A, V1428, P3, DOI 10.1016/j.chroma.2015.09.007; Giuliano G, 2017, CURR OPIN BIOTECH, V44, P169, DOI 10.1016/j.copbio.2017.02.001; Golicz AA, 2016, PLANT BIOTECHNOL J, V14, P1099, DOI 10.1111/pbi.12499; Gong XP, 2016, J PLANT NUTR, V39, P1087, DOI 10.1080/01904167.2015.1087568; Guzman C, 2016, APPL TRANSL GENOM, V11, P3, DOI 10.1016/j.atg.2016.10.004; Guzman C, 2016, FIELD CROP RES, V186, P157, DOI 10.1016/j.fcr.2015.12.002; Hashemi FSG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129069; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Ishii T, 2017, GM CROPS FOOD, V8, P44, DOI 10.1080/21645698.2016.1261787; Jha UC, 2016, EUPHYTICA, V208, P1, DOI 10.1007/s10681-015-1580-3; Kanatti A, 2016, INDIAN J GENET PL BR, V76, P299, DOI 10.5958/0975-6906.2016.00045.6; Krasileva KV, 2017, P NATL ACAD SCI USA, V114, pE913, DOI 10.1073/pnas.1619268114; Kumar J, 2017, PLANT CELL REP; Kumar S, 2016, FRONT PLANT SCI, V7; Liu D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155428; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; Mahalingam R, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3408-5; Manickavelu A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169416; Mazzeo MF, 2017, J AGR FOOD CHEM, V65, P3242, DOI 10.1021/acs.jafc.7b00571; McCartney CA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01542; Muthusamy V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122130; Rambla JL, 2017, J EXP BOT, V68, P429, DOI 10.1093/jxb/erw455; Randhawa HS, 2013, PLANT BREEDING, V132, P458, DOI 10.1111/pbr.12057; Rawat N, 2016, NAT GENET, V48, P1576, DOI 10.1038/ng.3706; Ren C, 2016, SCI REP, V6; Rotroff DM, 2016, INT J GENOMICS, DOI 10.1155/2016/1715985; Saltzman A, 2017, ANN NY ACAD SCI, V1390, P104, DOI 10.1111/nyas.13314; Salvi S, 2015, CURR OPIN BIOTECH, V32, P179, DOI 10.1016/j.copbio.2015.01.001; Schmidt M, 2016, THEOR APPL GENET, V129, P203, DOI 10.1007/s00122-015-2639-1; Schonhofen A, 2016, J PLANT REGIST, V10, P200, DOI 10.3198/jpr2015.10.0066crg; Sestili F, 2016, PLANT SCI, V252, P230, DOI 10.1016/j.plantsci.2016.08.001; Sestili F, 2015, PLANT SCI, V233, P127, DOI 10.1016/j.plantsci.2015.01.009; Sparla F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107779; Sprink T, 2016, PLANT BIOTECHNOL REP, V10, P345, DOI 10.1007/s11816-016-0418-3; Stangoulis JCR, 2007, EUPHYTICA, V154, P289, DOI 10.1007/s10681-006-9211-7; Swamy BPM, 2016, RICE, V9; Taheri S, 2017, MOL BREED, V37; Ting NC, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2607-4; Vadivel AKA, 2016, PHYTOCHEM REV, V15, P391, DOI 10.1007/s11101-015-9431-3; Velu G, 2017, PLANT SOIL, V411, P81, DOI 10.1007/s11104-016-3025-8; Wang Y, 2015, PLOS ONE, V10; Yauk YK, 2015, PLANT J, V82, P937, DOI 10.1111/tpj.12861; Zhai SN, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01197	68	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2214-7993	2214-8000		CURR OPIN FOOD SCI	Curr. Opin. Food Sci.	AUG	2017	16				SI		100	105		10.1016/j.cofs.2017.09.006				6	Food Science & Technology	Food Science & Technology	FO7ST	WOS:000417077600016					2018-01-05	
J	Grames, MS; Jackson, KL; Dayton, RD; Stanford, JA; Klein, RL				Grames, Mychal S.; Jackson, Kasey L.; Dayton, Robert D.; Stanford, John A.; Klein, Ronald L.			Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neurobiology; Issue 126; Adeno-associated virus; amyotrophic lateral sclerosis; gene therapy; gene transfer; intravenous injection; rotarod; tail vein injection; quantification of transduction; TDP-43	AMYOTROPHIC-LATERAL-SCLEROSIS; EXPRESSION; DELIVERY; PROMOTER; NEURONS; VECTOR; TDP-43	Adeno-associated virus (AAV) vectors are a key reagent in the neurosciences for clustered regularly interspaced short palindromic repeats (CRISPR), optogenetics, cre-lox targeting, etc. The purpose of this manuscript is to aid the investigator attempting expansive central nervous system (CNS) gene transfer in the rat via tail vein injection of AAV. Wde-scale expression is relevant for conditions with widespread pathology, and a rat model is significant due to its greater size and physiologic similarities to humans compared to mice. In this example application, a wide-scale neuronal transduction is used to mimic a neurodegenerative disease that affects the entire spinal cord, amyotrophic lateral sclerosis (ALS). The efficient wide-scale CNS transduction can also be used to deliver therapeutic protein factors in pre-clinical studies. After a post-injection expression interval of several weeks, the effects of the transduction are evaluated. For a green fluorescent protein (GFP) control vector, the amount of GFP in the cerebellum is estimated quickly and reliably by a basic imaging program. For motor disease phenotypes that are induced by the ALS related protein transactive response DNA-binding protein of 43 kDa (TDP-43), the deficits are scored by escape reflex and rotarod. Beyond disease modeling and gene therapy, there are diverse potential applications for the wide-scale gene targeting described here. The expanded use of this method will aid in expediting hypothesis testing in the neurosciences and neurogenetics.	[Grames, Mychal S.; Jackson, Kasey L.; Dayton, Robert D.; Klein, Ronald L.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Baton Rouge, LA 70803 USA; [Stanford, John A.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Lawrence, KS 66045 USA	Klein, RL (reprint author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Baton Rouge, LA 70803 USA.	Klein@lsuhsc.edu			Lied Foundation; National Institutes of Health [GM103418]; Karyopharm Therapeutics, Inc.; Meira GTx; ALS Association	This work was funded by the ALS Association, Karyopharm Therapeutics, Inc., Meira GTx, and a charitable donation for ALS research from Thomas Lawson, for which we are grateful. We thank Elysse Orchard and Donna Burney for advice and training. JAS was supported by the Lied Foundation and National Institutes of Health grant GM103418	Dayton RD, 2013, MOL THER, V21, P1324, DOI 10.1038/mt.2013.88; Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Jackson K., 2015, BMC NEUROSCI, V17, P69; Jackson KL, 2015, GENE THER, V22, P20, DOI 10.1038/gt.2014.101; Jackson KL, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00116; Jackson KL, 2016, EXPERT OPIN THER TAR, V20, P1153, DOI 10.1080/14728222.2016.1212016; Jackson KL, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.36; Lampe SEG, 2014, JOVE-J VIS EXP, DOI 10.3791/52037; van Hulst RA, 2003, CLIN PHYSIOL FUNCT I, V23, P237; Wang DB, 2010, MOL THER, V18, P2064, DOI 10.1038/mt.2010.191; Xu LF, 2001, HUM GENE THER, V12, P563, DOI 10.1089/104303401300042500	12	0	0	0	0	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	AUG	2017		126							e55994	10.3791/55994				7	Multidisciplinary Sciences	Science & Technology - Other Topics	FM8VM	WOS:000415369500058					2018-01-05	
J	Rivera-Torres, N; Kmiec, EB				Rivera-Torres, Natalia; Kmiec, Eric B.			A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Molecular Biology; Issue 126; Mutagenicity; point mutation repair; CRISPR/Cas9; single-stranded DNA oligonucleotides; gene editing	TARGETED GENE REPAIR; SINGLE-STRANDED OLIGONUCLEOTIDES; MAMMALIAN-CELLS; DNA OLIGONUCLEOTIDES; SEQUENCE CORRECTION; CYCLE PROGRESSION; CAS9 NUCLEASES; STEM-CELLS; REPLICATION; SPECIFICITY	Combinatorial gene editing using CRISPR/Cas9 and single-stranded oligonucleotides is an effective strategy for the correction of single-base point mutations, which often are responsible for a variety of human inherited disorders. Using a well-established cell-based model system, the point mutation of a single-copy mutant eGFP gene integrated into HCT116 cells has been repaired using this combinatorial approach. The analysis of corrected and uncorrected cells reveals both the precision of gene editing and the development of genetic lesions, when indels are created in uncorrected cells in the DNA sequence surrounding the target site. Here, the specific methodology used to analyze this combinatorial approach to the gene editing of a point mutation, coupled with a detailed experimental strategy to measuring indel formation at the target site, is outlined. This protocol outlines a foundational approach and workflow for investigations aimed at developing CRISPR/Cas9-based gene editing for human therapy. The conclusion of this work is that on-site mutagenesis takes place as a result of CRISPR/Cas9 activity during the process of point mutation repair. This work puts in place a standardized methodology to identify the degree of mutagenesis, which should be an important and critical aspect of any approach destined for clinical implementation.	[Rivera-Torres, Natalia; Kmiec, Eric B.] Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Gene Editing Inst, Wilmington, DE 19899 USA; [Rivera-Torres, Natalia; Kmiec, Eric B.] Christiana Care Hlth Syst, Res Inst, Wilmington, DE 19899 USA; [Rivera-Torres, Natalia; Kmiec, Eric B.] Univ Delaware, Dept Med Sci, Newark, DE 19716 USA	Kmiec, EB (reprint author), Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Gene Editing Inst, Wilmington, DE 19899 USA.; Kmiec, EB (reprint author), Christiana Care Hlth Syst, Res Inst, Wilmington, DE 19899 USA.; Kmiec, EB (reprint author), Univ Delaware, Dept Med Sci, Newark, DE 19716 USA.	eric.b.kmiec@christianacare.org					Aarts M, 2010, J CELL MOL MED, V14, P1657, DOI 10.1111/j.1582-4934.2009.00847.x; Alexeev V, 1998, NAT BIOTECHNOL, V16, P1343; Andrieu-Soler C, 2005, NUCLEIC ACIDS RES, V33, P3733, DOI 10.1093/nar/gki686; Beetham PR, 1999, P NATL ACAD SCI USA, V96, P8774, DOI 10.1073/pnas.96.15.8774; Bertoni C., HUM MOL GEN, V14, P221; Bertoni C, 2009, NUCLEIC ACIDS RES, V37, P7468, DOI 10.1093/nar/gkp757; Bialk P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129308; Brachman EE, 2004, J CELL SCI, V117, P3867, DOI 10.1242/jcs.01250; Brachman EE, 2005, DNA REPAIR, V4, P445, DOI 10.1016/j.dnarep.2004.11.007; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Engstrom JU, 2008, CELL CYCLE, V7, P1402, DOI 10.4161/cc.7.10.5826                                                            ; Engstrom JU, 2009, BIOESSAYS, V31, P159, DOI 10.1002/bies.200800119; Ferrara L, 2004, NUCLEIC ACIDS RES, V32, P5239, DOI 10.1093/nar/gkh822; Ferrara L, 2004, EXP CELL RES, V300, P170, DOI 10.1016/j.yexcr.2004.06.021; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; MANDECKI W, 1986, P NATL ACAD SCI USA, V83, P7177, DOI 10.1073/pnas.83.19.7177                                                         ; Moerschell R. P., P NATL ACAD SCI, V85, P524; Olsen PA, 2005, J GENE MED, V7, P1534, DOI 10.1002/jgm.804; Olsen PA, 2005, GENE THER, V12, P546, DOI 10.1038/sj.gt.3302437; Parekh-Olmedo H, 2005, GENE THER, V12, P639, DOI 10.1038/sj.gt.3302511; Pierce EA, 2003, GENE THER, V10, P24, DOI 10.1038/sj.3301857; Radecke S, 2006, J GENE MED, V8, P217, DOI 10.1002/jgm.828; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rivera-Torres N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169350; Rivera-Torres N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096483; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Strouse B, 2014, SCI REP-UK, V4, DOI 10.1038/srep03791; WALDER RY, 1986, GENE, V42, P133, DOI 10.1016/0378-1119(86)90289-1                                                    ; Wang Z, 2008, OLIGONUCLEOTIDES, V18, P21, DOI 10.1089/oli.2007.0093; Yoon K, 1996, P NATL ACAD SCI USA, V93, P2071, DOI 10.1073/pnas.93.5.2071; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zorin B, 2005, EUKARYOT CELL, V4, P1264, DOI 10.1128/EC.4.7.1264-1272.2005	35	0	0	0	0	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	AUG	2017		126							e56195	10.3791/56195				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FM8VM	WOS:000415369500086					2018-01-05	
J	Zheng, F; Zhang, ZT; Flamini, V; Jiang, WG; Cui, YX				Zheng, Fei; Zhang, Zhongtao; Flamini, Valentina; Jiang, Wen G.; Cui, Yuxin			The Axis of CXCR4/SDF-1 Plays a Role in Colon Cancer Cell Adhesion Through Regulation of the AKT and IGF1R Signalling Pathways	ANTICANCER RESEARCH			English	Article; Proceedings Paper	China-United Kingdom Cancer (CUKC) Conference	APR 22-23, 2017	Beijing Friendship Hosp, Beijing, PEOPLES R CHINA	Capital Med Univ, Peking Univ, Cardiff Univ, Royal Soc Med	Beijing Friendship Hosp	Colorectal cancer; CXCR4; CRISPR/Cas9; knockdown; migration; invasion	CHEMOKINE RECEPTOR CXCR4; BREAST-CANCER; METASTASIS; ACTIVATION; EXPRESSION; PATTERNS; SURVIVAL; SYSTEMS	Background/Aim: Colorectal cancer (CRC) is the third most common cancer in the world. The high mortality of this tumor is mainly due to its invasive properties, as it forms metastases in multiple organs, preferentially in the liver. There has evidence showing that C-X-C chemokine receptor type 4 (CXCR-4) and its ligand, stromal cell-derived factor-1 (SDF-1), plays an important role in cancer progression and metastasis. However, the molecular mechanism underling the CRCR4-mediated CRC metastasis has not been well characterized. In this study, we aimed to investigate the roles of CXCR4 in colorectal cancer using the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9)-based genomic editing technique. Materials and Methods: We knocked-down CXCR4 using specific guide-RNA linked CRISPR/Cas9 in HT115 and COLO201 colon cancer cell lines which exhibited high levels of endogenous CXCR4 gene expression. Stable HT115 cells with CXCR4 knock-down were established by CRISPR plasmid transfection and validation was confirmed using T7 endonuclease 1 (T7EN1), flow cytometry (FACS) and western blotting assays. Results: Knock-down of CXCR4 did not decrease proliferation of HT115 cells, but decreased the adhesion potential of cells to the human umbilical vein endothelial cells (HUVEC) and extracellular matrix. We further demonstrated that the AKT and type 1 insulin-like growth factor receptor (IGF1R) signalling pathways may be involved in the alteration of adhesion in CRC cells when CXCR4 is knocked down. Conclusion: Our data suggest that CXCR4 plays a key role in colorectal cancer progression via the mediation of tumor cell adhesion.	[Zheng, Fei; Flamini, Valentina; Jiang, Wen G.; Cui, Yuxin] Cardiff Univ, Cardiff China Med Res Collaborat, Sch Med, Cardiff, S Glam, Wales; [Zheng, Fei; Zhang, Zhongtao] Capital Med Univ, Beijing Friendship Hosp, Beijing Key Lab Canc Invas & Metastasis Res, Dept Gen Surg, Beijing, Peoples R China; [Zheng, Fei; Zhang, Zhongtao] Capital Med Univ, Beijing Friendship Hosp, Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China	Jiang, WG; Cui, YX (reprint author), Cardiff Univ, Cardiff China Med Res Collaborat, Sch Med, Cardiff, S Glam, Wales.	jiangw@cardiff.ac.uk; cuiy7@cardiff.ac.uk					Akekawatchai C, 2005, J BIOL CHEM, V280, P39701, DOI 10.1074/jbc.M509829200; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crudden C, 2015, GROWTH HORM IGF RES, V25, P2, DOI 10.1016/j.ghir.2014.10.002; Delgado-Martin C, 2011, J BIOL CHEM, V286, P37222, DOI 10.1074/jbc.M111.294116; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Heckmann D, 2014, CLIN CANCER RES, V20, P604, DOI 10.1158/1078-0432.CCR-13-0582; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Hu Tinghua, 2013, J Biomed Res, V27, P283, DOI 10.7555/JBR.27.20130069; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Murakami T, 2013, INT J CANCER, V132, P276, DOI 10.1002/ijc.27670; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rubie C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-22; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Shen XM, 2010, PANCREAS, V39, P81, DOI 10.1097/MPA.0b013e3181bb2ab7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI [10.3322/caac.20138, 10.3322/caac.21153, 10.3322/caac.21149]; Sobolik T, 2014, MOL BIOL CELL, V25, P566, DOI 10.1091/mbc.E13-07-0360; Song ZY, 2015, BIOMED PHARMACOTHER, V71, P46, DOI 10.1016/j.biopha.2015.01.020; Vanamala J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-238; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yasumoto K, 2006, CANCER RES, V66, P2181, DOI 10.1158/0008-5472.CAN-05-3393; Yu T, 2011, MOL CANCER RES, V9, P161, DOI 10.1158/1541-7786.MCR-10-0386; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zhao HL, 2015, ONCOTARGET, V6, P5022, DOI 10.18632/oncotarget.3217                                                        	28	0	0	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	AUG	2017	37	8					4361	4369		10.21873/anticanres.11830				9	Oncology	Oncology	FJ2SF	WOS:000412579000048	28739729				2018-01-05	
J	Cui, YX; Wu, B; Flamini, V; Evans, BAJ; Zhou, D; Jiang, WG				Cui, Yuxin; Wu, Bo; Flamini, Valentina; Evans, Bronwen A. J.; Zhou, Deshan; Jiang, Wen G.			Knockdown of EPHA1 Using CRISPR/CAS9 Suppresses Aggressive Properties of Ovarian Cancer Cells	ANTICANCER RESEARCH			English	Article; Proceedings Paper	China-United Kingdom Cancer (CUKC) Conference	APR 22-23, 2017	Beijing Friendship Hosp, Beijing, PEOPLES R CHINA	Capital Med Univ, Peking Univ, Cardiff Univ, Royal Soc Med	Beijing Friendship Hosp	EPHA1; CRISPR; CAS9; ovarian carcinoma cells; adhesion; migration	RECEPTOR TYROSINE KINASES; EPHRIN LIGANDS; CARCINOMA CELLS; DOWN-REGULATION; EXPRESSION; GENE; ACTIVATION; SURVIVAL; TRANSCRIPTION; METASTASIS	Background/Aim: Overexpression of erythropoietin-producing hepatocellular A1 (EPHA1), a member of the EPH super family, is frequently observed in various cancer types. The dysregulated interaction of EPHA1 with its ligand Ephrin A1 has been linked to the progression of ovarian cancer (OC). However, the contribution of EPHA1 in the regulation of the aggressive properties of OC cells remains unknown. Materials and Methods: In this study we investigated the differential expression of EPHA1 in human OC cells. The EPHA1 gene was knocked-down using the CRISPR/Cas9 technique to evaluate its effect on the progressive properties of OC cells. Results: After EPHA1 was knocked-down using a CRISPR/CAS9 genomic editing system in OC cells (SKOV3 and COV504), we observed cell-cycle arrest at the G(0)/G(1) phases in both OC cell lines. Knockdown of EPHA1 in the two OC cells inhibited their aggressive traits, including proliferation, invasion and migration, as well as improving their attachment to extracellular matrix. EPHA1 may play a role in OC through its regulation of multiple signaling pathways, such as matrix metalloproteinase-2 (MMP2), extracellular signal-regulated kinase 2 (ERK2) and proto-oncogene c-MYC. Conclusion: EPHA1 may promote the aggression of some OC cells and, thus, be considered a potential therapeutic target for the treatment of malignant OC.	[Cui, Yuxin; Wu, Bo; Flamini, Valentina; Evans, Bronwen A. J.; Jiang, Wen G.] Cardiff Univ, Cardiff China Med Res Collaborat, Sch Med, Henry Wellcome Bldg,Heath Park, Cardiff CF14 4XN, S Glam, Wales; [Wu, Bo; Zhou, Deshan] Capital Med Univ, Key Lab Canc Metastasis Beijing, Inst Canc, Dept Histol & Embryolog, Beijing, Peoples R China; [Evans, Bronwen A. J.] Cardiff Univ, Inst Mol & Expt Med, Sch Med, Cardiff, S Glam, Wales	Jiang, WG (reprint author), Cardiff Univ, Cardiff China Med Res Collaborat, Sch Med, Henry Wellcome Bldg,Heath Park, Cardiff CF14 4XN, S Glam, Wales.	jiangw@cf.ac.uk			CCMRC; Cancer Research Wales	The Authors thank the support from CCMRC and Cancer Research Wales. They also thank Fiona Ruge for her technical assistance.	Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chen G, 2010, ONCOL REP, V23, P563, DOI 10.3892/or_00000670; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dong YC, 2009, MODERN PATHOL, V22, P151, DOI 10.1038/modpathol.2008.188; El Bairi K, 2017, CELL ONCOL, V40, P105, DOI 10.1007/s13402-016-0309-1; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Giaginis C, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-8; Giaginis C, 2010, PATHOL ONCOL RES, V16, P267, DOI 10.1007/s12253-009-9221-6; Gucciardo E, 2014, CELL MOL LIFE SCI, V71, P3685, DOI 10.1007/s00018-014-1633-0; Hafner C, 2006, MODERN PATHOL, V19, P1369, DOI 10.1038/modpathol.3800660; Herath NI, 2009, BRIT J CANCER, V100, P1095, DOI 10.1038/sj.bjc.6604970; Herath NI, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-144; Herath NI, 2012, EUR J CANCER, V48, P753, DOI 10.1016/j.ejca.2011.07.003; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S                         ; Jiang WG, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-269; Jung M, 2017, CANCER RES, V77, P971, DOI 10.1158/0008-5472.CAN-15-2906; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Peng LB, 2013, INT J CLIN EXP PATHO, V6, P1854; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schuler S, 2013, ARCH GYNECOL OBSTET, V287, P1187, DOI 10.1007/s00404-013-2784-1; Shiuan E, 2016, CANCER RES, V76, P6452, DOI 10.1158/0008-5472.CAN-16-1521; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332; Toma MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102262; Wang JD, 2010, ONCOL REP, V24, P1577, DOI 10.3892/or_00001020; Wei Q, 2014, ACTA CRYSTALLOGR D, V70, P3135, DOI 10.1107/S1399004714021944; White BEP, 2014, CELL ADHES MIGR, V8, P327, DOI 10.4161/19336918.2014.970012; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Wu B, 2016, ANTICANCER RES, V36, P1211; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yamazaki T, 2009, J CELL SCI, V122, P243, DOI 10.1242/jcs.036467	35	0	0	2	2	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	AUG	2017	37	8					4415	4424		10.21873/anticanres.11836				10	Oncology	Oncology	FJ2SF	WOS:000412579000054	28739735				2018-01-05	
J	Sloan, DB				Sloan, Daniel B.			Nuclear and mitochondrial RNA editing systems have opposite effects on protein diversity	BIOLOGY LETTERS			English	Article						A-to-I RNA editing; ADAR; amino acid substitutions; constructive neutral evolution; proteome diversity	EVOLUTION; GENES	RNA editing can yield protein products that differ from those directly encoded by genomic DNA. This process is pervasive in the mitochondria of many eukaryotes, where it predominantly results in the restoration of ancestral protein sequences. Nuclear mRNAs in metazoans also undergo editing (adenosine-to-inosine or 'A-to-I' substitutions), and most of these edits appear to be nonadaptive 'misfirings' of adenosine deaminases. However, recent analysis of cephalopod transcriptomes found that many editing sites are shared by anciently divergent lineages within this group, suggesting they play some adaptive role. Recent discoveries have also revealed that some fungi have an independently evolved A-to-I editing mechanism, resulting in extensive recoding of their nuclear mRNAs. Here, phylogenetic comparisons were used to determine whether RNA editing generally restores ancestral protein sequences or creates derived variants. Unlike in mitochondrial systems, RNA editing in metazoan and fungal nuclear transcripts overwhelmingly leads to novel sequences not found in inferred ancestral proteins. Even for the subset of RNA editing sites shared by deeply divergent cephalopod lineages, the primary effect of nuclear editing is an increase-not a decrease-in protein divergence. These findings suggest fundamental differences in the forces responsible for the evolution of RNA editing in nuclear versus mitochondrial systems.	[Sloan, Daniel B.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Sloan, DB (reprint author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	dbsloan@rams.colostate.edu		Sloan, Daniel/0000-0002-3618-0897	Colorado State University; National Science Foundation [MCB-1412260]	This work was supported by Colorado State University and the National Science Foundation (MCB-1412260).	Alon S, 2015, ELIFE, V4, DOI 10.7554/eLife.05198; Burger G, 2016, TRENDS GENET, V32, P553, DOI 10.1016/j.tig.2016.06.005; Chateigner-Boutin AL, 2010, RNA BIOL, V7, P213, DOI 10.4161/rna.7.2.11343                                                           ; Chen L, 2013, P NATL ACAD SCI USA, V110, pE2741, DOI 10.1073/pnas.1218884110; COVELLO PS, 1993, TRENDS GENET, V9, P265, DOI 10.1016/0168-9525(93)90011-6                                                    ; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; Lavrov DV, 2016, CURR BIOL, V26, P86, DOI 10.1016/j.cub.2015.11.043; Liscovitch-Brauer N, 2017, CELL, V169, P191, DOI 10.1016/j.cell.2017.03.025; Liu HQ, 2016, GENOME RES, V26, P499, DOI 10.1101/gr.199877.115; Lukes J, 2011, IUBMB LIFE, V63, P528, DOI 10.1002/iub.489; Mower JP, 2008, MOL BIOL EVOL, V25, P52, DOI 10.1093/molbev/msm226; Mower JP, 2009, NUCLEIC ACIDS RES, V37, pW253, DOI 10.1093/nar/gkp337; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Pinto Y, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r5; Rudinger M, 2011, RNA, V17, P2058, DOI 10.1261/rna.02962911; Sloan DB, 2016, CURR BIOL, V26, pR22, DOI 10.1016/j.cub.2015.11.009; Teichert I, 2017, GENOME BIOL EVOL, V9, P855, DOI 10.1093/gbe/evx052; Xu GX, 2014, P NATL ACAD SCI USA, V111, P3769, DOI 10.1073/pnas.1321745111; Yu Y, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006191	20	0	0	5	5	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	1744-9561	1744-957X		BIOL LETTERS	Biol. Lett.	AUG 1	2017	13	8							20170314	10.1098/rsbl.2017.0314				5	Biology; Ecology; Evolutionary Biology	Life Sciences & Biomedicine - Other Topics; Environmental Sciences & Ecology; Evolutionary Biology	FI7FR	WOS:000412162800011					2018-01-05	
J	Wichman, L; Somasundaram, S; Breindel, C; Valerio, DM; McCarrey, JR; Hodges, CA; Khalil, AM				Wichman, Lauren; Somasundaram, Saigopal; Breindel, Christine; Valerio, Dana M.; McCarrey, John R.; Hodges, Craig A.; Khalil, Ahmad M.			Dynamic expression of long noncoding RNAs reveals their potential roles in spermatogenesis and fertility	BIOLOGY OF REPRODUCTION			English	Article						meiosis; spermatogenesis; epigenetics; lncRNAs; CRISPR/Cas9	SEX-CHROMOSOME INACTIVATION; GENE-EXPRESSION; X-INACTIVATION; CELL-CYCLE; MOUSE; TRANSCRIPTOME; PROMOTER; MEIOSIS; MAMMALS; ESCAPE	Mammalian reproduction requires that males and females produce functional haploid germ cells through complex cellular differentiation processes known as spermatogenesis and oogenesis, respectively. While numerous studies have functionally characterized protein-coding genes and small noncoding RNAs (microRNAs and piRNAs) that are essential for gametogenesis, the roles of regulatory long noncoding RNAs (lncRNAs) are yet to be fully characterized. Previously, we and others have demonstrated that intergenic regions of the mammalian genome encode thousands of long noncoding RNAs, and many studies have now demonstrated their critical roles in key biological processes. Thus, we postulated that some lncRNAs may also impact mammalian spermatogenesis and fertility. In this study, we identified a dynamic expression pattern of lncRNAs during murine spermatogenesis. Importantly, we identified a subset of lncRNAs and very few mR-NAs that appear to escape meiotic sex chromosome inactivation, an epigenetic process that leads to the silencing of the X-and Y-chromosomes at the pachytene stage of meiosis. Further, some of these lncRNAs and mRNAs show a strong testis expression pattern suggesting that they may play key roles in spermatogenesis. Lastly, we generated a mouse knockout of one X-linked IncRNA, Tslrn1 (testis-specific long noncoding RNA 1), and found that males carrying a Tslrn1 deletion displayed normal fertility but a significant reduction in spermatozoa. Our findings demonstrate that dysregulation of specific mammalian lncRNAs is a novel mechanism of low sperm count or infertility, thus potentially providing new biomarkers and therapeutic strategies. Summary Sentence Long non-coding RNAs are critical for mammalian spermatogenesis.	[Wichman, Lauren; Somasundaram, Saigopal; Breindel, Christine; Valerio, Dana M.; Hodges, Craig A.; Khalil, Ahmad M.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [McCarrey, John R.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Khalil, Ahmad M.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Khalil, Ahmad M.] Case Western Reserve Univ, Case Ctr Multimodal Evaluat Engn Cartilage, Cleveland, OH 44106 USA	Hodges, CA; Khalil, AM (reprint author), Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.	craig.hodges@case.edu; Dr.Ahmad.Khalil@gmail.com			March of Dimes grant [1-FY14-234]; Clinical and Translational Science Collaborative of Cleveland from the National Center for Advancing Translational Sciences (NCATS) [UL1TR000439]	Funding for the work was supported by March of Dimes grant #1-FY14-234 (AMK and JRM), and the Clinical and Translational Science Collaborative of Cleveland, UL1TR000439 from the National Center for Advancing Translational Sciences (NCATS) (Awarded to AMK).	Bao JQ, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.113308; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Choudhury DR, 2010, BIOL REPROD, V83, P663, DOI 10.1095/biolreprod.110.084889; Ding DQ, 2012, SCIENCE, V336, P732, DOI 10.1126/science.1219518; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; HOTTA Y, 1995, ADV BIOPHYS, V31, P101, DOI 10.1016/0065-227X(95)99386-4                                                    ; Hoyer-Fender S, 2003, CYTOGENET GENOME RES, V103, P245, DOI 10.1159/000076810; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khalil AM, 2007, EPIGENETICS-US, V2, P114, DOI 10.4161/epi.2.2.4612                                                            ; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Khalil AM, 2004, P NATL ACAD SCI USA, V101, P16583, DOI 10.1073/pnas.0406325101; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Kurihara M, 2014, J MOL BIOL, V426, P3069, DOI 10.1016/j.jmb.2014.06.018; Lesch BJ, 2012, NAT REV GENET, V13, P781, DOI 10.1038/nrg3294; Lin XW, 2016, RNA BIOL, V13, P1011, DOI 10.1080/15476286.2016.1218588; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCCARREY JR, 1992, NAT GENET, V2, P200, DOI 10.1038/ng1192-200; MCCARREY JR, 1992, DEV BIOL, V154, P160, DOI 10.1016/0012-1606(92)90056-M; Merry CR, 2016, ONCOTARGET, V7, P53230, DOI 10.18632/oncotarget.10637; Merry CR, 2015, BREAST CANCER RES TR, V150, P321, DOI 10.1007/s10549-015-3327-1; Penkner AM, 2005, CELL, V120, P789, DOI 10.1016/j.cell.2005.01.017; Ran ML, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136911; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Sosa E, 2015, DEVELOPMENT, V142, P3791, DOI 10.1242/dev.127191; van Dijk M, 2012, J CLIN INVEST, V122, P4003, DOI 10.1172/JCI65171; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wen KJ, 2016, GENOME RES, V26, P1233, DOI 10.1101/gr.199547.115; Yoneda R, 2016, MOL REPROD DEV, V83, P541, DOI 10.1002/mrd.22650; Zhou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092828	37	0	0	4	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	AUG	2017	97	2					313	323		10.1093/biolre/iox084				11	Reproductive Biology	Reproductive Biology	FJ8HM	WOS:000413005500014	29044429				2018-01-05	
J	Zhang, W; Ben-David, M; Sidhu, SS				Zhang, Wei; Ben-David, Moshe; Sidhu, Sachdev S.			Engineering cell signaling modulators from native protein-protein interactions	CURRENT OPINION IN STRUCTURAL BIOLOGY			English	Article							SMALL-MOLECULE INHIBITORS; DNA-DAMAGE RESPONSE; UBIQUITIN LIGASES; COMPUTATIONAL DESIGN; CRYSTAL-STRUCTURE; IN-VIVO; CANCER; BINDING; ANTIBODIES; DOMAINS	Recent studies on genome sequencing and genetic screens with RNAi and CRISPR technology have revolutionized our understanding of aberrant signaling networks in human diseases. A strategy combining both genetic and protein based technologies should be at the heart of modern drug development efforts, particularly in the era of precision medicine. Thus, there is an urgent need for efficient platforms to develop probes that can modulate protein function in cells to validate drug targets and to develop therapeutic leads. Advanced protein engineering has enabled the rapid production of monoclonal antibodies and small protein scaffold affinity reagents for diverse protein targets. Here, we review the most recent progress on engineering natural protein-protein interactions for modulation of cell signaling.	[Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, 160 Coll St, Toronto, ON M5S 3E1, Canada; Univ Toronto, Dept Mol Genet, 160 Coll St, Toronto, ON M5S 3E1, Canada	Sidhu, SS (reprint author), Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, 160 Coll St, Toronto, ON M5S 3E1, Canada.	sachdev.sidhu@utoronto.ca			Canadian Institutes of Health Research (CIHR); Mitacs Elevate program; CIHR (MOP) [136956]	We thank members of the Sidhu group for helpful discussions and Dr. Alexander Weiss for design of the graphical abstract. We apologize to the research groups whose work was not mentioned in this review due to space limitations. W.Z. is supported by fellowships from Canadian Institutes of Health Research (CIHR) and the Mitacs Elevate program. S.S.S. is supported by CIHR operating grant (MOP#136956).	Adams JJ, 2014, CURR OPIN STRUC BIOL, V24, P1, DOI 10.1016/j.sbi.2013.11.003; Adams JJ, 2014, METHODS MOL BIOL, V1060, P149, DOI 10.1007/978-1-62703-586-6_9; Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Auger A, 2015, MOL PHARMACEUT, V12, P2962, DOI 10.1021/acs.molpharmaceut.5b00233; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Bian YY, 2016, NAT CHEM BIOL, V12, P959, DOI [10.1038/NCHEMBIO.2178, 10.1038/nchembio.2178]; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Brown NG, 2016, CELL, V165, P1440, DOI 10.1016/j.cell.2016.05.037; Carpenter B, 2016, NATURE; D'Astolfo DS, 2015, CELL, V161, P674, DOI 10.1016/j.cell.2015.03.028; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161; Findlay GM, 2013, CELL, V152, P1008, DOI 10.1016/j.cell.2013.01.056; Gaj T, 2014, ACS CHEM BIOL, V9, P1662, DOI 10.1021/cb500282g; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Gorelik M, 2016, P NATL ACAD SCI USA, V113, P3527, DOI 10.1073/pnas.1519389113; GroSS Andrea, 2015, Front Bioeng Biotechnol, V3, P211, DOI 10.3389/fbioe.2015.00211; Guven-Maiorov E, 2014, CANCERS, V6, P663, DOI 10.3390/cancers6020663; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hendrickson WA, 2016, NAT STRUCT MOL BIOL, V23, P464, DOI 10.1038/nsmb.3215; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Ho CCM, 2015, J BIOL CHEM, V290, P12650, DOI 10.1074/jbc.M115.648220; Hojjat-Farsangi M, 2014, INT J MOL SCI, V15, P13768, DOI 10.3390/ijms150813768; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Junttila IS, 2012, NAT CHEM BIOL, V8, P990, DOI [10.1038/NCHEMBIO.1096, 10.1038/nchembio.1096]; Kaneko T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003021; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010; Kariolis MS, 2014, NAT CHEM BIOL, V10, P977, DOI [10.1038/NCHEMBIO.1636, 10.1038/nchembio.1636]; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259                                                ; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199                                                          ; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Leung I, 2016, P NATL ACAD SCI US; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Marcotte R, 2016, CELL, V164, P293, DOI 10.1016/j.cell.2015.11.062; Mari S, 2014, STRUCTURE, V22, P1639, DOI 10.1016/j.str.2014.09.006; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Michielssens S, 2014, ANGEW CHEM INT EDIT, V53, P10367, DOI 10.1002/anie.201403102; Miersch S, 2012, METHODS, V57, P486, DOI 10.1016/j.ymeth.2012.06.012; Mund T, 2014, P NATL ACAD SCI USA, V111, P16736, DOI 10.1073/pnas.1412152111; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; OTVOS L, 2014, FRONT CHEM, V2; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8                                                   ; Phillips AH, 2013, P NATL ACAD SCI USA, V110, P11379, DOI 10.1073/pnas.1302407110; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Rosenfeld L, 2016, TRENDS BIOCHEM SCI, V41, P421, DOI 10.1016/j.tibs.2016.03.002; Schreiber G, 2013, CURR OPIN STRUC BIOL, V23, P903, DOI 10.1016/j.sbi.2013.08.003; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004; Sidhu SS, 2012, FEBS LETT, V586, P2778, DOI 10.1016/j.febslet.2012.05.044; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1                                                   ; Sockolosky JT, 2016, P NATL ACAD SCI USA, V113, pE2646, DOI 10.1073/pnas.1604268113; Spangler JB, 2015, ANNU REV IMMUNOL, V33, P139, DOI 10.1146/annurev-immunol-032713-120211; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Uppalapati M, 2016, ACS CHEM BIOL, V11, P1058, DOI 10.1021/acschembio.5b01006; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Vazquez-Lombardi R, 2015, DRUG DISCOV TODAY, V20, P1271, DOI 10.1016/j.drudis.2015.09.004; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0                                                                ; Weiskopf K, 2016, J CLIN INVEST, V126, P2610, DOI 10.1172/JCI81603; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wu XL, 2014, ONCOTARGET, V5, P9546, DOI 10.18632/oncotarget.2542                                                        ; Wurch T, 2012, TRENDS BIOTECHNOL, V30, P575, DOI 10.1016/j.tibtech.2012.07.006; Ye X, 2010, ONCOGENE, V29, P5254, DOI 10.1038/onc.2010.268; Zhang W, 2016, MOL CELL, V62, P121, DOI 10.1016/j.molcel.2016.02.005; Zhang W, 2014, FEBS LETT, V588, P356, DOI 10.1016/j.febslet.2013.11.003; Zhang YN, 2013, NAT CHEM BIOL, V9, P51, DOI [10.1038/NCHEMBIO.1134, 10.1038/nchembio.1134]; Zhang Y, 2015, J AM CHEM SOC, V137, P38, DOI 10.1021/ja510519u	72	2	2	1	1	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0959-440X	1879-033X		CURR OPIN STRUC BIOL	Curr. Opin. Struct. Biol.	AUG	2017	45						25	35		10.1016/j.sbi.2016.11.002				11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FK0NE	WOS:000413175700006	27866084				2018-01-05	
J	Koonin, EV; Krupovic, M				Koonin, Eugene V.; Krupovic, Mart			Polintons, virophages and transpovirons: a tangled web linking viruses, transposons and immunity	CURRENT OPINION IN VIROLOGY			English	Article							PROGRAMMED CELL-DEATH; GIANT VIRUSES; SATELLITE VIRUSES; EVOLUTION; ELEMENTS; SYSTEMS; GENOME; PROVIROPHAGES; EUKARYOTES; WIDESPREAD	Virophages are satellite DNA viruses that depend for their replication on giant viruses of the family Mimiviridae. An evolutionary relationship exists between the virophages and Polintons, large self-synthesizing transposons that are wide spread in the genomes of diverse eukaryotes. Most of the Polintons encode homologs of major and minor icosahedral virus capsid proteins and accordingly are predicted to form virions. Additionally, metagenome analysis has led to the discovery of an expansive family of Polinton-like viruses (PLV) that are more distantly related to bona fide Polintons and virophages. Another group of giant virus parasites includes small, linear, double stranded DNA elements called transpovirons. Recent in-depth comparative genomic analysis has yielded evidence of the origin of the PLV and the transpovirons from Polintons. Integration of virophage genomes into genomes of both giant viruses and protists has been demonstrated. Furthermore, in an experimental coinfection system that consisted of a protist host, a giant virus and an associated virophage, the virophage integrated into the host genome and, after activation of its expression by a superinfecting giant virus, served as an agent of adaptive immunity. There is a striking analogy between this mechanism and the CRISPR-Cas system of prokaryotic adaptive immunity. Taken together, these findings show that Polintons, PLV, virophages and transpovirons form a dynamic network of integrating mobile genetic elements that contribute to the cellular antivirus defense and host virus coevolution.	[Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Krupovic, Mart] Inst Pasteur, Dept Microbiol, Unite Biol Mol Gene Chez Extremophile, Paris, France	Koonin, EV (reprint author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA.; Krupovic, M (reprint author), Inst Pasteur, Dept Microbiol, Unite Biol Mol Gene Chez Extremophile, Paris, France.	koonin@ncbi.nlm.nih.gov; krupovic@pasteur.fr		Krupovic, Mart/0000-0001-5486-0098	US Department of Health and Human Services	EVK is supported by intramural funds of the US Department of Health and Human Services (to the National Library of Medicine).	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Bekliz M, 2016, VIRUSES, V8, pE317; Bidle KD, 2016, CURR BIOL, V26, pR594, DOI 10.1016/j.cub.2016.05.056; Blanc G, 2015, P NATL ACAD SCI USA, V112, pE5318, DOI 10.1073/pnas.1506469112; Campos RK, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-95; Desnues C, 2012, P NATL ACAD SCI USA, V109, P18078, DOI 10.1073/pnas.1208835109; Desnues C, 2012, ADV VIRUS RES, V82, P63, DOI 10.1016/B978-0-12-394621-8.00013-3; Durand PM, 2016, CURR BIOL, V26, pR587, DOI 10.1016/j.cub.2016.05.057; Durand PM, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1088; Fischer MG, 2016, NATURE, V540, P288, DOI 10.1038/nature20593; Fischer MG, 2015, P NATL ACAD SCI USA, V112, P11750, DOI 10.1073/pnas.1515142112; Fischer MG, 2011, SCIENCE, V332, P231, DOI 10.1126/science.1199412; Gaia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061912; Gladyshev EA, 2011, P NATL ACAD SCI USA, V108, P20311, DOI 10.1073/pnas.1100266108; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Haapa-Paananen S, 2014, MOL PHYLOGENET EVOL, V78, P271, DOI 10.1016/j.ympev.2014.05.024; Hynes AP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5399; Iranzo J, 2016, MBIO, V7, DOI 10.1128/mBio.00978-16; Jurka J, 2007, ANNU REV GENOM HUM G, V8, P241, DOI 10.1146/annurev.genom.8.080706.092416; Kapitonov VV, 2006, P NATL ACAD SCI USA, V103, P4540, DOI 10.1073/pnas.0600833103; Katzourakis A, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0051-y; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670                                                         ; Koonin Eugene V, 2017, Bioessays, V39, P1, DOI 10.1002/bies.201600186; Koonin EV, 2016, NATURE, V540, P204, DOI 10.1038/540204a; Koonin EV, 2015, VIROLOGY, V479, P2, DOI 10.1016/j.virol.2015.02.039; Koonin EV, 2015, NAT REV GENET, V16, P184, DOI 10.1038/nrg3859; Koonin EV, 2015, SCIENTIST, V29, P46; Koonin EV, 2014, MICROBIOL MOL BIOL R, V78, P278, DOI 10.1128/MMBR.00049-13; Krupovic M, 2017, J VIROL, V91, DOI 10.1128/JVI.00210-17; Krupovic M, 2017, CURR OPIN MICROBIOL, V38, P36, DOI 10.1016/j.mib.2017.04.004; Krupovic M, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew019; Krupovic M, 2016, CURR OPIN MICROBIOL, V31, P25, DOI 10.1016/j.mib.2016.01.006; Krupovic M, 2016, ARCH VIROL, V161, P233, DOI 10.1007/s00705-015-2622-9; Krupovic M, 2015, NAT REV MICROBIOL, V13, P105, DOI 10.1038/nrmicro3389; Krupovic M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-36; Krupovic M, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-6; Krupovic M, 2011, NAT REV MICROBIOL, V9, P762, DOI 10.1038/nrmicro2676; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Makarova KS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-7; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Nee S, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160235; Pagarete A, 2015, VIRUSES-BASEL, V7, P3937, DOI 10.3390/v7072806; Palukaitis P, 2016, MOL PLANT MICROBE IN, V29, P181, DOI 10.1094/MPMI-10-15-0232-FI; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Stepanova O.A., 2005, DOKL AKAD NAUK+, V1, P158; Taylor BP, 2014, J THEOR BIOL, V354, P124, DOI 10.1016/j.jtbi.2014.03.008; Villain A, 2016, CURR OPIN VIROL, V17, P130, DOI 10.1016/j.coviro.2016.03.007; Wodarz D, 2013, ECOL EVOL, V3, P2103, DOI 10.1002/ece3.600; Wuitschick JD, 2002, NUCLEIC ACIDS RES, V30, P2524, DOI 10.1093/nar/30.11.2524                                                          ; Yutin N, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0207-4; Yutin N, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0054-9; Yutin N, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-158; Zhang XZ, 2012, P NATL ACAD SCI USA, V109, P18431, DOI 10.1073/pnas.1211702109; Zhou JL, 2015, J VIROL, V89, P1278, DOI 10.1128/JVI.03039-14; Zhou JL, 2013, J VIROL, V87, P4225, DOI 10.1128/JVI.03398-12; Ziebell H, 2010, ADV VIRUS RES, V76, P211, DOI 10.1016/S0065-3527(10)76006-1	60	0	0	8	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1879-6257			CURR OPIN VIROL	Curr. Opin. Virol.	AUG	2017	25						7	15		10.1016/j.coviro.2017.06.008				9	Virology	Virology	FJ6KF	WOS:000412866000004	28672161				2018-01-05	
J	Stovicek, V; Holkenbrink, C; Borodina, I				Stovicek, Vratislav; Holkenbrink, Carina; Borodina, Irina			CRISPR/Cas system for yeast genome engineering: advances and applications	FEMS YEAST RESEARCH			English	Review						CRISPR/Cas; CRISPR interference; genome editing; yeasts; CRISPR transcriptional regulation; Saccharomyces cerevisiae	GUIDE RNA DESIGN; SACCHAROMYCES-CEREVISIAE; YARROWIA-LIPOLYTICA; CRISPR-CAS9 SYSTEM; CHROMOSOMAL INTEGRATION; GENE-EXPRESSION; FISSION YEAST; CAS SYSTEMS; TOOL; STRAINS	The methods based on the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) system have quickly gained popularity for genome editing and transcriptional regulation in many organisms, including yeast. This review aims to provide a comprehensive overview of CRISPR application for different yeast species: from basic principles and genetic design to applications.	[Stovicek, Vratislav; Holkenbrink, Carina; Borodina, Irina] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Kemitorvet 220, DK-2800 Lyngby, Denmark	Borodina, I (reprint author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Kemitorvet 220, DK-2800 Lyngby, Denmark.	irbo@biosustain.dtu.dk			Novo Nordisk Foundation [16592]; European Union the 7th Framework Programme [BioREFINE-2G] [FP7-613771]	The work was financially supported by the Novo Nordisk Foundation [grant no. 16592] and by the European Union the 7th Framework Programme [BioREFINE-2G, grant no. FP7-613771].	Alexander WG, 2014, GENETICS, V198, P859, DOI 10.1534/genetics.114.170118; Apel A Reider, 2016, NUCLEIC ACIDS RES; Arras SDM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164322; Bao ZH, 2015, ACS SYNTH BIOL, V4, P585, DOI 10.1021/sb500255k; Blin K., 2016, SYNTH SYST BIOTECHNO, V1, P118, DOI 10.1016/j.synbio.2016.01.003; Borodina I, 2014, BIOTECHNOL J, V9, P609, DOI 10.1002/biot.201300445; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Cai LQ, 2016, GENES DIS, V3, P244, DOI 10.1016/j.gendis.2016.07.003; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chin YW, 2016, J IND MICROBIOL BIOT, V43, P1517, DOI 10.1007/s10295-016-1831-x; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deaner M, 2017, METAB ENG, V40, P14, DOI 10.1016/j.ymben.2017.01.012; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Enkler L, 2016, SCI REP-UK, V6, DOI 10.1038/srep35766; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Fernandez R, 2016, YEAST, V33, P549, DOI 10.1002/yea.3178; Gao SL, 2016, J IND MICROBIOL BIOT, V43, P1085, DOI 10.1007/s10295-016-1789-8; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Garst AD, 2017, NAT BIOTECHNOL, V35, P48, DOI 10.1038/nbt.3718; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Generoso WC, 2016, J MICROBIOL METH, V127, P203, DOI 10.1016/j.mimet.2016.06.020; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hoffman CS, 2015, GENETICS, V201, P403, DOI 10.1534/genetics.115.181503; Horwitz AA, 2015, CELL SYST, V1, P88, DOI 10.1016/j.cels.2015.02.001; Jacobs JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6344; Jakociunas T, 2016, METAB ENG, V34, P44, DOI 10.1016/j.ymben.2015.12.003; Jakociunas T, 2015, ACS SYNTH BIOL, V4, P1226, DOI 10.1021/acssynbio.5b00007; Jakounas T, 2015, METAB ENG, V28, P213, DOI [10.1016/j.ymbn.2015.01.008, 10.1016/j.ymben.2015.01.008]; Jensen NB, 2014, FEMS YEAST RES, V14, P238, DOI 10.1111/1567-1364.12118; Jessop-Fabre MM, 2016, BIOTECHNOL J, V11, P1110, DOI 10.1002/biot.201600147; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lander ES, 2016, CELL, V164, P18, DOI 10.1016/j.cell.2015.12.041; Laughery MF, 2015, YEAST, V32, P711, DOI 10.1002/yea.3098; Le Borgne S, 2012, METHODS MOL BIOL, V824, P451, DOI 10.1007/978-1-61779-433-9_24; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Li MJ, 2015, FEMS YEAST RES, V15, DOI 10.1111/1567-1364.12213; Liu HL, 2015, BIOINFORMATICS, V31, P3676, DOI 10.1093/bioinformatics/btv423; Liu Z, 2017, ACS SYNTH BIOL, DOI [10.1021/ac-ssynbio.6b00331, DOI 10.1021/AC-SSYNBIO.6B00331]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mans R, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov004; Min K, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00130-16; Mohr SE, 2016, FEBS J, V283, P3232, DOI 10.1111/febs.13777; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nishida K, 2016, SCIENCE; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ronda C, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0288-3; Ronda C, 2014, BIOTECHNOL BIOENG, V111, P1604, DOI 10.1002/bit.25233; Ryan OW, 2016, COLD SPRING HARB PRO; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Ryan OW, 2014, METHOD ENZYMOL, V546, P473, DOI 10.1016/B978-0-12-801185-0.00023-4; Schwartz C, 2016, ACS SYNTH BIOL, DOI [10.1021/acssyn-bio.6b00285, DOI 10.1021/ACSSYN-BIO.6B00285]; Schwartz CM, 2016, ACS SYNTH BIOL, V5, P356, DOI 10.1021/acssynbio.5b00162; Shi SB, 2016, METAB ENG, V33, P19, DOI 10.1016/j.ymben.2015.10.011; Smith JD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0900-9; Spohner SC, 2016, J BIOTECHNOL, V222, P104, DOI 10.1016/j.jbiotec.2016.02.023; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Stovicek Vratislav, 2015, Metabolic Engineering Communications, V2, P13, DOI 10.1016/j.meteno.2015.03.001; Stovicek V, 2015, J IND MICROBIOL BIOT, V42, P1519, DOI 10.1007/s10295-015-1684-8; Thevenieau F, 2009, YEAST BIOTECHNOLOGY, P589; Tsai CS, 2015, BIOTECHNOL BIOENG, V112, P2406, DOI 10.1002/bit.25632; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; van Erp PBG, 2015, CURR OPIN VIROL, V12, P85, DOI 10.1016/j.coviro.2015.03.011; Vanegas KG, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0632-x; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; Walter JM, 2016, J CELL PHYSIOL, V231, P2563, DOI 10.1002/jcp.25375; Wang Q, 2008, J AM CHEM SOC, V130, P6066, DOI 10.1021/ja800894n; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep31145; Weninger A, 2016, J BIOTECHNOL, V235, P139, DOI 10.1016/j.jbiotec.2016.03.027; Xu K, 2015, CELL MOL LIFE SCI, V72, P383, DOI 10.1007/s00018-014-1679-z; Xue ZX, 2013, NAT BIOTECHNOL, V31, P734, DOI 10.1038/nbt.2622; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhang GC, 2014, APPL ENVIRON MICROB, V80, P7694, DOI 10.1128/AEM.02310-14	78	1	1	27	27	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1567-1356	1567-1364		FEMS YEAST RES	FEMS Yeast Res.	AUG	2017	17	5							fox030	10.1093/femsyr/fox030				16	Biotechnology & Applied Microbiology; Microbiology; Mycology	Biotechnology & Applied Microbiology; Microbiology; Mycology	FJ5XY	WOS:000412828300002					2018-01-05	
J	Sato, R; Shibata, T; Tanaka, Y; Kato, C; Yamaguchi, K; Furukawa, Y; Shimizu, E; Yamaguchi, R; Imoto, S; Miyano, S; Miyake, K				Sato, Ryota; Shibata, Takuma; Tanaka, Yu; Kato, Chiharu; Yamaguchi, Kiyoshi; Furukawa, Yoichi; Shimizu, Eigo; Yamaguchi, Rui; Imoto, Seiya; Miyano, Satoru; Miyake, Kensuke			Requirement of glycosylation machinery in TLR responses revealed by CRISPR/Cas9 screening	INTERNATIONAL IMMUNOLOGY			English	Article						CRISPR/Cas9; glycosylation; library screening; TLR	TOLL-LIKE RECEPTORS; ENDOPLASMIC-RETICULUM; DENDRITIC CELLS; INNATE IMMUNITY; UNC93B1; TOLL-LIKE-RECEPTOR-9; EXPRESSION; ALPHA; TRAF3	The Toll family of receptors sense microbial products and activate a defense response. The molecular machinery required for the TLR response is not yet fully understood. In the present study, we used a clustered, regularly interspaced, short palindromic repeats (CRISPR)/CAS9 screening system to study TLR responses. We employed a cell line expressing TLR with an NF-kappa B-driven GFP reporter. The cell line was transduced with a guide RNA (gRNA) library and stimulated with TLR ligands. The cells impaired in GFP induction were sorted, and gRNAs were sequenced. Identified genes were ranked according to the count of sequence reads and the number of gRNA target sites. The screening system worked correctly, as molecules that were already known to be required for the TLR response were identified by the screening. Furthermore, this system revealed that the oligosaccharide transferase complex (OSTC) mediating co-translational glycosylation was required for TLR5, 7 and 9 responses. Protein expression of TLR5, but not an irrelevant molecule (CD44), was abolished by the lack of OSTC, suggesting the essential role of glycosylation in TLR5 protein stability. These results demonstrate that the screening system established here is able to reveal molecular mechanisms underlying the TLR response.	[Sato, Ryota; Shibata, Takuma; Tanaka, Yu; Kato, Chiharu; Miyake, Kensuke] Univ Tokyo, Div Innate Immun, Dept Microbiol & Immunol, Minato Ku, Tokyo 1088639, Japan; [Yamaguchi, Kiyoshi; Furukawa, Yoichi] Univ Tokyo, Div Clin Genome Res, Adv Clin Res Ctr, Minato Ku, Tokyo 1088639, Japan; [Shimizu, Eigo; Yamaguchi, Rui; Miyano, Satoru] Univ Tokyo, Lab DNA Informat Anal, Human Genome Ctr, Minato Ku, Tokyo 1088639, Japan; [Imoto, Seiya] Univ Tokyo, Div Hlth Med Data Sci, Human Intelligence Ctr, Minato Ku, Tokyo 1088639, Japan; [Miyake, Kensuke] Univ Tokyo, Lab Innate Immun, Ctr Expt Med & Syst Biol, Inst Med Sci,Minato ku, Tokyo 1088639, Japan	Miyake, K (reprint author), Univ Tokyo, Div Innate Immun, Dept Microbiol & Immunol, Minato Ku, Tokyo 1088639, Japan.; Miyake, K (reprint author), Univ Tokyo, Lab Innate Immun, Ctr Expt Med & Syst Biol, Inst Med Sci,Minato ku, Tokyo 1088639, Japan.	kmiyake@ims.u-tokyo.ac.jp			CREST, JST; Grant for Joint Research Project of the Institute of Medical Science at the University of Tokyo;  [16H06388];  [16K08827]	This work was partially supported by a Grant-in-Aid for Scientific Research (S) (16H06388) and (C) (16K08827); CREST, JST and a Grant for Joint Research Project of the Institute of Medical Science at the University of Tokyo.	Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Huh JW, 2014, P NATL ACAD SCI USA, V111, P7072, DOI 10.1073/pnas.1322838111; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; LOKESHWAR VB, 1991, J BIOL CHEM, V266, P17983; Matsumoto F, 2008, BIOCHEM BIOPH RES CO, V367, P693, DOI 10.1016/j.bbrc.2007.12.130; Miyake K, 2014, CURR OPIN IMMUNOL, V30, P85, DOI 10.1016/j.coi.2014.08.003; Murakami Y, 2014, J IMMUNOL, V193, P5208, DOI 10.4049/jimmunol.1400386; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shibata T, 2012, INT IMMUNOL, V24, P613, DOI 10.1093/intimm/dxs068; Shrimal S, 2015, SEMIN CELL DEV BIOL, V41, P71, DOI 10.1016/j.semcdb.2014.11.005; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372	24	0	0	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	AUG	2017	29	8					347	355		10.1093/intimm/dxx044				9	Immunology	Immunology	FJ6CE	WOS:000412840500001	28992181				2018-01-05	
J	Dagdas, YS; Chen, JS; Sternberg, SH; Doudna, JA; Yildiz, A				Dagdas, Yavuz S.; Chen, Janice S.; Sternberg, Samuel H.; Doudna, Jennifer A.; Yildiz, Ahmet			A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9	SCIENCE ADVANCES			English	Article							GUIDED ENDONUCLEASE CAS9; ADAPTIVE IMMUNITY; STRUCTURAL BASIS; TARGET CLEAVAGE; COMPLEX; RECOGNITION; SPECIFICITY; NUCLEASES; SYSTEMS; PLASTICITY	The Cas9 endonuclease is widely used for genome engineering applications by programming its single-guide RNA, and ongoing work is aimed at improving the accuracy and efficiency of DNA targeting. DNA cleavage of Cas9 is controlled by the conformational state of the HNH nuclease domain, but the mechanism that governs HNH activation at on-target DNA while reducing cleavage activity at off-target sites remains poorly understood. Using single-molecule Forster resonance energy transfer, we identified an intermediate state of Streptococcus pyogenes Cas9, representing a conformational checkpoint between DNA binding and cleavage. Upon DNA binding, the HNH domain transitions between multiple conformations before docking into its active state. HNH docking requires divalent cations, but not strand scission, and this docked conformation persists following DNA cleavage. Sequence mismatches between the DNA target and guide RNA prevent transitions from the checkpoint intermediate to the active conformation, providing selective avoidance of DNA cleavage at stably bound off-target sites.	[Dagdas, Yavuz S.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Chen, Janice S.; Doudna, Jennifer A.; Yildiz, Ahmet] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Sternberg, Samuel H.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Yildiz, Ahmet] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Sternberg, Samuel H.] Caribou Biosci Inc, Berkeley, CA 94710 USA	Doudna, JA; Yildiz, A (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.; Yildiz, A (reprint author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	doudna@berkeley.edu; yildiz@berkeley.edu		Dagdas, Yavuz Selim/0000-0002-8900-9794; Yildiz, Ahmet/0000-0003-4792-174X	NSF Graduate Research Fellowship; NIH [GM094522, GM118773]; NSF [MCB-1617028, MCB-1244557]; Howard Hughes Medical Institute	J.S.C.is supported by the NSF Graduate Research Fellowship. This work was supported by NIH [GM094522 and GM118773 (to A.Y.)], NSF [MCB-1617028 (to A. Y.) and MCB-1244557 (to J.A.D.)], and the Howard Hughes Medical Institute (to J.A.D.).	Anders C, 2016, MOL CELL, V61, P895, DOI 10.1016/j.molcel.2016.02.020; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bowen ME, 2005, BIOPHYS J, V89, P690, DOI 10.1529/biophysj.104.054064; Boyle E. A., 2016, BIORXIV, V2016; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Hirano S, 2016, MOL CELL, V61, P886, DOI 10.1016/j.molcel.2016.02.018; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Lim Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13350; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Palermo G, 2016, ACS CENTRAL SCI, V2, P756, DOI 10.1021/acscentsci.6b00218; Ray S, 2014, P NATL ACAD SCI USA, V111, P2990, DOI 10.1073/pnas.1321436111; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Singh D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12778; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wu Xuebing, 2014, Quant Biol, V2, P59; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889	32	4	4	5	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	AUG	2017	3	8							eaao0027	10.1126/sciadv.aao0027				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FI0CW	WOS:000411589900001	28808686	gold			2018-01-05	
J	Kim, SW; Lee, JH; Park, TS				Kim, Si Won; Lee, Jeong Hyo; Park, Tae Sub			Functional analysis of SH3 domain containing ring finger 2 during the myogenic differentiation of quail myoblast cells	ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES			English	Article						Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-Cas9; Knockout; Myoblast; Muscle Differentiation; SH3 Domain Containing Ring Finger 2 (SH3RF2); Functional Genomics	EXPRESSION; PROTEIN; GENE; PROMOTER; SYSTEM; VIRUS; FACT	Objective: Owing to the public availability of complete genome sequences, including avian species, massive bioinformatics analyses may be conducted for computational gene prediction and the identification of gene regulatory networks through various informatics tools. However, to evaluate the biofunctional activity of a predicted target gene, in vivo and in vitro functional genomic analyses should be a prerequisite. Methods: Due to a lack of quail genomic sequence information, we first identified the partial genomic structure and sequences of the quail SH3 domain containing ring finger 2 (SH3RF2) gene. Subsequently, SH3RF2 was knocked out using clustered regularly interspaced short palindromic repeat/Cas9 technology and single cell-derived SH3RF2 mutant sublines were established to study the biofunctional activity of SH3RF2 in quail myoblast (QM7) cells during muscle differentiation. Results: Through a T7 endonuclease I assay and genotyping analysis, we established an SH3RF2 knockout (KO) QM7# 4 subline with 61 and 155 nucleotide deletion mutations in SH3RF2. After the induction of myotube differentiation, the expression profiles were analyzed and compared between regular QM7 and SH3RF2 KO QM7# 4 cells by global RNA sequencing and bioinformatics analysis. Conclusion: We did not detect any statistically significant role of SH3RF2 during myotube differ-entiation in QM7 myoblast cells. However, additional experiments are necessary to examine the biofunctional activity of SH3RF2 in cell proliferation and muscle growth.	[Kim, Si Won; Lee, Jeong Hyo; Park, Tae Sub] Seoul Natl Univ, Grad Sch Int Agr Technol, Pyeongchang 25354, South Korea; [Kim, Si Won; Lee, Jeong Hyo; Park, Tae Sub] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang 25354, South Korea	Park, TS (reprint author), Seoul Natl Univ, Grad Sch Int Agr Technol, Pyeongchang 25354, South Korea.; Park, TS (reprint author), Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang 25354, South Korea.	taesubpark@snu.ac.kr			"Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea [PJ01111401]	This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ01111401)" Rural Development Administration, Republic of Korea.	Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Kawahara-Miki R, 2013, GENOMICS, V101, P345, DOI 10.1016/j.ygeno.2013.03.006; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; Kim TW, 2014, CARCINOGENESIS, V35, P624, DOI 10.1093/carcin/bgt338; Kumari A, 2009, J CELL BIOCHEM, V108, P508, DOI 10.1002/jcb.22280; LEE F, 1981, NATURE, V294, P228, DOI 10.1038/294228a0; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MAYO KE, 1982, CELL, V29, P99, DOI 10.1016/0092-8674(82)90094-0; MIYAZAKI J, 1989, GENE, V79, P269; Mullick A, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-43; NIWA H, 1991, GENE, V108, P193; Orphanides G, 1999, NATURE, V400, P284; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Wilhelm M, 2012, J BIOL CHEM, V287, P2247, DOI 10.1074/jbc.M111.269431; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178                                                           ; Zeng SX, 2010, MOL CELL BIOL, V30, P935, DOI 10.1128/MCB.01379-09	21	0	0	2	2	ASIAN-AUSTRALASIAN ASSOC ANIMAL PRODUCTION SOC	SEOUL	ROOM 708 SAMMO SPOREX, 1638-32, SEOWON-DONG, GWANAK-GU, SEOUL 151-730, SOUTH KOREA	1011-2367	1976-5517		ASIAN AUSTRAL J ANIM	Asian Australas. J. Anim. Sci.	AUG	2017	30	8					1183	1189		10.5713/ajas.16.0865				7	Agriculture, Dairy & Animal Science	Agriculture	FG5XE	WOS:000410425500017	28111446	green_published			2018-01-05	
J	Yoshida, K; Toden, S; Weng, WH; Shigeyasu, K; Miyoshi, J; Turner, J; Nagasaka, T; Ma, YL; Takayama, T; Fujiwara, T; Goel, A				Yoshida, Kazuhiro; Toden, Shusuke; Weng, Wenhao; Shigeyasu, Kunitoshi; Miyoshi, Jinsei; Turner, Jacob; Nagasaka, Takeshi; Ma, Yanlei; Takayama, Tetsuji; Fujiwara, Toshiyoshi; Goel, Ajay			SNORA21 - An Oncogenic Small Nucleolar RNA, with a Prognostic Biomarker Potential in Human Colorectal Cancer	EBIOMEDICINE			English	Article						snoRNA; SNORA21; Distant metastasis; Prognostic marker; Colorectal cancer	NONCODING RNAS; SNORNA U50; STEM-CELLS; STATISTICS; EXPRESSION; GENES	Background: Emerging evidence indicates that small nucleolar RNAs (snoRNAs) play a central role in oncogenesis. Herein, we systematically evaluated expression profiles of snoRNAs in colorectal cancer (CRC) and investigated their clinical and functional role in this malignancy. Methods: We compared expression levels of snoRNAs between cancer and normal tissues using publicly available datasets and identified the most differentially expressed and commonly upregulated snoRNAs in CRC. These results were examined in 489 colorectal tissues to assess their clinical significance, followed by a series of in vitro and in vivo experiments to evaluate the functional role of candidate snoRNAs. Results: Usingmultiple RNA profiling datasets, we identified consistent overexpression of SNORA21 in CRC. In the clinical validation cohorts, the expression level of SNORA21was upregulated in colorectal adenomas and cancers. Furthermore, elevated SNORA21 emerged as an independent factor for predicting poor survival. Both in vitro and in vivo experiments revealed that CRISPR/Cas9-mediated inhibition of SNORA21 expression resulted in decreased cell proliferation and invasion through modulation of multiple cancer related pathways. Conclusions: Wesystematically identified SNORA21 as a key oncogenic snoRNA in CRC, which plays an important role in cancer progression, and might serve as an important prognostic biomarker in CRC. (C) 2017 The Authors. Published by Elsevier B.V.	[Yoshida, Kazuhiro; Toden, Shusuke; Weng, Wenhao; Shigeyasu, Kunitoshi; Miyoshi, Jinsei; Goel, Ajay] Baylor Univ, Baylor Scott & White Res Inst, Charles A Sammons Canc Ctr,Med Ctr, Ctr Gastrointestinal Res,Ctr Translat Genom & Onc, Dallas, TX USA; [Shigeyasu, Kunitoshi; Fujiwara, Toshiyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol Surg & Surg Oncol, Okayama, Japan; [Miyoshi, Jinsei; Takayama, Tetsuji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Gastroenterol & Oncol, Tokushima, Japan; [Turner, Jacob] Baylor Univ, Med Ctr, Baylor Res Inst, Ctr Biostat, Dallas, TX USA; [Ma, Yanlei] Shanghai Tenth Peoples Hosp, Dept Gastrointestinal Surg, Shanghai, Peoples R China	Goel, A (reprint author), Baylor Univ, Baylor Scott & White Res Inst, Ctr Translat Genom & Oncol,Med Ctr, Ctr Gastrointestinal Res,Charles Sammons Canc Ctr, 3410 Worth St,Suite 610, Dallas, TX 75246 USA.	Ajay.Goel@BSWHealth.org		Goel, Ajay/0000-0003-1396-6341	National Cancer Institute, National Institutes of Health [CA72851, CA181572, CA184792, CA202797]; Cancer Prevention Research Institute of Texas (CPRIT) [RP140784]; Baylor Sammons Cancer Center and Foundation; Baylor Research Institute	The present work was supported by the grants CA72851, CA181572, CA184792 and CA202797 from the National Cancer Institute, National Institutes of Health, a grant (RP140784) from the Cancer Prevention Research Institute of Texas (CPRIT) (RP140784), pilot grants from the Baylor Sammons Cancer Center and Foundation, as well as funds from the Baylor Research Institute.	Chang LS, 2002, BIOCHEM BIOPH RES CO, V299, P196, DOI 10.1016/S0006-291X(02)02623-2                                                   ; Damas ND, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13875; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Dong XY, 2009, J GENET GENOMICS, V36, P447, DOI 10.1016/S1673-8527(08)60134-4; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Gao L, 2015, INT J CANCER, V136, pE623, DOI 10.1002/ijc.29169; Goel A, 2010, CURR OPIN GASTROEN, V26, P47, DOI 10.1097/MOG.0b013e328332b850; Gregorieff A, 2015, NATURE, V526, P715, DOI 10.1038/nature15382; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Li VSW, 2009, GASTROENTEROLOGY, V137, P176, DOI 10.1053/j.gastro.2009.03.005; Liao J., 2010, MOL CANC, V9; Maeda Ryo, 2009, Interact Cardiovasc Thorac Surg, V9, P640, DOI 10.1510/icvts.2009.202598; Mannoor K., 2014, MOL CANC, V13; Mannoor K, 2012, BBA-REV CANCER, V1826, P121, DOI 10.1016/j.bbcan.2012.03.005; Mei YP, 2012, ONCOGENE, V31, P2794, DOI 10.1038/onc.2011.449; Muller S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0358-5; Ofengand J, 1997, J MOL BIOL, V266, P246, DOI 10.1006/jmbi.1996.0737; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Okugawa Y, 2017, GUT, V66, P107, DOI 10.1136/gutjnl-2015-309359; Ploner A, 2009, RNA, V15, P1797, DOI 10.1261/rna.1740009; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Ravo M, 2015, ONCOTARGET, V6, P4677, DOI 10.18632/oncotarget.2911                                                        ; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Siprashvili Z, 2016, NAT GENET, V48, P53, DOI 10.1038/ng.3452; Toiyama Y, 2014, ANN SURG, V259, P735, DOI 10.1097/SLA.0b013e3182a6909d; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Tsukamoto S, 2011, CLIN CANCER RES, V17, P2444, DOI 10.1158/1078-0432.CCR-10-2884; Van Cutsem E, 2006, EUR J CANCER, V42, P2212, DOI 10.1016/j.ejca.2006.04.012                                                      ; Xu L, 2016, CLIN CANCER RES, V22, P773, DOI 10.1158/1078-0432.CCR-15-0737; Yoo PS, 2006, CLIN COLORECTAL CANC, V6, P202, DOI 10.3816/CCC.2006.n.036                                                          ; Zhang L, 2012, OSTEOARTHR CARTILAGE, V20, P1631, DOI 10.1016/j.joca.2012.08.016	33	0	0	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2352-3964			EBIOMEDICINE	EBioMedicine	AUG	2017	22						68	77		10.1016/j.ebiom.2017.07.009				10	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	FG9DI	WOS:000410738600012	28734806	gold			2018-01-05	
J	Xie, B; Yi, JP; Peng, J; Zhang, X; Lei, L; Zhao, DP; Lei, ZX; Nie, HM				Xie, Bei; Yi, Jipeng; Peng, Jian; Zhang, Xing; Lei, Lei; Zhao, Dapeng; Lei, Zhixin; Nie, Hemin			Characterization of synergistic anti-tumor effects of doxorubicin and p53 via graphene oxide-polyethyleneimine nanocarriers	JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY			English	Article						Graphene oxide; Polyethyleneimine; Doxorubicin; p53; Successive inhibition	LOW-MOLECULAR-WEIGHT; DRUG-RELEASE RESPONSE; VITRO GENE DELIVERY; CARBON NANOTUBES; CYCLODEXTRIN; NANOPARTICLE; THERAPY; POLYMER; SYSTEMS; VECTOR	Co-delivery of chemical drugs and therapeutic genes for synergistic therapy provides a promising strategy to treat devastating diseases. However, the real-time coordination patterns between chemical drugs and therapeutic genes remain poorly understood. Herein, the complexes of doxorubicin/graphene oxidepolyethyleneimine/p53 plasmid (Dox/GO-PEI/p53) were fabricated and employed to investigate the synergistic manner between Dox and p53 in the inhibition of HeLa cell growth. GO was conjugated with PEI to form the GO-PEI backbone as the delivery vector. The GO backbone provided surfaces with a high specific area to load Dox via the pi-pi stacking interaction, and was able to release Dox significantly faster at pH 5.0 than at pH 7.0, while the positively charged PEI section of GO-PEI could condense plasmids into GO-PEI/DNA nanoparticles via the electrostatic interaction. The nanoparticles efficiently mediated the transfection of DNA in HeLa cells, with lower cytotoxicity compared to PEI/DNA nanoparticles. Furthermore, the complexes of Dox/GO-PEI/p53 released Dox and expressed p53 gene in a sequential manner, and showed successive inhibition of the in vitro growth of HeLa cells. This type of drug/GO-PEI/DNA complex can be employed as a platform to investigate the coordination pattern between chemical drugs and therapeutic genes for tumor therapy. (C) 2017 Published by Elsevier Ltd on behalf of The editorial office of Journal of Materials Science & Technology.	[Xie, Bei; Yi, Jipeng; Peng, Jian; Zhao, Dapeng; Nie, Hemin] Hunan Univ, Inst Bionanotechnol & Tissue Engn, Coll Life Sci, Changsha 410082, Hunan, Peoples R China; [Zhang, Xing] Chinese Acad Sci, Shenyang Natl Lab Mat Sci, Inst Met Res, Shenyang 110016, Liaoning, Peoples R China; [Lei, Lei] Cent S Univ, Xiangya Stomatol Hosp, Dept Orthodont, Changsha 410008, Hunan, Peoples R China; [Lei, Zhixin] Changsha DMY Med Technol Co Ltd, Changsha 410005, Hunan, Peoples R China; [Nie, Hemin] Hunan Univ, Shenzhen Res Inst, Nanshan Hi New Technol & Ind Pk, Shenzhen 518057, Peoples R China	Nie, HM (reprint author), Hunan Univ, Inst Bionanotechnol & Tissue Engn, Coll Life Sci, Changsha 410082, Hunan, Peoples R China.; Zhang, X (reprint author), Chinese Acad Sci, Shenyang Natl Lab Mat Sci, Inst Met Res, Shenyang 110016, Liaoning, Peoples R China.	xingzhang@imr.ac.cn; niehemin@hnu.edu.cn			National Natural Science Foundation of China [31670997]; Natural Science Foundation of Hunan Province [2015JJ1007]; Basic Research Program of Shenzhen City [JCYJ20160530193417959]	This work was financially supported by the National Natural Science Foundation of China (No. 31670997), the Natural Science Foundation of Hunan Province (No. 2015JJ1007), and the Basic Research Program of Shenzhen City (No. JCYJ20160530193417959). The authors confirm that there are no conflicts of interest associated with this publication.	Bieber T, 2001, BIOTECHNIQUES, V30, P74; Braicu Ovidiu, 2015, Clujul Med, V88, P333, DOI 10.15386/cjmed-434; Davis ME, 2009, MOL PHARMACEUT, V6, P659, DOI 10.1021/mp900015y; Delyagina E., 2010, P 8 INT C SCI CLIN A; Depan D, 2011, MAT SCI ENG C-MATER, V31, P1305, DOI 10.1016/j.msec.2011.04.010; Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478; Forrest ML, 2005, BIOTECHNOL BIOENG, V89, P416, DOI 10.1002/bit.20356; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Gosselin MA, 2001, BIOCONJUGATE CHEM, V12, P989, DOI 10.1021/bc0100455; Guldi DM, 2003, ANGEW CHEM INT EDIT, V42, P4206, DOI 10.1002/anie.200351289; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/nnm.11.19, 10.2217/NNM.11.19]; Kim H, 2011, BIOCONJUGATE CHEM, V22, P2558, DOI 10.1021/bc200397j; Li X, 2012, J NANOMATER, V2012, P6, DOI DOI 10.1371/J0URNAL.P0NE.0039690; Liboiron BD, 2014, THER DELIV, V5, P149, DOI [10.4155/TDE.13.149, 10.4155/tde.13.149]; Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x; Liu Z, 2007, ACS NANO, V1, P50, DOI 10.1021/nn700040t; Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011; Murakami H, 2003, CHEM PHYS LETT, V378, P481, DOI 10.1016/S0009-2614(03)01329-0; Namgung R, 2011, BIOMATERIALS, V32, P3042, DOI 10.1016/j.biomaterials.2010.12.018; Namgung R, 2010, BIOMATERIALS, V31, P4204, DOI 10.1016/j.biomaterials.2010.01.123; Neu M, 2005, J GENE MED, V7, P992, DOI 10.1002/jgm.773; Niidome T, 2002, GENE THER, V9, P1647, DOI 10.1038/sj.gt.3301923; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Nunes A, 2010, SMALL, V6, P2281, DOI 10.1002/smll.201000864; Pun SH, 2004, BIOCONJUGATE CHEM, V15, P831, DOI 10.1021/bc049891g; Salehi R, 2014, J DRUG TARGET, V22, P327, DOI 10.3109/1061186X.2013.876645; Sun XM, 2008, NANO RES, V1, P203, DOI 10.1007/s12274-008-8021-8; Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x; Tang GP, 2006, J GENE MED, V8, P736, DOI 10.1002/jgm.874; Mega Tiber P, 2014, ONCOTARGETS THERAPY, V7, P2161; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410                                                                   ; Wang D., 2008, MACHINERY ELECT, V9, P3; Wang MX, 2012, BIOCONJUGATE CHEM, V23, P837, DOI 10.1021/bc200674e; Xiao YH, 2014, DRUG DELIV, V21, P362, DOI 10.3109/10717544.2013.846997; Yan L, 2012, CHEM SOC REV, V41, P97, DOI 10.1039/c1cs15193b; Zhang J, 2007, ACTA BIOMATER, V3, P838, DOI 10.1016/j.actbio.2007.05.011; Zhang JX, 2010, NANO TODAY, V5, P337, DOI 10.1016/j.nantod.2010.06.011	37	0	0	6	6	JOURNAL MATER SCI TECHNOL	SHENYANG	72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA	1005-0302			J MATER SCI TECHNOL	J. Mater. Sci. Technol.	AUG	2017	33	8					807	814		10.1016/j.jmst.2017.05.005				8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	FG8FX	WOS:000410666000008					2018-01-05	
J	Chen, LT; Qiu, XM; Zhang, N; Wang, Y; Wang, MY; Li, DJ; Wang, L; Du, Y				Chen, Lanting; Qiu, Xuemin; Zhang, Na; Wang, Yan; Wang, Mingyan; Li, Dajin; Wang, Ling; Du, Yan			APOBEC-mediated genomic alterations link immunity and viral infection during human papillomavirus-driven cervical carcinogenesis	BIOSCIENCE TRENDS			English	Review						Cervical cancer; human papillomavirus; inflammation; APOBEC	ABERRANT DNA METHYLATION; HUMAN CANCERS; INTRAEPITHELIAL NEOPLASIA; MUTATIONAL PROCESSES; CYTIDINE DEAMINASES; NATURAL-HISTORY; HPV INTEGRATION; HYPERMUTATION; STATISTICS; EXPRESSION	Cervical cancer is one of the most frequently diagnosed cancers and is a major cause of death from gynecologic cancers worldwide; the cancer burden from cervical cancer is especially heavy in less developed countries. Most cases of cervical cancer are caused by persistent infection with carcinogenic human papillomavirus (HPV) genotypes 16 and 18. Non-resolving inflammation caused by HPV infection provides a microenvironment that facilitates cancer development. Molecular alterations during the process of HPV-induced carcinogenesis are characterized by DNA methylation within the HPV genome, promoter hypermethylation of tumor suppressor genes in the host genome, as well as genomic instability caused by viral DNA integrating into the host genome. Catalytic polypeptide-like apolipoprotein B mRNA editing enzymes (APOBECs) normally function as part of the innate immune system. APOBEC expression is stimulated upon viral infection and plays an important role in HPVinduced cervical cancer. APOBECs catalyze the deamination of cytosine bases in nucleic acids, which leads to a conversion of target cytosine (C) to uracil (U) and consequently a change in the single-stranded DNA/ RNA sequence. APOBEC proteins mediate the complex interactions between HPV and the host genome and link immunity and viral infection during HPV-driven carcinogenesis. Understanding the effects of APOBECs in HPV-induced cervical carcinogenesis will enable the development of better tools for HPV infection control and personalized prevention and treatment strategies.	[Chen, Lanting; Qiu, Xuemin; Zhang, Na; Wang, Yan; Wang, Mingyan; Li, Dajin; Wang, Ling] Fudan Univ, Shanghai Med Coll, Hosp & Inst Obstet & Gynecol, Lab Reprod Immunol,IBS, Shanghai, Peoples R China; [Chen, Lanting; Qiu, Xuemin; Zhang, Na; Wang, Yan; Wang, Mingyan; Li, Dajin; Wang, Ling] Fudan Univ, Acad Integrat Med, Shanghai, Peoples R China; [Chen, Lanting; Qiu, Xuemin; Zhang, Na; Wang, Yan; Wang, Mingyan; Li, Dajin; Wang, Ling] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China; [Du, Yan] Fudan Univ, Obstet & Gynecol Hosp, Off Clin Epidemiol, 419 Fangxie Rd, Shanghai 200011, Peoples R China	Du, Y (reprint author), Fudan Univ, Obstet & Gynecol Hosp, Off Clin Epidemiol, 419 Fangxie Rd, Shanghai 200011, Peoples R China.; Wang, L (reprint author), Fudan Univ, IBS, Hosp & Inst Obstet & Gynecol, 413 Zhaozhou Rd, Shanghai 200011, Peoples R China.	Dr.wangling@fudan.edu.cn; sophiedu_61@163.com		Zhang, Na/0000-0002-5510-5702	e National Natural Science Foundation of China [31571196]; Program to Guide Medicine (" Yixueyindao") of the Shanghai Municipal Science and Technology Commission [15401932200]	This work was supported by the National Natural Science Foundation of China (grant no. 31571196 to Ling Wang), and the 2015 Program to Guide Medicine (" Yixueyindao") of the Shanghai Municipal Science and Technology Commission (grant no. 15401932200 to Ling Wang).	Ahasan MM, 2015, BIOCHEM BIOPH RES CO, V457, P295, DOI 10.1016/j.bbrc.2014.12.103; Akagi K, 2014, GENOME RES, V24, P185, DOI 10.1101/gr.164806.113; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Banister CE, 2017, ONCOTARGET, V8, P13375, DOI 10.18632/oncotarget.14533; Burk RD, 2017, NATURE, V543, P378, DOI 10.1038/nature21386                                                             ; Castellsague X, 2008, GYNECOL ONCOL, V110, pS4, DOI 10.1016/j.ygyno.2008.07.045; Rodriguez AC, 2010, J NATL CANCER I, V102, P315, DOI 10.1093/jnci/djq001; Chandrani P, 2015, BRIT J CANCER, V112, P1958, DOI 10.1038/bjc.2015.121; Chen S, 2015, INT J CLIN EXP MED, V8, P10548; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Clarke MA, 2012, CANCER EPIDEM BIOMAR, V21, P2125, DOI 10.1158/1055-9965.EPI-12-0905; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Deng Y, 2014, CANCER LETT, V343, P161, DOI 10.1016/j.canlet.2013.09.041; Flatley JE, 2009, CANCER EPIDEM BIOMAR, V18, P2782, DOI 10.1158/1055-9965.EPI-09-0493; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Hu Z, 2015, NAT GENET, V47, P158, DOI 10.1038/ng.3178; Jimenez-Wences H, 2014, ONCOL REP, V31, P2467, DOI 10.3892/or.2014.3142; Kukimoto I, 2015, J MED VIROL, V87, P1754, DOI 10.1002/jmv.24215; Lu XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097588; Marongiu L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-384; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Oaknin A, 2015, CLIN TRANSL ONCOL, V17, P1036, DOI 10.1007/s12094-015-1452-2; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(07)61416-0; Schmitz M, 2012, INT J CANCER, V131, pE593, DOI 10.1002/ijc.27433; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Song D, 2015, ONCOL LETT, V10, P600, DOI 10.3892/ol.2015.3295; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Van Doorslaer K, 2013, VIROLOGY, V445, P11, DOI [10.1016/j.viro1.2013.05.012, 10.1016/j.virol.2013.05.012]; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Wang R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0998-5; Wang Z, 2014, J VIROL, V88, P1308, DOI 10.1128/JVI.03091-13; Warren CJ, 2015, J VIROL, V89, P688, DOI 10.1128/JVI.02383-14; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Xu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066693; Xu YH, 2015, INT J CLIN EXP PATHO, V8, P12307; Yang HJ, 2013, CHIN J CANCER, V32, P42, DOI 10.5732/cjc.012.10033; Zhou JJ, 2016, CHINA CANC, V11, P854	44	0	0	2	2	IRCA-BSSA	TOKYO	PEARL CITY KOISHIKAWA 603, 2-4-5 KASUGA, BUNKYO-KU, TOKYO, 112-0003, JAPAN	1881-7815	1881-7823		BIOSCI TRENDS	BioSci. Trends	AUG	2017	11	4					383	388		10.5582/bst.2017.01103				6	Biology	Life Sciences & Biomedicine - Other Topics	FH0UC	WOS:000410855100003	28717061				2018-01-05	
J	Landete, JM; Arques, JL				Maria Landete, Jose; Luis Arques, Juan			Fluorescent Lactic Acid Bacteria and Bifidobacteria as Vehicles of DNA Microbial Biosensors	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						DNA microbial biosensors; lactic acid bacteria; bifidobacteria; fluorescent proteins; cloning vectors; clustered regularly interspaced short palindromic repeats	LACTOCOCCUS-LACTIS; LACTOBACILLUS-PLANTARUM; GENE-EXPRESSION; ENTEROCOCCUS-FAECALIS; REGULATORY PROTEINS; PROMOTER ANALYSIS; FOOD; REPORTER; MICE; CONSTRUCTION	Control and quantification of effector molecules such as heavy metals, toxins or other target molecules is of great biotechnological, social and economic interest. Microorganisms have regulatory proteins that recognize and modify the gene expression in the presence or absence of these compounds (effector molecules) by means of binding to gene sequences. The association of these recognizing gene sequences to reporter genes will allow the detection of effector molecules of interest with high sensitivity. Once investigators have these two elementsrecognizing gene sequences and reporter genes that emit signalswe need a suitable vehicle to introduce both elements. Here, we suggest lactic acid bacteria (LAB) and bifidobacteria as promising carrier microorganisms for these molecular biosensors. The use of fluorescent proteins as well as food-grade vectors and clustered regularly interspaced short palindromic repeats (CRISPR) are indispensable tools for introducing biosensors into these microorganisms. The use of these LAB and bifidobacteria would be of special interest for studying the intestinal environment or other complex ecosystems. The great variety of species adapted to many environments, as well as the possibility of applying several protocols for their transformation with recognizing gene sequences and reporter genes are considerable advantages. Finally, an effort must be made to find recognizable gene sequences.	[Maria Landete, Jose; Luis Arques, Juan] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Tecnol Alimentos, Madrid 28040, Spain	Arques, JL (reprint author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Tecnol Alimentos, Madrid 28040, Spain.	landete.josem@inia.es; arques@inia.es	Arques, Juan/S-4322-2017	Arques, Juan/0000-0002-8548-0183	Spanish Ministry of Economy and Competitiveness [RTA2013-00029-00-00]	This work was supported by project RTA2013-00029-00-00 from the Spanish Ministry of Economy and Competitiveness.	Allison GE, 1996, APPL ENVIRON MICROB, V62, P4450; Amaretti A, 2013, APPL MICROBIOL BIOT, V97, P809, DOI 10.1007/s00253-012-4241-7; Berlec A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0376-4; Bongaerts RJM, 2002, METHOD ENZYMOL, V358, P43; Canbay E, 2015, FOOD CHEM, V169, P197, DOI 10.1016/j.foodchem.2014.07.140; Chapman S, 2008, P NATL ACAD SCI USA, V105, P20038, DOI 10.1073/pnas.0807551105; Charteris WP, 1997, INT J FOOD MICROBIOL, V35, P1, DOI 10.1016/S0168-1605(96)01222-6; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Cronin M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-161; Daniel C, 2013, APPL ENVIRON MICROB, V79, P1086, DOI 10.1128/AEM.03221-12; de Vos WM, 1999, INT DAIRY J, V9, P3, DOI 10.1016/S0958-6946(99)00038-2; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Galvao TC, 2006, CURR OPIN BIOTECH, V17, P34, DOI 10.1016/j.copbio.2005.12.002; Garcia-Cayuela T, 2012, APPL MICROBIOL BIOT, V96, P171, DOI 10.1007/s00253-012-4087-z; Geoffroy MC, 2000, APPL ENVIRON MICROB, V66, P383, DOI 10.1128/AEM.66.1.383-391.2000                                                   ; Giepmans BNG, 2008, HISTOCHEM CELL BIOL, V130, P211, DOI 10.1007/s00418-008-0460-5; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Grimm V, 2014, APPL ENVIRON MICROB, V80, P2842, DOI 10.1128/AEM.04261-13; Guglielmetti S, 2008, INT J FOOD MICROBIOL, V124, P285, DOI 10.1016/j.ijfoodmicro.2008.03.033; Hilmi HTA, 2009, BIOTECHNOL LETT, V31, P119, DOI 10.1007/s10529-008-9846-7; Holzapfel WH, 2001, AM J CLIN NUTR, V73, p365S; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; Immonen N, 2007, BIOSENS BIOELECTRON, V22, P1982, DOI 10.1016/j.bios.2006.08.029; Jankovic I, 2010, CURR OPIN BIOTECH, V21, P175, DOI 10.1016/j.copbio.2010.03.009; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Justus T, 1999, MUTAGENESIS, V14, P351, DOI 10.1093/mutage/14.4.351                                                         ; Kassayova M, 2014, ANTICANCER RES, V34, P4969; Khan MS, 2017, ACS APPL MATER INTER, V9, P8609, DOI 10.1021/acsami.7b01675; Khan MS, 2017, ANAL CHEM, V89, P2107, DOI 10.1021/acs.analchem.6b04769; Khan MS, 2016, EUR BIOPHYS J BIOPHY, V45, P843, DOI 10.1007/s00249-016-1156-8; Koskenniemi K, 2009, J PROTEOME RES, V8, P4993, DOI 10.1021/pr9003823; Kremers GJ, 2011, J CELL SCI, V124, P157, DOI 10.1242/jcs.072744; Landete JM, 2016, TRENDS BIOTECHNOL, V34, P777, DOI 10.1016/j.tibtech.2016.04.011; Landete JM, 2015, APPL MICROBIOL BIOT, V99, P6865, DOI 10.1007/s00253-015-6770-3; Landete JM, 2014, INT J FOOD MICROBIOL, V175, P6, DOI 10.1016/j.ijfoodmicro.2014.01.008; Laplace JM, 2000, APPL MICROBIOL BIOT, V53, P685, DOI 10.1007/s002530000350                                                           ; Li RQ, 2011, BIOTECHNOL LETT, V33, P797, DOI 10.1007/s10529-010-0503-6; Linares DM, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0169-1; Lu WW, 2013, MOL BIOTECHNOL, V54, P170, DOI 10.1007/s12033-012-9558-z; Mohedano ML, 2015, J IND MICROBIOL BIOT, V42, P247, DOI 10.1007/s10295-014-1567-4; Magnani D, 2008, J BACTERIOL, V190, P536, DOI 10.1128/JB.01481-07; Landete JM, 2017, CRIT REV BIOTECHNOL, V37, P296, DOI 10.3109/07388551.2016.1144044; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Montenegro-Rodriguez C, 2015, BIOTECHNOL LETT, V37, P1405, DOI 10.1007/s10529-015-1802-8; Mukherjee A, 2015, CURR OPIN BIOTECH, V31, P16, DOI 10.1016/j.copbio.2014.07.010; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Oozeer R, 2005, APPL ENVIRON MICROB, V71, P1356, DOI 10.1128/AEM.71.3.1356-1363.2005; Park M, 2013, SENSORS-BASEL, V13, P5777, DOI 10.3390/s130505777; Portmann R, 2004, J BIOL INORG CHEM, V9, P396, DOI 10.1007/s00775-004-0536-1; Ravnikar M, 2010, APPL ENVIRON MICROB, V76, P6928, DOI 10.1128/AEM.00190-10; Rogers JK, 2015, NUCLEIC ACIDS RES, V43, P7648, DOI 10.1093/nar/gkv616; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sasson V, 2012, MOL CELL, V46, P399, DOI 10.1016/j.molcel.2012.04.032; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shareck J, 2004, CRIT REV BIOTECHNOL, V24, P155, DOI [10.1080/07388550490904288, 10.1080/0738850490904288]; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Stefanovic E, 2017, FOOD MICROBIOL, V61, P33, DOI 10.1016/j.fm.2016.08.009; Tauer C, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0150-z; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509                                                ; Van Pijkeren JP, 2012, BIOENGINEERED, V3, P209, DOI [10.4161/bioe.2104, 10.4161/bioe.21049]; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; van Zyl WF, 2015, APPL ENVIRON MICROB, V81, P5993, DOI 10.1128/AEM.01247-15; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943; Virolainen N, 2012, INT J FOOD MICROBIOL, V158, P126, DOI 10.1016/j.ijfoodmicro.2012.07.007; Wang YP, 2011, J MICROBIOL METH, V86, P390, DOI 10.1016/j.mimet.2011.06.009; Wang ZH, 2013, J CLIN GASTROENTEROL, V47, P25, DOI 10.1097/MCG.0b013e318266f6cf; Wu RN, 2011, INT J FOOD MICROBIOL, V147, P181, DOI 10.1016/j.ijfoodmicro.2011.04.003; Yang SW, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.01.029; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	72	0	0	7	7	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	AUG	2017	18	8							1728	10.3390/ijms18081728				11	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	FF4HB	WOS:000408897400129		gold			2018-01-05	
J	Kjelland, ME; Novak, B; Blue-McLendon, A; Romo, S; Kraemer, DC				Kjelland, Michael E.; Novak, Ben; Blue-McLendon, Alice; Romo, Salvador; Kraemer, Duane C.			Manipulating the avian egg: applications for embryo transfer, transgenics, and cloning	AVIAN BIOLOGY RESEARCH			English	Article						avian; Chicken; Gallus gallus domesticus; Turkey; Meleagris gallopavo; Emu; Dromaius novaehollandiae; Ostrich; Struthio camelus	AUK PINGUINUS-IMPENNIS; PRIMORDIAL GERM-CELLS; NUCLEAR TRANSFER; WATER-LOSS; INCUBATION; CULTURE; CHICKEN; BIRDS; EVOLUTION; ALCIDAE	In vitro production of germline chimeras and avian cloning may utilise the transfer of avian embryos from their original eggshell to a surrogate eggshell for culture during incubation. Such embryo transfer is valuable for avian cloning as the only alternative would be to transfer the cloned avian embryos into the infundibulum of recipient birds. Given the advances in paleogenomics, synthetic biology, and gene editing, a similar approach might be used to generate extinct species, i.e. de-extinction. One objective of the present research was to examine if ratite eggs could be manipulated via windowing and sham injection, similar to that which could allow for avian genome manipulation and subsequent development. The efficiency of interspecific avian embryo transfer using Chicken (Gallus gallus domesticus) donor eggs and Turkey (Meleagris gallopavo) recipient eggshells was also investigated. Egg windowing and embryo transfer techniques utilised in the present research were adapted from those found in the scientific literature. Presumed fertile eggs from Rhode Island Red (n = 40), Silkie (n = 2), and White Leghorn Chickens (n = 18), Turkey (n = 48), Emu (Dromaius novaehollandiae) (n = 79), and Ostrich (Struthio camelus) (n = 89) were used in this research. Of the 41 Chicken eggs used for transfers into recipient Turkey eggshells, only one (2.4%) produced a chick. Of 31 windowed Emu eggs, one embryo survived for 25 d but no chicks were produced. Of 36 windowed Ostrich eggs, one embryo survived and hatched. The efficiency of the windowing and embryo transfers to produce chicks was low and further refinements are needed. Importantly, the results herein establish that manipulating ratite embryos is possible.	[Kjelland, Michael E.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, Coll Agr & Life Sci, Ecol Syst Lab, 210 Nagle Hall, College Stn, TX 77843 USA; [Kjelland, Michael E.; Kraemer, Duane C.] Texas A&M Univ, Dept Vet Physiol & Pharmacol, Coll Vet Med & Biomed Sci, Reprod Sci Lab, College Stn, TX 77843 USA; [Kjelland, Michael E.] Conservat Genet & Biotech LLC, 10921 36 St SE, Valley City, ND 58072 USA; [Novak, Ben] Revive & Restore, 323 Pine St Suite D, Sausalito, CA 94965 USA; [Blue-McLendon, Alice] Texas A&M Univ, Dept Vet Physiol & Pharmacol, Coll Vet Med & Biomed Sci, Winnie Carter Wildlife Ctr, College Stn, TX 77843 USA; [Romo, Salvador] UNAM, Fac Estudios Super Cuautitlan, Cuautitlan, Estado De Mexic, Mexico	Kjelland, ME (reprint author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, Coll Vet Med & Biomed Sci, Reprod Sci Lab, College Stn, TX 77843 USA.; Kjelland, ME (reprint author), Conservat Genet & Biotech LLC, 10921 36 St SE, Valley City, ND 58072 USA.	mkjelland@hotmail.com			Schubot Exotic Bird Health Center at Texas AM University	The authors would like to thank Ann Hoang, Jay Massey, and members of the Reproductive Sciences Laboratory; Dale Hyatt, Melvin Carter and staff at the Poultry Science Research, Teaching, and Extension Center; Lisa Roberts-Helton at the Winnie Carter Wildlife Center; Dr. George Stoica of the Department of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences; Dr. Robert Burghardt of the Veterinary Integrative Biosciences Department, College of Veterinary Medicine & Biomedical Sciences; and Dr. Ian Tizard for their assistance with this project. This research was made possible by a grant, "Avian cloning to assist with preservation of endangered species: A pilot study" from the Schubot Exotic Bird Health Center at Texas A&M University. All procedures performed in the present research were conducted in accordance with the Animal Care Guidelines of the Institutional Animal Care and Use Committee of Texas A&M University.	Amadon Dean, 1947, CONDOR, V49, P159, DOI 10.2307/1364110; AR A, 1974, CONDOR, V76, P153, DOI 10.2307/1366725; AR A, 1980, AM ZOOL, V20, P373; Barrangou R, 2014, SCIENCE, V344, P707, DOI 10.1126/science.1252964; BENGTSON SA, 1984, AUK, V101, P1; BIRKHEAD TR, 1984, J ZOOL, V202, P177; Borwornpinyo S, 2005, POULTRY SCI, V84, P1477, DOI 10.1093/ps/84.9.1477                                                            ; Brown D., 1995, GUIDE PIGEONS DOVES; Cartwright A. L., 2000, INCUBATING HATCHING; Dimitrov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154303; Gomez MC, 2009, REPROD FERT DEVELOP, V21, P76, DOI 10.1071/RD08222; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hipfner JM, 2000, J AVIAN BIOL, V31, P112, DOI 10.1034/j.1600-048X.2000.310202.x; Hwang I, 2013, REPROD FERT DEVELOP, V25, P1142, DOI 10.1071/RD12256; Jefferey J. S., 2001, OSTRICH PRODUCTION; Jefferey J. S., 2001, EMU PRODUCTION; Jeffrey J. S., 1996, L5166 TEX A M U SYST; Johnson J., 2015, JOINT M AM ORN UN CO; Johnson JA, 2016, ANIM CONSERV, V19, P97, DOI 10.1111/acv.12273; Kjelland ME, 2014, AVIAN BIOL RES, V7, P131, DOI 10.3184/175815514X14065426847114; Kjelland ME, 2012, AVIAN BIOL RES, V5, P99, DOI 10.3184/175815512X13350293537608; Lai YY, 2015, SCI CHINA TECHNOL SC, V58, P273, DOI 10.1007/s11431-014-5737-4; LIVEZEY BC, 1993, J ZOOL, V230, P247, DOI 10.1111/j.1469-7998.1993.tb02686.x                                              ; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; Mitchell KJ, 2014, SCIENCE, V344, P898, DOI 10.1126/science.1251981; Moum T, 2002, MOL BIOL EVOL, V19, P1434, DOI 10.1093/oxfordjournals.molbev.a004206                                           ; Nagai H, 2014, METHODS, V66, P441, DOI 10.1016/j.ymeth.2013.05.005; Nagai H, 2011, DEV DYNAM, V240, P162, DOI 10.1002/dvdy.22520; Nicholls H, 2012, NATURE, V487, P279, DOI 10.1038/487279a; OLSEN PD, 1987, EMU, V87, P196, DOI 10.1071/MU9870196                                                               ; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; PERRY MM, 1988, NATURE, V331, P70, DOI 10.1038/331070a0; PRESTON FW, 1968, AUK, V85, P454, DOI 10.2307/4083294                                                                 ; RAHN H, 1974, CONDOR, V76, P147, DOI 10.2307/1366724; RAHN H, 1976, PHYSIOL ZOOL, V49, P245, DOI 10.1086/physzool.49.2.30152544                                                  ; ROWLETT K, 1987, BRIT POULTRY SCI, V28, P91, DOI 10.1080/00071668708416940; Sansinena MJ, 2005, THERIOGENOLOGY, V63, P1081, DOI 10.1016/j.theriogenology.2004.05.025; Shapiro B, 2002, SCIENCE, V295, P1683, DOI 10.1126/science.295.5560.1683; Shapiro B., 2016, PLANT AN GEN C 24 10; Shapiro B., 2016, FUNCT ECOL; Shapiro B., 2016, PLANT AN GEN C 24 11; Tyack SG, 2013, TRANSGENIC RES, V22, P1257, DOI 10.1007/s11248-013-9727-2; van de Lavoir MC, 2006, METHOD ENZYMOL, V418, P38, DOI 10.1016/S0076-6879(06)18003-9; van de Lavoir MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035664; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Veron N, 2015, DEV BIOL, V407, P68, DOI 10.1016/j.ydbio.2015.08.007; Zuo QS, 2016, G3-GENES GENOM GENET, V6, P1787, DOI 10.1534/g3.116.028803; Sang H., 2005, Method of preparing eggs for nuclear transfer and uses thereof, Patent No. [US20050015825, 50015825]; Sang H., 2005, Method of preparing eggs for nuclear transfer and uses thereof, Patent No. [2002356292, 356292]; Sang H., 2003, Method of preparing eggs for nuclear transfer and uses thereof, Patent No. [WO2003049537, 3049537]; Sang H., 2005, Method of preparing eggs for nuclear transfer and uses thereof, Patent No. [EP1455573, 1455573]	51	0	0	8	8	SCIENCE REVIEWS 2000 LTD	ST ALBANS	PO BOX 314, ST ALBANS AL1 4ZG, HERTS, ENGLAND	1758-1559	1758-1567		AVIAN BIOL RES	Avian Biol. Res.	AUG	2017	10	3					146	155		10.3184/175815617X14951979279268				10	Agriculture, Dairy & Animal Science; Ornithology; Zoology	Agriculture; Zoology	FG0MS	WOS:000409444500003					2018-01-05	
J	Jia, HY; Zhang, LM; Wang, TT; Han, J; Tang, H; Zhang, LP				Jia, Haiyan; Zhang, Longmei; Wang, Tongtong; Han, Jin; Tang, Hui; Zhang, Liping			Development of a CRISPR/Cas9-mediated gene-editing tool in Streptomyces rimosus	MICROBIOLOGY-SGM			English	Article						CRISPR/Cas9; gene editing; Streptomyces rimosus	PENTOSE-PHOSPHATE PATHWAY; BIOSYNTHETIC-PATHWAY; GENOME; SYSTEM; DELETION; MUTANTS; RICE	Clustered regularly interspaced short palindromic repeats, associated proteins (CRISPR/Cas), has been developed into a powerful, targeted genome-editing tool in a wide variety of species. Here, we report an extensive investigation of the type II CRISPR/Cas9 system for targeted gene editing in Streptomyces rimosus. S. rimosus is used in the production of the antibiotic oxytetracycline, and its genome differs greatly from other species of the genus Streptomyces in the conserved chromosome terminal and core regions, which is of major production and scientific research value. The genes zwf2 and devB were chosen as target genes, and were edited separately via single-site mutations, double-site mutations and gene fragment disruptions. The single-site mutation guided by sgRNA-1 or sgRNA-2, respectively, involved GG changing to CA, GC changing to AT, and GG changing to CC. The double-site mutations guided by sgRNA-1 and sgRNA-2 included deletions and/or point mutations. Consistently, all mutations occurred in the gRNA sequence regions. Deletion mutations were characterized by the absence of eight bases, including three bases upstream of the PAM (protospacer adjacent motif) sequence, the PAM sequence itself and two bases downstream of the PAM sequence. A mutant (zwf2(-)devB(-)) with a high yield of oxytetracycline was successfully obtained, whose oxytetracycline level was increased by 36.8% compared to the original strain. These results confirm that CRISPR/Cas9 can successfully serve as a useful targeted genome editing system in S. rimosus.	[Jia, Haiyan; Zhang, Longmei; Wang, Tongtong; Han, Jin; Tang, Hui; Zhang, Liping] Hebei Univ, Engn Lab Microbial Breeding & Preservat Hebei Pro, Key Lab Microbial Divers Res & Applicat Hebei Pro, Key Discipline Biol Engn Hebei Prov,Coll Life Sci, Baoding 071002, Peoples R China	Zhang, LP (reprint author), Hebei Univ, Engn Lab Microbial Breeding & Preservat Hebei Pro, Key Lab Microbial Divers Res & Applicat Hebei Pro, Key Discipline Biol Engn Hebei Prov,Coll Life Sci, Baoding 071002, Peoples R China.	zhanglphbu@sohu.com			National Natural Science Foundation of China [30970010]	This study was funded by the National Natural Science Foundation of China (grant number 30970010).	Bilyk O, 2016, CURR OPIN BIOTECH, V42, P98, DOI 10.1016/j.copbio.2016.03.008; Bown L, 2016, MOL MICROBIOL, V101, P122, DOI 10.1111/mmi.13378; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Huang He, 2015, Acta Biochim Biophys Sin (Shanghai), V47, P231, DOI 10.1093/abbs/gmv007; Kim H, 2016, J INTEGR PLANT BIOL, V58, P705, DOI 10.1111/jipb.12474; Kirby R, 2008, ANTON LEEUW INT J G, V94, P173, DOI 10.1007/s10482-008-9223-5; Koch L., 2015, NATURE REV GENETICS, V17, P6; Miclet E, 2001, J BIOL CHEM, V276, P34840, DOI 10.1074/jbc.M105174200                                                          ; Mikami M, 2016, PLANT CELL PHYSIOL, V57, P1058, DOI 10.1093/pcp/pcw049; Netzker T, 2016, APPL ENVIRON MICROB, V82, P3481, DOI 10.1128/AEM.00371-16; Onaka H, 2011, APPL ENVIRON MICROB, V77, P400, DOI 10.1128/AEM.01337-10; Prykhozhij SV, 2016, ZEBRAFISH, V13, P70, DOI 10.1089/zeb.2015.1158; Quetier F, 2016, PLANT SCI, V242, P65, DOI 10.1016/j.plantsci.2015.09.003; Samanta MK, 2016, TRANSGENIC RES, V25, P561, DOI 10.1007/s11248-016-9953-5; Sevillano L, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0425-7; Tang ZY, 2011, ENZYME MICROB TECH, V49, P17, DOI 10.1016/j.enzmictec.2011.04.002; Thong WL, 2016, J NAT PROD, V79, P857, DOI 10.1021/acs.jnatprod.5b00922; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; Wang Y, 2016, METHOD ENZYMOL, V575, P271, DOI 10.1016/bs.mie.2016.03.014; Wang Y, 2016, ACS SYNTH BIOL, V5, P721, DOI 10.1021/acssynbio.6b00060; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; [谢胜松 Xie Shengsong], 2015, [遗传, Hereditas(Beijing)], V37, P1125, DOI 10.16288/j.yczz.15-093; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Yu L, 2012, ENZYME MICROB TECH, V50, P318, DOI 10.1016/j.enzmictec.2012.03.001; Zhai Y, 2016, BIOCHEM BIOPH RES CO, V473, P329, DOI 10.1016/j.bbrc.2016.03.105; Zhang MZM, 2017, NAT CHEM BIOL, V13, P607, DOI 10.1038/nchembio.2341; Zheng XL, 2016, PLANT CELL REP, V35, P1545, DOI 10.1007/s00299-016-1967-1; Zhou Xiang-chun, 2016, Yi Chuan, V38, P227, DOI 10.16288/j.yczz.15-327; Zhu JJ, 2016, J GENET GENOMICS, V43, P25, DOI 10.1016/j.jgg.2015.10.006	30	0	0	6	6	MICROBIOLOGY SOC	LONDON	CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND	1350-0872	1465-2080		MICROBIOL-SGM	Microbiology-(UK)	AUG	2017	163	8					1148	1155		10.1099/mic.0.000501				8	Microbiology	Microbiology	FG1DN	WOS:000409533800003	28742008				2018-01-05	
J	Mathers, JC				Mathers, John C.			Nutrigenomics in the modern era	PROCEEDINGS OF THE NUTRITION SOCIETY			English	Article; Proceedings Paper	Nutrition-Society Summer Meeting / Conference on New Technology in Nutrition Research and Practice	JUL 11-14, 2016	Univ Coll Dublin, Dublin, IRELAND	Nutr Soc	Univ Coll Dublin	Nutrigenomics; Nutrigenetics; Metabolomics; Microbiome; Personalised nutrition; Organoids; Genome editing	BODY-MASS INDEX; COPY NUMBER VARIATION; DIETARY EXPOSURE; STEM-CELLS; IN-VITRO; FTO GENE; PERSONALIZED NUTRITION; MICROBIOTA COMPOSITION; POTENTIAL BIOMARKERS; GUT MICROBIOTA	The concept that interactions between nutrition and genetics determine phenotype was established by Garrod at the beginning of the 20th century through his ground-breaking work on inborn errors of metabolism. A century later, the science and technologies involved in sequencing of the human genome stimulated development of the scientific discipline which we now recognise as nutritional genomics (nutrigenomics). Much of the early hype around possible applications of this new science was unhelpful and raised expectations, which have not been realised as quickly as some would have hoped. However, major advances have been made in quantifying the contribution of genetic variation to a wide range of phenotypes and it is now clear that for nutrition-related phenotypes, such as obesity and common complex diseases, the genetic contribution made by SNP alone is often modest. There is much scope for innovative research to understand the roles of less well explored types of genomic structural variation, e.g. copy number variants, and of interactions between genotype and dietary factors, in phenotype determination. New tools and models, including stem cell-based approaches and genome editing, have huge potential to transform mechanistic nutrition research. Finally, the application of nutrigenomics research offers substantial potential to improve public health e. g. through the use of metabolomics approaches to identify novel biomarkers of food intake, which will lead to more objective and robust measures of dietary exposure. In addition, nutrigenomics may have applications in the development of personalised nutrition interventions, which may facilitate larger, more appropriate and sustained changes in eating (and other lifestyle) behaviours and help to reduce health inequalities.	[Mathers, John C.] Newcastle Univ, Inst Cellular Med, Human Nutr Res Ctr, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England	Mathers, JC (reprint author), Newcastle Univ, Inst Cellular Med, Human Nutr Res Ctr, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.	john.mathers@ncl.ac.uk		Mathers, John/0000-0003-3406-3002	BBSRC [BB/H011471/1]; EU [265494]; Medical Research Council [MR/ J010308/1]; Medical Research Council [MR/J010308/1]; Biotechnology and Biological Sciences Research Council [BB/G007993/1]; Biotechnology and Biological Sciences Research Council [BB/G007993/1]	My research in nutrigenomics has been supported by the BBSRC (BB/H011471/1), EU Seventh Framework Programme (265494) and Medical Research Council (MR/ J010308/1).	Astley SB, 2007, GENES NUTR, V2, P11, DOI 10.1007/s12263-007-0011-z; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bashiardes S, 2016, CELL METAB, V23, P393, DOI 10.1016/j.cmet.2016.02.015; Beckmann M, 2016, MOL NUTR FOOD RES, V60, P444, DOI 10.1002/mnfr.201500495; Beckmann M, 2013, P NUTR SOC, V72, P352, DOI 10.1017/S0029665113001237; Belsky DW, 2013, BIODEMOGR SOC BIOL, V59, P85, DOI 10.1080/19485565.2013.774628; Bouwens M, 2010, AM J CLIN NUTR, V91, P208, DOI 10.3945/ajcn.2009.28586; Callaway E, 2016, NATURE, V532, P289, DOI 10.1038/532289a; Carpenter D, 2015, HUM MOL GENET, V24, P3472, DOI 10.1093/hmg/ddv098; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Celis-Morales C, 2016, OBESITY, V24, P962, DOI 10.1002/oby.21422; Celis-Morales C, 2015, P NUTR SOC, V74, P130, DOI 10.1017/S0029665114001633; Celis-Morales C, 2015, GENES NUTR, V10, DOI 10.1007/s12263-014-0450-2; Celis-Morales C, 2016, GENES NUTR, V10, P476; Celis-Morales C, 2016, INT J EPIDEMIOL; Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Collins FS, 2013, NEW ENGL J MED, V369, P2369, DOI 10.1056/NEJMp1314561; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Falchi M, 2014, NAT GENET, V46, P492, DOI 10.1038/ng.2939; Fave G, 2011, METABOLOMICS, V7, P469, DOI 10.1007/s11306-011-0289-0; Fave G, 2009, GENES NUTR, V4, P135, DOI 10.1007/s12263-009-0120-y; FernandezCanon JM, 1996, NAT GENET, V14, P19, DOI 10.1038/ng0996-19; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fu JY, 2015, CELL METAB, V21, P507, DOI 10.1016/j.cmet.2015.03.016; Garrod AE, 1902, LANCET, V2, P1616; Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620; Hoeller U, 2016, BRIT J NUTR, V115, P202, DOI 10.1017/S0007114515004298; Huch M, 2015, DEVELOPMENT, V142, P3113, DOI 10.1242/dev.118570; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Joost HG, 2007, BRIT J NUTR, V98, P26, DOI 10.1017/S0007114507685195; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; LAJTHA LG, 1979, DIFFERENTIATION, V14, P23, DOI 10.1111/j.1432-0436.1979.tb01007.x                                              ; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lange K, 2015, MOL NUTR FOOD RES, V59, P1590, DOI 10.1002/mnfr.201400597; Lara J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-60; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Livingstone KM, 2015, OBES REV, V16, P666, DOI 10.1111/obr.12290; Lloyd AJ, 2011, AM J CLIN NUTR, V94, P981, DOI 10.3945/ajcn.111.017921; Lloyd AJ, 2011, BRIT J NUTR, V106, P812, DOI 10.1017/S0007114511001164; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Mathers JC, 2017, P NUTR SOC, V76, P265, DOI [10.1017/S0029665115004280, 10.1017/S002966511600080X]; Mejia-Bentez MA, 2015, DIABETOLOGIA, V58, P290, DOI 10.1007/s00125-014-3441-3; Meplan C, 2016, FASEB J, V30, P2812, DOI 10.1096/fj.201600251R; Mullally A, 2007, BLOOD, V109, P1355, DOI 10.1182/blood-2006-06-030858; Muller M, 2003, NAT REV GENET, V4, P315, DOI 10.1038/nrg1047; Nettleton JA, 2015, HUM MOL GENET, V24, P4728, DOI 10.1093/hmg/ddv186; Nielsen DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112665; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Penn L, 2010, GENES NUTR, V5, P205, DOI 10.1007/s12263-010-0175-9; Peregrin T, 2001, J AM DIET ASSOC, V10, P1036; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Peterson RE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-368; Qi QB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1610; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; ROPER JA, 1960, P NUTR SOC, V19, P39, DOI 10.1079/PNS19600012; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scalbert A, 2014, AM J CLIN NUTR, V99, P1286, DOI 10.3945/ajcn.113.076133; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Snykers S, 2009, STEM CELLS, V27, P577, DOI 10.1634/stemcells.2008-0963; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Thomas D, 2010, ANNU REV PUBL HEALTH, V31, P21, DOI 10.1146/annurev.publhealth.012809.103619; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Verma M, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00005; Vimaleswaran KS, 2009, AM J CLIN NUTR, V90, P425, DOI 10.3945/ajcn.2009.27652; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Zhang DD, 2015, NUTRIENTS, V7, P3054, DOI 10.3390/nu7043054; [Anonymous], NOBEL PRIZE PHYSL ME	71	9	10	19	47	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0029-6651	1475-2719		P NUTR SOC	Proc. Nutr. Soc.	AUG	2017	76	3					265	275		10.1017/S002966511600080X				11	Nutrition & Dietetics	Nutrition & Dietetics	FF9BQ	WOS:000409312200012	26621202				2018-01-05	
J	Petersen, B				Petersen, Bjoern			Basics of genome editing technology and its application in livestock species	REPRODUCTION IN DOMESTIC ANIMALS			English	Review							ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAKS; TAL EFFECTOR NUCLEASES; DNA-BINDING SPECIFICITY; CRISPR-CAS SYSTEMS; HOMOLOGOUS RECOMBINATION; CLEAVAGE DOMAIN; KNOCKOUT PIGS; EFFICIENT GENERATION; RESTRICTION ENZYMES	In the last decade, the research community has witnessed a blooming of targeted genome editing tools and applications. Novel programmable DNA nucleases such as zinc finger nucleases (ZFNs), transcription activator-like endonucleases (TALENs) and the clustered regularly interspaced short palindromic repeats/Cas9 system (CRISPR/Cas9) possess long recognition sites and are capable of cutting DNA in a very specific manner. These DNA nucleases mediate targeted genetic alterations by enhancing the DNA mutation rate via induction of double-strand breaks at a predetermined genomic site. Compared to conventional homologous recombination-based gene targeting, DNA nucleases, also referred to as Genome Editors (GEs), can increase the targeting rate around 10,000- to 100,000-fold. The successful application of different GEs has been shown in a myriad of different organisms, including insects, amphibians, plants, nematodes and several mammalian species, including human cells and embryos. In contrast to all other DNA nucleases, that rely on protein-DNA binding, CRISPR/Cas9 uses RNA to establish a specific binding of its DNA nuclease. Besides its capability to facilitate multiplexed genomic modifications in one shot, the CRISPR/Cas is much easier to design compared to all other DNA nucleases. Current results indicate that any DNA nuclease can be successfully employed in a broad range of organisms which renders them useful for improving the understanding of complex physiological systems such as reproduction, producing transgenic animals, including creating large animal models for human diseases, creating specific cell lines, and plants, and even for treating human genetic diseases. This review provides an update on DNA nucleases, their underlying mechanism and focuses on their application to edit the genome of livestock species.	[Petersen, Bjoern] Friedrich Loeffler Inst, Inst Farm Anim Genet, Neustadt, Germany	Petersen, B (reprint author), Friedrich Loeffler Inst, Inst Farm Anim Genet, Neustadt, Germany.	bjoern.petersen@fli.de					Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bi YZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31729; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Burkard C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006206; Butler JR, 2016, TRANSGENIC RES, V25, P751, DOI 10.1007/s11248-016-9958-0; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10482; [Anonymous], 2011, NAT BIOTECHNOL, V29, P681, DOI 10.1038/nbt.1935; Donoho G, 1998, MOL CELL BIOL, V18, P4070, DOI 10.1128/MCB.18.7.4070                                                           ; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Epinat JC, 2003, NUCLEIC ACIDS RES, V31, P2952, DOI 10.1093/nar/gkg375; Flisikowska T, 2014, J APPL GENET, V55, P53, DOI 10.1007/s13353-013-0182-9; Flisikowska T, 2012, GASTROENTEROLOGY, V143, P1173, DOI 10.1053/j.gastro.2012.07.110; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1144-4; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Guo RH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29855; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kim K, 2017, NAT BIOTECHNOL, V35, P435, DOI 10.1038/nbt.3816; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kim YG, 1997, GENE, V203, P43, DOI 10.1016/S0378-1119(97)00489-7; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Klymiuk N, 2013, HUM MOL GENET, V22, P4368, DOI 10.1093/hmg/ddt287; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Luo JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108185; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MILLER J, 1985, EMBO J, V4, P1609; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313                                                ; Park KE, 2017, SCI REP-UK, V7, DOI 10.1038/srep40176; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Petersen B, 2008, CLONING STEM CELLS, V10, P355, DOI 10.1089/clo.2008.0026; Petersen B, 2016, XENOTRANSPLANTATION, V23, P338, DOI 10.1111/xen.12258; Proudfoot C, 2015, TRANSGENIC RES, V24, P147, DOI 10.1007/s11248-014-9832-x; Qian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14435; Reyes LM, 2014, J IMMUNOL, V193, P5751, DOI 10.4049/jimmunol.1402059; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064                                                         ; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Song YJ, 2015, PROTEIN EXPRES PURIF, V112, P1, DOI 10.1016/j.pep.2015.04.004; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Tan WF, 2016, TRANSGENIC RES, V25, P273, DOI 10.1007/s11248-016-9932-x; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Voytas DF, 2009, SCIENCE, V326, P1491, DOI 10.1126/science.1183604; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep38854; Watanabe M, 2010, BIOCHEM BIOPH RES CO, V402, P14, DOI 10.1016/j.bbrc.2010.09.092; Wells KD, 2017, MOL REPROD DEV, V84, P1012, DOI 10.1002/mrd.22812; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Whyte JJ, 2011, MOL REPROD DEV, V78, P2, DOI 10.1002/mrd.21271; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079; Wu HB, 2015, P NATL ACAD SCI USA, V112, pE1530, DOI 10.1073/pnas.1421587112; Xiong K, 2013, MOL BIOL REP, V40, P4251, DOI 10.1007/s11033-013-2507-5; Yang DS, 2011, CELL RES, V21, P979, DOI 10.1038/cr.2011.70; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yu BL, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0126-9; Yu SL, 2011, CELL RES, V21, P1638, DOI 10.1038/cr.2011.153; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	92	1	1	33	33	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0936-6768	1439-0531		REPROD DOMEST ANIM	Reprod. Domest. Anim.	AUG	2017	52			3	SI		4	13		10.1111/rda.13012				10	Agriculture, Dairy & Animal Science; Reproductive Biology; Veterinary Sciences	Agriculture; Reproductive Biology; Veterinary Sciences	FF7OE	WOS:000409205000002	28815851				2018-01-05	
J	Takeuchi, M; Inoue, C; Goshima, A; Nagao, Y; Shimizu, K; Miyamoto, H; Shimizu, T; Hashimoto, H; Yonemura, S; Kawahara, A; Hirata, Y; Yoshida, M; Hibi, M				Takeuchi, Miki; Inoue, Chikako; Goshima, Akiko; Nagao, Yusuke; Shimizu, Koichi; Miyamoto, Hiroki; Shimizu, Takashi; Hashimoto, Hisashi; Yonemura, Shigenobu; Kawahara, Atsuo; Hirata, Yutaka; Yoshida, Masayuki; Hibi, Masahiko			Medaka and zebrafish contactin1 mutants as a model for understanding neural circuits for motor coordination	GENES TO CELLS			English	Article							VERTEBRATE GENOME EVOLUTION; CEREBELLAR PURKINJE-CELLS; ALPHA 6 SUBUNIT; EYE-MOVEMENTS; MYELINATED AXONS; NERVOUS-SYSTEM; GENE-EXPRESSION; GRANULE CELLS; SENSORY INPUT; INTEGRATOR	A spontaneous medaka ro mutant shows abnormal wobbling and rolling swimming behaviors. By positional cloning, we mapped the ro locus to a region containing the gene encoding Contactin1b (Cntn1b), which is an immunoglobulin (Ig)-superfamily domain-containing membrane-anchored protein. The ro mutant had a deletion in the cntn1b gene that introduced a premature stop codon. Furthermore, cntn1b mutants generated by the CRISPR/Cas9 system and trans-heterozygotes of the CRISPR mutant allele and ro had abnormal swimming behavior, indicating that the cntn1b gene was responsible for the ro-mutant phenotype. We also established zebrafish cntn1a and cntn1b mutants by transcription activator-like effector nucleases (TALENs). Zebrafish cntn1b but not cntn1a mutants showed abnormal swimming behaviors similar to those in the ro mutant, suggesting that Cntn1b plays a conserved role in the formation or function of the neural circuits that control swimming in teleosts. Although Cntn1-deficient mice have abnormal cerebellar neural circuitry, there was no apparent histological abnormality in the cerebellum of medaka or zebrafish cntn1b mutants. The medaka cntn1b mutants had defective optokinetic response (OKR) adaptation and abnormal rheotaxis (body positioning relative to water flow). Medaka and zebrafish cntn1b mutants are effective models for studying the neural circuits involved in motor learning and motor coordination.	[Takeuchi, Miki; Inoue, Chikako; Nagao, Yusuke; Shimizu, Takashi; Hashimoto, Hisashi; Hibi, Masahiko] Nagoya Univ, Biosci & Biotechnol Ctr, Lab Organogenesis & Organ Funct, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Goshima, Akiko; Shimizu, Koichi; Shimizu, Takashi; Hashimoto, Hisashi; Hibi, Masahiko] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Miyamoto, Hiroki; Hirata, Yutaka] Chubu Univ, Dept Comp Sci, 1200 Matsumoto, Kasugai, Aichi 4858501, Japan; [Yonemura, Shigenobu] Tokushima Univ, Grad Sch Med Sci, Dept Cell Biol, 3-18-15 Kuramoto, Tokushima, Tokushima 7708503, Japan; [Kawahara, Atsuo] Univ Yamanashi, Grad Sch Med Sci, Ctr Med Educ & Sci, Lab Dev Biol,Chuo Ku, 1110 Shimokato, Kofu, Yamanashi 4093898, Japan; [Yoshida, Masayuki] Hiroshima Univ, Grad Sch Biosphere Sci, 1-4-4 Kagamiyama, Hiroshima 7398528, Japan	Hibi, M (reprint author), Nagoya Univ, Biosci & Biotechnol Ctr, Lab Organogenesis & Organ Funct, Chikusa Ku, Nagoya, Aichi 4648601, Japan.; Hibi, M (reprint author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	hibi@bio.nagoya-u.ac.jp					Aksay E, 2007, NAT NEUROSCI, V10, P494, DOI 10.1038/nn1877; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; ARNOLD GP, 1974, BIOL REV, V49, P515, DOI 10.1111/j.1469-185X.1974.tb01173.x; Bae YK, 2009, DEV BIOL, V330, P406, DOI 10.1016/j.ydbio.2009.04.013; Bahn S, 1996, J NEUROCHEM, V66, P1810; Beck JC, 2004, J NEUROPHYSIOL, V92, P3546, DOI 10.1152/jn.00311.2004; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5                                                   ; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Compton AG, 2008, AM J HUM GENET, V83, P714, DOI 10.1016/j.ajhg.2008.10.022; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Davisson MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029538; Debowy O, 2011, J NEUROPHYSIOL, V105, P896, DOI 10.1152/jn.00313.2010; ECKMILLER R, 1983, EXP BRAIN RES, V49, P315; ESTANOL B, 1979, ARCH NEUROL-CHICAGO, V36, P281, DOI 10.1001/archneur.1979.00500410059008                                            ; FAIVRESARRAILH C, 1992, J NEUROSCI, V12, P257; GENNARINI G, 1989, J CELL BIOL, V109, P775, DOI 10.1083/jcb.109.2.775; Girault JA, 2002, CURR OPIN NEUROBIOL, V12, P476, DOI 10.1016/S0959-4388(02)00370-7                                                   ; GODAUX E, 1984, J PHYSIOL-LONDON, V346, P155, DOI 10.1113/jphysiol.1984.sp015013                                                  ; Granato M, 1996, DEVELOPMENT, V123, P399; Haenisch C, 2005, MOL CELL NEUROSCI, V28, P361, DOI 10.1016/j.mcn.2004.04.013; HOTSON JR, 1982, NEUROLOGY, V32, P31, DOI 10.1212/WNL.32.1.31                                                             ; Hsieh JY, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00147; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Hyodo-Taguchi Y, 1996, FISH BIOL J MEDAKA, V8, P11; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jones A, 1996, J NEUROCHEM, V67, P907; Kani S, 2010, DEV BIOL, V343, P1, DOI 10.1016/j.ydbio.2010.03.024; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kheradmand Amir, 2011, Front Neurol, V2, P53, DOI 10.3389/fneur.2011.00053; Kimura T, 2004, MECH DEVELOP, V121, P915, DOI 10.1016/j.mod.2004.03.033; Kimura T, 2010, BIOTECHNIQUES, V49, P582, DOI 10.2144/000113467; Kimura Y, 2013, CURR BIOL, V23, P843, DOI 10.1016/j.cub.2013.03.066; Kinoshita M, 2000, DEV GROWTH DIFFER, V42, P469; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; LEECH J, 1977, BRIT J OPHTHALMOL, V61, P774, DOI 10.1136/bjo.61.12.774; Major G, 2004, P NATL ACAD SCI USA, V101, P7739, DOI 10.1073/pnas.0401970101; Major G, 2004, P NATL ACAD SCI USA, V101, P7745, DOI 10.1073/pnas.0401992101; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marsh E, 1997, J NEUROPHYSIOL, V77, P1099; Murai KK, 2002, CURR BIOL, V12, P181, DOI 10.1016/S0960-9822(02)00680-2                                                   ; Nagao Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004246; Nagao Y, 2010, DEV BIOL, V347, P53, DOI 10.1016/j.ydbio.2010.08.001; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; PASTOR AM, 1994, P NATL ACAD SCI USA, V91, P807, DOI 10.1073/pnas.91.2.807; Peles E, 2000, CURR OPIN NEUROBIOL, V10, P558, DOI 10.1016/S0959-4388(00)00122-7; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345                                                              ; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Scalise K, 2016, J NEUROPHYSIOL, V116, P2067, DOI 10.1152/jn.00042.2016; Schweitzer J, 2007, MOL CELL NEUROSCI, V35, P194, DOI 10.1016/j.mcn.2007.02.018; Sengupta M, 2015, ELIFE, V4, DOI 10.7554/eLife.09158; Shimoda Y, 2009, CELL ADHES MIGR, V3, P64, DOI 10.4161/cam.3.1.7764; Stoeckli ET, 2010, CELL ADHES MIGR, V4, P523, DOI 10.4161/cam.4.4.12733; Tanabe K, 2010, J NEUROSCI, V30, P16983, DOI 10.1523/JNEUROSCI.3352-10.2010; Thiele TR, 2014, NEURON, V83, P679, DOI 10.1016/j.neuron.2014.04.018; Tomita H., 1990, THE MEDAKA BIOL, P111; Tomita H., 1975, MEDAKA KILLIFISH BIO, P251; Tomita H., 1992, FISH BIOL J MEDAKA, V4, P45; Uematsu K, 2007, BRAIN BEHAV EVOLUT, V69, P142, DOI 10.1159/000095203; Virgintino D, 1999, J COMP NEUROL, V413, P357, DOI 10.1002/(SICI)1096-9861(19991025)413:3<357::AID-CNE1>3.0.CO;2-S; Volkmann K, 2008, DEV BIOL, V313, P167, DOI 10.1016/j.ydbio.2007.10.024; Whitfield TT, 1996, DEVELOPMENT, V123, P241; Xenaki D, 2011, DEVELOPMENT, V138, P519, DOI 10.1242/dev.051912; ZEE DS, 1981, J NEUROPHYSIOL, V46, P878	70	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	AUG	2017	22	8					723	741		10.1111/gtc.12509				19	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	FF7VL	WOS:000409224300004	28639422				2018-01-05	
J	Sawamura, R; Osafune, N; Murakami, T; Furukawa, F; Kitano, T				Sawamura, Rie; Osafune, Natsumi; Murakami, Takahiro; Furukawa, Fumiya; Kitano, Takeshi			Generation of biallelic F0 mutants in medaka using the CRISPR/Cas9 system	GENES TO CELLS			English	Article							GENETICALLY FEMALE MEDAKA; CAUSES MASCULINIZATION; TARGETED MUTAGENESIS; ZEBRAFISH; EFFICIENT; TILAPIA; GENE; EXPRESSION; VERTEBRATE; NUCLEASE	Several animal models generated by genome editing methods develop somatic mosaic mutations including wild-type genome sequence in F0 generation because it is difficult to use editing tools at the one-cell stage. Producing complete knockout animals quickly is a great advantage in determining the function of target genes. This study investigated the generation of F0 knockout medaka using the CRISPR/Cas9 system. To determine whether this editing system induced mutations in the medaka genome at the one-cell stage, recombinant Cas9 protein, tracrRNA and crRNA for dead end (dnd), which is essential for germ cell development, were injected into one-cell stage embryos of olvas-DsRedExpress transgenic medaka. This allowed germ cells to be visualized by DsRed fluorescence. Genomic DNA extracted from embryos at the one-cell stage was analyzed by sequencing. Predictably, biallelic mutated sequence patterns in the target sites of dnd were found in the injected embryos. To investigate the phenotypes of the mutated fish, fluorescent and histological observations of germ cells were carried out using fry and adults. The mutations resulted in a complete loss of germ cells, suggesting loss of function of dnd in the injected embryos. Therefore, this system appears to be extremely effective for the production of F0 knockout medaka.	[Sawamura, Rie; Osafune, Natsumi; Murakami, Takahiro; Furukawa, Fumiya; Kitano, Takeshi] Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Chuo Ku, 2-39-1 Kurokami, Kumamoto 8608555, Japan	Kitano, T (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Chuo Ku, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	tkitano@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [16H04983, 16K14987]	We thank Drs Takashi Yamamoto (Hiroshima University), Masato Kinoshita (Kyoto University) and Yusaku Wada (FASMAC Co.) for helpful advice. We appreciate Ms Asami Fukuda (Kumamoto University) for technical support. This work was supported by Grants-in-Aid for Scientific Research (nos. 16H04983 and 16K14987 to T.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aluru N, 2015, AQUAT TOXICOL, V158, P192, DOI 10.1016/j.aquatox.2014.11.016; Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Edvardsen RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108622; Feng RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10131; Harel I, 2015, CELL, V160, P1013, DOI 10.1016/j.cell.2015.01.038; Hayashi Y, 2010, MOL REPROD DEV, V77, P679, DOI 10.1002/mrd.21203; Hong N, 2016, STEM CELL REP, V6, P411, DOI 10.1016/j.stemcr.2016.01.002; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Ishikawa Y, 2000, BIOESSAYS, V22, P487, DOI 10.1002/(SICI)1521-1878(200005)22:5<487::AID-BIES11>3.3.CO;2-#; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kawabata Y, 2012, NEUROSCIENCE, V218, P65, DOI 10.1016/j.neuroscience.2012.05.021; Kotani H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128319; Li MH, 2016, GEN COMP ENDOCR, V232, P191, DOI 10.1016/j.ygcen.2016.01.003; Li MH, 2014, GENETICS, V197, P591, DOI 10.1534/genetics.114.163667; Liu LX, 2009, GENE EXPR PATTERNS, V9, P541, DOI 10.1016/j.gep.2009.06.008; Murozumi N, 2014, ENDOCRINOLOGY, V155, P3136, DOI 10.1210/en.2013-2060; OZATO K, 1986, CELL DIFFER DEV, V19, P237, DOI 10.1016/0045-6039(86)90100-4; Shiraishi E, 2008, ENDOCRINOLOGY, V149, P1813, DOI 10.1210/en.2007-1535; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Yokoi S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005009; Zhang XB, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121418	24	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	AUG	2017	22	8					756	763		10.1111/gtc.12511				8	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	FF7VL	WOS:000409224300006	28707405				2018-01-05	
J	Di, QQ; Lin, Q; Huang, ZB; Chi, YL; Chen, XH; Zhang, WQ; Zhang, YY				Di, Qianqian; Lin, Qing; Huang, Zhibin; Chi, Yali; Chen, Xiaohui; Zhang, Wenqing; Zhang, Yiyue			Zebrafish nephrosin helps host defence against Escherichia coli infection	OPEN BIOLOGY			English	Article						neutrophil; nephrosin; infection; zebrafish	INFLAMMATORY RESPONSE; MACROPHAGES; NEUTROPHILS; MECHANISMS; BEHAVIOR; MODEL; METALLOPROTEINASES; MOLECULES; BACTERIA; DISEASE	Neutrophils play important roles in innate immunity and are mainly dependent on various enzyme-containing granules to kill engulfed microorganisms. Zebrafish nephrosin (npsn) is specifically expressed in neutrophils; however, its function is largely unknown. Here, we generated an npsn mutant (npsnsmu5) via CRISPR/Cas9 to investigate the in vivo function of Npsn. The overall development and number of neutrophils remained unchanged in npsn-deficient mutants, whereas neutrophil antibacterial function was defective. Upon infection with Escherichia coli, the npsnsmu5 mutants exhibited a lower survival rate and more severe bacterial burden, aswell as augmented inflammatory response to challenge with infection when compared with wild-type embryos, whereas npsn-overexpressing zebrafish exhibited enhanced host defence against E. coli infection. These findings demonstrated that zebrafish Npsn promotes host defence against bacterial infection. Furthermore, our findings suggested that npsn-deficient and -overexpressing zebrafish might serve as effective models of in vivo innate immunity.	[Di, Qianqian; Lin, Qing; Huang, Zhibin; Chi, Yali; Chen, Xiaohui; Zhang, Wenqing; Zhang, Yiyue] Southern Med Univ, Sch Basic Med Sci, Dept Dev Biol, Key Lab Zebrafish Modeling & Drug Screening Human, Guangzhou 510515, Guangdong, Peoples R China; [Lin, Qing; Zhang, Wenqing] South China Univ Technol, Sch Med, Lab Dev Biol & Regenerat Med, Guangzhou 510006, Guangdong, Peoples R China	Zhang, YY (reprint author), Southern Med Univ, Sch Basic Med Sci, Dept Dev Biol, Key Lab Zebrafish Modeling & Drug Screening Human, Guangzhou 510515, Guangdong, Peoples R China.	yiyue@smu.edu.cn			National Natural Science Foundation of China [31471378, 31701295]; Team Program of Guangdong Natural Science Foundation [2014A030312002]	This work was supported by the National Natural Science Foundation of China (Nos. 31471378 and 31701295) and the Team Program of Guangdong Natural Science Foundation (2014A030312002).	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chitramuthu BP, 2013, JOVE-J VIS EXP, DOI 10.3791/50644; Colucci-Guyon E, 2011, J CELL SCI, V124, P3053, DOI 10.1242/jcs.082792; de Oliveira S, 2013, J IMMUNOL, V190, P4349, DOI 10.4049/jimmunol.1203266; Dinarello CA, 1996, BLOOD, V87, P2095; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinauer MC, 2000, HEMATOLOGY, V2000, P303, DOI DOI 10.1182/ASHEDUCATI0N-2000.1.303; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Ge Gaoxiang, 2006, Birth Defects Research, V78, P47, DOI 10.1002/bdrc.20060; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hung CH, 1997, J BIOL CHEM, V272, P13772, DOI 10.1074/jbc.272.21.13772                                                        ; Jin H, 2006, DEV DYNAM, V235, P60, DOI 10.1002/dvdy.20613; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/2007-06-095398; Levy O, 2004, J LEUKOCYTE BIOL, V76, P909, DOI 10.1189/jlb.0604320; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Lieschke GJ, 2009, CURR BIOL, V19, pR678, DOI 10.1016/j.cub.2009.06.068; Mostowy S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003588; Nguyen-Chi Mai, 2014, Dis Model Mech, V7, P871, DOI 10.1242/dmm.014498; Norman LP, 2003, MOL CELL BIOL, V23, P1221, DOI 10.1128/MCB.23.4.1221-1230.2003; Novoa B, 2012, ADV EXP MED BIOL, V946, P253, DOI 10.1007/978-1-4614-0106-3_15; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Seeger A, 1996, MOL IMMUNOL, V33, P511, DOI 10.1016/0161-5890(96)00002-8; Shafer WM, 2002, CURR PHARM DESIGN, V8, P695, DOI 10.2174/1381612023395376; SHIMELL MJ, 1991, CELL, V67, P469, DOI 10.1016/0092-8674(91)90522-Z; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; SPITZNAGEL JK, 1985, REV INFECT DIS, V7, P398; Stephan A, 2016, IMMUNOLOGY, V148, P420, DOI 10.1111/imm.12620; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Tobin DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002349; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Tsai PL, 2004, J BIOL CHEM, V279, P11146, DOI 10.1074/jbc.M310423200; Tyrkalska SD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12077; van der Sar AM, 2003, CELL MICROBIOL, V5, P601, DOI 10.1046/j.1462-5822.2003.00303.x; Wang K, 2015, FISH SHELLFISH IMMUN, V44, P109, DOI 10.1016/j.fsi.2015.01.038; Wawrocki S, 2016, ACTA BIOCHIM POL, V63, P59, DOI 10.18388/abp.2015_1153; Westerfield M, 1999, METHOD CELL BIOL, V60, P339; WESTERFIELD M, 1993, ZEBRAFISH BOOK GUIDE; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067                                                       	43	0	0	2	2	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	2046-2441			OPEN BIOL	Open Biol	AUG	2017	7	8							170040	10.1098/rsob.170040				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FF2XK	WOS:000408759900001		gold			2018-01-05	
J	Blanchet, P; Bebin, M; Bruet, S; Cooper, GM; Thompson, ML; Duban-Bedu, B; Gerard, B; Piton, A; Suckno, S; Deshpande, C; Clowes, V; Vogt, J; Turnpenny, P; Williamson, MP; Alembik, Y; Glasgow, E; McNeill, A				Blanchet, Patricia; Bebin, Martina; Bruet, Shaam; Cooper, Gregory M.; Thompson, Michelle L.; Duban-Bedu, Benedicte; Gerard, Benedicte; Piton, Amelie; Suckno, Sylvie; Deshpande, Charu; Clowes, Virginia; Vogt, Julie; Turnpenny, Peter; Williamson, Michael P.; Alembik, Yves; Glasgow, Eric; McNeill, Alisdair		Clinical Sequencing; Deciphering Dev Disorders	MYT1L mutations cause intellectual disability and variable obesity by dysregulating gene expression and development of the neuroendocrine hypothalamus	PLOS GENETICS			English	Article							EARLY-ONSET OBESITY; HYPERPHAGIC OBESITY; OXYTOCIN; DEFICIENCY; DELETIONS; SIM1; DISORDERS; PATHWAYS; SPECTRUM; HUMANS	Deletions at chromosome 2p25.3 are associated with a syndrome consisting of intellectual disability and obesity. The smallest region of overlap for deletions at 2p25.3 contains PXDN and MYT1L. MYT1L is expressed only within the brain in humans. We hypothesized that single nucleotide variants (SNVs) in MYT1L would cause a phenotype resembling deletion at 2p25.3. To examine this we sought MYT1L SNVs in exome sequencing data from 4, 296 parent-child trios. Further variants were identified through a genematcher-facilitated collaboration. We report 9 patients with MYT1L SNVs (4 loss of function and 5 missense). The phenotype of SNV carriers overlapped with that of 2p25.3 deletion carriers. To identify the transcriptomic consequences of MYT1L loss of function we used CRISPR-Cas9 to create a knockout cell line. Gene Ontology analysis in knockout cells demonstrated altered expression of genes that regulate gene expression and that are localized to the nucleus. These differentially expressed genes were enriched for OMIM disease ontology terms "mental retardation". To study the developmental effects of MYT1L loss of function we created a zebrafish knockdown using morpholinos. Knockdown zebrafish manifested loss of oxytocin expression in the preoptic neuroendocrine area. This study demonstrates that MYT1L variants are associated with syndromic obesity in humans. The mechanism is related to dysregulated expression of neurodevelopmental genes and altered development of the neuroendocrine hypothalamus.	[Blanchet, Patricia] Hop Arnaud de Villeneuve, Dept Genet Med, Montpellier 5, France; [Bebin, Martina] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA; [Bruet, Shaam] Hop Univ Clermont Ferrand, Serv Genet Med, Clermont Ferrand, France; [Cooper, Gregory M.; Thompson, Michelle L.] HudsonAlpha Inst Biotechnol, Human Genet & Genom, Huntsville, AL USA; [Duban-Bedu, Benedicte; Clinical Sequencing] Ctr Genet Chromos, 51 Blvd Belfort, Lille, France; [Gerard, Benedicte; Piton, Amelie] Hop Univ Strasbourg, Lab Diagnost Genet, F-67000 Strasbourg, France; [Suckno, Sylvie] Hop St Vincent de Paul, Serv Neuropediat, Lille, France; [Deshpande, Charu] Guys Hosp, South East Thames Reg Genet Serv, London, England; [Clowes, Virginia] Northwick Pk Hosp & Clin Res Ctr, North West Thames Reg Genet Ctr, Harrow, Middx, England; [Vogt, Julie] Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England; [Turnpenny, Peter] Royal Devon & Exeter Hosp Heavitree, Peninsula Clin Genet, Exeter, Devon, England; [Williamson, Michael P.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield, S Yorkshire, England; [Alembik, Yves] CHU Hautepierre, Dept Med Genet, Strasbourg, France; [Deciphering Dev Disorders] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Glasgow, Eric] Georgetown Univ, Dept Med, Washington, DC USA; [McNeill, Alisdair] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England; [McNeill, Alisdair] Sheffield Childrens Hosp NHS Fdn Trust, Sheffield Clin Genet Serv, Sheffield, S Yorkshire, England	McNeill, A (reprint author), Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England.; McNeill, A (reprint author), Sheffield Childrens Hosp NHS Fdn Trust, Sheffield Clin Genet Serv, Sheffield, S Yorkshire, England.	A.mcneill@sheffield.ac.uk		Glasgow, Eric/0000-0001-7729-3954	Wellcome Trust; Health Innovation Challenge Fund [HICF-1009-003]; Department of Health; Wellcome Trust Sanger Institute [WT098051]; BDF Newlife [SG/15-16/07]; US National Human Genome Research Institute (NHGRI) [UM1HG007301]; National Cancer Institute (NCI) [R01CM 97139]; National Institute for Health Research, through the Comprehensive Clinical Research Network	Funding for the project was provided by the Wellcome Trust. We declare that those who collected data and deposited it in the DECIPHER database bear no responsibility for its use and interpretation in the current work. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant number WT098051). The cell biology part of the study was funded by a grant from BDF Newlife SG/15-16/07 (AM). This work was supported by grants from the US National Human Genome Research Institute (NHGRI; UM1HG007301) and the National Cancer Institute (NCI; R01CM 97139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the families who kindly agreed to be part of this study. This study makes use of data generated by the DECIPHER Consortium. A full list of centres who contributed to the generation of the data is available from http://decipher.sanger.ac.uk and via email from decipher@-sanger.ac.uk. The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. We are grateful to the patients and their families who contributed to this study. We would like to thank members of the HudsonAlpha CSER team, especially Shirley Simmons, Kelly East, Whitley Kelley, Kevin Bowling, Susan Hiatt, Candice Finnila, David Gray, James Lawlor, and Michelle Amaral, for help with sequencing data analysis. The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network.	Bonaglia MC, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-53; De Rocker N, 2015, GENET MED, V17, P460, DOI 10.1038/gim.2014.124; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doco-Fenzy M, 2014, EUR J HUM GENET, V22, P471, DOI 10.1038/ejhg.2013.189; Elsea SH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001827; Emerson E, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0296-x; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988                                                            ; Gamsjaeger R, 2013, J BIOL CHEM, V288, P35180, DOI 10.1074/jbc.M113.482075; GTEx Consortium, 2013, NAT GENET, V45, P580; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hempel A, 2016, J MED GENET, V53, P152, DOI 10.1136/jmedgenet-2015-103393; Herget U, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00002; Kasher PR, 2016, AM J HUM GENET, V98, P363, DOI 10.1016/j.ajhg.2015.12.014; Kaur Y, 2017, OBES REV; Khan K, 2011, AM J HUM GENET, V89, P464, DOI 10.1016/j.ajhg.2011.08.005; Khan MJ, 2016, PEDIAT OBES; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Kublaoui BM, 2008, MOL ENDOCRINOL, V22, P1723, DOI 10.1210/me.2008-0067; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maejima Y, 2011, AGING-US, V3, P1169, DOI 10.18632/aging.100408                                                           ; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Michaud JL, 2001, HUM MOL GENET, V10, P1465, DOI 10.1093/hmg/10.14.1465; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185                                                                   ; Ramachandrappa S, 2013, J CLIN INVEST, V123, P3042, DOI 10.1172/JCI68016; Rio M, 2013, CLIN GENET, V84, P31, DOI 10.1111/cge.12036; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Rosenfeld JA, 2017, J PEDIATR GENET, V6, P42, DOI 10.1055/s-0036-1584306; Shohat S, 2017, CELL REP, V18, P2217, DOI 10.1016/j.celrep.2017.02.007; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Stevens SJC, 2011, AM J MED GENET A, V155A, P2739, DOI 10.1002/ajmg.a.34274; Tolson KP, 2010, J NEUROSCI, V30, P3803, DOI 10.1523/JNEUROSCI.5444-09.2010; van der Klaauw AA, 2015, CELL, V161, P119, DOI 10.1016/j.cell.2015.03.008; Vasconcelos FF, 2016, CELL REP, V17, P469, DOI 10.1016/j.celrep.2016.09.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Voll SL, 2017, GENET MED, V19, P204, DOI 10.1038/gim.2016.98; Wang TY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13316; Watanabe T, 2014, JAMA PSYCHIAT, V71, P166, DOI 10.1001/jamapsychiatry.2013.3181; Wentzel C, 2010, MOL SYNDROMOL, V1, P75, DOI 10.1159/000314025; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Zhang R, 2017, NEUROSCI BULL, V33, P238, DOI 10.1007/s12264-017-0120-7	45	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	AUG	2017	13	8							e1006957	10.1371/journal.pgen.1006957				23	Genetics & Heredity	Genetics & Heredity	FF2YX	WOS:000408763800030	28859103	gold			2018-01-05	
J	Cheng, X; Waghulde, H; Mell, B; Morgan, EE; Pruett-Miller, SM; Joe, B				Cheng, Xi; Waghulde, Harshal; Mell, Blair; Morgan, Eric E.; Pruett-Miller, Shondra M.; Joe, Bina			Positional cloning of quantitative trait nucleotides for blood pressure and cardiac QT-interval by targeted CRISPR/Cas9 editing of a novel long non-coding RNA	PLOS GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SALT-SENSITIVE HYPERTENSION; DAHL S RATS; CONGENIC STRAINS; GENETIC-DETERMINANTS; LOCI; DISEASE; REGION; VARIANTS; PATHWAYS	Multiple GWAS studies have reported strong association of cardiac QT-interval to a region on HSA17. Interestingly, a rat locus homologous to this region is also linked to QT-intervals. The high resolution positional mapping study located the rat QT-interval locus to a <42.5kb region on RNO10. This region contained no variants in protein-coding sequences, but a prominent contiguous 19bp indel polymorphism was noted within a novel predicted long non-coding RNA (lncRNA), which we named as Rffl-lnc1. To assess the candidacy of this novel lncRNA on QT-interval, targeted CRISPR/Cas9 based genome-engineering approaches were applied on the rat strains used to map this locus. Targeted disruption of the rat Rffl-lnc1 locus caused aberrant, short QT-intervals and elevated blood pressure. Further, to specifically examine the significance of the 19bp polymorphism within the Rffl-lnc1 locus, a CRISPR/Cas9 based targeted knock-in rescue model was constructed by inserting the 19bp into the strain which contained the deletion polymorphism. The knock-in alleles successfully rescued the aberrant QT-interval and blood pressure phenotypes. Further studies revealed that the 19bp polymorphism was necessary and sufficient to recapitulate the phenotypic effect of the previously mapped < 42.5kb rat locus. To our knowledge, this study is the first demonstration of a combination of both CRISPR/Cas9 based targeted disruption as well as CRISPR/Cas9 based targeted knock-in rescue approaches applied for a mammalian positional cloning study, which defines the quantitative trait nucleotides (QTNs) within a rat long non-coding RNA as being important for the pleiotropic regulation of both cardiac QT-intervals and blood pressure.	[Cheng, Xi; Waghulde, Harshal; Mell, Blair; Morgan, Eric E.; Joe, Bina] Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, Program Physiol Genom,Ctr Hypertens & Personalize, 2801 W Bancroft St, Toledo, OH 43606 USA; [Morgan, Eric E.] Univ Toledo, Med Ctr, Dept Radiol, 2801 W Bancroft St, Toledo, OH 43606 USA; [Pruett-Miller, Shondra M.] St Jude Childrens Res Hosp, Ctr Adv Genome Engn, Dept Cell & Mol Biol, 332 N Lauderdale St, Memphis, TN 38105 USA	Joe, B (reprint author), Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, Program Physiol Genom,Ctr Hypertens & Personalize, 2801 W Bancroft St, Toledo, OH 43606 USA.	bina.joe@utoledo.edu			National Heart, Lung and Blood Institute of the National Institutes of Health [HL020176]	Dr. Bina Joe is funded by the National Heart, Lung and Blood Institute of the National Institutes of Health (HL020176, https//projectreporter.nih.gov/reporter.cfm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Arking DE, 2014, NAT GENET, V46, P826, DOI 10.1038/ng.3014; Basson J, 2012, CURR HYPERTENS REP, V14, P46, DOI 10.1007/s11906-011-0241-8; Butler Merlin G, 2010, J Med Liban, V58, P175; Chauvet C, 2008, J HYPERTENS, V26, P893, DOI 10.1097/HJH.0b013e3282f85ded; Cheng X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153519; Cicila GT, 2009, HYPERTENSION, V53, P725, DOI 10.1161/HYPERTENSIONAHA.108.126649; Clement DL, 2004, CURR PHARM DESIGN, V10, P3615, DOI 10.2174/1381612043382819; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Cowley AW, 2016, PHYSIOL GENOMICS, V48, P62, DOI 10.1152/physiolgenomics.00097.2015; Cowley AW, 2014, PHYSIOL GENOMICS, V46, P398, DOI 10.1152/physiolgenomics.00179.2013; Deng AY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151399; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5                                                   ; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Garrett MR, 2001, HYPERTENSION, V38, P779, DOI 10.1161/hy1001.091503                                                           ; Garrett MR, 1998, GENOME RES, V8, P711, DOI 10.1101/gr.8.7.711                                                              ; Gopalakrishnan K, 2015, HYPERTENSION, V65, P200, DOI 10.1161/HYPERTENSIONAHA.114.04498; Gopalakrishnan Kathirvel, 2012, Frontiers in Genetics, V3, P138, DOI 10.3389/fgene.2012.00138; Gopalakrishnan K, 2011, HYPERTENSION, V57, P764, DOI 10.1161/HYPERTENSIONAHA.110.165803; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Herrera VLM, 2006, PHYSIOL GENOMICS, V26, P172, DOI 10.1152/physiolgenomics.00285.2005; Herrera VL, 2013, PLOS ONE, V8; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kouremenos N, 2014, HELL J CARDIOL, V55, P9; Kumarasamy S, 2011, HYPERTENS RES, V34, P1263, DOI 10.1038/hr.2011.116; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lip GYH, 2000, EUR HEART J, V21, P1653, DOI 10.1053/euhj.2000.2339; Lu XF, 2015, HUM MOL GENET, V24, P865, DOI 10.1093/hmg/ddu478; MCINNES GT, 1995, J HYPERTENS, V13, pS49, DOI 10.1097/00004872-199508001-00008                                                ; McIntyre H, 1997, J CARDIOVASC ELECTR, V8, P887, DOI 10.1111/j.1540-8167.1997.tb00850.x                                              ; Merai R, 2016, MMWR-MORBID MORTAL W, V65, P1261, DOI 10.15585/mmwr.mm6545a3; Moreno C, 2007, PHYSIOL GENOMICS, V31, P228, DOI 10.1152/physiolgenomics.00280.2006; Morgan EE, 2004, AM J PHYSIOL-HEART C, V287, pH2049, DOI 10.1152/ajpheart.00393.2004; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Nie Y, 2016, PHYSIOL GENOMICS, V48, P409, DOI 10.1152/physiolgenomics.00004.2016; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Pillai R, 2013, PHYSIOL GENOMICS, V45, P729, DOI 10.1152/physiolgenomics.00077.2013; Rapp JP, 2000, PHYSIOL REV, V80, P135; Saad Y, 2008, MAMM GENOME, V19, P85, DOI 10.1007/s00335-007-9084-7; Saad Y, 2007, HYPERTENSION, V50, P891, DOI 10.1161/HYPERTENSIONAHA.107.097105; Saad Y, 2007, GENOMICS, V89, P343, DOI 10.1016/j.ygeno.2006.12.005; Salvi E, 2012, HYPERTENSION, V59, P248, DOI 10.1161/HYPERTENSIONAHA.111.181990; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; WINTERTON SJ, 1994, CARDIOVASC RES, V28, P47, DOI 10.1093/cvr/28.1.47	46	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	AUG	2017	13	8							e1006961	10.1371/journal.pgen.1006961				20	Genetics & Heredity	Genetics & Heredity	FF2YX	WOS:000408763800033	28827789	gold			2018-01-05	
J	Gomez-Velazquez, M; Badia-Careaga, C; Lechuga-Vieco, AV; Nieto-Arellano, R; Tena, JJ; Rollan, I; Alvarez, A; Torroja, C; Caceres, EF; Roy, A; Galjart, N; Delgado-Olguin, P; Sanchez-Cabo, F; Enriquez, JA; Gomez-Skarmeta, JL; Manzanares, M				Gomez-Velazquez, Melisa; Badia-Careaga, Claudio; Victoria Lechuga-Vieco, Ana; Nieto-Arellano, Rocio; Tena, Juan J.; Rollan, Isabel; Alvarez, Alba; Torroja, Carlos; Caceres, Eva F.; Roy, Anna; Galjart, Niels; Delgado-Olguin, Paul; Sanchez-Cabo, Fatima; Antonio Enriquez, Jose; Luis Gomez-Skarmeta, Jose; Manzanares, Miguel			CTCF counter-regulates cardiomyocyte development and maturation programs in the embryonic heart	PLOS GENETICS			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTORS; NEURAL DEVELOPMENT; DNA INTERACTIONS; HUMAN GENOME; HUMAN-CELLS; MITOCHONDRIAL; ORGANIZATION; MAP; DIFFERENTIATION	Cardiac progenitors are specified early in development and progressively differentiate and mature into fully functional cardiomyocytes. This process is controlled by an extensively studied transcriptional program. However, the regulatory events coordinating the progression of such program from development to maturation are largely unknown. Here, we show that the genome organizer CTCF is essential for cardiogenesis and that it mediates genomic interactions to coordinate cardiomyocyte differentiation and maturation in the developing heart. Inactivation of Ctcf in cardiac progenitor cells and their derivatives in vivo during development caused severe cardiac defects and death at embryonic day 12.5. Genome wide expression analysis in Ctcf mutant hearts revealed that genes controlling mitochondrial function and protein production, required for cardiomyocyte maturation, were upregulated. However, mitochondria from mutant cardiomyocytes do not mature properly. In contrast, multiple development regulatory genes near predicted heart enhancers, including genes in the IrxA cluster, were downregulated in Ctcf mutants, suggesting that CTCF promotes cardiomyocyte differentiation by facilitating enhancer-promoter interactions. Accordingly, loss of CTCF disrupts gene expression and chromatin interactions as shown by chromatin conformation capture followed by deep sequencing. Furthermore, CRISPR-mediated deletion of an intergenic CTCF site within the IrxA cluster alters gene expression in the developing heart. Thus, CTCF mediates local regulatory interactions to coordinate transcriptional programs controlling transitions in morphology and function during heart development.	[Gomez-Velazquez, Melisa; Badia-Careaga, Claudio; Victoria Lechuga-Vieco, Ana; Nieto-Arellano, Rocio; Rollan, Isabel; Alvarez, Alba; Torroja, Carlos; Caceres, Eva F.; Sanchez-Cabo, Fatima; Antonio Enriquez, Jose; Manzanares, Miguel] CNIC, Madrid, Spain; [Tena, Juan J.; Luis Gomez-Skarmeta, Jose] Univ Pablo de Olavide Junta de Andalucia, CSIC, CABD, Seville, Spain; [Roy, Anna; Delgado-Olguin, Paul] Hosp Sick Children, Translat Med, Toronto, ON, Canada; [Roy, Anna; Delgado-Olguin, Paul] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Galjart, Niels] Erasmus MC, Dept Cell Biol & Genet, Rotterdam, Netherlands; [Delgado-Olguin, Paul] Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON, Canada; [Caceres, Eva F.] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden	Manzanares, M (reprint author), CNIC, Madrid, Spain.	mmanzanares@cnic.es	Tena, Juan/M-2265-2014; Manzanares, Miguel/E-1702-2015; Enriquez, Jose Antonio/M-8468-2016; Torroja, Carlos/N-6022-2014	Tena, Juan/0000-0001-8165-7984; Manzanares, Miguel/0000-0003-4849-2836; Enriquez, Jose Antonio/0000-0002-3671-2961; Torroja, Carlos/0000-0001-8914-3400	Spanish Ministerio de Economia y Competitividad [BFU2011-23083, BFU2014-54608-P, BFU2013-41322-P, BFU2014-58449-JIN]; Comunidad Autonoma de Madrid; Andalusian regional government [BIO-396]; Universidad Pablo de Olavide; Heart and Stroke Foundation of Canada [G-17-0018613]; Operational Funds from the Hospital for Sick Children; Natural Sciences and Engineering Research Council of Canada (NSERC) [500865]; Canadian Institutes of Health Research (CIHR) [PJT-149046]; Spanish Ministerio de Economia y Competitividad and the Pro-CNIC Foundation; Severo Ochoa Center of Excellence [SEV-2015-0505]	This work was funded by the Spanish Ministerio de Economia y Competitividad (grants BFU2011-23083 and BFU2014-54608-P to MM, BFU2013-41322-P to JLGS and BFU2014-58449-JIN to JJT), the Comunidad Autonoma de Madrid (grant CELLDD-CM to MM), the Andalusian regional government (grant BIO-396 to JLGS), the Universidad Pablo de Olavide (postdoctoral grant to JJT). PDO is funded by the Heart and Stroke Foundation of Canada (G-17-0018613), Operational Funds from the Hospital for Sick Children, the Natural Sciences and Engineering Research Council of Canada (NSERC) (500865 to PDO), and the Canadian Institutes of Health Research (CIHR) (PJT-149046). The CNIC is supported by the Spanish Ministerio de Economia y Competitividad and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao ZZ, 1999, SCIENCE, V283, P1161, DOI 10.1126/science.283.5405.1161                                                   ; Beutner G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113330; Bonora G, 2014, CURR OPIN GENET DEV, V27, P92, DOI 10.1016/j.gde.2014.05.002; Bosse A, 1997, MECH DEVELOP, V69, P169, DOI 10.1016/S0925-4773(97)00165-2                                                   ; Brand NJ, 2010, METHODS MOL BIOL, V633, P113, DOI 10.1007/978-1-59745-019-5_9; Bruneau BG, 2002, CIRC RES, V90, P509, DOI 10.1161/01.RES.0000013072.51957.B7; Bruneau BG, 2001, MOL CELL BIOL, V21, P1730, DOI 10.1128/MCB.21.5.1730-1736.2001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Gomez-Skarmeta JL, 2002, CURR OPIN GENET DEV, V12, P403, DOI 10.1016/S0959-437X(02)00317-9; Guaras A, 2016, CELL REP, V15, P197, DOI 10.1016/j.celrep.2016.03.009; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hirayama T, 2012, CELL REPORTS, V2, P345, DOI 10.1016/j.celrep.2012.06.014; Hirschy A, 2006, DEV BIOL, V289, P430, DOI 10.1016/j.ydbio.2005.10.046; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kemp CJ, 2014, CELL REP, V7, P1020, DOI 10.1016/j.celrep.2014.04.004; Kim KH, 2012, CIRC RES, V110, P1513, DOI 10.1161/CIRCRESAHA.112.265041; Klein FA, 2015, BIOINFORMATICS, V31, P3085, DOI 10.1093/bioinformatics/btv335; Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618; Luna-Zurita L, 2010, J CLIN INVEST, V120, P3493, DOI 10.1172/JCI42666; Martin D, 2011, NAT STRUCT MOL BIOL, V18, P708, DOI 10.1038/nsmb.2059; Moore JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034915; Nikolic T, 2014, CELL MOL IMMUNOL, V11, P58, DOI 10.1038/cmi.2013.41; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pohl A, 2014, BIOINFORMATICS, V30, P1618, DOI 10.1093/bioinformatics/btu056; Quitschke WW, 2000, NUCLEIC ACIDS RES, V28, P3370, DOI 10.1093/nar/28.17.3370; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sams DS, 2016, CELL REP, V17, P2418, DOI 10.1016/j.celrep.2016.11.004; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Soshnikova N, 2010, DEV CELL, V19, P819, DOI 10.1016/j.devcel.2010.11.009; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Tena JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1301; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; van Weerd JH, 2014, CIRC RES, V115, P432, DOI 10.1161/CIRCRESAHA.115.303591; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; Watson LA, 2014, J NEUROSCI, V34, P2860, DOI 10.1523/JNEUROSCI.3769-13.2014; Yaguchi T, 2007, ANN NY ACAD SCI, V1100, P306, DOI 10.1196/annals.1395.032; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	58	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	AUG	2017	13	8							e1006985	10.1371/journal.pgen.1006985				25	Genetics & Heredity	Genetics & Heredity	FF2YX	WOS:000408763800046	28846746	gold			2018-01-05	
J	Jeong, E; Moon, SU; Song, M; Yoon, S				Jeong, Euna; Moon, Sung Ung; Song, Mee; Yoon, Sukjoon			Transcriptome modeling and phenotypic assays for cancer precision medicine	ARCHIVES OF PHARMACAL RESEARCH			English	Review						Cancer transcriptome; Phenotypic screening; Precision medicine; Biomarker	OF-FUNCTION SCREENS; CELL-LINES; GENE-EXPRESSION; DRUG-SENSITIVITY; BREAST-CANCER; CRISPR-CAS9; DISCOVERY; PATTERNS; COMPLEX; GENOME	Cancer precision medicine requires clinically actionable biomarkers for patient stratification and a better prediction of clinical outcome. Although thousands of cancer-enriched mutated genes have been reported by global sequencing projects, to date, only a few oncogenic mutations have been confirmed as effective biomarkers in cancer therapies. The low frequency and varied profile (i.e., allele frequency, mutation position) of mutant genes among cancer types limit the utility of predictive biomarkers. The recent explosion of cancer transcriptome and phenotypic screening data provides another opportunity for finding transcript-level biomarkers and targets, thus overcoming the limitation of cancer mutation analyses. Technological developments enable the rapid and extensive discovery of potential target-biomarker combinations from large-scale transcriptome-level screening combined with physiologically relevant phenotypic assays. Here, we summarized recent progress as well as discussed the outlook of transcriptome-oriented data mining strategies and phenotypic assays for the identification of non-genetic biomarkers and targets in cancer drug discovery.	[Jeong, Euna; Moon, Sung Ung; Song, Mee; Yoon, Sukjoon] Sookmyung Womens Univ, Ctr Adv Bioinformat & Syst Med, Hyochangwon Gil 52, Seoul 140742, South Korea; [Yoon, Sukjoon] Sookmyung Womens Univ, Dept Biol Sci, Hyochangwon Gil 52, Seoul 140742, South Korea	Yoon, S (reprint author), Sookmyung Womens Univ, Ctr Adv Bioinformat & Syst Med, Hyochangwon Gil 52, Seoul 140742, South Korea.; Yoon, S (reprint author), Sookmyung Womens Univ, Dept Biol Sci, Hyochangwon Gil 52, Seoul 140742, South Korea.	yoonsj@sookmyung.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MEST) [NRF-2015R1D1A1A01057815, NRF-2016R1D1A1B03935110, NRF-2016R1A5A1011974]	This research was supported by grants from the National Research Foundation of Korea (NRF), including the Basic Science Research Program (NRF-2015R1D1A1A01057815 and NRF-2016R1D1A1B03935110) and the Science Research Center Program (NRF-2016R1A5A1011974), which is funded by the Korean government (MEST).	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Aken BL, 2016, DATABASE, V2016, DOI DOI 10.1093/DATABASE/BAW093; Arai K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162394; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bray MA, 2016, NAT PROTOC, V11, P1757, DOI 10.1038/nprot.2016.105; Caicedo JC, 2016, CURR OPIN BIOTECH, V39, P134, DOI 10.1016/j.copbio.2016.04.003; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Deeken JF, 2009, MOL PHARMACOL, V76, P946, DOI 10.1124/mol.109.056192; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Erb MA, 2017, NATURE, V543, P270, DOI 10.1038/nature21688; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Fu JQ, 2017, SLAS DISCOV, V22, P525, DOI 10.1177/2472555217696796; Gimenez CA, 2016, GENE THER, V23, P543, DOI 10.1038/gt.2016.28; GONZALEZ D, 2013, CLIN PHARMACOL THER, V93, P252, DOI DOI 10.1038/CLPT.2012.237; Gu Y, 2017, BRIEF BIOINFORM, DOI [10.1093/bib/bbw142, DOI 10.1093/BIB/BBW142]; Hannus M, 2014, NUCLEIC ACIDS RES, V42, P8049, DOI 10.1093/nar/gku480; Hatzis C, 2014, CANCER RES, V74, P4016, DOI 10.1158/0008-5472.CAN-14-0725; Hong Y, 2017, BIOCHEM BIOPH RES CO, V487, P307, DOI 10.1016/j.bbrc.2017.04.055; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Horman SR, 2015, FUTURE MED CHEM, V7, P513, DOI [10.4155/FMC.14.163, 10.4155/fmc.14.163]; Howes AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108283; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Jaiswal A, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0440-2; Jeong E, 2015, BIOINFORMATICS, V31, P1508, DOI 10.1093/bioinformatics/btu835; Jiang GL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2911-z; Kelloff GJ, 2012, NAT REV DRUG DISCOV, V11, P201, DOI 10.1038/nrd3651; Kim N, 2016, SCI REP-UK, V6, DOI 10.1038/srep29721; Yoon Sukjoon, 2013, Genomics & Informatics, V11, P239, DOI 10.5808/GI.2013.11.4.239; Kim N, 2012, INT J CANCER, V131, P2456, DOI 10.1002/ijc.27529; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; Li J, 2017, CANCER CELL, V31, P225, DOI 10.1016/j.ccell.2017.01.005; LIU Y, 2017, GENES-BASEL, V8, DOI DOI 10.3390/GENES8030086; Marhefka JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046086; Marugan Carlos, 2015, Front Oncol, V5, P299, DOI 10.3389/fonc.2015.00299; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Pereira LP, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040368; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Rameseder J, 2015, J BIOMOL SCREEN, V20, P985, DOI 10.1177/1087057115583037; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Rauscher B, 2017, NUCLEIC ACIDS RES, V45, pD679, DOI 10.1093/nar/gkw997; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Riba A, 2017, CELL SYST, V4, P182, DOI 10.1016/j.cels.2017.01.011; Riss T. L, 2004, ASSAY GUIDANCE MANUA; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Rotem A, 2015, P NATL ACAD SCI USA, V112, P5708, DOI 10.1073/pnas.1505979112; Roychowdhury S, 2016, CA-CANCER J CLIN, V66, P75, DOI 10.3322/caac.21329; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Singh S, 2014, J BIOMOL SCREEN, V19, P640, DOI 10.1177/1087057114528537; Song M, 2017, FASEB J, V31, P625, DOI 10.1096/fj.201600953; Song M, 2015, COMPUT BIOL CHEM, V58, P192, DOI 10.1016/j.compbiolchem.2015.07.005; Sundar R, 2017, CURR PROB CANCER, V41, P302, DOI 10.1016/j.currproblcancer.2017.05.002; Thoma CR, 2014, ADV DRUG DELIVER REV, V69, P29, DOI 10.1016/j.addr.2014.03.001; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Vempati UD, 2014, J BIOMOL SCREEN, V19, P803, DOI 10.1177/1087057114522514; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Zeng X, 2017, BIOINFORMATICS, V33, P3276, DOI 10.1093/bioinformatics/btx340; Zheng W, 2013, DRUG DISCOV TODAY, V18, P1067, DOI 10.1016/j.drudis.2013.07.001	63	0	0	4	4	PHARMACEUTICAL SOC KOREA	SEOUL	1489-3 SUHCHO-DONG, SUHCHO-KU, SEOUL 137-071, SOUTH KOREA	0253-6269	1976-3786		ARCH PHARM RES	Arch. Pharm. Res.	AUG	2017	40	8					906	914		10.1007/s12272-017-0940-z				9	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	FF2ZV	WOS:000408766200003	28766239				2018-01-05	
J	Bayer-Csaszar, E; Haag, S; Jorg, A; Glass, F; Hartel, B; Obata, T; Meyer, EH; Brennicke, A; Takenaka, M				Bayer-Csaszar, Eszter; Haag, Sascha; Joerg, Anja; Glass, Franziska; Haertel, Barbara; Obata, Toshihiro; Meyer, Etienne H.; Brennicke, Axel; Takenaka, Mizuki			The conserved domain in MORF proteins has distinct affinities to the PPR and E elements in PPR RNA editing factors	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Article						RNA editing; Mitochondria; chloroplast; MEF proteins; MORF proteins; Protein-protein interaction; Arabidopsis thaliarza	PENTATRICOPEPTIDE REPEAT PROTEIN; MOTIF-CONTAINING PROTEIN; ARABIDOPSIS-THALIANA; DYW DOMAIN; FUNCTIONAL-ANALYSIS; PLANT-MITOCHONDRIA; BINDING PROTEINS; GENE-EXPRESSION; MESSENGER-RNAS; TRANSCRIPT	In plant organelles specific nucleotide motifs at C to U RNA editing sites are recognized by the PLS-class of pentatricopeptide repeat (PPR) proteins, which are additionally characterized by a C-terminal E domain. The PPR elements bind the nucleotides in the target RNA, while the function of the E domain has remained unknown. At most sites RNA editing also requires multiple organellar RNA editing factor (MORF) proteins. To understand how these two types of proteins are involved in RNA editing complexes, we systematically analyzed their protein-protein interactions. In vivo pull-down and yeast two-hybrid assays show that MORF proteins connect with selected PPR proteins. In a loss of function mutant of MORF1, a single amino acid alteration in the conserved MORF domain abrogates interactions with many PLS-class PPR proteins, implying the requirement of direct interaction to PPR proteins for the RNA editing function of MORF1. Subfragment analyses show that predominantly the N-terminal/central regions of the MORF domain in MORF1 and MORF3 bind the PPR proteins. Within the PPR proteins, the E domains in addition to PPR elements contact MORF proteins. In chimeric PPR proteins, different E domains alter the specificity of the interaction with MORF proteins. The selective interactions between E domain containing PPR and MORF proteins suggest that the E domains and MORF proteins play a key role for specific protein complexes to assemble at different RNA editing sites.	[Bayer-Csaszar, Eszter; Haag, Sascha; Joerg, Anja; Glass, Franziska; Haertel, Barbara; Brennicke, Axel; Takenaka, Mizuki] Univ Ulm, Mol Bot, D-89069 Ulm, Germany; [Obata, Toshihiro; Meyer, Etienne H.] Max Planck Inst Mol Pflanzenphysiol, D-14476 Potsdam, Golm, Germany	Takenaka, M (reprint author), Univ Ulm, Mol Bot, D-89069 Ulm, Germany.	mizuki.takenaka@uni-ulm.de		Meyer, Etienne/0000-0003-4712-9824	Deutsche Forschungsgemeinschaft [TA642/10-1, TA 642/6-1, TA 642/3-1, BR726/11-2]; Heisenberg fellowship from Deutsche Forschungsgenieinschaft [TA642/4-2]	This work was supported by grants to MT and AB from the Deutsche Forschungsgemeinschaft [TA642/10-1, TA 642/6-1, TA 642/3-1 to MT.; BR726/11-2 to AB.]; a Heisenberg fellowship from Deutsche Forschungsgenieinschaft [TA642/4-2 to MT.].	Andres C, 2007, PHYSIOL PLANTARUM, V129, P14, DOI 10.1111/j.1399-3054.2006.00766.x; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Boussardon C, 2014, NEW PHYTOL, V203, P1090, DOI 10.1111/nph.12928; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Braun P, 2013, ANNU REV PLANT BIOL, V64, P161, DOI 10.1146/annurev-arplant-050312-120140; Braun P, 2012, PROTEOMICS, V12, P1499, DOI 10.1002/pmic.201100598; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chateigner-Boutin AL, 2013, PLANT J, V74, P935, DOI 10.1111/tpj.12180; Cheng SF, 2016, PLANT J, V85, P532, DOI 10.1111/tpj.13121; Colcombet J, 2013, RNA BIOL, V10, P1557, DOI 10.4161/rna.26128; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Glass F, 2015, MOL PLANT, V8, P1466, DOI 10.1016/j.molp.2015.05.008; Haag S, 2017, NUCLEIC ACIDS RES, V45, P4915, DOI 10.1093/nar/gkx099; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Hayes ML, 2013, J BIOL CHEM, V288, P36519, DOI 10.1074/jbc.M113.485755; James P, 1996, GENETICS, V144, P1425; Kobayashi K, 2012, NUCLEIC ACIDS RES, V40, P2712, DOI 10.1093/nar/gkr1084; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Liu YJ, 2013, PLANT CELL, V25, P868, DOI 10.1105/tpc.112.106781; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Nakamura T, 2012, PLANT CELL PHYSIOL, V53, P1171, DOI 10.1093/pcp/pcs069; Obata T, 2011, PHYTOCHEMISTRY, V72, P1081, DOI 10.1016/j.phytochem.2010.11.003; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Pyo YJ, 2013, PLANT PHYSIOL, V163, P1844, DOI 10.1104/pp.113.227199; Ramos-Vega M, 2015, NEW PHYTOL, V208, P430, DOI 10.1111/nph.13468; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Ruwe H, 2013, FEBS LETT, V587, P1429, DOI 10.1016/j.febslet.2013.03.022; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schutze K., 2009, BIMOLECULAR FLUORESC, P189; Shi XW, 2016, PLANT PHYSIOL, V170, P294, DOI 10.1104/pp.15.01280; Shi XW, 2015, NUCLEIC ACIDS RES, V43, P3814, DOI 10.1093/nar/gkv245; Sosso D, 2012, PLANT CELL, V24, P676, DOI 10.1105/tpc.111.091074; Sparkes I.A., 2006, NAT PROTOCOL; Sun T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005028; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Takenaka M, 2007, METHOD ENZYMOL, V424, P439, DOI 10.1016/S0076-6879(07)24020-0; Takenaka M, 2014, MOL PLANT, V7, P582, DOI 10.1093/mp/sst170; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Takenaka M, 2011, METHODS MOL BIOL, V718, P163, DOI 10.1007/978-1-61779-018-8_10; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Takenaka M, 2010, PLANT PHYSIOL, V152, P939, DOI 10.1104/pp.109.151175; Tanz SK, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00214; Tillich M, 2009, P NATL ACAD SCI USA, V106, P6002, DOI 10.1073/pnas.0808529106; Tseng CC, 2010, PLANT MOL BIOL, V73, P309, DOI 10.1007/s11103-010-9616-5; Verbitskiy D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397992; Verbitskiy D, 2012, PLANT CELL PHYSIOL, V53, P358, DOI 10.1093/pcp/pcr182; Vermel M, 2002, P NATL ACAD SCI USA, V99, P5866, DOI 10.1073/pnas.092019599; Walter M, 2002, EMBO J, V21, P6905, DOI 10.1093/emboj/cdf686; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yan JJ, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.37; Yu QB, 2009, PLANT J, V59, P1011, DOI 10.1111/j.1365-313X.2009.03930.x; Zehrmann A, 2015, J BIOL CHEM, V290, P6445, DOI 10.1074/jbc.M114.602086; Zehrmann A, 2009, PLANT CELL, V21, P558, DOI 10.1105/tpc.108.064535; Zhang F, 2014, P NATL ACAD SCI USA, V111, P2023, DOI 10.1073/pnas.1316183111; Zhang HD, 2015, PHOTOSYNTH RES, V126, P311, DOI 10.1007/s11120-015-0171-4; Zhou W., 2008, P IEEE POW EN SOC TR, P1	63	1	1	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	AUG	2017	1860	8					813	828		10.1016/j.bbagrm.2017.05.004				16	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FD6SS	WOS:000407658800001	28549935				2018-01-05	
J	Li, P; Shi, ML; Shen, WL; Zhang, Z; Xie, DJ; Zhang, XY; He, C; Zhang, Y; Zhao, ZH				Li, Ping; Shi, Ming-Lei; Shen, Wen-Long; Zhang, Zhang; Xie, De-Jian; Zhang, Xiang-Yuan; He, Chao; Zhang, Yan; Zhao, Zhi-Hu			Coordinated regulation of IFITM1, 2 and 3 genes by an IFN-responsive enhancer through long-range chromatin interactions	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Article						IFN; IFITM; Enhancer; Long-range interactions; Influenza A virus	BETA-GENE; FAMILY PROTEINS; GLOBIN LOCUS; BAF COMPLEX; VIRUS; TRANSCRIPTION; INDUCTION; PROMOTER; INTERFERONS; EXPRESSION	Interferon-induced transmembrane protein (IFITM) 1, 2 and 3 genes encode a family of interferon (IFN)-induced transmembrane proteins that block entry of a broad spectrum of pathogens. However, the transcriptional regulation of these genes, especially whether there exist any enhancers and their roles during the IFN induction process remain elusive. Here, through public data mining, episomal luciferase reporter assay and in vivo CRISPRCas9 genome editing, we identified an IFN-responsive enhancer located 35 kb upstream of IFITM3 gene promoter upregulating the IFN-induced expression of IFITM1, 2 and 3 genes. Chromatin immunoprecipitation (ChIP), electrophoretic mobility shift assay (EMSA) and luciferase reporter assay demonstrated that signal transducers and activators of transcription (STAT) 1 bound to the enhancer with the treatment of IFN and was indispensable for the enhancer activity. Furthermore, using chromosome conformation capture technique, we revealed that the IFITM1, 2 and 3 genes physically clustered together and constitutively looped to the distal enhancer through long-range interactions in both HEK293 and A549 cells, providing structural basis for coordinated regulation of IFITM1, 2 and 3 by the enhancer. Finally, we showed that in vivo truncation of the enhancer impaired IFN-induced resistance to influenza A virus (IAV) infection. These findings expand our understanding of the mechanisms underlying the transcriptional regulation of IFITM1, 2 and 3 expression and its ability to mediate IFN signaling.	[Li, Ping; Shi, Ming-Lei; Shen, Wen-Long; Zhang, Zhang; Xie, De-Jian; Zhang, Xiang-Yuan; He, Chao; Zhang, Yan; Zhao, Zhi-Hu] Beijing Inst Biotechnol, 20 Dongdajie St, Beijing 100071, Peoples R China	Zhang, Y; Zhao, ZH (reprint author), Beijing Inst Biotechnol, 20 Dongdajie St, Beijing 100071, Peoples R China.	zany1983@163.com; zhaozh@bmi.ac.cn			National Basic Research Program of China [2013CB966802]; National Natural Science Foundation of China [31370762, 81372218]; National Key Technology R&D Program of China [2015BAI08B03]; National Natural Science Foundation of China	We thank Cheng-Cai Lai for excellent technical assistance and Bing-Yu Ye for helpful advice. This work was supported by the National Basic Research Program of China [2013CB966802]; National Natural Science Foundation of China [31370762, 81372218] and National Key Technology R&D Program of China [2015BAI08B03]. Funding for open access charge: National Natural Science Foundation of China.	Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537; Banerjee AR, 2014, NUCLEIC ACIDS RES, V42, P12537, DOI 10.1093/nar/gku1018; Bhinge AA, 2007, GENOME RES, V17, P910, DOI 10.1101/gr.5574907; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Cuddapah S, 2008, FEBS LETT, V582, P391, DOI 10.1016/j.febslet.2007.12.033; Cui KR, 2004, MOL CELL BIOL, V24, P4476, DOI 10.1128/MCB.24.10.4476-4486.2004; De L. W., 2003, CHROMOSOME RES, V11, P447; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Laat W.D., 2013, NATURE, V502, P499; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1                                                   ; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Liu H, 2002, MOL CELL BIOL, V22, P6471, DOI 10.1128/MCB.22.18.6471-6479.2002; Markenscoff-Papadimitriou E, 2014, CELL, V159, P543, DOI 10.1016/j.cell.2014.09.033; Maston GA, 2012, ANNU REV GENOM HUM G, V13, P29, DOI 10.1146/annurev-genom-090711-163723; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Mills TC, 2014, J INFECT DIS, V209, P1028, DOI 10.1093/infdis/jit468; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Murakawa Y, 2016, TRENDS GENET, V32, P76, DOI 10.1016/j.tig.2015.11.004; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Plank JL, 2014, MOL CELL, V55, P5, DOI 10.1016/j.molcel.2014.06.015; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platt JL, 2016, EMBO REP, V17, P1410, DOI 10.15252/embr.201642198; Reed LJ, 1938, AM J EPIDEMIOL, V27; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schorg A, 2015, NUCLEIC ACIDS RES, V43, P5810, DOI 10.1093/nar/gkv506; Stephen P. B., 2005, GENE DEV, V19, P2953; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.10.010; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Xu YC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005992; Yuasa K, 2016, GENES CELLS, V21, P25, DOI 10.1111/gtc.12316; Zhang Y, 2015, BBA-MOL CELL RES, V1853, P481, DOI 10.1016/j.bbamcr.2014.12.002; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433; Zhou GL, 2006, MOL CELL BIOL, V26, P5096, DOI 10.1128/MCB.02454-05	49	0	0	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	AUG	2017	1860	8					885	893		10.1016/j.bbagrm.2017.05.003				9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FD6SS	WOS:000407658800007	28511927				2018-01-05	
J	Burdick, RC; Delviks-Frankenberry, KA; Chen, JB; Janaka, SK; Sastri, J; Hu, WS; Pathak, VK				Burdick, Ryan C.; Delviks-Frankenberry, Krista A.; Chen, Jianbo; Janaka, Sanath K.; Sastri, Jaya; Hu, Wei-Shau; Pathak, Vinay K.			Dynamics and regulation of nuclear import and nuclear movements of HIV-1 complexes	PLOS PATHOGENS			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SINGLE-PARTICLE TRACKING; GAG PROTEIN; T-LYMPHOCYTES; LIVING CELLS; INFECTION; APOBEC3F; DNA; CYCLOPHILIN; INTEGRATION	The dynamics and regulation of HIV-1 nuclear import and its intranuclear movements after import have not been studied. To elucidate these essential HIV-1 post-entry events, we labeled viral complexes with two fluorescently tagged virion-incorporated proteins (APO-BEC3F or integrase), and analyzed the HIV-1 dynamics of nuclear envelope ( NE) docking, nuclear import, and intranuclear movements in living cells. We observed that HIV-1 complexes exhibit unusually long NE residence times (1.5 +/- 1.6 hrs) compared to most cellular cargos, which are imported into the nuclei within milliseconds. Furthermore, nuclear import requires HIV-1 capsid ( CA) and nuclear pore protein Nup358, and results in significant loss of CA, indicating that one of the viral core uncoating steps occurs during nuclear import. Our results showed that the CA-Cyclophilin A interaction regulates the dynamics of nuclear import by delaying the time of NE docking as well as transport through the nuclear pore, but blocking reverse transcription has no effect on the kinetics of nuclear import. We also visualized the translocation of viral complexes docked at the NE into the nucleus and analyzed their nuclear movements and determined that viral complexes exhibited a brief fast phase (<9 min), followed by a long slow phase lasting several hours. A comparison of the movement of viral complexes to those of proviral transcription sites supports the hypothesis that HIV-1 complexes quickly tether to chromatin at or near their sites of integration in both wildtype cells and cells in which LEDGF/p75 was deleted using CRISPR/cas9, indicating that the tethering interactions do not require LEDGF/p75. These studies provide novel insights into the dynamics of viral complex-NE association, regulation of nuclear import, viral core uncoating, and intranuclear movements that precede integration site selection.	[Burdick, Ryan C.; Delviks-Frankenberry, Krista A.; Janaka, Sanath K.; Sastri, Jaya; Pathak, Vinay K.] Natl Canc Inst Frederick, Viral Mutat Sect, HIV Dynam & Replicat Program, Frederick, MD 21702 USA; [Chen, Jianbo; Hu, Wei-Shau] Natl Canc Inst Frederick, Viral Recombinat Sect, HIV Dynam & Replicat Program, Frederick, MD USA	Pathak, VK (reprint author), Natl Canc Inst Frederick, Viral Mutat Sect, HIV Dynam & Replicat Program, Frederick, MD 21702 USA.	vinay.pathak@nih.gov		Janaka, Sanath Kumar/0000-0003-2341-1526	National Institutes of Health, National Cancer Institute, Center for Cancer Research; Intramural AIDS Targeted Antiviral Program	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, and by Intramural AIDS Targeted Antiviral Program grant funding to VKP and to WSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002413; Ambrose Z, 2014, VIROLOGY, V454, P371, DOI 10.1016/j.virol.2014.02.004; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth931; Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740; Bichel K, 2013, RETROVIROLOGY, V10; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143                                                            ; Burdick RC, 2013, P NATL ACAD SCI USA, V110, pE4780, DOI 10.1073/pnas.1315996110; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/icb.200706154; Campbell EM, 2007, VIROLOGY, V360, P286, DOI 10.1016/j.virol.2006.10.025; Campbell EM, 2015, NAT REV MICROBIOL, V13, P471, DOI 10.1038/nrmicro3503; Cermakova K, 2016, TRENDS PHARMACOL SCI, V37, P660, DOI 10.1016/j.tips.2016.05.005; Chen JB, 2016, P NATL ACAD SCI USA, V113, pE201, DOI 10.1073/pnas.1518572113; Chen J, 2014, P NATL ACAD SCI USA, V111, pE5205, DOI 10.1073/pnas.1413169111; Chen JB, 2009, P NATL ACAD SCI USA, V106, P13535, DOI 10.1073/pnas.0906822106; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Chin CR, 2015, CELL REP, V13, P1717, DOI 10.1016/j.celrep.2015.10.036; Coleman Robert A, 2015, Cold Spring Harb Symp Quant Biol, V80, P1, DOI 10.1101/sqb.2015.80.027201; Colgan J, 1996, J VIROL, V70, P4299; Cosnefroy O, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0292-7; Craigie R, 2014, MICROBIOL SPECTR, V2; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217                                                          ; De Laco A, 2014, RETROVIROLOGY, V11; Dharan A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005700; Di Nunzio F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046037; Di Primio C, 2013, P NATL ACAD SCI USA, V110, P5636, DOI 10.1073/pnas.1216254110; Dion V, 2013, CELL, V152, P1355, DOI 10.1016/j.cell.2013.02.010; Donahue DA, 2017, J VIROL, V91, DOI 10.1128/JVI.02303-16; Fernandez J, 2015, J BIOL CHEM, V290, P4631, DOI 10.1074/jbc.M114.613133; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Francis AC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005709; Francis AC, 2014, AIDS RES HUM RETROV, V30, P717, DOI [10.1089/aid.2013.0277, 10.1089/AID.2013.0277]; FREED EO, 1995, J VIROL, V69, P3949; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1                                                   ; Hulme AE, 2015, J VIROL, V89, P5350, DOI 10.1128/JVI.00476-15; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kelich JM, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.47; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Lelek M, 2015, NATURE COMMUNICATION, V6; Li Y, 2009, J VIROL, V83, P10951, DOI 10.1128/JVI.00682-09; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; LIU C., 2016, NATURE COMMUNICATION, V7; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6                                                    ; Lukic Z, 2014, J VIROL, V88, P13613, DOI 10.1128/JVI.02219-14; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Malikov V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7660; Marini B, 2015, NATURE, V521, P227, DOI 10.1038/nature14226; Matreyek KA, 2011, J VIROL, V85, P7818, DOI 10.1128/JVI.00325-11; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Mbisa JL, 2010, J VIROL, V84, P5250, DOI 10.1128/JVI.02358-09; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Meehan AM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003969; Mueller F, 2013, NAT METHODS, V10, P277, DOI 10.1038/nmeth.2406; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000                                              ; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc01-06-0308; Pawlica P, 2014, VIRUSES-BASEL, V6, P4195, DOI 10.3390/v6114195; Peng K, 2014, ELIFE, V3, DOI 10.7554/eLife.04114; Pereira CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017016; Platt EJ, 1998, J VIROL, V72, P2855; Quercioli V, 2016, J VIROL, V90, P5205, DOI 10.1128/JVI.03188-15; Rankovic S, 2017, J VIROL; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Sabo Y, 2013, CELL HOST MICROBE, V14, P535, DOI 10.1016/j.chom.2013.10.012; Santos CD, 2016, PLOS PATHOGENS, V12; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373                                                ; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schrijvers R, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-84; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00969; Sherry B, 1998, P NATL ACAD SCI USA, V95, P1758, DOI 10.1073/pnas.95.4.1758; Sowd GA, 2016, P NATL ACAD SCI US; Thys W, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-7; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; Tu LC, 2013, EMBO J, V32, P3220, DOI 10.1038/emboj.2013.239; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; van den Bogaard Patrick T C, 2009, Methods Mol Biol, V464, P91, DOI 10.1007/978-1-60327-461-6_6; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xu HZ, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-70; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	89	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7366	1553-7374		PLOS PATHOG	PLoS Pathog.	AUG	2017	13	8							e1006570	10.1371/journal.ppat.1006570				38	Microbiology; Parasitology; Virology	Microbiology; Parasitology; Virology	FF2WV	WOS:000408758400042	28827840	gold			2018-01-05	
J	Denner, J				Denner, Joachim			Can Antiretroviral Drugs Be Used to Treat Porcine Endogenous Retrovirus (PERV) Infection after Xenotransplantation?	VIRUSES-BASEL			English	Review						porcine endogenous retroviruses; PERV; antiretroviral drugs; reverse transcriptase; integrase	HIV-1 REVERSE-TRANSCRIPTASE; VIRUS TYPE-1 REPLICATION; TRANSGENIC PIGS; HUMAN-CELLS; NEUTRALIZING ANTIBODIES; PROTEASE INHIBITORS; RNA INTERFERENCE; SUSCEPTIBILITY; SAFETY; AZT	Porcine endogenous retroviruses (PERVs) are integrated in the genome of all pigs; they are released as infectious particles, and under certain conditions they can infect human cells. Therefore, they represent a risk when pigs are used as sources of cells, tissues, or organs for xenotransplantation. Xenotransplantation is under development due to the increasing shortage of human transplants. Whereas most porcine microorganisms which may be able to induce a disease (zoonosis) in the transplant recipient can be eliminated, this is not possible in the case of PERVs. Antiretroviral drugs which had been developed for the treatment of human immunodeficiency virus-1 (HIV-1) infections have been tested in vitro for their efficacy in inhibiting PERV replication. Inhibitors of the viral reverse transcriptase and of the integrase have been found effective. The most effective inhibitor of the reverse transcriptase was azidothymidine (AZT); the integrase inhibitors were the most potent inhibitors of PERV. Although in the past PERV transmission has not been observed after experimental or clinical xenotransplantation of pig cells or organs, and although PERVs may one day be inactivated in pigs by genome editing using CRISPR/Cas, knowing which antiretroviral drugs can effectively restrict PERV infection will still be important.	[Denner, Joachim] Robert Koch Inst, Nordufer 20, D-13353 Berlin, Germany	Denner, J (reprint author), Robert Koch Inst, Nordufer 20, D-13353 Berlin, Germany.	DennerJ@rki.de		Denner, Joachim/0000-0003-3244-6085	DFG Transregio Sonderforschungsbereich Xenotransplantation [TRR 127]	The study was supported by the DFG Transregio Sonderforschungsbereich Xenotransplantation, TRR 127. I would like to thank A. Hauser, Robert Koch Institute, for critical reading the manuscript and helpful comments and M. Ozel, Robert Koch Institute, for the electron microscopic pictures of PERV. In addition, I would like to thank the reviewers for critical comments helping to improve the manuscript.	Argaw T, 2016, XENOTRANSPLANTATION, V23, P151, DOI 10.1111/xen.12230; Baba M, 1999, ANTIMICROB AGENTS CH, V43, P2350; Baba M, 1998, MOL PHARMACOL, V53, P1097; BROOK I, 1987, JAMA-J AM MED ASSOC, V258, P1517, DOI 10.1001/jama.258.11.1517; Cooper DKC, 2014, XENOTRANSPLANTATION, V21, P397, DOI 10.1111/xen.12127; Cowan P. J., 2017, AM J TRANSPLANT; D'Andrea G, 2008, CURR CLIN PHARMACOL, V3, P20, DOI 10.2174/157488408783329913; Das K, 2013, CURR OPIN VIROL, V3, P119, DOI 10.1016/j.coviro.2013.03.014; Das K, 2013, CURR OPIN VIROL, V3, P111, DOI 10.1016/j.coviro.2013.03.012; Demange A, 2015, J GEN VIROL, V96, P3124, DOI 10.1099/jgv.0.000236; Denner J, 2016, ANN TRANSPL, V21, P717, DOI 10.12659/AOT.900531; Denner J, 2015, INT J SURG, V23, P306, DOI 10.1016/j.ijsu.2015.08.032; Denner J, 2015, XENOTRANSPLANTATION, V22, P151, DOI 10.1111/xen.12150; Denner J, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-260; Denner J, 2012, CLIN MICROBIOL REV, V25, P318, DOI 10.1128/CMR.05011-11; Denner J, 2010, RETROVIRUSES: MOLECULAR BIOLOGY, GENOMICS AND PATHOGENESIS, P35; Dieckhoff B, 2008, XENOTRANSPLANTATION, V15, P36, DOI 10.1111/j.1399-3089.2008.00442.x; Fiebig U, 2003, VIROLOGY, V307, P406, DOI 10.1016/S0042-6822(02)00140-X; Fishman JA, 2004, AM J TRANSPLANT, V4, P1383, DOI 10.1111/j.1600-6143.2004.00542.x; Gunthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900; Karlas A, 2004, VIROLOGY, V325, P18, DOI 10.1016/j.virol.2004.04.022; Kaulitz D, 2011, VIROLOGY, V411, P78, DOI 10.1016/j.virol.2010.12.032; Kirtane AR, 2016, J PHARM SCI-US, V105, P3471, DOI 10.1016/j.xphs.2016.09.015; Lackey P, 2017, CLIN DRUG INVEST, V37, P51, DOI 10.1007/s40261-016-0456-1; MITSUYA H, 1985, CANCER RES, V45, P4583; Morozov VA, 2017, VIRUS RES, V227, P34, DOI 10.1016/j.virusres.2016.08.012; OSTERTAG W, 1974, P NATL ACAD SCI USA, V71, P4980, DOI 10.1073/pnas.71.12.4980; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Patience C, 2001, J VIROL, V75, P2771, DOI 10.1128/JVI.75.6.2771-2775.2001; Powell SK, 2000, ANTIMICROB AGENTS CH, V44, P3432, DOI 10.1128/AAC.44.12.3432-3433.2000; Qari SH, 2001, J VIROL, V75, P1048, DOI 10.1128/JVI.75.2.1048-1053.2001; Ramsoondar J, 2009, XENOTRANSPLANTATION, V16, P164, DOI 10.1111/j.1399-3089.2009.00525.x; Semaan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122059; Semaan M, 2012, XENOTRANSPLANTATION, V19, P112, DOI 10.1111/j.1399-3089.2012.00683.x; Shi M, 2007, ANTIMICROB AGENTS CH, V51, P2600, DOI 10.1128/AAC.00212-07; Shi M, 2009, ANTIVIR RES, V83, P201, DOI 10.1016/j.antiviral.2009.04.011; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; Specke V, 2001, VIROLOGY, V285, P177, DOI 10.1006/viro.2001.0934; Stephan O, 2001, XENOTRANSPLANTATION, V8, P310, DOI 10.1034/j.1399-3089.2001.00098.x; Waechter A, 2014, IMMUNOL RES, V58, P9, DOI 10.1007/s12026-013-8430-y; Wang X, 2002, Antivir Chem Chemother, V13, P177; Wang X, 2002, MOL PHARMACOL, V61, P1359, DOI 10.1124/mol.61.6.1359; World Health Organization, 2016, CONGUID UANT DRU; Wilhelm M, 2002, CELL MOL LIFE SCI, V59, P2184, DOI 10.1007/s000180200017; Wynyard S, 2014, XENOTRANSPLANTATION, V21, P309, DOI 10.1111/xen.12102; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191	46	0	0	9	9	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1999-4915			VIRUSES-BASEL	Viruses-Basel	AUG	2017	9	8							213	10.3390/v9080213				8	Virology	Virology	FF2QW	WOS:000408742900027		gold			2018-01-05	
J	Litwin, TR; Clarke, MA; Dean, M; Wentzensen, N				Litwin, Tamara R.; Clarke, Megan A.; Dean, Michael; Wentzensen, Nicolas			Somatic Host Cell Alterations in HPV Carcinogenesis	VIRUSES-BASEL			English	Review						HPV; somatic mutation; cervical cancer; APOBEC; significantly mutated gene; copy number variation; chromosomal instability; head and neck cancer; integration	HUMAN-PAPILLOMAVIRUS TYPE-16; INVASIVE PENILE CANCER; LOWER GENITAL-TRACT; CLASS-I LOSS; CERVICAL-CANCER; GENOMIC INSTABILITY; PHOSPHATIDYLINOSITOL 3-KINASE; INTRAEPITHELIAL NEOPLASIA; MUTATIONAL LANDSCAPE; INTEGRATION SITES	High-risk human papilloma virus (HPV) infections cause cancers in different organ sites, most commonly cervical and head and neck cancers. While carcinogenesis is initiated by two viral oncoproteins, E6 and E7, increasing evidence shows the importance of specific somatic events in host cells for malignant transformation. HPV-driven cancers share characteristic somatic changes, including apolipoprotein B mRNA editing catalytic polypeptide-like (APOBEC)-driven mutations and genomic instability leading to copy number variations and large chromosomal rearrangements. HPV-associated cancers have recurrent somatic mutations in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) and phosphatase and tensin homolog (PTEN), human leukocyte antigen A and B (HLA-A and HLA-B)-A/B, and the transforming growth factor beta (TGF beta) pathway, and rarely have mutations in the tumor protein p53 (TP53) and RB transcriptional corepressor 1 (RB1) tumor suppressor genes. There are some variations by tumor site, such as NOTCH1 mutations which are primarily found in head and neck cancers. Understanding the somatic events following HPV infection and persistence can aid the development of early detection biomarkers, particularly when mutations in precancers are characterized. Somatic mutations may also influence prognosis and treatment decisions.	[Litwin, Tamara R.; Clarke, Megan A.] NCI, Canc Prevent Fellowship Program, Div Canc Prevent, Rockville, MD 20850 USA; [Litwin, Tamara R.; Clarke, Megan A.; Wentzensen, Nicolas] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, Rockville, MD 20850 USA; [Dean, Michael] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, Gaithersburg, MD 20850 USA	Wentzensen, N (reprint author), NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, Rockville, MD 20850 USA.	tamara.litwin@nih.gov; megan.clarke@nih.gov; deanm@mail.nih.gov; wentzenn@mail.nih.gov			National Cancer Institute [Z01 CP010124-21]	This work was supported by the Intramural Research Program of the National Cancer Institute, Z01 CP010124-21.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Akagi K, 2014, GENOME RES, V24, P185, DOI 10.1101/gr.164806.113; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Backes DM, 2009, CANCER CAUSE CONTROL, V20, P449, DOI 10.1007/s10552-008-9276-9; Banister CE, 2017, ONCOTARGET, V8, P13375, DOI 10.18632/oncotarget.14533; Bezerra ALR, 2001, CANCER, V91, P2315, DOI 10.1002/1097-0142(20010615)91:12<2315::AID-CNCR1263>3.0.CO;2-C; Bezerra SM, 2015, HUM PATHOL, V46, P532, DOI 10.1016/j.humpath.2014.12.004; Bodelon C, 2016, INT J CANCER, V139, P2001, DOI 10.1002/ijc.30243; Bodelon C, 2016, CARCINOGENESIS, V37, P188, DOI 10.1093/carcin/bgv171; Boyer SN, 1996, CANCER RES, V56, P4620; Burk RD, 2017, NATURE, V543, P378, DOI 10.1038/nature21386                                                             ; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Busso-Lopes AF, 2015, CANCER PREV RES, V8, P149, DOI 10.1158/1940-6207.CAPR-14-0284; Cancer Genome Atlas Network, 2015, NATURE, V517, P576, DOI DOI 10.1038/NATURE14129; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chang HS, 2010, INT J BIOCHEM CELL B, V42, P1831, DOI 10.1016/j.biocel.2010.07.019; Chen D, 2015, TRENDS GENET, V31, P41, DOI 10.1016/j.tig.2014.10.005; Cheng HX, 2015, CANCER BIOL THER, V16, P1252, DOI 10.1080/15384047.2015.1056418; Chung CH, 2015, ANN ONCOL, V26, P1216, DOI 10.1093/annonc/mdv109; Chung TKH, 2017, GYNECOL ONCOL, V146, P334, DOI 10.1016/j.ygyno.2017.05.038; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Cui B, 2009, INT J ONCOL, V34, P409, DOI 10.3892/ijo_00000164; Cuschieri K, 2008, CANCER EPIDEM BIOMAR, V17, P2536, DOI 10.1158/1055-9965.EPI-08-0306; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Deng W, 2008, CANCER RES, V68, P7200, DOI 10.1158/0008-5472.CAN-07-6569; Djajadiningrat RS, 2015, J UROLOGY, V193, P526, DOI 10.1016/j.juro.2014.08.087; Doorbar J, 2015, REV MED VIROL, V25, P2, DOI 10.1002/rmv.1822; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Duensing S, 2001, BBA-REV CANCER, V1471, pM81, DOI 10.1016/S0304-419X(00)00025-1; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532                                                         ; El-Naggar AK, 2012, HEAD NECK-J SCI SPEC, V34, P459, DOI 10.1002/hed.21974; Feber A, 2016, CANCER RES, V76, P4720, DOI 10.1158/0008-5472.CAN-15-3134; Feldman R, 2016, HEAD NECK-J SCI SPEC, V38, pE1625, DOI 10.1002/hed.24290; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Fowler NL, 2004, GYNECOL ONCOL, V92, P914, DOI 10.1016/j.ygyno.2003.11.037; Godinho MFE, 2012, BRIT J CANCER, V107, P947, DOI 10.1038/bjc.2012.351; Habig M, 2006, ARCH VIROL, V151, P1961, DOI 10.1007/s00705-006-0768-1; Hartwig S, 2015, PAPILLOMAVIRUS RES, V1, P90, DOI 10.1016/j.pvr.2015.06.003; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Heselmeyer K, 1997, BRIT J CANCER, V76, P1271, DOI 10.1038/bjc.1997.547; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703                                                     ; Hou MM, 2014, ONCOTARGET, V5, P11168, DOI 10.18632/oncotarget.2584                                                        ; Hu Z, 2015, NAT GENET, V47, P158, DOI 10.1038/ng.3178; Huang JJ, 2016, BIOCHEM SOC T, V44, P1441, DOI 10.1042/BST20160065; Husain RSA, 2015, ANN GLOB HEALTH, V81, P675, DOI 10.1016/j.aogh.2015.08.026; Iida K, 2011, BRIT J CANCER, V105, P420, DOI 10.1038/bjc.2011.222; Izumchenko E, 2015, CANCER PREV RES, V8, P277, DOI 10.1158/1940-6207.CAPR-14-0257; Izumi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041116; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Kang S, 2007, GYNECOL ONCOL, V105, P662, DOI 10.1016/j.ygyno.2007.01.045; Kashofer K, 2017, GYNECOL ONCOL, V146, P314, DOI 10.1016/j.ygyno.2017.05.018; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701                                                            ; Kinde I, 2013, SCI TRANSL MED, V167, pra164, DOI DOI 10.1126/SCITRANSLMED.3004952; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699                                                          ; Koncar RF, 2017, CANCER MED-US, V6, P1673, DOI 10.1002/cam4.1108; Koopman LA, 2000, J EXP MED, V191, P961, DOI 10.1084/jem.191.6.961; Lechner M, 2013, GENOME MED, V5, DOI 10.1186/gm453; Lee DK, 2002, J BIOL CHEM, V277, P38557, DOI 10.1074/jbc.M206786200; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Lesseur C, 2016, NAT GENET, V48, P1544, DOI 10.1038/ng.3685; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lont AP, 2006, INT J CANCER, V119, P1078, DOI 10.1002/ijc.21961; Lou H, 2015, CLIN CANCER RES, V21, P5360, DOI 10.1158/1078-0432.CCR-14-1837; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Ma YY, 2000, ONCOGENE, V19, P2739, DOI 10.1038/sj.onc.1203597                                                          ; Markowska A, 2014, WSPOLCZESNA ONKOL, V18, P143, DOI 10.5114/wo.2014.43154; Martinez-Nava GA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157344; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; McDaniel AS, 2015, CANCER RES, V75, P5219, DOI 10.1158/0008-5472.CAN-15-1004; McIntyre JB, 2013, GYNECOL ONCOL, V128, P409, DOI 10.1016/j.ygyno.2012.12.019; Millis SZ, 2016, JAMA ONCOL, V2, P1565, DOI 10.1001/jamaoncol.2016.0891; Mirabello L., 2017, CELL IN PRESS; Mirabello L, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw100; Miralles-Guri C, 2009, J CLIN PATHOL, V62, P870, DOI 10.1136/jcp.2008.063149; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Moscicki AB, 2006, VACCINE, V24, P42, DOI 10.1016/j.vaccine.2006.06.018; MUNGER K, 1989, EMBO J, V8, P4099; Murvai M, 2004, ARCH VIROL, V149, P2379, DOI 10.1007/s00705-004-0376-x; Ndiaye C, 2014, LANCET ONCOL, V15, P1319, DOI 10.1016/S1470-2045(14)70471-1; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Pinto AP, 2010, MODERN PATHOL, V23, P404, DOI 10.1038/modpathol.2009.179; Prigge ES, 2017, MUTAT RES-REV MUTAT, V772, P51, DOI 10.1016/j.mrrev.2016.06.005; Qureshi R, 2016, TUMOR BIOL, V37, P9089, DOI 10.1007/s13277-016-4789-4; Rajendra S, 2016, J MED GENET, V53, P227, DOI 10.1136/jmedgenet-2015-103411; Rashmi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092948; Rebhandl Stefan, 2015, Oncoscience, V2, P320; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Rositch AF, 2013, INT J CANCER, V133, P1271, DOI 10.1002/ijc.27828; Rusan M, 2015, CLIN CANCER RES, V21, P2009, DOI 10.1158/1078-0432.CCR-14-1101; Salam M, 1995, Eur J Surg Oncol, V21, P290, DOI 10.1016/S0748-7983(95)91591-5; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9                                              ; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Schaal C, 2014, ADV CANCER RES, V121, P147, DOI 10.1016/B978-0-12-800249-0.00004-4; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Schiffman M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.86; Schmitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039632; Seiwert TY, 2015, CLIN CANCER RES, V21, P632, DOI 10.1158/1078-0432.CCR-13-3310; Serup-Hansen E, 2014, J CLIN ONCOL, V32, P1812, DOI 10.1200/JCO.2013.52.3464; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042                                                                    ; Simonelli V, 2005, NUCLEIC ACIDS RES, V33, P4404, DOI 10.1093/nar/gki749; Spaans VM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133670; Spaans VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093451; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Thomas LK, 2014, EUR J CANCER, V50, P85, DOI 10.1016/j.ejca.2013.08.022; Tinhofer I, 2016, ANN ONCOL, V27, P2262, DOI 10.1093/annonc/mdw426; Tornesello ML, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0255-5; Trietsch MD, 2015, GYNECOL ONCOL, V136, P143, DOI 10.1016/j.ygyno.2014.11.002; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Verlaat Wina, 2015, J Pathol Clin Res, V1, P207, DOI 10.1002/cjp2.27; Vermeulen CFW, 2005, HUM IMMUNOL, V66, P1167, DOI 10.1016/j.humimm.2005.10.011; Vermeulen CFW, 2007, GYNECOL ONCOL, V105, P593, DOI 10.1016/j.ygyno.2007.02.016; Vieira V.C., 2014, MBIO, P5; Vinokurova S, 2008, CANCER RES, V68, P307, DOI 10.1158/0008-5472.CAN-07-2754; Vogt PK, 2007, TRENDS BIOCHEM SCI, V32, P342, DOI 10.1016/j.tibs.2007.05.005; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F                 ; Warren CJ, 2015, J VIROL, V89, P688, DOI 10.1128/JVI.02383-14; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009                                                   ; Wentzensen N, 2002, ONCOGENE, V21, P419, DOI 10.1038/sj.onc.1205104; Wentzensen N, 2017, INT J CANCER, V140, P2192, DOI 10.1002/ijc.30579; Wentzensen N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv257; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Westra WH, 2008, CLIN CANCER RES, V14, P366, DOI 10.1158/1078-0432.CCR-07-1402; Wright AA, 2013, CANCER-AM CANCER SOC, V119, P3776, DOI 10.1002/cncr.28288; Zhang WS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24927; Zhu HY, 2016, TUMOR BIOL, V37, P7075, DOI 10.1007/s13277-016-5028-8	134	0	0	4	4	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1999-4915			VIRUSES-BASEL	Viruses-Basel	AUG	2017	9	8							206	10.3390/v9080206				22	Virology	Virology	FF2QW	WOS:000408742900025		gold			2018-01-05	
J	Zhang, YJ; Xia, GH; Zhang, YQ; Liu, JX; Liu, XW; Li, WH; Lv, YY; Wei, SH; Liu, J; Quan, JX				Zhang, Yuanjun; Xia, Guanghao; Zhang, Yaqiong; Liu, Juxiang; Liu, Xiaowei; Li, Weihua; Lv, Yaya; Wei, Suhong; Liu, Jing; Quan, Jinxing			Palmitate induces VSMC apoptosis via toll like receptor (TLR)4/ROS/p53 pathway	ATHEROSCLEROSIS			English	Article						Palmitate; Vascular smooth muscle cells; Apoptosis; Oxidative stress; Toll-like receptor 4	SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; KAPPA-B; ACTIVATION; INFLAMMATION; DYSFUNCTION; DEATH; TLR4; BETA	Background and aims: Toll-like receptor 4 (TLR4) has been implicated in vascular inflammation, as well as in the pathogenesis of atherosclerosis and diabetes. Vascular smooth muscle cell (VSMC) apoptosis has been shown to induce plaque vulnerability in atherosclerosis. Previous studies reported that palmitate induced apoptosis in VSMCs; however, the role of TLR4 in palmitate-induced apoptosis in VSMCs has not yet been defined. In this study, we investigated whether or not palmitate-induced apoptosis depended on the activation of the TLR4 pathway. Methods: VSMCs were treated with or without palmitate, CRISPR/Cas9z-mediated genome editing methods were used to deplete TLR4 expression, while NADPH oxidase inhibitors were used to inhibit reactive oxygen species (ROS) generation. Cell apoptosis was detected by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay, ROS was measured using the 20,7'-dichlorodihydrofluorescein diacetate (DCFH-DA) method, the mRNA and protein expression levels of caspase 3, caspase 9, BCL-2 and p53 were studied by real-time polymerase chain reaction (RT-PCR) and ELISA. Results: Palmitate significantly promotes VSMC apoptosis, ROS generation, and expression of caspase 3, caspase 9 and p53; while NADPH oxidase inhibitor pretreatment markedly attenuated these effects. Moreover, knockdown of TLR4 significantly blocked palmitate-induced ROS generation and VSMC apoptosis accompanied by inhibition of caspase 3, caspase 9, p53 expression and restoration of BCL-2 expression. Conclusions: Our results suggest that palmitate-induced apoptosis depends on the activation of the TLR4/ROS/p53 signaling pathway, and that TLR4 may be a potential therapeutic target for the prevention and treatment of atherosclerosis. (C) 2017 Elsevier B.V. All rights reserved.	[Zhang, Yuanjun; Xia, Guanghao; Liu, Juxiang; Liu, Xiaowei; Lv, Yaya; Wei, Suhong; Liu, Jing; Quan, Jinxing] Gansu Prov Hosp, Dept Endocrinol, Lanzhou, Peoples R China; [Zhang, Yuanjun; Zhang, Yaqiong] Gansu Univ Tradit Chinese Med, Lanzhou, Peoples R China; [Xia, Guanghao; Liu, Juxiang; Li, Weihua; Lv, Yaya; Wei, Suhong; Liu, Jing; Quan, Jinxing] Key Lab Endocrine & Metab Dis Gansu Prov, Lanzhou, Peoples R China	Quan, JX (reprint author), Gansu Prov Hosp, Key Lab Endocrine & Metab Dis Gansu Prov, Dept Endocrinol, Lanzhou 730000, Peoples R China.	quanxt@sina.com			National Natural Science Foundation of China [81260136, 30960147]	This research was supported by grants from the National Natural Science Foundation of China (Grant number: 81260136, 30960147).	Biondi-Zoccai GGL, 2003, J AM COLL CARDIOL, V41, P1071, DOI 10.1016/S0735-1097(03)00088-3; Brodeur MR, 2013, J VASC RES, V50, P430, DOI 10.1159/000354235; Cai Y, 2007, FREE RADICAL BIO MED, V42, P64, DOI 10.1016/j.freeradbiomed.2006.09.018; Carrillo-Sepulveda MA, 2015, J MOL MED, V93, P1341, DOI 10.1007/s00109-015-1318-7; CERSOSIMO E, 2014, PHYSL REP, V2; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; den Dekker WK, 2012, ARTERIOSCL THROM VAS, V32, P1960, DOI 10.1161/ATVBAHA.112.250605; Dyntar D, 2001, DIABETES, V50, P2105, DOI 10.2337/diabetes.50.9.2105; Gade Wayne, 2010, Clin Lab Sci, V23, P51; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Jialal I, 2015, J DIABETES COMPLICAT, V29, P617, DOI 10.1016/j.jdiacomp.2015.04.002; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim JE, 2008, J PHARMACOL SCI, V106, P394, DOI 10.1254/jphs.FP0071857; Knopp RH, 2000, P SOC EXP BIOL MED, V225, P191, DOI 10.1046/j.1525-1373.2000.22524.x; Leskinen MJ, 2003, ARTERIOSCL THROM VAS, V23, P238, DOI 10.1161/01.ATV.0000051405.68811.4D; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Liu YM, 2011, ACTA PHARMACOL SIN, V32, P1475, DOI 10.1038/aps.2011.120; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; Mathew M, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-9; Mattern HM, 2007, PHYSIOL RES, V56, P149; Miriyala S, 2006, CIRCULATION, V113, P2818, DOI 10.1161/CIRCULATIONAHA.106.611822; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Park HS, 2006, CARDIOVASC RES, V72, P447, DOI 10.1016/j.cardiores.2006.09.012; Quan JX, 2014, J DIABETES, V6, P33, DOI 10.1111/1753-0407.12073; Rho MC, 2007, TOXICOL APPL PHARM, V220, P311, DOI 10.1016/j.taap.2007.02.008; Roshan M. H., 2016, INT J INFLAM, V10; Shen H, 2013, ARTERIOSCL THROM VAS, V33, P2596, DOI 10.1161/ATVBAHA.113.302099; Shinohara M, 2007, ARTERIOSCL THROM VAS, V27, P2384, DOI 10.1161/ATVBAHA.106.139253; Wang X., 2016, SCI REP; Wang XF, 2007, J CARDIOVASC PHARM, V49, P253, DOI 10.1097/FJC.0b013e318033dfb3; Wei CD, 2013, MOL MED REP, V7, P855, DOI 10.3892/mmr.2013.1276; Yamagishi S, 2002, MOL MED, V8, P179; Yang X, 2005, PHYSIO HEART CITE PH, V289, P1069; Yli-Jama P, 2002, J INTERN MED, V251, P19, DOI 10.1046/j.1365-2796.2002.00922.x                                                	36	1	1	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	AUG	2017	263						74	81		10.1016/j.atherosclerosis.2017.06.002				8	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	FD6JE	WOS:000407634000887	28609685				2018-01-05	
J	Uchibori-Asano, M; Kayukawa, T; Sezutsu, H; Shinoda, T; Daimon, T				Uchibori-Asano, Miwa; Kayukawa, Takumi; Sezutsu, Hideki; Shinoda, Tetsuro; Daimon, Takaaki			Severe developmental timing defects in the prothoracicotropic hormone (PTTH)-deficient silkworm, Bombyx mori	INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Ecdysone; Endocrinology; Genome editing; Metamorphosis; Steroidogenesis	LARVAL-PUPAL METAMORPHOSIS; MANDUCA-SEXTA L; JUVENILE-HORMONE; ECDYSTEROID BIOSYNTHESIS; DROSOPHILA-MELANOGASTER; TOBACCO HORNWORM; TEMPORAL ORGANIZATION; THRESHOLD SIZE; BRAIN; EVENTS	The insect neuropeptide prothoracicotropic hormone (PTTH) triggers the biosynthesis and release of the molting hormone ecdysone in the prothoracic gland (PG), thereby controlling the timing of molting and metamorphosis. Despite the well-documented physiological role of PTTH and its signaling pathway in the PG, it is not clear whether PTTH is an essential hormone for ecdysone biosynthesis and development. To address this question, we established and characterized a PTTH knockout line in the silkworm, Bombyx mori. We found that PTTH knockouts showed a severe developmental delay in both the larval and pupal stages. Larval phenotypes of PTTH knockouts can be classified into three major classes: (i) developmental arrest during the second larval instar, (ii) precocious metamorphosis after the fourth larval instar (one instar earlier in comparison to the control strain), and (iii) metamorphosis to normal-sized pupae after completing the five larval instar stages. In PTTH knockout larvae, peak levels of ecdysone titers in the hemolymph were dramatically reduced and the timing of peaks was delayed, suggesting that protracted larval development is a result of the reduced and delayed synthesis of ecdysone in the PG. Despite these defects, low basal levels of ecdysone were maintained in PTTH knockout larvae, suggesting that the primary role of PTTH is to upregulate ecdysone biosynthesis in the PG during molting stages, and low basal levels of ecdysone can be maintained in the absence of PTTH. We also found that mRNA levels of genes involved in ecdysone biosynthesis and ecdysteroid signaling pathways were significantly reduced in PTTH knockouts. Our results provide genetic evidence that PTTH is not essential for development, but is required to coordinate growth and developmental timing. (C) 2017 Elsevier Ltd. All rights reserved.	[Uchibori-Asano, Miwa; Kayukawa, Takumi; Sezutsu, Hideki; Shinoda, Tetsuro; Daimon, Takaaki] Natl Agr & Food Res Org, Inst Agrobiol Sci, Owashi 1-2, Tsukuba, Ibaraki 3058634, Japan; [Daimon, Takaaki] Kyoto Univ, Grad Sch Agr, Dept Appl Biosci, Sakyo Ku, Kyoto 6068502, Japan	Daimon, T (reprint author), Kyoto Univ, Grad Sch Agr, Dept Appl Biosci, Sakyo Ku, Kyoto 6068502, Japan.	takaakidaimon2@gmail.com		Daimon, Takaaki/0000-0002-8382-1132	Ministry of Education, Culture, Sports, Science and Technology [25252059, 16K15071, 17H03943]; Sumitomo Foundation [160096]	This research was financially supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology (nos. 25252059,16K15071 and 17H03943 to T.D.) and in part by Grant for Basic Science Research Projects from the Sumitomo Foundation (no. 160096 to T.D.).	ASANO S, 1987, APPL ENTOMOL ZOOL, V22, P424, DOI 10.1303/aez.22.424                                                              ; DAI JD, 1995, DEV BIOL, V171, P212, DOI 10.1006/dbio.1995.1272; Daimon T, 2003, INSECT BIOCHEM MOLEC, V33, P749, DOI 10.1016/S0965-1748(03)00084-5; Daimon T, 2015, P NATL ACAD SCI USA, V112, pE4226, DOI 10.1073/pnas.1506645112; Daimon T, 2014, DEV GROWTH DIFFER, V56, P14, DOI 10.1111/dgd.12096; Enya S, 2015, INSECT BIOCHEM MOLEC, V61, P1, DOI 10.1016/j.ibmb.2015.04.001; Enya S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06586; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gu SH, 1996, J INSECT PHYSIOL, V42, P625, DOI 10.1016/0022-1910(96)00025-X; Gu SH, 1997, MOL CELL ENDOCRINOL, V127, P109, DOI 10.1016/S0303-7207(96)03995-0; Gu SH, 2009, INSECT BIOCHEM MOLEC, V39, P171, DOI 10.1016/j.ibmb.2008.10.012; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; Hua YJ, 1999, J BIOL CHEM, V274, P31169, DOI 10.1074/jbc.274.44.31169; Iga M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103239; ISHIZAKI H, 1994, INT J DEV BIOL, V38, P301; Jindra M, 2015, CURR OPIN INSECT SCI, V11, P39, DOI 10.1016/j.cois.2015.08.004; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kamimura Manabu, 2003, Journal of Insect Biotechnology and Sericology, V72, P197; Kaneko Y, 2011, MOL CELL ENDOCRINOL, V335, P204, DOI 10.1016/j.mce.2011.01.012; KATAOKA H, 1991, AGR BIOL CHEM TOKYO, V55, P73, DOI 10.1080/00021369.1991.10870535                                                  ; KAWAKAMI A, 1990, SCIENCE, V247, P1333, DOI 10.1126/science.2315701                                                         ; KIGUCHI K, 1981, J INSECT PHYSIOL, V27, P805, DOI 10.1016/0022-1910(81)90072-X; Lin JL, 2007, J INSECT PHYSIOL, V53, P622, DOI 10.1016/j.jinphys.2007.03.004; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; MIZOGUCHI A, 1990, DEV GROWTH DIFFER, V32, P591; Mizoguchi A, 2015, INSECT BIOCHEM MOLEC, V58, P39, DOI 10.1016/j.ibmb.2015.01.001; Muramatsu D, 2008, MECH DEVELOP, V125, P411, DOI 10.1016/j.mod.2008.02.001; NAGATA M, 1987, J INSECT PHYSIOL, V33, P723, DOI 10.1016/0022-1910(87)90057-6; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; NIJHOUT HF, 1975, BIOL BULL, V149, P214, DOI 10.2307/1540491; NIJHOUT HF, 1974, J EXP BIOL, V61, P481; NIJHOUT HF, 1981, AM ZOOL, V21, P631; Nijhout H.F., 1998, INSECT HORMONES; Niwa R, 2005, INSECT MOL BIOL, V14, P563, DOI 10.1111/j.1365-2583.2005.00587.x; Niwa R, 2014, BIOSCI BIOTECH BIOCH, V78, P1283, DOI 10.1080/09168451.2014.942250; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; NOGUTI T, 1995, FEBS LETT, V376, P251, DOI 10.1016/0014-5793(95)01296-8; Ou QX, 2016, CELL REP, V16, P247, DOI 10.1016/j.celrep.2016.05.053; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Rewitz KF, 2013, CURR TOP DEV BIOL, V103, P1, DOI 10.1016/B978-0-12-385979-2.00001-0; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Sakurai S, 1998, J INSECT PHYSIOL, V44, P867, DOI 10.1016/S0022-1910(98)00075-4                                                   ; SAKURAI S, 1984, J INSECT PHYSIOL, V30, P657, DOI 10.1016/0022-1910(84)90051-9; Sonobe H, 2004, ZOOL SCI, V21, P503, DOI 10.2108/zsj.21.503; Takasu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073458; Tamura T, 2000, NAT BIOTECHNOL, V18, P81; Tanaka Y., 2011, ENDOCRINOLOGY, V2, P107; Tazima Y., 1978, SILKWORM IMPORTANT T; TRUMAN JW, 1974, J EXP BIOL, V60, P371; Watanabe K, 2007, MOL CELL ENDOCRINOL, V273, P51, DOI 10.1016/j.mce.2007.05.008; Yamanaka N, 2006, P NATL ACAD SCI USA, V103, P8622, DOI 10.1073/pnas.0511196103; Yamanaka N, 2005, J BIOL CHEM, V280, P14684, DOI 10.1074/jbc.M500308200; Yamanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P2808, DOI 10.1271/bbb.70420; Yamanaka N, 2015, CELL, V163, P907, DOI 10.1016/j.cell.2015.10.022; Yamanaka N, 2013, SCIENCE, V341, P1113, DOI 10.1126/science.1241210; Yamanaka N, 2011, J COMP NEUROL, V519, P238, DOI 10.1002/cne.22517	59	1	1	17	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-1748	1879-0240		INSECT BIOCHEM MOLEC	Insect Biochem. Mol. Biol.	AUG	2017	87						14	25		10.1016/j.ibmb.2017.06.007				12	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	FE5ZG	WOS:000408289200002	28627423				2018-01-05	
J	Douris, V; Papapostolou, KM; Ilias, A; Roditakis, E; Kounadi, S; Riga, M; Nauen, R; Vontas, J				Douris, Vassilis; Papapostolou, Kyriaki-Maria; Ilias, Aris; Roditakis, Emmanuel; Kounadi, Styliani; Riga, Maria; Nauen, Ralf; Vontas, John			Investigation of the contribution of RyR target-site mutations in diamide resistance by CRISPR/Cas9 genome modification in Drosophila	INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Insecticide resistance; Diamides; Tuta absoluta; CRISPR/Cas9; Ryanodine receptor	INSECTICIDE BINDING-SITES; RYANODINE RECEPTOR; PLUTELLA-XYLOSTELLA; DIAMONDBACK MOTH; FUNCTIONAL-CHARACTERIZATION; HELICOVERPA-ARMIGERA; FLUBENDIAMIDE; MODE; CHLORANTRANILIPROLE; MELANOGASTER	Diamide insecticides are used widely against lepidopteran pests, acting as potent activators of insect Ryanodine Receptors (RyRs) and thus inducing muscle contraction and eventually death. However, resistant phenotypes have recently evolved in the field, associated with the emergence of target site resistance mutations (G4946E/V and I4790M). We investigated the frequency of the mutations found in a resistant population of Tuta absoluta from Greece (G4946V similar to 79% and I4790M similar to 21%) and the associated diamide resistance profile: there are very high levels of resistance against chlorantraniliprole (9329-fold) and flubendiamide (4969-fold), but moderate levels against cyantraniliprole (191-fold). To further investigate functionally the contribution of each mutation in the resistant phenotype, we used CRISPR/Cas9 to generate genome modified Drosophila carrying alternative allele combinations, and performed toxicity bioassays against all three diamides. Genome modified flies bearing the G4946V mutation exhibited high resistance ratios to flubendiamide (91.3-fold) and chlorantraniliprole (194.7-fold) when compared to cyantraniliprole (5.4-fold). Flies naturally wildtype for the I4790M mutation were moderately resistant to flubendiamide (15.3-fold) but significantly less resistant to chlorantraniliprole (7.5-fold), and cyantraniliprole (2.3-fold). These findings provide in vivo functional genetic confirmation for the role and relative contribution of RyR mutations in diamide resistance and suggest that the mutations confer subtle differences on the relative binding affinities of the three diamides at an overlapping binding site on the RyR protein. (C) 2017 Elsevier Ltd. All rights reserved.	[Douris, Vassilis; Papapostolou, Kyriaki-Maria; Kounadi, Styliani; Riga, Maria; Vontas, John] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, 100 N Plastira St, GR-70013 Iraklion, Crete, Greece; [Douris, Vassilis; Papapostolou, Kyriaki-Maria; Kounadi, Styliani; Riga, Maria] Univ Crete, Dept Biol, Lab Mol Entomol, GR-70013 Iraklion, Crete, Greece; [Ilias, Aris; Roditakis, Emmanuel] Hellen Agr Org Demeter, Inst Olive Tree Subtrop Crops & Viticulture, Iraklion, Crete, Greece; [Nauen, Ralf] Bayer AG, Crop Sci Div, R&D Pest Control Biol, Alfred Nobel Str 50, D-40789 Monheim, Germany; [Vontas, John] Agr Univ Athens, Dept Crop Sci, Lab Pesticide Sci, 75 Iera Odos St, GR-11855 Athens, Greece	Douris, V; Vontas, J (reprint author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, 100 N Plastira St, GR-70013 Iraklion, Crete, Greece.	vdouris@imbb.forth.gr; vontas@imbb.forth.gr		Roditakis, Emmanouil/0000-0002-5938-2977; Douris, Vassilis/0000-0003-4608-7482			Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a                                                           ; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Douris V, 2016, P NATL ACAD SCI USA, V113, P14692, DOI 10.1073/pnas.1618258113; Ebbinghaus-Kintscher U, 2006, CELL CALCIUM, V39, P21, DOI 10.1016/j.ceca.2005.09.002; FINNEY DJ, 1964, PROBIT ANAL; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Guo L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06924; Hirooka T., 2007, Pflanzenschutz-Nachrichten Bayer, V60, P183; Huang Y., 2016, MOL BIOL, V75, P98, DOI [10.1016/j.ibmb.2016.06.004, DOI 10.1016/J.IBMB.2016.06.004]; Isaacs AK, 2012, CHEM RES TOXICOL, V25, P1571, DOI 10.1021/tx300326m; Jeanguenat A, 2013, PEST MANAG SCI, V69, P7, DOI 10.1002/ps.3406; Kato K, 2009, BIOCHEMISTRY-US, V48, P10342, DOI 10.1021/bi900866s; Khan SA, 2017, SCI REP-UK, V7, DOI 10.1038/srep40025; Koutroumpa FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep29620; Lahm GP, 2007, BIOORG MED CHEM LETT, V17, P6274, DOI 10.1016/j.bmc1.2007.09.012; Lahm GP, 2009, BIOORGAN MED CHEM, V17, P4127, DOI 10.1016/j.bmc.2009.01.018; Ltimmen P., 2013, ADV INSECT PHYSL, V44, P287; Ltimmen P., 2007, SYNTHESIS CHEM AGR 7, V948, P235; Nauen R., 2016, ADV INSECT CONTROL R, P219; Nauen R, 2006, PEST MANAG SCI, V62, P690, DOI 10.1002/ps.1254; Navajas M, 1999, EXP APPL ACAROL, V23, P851, DOI 10.1023/A:1006251220052; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Qi SZ, 2014, J AGR FOOD CHEM, V62, P4077, DOI 10.1021/jf501236h; Qi SZ, 2013, PESTIC BIOCHEM PHYS, V107, P321, DOI 10.1016/j.pestbp.2013.09.004; Roditakis E, 2006, PESTIC BIOCHEM PHYS, V85, P161, DOI 10.1016/j.pestbp.2005.11.007; Roditakis E, 2017, INSECT BIOCHEM MOLEC, V80, P11, DOI 10.1016/j.ibmb.2016.11.003; Roditakis E, 2013, PEST MANAG SCI, V69, P834, DOI 10.1002/ps.3442; Sakuma M, 1998, APPL ENTOMOL ZOOL, V33, P339, DOI 10.1303/aez.33.339                                                              ; Sattelle David B., 2008, Invertebrate Neuroscience, V8, P107, DOI 10.1007/s10158-008-0076-4; Somers J, 2015, INSECT BIOCHEM MOLEC, V64, P116, DOI 10.1016/j.ibmb.2015.01.018; Steinbach D, 2015, INSECT BIOCHEM MOLEC, V63, P14, DOI 10.1016/j.ibmb.2015.05.001; Teixeira LA, 2013, PESTIC BIOCHEM PHYS, V106, P76, DOI 10.1016/j.pestbp.2013.01.010; Tohnishi M, 2005, J PESTIC SCI, V30, P354, DOI 10.1584/jpestics.30.354; Troczka B, 2012, INSECT BIOCHEM MOLEC, V42, P873, DOI 10.1016/j.ibmb.2012.09.001; Troczka BJ, 2017, NEUROTOXICOLOGY, V60, P224, DOI 10.1016/j.neuro.2016.05.012; Troczka BJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14680; Wang J, 2016, INSECT BIOCHEM MOLEC, V76, P11, DOI 10.1016/j.ibmb.2016.06.008; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Zhu GH, 2016, INSECT BIOCHEM MOLEC, V75, P1, DOI 10.1016/j.ibmb.2016.05.006; Zimmer CT, 2016, INSECT BIOCHEM MOLEC, V73, P62, DOI 10.1016/j.ibmb.2016.04.007	41	1	1	10	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-1748	1879-0240		INSECT BIOCHEM MOLEC	Insect Biochem. Mol. Biol.	AUG	2017	87						127	135		10.1016/j.ibmb.2017.06.013				9	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	FE5ZG	WOS:000408289200014	28669775				2018-01-05	
J	Wang, J; Wang, HD; Liu, SY; Liu, LP; Tay, WT; Walsh, TK; Yang, YH; Wu, YD				Wang, Jing; Wang, Huidong; Liu, Shaoyan; Liu, Laipan; Tay, Wee Tek; Walsh, Thomas K.; Yang, Yihua; Wu, Yidong			CRISPR/Cas9 mediated genome editing of Helicoverpa armigera with mutations of an ABC transporter gene HaABCA2 confers resistance to Bacillus thuringiensis Cry2A toxins	INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Helicoverpa armigera; Cry2Aa; Cry2Ab; Bt resistance; ABC transporter; CRISPR/Cas9	INSECT RESISTANCE; LEPIDOPTERA; NOCTUIDAE; AUSTRALIA; RECEPTOR; CADHERIN; MIDGUT; CRY1AC; MODE; DNA	High levels of resistance to Bt toxin Cry2Ab have been identified to be genetically linked with loss of function mutations of an ABC transporter gene (ABCA2) in two lepidopteran insects, Helicoverpa armigera and Helicoverpa punctigera. To further confirm the causal relationship between the ABCA2 gene (HaABCA2) and Cry2Ab resistance in H. armigera, two HaABCA2 knockout strains were created from the susceptible SCD strain with the CRISPR/Cas9 genome editing system. One strain (SCD-A2KO1) is homozygous for a 2-bp deletion in exon 2 of HaABCA2 created by non-homologous end joining (NHEJ). The other strain (SCD-A2KO2) is homozygous for a 5-bp deletion in exon 18 of HaABCA2 made by homology directed repair (HDR), which was produced to mimic the r2 resistance allele of a field-derived Cry2Ab-resistant strain from Australia. Both knockout strains obtained high levels of resistance to both Cry2Aa (>120-fold) and Cry2Ab (>100-fold) compared with the original SCD strain, but no or very limited resistance to Cry1Ac (<4-fold). Resistance to Cry2Ab in both knockouts is recessive, and genetic complementary tests confirmed Cry2Ab resistance alleles are at the same locus (i.e. HaABCA2) for the two strains. Brush border membrane vesicles (BBMVs) of midguts from both knockout strains lost binding with Cry2Ab, but maintained the same binding with Cry1Ac as the SCD strain. In vivo functional evidence from this study demonstrates knockout of HaABCA2 confers high levels of resistance to both Cry2Aa and Cry2Ab, confirming that HaABCA2 plays a key role in mediating toxicity of both Cry2Aa and Cry2Ab against H. armigera. (C) 2017 Elsevier Ltd. All rights reserved.	[Wang, Jing; Wang, Huidong; Liu, Shaoyan; Liu, Laipan; Yang, Yihua; Wu, Yidong] Nanjing Agr Univ, Coll Plant Protect, Nanjing 210095, Jiangsu, Peoples R China; [Tay, Wee Tek; Walsh, Thomas K.] CSIRO, Black Mt Labs, Canberra, ACT, Australia	Wu, YD (reprint author), Nanjing Agr Univ, Coll Plant Protect, Nanjing 210095, Jiangsu, Peoples R China.	wangjing610610@163.com; 2013202034@njau.edu.cn; 2015202039@njau.edu.cn; 2013202036@njau.edu.cn; Weetek.Tay@csiro.au; Tom.Walsh@csiro.au; yhyang@njau.edu.cn; wyd@njau.edu.cn	Wu, Yidong/E-9720-2012; Walsh, Thomas/C-1263-2009	Wu, Yidong/0000-0003-3456-3373; Walsh, Thomas/0000-0001-8425-0135	National Natural Science Foundation of China [31530060, 31272064]; Innovation Team Program for Jiangsu universities [2013-6]; CSIRO Health & Biosecurity 'Genes of Biosecurity Significance' [R-8681-1]	This work was funded by grants (No. 31530060 to YW; No. 31272064 to YY) from National Natural Science Foundation of China, and a grant (No. 2013-6) from Innovation Team Program for Jiangsu universities. WIT and TKW acknowledged funding support from CSIRO Health & Biosecurity 'Genes of Biosecurity Significance' (R-8681-1).	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bretschneider A, 2016, INSECT BIOCHEM MOLEC, V76, P109, DOI [10.1016/j.ibmb.2016.07.00, 10.1016/j.ibmb.2016.07.008]; Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Chakroun M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24311; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Downes S, 2016, CURR OPIN INSECT SCI, V15, P78, DOI 10.1016/j.cois.2016.04.002; Gahan L.J., 2010, PLOS GENET, V6; Heckel DG, 2012, PESTIC BIOCHEM PHYS, V104, P103, DOI 10.1016/j.pestbp.2012.05.007; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jurat-Fuentes J.L., 2011, APPL ENVIRON MICROB, V77, P3182; Khan SA, 2017, SCI REP-UK, V7, DOI 10.1038/srep40025; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119618; LeOra Software, 2002, POL PLUS US GUID PRO; Liu YB, 1997, APPL ENVIRON MICROB, V63, P2218; Mahon RJ, 2008, J ECON ENTOMOL, V101, P909, DOI 10.1603/0022-0493(2008)101[909:IOCRIA]2.0.CO;2                                  ; Mahon RJ, 2007, J ECON ENTOMOL, V100, P894, DOI 10.1603/0022-0493(2007)100[894:RTBTTC]2.0.CO;2                                  ; Ohsawa M, 2012, APPL ENVIRON MICROB, V78, P4755, DOI 10.1128/AEM.07123-11; Park Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-46; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tay WT, 2017, SCI REP-UK, V7, DOI 10.1038/srep45302; Tay WT, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005534; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; Wang J, 2016, INSECT BIOCHEM MOLEC, V76, P11, DOI 10.1016/j.ibmb.2016.06.008; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3                                                    ; Wu YD, 2014, ADV INSECT PHYSIOL, V47, P297, DOI 10.1016/B978-0-12-800197-4.00006-3; Yang YH, 2009, B ENTOMOL RES, V99, P175, DOI 10.1017/S0007485308006226; Yang YH, 2013, J ECON ENTOMOL, V106, P375, DOI 10.1603/EC12286	27	1	1	22	22	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-1748	1879-0240		INSECT BIOCHEM MOLEC	Insect Biochem. Mol. Biol.	AUG	2017	87						147	153		10.1016/j.ibmb.2017.07.002				7	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	FE5ZG	WOS:000408289200016	28705634				2018-01-05	
J	Fernandez, A; Josa, S; Montoliu, L				Fernandez, Almudena; Josa, Santiago; Montoliu, Lluis			A history of genome editing in mammals	MAMMALIAN GENOME			English	Article							ZINC-FINGER NUCLEASES; EMBRYONIC STEM-CELLS; CRISPR-CAS SYSTEMS; HOMOLOGOUS RECOMBINATION; IN-VIVO; EFFICIENT GENERATION; ZYGOTE INJECTION; GENE CORRECTION; KNOCKOUT RATS; C57BL/6N MICE	Genome editing is now a routine procedure in many mammalian genetics laboratories. The ostensibly short but intense history of genome-editing approaches illustrates how a disruptive technology can universally colonize a field when this new methodology, conceived to alter mammalian genomes at specific locations, is found to efficiently and robustly deliver results. This review summarizes the early development of genome editing using nucleases, from the pioneering experiments using yeast meganucleases, to the latest prokaryotic nucleases used for precise genome manipulation. Gene-editing nucleases belong to one of three known categories: zinc-finger nucleases (ZFN), transcription activator-like effector nucleases (TALEN), and clustered regularly interspaced short palindromic repeats (CRISPR) and their associated proteins (Cas) tools. All operate on the same principle; they are all capable of inducing a double-strand break (DSB) at a defined genomic sequence that is subsequently corrected by endogenous DNA repair mechanisms. DSBs can be repaired through non-homologous end joining (NHEJ), resulting in small insertions and/or deletions (INDELs) and, hence, often leading to gene disruption. Alternatively, DSBs can be repaired through homology-driven repair (HDR), in the presence of donor homologous DNA sequences, resulting in gene-editing events.	[Fernandez, Almudena; Josa, Santiago; Montoliu, Lluis] CSIC, CNB, Dept Biol Mol & Celular, Campus Cantoblanco,Darwin 3, Madrid 28049, Spain; [Fernandez, Almudena; Josa, Santiago; Montoliu, Lluis] Inst Salud Carlos III, CIBERER, Madrid, Spain	Montoliu, L (reprint author), CSIC, CNB, Dept Biol Mol & Celular, Campus Cantoblanco,Darwin 3, Madrid 28049, Spain.; Montoliu, L (reprint author), Inst Salud Carlos III, CIBERER, Madrid, Spain.	montoliu@cnb.csic.es		Montoliu, Lluis/0000-0003-3941-1176	Spanish Ministry of Economy and Competitiveness (MINECO) [BIO2015-70978]; Biomedical and Biological Sciences (BMBS) European Cooperation in Science and Technology (COST) action [BM1308 SALAAM]; Spanish Biomedical Research Networking Centre on Rare Diseases (CIBERER) from the National Institute of Heath Carlos III (Instituto de Salud Carlos III, ISCIII)	LM's laboratory is funded through the Spanish Ministry of Economy and Competitiveness (MINECO) [BIO2015-70978], the Biomedical and Biological Sciences (BMBS) European Cooperation in Science and Technology (COST) action [BM1308 SALAAM], and the Spanish Biomedical Research Networking Centre on Rare Diseases (CIBERER) from the National Institute of Heath Carlos III (Instituto de Salud Carlos III, ISCIII). The authors thank Kenneth McCreath for English language editing assistance.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Bevacqua RJ, 2016, THERIOGENOLOGY, V86, P1886, DOI 10.1016/j.theriogenology.2016.06.010; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001                                                   ; Biffi A, 2015, CELL STEM CELL, V16, P348, DOI 10.1016/j.stem.2015.03.009; Birling MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep43331; Bochtler M, 2012, BIOL CHEM, V393, P1055, DOI 10.1515/hsz-2012-0164; BRINSTER RL, 1989, P NATL ACAD SCI USA, V86, P7087, DOI 10.1073/pnas.86.18.7087; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2015, METHODS MOL BIOL, V1239, P133, DOI 10.1007/978-1-4939-1862-1_7; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Cohen-Tannoudji M, 1998, MOL CELL BIOL, V18, P1444, DOI 10.1128/MCB.18.3.1444                                                           ; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Cui C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10482; Ellis BL, 2013, GENE THER, V20, P35, DOI 10.1038/gt.2011.211; Fenina M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039895; Fischer K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29081; Flynn R, 2015, EXP HEMATOL, V43, P838, DOI 10.1016/j.exphem.2015.06.002; Gao YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1144-4; Garate Z, 2015, STEM CELL REP, V5, P1053, DOI 10.1016/j.stemcr.2015.10.002; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Guo RH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29855; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Han Y, 2015, ARTERIOSCL THROM VAS, V35, P312, DOI 10.1161/ATVBAHA.114.305017; Harms DW, 2014, CURR PROTOC HUM GENE, V83, P1; HASTY P, 1991, MOL CELL BIOL, V11, P4509, DOI 10.1128/MCB.11.9.4509                                                           ; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Hermann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041796; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; KUCHERLAPATI RS, 1984, P NATL ACAD SCI-BIOL, V81, P3153, DOI 10.1073/pnas.81.10.3153; Kwon DN, 2013, SCI REP-UK, V3, DOI 10.1038/srep01981; Lai SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146562; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Lillico SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep21645; Liu HL, 2014, CELL STEM CELL, V14, P323, DOI 10.1016/j.stem.2014.01.018; Liu X, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3368; Liu X, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3565; Low BE, 2014, INVEST OPHTH VIS SCI, V55, P387, DOI 10.1167/iovs.13-13278; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Lv QY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25029; Ma YW, 2014, FEBS J, V281, P3779, DOI 10.1111/febs.12935; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Maier DA, 2013, HUM GENE THER, V24, P245, DOI 10.1089/hum.2012.172; Mak TW, 2007, CELL, V131, P1027, DOI 10.1016/j.cell.2007.11.033; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mani M, 2005, BIOCHEM BIOPH RES CO, V334, P1191, DOI 10.1016/j.bbrc.2005.07.021; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Menoret S, 2013, FASEB J, V27, P703, DOI 10.1096/fj.12-219907; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Mojica FJM, 2016, TRENDS MICROBIOL, V24, P811, DOI 10.1016/j.tim.2016.06.005; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Niemann H, 2016, TRANSGENIC RES, V25, P361, DOI 10.1007/s11248-016-9934-8; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Overlack N, 2012, INVEST OPHTH VIS SCI, V53, P4140, DOI 10.1167/iovs.12-9812; Pan FC, 2006, DEV DYNAM, V235, P247, DOI 10.1002/dvdy.20608; Panda SK, 2013, GENETICS, V195, P703, DOI 10.1534/genetics.113.156570; Park KE, 2017, SCI REP-UK, V7, DOI 10.1038/srep40176; Peng J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16705; Periwal V, 2017, BRIEF BIOINFORM, V18, P698, DOI 10.1093/bib/bbw052; Petersen B, 2015, CHROMOSOME RES, V23, P7, DOI 10.1007/s10577-014-9451-7; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Porteus Matthew, 2008, V435, P47, DOI 10.1007/978-1-59745-232-8_4; Proudfoot C, 2015, TRANSGENIC RES, V24, P147, DOI 10.1007/s11248-014-9832-x; Qian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14435; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Ramalingam S, 2014, CURR GENE THER, V14, P461, DOI 10.2174/1566523214666140918101725                                               ; Remy S, 2010, TRANSGENIC RES, V19, P363, DOI 10.1007/s11248-009-9323-7; Sakuma T, 2016, METHODS MOL BIOL, V1338, P61, DOI 10.1007/978-1-4939-2932-0_6; Seruggia D, 2015, NUCLEIC ACIDS RES, V43, P4855, DOI 10.1093/nar/gkv375; Seruggia D, 2014, TRANSGENIC RES, V23, P707, DOI 10.1007/s11248-014-9823-y; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; SMITHIES O, 1984, COLD SPRING HARB SYM, V49, P161, DOI 10.1101/SQB.1984.049.01.019                                                     ; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0                                                                ; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Swarthout JT, 2011, ANN NEUROSCI, V18, P25, DOI 10.5214/ans.0972.7531.1118109; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wang HY, 2013, NAT BIOTECHNOL, V31, P530, DOI 10.1038/nbt.2595; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang X., 2016, SCI REP, V6, P20620; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; Wang YF, 2014, LECT NOTES COMPUT SC, V8544, P1; Wang ZD, 2015, CHROMOSOME RES, V23, P17, DOI 10.1007/s10577-014-9452-6; Wefers B, 2013, NAT PROTOC, V8, P2355, DOI 10.1038/nprot.2013.142; Wei JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11735; Whitelaw CBA, 2016, J PATHOL, V238, P247, DOI 10.1002/path.4648; Wu HB, 2015, P NATL ACAD SCI USA, V112, pE1530, DOI 10.1073/pnas.1421587112; Wu J, 2017, CELL, V168, P473, DOI 10.1016/j.cell.2016.12.036; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Xin JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084250; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yu SL, 2011, CELL RES, V21, P1638, DOI 10.1038/cr.2011.153; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396	112	1	1	43	43	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2017	28	7-8			SI		237	246		10.1007/s00335-017-9699-2				10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FE7SV	WOS:000408408100002	28589393				2018-01-05	
J	Cebrian-Serrano, A; Davies, B				Cebrian-Serrano, Alberto; Davies, Benjamin			CRISPR-Cas orthologues and variants: optimizing the repertoire, specificity and delivery of genome engineering tools	MAMMALIAN GENOME			English	Article							STAPHYLOCOCCUS-AUREUS CAS9; RNA-GUIDED ENDONUCLEASE; TARGET DNA RECOGNITION; ALTERED PAM SPECIFICITIES; HOMOLOGY-DIRECTED REPAIR; HUMAN-CELLS; STREPTOCOCCUS-THERMOPHILUS; CRYSTAL-STRUCTURE; NEISSERIA-MENINGITIDIS; IN-VIVO	Robust and cost-effective genome editing in a diverse array of cells and model organisms is now possible thanks to the discovery of the RNA-guided endonucleases of the CRISPR-Cas system. The commonly used Cas9 of Streptococcus pyogenes shows high levels of activity but, depending on the application, has been associated with some shortcomings. Firstly, the enzyme has been shown to cause mutagenesis at genomic sequences resembling the target sequence. Secondly, the stringent requirement for a specific motif adjacent to the selected target site can limit the target range of this enzyme. Lastly, the physical size of Cas9 challenges the efficient delivery of genomic engineering tools based on this enzyme as viral particles for potential therapeutic applications. Related and parallel strategies have been employed to address these issues. Taking advantage of the wealth of structural information that is becoming available for CRISPR-Cas effector proteins, Cas9 has been redesigned by mutagenizing key residues contributing to activity and target recognition. The protein has also been shortened and redesigned into component subunits in an attempt to facilitate its efficient delivery. Furthermore, the CRISPR-Cas toolbox has been expanded by exploring the properties of Cas9 orthologues and other related effector proteins from diverse bacterial species, some of which exhibit different target site specificities and reduced molecular size. It is hoped that the improvements in accuracy, target range and efficiency of delivery will facilitate the therapeutic application of these site-specific nucleases.	[Cebrian-Serrano, Alberto; Davies, Benjamin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	Davies, B (reprint author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	ben.davies@well.ox.ac.uk			Wellcome Trust [203141/Z/16/Z]	Support for this work was received from the Wellcome Trust (203141/Z/16/Z).	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Anders C, 2016, MOL CELL, V61, P895, DOI 10.1016/j.molcel.2016.02.020; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Aouida M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133373; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Betermier M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004086; Bialk P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129308; Bolukbasi MF, 2015, NAT METHODS, V12, P1150, DOI 10.1038/nmeth.3624; Chen BH, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1533; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chu V, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0234-4; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Eggenschwiler R, 2016, SCI REP-UK, V6, DOI 10.1038/srep38198; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fujii W, 2016, BIOCHEM BIOPH RES CO, V477, P473, DOI 10.1016/j.bbrc.2016.06.070; Gao P, 2016, CELL RES, V26, P901, DOI 10.1038/cr.2016.88; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Glemzaite M, 2015, RNA BIOL, V12, P1, DOI 10.1080/15476286.2015.1017209; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Greene EC, 2016, J BIOL CHEM, V291, P11572, DOI 10.1074/jbc.R116.724807; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hara S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11221; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hirano S, 2016, MOL CELL, V61, P886, DOI 10.1016/j.molcel.2016.02.018; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaminski R, 2016, GENE THER, V23, P690, DOI 10.1038/gt.2016.41; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14500; Kim HK, 2017, NAT METHODS, V14, P153, DOI [10.1038/NMETH.4104, 10.1038/nmeth.4104]; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Lee AYF, 2014, FEBS OPEN BIO, V4, P637, DOI 10.1016/j.fob.2014.06.007; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mianne J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0273-4; Miyaoka Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23549; Muller M, 2016, MOL THER, V24, P636, DOI 10.1038/mt.2015.218; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Osborn MJ, 2015, HUM GENE THER, V26, P114, DOI 10.1089/hum.2014.111; Pan Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35794; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Sakuma T, 2016, GENES CELLS, V21, P1253, DOI 10.1111/gtc.12437; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sinha S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006714; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Terao M, 2016, EXP ANIM TOKYO, V65, P275, DOI 10.1538/expanim.15-0116; Toth E, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0147-0; Truong DJJ, 2015, NUCLEIC ACIDS RES, V43, P6450, DOI 10.1093/nar/gkv601; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Watkins-Chow DE, 2017, G3-GENES GENOM GENET, V7, P719, DOI 10.1534/g3.116.038091; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Wu JB, 2016, STEM CELL RES, V16, P220, DOI 10.1016/j.scr.2016.01.003; Xu K, 2015, CELL MOL LIFE SCI, V72, P383, DOI 10.1007/s00018-014-1679-z; Yamada M, 2017, MOL CELL, V65, P1109, DOI 10.1016/j.molcel.2017.02.007; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Ye L, 2016, P NATL ACAD SCI USA, V113, P10661, DOI 10.1073/pnas.1612075113; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; ZHANG XF, 2016, SCI REP UK, V6; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405	101	2	2	11	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2017	28	7-8			SI		247	261		10.1007/s00335-017-9697-4				15	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FE7SV	WOS:000408408100003	28634692	gold			2018-01-05	
J	Danner, E; Bashir, S; Yumlu, S; Wurst, W; Wefers, B; Kuhn, R				Danner, Eric; Bashir, Sanum; Yumlu, Saniye; Wurst, Wolfgang; Wefers, Benedikt; Kuehn, Ralf			Control of gene editing by manipulation of DNA repair mechanisms	MAMMALIAN GENOME			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGY-DIRECTED REPAIR; PLURIPOTENT STEM-CELLS; END RESECTION; CRISPR-CAS9 NUCLEASES; KNOCK-IN; MUSCULAR-DYSTROPHY; MAMMALIAN-CELLS; MOUSE MODEL; DONOR DNA	DNA double-strand breaks (DSBs) are produced intentionally by RNA-guided nucleases to achieve genome editing through DSB repair. These breaks are repaired by one of two main repair pathways, classic non-homologous end joining (c-NHEJ) and homology-directed repair (HDR), the latter being restricted to the S/G2 phases of the cell cycle and notably less frequent. Precise genome editing applications rely on HDR, with the abundant c-NHEJ formed mutations presenting a barrier to achieving high rates of precise sequence modifications. Here, we give an overview of HDR- and c-NHEJ-mediated DSB repair in gene editing and summarize the current efforts to promote HDR over c-NHEJ.	[Danner, Eric; Bashir, Sanum; Yumlu, Saniye; Kuehn, Ralf] Max Delbruck Centrum Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany; [Bashir, Sanum; Yumlu, Saniye; Kuehn, Ralf] Berlin Inst Hlth, Kapelle Ufer 2, D-10117 Berlin, Germany; [Wurst, Wolfgang; Wefers, Benedikt] Deutsch Zentrum Neurodegenerat Erkrankungen eV DZ, Feodor Lynen Str 17, D-81377 Munich, Germany; [Wurst, Wolfgang; Wefers, Benedikt] Helmholtz Zentrum Munchen, Inst Dev Genet, German Res Ctr Environm Hlth, D-85764 Neuherberg, Germany; [Wurst, Wolfgang] Tech Univ Munchen Weihenstephan, Chair Dev Genet, Helmholtz Zentrum Munchen, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Wurst, Wolfgang] Munich Cluster Syst Neurol SyNergy, Feodor Lynen Str 17, D-81377 Munich, Germany	Kuhn, R (reprint author), Max Delbruck Centrum Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.; Kuhn, R (reprint author), Berlin Inst Hlth, Kapelle Ufer 2, D-10117 Berlin, Germany.	eric.danner@mdc-berlin.de; sanum.bashir@mdc-berlin.de; saniye.yumlu@mdc-berlin.de; wurst@helmholtz-muenchen.de; benedikt.wefers@dzne.de; ralf.kuehn@mdc-berlin.de	Kuhn, Ralf/U-1278-2017	Kuhn, Ralf/0000-0003-1694-9803	BMBF [VIP 03V0261]	Funding was provided by BMBF (Grant No: VIP 03V0261).	Aida T, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3331-9; Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Arras SDM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163049; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Betermier M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004086; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; Boel A, 2016, SCI REP-UK, V6, DOI 10.1038/srep30330; Bond DM, 2014, TRENDS CELL BIOL, V24, P100, DOI 10.1016/j.tcb.2013.08.001; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Byrum J, 2004, NUCLEIC ACIDS RES, V32, P2776, DOI 10.1093/nar/gkh592; Canny MD, 2016, BIORXIV, DOI [10.1101/060954, DOI 10.1101/060954]; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/NMETH.1648, 10.1038/nmeth.1648]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; Davis L, 2016, CELL REP, V17, P1872, DOI 10.1016/j.celrep.2016.10.049; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; Davis L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023981; Dehairs J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28973; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI [10.1146/annurev.biochern.77.061306.125255, 10.1146/annurev.biochem.77.061306.125255]; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Glaser A, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.48; Greco GE, 2016, DNA REPAIR, V43, P18, DOI 10.1016/j.dnarep.2016.04.004; Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hasty P, 2000, GENE TARGETING PRACT, P1; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Howden SE, 2016, STEM CELL REP, V7, P508, DOI 10.1016/j.stemcr.2016.07.001; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hustedt N, 2017, NAT CELL BIOL, V19, P1, DOI 10.1038/ncb3452; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Jayathilaka K, 2008, P NATL ACAD SCI USA, V105, P15848, DOI 10.1073/pnas.0808046105; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Kim E, 2012, GENOME RES, V22, P1327, DOI 10.1101/gr.138792.112; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Kuhn R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0810-2; Lavin MF, 2015, BIOMOLECULES, V5, P2877, DOI 10.3390/biom5042877; Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lindsay H, 2016, NAT BIOTECHNOL, V34, P701, DOI 10.1038/nbt.3628; Liu J, 2011, CRIT REV BIOCHEM MOL, V46, P240, DOI 10.3109/10409238.2011.576007; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Menchon G, 2016, SCI REP-UK, V6, DOI 10.1038/srep22878; Miyaoka Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23549; Mladenov E, 2016, SEMIN CANCER BIOL, V37-38, P51, DOI 10.1016/j.semcancer.2016.03.003; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakamura AJ, 2010, CELL CYCLE, V9, P389, DOI 10.4161/cc.9.2.10475                                                            ; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ren JT, 2017, CLIN CANCER RES, V23, P2255, DOI 10.1158/1078-0432.CCR-16-1300; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Robert F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0215-6; Rodgers K, 2016, J CELL PHYSIOL, V231, P15, DOI 10.1002/jcp.25053; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schmid-Burgk JL, 2014, GENOME RES, V24, P1719, DOI 10.1101/gr.176701.114; Schwertman P, 2016, NAT REV MOL CELL BIO, V17, P379, DOI 10.1038/nrm.2016.58; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Smeenk G, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00122; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Symington LS, 2016, CRIT REV BIOCHEM MOL, V51, P195, DOI 10.3109/10409238.2016.1172552; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang JB, 2012, GENOME RES, V22, P1316, DOI 10.1101/gr.122879.111; Waters CA, 2014, DNA REPAIR, V17, P39, DOI 10.1016/j.dnarep.2014.02.008; Wyvekens N, 2015, CURR PROTOC MOL BIOL, V112, DOI [10.1002/0471142727.mb3103s112, DOI 10.1002/0471142727.MB3103S112]; Xi LH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0791-1; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xue HY, 2016, GENE THER, V23, P557, DOI 10.1038/gt.2016.25; Yang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21264; Yoo E, 2005, ONCOGENE, V24, P5423, DOI 10.1038/sj.onc.1208710; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zakharyevich K, 2010, MOL CELL, V40, P1001, DOI 10.1016/j.molcel.2010.11.032; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	105	1	1	9	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2017	28	7-8			SI		262	274		10.1007/s00335-017-9688-5				13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FE7SV	WOS:000408408100004	28374058				2018-01-05	
J	Szafranski, P; Karolak, JA; Lanza, D; Gajecka, M; Heaney, J; Stankiewicz, P				Szafranski, Przemyslaw; Karolak, Justyna A.; Lanza, Denise; Gajecka, Marzena; Heaney, Jason; Stankiewicz, Pawel			CRISPR/Cas9-mediated deletion of lncRNA Gm26878 in the distant Foxf1 enhancer region	MAMMALIAN GENOME			English	Article							LONG NONCODING RNAS; ALVEOLAR-CAPILLARY DYSPLASIA; PULMONARY VEINS; GENOME; TRANSCRIPTION; EVOLUTION; LUNG; MISALIGNMENT; EXPRESSION; LANDSCAPE	Recent genome editing techniques, including CRISPR mutagenesis screens, offer unparalleled opportunities to study the regulatory non-coding genomic regions, enhancers, promoters, and functional non-coding RNAs. Heterozygous point mutations in FOXF1 and genomic deletion copy-number variants at chromosomal region 16q24.1 involving FOXF1 or its regulatory region mapping 300 kb upstream of FOXF1 and leaving it intact have been identified in the vast majority of patients with a lethal neonatal lung disease, alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV). Homozygous Foxf1 (-/-) mice have been shown to die by embryonic day 8.5 because of defects in the development of extraembryonic and lateral mesoderm-derived tissues, whereas heterozygous Foxf1 (+/-) mice exhibit features resembling ACDMPV. We have previously defined a human lung-specific enhancer region encoding two long non-coding RNAs, LINC01081 and LINC01082, expressed in the lungs. To investigate the biological significance of lncRNAs in the Foxf1 enhancer region, we have generated a CRISPR/Cas9-mediated 2.4 kb deletion involving the entire lncRNA-encoding gene Gm26878, located in the mouse region syntenic with the human Foxf1 upstream enhancer. Very recently, this mouse genomic region has been shown to function as a Foxf1 enhancer. Our results indicate that homozygous loss of Gm26878 is neonatal lethal with low penetrance. No changes in Foxf1 expression were observed, suggesting that the regulation of Foxf1 expression differs between mouse and human.	[Szafranski, Przemyslaw; Karolak, Justyna A.; Lanza, Denise; Heaney, Jason; Stankiewicz, Pawel] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Karolak, Justyna A.; Gajecka, Marzena] Poznan Univ Med Sci, Dept Genet & Pharmaceut Microbiol, Poznan, Poland; [Karolak, Justyna A.; Gajecka, Marzena] Polish Acad Sci, Inst Human Genet, Poznan, Poland	Heaney, J; Stankiewicz, P (reprint author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	heaney@bcm.edu; pawels@bcm.edu			National Institutes of Health [RO1HL101975]; National Organization for Rare Disorders [NORD]	This work was supported by the National Institutes of Health (Grant No. RO1HL101975) to P.S. and the National Organization for Rare Disorders (Grant No. NORD grants 2012 and 2014) to P.Sz.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bishop NB, 2011, AM J RESP CRIT CARE, V184, P172, DOI 10.1164/rccm.201010-1697CI; Brunner AL, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r75; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Fu Yutao, 2005, Genome Inform, V16, P68; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Kalinichenko VV, 2001, AM J PHYSIOL-LUNG C, V280, pL695; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Lai KMV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125522; LANGSTON C, 1991, Pediatric Pathology, V11, P163; Lopes R, 2016, NAT REV MOL CELL BIO, V17, P597, DOI 10.1038/nrm.2016.79; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Mattick JS, 2010, DEV CELL, V19, P485, DOI 10.1016/j.devcel.2010.10.003; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Mouse EC, 2012, GENOME BIOL, V13, P418, DOI DOI 10.1186/GB-2012-13-8-418; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sambrook J, 1989, MOL CLONING LAB MANU; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Sen P, 2004, J PEDIATR-US, V145, P646, DOI 10.1016/j.jpeds.2004.06.08; Seo H, 2016, HISTOCHEM CELL BIOL, V146, P289, DOI 10.1007/s00418-016-1445-4; Stankiewicz P, 2009, AM J HUM GENET, V84, P780, DOI 10.1016/j.ajhg.2009.05.005; Steele-Perkins G, 2001, GENE DEV, V15, P2250, DOI 10.1101/gad.870101; Szafranski P, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0278-2; Szafranski P, 2016, HUM GENET, V135, P569, DOI 10.1007/s00439-016-1655-9; Szafranski P, 2014, AM J MED GENET A, V164, P2013, DOI 10.1002/ajmg.a.36606; Szafranski P, 2013, GENOME RES, V23, P23, DOI 10.1101/gr.141887.112; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wright JB, 2016, TRENDS GENET, V32, P526, DOI 10.1016/j.tig.2016.06.004; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	39	0	0	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2017	28	7-8			SI		275	282		10.1007/s00335-017-9686-7				8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FE7SV	WOS:000408408100005	28405742				2018-01-05	
J	Peterson, KA; Beane, GL; Goodwin, LO; Kutny, PM; Reinholdt, LG; Murray, SA				Peterson, Kevin A.; Beane, Glen L.; Goodwin, Leslie O.; Kutny, Peter M.; Reinholdt, Laura G.; Murray, Stephen A.			CRISPRtools: a flexible computational platform for performing CRISPR/Cas9 experiments in the mouse	MAMMALIAN GENOME			English	Article							ONE-STEP GENERATION; OFF-TARGET SITES; GENE-FUNCTION; GENOME; SYSTEM; MICE; CRISPR-CAS9; DESIGN; DNA; ELECTROPORATION	Genome editing using the CRISPR/Cas9 RNA-guided endonuclease system has rapidly become a driving force for discovery in modern biomedical research. This simple yet elegant system has been widely used to generate both loss-of-function alleles and precision knock-in mutations using single-stranded donor oligonucleotides. Our CRISPRtools platform supports both of these applications in order to facilitate the use of CRISPR/Cas9. While there are several tools that facilitate CRISPR/Cas9 design and screen for potential off-target sites, the process is typically performed sequentially on single genes, limiting scalability for large-scale programs. Here, the design principle underlying gene ablation is based upon using paired guides flanking a critical region/exon of interest to create deletions. Guide pairs are rank ordered based upon published efficiency scores and off-target analyses, and reported in a concise format for downstream implementation. The exon deletion strategy simplifies characterization of founder animals and is the strategy employed for the majority of knockouts in the mouse. In proof-of-principle experiments, the effectiveness of this approach is demonstrated using microinjection and electroporation to introduce CRISPR/Cas9 components into mouse zygotes to delete critical exons.	[Peterson, Kevin A.; Beane, Glen L.; Goodwin, Leslie O.; Kutny, Peter M.; Reinholdt, Laura G.; Murray, Stephen A.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	Murray, SA (reprint author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	Steve.Murray@jax.org			Office Of The Director, National Institutes Of Health [OD011185, UM1OD023222, OD010972]	We would like to thank Charles Vejnar, Miguel Moreo-Mateos, and A. Giraldez at Yale University for kindly providing the CRISPRscan code; Susan Kales and Rachel Urban for technical support; Haoyi Wang and Wen-bo Wang for providing insight into electroporation experiments; and the Genetic Engineering Technologies and Transgenic Genotyping Services at the Jackson Laboratory. This work was supported by the Office Of The Director, National Institutes Of Health under Award Number OD011185 and UM1OD023222 (to S.A.M.), and OD010972 (to L.G.R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Chu V, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0234-4; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114485; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Maquat LE, 2001, RNA, V7, P445, DOI 10.1017/S1355838201002229; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Oliveros JC, 2016, NUCLEIC ACIDS RES, V44, pW267, DOI 10.1093/nar/gkw407; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qin WN, 2015, GENETICS, V200, P423, DOI 10.1534/genetics.115.176594; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang WB, 2016, J GENET GENOMICS, V43, P319, DOI 10.1016/j.jgg.2016.02.004; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang XY, 2016, NAT GENET, V48, P176, DOI 10.1038/ng.3470	31	1	1	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2017	28	7-8			SI		283	290		10.1007/s00335-017-9681-z				8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FE7SV	WOS:000408408100006	28280930				2018-01-05	
J	Birling, MC; Herault, Y; Pavlovic, G				Birling, Marie-Christine; Herault, Yann; Pavlovic, Guillaume			Modeling human disease in rodents by CRISPR/Cas9 genome editing	MAMMALIAN GENOME			English	Article							COPY-NUMBER VARIATION; DUCHENNE MUSCULAR-DYSTROPHY; KNOCKOUT MOUSE CONSORTIUM; MAMMALIAN GENE-FUNCTION; CHROMOSOMAL REARRANGEMENTS; SEGMENTAL DUPLICATIONS; RAPID GENERATION; COMPLEX TRAITS; DNA ELEMENTS; MICE	Modeling human disease has proven to be a challenge for the scientific community. For years, generating an animal model was complicated and restricted to very few species. With the rise of CRISPR/Cas9, it is now possible to generate more or less any animal model. In this review, we will show how this technology is and will change our way to obtain relevant disease animal models and how it should impact human health.	[Birling, Marie-Christine; Herault, Yann; Pavlovic, Guillaume] Univ Strasbourg, CNRS, ICS, CELPHEDIA,PHENOMIN,INSERM, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France; [Herault, Yann] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France; [Herault, Yann] CNRS, UMR7104, Illkirch Graffenstaden, France; [Herault, Yann] INSERM, U964, F-U964 Illkirch Graffenstaden, France; [Herault, Yann] Univ Strasbourg, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France	Birling, MC (reprint author), Univ Strasbourg, CNRS, ICS, CELPHEDIA,PHENOMIN,INSERM, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.	birlingm@igbmc.fr		Herault, Yann/0000-0001-7049-6900; Pavlovic, Guillaume/0000-0001-9122-4592			Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Barau J, 2016, SCIENCE, V354, P909, DOI 10.1126/science.aah5143; Bilovocky NA, 2003, J NEUROSCI, V23, P5105; Birling MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep43331; Boroviak K, 2016, GENESIS, V54, P78, DOI 10.1002/dvg.22915; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Buffenstein R, 2014, AGING-US, V6, P913, DOI 10.18632/aging.100704                                                           ; Carneiro AMD, 2009, P NATL ACAD SCI USA, V106, P2047, DOI 10.1073/pnas.0809449106; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a                                                                 ; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Courtney DG, 2016, GENE THER, V23, P108, DOI 10.1038/gt.2015.82; Dasouki MJ, 2011, AM J MED GENET A, V155A, P1654, DOI 10.1002/ajmg.a.34080; de Angelis MH, 2015, NAT GENET, V47, P969, DOI 10.1038/ng.3360; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eisener-Dorman AF, 2009, BRAIN BEHAV IMMUN, V23, P318, DOI 10.1016/j.bbi.2008.09.001; European Commission, 2013, 7 EUR COMM; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Frankish A, 2014, METHODS MOL BIOL, V1167, P129, DOI 10.1007/978-1-4939-0835-6_10; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Gregorova S, 2008, GENOME RES, V18, P509, DOI 10.1101/gr.7160508; Guo MH, 2016, P NATL ACAD SCI USA, V114, pE327; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Hubbard J, 2015, SLEEP, V38, P979, DOI 10.5665/sleep.4754; Huddleston J, 2016, GENETICS, V202, P1251, DOI 10.1534/genetics.115.180539; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Justice MJ, 2016, DIS MODEL MECH, V9, P101, DOI 10.1242/dmm.024547; Kafkafi N, 2017, NAT METHODS, V14, P462, DOI 10.1038/nmeth.4259; Koirala P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14422; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kraft K, 2015, CELL REP, V10, P833, DOI 10.1016/j.celrep.2015.01.016; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05290; Li JH, 2015, J MOL CELL BIOL, V7, P284, DOI 10.1093/jmcb/mjv016; Lin XT, 2016, DIABETES, V65, P2134, DOI 10.2337/db16-0061; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Maillard AM, 2015, MOL PSYCHIATR, V20, P140, DOI 10.1038/mp.2014.145; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Perlman Robert L., 2016, Evolution Medicine and Public Health, P170, DOI 10.1093/emph/eow014; Pound P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3387; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Roberts R, 2013, J AM COLL CARDIOL, V61, P2029, DOI 10.1016/j.jacc.2012.12.054; Rosen B, 2015, MAMM GENOME, V26, P456, DOI 10.1007/s00335-015-9598-3; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; Sharma A, 2017, PHYSIOLOGY, V32, P42, DOI 10.1152/physiol.00009.2016; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7                                                   ; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Sittig LJ, 2016, NEURON, V91, P1253, DOI 10.1016/j.neuron.2016.08.013; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1                                                   ; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tai DJC, 2016, NAT NEUROSCI, V19, P517, DOI 10.1038/nn.4235; Torres F, 2016, J MED GENET, V53, P73, DOI 10.1136/jmedgenet-2015-103366; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Qi S., 2001, GENOME BIOL, DOI [10.1186/gb-2001-2-11-research0046</bib>, DOI 10.1186/GB-2001-2-11-RESEARCH0046</BIB>]; Wu XM, 2016, MOL BIOL EVOL, V33, P518, DOI 10.1093/molbev/msv251; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Young NS, 2013, SEMIN HEMATOL, V50, P88, DOI 10.1053/j.seminhematol.2013.03.024; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354                                                          ; Zhu QM, 2017, ARTERIOSCL THROM VAS, V37, P264, DOI 10.1161/ATVBAHA.116.308614	79	0	0	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2017	28	7-8			SI		291	301		10.1007/s00335-017-9703-x				11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FE7SV	WOS:000408408100007	28677007	gold			2018-01-05	
J	Meek, S; Mashimo, T; Burdon, T				Meek, Stephen; Mashimo, Tomoji; Burdon, Tom			From engineering to editing the rat genome	MAMMALIAN GENOME			English	Article							EMBRYONIC STEM-CELLS; ZINC-FINGER NUCLEASES; KNOCK-IN RAT; SELF-RENEWAL; HOMOLOGOUS RECOMBINATION; GERMLINE TRANSMISSION; CONDITIONAL ALLELES; ACTIVATED RECEPTORS; MAMMALIAN GENOME; GENE KNOCKOUT	Since its domestication over 100 years ago, the laboratory rat has been the preferred experimental animal in many areas of biomedical research (Lindsey and Baker The laboratory rat. Academic, New York, pp 1-52, 2006). Its physiology, size, genetics, reproductive cycle, cognitive and behavioural characteristics have made it a particularly useful animal model for studying many human disorders and diseases. Indeed, through selective breeding programmes numerous strains have been derived that are now the mainstay of research on hypertension, obesity and neurobiology (Okamoto and Aoki Jpn Circ J 27:282-293, 1963; Zucker and Zucker J Hered 52(6):275-278, 1961). Despite this wealth of genetic and phenotypic diversity, the ability to manipulate and interrogate the genetic basis of existing phenotypes in rat strains and the methodology to generate new rat models has lagged significantly behind the advances made with its close cousin, the laboratory mouse. However, recent technical developments in stem cell biology and genetic engineering have again brought the rat to the forefront of biomedical studies and enabled researchers to exploit the increasingly accessible wealth of genome sequence information. In this review, we will describe how a breakthrough in understanding the molecular basis of self-renewal of the pluripotent founder cells of the mammalian embryo, embryonic stem (ES) cells, enabled the derivation of rat ES cells and their application in transgenesis. We will also describe the remarkable progress that has been made in the development of gene editing enzymes that enable the generation of transgenic rats directly through targeted genetic modifications in the genomes of zygotes. The simplicity, efficiency and cost-effectiveness of the CRISPR/Cas gene editing system, in particular, mean that the ability to engineer the rat genome is no longer a limiting factor. The selection of suitable targets and gene modifications will now become a priority: a challenge where ES culture and gene editing technologies can play complementary roles in generating accurate bespoke rat models for studying biological processes and modelling human disease.	[Meek, Stephen; Burdon, Tom] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Meek, Stephen; Burdon, Tom] Univ Edinburgh, RD VS, Easter Bush EH25 9RG, Midlothian, Scotland; [Mashimo, Tomoji] Osaka Univ, Inst Expt Anim Sci, Grad Sch Med, Suita, Osaka 5650871, Japan; [Mashimo, Tomoji] Osaka Univ, Grad Sch Med, Genome Editing Res & Dev R&D Ctr, Suita, Osaka 5650871, Japan	Meek, S; Burdon, T (reprint author), Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland.; Meek, S; Burdon, T (reprint author), Univ Edinburgh, RD VS, Easter Bush EH25 9RG, Midlothian, Scotland.	stephen.meek@roslin.ed.ac.uk; tom.burdon@roslin.ed.ac.uk			BBSRC [BB/J004316/1, BB/M023397/1]	The authors would like to thank Dr Michael Clinton for helpful discussions and editorial advice on the manuscript. TB and SM are supported by BBSRC awards BB/J004316/1 and BB/M023397/1.	ARMSTRONG DT, 1988, BIOL REPROD, V39, P511, DOI 10.1095/biolreprod39.3.511; Blair K, 2012, BIOL OPEN, V1, P58, DOI 10.1242/bio.2011029; Brown AJ, 2013, NAT METHODS, V10, P638, DOI 10.1038/nmeth.2516; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Charreau B, 1996, TRANSGENIC RES, V5, P223, DOI 10.1007/BF01972876; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Chen YY, 2013, STEM CELL REP, V1, P209, DOI 10.1016/j.stemcr.2013.07.003; Chen YT, 2017, SCI CHINA LIFE SCI, V60, P152, DOI 10.1007/s11427-016-5049-y; Chuykin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009794; Cocks TM, 1999, NATURE, V398, P156, DOI 10.1038/18223                                                                   ; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; de Leon VP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088146; Debeb BG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007216; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200                                                          ; Dozortsev D, 1998, ZYGOTE, V6, P143, DOI 10.1017/S0967199498000069; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Febo M, 2011, FRONT PSYCHIATRY, V2, P1; Feduccia AA, 2010, JOVE-J VIS EXP, V42, P5; Ferguson C, 2013, ALCOHOL, V47, P595, DOI 10.1016/j.alcohol.2013.09.043; Flister MJ, 2015, J CARDIOVASC TRANSL, V8, P269, DOI 10.1007/s12265-015-9626-4; Flister MJ, 2013, GENOME RES, V23, P1996, DOI 10.1101/gr.160283.113; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Goto T, 2015, MOL REPROD DEV, V82, P916, DOI 10.1002/mrd.22584; Guo G, 2016, STEM CELL REP, V6, P437, DOI 10.1016/j.stemcr.2016.02.005; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; Harris AP, 2015, EUR J NEUROSCI, V42, P2125, DOI 10.1111/ejn.12939; Hirabayashi M, 2010, MOL REPROD DEV, V77, P474, DOI 10.1002/mrd.21181; Hirst WD, 2003, MOL PHARMACOL, V64, P1295, DOI 10.1124/mol.64.6.1295; Hong J, 2012, STEM CELLS DEV, V21, P1571, DOI 10.1089/scd.2011.0370; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Ivics Z, 2014, NAT PROTOC, V9, P773, DOI 10.1038/nprot.2014.008; Izsvak Z, 2010, NAT METHODS, V7, P443, DOI [10.1038/nmeth.1461, 10.1038/NMETH.1461]; Jacob HJ, 2010, TRENDS GENET, V26, P510, DOI 10.1016/j.tig.2010.08.006; Kawabata A, 2003, LIFE SCI, V74, P247, DOI 10.1016/j.lfs.2003.09.011; Kawagoe J, 2002, JPN J PHARMACOL, V88, P77, DOI 10.1254/jjp.88.77; Kawamata M, 2010, P NATL ACAD SCI USA, V107, P14223, DOI 10.1073/pnas.1009582107; KEEFER CL, 1982, J EXP ZOOL, V224, P371, DOI 10.1002/jez.1402240310; Kitada K, 2009, METHODS, V49, P236, DOI 10.1016/j.ymeth.2009.04.010; Kobayashi T, 2012, STEM CELLS DEV, V21, P2981, DOI 10.1089/scd.2012.0065; Kokare DM, 2011, J PHARMACOL TOX MET, V64, P246, DOI 10.1016/j.vascn.2011.08.002; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lan H, 2016, FEBS LETT, V590, P3416, DOI 10.1002/1873-3468.12388; Lee EC, 2014, NAT BIOTECHNOL, V32, P356, DOI 10.1038/nbt.2825; Leon WC, 2010, J ALZHEIMERS DIS, V20, P113, DOI 10.3233/JAD-2010-1349; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4                                                    ; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li J, 2015, CIRC RES, V116, P1655, DOI 10.1161/CIRCRESAHA.116.306287; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li TD, 2016, SCI REP-UK, V6, DOI 10.1038/srep33225; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Lindsey JR, 2006, AM COLL LAB, P1, DOI 10.1016/B978-012074903-4/50004-2; Lu BS, 2007, MAMM GENOME, V18, P338, DOI 10.1007/s00335-007-9025-5; Ma YW, 2014, FEBS J, V281, P3779, DOI 10.1111/febs.12935; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Macdonald LE, 2014, P NATL ACAD SCI USA, V111, P5147, DOI 10.1073/pnas.1323896111; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407                                                         ; Marsan E, 2016, NEUROBIOL DIS, V89, P180, DOI 10.1016/j.nbd.2016.02.010; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mashimo T, 2005, J APPL PHYSIOL, V98, P371, DOI 10.1152/japplphysiol.01006.2004; Mashimo T, 2008, NAT GENET, V40, P514, DOI 10.1038/ng0508-514; Mashimo T, 2012, CELL REPORTS, V2, P685, DOI 10.1016/j.celrep.2012.08.009; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Matsui H, 2004, BIOCHEM BIOPH RES CO, V320, P383, DOI 10.1016/j.bbrc.2004.05.185; Meek S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25592; Meek S, 2013, STEM CELLS, V31, P2104, DOI 10.1002/stem.1466; Menoret S, 2013, FASEB J, V27, P703, DOI 10.1096/fj.12-219907; Miyoshi K, 2016, J MAMM OVA RES, V33, P11; MULLINS JJ, 1990, NATURE, V344, P541, DOI 10.1038/344541a0                                                                ; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Parker CC, 2014, NEUROPHARMACOLOGY, V76, P250, DOI 10.1016/j.neuropharm.2013.05.047; Popova E, 2005, METH MOLEC MED, V108, P33; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Rajendran G, 2013, J BIOL CHEM, V288, P24351, DOI 10.1074/jbc.M113.455725; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; Serikawa T, 2009, EXP ANIM TOKYO, V58, P333, DOI 10.1538/expanim.58.333; Smits BMG, 2004, GENOMICS, V83, P332, DOI 10.1016/j.ygeno.2003.08.010; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Tesson L, 2005, TRANSGENIC RES, V14, P531, DOI 10.1007/s11248-005-5077-z; Tesson L, 2016, METHODS MOL BIOL, V1338, P245, DOI 10.1007/978-1-4939-2932-0_18; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Tong C, 2012, J GENET GENOMICS, V39, P275, DOI 10.1016/j.jgg.2012.04.004; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Twigger S, 2002, NUCLEIC ACIDS RES, V30, P125, DOI 10.1093/nar/30.1.125; Uenoyama Y, 2015, J NEUROENDOCRINOL, V27, P187, DOI 10.1111/jne.12257; van Boxtel R, 2010, METHODS MOL BIOL, V597, P151, DOI 10.1007/978-1-60327-389-3_11; von Horsten S, 2003, HUM MOL GENET, V12, P617, DOI 10.1093/hmg/ddg075; Wallace HAC, 2007, CELL, V128, P197, DOI 10.1016/j.cell.2006.11.044; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; Wang SJ, 2015, DATABASE-OXFORD, DOI 10.1093/database/bau128; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wei SJ, 2015, ATHEROSCLEROSIS, V243, P589, DOI 10.1016/j.atherosclerosis.2015.10.093; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wright DA, 2014, BIOCHEM J, V462, P15, DOI 10.1042/BJ20140295; Wu ZR, 2009, BIOL REPROD, V81, P77, DOI 10.1095/biolreprod.108.072645; Yamamoto S, 2015, TRANSGENIC RES, V24, P991, DOI 10.1007/s11248-015-9909-1; Yamamoto S, 2012, TRANSGENIC RES, V21, P743, DOI 10.1007/s11248-011-9564-0; Yan HX, 2012, CARCINOGENESIS, V33, P2001, DOI 10.1093/carcin/bgs238; Yanagihara K, 2002, P NATL ACAD SCI USA, V99, P11317, DOI 10.1073/pnas.132403399; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Yu DD, 2016, ONCOTARGET, V7, P61656, DOI 10.18632/oncotarget.11429; Zan YH, 2003, NAT BIOTECHNOL, V21, P645, DOI 10.1038/nbt830; Zhao XY, 2010, J GENET GENOMICS, V37, P467, DOI 10.1016/S1673-8527(09)60066-7; Zhu XH, 2015, HYPERTENSION, V66, P571, DOI 10.1161/HYPERTENSIONAHA.115.05183; ZUCKER LM, 1961, J HERED, V52, P275, DOI 10.1093/oxfordjournals.jhered.a107093                                           	121	0	0	26	26	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2017	28	7-8			SI		302	314		10.1007/s00335-017-9705-8				13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FE7SV	WOS:000408408100008	28752194	gold			2018-01-05	
J	Woodcock, ME; Idoko-Akoh, A; McGrew, MJ				Woodcock, Mark E.; Idoko-Akoh, Alewo; McGrew, Michael J.			Gene editing in birds takes flight	MAMMALIAN GENOME			English	Article							PRIMORDIAL GERM-CELLS; IN-VIVO TRANSFECTION; TRANSGENIC CHICKENS; ELECTROPORATED TRANSGENES; STABLE INTEGRATION; CHIMERIC CHICKENS; LONG-TERM; DNA; EXPRESSION; SYSTEM	The application of gene editing (GE) technology to create precise changes to the genome of bird species will provide new and exciting opportunities for the biomedical, agricultural and biotechnology industries, as well as providing new approaches for producing research models. Recent advances in modifying both the somatic and germ cell lineages in chicken indicate that this species, and conceivably soon other avian species, has joined a growing number of model organisms in the gene editing revolution.	[Woodcock, Mark E.; Idoko-Akoh, Alewo; McGrew, Michael J.] Univ Edinburgh, Roslin Inst, Easter Bush Campus, Edinburgh EH25 9RG, Midlothian, Scotland; [Woodcock, Mark E.; Idoko-Akoh, Alewo; McGrew, Michael J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush Campus, Edinburgh EH25 9RG, Midlothian, Scotland	Woodcock, ME (reprint author), Univ Edinburgh, Roslin Inst, Easter Bush Campus, Edinburgh EH25 9RG, Midlothian, Scotland.; Woodcock, ME (reprint author), Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush Campus, Edinburgh EH25 9RG, Midlothian, Scotland.	mark.woodcock@roslin.ed.ac.uk					Abe K, 2015, P NATL ACAD SCI USA, V112, P7599, DOI 10.1073/pnas.1413484112; Abu-Bonsrah KD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34524; Agate RJ, 2009, P NATL ACAD SCI USA, V106, P17963, DOI 10.1073/pnas.0909139106; Ahn J, 2017, POULTRY SCI, V96, P1445, DOI 10.3382/ps/pew435; Aslam ML, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0117-4; Austad SN, 2011, ILAR J, V52, P89, DOI 10.1093/ilar.52.1.89                                                            ; Bai YC, 2016, G3-GENES GENOM GENET, V6, P917, DOI 10.1534/g3.116.027706; Bibikova M, 2002, GENETICS, V161, P1169; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; BOSSELMAN RA, 1989, SCIENCE, V243, P533, DOI 10.1126/science.2536194; Bronner-Fraser M, 2008, METHOD CELL BIOL, V87, P75, DOI 10.1016/S0091-679X(08)00204-5; Brown WRA, 2003, NAT REV GENET, V4, P87, DOI 10.1038/nrg998                                                                  ; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Chavali PL, 2015, METHOD CELL BIOL, V129, P83, DOI 10.1016/bs.mcb.2015.03.008; Chen J, 2016, ONCOTARGET, V7, P56129, DOI 10.18632/oncotarget.9794; Choi JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012968; Collarini E, 2015, POULTRY SCI, V94, P799, DOI [10.3382/ps.2014-04372, 10.3382/ps.2014-4372]; Cooper CA, 2017, TRANSGENIC RES, V26, P331, DOI 10.1007/s11248-016-0003-0; Daly OM, 2016, J CELL SCI, V129, P1769, DOI 10.1242/jcs.186221; de Leon VP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088146; Dimitrov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154303; Dodgson JB, 2004, CURR PROTOC HUM GENE, V15, P15; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Emmerson DA, 1997, POULTRY SCI, V76, P1121, DOI 10.1093/ps/76.8.1121                                                            ; Fan BL, 2011, ANIM BIOTECHNOL, V22, P211, DOI 10.1080/10495398.2011.626885; FAO. FAO Statistics, 2014, FAO STAT; Fulton JE, 2004, POULTRY SCI, V83, P658, DOI 10.1093/ps/83.4.658                                                             ; GINSBURG M, 1986, J EMBRYOL EXP MORPH, V95, P53; Glover JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077222; Hocking PM, 2010, BRIT POULTRY SCI, V51, P44, DOI 10.1080/00071668.2010.507333; Hong YH, 1998, TRANSGENIC RES, V7, P247, DOI 10.1023/A:1008861826681                                                         ; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jordan BJ, 2014, J BIOTECHNOL, V173, P86, DOI 10.1016/j.jbiotec.2014.01.016; Kaleri HA, 2011, GENET MOL BIOL, V34, P231, DOI 10.1590/S1415-47572011005000011                                                 ; Kawabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048512; Kobayashi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122006; Kong BW, 2008, ANIM GENET, V39, P180, DOI 10.1111/j.1365-2052.2008.01702.x; Lee HC, 2016, STEM CELLS DEV, V25, P68, DOI 10.1089/scd.2015.0208; Lee SH, 2007, POULTRY SCI, V86, P2221, DOI 10.1093/ps/86.10.2221                                                           ; Lee SH, 2013, POULTRY SCI, V92, P2396, DOI 10.3382/ps.2013-03223; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; Lillico SG, 2005, DRUG DISCOV TODAY, V3, P1; Lillico SG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02847; Liu JN, 2013, AVIAN BIOL RES, V6, P187, DOI 10.3184/175815513X13740778695007; Liu TY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114851; Liu WC, 2015, NAT NEUROSCI, V18, P1617, DOI 10.1038/nn.4133; Lyall J, 2011, SCIENCE, V331, P223, DOI 10.1126/science.1198020; Macdonald J, 2012, P NATL ACAD SCI USA, V109, pE1466, DOI 10.1073/pnas.1118715109; Macdonald J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015518; Mak SS, 2015, GENESIS, V53, P669, DOI 10.1002/dvg.22900; MARCELLE C, 1995, DEV BIOL, V172, P100, DOI 10.1006/dbio.1995.0008; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; McGrew MJ, 2013, ENCY SUSTAINABILITY, P638; Mello Claudio V, 2014, Cold Spring Harb Protoc, V2014, P1237, DOI 10.1101/pdb.emo084574; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Naito M, 2015, ANIM REPROD SCI, V153, P50, DOI 10.1016/j.anireprosci.2014.12.003; Nakamura Y, 2007, POULTRY SCI, V86, P2182, DOI 10.1093/ps/86.10.2182                                                           ; Nakamura Y, 2008, REPROD FERT DEVELOP, V20, P900, DOI 10.1071/RD08138; Nishijima K, 2013, DEV GROWTH DIFFER, V55, P207, DOI 10.1111/dgd.12032; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Oishi I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-5; PAGE N, 1991, BIOCHEM SOC T, V19, pS328, DOI 10.1042/bst019328s                                                              ; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; PERRY MM, 1988, NATURE, V331, P70, DOI 10.1038/331070a0; Petitte JN, 1997, POULTRY SCI, V76, P1084, DOI 10.1093/ps/76.8.1084                                                            ; Rathgeber BM, 2013, POULTRY SCI, V92, P2457, DOI 10.3382/ps.2013-03139; ROMANOFF A. L., 1949, AVIAN EGG; SALTER DW, 1987, VIROLOGY, V157, P236, DOI 10.1016/0042-6822(87)90334-5; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; Sayegh CE, 1999, VET IMMUNOL IMMUNOP, V72, P31, DOI 10.1016/S0165-2427(99)00114-2; Serralbo O, 2013, GENESIS, V51, P372, DOI 10.1002/dvg.22388; Sheridan C, 2016, NAT BIOTECHNOL, V34, P117, DOI 10.1038/nbt0216-117; Sherman A, 1998, NAT BIOTECHNOL, V16, P1050; Smith LB, 2015, ANDROLOGY-US, V3, P1035, DOI 10.1111/andr.12107; Stern CD, 2005, DEV CELL, V8, P9, DOI 10.1016/j.devcel.2004.11.018; Takahashi Y, 2008, METHOD CELL BIOL, V87, P271, DOI 10.1016/S0091-679X(08)00214-8; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497                                                        ; Taylor L, 2017, DEVELOPMENT, V144, P928, DOI 10.1242/dev.145367; THOMPSON CB, 1987, CELL, V51, P371, DOI 10.1016/0092-8674(87)90633-7                                                    ; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; Tyack SG, 2013, TRANSGENIC RES, V22, P1257, DOI 10.1007/s11248-013-9727-2; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Velho Tarciso A F, 2014, Cold Spring Harb Protoc, V2014, P1284, DOI 10.1101/pdb.prot084608; Veron N, 2015, DEV BIOL, V407, P68, DOI 10.1016/j.ydbio.2015.08.007; Wang HY, 2013, NAT BIOTECHNOL, V31, P530, DOI 10.1038/nbt.2595; Wang L, 2017, AEBMR ADV ECON, V48, P1; Wargelius A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21284; Wheeler MB, 2003, J ANIM SCI, V81, P32; Whyte J, 2015, STEM CELL REP, V5, P1171, DOI 10.1016/j.stemcr.2015.10.008; Wick G, 2006, ADV IMMUNOL, V92, P71, DOI 10.1016/S0065-2776(06)92002-1; Williams AL, 2015, BIRTH DEFECTS RES C, V105, P87, DOI 10.1002/bdrc.21095; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Xu SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21271; Zhu L, 2005, NAT BIOTECHNOL, V23, P1159, DOI 10.1038/nbt1132	98	0	0	15	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2017	28	7-8			SI		315	323		10.1007/s00335-017-9701-z				9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FE7SV	WOS:000408408100009	28612238	gold			2018-01-05	
J	Eaton, SL; Wishart, TM				Eaton, S. L.; Wishart, T. M.			Bridging the gap: large animal models in neurodegenerative research	MAMMALIAN GENOME			English	Review							SPINAL MUSCULAR-ATROPHY; NEURONAL CEROID-LIPOFUSCINOSIS; NONHUMAN PRIMATE MODELS; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; BLOOD-TRANSFUSION; PRION DISEASES; MOUSE MODEL; ATAXIA-TELANGIECTASIA	The world health organisation has declared neurological disorders as one of the greatest public health risks in the world today. Yet, despite this growing concern, the mechanisms underpinning many of these conditions are still poorly understood. This may in part be due to the seemingly diverse nature of the initiating insults ranging from genetic (such as the Ataxia's and Lysosomal storage disorders) through to protein misfolding and aggregation (i.e. Prions), and those of a predominantly unknown aetiology (i.e. Alzheimer's and Parkinson's disease). However, efforts to elucidate mechanistic regulation are also likely to be hampered because of the complexity of the human nervous system, the apparent selective regional vulnerability and differential degenerative progression. The key to elucidating these aetiologies is determining the regional molecular cascades, which are occurring from the early through to terminal stages of disease progression. Whilst much molecular data have been captured at the end stage of disease from post-mortem analysis in humans, the very early stages of disease are often conspicuously asymptomatic, and even if they were not, repeated sampling from multiple brain regions of "affected" patients and "controls" is neither ethical nor possible. Model systems therefore become fundamental for elucidating the mechanisms governing these complex neurodegenerative conditions. However, finding a model that precisely mimics the human condition can be challenging and expensive. Whilst cellular and invertebrate models are frequently used in neurodegenerative research and have undoubtedly yielded much useful data, the comparatively simplistic nature of these systems makes insights gained from such a stand alone model limited when it comes to translation. Given the recent advances in gene editing technology, the options for novel model generation in higher order species have opened up new and exciting possibilities for the field. In this review, we therefore explain some of the reasons why larger animal models often appear to give a more robust recapitulation of human neurological disorders and why they may be a critical stepping stone for effective therapeutic translation.	[Eaton, S. L.; Wishart, T. M.] Univ Edinburgh, Roslin Inst, Easter Bush Campus, Edinburgh EH25 9RG, Midlothian, Scotland; [Eaton, S. L.; Wishart, T. M.] Univ Edinburgh, Royal Dick Vet Studies, Easter Bush Campus, Edinburgh EH25 9RG, Midlothian, Scotland; [Wishart, T. M.] Euan MacDonald Ctr MND Res, Chancellors Bldg,49 Little France, Edinburgh EH16 4SB, Midlothian, Scotland	Wishart, TM (reprint author), Univ Edinburgh, Roslin Inst, Easter Bush Campus, Edinburgh EH25 9RG, Midlothian, Scotland.; Wishart, TM (reprint author), Univ Edinburgh, Royal Dick Vet Studies, Easter Bush Campus, Edinburgh EH25 9RG, Midlothian, Scotland.; Wishart, TM (reprint author), Euan MacDonald Ctr MND Res, Chancellors Bldg,49 Little France, Edinburgh EH16 4SB, Midlothian, Scotland.	t.m.wishart@roslin.ed.ac.uk			BBSRC [BB/J004332/1]; MRC [MR/M010341/1 - TMW]	The authors would like to thank Mrs Jane Gebbie and Professor Bruce Whitelaw for their critical appraisal of the manuscript, and TMW and SLE are funded by the BBSRC (Roslin Institute strategic programme grant BB/J004332/1) and the MRC (MR/M010341/1 - TMW).	Amorim IS, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.401; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0                                                   ; BEALE A M, 1989, Journal of Environmental Pathology Toxicology and Oncology, V9, P417; Beck SE, 2015, EUR J PHARMACOL, V759, P303, DOI 10.1016/j.ejphar.2015.03.018; Beraldi R, 2015, HUM MOL GENET, V24, P6473, DOI 10.1093/hmg/ddv356; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; Bowen A, 2015, P NATL ACAD SCI USA, V112, P11335, DOI 10.1073/pnas.1504955112; Carryl H, 2015, ACS CHEM NEUROSCI, V6, P1276, DOI 10.1021/acschemneuro.5b00044; Chahroudi A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003958; Chang RB, 2015, DRUG DES DEV THER, V9, P2179, DOI 10.2147/DDDT.S58470; Checchi M, 2016, VOX SANG, V111, P325, DOI 10.1111/vox.12426; Chouraki V, 2014, ADV GENET, V87, P245, DOI 10.1016/B978-0-12-800149-3.00005-6; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Dezzutti CS, 2015, SOCIETY, V18, P20301; Dolezalova D, 2014, J COMP NEUROL, V522, P2784, DOI 10.1002/cne.23575; Duque SI, 2015, ANN NEUROL, V77, P399, DOI 10.1002/ana.24332; Elbirt D, 2015, ISR MED ASSOC J, V17, P54; Emborg ME, 2007, ILAR J, V48, P339, DOI 10.1093/ilar.48.4.339                                                           ; Foster J, 1998, CURR OPIN MICROBIOL, V1, P442, DOI 10.1016/S1369-5274(98)80063-5                                                   ; FROHNA PA, 1995, SYNAPSE, V19, P46, DOI 10.1002/syn.890190107; Fuller HR, 2016, EXPERT REV PROTEOMIC, V13, P659, DOI 10.1080/14789450.2016.1202768; Garner JP, 2014, ILAR J, V55, P438, DOI 10.1093/ilar/ilu047; Geraets RD, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0414-2; Greek R, 2013, INT J MED SCI, V10, P206, DOI 10.7150/ijms.5529; Grow DA, 2016, STEM CELL RES, V17, P352, DOI 10.1016/j.scr.2016.08.013; Hall VJ, 2015, DIS MODEL MECH, V8, P1265, DOI 10.1242/dmm.019489; Heuer E, 2012, CURR PHARM DESIGN, V18, P1159, DOI 10.2174/138161212799315885                                                      ; Holm IE, 2016, J PATHOL, V238, P267, DOI 10.1002/path.4654; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Howland DS, 2014, MOVEMENT DISORD, V29, P1397, DOI 10.1002/mds.26008; Hunter G, 2016, HUM MOL GENET, V25, P2853, DOI 10.1093/hmg/ddw141; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/vir.O.18580-0; Jackson WS, 2013, P NATL ACAD SCI USA, V110, P14759, DOI 10.1073/pnas.1312006110; Jagmag Shail A, 2015, Front Neurosci, V9, P503, DOI 10.3389/fnins.2015.00503; Keifer J, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00069; Li XJ, 2012, J GENET GENOMICS, V39, P239, DOI 10.1016/j.jgg.2012.05.002; Lorenzen E, 2015, VET RES, V46, DOI 10.1186/s13567-015-0241-9; McGreevy JW, 2015, DIS MODEL MECH, V8, P195, DOI 10.1242/dmm.018424; Mikkelsen M, 1999, NEUROTOXICOL TERATOL, V21, P169, DOI 10.1016/S0892-0362(98)00037-3; Morton AJ, 2014, HUM MOL GENET, V23, P3375, DOI 10.1093/hmg/ddu047; Morton AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015752; Moser JM, 2013, MOL GENET GENOMICS, V288, P207, DOI 10.1007/s00438-013-0741-0; Mutsaers CA, 2013, GENOME MED, V5, DOI 10.1186/gm498; Palmer DN, 2015, BBA-MOL BASIS DIS, V1852, P2279, DOI 10.1016/j.bbadis.2015.06.013; Park KHJ, 2015, AGING DIS, V6, P380, DOI 10.14336/AD.2015.0506; Peeters M, 2012, CLIN MICROBIOL INFEC, V18, P514, DOI 10.1111/j.1469-0691.2012.03843.x; Philips T, 2015, CURR PROTOC PHARM, V69, p5 67 1, DOI DOI 10.1002/0471141755.PH0567S69; Pinnapureddy AR, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0327-5; Pontikis CC, 2005, NEUROBIOL DIS, V20, P823, DOI 10.1016/j.nbd.2005.05.018; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; Price DL, 1998, SCIENCE, V282, P1079, DOI 10.1126/science.282.5391.1079; Rae MG, 2016, J NEUROPHYSIOL, V116, P1304, DOI 10.1152/jn.00248.2016; Ramaswamy S, 2007, ILAR J, V48, P356, DOI 10.1093/ilar.48.4.356                                                           ; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; Schook LB, 2015, ANNU REV ANIM BIOSCI, V3, P219, DOI 10.1146/annurev-animal-022114-110815; Siso S, 2012, PRION, V6, P174, DOI 10.4161/pri.18990; Stanzione P, 2011, ANN I SUPER SANITA, V47, P49, DOI 10.4415/ANN_11_01_11; Toledano A, 2012, NEUROLOGIA, V27, P354, DOI 10.1016/j.nrl.2011.05.008; van Vliet D, 2013, PSYCHOL MED, V43, P423, DOI 10.1017/S0033291712001122; Wang X., 2016, SCI REP, V6, P20620; Weber K, 2013, J CHILD NEUROL, V28, P1123, DOI 10.1177/0883073813493666; Whitelaw CBA, 2016, J PATHOL, V238, P247, DOI 10.1002/path.4648; Wishart TM, 2014, J CLIN INVEST, V124, P1821, DOI 10.1172/JCI71318; Wishart TM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002936; Yang DS, 2010, HUM MOL GENET, V19, P3983, DOI 10.1093/hmg/ddq313; Yang HQ, 2014, CELL RES, V24, P464, DOI 10.1038/cr.2014.25; Yang JF, 2016, NEUROSCI LETT, V611, P51, DOI 10.1016/j.neulet.2015.11.023; Yap PL, 1998, VOX SANG, V74, P131, DOI 10.1111/j.1423-0410.1998.tb05410.x                                              ; Yun Jun-Won, 2015, Lab Anim Res, V31, P155, DOI 10.5625/lar.2015.31.4.155; Zahs KR, 2015, NEURON, V85, P893, DOI 10.1016/j.neuron.2015.02.021	70	0	0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2017	28	7-8			SI		324	337		10.1007/s00335-017-9687-6				14	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FE7SV	WOS:000408408100010	28378063	gold			2018-01-05	
J	Telugu, BP; Park, KE; Park, CH				Telugu, Bhanu P.; Park, Ki-Eun; Park, Chi-Hun			Genome editing and genetic engineering in livestock for advancing agricultural and biomedical applications	MAMMALIAN GENOME			English	Article							EMBRYONIC STEM-CELLS; DOUBLE-STRAND BREAKS; LARGE ANIMAL-MODELS; TRANSGENIC PIGS; EFFICIENT GENERATION; CRISPR/CAS9 SYSTEM; NUCLEAR TRANSFER; PRION PROTEIN; KNOCKOUT PIGS; FARM-ANIMALS	Genetic modification of livestock has a longstanding and successful history, starting with domestication several thousand years ago. Modern animal breeding strategies predominantly based on marker-assisted and genomic selection, artificial insemination, and embryo transfer have led to significant improvement in the performance of domestic animals, and are the basis for regular supply of high quality animal derived food. However, the current strategy of breeding animals over multiple generations to introduce novel traits is not realistic in responding to the unprecedented challenges such as changing climate, pandemic diseases, and feeding an anticipated 3 billion increase in global population in the next three decades. Consequently, sophisticated genetic modifications that allow for seamless introgression of novel alleles or traits and introduction of precise modifications without affecting the overall genetic merit of the animal are required for addressing these pressing challenges. The requirement for precise modifications is especially important in the context of modeling human diseases for the development of therapeutic interventions. The animal science community envisions the genome editors as essential tools in addressing these critical priorities in agriculture and biomedicine, and for advancing livestock genetic engineering for agriculture, biomedical as well as "dual purpose" applications.	[Telugu, Bhanu P.; Park, Ki-Eun; Park, Chi-Hun] Univ Maryland, Anim & Avian Sci, 2121 ANSC Bldg, College Pk, MD 20742 USA; [Telugu, Bhanu P.; Park, Ki-Eun; Park, Chi-Hun] ARS, Anim Biosci & Biotechnol Lab, USDA, Beltsville, MD USA; [Telugu, Bhanu P.; Park, Ki-Eun] RenOVAte Biosci Inc, Reisterstown, MD USA	Telugu, BP (reprint author), Univ Maryland, Anim & Avian Sci, 2121 ANSC Bldg, College Pk, MD 20742 USA.; Telugu, BP (reprint author), ARS, Anim Biosci & Biotechnol Lab, USDA, Beltsville, MD USA.; Telugu, BP (reprint author), RenOVAte Biosci Inc, Reisterstown, MD USA.	btelugu@umd.edu			Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2015-67015-22845]; Maryland Agricultural Experiment Station	The primary author was supported by Agriculture and Food Research Initiative Competitive Grant #2015-67015-22845 from the USDA National Institute of Food and Agriculture, and Maryland Agricultural Experiment Station.	Alberio R, 2010, STEM CELLS DEV, V19, P1627, DOI 10.1089/scd.2010.0012; Barry JS, 2008, THERIOGENOLOGY, V69, P55, DOI 10.1016/j.theriogenology.2007.09.021; Betteridge KJ, 2003, ANIM REPROD SCI, V79, P203, DOI 10.1016/S0378-4320(03)00166-0; Bleck GT, 1998, J ANIM SCI, V76, P3072; BRINSTER RL, 1981, CELL, V27, P223, DOI 10.1016/0092-8674(81)90376-7; BRINSTER RL, 1989, CELL, V59, P239, DOI 10.1016/0092-8674(89)90282-1; BUHLER TA, 1990, BIO-TECHNOL, V8, P140, DOI 10.1038/nbt0290-140; Cabot RA, 2001, ANIM BIOTECHNOL, V12, P205, DOI 10.1081/ABIO-100108347; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Camus S, 2015, NEUROBIOL LEARN MEM, V124, P123, DOI 10.1016/j.nlm.2015.06.012; CAPECCHI MR, 1980, CELL, V22, P479, DOI 10.1016/0092-8674(80)90358-X; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Carlson DF, 2011, TRANSGENIC RES, V20, P29, DOI 10.1007/s11248-010-9386-5; Carvalho-Oliveira I, 2007, EXPERT REV MOL DIAGN, V7, P407, DOI 10.1586/14737159.7.4.407; Casal M, 2006, EUR J HUM GENET, V14, P266, DOI 10.1038/sj.ejhg.5201535; Chang Keejong, 2002, BMC Biotechnol, V2, P5, DOI 10.1186/1471-2393-2-5; Chen FJ, 2015, J GENET GENOMICS, V42, P437, DOI 10.1016/j.jgg.2015.05.002; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Clark KJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S13; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cuffee Y, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0483-3; Denning C, 2001, NAT BIOTECHNOL, V19, P559, DOI 10.1038/89313; Ebert KM, 1991, NAT BIOTECHNOL, V9, P835; Federspiel MJ, 1997, METHOD CELL BIOL, V52, P179, DOI 10.1016/S0091-679X(08)60379-9; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Galli C, 2012, REPROD DOMEST ANIM, V47, P2, DOI 10.1111/j.1439-0531.2012.02045.x; Gandolfi F, 2000, THERIOGENOLOGY, V53, P127, DOI 10.1016/S0093-691X(99)00246-0; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Goliasova E, 2004, ANIM GENET, V35, P293, DOI 10.1111/j.1365-2052.2004.01155.x; Golovan SP, 2001, NAT BIOTECHNOL, V19, P741, DOI 10.1038/90788; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380                                                         ; GRAESSMANN A, 1979, J VIROL, V32, P989; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Harris MJ, 2010, BIRTH DEFECTS RES A, V88, P653, DOI 10.1002/bdra.20676; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hofmann A, 2003, EMBO REP, V4, P1054, DOI [10.1038/sj.embor.7400007, 10.1038/sj.embor.embor7400007]; Honaramooz A, 2008, FASEB J, V22, P374, DOI 10.1096/fj.07-8935com; Houde C, 2004, J NEUROSCI, V24, P9977, DOI 10.1523/JNEUROSCI.3356-04.2004; Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Jabed A, 2012, P NATL ACAD SCI USA, V109, P16811, DOI 10.1073/pnas.1210057109; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kang JT, 2016, REPROD DOMEST ANIM, V51, P970, DOI 10.1111/rda.12775; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kong BW, 2008, ANIM GENET, V39, P180, DOI 10.1111/j.1365-2052.2008.01702.x; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Lavine G, 2009, AM J HEALTH-SYST PH, V66, P518, DOI 10.2146/news090023; Lavitrano M, 1997, TRANSPLANT P, V29, P3508, DOI 10.1016/S0041-1345(97)00998-6                                                   ; Lavitrano M, 2006, REPROD FERT DEVELOP, V18, P19, DOI 10.1071/RD05124; Li XJ, 2012, J GENET GENOMICS, V39, P239, DOI 10.1016/j.jgg.2012.05.002; Lillico SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep21645; Lyall J, 2011, SCIENCE, V331, P223, DOI 10.1126/science.1198020; Macdonald J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015518; Maga EA, 2006, FOODBORNE PATHOG DIS, V3, P384, DOI 10.1089/fpd.2006.3.384; Maga EA, 2006, TRANSGENIC RES, V15, P515, DOI 10.1007/s11248-006-0014-3; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McNatty KP, 2005, MOL CELL ENDOCRINOL, V234, P57, DOI 10.1016/j.mce.2004.08.013; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Montier T, 2004, TRENDS BIOTECHNOL, V22, P586, DOI 10.1016/j.tibtech.2004.09.009; Morton AJ, 2013, J HUNTINGTONS DIS, V2, P3, DOI 10.3233/JHD-130050; Navarro SJ, 2012, G3-GENES GENOM GENET, V2, P99, DOI 10.1534/g3.111.000778; Ni Jun, 2008, Briefings in Functional Genomics & Proteomics, V7, P444, DOI 10.1093/bfgp/eln049; Nicholson A, 2010, OBESITY, V18, P1902, DOI 10.1038/oby.2009.477; Nowak-Imialek M, 2013, REPROD FERT DEVELOP, V25, P103, DOI 10.1071/RD12265; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Park KE, 2017, SCI REP-UK, V7, DOI 10.1038/srep42458; Park KE, 2017, SCI REP-UK, V7, DOI 10.1038/srep40176; Patterson JK, 2008, EXP BIOL MED, V233, P651, DOI 10.3181/0709-MR-262; Peng J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16705; Petersen B, 2016, XENOTRANSPLANTATION, V23, P338, DOI 10.1111/xen.12258; Petersen B, 2015, TRANSGENIC RES, V24, P381, DOI 10.1007/s11248-015-9862-z; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; PORTER TE, 1995, ENDOCRINOLOGY, V136, P3721, DOI 10.1210/en.136.9.3721; Prather RS, 2008, BIOTECHNOL GENET ENG, V25, P245; Pursel VG, 2004, ANIM BIOTECHNOL, V15, P33, DOI 10.1081/ABIO-120029812; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Scheerlinck JPY, 2008, TRENDS BIOTECHNOL, V26, P259, DOI 10.1016/j.tibtech.2008.02.002; Schmidt C, 2006, NAT BIOTECHNOL, V24, P877, DOI 10.1038/nbt0806-877; SMITH C, 1989, ANIM PROD, V49, P49, DOI 10.1017/S0003356100004244                                                       ; Solaiman F, 2000, MOL REPROD DEV, V56, P309, DOI 10.1002/(SICI)1098-2795(200006)56:2+<309::AID-MRD22>3.0.CO;2-Y; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; SZYBALSKA EH, 1962, P NATL ACAD SCI USA, V48, P2026, DOI 10.1073/pnas.48.12.2026; Tan WF, 2016, TRANSGENIC RES, V25, P273, DOI 10.1007/s11248-016-9932-x; Tanihara F, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600803; Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468; Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Tickle C, 2004, MECH DEVELOP, V121, P1019, DOI 10.1016/j.mod.2004.05.015; van Veen HA, 2012, J BIOTECHNOL, V162, P319, DOI 10.1016/j.jbiotec.2012.09.005; VIZE PD, 1988, J CELL SCI, V90, P295; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Wang KK, 2015, SCI REP-UK, V5, DOI 10.1038/srep16623; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13348; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08256; Whitelaw CBA, 2016, J PATHOL, V238, P247, DOI 10.1002/path.4648; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; WRIGHT G, 1991, BIO-TECHNOL, V9, P830, DOI 10.1038/nbt0991-830; WU CL, 1993, NAT GENET, V3, P235, DOI 10.1038/ng0393-235; Yin XJ, 2005, REPRODUCTION, V129, P245, DOI 10.1530/rep.1.00403; Yong Z, 1998, Biol Reprod, V58, P266, DOI 10.1095/biolreprod58.1.266; Yu GH, 2006, J GEN VIROL, V87, P1019, DOI 10.1099/vir.0.81384-0; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7; Zhou XY, 2016, HUM MUTAT, V37, P110, DOI 10.1002/humu.22913	116	0	0	57	57	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2017	28	7-8			SI		338	347		10.1007/s00335-017-9709-4				10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FE7SV	WOS:000408408100011	28712062				2018-01-05	
J	Bassett, AR				Bassett, Andrew R.			Editing the genome of hiPSC with CRISPR/Cas9: disease models	MAMMALIAN GENOME			English	Review							PLURIPOTENT STEM-CELLS; HUMAN IPS CELLS; SEVERE COMBINED IMMUNODEFICIENCY; RNA-GUIDED ENDONUCLEASE; GENE-EXPRESSION; EPIGENETIC MECHANISMS; T-CELLS; HOMOLOGOUS RECOMBINATION; CRISPR-CAS9 NUCLEASES; FUNCTIONAL CORRECTION	The advent of human-induced pluripotent stem cell (hiPSC) technology has provided a unique opportunity to establish cellular models of disease from individual patients, and to study the effects of the underlying genetic aberrations upon multiple different cell types, many of which would not normally be accessible. Combining this with recent advances in genome editing techniques such as the clustered regularly interspaced short palindromic repeat (CRISPR) system has provided an ability to repair putative causative alleles in patient lines, or introduce disease alleles into a healthy "WT" cell line. This has enabled analysis of isogenic cell pairs that differ in a single genetic change, which allows a thorough assessment of the molecular and cellular phenotypes that result from this abnormality. Importantly, this establishes the true causative lesion, which is often impossible to ascertain from human genetic studies alone. These isogenic cell lines can be used not only to understand the cellular consequences of disease mutations, but also to perform high throughput genetic and pharmacological screens to both understand the underlying pathological mechanisms and to develop novel therapeutic agents to prevent or treat such diseases. In the future, optimising and developing such genetic manipulation technologies may facilitate the provision of cellular or molecular gene therapies, to intervene and ultimately cure many debilitating genetic disorders.	[Bassett, Andrew R.] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England	Bassett, AR (reprint author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England.	ab42@sanger.ac.uk			Wellcome Trust	The author would like to acknowledge the Wellcome Trust for funding, and Sarah Cooper for critical reading of the manuscript.	Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Andersson-Rolf A, 2017, NAT METHODS, V14, P287, DOI [10.1038/NMETH.4156, 10.1038/nmeth.4156]; Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bell CC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1002; Bertero A, 2016, DEVELOPMENT, V143, P4405, DOI 10.1242/dev.138081; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Boland MJ, 2017, BRAIN, V140, P582, DOI 10.1093/brain/aww357; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chang CW, 2015, CELL REP, V12, P1668, DOI 10.1016/j.celrep.2015.08.013; Chen FQ, 2015, METHODS MOL BIOL, V1239, P251, DOI 10.1007/978-1-4939-1862-1_14; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choudhury SR, 2016, ONCOTARGET, V7, P46545, DOI 10.18632/oncotarget.10234; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Davis RP, 2012, CIRCULATION, V125, P3079, DOI 10.1161/CIRCULATIONAHA.111.066092; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; DeRosa BA, 2012, NEUROSCI LETT, V516, P9, DOI 10.1016/j.neulet.2012.02.086; Devine MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1453; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Economides AN, 2013, P NATL ACAD SCI USA, V110, pE3179, DOI 10.1073/pnas.1217812110; Eggenschwiler R, 2016, SCI REP-UK, V6, DOI 10.1038/srep38198; Emborg ME, 2013, CELL REP, V3, P646, DOI 10.1016/j.celrep.2013.02.016; Fesnak AD, 2016, NAT REV CANCER, V16, P566, DOI 10.1038/nrc.2016.97; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Flynn R, 2015, EXP HEMATOL, V43, P838, DOI 10.1016/j.exphem.2015.06.002; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Garcia M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003500; Gharib WH, 2011, BRIEF BIOINFORM, V12, P436, DOI 10.1093/bib/bbr031; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Gos M, 2013, ACTA NEUROBIOL EXP, V73, P19; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hallett PJ, 2015, CELL STEM CELL, V16, P269, DOI 10.1016/j.stem.2015.01.018; Heman-Ackah SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28420; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Horii T, 2013, INT J MOL SCI, V14, P19774, DOI 10.3390/ijms141019774; Horikiri T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170342; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hrvatin S, 2014, P NATL ACAD SCI USA, V111, P3038, DOI 10.1073/pnas.1400709111; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Huch M, 2015, DEVELOPMENT, V142, P3113, DOI 10.1242/dev.118570; Hug N, 2016, NUCLEIC ACIDS RES, V44, P1483, DOI 10.1093/nar/gkw010; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; Imamura K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34904; Ishikawa T, 2016, HUM MOL GENET, DOI [10.1093/hmg/ddw339, DOI 10.1093/HMG/DDW339]; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kwart D, 2017, NAT PROTOC, V12, P329, DOI 10.1038/nprot.2016.171; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landgrave-Gomez J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00058; Lee K, 2014, P NATL ACAD SCI USA, V111, P7260, DOI 10.1073/pnas.1406376111; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Liu ZL, 2016, STEM CELL REP, V7, P496, DOI 10.1016/j.stemcr.2016.07.021; Lunter G, 2006, PLOS COMPUT BIOL, V2, P2, DOI 10.1371/journal.pcbi.0020005; LUUKKONEN BGM, 1995, J VIROL, V69, P4086; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Merkert S, 2016, STEM CELL RES, V16, P377, DOI 10.1016/j.scr.2016.02.027; Merkert S, 2014, STEM CELL REP, V2, P107, DOI 10.1016/j.stemcr.2013.12.003; Mertens J, 2016, NAT REV NEUROSCI, V17, P424, DOI 10.1038/nrn.2016.46; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Miyaoka Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23549; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Mock U, 2016, NAT PROTOC, V11, P598, DOI 10.1038/nprot.2016.027; Morrison M, 2015, STEM CELL REV REP, V11, P681, DOI 10.1007/s12015-015-9599-3; Waterston RH, 2002, NATURE, V420, P520, DOI [10.1038/nature01262, DOI 10.1038/NATURE01262]; Murakami N, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0286-y; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagashima H, 2016, THERIOGENOLOGY, V86, P422, DOI 10.1016/j.theriogenology.2016.04.056; Nguyen Ha Nam, 2011, Cell Stem Cell, V8, P267, DOI 10.1016/j.stem.2011.01.013; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Nishizaki SS, 2017, TRENDS GENET, V33, P34, DOI 10.1016/j.tig.2016.10.008; Niu XH, 2016, J BIOL CHEM, V291, P16576, DOI 10.1074/jbc.M116.719237; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Park CY, 2016, NAT PROTOC, V11, P2154, DOI 10.1038/nprot.2016.129; Park CY, 2015, CELL STEM CELL, V17, P213, DOI 10.1016/j.stem.2015.07.001; Passier R, 2016, CELL STEM CELL, V18, P309, DOI 10.1016/j.stem.2016.02.011; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Quax TEF, 2015, MOL CELL, V59, P149, DOI 10.1016/j.molcel.2015.05.035; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432; Salarinia R, 2016, CURR CANCER DRUG TAR, V16, P773, DOI 10.2174/1568009616666151207110143; Santos DP, 2016, CURR PROTOC STEM CEL, DOI [10.1002/cpsc.15, DOI 10.1002/CPSC.15]; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Soares FAC, 2014, STEM CELL REP, V3, P931, DOI 10.1016/j.stemcr.2014.11.006; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Song B, 2015, STEM CELLS DEV, V24, P1053, DOI 10.1089/scd.2014.0347; Sontag S, 2017, STEM CELLS, V35, P898, DOI 10.1002/stem.2565; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Streeter I, 2016, NUCLEIC ACIDS RES, DOI [10.1093/nar/gkw928, DOI 10.1093/NAR/GKW928]; Sweeney CL, 2017, MOL THER, V25, P321, DOI 10.1016/j.ymthe.2016.11.012; Takagi R, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500887; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wang G, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.152; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Wheeler HE, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006423; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Wu JB, 2016, STEM CELL RES, V16, P220, DOI 10.1016/j.scr.2016.01.003; Wu JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep18759; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Xie N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165499; Xu XH, 2017, STEM CELL REP, V8, P619, DOI 10.1016/j.stemcr.2017.01.022; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021; Yusa K, 2013, NAT PROTOC, V8, P2061, DOI 10.1038/nprot.2013.126; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; ZIMMER A, 1994, J CELL BIOL, V127, P1111, DOI 10.1083/jcb.127.4.1111	157	0	0	16	16	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2017	28	7-8			SI		348	364		10.1007/s00335-017-9684-9				17	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FE7SV	WOS:000408408100012	28303292	gold			2018-01-05	
J	Wells, S; Joly, JS				Wells, Sara; Joly, Jean Stephane			The trouble with collective nouns for genome editing	MAMMALIAN GENOME			English	Article								We should start as we mean to go on and try to avoid the confusion most of us experience when bombarded with acronyms with overstated significations. You will be familiar with the situation, you are in a seminar or a meeting and someone who has been using a set of acronyms for years, includes them in sentence after sentence that has you lost because you don't know what some or most of them stand for. Even worse when scientists start making verbs out of them, CRISPR seems to have fallen into this category; how many of us have heard someone asking if a mutation can be CRISPRed! Does it matter though? We are all familiar with informal language in scientific talks and discussions which is replaced by more formal dialect when research is published or presented to the general public. However, when an ill-defined acronym slips outside of laboratory chatter and is widely recognised by the general public, we need to proceed with caution to avoid misinterpretation and misunderstandings.	[Wells, Sara] MRC Harwell Inst, Mary Lyon Ctr, Harwell Campus, Didcot OX11 0RD, Oxon, England; [Joly, Jean Stephane] CNRS, TEFOR Infrastruct, NeuroPSI, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France	Joly, JS (reprint author), CNRS, TEFOR Infrastruct, NeuroPSI, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	joly@inaf.cnrs-gif.fr			Agence Nationale de la Recherche [TEFOR-ANR-11-INBS-0014]		Special Eurobarometer 341, 2010, SPEC EUR 341; Scheben A, 2017, SCIENCE, V355, P1122, DOI 10.1126/science.aal4680; Tagliabue G, 2015, NAT BIOTECHNOL, V33, P907, DOI 10.1038/nbt.3333; Yang YT, 2016, J SCI FOOD AGR, V96, P1851, DOI 10.1002/jsfa.7523	4	0	0	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2017	28	7-8			SI		365	366		10.1007/s00335-017-9707-6				2	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FE7SV	WOS:000408408100013	28726008				2018-01-05	
J	Knowlton, MN; Smith, CL				Knowlton, Michelle N.; Smith, Cynthia L.			Naming CRISPR alleles: endonuclease-mediated mutation nomenclature across species	MAMMALIAN GENOME			English	Article							ZINC-FINGER NUCLEASES; EFFICIENT TARGETED MUTAGENESIS; MODEL ORGANISM DATABASE; EFFECTOR NUCLEASES; GENOME DATABASE; HOMOLOGOUS RECOMBINATION; HERITABLE MUTATIONS; CIONA-INTESTINALIS; CYNOMOLGUS MONKEY; BRASSICA-OLERACEA	The widespread use of CRISPR/Cas and other targeted endonuclease technologies in many species has led to an explosion in the generation of new mutations and alleles. The ability to generate many different mutations from the same target sequence either by homology-directed repair with a donor sequence or non-homologous end joining-induced insertions and deletions necessitates a means for representing these mutations in literature and databases. Standardized nomenclature can be used to generate unambiguous, concise, and specific symbols to represent mutations and alleles. The research communities of a variety of species using CRISPR/Cas and other endonuclease-mediated mutation technologies have developed different approaches to naming and identifying such alleles and mutations. While some organism-specific research communities have developed allele nomenclature that incorporates the method of generation within the official allele or mutant symbol, others use metadata tags that include method of generation or mutagen. Organism-specific research community databases together with organism-specific nomenclature committees are leading the way in providing standardized nomenclature and metadata to facilitate the integration of data from alleles and mutations generated using CRISPR/Cas and other targeted endonucleases.	[Knowlton, Michelle N.; Smith, Cynthia L.] Jackson Lab, Mouse Genome Informat, 600 Main St, Bar Harbor, ME 04609 USA	Knowlton, MN (reprint author), Jackson Lab, Mouse Genome Informat, 600 Main St, Bar Harbor, ME 04609 USA.	michelle.knowlton@jax.org		Smith, Cynthia/0000-0003-3691-0324	National Institutes of Health [HG000330]	We would like to thank the following people for their assistance in determining the nomenclature guidelines for different species: Tanya Berardini and Benson Lindsey (TAIR), Stacia R Engel (SGD), Christina James-Zorn (Xenbase), Fiona McCarthy and James M Reecy (cattle, chicken and pig nomenclature), Gillian Millburn (FlyBase), Marty Sachs (MaizeGDB), Amy G Singer (ZFIN), Mary Ann Tuli (WormBase). Supported by National Institutes of Health Grant HG000330.	Andorf CM, 2016, NUCLEIC ACIDS RES, V44, pD1195, DOI 10.1093/nar/gkv1007; Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Aryan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060082; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Awata H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15885; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; Blake JA, 2017, NUCLEIC ACIDS RES, V45, pD723, DOI 10.1093/nar/gkw1040; Blitz IL, 2016, DEVELOPMENT, V143, P2868, DOI 10.1242/dev.138057; Burt DW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S2-S5; Campbell PD, 2015, DEVELOPMENT, V142, P2996, DOI 10.1242/dev.124586; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Char SN, 2015, PLANT BIOTECHNOL J, V13, P1002, DOI 10.1111/pbi.12344; Chen L, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-24; Cherry J M, 1995, Trends Genet, P11; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981; Dong ZJ, 2014, ZEBRAFISH, V11, P265, DOI 10.1089/zeb.2014.0974; Dong ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028897; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Fei JF, 2014, STEM CELL REP, V3, P444, DOI 10.1016/j.stemcr.2014.06.018; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Flowers GP, 2014, DEVELOPMENT, V141, P2165, DOI 10.1242/dev.105072; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Guan GJ, 2014, MAR BIOTECHNOL, V16, P739, DOI 10.1007/s10126-014-9587-7; Guha Tuhin Kumar, 2017, Comput Struct Biotechnol J, V15, P146, DOI 10.1016/j.csbj.2016.12.006; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Hayashi T, 2014, DEV GROWTH DIFFER, V56, P115, DOI 10.1111/dgd.12103; Honda A, 2015, EXP ANIM TOKYO, V64, P31, DOI 10.1538/expanim.14-0034; Howe DG, 2013, NUCLEIC ACIDS RES, V41, pD854, DOI 10.1093/nar/gks938; Hu Z, 2014, STANDARD GENETIC NOM; Hu Z, 2011, STANDARD GENETIC NOM; International Committee on Standardized Genetic Nomenclature for Mice, 2016, RUL NOM MOUS CHROM A; International Committee on Standardized Genetic Nomenclature for Mice, 2015, GUID NOM GEN GEN MAR; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; James-Zorn C, 2015, GENESIS, V53, P486, DOI 10.1002/dvg.22873; Jia HG, 2016, PLANT BIOTECHNOL J, V14, P1291, DOI 10.1111/pbi.12495; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jung JH, 2016, PLANT MOL BIOL, V92, P131, DOI 10.1007/s11103-016-0499-y; Karpinka JB, 2015, NUCLEIC ACIDS RES, V43, pD756, DOI 10.1093/nar/gku956; Kawai N, 2012, DEV GROWTH DIFFER, V54, P535, DOI 10.1111/j.1440-169X.2012.01355.x; Kim E, 2016, NUCLEIC ACIDS RES, V44, pD848, DOI 10.1093/nar/gkv1155; Lang ZB, 2015, MOL CELL, V57, P971, DOI 10.1016/j.molcel.2015.01.009; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li MH, 2013, ENDOCRINOLOGY, V154, P4814, DOI 10.1210/en.2013-1451; Li MH, 2016, GEN COMP ENDOCR, V232, P191, DOI 10.1016/j.ygcen.2016.01.003; Li MH, 2014, GENETICS, V197, P591, DOI 10.1534/genetics.114.163667; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Lin SC, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-63; Lyne R, 2015, GENESIS, V53, P547, DOI 10.1002/dvg.22869; Markert MJ, 2016, G3-GENES GENOM GENET, V6, P905, DOI 10.1534/g3.116.027029; Marton I, 2010, PLANT PHYSIOL, V154, P1079, DOI 10.1104/pp.110.164806; Mashimo T, 2014, DEV GROWTH DIFFER, V56, P46, DOI 10.1111/dgd.12110; Menchaca A, 2016, THERIOGENOLOGY, V86, P160, DOI 10.1016/j.theriogenology.2016.04.028; Merlin C, 2013, GENOME RES, V23, P159, DOI 10.1101/gr.145599.112; Mizuno S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13632; Mungall CJ, 2017, NUCLEIC ACIDS RES, V45, pD712, DOI 10.1093/nar/gkw1128; Naitou A, 2015, BIOL OPEN, V4, P364, DOI 10.1242/bio.20149738; Nakanishi T, 2015, SCI REP-UK, V5, DOI 10.1038/srep18312; Nakanishi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098363; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Reegan AD, 2016, BIOSCI TRENDS, V10, P424, DOI 10.5582/bst.2016.01180; Rocha-Martins M, 2015, AN ACAD BRAS CIENC, V87, P1323, DOI 10.1590/0001-3765201520140710; Sakurai T, 2016, J PHARMACOL EXP THER, V356, P341, DOI 10.1124/jpet.115.229740; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sasaki H, 2014, DEV GROWTH DIFFER, V56, P499, DOI 10.1111/dgd.12149; Sato M, 2014, XENOTRANSPLANTATION, V21, P291, DOI 10.1111/xen.12089; Seruggia D, 2014, TRANSGENIC RES, V23, P707, DOI 10.1007/s11248-014-9823-y; SGD Project, 2017, SACCH CER; Shaheen R, 2016, AM J HUM GENET, V98, P643, DOI 10.1016/j.ajhg.2016.02.010; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; Shi ZY, 2017, GENESIS, V55, DOI 10.1002/dvg.23006; Shimoyama M, 2015, NUCLEIC ACIDS RES, V43, pD743, DOI 10.1093/nar/gku1026; Shin SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep27810; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Singer M, 2017, TRENDS PARASITOL, V33, P202, DOI 10.1016/j.pt.2016.09.012; Sizova I, 2013, PLANT J, V73, P873, DOI 10.1111/tpj.12066; Smidler AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074511; Somaratne Y, 2017, PLANT J, V90, P96, DOI 10.1111/tpj.13476; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Sugano SS, 2014, PLANT CELL PHYSIOL, V55, P475, DOI 10.1093/pcp/pcu014; Sun ZJ, 2013, J INTEGR PLANT BIOL, V55, P1092, DOI 10.1111/jipb.12091; Tang L, 2015, ANIM REPROD, V12, P93; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Treen N, 2014, DEVELOPMENT, V141, P481, DOI 10.1242/dev.099572; Waaijers S, 2014, METHODS, V68, P381, DOI 10.1016/j.ymeth.2014.03.024; Wain HM, 2002, GENOMICS, V79, P464, DOI 10.1006/geno.2002.6748; Wan HF, 2015, CELL RES, V25, P258, DOI 10.1038/cr.2014.158; Wang TS, 2014, GENE, V543, P28, DOI 10.1016/j.gene.2014.04.013; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wang Yu, 2014, Cell Regen (Lond), V3, P3, DOI 10.1186/2045-9769-3-3; Watanabe T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2020; Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4; Wolfs JM, 2016, P NATL ACAD SCI USA, V113, P14988, DOI 10.1073/pnas.1616343114; WormBase, 2017, WORMMINE WS257 INT D; Wu HB, 2015, P NATL ACAD SCI USA, V112, pE1530, DOI 10.1073/pnas.1421587112; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Wu Y., 2016, NEURODEV DISORD, V8, P23, DOI DOI 10.1186/S11689-016-9156-7; Xu HF, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0487; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045; Yates B, 2017, NUCLEIC ACIDS RES, V45, pD619, DOI 10.1093/nar/gkw1033; Zhang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep20315; Zhang DL, 2015, ELIFE, V4, DOI 10.7554/eLife.08898; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhang JP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1164-8; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396; Zhang XM, 2016, ASIAN AUSTRAL J ANIM, V29, P1500, DOI 10.5713/ajas.16.0130; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zhang ZJ, 2016, PLANT CELL REP, V35, P1519, DOI 10.1007/s00299-015-1900-z	114	0	0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2017	28	7-8			SI		367	376		10.1007/s00335-017-9698-3				10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FE7SV	WOS:000408408100014	28589392	gold			2018-01-05	
J	Teboul, L; Murray, SA; Nolan, PM				Teboul, Lydia; Murray, Stephen A.; Nolan, Patrick M.			Phenotyping first-generation genome editing mutants: a new standard?	MAMMALIAN GENOME			English	Article							ONE-STEP GENERATION; SOMATIC MOSAICISM; MICE; MOUSE; DISRUPTION; MUTATIONS; NUCLEASES	The unprecedented efficiency of the CRISPR/Cas9 system in genome engineering has opened the prospect of employing mutant founders for phenotyping cohorts, thus accelerating research projects by circumventing the requirement to generate cohorts using conventional two- or three-generation crosses. However, these first-generation mutants are often genetic mosaics, with a complex and difficult to define genetic make-up. Here, we discuss the potential benefits, challenges and scientific validity of such models.	[Teboul, Lydia] MRC Harwell Inst, Mary Lyon Ctr, Harwell Sci Campus, Didcot, Oxon, England; [Murray, Stephen A.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Nolan, Patrick M.] MRC Harwell Inst, Mammalian Genet Unit, Harwell Sci Campus, Didcot, Oxon, England	Teboul, L (reprint author), MRC Harwell Inst, Mary Lyon Ctr, Harwell Sci Campus, Didcot, Oxon, England.	l.teboul@har.mrc.ac.uk; Steve.Murray@jax.org; p.nolan@har.mrc.ac.uk					Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Davies FCJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46019; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Ertzeid G, 2001, HUM REPROD, V16, P221, DOI 10.1093/humrep/16.2.221; Guimier A, 2015, NAT GENET, V47, P1260, DOI 10.1038/ng.3376; Karp NA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15475; Kilkenny C, 2010, J GENE MED, V12, P561, DOI 10.1002/jgm.1473; Liu XQ, 2017, NAT GENET, V49, P1152, DOI 10.1038/ng.3870; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; Lozano G, 2007, P NATL ACAD SCI USA, V104, P4245, DOI 10.1073/pnas.0700173104; Meehan TF, 2017, NAT GENET, V49, P1231, DOI 10.1038/ng.3901; Mianne J, 2017, METHODS, V121, P68, DOI 10.1016/j.ymeth.2017.03.016; Mianne J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0273-4; Perrimon N, 1998, INT J DEV BIOL, V42, P243; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Rossant J, 1998, TRENDS GENET, V14, P358, DOI 10.1016/S0168-9525(98)01552-2; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Sunagawa GA, 2016, CELL REP, V14, P662, DOI 10.1016/j.celrep.2015.12.052; Thomas HR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117764; Thomas HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114632; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsuchiya Y, 2015, GENES CELLS, V20, P992, DOI 10.1111/gtc.12305; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang W, 2007, P NATL ACAD SCI USA, V104, P4501, DOI 10.1073/pnas.0607953104; WILKIE TM, 1986, DEV BIOL, V118, P9, DOI 10.1016/0012-1606(86)90068-0; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Zhang DH, 2014, DEV BIOL, V395, P96, DOI 10.1016/j.ydbio.2014.08.025; Zhong H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08366	29	0	0	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2017	28	7-8			SI		377	382		10.1007/s00335-017-9711-x				6	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FE7SV	WOS:000408408100015	28756587	gold			2018-01-05	
J	Kenyon, J; Fray, MD				Kenyon, Janet; Fray, Martin D.			Sharing mutations: are biobanks still required in the post-CRISPR/Cas9 era?	MAMMALIAN GENOME			English	Article							QUALITY-CONTROL; MOUSE	Cryopreservation is seen as a key aspect of good colony management which supports the drive towards improvements in animal care and the implementation of the 3Rs. However, following the advent of gene editing technologies, the generation of new mouse models is quicker and cheaper than ever before. This has led some to question the future value of biobanks around the world. In the following commentary, we argue that the need to cryopreserve mouse strains and distribute them from well-funded repositories is as strong as it has ever been. Repositories are not simply archives for unwanted mouse strains. Biobanks distribute identical QC verified mouse strains to the community and eliminate the need to recreate mice. They provide a check point in the development of mouse strains that minimises genetic drift and breeding failures. What is more, cryopreservation makes resource sharing easier, cheaper and improves animal care by eliminating the need for live animal shipments.	[Kenyon, Janet; Fray, Martin D.] MRC Harwell Inst, Mary Lyon Ctr, Harwell Campus, Didcot OX11 0RD, Oxon, England	Fray, MD (reprint author), MRC Harwell Inst, Mary Lyon Ctr, Harwell Campus, Didcot OX11 0RD, Oxon, England.	m.fray@har.mrc.ac.uk					Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Lloyd K, 2015, NATURE, V522, P151, DOI 10.1038/522151a; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Mianne J, 2017, METHODS, V121, P68, DOI 10.1016/j.ymeth.2017.03.016; Scavizzi F, 2015, TRANSGENIC RES, V24, P921, DOI 10.1007/s11248-015-9897-1; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; Taft RA, 2006, TRENDS GENET, V22, P649, DOI 10.1016/j.tig.2006.09.010; Takeo T, 2010, LAB ANIM-UK, V44, P132, DOI 10.1258/la.2009.009074; WHITTINGHAM DG, 1972, SCIENCE, V178, P411, DOI 10.1126/science.178.4059.411; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017	12	0	0	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2017	28	7-8			SI		383	387		10.1007/s00335-017-9710-y				5	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FE7SV	WOS:000408408100016	28726007				2018-01-05	
J	Greenfield, A				Greenfield, Andy			Editing mammalian genomes: ethical considerations	MAMMALIAN GENOME			English	Article							DISEASE	Genome editing is facilitating the manipulation of genomes on an unprecedented scale. It promises to revolutionize our ability to study gene function and generate models of human genetic disease in a range of organisms, most notably in mammals such as the mouse. Is this new technology likely to be disruptive to our research practices in any way? Will it alter the ways in which we implement the ethical imperatives of the 3Rs? In short, what ethical questions are raised by genome editing of mammals in a biomedical research context?.	[Greenfield, Andy] MRC Harwell Inst, Mammalian Genet Unit, Harwell Campus, Didcot OX11 0RD, Oxon, England	Greenfield, A (reprint author), MRC Harwell Inst, Mammalian Genet Unit, Harwell Campus, Didcot OX11 0RD, Oxon, England.	a.greenfield@har.mrc.ac.uk					Anderson E, 2005, ANIMAL RIGHTS CURREN; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Crary A, 2007, WITGENSTEIN MORAL LI; Diamond C, 1991, REALISM REALISTIC SP; Jordan DM, 2015, NATURE, V524, P225, DOI 10.1038/nature14497; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Nuffield Council on Bioethics, 2016, GEN ED ETH REV; Williams B., 2006, PHILOHUMANISTIC DI	8	0	0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2017	28	7-8			SI		388	393		10.1007/s00335-017-9702-y				6	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FE7SV	WOS:000408408100017	28653171				2018-01-05	
J	Umenhoffer, K; Draskovits, G; Nyerges, A; Karcagi, I; Bogos, B; Timar, E; Csorgo, B; Herczeg, R; Nagy, I; Feher, T; Pal, C; Posfai, G				Umenhoffer, Kinga; Draskovits, Gabor; Nyerges, Akos; Karcagi, Ildiko; Bogos, Balazs; Timar, Edit; Csoergo, Balint; Herczeg, Robert; Nagy, Istvan; Feher, Tamas; Pal, Csaba; Posfai, Gyoergy			Genome-Wide Abolishment of Mobile Genetic Elements Using Genome Shuffling and CRISPR/Cas-Assisted MAGE Allows the Efficient Stabilization of a Bacterial Chassis	ACS SYNTHETIC BIOLOGY			English	Article						bacterial genome reduction; CRISPR/Cas-assisted multiplex automated genome editing; genome shuffling; genome stabilization; mutation rate; transposon inactivation	ESCHERICHIA-COLI-B; PROTEIN-PRODUCTION; FLUCTUATION ANALYSIS; SYNTHETIC BIOLOGY; STRAINS REL606; MUTATION-RATE; EXPRESSION; EVOLUTION; REARRANGEMENTS; STABILITY	The ideal bacterial chassis provides a simplified, stable and predictable host environment for synthetic biological circuits. Mutability and evolution can, however, compromise stability, leading to deterioration of artificial genetic constructs. By eliminating certain sources of instability, these undesired genetic changes can be mitigated. Specifically, deletion of prophages and insertion sequences, nonessential constituents of bacterial genomes, has been shown to be beneficial in cellular and genetic stabilization. Here, we sought to establish a rapid methodology to improve the stability of microbial hosts. The novel workflow involves genome shuffling between a mobile genetic element-free strain and the target cell, and subsequent rounds of CRISPR/Cas-assisted MAGE on multiplex targets. The power and speed of the procedure was demonstrated on E. coli BL21(DE3), a host routinely used for plasmid-based heterologous protein expression. All 9 prophages and 50 insertion elements were efficiently deleted or inactivated. Together with additional targeted manipulations (e.g., inactivation of error-prone DNA-polymerases), the changes resulted in an improved bacterial host with a hybrid (harboring segments of K-12 DNA), 9%-downsized and clean genome. The combined capacity of phage-mediated generalized transduction and CRISPR/Cas-selected MAGE offers a way for rapid, large scale editing of bacterial genomes.	[Umenhoffer, Kinga; Draskovits, Gabor; Nyerges, Akos; Karcagi, Ildiko; Bogos, Balazs; Timar, Edit; Csoergo, Balint; Feher, Tamas; Pal, Csaba; Posfai, Gyoergy] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Synthet & Syst Biol Unit, H-6726 Szeged, Hungary; [Herczeg, Robert; Nagy, Istvan] Seqom Biotechnol Ltd, H-6782 Morahalom, Hungary; [Nagy, Istvan] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6726 Szeged, Hungary; [Bogos, Balazs] ETH Zurich Theoret Biol, Inst Integrat Biol, Univ Str 16,CHN K18, CH-8092 Zurich, Switzerland	Posfai, G (reprint author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Synthet & Syst Biol Unit, H-6726 Szeged, Hungary.	posfai.gyorgy@brc.mta.hu		Nyerges, Akos/0000-0002-1581-490X	Hungarian Scientific Research Fund [PD 106231, OTKA PD 109572, K116455, GINOP-2.3.2-15-2016-00001]; Hungarian Academy of Sciences Postdoctoral Fellowship Program Grant [SZ-039/2013]; Boehringer Ingelheim Fonds; GINOP (MolMedEx TUMORDNS) [GINOP-2.3.2-15-2016-00020]; GINOP (EVOMER) [GINOP-2.3.2-15-2016-00014]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	We thank Balint Balazs, Balint Mirk Vasarhelyi for genome sequence analysis, Ferenc Sarlos for UV intensity measurements and Lili Koczian for technical assistance. This work was supported by grants from the Hungarian Scientific Research Fund PD 106231 (to K.U.) OTKA PD 109572 (to B.C.). K116455 (G.P.) and GINOP-2.3.2-15-2016-00001 (G.P.); Hungarian Academy of Sciences Postdoctoral Fellowship Program Grant SZ-039/2013 (to B. Bogos). A.N. was supported by a PhD fellowship from the Boehringer Ingelheim Fonds. C.P. and G.D. were supported by GINOP (MolMedEx TUMORDNS) GINOP-2.3.2-15-2016-00020 and GINOP (EVOMER) GINOP-2.3.2-15-2016-00014. I.N. was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8                                                   ; Binnenkade L, 2014, APPL ENVIRON MICROB, V80, P5304, DOI 10.1128/AEM.01480-14; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Bonde MT, 2014, NUCLEIC ACIDS RES, V42, pW408, DOI 10.1093/nar/gku428; Bondy-Denomy J, 2014, J MICROBIOL, V52, P235, DOI 10.1007/s12275-014-4083-3; Chakiath CS, 2007, BIOTECHNIQUES, V43, P466, DOI 10.2144/000112585; Csorgo B, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-11; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898                                                          ; Feher T, 2006, MUTAT RES-FUND MOL M, V595, P184, DOI 10.1016/j.mrfmmm.2005.11.004; Feher T, 2012, MICROB BIOTECHNOL, V5, P466, DOI 10.1111/j.1751-7915.2011.00292.x; Foster PL, 2007, CRIT REV BIOCHEM MOL, V42, P373, DOI 10.1080/10409230701648494; Foster PL, 2005, MUTAT RES-FUND MOL M, V569, P3, DOI 10.1016/j.mrfmmm.2004.07.017; Frisch D., 2013, GENET ENG BIOTECHNOL, V33, P34; Fuchs RP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012682; Gallagher RR, 2014, NAT PROTOC, V9, P2301, DOI 10.1038/nprot.2014.082; Green M.R., 2012, MOL CLONING LAB MANU; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988                                                 ; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hall BG, 1998, MOL BIOL EVOL, V15, P1; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; He SS, 2015, MBIO, V6, DOI 10.1128/mBio.00762-15; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jurgen B, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-41; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Karcagi I, 2016, MOL BIOL EVOL, V33, P1257, DOI 10.1093/molbev/msw009; Kolisnychenko V, 2002, GENOME RES, V12, P640, DOI 10.1101/gr.217202; Korpimaki T, 2003, J MICROBIOL METH, V53, P37, DOI 10.1016/S0167-7012(02)00213-0                                                   ; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Marisch K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-58; NAAS T, 1995, MOL BIOL EVOL, V12, P198; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736; Nyerges A, 2016, P NATL ACAD SCI USA, V113, P2502, DOI 10.1073/pnas.1520040113; Penn K, 2009, ISME J, V3, P1193, DOI 10.1038/ismej.2009.58; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089                                                                ; Phue JN, 2005, BIOTECHNOL BIOENG, V90, P805, DOI 10.1002/bit.20478; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Posfai G, 1999, NUCLEIC ACIDS RES, V27, P4409, DOI 10.1093/nar/27.22.4409; Raeside C, 2014, MBIO, V5, DOI 10.1128/mBio.01377-14; RALEIGH EA, 1992, MOL MICROBIOL, V6, P1079, DOI 10.1111/j.1365-2958.1992.tb01546.x; Renda BA, 2014, MOL BIOSYST, V10, P1668, DOI 10.1039/c3mb70606k; Ronda C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19452; SARKAR S, 1992, GENETICA, V85, P173, DOI 10.1007/BF00120324; Schneider D, 2000, GENETICS, V156, P477; Sharma SS, 2007, BIOTECHNOL BIOENG, V98, P1056, DOI 10.1002/bit.21491; Sharma SS, 2007, METAB ENG, V9, P133, DOI 10.1016/j.ymben.2006.10.002; Sleight Sean C, 2010, J Biol Eng, V4, P12, DOI 10.1186/1754-1611-4-12; Studier FW, 2009, J MOL BIOL, V394, P653, DOI 10.1016/j.jmb.2009.09.021; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Umenhoffer K, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-38; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101                                             ; Xu JS, 2006, APPL MICROBIOL BIOT, V73, P780, DOI 10.1007/s00253-006-0547-7; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yang S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks972; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	62	0	0	12	12	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	AUG	2017	6	8					1471	1483		10.1021/acssynbio.6b00378				13	Biochemical Research Methods	Biochemistry & Molecular Biology	FE6BK	WOS:000408294800005	28426191				2018-01-05	
J	Shen, CC; Sung, LY; Lin, SY; Lin, MW; Hu, YC				Shen, Chih-Che; Sung, Li-Yu; Lin, Shih-Yeh; Lin, Mei-Wei; Hu, Yu-Chen			Enhancing Protein Production Yield from Chinese Hamster Ovary Cells by CRISPR Interference	ACS SYNTHETIC BIOLOGY			English	Article						CRISPRi; CHO cell; cell engineering; DHFR; MTX selection; protein production	STAPHYLOCOCCUS-AUREUS CAS9; CHO-CELLS; SUCCINATE PRODUCTION; FUTURE-DIRECTIONS; MAMMALIAN-CELLS; HUMAN GENOME; EXPRESSION; GENE; LINES; ENDONUCLEASE	Chinese hamster ovary (CHO) cells are an important host for biopharmaceutical production. Generation of stable CHO cells typically requires cointegration of dhfr and a foreign gene into chromosomes and subsequent methotrexate (MTX) selection for coamplification of dhfr and foreign gene. CRISPR. interference (CRISPRi) is an emerging system that effectively suppresses gene transcription through the coordination of dCas9 protein and guide RNA (gRNA). However, CRISPRi has yet to be exploited in CHO cells. Here we constructed vectors expressing the functional CRISPRi system and proved effective CRISPRi-mediated suppression of dhfr transcription in CHO cells. We next generated stable CHO cell clones coexpressing DHFR, the model protein (EGFP), dCas9 and gRNA targeting dhfr. Combined with MTX selection, CRISPRi-mediated repression of dhfr imparted extra selective pressure to force CHO cells to coamplify more copies of dhfr and egfp genes. Compared with the traditional method relying on MTX selection (up to 250 nM), the CRISPRi approach increased the dhfr copy number similar to 3-fold, egfp copy number similar to 3.6-fold and enhanced the EGFP expression similar to 3.8-fold, without impeding the cell growth. Furthermore, we exploited the CRISPRi approach to enhance the productivity of granulocyte colony stimulating factor (G-CSF) similar to 2.3-fold. Our data demonstrate, for the first time, the application of CRISPRi in CHO cells to enhance recombinant protein production and may pave a new avenue to CHO cell engineering.	[Shen, Chih-Che; Sung, Li-Yu; Lin, Shih-Yeh; Lin, Mei-Wei; Hu, Yu-Chen] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan	Hu, YC (reprint author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.	yuchen@che.nthu.edu.tw		Hu, Yu-Chen/0000-0002-9997-4467	Ministry of Science and Technology, Taiwan [MOST 105-2622-8-007-009, 104-2622-8-007-001, 103-2622-E-007-025]	We acknowledge the financial support from the Ministry of Science and Technology, Taiwan (MOST 105-2622-8-007-009, 104-2622-8-007-001, 103-2622-E-007-025).	Barrangou R, 2015, NUCLEIC ACIDS RES, V43, P3407, DOI 10.1093/nar/gkv226; Betts Z, 2016, BIOTECHNOL J, V11, P554, DOI 10.1002/biot.201500159; Cacciatore JJ, 2010, BIOTECHNOL ADV, V28, P673, DOI 10.1016/j.biotechadv.2010.04.003; Chen BH, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1533; Choi KR, 2016, BIOTECHNOL ADV, V34, P1180, DOI 10.1016/j.biotechadv.2016.08.002; Chung ME, 2017, BIOTECHNOL BIOENG, V114, P172, DOI 10.1002/bit.26056; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Fischer S, 2015, BIOTECHNOL ADV, V33, P1878, DOI 10.1016/j.biotechadv.2015.10.015; Fu BXH, 2014, NUCLEIC ACIDS RES, V42, P13778, DOI 10.1093/nar/gku1102; Ghosh S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw063; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gray L. M., 2015, BIOTECHNOL J, V10, P1446; Hansen HG, 2017, BIOTECHNOL ADV, V35, P64, DOI 10.1016/j.biotechadv.2016.11.008; Hitoshi N., 1991, GENE, V108, P193; Hofmann I, 2015, BIOTECHNOL BIOENG, V112, P2505, DOI 10.1002/bit.25670; Hong WWL, 2007, VACCINE, V25, P4103, DOI 10.1016/j.vaccine.2007.02.012; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang CH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0595-3; Jakociunas T, 2016, METAB ENG, V34, P44, DOI 10.1016/j.ymben.2015.12.003; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lattenmayer C, 2007, J BIOTECHNOL, V128, P716, DOI 10.1016/j.jbiotec.2006.12.016; Lee JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08572; Lee KH, 2013, J BIOSCI BIOENG, V116, P754, DOI 10.1016/j.jbiosc.2013.05.032; Lee N, 2016, ACS SYNTH BIOL, V5, P1211, DOI 10.1021/acssynbio.5b00249; Lewis AM, 2016, BIOTECHNOL BIOENG, V113, P26, DOI 10.1002/bit.25673; Lewis NE, 2013, NAT BIOTECHNOL, V31, P759, DOI 10.1038/nbt.2624; Li H, 2016, METAB ENG, V38, P293, DOI 10.1016/j.ymben.2016.09.006; Li SY, 2016, METAB ENG, V38, P274, DOI [10.1016.j.ymben.2016.09.003, 10.1016/j.ymben.2016.09.003]; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; Muller M, 2016, MOL THER, V24, P636, DOI 10.1038/mt.2015.218; Ng SK, 2007, METAB ENG, V9, P304, DOI 10.1016/j.ymben.2007.01.001; Noguchi C., 2013, PLOS ONE, V7; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ritter A, 2016, BIOTECHNOL BIOENG, V113, P2433, DOI 10.1002/bit.26009; Romand S, 2016, BIOTECHNOL BIOENG, V113, P1094, DOI 10.1002/bit.25877; Ronda C, 2014, BIOTECHNOL BIOENG, V111, P1604, DOI 10.1002/bit.25233; Shin J, 2015, BIOTECHNOL BIOPROC E, V20, P825, DOI 10.1007/s12257-015-0233-7; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wu SC, 2008, VACCINE, V26, P4969, DOI 10.1016/j.vaccine.2008.06.081; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Yamamoto S, 2000, J BIOSCI BIOENG, V89, P534, DOI 10.1016/S1389-1723(00)80052-3; Zboray K, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv475; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	55	1	1	8	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	AUG	2017	6	8					1509	1519		10.1021/acssynbio.7b00020				11	Biochemical Research Methods	Biochemistry & Molecular Biology	FE6BK	WOS:000408294800008	28418635				2018-01-05	
J	Cao, MF; Gao, MR; Lopez-Garcia, CL; Wu, YT; Seetharam, AS; Severin, AJ; Shao, ZY				Cao, Mingfeng; Gao, Meirong; Lopez-Garcia, Carmen Lorena; Wu, Yutong; Seetharam, Arun Somwarpet; Severin, Andrew Josef; Shao, Zengyi			Centromeric DNA Facilitates Nonconventional Yeast Genetic Engineering	ACS SYNTHETIC BIOLOGY			English	Article						nonconventional yeasts; episomal plasmids; centromeres; CRISPR/Cas9; Scheffersomyces stipitis; CEN epigeneticity	SACCHAROMYCES-CEREVISIAE; PICHIA-STIPITIS; YARROWIA-LIPOLYTICA; BUDDING YEAST; XYLITOL DEHYDROGENASE; XYLOSE FERMENTATION; AROMATIC-COMPOUNDS; CONTENT EVOLUTION; CANDIDA-ALBICANS; SEQUENCES	Many nonconventional yeast species have highly desirable features that are not possessed by model yeasts, despite that significant technology hurdles to effectively manipulate them lay in front. Scheffersornyces stipitis is one of the most important exemplary nonconventional yeasts in biorenewables industry, which has a high native xylose utilization capacity. Recent study suggested its much better potential than Saccharomyces cerevisiae as a well-suited microbial biomanufacturing platform for producing high-value compounds derived from shikimate pathway, many of which are associated with potent nutraceutical or pharmaceutical properties. However, the broad application of S. stipitis is hampered by the lack of stable episomal expression platforms and precise genome-editing tools. Here we report the success in pinpointing the centromeric DNA as the partitioning element to guarantee stable extra-chromosomal DNA segregation. The identified centromeric sequence not only stabilized episomal plasmid, enabled homogeneous gene expression, increased the titer of a commercially relevant compound by 3-fold, and also dramatically increased gene knockout efficiency from <1% to more than 80% with the expression of CRISPR components on the new stable plasmid. This study elucidated that establishment of a stable minichromosome-like expression platform is key to achieving functional modifications of nonconventional yeast species in order to expand the current collection of microbial factories.	[Cao, Mingfeng; Gao, Meirong; Lopez-Garcia, Carmen Lorena; Wu, Yutong; Shao, Zengyi] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA; [Cao, Mingfeng; Gao, Meirong; Shao, Zengyi] Iowa State Univ, Engn Res Ctr Biorenewable Chem CBiRC, NSF, Ames, IA 50011 USA; [Seetharam, Arun Somwarpet; Severin, Andrew Josef] Iowa State Univ, Genome Informat Facil, Off Biotechnol, Ames, IA 50011 USA; [Lopez-Garcia, Carmen Lorena; Shao, Zengyi] Iowa State Univ, Interdept Microbiol Program, Ames, IA 50011 USA; [Shao, Zengyi] Iowa State Univ, Ames Lab, Biorenewables Res Lab 4140, Ames, IA 50011 USA	Shao, ZY (reprint author), Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.; Shao, ZY (reprint author), Iowa State Univ, Engn Res Ctr Biorenewable Chem CBiRC, NSF, Ames, IA 50011 USA.; Shao, ZY (reprint author), Iowa State Univ, Interdept Microbiol Program, Ames, IA 50011 USA.; Shao, ZY (reprint author), Iowa State Univ, Ames Lab, Biorenewables Res Lab 4140, Ames, IA 50011 USA.	zyshao@iastate.edu		Seetharam, Arun/0000-0002-6789-9298	Iowa Energy Center [4782024]; National Science Foundation [EEC-0813570, EPS-1101284]	This work was supported in part by Iowa Energy Center (4782024) and the National Science Foundation Grants (EEC-0813570 and EPS-1101284). We thank Dr. Thomas W. Jeffries for providing the strain S. stipitis FLP-UC7 (ura3-3, NRRL Y21448). We also thank Dr. Shawn M. Rigby for performing flow cytometry analysis, and Dr. Margaret Carter for confocal microscope examination.	Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Caetano-Anolles G., 2011, EVOLUTIONARY GENOMIC; CHAN CSM, 1980, P NATL ACAD SCI-BIOL, V77, P6329, DOI 10.1073/pnas.77.11.6329; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Foureau E, 2013, BIOTECHNOL LETT, V35, P1035, DOI 10.1007/s10529-013-1169-7; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Galanie S, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0332-3; Galanie S, 2015, SCIENCE, V349, P1095, DOI 10.1126/science.aac9373; Galtier N, 2001, GENETICS, V159, P907; Gao MR, 2017, ACS SYNTH BIOL, V6, P29, DOI 10.1021/acssynbio.6b00132; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Ghosh SK, 2007, P NATL ACAD SCI USA, V104, P13034, DOI 10.1073/pnas.0702996104; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; HIETER P, 1985, CELL, V42, P913, DOI 10.1016/0092-8674(85)90287-9; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7                                                    ; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397                                                            ; HOUTTEMAN SW, 1993, MOL CELL BIOL, V13, P1489, DOI 10.1128/MCB.13.3.1489                                                           ; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jin YS, 2005, APPL ENVIRON MICROB, V71, P8249, DOI 10.1128/AEM.71.12.8249-8256.2005; Kim SR, 2013, FEMS YEAST RES, V13, P312, DOI 10.1111/1567-1364.12036; Kim SR, 2012, METAB ENG, V14, P336, DOI 10.1016/j.ymben.2012.04.001; Kobayashi N, 2015, CURR BIOL, V25, P2026, DOI 10.1016/j.cub.2015.06.023; Koopman F, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-155; Kretzschmar A, 2013, CURR GENET, V59, P63, DOI 10.1007/s00294-013-0389-7; LAMBIE EJ, 1988, CELL, V52, P863, DOI 10.1016/0092-8674(88)90428-X; Laplaza JM, 2006, ENZYME MICROB TECH, V38, P741, DOI 10.1016/j.enzmictec.2005.07.024; Liachko I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000946; Liu LQ, 2014, FEMS YEAST RES, V14, P1124, DOI 10.1111/1567-1364.12201; Lu P, 1998, APPL MICROBIOL BIOT, V49, P141, DOI 10.1007/s002530051150; Lynch DB, 2010, GENOME BIOL EVOL, V2, P572, DOI 10.1093/gbe/evq042; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Morales L, 2013, GENOME BIOL EVOL, V5, P2524, DOI 10.1093/gbe/evt201; Padmanabhan S, 2008, P NATL ACAD SCI USA, V105, P19797, DOI 10.1073/pnas.0809770105; Peden J., 2014, CODONW CORRES ANAL C; Quinlan A. R., 2014, CURR PROTOC BIOINFOR, V47, DOI DOI 10.1002/0471250953.BI1112S47; Sanyal K, 2004, P NATL ACAD SCI USA, V101, P11374, DOI 10.1073/pnas.0404318101; SCHULMAN IG, 1993, MOL CELL BIOL, V13, P3156, DOI 10.1128/MCB.13.6.3156                                                           ; Shao Zengyi, 2014, Curr Protoc Chem Biol, V6, P65, DOI 10.1002/9780470559277.ch130191; Shao ZY, 2013, METHODS MOL BIOL, V1073, P85, DOI 10.1007/978-1-62703-625-2_9; Shao ZY, 2012, METHOD ENZYMOL, V517, P203, DOI 10.1016/B978-0-12-404634-4.00010-3; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Siddiqui MS, 2012, FEMS YEAST RES, V12, P144, DOI 10.1111/j.1567-1364.2011.00774.x; Steiner FA, 2015, CURR OPIN GENET DEV, V31, P28, DOI 10.1016/j.gde.2015.03.010; STEINER NC, 1994, CELL, V79, P865, DOI 10.1016/0092-8674(94)90075-2; Suastegui M, 2016, BIOTECHNOL BIOENG, V113, P2676, DOI 10.1002/bit.26037; Suastegui M, 2016, J IND MICROBIOL BIOT, V43, P1611, DOI 10.1007/s10295-016-1824-9; Yen Ting L., 2014, MICROBIAL SPECTRUM, DOI [10.1128/microbiolspec.PLAS-0003-2013, DOI 10.1128/MICROBIOLSPEC.PLAS-0003-2013]; Trantas E, 2009, METAB ENG, V11, P355, DOI 10.1016/j.ymben.2009.07.004; Trenchard IJ, 2015, METAB ENG, V30, P96, DOI 10.1016/j.ymben.2015.05.001; Vernis L, 2001, J MOL BIOL, V305, P203, DOI 10.1006/jmbi.2000.4300; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; Wiens GR, 1998, CELL, V93, P313, DOI 10.1016/S0092-8674(00)81157-5                                                   ; YANG VW, 1994, APPL ENVIRON MICROB, V60, P4245; Yoshida K, 2013, J MOL BIOL, V425, P4696, DOI 10.1016/j.jmb.2013.09.020; Young EM, 2014, P NATL ACAD SCI USA, V111, P131, DOI 10.1073/pnas.1311970111; Young EM, 2012, METAB ENG, V14, P401, DOI 10.1016/j.ymben.2012.03.004	63	1	1	11	11	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	AUG	2017	6	8					1545	1553		10.1021/acssynbio.7b00046				9	Biochemical Research Methods	Biochemistry & Molecular Biology	FE6BK	WOS:000408294800011	28391682				2018-01-05	
J	Musunuru, K				Musunuru, Kiran			The Hope and Hype of CRISPR-Cas9 Genome Editing A Review	JAMA CARDIOLOGY			English	Review							PLURIPOTENT STEM-CELLS; IN-VIVO; MUSCULAR-DYSTROPHY; MOUSE MODEL; CAS9; EFFICIENCY; NUCLEASES; SPECIFICITY; GENERATION; DISEASE	IMPORTANCE Clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR-associated protein 9 (CRISPR-Cas9) has garnered a great degree of attention since its first reported uses in mammalian cells in early 2013 due to its perceived impact with respect to potential research applications and, especially, therapeutic applications. OBSERVATIONS CRISPR-Cas9 is being widely used in the laboratory and has greatly improved the ability to generate genetically modified animal models of human diseases. First steps have been reported with respect to proof-of-concept cardiovascular therapeutic applications in mouse models which might eventually lead to new treatments for patients as well as modification of human embryos, which raises a host of social, ethical, and legal questions. CONCLUSIONS AND RELEVANCE CRISPR-Cas9 is already having a substantial effect on cardiovascular basic science research. Although the first steps toward potential therapies have been taken, there are substantial obstacles that will need to be overcome if CRISPR-Cas9 is to be used in the practice of cardiovascular medicine.	[Musunuru, Kiran] Univ Penn, Perelman Sch Med, Dept Med, Cardiovasc Inst, Philadelphia, PA 19104 USA	Musunuru, K (reprint author), Univ Penn, Perelman Sch Med, Dept Med, Smilow Ctr Translat Res,Cardiovasc Inst, 3400 Civ Ctr Blvd,11-104, Philadelphia, PA 19104 USA.	kiranmusunuru@gmail.com					Blendon RJ, 2016, NEW ENGL J MED, V374, P1406, DOI 10.1056/NEJMp1602010; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gartner Inc, RES METH GARTN HYP C; Gupta RM, 2014, J CLIN INVEST, V124, P4154, DOI 10.1172/JCI72992; Hendel A, 2014, CELL REP, V7, P293, DOI 10.1016/j.celrep.2014.02.040; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Matsa E, 2016, PHYSIOL REV, V96, P1093, DOI 10.1152/physrev.00036.2015; Musunuru K, 2013, DIS MODEL MECH, V6, P896, DOI 10.1242/dmm.012054; National Academies of Sciences Engineering and Medicine, 2017, HUM GEN ED SCI ETH G; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Staahl BT, 2017, NAT BIOTECHNOL, V35, P431, DOI 10.1038/nbt.3806; Strong A, 2017, NAT REV CARDIOL, V14, P11, DOI 10.1038/nrcardio.2016.139; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang X, 2016, ARTERIOSCL THROM VAS, V36, P783, DOI 10.1161/ATVBAHA.116.307227; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471	43	1	1	18	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2380-6583	2380-6591		JAMA CARDIOL	JAMA Cardiol.	AUG	2017	2	8					914	919		10.1001/jamacardio.2017.1713				6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	FD8WZ	WOS:000407806100016	28614576				2018-01-05	
J	Vervoort, Y; Linares, AG; Roncoroni, M; Liu, CX; Steensels, J; Verstrepen, KJ				Vervoort, Yannick; Linares, Alicia Gutierrez; Roncoroni, Miguel; Liu, Chengxun; Steensels, Jan; Verstrepen, Kevin J.			High-throughput system-wide engineering and screening for microbial biotechnology	CURRENT OPINION IN BIOTECHNOLOGY			English	Review							SACCHAROMYCES-CEREVISIAE; MICROFLUIDICS PLATFORM; DROPLET MICROFLUIDICS; GENOME EVOLUTION; SINGLE CELLS; YEAST-CELLS; SCALE; MAGE; MICROORGANISMS; CRISPR/CAS9	Genetic engineering and screening of large number of cells or populations is a crucial bottleneck in today's systems biology and applied (micro)biology. Instead of using standard methods in bottles, flasks or 96-well plates, scientists are increasingly relying on high-throughput strategies that miniaturize their experiments to the nanoliter and picoliter scale and the single cell level. In this review, we summarize different high throughput system-wide genome engineering and screening strategies for microbes. More specifically, we will emphasize the use of multiplex automated genome evolution (MAGE) and CRISPR/Cas systems for high-throughput genome engineering and the application of (lab-on-chip) nanoreactors for high-throughput single-cell or population screening.	[Vervoort, Yannick; Linares, Alicia Gutierrez; Roncoroni, Miguel; Steensels, Jan; Verstrepen, Kevin J.] VIB Ctr Microbiol, Lab Syst Biol, Gaston Geenslaan 1, B-3001 Leuven, Belgium; [Vervoort, Yannick; Linares, Alicia Gutierrez; Roncoroni, Miguel; Steensels, Jan; Verstrepen, Kevin J.] Katholieke Univ Leuven, Lab Genet & Genom, Gaston Geenslaan 1, B-3001 Leuven, Belgium; [Vervoort, Yannick; Liu, Chengxun] Imec Life Sci Technol, Kapeldreef 75, B-3001 Leuven, Belgium	Verstrepen, KJ (reprint author), VIB Ctr Microbiol, Lab Syst Biol, Gaston Geenslaan 1, B-3001 Leuven, Belgium.; Verstrepen, KJ (reprint author), Katholieke Univ Leuven, Lab Genet & Genom, Gaston Geenslaan 1, B-3001 Leuven, Belgium.	kevin.verstrepen@biw.vib-kuleuven.be		Verstrepen, Kevin/0000-0002-3077-6219	Baillet-Latour Fund; KU Leuven Program Financing; European Research Council (ERC) Starting Grant [241426]; Human Frontier Science (HFSP) program [RGP0050/2013]; VIB; European Molecular Biology Organization (EMBO) Young Investigator program; FWO; Agentschap voor Innovatie door Wetenschap en Technology (IWT)	YV acknowledges the financial support by the Baillet-Latour Fund. Work in the lab of KJV is supported by KU Leuven Program Financing, European Research Council (ERC) Starting Grant [grant number 241426], Human Frontier Science (HFSP) program [grant number RGP0050/2013], VIB, European Molecular Biology Organization (EMBO) Young Investigator program, FWO, and Agentschap voor Innovatie door Wetenschap en Technology (IWT).	Bachmann H, 2013, P NATL ACAD SCI USA, V110, P14302, DOI 10.1073/pnas.1308523110; Baker JD, 2016, ANAL CHEM, V88, P8476, DOI 10.1021/acs.analchem.6b00889; Barkal LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10610; Basova EY, 2015, ANALYST, V140, P22, DOI 10.1039/c4an01209g; Boitard L, 2015, ENG LIFE SCI, V15, P318, DOI 10.1002/elsc.201400089; Bonde MT, 2015, ACS SYNTH BIOL, V4, P17, DOI 10.1021/sb5001565; Bonde MT, 2014, NUCLEIC ACIDS RES, V42, pW408, DOI 10.1093/nar/gku428; DiCarlo JE, 2013, ACS SYNTH BIOL, V2, P741, DOI 10.1021/sb400117c; Eastburn DJ, 2015, NUCL ACIDS RES, V43, pe86; Eyer K, 2013, JOVE-J VIS EXP, V80; Fernandez-Ricaud L, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1134-2; Gach PC, 2016, ACS SYNTH BIOL, V5, P426, DOI 10.1021/acssynbio.6b00011; Gallagher RR, 2014, NAT PROTOC, V9, P2301, DOI 10.1038/nprot.2014.082; Ge ZF, 2016, LAB CHIP, V16, P480, DOI 10.1039/c5lc00978b; Gemayel R, 2015, MOL CELL, V59, P615, DOI 10.1016/j.molcel.2015.07.003; Generoso WC, 2016, J MICROBIOL METH, V127, P203, DOI 10.1016/j.mimet.2016.06.020; Hosokawa M, 2015, BIOSENS BIOELECTRON, V67, P379, DOI 10.1016/j.bios.2014.08.059; Hu HX, 2015, LAB CHIP, V15, P3989, DOI 10.1039/c5lc00686d; Hu R, 2016, TALANTA, V153, P253, DOI 10.1016/j.talanta.2016.03.013; Huang MT, 2015, P NATL ACAD SCI USA, V112, pE4689, DOI 10.1073/pnas.1506460112; Hussain M, 2016, J PHARMACEUT BIOMED, V123, P128, DOI 10.1016/j.jpba.2016.01.050; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; Jakounas T, 2015, METAB ENG, V28, P213, DOI [10.1016/j.ymbn.2015.01.008, 10.1016/j.ymben.2015.01.008]; Jin SH, 2016, LAB CHIP, V16, P1358, DOI 10.1039/c5lc01422k; Jing TY, 2015, BIOSENS BIOELECTRON, V66, P19, DOI 10.1016/j.bios.2014.11.001; Jo MC, 2015, P NATL ACAD SCI USA, V112, P9364, DOI 10.1073/pnas.1510328112; Kaminski TS, 2016, LAB CHIP, V16, P2168, DOI 10.1039/c6lc00367b; Kim JS, 2016, NAT PROTOC, V11, P1573, DOI 10.1038/nprot.2016.104; Labanieh L, 2016, MICROMACHINES, V116, P1477; Lan F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11784; Lee SS, 2012, P NATL ACAD SCI USA, V109, P4916, DOI 10.1073/pnas.1113505109; Liu P, 2015, CELL REP, V13, P634, DOI 10.1016/j.celrep.2015.09.012; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Meyer A, 2015, NAT CHEM, V7, P673, DOI [10.1038/NCHEM.2301, 10.1038/nchem.2301]; Najah M, 2014, CHEM BIOL, V21, P1722, DOI 10.1016/j.chembiol.2014.10.020; Nyerges A, 2016, P NATL ACAD SCI USA, V113, P2502, DOI 10.1073/pnas.1520040113; Obexer R, 2017, NAT CHEM, V9, P50, DOI [10.1038/NCHEM.2596, 10.1038/nchem.2596]; Ohashi H, 2015, BIOMED RES INT, V2015; Ostafe R, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4886771; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Quintin M, 2016, ACS SYNTH BIOL, V5, P452, DOI 10.1021/acssynbio.5b00219; Ronda C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19452; Sevin DC, 2017, NAT METHODS, V14, P187, DOI [10.1038/NMETH.4103, 10.1038/nmeth.4103]; Shi SB, 2016, METAB ENG, V33, P19, DOI 10.1016/j.ymben.2015.10.011; Shields CW, 2015, LAB CHIP, V15, P1230, DOI 10.1039/c4lc01246a; Si T, 2015, ACS SYNTH BIOL, V4, P283, DOI 10.1021/sb500074a; Steensels J, 2014, FEMS MICROBIOL REV, V38, P947, DOI 10.1111/1574-6976.12073; Tesauro C, 2015, SINGLE CELL PROTEIN; Wang BL, 2014, NAT BIOTECHNOL, V32, P473, DOI 10.1038/nbt.2857; Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/nmeth.1971, 10.1038/NMETH.1971]; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wei TY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22646; Wen N, 2016, MOLECULES, V21, DOI 10.3390/molecules21070881; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yuan JZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33883; Zackrisson M, 2016, G3-GENES GENOM GENET, V6, P3003, DOI 10.1534/g3.116.032342; Zhang GQ, 2015, ACS SYNTH BIOL, V4, P1101, DOI 10.1021/acssynbio.5b00074; Zhang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27943; Zhao Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159004	60	4	4	25	25	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0958-1669	1879-0429		CURR OPIN BIOTECH	Curr. Opin. Biotechnol.	AUG	2017	46						120	125		10.1016/j.copbio.2017.02.011				6	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FE2WH	WOS:000408077400019	28346890	gold			2018-01-05	
J	Jakociunas, T; Jensen, MK; Keasling, JD				Jakociunas, Tadas; Jensen, Michael K.; Keasling, Jay D.			System-level perturbations of cell metabolism using CRISPR/Cas9	CURRENT OPINION IN BIOTECHNOLOGY			English	Review							ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; CRISPR-CAS9; PATHWAY; DNA; INTERFERENCE; PROMOTERS; SCREENS; REPEATS; PROTEIN	CRISPR/Cas9 (clustered regularly interspaced palindromic repeats and the associated protein Cas9) techniques have made genome engineering and transcriptional reprogramming studies more advanced and cost-effective. For metabolic engineering purposes, the CRISPR-based tools have been applied to single and multiplex pathway modifications and transcriptional regulations. The effectiveness of these tools allows researchers to implement genome-wide perturbations, test model-guided genome editing strategies, and perform transcriptional reprogramming perturbations in a more advanced manner than previously possible. In this mini-review we highlight recent studies adopting CRISPR/Cas9 for systems-level perturbations and model-guided metabolic engineering.	[Jakociunas, Tadas; Jensen, Michael K.; Keasling, Jay D.] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, Lyngby, Denmark; [Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA; [Keasling, Jay D.] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	Jensen, MK (reprint author), Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, Lyngby, Denmark.	mije@biosustian.dtu.dk			Novo Nordisk Foundation; Joint BioEnergy Institute - US Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	This work was funded by the Novo Nordisk Foundation and by Joint BioEnergy Institute (http://www.jbei.org/), which is supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the US Department of Energy.	Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Angermayr SA, 2015, TRENDS BIOTECHNOL, V33, P352, DOI 10.1016/j.tibtech.2015.03.009; Bassett AR, 2015, J GENET GENOMICS, V42, P301, DOI 10.1016/j.jgg.2015.03.011; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Cress BF, 2016, NUCLEIC ACIDS RES, V44, P4472, DOI 10.1093/nar/gkw231; Cress BF, 2015, ACS SYNTH BIOL, V4, P987, DOI 10.1021/acssynbio.5b00012; Deaner M, 2017, METAB ENG, V40, P14, DOI 10.1016/j.ymben.2017.01.012; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Elhadi D, 2016, METAB ENG, V38, P358, DOI 10.1016/j.ymben.2016.09.001; Garst AD, 2017, NAT BIOTECHNOL, V35, P48, DOI 10.1038/nbt.3718; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gordon GC, 2016, METAB ENG, V38, P170, DOI 10.1016/j.ymben.2016.07.007; Gray L. M., 2015, BIOTECHNOL J, V10, P1446; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang H, 2016, ACS SYNTH BIOL, V5, P1355, DOI 10.1021/acssynbio.6b00044; Huang He, 2015, Acta Biochim Biophys Sin (Shanghai), V47, P231, DOI 10.1093/abbs/gmv007; Jacobs JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6344; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Jakociunas T, 2016, METAB ENG, V34, P44, DOI 10.1016/j.ymben.2015.12.003; Jakociunas T, 2015, ACS SYNTH BIOL, V4, P1226, DOI 10.1021/acssynbio.5b00007; Jakounas T, 2015, METAB ENG, V28, P213, DOI [10.1016/j.ymbn.2015.01.008, 10.1016/j.ymben.2015.01.008]; Jessop-Fabre MM, 2016, BIOTECHNOL J, V11, P1110, DOI 10.1002/biot.201600147; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khatodia S, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2015.00506, 10.3389/fpls.2016.00506]; Kiessling MK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3042-2; Kim SK, 2016, METAB ENG, V38, P228, DOI 10.1016/j.ymben.2016.08.006; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Lee JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08572; Li H, 2016, METAB ENG, V38, P293, DOI 10.1016/j.ymben.2016.09.006; Li SY, 2016, METAB ENG, V38, P274, DOI [10.1016.j.ymben.2016.09.003, 10.1016/j.ymben.2016.09.003]; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; Ranganathan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000744; Ronda C, 2014, BIOTECHNOL BIOENG, V111, P1604, DOI 10.1002/bit.25233; Schwartz CM, 2016, ACS SYNTH BIOL, V5, P356, DOI 10.1021/acssynbio.5b00162; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smith JD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0900-9; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Theisen MK, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004800; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; Vanegas KG, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0632-x; Wang Y, 2015, J BIOTECHNOL, V200, P1, DOI 10.1016/j.jbiotec.2015.02.005; Wendt KE, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0514-7; Weninger A, 2016, J BIOTECHNOL, V235, P139, DOI 10.1016/j.jbiotec.2016.03.027; Yao L, 2016, ACS SYNTH BIOL, V5, P207, DOI 10.1021/acssynbio.5b00264; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052	57	3	3	14	16	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0958-1669	1879-0429		CURR OPIN BIOTECH	Curr. Opin. Biotechnol.	AUG	2017	46						134	140		10.1016/j.copbio.2017.03.014				7	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FE2WH	WOS:000408077400021	28365497				2018-01-05	
J	Wu, WY; Tang, LS; D'Amore, PA; Lei, HT				Wu, Wenyi; Tang, Luosheng; D'Amore, Patricia A.; Lei, Hetian			Application of CRISPR-Cas9 in eye disease	EXPERIMENTAL EYE RESEARCH			English	Review							ZINC-FINGER NUCLEASES; STRAND BREAK REPAIR; COMPLETE GENOME SEQUENCE; PLURIPOTENT STEM-CELLS; TRUNCATED GUIDE RNAS; CAS SYSTEMS; IN-VIVO; STREPTOCOCCUS-THERMOPHILUS; HOMOLOGOUS RECOMBINATION; RETINITIS-PIGMENTOSA	The system of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated nuclease (Cas)9 is an effective instrument for revising the genome with great accuracy. This system has been widely employed to generate mutants in genomes from plants to human cells. Rapid improvements in Cas9 specificity in eukaryotic cells have opened great potential for the use of this technology as a therapeutic. Herein, we summarize the recent advancements of CRISPR-Cas9 use in research on human cells and animal models, and outline a basic and clinical pipeline for CRISPR-Cas9-based treatments of genetic eye diseases. (C) 2017 Elsevier Ltd. All rights reserved.	[Wu, Wenyi; D'Amore, Patricia A.; Lei, Hetian] Harvard Med Sch, Schepens Eye Res Inst, Massachusetts Eye & Ear, Dept Ophthalmol, 20 Staniford St, Boston, MA 02114 USA; [Wu, Wenyi; Tang, Luosheng] Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Hunan, Peoples R China; [D'Amore, Patricia A.] Harvard Med Sch, Dept Pathol, Boston, MA 02114 USA	Lei, HT (reprint author), Harvard Med Sch, Schepens Eye Res Inst, Massachusetts Eye & Ear, Dept Ophthalmol, 20 Staniford St, Boston, MA 02114 USA.	hetian_lei@meei.harvard.edu			National Institutes of Health, National Eye Institute [R01 EY012509]; China Scholarship Council (CSC) [201606370201]; Central South University student innovation project [2016zzts148]	This work was supported by National Institutes of Health, National Eye Institute Grant R01 EY012509 (to H.L.), China Scholarship Council (CSC NO. 201606370201) (to W.W.) and Central South University student innovation project 2016zzts148 (to W.W.)	Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bassuk AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19969; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001                                                   ; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bompada P, 2016, INT J BIOCHEM CELL B, V81, P82, DOI 10.1016/j.biocel.2016.10.022; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022                                                      ; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cloney R, 2017, NAT REV GENET, V18, P146, DOI 10.1038/nrg.2017.1; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Du J, 2011, J GENE MED, V13, P312, DOI 10.1002/jgm.1574; Duan YJ, 2016, J BIOL CHEM, V291, P16339, DOI 10.1074/jbc.M116.729467; Feuer WJ, 2016, OPHTHALMOLOGY, V123, P558, DOI 10.1016/j.ophtha.2015.10.025; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292                                                           ; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2014, METHOD ENZYMOL, V546, P21, DOI 10.1016/B978-0-12-801185-0.00002-7; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Guan YT, 2016, EMBO MOL MED, V8, P477, DOI 10.15252/emmm.201506039; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; He ZY, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2536-3; Heidenreich M, 2016, NAT REV NEUROSCI, V17, P36, DOI 10.1038/nrn.2015.2; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hotta A, 2015, ANNU REV GENET, V49, P47, DOI 10.1146/annurev-genet-112414-054926; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang Xionggao, 2017, Invest Ophthalmol Vis Sci, V58, P1228, DOI 10.1167/iovs.16-20537; Hung SSC, 2016, PROG RETIN EYE RES, V53, P1, DOI 10.1016/j.preteyeres.2016.05.001; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jennings C, 2016, NAT NEUROSCI, V19, P1123, DOI 10.1038/nn.4362; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43932; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; KIM E, 2017, NAT COMMUN, V8; Kim K, 2017, GENOME RES, V27, P419, DOI 10.1101/gr.219089.116; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kitazawa K, 2017, EXP EYE RES, V154, P30, DOI 10.1016/j.exer.2016.11.005; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052                                                                   ; Komor A. C., 2016, CELL; Kuliszewski MA, 2011, MOL THER, V19, P895, DOI 10.1038/mt.2011.18; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Latella MC, 2016, MOL THER-NUCL ACIDS, V5, P1, DOI 10.1038/mtna.2016.92; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Li HL, 2009, GENE THER, V16, P1146, DOI 10.1038/gt.2009.84; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Liu Z, 2014, NEUROSCI BULL, V30, P381, DOI 10.1007/s12264-014-1434-8; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nash BM, 2015, TRANSL PEDIATR, V4, P139, DOI 10.3978/j.issn.2224-4336.2015.04.03; Priglinger CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146887; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ruan GX, 2017, MOL THER, V25, P331, DOI 10.1016/j.ymthe.2016.12.006; RUDIN N, 1989, GENETICS, V122, P519; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shmakov S, 2017, NAT REV MICROBIOL; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Steinert J, 2015, PLANT J, V84, P1295, DOI 10.1111/tpj.13078; Steinhart Z, 2017, NAT MED, V23, P60, DOI 10.1038/nm.4219; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Valletta S, 2015, ONCOTARGET, V6, P44061, DOI 10.18632/oncotarget.6392; Wan CF, 2015, MOL MED REP, V12, P4803, DOI 10.3892/mmr.2015.4054; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; Wang XL, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.95; Wiley LA, 2015, PROG RETIN EYE RES, V44, P15, DOI 10.1016/j.preteyeres.2014.10.002; Wu J, 2015, NATURE, V521, P316, DOI 10.1038/nature14413; Wu WH, 2016, MOL THER, V24, P1388, DOI 10.1038/mt.2016.107; Wu YX, 2015, CELL RES, V25, P67, DOI 10.1038/cr.2014.160; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Wyvekens N, 2015, HUM GENE THER, V26, P425, DOI 10.1089/hum.2015.084; Xiao A., 2013, NUCLEIC ACIDS RES; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yiu G, 2016, INVEST OPHTH VIS SCI, V57, P5490, DOI 10.1167/iovs.16-20296; Yu WH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14716; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zhou JK, 2014, INT J BIOCHEM CELL B, V46, P49, DOI 10.1016/j.biocel.2013.10.010; Zhou R, 2010, F1000 BIOL REP, V2	107	1	1	23	23	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	AUG	2017	161						116	123		10.1016/j.exer.2017.06.007				8	Ophthalmology	Ophthalmology	FE2UQ	WOS:000408072800014	28619505				2018-01-05	
J	Shao, HG; Li, XS; Lok, JB				Shao, Hongguang; Li, Xinshe; Lok, James B.			Heritable genetic transformation of Strongyloides stercoralis by microinjection of plasmid DNA constructs into the male germline	INTERNATIONAL JOURNAL FOR PARASITOLOGY			English	Article						Strongyloides; Transgenesis; Male; Microinjection; CRISPR/Cas9	CAENORHABDITIS-ELEGANS; TRANSGENE EXPRESSION; PARASITIC NEMATODES; RATTI	Heretofore, transgenesis in the parasitic nematode genus Strongyloides has relied on microinjecting trans gene constructs into gonadal syncytia of free-living females. We now report transgenesis in Strongyloides stercoralis by microinjecting constructs into the syncytial testes of free-living males. Crosses of individual males microinjected with a construct encoding GFP with cohorts of 12 non-injected females produced a mean of 7.28 +/- 2.09 transgenic progeny. Progeny of males and females microinjected with distinct reporter constructs comprised 2.6% +/- 0.7% of individuals expressing both paternal and maternal transgenes. Implications of this finding for deployment of CRISPR/Cas9 mutagenesis in Strongyloides spp. are discussed. (C) 2017 Australian Society for Parasitology. Published by Elsevier Ltd. All rights reserved.	[Shao, Hongguang; Li, Xinshe; Lok, James B.] Univ Penn, Sch Vet Med, Dept Pathobiol, 3800 Spruce St, Philadelphia, PA 19104 USA	Lok, JB (reprint author), Univ Penn, Sch Vet Med, Dept Pathobiol, 3800 Spruce St, Philadelphia, PA 19104 USA.	jlok@vet.upenn.edu			US National Institutes of Health [AI50688, AI105856, NIH OD P40-10939]	This work was funded by the US National Institutes of Health (Grants AI50688, AI105856 and NIH OD P40-10939). We thank Tegegn Jaleta, Gongyi Ren, Nicole Bacarella, Lindsay McMenemy and Erika Klemp for technical assistance.	Evans T.C., 2006, C ELEGANS RES COMMUN, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1]; FIRE A, 1986, EMBO J, V5, P2673; Genchi C, 2009, VET PARASITOL, V163, P286, DOI 10.1016/j.vetpar.2009.03.026; Grant WN, 2006, INT J PARASITOL, V36, P475, DOI 10.1016/j.ijpara.2005.12.002; HAMMOND MP, 1994, J PARASITOL, V80, P689, DOI 10.2307/3283247; Junio AB, 2008, EXP PARASITOL, V118, P253, DOI 10.1016/j.exppara.2007.08.018; KIMBLE J, 1982, NATURE, V299, P456, DOI 10.1038/299456a0; Kulkarni A, 2016, CHROMOSOMA, V125, P725, DOI 10.1007/s00412-015-0562-5; Li X, 2011, MOL BIOCHEM PARASIT, V179, P114, DOI 10.1016/j.molbiopara.2011.06.002; Li XS, 2006, INT J PARASITOL, V36, P671, DOI 10.1016/j.ijpara.2005.12.007; Lints R., 2009, WORMATLAS, DOI [10.3908/wormatlas.1.23, DOI 10.3908/WORMATLAS.1.23]; Lok JB, 2017, PARASITOLOGY, V144, P327, DOI 10.1017/S0031182016000391; Lok JB, 2012, PARASITOLOGY, V139, P574, DOI 10.1017/S0031182011001387; Lok JB, 2002, MOL BIOCHEM PARASIT, V119, P279, DOI 10.1016/S0166-6851(01)00414-5; Lok J.B., 2007, C ELEGANS RES COMMUN, DOI [10.1895/wormbook.1.134.1, DOI 10.1895/WORMBOOK.1.134.1]; Mello C, 1995, METHOD CELL BIOL, V48, P451; NOLAN TJ, 1993, J INFECT DIS, V168, P1479, DOI 10.1093/infdis/168.6.1479                                                       ; Sakamoto M, 2013, PARASITOL RES, V112, P4009, DOI 10.1007/s00436-013-3591-0; Schad G.A., 1989, P85; SCHAD GA, 1984, EXP PARASITOL, V57, P287, DOI 10.1016/0014-4894(84)90103-6; Shao HG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002871; Stiernagle T., 2006, MAINTENANCE C ELEGAN, DOI [DOI 10.1895/WORMBOOK.1.101.1, 10.1895/wormbook.1.101.1]; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484                                                           ; Stoltzfus JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038587; Viney M.E, 2015, C ELEGANS RES COMMUN, DOI DOI 10.1895/WORMBOOK.1.141.2	25	2	2	5	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-7519	1879-0135		INT J PARASITOL	Int. J. Parasit.	AUG	2017	47	9					511	515		10.1016/j.ijpara.2017.04.003				5	Parasitology	Parasitology	FE2VV	WOS:000408076200001	28577882				2018-01-05	
J	Wu, YY; Smith, AE; Reineke, TM				Wu, Yaoying; Smith, Adam E.; Reineke, Theresa M.			Lipophilic Polycation Vehicles Display High Plasmid DNA Delivery to Multiple Cell Types	BIOCONJUGATE CHEMISTRY			English	Article							GENE DELIVERY; SIRNA DELIVERY; LIPID NANOPARTICLES; NONVIRAL VECTORS; PDNA VEHICLES; RNA DELIVERY; THERAPY; POLY(GLYCOAMIDOAMINE)S; POLYMERS; TRANSFECTION	A class of cationic poly(alkylamidoamine)s (PAAAs) containing lipophilic methylene linkers were designed and examined as in vitro plasmid DNA (pDNA) delivery agents. The PAAAs were synthesized via step-growth polymerization between a diamine monomer and each of four different diacid chloride monomers with varying methylene linker lengths, including glutaryl chloride, adipoyl chloride, pimeloyl chloride, and suberoyl chloride, which served to systematically increase the lipophilicity of the polymers. The synthesized polymers successfully complexed with pDNA in reduced serum medium at N/P ratios of 5 and greater, resulting in polyplexes with hydrodynamic diameters of approximately 1 pm. These polyplexes were tested for in vitro transgene expression and cytotoxicity using HDFa (human dermal fibroblast), HeLa (human cervical carcinoma), HMEC (human mammary epithelial), and HUVEC (human umbilical vein endothelial) cells. Interestingly, select PAAA polyplex formulations were found to be more effective than Lipofectamine 2000 at promoting transgene expression (GFP) while maintaining comparable or higher cell viability. Transgene expression was highest in HeLa cells (similar to 90% for most formulations) and lowest in HDFa cells (up to similar to 20%) as measured by GFP fluorescence. In addition, the cytotoxicity of PAAA polyplex formulations was significantly increased as the molecular weight, N/ P ratio, and methylene linker length were increased. The PAAA vehicles developed herein provide a new delivery vehicle design strategy of displaying attributes of both polycations and lipids, which show promise as a tunable scaffold for refining the structure activity toxicity profiles for future genome editing studies.	[Wu, Yaoying; Smith, Adam E.; Reineke, Theresa M.] Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA; [Smith, Adam E.] Univ Mississippi, Dept Chem Engn, 134 Anderson, University, MS 38677 USA; [Wu, Yaoying] Duke Univ, Dept Biomed Engn, 101 Sci Dr, Durham, NC 27705 USA	Reineke, TM (reprint author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	treineke@umn.edu		Wu, Yaoying/0000-0003-0570-2493	National Institutes of Health (NIH) Director's New Innovator Award Program [DP2OD006669-01]; Bio-Rad, Inc.	We thank Young Joon Kim and Luis Ugozzoli at Bio-Rad, Inc. for their support of the flow cytometry experiments and the National Institutes of Health (NIH) Director's New Innovator Award Program (DP2OD006669-01) and Bio-Rad, Inc. for financial support of this project.	Bansal R, 2012, J MATER CHEM, V22, P25427, DOI 10.1039/c2jm35243e; Bouard D, 2009, BRIT J PHARMACOL, V157, P153, DOI 10.1038/bjp.2008.349; Cheng XW, 2016, ADV DRUG DELIVER REV, V99, P129, DOI 10.1016/j.addr.2016.01.022; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Dong YZ, 2016, NANO LETT, V16, P842, DOI 10.1021/acs.nanolett.5b02428; Gomes-da-Silva LC, 2012, ACCOUNTS CHEM RES, V45, P1163, DOI 10.1021/ar300048p; Grandinetti G, 2012, MOL PHARMACEUT, V9, P2256, DOI 10.1021/mp300142d; Grandinetti G, 2012, MOL PHARMACEUT, V9, P523, DOI 10.1021/mp200368p; Guo X, 2012, ACCOUNTS CHEM RES, V45, P971, DOI 10.1021/ar200151m; Hill J, 2016, TRENDS BIOTECHNOL, V34, P26, DOI [10.1016/j.tibtech.2015.10.004, 10.1016/j.tibtech.2015.11.004]; Ibraheem D, 2014, INT J PHARMACEUT, V459, P70, DOI 10.1016/j.ijpharm.2013.11.041; Ingle NP, 2011, TRENDS BIOTECHNOL, V29, P443, DOI 10.1016/j.tibtech.2011.04.012; Jones CH, 2013, MOL PHARMACEUT, V10, P4082, DOI 10.1021/mp400467x; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Kuchelmeister HY, 2013, ANGEW CHEM INT EDIT, V52, P14016, DOI 10.1002/anie.201306929; Le Corre SS, 2015, ORG BIOMOL CHEM, V13, P1122, DOI 10.1039/c4ob01770f; Liu YM, 2010, BIOMACROMOLECULES, V11, P316, DOI 10.1021/bm9008233; Liu YM, 2005, J AM CHEM SOC, V127, P3004, DOI 10.1021/ja0436446                                                               ; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Mahon KP, 2010, BIOCONJUGATE CHEM, V21, P1448, DOI 10.1021/bc100041r; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Piest M, 2010, J CONTROL RELEASE, V148, P83, DOI 10.1016/j.jconrel.2010.07.109; Rehman ZU, 2013, J CONTROL RELEASE, V166, P46, DOI 10.1016/j.jconrel.2012.12.014; Reineke TM, 2006, J POLYM SCI POL CHEM, V44, P6895, DOI 10.1002/pola.21697; Rheiner S, 2015, AIMS BIOPHYS, V2, P284, DOI 10.3934/biophy.2015.3.284; Srinivasachari S, 2009, BIOMATERIALS, V30, P928, DOI 10.1016/j.biomaterials.2008.09.067; Sun S, 2012, BIOCONJUGATE CHEM, V23, P135, DOI 10.1021/bc200572w; Valencia-Serna J, 2013, J CONTROL RELEASE, V172, P495, DOI 10.1016/j.jconrel.2013.05.014; Wang YH, 2015, ADV DRUG DELIVER REV, V87, P68, DOI 10.1016/j.addr.2015.02.007; Wolk C, 2015, BIOCONJUGATE CHEM, V26, P2461, DOI 10.1021/acs.bioconjchem.5b00505; Won YY, 2009, J CONTROL RELEASE, V139, P88, DOI 10.1016/j.jconrel.2009.06.031; Xue HY, 2015, CURR PHARM DESIGN, V21, P3140, DOI 10.2174/1381612821666150531164540                                               ; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763	35	0	0	19	19	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	AUG	2017	28	8					2035	2040		10.1021/acs.bioconjchem.7b00306				6	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	FE2VJ	WOS:000408075000003	28731685				2018-01-05	
J	Clements, TP; Tandon, B; Lintel, HA; McCarty, JH; Wagner, DS				Clements, Thomas P.; Tandon, Bhavna; Lintel, Hendrik A.; McCarty, Joseph H.; Wagner, Daniel S.			RICE CRISPR: Rapidly increased cut ends by an exonuclease Cas9 fusion in zebrafish	GENESIS			English	Article						Danio rerio; S. pyogenes Cas9; targeted mutagenesis	ESCHERICHIA-COLI; RECOMBINATION; SYSTEM; CELLS	Application of CRISPR-Cas9 technology in diverse organisms has resulted in an explosion of genome modification efforts. To expand the toolbox of applications, we have created an E. coli Exonuclease I (sbcB)-Cas9 fusion that has altered enzymatic activity in zebrafish embryos. This Cas9 variant has increased mutation efficiency and favors longer deletions relative to wild-type Cas9. We anticipate that this variant will allow for more efficient screening for F0 phenotypes and mutation of a larger spectrum of genomic targets including deletion of regulatory regions and creating loss of function mutations in transcription units with poor sequence conservation such as lncRNAs where larger deletions may be required for loss of function.	[Clements, Thomas P.; Tandon, Bhavna; Lintel, Hendrik A.; Wagner, Daniel S.] Rice Univ, Dept BioSci, MS-140,POB 1892, Houston, TX 77251 USA; [McCarty, Joseph H.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA	Wagner, DS (reprint author), Rice Univ, Dept BioSci, MS-140,POB 1892, Houston, TX 77251 USA.	dswagner@rice.edu			NIH [R21 NS085688]	NIH, Grant/Award number: R21 NS085688	Carrington B, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv802; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hirota S, 2015, DEVELOPMENT, V142, P4363, DOI 10.1242/dev.113746; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; KUSHNER SR, 1971, P NATL ACAD SCI USA, V68, P824, DOI 10.1073/pnas.68.4.824; LEHMAN IR, 1964, J BIOL CHEM, V239, P2628; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Nguyen HL, 2011, LAB INVEST, V91, P1554, DOI 10.1038/labinvest.2011.124; PHILLIPS GJ, 1988, J BACTERIOL, V170, P2089, DOI 10.1128/jb.170.5.2089-2094.1988                                                 ; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Thomas HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114632; Thoms B, 2008, J BACTERIOL, V190, P179, DOI 10.1128/JB.01052-07; Thyme SB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11750; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396	19	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-954X	1526-968X		GENESIS	Genesis	AUG	2017	55	8							e23044	10.1002/dvg.23044				6	Developmental Biology; Genetics & Heredity	Developmental Biology; Genetics & Heredity	FE0ST	WOS:000407930700004					2018-01-05	
J	Wang, JZ; Wu, P; Shi, ZM; Xu, YL; Liu, ZJ				Wang, Jing-Zhang; Wu, Peng; Shi, Zhi-Min; Xu, Yan-Li; Liu, Zhi-Jun			The AAV-mediated and RNA-guided CRISPR/Cas9 system for gene therapy of DMD and BMD	BRAIN & DEVELOPMENT			English	Review						Duchenne muscular dystrophy; Becker muscular dystrophy; Dystrophin; CRISPR/Cas9; Adeno-associated virus vector; Gene therapy	DUCHENNE MUSCULAR-DYSTROPHY; OFF-TARGET CLEAVAGE; BLOOD-BRAIN-BARRIER; PRECISION MEDICINE; MDX MICE; IMMUNE-RESPONSES; MUSCLE PATHOLOGY; MOUSE MODEL; STEM-CELLS; CRISPR-CAS9	Mutations in the dystrophin gene (Dmd) result in Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD), which afflict many newborn boys. In 2016, Brain and Development published several interesting articles on DMD treatment With antisense oligonucleotide, kinase inhibitor, and prednisolone. Even more strikingly, three articles in the issue 6271 of Science in 2016 provide new insights into gene therapy of DMD and BMD via the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9). In brief, adeno-associated virus (AAV) vectors transport guided RNAs (gRNAs) and Cas9 into mdx mouse model, gRNAs recognize the mutated Dmd exon 23 (having a stop codon), and Cas9 cut the mutated exon 23 off the Dmd gene. These manipulations restored expression of truncated but partially functional dystrophin, improved skeletal and cardiac muscle function, and increased survival of mdx mice significantly. This review concisely summarized the related advancements and discussed their primary implications in the future gene therapy of DMD, including AAV-vector selection, gRNA designing, Cas9 optimization, dystrophin-restoration efficiency, administration routes, and systemic and long-term therapeutic efficacy. Future orientations, including off-target effects, safety concerns, immune responses, precision medicine, and Dmd-editing in the brain (potentially blocked by the blood brain barrier) were also elucidated briefly. Collectively, the AAV-mediated and RNA-guided CRISPR/Cas9 system has major superiorities compared with traditional gene therapy, and might contribute to the treatment of DMD and BMD substantially in the near future. (c) 2017 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Wang, Jing-Zhang; Shi, Zhi-Min; Xu, Yan-Li; Liu, Zhi-Jun] Hebei Univ Engn, Affiliated Hosp, Coll Med, Handan 056002, Peoples R China; [Wu, Peng] Hebei Univ Engn, Dept Social Sci, Handan 056038, Peoples R China	Wang, JZ; Liu, ZJ (reprint author), Hebei Univ Engn, Affiliated Hosp, Dept Med Technol, Coll Med, 81 83 Cong Tai Rd, Handan 056002, Hebei, Peoples R China.	wangjingzhang1981@gmail.com; gdyylzj@163.com			National Natural Science Foundation of China [81373095]; Science and Technology Department of Hebei Province of China [13277744D, 12276104D-58]; Scientific Research Foundation for Colleges and Universities from Education Department of Hebei Province of China [QN20131051]	The authors gratefully thank the fundings from National Natural Science Foundation of China (No. 81373095), Science and Technology Department of Hebei Province of China (No. 13277744D, 12276104D-58), and Scientific Research Foundation for Colleges and Universities from Education Department of Hebei Province of China (No. QN20131051).	Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Alexander MS, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-27; Annunziato S, 2016, GENE DEV, V30, P1470, DOI 10.1101/gad.279190.116; Beroud C, 2007, HUM MUTAT, V28, P196, DOI 10.1002/humu.20428; Carels N, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0035-4; Cazzella V, 2012, MOL THER, V20, P2134, DOI 10.1038/mt.2012.178; Cearley CN, 2007, J NEUROSCI, V27, P9928, DOI 10.1523/JNEUROSCI.2185-07.2007; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cholerton B, 2016, AM J PATHOL, V186, P500, DOI 10.1016/j.ajpath.2015.12.001; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Cyrulnik SE, 2008, NEUROSCI BIOBEHAV R, V32, P486, DOI 10.1016/j.neubiorev.2007.09.001; De Arcangelis V, 2016, J CELL PHYSIOL, V231, P224, DOI 10.1002/jcp.25075; Echigoya Y, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2014.76; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Feng WY, 2015, INT J MOL SCI, V16, P6545, DOI 10.3390/ijms16036545; Godfrey C, 2015, HUM MOL GENET, V24, P4225, DOI 10.1093/hmg/ddv155; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Goto M, 2016, BRAIN DEV-JPN, V38, P785, DOI 10.1016/j.braindev.2016.04.001; Graham KM, 2010, J NEUROL SCI, V294, P43, DOI 10.1016/j.jns.2010.04.007; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Gregorevic P, 2006, NAT MED, V12, P787, DOI 10.1038/nm1439; Gupte AA, 2016, CARDIOLOGY, V133, P178, DOI 10.1159/000442044; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hendriksen RGF, 2015, NEUROSCI BIOBEHAV R, V51, P255, DOI 10.1016/j.neubiorev.2015.01.023; Hollinger K, 2015, CURR OPIN NEUROL, V28, P522, DOI 10.1097/WCO.0000000000000241; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jarmin S, 2014, EXPERT OPIN BIOL TH, V14, P209, DOI 10.1517/14712598.2014.866087; Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Lai C, 2016, EXPERT REV HEMATOL, V9, P1, DOI 10.1586/17474086.2016.1107471; Lauschke VM, 2016, TRENDS PHARMACOL SCI, V37, P85, DOI 10.1016/j.tips.2015.10.006; Li DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015286; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Ma YW, 2014, FEBS J, V281, P5186, DOI 10.1111/febs.13110; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsuo M, 2016, BRAIN DEV-JPN, V38, P4, DOI 10.1016/j.braindev.2015.05.014; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Miles MT, 2011, J NEUROL SCI, V303, P53, DOI 10.1016/j.jns.2011.01.015; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Monforte M, 2014, J NEUROL SCI, V347, P301, DOI 10.1016/j.jns.2014.10.030; Nance ME, 2015, HUM GENE THER, V26, P786, DOI 10.1089/hum.2015.107; Negishi Y, 2014, MOL PHARMACEUT, V11, P1053, DOI 10.1021/mp4004755; Nelson CE, 2016, NAT BIOTECHNOL, V34, P298, DOI 10.1038/nbt.3501; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; Nishida A, 2016, BRAIN DEV-JPN, V38, P738, DOI 10.1016/j.braindev.2016.03.003; Ousterout DG, 2015, MOL THER, V23, P523, DOI [10.1038/mt.2074.234, 10.1038/mt.2014.234]; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Ryu H, 2015, NEUROMUSCULAR DISORD, V25, pS255, DOI 10.1016/j.nmd.2015.06.254; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Snow WM, 2013, NEUROSCI BIOBEHAV R, V37, P743, DOI 10.1016/j.neubiorev.2013.03.016; Sun GL, 2010, J NEUROL SCI, V297, P19, DOI 10.1016/j.jns.2010.06.031; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Taglia Antonella, 2015, Acta Myol, V34, P9; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Twilt M, 2016, EBIOMEDICINE, V4, P24, DOI 10.1016/j.ebiom.2016.02.009; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; van Putten M, 2014, J MOL CELL CARDIOL, V69, P17, DOI 10.1016/j.yjmcc.2014.01.009; van Putten M, 2013, FASEB J, V27, P2484, DOI 10.1096/fj.12-224170; van Putten M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031937; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Vila MC, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0070-6; Vry J, 2014, EUR J PAEDIATR NEURO, V18, P140, DOI 10.1016/j.ejpn.2013.09.005; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang JW, 2015, BIOTECHNIQUES, V58, P161, DOI 10.2144/000114261; Wang JZ, 2016, PHARMACOL RES, V104, P124, DOI 10.1016/j.phrs.2015.12.024; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Wu B, 2012, AM J PATHOL, V181, P392, DOI 10.1016/j.ajpath.2012.04.006; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Zamani GR, 2015, NEUROL SCI, V36, P2011, DOI 10.1007/s10072-015-2290-2; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125; Zhang HW, 2011, MOL THER, V19, P1440, DOI 10.1038/mt.2011.98; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	84	1	1	18	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	AUG	2017	39	7					547	556		10.1016/j.braindev.2017.03.024				10	Clinical Neurology	Neurosciences & Neurology	FD9WV	WOS:000407873700001	28390761				2018-01-05	
J	Sharma, S; Kaur, R; Singh, A				Sharma, Samriti; Kaur, Rajinder; Singh, Anupama			Recent advances in CRISPR/Cas mediated genome editing for crop improvement	PLANT BIOTECHNOLOGY REPORTS			English	Review						Plant breeding; Genetic engineering; CRISPR/Cas9; TALENs; ZFNs; Crop improvement	SEQUENCE-SPECIFIC CONTROL; ZINC-FINGER NUCLEASES; GENE-EXPRESSION; GUIDE-RNA; RESISTANCE; TRANSCRIPTION; INTERFERENCE; SYSTEMS; RICE; RIBONUCLEOPROTEINS	Plant breeding is one of the oldest sustainable agriculture methods used to increase the yield, quality and other biomaterial for human use. Many crops like fruits, vegetables, ornamental flowers, shrubs and trees, have been long cultivated to satisfy human food and aesthetical needs. Conventional breeding technologies like selection, hybridization, mutation through physical and chemical methods, and modern transgenic approaches are often used to improve the desired traits without inducing the pleiotropic effects. But these breeding methods are highly laborious and complicated to enhance crop production. Recently, targeted genome editing through engineered nuclease including zinc finger nuclease, transcription activator like effector nuclease and clustered regularly interspaced short palindromic repeats (CRISPRs) have been used to improve various traits in plants. Genome editing has emerged as a novel alternative approach to classical breeding with higher mutagenic efficiency. Here, we briefly cover the strengths of CRISPRs in comparison with other genome editing techniques. We also discuss its potential applications in genetic improvement of various crops and future prospective.	[Sharma, Samriti; Kaur, Rajinder; Singh, Anupama] Dr Yashwant Singh Parmar Univ Hort & Forestry Nau, Dept Biotechnol, Solan, India	Sharma, S (reprint author), Dr Yashwant Singh Parmar Univ Hort & Forestry Nau, Dept Biotechnol, Solan, India.	1992samritisharma@gmail.com; rkaur_uhf@rediffmail.com; anupama_58@yahoo.co.in					Bai B, 2016, PLANT SCI, V247, P25, DOI 10.1016/j.plantsci.2016.02.017; Baltes NJ, 2015, TRENDS BIOTECHNOL, V33, P120, DOI 10.1016/j.tibtech.2014.11.008; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Butler NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144591; Cai YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136064; Capuano F, 2014, ANAL CHEM, V86, P3697, DOI 10.1021/ac500447w; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chawla R, 2012, PLANT BIOTECHNOL J, V10, P913, DOI 10.1111/j.1467-7652.2012.00720.x; Chen XG, 2017, SCI REP-UK, V7, DOI 10.1038/srep44304; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Clasen BM, 2016, PLANT BIOTECHNOL J, V14, P169, DOI 10.1111/pbi.12370; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Doudna AJ, 2014, SCI RES, V346; Du H, 2016, J BIOTECHNOL, V217, P90; Eldin HHN, 2017, NAT BIOTECHNOL, V35, P377; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hackett JB, 2017, PLANT PHYSIOL, DOI [10.1104/pp.16.01623, DOI 10.1104/PP.16.01623]; Hahn F, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00039; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hanania U, 2017, PLANT BIOTECHNOL J, V15, P1120, DOI 10.1111/pbi.12702; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Humanes JG, 2017, PLANT J, V89, P1251; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jain M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00375; Janga MR, 2017, PLANT MOL BIOL, V94, P349, DOI 10.1007/s11103-017-0599-3; Jia H, 2016, PLANT BIOTECHNOL J, V15, P1; Jia H, 2014, PLOS ONE, V9, P1; Jiang W, 2013, NUCLEIC ACIDS RES, V41, P1; Jiang WZ, 2017, PLANT BIOTECHNOL J, V15, P648, DOI 10.1111/pbi.12663; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Kelliher T, 2017, NATURE, V542, P105, DOI 10.1038/nature20827; Khatodia S, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2015.00506, 10.3389/fpls.2016.00506]; Kim H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14406; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Li XF, 2017, J GENET GENOMICS, V44, P175, DOI 10.1016/j.jgg.2017.02.001; Liang Z, 2016, NAT COMMUN, DOI [10.1038/ncomms14261:1-5, DOI 10.1038/NCOMMS14261:1-5]; Liu JM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01825; Liu WS, 2013, NAT REV GENET, V14, P781, DOI 10.1038/nrg3583; Lo A, 2017, F1000 RES, V6, P1; Lowder L, 2017, METHODS MOL BIOL, V1578, P291, DOI 10.1007/978-1-4939-6859-6_25; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; MacPherson CR, 2015, NAT BIOTECHNOL, V33, P805, DOI 10.1038/nbt.3291; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Malnoy M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01904; Mao Y, 2013, MOL PLANT, DOI [10.1038/cr.2013.114, DOI 10.1038/CR.2013.114]; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nemudryi AA, 2014, ACTA NATURAE, V6, P19; Nishitani C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31481; O'Brien A, 2014, BIOINFORMATICS, V30, P2673, DOI 10.1093/bioinformatics/btu354; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Pyott DE, 2016, MOL PLANT PATHOL, V17, P1276, DOI 10.1111/mpp.12417; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qi WW, 2017, GENETICS, V205, P1489, DOI 10.1534/genetics.116.199331; Ryder P, 2017, PLANT CELL REP, V36, P1005, DOI 10.1007/s00299-017-2125-0; Shopan J, 2017, PLANT J, V90, P929, DOI 10.1111/tpj.13519; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Soyk S, 2017, NAT GENET, V49, P162, DOI 10.1038/ng.3733; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Sun YW, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00298; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Tang X, 2017, NAT PLANTS, V3, DOI [10.1038/nplants.2017.56, 10.1038/nplants.2017.18]; Tian SW, 2017, PLANT CELL REP, V36, P399, DOI 10.1007/s00299-016-2089-5; Tohidfar M, 2015, BIOTECHNOL AGRON SOC, V19, P62; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Vouldoukis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018289; Waltz E, 2015, NAT BIOTECHNOL, V33, P326, DOI 10.1038/nbt0415-326c; Waltz E, 2015, NAT BIOTECHNOL, V33, P12, DOI 10.1038/nbt0115-12; Wang FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154027; Wang SH, 2015, PLANT CELL REP, V34, P1473, DOI 10.1007/s00299-015-1816-7; Wang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053938; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wu L, 2016, RICE, V9, P1; Xiao A, 2014, BIOINFORMATICS, V30, P1180, DOI 10.1093/bioinformatics/btt764; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xiong JS, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2015.19; Xu RF, 2017, PLANT BIOTECHNOL J, V15, P713, DOI 10.1111/pbi.12669; Zhang BB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174201; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang Y, 2016, NAT COMMUN, DOI [10.1038/ncomms12617:1-8, DOI 10.1038/NCOMMS12617:1-8]; Zhang YR, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2873-8; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zhou H, 2016, SCI REP-UK, V6, DOI 10.1038/srep37395; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811	101	0	0	50	50	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1863-5466	1863-5474		PLANT BIOTECHNOL REP	Plant Biotechnol. Rep.	AUG	2017	11	4					193	207		10.1007/s11816-017-0446-7				15	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	FE2XD	WOS:000408080100001					2018-01-05	
J	Wojtala, JW; Briggs, J				Wojtala, Jennifer Woodside; Briggs, Jewell			The Importance of CRISPR-9 Due Diligence	BIOTECHNOLOGY LAW REPORT			English	Article						CRISPR; CRISPR-Cas9; patent interference; priority contest; Broad; Berkeley; Charpentier		On February 15, 2017, the United States Patent and Trademark Office's Patent Trial and Appeal Board announced its long-awaited decision finding no interference-in-fact between patents and patent applications directed to CRISPR-Cas9 owned by Broad Institute, Inc. et al. and patent applications owned by Regents of the University of California et al. The decision found that the CRISPR-Cas9 gene-editing system in a eukaryotic environment (as generally claimed by Broad Institute) was found to be patentably distinct from a CRISPR-Cas9 gene-editing system in any environment, including in prokaryotic cells or in vitro (as claimed by the University of California), "because one of ordinary skill in the art would not have reasonably expected a CRISPR-Cas9 system to be successful in a eukaryotic environment.'' Therefore, no interference of the claims was found and the proceedings were terminated. This decision has been appealed to the Federal Circuit Court of Appeals. The background, implications of this decision, and possible future issues related to the respective patent portfolios are explored herein.	[Wojtala, Jennifer Woodside; Briggs, Jewell] Harness Dickeys Michigan Off, Troy, MI 48098 USA	Wojtala, JW (reprint author), Harness Dickeys Michigan Off, Troy, MI 48098 USA.	jwoodside@hdp.com; jbriggs@hdp.com					Abudayyeh Omar O., 2016, SCI; Begley S, 2017, STAT; Cohen Jon, 2017, SCI; Contreras Jorge L., 2017, SCI, V355, P6326; Contreras JL, 2017, SCIENCE, V355, P698, DOI 10.1126/science.aal4222; Cyranoski David, 2016, NATURE; Grant Bob, 2015, SCIENTIST; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Ledford H, 2015, NATURE; Ledford H, 2016, NATURE, V531, P156, DOI 10.1038/531156a; Ledford H, 2016, NATURE, V529, P265, DOI 10.1038/nature.2015.17961; Christine Lee, 2017, UC APPEALS DECISION; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; McGuire Lee, 2017, JOURNALISTS STATEMEN; Nishida Keiji, 2016, SCI; Noonan Kevin E., 2007, U CALIFORNIA BERKELE; Reardon S, 2016, NATURE; Sanders Robert, 2017, BERKELEY NEWS   0413; Stanganelli Joe, 2017, CRISPR CUTS 5 COMPLE; Tuttle Benjamin C., 2016, J PAT TRADEMARK OFF, V98, P393; Tuttle Benjamin C., 2016, J PAT TRADEMARK OFF, V98, P391; Vidyadager Aparna, 2017, LIVESCIENCE; Xin Luo, 2016, DONGWUXUE YANJIU, V37, P241; Zetsche Bernd, 2015, CELL; Zimmer Carl, 2015, QUANTA MAG      0206; [Anonymous], 2017, USPTO Patent Application Retrieval Information for U.S. App, Patent No. [13/842,859, 13842859]; [Anonymous], 2016, THE NEXT NEW THING; [Anonymous], 2012, U.S. provisional patent application Serial, Patent No. [61/652,086, 61652086]	29	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0730-031X	1557-8704		BIOTECHNOL LAW REP	Biotechnol. Law Rep.	AUG	2017	36	4					167	174		10.1089/blr.2017.29024.jww				8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FD8ME	WOS:000407778000003					2018-01-05	
J	Farhang, N; Brunger, JM; Stover, JD; Thakore, PI; Lawrence, B; Guilak, F; Gersbach, CA; Setton, LA; Bowles, RD				Farhang, Niloofar; Brunger, Jonathan M.; Stover, Joshua D.; Thakore, Pratiksha I.; Lawrence, Brandon; Guilak, Farshid; Gersbach, Charles A.; Setton, Lori A.; Bowles, Robby D.			CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments	TISSUE ENGINEERING PART A			English	Article						CRISPR; epigenome editing; adipose derived stem cells; receptor; inflammation; intervertebral disc	MESENCHYMAL STEM-CELLS; INTERVERTEBRAL DISC DEGENERATION; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; NUCLEUS PULPOSUS CELLS; TNF-ALPHA; GENE-THERAPY; INHIBIT CHONDROGENESIS; RHEUMATOID-ARTHRITIS; EXPRESSION PROFILE	Musculoskeletal diseases have been associated with inflammatory cytokine action, particularly action by TNF-alpha and IL-1 beta. These inflammatory cytokines promote apoptosis and senescence of cells in diseased tissue and extracellular matrix breakdown. Stem cell-based therapies are being considered for the treatment of musculoskeletal diseases, but the presence of these inflammatory cytokines will have similar deleterious action on therapeutic cells delivered to these environments. Methods that prevent inflammatory-induced apoptosis and proinflammatory signaling, in cell and pathway-specific manners are needed. In this study we demonstrate the use of clustered regularly interspaced short palindromic repeats (CRISPR)-based epigenome editing to alter cell response to inflammatory environments by repressing inflammatory cytokine cell receptors, specifically TNFR1 and IL1R1. We targeted CRISPR/Cas9-based repressors to TNFR1 and IL1R1 gene regulatory elements in human adipose-derived stem cells (hADSCs) and investigated the functional outcomes of repression of these genes. Efficient signaling regulation was demonstrated in engineered hADSCs, as activity of the downstream transcription factor NF-kappa B was significantly reduced or maintained at baseline levels in the presence of TNF-alpha or IL-1 beta. Pellet culture of undifferentiated hADSCs demonstrated improved survival in engineered hADSCs treated with TNF-alpha or IL-1 beta, while having little effect on their immunomodulatory properties. Furthermore, engineered hADSCs demonstrated improved chondrogenic differentiation capacity in the presence of TNF-alpha or IL-1 beta, as shown by superior production of glycosaminglycans in this inflammatory environment. Overall this work demonstrates a novel method for modulating cell response to inflammatory signaling that has applications in engineering cells delivered to inflammatory environments, and as a direct gene therapy to protect endogenous cells exposed to chronic inflammation, as observed in a broad spectrum of degenerative musculoskeletal pathology.	[Farhang, Niloofar; Stover, Joshua D.; Bowles, Robby D.] Univ Utah, Dept Bioengn, 20 S 2030 E,RM 108, Salt Lake City, UT 84112 USA; [Brunger, Jonathan M.; Thakore, Pratiksha I.; Gersbach, Charles A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Lawrence, Brandon; Bowles, Robby D.] Univ Utah, Dept Orthopaed, Salt Lake City, UT USA; [Guilak, Farshid; Setton, Lori A.] Washington Univ St Louis, Dept Biomed Engn, St Louis, MO USA; [Guilak, Farshid; Setton, Lori A.] Washington Univ St Louis, Dept Orthopaed Surg, St Louis, MO USA; [Guilak, Farshid; Setton, Lori A.] Shriners Hosp Children St Louis, St Louis, MO USA	Bowles, RD (reprint author), Univ Utah, Dept Bioengn, 20 S 2030 E,RM 108, Salt Lake City, UT 84112 USA.	robert.bowles@utah.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R03AR068777, R01AR047442, R01AR069588]; AO Foundation; University of Utah Flow Cytometry Facility [5P30CA042014-24]	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Numbers R03AR068777 (RDB), R01AR047442, R01AR069588 (LAS), and AO Foundation Startup Grant. The content is solely the responsibility, of the authors and does not necessarily represent the official views of the National Institutes of Health. Flow cytometry was supported in part by the University of Utah Flow Cytometry Facility in addition to the National Cancer Institute through Award Number 5P30CA042014-24. The authors acknowledge the University of Utah research histology and DNA sequencing core facilities.	Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Akyol S, 2010, TURK NEUROSURG, V20, P492, DOI 10.5137/1019-5149.JTN.3394-10.1; Anderson JA, 2014, AM J SPORT MED, V42, P2253, DOI 10.1177/0363546513508744; Basu R, 2015, NAT IMMUNOL, V16, P286, DOI 10.1038/ni.3099; Bellehumeur C, 2009, HUM REPROD, V24, P2193, DOI 10.1093/humrep/dep192; Bertolo A, 2011, EUR SPINE J, V20, P592, DOI 10.1007/s00586-010-1662-9; Boraschi D, 2013, SEMIN IMMUNOL, V25, P394, DOI 10.1016/j.smim.2013.10.023; Brunger JM, 2017, ARTHRITIS RHEUMATOL, V69, P1111, DOI 10.1002/art.39982; Bustos ML, 2014, AM J RESP CRIT CARE, V189, P787, DOI 10.1164/rccm.201306-1043OC; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Campo GM, 2008, OSTEOARTHR CARTILAGE, V16, P1474, DOI 10.1016/j.joca.2008.04.002; Cao C, 2015, SPINE J, V15, P530, DOI 10.1016/j.spinee.2014.11.021; Dashtdar H, 2011, J ORTHOP RES, V29, P1336, DOI 10.1002/jor.21413; Davatchi F, 2011, INT J RHEUM DIS, V14, P211, DOI 10.1111/j.1756-185X.2011.01599.x; DelaRosa O, 2009, TISSUE ENG PT A, V15, P2795, DOI [10.1089/ten.tea.2008.0630, 10.1089/ten.TEA.2008.0630]; Demircan MN, 2007, EUR SPINE J, V16, P983, DOI 10.1007/s00586-007-0374-2; Ding F, 2013, APOPTOSIS, V18, P777, DOI 10.1007/s10495-013-0839-1; Djouad F, 2009, NAT REV RHEUMATOL, V5, P392, DOI 10.1038/nrrheum.2009.104; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Estes BT, 2006, ARTHRITIS RHEUM, V54, P1222, DOI 10.1002/art.21779; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Gabr MA, 2011, J ORTHOP RES, V29, P1, DOI 10.1002/jor.21206; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Heldens GTH, 2012, TISSUE ENG PT A, V18, P45, DOI [10.1089/ten.tea.2011.0083, 10.1089/ten.TEA.2011.0083]; Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jo CH, 2014, STEM CELLS, V32, P1254, DOI 10.1002/stem.1634; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Kelly ML, 2010, SHOCK, V33, P602, DOI 10.1097/SHK.0b013e3181cc0913; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Kregar VN, 2014, EUR SPINE J, V23, pS364; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Le Maitre Christine Lyn, 2007, Arthritis Res Ther, V9, pR77; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Lee S, 2009, CLIN BIOCHEM, V42, P1504, DOI 10.1016/j.clinbiochem.2009.06.017; Cui LY, 2007, ACTA PHARMACOL SIN, V28, P1671, DOI 10.1111/j.1745-7254.2007.00642.x; Ma CJ, 2015, CURR STEM CELL RES T, V10, P285, DOI 10.2174/1574888X10666150416114027                                               ; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Mattar P, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00560; McGarrity GJ, 2013, J GENE MED, V15, P78, DOI 10.1002/jgm.2691; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; McNulty AL, 2013, J ORTHOP RES, V31, P1039, DOI 10.1002/jor.22334; Millward-Sadler SJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2693; Nasto LA, 2012, SPINE, V37, P1819, DOI 10.1097/BRS.0b013e31824ee8f7; Oehme D, 2015, STEM CELLS INT, DOI 10.1155/2015/946031; Orozco L, 2013, TRANSPLANTATION, V95, P1535, DOI 10.1097/TP.0b013e318291a2da; Orozco L, 2011, TRANSPLANTATION, V92, P822, DOI 10.1097/TP.0b013e3182298a15; Ousema PH, 2012, BIOMATERIALS, V33, P8967, DOI 10.1016/j.biomaterials.2012.08.045; Ozler K, 2016, ACTA ORTHOP TRAUMATO, V50, P356, DOI 10.3944/AOTT.2015.15.0115; Palfi S, 2014, LANCET, V383, P1138, DOI 10.1016/S0140-6736(13)61939-X; Papapetrou EP, 2016, MOL THER, V24, P678, DOI 10.1038/mt.2016.38; Park JB, 2001, SPINE, V26, P618, DOI 10.1097/00007632-200103150-00011; Philpott NJ, 2007, HUM GENE THER, V18, P483, DOI 10.1089/hum.2007.013; Purmessur D, 2013, BIOCHEM BIOPH RES CO, V433, P151, DOI 10.1016/j.bbrc.2013.02.034; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Roemeling-van Rhijn Marieke, 2013, J Stem Cell Res Ther, VSuppl 6, P20780; Roman-Blas JA, 2006, OSTEOARTHR CARTILAGE, V14, P839, DOI 10.1016/j.joca.2006.04.008; Rosemann T, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-48; Sakai D, 2005, SPINE, V30, P2379, DOI 10.1097/01.brs.0000184365.28481.e3; Sakai D, 2015, NAT REV RHEUMATOL, V11, P243, DOI 10.1038/nrrheum.2015.13; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Seguin CA, 2006, MATRIX BIOL, V25, P409, DOI 10.1016/j.matbio.2006.07.002; Shamji MF, 2010, ARTHRITIS RHEUM-US, V62, P1974, DOI 10.1002/art.27444; Singh M., 2016, BIOCH ANAL BIOCH, V5, P273; Storheim K, 2014, ANN RHEUM DIS, V73, P949, DOI 10.1136/annrheumdis-2014-205327; Studer RK, 2011, SPINE, V36, P593, DOI 10.1097/BRS.0b013e3181da38d5; Sun ZY, 2015, CELL BIOCHEM BIOPHYS, V72, P115, DOI 10.1007/s12013-014-0417-3; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Takahashi H, 1996, SPINE, V21, P218, DOI 10.1097/00007632-199601150-00011; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; van Buul GM, 2012, OSTEOARTHR CARTILAGE, V20, P1186, DOI 10.1016/j.joca.2012.06.003; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; VonKorff M, 1996, SPINE, V21, P2833, DOI 10.1097/00007632-199612150-00004; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Wang SS, 2015, J MOL HISTOL, V46, P475, DOI 10.1007/s10735-015-9640-5; Wang T, 2015, BIOCHIMIE, V115, P1, DOI 10.1016/j.biochi.2015.04.011; Wanner JP, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4369; Wehling N, 2009, ARTHRITIS RHEUM-US, V60, P801, DOI 10.1002/art.24352; Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20                                              ; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Wolbank S, 2009, TISSUE ENG PT A, V15, P1843, DOI 10.1089/ten.tea.2008.0205; Wu CC, 2011, BIOMATERIALS, V32, P5847, DOI 10.1016/j.biomaterials.2011.05.002; Wuertz K, 2008, SPINE, V33, P1843, DOI 10.1097/BRS.0b013e31817b8f53; Wuertz K, 2012, EUR CELLS MATER, V23, P103; Yazdany J, 2008, CURR OPIN RHEUMATOL, V20, P159, DOI 10.1097/BOR.0b013e3282f50ec4; Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010; Yoshikawa T, 2010, SPINE, V35, pE475, DOI 10.1097/BRS.0b013e3181cd2cf4; Zhang F, 2016, INT J MOL MED, V37, P1439, DOI 10.3892/ijmm.2016.2573; Zhao CQ, 2007, APOPTOSIS, V12, P2155, DOI 10.1007/s10495-007-0137-x; Zheng CH, 2015, EUR CELLS MATER, V29, P224, DOI 10.22203/eCM.v029a17                                                            ; Zhongyi Sun, 2015, Spine (Phila Pa 1976), V40, P224, DOI 10.1097/BRS.0000000000000733; [Anonymous], 2014, AUTOLOGOUS ADIPOSE T; [Anonymous], 2014, ADIPOSE CELLS DEGENE	105	2	2	4	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	AUG	2017	23	15-16			SI		738	749		10.1089/ten.tea.2016.0441				12	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	FD6YK	WOS:000407673600003	28095751				2018-01-05	
J	Hart, T; Tong, AHY; Chan, K; Van Leeuwen, J; Seetharaman, A; Aregger, M; Chandrashekhar, M; Hustedt, N; Seth, S; Noonan, A; Habsid, A; Sizova, O; Nedyalkova, L; Climie, R; Tworzyanski, L; Lawson, K; Sartori, MA; Alibeh, S; Tieu, D; Masud, S; Mero, P; Weiss, A; Brown, KR; Usaj, M; Billmann, M; Rahman, M; Constanzo, M; Myers, CL; Andrews, BJ; Boone, C; Durocher, D; Moffat, J				Hart, Traver; Tong, Amy Hin Yan; Chan, Katie; Van Leeuwen, Jolanda; Seetharaman, Ashwin; Aregger, Michael; Chandrashekhar, Megha; Hustedt, Nicole; Seth, Sahil; Noonan, Avery; Habsid, Andrea; Sizova, Olga; Nedyalkova, Lyudmila; Climie, Ryan; Tworzyanski, Leanne; Lawson, Keith; Sartori, Maria Augusta; Alibeh, Sabriyeh; Tieu, David; Masud, Sanna; Mero, Patricia; Weiss, Alexander; Brown, Kevin R.; Usaj, Matej; Billmann, Maximilian; Rahman, Mahfuzur; Constanzo, Michael; Myers, Chad L.; Andrews, Brenda J.; Boone, Charles; Durocher, Daniel; Moffat, Jason			Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens	G3-GENES GENOMES GENETICS			English	Article						genetic screens; CRISPR/Cas9; core essential genes; cancer cell lines	HUMAN-CELLS; GENE ESSENTIALITY; CRISPR-CAS9; VULNERABILITIES; IDENTIFICATION; NETWORKS; RNAI	The adaptation of CRISPR/SpCas9 technology to mammalian cell lines is transforming the study of human functional genomics. Pooled libraries of CRISPR guide RNAs (gRNAs) targeting human protein-coding genes and encoded in viral vectors have been used to systematically create gene knockouts in a variety of human cancer and immortalized cell lines, in an effort to identify whether these knockouts cause cellular fitness defects. Previous work has shown that CRISPR screens are more sensitive and specific than pooled-library shRNA screens in similar assays, but currently there exists significant variability across CRISPR library designs and experimental protocols. In this study, we reanalyze 17 genome-scale knockout screens in human cell lines from three research groups, using three different genome-scale gRNA libraries. Using the Bayesian Analysis of Gene Essentiality algorithm to identify essential genes, we refine and expand our previously defined set of human core essential genes from 360 to 684 genes. We use this expanded set of reference core essential genes, CEG2, plus empirical data from six CRISPR knockout screens to guide the design of a sequence-optimized gRNA library, the Toronto KnockOut version 3.0 (TKOv3) library. We then demonstrate the high effectiveness of the library relative to reference sets of essential and nonessential genes, as well as other screens using similar approaches. The optimized TKOv3 library, combined with the CEG2 reference set, provide an efficient, highly optimized platform for performing and assessing gene knockout screens in human cell lines.	[Hart, Traver] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, 1400 Pressler St,Unit 1410, Houston, TX 77030 USA; [Seth, Sahil] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, 1400 Pressler St,Unit 1410, Houston, TX 77030 USA; [Tong, Amy Hin Yan; Chan, Katie; Van Leeuwen, Jolanda; Seetharaman, Ashwin; Aregger, Michael; Noonan, Avery; Habsid, Andrea; Sizova, Olga; Nedyalkova, Lyudmila; Climie, Ryan; Tworzyanski, Leanne; Lawson, Keith; Sartori, Maria Augusta; Alibeh, Sabriyeh; Tieu, David; Masud, Sanna; Mero, Patricia; Weiss, Alexander; Brown, Kevin R.; Usaj, Matej; Constanzo, Michael; Andrews, Brenda J.; Boone, Charles; Moffat, Jason] Univ Toronto, Donnelly Ctr, Room 802,160 Coll St, Toronto, ON M5S 3E1, Canada; [Tieu, David; Masud, Sanna; Andrews, Brenda J.; Boone, Charles; Durocher, Daniel; Moffat, Jason] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Hustedt, Nicole; Durocher, Daniel] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Billmann, Maximilian; Rahman, Mahfuzur; Myers, Chad L.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Andrews, Brenda J.; Boone, Charles; Moffat, Jason] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	Hart, T (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, 1400 Pressler St,Unit 1410, Houston, TX 77030 USA.; Moffat, J (reprint author), Univ Toronto, Donnelly Ctr, Room 802,160 Coll St, Toronto, ON M5S 3E1, Canada.	ghart1@mdanderson.org; j.moffat@utoronto.ca			MD Anderson Cancer Center [P30 CA016672]; Cancer Prevention & Research Institute of Texas [RR160032]; Canada Vanier Graduate Scholarship; Swiss National Science Foundation; Canadian Institutes for Health Research [MOP-142375]; Canadian Cancer Society Research Institute grant [703893]; Ontario Research Fund grant [ORF-RE7-037]	We thank members of the Moffat, Hart, Durocher, and Angers laboratories for helpful discussions. D.D. and C.B. are Canada Research Chairs (Tier 1) in the Molecular Mechanisms of Genome Integrity and Genetics, respectively. J.M. is a Canada Research Chair (Tier 2) in Functional Genetics. T.H. was supported by MD Anderson Cancer Center support grant P30 CA016672 (the Bioinformatics Shared Resource) and the Cancer Prevention & Research Institute of Texas grant RR160032. N.H. is a long-term fellow of the Human Science Frontier Program. K.L. holds a Canada Vanier Graduate Scholarship, M.A. holds a postdoctoral fellowship award from the Swiss National Science Foundation, and M. Chandrashekhar. holds an Ontario Graduate Scholarship. This work was supported from grants funded by the Canadian Institutes for Health Research to J.M. (no. MOP-142375), the Canadian Cancer Society Research Institute grant to D.D. (no. 703893), and the Ontario Research Fund grant to B.J.A., C.B., and J.M. (no. ORF-RE7-037).	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hart T, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1015-8; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Heigwer F, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0915-2; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; LIU XD, 2016, SCI REP UK, V6; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Park J, 2016, BIOINFORMATICS, V32, P2017, DOI 10.1093/bioinformatics/btw103; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Steinhart Z, 2017, NAT MED, V23, P60, DOI 10.1038/nm.4219; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	25	3	3	9	9	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	2160-1836			G3-GENES GENOM GENET	G3-Genes Genomes Genet.	AUG	2017	7	8					2719	2727		10.1534/g3.117.041277				9	Genetics & Heredity	Genetics & Heredity	FD1RI	WOS:000407314000027	28655737	gold			2018-01-05	
J	Garczynski, SF; Martin, JA; Griset, M; Willett, LS; Cooper, WR; Swisher, KD; Unruh, TR				Garczynski, Stephen F.; Martin, Jessica A.; Griset, Margaret; Willett, Laura S.; Cooper, W. Rodney; Swisher, Kylie D.; Unruh, Thomas R.			CRISPR/Cas9 Editing of the Codling Moth (Lepidoptera: Tortricidae) CpomOR1 Gene Affects Egg Production and Viability	JOURNAL OF ECONOMIC ENTOMOLOGY			English	Article						CRISPR/Cas9; genome editing; odorant receptor	DROSOPHILA ODORANT RECEPTORS; OLFACTORY RECEPTORS; HELIOTHIS-VIRESCENS; IDENTIFICATION; EXPRESSION; PROTEINS; SEQUENCE; CAS9; MUTAGENESIS; NUCLEASES	The codling moth, Cydia pomonella (L.) (Lepidoptera: Tortricidae), is a major pest of pome fruit worldwide. Incorporation of semiochemicals, including the main sex pheromone (codlemone), into codling moth IPM programs has drastically reduced the amount of chemical insecticides needed to control this orchard pest. Odorant receptors located in sensory neuron membranes in the antennae are key sensors in the detection of semiochemicals and trigger downstream signaling events leading to a behavioral response. CpomOR1 is an odorant receptor belonging to the pheromone receptor subfamily in codling moth, and is a prime candidate for being a codlemone receptor based on its high expression levels in male antennae. In this study, the CpomOR1 gene was targeted using CRISPR/Cas9 genome editing to knockdown functional OR1 protein production to determine physiological function(s). By injecting early stage eggs, mutations were successfully introduced, including both deletions and insertions. When attempting to create stable populations of codling moth through mating of males with females containing mutations of the CpomOR1 gene, it was found that fecundity and fertility were affected, with edited females producing nonviable eggs. The role of CpomOR1 in fecundity and fertility in codling moth is unknown and will be the focus of future studies.	[Garczynski, Stephen F.; Martin, Jessica A.; Griset, Margaret; Willett, Laura S.; Cooper, W. Rodney; Swisher, Kylie D.; Unruh, Thomas R.] USDA ARS, Temperate Tree Fruit & Vegetable Res Unit, Wapato, WA 98951 USA; [Griset, Margaret; Willett, Laura S.] Univ Connecticut, Dept Chem, Dept Chem, U-60, Storrs, CT USA	Garczynski, SF (reprint author), USDA ARS, Temperate Tree Fruit & Vegetable Res Unit, Wapato, WA 98951 USA.	steve.garczynski@ars.usda.gov; jmartin54321@gmail.com; margaret.griset@gmail.com; laura.willett@ars.usda.gov; rodney.cooper@ars.usda.gov; Kylie.Swisher@ARS.USDA.GOV; tom.unruh@gmail.com					Bassett AR, 2014, J GENET GENOMICS, V41, P7, DOI 10.1016/j.jgg.2013.12.004; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Baumann AMT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8673; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bi HL, 2016, INSECT SCI, V23, P469, DOI 10.1111/1744-7917.12341; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Crosslin JM, 2011, SOUTHWEST ENTOMOL, V36, P125, DOI 10.3958/059.036.0202; EDWARDS D, 1987, BIOMETRICS, V43, P913, DOI 10.2307/2531545                                                                 ; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894                                                          ; Garczynski SF, 2012, INSECT SCI, V19, P64, DOI 10.1111/j.1744-7917.2011.01423.x; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Huang Y., 2016, MOL BIOL, V75, P98, DOI [10.1016/j.ibmb.2016.06.004, DOI 10.1016/J.IBMB.2016.06.004]; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Klinner C. F., 2016, FRONT ECOL EVOL, V4, P130; Knight AL, 2012, ENVIRON ENTOMOL, V41, P407, DOI 10.1603/EN11310; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Koutroumpa FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep29620; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; LI XY, 2015, NAT COMMUN, V6; Ma SY, 2014, SCI REP UK, V4; Martin JA, 2016, INSECT SCI, V23, P277, DOI 10.1111/1744-7917.12196; Montagne N, 2015, PROG MOL BIOL TRANSL, V130, P55, DOI 10.1016/bs.pmbts.2014.11.003; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6                                                   ; Walker WB, 2016, SCI REP-UK, V6, DOI 10.1038/srep23518; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Xin H., 2014, PLOS ONE, V9; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Witzgall P, 2008, ANNU REV ENTOMOL, V53, P503, DOI 10.1146/annurev.ento.53.103106.093323; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhang YP, 1998, J VIROL METHODS, V71, P45, DOI 10.1016/S0166-0934(97)00190-0; Zhang ZJ, 2015, J INSECT PHYSIOL, V79, P73, DOI 10.1016/j.jinsphys.2015.06.004; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003	42	0	0	6	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-0493	1938-291X		J ECON ENTOMOL	J. Econ. Entomol.	AUG	2017	110	4					1847	1855		10.1093/jee/tox166				9	Entomology	Entomology	FC9MG	WOS:000407164900057	28854653				2018-01-05	
J	Uz, M; Altinkaya, SA; Mallapragada, SK				Uz, Metin; Altinkaya, Sacide Alsoy; Mallapragada, Surya K.			Stimuli responsive polymer-based strategies for polynucleotide delivery	JOURNAL OF MATERIALS RESEARCH			English	Review							INTRACELLULAR SIRNA DELIVERY; NONVIRAL GENE DELIVERY; TRANSFER RADICAL POLYMERIZATION; BLOCK-COPOLYMER MICELLES; POLYELECTROLYTE COMPLEX MICELLES; TARGETED DRUG-DELIVERY; IN-VIVO DELIVERY; PENTABLOCK COPOLYMERS; NUCLEIC-ACIDS; RNA DELIVERY	In recent years, stimuli responsive polymer based gene delivery vehicle design for cancer treatment and treatment of other genetic disorders has received extensive attention. Early studies focusing on DNA delivery have been facilitated by functional polymers and this area has seen further growth spurred by recent gene silencing strategies developed for small RNA [i.e., small interfering RNA (siRNA) or micro RNA (miRNA)] delivery. DNA and small RNAs possess analogous properties; however, their explicit differences define the specific challenges associated with the delivery route and the design of functional materials to overcome distinct challenges. Apart from classical gene delivery, the recent advances in genome editing have revealed the necessity of new delivery devices for genome editing tools. A system involving CRISPR (clustered, regularly interspaced, short palindromic repeats) and an endonuclease CRISPR-associated protein 9 (Cas9) coupled with a short, single-guide RNA (sgRNA) has emerged as a promising tool for genome editing along with functional delivery systems. For all these nucleic acid based treatments, the internal or external physiochemical changes in the biological tissue/cells play a major role in the design of stimuli responsive delivery materials for both in vitro and in vivo applications. This review emphasizes the recent advances in the use of pH, temperature, and redox potential-responsive polymers overcoming hurdles for delivery of gene and gene editing tools for both in vitro and in vivo applications. Specifically the chapter focuses on recently proposed delivery strategies, types of delivery systems, and polymer synthesis/modification methods. The recent advances in CRISPR/Cas9-sgRNA technology and delivery are also described in a separate section. The review ends with current clinical trials, concluding remarks, and future perspectives.	[Uz, Metin; Mallapragada, Surya K.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA; [Altinkaya, Sacide Alsoy] Izmir Inst Technol, Dept Chem Engn, TR-35430 Izmir, Turkey	Mallapragada, SK (reprint author), Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.	suryakm@iastate.edu			US Army Medical Research and Materiel Command [W81XWH-10-1-0806]; Stanley Endowed Chair in Interdisciplinary Engineering	We would like to thank the US Army Medical Research and Materiel Command (Grant number W81XWH-10-1-0806) and the Stanley Endowed Chair in Interdisciplinary Engineering for supporting the work.	Adams JR, 2013, MACROMOL CHEM PHYS, V214, P1321, DOI 10.1002/macp.201300034; Agarwal A, 2005, J CONTROL RELEASE, V103, P245, DOI 10.1016/j.jconrel.2004.11.022; Agarwal A, 2008, CURR TOP MED CHEM, V8, P311; Agarwal A, 2008, BIOMATERIALS, V29, P607, DOI 10.1016/j.biomaterials.2007.10.010; Agarwal A, 2007, J CONTROL RELEASE, V121, P28, DOI 10.1016/j.jconrel.2007.05.008; Agarwal A, 2007, J BIOMED MATER RES A, V81A, P24, DOI 10.1002/jbm.a.30920; Alexander Cameron, 2006, Expert Opin Drug Deliv, V3, P573, DOI 10.1517/17425247.3.5.573; An KK, 2014, INT J MOL SCI, V15, P9067, DOI 10.3390/ijms15059067; BAE YH, 1991, PHARMACEUT RES, V8, P531, DOI 10.1023/A:1015871732706; Ballarin-Gonzalez B, 2012, ADV DRUG DELIVER REV, V64, P1717, DOI 10.1016/j.addr.2012.07.004; Bao HQ, 2010, MACROMOLECULES, V43, P5679, DOI 10.1021/ma100894p; Bartlett DW, 2008, BIOTECHNOL BIOENG, V99, P975, DOI 10.1002/bit.21668; Batrakova EV, 2001, J PHARMACOL EXP THER, V299, P483; Beyerle A, 2010, TOXICOL APPL PHARM, V242, P146, DOI 10.1016/j.taap.2009.10.001; Bora RS, 2012, MOL MED REP, V6, P9, DOI 10.3892/mmr.2012.871; Boulaiz H, 2005, CELL MOL BIOL, V51, P3, DOI 10.1170/T594; Breunig M, 2008, J CONTROL RELEASE, V130, P57, DOI 10.1016/j.jconrel.2008.05.016; Cai XJ, 2011, J MATER CHEM, V21, P14639, DOI 10.1039/c1jm11693b; Calejo MT, 2013, INT J PHARMACEUT, V448, P105, DOI 10.1016/j.ijpharm.2013.03.028; Cantini L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073348; Cardoso AM, 2014, MOL PHARMACEUT, V11, P819, DOI 10.1021/mp400510a; Chen S., 2008, TUMOR TARGETING DRUG; Cheng C, 2012, BIOMATERIALS, V33, P6868, DOI 10.1016/j.biomaterials.2012.06.020; Cheng R, 2011, J CONTROL RELEASE, V152, P2, DOI 10.1016/j.jconrel.2011.01.030; Cho WS, 2010, TOXICOL APPL PHARM, V245, P116, DOI 10.1016/j.taap.2010.02.013; Choi SH, 2006, BIOMACROMOLECULES, V7, P1864, DOI 10.1021/bm060182a; Choi SW, 2010, BIOTECHNOL PROGR, V26, P57, DOI 10.1002/btpr.310; Chong YK, 2007, MACROMOLECULES, V40, P9262, DOI 10.1021/ma071100t; Christie RJ, 2011, BIOMACROMOLECULES, V12, P3174, DOI 10.1021/bm2006714; Coessens V, 2001, PROG POLYM SCI, V26, P337, DOI 10.1016/S0079-6700(01)00003-X                                                   ; Convertine AJ, 2010, BIOMACROMOLECULES, V11, P2904, DOI 10.1021/bm100652w; Convertine AJ, 2009, J CONTROL RELEASE, V133, P221, DOI 10.1016/j.jconrel.2008.10.004; Cooperstein MA, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-19; Cuggino JC, 2011, SOFT MATTER, V7, P11259, DOI 10.1039/c1sm06357j; Davis ME, 2002, CURR OPIN BIOTECH, V13, P128, DOI 10.1016/S0958-1669(02)00294-X; Determan MD, 2005, POLYMER, V46, P6933, DOI 10.1016/j.polymer.2005.05.138; Determan MD, 2007, J BIOMED MATER RES A, V81A, P326, DOI 10.1002/jbm.a.30991; Dong J, 2013, SOFT MATTER, V9, P370, DOI 10.1039/c2sm27116h; Du FS, 2010, SOFT MATTER, V6, P835, DOI 10.1039/b915020j; Elbakry A, 2009, NANO LETT, V9, P2059, DOI 10.1021/nl9003865; Fan B, 2017, THERANOSTICS, V7, P357, DOI 10.7150/thno.16855; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; Fleige E, 2012, ADV DRUG DELIVER REV, V64, P866, DOI 10.1016/j.addr.2012.01.020; Giljohann DA, 2009, J AM CHEM SOC, V131, P2072, DOI 10.1021/ja808719p; Gu X, 2013, SOFT MATTER, V9, P7267, DOI 10.1039/c3sm50904d; Gunasekaran K, 2011, MACROMOL RAPID COMM, V32, P654, DOI 10.1002/marc.201000804; Guo ST, 2011, BIOMATERIALS, V32, P879, DOI 10.1016/j.biomaterials.2010.09.052; Guo X, 2012, ACCOUNTS CHEM RES, V45, P971, DOI 10.1021/ar200151m; Hamaguchi T, 2005, BRIT J CANCER, V92, P1240, DOI 10.1038/sj.bjc.6602479; Harada M, 2011, CANCER SCI, V102, P192, DOI 10.1111/j.1349-7006.2010.01745.x; Hatakeyama H, 2009, J CONTROL RELEASE, V139, P127, DOI 10.1016/j.jconrel.2009.06.008; Heidel JD, 2011, PHARM RES-DORDR, V28, P187, DOI 10.1007/s11095-010-0178-7; Hinton TM, 2012, BIOMATERIALS, V33, P7631, DOI 10.1016/j.biomaterials.2012.06.090; Hoyer J, 2012, ACCOUNTS CHEM RES, V45, P1048, DOI 10.1021/ar2002304; Hu QD, 2016, BIOMATERIALS, V104, P192, DOI 10.1016/j.biomaterials.2016.07.016; Hu-Lieskovan S, 2005, CANCER RES, V65, P8984, DOI 10.1158/0008-5472.CAN-05-0565; Jo YI, 2015, BBA-REV CANCER, V1856, P234, DOI 10.1016/j.bbcan.2015.09.003; Joglekar M, 2013, BIOTECHNOL J, V8, P931, DOI 10.1002/biot.201300073; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/nnm.11.19, 10.2217/NNM.11.19]; Jones CH, 2013, MOL PHARMACEUT, V10, P4082, DOI 10.1021/mp400467x; Nguyen J, 2012, ACCOUNTS CHEM RES, V45, P1153, DOI 10.1021/ar3000162; Jung H, 2015, MACROMOL RES, V23, P449, DOI 10.1007/s13233-015-3060-y; Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3                                                   ; Kato K, 2012, INVEST NEW DRUG, V30, P1621, DOI 10.1007/s10637-011-9709-2; Kelley EG, 2013, CHEM SOC REV, V42, P7057, DOI 10.1039/c3cs35512h; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Klaikherd A, 2009, J AM CHEM SOC, V131, P4830, DOI 10.1021/ja809475a; Konstan MW, 2004, HUM GENE THER, V15, P1255, DOI 10.1089/hum.2004.15.1255                                                        ; Kumar V, 2015, MOL PHARMACEUT, V12, P1289, DOI 10.1021/mp500847s; Kwok A, 2011, NANOMED-NANOTECHNOL, V7, P210, DOI 10.1016/j.nano.2010.07.005; LaFountaine JS, 2015, INT J PHARMACEUT, V494, P180, DOI 10.1016/j.ijpharm.2015.08.029; Lai JP, 2014, POLYMER, V55, P2761, DOI 10.1016/j.polymer.2014.04.036; Lee CC, 2008, BIOCONJUGATE CHEM, V19, P428, DOI 10.1021/bc7001659; Lee ES, 2005, NANO LETT, V5, P325, DOI 10.1021/nl0479987; Lee ES, 2008, J CONTROL RELEASE, V129, P228, DOI 10.1016/j.jconrel.2008.04.024; Lee ES, 2008, J CONTROL RELEASE, V132, P164, DOI 10.1016/j.jconrel.2008.05.003; Lee JS, 2009, NANO LETT, V9, P2402, DOI 10.1021/nl9009793; Lee SH, 2008, J CONTROL RELEASE, V125, P25, DOI 10.1016/j.jconrel.2007.09.011; Lee SH, 2007, BIOCHEM BIOPH RES CO, V357, P511, DOI 10.1016/j.bbrc.2007.03.185; Lee SH, 2008, INT J PHARMACEUT, V364, P94, DOI 10.1016/j.ijpharm.2008.07.027; Lee S, 2012, BIOMACROMOLECULES, V13, P1190, DOI 10.1021/bm300151m; Lee Y, 2012, ADV POLYM SCI, V249, P95, DOI 10.1007/12_2011_129; Li HM, 2015, POLYM CHEM-UK, V6, P1952, DOI 10.1039/c4py01623h; Li J, 2013, J CONTROL RELEASE, V172, P589, DOI 10.1016/j.jconrel.2013.04.010; Lin S, 2008, BIOMACROMOLECULES, V9, P109, DOI 10.1021/bm7008747; Lin WJ, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8110397; Lin YL, 2010, BIOMATERIALS, V31, P7150, DOI 10.1016/j.biomaterials.2010.05.048; Liu J, 2016, J CONTROL RELEASE, V244, P83, DOI 10.1016/j.jconrel.2016.11.014; Liu X, 2010, MACROMOLECULES, V43, P4771, DOI 10.1021/ma902658n; Lundy BB, 2013, BIOCONJUGATE CHEM, V24, P398, DOI [10.1021/bc30044386k, 10.1021/bc300486k]; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Ma XO, 2016, RSC ADV, V6, P13129, DOI 10.1039/c5ra22541h; Ma YZ, 2010, MACROMOL BIOSCI, V10, P202, DOI 10.1002/mabi.200900230; Mao ZW, 2007, BIOMATERIALS, V28, P4488, DOI 10.1016/j.biomaterials.2007.06.033; Matsumoto S, 2009, BIOMACROMOLECULES, V10, P119, DOI 10.1021/bm800985e; Matsumura Y, 2014, JPN J CLIN ONCOL, V44, P515, DOI 10.1093/jjco/hyu046; Matyjaszewski K, 2009, NAT CHEM, V1, P276, DOI [10.1038/nchem.257, 10.1038/NCHEM.257]; Melik-Nubarov NS, 1999, FEBS LETT, V446, P194, DOI 10.1016/S0014-5793(99)00208-2                                                   ; Merkel OM, 2009, J CONTROL RELEASE, V138, P148, DOI 10.1016/j.jconrel.2009.05.016; Moore R, 2015, NUCLEIC ACIDS RES, V43, P1297, DOI 10.1093/nar/gku1326; Vicentini FTMD, 2013, PHARM RES-DORDR, V30, P915, DOI 10.1007/s11095-013-0971-1; Mukherjee S, 1997, PHYSIOL REV, V77, P759; Murthy N, 2003, J CONTROL RELEASE, V89, P365, DOI 10.1016/S0168-3659(03)00099-3; Nelson CE, 2013, ACS NANO, V7, P8870, DOI 10.1021/nn403325f; Oishi M, 2005, J AM CHEM SOC, V127, P1624, DOI 10.1021/ja044941d; Oishi M, 2006, CHEM LETT, V35, P1046, DOI 10.1246/cl.2006.1046                                                            ; Onaca O, 2009, MACROMOL BIOSCI, V9, P129, DOI 10.1002/mabi.200800248; Oupicky D, 2003, MACROMOLECULES, V36, P6863, DOI 10.1021/ma034039a; Patil ML, 2011, ACS NANO, V5, P1877, DOI 10.1021/nn102711d; Pezzoli D, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1523-7; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qian JM, 2015, ACTA BIOMATER, V15, P102, DOI 10.1016/j.actbio.2014.12.018; Qian XM, 2014, BIOMATERIALS, V35, P2322, DOI 10.1016/j.biomaterials.2013.11.039; Ray JG, 2012, MACROMOL RAPID COMM, V33, P819, DOI 10.1002/marc.201100881; Resnier P, 2013, BIOMATERIALS, V34, P6429, DOI 10.1016/j.biomaterials.2013.04.060; Ripoll M, 2016, ACS APPL MATER INTER, V8, P30665, DOI 10.1021/acsami.6b09365; Rizzardo E, 2007, MACROMOL SYMP, V248, P104, DOI 10.1002/masy.200750211; Rozema DB, 2007, P NATL ACAD SCI USA, V104, P12982, DOI 10.1073/pnas.0703778104; Sakurai Y, 2011, BIOMATERIALS, V32, P5733, DOI 10.1016/j.biomaterials.2011.04.047; Sakurai Y, 2009, BIOL PHARM BULL, V32, P928, DOI 10.1248/bpb.32.928                                                              ; Salcher EE, 2010, TOP CURR CHEM, V296, P227, DOI 10.1007/128_2010_69; Sanjoh M, 2012, BIOMACROMOLECULES, V13, P3641, DOI 10.1021/bm301095a; Schilli CM, 2004, MACROMOLECULES, V37, P7861, DOI 10.1021/ma035838w; Scholz C, 2012, J CONTROL RELEASE, V161, P554, DOI 10.1016/j.jconrel.2011.11.014; Schwerdt A, 2008, HUM GENE THER, V19, P1283, DOI [10.1089/hum.2008.064, 10.1089/hgt.2008.064]; Segura T, 2007, BIOCONJUGATE CHEM, V18, P736, DOI 10.1021/bc060284y; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; Shim MS, 2012, ADV DRUG DELIVER REV, V64, P1046, DOI 10.1016/j.addr.2012.01.018; Su J, 2011, J AM CHEM SOC, V133, P11850, DOI 10.1021/ja203077x; Sun TM, 2008, BIOMATERIALS, V29, P4348, DOI 10.1016/j.biomaterials.2008.07.036; Synatschke CV, 2011, BIOMACROMOLECULES, V12, P4247, DOI 10.1021/bm201111d; Tachaboonyakiat W, 2016, J APPL POLYM SCI, V133, DOI 10.1002/app.43852; Takahashi A, 2013, CANCER SCI, V104, P920, DOI 10.1111/cas.12153; Takemoto H, 2010, BIOMATERIALS, V31, P8097, DOI 10.1016/j.biomaterials.2010.07.015; Talelli M, 2011, NANOMEDICINE-UK, V6, P1245, DOI [10.2217/nnm.11.91, 10.2217/NNM.11.91]; Tangsangasaksri M, 2016, BIOMACROMOLECULES, V17, P246, DOI 10.1021/acs.biomac.5b01334; Tortorella S, 2014, J MEMBRANE BIOL, V247, P291, DOI 10.1007/s00232-014-9637-0; Turk M, 2007, J TISSUE ENG REGEN M, V1, P377, DOI 10.1002/term.47; Turk M, 2004, J CONTROL RELEASE, V96, P325, DOI 10.1016/j.jconrel.2004.01.013; Uz M, 2015, RSC ADV, V5, P43515, DOI 10.1039/c5ra06252g; Varkouhi AK, 2012, EUR J PHARM SCI, V45, P459, DOI 10.1016/j.ejps.2011.09.002; Varkouhi AK, 2010, BIOCONJUGATE CHEM, V21, P2339, DOI 10.1021/bc1003789; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; Vicent MJ, 2005, ANGEW CHEM INT EDIT, V44, P4061, DOI 10.1002/anie.200462960; Walker GF, 2005, MOL THER, V11, P418, DOI 10.1016/j.ymthe.2004.11.006; Wang LY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050626; Ward MA, 2011, POLYMERS-BASEL, V3, P1215, DOI 10.3390/polym3031215; Wei H, 2006, BIOMATERIALS, V27, P2028, DOI 10.1016/j.biomaterials.2005.09.028; Wen YT, 2014, ADV FUNCT MATER, V24, P3874, DOI 10.1002/adfm.201303687; Wiethoff CM, 2003, J PHARM SCI, V92, P203, DOI 10.1002/jps.10286; Xin Y, 2012, POLYM CHEM-UK, V3, P3045, DOI 10.1039/c2py20290e; Xu HF, 2009, J MATER CHEM, V19, P4183, DOI 10.1039/b901141b; Yang JH, 2010, BIOMATERIALS, V31, P144, DOI 10.1016/j.biomaterials.2009.09.027; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yin J, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8070268; York AW, 2010, BIOMACROMOLECULES, V11, P505, DOI 10.1021/bm901249n; Yousefi A, 2013, J CONTROL RELEASE, V170, P209, DOI 10.1016/j.jconrel.2013.05.040; Yu HJ, 2011, ACS NANO, V5, P9246, DOI 10.1021/nn203503h; Yu M, 2016, POLYMER, V96, P146, DOI 10.1016/j.polymer.2016.05.010; Yuanpei L., 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/6/065104; Zha LS, 2011, SOFT MATTER, V7, P5908, DOI 10.1039/c0sm01307b; Zhang BQ, 2012, INT J PHARMACEUT, V427, P88, DOI 10.1016/j.ijpharm.2011.10.018; Zhang BQ, 2011, ACS NANO, V5, P129, DOI 10.1021/nn1018939; Zhang BQ, 2011, ACTA BIOMATER, V7, P1570, DOI 10.1016/j.actbio.2010.11.032; Zhang BQ, 2011, ACTA BIOMATER, V7, P1580, DOI 10.1016/j.actbio.2010.11.033; Zhang BQ, 2009, PHARM RES-DORD, V26, P700, DOI 10.1007/s11095-008-9813-y; Zhang Q, 2012, CHEM COMMUN, V48, P7542, DOI 10.1039/c2cc32408c; Zhang TT, 2015, CANCER LETT, V365, P156, DOI 10.1016/j.canlet.2015.05.003; Zhang WQ, 2005, MACROMOLECULES, V38, P5743, DOI 10.1021/ma0509199; Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001; Zhao ZX, 2012, BIOMATERIALS, V33, P6793, DOI 10.1016/j.biomaterials.2012.05.067; Zheng MY, 2012, BIOMATERIALS, V33, P6551, DOI 10.1016/j.biomaterials.2012.05.055; Zhou L, 2013, ACTA BIOMATER, V9, P6019, DOI 10.1016/j.actbio.2012.12.030; Zintchenko A, 2006, BIOCONJUGATE CHEM, V17, P766, DOI 10.1021/bc050292z	174	0	0	28	28	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0884-2914	2044-5326		J MATER RES	J. Mater. Res.	AUG	2017	32	15					2930	2953		10.1557/jmr.2017.116				24	Materials Science, Multidisciplinary	Materials Science	FD7ZQ	WOS:000407745200007					2018-01-05	
J	Lehmann, J; Seebode, C; Emmert, S				Lehmann, Janin; Seebode, Christina; Emmert, Steffen			Research on genodermatoses using novel genome-editing tools	JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT			English	Review							ZINC-FINGER NUCLEASES; DYSTROPHIC EPIDERMOLYSIS-BULLOSA; CORRECTIVE GENE-TRANSFER; STEM-CELL CLONES; SKIN-DISEASE; MOUSE MODEL; T-CELLS; THERAPY; CRISPR/CAS9; CRISPR-CAS9	Genodermatoses comprise a clinically heterogeneous group of mostly devastating disorders affecting the skin. To date, treatment options have in general been limited to symptom relief. However, the recent technical evolution in genome editing has ushered in a new era in the development of causal therapies for rare monogenetic diseases such as genodermatoses. The present review revisits the advantages and drawbacks of engineered nuclease tools currently available: zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), meganucleases, and - the most innovative - clustered regularly interspaced short palindromic repeats (CRISPR)-associated (Cas) nuclease 9 (CRISPR/Cas9) system. A mechanistic overview of the different modes of action of these programmable nucleases as well as their significance for causal therapy of genodermatoses is presented. Remaining limitations and challenges such as efficient delivery and off-target activity are critically discussed, highlighting both the past and future of gene therapy in dermatology.	[Lehmann, Janin; Seebode, Christina; Emmert, Steffen] Univ Med Ctr, Clin Dermatol & Venereol, Rostock, Germany; [Lehmann, Janin; Emmert, Steffen] Univ Med Ctr Goettingen, Clin Dermatol Venereol & Allergol, Gottingen, Germany	Emmert, S (reprint author), Univ Med Ctr Rostock, Dept Dermatol & Venereol, Strempelstr 13, D-18057 Rostock, Germany.	steffen.emmert@med.uni-rostock.de			German Cancer Aid (Deutsche Krebshilfe e.V.) [111377]; Claudia von Schilling Foundation for Breast Cancer Research; FORUN program of the University Medical Center Rostock	We would like to acknowledge and express our appreciation to the German Cancer Aid (Deutsche Krebshilfe e.V., grant number 111377), the Claudia von Schilling Foundation for Breast Cancer Research, and the FORUN program of the University Medical Center Rostock.	Akiyama M, 2005, J CLIN INVEST, V115, P1777, DOI 10.1172/JCI14834; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; Bornert O, 2017, EXP DERMATOL, V26, P3, DOI 10.1111/exd.13141; Bowden PE, 2011, J INVEST DERMATOL, V131, P1403, DOI 10.1038/jid.2011.121; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Cao TY, 2001, J CELL BIOL, V152, P651, DOI 10.1083/jcb.152.3.651; Chamcheu JC, 2012, EXP DERMATOL, V21, P481, DOI 10.1111/j.1600-0625.2012.01534.x; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Cyranoski D, 2016, NATURE, V539, P479, DOI 10.1038/nature.2016.20988; Di WL, 2011, MOL THER, V19, P408, DOI 10.1038/mt.2010.201; Dupuy A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078678; Feramisco JD, 2009, J INVEST DERMATOL, V129, P2628, DOI 10.1038/jid.2009.108; FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949                                                    ; FRIEDMANN T, 1992, NAT GENET, V2, P93, DOI 10.1038/ng1092-93                                                               ; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim JS, 2010, NAT METHODS, V7, P91, DOI 10.1038/nmeth0210-91a; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156; Kohn DB, 2000, PEDIATR RES, V48, P578, DOI 10.1203/00006450-200011000-00002                                                ; Kuschal C, 2013, P NATL ACAD SCI USA, V110, P19483, DOI 10.1073/pnas.1312088110; Lehmann J, 2017, CELL MOL LIFE SCI, V74, P2081, DOI 10.1007/s00018-017-2455-7; Lehmann J, 2014, J DTSCH DERMATOL GES, V12, P867, DOI 10.1111/ddg.12419; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; March O. P., 2017, EXP PHYSL; McDonough PG, 1997, ANN NY ACAD SCI, V816, P378, DOI 10.1111/j.1749-6632.1997.tb52165.x; Bodnar AM, 2013, MOL BIOTECHNOL, V53, P228, DOI 10.1007/s12033-012-9619-3; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Pellagatti A, 2015, ARCH TOXICOL, V89, P1023, DOI 10.1007/s00204-015-1504-y; Perdoni C, 2016, TRANSL RES, V168, P50, DOI 10.1016/j.trsl.2015.05.008; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Petek LM, 2010, MOL THER, V18, P1624, DOI 10.1038/mt.2010.102; Qasim W, 2015, BLOOD, V126, P2046; Ramamoorth Murali, 2015, J Clin Diagn Res, V9, pGE01, DOI 10.7860/JCDR/2015/10443.5394; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roedl D, 2011, J DERMATOL SCI, V61, P194, DOI 10.1016/j.jdermsci.2010.12.004; ROSENBERG SA, 1990, NEW ENGL J MED, V323, P570, DOI 10.1056/NEJM199008303230904; Sebastiano V, 2014, SCI TRANSL MED, V6; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Sibbald B, 2001, CAN MED ASSOC J, V164, P1612; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; VASSAR R, 1991, CELL, V64, P365, DOI 10.1016/0092-8674(91)90645-F; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang L, 2016, INT J MOL SCI, V17; Warrick E, 2012, MOL THER, V20, P798, DOI 10.1038/mt.2011.233; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wu WB, 2017, P NATL ACAD SCI USA, V114, P1660, DOI 10.1073/pnas.1614775114; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825	56	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1610-0379	1610-0387		J DTSCH DERMATOL GES	J. Dtsch. Dermatol. Ges.	AUG	2017	15	8					783	789		10.1111/ddg.13270				7	Dermatology	Dermatology	FC7ET	WOS:000407004700002	28622433				2018-01-05	
J	Nonaka, S; Arai, C; Takayama, M; Matsukura, C; Ezura, H				Nonaka, Satoko; Arai, Chikako; Takayama, Mariko; Matsukura, Chiaki; Ezura, Hiroshi			Efficient increase of gamma-aminobutyric acid (GABA) content in tomato fruits by targeted mutagenesis	SCIENTIFIC REPORTS			English	Article							PLANT GLUTAMATE-DECARBOXYLASE; SPONTANEOUSLY HYPERTENSIVE-RATS; CALMODULIN-BINDING DOMAIN; MICRO-TOM; AUTOINHIBITORY DOMAIN; SOLANUM-LYCOPERSICON; ARABIDOPSIS-THALIANA; STRUCTURAL BASIS; BLOOD-PRESSURE; ACCUMULATION	gamma-Aminobutyric acid (GABA) is a non-proteinogenic amino acid that has hypotensive effects. Tomato (Solanum lycopersicum L.) is among the most widely cultivated and consumed vegetables in the world and contains higher levels of GABA than other major crops. Increasing these levels can further enhance the blood pressure-lowering function of tomato fruit. Glutamate decarboxylase (GAD) is a key enzyme in GABA biosynthesis; it has a C-terminal autoinhibitory domain that regulates enzymatic function, and deleting this domain increases GAD activity. The tomato genome has five GAD genes (SlGAD1-5), of which two (SlGAD2 and SlGAD3) are expressed during tomato fruit development. To increase GABA content in tomato, we deleted the autoinhibitory domain of SlGAD2 and SlGAD3 using clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) 9 technology. Introducing a stop codon immediately before the autoinhibitory domain increased GABA accumulation by 7 to 15 fold while having variable effects on plant and fruit size and yield. This is the first study describing the application of the CRISPR/Cas9 system to increase GABA content in tomato fruits. Our findings provide a basis for the improvement of other types of crop by CRISPR/Cas9-based genetic modification.	[Nonaka, Satoko; Takayama, Mariko; Matsukura, Chiaki; Ezura, Hiroshi] Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan; [Nonaka, Satoko; Matsukura, Chiaki; Ezura, Hiroshi] Univ Tsukuba, Ctr Gene Res, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan; [Arai, Chikako] Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan	Ezura, H (reprint author), Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.; Ezura, H (reprint author), Univ Tsukuba, Ctr Gene Res, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	ezura.hiroshi.fa@u.tsukuba.ac.jp			Cabinet Office, Government of Japan, Cross-ministerial Strategic Innovation Promotion Program, the 'Technologies. For creating next-generation agriculture, forestry and fisheries' grant (funding agency: , NARO); JSPS KAKENHI [15K07253]; Cooperative Research Grant from the Gene Research Centre of the University of Tsukuba	We thank Dr Masaki Endo (NARO, Japan) for the kindly instructions on how to construct the vector for the CRISPR/Cas9 system, and Prof. Puchta Holger and Prof. Seiichi Toki for providing the plasmids (pZD_AtU6_Hpger_Cas9_NPTII and pDeCas9_Kan). This work was supported by the Cabinet Office, Government of Japan, Cross-ministerial Strategic Innovation Promotion Program, the 'Technologies. For creating next-generation agriculture, forestry and fisheries' grant (funding agency: Bio-oriented Technology Research Advancement Institution, NARO) to H.E., a Grant-in-Aid for Scientific Research (C) (Grant Number 15K07253) from JSPS KAKENHI to S.N., and a Cooperative Research Grant from the Gene Research Centre of the University of Tsukuba to H.E. and S.N.	Akama K, 2007, J EXP BOT, V58, P2699, DOI 10.1093/ixb/erm120; Akihiro T, 2008, PLANT CELL PHYSIOL, V49, P1378, DOI 10.1093/pcp/pcn113; Aoki H, 2003, BIOSCI BIOTECH BIOCH, V67, P1018, DOI 10.1271/bbb.67.1018; ARAZI T, 1995, PLANT PHYSIOL, V108, P551, DOI 10.1104/pp.108.2.551; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; BAUM G, 1993, J BIOL CHEM, V268, P19610; Baum G, 1996, EMBO J, V15, P2988; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Bown AW, 1997, PLANT PHYSIOL, V115, P1; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777; ELLIOTT KAC, 1959, J PHYSIOL-LONDON, V146, P70, DOI 10.1113/jphysiol.1959.sp006178                                                  ; Fait A, 2011, PLANT PHYSIOL, V157, P1026, DOI 10.1104/pp.111.179986; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Fukuwatari Y, 2001, E MED, V17, P1; Gut H, 2009, J MOL BIOL, V392, P334, DOI 10.1016/j.jmb.2009.06.080; Inoue K, 2003, EUR J CLIN NUTR, V57, P490, DOI 10.1038/sj.ejcn.1601555; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; JAKOBY WB, 1962, METHOD ENZYMOL, V5, P765, DOI 10.1016/S0076-6879(62)05311-2; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kazami Daiji, 2002, Nippon Shokuhin Kagaku Kogaku Kaishi, V49, P409; Koike S, 2013, PLANT CELL PHYSIOL, V54, P793, DOI 10.1093/pcp/pct035; Matsumoto Y., 1997, EHIME KOUGI KENKYU H, V35, P97; Mikami M, 2015, PLANT MOL BIOL, V88, P561, DOI 10.1007/s11103-015-0342-x; Okabe Y, 2011, PLANT CELL PHYSIOL, V52, P1994, DOI 10.1093/pcp/pcr134; OMORI M, 1987, NIPPON NOGEIK KAISHI, V61, P1449; Pan C., 2016, NAT SCI REP, V6, P24765, DOI DOI 10.1038/SREP24765; Park KB, 2007, BIORESOURCE TECHNOL, V98, P1675, DOI 10.1016/j.biortech.2006.06.006; Renault H, 2011, PLANT CELL PHYSIOL, V52, P894, DOI 10.1093/pcp/pcr041; Rolin D, 2000, AUST J PLANT PHYSIOL, V27, P61, DOI 10.1071/PP99051; SAIKUSA T, 1994, J AGR FOOD CHEM, V42, P1122, DOI 10.1021/jf00041a015; Saito T, 2011, PLANT CELL PHYSIOL, V52, P283, DOI 10.1093/pcp/pcr004; Sun HJ, 2006, PLANT CELL PHYSIOL, V47, P426, DOI 10.1093/pcp/pci251; TAKAHASHI H, 1961, JPN J PHYSIOL, V11, P89; TAKAHASHI HIDEHIKO, 1955, JAPANESE JOUR PHYSIOL, V5, P334; Takayama M, 2017, PLANT CELL REP, V36, P103, DOI 10.1007/s00299-016-2061-4; Takayama M, 2015, PLANT CELL PHYSIOL, V56, P1533, DOI 10.1093/pcp/pcv075; Trobacher CP, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-144; TSUSHIDA T, 1987, AGR BIOL CHEM TOKYO, V51, P2865; Yamakoshi J, 2007, BIOSCI BIOTECH BIOCH, V71, P165, DOI 10.1271/bbb.60424; Yap KL, 2003, J MOL BIOL, V328, P193, DOI 10.1016/S0022-2836(03)00271-7; Yuan T, 1998, J BIOL CHEM, V273, P30328, DOI 10.1074/jbc.273.46.30328; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5; Zik M, 2006, BBA-PROTEINS PROTEOM, V1764, P872, DOI 10.1016/j.bbapap.2006.02.007	48	0	0	25	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 1	2017	7								7057	10.1038/s41598-017-06400-y				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FC3UF	WOS:000406764200089	28765632	gold			2018-01-05	
J	McMillan, BJ; Zimmerman, B; Egan, ED; Lofgren, M; Xu, X; Hesser, A; Blacklow, SC				McMillan, Brian J.; Zimmerman, Brandon; Egan, Emily D.; Lofgren, Michael; Xu, Xiang; Hesser, Anthony; Blacklow, Stephen C.			Structure of human POFUT1, its requirement in ligand-independent oncogenic Notch signaling, and functional effects of Dowling-Degos mutations	GLYCOBIOLOGY			English	Article						Dowling-Degos disease; GDP-fucose; notch signaling; POFUT1; T-ALL; X-ray crystallography	DELTA-LIKE 4; PROTEIN O-FUCOSYL-TRANSFERASE-1; LYMPHOBLASTIC-LEUKEMIA; REGULATORY REGION; O-FUCOSE; GLYCOSYLATION; BINDING; FRINGE; DOMAIN; RECEPTOR	Protein O-fucosyltransferase-1 (POFUT1), which transfers fucose residues to acceptor sites on serine and threonine residues of epidermal growth factor-like repeats of recipient proteins, is essential for Notch signal transduction in mammals. Here, we examine the consequences of POFUT1 loss on the oncogenic signaling associated with certain leukemia-associated mutations of human Notch1, report the structures of human POFUT1 in free and GDP-fucose bound states, and assess the effects of Dowling-Degos mutations on human POFUT1 function. CRISPR-mediated knockout of POFUT1 in U2OS cells suppresses both normal Notch1 signaling, and the ligand-independent signaling associated with leukemogenic mutations of Notch1. Normal and oncogenic signaling are rescued by wild-type POFUT1 but rescue is impaired by an active-site R240A mutation. The overall structure of the human enzyme closely resembles that of the Caenorhabditis elegans protein, with an overall backbone RMSD of 0.93 angstrom, despite primary sequence identity of only 39% in the mature protein. GDP-fucose binding to the human enzyme induces limited backbone conformational movement, though the side chains of R43 and D244 reorient to make direct contact with the fucose moiety in the complex. The reported Dowling-Degos mutations of POFUT1, except for M262T, fail to rescue Notch1 signaling efficiently in the CRISPR-engineered POFUT1(-/-) background. Together, these studies identify POFUT1 as a potential target for cancers driven by Notch1 mutations and provide a structural roadmap for its inhibition.	[McMillan, Brian J.; Zimmerman, Brandon; Egan, Emily D.; Lofgren, Michael; Xu, Xiang; Hesser, Anthony; Blacklow, Stephen C.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Blacklow, Stephen C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA	Blacklow, SC (reprint author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Blacklow, SC (reprint author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.	blacklow@hms.harvard.edu			National Institutes of Health [CA092433]; Leukemia and Lymphoma Society	National Institutes of Health [CA092433 to S.C.B.], and a Leukemia and Lymphoma Society Postdoctoral Fellowship (to M.L.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrawes MB, 2013, J BIOL CHEM, V288, P25477, DOI 10.1074/jbc.M113.454850; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Basmanav FB, 2015, J INVEST DERMATOL, V135, P615, DOI 10.1038/jid.2014.406; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Cordle J, 2008, J BIOL CHEM, V283, P11785, DOI 10.1074/jbc.M708424200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ge CH, 2008, P NATL ACAD SCI USA, V105, P1539, DOI 10.1073/pnas.0702846105; Ge CH, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-48; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gordon WR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006613; Gordon WR, 2009, BLOOD, V113, P4381, DOI 10.1182/blood-2008-08-174748; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochems.73.011303.074043; Hicks C, 2000, NAT CELL BIOL, V2, P515; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lira-Navarrete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025365; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Okamura Y, 2008, MECH DEVELOP, V125, P663, DOI 10.1016/j.mod.2008.04.007; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Rana NA, 2011, CURR OPIN STRUC BIOL, V21, P583, DOI 10.1016/j.sbi.2011.08.008; Roti G, 2013, CANCER CELL, V23, P390, DOI 10.1016/j.ccr.2013.01.015; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Stanley P, 2010, CURR TOP DEV BIOL, V92, P131, DOI 10.1016/S0070-2153(10)92004-8; Takeuchi H, 2014, BIOCHEM BIOPH RES CO, V453, P235, DOI 10.1016/j.bbrc.2014.05.115; Taylor P, 2014, P NATL ACAD SCI USA, V111, P7290, DOI 10.1073/pnas.1319683111; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Xu X, 2015, STRUCTURE, V23, P1227, DOI 10.1016/j.str.2015.05.001; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19162, DOI 10.1073/pnas.0902834106; ZIMBERSTROBL U, 1994, EMBO J, V13, P4973	38	0	0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	AUG	2017	27	8					777	786		10.1093/glycob/cwx020				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FC9FO	WOS:000407146700010					2018-01-05	
J	Hay, EA; Knowles, C; Kolb, A; MacKenzie, A				Hay, Elizabeth A.; Knowles, Christopher; Kolb, Andreas; MacKenzie, Alasdair			Using the CRISPR/Cas9 system to understand neuropeptide biology and regulation	NEUROPEPTIDES			English	Review						Genome editing; Non-homologous end joining; Homology-directed repair; Off-target effects	HOMOLOGY-DIRECTED REPAIR; STRAND BREAK REPAIR; SEQUENCE-SPECIFIC CONTROL; EMBRYONIC STEM-CELLS; MAMMALIAN-CELLS; GENE-EXPRESSION; GENOME; DNA; RECOMBINATION; RNA	Neuropeptides and their receptors play a role in physiological responses such as appetite, stress and inflammatory pain. With neuropeptides having such diverse and important physiological roles, knocking-out the genes encoding them, their receptors, parts of their regulatory sequences, or reproducing disease associated polymorphic variants are important steps in studying neuropeptides and how they may contribute to disease. Previously, knock-outs were generated using methods such as targeted homologous recombination in embryonic stem cells but this method is costly and time-consuming. The CRISPR/Cas9 system has rapidly taken over the genome editing field and will advance our understanding of neuropeptide genes and their regulation. With CRISPR/Cas9 technology, the time and costs involved in producing transgenic animal models, is greatly reduced. In this review, we describe how the system can be used to manipulate genomic sequences by "knock-out" or "knock in" mutations in cell lines or in animal models. We also discuss the specificity of the system and methods to limit off-target effects. When combined with the availability of genome sequences, CRISPR/Cas9 directed genome editing in vitro and in vivo, promises to provide a deeper understanding of the biology of the neuropeptides in health and disease than has ever been available before. (C) 2016 The Authors. Published by Elsevier Ltd.	[Hay, Elizabeth A.; Knowles, Christopher; Kolb, Andreas; MacKenzie, Alasdair] Univ Aberdeen, Aberdeen, Scotland	Hay, EA (reprint author), Univ Aberdeen, Aberdeen, Scotland.	elizabeth.hay@abdn.ac.uk			Wellcome Trust ISSF [105625/Z/14/Z]; Medical Research Scotland [PhD-719-2013]; GW Pharmaceuticals [PhD-719-2013 - S.5242.001]; BBSRC [BB/J012343/1]	Funding was provided by a Wellcome Trust ISSF starting grant (105625/Z/14/Z), Medical Research Scotland (PhD-719-2013), GW Pharmaceuticals (PhD-719-2013 - S.5242.001) and the BBSRC (BB/J012343/1).	ADAIR GM, 1989, P NATL ACAD SCI USA, V86, P4574, DOI 10.1073/pnas.86.12.4574; Armstrong GAB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150188; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brenneman M, 1996, P NATL ACAD SCI USA, V93, P3608, DOI 10.1073/pnas.93.8.3608; Brown AJ, 2013, NAT METHODS, V10, P638, DOI 10.1038/nmeth.2516; Capecchi M. R., 2005, NAT REV GENET, V6; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/NMETH.1648, 10.1038/nmeth.1648]; Chu V, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0234-4; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Doyle A, 2012, TRANSGENIC RES, V21, P327, DOI 10.1007/s11248-011-9537-3; Hay EA, 2016, NEUROPEPTIDES, V64, P101; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Horii T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04513; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Lang R, 2015, PHARMACOL REV, V67, P118, DOI 10.1124/pr.112.006536; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lee J. H., 2015, SCI REP UK, V5; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; lnui M., 2014, SCI REP, V4, P5396; Ma YW, 2014, FEBS J, V281, P5186, DOI 10.1111/febs.13110; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsunami K, 2008, TRANSPL P, V40, P2776, DOI 10.1016/j.transproceed.2008.08.023; Park K.-E., 2016, INT J MOL SCI, V17; Perez C, 2005, BIOTECHNIQUES, V39, P109, DOI 10.2144/05391GT01; Picciotto MR, 2010, BRAIN RES, V1314, P206, DOI 10.1016/j.brainres.2009.08.033; Pinter E, 2014, BRIT J CLIN PHARMACO, V77, P5, DOI 10.1111/bcp.12097; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Riballo E, 2009, NUCLEIC ACIDS RES, V37, P482, DOI 10.1093/nar/gkn957; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rong ZL, 2014, PROTEIN CELL, V5, P258, DOI 10.1007/s13238-014-0032-5; Sargent RG, 1997, MOL CELL BIOL, V17, P267, DOI 10.1128/MCB.17.1.267                                                            ; Skames W. C, 2015, GENOME BIOL, V16, P109; Slaymaker l. M, 2015, SCIENCE; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tichy ED, 2010, STEM CELLS DEV, V19, P1699, DOI 10.1089/scd.2010.0058; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xi LH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0791-1; Yang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21264; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	56	0	0	14	14	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4179	1532-2785		NEUROPEPTIDES	Neuropeptides	AUG	2017	64						19	25		10.1016/j.npep.2016.11.010				7	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	FD2ZQ	WOS:000407403700004	28038787	gold			2018-01-05	
J	Hay, EA; Khalaf, AR; Marini, P; Brown, A; Heath, K; Sheppard, D; MacKenzie, A				Hay, Elizabeth Anne; Khalaf, Abdulla Razak; Marini, Pietro; Brown, Andrew; Heath, Karyn; Sheppard, Darrin; MacKenzie, Alasdair			An analysis of possible off target effects following CAS9/CRISPR targeted deletions of neuropeptide gene enhancers from the mouse genome	NEUROPEPTIDES			English	Article						Neuropeptide, enhancer; CAS9/CRISPR; Off-target effects; Transgenic mouse; CAS9 mRNA; gRNA; 1-cell mouse embryo; Cytoplasmic microinjection; CRISPR design tool; UCSC browser BLAT; PCR; Sanger sequencing	SPECIFICITY; NUCLEASES	We have successfully used comparative genomics to identify putative regulatory elements within the human genome that contribute to the tissue specific expression of neuropeptides such as galanin and receptors such as CBI. However, a previous inability to rapidly delete these elements from the mouse genome has prevented optimal assessment of their function in-vivo. This has been solved using CAS9/CRISPR genome editing technology which uses a bacterial endonuclease called CAS9 that, in combination with specifically designed guide RNA (gRNA) molecules, cuts specific regions of the mouse genome. However, reports of "off target" effects, whereby the CAS9 endonuclease is able to cut sites other than those targeted, limits the appeal of this technology. We used cytoplasmic microinjection of gRNA and CAS9 mRNA into 1-cell mouse embryos to rapidly generate enhancer knockout mouse lines. The current study describes our analysis of the genomes of these enhancer knockout lines to detect possible off-target effects. Bioinformatic analysis was used to identify the most likely putative off-target sites and to design PCR primers that would amplify these sequences from genomic DNA of founder enhancer deletion mouse lines. Amplified DNA was then sequenced and blasted against the mouse genome sequence to detect off-target effects. Using this approach we were unable to detect any evidence of off-target effects in the genomes of three founder lines using any of the four gRNAs used in the analysis. This study suggests that the problem of off-target effects in transgenic mice have been exaggerated and that CAS9/CRISPR represents a highly effective and accurate method of deleting putative neuropeptide gene enhancer sequences from the mouse genome. (C) 2016 The Authors. Published by Elsevier Ltd.	[Hay, Elizabeth Anne; Khalaf, Abdulla Razak; Marini, Pietro; Brown, Andrew; Heath, Karyn; Sheppard, Darrin; MacKenzie, Alasdair] Univ Aberdeen, Inst Med Sci, Sch Med Med Sci & Nutr, Foresterhill, Aberdeen AB25 2ZD, Scotland	MacKenzie, A (reprint author), Univ Aberdeen, Inst Med Sci, Sch Med Med Sci & Nutr, Foresterhill, Aberdeen AB25 2ZD, Scotland.	mbi167@abdn.ac.uk	Marini, Pietro/C-5746-2013	Marini, Pietro/0000-0002-8456-4473	Wellcome Trust ISSF starting grant [105625/Z/14/Z]; Medical Research Scotland [PhD-719-2013]; GW Pharmaceuticals [PhD-719-2013 - S.5242.001]	These studies were funded by a Wellcome Trust (105625/Z/14/Z) ISSF starting grant, Medical Research Scotland (PhD-719-2013) and GW Pharmaceuticals (PhD-719-2013 - S.5242.001).	Chu V, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0234-4; Davidson S, 2011, NEUROPSYCHOPHARMACOL, V36, P2211, DOI 10.1038/npp.2011.93; Freimann K, 2015, EXPERT OPIN THER TAR, V19, P1665, DOI 10.1517/14728222.2015.1072513; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Harms D.W., 2014, CURR PROTOC HUM GENE, V83, p[15, 1]; Horii T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04513; Lang R., 2015, PHARMACOL REV, V67, P118; Jamal M, 2016, CURR ISSUES MOL BIOL, V20, P1; Lin S., 2015, ELIFE, V3; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Nagy A. G. M., 2003, MANIPULATING MOUSE E; Peng RX, 2016, FEBS J, V283, P1218, DOI 10.1111/febs.13586; Pinter E, 2014, BRIT J CLIN PHARMACO, V77, P5, DOI 10.1111/bcp.12097; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shanley L, 2010, NEUROSIGNALS, V18, P173, DOI 10.1159/000322010; Shanley L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-10; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Singh P., 2014, GENETICS; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37	20	1	1	8	8	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4179	1532-2785		NEUROPEPTIDES	Neuropeptides	AUG	2017	64						101	107		10.1016/j.npep.2016.11.003				7	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	FD2ZQ	WOS:000407403700013	27866656	gold			2018-01-05	
J	Mavlyutov, TA; Yang, H; Epstein, ML; Ruoho, AE; Yang, J; Guo, LW				Mavlyutov, Timur A.; Yang, Huan; Epstein, Miles L.; Ruoho, Arnold E.; Yang, Jay; Guo, Lian-Wang			APEX2-enhanced electron microscopy distinguishes sigma-1 receptor localization in the nucleoplasmic reticulum	ONCOTARGET			English	Article						the sigma-1 receptor; APEX2-enhanced electron microscopy; nucleoplasmic reticulum; nuclear envelope; serial sectioning	AMYOTROPHIC-LATERAL-SCLEROSIS; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; ALZHEIMERS-DISEASE; C-TERMINALS; CELL-DEATH; MICE; ALS; PURIFICATION; FLUVOXAMINE	The sigma-1 receptor (Sig1R) is an endoplasmic reticulum chaperonin that is attracting tremendous interest as a potential anti-neurodegenerative target. While this membrane protein is known to reside in the inner nuclear envelope (NE) and influences transcription, apparent Sig1R presence in the nucleoplasm is often observed, seemingly contradicting its NE localization. We addressed this confounding issue by applying an antibody-free approach of electron microscopy (EM) to define Sig1R nuclear localization. We expressed APEX2 peroxidase fused to Sig1R-GFP in a Sig1R-null NSC34 neuronal cell line generated with CRISPR-Cas9. APEX2-catalyzed gold/silver precipitation markedly improved EM clarity and confirmed an apparent intra-nuclear presence of Sig1R. However, serial sectioning combined with APEX2-enhanced EM revealed that Sig1R actually resided in the nucleoplasmic reticulum (NR), a specialized nuclear compartment formed via NE invagination into the nucleoplasm. NR cross-sections also indicated Sig1R in ring-shaped NR membranes. Thus, this study distinguishes Sig1R in the NR which could otherwise appear localized in the nucleoplasm if detected with low-resolution methods. Our finding is important for uncovering potential Sig1R regulations in the nucleus.	[Mavlyutov, Timur A.; Yang, Huan; Guo, Lian-Wang] Univ Wisconsin, Wisconsin Inst Med Res, Dept Surg, Madison, WI 53705 USA; [Epstein, Miles L.; Ruoho, Arnold E.] Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA; [Yang, Jay] Univ Wisconsin, Wisconsin Inst Med Res, Dept Anesthesiol, Madison, WI 53705 USA; [Guo, Lian-Wang] Univ Wisconsin, McPherson Eye Res Inst, Madison, WI 53705 USA; [Guo, Lian-Wang] Ohio State Univ, Davis Heart & Lung Res Inst, Dept Surg, Columbus, OH 43210 USA; [Guo, Lian-Wang] Ohio State Univ, Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, Columbus, OH 43210 USA	Guo, LW (reprint author), Univ Wisconsin, Wisconsin Inst Med Res, Dept Surg, Madison, WI 53705 USA.; Guo, LW (reprint author), Univ Wisconsin, McPherson Eye Res Inst, Madison, WI 53705 USA.; Guo, LW (reprint author), Ohio State Univ, Davis Heart & Lung Res Inst, Dept Surg, Columbus, OH 43210 USA.; Guo, LW (reprint author), Ohio State Univ, Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	Lianwang.Guo@osumc.edu			National Eye Institute [R01EY022678]; Morgridge Institute for Research; James Christenson Estate Macular Degeneration Research Award; NIGMS [R01GM107054]; NEI [P30EY016665]	This work was supported by the National Eye Institute grant R01EY022678 and the Morgridge Institute for Research & the James Christenson Estate Macular Degeneration Research Award (to L-W Guo), NIGMS R01GM107054 (to JY), and the NEI grant P30EY016665 (to the University of Wisconsin Vision Core).	Al-Saif A, 2011, ANN NEUROL, V70, P913, DOI 10.1002/ana.22534; Chu UB, 2015, EBIOMEDICINE, V2, P1806, DOI 10.1016/j.ebiom.2015.10.017; Collina S, 2013, EXPERT OPIN THER PAT, V23, P597, DOI 10.1517/13543776.2013.769522; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Francardo V, 2014, BRAIN, V137, P1998, DOI 10.1093/brain/awu107; Frost B, 2016, NUCLEUS-PHILA, V7, P275, DOI 10.1080/19491034.2016.1183859; Furuse T, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-11; Ha YJ, 2014, CELL TISSUE RES, V356, P15, DOI 10.1007/s00441-013-1774-8; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072                                                         ; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hedskog L, 2013, P NATL ACAD SCI USA, V110, P7916, DOI 10.1073/pnas.1300677110; Ishikawa M, 2007, BIOL PSYCHIAT, V62, P878, DOI 10.1016/j.biopsych.2007.04.001; Jiang GL, 2006, INVEST OPHTH VIS SCI, V47, P5576, DOI 10.1137/iovs.06-0608; Kourrich S, 2013, CELL, V152, P236, DOI 10.1016/j.cell.2012.12.004; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Lee SY, 2016, CELL REP, V15, P1837, DOI 10.1016/j.celrep.2016.04.064; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Matsumoto RR, 2014, ADV PHARMACOL, V69, P323, DOI 10.1016/B978-0-12-420118-7.00009-3; Mavlyutov TA, 2013, NEUROSCIENCE, V240, P129, DOI 10.1016/j.neuroscience.2013.02.035; Mavlyutov TA, 2012, NEUROSCIENCE, V206, P60, DOI 10.1016/j.neuroscience.2011.12.040; Mavlyutov TA, 2010, NEUROSCIENCE, V167, P247, DOI 10.1016/j.neuroscience.2010.02.022; Mavlyutov TA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10689; Mavlyutov TA, 2015, J PHARMACOL SCI, V127, P10, DOI 10.1016/j.jphs.2014.12.013; Mavlyutov TA, 2011, MOL VIS, V17, P1034; Miki Y, 2015, NEUROBIOL DIS, V74, P25, DOI 10.1016/j.nbd.2014.11.005; Miki Y, 2014, NEUROPATHOLOGY, V34, P148, DOI 10.1111/neup.12080; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Ramachandran S, 2007, PROTEIN EXPRES PURIF, V51, P283, DOI 10.1016/j.pep.2006.07.019; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmidt HR, 2016, NATURE, V532, P527, DOI 10.1038/nature17391; Shimazawa M, 2015, EXP EYE RES, V132, P64, DOI 10.1016/j.exer.2015.01.017; Smith SB, 2008, INVEST OPHTH VIS SCI, V49, P4154, DOI 10.1167/iovs.08-1824; Su TP, 2016, TRENDS PHARMACOL SCI, V37, P262, DOI 10.1016/j.tips.2016.01.003; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Tsai SA, 2015, P NATL ACAD SCI US; Urfer R, 2014, STROKE, V45, P3304, DOI 10.1161/STROKEAHA.114.005835; Wang J, 2016, P NATL ACAD SCI USA, V113, pE3764, DOI 10.1073/pnas.1521749113; Watanabe S, 2016, EMBO MOL MED, V8, P1421, DOI 10.15252/emmm.201606403; Wavre-Shapton ST, 2015, HUM MOL GENET, V24, P7060, DOI 10.1093/hmg/ddv406	40	2	2	4	4	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	AUG 1	2017	8	31					51317	51330		10.18632/oncotarget.17906				14	Oncology; Cell Biology	Oncology; Cell Biology	FC3CZ	WOS:000406717200091	28881650	green_published			2018-01-05	
J	Fu, BXH; Wainberg, M; Kundaje, A; Fire, AZ				Fu, Becky Xu Hua; Wainberg, Michael; Kundaje, Anshul; Fire, Andrew Z.			High-Throughput Characterization of Cascade type I-E CRISPR Guide Efficacy Reveals Unexpected PAM Diversity and Target Sequence Preferences	GENETICS			English	Article						CRISPR-Cas; CRISPR-interference; Cascade; guide efficacy; phage	ESCHERICHIA-COLI; CAS SYSTEMS; SPACER ACQUISITION; ENDONUCLEASE CAS9; STRUCTURAL BASIS; SEED SEQUENCE; DNA TARGET; RNA; ADAPTATION; IMMUNITY	Interactions between Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) RNAs and CRISPR-associated (Cas) proteins form an RNA-guided adaptive immune system in prokaryotes. The adaptive immune system utilizes segments of the genetic material of invasive foreign elements in the CRISPR locus. The loci are transcribed and processed to produce small CRISPR RNAs (crRNAs), with degradation of invading genetic material directed by a combination of complementarity between RNA and DNA and in some cases recognition of adjacent motifs called PAMs (Protospacer Adjacent Motifs). Here we describe a general, high-throughput procedure to test the efficacy of thousands of targets, applying this to the Escherichia coli type I-E Cascade (CRISPR-associated complex for antiviral defense) system. These studies were followed with reciprocal experiments in which the consequence of CRISPR activity was survival in the presence of a lytic phage. From the combined analysis of the Cascade system, we found that (i) type I-E Cascade PAM recognition is more expansive than previously reported, with at least 22 distinct PAMs, with many of the noncanonical PAMs having CRISPR-interference abilities similar to the canonical PAMs; (ii) PAM positioning appears precise, with no evidence for tolerance to PAM slippage in interference; and (iii) while increased guanine-cytosine (GC) content in the spacer is associated with higher CRISPR-interference efficiency, high GC content (>62.5%) decreases CRISPR-interference efficiency. Our findings provide a comprehensive functional profile of Cascade type I-E interference requirements and a method to assay spacer efficacy that can be applied to other CRISPR-Cas systems.	[Fu, Becky Xu Hua; Kundaje, Anshul; Fire, Andrew Z.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Fire, Andrew Z.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Wainberg, Michael; Kundaje, Anshul] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	Fu, BXH; Kundaje, A; Fire, AZ (reprint author), Stanford Univ, 300 Pasteur Dr,Rm L235,Mail Stop M5324, Stanford, CA 94305 USA.	xuhua@stanford.edu; akundaje@stanford.edu; afire@stanford.edu			Natural Sciences and Engineering Research Council of Canada [PGSD3-476082-2015]; Alfred Sloan Foundation Fellowship; National Science Foundation;  [R01GM37706];  [T32GM00779]	We thank Allan Campbell, Alice Del Campillo-Campbell, Armin Dale Kaiser, Michael Bassik, Gavin Sherlock, Stuart Kim, Joe Davis, Massa Shoura, Stan Cohen, and colleagues in our laboratories for their help and suggestions. This work was supported by grants R01GM37706 (A.Z.F.) and T32GM00779 (B.X.H.F.), National Science Foundation Graduate Fellowship (B.X.H.F.), Natural Sciences and Engineering Research Council of Canada PGSD3-476082-2015 (M.W.), and an Alfred Sloan Foundation Fellowship (A.K.).	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2015, NUCLEIC ACIDS RES, V43, P530, DOI 10.1093/nar/gku1285; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Box AM, 2016, J BACTERIOL, V198, P578, DOI 10.1128/JB.00747-15; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Caliando BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7989; CAMPBELL A, 1963, J BACTERIOL, V85, P1202; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Chang YZ, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0594-4; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478                                                                 ; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Jagadeesh KA, 2016, NAT GENET, V48, P1581, DOI 10.1038/ng.3703; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Kiro R, 2014, RNA BIOL, V11, P42, DOI 10.4161/rna.27766; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Maniv I, 2016, J BACTERIOL, V198, P941, DOI 10.1128/JB.00897-15; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rath D, 2015, NUCLEIC ACIDS RES, V43, P237, DOI 10.1093/nar/gku1257; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Staals RHJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12853; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Washburn RS, 2015, BIOMOLECULES, V5, P1063, DOI 10.3390/biom5021063; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wong N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0784-0; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	61	0	0	8	8	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	AUG	2017	206	4					1727	1738		10.1534/genetics.117.202580				12	Genetics & Heredity	Genetics & Heredity	FC6LR	WOS:000406952400002	28634160				2018-01-05	
J	Porath, HT; Schaffer, AA; Kaniewska, P; Alon, S; Eisenberg, E; Rosenthal, J; Levanon, EY; Levy, O				Porath, Hagit T.; Schaffer, Amos A.; Kaniewska, Paulina; Alon, Shahar; Eisenberg, Eli; Rosenthal, Joshua; Levanon, Erez Y.; Levy, Oren			A-to-I RNA Editing in the Earliest-Diverging Eumetazoan Phyla	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						RNA editing; ADAR; evolution; coral	CORAL ACROPORA-MILLEPORA; ELEGANS MESSENGER-RNA; GENOME-WIDE ANALYSIS; LARGE GENE LISTS; C. ELEGANS; ADENOSINE-DEAMINASE; NONCODING REGIONS; ENZYME; RECEPTOR; SITES	The highly conserved ADAR enzymes, found in all multicellular metazoans, catalyze the editing of mRNA transcripts by the deamination of adenosines to inosines. This type of editing has two general outcomes: site specific editing, which frequently leads to recoding, and clustered editing, which is usually found in transcribed genomic repeats. Here, for the first time, we looked for both editing of isolated sites and clustered, non-specific sites in a basal metazoan, the coral Acropora millepora during spawning event, in order to reveal its editing pattern. We found that the coral editome resembles the mammalian one: it contains more than 500,000 sites, virtually all of which are clustered in non-coding regions that are enriched for predicted dsRNA structures. RNA editing levels were increased during spawning and increased further still in newly released gametes. This may suggest that editing plays a role in introducing variability in coral gametes.	[Porath, Hagit T.; Schaffer, Amos A.; Levanon, Erez Y.; Levy, Oren] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Kaniewska, Paulina] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia; [Alon, Shahar; Eisenberg, Eli] Tel Aviv Univ, Raymond & Beverly Sackler Sch Phys & Astron, Tel Aviv, Israel; [Alon, Shahar; Eisenberg, Eli] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Rosenthal, Joshua] Marine Biol Lab, Eugene Bell Ctr Regenerat Biol & Tissue Engn, Woods Hole, MA 02543 USA; [Levanon, Erez Y.; Levy, Oren] MIT, Media Lab, Cambridge, MA 02139 USA; [Levanon, Erez Y.; Levy, Oren] MIT, McGovern Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Levanon, EY; Levy, O (reprint author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.; Levanon, EY; Levy, O (reprint author), MIT, Media Lab, Cambridge, MA 02139 USA.; Levanon, EY; Levy, O (reprint author), MIT, McGovern Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	Erez.levanon@biu.ac.il; Oren.Levy@biu.ac.il	Eisenberg, Eli/D-2587-2009	Eisenberg, Eli/0000-0001-8681-3202; Levanon, Erez/0000-0002-3641-4198	Australian Research Council; European Research Council [311257]; I-CORE Program of the Planning and Budgeting Committee in Israel [41/11, 1796/12]; Israel Science Foundation [1380/14]	We thank Heron Island Research Station staff for their help during our spawning experiments. This work was supported by the Australian Research Council (to PK), the European Research Council (grant 311257), the I-CORE Program of the Planning and Budgeting Committee in Israel (grants 41/11 and 1796/12), and the Israel Science Foundation (1380/14). The sequencing data of the one sample coral was deposited in the Sequence Read Archive (SRA), under accession number SRP080785.	Albertin CB, 2015, NATURE, V524, P220, DOI 10.1038/nature14668; Alon S, 2015, ELIFE, V4, DOI 10.7554/eLife.05198; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bazak L, 2014, NUCLEIC ACIDS RES, V42, P6876, DOI 10.1093/nar/gku414; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garrett S, 2012, SCIENCE, V335, P848, DOI 10.1126/science.1212795; Goldstein B, 2016, GENOME RES; Grice LF, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0279-3; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Isomura N, 2013, SCI REP, V3, P698; Kaniewska P, 2015, ELIFE, V4, DOI 10.7554/eLife.09991; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kohn AB, 2015, INTEGR COMP BIOL, V55, P1111, DOI 10.1093/icb/icv065; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5943; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; McCormick RF, 2015, G3-GENES GENOM GENET, V5, P655, DOI 10.1534/g3.115.017012; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Nejepinska J, 2012, NUCLEIC ACIDS RES, V40, P399, DOI 10.1093/nar/gkr702; O'Connell MA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005687; OCONNELL MA, 1995, MOL CELL BIOL, V15, P1389; Padilla-Gamino JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038440; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Picardi E, 2013, BIOINFORMATICS, V29, P1813, DOI 10.1093/bioinformatics/btt287; Pinto Y, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r5; Porath HT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5726; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]; Rieder LE, 2015, BMC BIOL, V13, DOI 10.1186/s12915-014-0111-3; Rosenberg Y, 2017, MOL ECOL, V26, P2698, DOI 10.1111/mec.14062; Rosenthal JJC, 2002, NEURON, V34, P743, DOI 10.1016/S0896-6273(02)00701-8                                                   ; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992                                                                   ; Rula EY, 2008, J NEUROSCI, V28, P6196, DOI 10.1523/JNEUROSCI.0443-08.2008; SNEATH PHA, 1962, NATURE, V193, P855, DOI 10.1038/193855a0; St Laurent G, 2013, NAT STRUCT MOL BIOL, V20, P1333, DOI 10.1038/nsmb.2675; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wheeler EC, 2015, RNA BIOL, V12, P162, DOI 10.1080/15476286.2015.1017220; Whipple JM, 2015, RNA, V21, P786, DOI 10.1261/rna.048801.114; Xu GX, 2014, P NATL ACAD SCI USA, V111, P3769, DOI 10.1073/pnas.1321745111; Zhao HQ, 2015, GENOME RES, V25, P66, DOI 10.1101/gr.176107.114; ZUCKERKANDL EMILE, 1965, P97	61	1	1	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	AUG	2017	34	8					1890	1901		10.1093/molbev/msx125				12	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	FC6DD	WOS:000406929700006	28453786				2018-01-05	
J	Elkon, R; Agami, R				Elkon, Ran; Agami, Reuven			Characterization of noncoding regulatory DNA in the human genome	NATURE BIOTECHNOLOGY			English	Review							TRANSCRIPTION FACTOR-BINDING; PARALLEL REPORTER ASSAY; CAPTURE HI-C; GENE-EXPRESSION; HUMAN-CELLS; HIGH-THROUGHPUT; CHROMATIN-STRUCTURE; ENHANCER ACTIVITY; IN-VIVO; SYSTEMATIC DISSECTION	Genetic variants associated with common diseases are usually located in noncoding parts of the human genome. Delineation of the full repertoire of functional noncoding elements, together with efficient methods for probing their biological roles, is therefore of crucial importance. Over the past decade, DNA accessibility and various epigenetic modifications have been associated with regulatory functions. Mapping these features across the genome has enabled researchers to begin to document the full complement of putative regulatory elements. High-throughput reporter assays to probe the functions of regulatory regions have also been developed but these methods separate putative regulatory elements from the chromosome so that any effects of chromatin context and long-range regulatory interactions are lost. Definitive assignment of function(s) to putative cis-regulatory elements requires perturbation of these elements. Genome-editing technologies are now transforming our ability to perturb regulatory elements across entire genomes. Interpretation of high-throughput genetic screens that incorporate genome editors might enable the construction of an unbiased map of functional noncoding elements in the human genome.	[Elkon, Ran] Sackler Sch Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel; [Elkon, Ran] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Agami, Reuven] Netherlands Canc Inst, Div Oncogen, Amsterdam, Netherlands; [Agami, Reuven] Rotterdam Univ, Erasmus MC, Rotterdam, Netherlands	Elkon, R (reprint author), Sackler Sch Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel.; Elkon, R (reprint author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.; Agami, R (reprint author), Netherlands Canc Inst, Div Oncogen, Amsterdam, Netherlands.; Agami, R (reprint author), Rotterdam Univ, Erasmus MC, Rotterdam, Netherlands.	ranel@tauex.tau.ac.il; r.agami@nki.nl			EEF-CEC/EU ERC-AdV; NWO [NGI 93512001/2012]; Israel Cancer Association	R.E. is a Faculty Fellow of the Edmond J. Safra Center for Bioinformatics at Tel Aviv University. This work was supported by funds from the EEF-CEC/EU ERC-AdV and NWO (NGI 93512001/2012) programs to R.A. and from the Israel Cancer Association to R.E.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Bahcall OG, 2015, NAT REV GENET, V16, P375, DOI 10.1038/nrg3969; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birnbaum RY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004592; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cheng C, 2012, GENOME RES, V22, P1658, DOI 10.1101/gr.136838.111; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Danko CG, 2015, NAT METHODS, V12, P433, DOI [10.1038/nmeth.3329, 10.1038/NMETH.3329]; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Deniz E, 2017, FUNCT INTEGR GENOMIC, V17, P135, DOI 10.1007/s10142-016-0524-x; Deplancke B, 2016, CELL, V166, P538, DOI 10.1016/j.cell.2016.07.012; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dryden NH, 2014, GENOME RES, V24, P1854, DOI 10.1101/gr.175034.114; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Fanucchi S, 2013, CELL, V155, P606, DOI 10.1016/j.cell.2013.09.051; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao XF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku836; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Grimmer MR, 2016, NATURE, V529, P34, DOI 10.1038/nature16330; Grubert F, 2015, CELL, V162, P1051, DOI 10.1016/j.cell.2015.07.048; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Haeussler M, 2016, J GENET GENOMICS, V43, P239, DOI 10.1016/j.jgg.2016.04.008; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Harvey CT, 2015, BIOINFORMATICS, V31, P1235, DOI 10.1093/bioinformatics/btu802; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang QY, 2015, J GENET GENOMICS, V42, P87, DOI 10.1016/j.jgg.2015.02.001; Inoue F, 2015, GENOMICS, V106, P159, DOI 10.1016/j.ygeno.2015.06.005; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Karczewski KJ, 2013, P NATL ACAD SCI USA, V110, P9607, DOI 10.1073/pnas.1219099110; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kheradpour P, 2013, GENOME RES, V23, P800, DOI 10.1101/gr.144899.112; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Koch Frederic, 2011, Transcription, V2, P263, DOI 10.4161/trns.2.6.18747; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kungulovski G, 2016, TRENDS GENET, V32, P101, DOI 10.1016/j.tig.2015.12.001; Kwasnieski JC, 2014, GENOME RES, V24, P1595, DOI 10.1101/gr.173518.114; Leveille N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7520; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lizio M, 2015, FRONT GENET, V6, DOI [10.3389/faene.2015.00331, 10.3389/fgene.2015.00331]; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mahfouz MM, 2014, PLANT BIOTECHNOL J, V12, P1006, DOI 10.1111/pbi.12256; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Melo CA, 2013, CELL RES, V23, P1151, DOI 10.1038/cr.2013.97; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Muerdter F, 2015, GENOMICS, V106, P145, DOI 10.1016/j.ygeno.2015.06.001; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Plank JL, 2014, MOL CELL, V55, P5, DOI 10.1016/j.molcel.2014.06.015; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Romanel A, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0084-2; Romanoski CE, 2015, NATURE, V518, P314, DOI 10.1038/518314a; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Shen SQ, 2016, GENOME RES, V26, P238, DOI 10.1101/gr.193789.115; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Skelly DA, 2011, GENOME RES, V21, P1728, DOI 10.1101/gr.119784.110; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Smith RP, 2013, NAT GENET, V45, P1021, DOI 10.1038/ng.2713; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Song L., 2010, COLD SPRING HARB PRO; Spisak S, 2015, NAT MED, V21, P1357, DOI 10.1038/nm.3975; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tehranchi AK, 2016, CELL, V165, P730, DOI 10.1016/j.cell.2016.03.041; Teytelman Leonid, 2013, Proc Natl Acad Sci U S A, V110, P18602, DOI 10.1073/pnas.1316064110; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; Vanhille L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7905; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei CX, 2013, J GENET GENOMICS, V40, P281, DOI 10.1016/j.jgg.2013.03.013; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; White MA, 2013, P NATL ACAD SCI USA, V110, P11952, DOI 10.1073/pnas.1307449110; Whitington T, 2016, NAT GENET, V48, P387, DOI 10.1038/ng.3523; Wu H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004610; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	168	0	0	17	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2017	35	8					732	746		10.1038/nbt.3863				15	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FC8XV	WOS:000407125800014	28787426				2018-01-05	
J	Gornalusse, GG; Hirata, RK; Funk, SE; Riolobos, L; Lopes, VS; Manske, G; Prunkard, D; Colunga, AG; Hanafi, LA; Clegg, DO; Turtle, C; Russell, DW				Gornalusse, German G.; Hirata, Roli K.; Funk, Sarah E.; Riolobos, Laura; Lopes, Vanda S.; Manske, Gabriel; Prunkard, Donna; Colunga, Aric G.; Hanafi, Laila-Aicha; Clegg, Dennis O.; Turtle, Cameron; Russell, David W.			HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells	NATURE BIOTECHNOLOGY			English	Article							CD8+ T-CELLS; NATURAL-KILLER-CELLS; MEDIATED CYTOTOXICITY; HEMATOPOIETIC STEM; MICE; DEFICIENT; BETA-2-MICROGLOBULIN; RECEPTOR; VIRUS; RECOGNITION	Polymorphisms in the human leukocyte antigen (HLA) class I genes can cause the rejection of pluripotent stem cell (PSC)-derived products in allogeneic recipients. Disruption of the Beta-2 Microglobulin (B2M) gene eliminates surface expression of all class I molecules, but leaves the cells vulnerable to lysis by natural killer (NK) cells. Here we show that this 'missing-self' response can be prevented by forced expression of minimally polymorphic HLA-E molecules. We use adeno-associated virus (AAV)-mediated gene editing to knock in HLA-E genes at the B2M locus in human PSCs in a manner that confers inducible, regulated, surface expression of HLA-E single-chain dimers (fused to B2M) or trimers (fused to B2M and a peptide antigen), without surface expression of HLA-A, B or C. These HLA-engineered PSCs and their differentiated derivatives are not recognized as allogeneic by CD8(+) T cells, do not bind anti-HLA antibodies and are resistant to NK-mediated lysis. Our approach provides a potential source of universal donor cells for applications where the differentiated derivatives lack HLA class II expression.	[Gornalusse, German G.; Hirata, Roli K.; Funk, Sarah E.; Riolobos, Laura; Manske, Gabriel; Prunkard, Donna; Colunga, Aric G.; Russell, David W.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Lopes, Vanda S.; Clegg, Dennis O.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Ctr Stem Cell Biol & Engn, Santa Barbara, CA 93106 USA; [Hanafi, Laila-Aicha; Turtle, Cameron] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Russell, David W.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Russell, DW (reprint author), Univ Washington, Dept Med, Seattle, WA 98195 USA.; Russell, DW (reprint author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	drussell@u.washington.edu			US National Institutes of Health (NIH) [DK55759, HL007093, 1S10OD010652-01]; California Institute for Regenerative Medicine [DR3-07438, TG2-01161, TG2-01151, CL1-00521, FA1-00616]; Garland Initiative for Vision; Foundation Fighting Blindness Wynn-Gund Translational Research Acceleration Program; UCSB Institute for Collaborative Biotechnologies from the US Army Research Office [W911NF-09-0001]; Cooperative Centers of Excellence in Hematology: NIH [DK106829]	This work was supported by US National Institutes of Health (NIH) grants DK55759 and HL007093 to D.W.R. 1S10OD010652-01 to the UW Shared IVIS Core Facility, and HL007093 to A.G.C. as well as California Institute for Regenerative Medicine grants DR3-07438, TG2-01161, TG2-01151, CL1-00521 and FA1-00616 to D.O.C. We also acknowledge support from the Garland Initiative for Vision, The Foundation Fighting Blindness Wynn-Gund Translational Research Acceleration Program and the UCSB Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the US Army Research Office. The authors thank R. Stolitenko for technical assistance, D. Geraghty (FHCRC) for providing HLA-E plasmids, D. McDonald (FHCRC) for cytogenetic analyses, D. Youngs (Bloodworks Northwest) for help in performing CDC assays, P. Treuting, B. Johnson and Y.-T. Tien (University of Washington) for histology and immunohistochemistry analysis, W. Loomis for assistance in IVIS image analysis, S. Quaratella (Medtronic Inc.) for providing PVA sponges, M. Gerace and D. Yadock (FHCRC) for providing CD8<SUP>+</SUP> T and CD56<SUP>+</SUP> NK cells (funding provided by the Cooperative Centers of Excellence in Hematology: NIH Grant DK106829)) and C. Levy (FHCRC) for help with graphing programs.	ARCEGOMEZ B, 1978, TISSUE ANTIGENS, V11, P96, DOI 10.1111/j.1399-0039.1978.tb01233.x; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; BRACIALE TJ, 1992, CURR OPIN IMMUNOL, V4, P59, DOI 10.1016/0952-7915(92)90126-Y                                                    ; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869                                                                   ; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Chamberlain JR, 2004, SCIENCE, V303, P1198, DOI 10.1126/science.1088757; DeSandro A, 1999, AM J HUM GENET, V65, P279, DOI 10.1086/302519; EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875; Feng Q, 2014, STEM CELL REP, V3, P817, DOI 10.1016/j.stemcr.2014.09.010; Gadola SD, 2000, CLIN EXP IMMUNOL, V121, P173, DOI 10.1046/j.1365-2249.2000.01264.x; GONG JH, 1994, LEUKEMIA, V8, P652; Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475; Horowitz A., 2013, SCI TRANSL MED, V5; HOU S, 1992, J IMMUNOL, V149, P1319; Huang YM, 2005, J IMMUNOL, V175, P3753, DOI 10.4049/jimmunol.175.6.3753                                                     ; Ichiryu Naoki, 2013, Methods Mol Biol, V1029, P1, DOI 10.1007/978-1-62703-478-4_1; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Khan IF, 2010, MOL THER, V18, P1192, DOI 10.1038/mt.2010.55; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199                                                          ; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205                                                         ; Lilienfeld BG, 2007, XENOTRANSPLANTATION, V14, P126, DOI 10.1111/i.1399-3089.2007.00378.x; Lu PF, 2013, STEM CELL REV REP, V9, P806, DOI 10.1007/s12015-013-9457-0; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Miller JD, 2003, J IMMUNOL, V171, P1369, DOI 10.4049/jimmunol.171.3.1369                                                     ; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Pazmany L, 1996, SCIENCE, V274, P792, DOI 10.1126/science.274.5288.792; Pegram HJ, 2011, IMMUNOL CELL BIOL, V89, P216, DOI 10.1038/icb.2010.78; Pietra G, 2003, P NATL ACAD SCI USA, V100, P10896, DOI 10.1073/pnas.1834449100; Pietra G, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/907092; Riolobos L, 2013, MOL THER, V21, P1232, DOI 10.1038/mt.2013.59; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Russell DW, 1998, NAT GENET, V18, P325, DOI 10.1038/ng0498-325                                                              ; SPRIGGS MK, 1992, P NATL ACAD SCI USA, V89, P6070, DOI 10.1073/pnas.89.13.6070; Street SEA, 2004, J EXP MED, V199, P879, DOI 10.1084/jem.20031981; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0                                                   ; Taylor CJ, 2012, CELL STEM CELL, V11, P147, DOI 10.1016/j.stem.2012.07.014; Wang DC, 2015, STEM CELL TRANSL MED, V4, P1234, DOI 10.5966/sctm.2015-0049; Zappacosta F, 1997, P NATL ACAD SCI USA, V94, P6313, DOI 10.1073/pnas.94.12.6313; ZARCONE D, 1987, CANCER RES, V47, P2674; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	43	4	4	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2017	35	8					765	772		10.1038/nbt.3860				8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FC8XV	WOS:000407125800019	28504668				2018-01-05	
J	Mundel, P				Mundel, Peter			Podocytes and the quest for precision medicines for kidney diseases	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Review						Podocytes; Genetics; Proteinuria; FSGS; CD80	GLOMERULAR EPITHELIAL-CELLS; PLURIPOTENT STEM-CELLS; RAT-KIDNEY; NEPHROTIC-SYNDROME; DIFFERENTIAL DISPLAY; MESSENGER-RNAS; SLIT DIAPHRAGM; EGF RECEPTOR; SYNAPTOPODIN; PROTEIN	In this review, I describe a 30-year journey in the quest for precision medicines for patients with kidney diseases. In 1987, when I started my reseach career, most scientists studying glomerular disease biology were focused on mesangial cells. The crucial role of the podocyte in many kidney diseases characterized by proteinuria, including focal segmental glomerulosclerosis (FSGS) and diabetic nephropathy, had not yet been recognized. We were not aware of genetic causes or drivers of kidney diseases nor of molecular markers and cell culture systems for mechanistic studies of podocyte biology. Tools for generating podocyte-specific knockout mice did not exist, and the key role of the podocyte actin cytoskeleton in the pathogenesis of proteinuria had not yet been identified. Clinically, treatment options for proteinuric kidney diseases were empiric, non-specific, and restricted to steroids and cyclosporine, without an understanding of their underlying mechanism of action. Since then, we have come a long way: a host of genetic causes for FSGS affecting podocytes has been identified, and with the advent of next generation sequencing approaches, the number of genetic causes continues to increase. Thinking "outside the box," empowered me to turn my attention to podocytes, develop the first differentiated podocyte cell culture system, and pioneer studies on the critical role of the podocyte actin cytoskeleton. Now, with the advent of iPSCs, we can build on these efforts by generating human podocytes and kidney organoids from patient cells, which, in combination with CRISPR-Cas9 gene editing and big data analyses, represent important next generation tools for bringing urgently needed precision medicines to patients with kidney disease. These new directions in kidney research should also increase the feasibility of much needed clinical trials in the kidney space. From Heidelberg to Boston, it has been an amazing scientific adventure. I will close with my thoughts about the path forward in making precision medicines for kidney diseases a reality.	[Mundel, Peter] Goldfinch Bio, 215 First St,4th Floor, Cambridge, MA 02142 USA	Mundel, P (reprint author), Goldfinch Bio, 215 First St,4th Floor, Cambridge, MA 02142 USA.	pmundel@goldfinchbio.com					Akilesh S, 2011, J CLIN INVEST, V121, P4127, DOI 10.1172/JCI46458; ARDAILLOU N, 1992, J CELL PHYSIOL, V152, P599, DOI 10.1002/jcp.1041520320; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Blattner SM, 2013, KIDNEY INT, V84, P920, DOI 10.1038/ki.2013.175; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Brenner L, 2016, SEMIN NEPHROL, V36, P481, DOI 10.1016/j.semnephrol.2016.08.009; Buvall L, 2017, J AM SOC NEPHROL, V28, P837, DOI 10.1681/ASN.2016040414; Buvall L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3863; Chen JC, 2016, J AM SOC NEPHROL, V27, P1689, DOI 10.1681/ASN.2015040415; Chen JC, 2015, J AM SOC NEPHROL, V26, P1115, DOI 10.1681/ASN.2014020192; Ciampi O, 2016, STEM CELL RES, V17, P130, DOI 10.1016/j.scr.2016.06.001; Coers W, 1996, EXP NEPHROL, V4, P184; Deller T, 2003, P NATL ACAD SCI USA, V100, P10494, DOI 10.1073/pnas.1832384100; FARQUHAR MG, 1975, KIDNEY INT, V8, P197, DOI 10.1038/ki.1975.103; Faul C, 2005, J CELL BIOL, V169, P415, DOI 10.1083/jcb.200411169; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Faul C, 2007, MOL CELL BIOL, V27, P8215, DOI 10.1128/MCB.00950-07; FRIES JWU, 1989, LAB INVEST, V60, P205; Gee HY, 2013, J CLIN INVEST, V123, P3243, DOI 10.1172/JCI69134; GILBERT P, 1990, J HISTOCHEM CYTOCHEM, V38, P1919, DOI 10.1177/38.12.2254651                                                           ; Greka A, 2011, ANN REV PHYSL; Greka A, 2016, SEMIN NEPHROL, V36, P448, DOI [10.1016/j.semnephrol.2016.09.004, 10.1016/j.semnephrol.2016.09.006, 10.1016/j.semnephrol.2016.09.005]; Greka A, 2011, J AM SOC NEPHROL, V22, P1969, DOI 10.1681/ASN.2011040370; Hall YN, 2017, CLIN J AM SOC NEPHRO, V12, P346, DOI 10.2215/CJN.09310916; Haraldsson B, 2013, NEW ENGL J MED, V369, P2453, DOI 10.1056/NEJMe1312835; Heyer CM, 2016, J AM SOC NEPHROL, V27, P2872, DOI 10.1681/ASN.2015050583; Ju WJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7071; KARNOVSKY MJ, 1975, J CELL BIOL, V65, P233, DOI 10.1083/jcb.65.1.233; KERJASCHKI D, 1978, LAB INVEST, V39, P430; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591                                                           ; KRIZ W, 1994, CONTRIB NEPHROL, V107, P1; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; LIANG P, 1992, CANCER RES, V52, P6966; LIANG P, 1993, NUCLEIC ACIDS RES, V21, P3269, DOI 10.1093/nar/21.14.3269; Mathieson PW, 2008, NEW ENGL J MED, V359, P2492, DOI 10.1056/NEJMcibr0806881; MENDRICK DL, 1988, KIDNEY INT, V33, P818, DOI 10.1038/ki.1988.73; Morizane R, 2015, NAT BIOTECHNOL, V33, P1193, DOI 10.1038/nbt.3392; MUNDEL P, 1988, CELL TISSUE RES, V254, P183; MUNDEL P, 1991, J HISTOCHEM CYTOCHEM, V39, P1047, DOI 10.1177/39.8.1856454                                                            ; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193                                                           ; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; MUNDEL P, 1995, ANAT EMBRYOL, V192, P387; Mundel P, 2016, SEMIN NEPHROL, V36, P459, DOI 10.1016/j.semnephrol.2016.09.008; Mundel P, 2015, CURR OPIN NEPHROL HY, V24, P388, DOI 10.1097/MNH.0000000000000137; NORGAARD JOR, 1987, LAB INVEST, V57, P277; Palmer SC, 2011, AM J KIDNEY DIS, V58, P335, DOI 10.1053/j.ajkd.2011.06.006; Pollak M, 2016, SEMIN NEPHROL, V36, P467, DOI 10.1016/j.semnephrol.2016.09.010; Quaggin SE, 2016, NEW ENGL J MED, V374, P281, DOI 10.1056/NEJMcibr1514351; Rastaldi MP, 2006, FASEB J, V20, P976, DOI 10.1096/fj.05-4962fje; REEVES WH, 1980, J CELL BIOL, V85, P735, DOI 10.1083/jcb.85.3.735; Reiser J, 2004, J BIOL CHEM, V279, P34827, DOI 10.1074/jbc.M401973200; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; RODEWALD R, 1974, J CELL BIOL, V60, P423, DOI 10.1083/jcb.60.2.423; RYAN GB, 1976, KIDNEY INT, V9, P36, DOI 10.1038/ki.1976.5; Schaldecker T, 2013, J CLIN INVEST, V123, P5298, DOI 10.1172/JCI71165; SCHNEEBERGER EE, 1975, KIDNEY INT, V8, P48, DOI 10.1038/ki.1975.75; Sharmin S, 2016, J AM SOC NEPHROL, V27, P1778, DOI 10.1681/ASN.2015010096; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Song B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046453; Takasato Minoru, 2016, Nature, V536, P238, DOI 10.1038/nature17982; Tian DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001200; Vivante A, 2016, NAT REV NEPHROL, V12, P133, DOI 10.1038/nrneph.2015.205; Weins A, 2001, J CELL BIOL, V155, P393, DOI 10.1083/jcb.200012039; WEINSTEIN T, 1992, J AM SOC NEPHROL, V3, P1279; Wong JS, 2012, EMBO J, V31, P1028, DOI 10.1038/emboj.2011.464; Xinaris C, 2016, J AM SOC NEPHROL, V27, P1400, DOI 10.1681/ASN.2015030316; Yanagida-Asanuma E, 2007, AM J PATHOL, V171, P415, DOI 10.2353/ajpath.2007.070075; Yu CC, 2013, NEW ENGL J MED, V369, P2416, DOI 10.1056/NEJMoa1304572; Zhang XL, 2013, J NEUROSCI, V33, P12510, DOI 10.1523/JNEUROSCI.2983-12.2013	71	0	0	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	AUG	2017	469	7-8					1029	1037		10.1007/s00424-017-2015-x				9	Physiology	Physiology	FC8HL	WOS:000407082300021	28646406				2018-01-05	
J	Dreissig, S; Schiml, S; Schindele, P; Weiss, O; Rutten, T; Schubert, V; Gladilin, E; Mette, MF; Puchta, H; Houben, A				Dreissig, Steven; Schiml, Simon; Schindele, Patrick; Weiss, Oda; Rutten, Twan; Schubert, Veit; Gladilin, Evgeny; Mette, Michael F.; Puchta, Holger; Houben, Andreas			Live-cell CRISPR imaging in plants reveals dynamic telomere movements	PLANT JOURNAL			English	Article						CRISPR-dCas9; live cell imaging; telomeres; chromatin dynamics; nucleus; Nicotiana benthamiana; technical advance	REPETITIVE DNA-SEQUENCES; ARABIDOPSIS-THALIANA; LIVING CELLS; CHROMATIN; VISUALIZATION; TRANSCRIPTION; ORGANIZATION; CHROMOSOME; SYSTEM; GENOME	Elucidating the spatiotemporal organization of the genome inside the nucleus is imperative to our understanding of the regulation of genes and non-coding sequences during development and environmental changes. Emerging techniques of chromatin imaging promise to bridge the long-standing gap between sequencing studies, which reveal genomic information, and imaging studies that provide spatial and temporal information of defined genomic regions. Here, we demonstrate such an imaging technique based on two orthologues of the bacterial clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein 9 (Cas9). By fusing eGFP/mRuby2 to catalytically inactive versions of Streptococcus pyogenes and Staphylococcus aureus Cas9, we show robust visualization of telomere repeats in live leaf cells of Nicotiana benthamiana. By tracking the dynamics of telomeres visualized by CRISPR-dCas9, we reveal dynamic telomere movements of up to 2 mu m over 30 min during interphase. Furthermore, we show that CRISPR-dCas9 can be combined with fluorescence-labelled proteins to visualize DNA-protein interactions in vivo. By simultaneously using two dCas9 orthologues, we pave the way for the imaging of multiple genomic loci in live plants cells. CRISPR imaging bears the potential to significantly improve our understanding of the dynamics of chromosomes in live plant cells.	[Dreissig, Steven; Weiss, Oda; Rutten, Twan; Schubert, Veit; Gladilin, Evgeny; Mette, Michael F.; Houben, Andreas] Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Gatersleben, Seeland, Germany; [Schiml, Simon; Schindele, Patrick; Puchta, Holger] Karlsruhe Inst Technol, Bot Inst, POB 6980, D-76049 Karlsruhe, Germany; [Mette, Michael F.] King Abdullah Univ Sci & Technol, Thuwal 239556900, Saudi Arabia	Houben, A (reprint author), Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Gatersleben, Seeland, Germany.; Puchta, H (reprint author), Karlsruhe Inst Technol, Bot Inst, POB 6980, D-76049 Karlsruhe, Germany.	holger.puchta@kit.edu; houben@ipk-gatersleben.de		Rutten, Twan/0000-0001-5891-6503; Dreissig, Steven/0000-0002-4766-9698; Schubert, Veit/0000-0002-3072-0485; Houben, Andreas/0000-0003-3419-239X; Puchta, Holger/0000-0003-1073-8546	DFG [DFG HO1779/22-1, HO1779/28-1]; European Research Council [COMREC 26852]	We would like to acknowledge Uwe Sonnewald (Friedrich-Alexander University Erlangen-Nuremberg, Germany) for providing us with pUL50-GFP. We are also thankful to Martina Dvorackova and Jiri Fajkus (Institute of Biophysics, Brno, Czech Republic) for providing us with TRB1-GFP. This work was supported by the DFG (grant DFG HO1779/22-1, HO1779/28-1, to A.H.) and the European Research Council (Advanced Grant COMREC 26852, to H.P.).	Anton T, 2014, NUCLEUS-AUSTIN, V5, P163, DOI [10.4161/nucl.2848, 10.4161/nucl.28488]; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Bonev B, 2016, NAT REV GENET, V17, P661, DOI 10.1038/nrg.2016.112; Chen BH, 2016, ANNU REV BIOPHYS, V45, P1, DOI 10.1146/annurev-biophys-062215-010830; Chen BH, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1533; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Dvorackova M, 2010, PLANT J, V61, P637, DOI 10.1111/j.1365-313X.2009.04094.x; FAJKUS J, 1995, MOL GEN GENET, V247, P633, DOI 10.1007/BF00290355; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Fujimoto S, 2016, J EXP BOT, V67, P6101, DOI 10.1093/jxb/erw371; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Ishii T, 2015, CHROMOSOME RES, V23, P709, DOI 10.1007/s10577-015-9477-5; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kato N, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-11-research0045; Koo DH, 2016, CHROMOSOME RES, V24, P467, DOI 10.1007/s10577-016-9537-5; Kozubek S, 2000, ANAL BIOCHEM, V282, P29, DOI 10.1006/abio.2000.4538; Lamm CE, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030073; Lindhout BI, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm618; Ma HH, 2016, J CELL BIOL, V214, P529, DOI 10.1083/jcb.201604115; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Ma HH, 2013, P NATL ACAD SCI USA, V110, P21048, DOI 10.1073/pnas.1319097110; NIMMO ER, 1994, EMBO J, V13, P3801; Pacher M, 2017, PLANT J, V90, P819, DOI 10.1111/tpj.13469; Phan Hoang Trong, 2016, Methods Mol Biol, V1349, P35, DOI 10.1007/978-1-4939-3008-1_3; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; Puchta H, 2017, CURR OPIN PLANT BIOL, V36, P1, DOI 10.1016/j.pbi.2016.11.011; Gutierrez C, 2015, PLANT J, V83, P1, DOI [10.1111/tpj.12909, 10.1111/tpj.13100]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qin PW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14725; Sanchez ME, 2001, CHROMOSOME RES, V9, P121; Schrumpfova PP, 2014, PLANT J, V77, P770, DOI 10.1111/tpj.12428; Schrumpfova PP, 2016, PLANT SCI, V7, P851; Schubert V, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00389; Shao SP, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw066; Steinert J, 2015, PLANT J, V84, P1295, DOI 10.1111/tpj.13078; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhou YX, 2017, CELL RES, V27, P298, DOI 10.1038/cr.2017.9	42	2	2	17	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	AUG	2017	91	4					565	573		10.1111/tpj.13601				9	Plant Sciences	Plant Sciences	FC7HC	WOS:000407011100001	28509419	gold			2018-01-05	
J	Zhang, YW; Bai, Y; Wu, GH; Zou, SH; Chen, YF; Gao, CX; Tang, DZ				Zhang, Yunwei; Bai, Yang; Wu, Guangheng; Zou, Shenghao; Chen, Yongfang; Gao, Caixia; Tang, Dingzhong			Simultaneous modification of three homoeologs of TaEDR1 by genome editing enhances powdery mildew resistance in wheat	PLANT JOURNAL			English	Article						genome editing; CRISPR/Cas9; hexaploid wheat; Triticum aestivum L.; powdery mildew; Blumeria graminis; EDR1	EDR1 PROTEIN-KINASE; DISEASE RESISTANCE; HEXAPLOID WHEAT; CELL-DEATH; CRISPR/CAS SYSTEM; DRAFT GENOME; ARABIDOPSIS; PLANT; RICE; IMMUNITY	Wheat (Triticum aestivum L.) incurs significant yield losses from powdery mildew, a major fungal disease caused by Blumeria graminis f. sp. tritici (Bgt). enhanced disease resistance1 (EDR1) plays a negative role in the defense response against powdery mildew in Arabidopsis thaliana; however, the edr1 mutant does not show constitutively activated defense responses. This makes EDR1 an ideal target for approaches using new genome-editing tools to improve resistance to powdery mildew. We cloned TaEDR1 from hexaploid wheat and found high similarity among the three homoeologs of EDR1. Knock-down of TaEDR1 by virus-induced gene silencing or RNA interference enhanced resistance to powdery mildew, indicating that TaEDR1 negatively regulates powdery mildew resistance in wheat. We used CRISPR/Cas9 technology to generate Taedr1 wheat plants by simultaneous modification of the three homoeologs of wheat EDR1. No off-target mutations were detected in the Taedr1 mutant plants. The Taedr1 plants were resistant to powdery mildew and did not show mildew-induced cell death. Our study represents the successful generation of a potentially valuable trait using genome-editing technology in wheat and provides germplasm for disease resistance breeding.	[Zhang, Yunwei; Bai, Yang; Wu, Guangheng; Zou, Shenghao; Chen, Yongfang; Gao, Caixia; Tang, Dingzhong] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China; [Zhang, Yunwei; Bai, Yang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wu, Guangheng] Wuyi Univ, Fujian Prov Key Lab Ecoind Green Technol, Coll Ecol & Resources Engn, Wuyishan 354300, Fujian, Peoples R China; [Tang, Dingzhong] Fujian Agr & Forestry Univ, Plant Immun Ctr, Minist Educ Genet Breeding & Multiple Utilizat Cr, Key Lab, Fuzhou 350002, Peoples R China; [Tang, Dingzhong] Fujian Agr & Forestry Univ, State Key Lab Ecol Control Fujian Taiwan Crop Pes, Fuzhou 350002, Peoples R China	Gao, CX; Tang, DZ (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China.; Tang, DZ (reprint author), Fujian Agr & Forestry Univ, Plant Immun Ctr, Minist Educ Genet Breeding & Multiple Utilizat Cr, Key Lab, Fuzhou 350002, Peoples R China.; Tang, DZ (reprint author), Fujian Agr & Forestry Univ, State Key Lab Ecol Control Fujian Taiwan Crop Pes, Fuzhou 350002, Peoples R China.	cxgao@genetics.ac.cn; dztang@genetics.ac.cn			National Science Fund for Distinguished Young Scholars of China [31525019]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB11020100]; Ministry of Science and Technology of China [2015CB910202, 2014DFA31540]; National Key Research and Development Program of China [2016YFD0101804]; Chinese Academy of Sciences [KFZD-SW-107]	We thank Xiangqi Zhang for BSMV constructs and Bgt isolate E09. The work was supported by grants from National Science Fund for Distinguished Young Scholars of China (31525019), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB11020100), the Ministry of Science and Technology of China (2015CB910202 and 2014DFA31540) to DT, the National Key Research and Development Program of China (2016YFD0101804) and the Chinese Academy of Sciences (KFZD-SW-107) to CG.	Acevedo-Garcia J, 2017, PLANT BIOTECHNOL J, V15, P367, DOI 10.1111/pbi.12631; Belkhadirl Y, 2014, TRENDS BIOCHEM SCI, V39, P447, DOI 10.1016/j.tibs.2014.06.006; Brunner S, 2011, PLANT BIOTECHNOL J, V9, P897, DOI 10.1111/j.1467-7652.2011.00603.x; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; Frye CA, 1998, PLANT CELL, V10, P947; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Humphry M, 2006, MOL PLANT PATHOL, V7, P605, DOI 10.1111/j.1364-3703.2006.00362.X; Hurni S, 2013, PLANT J, V76, P957, DOI 10.1111/tpj.12345; Jia HG, 2017, PLANT BIOTECHNOL J, V15, P817, DOI 10.1111/pbi.12677; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kelliher T, 2017, NATURE, V542, P105, DOI 10.1038/nature20827; Kim JA, 2003, BIOCHEM BIOPH RES CO, V300, P868, DOI 10.1016/S0006-291X(02)02944-3; Kusch S, 2016, GENOME BIOL EVOL, V8, P878, DOI 10.1093/gbe/evw036; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; [Li Jiarui 李加瑞], 2005, [遗传学报, Acta Genetica Sinica], V32, P846; Li J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.139, 10.1038/nplants.2016.139]; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu J, 2016, PLANT PHYSIOL, V170, P1799, DOI 10.1104/pp.15.01784; Liu XM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3070; Lozano-Duran R, 2015, TRENDS PLANT SCI, V20, P12, DOI 10.1016/j.tplants.2014.09.003; [Niu Jishan 牛吉山], 2005, [植物生理与分子生物学学报, Journal of Plant Physiology and Molecular Biology], V31, P477; Pan HR, 2012, PLANT J, V69, P831, DOI 10.1111/j.1365-313X.2011.04835.x; Peterhansel C, 1997, PLANT CELL, V9, P1397; Rasco-Gaunt S, 2001, J EXP BOT, V52, P865, DOI 10.1093/jexbot/52.357.865                                                       ; Sanchez-Martin J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1082-1; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Serrano I, 2014, PLANT CELL, V26, P4532, DOI 10.1105/tpc.114.131540; Shan QW, 2015, PLANT BIOTECHNOL J, V13, P791, DOI 10.1111/pbi.12312; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; Shen XL, 2011, PLANT CELL ENVIRON, V34, P179, DOI 10.1111/j.1365-3040.2010.02219.x; Singh RP, 2016, ANNU REV PHYTOPATHOL, V54, P303, DOI 10.1146/annurev-phyto-080615-095835; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Soyk S, 2017, NAT GENET, V49, P162, DOI 10.1038/ng.3733; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tang DZ, 2005, PLANT PHYSIOL, V138, P1018, DOI 10.1104/pp.105.060400; Tang F, 2016, PLANT PHYSIOL, V170, P26, DOI 10.1104/pp.15.01661; Unniyampurath U, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030291; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; WOLTER M, 1993, MOL GEN GENET, V239, P122; Wu GH, 2015, PLANT CELL, V27, P857, DOI 10.1105/tpc.114.134668; Xie X., 2017, PHYSIOL PLANTARUM, V1, P1; Xing LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072571; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Zhang YM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11649; Zhao CZ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004389; Zhou HB, 2007, PLANT J, V52, P420, DOI 10.1111/j.1365-313X.2007.03246.x; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zhou RH, 2005, THEOR APPL GENET, V110, P640, DOI 10.1007/s00122-004-1889-0	58	1	1	43	43	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	AUG	2017	91	4					714	724		10.1111/tpj.13599				11	Plant Sciences	Plant Sciences	FC7HC	WOS:000407011100012	28502081				2018-01-05	
J	Li, H; Zhao, YB				Li, Hua; Zhao, Yangbing			Increasing the safety and efficacy of chimeric antigen receptor T cell therapy	PROTEIN & CELL			English	Review						chimeric antigen receptors; cancer adoptive immunotherapy; T lymphocytes; gene therapy; gene editing	TUMOR-INFILTRATING LYMPHOCYTES; LENTIVIRAL GENE-TRANSFER; ANTITUMOR-ACTIVITY; CANCER-IMMUNOTHERAPY; ADOPTIVE IMMUNOTHERAPY; TARGETING NEOANTIGENS; METASTATIC MELANOMA; DONOR LYMPHOCYTES; SUICIDE-GENE; SOLID TUMORS	Chimeric antigen receptor (CAR) T cell therapy is a promising cancer treatment that has recently been undergoing rapid development. However, there are still some major challenges, including precise tumor targeting to avoid off-target or "on-target/off-tumor" toxicity, adequate T cell infiltration and migration to solid tumors and T cell proliferation and persistence across the physical and biochemical barriers of solid tumors. In this review, we focus on the primary challenges and strategies to design safe and effective CAR T cells, including using novel cutting-edge technologies for CAR and vector designs to increase both the safety and efficacy, further T cell modification to overcome the tumor-associated immune suppression, and using gene editing technologies to generate universal CAR T cells. All these efforts promote the development and evolution of CAR T cell therapy and move toward our ultimate goal-curing cancer with high safety, high efficacy, and low cost.	[Li, Hua; Zhao, Yangbing] Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA; [Li, Hua] Chengdu Mil Gen Hosp, Canc Ctr, Chengdu 610083, Sichuan, Peoples R China	Zhao, YB (reprint author), Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA.	yangbing@upenn.edu					Ahmed N, 2015, J CLIN ONCOL, V33, P1688, DOI 10.1200/JCO.2014.58.0225; Alvarez-Rueda N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025220; Ankri C, 2013, J IMMUNOL, V191, P4121, DOI 10.4049/jimmunol.1203085; Barrett DM, 2014, CURR OPIN PEDIATR, V26, P43, DOI 10.1097/MOP.0000000000000043; Beane JD, 2015, MOL THER, V23, P1380, DOI 10.1038/mt.2015.71; Beatty GL, 2014, CANCER IMMUNOL RES, V2, P112, DOI 10.1158/2326-6066.CIR-13-0170; Berdien B, 2014, GENE THER, V21, P539, DOI 10.1038/gt.2014.26; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719                                                   ; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Carpenter RO, 2013, CLIN CANCER RES, V19, P2048, DOI 10.1158/1078-0432.CCR-12-2422; Caruso HG, 2015, CANCER RES, V75, P3505, DOI 10.1158/0008-5472.CAN-15-0139; Cherkassky L, 2016, J CLIN INVEST, V126, P3130, DOI 10.1172/JCI83092; Chinnasamy D, 2010, J CLIN INVEST, V120, P3953, DOI 10.1172/JCI43490; Chmielewski M, 2004, J IMMUNOL, V173, P7647, DOI 10.4049/jimmunol.173.12.7647                                                    ; Chmielewski M, 2015, EXPERT OPIN BIOL TH, V15, P1145, DOI 10.1517/14712598.2015.1046430; Chmielewski M, 2014, IMMUNOL REV, V257, P83, DOI 10.1111/imr.12125; Ciceri F, 2009, LANCET ONCOL, V10, P489, DOI 10.1016/S1470-2045(09)70074-9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Craddock JA, 2010, J IMMUNOTHER, V33, P780, DOI 10.1097/CJI.0b013e3181ee6675; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Faitschuk E, 2016, BLOOD, V128, P1711, DOI 10.1182/blood-2016-01-692046; Feng KC, 2016, SCI CHINA LIFE SCI, V59, P468, DOI 10.1007/s11427-016-5023-8; Finney HM, 1998, J IMMUNOL, V161, P2791; FitzGerald DJ, 2011, CANCER RES, V71, P6300, DOI 10.1158/0008-5472.CAN-11-1374; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Haso W, 2013, BLOOD, V121, P1165, DOI 10.1182/blood-2012-06-438002; Hong H, 2014, J IMMUNOTHER, V37, P93, DOI 10.1097/CJI.0000000000000018; Hoyos V, 2010, LEUKEMIA, V24, P1160, DOI 10.1038/leu.2010.75; Hudecek M, 2013, CLIN CANCER RES, V19, P3153, DOI 10.1158/1078-0432.CCR-13-0330; Hudecek M, 2010, BLOOD, V116, P4532, DOI 10.1182/blood-2010-05-283309; Johnson LA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4963; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Kloss CC, 2013, NAT BIOTECHNOL, V31, P71, DOI 10.1038/nbt.2459; Lamers CHJ, 2006, CYTOTHERAPY, V8, P542, DOI 10.1080/14653240601056396; Lamers Cor H J, 2006, J Clin Oncol, V24, pe20, DOI 10.1200/JCO.2006.05.9964; Lanitis E, 2013, CANCER IMMUNOL RES, V1, P43, DOI 10.1158/2326-6066.CIR-13-0008; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Liu XJ, 2017, CELL RES, V27, P154, DOI 10.1038/cr.2016.142; Liu XJ, 2016, CANCER RES, V76, P1578, DOI 10.1158/0008-5472.CAN-15-2524; Liu XJ, 2015, CANCER RES, V75, P3596, DOI 10.1158/0008-5472.CAN-15-0159; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; Lu YC, 2016, SEMIN IMMUNOL, V28, P22, DOI 10.1016/j.smim.2015.11.002; MacLeod DT, 2017, MOL THER, V25, P949, DOI 10.1016/j.ymthe.2017.02.005; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70                                                              ; Mardiros A, 2013, BLOOD, V122, P3138, DOI 10.1182/blood-2012-12-474056; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Maus MV, 2013, CANCER IMMUNOL RES, V1, P26, DOI 10.1158/2326-6066.CIR-13-0006; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Newick K, 2016, CANCER IMMUNOL RES, V4, P541, DOI 10.1158/2326-6066.CIR-15-0263; Oliveira G, 2012, CURR OPIN HEMATOL, V19, P427, DOI 10.1097/MOH.0b013e32835822f5; Oren R, 2014, J IMMUNOL, V193, P5733, DOI 10.4049/jimmunol.1301769; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/mt.sj.6300104; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Philip B, 2014, BLOOD, V124, P1277, DOI 10.1182/blood-2014-01-545020; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Posey AD, 2016, IMMUNITY, V44, P1444, DOI 10.1016/j.immuni.2016.05.014; Prosser ME, 2012, MOL IMMUNOL, V51, P263, DOI 10.1016/j.molimm.2012.03.023; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Qasim W, 2017, SCI TRANSL MED, V9; Rafiq S, 2017, LEUKEMIA, V31, P1788, DOI 10.1038/leu.2016.373; Reiter Y, 1997, P NATL ACAD SCI USA, V94, P4631, DOI 10.1073/pnas.94.9.4631; Ren JT, 2017, CLIN CANCER RES, V23, P2255, DOI 10.1158/1078-0432.CCR-16-1300; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Roybal KT, 2016, CELL, V167, P419, DOI 10.1016/j.cell.2016.09.011; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Sakemura R, 2016, CANCER IMMUNOL RES, V4, P658, DOI 10.1158/2326-6066.CIR-16-0043; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sampson JH, 2014, CLIN CANCER RES, V20, P972, DOI 10.1158/1078-0432.CCR-13-0709; Schubert ML, 2016, HUM GENE THER, V27, P758, DOI 10.1089/hum.2016.097; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Singh JA, 2011, J RHEUMATOL, V38, P10, DOI 10.3899/jrheum.100717; Singh Nathan, 2014, Cancer Immunol Res, V2, P1059, DOI 10.1158/2326-6066.CIR-14-0051; Smith MR, 2003, ONCOGENE, V22, P7359, DOI 10.1038/sj.onc.1206939; Suzuki M, 2015, EXPERT OPIN THER TAR, V19, P349, DOI 10.1517/14728222.2014.986459; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Till BG, 2008, BLOOD, V112, P2261, DOI 10.1182/blood-2007-12-128843; Till BG, 2012, BLOOD, V119, P3940, DOI 10.1182/blood-2011-10-387969; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Torikai H, 2013, BLOOD, V122, P1341, DOI 10.1182/blood-2013-03-478255; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tugues S, 2015, CELL DEATH DIFFER, V22, P237, DOI 10.1038/cdd.2014.134; Vera J, 2006, BLOOD, V108, P3890, DOI 10.1128/blood-2006-04-017061; Wang XL, 2011, BLOOD, V118, P1255, DOI 10.1182/blood-2011-02-337360; Watanabe K, 2015, J IMMUNOL, V194, P911, DOI 10.4049/jimmunol.1402346; Wilkie S, 2012, J CLIN IMMUNOL, V32, P1059, DOI 10.1007/s10875-012-9689-9; Wolchok JD, 2013, ANN NY ACAD SCI, V1291, P1, DOI 10.1111/nyas.12180; Wu CY, 2015, SCIENCE, V350, DOI 10.1126/science.aab4077; Yarchoan M, 2017, NAT REV CANCER, V17, P209, DOI 10.1038/nrc.2016.154; Zah E, 2016, CANCER IMMUNOL RES, V4, P498, DOI 10.1158/2326-6066.CIR-15-0231; Zhang L, 2015, CLIN CANCER RES, V21, P2278, DOI 10.1158/1078-0432.CCR-14-2085; Zhang L, 2011, MOL THER, V19, P751, DOI 10.1038/mt.2010.313; Zhang W.Y, 2016, SIGNAL TRANSDUCT TAR, V1, P16002, DOI [10.1038/sigtrans.2016.2, DOI 10.1038/SIGTRANS.2016.2]; Zhao YB, 2010, CANCER RES, V70, P9053, DOI 10.1158/0008-5472.CAN-10-2880; Zhao YB, 2009, J IMMUNOL, V183, P5563, DOI 10.4049/jimmunol.0900447; Zhao YB, 2006, MOL THER, V13, P151, DOI 10.1016/j.ymthe.2005.07.688; Zhu XK, 2015, ONCOTARGET, V6, P171, DOI 10.18632/oncotarget.2767                                                        	103	0	0	13	13	HIGHER EDUCATION PRESS	BEIJING	NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA	1674-800X	1674-8018		PROTEIN CELL	Protein Cell	AUG	2017	8	8					573	589		10.1007/s13238-017-0411-9				17	Cell Biology	Cell Biology	FC7DU	WOS:000407002200004	28434147	gold			2018-01-05	
J	Liang, PP; Sun, HW; Ying, S; Zhang, XY; Xie, XW; Zhang, JR; Zhen, Z; Chen, YX; Ding, CH; Xiong, YY; Ma, WB; Dan, L; Huang, JJ; Zhou, SY				Liang, Puping; Sun, Hongwei; Ying Sun; Zhang, Xiya; Xie, Xiaowei; Zhang, Jinran; Zhen Zhang; Chen, Yuxi; Ding, Chenhui; Xiong, Yuanyan; Ma, Wenbin; Dan Liu; Huang, Junjiu; Zhou Songyang			Effective gene editing by high-fidelity base editor 2 in mouse zygotes	PROTEIN & CELL			English	Article						base editor; high-fidelity; mouse embryos; proximal-site deamination; whole-genome sequencing	ZINC-FINGER NUCLEASES; STRANDED DNA CLEAVAGE; TRUNCATED GUIDE RNAS; HUMAN-CELLS; TARGET DNA; GENOME; CRISPR; CAS9; ENDONUCLEASE; MUTAGENESIS	Targeted point mutagenesis through homologous recombination has been widely used in genetic studies and holds considerable promise for repairing disease-causing mutations in patients. However, problems such as mosaicism and low mutagenesis efficiency continue to pose challenges to clinical application of such approaches. Recently, a base editor (BE) system built on cytidine (C) deaminase and CRISPR/Cas9 technology was developed as an alternative method for targeted point mutagenesis in plant, yeast, and human cells. Base editors convert C in the deamination window to thymidine (T) efficiently, however, it remains unclear whether targeted base editing in mouse embryos is feasible. In this report, we generated a modified high-fidelity version of base editor 2 (HF2-BE2), and investigated its base editing efficacy in mouse embryos. We found that HF2-BE2 could convert C to T efficiently, with up to 100% biallelic mutation efficiency in mouse embryos. Unlike BE3, HF2-BE2 could convert C to T on both the target and non-target strand, expanding the editing scope of base editors. Surprisingly, we found HF2-BE2 could also deaminate C that was proximal to the gRNA-binding region. Taken together, our work demonstrates the feasibility of generating point mutations in mouse by base editing, and underscores the need to carefully optimize base editing systems in order to eliminate proximal-site deamination.	[Liang, Puping; Sun, Hongwei; Ying Sun; Zhang, Xiya; Xie, Xiaowei; Zhang, Jinran; Zhen Zhang; Chen, Yuxi; Xiong, Yuanyan; Ma, Wenbin; Huang, Junjiu; Zhou Songyang] Sun Yat Sen Univ, Minist Educ, Guangzhou Key Lab Hlth Aging Res, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Puping; Sun, Hongwei; Ying Sun; Zhang, Xiya; Xie, Xiaowei; Zhang, Jinran; Zhen Zhang; Chen, Yuxi; Xiong, Yuanyan; Ma, Wenbin; Huang, Junjiu; Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, SYSU BCM Joint Res Ctr, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Puping; Huang, Junjiu; Zhou Songyang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Puping; Ding, Chenhui; Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, Key Lab Reprod Med Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Puping; Ding, Chenhui; Zhou Songyang] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Zhen Zhang] Guangzhou Magigen Biotechnol Co Ltd, Guangzhou 510320, Guangdong, Peoples R China; [Dan Liu; Zhou Songyang] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, One Baylor Plaza, Houston, TX 77030 USA	Liang, PP; Huang, JJ; Zhou, SY (reprint author), Sun Yat Sen Univ, Minist Educ, Guangzhou Key Lab Hlth Aging Res, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China.; Liang, PP; Huang, JJ; Zhou, SY (reprint author), Sun Yat Sen Univ, Sch Life Sci, SYSU BCM Joint Res Ctr, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.; Liang, PP; Huang, JJ; Zhou, SY (reprint author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.; Liang, PP; Zhou, SY (reprint author), Sun Yat Sen Univ, Sch Life Sci, Key Lab Reprod Med Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China.; Liang, PP; Zhou, SY (reprint author), Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.; Zhou, SY (reprint author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, One Baylor Plaza, Houston, TX 77030 USA.	liangpp5@mail.sysu.edu.cn; hjunjiu@mail.sysu.edu.cn; songyanz@mail.sysu.edu.cn			National Natural Science Foundation of China [91640119, 31601196, 81330055, 31371508, 31671540]; Natural Science Foundation of Guangdong Province [2016A030310206, 2014A030312011]; Science and Technology Planning Project of Guangdong Province [2015B020228002, 2015A020212005]; Guangzhou Science and Technology Project [201605030012, 201707010085]; Fundamental Research Funds for the Central Universities [161gzd13, 161gpy31]; CPRIT [RP160462]; Welch Foundation [Q-1673]; C-BASS Shared Resource at Dan L. Duncan Cancer Center (DLDCC) of Baylor College of Medicine [P30CA125123];  [CA211653]	This work was supported by the National Natural Science Foundation of China (Grant Nos. 91640119, 31601196, 81330055, 31371508, and 31671540), the Natural Science Foundation of Guangdong Province (2016A030310206 and 2014A030312011), the Science and Technology Planning Project of Guangdong Province (2015B020228002 and 2015A020212005), the Guangzhou Science and Technology Project (201605030012 and 201707010085), and the Fundamental Research Funds for the Central Universities (161gzd13 and 161gpy31). We would also like to acknowledge the support of CA211653, CPRIT RP160462, the Welch Foundation Q-1673, and the C-BASS Shared Resource at the Dan L. Duncan Cancer Center (DLDCC) of Baylor College of Medicine (P30CA125123).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Bansal V, 2011, BIOINFORMATICS, V27, P2047, DOI 10.1093/bioinformatics/btr344; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Fu YF, 2014, METHOD ENZYMOL, V546, P21, DOI 10.1016/B978-0-12-801185-0.00002-7; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kidane D, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.42; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim K, 2017, NAT BIOTECHNOL; Kim YB, 2017, NAT BIOTECHNOL; KINGMA PS, 1995, J BIOL CHEM, V270, P21441, DOI 10.1074/jbc.270.37.21441                                                        ; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li J, 2016, MOL PLANT; Lu Y, 2016, MOL PLANT; Ma WJ, 2009, MOL CELL BIOL, V29, P1212, DOI 10.1128/MCB.01499-08; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nishida K., 2016, SCIENCE, V353; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Porteus MH, 2006, MOL THER, V13, P438, DOI 10.1016/j.ymthe.2005.08.003; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; SARACONI G, 2014, GENOME BIOL, V15; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13330; ZHANG XF, 2016, SCI REP UK, V6; Zong Y, 2017, NAT BIOTECHNOL	44	6	6	12	12	HIGHER EDUCATION PRESS	BEIJING	NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA	1674-800X	1674-8018		PROTEIN CELL	Protein Cell	AUG	2017	8	8					601	611		10.1007/s13238-017-0418-2				11	Cell Biology	Cell Biology	FC7DU	WOS:000407002200006	28585179	gold			2018-01-05	
J	Tsunematsu, H; Uyeda, A; Yamamoto, N; Sugo, N				Tsunematsu, Hiroto; Uyeda, Akiko; Yamamoto, Nobuhiko; Sugo, Noriyuki			Immunocytochemistry and fluorescence imaging efficiently identify individual neurons with CRISPR/Cas9-mediated gene disruption in primary cortical cultures	BMC NEUROSCIENCE			English	Article						CREB; FOS; CRISPR/Cas9; Cortical neuron; Gene disruption; Immunocytochemistry	DENDRITIC GROWTH; STEM-CELLS; CREB GENE; SYSTEM; MICE; TRANSCRIPTION; GENERATION; CRISPR; MOUSE; CAS9	Background: CRISPR/Cas9 system is a powerful method to investigate the role of genes by introducing a mutation selectively and efficiently to specific genome positions in cell and animal lines. However, in primary neuron cultures, this method is affected by the issue that the effectiveness of CRISPR/Cas9 is different in each neuron. Here, we report an easy, quick and reliable method to identify mutants induced by the CRISPR/Cas9 system at a single neuron level, using immunocytochemistry (ICC) and fluorescence imaging. Results: Dissociated cortical cells were transfected with CRISPR/Cas9 plasmids targeting the transcription factor cAMP-response element binding protein (CREB). Fluorescence ICC with CREB antibody and quantitative analysis of fluorescence intensity demonstrated that CREB expression disappeared in a fraction of the transfected neurons. The downstream FOS expression was also decreased in accordance with suppressed CREB expression. Moreover, dendritic arborization was decreased in the transfected neurons which lacked CREB immunoreactivity. Conclusions: Detection of protein expression is efficient to identify individual postmitotic neurons with CRISPR/Cas9-mediated gene disruption in primary cortical cultures. The present method composed of CRISPR/Cas9 system, ICC and fluorescence imaging is applicable to study the function of various genes at a single-neuron level.	[Tsunematsu, Hiroto; Uyeda, Akiko; Yamamoto, Nobuhiko; Sugo, Noriyuki] Osaka Univ, Grad Sch Frontier Biosci, Cellular & Mol Neurobiol, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan	Sugo, N (reprint author), Osaka Univ, Grad Sch Frontier Biosci, Cellular & Mol Neurobiol, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	sugo@fbs.osaka-u.ac.jp			MEXT KAKENHI [23115102]; JSPS KAKENHI [25640035, 15K14350, 17K07109]	This work was supported by MEXT KAKENHI on Innovative Areas "Mesoscopic Neurocircuitry" (No. 23115102) to N.Y. This work was also supported by JSPS KAKENHI Grant Nos. 25640035, 15K14350 and 17K07109 to N.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blendy JA, 1996, EMBO J, V15, P1098; BLENDY JA, 1995, BRAIN RES, V681, P8, DOI 10.1016/0006-8993(95)00274-T; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0                                                                ; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894                                                         ; Hata R, 1998, J CEREBR BLOOD F MET, V18, P1325, DOI 10.1097/00004647-199812000-00007                                                ; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Incontro S, 2014, NEURON, V83, P1051, DOI 10.1016/j.neuron.2014.07.043; Krichevsky AM, 2002, P NATL ACAD SCI USA, V99, P11926, DOI 10.1073/pnas.182272699; KUCHERLAPATI RS, 1984, P NATL ACAD SCI-BIOL, V81, P3153, DOI 10.1073/pnas.81.10.3153; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Luo WS, 2016, SCI REP-UK, V6, DOI 10.1038/srep35747; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malik AN, 2014, NAT NEUROSCI, V17, P1330, DOI 10.1038/nn.3808; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Qiu P, 2004, BIOTECHNIQUES, V36, P702; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7                                                   ; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Straub C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105584; Sugo N, 2010, EUR J NEUROSCI, V31, P1521, DOI 10.1111/j.1460-9568.2010.07218.x; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025	28	0	0	3	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	AUG 1	2017	18								55	10.1186/s12868-017-0377-9				9	Neurosciences	Neurosciences & Neurology	FC6UX	WOS:000406978300001	28764650	gold			2018-01-05	
J	Okada, M; Chikuma, S; Kondo, T; Hibino, S; Machiyama, H; Yokosuka, T; Nakano, M; Yoshimura, A				Okada, Masahiro; Chikuma, Shunsuke; Kondo, Taisuke; Hibino, Sana; Machiyama, Hiroaki; Yokosuka, Tadashi; Nakano, Miyako; Yoshimura, Akihiko			Blockage of Core Fucosylation Reduces Cell-Surface Expression of PD-1 and Promotes Anti-tumor Immune Responses of T Cells	CELL REPORTS			English	Article							CHRONIC INFECTION; CANCER-IMMUNITY; LUNG-CANCER; E-CADHERIN; IN-VIVO; RECEPTOR; ANTIGEN; ALPHA-1,6-FUCOSYL-TRANSFERASE; ANTIBODY; FUCOSE	Programmed cell death 1 (PD-1) is highly expressed on exhausted T cells and inhibits T cell activation. Antibodies that block the interaction between PD-1 and its ligand prevent this inhibitory signal and reverse T cell dysfunction, providing beneficial antitumor responses in a substantial number of patients. Mechanisms for the induction and maintenance of high PD-1 expression on exhausted T cells have not been fully understood. Utilizing a genome-wide loss-of-function screening method based on the CRISPR-Cas9 system, we identified genes involved in the core fucosylation pathway as positive regulators of cell-surface PD-1 expression. Inhibition of Fut8, a core fucosyltransferase, by genetic ablation or pharmacologic inhibition reduced cell-surface expression of PD-1 and enhanced T cell activation, leading to more efficient tumor eradication. Taken together, our findings suggest that blocking core fucosylation of PD-1 can be a promising strategy for improving anti-tumor immune responses.	[Okada, Masahiro; Chikuma, Shunsuke; Kondo, Taisuke; Hibino, Sana; Yoshimura, Akihiko] Keio Univ, Dept Microbiol & Immunol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Machiyama, Hiroaki; Yokosuka, Tadashi] Tokyo Med Univ, Dept Immunol, Shinjuku Ku, Tokyo 1608402, Japan; [Nakano, Miyako] Hiroshima Univ, Grad Sch Adv Sci Matter, Higashihiroshima, Hiroshima 7398530, Japan; [Okada, Masahiro] RIKEN Ctr Integrat Med Sci, Lab Immunotherapy, Yokohama, Kanagawa 2300045, Japan	Okada, M; Yoshimura, A (reprint author), Keio Univ, Dept Microbiol & Immunol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan.; Okada, M (reprint author), RIKEN Ctr Integrat Med Sci, Lab Immunotherapy, Yokohama, Kanagawa 2300045, Japan.	okada@z5.keio.jp; yoshimura@a6.keio.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25221305]; Advanced Research and Development Programs for Medical Innovation (AMED-CREST); Takeda Science Foundation; Uehara Memorial Foundation; Keio Gijuku Academic Developmental Funds;  [17H05801];  [17K15451]	MO5 cells were a kind gift from Dr. Kenneth L. Rock. CRISPR vectors were a kind gift from Dr. Feng Zhang. The CRISRP gRNA library was a kind gift from Dr. Kosuke Yusa. We thank N. Shiino, M. Asakawa, H. Yamane, C. Ohkura, and Y. Hirata for their technical assistance. We acknowledge S. Usui and A. Naya for their technical assistance for glycoproteomics and Y. Ushijima for manuscript preparation. This work was supported by special grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 25221305 to A.Y.), Grant-in-Aid for Scientific Research on Innovative Areas (no. 17H05801 to S.C.), Grant-in-Aid for Young Scientists (B) (no. 17K15451 to M.O.), Advanced Research and Development Programs for Medical Innovation (AMED-CREST) (to A. Y.), the Takeda Science Foundation (to A.Y.), Uehara Memorial Foundation (to A.Y.), and Keio Gijuku Academic Developmental Funds (to A.Y.).	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Austin JW, 2014, J IMMUNOL, V192, P4876, DOI 10.4049/jimmunol.1302750; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Charlton JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119200; Charlton JJ, 2013, J IMMUNOL, V190, P6104, DOI 10.4049/jimmunol.1201617; Chen CY, 2013, P NATL ACAD SCI USA, V110, P630, DOI 10.1073/pnas.1220425110; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chikuma S, 2016, INT J CLIN ONCOL, V21, P448, DOI 10.1007/s10147-016-0958-0; Chikuma S, 2009, J IMMUNOL, V182, P6682, DOI 10.4049/jimmunol.0900080; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Fujii H, 2016, GASTROENTEROLOGY, V150, P1620, DOI 10.1053/j.gastro.2016.03.002; Fukuda T, 2011, J BIOL CHEM, V286, P18434, DOI 10.1074/jbc.M110.172536; Gao CX, 2012, J BIOL CHEM, V287, P16699, DOI 10.1074/jbc.M111.315333; Geng F, 2004, CELL RES, V14, P423, DOI 10.1038/sj.cr.7290243; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoffmann M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005661; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Ito Y, 2003, CANCER LETT, V200, P167, DOI 10.1016/S0304-3835(03)00383-5; Kanda Y, 2007, J BIOTECHNOL, V130, P300, DOI 10.1016/j.jbiotec.2007.04.025; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; KUBO M, 1994, INT IMMUNOL, V6, P179, DOI 10.1093/intimm/6.2.179                                                          ; Li CW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12632; Li WZ, 2015, J IMMUNOL, V194, P2596, DOI 10.4049/jimmunol.1402678; Lim SO, 2016, CANCER CELL, V30, P925, DOI 10.1016/j.ccell.2016.10.010; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Lu PY, 2014, J EXP MED, V211, P515, DOI 10.1084/jem.20130208; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; Muinelo-Romay L, 2008, INT J CANCER, V123, P641, DOI 10.1002/ijc.23521; Noda K, 2003, CANCER RES, V63, P6282; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832                                                     ; Okada M, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0129-1; Okeley NM, 2013, P NATL ACAD SCI USA, V110, P5404, DOI 10.1073/pnas.1222263110; Osumi D, 2009, CANCER SCI, V100, P888, DOI 10.1111/j.1349-7006.2009.01125.x; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Takahashi T, 2000, INT J CANCER, V88, P914, DOI 10.1002/1097-0215(20001215)88:6<914::AID-IJC12>3.0.CO;2-1; Taylor A, 2016, IMMUNITY, V44, P274, DOI 10.1016/j.immuni.2016.01.018; Terawaki S, 2011, J IMMUNOL, V186, P2772, DOI 10.4049/jimmunol.1003208; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Voss M, 2014, EMBO J, V33, P2890, DOI 10.15252/embj.201488375; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wang YQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08264; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741	68	0	0	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	AUG 1	2017	20	5					1017	1028		10.1016/j.celrep.2017.07.027				12	Cell Biology	Cell Biology	FC2PI	WOS:000406680000001	28768188	gold			2018-01-05	
J	Lessard, S; Gatof, ES; Beaudoin, M; Schupp, PG; Sher, F; Ali, A; Prehar, S; Kurita, R; Nakamura, Y; Baena, E; Ledoux, J; Oceandy, D; Bauer, DE; Lettre, G				Lessard, Samuel; Gatof, Emily Stern; Beaudoin, Melissa; Schupp, Patrick G.; Sher, Falak; Ali, Adnan; Prehar, Sukhpal; Kurita, Ryo; Nakamura, Yukio; Baena, Esther; Ledoux, Jonathan; Oceandy, Delvac; Bauer, Daniel E.; Lettre, Guillaume			An erythroid-specific ATP2B4 enhancer mediates red blood cell hydration and malaria susceptibility	JOURNAL OF CLINICAL INVESTIGATION			English	Article							TRANSCRIPTION FACTOR-BINDING; FETAL-HEMOGLOBIN; SATURATING MUTAGENESIS; REGULATORY ELEMENTS; GENE-EXPRESSION; ATPASE 4; DISEASE; BCL11A; LOCI; VARIANT	The lack of mechanistic explanations for many genotype-phenotype associations identified by GWAS precludes thorough assessment of their impact on human health. Here, we conducted an expression quantitative trait locus (eQTL) mapping analysis in erythroblasts and found erythroid-specific eQTLs for ATP2B4, the main calcium ATPase of red blood cells (rbc). The same SNPs were previously associated with mean corpuscular hemoglobin concentration (MCHC) and susceptibility to severe malaria infection. We showed that Atp2b4(-/-) mice demonstrate increased MCHC, confirming ATP2B4 as the causal gene at this GWAS locus. Using CRISPR-Cas9, we fine mapped the genetic signal to an erythroid-specific enhancer of ATP2B4. Erythroid cells with a deletion of the ATP2B4 enhancer had abnormally high intracellular calcium levels. These results illustrate the power of combined transcriptomic, epigenomic, and genome-editing approaches in characterizing noncoding regulatory elements in phenotype-relevant cells. Our study supports ATP2B4 as a potential target for modulating rbc hydration in erythroid disorders and malaria infection.	[Lessard, Samuel; Beaudoin, Melissa; Ledoux, Jonathan; Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ, Canada; [Lessard, Samuel; Beaudoin, Melissa; Ledoux, Jonathan; Lettre, Guillaume] Univ Montreal, Montreal, PQ, Canada; [Gatof, Emily Stern; Schupp, Patrick G.; Sher, Falak; Bauer, Daniel E.] Harvard Med Sch, Div Hematol Oncol,, Boston Childrens Hosp,Harvard Stem Cell Inst, Dept Pediat Oncol,Dana Farber Canc Inst,Dept Pedi, Boston, MA USA; [Gatof, Emily Stern] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Ali, Adnan; Baena, Esther] Univ Manchester, Canc Res UK Manchester Inst, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Prehar, Sukhpal; Oceandy, Delvac] Univ Manchester, Div Cardiovasc Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Kurita, Ryo; Nakamura, Yukio] RIKEN BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan; [Nakamura, Yukio] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan	Bauer, DE (reprint author), Boston Childrens Hosp, Karp 8211,One Blackfan Circle, Boston, MA 02115 USA.; Lettre, G (reprint author), Montreal Heart Inst, Res Ctr, 3rd Floor,5000 Belanger St, Montreal, PQ H1T 1C8, Canada.	daniel.bauer@childrens.harvard.edu; guil-laume.lettre@umontreal.ca	Ledoux, Jonathan/D-2945-2012	Ledoux, Jonathan/0000-0001-8540-7763	Canadian Institute of Health Research (CIHR); Fondation Pierre Lavoie; American Society of Hematology HONORS award; Cancer Research UK Clinical Training Award [C147/A19496]; Cancer Research UK [C5759/A20971]; British Heart Foundation Intermediate Fellowship [FS/09/046/28043]; British Heart Foundation [PG/13/12/30017, PG/16/77/32400]; National Institute of Diabetes and Digestive and Kidney Diseases [K08DK093705, R03DK109232]; National Heart, Lung, and Blood Institute [DP2OD022716]; Burroughs Wellcome Fund; American Society of Hematology; Doris Duke Charitable foundation; Charles H. Hood foundation; Cooley's Anemia foundation; CIHR [123382]; National Sciences and Engineering Research Council of Canada [RGPIN-2016-04597]; Montreal Heart Institute Foundation; Canada Research Chair Program	Part of this research has been conducted using the UKBB resource under application number 11707. The authors wish to thank Gerald Lilly and Louis R. Villeneuve for assistance and Seth L. Alper, Carlo Brugnara, and Elizabeth Egan for comments. SL holds fellowships from the Canadian Institute of Health Research (CIHR) and the "Fondation Pierre Lavoie." ESG was the recipient of an American Society of Hematology HONORS award. AA holds a Cancer Research UK Clinical Training Award (C147/A19496). EB is supported by a Cancer Research UK start-up grant (C5759/A20971). DO was supported by a British Heart Foundation Intermediate Fellowship (FS/09/046/28043) and British Heart Foundation project grants (PG/13/12/30017 and PG/16/77/32400). DEB was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (K08DK093705, R03DK109232), the National Heart, Lung, and Blood Institute (DP2OD022716), the Burroughs Wellcome Fund, the American Society of Hematology, and the Doris Duke Charitable, Charles H. Hood, and Cooley's Anemia foundations. GL was supported by grants from the CIHR (no. 123382), the Doris Duke Charitable Foundation, the National Sciences and Engineering Research Council of Canada (RGPIN-2016-04597), the Montreal Heart Institute Foundation, and the Canada Research Chair Program.	Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Bartolucci P, 2012, BLOOD, V120, P3136, DOI 10.1182/blood-2012-04-424184; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Canver MC, 2017, NAT GENET, V49, P625, DOI 10.1038/ng.3793; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Cavalli M, 2016, HUM GENET, V135, P485, DOI 10.1007/s00439-016-1654-x; Chami N., 2016, J CLIN INVEST, V99, P8; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; GTEx Consortium, 2013, NAT GENET, V45, P580; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lessard S, 2015, GENOME MED, V7, DOI 10.1186/s13073-014-0122-2; Li J, 2013, HUM MOL GENET, V22, P1457, DOI 10.1093/hmg/dds534; Masuda T, 2016, SCIENCE, V351, P285, DOI 10.1126/science.aad3312; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Mohamed TMA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11074; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Panousis NI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0467-2; Kundaje A, 2015, NATURE, V518, P317, DOI DOI 10.1038/NATURE14248; Rockett KA, 2014, NAT GENET, V46, P1197, DOI 10.1038/ng.3107; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Tiffert T, 2005, BLOOD, V105, P4853, DOI 10.1182/blood-2004-12-4948; Timmann C, 2012, NATURE, V489, P443, DOI 10.1038/nature11334; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Xu J, 2012, DEV CELL, V23, P796, DOI 10.1016/j.devcel.2012.09.003; Zambo B, 2017, CELL CALCIUM, V65, P73, DOI 10.1016/j.ceca.2017.02.001	37	0	0	4	4	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	AUG 1	2017	127	8					3065	3074		10.1172/JCI94378				10	Medicine, Research & Experimental	Research & Experimental Medicine	FC2PD	WOS:000406679500019	28714864				2018-01-05	
J	Kemaladewi, DU; Maino, E; Hyatt, E; Hou, HY; Ding, M; Place, KM; Zhu, XY; Bassi, P; Baghestani, Z; Deshwar, AG; Merico, D; Xiong, HY; Frey, BJ; Wilson, MD; Ivakine, EA; Cohn, RD				Kemaladewi, Dwi U.; Maino, Eleonora; Hyatt, Elzbieta; Hou, Huayun; Ding, Maylynn; Place, Kara M.; Zhu, Xinyi; Bassi, Prabhpreet; Baghestani, Zahra; Deshwar, Amit G.; Merico, Daniele; Xiong, Hui Y.; Frey, Brendan J.; Wilson, Michael D.; Ivakine, Evgueni A.; Cohn, Ronald D.			Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism	NATURE MEDICINE			English	Article							IN-VIVO; GENOME; MICE; CAS9; CRISPR-CAS9; RECOGNITION; EXPRESSION; MUTATIONS; SITES; CELLS	Splice-site defects account for about 10% of pathogenic mutations that cause Mendelian diseases(1). Prevalence is higher in neuromuscular disorders (NMDs)(2), owing to the unusually large size and multi-exonic nature of genes encoding muscle structural proteins. Therapeutic genome editing to correct disease-causing splice-site mutations has been accomplished only through the homology-directed repair pathway(3-5), which is extremely inefficient in postmitotic tissues such as skeletal muscle(6). Here we describe a strategy using nonhomologous end-joining (NHEJ) to correct a pathogenic splice-site mutation. As a proof of principle, we focus on congenital muscular dystrophy type 1A (MDC1A), which is characterized by severe muscle wasting and paralysis(7). Specifically, we correct a splice-site mutation that causes the exclusion of exon 2 from Lama2 mRNA and the truncation of Lama2 protein in the dy(2J)/dy(2J) mouse model of MDC1A(8). Through systemic delivery of adeno-associated virus (AAV) carrying clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 genome-editing components, we simultaneously excise an intronic region containing the mutation and create a functional donor splice site through NHEJ. This strategy leads to the inclusion of exon 2 in the Lama2 transcript and restoration of full-length Lama2 protein. Treated dy(2J)/dy(2J) mice display substantial improvement in muscle histopathology and function without signs of paralysis.	[Kemaladewi, Dwi U.; Maino, Eleonora; Hyatt, Elzbieta; Hou, Huayun; Ding, Maylynn; Place, Kara M.; Zhu, Xinyi; Bassi, Prabhpreet; Baghestani, Zahra; Merico, Daniele; Wilson, Michael D.; Ivakine, Evgueni A.; Cohn, Ronald D.] Hosp Sick Children Res Inst, Program Genet & Genome Biol, Toronto, ON, Canada; [Maino, Eleonora; Hou, Huayun; Bassi, Prabhpreet; Wilson, Michael D.; Cohn, Ronald D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Deshwar, Amit G.; Merico, Daniele; Xiong, Hui Y.; Frey, Brendan J.] Deep Genom, Toronto, ON, Canada; [Merico, Daniele] Hosp Sick Children Res Inst, Ctr Appl Genom TCAG, Toronto, ON, Canada; [Frey, Brendan J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada; [Frey, Brendan J.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Wilson, Michael D.] Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON, Canada; [Cohn, Ronald D.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Cohn, Ronald D.] Hosp Sick Children, Toronto, ON, Canada	Ivakine, EA; Cohn, RD (reprint author), Hosp Sick Children Res Inst, Program Genet & Genome Biol, Toronto, ON, Canada.; Cohn, RD (reprint author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.; Cohn, RD (reprint author), Univ Toronto, Dept Pediat, Toronto, ON, Canada.; Cohn, RD (reprint author), Hosp Sick Children, Toronto, ON, Canada.	zhenya.ivakine@sickkids.ca; ronald.cohn@sickkids.ca	Wilson, Michael/K-6294-2014	Wilson, Michael/0000-0002-4015-3066	AFM-Telethon postdoctoral fellowship and Cure CMD; Ermenegildo Zegna Founder's scholarship; Canada Research Chair (Tier 2) in Comparative Genomics; Ontario Ministry of Research, Innovation and Science; Canadian Institute for Health Research; Natural Sciences and Engineering Research Council of Canada; SickKids Foundation; RS McLaughlin Foundation; Women's Auxiliary Chairs	The Cohn lab members are gratefully acknowledged for their technical support and critical input in this study. We thank I. Vukobradovic and A. Fleniken (Clinical Phenotyping Core, Toronto Centre for Phenogenomics), C. Rand (Aurora Scientific), and M. Justice, J. Dowling, and J. Ruston (Genetics and Genome Biology) for their critical inputs to this study. T. Paton, S. Perreira, G. Casallo, B. Thiruvahindrapuram, W. Sung (Toronto Center for Applied Genomics), and A. Cui (Deep Genomics) are acknowledged for their support in genomic and bioinformatics analyses. This work was supported by an AFM-Telethon postdoctoral fellowship and Cure CMD (to D.U.K.); an Ermenegildo Zegna Founder's scholarship (to E.M.); a Canada Research Chair (Tier 2) in Comparative Genomics and an Early Researcher Award from the Ontario Ministry of Research, Innovation and Science (to M.D.W.); and the Canadian Institute for Health Research, Natural Sciences and Engineering Research Council of Canada, the SickKids Foundation, RS McLaughlin Foundation and Women's Auxiliary Chairs (to R.D.C.).	Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758; Call JA, 2016, METHODS MOL BIOL, V1460, P3, DOI 10.1007/978-1-4939-3810-0_1; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Durbeej M, 2015, CURR TOP MEMBR, V76, P31, DOI 10.1016/bs.ctm.2015.05.002; Ferdousi LV, 2014, STEM CELL RES, V13, P492, DOI 10.1016/j.scr.2014.08.005; Geranmayeh F, 2010, NEUROMUSCULAR DISORD, V20, P241, DOI 10.1016/j.nmd.2010.02.001; Guiraud S, 2015, ANNU REV GENOM HUM G, V16, P281, DOI 10.1146/annurev-genom-090314-025003; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Tsai S.Q., 2015, NAT BIOTECHNOL, V33, P187; Iyer SR, 2016, METHODS MOL BIOL, V1460, P293, DOI 10.1007/978-1-4939-3810-0_20; Jian XQ, 2014, NUCLEIC ACIDS RES, V42, P13534, DOI 10.1093/nar/gku1206; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kemaladewi DU, 2012, FASEB J, V26, P1462, DOI 10.1096/fj.11-191189; Kim E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14500; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705; Gombash Lampe S.E., 2014, JOVE-J VIS EXP, V93; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Roca X, 2013, GENE DEV, V27, P129, DOI 10.1101/gad.209759.112; Roca X, 2012, GENE DEV, V26, P1098, DOI 10.1101/gad.190173.112; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; Stepson P.D., 2014, HUM GENET, V133, P1; SUNADA Y, 1995, HUM MOL GENET, V4, P1055, DOI 10.1093/hmg/4.6.1055; Tan JZ, 2016, NUCLEIC ACIDS RES, V44, P3908, DOI 10.1093/nar/gkw163; Tanguy Y, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00036; Tatem K. S., 2014, JOVE-J VIS EXP, V91, P51785, DOI DOI 10.3791/51785; Vilquin JT, 2000, NEUROMUSCULAR DISORD, V10, P59, DOI 10.1016/S0960-8966(99)00056-5                                                   ; Wojtal D, 2016, AM J HUM GENET, V98, P90, DOI 10.1016/j.ajhg.2015.11.012; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418                                                        ; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yu QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059627; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	40	2	2	11	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					984	+		10.1038/nm.4367				8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FC6JY	WOS:000406947600014	28714989				2018-01-05	
J	Pickett, MA; Dush, MK; Nascone-Yoder, NM				Pickett, Melissa A.; Dush, Michael K.; Nascone-Yoder, Nanette M.			Acetylcholinesterase plays a non-neuronal, non-esterase role in organogenesis	DEVELOPMENT			English	Article						Acetylcholinesterase; Morphogenesis; Gut; Intestine; Fibronectin; Xenopus laevis	AGRICULTURAL PESTICIDE EXPOSURES; ZEBRAFISH DANIO-RERIO; SAN-JOAQUIN VALLEY; XENOPUS-LAEVIS; LARVAL DEVELOPMENT; NEURITE OUTGROWTH; COMMON MECHANISM; KNOCKOUT MOUSE; BIRTH-DEFECTS; GUT	Acetylcholinesterase (AChE) is crucial for degrading acetylcholine at cholinergic synapses. In vitro studies suggest that, in addition to its role in nervous system signaling, AChE can also modulate non-neuronal cell properties, although it remains controversial whether AChE functions in this capacity in vivo. Here, we show that AChE plays an essential non-classical role in vertebrate gut morphogenesis. Exposure of Xenopus embryos to AChE-inhibiting chemicals results in severe defects in intestinal development. Tissue-targeted loss-of-function assays (via microinjection of antisense morpholino or CRISPR-Cas9) confirm that AChE is specifically required in the gut endoderm tissue, a non-neuronal cell population, where it mediates adhesion to fibronectin and regulates cell rearrangement events that drive gut lengthening and digestive epithelial morphogenesis. Notably, the classical esterase activity of AChE is dispensable for this activity. As AChE is deeply conserved, widely expressed outside of the nervous system, and the target of many environmental chemicals, these results have wide-reaching implications for development and toxicology.	[Pickett, Melissa A.; Nascone-Yoder, Nanette M.] North Carolina State Univ, Dept Biol, Environm & Mol Toxicol Program, Raleigh, NC 27606 USA; [Dush, Michael K.; Nascone-Yoder, Nanette M.] North Carolina State Univ, Dept Mol Biomed Sci, Coll Vet Med, Raleigh, NC 27607 USA	Nascone-Yoder, NM (reprint author), North Carolina State Univ, Dept Biol, Environm & Mol Toxicol Program, Raleigh, NC 27606 USA.; Nascone-Yoder, NM (reprint author), North Carolina State Univ, Dept Mol Biomed Sci, Coll Vet Med, Raleigh, NC 27607 USA.	nmnascon@ncsu.edu			National Institutes of Health [R01DK085300]; U.S. Department of Education Graduate Assistance in Areas of National Need [P200A090129]	This work was funded by the National Institutes of Health (R01DK085300) and the U.S. Department of Education Graduate Assistance in Areas of National Need (P200A090129). Deposited in PMC for release after 12 months.	Anderson AA, 2008, J CELL PHYSIOL, V215, P82, DOI 10.1002/jcp.21288; ASHANI Y, 1992, BIOCHEM BIOPH RES CO, V184, P719, DOI 10.1016/0006-291X(92)90649-6; Bacchetta R, 2008, SCI TOTAL ENVIRON, V392, P110, DOI 10.1016/j.scitotenv.2007.11.031; Behra M, 2004, TOXICOL SCI, V77, P325, DOI 10.1093/toxsci/kfh020; Behra M, 2002, NAT NEUROSCI, V5, P111, DOI 10.1038/nn788; Bertrand C, 2001, J BIOL CHEM, V276, P464, DOI 10.1074/jbc.M006308200; Bicker G, 2004, CELL TISSUE RES, V317, P207, DOI 10.1007/s00441-004-0905-7; Bonfanti P, 2004, AQUAT TOXICOL, V70, P189, DOI 10.1016/j.aquatox.2004.09.007; Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415                                                        ; Bytyqi AH, 2004, EUR J NEUROSCI, V20, P2953, DOI 10.1111/j.1460-9568.2004.03753.x; Carmichael SL, 2016, BIRTH DEFECTS RES A, V106, P27, DOI 10.1002/bdra.23459; Carmichael SL, 2014, ENVIRON RES, V135, P133, DOI 10.1016/j.envres.2014.08.030; Cervantes S, 2009, DEV BIOL, V326, P285, DOI 10.1016/j.ydbio.2008.11.020; Chalmers AD, 1998, DEV DYNAM, V212, P509, DOI 10.1002/(SICI)1097-0177(199808)212:4<509::AID-AJA4>3.0.CO;2-L; Chalmers AD, 2000, DEVELOPMENT, V127, P381; Cousin X, 2005, BIOESSAYS, V27, P189, DOI 10.1002/bies.20153; Darboux I, 1996, EMBO J, V15, P4835; Davidson LA, 2006, CURR BIOL, V16, P833, DOI 10.1016/j.cub.2006.03.038; de Almeida PG, 2016, DEV DYNAM, V245, P520, DOI 10.1002/dvdy.24391; Downes GB, 2004, DEV BIOL, V270, P232, DOI 10.1016/j.ydbio.2004.02.027; Drews U., 1975, PROG HISTOCHEM CYTOC, V7, P1; DUPREE JL, 1994, J NEUROSCI RES, V39, P567, DOI 10.1002/jnr.490390508                                                           ; Dush MK, 2013, DEVELOPMENT, V140, P1457, DOI 10.1242/dev.086850; Duysen EG, 2002, DEV BRAIN RES, V137, P43, DOI 10.1016/S0165-3806(02)00367-X; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9                                                    ; Gilbert MM, 2005, FRONT BIOSCI, V10, P2177, DOI 10.2741/1689; Grisaru D, 1999, MOL CELL BIOL, V19, P788; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Inkson CA, 2004, BONE, V35, P819, DOI 10.1016/j.bone.2004.05.026; Johnson G, 1999, BIOCHEM BIOPH RES CO, V258, P758, DOI 10.1006/bbrc.1999.0705                                                          ; Johnson G, 2004, BIOCHEM BIOPH RES CO, V319, P448, DOI 10.1016/j.bbrc.2004.05.018; Johnson G, 2008, FEBS J, V275, P5129, DOI 10.1111/j.1742-4658.2008.06644.x; Johnson G, 2008, BIOCHEM J, V411, P507, DOI 10.1042/BJ20071404; Kedinger M, 1998, PHILOS T R SOC B, V353, P847, DOI 10.1098/rstb.1998.0249; Keller M, 2001, CELL TISSUE RES, V306, P187, DOI 10.1007/s004410100444; LAYER PG, 1993, CELL TISSUE RES, V273, P219, DOI 10.1007/BF00312823                                                              ; Aronzon CM, 2014, CHEMOSPHERE, V100, P50, DOI 10.1016/j.chemosphere.2013.12.078; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; Marsden M, 2001, DEVELOPMENT, V128, P3635; Matsuyama M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000427; Mileson BE, 1998, TOXICOL SCI, V41, P8; Nieuwkoop PD, 1994, NORMAL TABLE XENOPUS; Ohta K, 2009, COMP BIOCHEM PHYS B, V153, P310, DOI 10.1016/j.cbpb.2009.04.001; Pamanji R, 2015, ENVIRON SCI POLLUT R, V22, P7744, DOI 10.1007/s11356-015-4120-8; Pamanji R, 2015, ENVIRON TOXICOL PHAR, V39, P887, DOI 10.1016/j.etap.2015.02.020; Paraoanu LE, 2004, FEBS LETT, V576, P161, DOI 10.1016/j.tebslet.2004.08.078; Pope C, 2005, ENVIRON TOXICOL PHAR, V19, P433, DOI 10.1016/j.etap.2004.12.048; Reed RA, 2009, DEV DYNAM, V238, P3111, DOI 10.1002/dvdy.22157; ROMERO P, 1989, ENVIRON RES, V50, P256, DOI 10.1016/S0013-9351(89)80006-4; Sharma KV, 2001, J NEUROSCI RES, V63, P165, DOI 10.1002/1097-4547(20010115)63:2<165::AID-JNR1008>3.3.CO;2-F; Sherman JD, 1995, INT J OCCUP MED TOX, V4, P417; Silman I, 2005, CURR OPIN PHARMACOL, V5, P293, DOI 10.1016/j.coph.2005.01.014; Sive H.L., 2000, EARLY DEV XENOPUS LA; SNAWDER JE, 1989, J ENVIRON SCI HEAL B, V24, P205, DOI 10.1080/03601238909372644                                                       ; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Spieker J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170252; Spieker J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161675; Syed M, 2008, CLIN EXP METASTAS, V25, P787, DOI 10.1007/s10585-008-9192-0; Trinh LA, 2004, DEV CELL, V6, P371; Vogel-Hopker A, 2012, PROTEIN PEPTIDE LETT, V19, P155; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; WYTTENBACH CR, 1985, AM J ANAT, V174, P187, DOI 10.1002/aja.1001740208; Xiang AC, 2008, CELL MOL LIFE SCI, V65, P1768, DOI 10.1007/s00018-008-8016-3; Xie WH, 2000, J PHARMACOL EXP THER, V293, P896; Yang L, 2002, NEUROSCI RES, V42, P261, DOI 10.1016/S0168-0102(02)00005-6; YARNITZKY T, 1995, DEV BIOL, V169, P609, DOI 10.1006/dbio.1995.1173                                                          	66	0	0	4	4	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	AUG 1	2017	144	15					2764	2770		10.1242/dev.149831				7	Developmental Biology	Developmental Biology	FC2NC	WOS:000406673600009	28684626				2018-01-05	
J	Aslan, Y; Tadjuidje, E; Zorn, AM; Cha, SW				Aslan, Yetki; Tadjuidje, Emmanuel; Zorn, Aaron M.; Cha, Sang-Wook			High-efficiency non-mosaic CRISPR-mediated knock-in and indel mutation in F0 Xenopus	DEVELOPMENT			English	Article						CRISPR/Cas9; F0; Xenopus tropicalis; Xenopus laevis; Homology-directed repair (HDR); Non-mosaic	HOMOLOGOUS RECOMBINATION; MESSENGER-RNAS; HOST TRANSFER; GENOME; DNA; TROPICALIS; SYSTEM; ZEBRAFISH; OOCYTES; LAEVIS	The revolution in CRISPR-mediated genome editing has enabled the mutation and insertion of virtually any DNA sequence, particularly in cell culture where selection can be used to recover relatively rare homologous recombination events. The efficient use of this technology in animal models still presents a number of challenges, including the time to establish mutant lines, mosaic gene editing in founder animals, and low homologous recombination rates. Here we report a method for CRISPR-mediated genome editing in Xenopus oocytes with homology-directed repair (HDR) that provides efficient non-mosaic targeted insertion of small DNA fragments (40-50 nucleotides) in 4.4-25.7% of F0 tadpoles, with germline transmission. For both CRISPR/Cas9-mediated HDR gene editing and indel mutation, the gene-edited F0 embryos are uniformly heterozygous, consistent with a mutation in only the maternal genome. In addition to efficient tagging of proteins in vivo, this HDR methodology will allow researchers to create patient-specific mutations for human disease modeling in Xenopus.	[Aslan, Yetki; Tadjuidje, Emmanuel; Zorn, Aaron M.; Cha, Sang-Wook] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA	Cha, SW (reprint author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	sang-wook.cha@cchmc.org		Cha, Sang-Wook/0000-0002-5171-5685	National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK078392, K01 DK101618]	This work was partially supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK078392, K01 DK101618) to S.-W.C. Deposited in PMC for release after 12 months.	Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bassett AR, 2014, BIOL OPEN, V3, P42, DOI 10.1242/bio.20137120; Bhattacharya D, 2015, DEV BIOL, V408, P196, DOI 10.1016/j.ydbio.2015.11.003; Blitz IL, 2016, DEVELOPMENT, V143, P2868, DOI 10.1242/dev.138057; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Evans PM, 2010, MOL CELL BIOL, V30, P372, DOI 10.1128/MCB.00063-09; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Grainger Robert M, 2012, Methods Mol Biol, V917, P3, DOI 10.1007/978-1-61779-992-1_1; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Hagmann M, 1996, BIOL CHEM H-S, V377, P239, DOI 10.1515/bchm3.1996.377.4.239; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; HEASMAN J, 1991, METHOD CELL BIOL, V36, P213; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Kotani H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128319; Li J, 2015, ONCOTARGET, V6, P17891, DOI 10.18632/oncotarget.4547                                                        ; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; MASHAL RD, 1995, NAT GENET, V9, P177, DOI 10.1038/ng0295-177; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Mir Adnan, 2008, V469, P417, DOI 10.1007/978-1-60327-469-2_26; Miura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12799; Miyamoto K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142946; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakajima K, 2015, BIOL OPEN, V4, P180, DOI 10.1242/bio.201410009; Nakayama T, 2014, METHOD ENZYMOL, V546, P355, DOI 10.1016/B978-0-12-801185-0.00017-9; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Nieuwkoop PD, 1994, NORMAL TABLE XENOPUS; Olson David J, 2012, Methods Mol Biol, V917, P167, DOI 10.1007/978-1-61779-992-1_10; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ratzan W, 2017, DEV BIOL, V426, P188, DOI 10.1016/j.ydbio.2016.03.006; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Shi ZY, 2017, GENESIS, V55, DOI 10.1002/dvg.23006; Shi ZY, 2015, FASEB J, V29, P4914, DOI 10.1096/fj.15-273425; SHUTTLEWORTH J, 1988, GENE, V72, P267, DOI 10.1016/0378-1119(88)90152-7; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Truett GE, 2000, BIOTECHNIQUES, V29, P52; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang FQ, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0006-1; Wang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076854; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang Liu, 2014, Journal of Environmental & Occupational Medicine, V31, P1; Yu ZS, 2014, BIOL OPEN, V3, P271, DOI 10.1242/bio.20147682	48	1	1	5	5	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	AUG 1	2017	144	15					2852	2858		10.1242/dev.152967				7	Developmental Biology	Developmental Biology	FC2NC	WOS:000406673600016	28694259				2018-01-05	
J	Naranbhai, V; Carrington, M				Naranbhai, Vivek; Carrington, Mary			Host genetic variation and HIV disease: from mapping to mechanism	IMMUNOGENETICS			English	Review						HIV; Host genetics; HLA; CCR5; Immunology	GENOME-WIDE ASSOCIATION; TO-CHILD TRANSMISSION; HLA-C EXPRESSION; CLASS-I; CONTAINING REGIMENS; RESISTANCE ALLELE; IMMUNE-ACTIVATION; AIDS RESTRICTION; POPULATION-LEVEL; INFECTED MEN	This review aims to provide a summary of current knowledge of host genetic effects on human immunodeficiency virus (HIV) disease. Mapping of simple single nucleotide polymorphisms (SNP) has been largely successful in HIV, but more complex genetic associations involving haplotypic or epigenetic variation, for example, remain elusive. Mechanistic insights explaining SNP associations are incomplete, but continue to be forthcoming. The number of robust immunogenetic correlates of HIV is modest and their discovery mostly predates the genome-wide era. Nevertheless, genome-wide evaluations have nicely validated the impact of HLA and CCR5 variants on HIV disease, and importantly, made clear the many false positive associations that were previously suggested by studies using the candidate gene approach. We describe how multiple HIV outcome measures such as acquisition, viral control, and immune decline have been studied in adults and in children, but that collectively these identify only the two replicable loci responsible for modifying HIV disease, CCR5, and HLA. Recent heritability estimates in this disease corroborate the modest impact of genetic determinants and their oligogenic nature. While the mechanism of protection afforded by genetic variants that diminish CCR5 expression is clear, new aspects of HLA class I-mediated protection continue to be uncovered. We describe how these genetic findings have enhanced insights into immunobiology, been clinically translated into CCR5 antagonists, allowed prioritization of antigens for vaccination efforts, and identified targets for genome-editing interventions. Finally, we describe how studies of genetically complex parts of the genome using new tools may begin revealing additional correlates.	[Naranbhai, Vivek; Carrington, Mary] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Canc & Inflammat Program, Frederick, MD USA; [Naranbhai, Vivek; Carrington, Mary] Ragon Inst MGH MIT & Harvard, Boston, MA USA; [Naranbhai, Vivek] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa	Naranbhai, V (reprint author), Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Canc & Inflammat Program, Frederick, MD USA.; Naranbhai, V (reprint author), Ragon Inst MGH MIT & Harvard, Boston, MA USA.; Naranbhai, V (reprint author), Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.	vnaranbhai@mgh.harvard.edu			Frederick National Laboratory for Cancer Research [HHSN261200800001E]; Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research	This project has been funded in whole or in part with federal funds from the Frederick National Laboratory for Cancer Research, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported in part by the Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research.	Adland E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004954; Alkhatib G, 1997, VIROLOGY, V234, P340, DOI 10.1006/viro.1997.8673; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Bandera A, 2017, EXPERT REV ANTI-INFE, V15, P43, DOI 10.1080/14787210.2017.1250624; Bartha I, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005339; Bartha I, 2013, ELIFE, V2, DOI 10.7554/eLife.01123; Bashirova AA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004196; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Burian A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163297; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Carlson JM, 2008, MICROBES INFECT, V10, P455, DOI 10.1016/j.micinf.2008.01.013; Carlson JM, 2016, NAT MED, V22, P606, DOI 10.1038/nm.4100; Carlson JM, 2012, J VIROL, V86, P13202, DOI 10.1128/JVI.01998-12; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Chantarangsu S, 2011, CLIN INFECT DIS, V53, P341, DOI 10.1093/cid/cir403; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Dahirel V, 2011, P NATL ACAD SCI USA, V108, P11530, DOI 10.1073/pnas.1105315108; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8                                                   ; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Ferguson AL, 2013, IMMUNITY, V38, P606, DOI 10.1016/j.immuni.2012.11.022; Ferreira MAR, 2010, AM J HUM GENET, V86, P88, DOI 10.1016/j.ajhg.2009.12.008; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198                                                          ; Fraser C, 2014, SCIENCE, V343, P1328, DOI 10.1126/science.1243727; Galvani AP, 2003, P NATL ACAD SCI USA, V100, P15276, DOI 10.1073/pnas.2435085100; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Garcia-Beltran WF, 2016, NAT IMMUNOL, V17, P1067, DOI 10.1038/ni.3513; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Herbeck JT, 2012, AIDS, V26, P193, DOI 10.1097/QAD.0b013e32834db418; Herbeck JT, 2010, J INFECT DIS, V201, P618, DOI 10.1086/649842; H. I. V. C. S. International, 2010, SCIENCE, V330, P1551; Holzemer A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001900; Horowitz A, 2016, SCI IMMUNOL, V1, DOI [10.1126/sciimmunol.aag1672, DOI 10.1126/SCIIMMUNOL.AAG1672]; Huang JH, 2009, J EXP MED, V206, P2959, DOI 10.1084/jem.20091386; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Hummel S, 2005, GENES IMMUN, V6, P371, DOI 10.1038/sj.gene.6364172; Irvin MR, 2011, PHARMACOGENET GENOM, V21, P798, DOI 10.1097/FPC.0b013e32834b68f9; Johnson EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118149; Jones DC, 2011, J IMMUNOL, V186, P2990, DOI 10.4049/jimmunol.1003078; Joubert BR, 2010, GENOME MED, V2, DOI 10.1186/gm138; Juarez-Molina CI, 2014, J VIROL, V88, P10392, DOI 10.1128/JVI.01162-14; Julg B, 2011, J INFECT DIS, V203, P803, DOI 10.1093/infdis/jiq122; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; KRONER BL, 1995, AIDS, V9, P275; Kulkarni S, 2013, P NATL ACAD SCI USA, V110, P20705, DOI 10.1073/pnas.1312237110; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; Leger PD, 2014, J NEUROVIROL, V20, P304, DOI 10.1007/s13365-014-0235-9; Lehmann DS, 2015, PHARMACOGENET GENOM, V25, P51, DOI 10.1097/FPC.0000000000000106; Levine AJ, 2012, AM J MED GENET B, V159B, P669, DOI 10.1002/ajmg.b.32071; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Lingappa JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028632; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lucotte G, 1998, J ACQ IMMUN DEF SYND, V19, P174, DOI 10.1097/00042560-199810010-00011                                                ; MacDonald KS, 1998, J INFECT DIS, V177, P551, DOI 10.1086/514243                                                                  ; Mackelprang RD, 2008, J INFECT DIS, V197, P1156, DOI 10.1086/529528; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2013, IMMUNOL REV, V254, P245, DOI 10.1111/imr.12071; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907                                                   ; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Matzaraki V, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1207-1; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; McLaren PJ, 2015, P NATL ACAD SCI USA, V112, P14658, DOI 10.1073/pnas.1514867112; McLaren PJ, 2015, NAT IMMUNOL, V16, P577, DOI 10.1038/ni.3147; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; Merino AM, 2013, CLIN EXP IMMUNOL, V174, P414, DOI 10.1111/cei.12187; Misrahi M, 1998, JAMA-J AM MED ASSOC, V279, P277, DOI 10.1001/jama.279.4.277; Mlisana K, 2014, CLIN INFECT DIS, V59, P1322, DOI 10.1093/cid/ciu573; Moore CB, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofu113; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; NIXON DF, 1988, NATURE, V336, P484, DOI 10.1038/336484a0                                                                ; Norman PJ, 2016, AM J HUM GENET, V99, P375, DOI 10.1016/j.ajhg.2016.06.023; Novembre J, 2005, PLOS BIOL, V3, P1954, DOI 10.1371/journal.pbio.0030339; O'Connor GM, 2015, J VIROL, V89, P5213, DOI 10.1128/JVI.03586-14; Park RJ, 2017, NAT GENET, V49, P193, DOI 10.1038/ng.3741; Payne R, 2014, P NATL ACAD SCI USA, V111, pE5393, DOI 10.1073/pnas.1413339111; Pelak K., 2011, AM SOC HUM GEN ASHG; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Petrovski S, 2011, AIDS, V25, P513, DOI 10.1097/QAD.0b013e328343817b; Polycarpou A, 2002, AIDS RES HUM RETROV, V18, P741, DOI 10.1089/08892220260139477; Ramsuran V, 2017, J IMMUNOL, V198, P2320, DOI 10.4049/jimmunol.1601679; Ramsuran V, 2015, HUM MOL GENET, V24, P4268, DOI 10.1093/hmg/ddv158; Ramsuran V, 2011, CLIN INFECT DIS, V52, P1248, DOI 10.1093/cid/cir119; Ranasinghe S, 2013, NAT MED, V19, P930, DOI 10.1038/nm.3229; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Sabeti PC, 2005, PLOS BIOL, V3, P1963, DOI 10.1371/journal.pbio.0030378; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Sereti I, 2016, CURR OPIN HIV AIDS, V11, P129, DOI 10.1097/COH.0000000000000244; Shrestha S, 2010, AIDS, V24, P583, DOI 10.1097/QAD.0b013e3283353c9e; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Tang JM, 1999, AIDS RES HUM RETROV, V15, P317, DOI 10.1089/088922299311277                                                         ; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Troyer JL, 2011, J INFECT DIS, V203, P1491, DOI 10.1093/infdis/jir046; Ulveling D, 2016, HEPATOLOGY, V64, P1462, DOI 10.1002/hep.28695; van der Helm JJ, 2014, LANCET HIV, V1, pE41, DOI 10.1016/S2352-3018(14)70016-5; Vince N, 2016, AM J HUM GENET, V99, P1353, DOI 10.1016/j.ajhg.2016.09.023; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0                                                                ; Wei ZJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10879; Zhu J, 2014, CELL REP, V9, P752, DOI 10.1016/j.celrep.2014.09.031; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	112	1	1	12	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0093-7711	1432-1211		IMMUNOGENETICS	Immunogenetics	AUG	2017	69	8-9					489	498		10.1007/s00251-017-1000-z				10	Genetics & Heredity; Immunology	Genetics & Heredity; Immunology	FC4CG	WOS:000406785500003	28695282	gold			2018-01-05	
J	Logan, GJ; Dane, AP; Hallwirth, CV; Smyth, CM; Wilkie, EE; Amaya, AK; Zhu, EH; Khandekar, N; Ginn, SL; Liao, SHY; Cunningham, SC; Sasaki, N; Cabanes-Creus, M; Tam, PPL; Russell, DW; Lisowski, L; Alexander, IE				Logan, Grant J.; Dane, Allison P.; Hallwirth, Claus V.; Smyth, Christine M.; Wilkie, Emilie E.; Amaya, Anais K.; Zhu, Erhua; Khandekar, Neeta; Ginn, Samantha L.; Liao, Sophia H. Y.; Cunningham, Sharon C.; Sasaki, Natsuki; Cabanes-Creus, Marti; Tam, Patrick P. L.; Russell, David W.; Lisowski, Leszek; Alexander, Ian E.			Identification of liver-specific enhancer-promoter activity in the 3 ' untranslated region of the wild-type AAV2 genome	NATURE GENETICS			English	Article							ADENOASSOCIATED VIRUS VECTORS; HUMAN GENE-THERAPY; HEPATOCELLULAR-CARCINOMA; RECOMBINANT PLASMID; HELPER ADENOVIRUS; GENOTOXICITY RISK; HERPES-SIMPLEX; INFORM DEBATE; MOUSE-LIVER; HUMAN-CELLS	Vectors based on adeno-associated virus type 2 (AAV2) are powerful tools for gene transfer and genome editing applications(1,2). The level of interest in this system has recently surged in response to reports of therapeutic efficacy in human clinical trials, most notably for those in patients with hemophilia B (ref. 3). Understandably, a recent report drawing an association between AAV2 integration events and human hepatocellular carcinoma (HCC)(4) has generated controversy about the causal or incidental nature of this association and the implications for AAV vector safety(5-9). Here we describe and functionally characterize a previously unknown liver-specific enhancer-promoter element in the wild-type AAV2 genome that is found between the stop codon of the cap gene, which encodes proteins that form the capsid, and the right-hand inverted terminal repeat. This 124-nt sequence is within the 163-nt common insertion region of the AAV genome, which has been implicated in the dysregulation of known HCC driver genes(4) and thus offers added insight into the possible link between AAV integration events and the multifactorial pathogenesis of HCC10.	[Logan, Grant J.; Dane, Allison P.; Hallwirth, Claus V.; Smyth, Christine M.; Amaya, Anais K.; Zhu, Erhua; Khandekar, Neeta; Ginn, Samantha L.; Liao, Sophia H. Y.; Cunningham, Sharon C.; Sasaki, Natsuki; Alexander, Ian E.] Univ Sydney, Childrens Med Res Inst, Gene Therapy Res Unit, Sydney, NSW, Australia; [Wilkie, Emilie E.] Univ Sydney, Sydney Childrens Hosp Network, Sydney, NSW, Australia; [Wilkie, Emilie E.; Tam, Patrick P. L.] Univ Sydney, Childrens Med Res Inst, Bioinformat Unit, Sydney, NSW, Australia; [Cabanes-Creus, Marti; Lisowski, Leszek] Univ Sydney, Childrens Med Res Inst, Embryol Unit, Sydney, NSW, Australia; [Cabanes-Creus, Marti] Univ Sydney, Childrens Med Res Inst, Translat Vectorol Grp, Sydney, NSW, Australia; [Russell, David W.] UCL, Inst Child Hlth, Mol Immunol Unit, Ctr Immunodeficiency, London, England; [Russell, David W.] Univ Washington, Dept Med, Seattle, WA USA; [Lisowski, Leszek] Mil Inst Hyg & Epidemiol, Pulawy, Poland; [Alexander, Ian E.] Univ Sydney, Discipline Child & Adolescent Hlth, Westmead, NSW, Australia; [Dane, Allison P.] UCL Royal Free Med Sch, Freeline Therapeut, London, England	Alexander, IE (reprint author), Univ Sydney, Childrens Med Res Inst, Gene Therapy Res Unit, Sydney, NSW, Australia.; Alexander, IE (reprint author), Univ Sydney, Discipline Child & Adolescent Hlth, Westmead, NSW, Australia.	ian.alexander@health.nsw.gov.au		Alexander, Ian E/0000-0002-6213-5627	Australian National Health and Medical Research Council (NHMRC) [477110]; Children's Medical Research Institute (CMRI); University of Sydney; Institute of Child Health, London; NHMRC [APP1008021, APP1022498, APP1080330]	We thank M. Latham for assistance in manuscript preparation, M. Grompe (Oregon Stem Cell Center, Oregon Health and Science University) for the FRG mice, J. Laurence (University of Sydney) for the HuH-7 cells, S. Goss (University of Oxford) for the BWTG3 cells and G. Sharbeen (University of New South Wales) for the MiaPaCa2 pancreatic carcinoma cell line. This work was supported by an Australian National Health and Medical Research Council (NHMRC) Postgraduate Research Scholarship (477110; A.P.D.), Children's Medical Research Institute (CMRI) Ph.D. stipends (A.P.D., A.K.A. and M.C.-C.), a University of Sydney International Scholarship (A.K.A.), an Institute of Child Health, London stipend (M.C.-C.) and NHMRC project grants APP1008021 (I.E.A.), APP1022498 (I.E.A.) and APP1080330 (I.E.A.).	Alam S, 2014, CANCER BIOL THER, V15, P1013, DOI 10.4161/cbt.29172; ATCHISON RW, 1965, SCIENCE, V149, P754, DOI 10.1126/science.149.3685.754; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Balogh J, 2016, J HEPATOCELL CARCINO, V3, P41, DOI 10.2147/JHC.S61146; Berns KI, 2015, HUM GENE THER, V26, P779, DOI 10.1089/hum.2015.29014.kib; Berthet C, 2005, P NATL ACAD SCI USA, V102, P13634, DOI 10.1073/pnas.0504583102; Buning H, 2015, MOL THER, V23, P1673, DOI 10.1038/mt.2015.182; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; CASTO BC, 1967, VIROLOGY, V32, P52, DOI 10.1016/0042-6822(67)90251-6                                                    ; Chandler RJ, 2016, MOL THER, V24, P198, DOI 10.1038/mt.2016.17; Cunningham SC, 2008, MOL THER, V16, P1081, DOI 10.1038/mt.2008.72; Cunningham SC, 2015, HEPATOLOGY, V62, P417, DOI 10.1002/hep.27842; Cunningham SC, 2009, MOL THER, V17, P1340, DOI 10.1038/mt.2009.88; Dane AP, 2009, MOL THER, V17, P1548, DOI 10.1038/mt.2009.139; DOOLITTLE DP, 1974, J HERED, V65, P194, DOI 10.1093/oxfordjournals.jhered.a108500                                           ; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flotte T, 1996, HUM GENE THER, V7, P1145, DOI 10.1089/hum.1996.7.9-1145                                                       ; FLOTTE TR, 1992, AM J RESP CELL MOL, V7, P349, DOI 10.1165/ajrcmb/7.3.349                                                          ; FLOTTE TR, 1993, J BIOL CHEM, V268, P3781; Gaj T, 2016, MOL THER, V24, P458, DOI 10.1038/mt.2015.151; GEORGFRIES B, 1984, VIROLOGY, V134, P64, DOI 10.1016/0042-6822(84)90272-1; Gil-Farina I, 2016, MOL THER, V24, P1100, DOI 10.1038/mt.2016.52; Gorman C., 1985, DNA CLONING PRACTICA, V1, P143; Haberman RP, 2000, J VIROL, V74, P8732, DOI 10.1128/JVI.74.18.8732-8739.2000                                                ; Hastie E, 2015, HUM GENE THER, V26, P257, DOI 10.1089/hum.2015.025; HEILBRONN R, 1990, J VIROL, V64, P3012; HOGGAN MD, 1966, P NATL ACAD SCI USA, V55, P1467, DOI 10.1073/pnas.55.6.1467; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; LAUGHLIN CA, 1983, GENE, V23, P65, DOI 10.1016/0378-1119(83)90217-2; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; MAYOR HD, 1976, AM J OBSTET GYNECOL, V126, P100, DOI 10.1016/0002-9378(76)90472-5                                                    ; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Miller DG, 2006, NAT BIOTECHNOL, V24, P1022, DOI 10.1038/nbt1231; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nault JC, 2016, MOL THER, V24, P659, DOI 10.1038/mt.2016.47; Nault JC, 2015, NAT GENET, V47, P1187, DOI 10.1038/ng.3389; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Quan A, 2001, J ALLERGY CLIN IMMUN, V108, P340; Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002; Rubenstein RC, 1997, GENE THER, V4, P384, DOI 10.1038/sj.gt.3300417; Russell DW, 2015, NAT GENET, V47, P1104, DOI 10.1038/ng.3407; Russell DW, 1998, NAT GENET, V18, P325, DOI 10.1038/ng0498-325                                                              ; SAMULSKI RJ, 1982, P NATL ACAD SCI-BIOL, V79, P2077, DOI 10.1073/pnas.79.6.2077; SAMULSKI RJ, 1987, J VIROL, V61, P3096; Schmidt M, 2016, MOL THER, V24, P660, DOI 10.1038/mt.2016.48; SENAPATHY P, 1984, J MOL BIOL, V179, P1, DOI 10.1016/0022-2836(84)90303-6; SZPIRER C, 1975, DIFFERENTIATION, V4, P85, DOI 10.1111/j.1432-0436.1975.tb01446.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Thwaite R, 2015, GENE THER, V22, P196, DOI 10.1038/gt.2014.103; Urabe M, 2002, HUM GENE THER, V13, P1935, DOI 10.1089/10430340260355347                                                       ; Xiao X, 1998, J VIROL, V72, P2224; YANG QC, 1994, J VIROL, V68, P4847; Zaiss AK, 2002, J VIROL, V76, P4580, DOI 10.1128/JVI.76.9.4580-4590.2002; Zanta-Boussif MA, 2009, GENE THER, V16, P605, DOI 10.1038/gt.2009.3	58	2	2	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2017	49	8					1267	+		10.1038/ng.3893				10	Genetics & Heredity	Genetics & Heredity	FB8OI	WOS:000406397900018	28628105				2018-01-05	
J	Yin, KQ; Gao, CX; Qiu, JL				Yin, Kangquan; Gao, Caixia; Qiu, Jin-Long			Progress and prospects in plant genome editing	NATURE PLANTS			English	Review							CRISPR-CAS SYSTEM; STAPHYLOCOCCUS-AUREUS CAS9; DOUBLE-STRAND BREAKS; TARGETED MUTAGENESIS; HUMAN-CELLS; RIBONUCLEOPROTEIN COMPLEXES; TRANSCRIPTIONAL REGULATION; DEAMINASE FUSIONS; MAMMALIAN-CELLS; IMMUNE-SYSTEM	The emergence of sequence-specific nucleases that enable genome editing is revolutionizing basic and applied biology. Since the introduction of CRISPR-Cas9, genome editing has become widely used in transformable plants for characterizing gene function and improving traits, mainly by inducing mutations through non-homologous end joining of double-stranded breaks generated by CRISPR-Cas9. However, it would be highly desirable to perform precision gene editing in plants, especially in transformation-recalcitrant species. Recently developed Cas9 variants, novel RNA-guided nucleases and base-editing systems, and DNA-free CRISPR-Cas9 delivery methods now provide great opportunities for plant genome engineering. In this Review Article, we describe the current status of plant genome editing, focusing on newly developed genome editing tools and methods and their potential applications in plants. We also discuss the specific challenges facing plant genome editing, and future prospects.	[Yin, Kangquan; Qiu, Jin-Long] Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Gao, Caixia] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China; [Gao, Caixia] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Genome Editing, Beijing 100101, Peoples R China	Qiu, JL (reprint author), Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Beijing 100101, Peoples R China.; Gao, CX (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China.; Gao, CX (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Genome Editing, Beijing 100101, Peoples R China.	cxgao@genetics.ac.cn; qiujl@im.ac.cn		Qiu, Jin-Long/0000-0001-8054-2552	National Transgenic Science and Technology Program [2016ZX08010-002]; National Key Research and Development Program of China [2016YFD0100602]; Scientific Program of Beijing Municipal Commission of Science and Technology [Z171100001517001]; Chinese Academy of Sciences [XDB11030500]; National Natural Science Foundation of China [31672015]	We apologize for the omission of any references that could not be included in this Review Article due to the space constraints. The work in the authors' labs was supported by grants from the National Transgenic Science and Technology Program (2016ZX08010-002), the National Key Research and Development Program of China (2016YFD0100602), the Scientific Program of Beijing Municipal Commission of Science and Technology (Z171100001517001), the Chinese Academy of Sciences (XDB11030500), and the National Natural Science Foundation of China (31672015).	Ali Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0799-6; Baltes NJ, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.145; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brazelton VA, 2015, GM CROPS FOOD, V6, P266, DOI 10.1080/21645698.2015.1137690; Butler NM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01045; Carlson JC, 2014, NAT CHEM BIOL, V10, P216, DOI [10.1038/nchembio.1453, 10.1038/NCHEMBIO.1453]; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Deng WL, 2015, P NATL ACAD SCI USA, V112, P11870, DOI 10.1073/pnas.1515692112; Endo M, 2016, PLANT PHYSIOL, V170, P667, DOI 10.1104/pp.15.01663; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gil-Humanes J, 2017, PLANT J, V89, P1251, DOI 10.1111/tpj.13446; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu XX, 2017, J GENET GENOMICS, V44, P71, DOI 10.1016/j.jgg.2016.12.001; Hu XX, 2016, MOL PLANT, V9, P943, DOI 10.1016/j.molp.2016.03.003; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; Ji X, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.144, 10.1038/nplants.2015.144]; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Kaya H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26871; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14406; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Latorre A, 2016, ANGEW CHEM INT EDIT, V55, P3548, DOI 10.1002/anie.201512002; Li JY, 2017, MOL PLANT, V10, P526, DOI 10.1016/j.molp.2016.12.001; Li J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.139, 10.1038/nplants.2016.139]; Liang Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14261; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Lowe K, 2016, PLANT CELL, V28, P1998, DOI 10.1105/tpc.16.00124; Lu YM, 2017, MOL PLANT, V10, P523, DOI 10.1016/j.molp.2016.11.013; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Nishida K, 2016, SCIENCE, V353, P8729; Ochiai H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv624; Osterberg JT, 2017, TRENDS PLANT SCI, V22, P373, DOI 10.1016/j.tplants.2017.01.004; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; Puchta H, 1996, P NATL ACAD SCI USA, V93, P5055, DOI 10.1073/pnas.93.10.5055; Puchta H, 2014, PLANT J, V78, P727, DOI 10.1111/tpj.12338; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ren B, 2017, SCI CHINA LIFE SCI, V60, P516, DOI 10.1007/s11427-016-0406-x; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Sadhu MJ, 2016, SCIENCE, V352, P1113, DOI 10.1126/science.aaf5124; Salvi S, 2014, BIOTECH AGR FOREST, V69, P287, DOI 10.1007/978-3-662-44406-1_15; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shi JR, 2017, PLANT BIOTECHNOL J, V15, P207, DOI 10.1111/pbi.12603; Shimatani Z, 2017, NAT BIOTECHNOL, V35, P441, DOI 10.1038/nbt.3833; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sprink T, 2016, PLANT CELL REP, V35, P1493, DOI 10.1007/s00299-016-1990-2; Steinert J, 2015, PLANT J, V84, P1295, DOI 10.1111/tpj.13078; Sun YW, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00298; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Tak YG, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0050-4; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tang X, 2017, NAT PLANTS, V3, DOI [10.1038/nplants.2017.56, 10.1038/nplants.2017.18]; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; de Toledo Thomazella D. P., 2016, PREPRINT; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Wang FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154027; Wang MG, 2017, MOL PLANT, V10, P1007, DOI 10.1016/j.molp.2017.03.002; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Weinthal DM, 2013, PLANT PHYSIOL, V162, P390, DOI 10.1104/pp.112.212910; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Xu RF, 2017, PLANT BIOTECHNOL J, V15, P713, DOI 10.1111/pbi.12669; Xu RF, 2014, RICE, V7, DOI 10.1186/s12284-014-0005-6; Yang LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13330; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang DD, 2016, J GENET GENOMICS, V43, P251, DOI 10.1016/j.jgg.2016.03.001; Zhang HY, 2017, SCI REP-UK, V7, DOI 10.1038/srep41993; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12617; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811	90	2	2	62	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2055-026X	2055-0278		NAT PLANTS	Nat. Plants	AUG	2017	3	8							17107	10.1038/nplants.2017.107				6	Plant Sciences	Plant Sciences	FC4ZK	WOS:000406850200004	28758991				2018-01-05	
J	Jacobs, TB; Zhang, N; Patel, D; Martin, GB				Jacobs, Thomas B.; Zhang, Ning; Patel, Dhruv; Martin, Gregory B.			Generation of a Collection of Mutant Tomato Lines Using Pooled CRISPR Libraries	PLANT PHYSIOLOGY			English	Article							PLANT GENOME; RIBONUCLEOPROTEIN COMPLEXES; TARGETED MUTAGENESIS; SOMACLONAL VARIATION; DISEASE RESISTANCE; HUMAN-CELLS; OFF-TARGET; SYSTEM; GENE; DNA	The high efficiency of clustered regularly interspaced short palindromic repeats (CRISPR)-mediated mutagenesis in plants enables the development of high-throughput mutagenesis strategies. By transforming pooled CRISPR libraries into tomato (Solanum lycopersicum), collections of mutant lines were generated with minimal transformation attempts and in a relatively short period of time. Identification of the targeted gene(s) was easily determined by sequencing the incorporated guide RNA(s) in the primary transgenic events. From a single transformation with a CRISPR library targeting the immunity-associated leucine-rich repeat subfamily XII genes, heritable mutations were recovered in 15 of the 54 genes targeted. To increase throughput, a second CRISPR library was made containing three guide RNAs per construct to target 18 putative transporter genes. This resulted in stable mutations in 15 of the 18 targeted genes, with some primary transgenic plants having as many as five mutated genes. Furthermore, the redundancy in this collection of plants allowed for the association of aberrant T0 phenotypes with the underlying targeted genes. Plants with mutations in a homolog of an Arabidopsis (Arabidopsis thaliana) boron efflux transporter displayed boron deficiency phenotypes. The strategy described here provides a technically simple yet high-throughput approach for generating a collection of lines with targeted mutations and should be applicable to any plant transformation system.	[Jacobs, Thomas B.; Zhang, Ning; Patel, Dhruv; Martin, Gregory B.] Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Martin, Gregory B.] Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY 14853 USA; [Jacobs, Thomas B.] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Jacobs, Thomas B.] VIB Ctr Plant Syst Biol, B-9052 Ghent, Belgium; [Patel, Dhruv] Univ Calif Berkeley, Dept Plant & Microbial Biol, Koshland Hall, Berkeley, CA 94720 USA	Jacobs, TB; Martin, GB (reprint author), Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA.; Martin, GB (reprint author), Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY 14853 USA.; Jacobs, TB (reprint author), Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium.; Jacobs, TB (reprint author), VIB Ctr Plant Syst Biol, B-9052 Ghent, Belgium.	jacobs@ugent.vib.be; gbm7@cornell.edu		Jacobs, Thomas/0000-0002-5408-492X; Zhang, Ning/0000-0003-2775-1755	National Science Foundation [IOS-1451754, IOS-1546625]	This work was supported by the National Science Foundation (grant nos. IOS-1451754 and IOS-1546625 to G.B.M.).	Andolfo G, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-120; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Carter JD, 2013, PLANT PHYSIOL, V162, P145, DOI 10.1104/pp.113.213876; Char SN, 2017, PLANT BIOTECHNOL J, V15, P257, DOI 10.1111/pbi.12611; Clarke CR, 2013, NEW PHYTOL, V200, P847, DOI 10.1111/nph.12408; De Buck S, 2009, PLANT J, V60, P134, DOI 10.1111/j.1365-313X.2009.03942.x; DEPICKER A, 1985, MOL GEN GENET, V201, P477, DOI 10.1007/BF00331342; Endo M, 2016, PLANT PHYSIOL, V170, P667, DOI 10.1104/pp.15.01663; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Frary A, 2005, METH MOL B, V286, P141; Ghedira R, 2013, PLANTA, V238, P1025, DOI 10.1007/s00425-013-1948-3; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8                                                   ; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hind SR, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.128, 10.1038/nplants.2016.128]; Iaffaldano B, 2016, IND CROP PROD, V89, P356, DOI 10.1016/j.indcrop.2016.05.029; JACOBS TB, 2016, JOVE J VIS EXP APR, DOI DOI 10.3791/53843; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; LARKIN PJ, 1981, THEOR APPL GENET, V60, P197, DOI 10.1007/BF02342540; Lein W, 2008, PLANT BIOTECHNOL J, V6, P246, DOI 10.1111/j.1467-7652.2007.00313.x; Liang Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14261; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Mathieu J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004227; McCarty DR, 2005, PLANT J, V44, P52, DOI 10.1111/j.1365-313X.2005.02509.x; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Minoia Silvia, 2010, BMC Res Notes, V3, P69, DOI 10.1186/1756-0500-3-69; Miwa K, 2013, PLANT PHYSIOL, V163, P1699, DOI 10.1104/pp.113.225995; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321                                                           ; Rosli HG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r139; Saito T, 2011, PLANT CELL PHYSIOL, V52, P283, DOI 10.1093/pcp/pcr004; Schwessinger B, 2012, ANNU REV PLANT BIOL, V63, P451, DOI 10.1146/annurev-arplant-042811-105518; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Tadege M, 2008, PLANT J, V54, P335, DOI 10.1111/j.1365-313X.2008.03418.x; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Torella JP, 2014, NAT PROTOC, V9, P2075, DOI 10.1038/nprot.2014.145; Uraguchi S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00125; van Kregten M, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.164, 10.1038/NPLANTS.2016.164]; VANDENBULK RW, 1990, THEOR APPL GENET, V80, P817, DOI 10.1007/BF00224199; Vazquez-Vilar M, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0101-2; Wang L, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.185, 10.1038/nplants.2016.185]; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Zhang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12617; Zheng Y, 2016, MOL PLANT, V9, P1667, DOI 10.1016/j.molp.2016.09.014; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	57	1	1	27	27	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	AUG	2017	174	4					2023	2037		10.1104/pp.17.00489				15	Plant Sciences	Plant Sciences	FC5EY	WOS:000406865900007	28646085				2018-01-05	
J	Fu, YD; Zhou, ZC; Wang, H; Gong, P; Guo, RP; Wang, JM; Lu, XY; Qi, F; Liu, L				Fu, Yudong; Zhou, Zhongcheng; Wang, Hua; Gong, Peng; Guo, Renpeng; Wang, Jinmiao; Lu, Xinyi; Qi, Feng; Liu, Lin			IFITM1 suppresses expression of human endogenous retroviruses in human embryonic stem cells	FEBS OPEN BIO			English	Article						H3K9me3; human embryonic stem cell; IFITM1	INDUCED TRANSMEMBRANE PROTEIN-1; INFLUENZA-A VIRUS; GENOME EVOLUTION; TIGHT JUNCTIONS; TELOMERE LENGTH; DENGUE VIRUS; GENE FAMILY; CANCER; IDENTIFICATION; ELEMENTS	Interferon-induced transmembrane protein 1 (IFITM1), a member of the IFITM protein family, is a component of a multimeric complex involved in the transduction of antiproliferation and cell adhesion signals. IFITM1 is thought to play a role in antiproliferation and immune surveillance, and has been shown to restrict infection by numerous viruses. It is highly expressed in human embryonic stem cells (hESCs) but its role in hESCs remains to be elucidated. In this study, knockout of IFITM1 mediated by CRISPR/Cas9 in hESCs did not affect self-renewal, pluripotency, telomerase activity or telomeres. However expression of human endogenous retroviruses (HERVs) was higher than in wild-type hESCs, and there was also a reduced level of trimethylation of histone H3 on lysine 9 at HERV loci. These data show that IFITM1 suppresses HERVs in hESCs by regulating epigenetic modifications.	[Fu, Yudong; Zhou, Zhongcheng; Wang, Hua; Gong, Peng; Guo, Renpeng; Lu, Xinyi; Liu, Lin] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Fu, Yudong; Zhou, Zhongcheng; Wang, Hua; Gong, Peng; Guo, Renpeng; Liu, Lin] Nankai Univ, Dept Cell Biol & Genet, Coll Life Sci, Tianjin, Peoples R China; [Wang, Jinmiao; Qi, Feng] Tianjin Med Univ, Gen Hosp, Dept Gen Surg, Tianjin 300052, Peoples R China; [Lu, Xinyi] Nankai Univ, Coll Pharm, Tianjin, Peoples R China	Liu, L (reprint author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.; Qi, F (reprint author), Tianjin Med Univ, Gen Hosp, Dept Gen Surg, Tianjin 300052, Peoples R China.	qf@medmail.com.cn; liulin@nankai.edu.cn			China Ministry of Science and Technology Program of International ST Cooperation [2014DFA30450]	We thank Haifeng Fu, Haiying Wang and Jian Mao for assisting experiments, and David Keefe and Fang Wang for providing hESC lines. This study was supported by China Ministry of Science and Technology Program of International S&T Cooperation (2014DFA30450).	ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306                                                          ; Andreu P, 2006, CANCER RES, V66, P1949, DOI 10.1158/0008-5472.CAN-05-2731; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47                                                           ; Chattopadhyay I, 2009, ONCOL REP, V21, P1135, DOI 10.3892/or_00000333; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Dan JM, 2014, DEV CELL, V29, P7, DOI 10.1016/j.devcel.2014.03.004; DEBLANDRE GA, 1995, J BIOL CHEM, V270, P23860, DOI 10.1074/jbc.270.40.23860                                                        ; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Downey RF, 2015, INT J CANCER, V137, P1249, DOI 10.1002/ijc.29003; Elsasser SJ, 2015, NATURE, V522, P240, DOI 10.1038/nature14345; Grow EJ, 2015, NATURE, V522, P221, DOI 10.1038/nature14308; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; Gyorffy B, 2008, INT J GYNECOL CANCER, V18, P1215, DOI 10.1111/j.1525-1438.2007.01169.x; Hatano H, 2008, CLIN CANCER RES, V14, P6097, DOI 10.1158/1078-0432.CCR-07-4761; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Kassiotis G, 2014, J IMMUNOL, V192, P1343, DOI 10.4049/jimmunol.1302972; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670                                                         ; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Lin TY, 2013, CELL REP, V5, P895, DOI 10.1016/j.celrep.2013.10.033; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Lu XY, 2014, NAT STRUCT MOL BIOL, V21, P423, DOI 10.1038/nsmb.2799; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pan Z, 2010, NEOPLASMA, V57, P123, DOI 10.4149/neo_2010_02_123; Seyfried NT, 2008, CANCER LETT, V263, P243, DOI 10.1016/j.canlet.2008.01.007; Smith SE, 2014, CURR OPIN VIROL, V4, P71, DOI 10.1016/j.coviro.2013.11.004; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.10.010; Thompson PJ, 2016, MOL CELL, V62, P766, DOI 10.1016/j.molcel.2016.03.029; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang F, 2013, P NATL ACAD SCI USA, V110, pE1906, DOI 10.1073/pnas.1306639110; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Wilkins C, 2013, HEPATOLOGY, V57, P461, DOI 10.1002/hep.26066; Yang BX, 2015, CELL, V163, P230, DOI 10.1016/j.cell.2015.08.037; Yang J, 2016, CELL REP, V15, P1809, DOI 10.1016/j.celrep.2016.04.058	38	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2211-5463			FEBS OPEN BIO	FEBS Open Bio	AUG	2017	7	8					1102	1110		10.1002/2211-5463.12246				9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FC2QK	WOS:000406682900005	28781951	gold			2018-01-05	
J	Di Leo, M; Bianco, M; Zuppardo, RA; Guslandi, M; Calabrese, F; Mannucci, A; Neri, TM; Testoni, PA; Leandro, G; Cavestro, GM				Di Leo, Milena; Bianco, Margherita; Zuppardo, Raffaella Alessia; Guslandi, Mario; Calabrese, Federica; Mannucci, Alessandro; Neri, Tauro Maria; Testoni, Pier Alberto; Leandro, Gioacchino; Cavestro, Giulia Martina			Meta-analysis of the impact of SPINK1 p.N34S gene variation in Caucasic patients with chronic pancreatitis. An update	DIGESTIVE AND LIVER DISEASE			English	Article						Alcohol; Genetic pancreatitis; PSTI; TATI	IDIOPATHIC CHRONIC-PANCREATITIS; SERINE-PROTEASE INHIBITOR; ALCOHOLIC CHRONIC-PANCREATITIS; KAZAL TYPE-1 SPINK1; CATIONIC TRYPSINOGEN PRSS1; N34S MUTATION; CFTR GENE; CLINICAL-TRIALS; RECURRENT ACUTE; UNITED-STATES	Background: SPINKI p.N34S gene variation is one of the endogenous factors which seem to be associated with chronic pancreatitis (CP). However, in literature there is no clear agreement regarding its contribution in different ethnicity and CP etiologies. Aim: To investigate the role of SPINKI p.N34S gene variation in CP patients with European origin by means of meta-analysis. Methods: Literature search was conducted and case-control studies evaluating Caucasian population, published between May 2007 and May 2015, were included. We also included Caucasian selected studies analyzed in previous meta-analysis. We carried out meta-analysis including all selected studies. After that, we performed two additional meta-analyses considering the incidence of SPINKI p.N34S gene variation in alcoholic or in idiopathic CP patients vs control group. Results: Twenty-five studies were included and the total number of subjects was 8800 (2981 cases and 5819 controls). The presence of p.N34S variation increased nine times the overall CP risk in population of European origin [OR 9.695 (CI 95% 7.931-11.851)]. Also, the contribution of SPINKI in idiopathic pancreatitis [OR 13.640 (CI 95% 8.858-21.002)] was found to be higher than in alcoholic CP [5.283 (CI 95% 3.449-8.092)]. Conclusion: The association between SPINKI p.N34S gene variation and CP is confirmed. Also, we confirmed that the idiopathic etiology needs a better definition by means of genetic analysis. (C) 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.	[Di Leo, Milena; Zuppardo, Raffaella Alessia; Guslandi, Mario; Calabrese, Federica; Mannucci, Alessandro; Testoni, Pier Alberto; Cavestro, Giulia Martina] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst, Div Expt Oncol, Gastroenterol & Gastrointestinal Endoscopy Unit, Milan, Italy; [Bianco, Margherita; Leandro, Gioacchino] Gastroenterol Hosp S De Bellis IRCCS, Gastroenterol Unit 1, Castellana Grotte, BA, Italy; [Neri, Tauro Maria] Univ Hosp Parma, Mol Genet Lab, Diagnost Dept, Unit Med Genet, Parma, Italy; [Leandro, Gioacchino] UCL, Inst Digest & Liver Hlth, London, England	Di Leo, M (reprint author), Via Olgettina 60, I-20132 Milan, Italy.	dileo.milena1984@gmail.com			Italian Ministry of Research and University	This study was funded by Italian Ministry of Research and University. The funding source had no role in the design or conduct of the study, nor in the collection, management, analysis, or interpretation of data nor in the preparation, review, or approval of the manuscript.	Aoun E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002003; Apte MV, 2008, J GASTROEN HEPATOL, V23, pS63, DOI 10.1111/j.1440-1746.2007.05287.x; Audrezet MP, 2002, EUR J HUM GENET, V10, P100, DOI 10.1038/sj/ejhg/5200786; Ballard DD, 2015, PANCREAS, V44, P116, DOI 10.1097/MPA.0000000000000225; Cavestro GM, 2010, AM J GASTROENTEROLOG; Chen JM, 2001, GASTROENTEROLOGY, V120, P1061, DOI 10.1053/gast.2001.23094; Cichoz-Lach H, 2012, POL ARCH MED WEWN, V122, P277, DOI 10.20452/pamw.1293                                                              ; DEMETS DL, 1987, STAT MED, V6, P341, DOI 10.1002/sim.4780060325; Derikx MHM, 2010, BEST PRACT RES CL GA, V24, P251, DOI 10.1016/j.bpg.2010.02.001; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diaconu BL, 2009, J GASTROINTEST LIVER, V18, P143; Drenth JPH, 2002, GUT, V50, P687, DOI 10.1136/gut.50.5.687; Dufour MC, 2003, PANCREAS, V27, P286, DOI 10.1097/00006676-200311000-00002; Felderbauer P, 2008, AM J GASTROENTEROL, V103, P368, DOI 10.1111/j.1572-0241.2007.01695.x; Freidreich N., 1878, DIS PANCREAS; Frulloni L, CHRONIC PANCREATITIS; Gasiorowska A, 2011, DIGEST DIS SCI, V56, P894, DOI 10.1007/s10620-010-1349-4; Gomez-Lira M, 2003, EUR J HUM GENET, V11, P543, DOI 10.1038/sj.ejhg.5200989; Ravi Kanth VV, 2014, WORLD J GASTROINTEST, V5, P427; KAZAL LA, 1948, J AM CHEM SOC, V70, P3034, DOI 10.1021/ja01189a060; Kereszturi E, 2009, GUT, V58, P545, DOI 10.1136/gut.2008.164947; Kuwata K, 2002, J GASTROENTEROL, V37, P928, DOI 10.1007/s005350200156; LaRusch J, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2014.13; Leandro G., 2005, METAANALYSIS MED RES; Lempinen M, 2005, SCAND J GASTROENTERO, V40, P225, DOI 10.1080/00365520510011560; Madro A, 2015, GASTROENTEROLOGY RES, V2015; Mariani A, 2009, DIGEST LIVER DIS, V41, P753, DOI 10.1016/j.dld.2009.01.009; Matsubayashi H, 2003, CANCER BIOL THER, V2, P652; Mora J, 2009, PANCREATOLOGY, V9, P644, DOI 10.1159/000181177; Muddana V, 2008, WORLD J GASTROENTERO, V14, P4486, DOI 10.3748/wjg.14.4486; Ohmuraya M, 2011, EXP ANIM TOKYO, V60, P433; Perri F, 2003, EUR J HUM GENET, V11, P687, DOI 10.1038/sj.ejhg.5201035; Pfutzer RH, 2000, GASTROENTEROLOGY, V119, P615, DOI 10.1053/gast.2000.18017; Plendl H, 2001, AM J MED GENET, V100, P252, DOI 10.1002/ajmg.1287; Rinderknecht Heinrich, 1993, P219; Rosendahl J, 2013, GUT, V62, P582, DOI [10.1136/gutjnl-2012-303192, 10.1136/gutjnl-2011-300645]; SARLES H, 1979, DIGESTION, V19, P110, DOI 10.1159/000198331                                                               ; Schneider A, 2003, DIGEST DIS SCI, V48, P1110, DOI 10.1023/A:1023768829772                                                         ; Schneider A, 2005, CLIN LAB MED, V25, P61, DOI 10.1016/j.cll.2004.12.005; Schneider A, 2011, GASTROENTEROLOGY; Schneider A, 2002, BEST PRACTICE RES CL; Schubert S, 2014, PANCREAS, V43, P1078, DOI 10.1097/MPA.0000000000000166; Sisman G, 2015, TURK J GASTROENTEROL, V26, P176, DOI 10.5152/tjg.2015.4287; Sobczynska-Tomaszewska A, 2006, J PEDIATR GASTR NUTR, V43, P299, DOI 10.1097/01.mpg.0000232570.48773.df                                              ; Threadgold J, 2002, GUT, V50, P675, DOI 10.1136/gut.50.5.675; Truninger K, 2002, AM J GASTROENTEROL, V97, P1133; Tzetis M, 2007, CLIN GENET, V71, P451, DOI 10.1111/j.1399-0004.2007.00788.x; Whitcomb DC, 2008, PANCREATOLOGY, V8, P520, DOI 10.1159/000152001; Whitcomb DC, 2012, CURR OPIN GASTROEN, V28, P501, DOI 10.1097/MOG.0b013e328356e7f3; Whitcomb DC, 2012, NAT REV GASTRO HEPAT, V9, P418, DOI 10.1038/nrgastro.2012.100; Wilcox CM, 2006, GASTROINTEST ENDOSC, V63, P1037, DOI 10.1016/j.gie.2006.02.024; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2001, JAMA-J AM MED ASSOC, V285, P2716, DOI 10.1001/jama.285.21.2716-a; Witt H, 2002, GUT, V50, P590, DOI 10.1136/gut.50.5.590; Witt H, 2013, NAT GENET, V45, P1216, DOI 10.1038/ng.2730; Yadav D, 2007, PANCREAS, V34, P390, DOI 10.1097/mpa.0b013e318040b332; Yadav D, 2010, NAT REV GASTRO HEPAT, V7, P131, DOI 10.1038/nrgastro.2010.6	57	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	AUG	2017	49	8					847	853		10.1016/j.dld.2017.04.023				7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	FB5ZV	WOS:000406221800003	28546062				2018-01-05	
J	Liu, J; Law, RA; Koles, PG; Saxe, JC; Bottomley, M; Sulentic, CEW				Liu, Jing; Law, Rebecca A.; Koles, Paul G.; Saxe, Jonathan C.; Bottomley, Michael; Sulentic, Courtney E. W.			Allelic frequencies of the hs1.2 enhancer within the immunoglobulin heavy chain region in Dayton, Ohio patients screened for celiac disease with duodenal biopsy	DIGESTIVE AND LIVER DISEASE			English	Article						Autoimmune disease; Celiac disease; Gene regulation; Immunoglobulin heavy chain region (IGH); Ig dysregulation; 3 ' IGH regulatory region	CLASS-SWITCH RECOMBINATION; ARYL-HYDROCARBON RECEPTOR; REGULATORY REGION; MHC REGION; HS1,2; RISK; ASSOCIATION; POLYMORPHISMS; ARTHRITIS	Background: Genetic and environmental factors contribute to the development of celiac disease (CD), but specific genetic predisposing factors remain poorly understood. One candidate is allele 2 of the hs1.2 enhancer within the immunoglobulin heavy chain region. In humans, there are four possible alleles and a previous study of an Italian cohort demonstrated a significantly increased frequency of allele 2 in patients with CD. Aims: The purpose of the current study was to determine if a similar association between allele 2 and CD exists in an American population from Dayton, OH. Methods: Subjects were screened for CD via esophagogastroduodenoscopy with duodenal biopsy. All biopsies were microscopically scored using a modified Marsh-Oberhuber classification. DNA was isolated from patients' buccal cells for hs1.2 genotype analysis using PCR. Results: Unlike the Italian cohort, allele 2 frequency was not significantly different in patients with histopathologic evidence of CD compared to patients without such evidence. However, our patient population as a whole demonstrated a significantly increased allele 2 frequency when compared to that previously reported within diverse ethnic populations. Conclusions: Since our comparative control patients do not necessarily reflect a healthy control population, an overall increase in allele 2 may reflect an association between allele 2 of the hs1.2 enhancer and a spectrum of gastrointestinal disorders. (C) 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.	[Liu, Jing; Law, Rebecca A.; Sulentic, Courtney E. W.] Wright State Univ, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA; [Koles, Paul G.] Wright State Univ, Dept Pathol, Dayton, OH 45435 USA; [Saxe, Jonathan C.] Wright State Univ, Dept Med, Dayton, OH 45435 USA; [Saxe, Jonathan C.] Dayton Gastroenterol, Dayton, OH USA; [Bottomley, Michael] Wright State Univ, Boonshoft Sch Med, Dayton, OH 45435 USA; [Bottomley, Michael] Wright State Univ, Ctr Stat Consulting, Dayton, OH 45435 USA	Sulentic, CEW (reprint author), Wright State Univ, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA.	courtney.sulentic@wright.edu			 [NIEHSR01ES014676];  [R01ES014676-03S2]	The authors are grateful to the patients who consented to take part in this study. In addition, we thank Dr. Donald Lutter and Kathleen Hosner, RN for recruiting patients into this study. We also thank Amanda Lutter and Dr. Luke Andera for assisting in the completion of the PCR analysis and gel electrophoresis of DNA samples for genotyping; Dr. Lisa Farinella Anacker for reviewing the dueodenal biopsies and independently assigning a histopathologic classification; and Aubrey Morris, Zahra Alfaheeda and Robert Johnson for reviewing genotyping gels and independently calling alleles. This research was supported by NIEHSR01ES014676 and R01ES014676-03S2.	Bevan S, 1999, J MED GENET, V36, P687; Caja S, 2011, CELL MOL IMMUNOL, V8, P103, DOI 10.1038/cmi.2010.65; Catassi C, 2014, J PEDIATR GASTR NUTR, V59, pS7, DOI 10.1097/01.mpg.0000450393.23156.59; Celiloglu C, 2011, TURKISH J PEDIATR, V53, P241; Cianci R, 2008, J BIOL REG HOMEOS AG, V22, P99; Cianci R, 2008, J INVEST DERMATOL, V128, P1920, DOI 10.1038/jid.2008.40; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828                                       ; Denizot Y, 2001, IMMUNOLOGY, V103, P35, DOI 10.1046/j.1365-2567.2001.01217.x                                                ; Dickson BC, 2006, J CLIN PATHOL, V59, P1008, DOI 10.1136/jcp.2005.035345; Dieli-Crimi R, 2015, J AUTOIMMUN, V64, P26, DOI 10.1016/j.jaut.2015.07.003; du Pre MF, 2015, BEST PRACT RES CL GA, V29, P413, DOI 10.1016/j.bpg.2015.04.001; Dunnick WA, 2011, J IMMUNOL, V187, P4733, DOI 10.4049/jimmunol.1101808; Esser C, 2015, PHARMACOL REV, V67, P259, DOI 10.1124/pr.114.009001; Fernando TM, 2012, J IMMUNOL, V188, P3294, DOI 10.4049/jimmunol.1101111; Frezza D, 2004, SCAND J GASTROENTERO, V39, P1083, DOI 10.1080/00365520410007999; Frezza D, 2012, ANN RHEUM DIS, V71, P1309, DOI 10.1136/ard.2010.147025; Garner CP, 2009, HUM MOL GENET, V18, P4219, DOI 10.1093/hmg/ddp364; Giambra V, 2006, ANN HUM GENET, V70, P946, DOI 10.1111/j.1469-1809.2006.00273.x; Giambra V, 2005, GENE, V346, P105, DOI 10.1016/j.gene.2004.10.009; Guo CC, 2015, GENET MOL RES, V14, P13221, DOI 10.4238/2015.October.26.19; Gutierrez-Achury J, 2015, NAT GENET, V47, P577, DOI 10.1038/ng.3268; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Petras R, 2010, STERNBERGS DIAGNOSTI; Petronzelli F, 1997, ANN HUM GENET, V61, P307; Pinaud E, 2011, ADV IMMUNOL, V110, P27, DOI 10.1016/B978-0-12-387663-8.00002-8; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Stoven S, 2013, AM J GASTROENTEROL, V108, pS94; Tolusso B, 2009, ANN RHEUM DIS, V68, P416, DOI 10.1136/ard.2008.095414; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093180	32	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	AUG	2017	49	8					887	892		10.1016/j.dld.2017.03.023				6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	FB5ZV	WOS:000406221800009	28473300				2018-01-05	
J	Mellis, IA; Gupte, R; Raj, A; Rouhanifard, SH				Mellis, Ian A.; Gupte, Rohit; Raj, Arjun; Rouhanifard, Sara H.			Visualizing adenosine-to-inosine RNA editing in single mammalian cells	NATURE METHODS			English	Article							NUCLEAR RETENTION; GENE-EXPRESSION; MESSENGER-RNA; ENZYME ADAR2; CYANOETHYLATION; GLUR2; DSRNA	Conversion of adenosine to inosine is a frequent type of RNA editing, but important details about the biology of this conversion remain unknown because of a lack of imaging tools. We developed inoFISH to directly visualize and quantify adenosine-to-inosine-edited transcripts in situ. We found that editing of the GRIA2, EIF2AK2, and NUP43 transcripts is uncorrelated with nuclear localization and paraspeckle association. Further, NUP43 exhibits constant editing levels between single cells, while GRIA2 editing levels vary.	[Mellis, Ian A.; Gupte, Rohit; Raj, Arjun; Rouhanifard, Sara H.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Mellis, Ian A.; Raj, Arjun] Univ Penn, Perelman Sch Med, Genom & Computat Biol Grp, Philadelphia, PA 19104 USA; [Raj, Arjun] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA	Rouhanifard, SH (reprint author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	sara.rouhanifard@gmail.com		Mellis, Ian/0000-0002-6239-4821	NIH/NIGMS [T32GM007170]; NIH/NHGRI [T32HG000046]; NIH/NINDS [F30NS100595]; NIH [1F32GM120929-01A1, 4DN U01 HL129998]; NSF CAREER [1350601]; NIH New Innovator [1DP2OD008514]; NIH/NIBIB [R33 EB019767]; NIH Center for Photogenomics [RM1 HG007743]	We thank K. Nishikura and M. Sakurai for helpful discussions, and we thank C. Bartman and B. Emert for comments and suggestions. I.A.M. acknowledges support from NIH/NIGMS T32GM007170 (University of Pennsylvania MSTP), NIH/NHGRI T32HG000046 and NIH/NINDS F30NS100595; S.H.R. from NIH 1F32GM120929-01A1; and A.R. from NSF CAREER Award 1350601, NIH New Innovator 1DP2OD008514, NIH/NIBIB R33 EB019767, NIH 4DN U01 HL129998, and NIH Center for Photogenomics RM1 HG007743.	BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X; Cabili MN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0586-4; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Duffy DJ, 2015, ONCOTARGET, V6, P43182, DOI 10.18632/oncotarget.6568; Higuchi M, 2000, NATURE, V406, P78; Kuhlwilm M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083218                                                    ; Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542; Levesque MJ, 2013, NAT METHODS, V10, P865, DOI [10.1038/NMETH.2589, 10.1038/nmeth.2589]; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Mellis I. A., 2017, PROTOCOL EXCHANGE; OConnell MA, 1997, J BIOL CHEM, V272, P473; PASCHEN W, 1994, J NEUROCHEM, V63, P1596, DOI 10.1046/j.1471-4159.1994.63051596.x                                             ; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Sakurai M, 2010, NAT CHEM BIOL, V6, P733, DOI [10.1038/nchembio.434, 10.1038/.NCHEMBIO.434]; Seeburg PH, 2001, BRAIN RES, V907, P233, DOI 10.1016/S0006-8993(01)02445-3; Shaffer SM, 2015, LAB CHIP, V15, P3170, DOI 10.1039/c5lc00459d; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Whitney NP, 2008, FASEB J, V22, P2888, DOI 10.1096/fj.07-104661; Yamashita T, 2012, NEUROSCI RES, V73, P42, DOI 10.1016/j.neures.2012.02.002; YOSHIDA M, 1968, BIOCHIM BIOPHYS ACTA, V157, P455, DOI 10.1016/0005-2787(68)90145-7; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	24	2	2	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	AUG	2017	14	8					801	+		10.1038/NMETH.4332				7	Biochemical Research Methods	Biochemistry & Molecular Biology	FB9XX	WOS:000406493800018	28604724				2018-01-05	
J	Aydin, S; Personne, Y; Newire, E; Laverick, R; Russell, O; Roberts, AP; Enne, VI				Aydin, Seyid; Personne, Yoann; Newire, Enas; Laverick, Rebecca; Russell, Oliver; Roberts, Adam P.; Enne, Virve I.			Presence of Type I-F CRISPR/Cas systems is associated with antimicrobial susceptibility in Escherichia coli	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY			English	Article							RESISTANCE PLASMIDS; CAS SYSTEMS; BACTERIA; IMMUNITY; VIRULENCE; ARCHAEA; SPREAD	Background: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and their associated cas genes are sequence-specific DNA nuclease systems found in bacteria and archaea. CRISPR/Cas systems use RNA transcripts of previously acquired DNA (spacers) to target invading genetic elements with the same sequence, including plasmids. In this research we studied the relationship between CRISPR/Cas systems and multidrug resistance in Escherichia coli. Methods: The presence of Type I-E and Type I-F CRISPR systems was investigated among 82 antimicrobial-susceptible and 96 MDR clinical E. coli isolates by PCR and DNA sequencing. Phylogrouping and MLST were performed to determine relatedness of isolates. RT-PCR was performed to ascertain the expression of associated cas genes. Results: Type I-F CRISPR was associated with the B2 phylogroup and was significantly overrepresented in the susceptible group (22.0%) compared with the MDR group (2.1%). The majority of CRISPR I-F-containing isolates had spacer sequences that matched IncF and IncI plasmids. RT-PCR demonstrated that Type I-F cas genes were expressed and therefore potentially functional. Conclusions: The CRISPR I-F system is more likely to be found in antimicrobial-susceptible E. coli. Given that the Type I-F system is expressed in WT isolates, we suggest that this difference could be due to the CRISPR systempotentially interfering with the acquisition of antimicrobial resistance plasmids, maintaining susceptibility in these isolates.	[Aydin, Seyid; Personne, Yoann; Laverick, Rebecca; Russell, Oliver; Enne, Virve I.] UCL, Div Infect & Immun, Royal Free Hosp Campus,Rowland Hill St, London NW3 2PF, England; [Newire, Enas; Roberts, Adam P.] UCL Eastman Dent Inst, Dept Microbial Dis, 256 Grays Inn Rd, London WC1X 8LD, England; [Roberts, Adam P.] Univ Liverpool Liverpool Sch Trop Med, Dept Parasitol, Pembroke Pl, Liverpool L3 5QA, Merseyside, England	Enne, VI (reprint author), UCL, Div Infect & Immun, Royal Free Hosp Campus,Rowland Hill St, London NW3 2PF, England.	v.enne@ucl.ac.uk	Roberts, Adam/C-1787-2008		Schlumberger Foundation's Faculty for the Future Program	This study was supported by internal funding. E. N. is supported by the Schlumberger Foundation's Faculty for the Future Program.	Adams-Sapper S, 2013, ANTIMICROB AGENTS CH, V57, P490, DOI 10.1128/AAC.01025-12; Almendros C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050797; Bengtsson S, 2012, J ANTIMICROB CHEMOTH, V67, P69, DOI 10.1093/jac/dkr421; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194; Diez-Villasenor C, 2010, MICROBIOL-SGM, V156, P1351, DOI 10.1099/mic.0.036046-0; Enne VI, 2006, ANTIMICROB AGENTS CH, V50, P3003, DOI 10.1128/AAC.00137-06; Golding GR, 2012, DIAGN MICR INFEC DIS, V74, P242, DOI 10.1016/j.diagmicrobio.2012.07.003; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Louwen R, 2014, MICROBIOL MOL BIOL R, V78, P74, DOI 10.1128/MMBR.00039-13; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mathers AJ, 2015, CLIN MICROBIOL REV, V28, P565, DOI 10.1128/CMR.00116-14; Riley LW, 2014, CLIN MICROBIOL INFEC, V20, P380, DOI 10.1111/1469-0691.12646; Touchon M, 2012, MICROBIOL-SGM, V158, P2997, DOI 10.1099/mic.0.060814-0; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Vogwill T, 2015, EVOL APPL, V8, P284, DOI 10.1111/eva.12202; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09	26	0	0	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7453	1460-2091		J ANTIMICROB CHEMOTH	J. Antimicrob. Chemother.	AUG	2017	72	8					2213	2218		10.1093/jac/dkx137				6	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	FB5BC	WOS:000406155400008	28535195				2018-01-05	
J	Jiang, DN; Chen, JL; Fan, Z; Tan, DJ; Zhao, J; Shi, HJ; Liu, ZL; Tao, WJ; Li, MH; Wang, DS				Jiang, Dongneng; Chen, Jinlin; Fan, Zheng; Tan, Dejie; Zhao, Jiue; Shi, Hongjuan; Liu, Zhilong; Tao, Wenjing; Li, Minghui; Wang, Deshou			CRISPR/Cas9-induced disruption of wt1a and wt1b reveals their different roles in kidney and gonad development in Nile tilapia	DEVELOPMENTAL BIOLOGY			English	Article						Wilms tumor 1; Nile tilapia; CRISPR/Cas9; Kidney; Gonad; Sex determination and differentiation; Reproduction	WILMS-TUMOR GENE; OREOCHROMIS-NILOTICUS; SEX DETERMINATION; PROTEIN WT1; ZEBRAFISH PRONEPHROS; FRASIER-SYNDROME; SUPPRESSOR GENE; ORYZIAS-LATIPES; SERTOLI-CELLS; TELEOST FISH	Wilms tumor 1 (Wt1) is an essential factor for urogenital system development. Teleosts have two wt1s, named as wt1a and wt1b. In this study, the expression pattern of wt1a and wt1b and their functions on the urogenital system were analyzed by in situ hybridization and CRISPR/Cas9. wt1a was found to be expressed in the glomerulus at 3 dah (days after hatching), earlier than wt1b. wan and wt1b were simultaneously expressed in the somatic cells of gonads at 3 dah, while their cell locations were similar, but not identical in adult fish gonads. The wt1a(-/-) fish displayed pericardial edema and yolk sac edema at 3 dah and subsequently expanded as general body edema at 6 dah, failed to develop glomerulus and died during 6-10 dah, whereas the wt1b(-/-) fish were phenotypically normal. Immunohistochemical analyses revealed that the germ cell marker Vasa was expressed, while somatic cell genes Cyp19ala, Amh, Gsdf and Dmrt1 were not expressed in the ipt1a(-/-) gonads at 6 dah. The sex phenotypes of XX and XY in the wtb(-/-) fish were not affected. Real-time PCR revealed that the ovarian cyp19ala expression was up-regulated in XX wt1b(-/-) fish, compared with XX control at 90 dah. Serum estradiol-17 beta level was also up-regulated in XX wt1b(-/-) fish at 90 and 180 dah. The XY wt1b(-/-) fish had normal serum estradiol-17 beta and 11-ketotestosterone levels and remained fertile. These results suggest that Wt1a and Wt1b have different functions in the kidneys and gonads of tilapia.	[Jiang, Dongneng; Chen, Jinlin; Fan, Zheng; Tan, Dejie; Zhao, Jiue; Shi, Hongjuan; Liu, Zhilong; Tao, Wenjing; Li, Minghui; Wang, Deshou] Southwest Univ, Sch Life Sci, Key Lab Aquat Sci Chongqing, Key Lab Freshwater Fish Reprod & Dev,Minist Educ, Chongqing 400715, Peoples R China; [Jiang, Dongneng] Guangdong Ocean Univ, Fisheries Coll, Key Lab Marine Ecol & Aquaculture Environm Zhanji, Key Lab Aquaculture South China Sea Aquat Econ An, Zhanjiang 524088, Peoples R China	Wang, DS (reprint author), Southwest Univ, Sch Life Sci, Key Lab Aquat Sci Chongqing, Key Lab Freshwater Fish Reprod & Dev,Minist Educ, Chongqing 400715, Peoples R China.	wdeshou@swu.edu.cn			National Natural Science Foundation of China [31630082, 91331119, 31602134, 31502147]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20130182130003]; Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission [cstc2015jcyjB80001]; National Science Foundation [2016T90830, 2015M570765, 2013M542239]; Chongqing Postdoctoral Science Foundation [Xm2015028]; Doctor Foundation Project of Southwest University [SWU112027]; Fundamental Research Funds for the Central Universities [XDJK2016E090, XDJK2016E091, XDJK2016C157, XDJIC2013D019, XDJK2013C039]	This work was supported by grants 31630082, 91331119, 31602134 and 31502147 from the National Natural Science Foundation of China; grant 20130182130003 from the Specialized Research Fund for the Doctoral Program of Higher Education of China; grants cstc2015jcyjB80001 from the Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission; grants 2016T90830, 2015M570765 and 2013M542239 from National Science Foundation for Post-doctoral Scientists of China; grant Xm2015028 from Chongqing Postdoctoral Science Foundation; grant SWU112027 from Doctor Foundation Project of Southwest University; grants XDJK2016E090, XDJK2016E091, XDJK2016C157, XDJIC2013D019 and XDJK2013C039 from the Fundamental Research Funds for the Central Universities.	ARMSTRONG JF, 1993, MECH DEVELOP, V40, P85, DOI 10.1016/0925-4773(93)90090-K                                                    ; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Bollig F, 2006, DEV DYNAM, V235, P554, DOI 10.1002/dvdy.20645; Bollig F, 2009, DEVELOPMENT, V136, P2883, DOI 10.1242/dev.031773; Bradford ST, 2009, HUM MOL GENET, V18, P3429, DOI 10.1093/hmg/ddp283; Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; Caricasole A, 1996, P NATL ACAD SCI USA, V93, P7562, DOI 10.1073/pnas.93.15.7562                                                         ; Carmona R, 2001, CELL TISSUE RES, V303, P173, DOI 10.1007/s004410000307                                                           ; Chakraborty T, 2016, SCI REP-UK, V6, DOI 10.1038/srep19480; Chen M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114702; Gao F, 2004, MOL CELL BIOL, V24, P9899, DOI 10.1128/MCB.24.22.9899-9910.2004; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Gao F, 2014, HUM MOL GENET, V23, P333, DOI 10.1093/hmg/ddt423; Gerlach GF, 2013, WIRES DEV BIOL, V2, P559, DOI 10.1002/wdev.92; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Gurates B, 2003, MOL CELL ENDOCRINOL, V208, P61, DOI 10.1016/S0303-7207(03)00198-9; Gurates B, 2002, J CLIN ENDOCR METAB, V87, P4369, DOI 10.1210/jc.2002-020522; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6                                                   ; Ji S., 2013, ELECTRON J DIFFER EQ, V2013, P1; Jiang DN, 2016, MOL REPROD DEV, V83, P497, DOI 10.1002/mrd.22642; Joseph A, 2009, DEV BIOL, V325, P6, DOI 10.1016/j.ydbio.2008.10.012; Josso N, 2003, TRENDS ENDOCRIN MET, V14, P91, DOI 10.1016/S1043-2760(03)00005-5; Karl J, 1998, DEV BIOL, V203, P323, DOI 10.1006/dbio.1998.9068                                                          ; Kennedy D, 1996, NAT GENET, V12, P329, DOI 10.1038/ng0396-329; KENT J, 1995, ONCOGENE, V11, P1781; Kim J, 1999, MOL CELL BIOL, V19, P2289; Klamt B, 1998, HUM MOL GENET, V7, P709, DOI 10.1093/hmg/7.4.709; Kluver N, 2009, DEV BIOL, V325, P179, DOI 10.1016/j.ydbio.2008.10.009; Kobayashi T, 2003, CYTOGENET GENOME RES, V101, P289, DOI 10.1159/000074351; Kobayashi T, 2004, DEV DYNAM, V231, P518, DOI 10.1002/dvdy.20158; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Kuure S, 2000, MECH DEVELOP, V92, P31, DOI 10.1016/S0925-4773(99)00323-8; Laity JH, 2000, P NATL ACAD SCI USA, V97, P11932, DOI 10.1073/pnas.97.22.11932                                                        ; Li MH, 2013, ENDOCRINOLOGY, V154, P4814, DOI 10.1210/en.2013-1451; Li MH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005678; Li MH, 2014, GENETICS, V197, P591, DOI 10.1534/genetics.114.163667; Little M, 1997, HUM MUTAT, V9, P209, DOI 10.1002/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2; Liu C, 2016, DEVELOPMENT, V143, P3700, DOI 10.1242/dev.135756; Masse J, 2009, INT J DEV BIOL, V53, P411, DOI 10.1387/ijdb.082680jm; Menke A, 1998, KIDNEY INT, V53, P1512, DOI 10.1046/j.1523-1755.1998.00935.x                                                ; MUNDLOS S, 1993, DEVELOPMENT, V119, P1329; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Nakamura S, 2006, DEV BIOL, V295, P678, DOI 10.1016/j.ydbio.2006.03.052; Palmer RE, 2001, CURR BIOL, V11, P1805, DOI 10.1016/S0960-9822(01)00560-7; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Pfennig F, 2015, GEN COMP ENDOCR, V223, P87, DOI 10.1016/j.ygcen.2015.09.025; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; Schnerwitzki D, 2014, DEV BIOL, V393, P24, DOI 10.1016/j.ydbio.2014.06.026; Scholz H, 2005, PHYSIOLOGY, V20, P54, DOI 10.1152/physiol.00048.2004; Shi HJ, 2017, J ENDOCRINOL, V233, P65, DOI 10.1530/JOE-16-0551; Shimamura R, 1997, CLIN CANCER RES, V3, P2571; Sim EUH, 2002, ONCOGENE, V21, P2948, DOI 10.1038/sj/onc/1205373; Spotila LD, 1998, COMP BIOCHEM PHYS B, V119, P761, DOI 10.1016/S0305-0491(98)00053-4; Sun LN, 2014, ENDOCRINOLOGY, V155, P1476, DOI 10.1210/en.2013-1959; Sun YL, 2014, AQUACULTURE, V433, P19, DOI 10.1016/j.aquaculture.2014.05.035; Takasawa K, 2014, FASEB J, V28, P2020, DOI 10.1096/fj.13-246108; Tao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063604; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Xie QP, 2016, ENDOCRINOLOGY, V157, P2500, DOI 10.1210/en.2015-2049; Yamamura Y, 2005, ZOOL SCI, V22, P1045, DOI 10.2108/zsj.22.1045                                                             ; Yu XG, 2014, MOL CELL ENDOCRINOL, V392, P152, DOI 10.1016/j.mce.2014.05.013; Zhang LJ, 2015, P NATL ACAD SCI USA, V112, P4003, DOI 10.1073/pnas.1422371112; Zhang XL, 2014, J CHEM-NY, DOI 10.1155/2014/249485; Zhang ZW, 2015, MOL ENDOCRINOL, V29, P76, DOI 10.1210/me.2014-1256	65	0	0	10	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	AUG 1	2017	428	1					63	73		10.1016/j.ydbio.2017.05.017				11	Developmental Biology	Developmental Biology	FB6LU	WOS:000406255300005	28527702				2018-01-05	
J	Gahan, JM; Schnitzler, CE; DuBuc, TQ; Doonan, LB; Kanska, J; Gornik, SG; Barreira, S; Thompson, K; Schiffer, P; Baxevanis, AD; Frank, U				Gahan, James M.; Schnitzler, Christine E.; DuBuc, Timothy Q.; Doonan, Liam B.; Kanska, Justyna; Gornik, Sebastian G.; Barreira, Sofia; Thompson, Kerry; Schiffer, Philipp; Baxevanis, Andreas D.; Frank, Uri			Functional studies on the role of Notch signaling in Hydractinia development	DEVELOPMENTAL BIOLOGY			English	Article						Neurogenesis; Cnidaria; Morphogenesis; Nematocyte; Regeneration	CNIDARIAN NEMATOSTELLA-VECTENSIS; PROGENITOR CELLS; NERVE-CELLS; STEM-CELLS; HYDRA; NEUROGENESIS; PATHWAY; DIFFERENTIATION; METAMORPHOSIS; REGENERATION	The function of Notch signaling was previously studied in two cnidarians, Hydra and Nematostella, representing the lineages Hydrozoa and Anthozoa, respectively. Using pharmacological inhibition in Hydra and a combination of pharmacological and genetic approaches in Nematostella, it was shown in both animals that Notch is required for tentacle morphogenesis and for late stages of stinging cell maturation. Surprisingly, a role for Notch in neural development, which is well documented in bilaterians, was evident in embryonic Nematostella but not in adult Hydra. Adult neurogenesis in the latter seemed to be unaffected by DAFT, a drug that inhibits Notch signaling. To address this apparent discrepancy, we studied the role of Notch in Hydractinia echinata, an additional hydrozoan, in all life stages. Using CRISPR-Cas9 mediated mutagenesis, transgenesis, and pharmacological interference we show that Notch is dispensable for Hydractinia normal neurogenesis in all life stages but is required for the maturation of stinging cells and for tentacle morphogenesis. Our results are consistent with a conserved role for Notch in morphogenesis and nematogenesis across Cnidaria, and a lineage specific loss of Notch dependence in neurogenesis in hydrozoans.	[Gahan, James M.; DuBuc, Timothy Q.; Doonan, Liam B.; Kanska, Justyna; Gornik, Sebastian G.; Frank, Uri] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [Schnitzler, Christine E.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL 32080 USA; [Schnitzler, Christine E.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Schnitzler, Christine E.; Barreira, Sofia; Baxevanis, Andreas D.] NHGRI, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Thompson, Kerry] Natl Univ Ireland, Sch Med, Discipline Anat, Ctr Microscopy & Imaging, Galway, Ireland; [Schiffer, Philipp] UCL, Dept Genet Environm & Evolut, London, England	Frank, U (reprint author), Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland.	uri.frank@nuigalway.ie		Frank, Uri/0000-0003-2094-6381; Thompson, Kerry/0000-0003-2721-8977	Science Foundation Ireland (SFI) [11/PI/1020]; Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (NIH); Beckman Fund Scholarship; Irish Higher Education Authority, Programme for Research in Third Level Institutions; Starting Investigator Research Grant (SIRG) from SFI [13/SIRG/2125]; EMBO Long Term Fellowship [ALTF-68-2016];  [623748]	We thank members of our lab for comments and discussions. We are indebted to Werner A Muller for drawings in Fig. 3. Thanks are also due to the staff of the Station Biologique Roscoff, France for providing Hydractinia echinata colonies. We also thank Thomas Leitz for providing GLWamide antibodies. This research was funded by Science Foundation Ireland (SFI) through a Principal Investigator Award to UF (grant No. 11/PI/1020). It was also supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (NIH). JMG was a recipient of a Beckman Fund Scholarship. KT was funded by the Irish Higher Education Authority, Programme for Research in Third Level Institutions. SGG was funded by a Starting Investigator Research Grant (SIRG) (13/SIRG/2125)from SFI and by a Marie Curie Incoming International Fellow award (623748). TQD was funded by an EMBO Long Term Fellowship(ALTF-68-2016).	Bradshaw B, 2015, ELIFE, V4, DOI 10.7554/eLife.05506; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Chitnis A, 1996, DEVELOPMENT, V122, P2295; Dubuc TQ, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-24; Flici H, 2017, CELL REP, V18, P1395, DOI 10.1016/j.celrep.2017.01.019; Fritz AE, 2013, DEVELOPMENT, V140, P2212, DOI 10.1242/dev.088260; Gahan JM, 2016, CURR OPIN GENET DEV, V40, P65, DOI 10.1016/j.gde.2016.06.006; Gajewski M., 1996, ROUX ARCH DEVEL BIOL, P205; Galliot B, 2011, EUR J NEUROSCI, V34, P847, DOI 10.1111/j.1460-9568.2011.07829.x; Gazave E, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160242; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Hager G, 1997, DEVELOPMENT, V124, P569; Hartenstein V, 2015, DEV CELL, V32, P390, DOI 10.1016/j.devcel.2015.02.004; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Kasbauer T, 2007, DEV BIOL, V303, P376, DOI 10.1016/j.ydbio.2006.11.022; Kelava I., 2015, PHILOS T R SOC LON B, P370; Khalturin K, 2007, DEV BIOL, V309, P32, DOI 10.1016/j.ydbio.2007.06.013; Layden MJ, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-30; Leclere L, 2012, DEV BIOL, V364, P236, DOI 10.1016/j.ydbio.2012.01.018; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Marlow H, 2012, DEV BIOL, V362, P295, DOI 10.1016/j.ydbio.2011.11.012; MARTIN VJ, 1990, BIOL BULL, V178, P10, DOI 10.2307/1541532                                                                 ; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Miljkovic-Licina M, 2007, DEVELOPMENT, V134, P1191, DOI 10.1242/dev.02804; Millane RC, 2011, DEVELOPMENT, V138, P2429, DOI 10.1242/dev.064931; Munder S, 2013, DEV BIOL, V383, P146, DOI 10.1016/j.ydbio.2013.08.022; Munder S, 2010, DEV BIOL, V344, P331, DOI 10.1016/j.ydbio.2010.05.517; MULLER WA, 1973, ROUX ARCH DEV BIOL, V173, P122, DOI 10.1007/BF00575138; Rentzsch F., 2016, WILEY INTERDISCIP RE; Richards GS, 2015, DEVELOPMENT, V142, P3332, DOI 10.1242/dev.123745; Richards GS, 2014, DEVELOPMENT, V141, P4681, DOI 10.1242/dev.112029; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Schmich J, 1998, DEV GENES EVOL, V208, P267, DOI 10.1007/s004270050181; Seipp S., 2010, INVERTEBR NEUROSCI, V23, P23; Szczepanek S, 2002, J CELL SCI, V115, P745; Technau U, 2011, DEVELOPMENT, V138, P1447, DOI 10.1242/dev.048959; Wenger Y., 2016, PHILOS T R SOC LON B, P371; Zapata F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139068	40	0	0	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	AUG 1	2017	428	1					224	231		10.1016/j.ydbio.2017.06.006				8	Developmental Biology	Developmental Biology	FB6LU	WOS:000406255300017	28601529				2018-01-05	
J	Srinivasan, S; Guha, M; Kashina, A; Avadhani, NG				Srinivasan, Satish; Guha, Manti; Kashina, Anna; Avadhani, Narayan G.			Mitochondrial dysfunction and mitochondrial dynamics-The cancer connection	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Review						Mitochondrial dysfunction; retrograde signaling; mitochondrial dynamics; mitochondrial fission; cancer	CYTOCHROME-C-OXIDASE; UNFOLDED PROTEIN RESPONSE; NUCLEAR GENE TARGETS; MAMMALIAN-CELLS; DNA MUTATIONS; OXIDATIVE STRESS; QUALITY-CONTROL; TUMOR-GROWTH; SUCCINATE-DEHYDROGENASE; PROMOTES TUMORIGENESIS	Mitochondrial dysfunction is a hallmark of many diseases. The retrograde signaling initiated by dysfunctional mitochondria can bring about global changes in gene expression that alters cell morphology and function. Typically, this is attributed to disruption of important mitochondria functions, such as ATP production, integration of metabolism, calcium homeostasis and regulation of apoptosis. Recent studies showed that in addition to these factors, mitochondrial dynamics might play an important role in stress signaling. Normal mitochondria are highly dynamic organelles whose size, shape and network are controlled by cell physiology. Defective mitochondrial dynamics play important roles in human diseases. Mitochondrial DNA defects and defective mitochondrial function have been reported in many cancers. Recent studies show that increased mitochondrial fission is a pro-tumorigenic phenotype. In this paper, we have explored the current understanding of the role of mitochondrial dynamics in pathologies. We present new data on mitochondria dynamics and dysfunction to illustrate a causal link between mitochondrial DNA defects, excessive fission, mitochondrial retrograde signaling and cancer progression. This article is part of a Special Issue entitled Mitochondria in Cancer, edited by Giuseppe Gasparre, Rodrigue Rossignol and Pierre Sonveaux. (C) 2017 Elsevier B.V. All rights reserved.	[Srinivasan, Satish; Guha, Manti; Kashina, Anna; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Biomed Sci, 3800 Spruce St,189E, Philadelphia, PA 19104 USA	Avadhani, NG (reprint author), 3800 Spruce St,Room 189E Vet, Philadelphia, PA 19104 USA.	narayan@vet.upenn.edu			NCI [CA-22762]; Harriet Ellison Woodward Foundation; Breast Cancer Alliance Young Investigator Grant	We thank Gordon Ruthel for assistance with the imaging studies. This work was funded by NCI grant CA-22762, an Endowment from Harriet Ellison Woodward Foundation to NGA and a Breast Cancer Alliance Young Investigator Grant to MG.	AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915                                                         ; Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910                                                         ; Amuthan Govindasamy, 2002, Oncogene, V21, P7839, DOI 10.1038/sj.onc.1205983; Arismendi-Morillo Gabriel, 2009, Int J Biochem Cell Biol, V41, P2062, DOI 10.1016/j.biocel.2009.02.002; Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53                                                           ; Ashley N, 2009, BIOCHEM BIOPH RES CO, V378, P450, DOI 10.1016/j.bbrc.2008.11.059; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baker MJ, 2014, BRIT J PHARMACOL, V171, P1870, DOI 10.1111/bph.12430; Bansal S, 2014, J BIOL CHEM, V289, P9936, DOI 10.1074/jbc.M113.525659; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Barnes LM, 2006, BIOTECHNOL BIOENG, V94, P530, DOI 10.1002/bit.20856; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Benbrik E, 1997, J NEUROL SCI, V149, P19, DOI 10.1016/S0022-510X(97)05376-8; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Benischke AS, 2014, MITOCHONDRION, V17, P182, DOI 10.1016/j.mito.2014.04.001; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bestwick ML, 2013, TRENDS BIOCHEM SCI, V38, P283, DOI 10.1016/j.tibs.2013.03.006; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522                                                          ; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Biswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028; Biswas G, 2005, CELL DEATH DIFFER, V12, P266, DOI 10.1038/sj.cdd.4401553; Biswas G., 2008, J BIOL CHEM, V13; Biswas G, 2008, P NATL ACAD SCI USA, V105, P186, DOI 10.1073/pnas.0706183104; Boland ML, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00292; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devce1.2007.11.019; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200                                                          ; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013                                                     ; Chandran K, 2009, BIOPHYS J, V96, P1388, DOI 10.1016/j.bpj.2008.10.042; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chowdhury A. R., 2016, ONCOGENE, V27; Cobbold P. H., 1990, CELL BIOL, V1, P311; Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859                                                                   ; Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475; Correia RL, 2011, MITOCHONDRION, V11, P48, DOI 10.1016/j.mito.2010.07.001; Dakubo GD, 2006, J CLIN PATHOL, V59, P10, DOI 10.1136/jcp.2005.027664; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dasgupta S, 2008, CANCER RES, V68, P700, DOI 10.1158/0008-5472.CAN-07-5532; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Fan WW, 2012, GENE DEV, V26, P384, DOI 10.1101/gad.175802.111; Ferreira-da-Silva A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122308; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gallardo ME, 2006, HUM MUTAT, V27, P575, DOI 10.1002/humu.20338; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5                                                   ; Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028; Guantes R, 2015, GENOME RES, V25, P633, DOI 10.1101/gr.178426.114; Guha M., 2013, MITOCHONDRIAL RETROG; Guha M, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.45; Guha M, 2013, MITOCHONDRION, V13, P577, DOI [10.1016/j.mito.2013.08.007, 10.1016/j.mito2013.08.007]; Guha M, 2010, BBA-BIOENERGETICS, V1797, P1055, DOI 10.1016/j.bbabio.2010.02.008; Guha M, 2009, MOL BIOL CELL, V20, P4107, DOI 10.1091/mbc.E09-04-0296; Guo JH, 2011, CANCER RES, V71, P2978, DOI 10.1158/0008-5472.CAN-10-3482; Hagenbuchner J, 2013, ONCOGENE, V32, P4748, DOI 10.1038/onc.2012.500; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; Hild G, 2010, CYTOSKELETON, V67, P609, DOI 10.1002/cm.20473; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Horton T. M., 1996, CANCER, V15, P95; Imanishi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023401; Inoue-Yamauchi A, 2012, BIOCHEM BIOPH RES CO, V421, P81, DOI 10.1016/j.bbrc.2012.03.118; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Kalabis J, 2012, NAT PROTOC, V7, P235, DOI 10.1038/nprot.2011.437; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Keibler MA, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0156-6; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; Lobert VH, 2011, PHYSIOLOGY, V26, P171, DOI 10.1152/physiol.00054.2010; Lorente G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085817; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Luo Y, 1997, P NATL ACAD SCI USA, V94, P9705, DOI 10.1073/pnas.94.18.9705                                                         ; Magda D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-521; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8                                                   ; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; Masramon L, 2006, J CELL SCI, V119, P1477, DOI 10.1242/jcs.02871; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Moro L, 2009, CELL DEATH DIFFER, V16, P571, DOI 10.1038/cdd.2008.178; Naito A, 2008, CANCER SCI, V99, P1584, DOI 10.1111/j.1349-7006.2008.00879.x; Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Niemann S, 2000, NAT GENET, V26, P268; NIRANJAN BG, 1982, SCIENCE, V215, P73, DOI 10.1126/science.6797067; Oda T, 2010, STRUCTURE, V18, P761, DOI 10.1016/j.str.2010.05.009; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Paglia G, 2016, J PROTEOME RES, V15, P608, DOI 10.1021/acs.jproteome.5b01020; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Park JS, 2009, HUM MOL GENET, V18, P1578, DOI 10.1093/hmg/ddp069; Parker AL, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00153; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Pellegrino MW, 2013, BBA-MOL CELL RES, V1833, P410, DOI 10.1016/j.bbamcr.2012.02.019; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111; Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012; Picaud S, 2011, J INHERIT METAB DIS, V34, P671, DOI 10.1007/s10545-011-9294-8; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; Sharma LK, 2011, HUM MOL GENET, V20, P4605, DOI 10.1093/hmg/ddr395; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Singh KK, 1999, ONCOGENE, V18, P6641, DOI 10.1038/sj.onc.1203056; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245                                                           ; Srinivasan S, 2016, ONCOGENE, V35, P1585, DOI 10.1038/onc.2015.227; Srinivasan S, 2007, ANN NY ACAD SCI, V1117, P51, DOI 10.1196/annals.1402.067; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; Srinivasan S, 2010, ANN NY ACAD SCI, V1192, P245, DOI 10.1111/j.1749-6632.2009.05377.x; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tanaka K, 2016, AM J CANCER RES, V6, P781; Tang WG, 2012, CARCINOGENESIS, V33, P1762, DOI 10.1093/carcin/bgs190; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Thompson CB, 2009, NEW ENGL J MED, V360, P813, DOI 10.1056/NEJMe0810213; Torsvik A, 2014, CANCER MED-US, V3, P812, DOI 10.1002/cam4.219; Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326; Twig G, 2006, AM J PHYSIOL-CELL PH, V291, pC176, DOI 10.1152/ajpcell.00348.2005; Uyeda TQP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026200; van C. J., 2009, J CELL SCI, V122, P305; Wallace D C, 2009, Cold Spring Harb Symp Quant Biol, V74, P383, DOI 10.1101/sqb.2009.74.031; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, ONCOGENE, V31, P2491, DOI 10.1038/onc.2011.416; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Woo DK, 2012, AM J PATHOL, V180, P24, DOI 10.1016/j.ajpath.2011.10.003; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang G, 2016, J CLIN INVEST, V126, P1834, DOI 10.1172/JCI82661; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445                                                            	153	6	6	10	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	AUG	2017	1858	8			SI		602	614		10.1016/j.bbabio.2017.01.004				13	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FA9KF	WOS:000405763800006	28104365				2018-01-05	
J	Ekoue, DN; He, CX; Diamond, AM; Bonini, MG				Ekoue, Dede N.; He, Chenxia; Diamond, Alan M.; Bonini, Marcelo G.			Manganese superoxide dismutase and glutathione peroxidase-1 contribute to the rise and fall of mitochondrial reactive oxygen species which drive oncogenesis	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Review						Oxidative stress; Cancer; Manganese superoxide dismutase; Selenium; Glutathione peroxidase	PROSTATE-CANCER RISK; BREAST-CANCER; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; RAT HEPATOCYTES; MNSOD; LOCALIZATION; POLYMORPHISM; SOD2; GENE	Reactive oxygen species (ROS) largely originating in the mitochondria play essential roles in the metabolic and (epi)genetic reprogramming of cancer cell evolution towards more aggressive phenotypes. Recent studies have indicated that the activity of superoxide dismutase (SOD2) may promote tumor progression by serving as a source of hydrogen peroxide (H2O2). H2O2 is a form of ROS that is particularly active as a redox agent affecting cell signaling due to its ability to freely diffuse out of the mitochondria and alter redox active amino acid residues on regulatory proteins. Therefore, there is likely a dichotomy whereas SOD2 can be considered a protective antioxidant, as well as a pro-oxidant during cancer progression, with these effects depending on the accumulation and detoxification of H2O2. Glutathione peroxidase-1 GPX1, is a selenium-dependent scavenger of H2O2 which partitions between the mitochondria and the cytosol. Epidemiologic studies indicated that allelic variations in the SOD2 and GPX1 genes alter the distribution and relative concentrations of SOD2 and GPX1 in mitochondria, thereby affecting the dynamic between the production and elimination of H2O2. Experimental and epidemiological evidence supporting a conflicting role of SOD2 in tumor biology, and epidemiological evidence that SOD2 and GPX1 can interact to affect cancer risk and progression indicated that it is the net accumulation of mitochondrial H2O2 (mtH(2)O(2)) resulting from of the balance between the activities SOD2 and anti-oxidants such as GPX1 that determines whether SOD2 prevents or promotes oncogenesis. In this review, research supporting the idea that GPX1 is a gatekeeper restraining the oncogenic power of mitochondrial ROS generated by SOD2 is presented. This article is part of a Special Issue entitled Mitochondria in Cancer, edited by Giuseppe Gasparre, Rodrigue Rossignol and Pierre Sonveaux. (C) 2017 Published by Elsevier B.V.	[Ekoue, Dede N.; He, Chenxia; Diamond, Alan M.; Bonini, Marcelo G.] Univ Illinois, Dept Pathol & Med, Chicago, IL USA	Bonini, MG (reprint author), 909 S Wolcott Ave,COMRB 1131, Chicago, IL 60612 USA.	mbonini@uic.edu			U.S. Department of Defense [67263-RT-REP]; National Institutes of Health [1RO1HL125356, RO1CA127943, R21CA182103]; UIC Cancer Center Pilot; Research Supplement to Promote Diversity in Health-Related Research [RO1CA127943S1]	This work was supported by grants from the U.S. Department of Defense 67263-RT-REP to M.G.B., National Institutes of Health Grants 1RO1HL125356 (M.G.B., Co-PI) and RO1CA127943, R21CA182103 to A.M.D. and a UIC Cancer Center Pilot Grant to A.M.D. and M.B. and a Research Supplement to Promote Diversity in Health-Related Research RO1CA127943S1 to A.M.D.	Ambrosone CB, 1999, CANCER RES, V59, P602; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; ASAYAMA K, 1994, HISTOCHEMISTRY, V102, P213, DOI 10.1007/BF00268898                                                              ; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Bera S, 2014, CANCER RES, V74, P5118, DOI 10.1158/0008-5472.CAN-14-0660; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Caban K, 2006, CELL MOL LIFE SCI, V63, P73, DOI 10.1007/s00018-005-5402-y; Cooper ML, 2008, CANCER RES, V68, P10171, DOI 10.1158/0008-5472.CAN-08-1827; Cox DG, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-217; Cox DG, 2004, CANCER EPIDEM BIOMAR, V13, P1821; Dhar SK, 2012, FREE RADICAL BIO MED, V52, P2209, DOI 10.1016/j.freeradbiomed.2012.03.009; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525                                             ; Haigis MC, 2012, CANCER RES, V72, P2468, DOI 10.1158/0008-5472.CAN-11-3633; Hart PC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7053; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; He CX, 2016, TRENDS BIOCHEM SCI, V41, P568, DOI 10.1016/j.tibs.2016.04.004; Hirche TO, 2005, J IMMUNOL, V174, P1557, DOI 10.4049/jimmunol.174.3.1557                                                     ; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Hondal RJ, 2013, ANTIOXID REDOX SIGN, V18, P1675, DOI 10.1089/ars.2012.5013; Hu YJ, 2003, CANCER RES, V63, P3347; Jin CH, 2015, FREE RADICAL BIO MED, V81, P77, DOI 10.1016/j.freeradbiomed.2014.12.026; Kang D, 2007, CANCER EPIDEM BIOMAR, V16, P1581, DOI 10.1158/1055-9965.EPI-07-0160; Kang SW, 2015, INT J CLIN EXP MED, V8, P14647; Li F, 2011, FREE RADICAL RES, V45, P1154, DOI 10.3109/10715762.2011.604321; Li HJ, 2005, CANCER RES, V65, P2498, DOI 10.1158/0008-5472.CAN-04-3535; Li N, 2014, TUMOR BIOL, V35, P955, DOI 10.1007/s13277-013-1127-y; Li SJ, 2000, CANCER RES, V60, P3927; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; Ma XY, 2010, BREAST CANCER RES TR, V122, P509, DOI 10.1007/s10549-009-0725-2; Mikhak B, 2008, CARCINOGENESIS, V29, P2335, DOI 10.1093/carcin/bgn212; Miriyala S, 2012, BBA-MOL BASIS DIS, V1822, P794, DOI 10.1016/j.bbadis.2011.12.002; Nelson KK, 2003, CLIN CANCER RES, V9, P424; Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010; ShimodaMatsubayashi S, 1996, BIOCHEM BIOPH RES CO, V226, P561, DOI 10.1006/bbrc.1996.1394; Sullivan LB, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-17; Sutton A, 2005, PHARMACOGENET GENOM, V15, P311, DOI 10.1097/01213011-200505000-00006                                                ; Sutton A, 2006, CANCER RES, V66, P2844, DOI 10.1158/0008-5472.CAN-05-2566; Sutton A, 2003, PHARMACOGENETICS, V13, P145, DOI 10.1097/01.fpc.0000054067.64000.8f; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; UTSUNOMIYA H, 1991, J HISTOCHEM CYTOCHEM, V39, P1167, DOI 10.1177/39.9.1918936                                                            ; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Zhuo P, 2009, BIOCHIM BIOPHYS ACTA, V115, P227; Zhuo P, 2009, CANCER RES, V69, P8183, DOI 10.1158/0008-5472.CAN-09-1791; Zou XH, 2016, ANTIOXID REDOX SIGN, V25, P326, DOI 10.1089/ars.2016.6641	47	1	1	9	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	AUG	2017	1858	8			SI		628	632		10.1016/j.bbabio.2017.01.006				5	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FA9KF	WOS:000405763800008	28087256				2018-01-05	
J	Lytovchenko, O; Kunji, ERS				Lytovchenko, Oleksandr; Kunji, Edmund R. S.			Expression and putative role of mitochondrial transport proteins in cancer	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Review						Mitochondrial metabolism; Regulation in cancer; Transporters; Mitochondrial carrier; Pyruvate carrier; Cancer metabolism	PERMEABILITY TRANSITION PORE; ADENINE-NUCLEOTIDE TRANSLOCASE; INDUCED CONFORMATIONAL-CHANGES; SKELETAL-MUSCLE UCP2; RENAL-CELL CARCINOMA; ATP-MG/PI CARRIER; NF-KAPPA-B; UNCOUPLING PROTEIN-2; GENE-EXPRESSION; PYRUVATE CARRIER	Cancer cells undergo major changes in energy and biosynthetic metabolism. One of them is the Warburg effect, in which pyruvate is used for fermentation rather for oxidative phosphorylation. Another major one is their increased reliance on glutamine, which helps to replenish the pool of Krebs cycle metabolites used for other purposes, such as amino acid or lipid biosynthesis. Mitochondria are central to these alterations, as the biochemical pathways linking these processes run through these organelles. Two membranes, an outer and inner membrane, surround mitochondria, the latter being impermeable to most organic compounds. Therefore, a large number of transport proteins are needed to link the biochemical pathways of the cytosol and mitochondrial matrix. Since the transport steps are relatively slow, it is expected that many of these transport steps are altered when cells become cancerous. In this review, changes in expression and regulation of these transport proteins are discussed as well as the role of the transported substrates. This article is part of a Special Issue entitled Mitochondria in Cancer, edited by Giuseppe Gasparre, Rodrigue Rossignol and Pierre Sonveaux.	[Lytovchenko, Oleksandr; Kunji, Edmund R. S.] Cambridge Biomed Campus, MRC, Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England; [Lytovchenko, Oleksandr] Karolinska Inst, Dept Med Biochem & Biophys, Retzius Vag 8, Stockholm, Sweden	Kunji, ERS (reprint author), Cambridge Biomed Campus, MRC, Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	ek@mrc-mbu.cam.ac.uk		Kunji, Edmund/0000-0002-0610-4500	Marie Curie Initial Training Networks (ITN) grant 'MEET' (Mitochondrial European Educational Training) [317433]; Medical Research Council [MC_U105663139]	OL was supported by Marie Curie Initial Training Networks (ITN) grant 'MEET' (Mitochondrial European Educational Training Project, Grant Agreement no. 317433). The work of ERSK is funded by the Medical Research Council, grant MC_U105663139.	Albanese C, 2015, AGING-US, V7, P519, DOI 10.18632/aging.100785                                                           ; Alberghina L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.513; Alcala S, 2008, ONCOGENE, V27, P44, DOI 10.1038/sj.onc.1210600; Aluvila S, 2010, MOL PHARMACOL, V77, P26, DOI 10.1124/mol.109.058750; Amoedo ND, 2016, BBA-MOL CELL RES, V1863, P2394, DOI 10.1016/j.bbamcr.2016.04.011; Antunes D, 2014, BBA-MOL CELL BIOL L, V1841, P896, DOI 10.1016/j.bbalip.2014.03.004; Argiles JM, 2002, BIOCHEM BIOPH RES CO, V293, P1145, DOI 10.1016/S0006-291X(02)00355-8; Arigoni M, 2013, AM J PATHOL, V182, P2058, DOI 10.1016/j.ajpath.2013.02.046; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565                                                                   ; Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792; Baffy G, 2011, BRIT J CANCER, V105, P469, DOI 10.1038/bjc.2011.245; Baffy G, 2010, MITOCHONDRION, V10, P243, DOI 10.1016/j.mito.2009.12.143; Barbosa IA, 2012, BBA-REV CANCER, V1826, P238, DOI 10.1016/j.bbcan.2012.04.005; Barupala DP, 2016, ARCH BIOCHEM BIOPHYS, V592, P60, DOI 10.1016/j.abb.2016.01.010; Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493; Bender T., 2015, BIOCH BIOPHYS ACTA M, P1; Bing C, 2000, CANCER RES, V60, P2405; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Braun N, 2015, SCI REP-UK, V5, DOI 10.1038/srep13450; Brenner C, 2006, ONCOGENE, V25, P4744, DOI 10.1038/sj.onc.1209609; Brenner C, 2011, ONCOGENE, V30, P883, DOI 10.1038/onc.2010.501; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Brower JV, 2007, J BIOL CHEM, V282, P29658, DOI 10.1074/jbc.M704386200; Buttner S, 2011, EMBO J, V30, P2779, DOI 10.1038/emboj.2011.197; Busquets S, 2001, FEBS LETT, V505, P255, DOI 10.1016/S0014-5793(01)02815-0; Busquets S, 2005, FEBS LETT, V579, P717, DOI 10.1016/j.febslet.2004.12.050; Catalina-Rodriguez O, 2012, ONCOTARGET, V3, P1220; Chang KW, 2011, MOL GENET METAB, V103, P293, DOI 10.1016/j.ymgme.2011.03.013; Chen HY, 2014, ONCOL LETT, V7, P1422, DOI 10.3892/ol.2014.1947; Chen YW, 2011, FUNCT INTEGR GENOMIC, V11, P225, DOI 10.1007/s10142-011-0210-y; Cheng LH, 2010, GYNECOL ONCOL, V117, P159, DOI 10.1016/j.ygyno.2010.01.041; Chevrollier A, 2005, J BIOENERG BIOMEMBR, V37, P307, DOI 10.1007/s10863-005-8642-5; Chevrollier A, 2011, BBA-BIOENERGETICS, V1807, P562, DOI 10.1016/j.bbabio.2010.10.008; Coller HA, 2014, AM J PATHOL, V184, P4, DOI 10.1016/j.ajpath.2013.07.035; Corbet C, 2017, BBA-REV CANCER, V1868, P7, DOI 10.1016/j.bbcan.2017.01.002; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Criscuolo F, 2005, AM NAT, V166, P686, DOI 10.1086/497439; del Rey M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126555; Delahanty RJ, 2011, AM J EPIDEMIOL, V174, P1115, DOI 10.1093/aje/kwr233; Derdak Z, 2006, CARCINOGENESIS, V27, P956, DOI 10.1093/carcin/bgi335; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Dolatshad H, 2015, LEUKEMIA, V29, P1092, DOI 10.1038/leu.2014.331; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; Dolce V, 2001, P NATL ACAD SCI USA, V98, P2284, DOI 10.1073/pnas.031430998; Donadelli M, 2015, WORLD J GASTROENTERO, V21, P3232, DOI 10.3748/wjg.v21.i11.3232; Dong H, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-60; Edvardson S, 2013, J MED GENET, V50, P240, DOI 10.1136/jmedgenet-2012-101485; el Dein OS, 2012, BIOCHEM PHARMACOL, V83, P1172, DOI 10.1016/j.bcp.2012.01.017; Elliott RL, 2012, J CANC RES, V3, P278; Esteves P, 2014, CANCER RES, V74, P3971, DOI 10.1158/0008-5472.CAN-13-3383; Favre C, 2010, ONCOGENE, V29, P3964, DOI 10.1038/onc.2010.146; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.E06-12-1109; Frezza C, 2014, INT J BIOCHEM CELL B, V48, P11, DOI [10.1016/j.bioce1.2013.12.013, 10.1016/j.biocel.2013.12.013]; Frezza C, 2009, SEMIN CANCER BIOL, V19, P4, DOI 10.1016/j.semcancer.2008.11.008; Pons DG, 2015, FREE RADICAL BIO MED, V86, P67, DOI 10.1016/j.freeradbiomed.2015.04.032; Gabrielson M, 2016, BIOCHEM BIOPH RES CO, V469, P1090, DOI 10.1016/j.bbrc.2015.12.088; Gabrielson M, 2013, ONCOL REP, V29, P1268, DOI 10.3892/or.2013.2247; Gallerne C, 2010, INT J BIOCHEM CELL B, V42, P623, DOI 10.1016/j.biocel.2009.12.024; Gallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017827; Gnoni GV, 2009, IUBMB LIFE, V61, P987, DOI 10.1002/iub.249; Gonidi M, 2011, PATHOL RES PRACT, V207, P377, DOI 10.1016/j.prp.2011.03.007; Gutierrez-Aguilar M, 2013, BIOCHEM J, V454, P371, DOI 10.1042/BJ20121753; Halestrap AP, 2003, CURR MED CHEM, V10, P1507, DOI 10.2174/0929867033457278                                                        ; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9                                                   ; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harborne SPD, 2015, BBA-BIOENERGETICS, V1847, P1245, DOI 10.1016/j.bbabio.2015.07.002; Harris T, 2011, CLIN CANCER RES, V17, P690, DOI 10.1158/1078-0432.CCR-10-1892; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hensley C. T., 2013, REV SERIES GLUTAMINE, V123; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hirschey MD, 2015, SEMIN CANCER BIOL, V35, pS129, DOI 10.1016/j.semcancer.2015.10.002; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Hsiao CP, 2014, J PAIN SYMPTOM MANAG, V48, P1080, DOI 10.1016/j.jpainsymman.2014.03.010; Hsiao C.-P., 2015, CANC NURS, V36, P189; Huang WJ, 2013, CELL RES, V23, P724, DOI 10.1038/cr.2013.15; Hung HI, 2013, J BIOL CHEM, V288, P677, DOI 10.1074/jbc.M112.422667; Hurtaud C, 2006, CELL MOL LIFE SCI, V63, P1780, DOI 10.1007/s00018-006-6129-0; Infantino V., 2014, BIOCHIM BIOPHYS ACTA, V1839, P1; Infantino V, 2014, BBA-GENE REGUL MECH, V1839, P1217, DOI 10.1016/j.bbagrm.2014.07.013; Jang JY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1857; Jang JY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-160; Jin X, 2009, J HEPATOL, V50, P1019, DOI 10.1016/j.jhep.2008.10.034; Joo H., 2009, BIOCENT, V1, P1; Katz C, 2012, J BIOL CHEM, V287, P15016, DOI 10.1074/jbc.M111.328377; Kheirelseid EAH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-12; Kim S, 2014, ANN HEMATOL, V93, P437, DOI 10.1007/s00277-013-1884-0; Kim WT, 2016, YONSEI MED J, V57, P865, DOI 10.3349/ymj.2016.57.4.865; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kolukula VK, 2014, ONCOTARGET, V5, P1212, DOI 10.18632/oncotarget.1831                                                        ; KOVACEVI.Z, 1970, BIOCHEM J, V118, P265, DOI 10.1042/bj1180265                                                               ; KOVACEVIC Z, 1982, BIOCHIM BIOPHYS ACTA, V687, P291, DOI 10.1016/0005-2736(82)90557-0; KOZAK UC, 1992, MOL ENDOCRINOL, V6, P763, DOI 10.1210/me.6.5.763                                                              ; Kuai XY, 2010, WORLD J GASTROENTERO, V16, P5773, DOI 10.3748/wjg.v16.i45.5773; Kunji E. R. S., 2012, STRUCTURAL MECH ASPE, P174; Kvamme E, 2001, J NEUROSCI RES, V66, P951, DOI 10.1002/jnr.10041                                                               ; Kwong JQ, 2014, CELL DEATH DIFFER, V21, P1209, DOI 10.1038/cdd.2014.36; Lago CU, 2012, ONCOGENE, V31, P4725, DOI 10.1038/onc.2011.630; Lando M, 2013, J PATHOL, V230, P59, DOI 10.1002/path.4168; Lazebnik Y, 2010, NAT REV CANCER, V10, P232, DOI 10.1038/nrc2827; Le Bras M, 2006, CANCER RES, V66, P9143, DOI 10.1158/0008-5472.CAN-05-4407; Lee CF, 2009, WORLD J GASTROENTERO, V15, P356, DOI 10.3748/wjg.15.356; Leibowitz-Amit R, 2006, CANCER RES, V66, P8687, DOI 10.1158/0008-5472.CAN-05-2294; Lena A, 2010, FEBS J, V277, P2853, DOI 10.1111/j.1742-4658.2010.07702.x; Li Mark Xiang, 2015, F1000Prime Rep, V7, P42, DOI 10.12703/P7-42; Li WJ, 2015, CANCER PREV RES, V8, P487, DOI 10.1158/1940-6207.CAPR-14-0297-T; Li WJ, 2013, CANCER BIOMARK, V13, P377, DOI 10.3233/CBM-130369; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Phan Liem Minh, 2014, [Cancer Biology and Medicine, 癌症生物学与医学], V11, P1, DOI 10.7497/j.issn.2095-3941.2014.01.001; Lim HY, 2015, BIOCHEM BIOPH RES CO, V460, P938, DOI 10.1016/j.bbrc.2015.03.130; Lindqvist BM, 2012, EPIGENETICS-US, V7, P300, DOI 10.4161/epi.7.3.19064; Lunetti P, 2016, J BIOL CHEM, V291, P19746, DOI 10.1074/jbc.M116.736876; Maldonado EN, 2014, MITOCHONDRION, V19, P78, DOI 10.1016/j.mito.2014.09.002; Martin LA, 2016, J BIOENERG BIOMEMBR, V48, P137, DOI 10.1007/s10863-014-9592-6; McCommis KS, 2015, BIOCHEM J, V466, P443, DOI 10.1042/BJ20141171; Menga A, 2015, INT J BIOCHEM CELL B, V60, P157, DOI 10.1016/j.biocel.2015.01.004; MOLINA M, 1995, BIOCHEM J, V308, P629, DOI 10.1042/bj3080629                                                               ; Moreno-Sanchez R, 2014, INT J BIOCHEM CELL B, V50, P10, DOI 10.1016/j.biocel.2014.01.025; Motamedian E, 2015, IRAN J BASIC MED SCI, V18, P267; Muhlenhoff U, 2015, EUR J CELL BIOL, V94, P292, DOI 10.1016/j.ejcb.2015.05.003; Nancolas B, 2016, BIOCHEM J, V473, P929, DOI 10.1042/BJ20151120; Nath K, 2016, BBA-REV CANCER, V1866, P151, DOI 10.1016/j.bbcan.2016.08.001; Neesse A, 2012, CURR PHARM BIOTECHNO, V13, P2273, DOI 10.2174/138920112802501953                                                      ; Nohara K, 2012, TOXICOL SCI, V129, P293, DOI 10.1093/toxsci/kfs203; NOSEK MT, 1992, ARCH BIOCHEM BIOPHYS, V296, P691, DOI 10.1016/0003-9861(92)90628-A; Nowinski SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9137; Oehler V. G., 2013, DERIVATION DIAGNOSTI, V114, P3292; Pain D, 2016, CURR OPIN GENET DEV, V38, P45, DOI 10.1016/j.gde.2016.03.006; Palmieri EM, 2015, BBA-BIOENERGETICS, V1847, P729, DOI 10.1016/j.bbabio.2015.04.009; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060                                                        ; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pierri CL, 2014, CELL MOL LIFE SCI, V71, P349, DOI 10.1007/s00018-013-1389-y; Porcelli V., 2014, J BIOL CHEM; Qiao C, 2015, J CELL PHYSIOL, V230, P1054, DOI 10.1002/jcp.24833; RACKER E, 1972, AM SCI, V60, P56; Ramsay EE, 2011, PHARM RES-DORDR, V28, P2731, DOI 10.1007/s11095-011-0584-5; Rauckhorst AJ, 2016, CURR OPIN GENET DEV, V38, P102, DOI 10.1016/j.gde.2016.05.003; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2                                                   ; Robbins D, 2011, INT J MOL SCI, V12, P5285, DOI 10.3390/ijms12085285; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Romero-Garcia S, 2011, CANCER BIOL THER, V12, P939, DOI 10.4161/cbt.12.11.18140; Rouault TA, 2016, CURR OPIN GENET DEV, V38, P31, DOI 10.1016/j.gde.2016.02.004; Rudolph A, 2013, ENDOCR-RELAT CANCER, V20, P875, DOI 10.1530/ERC-13-0349; Rupprecht A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088474; Sanchis D, 1998, FEBS LETT, V436, P415, DOI 10.1016/S0014-5793(98)01178-8; Santandreu FM, 2009, CELL PHYSIOL BIOCHEM, V24, P379, DOI 10.1159/000257430; Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026; Schell JC, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-6; Sciacovelli M., 2014, METABOLIC ALTERATION; Senyilmaz Deniz, 2015, F1000Prime Rep, V7, P41, DOI 10.12703/P7-41; Seyfried TN, 2014, CARCINOGENESIS, V35, P515, DOI 10.1093/carcin/bgt480; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Solaini G, 2011, BBA-BIOENERGETICS, V1807, P534, DOI 10.1016/j.bbabio.2010.09.003; SOUBA WW, 1993, ANN SURG, V218, P715, DOI 10.1097/00000658-199312000-00004; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; Stiban J, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1066, DOI 10.1134/S0006297916100059; STIPANI I, 1989, BIOCHEM BIOPH RES CO, V164, P1281, DOI 10.1016/0006-291X(89)91808-1                                                    ; Su WP, 2012, CARCINOGENESIS, V33, P2065, DOI 10.1093/carcin/bgs253; Sun Jiakang, 2010, Mol Cell Pharmacol, V2, P101; Tan MGK, 2004, J BIOL CHEM, V279, P45235, DOI 10.1074/jbc.M403683200; Thangaratnarajah C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6491; Thoma CR, 2014, ADV DRUG DELIVER REV, V69, P29, DOI 10.1016/j.addr.2014.03.001; Tiede LM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.128; Tina E, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-350; TKACOVA E, 1985, BIOCHEM INT, V11, P45; Todisco S, 2016, BIOCHEM PHARMACOL, V100, P112, DOI 10.1016/j.bcp.2015.11.019; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Traba J., 2012, SCAMC 1 PROMOTES CAN, P650; Troadec MB, 2011, BLOOD, V117, P5494, DOI 10.1182/blood-2010-11-319483; Tsai CW, 2006, J FORMOS MED ASSOC, V105, P852, DOI 10.1016/S0929-6646(09)60274-6                                                   ; Ubah OC, 2014, CURR PHARM DESIGN, V20, P201, DOI 10.2174/13816128113199990031                                                    ; Vanderperre B, 2015, CURR OPIN CELL BIOL, V33, P35, DOI 10.1016/j.ceb.2014.10.008; Verschoor M. L., 2013, MITOCHONDRIA CANC PR, V2013; Visconte V, 2015, LEUKEMIA, V29, P188, DOI 10.1038/leu.2014.170; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang CL, 2014, EUR J MED RES, V19, DOI 10.1186/s40001-014-0049-5; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wei ZL, 2009, NEUROTOX RES, V16, P14, DOI 10.1007/s12640-009-9039-8; Wilkins HM, 2012, FREE RADICAL BIO MED, V52, P410, DOI 10.1016/j.freeradbiomed.2011.10.495; Wilmore D., 2001, J NUTR, P2539; Wilting SM, 2008, GENE CHROMOSOME CANC, V47, P890, DOI 10.1002/gcc.20590; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wong C. C., 2016, GASTROENTEROLOGY; Yang ZQ, 2007, MOL BIOL CELL, V18, P4681, DOI 10.1091/mbc.E06-12-1161; Yu G., 2015, BIOSCI REP, V35; Yu K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000129; Yuan Y, 2012, MED ONCOL, V29, P957, DOI 10.1007/s12032-011-9892-1; Yuneva M, 2008, CELL CYCLE, V7, P2083, DOI 10.4161/cc.7.14.6256                                                            ; Zamora M, 2006, EXP CELL RES, V312, P1813, DOI 10.1016/j.yexcr.2006.02.014; Zamora M, 2004, J BIOL CHEM, V279, P38415, DOI 10.1074/jbc.M404928200; Zamora M, 2004, FEBS LETT, V563, P155, DOI 10.1016/S0014-5793(04)00293-5; Zastre JA, 2013, J NUTR BIOCHEM, V24, P1616, DOI 10.1016/j.jnutbio.2013.02.002; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6                                                   ; Zhang Y, 2013, CANCER BIOL THER, V14, P81, DOI 10.4161/cbt.22958; Zhong YL, 2015, ONCOTARGET, V6, P37758, DOI 10.18632/oncotarget.5386; Zhou XS, 2015, ONCOTARGET, V6, P9271, DOI 10.18632/oncotarget.3375                                                        ; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A                                                    	203	0	0	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	AUG	2017	1858	8			SI		641	654		10.1016/j.bbabio.2017.03.006				14	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FA9KF	WOS:000405763800010	28342810	gold			2018-01-05	
J	Baffy, G				Baffy, Gyorgy			Mitochondrial uncoupling in cancer cells: Liabilities and opportunities	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Review						Cancer cell; Metabolic flexibility; Mitochondrial respiration; Uncoupling; Hypoxia-inducible factor; Chemoresistance	HYPOXIA-INDUCIBLE FACTOR-1; CELLULAR-ENERGY METABOLISM; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; PROTEINS UCP2; COLON-CANCER; CYTOCHROME-OXIDASE; GENE-EXPRESSION; ANION CARRIERS; ROS PRODUCTION	Acquisition of the endosymbiotic ancestor of mitochondria was a critical event in eukaryote evolution. Mitochondria offered an unparalleled source of metabolic energy through oxidative phosphorylation and allowed the development of multicellular life. However, as molecular oxygen had become the terminal electron acceptor in most eukaryotic cells, the electron transport chain proved to be the largest intracellular source of superoxide, contributing to macromolecular injury, aging, and cancer. Hence, the 'contract of endosymbiosis' represents a compromise between the possibilities and perils of multicellular life. Uncoupling proteins (UCPs), a group of the solute carrier family of transporters, may remove some of the physiologic constraints that link mitochondrial respiration and ATP synthesis by mediating inducible proton leak and limiting oxidative cell injury. This important property makes UCPs an ancient partner in the metabolic adaptation of cancer cells. Efforts are underway to explore the therapeutic opportunities stemming from the intriguing relationship of UCPs and cancer. This article is part of a Special Issue entitled Mitochondria in Cancer, edited by Giuseppe Gasparre, Rodrigue Rossignol and Pierre Sonveaux. Published by Elsevier B.V.	[Baffy, Gyorgy] VA Boston Healthcare Syst, Dept Med, Boston, MA 02130 USA; [Baffy, Gyorgy] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA	Baffy, G (reprint author), VA Boston Healthcare Syst, 150 S Huntington Ave,Room 6A-46, Boston, MA 02130 USA.	gbaffy@bwh.harvard.edu					Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792; Baffy G, 2010, MITOCHONDRION, V10, P243, DOI 10.1016/j.mito.2009.12.143; Baronzio G, 2003, SEMIN THROMB HEMOST, V29, P489; Belcher CM, 2008, SCIENCE, V321, P1197, DOI 10.1126/science.1160978; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Berry S, 2002, J MOL EVOL, V54, P595, DOI 10.1007/s00239-001-0056-3; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707                                                               ; Brand MD, 2004, BIOCHEM SOC SYMP, P203; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; BROWN GC, 1992, BIOCHEM J, V284, P1; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Busk M, 2008, INT J CANCER, V122, P2726, DOI 10.1002/ijc.23449; Casteilla L, 2001, IUBMB LIFE, V52, P181, DOI 10.1080/15216540152845984                                                       ; Chandel NS, 2000, ONCOGENE, V19, P3840, DOI 10.1038/sj.onc.1203727; Chandel NS, 1997, J BIOL CHEM, V272, P18808, DOI 10.1074/jbc.272.30.18808; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chevrollier A, 2011, BBA-BIOENERGETICS, V1807, P562, DOI 10.1016/j.bbabio.2010.10.008; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536                                                               ; Dalla Pozza E, 2012, BBA-MOL CELL RES, V1823, P1856, DOI 10.1016/j.bbamcr.2012.06.007; Dando I, 2013, BBA-MOL CELL RES, V1833, P672, DOI 10.1016/j.bbamcr.2012.10.028; Davila AF, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/2/026008; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Denko N.C., 2008, NAT REV CANC; Derdak Z, 2006, CARCINOGENESIS, V27, P956, DOI 10.1093/carcin/bgi335; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Diehl AM, 1999, J BIOENERG BIOMEMBR, V31, P493, DOI 10.1023/A:1005452624640                                                         ; Dulloo AG, 2001, BRIT J NUTR, V86, P123, DOI 10.1079/BJN2001412; ERECINSKA M, 1982, J MEMBRANE BIOL, V70, P1, DOI 10.1007/BF01871584                                                              ; Esteves P, 2014, CANCER RES, V74, P3971, DOI 10.1158/0008-5472.CAN-13-3383; Esteves TC, 2005, BBA-BIOENERGETICS, V1709, P35, DOI 10.1016/j.bbabio.2005.06.002; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Frezza C, 2009, SEMIN CANCER BIOL, V19, P4, DOI 10.1016/j.semcancer.2008.11.008; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Pons DG, 2015, FREE RADICAL BIO MED, V86, P67, DOI 10.1016/j.freeradbiomed.2015.04.032; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Gonidi M, 2011, PATHOL RES PRACT, V207, P377, DOI 10.1016/j.prp.2011.03.007; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805                                                         ; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419                                                   ; Hubei T., 2008, BIOCHIM BIOPHYS ACTA, V1777, P48; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/ncr1046; Inoue M, 2003, CURR MED CHEM, V10, P2495, DOI 10.2174/0929867033456477; Jarmuszkiewicz W, 2010, BBA-BIOENERGETICS, V1797, P792, DOI 10.1016/j.bbabio.2009.12.005; Kietzmann T, 2005, SEMIN CELL DEV BIOL, V16, P474, DOI 10.1016/j.semcdb.2005.03.010; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Kitano H, 2004, NAT REV CANCER, V4, P227, DOI 10.1038/nrc1300; Klingenberg M, 1999, J BIOENERG BIOMEMBR, V31, P419, DOI 10.1023/A:1005440221914; Kuai XY, 2010, WORLD J GASTROENTERO, V16, P5773, DOI 10.3748/wjg.v16.i45.5773; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Li WJ, 2015, CANCER PREV RES, V8, P487, DOI 10.1158/1940-6207.CAPR-14-0297-T; Maher EA, 2012, NMR BIOMED, V25, P1234, DOI 10.1002/nbm.2794; Mailloux RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013289; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X                                                   ; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Mattiasson G, 2006, ANTIOXID REDOX SIGN, V8, P1, DOI 10.1089/ars.2006.8.1                                                            ; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Nedergaard J, 2003, EXP PHYSIOL, V88, P65, DOI 10.1113/eph8802502; Nicholls DG, 1999, J BIOENERG BIOMEMBR, V31, P399, DOI 10.1023/A:1005436121005; Nicholls D.G., 1992, BIOENERGETICS INTRO; Nowinski SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9137; Nubel T, 2006, HORM RES, V65, P300, DOI 10.1159/000092847; Orr DL, 2015, NAT CHEM BIOL, V11, P834, DOI 10.1038/NCHEMBIO.1910; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Pennington JD, 2005, DRUG RESIST UPDATE, V8, P322, DOI 10.1016/j.drup.2005.09.002; Pfefferle A, 2013, BBA-MOL CELL RES, V1833, P80, DOI 10.1016/j.bbamcr.2012.10.006; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Rial E, 2011, CHEM BIOL, V18, P264, DOI 10.1016/j.chembiol.2010.12.012; Rousset S, 2007, FEBS LETT, V581, P479, DOI 10.1016/j.febslet.2007.01.010; Santandreu FM, 2010, FREE RADICAL BIO MED, V49, P658, DOI 10.1016/j.freeradbiomed.2010.05.031; Sastre-Serra J, 2013, FREE RADICAL BIO MED, V61, P11, DOI 10.1016/j.freeradbiomed.2013.03.005; Sastre-Serra J, 2010, FREE RADICAL BIO MED, V48, P506, DOI 10.1016/j.freeradbiomed.2009.11.025; Schonenberger Miriam J, 2015, Front Cell Dev Biol, V3, P42, DOI 10.3389/fcell.2015.00042; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Sheets AR, 2008, AM J PHYSIOL-GASTR L, V294, pG1017, DOI 10.1152/ajpgi.00016.2008; Skulachev VP, 1999, J BIOENERG BIOMEMBR, V31, P431, DOI 10.1023/A:1005492205984; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795                                                       ; Sokolova IM, 2005, FEBS LETT, V579, P313, DOI 10.1016/j.febslet.2004.11.103; Solaini G, 2011, BBA-BIOENERGETICS, V1807, P534, DOI 10.1016/j.bbabio.2010.09.003; Sotgia F, 2012, CELL CYCLE, V11, P1445, DOI 10.4161/cc.19841; Sowter HM, 2001, CANCER RES, V61, P6669; Speijer D, 2014, BIOESSAYS, V36, P634, DOI 10.1002/bies.201400033; Su WP, 2012, CARCINOGENESIS, V33, P2065, DOI 10.1093/carcin/bgs253; SUSSMAN I, 1980, BIOCHIM BIOPHYS ACTA, V591, P209, DOI 10.1016/0005-2728(80)90153-X; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Van der Giezen M, 2012, J EUKARYOT MICROBIOL, V59, P111, DOI 10.1111/j.1550-7408.2011.00605.x; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Wang RH, 2016, INT J MED SCI, V13, P507, DOI 10.7150/ijms.15449; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1930, METABOLISM TUMORS, P254; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wilson DF, 2015, AM J PHYSIOL-ENDOC M, V308, pE506, DOI 10.1152/ajpendo.00544.2014; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Yoshida GJ, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0221-y; Yu G., 2015, BIOSCI REP, V35; Yu XF, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0480-4; Yu XX, 2000, FASEB J, V14, P1611, DOI 10.1096/fj.14.11.1611; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015; Zhau HYE, 2011, CLIN CANCER RES, V17, P2159, DOI 10.1158/1078-0432.CCR-10-2523; Zhdanov AV, 2014, BBA-BIOENERGETICS, V1837, P51, DOI 10.1016/j.bbabio.2013.07.008	120	1	1	10	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	AUG	2017	1858	8			SI		655	664		10.1016/j.bbabio.2017.01.005				10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FA9KF	WOS:000405763800011	28088333				2018-01-05	
J	Guerra, F; Arbini, AA; Moro, L				Guerra, Flora; Arbini, Arnaldo A.; Moro, Loredana			Mitochondria and cancer chemoresistance	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Review						Mitochondria; Mitochondrial DNA; Cancer chemoresistance	EPITHELIAL-MESENCHYMAL TRANSITION; COMPLEX I DYSFUNCTION; DNA-DEPLETED CELLS; STEM-CELLS; BREAST-CANCER; PROSTATE-CANCER; TUMOR-CELLS; LUNG-CANCER; COPY NUMBER; OXIDATIVE-PHOSPHORYLATION	Mitochondria, known for more than a century as the energy powerhouse of a cell, represent key intracellular signaling hub that are emerging as important determinants of several aspects of cancer development and progression, including metabolic reprogramming, acquisition of metastatic capability, and response to chemotherapeutic drugs. The majority of cancer cells harbors somatic mutations in the mitochondrial genome (mtDNA) and/or alterations in the mtDNA content, leading to mitochondrial dysfunction. Decreased mtDNA content is also detected in tumor-initiating cells, a subpopulation of cancer cells that are believed to play an integral role in cancer recurrence following chemotherapy. Although mutations in mitochondrial genes are common in cancer cells, they do not shut down completely the mitochondrial energy metabolism and functionality. Instead, they promote rewiring of the bioenergetics and biosynthetic profile of a cancer cell through a mitochondria-to-nucleus signaling activated by "dysfunctional" mitochondria that results in changes in transcription and/or activity of cancer related genes and signaling pathways. Different cancer cell types may undergo different bioenergetic changes, some to more glycolytic and some to more oxidative. These different metabolic signatures may coexist within the same tumor mass (intra-tumor heterogeneity). In this review we describe the current understanding of mitochondrial dysfunction in the context of cancer chemoresistance with special attention to the role of mtDNA alterations. We put emphasis on potential therapeutic strategies targeting different metabolic events specific to cancer cells, including glycolysis, glutaminolysis, oxidative phosphorylation, and the retrograde signaling, to prevent chemoresistance. We also highlight novel genome-editing strategies aimed at "correcting" mtDNA defects in cancer cells. We conclude on the importance of considering intratumor metabolic heterogeneity to develop effective metabolism-based cancer therapy that can overcome chemoresistance. This article is part of a Special Issue entitled Mitochondria in Cancer, edited by Giuseppe Gasparre, Rodrigue Rossignol and Pierre Sonveaux. (C) 2017 Elsevier B.V. All rights reserved.	[Moro, Loredana] CNR, Inst Biomembranes & Bioenerget, Via Amendola 165-A, I-70126 Bari, Italy; [Guerra, Flora] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Via Prov Lecce Monteroni 165, I-73100 Lecce, Italy; [Arbini, Arnaldo A.] NYU, Dept Pathol, Langone Med Ctr, 550 First Ave, New York, NY 10016 USA	Moro, L (reprint author), CNR, Inst Biomembranes & Bioenerget, Via Amendola 165-A, I-70126 Bari, Italy.	l.moro@ibbe.cnr.it	Guerra, Flora/D-1755-2014	Guerra, Flora/0000-0003-3379-7469; Arbini, Arnaldo/0000-0003-0345-4174	Italian Ministry of Economy and Finance; FCRP (Fondazione Cassa di Risparmio di Puglia) grant "Identificazione di molecole attive per lo sviluppo di nuovi farmaci antitumorali contro it carcinoma di prostata"; Regione Puglia [T7WGSJ3]	This work was supported by a grant from Italian Ministry of Economy and Finance to the CNR for the Project "FaReBio di Qualita" and the FCRP (Fondazione Cassa di Risparmio di Puglia) grant "Identificazione di molecole attive per lo sviluppo di nuovi farmaci antitumorali contro it carcinoma di prostata" (to L.M.), and by a grant from Regione Puglia _T7WGSJ3 "Sviluppo di nuove metodologie e strumenti Innovativi per la diagnoSl ed it trattamento Terapeutico di tumori Epiteliali uMAni (SISTEMA)" (to F.G.). L.M. is grateful to L. Saponaro and F. Moro for continuous support.	Amadori D, 1998, BREAST CANCER RES TR, V49, P209, DOI 10.1023/A:1006063412726                                                         ; Arbini AA, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.45; Arbini AA, 2011, AM J PATHOL, V178, P2367, DOI 10.1016/j.ajpath.2011.01.050; Arnould T, 2003, FASEB J, V17, P2145, DOI 10.1096/fj.03-0075fje; Bacman SR, 2014, METHOD ENZYMOL, V547, P373, DOI 10.1016/B978-0-12-801415-8.00018-7; Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Bhutia YD, 2016, BBA-MOL CELL RES, V1863, P2531, DOI 10.1016/j.bbamcr.2015.12.017; Bianchi K, 2006, CELL DEATH DIFFER, V13, P586, DOI 10.1038/sj.cdd.4401784; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Biswas G, 2005, CELL DEATH DIFFER, V12, P266, DOI 10.1038/sj.cdd.4401553; Blagosklonny MV, 2005, CELL DEATH DIFFER, V12, P592, DOI 10.1038/sj.cdd.4401610; Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cho YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032778; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Colak S, 2014, CELL DEATH DIFFER, V21, P1170, DOI 10.1038/cdd.2014.37; Cook CC, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.141; Cook CC, 2012, BBA-GEN SUBJECTS, V1820, P652, DOI 10.1016/j.bbagen.2011.08.017; Cormio A, 2009, BIOCHEM BIOPH RES CO, V390, P1182, DOI 10.1016/j.bbrc.2009.10.114; Costa-Guda Jessica, 2007, BMC Endocr Disord, V7, P8, DOI 10.1186/1472-6823-7-8; Cui HH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-110; Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Deschauer M, 2003, NEUROLOGY, V60, P1357, DOI 10.1212/01.WNL.0000055869.99975.4B                                              ; Di Cosimo S, 2003, DRUGS TODAY, V39, P157, DOI 10.1358/dot.2003.39.3.799451; Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972; Fath MA, 2009, CANCER BIOL THER, V8, P1228, DOI 10.4161/cbt.8.13.8631                                                           ; Feng S, 2011, ONCOL LETT, V2, P899, DOI 10.3892/ol.2011.322; Ferramosca A, 2016, BIOCHEM BIOPH RES CO, V473, P1133, DOI 10.1016/j.bbrc.2016.04.028; Folmes CDL, 2016, CURR OPIN GENET DEV, V38, P1, DOI 10.1016/j.gde.2016.02.001; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Gammage PA, 2016, METHODS MOL BIOL, V1351, P145, DOI 10.1007/978-1-4939-3040-1_11; Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672; Gasparre G, 2008, HUM MOL GENET, V17, P986, DOI 10.1093/hmg/ddm371; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Gasparre G, 2011, CANCER RES, V71, P6220, DOI 10.1158/0008-5472.CAN-11-1042; Gasparre G, 2011, BBA-BIOENERGETICS, V1807, P633, DOI 10.1016/j.bbabio.2010.08.006; Gasparre G, 2009, HUM MUTAT, V30, P391, DOI 10.1002/humu.20870; Gilkerson RW, 2000, FEBS LETT, V474, P1, DOI 10.1016/S0014-5793(00)01527-1                                                   ; Girolimetti G, 2014, BIOMED RES INT, DOI 10.1155/2014/787143; Gonzalez-Sanchez E, 2014, MOL PHARMACEUT, V11, P1856, DOI 10.1021/mp400732p; Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456; Guaragnella N, 2014, BIOCHEM PHARMACOL, V92, P62, DOI 10.1016/j.bcp.2014.07.027; Guerra F, 2012, J CLIN ONCOL, V30, pE373, DOI 10.1200/JCO.2012.43.5933; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; Guha M, 2014, ONCOGENE, V33, P5238, DOI 10.1038/onc.2013.467; Guha M, 2013, MITOCHONDRION, V13, P577, DOI [10.1016/j.mito.2013.08.007, 10.1016/j.mito2013.08.007]; Guha M, 2010, MOL BIOL CELL, V21, P3578, DOI 10.1091/mbc.E10-03-0192; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126; Hassanein M, 2015, INT J CANCER, V137, P1587, DOI 10.1002/ijc.29535; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Higuchi M, 2006, ONCOGENE, V25, P1437, DOI 10.1038/sj.onc.1209190; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hoshida Y, 2007, HEPATO-GASTROENTEROL, V54, P489; Hsu CC, 2016, EXP BIOL MED, V241, P1281, DOI 10.1177/1535370216641787; Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176; Hur H, 2013, INT J ONCOL, V42, P44, DOI 10.3892/ijo.2012.1687; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jin L, 2016, ONCOGENE, V35, P3619, DOI 10.1038/onc.2015.447; Kalsbeek AMF, 2016, AGING; Kang MG, 2016, ANN LAB MED, V36, P101, DOI 10.3343/alm.2016.36.2.101; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477                                                         ; Kloss-Brandstatter A, 2010, AM J HUM GENET, V87, P802, DOI 10.1016/j.ajhg.2010.11.001; Koochekpour S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074688; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Lee W, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.34; Lee W, 2008, EXP MOL MED, V40, P109, DOI 10.3858/emm.2008.40.1.109                                                       ; Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Li X., 2016, ONCOTARGET; Liu H, 2001, BIOCHEMISTRY-US, V40, P5542, DOI 10.1021/bi002426w; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091606; Liu YS, 2013, ULTRASTRUCT PATHOL, V37, P258, DOI 10.3109/01913123.2013.770112; Lunt SJ, 2009, CLIN EXP METASTAS, V26, P19, DOI 10.1007/s10585-008-9182-2; Magda D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-521; Matre P., 2016, ONCOTARGET; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Mediani L, 2016, ONCOTARGET, V7, P5521, DOI 10.18632/oncotarget.6315; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Milane L, 2011, J CONTROL RELEASE, V155, P237, DOI 10.1016/j.jconrel.2011.03.032; Milane L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024075; Milane L, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-3; Milane L, 2011, NANOMED-NANOTECHNOL, V7, P435, DOI 10.1016/j.nano.2010.12.009; Milane L, 2011, MOL PHARMACEUT, V8, P185, DOI 10.1021/mp1002653; Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103; Mizutani S, 2009, CANCER SCI, V100, P1680, DOI 10.1111/j.1349-7006.2009.01238.x; Montopoli M, 2011, CURR CANCER DRUG TAR, V11, P226, DOI 10.2174/156800911794328501; MORAIS R, 1994, CANCER RES, V54, P3889; Moro L, 2009, CELL DEATH DIFFER, V16, P571, DOI 10.1038/cdd.2008.178; Moro L, 2008, CELL ONCOL, V30, P307, DOI 10.3233/CLO-2008-0427; Moschoi R, 2016, BLOOD, V128, P253, DOI 10.1182/blood-2015-07-655860; Naito A, 2008, CANCER SCI, V99, P1584, DOI 10.1111/j.1349-7006.2008.00879.x; Nath K, 2015, NMR BIOMED, V28, P395, DOI 10.1002/nbm.3260; Nath K, 2015, NMR BIOMED, V28, P281, DOI 10.1002/nbm.3240; Neuzil J, 2013, MITOCHONDRION, V13, P199, DOI 10.1016/j.mito.2012.07.112; Nie HR, 2016, MITOCHONDRION, V26, P104, DOI 10.1016/j.mito.2015.12.001; Nomura A., 2016, ONCOTARGET; Obre E, 2015, INT J BIOCHEM CELL B, V59, P167, DOI 10.1016/j.biocel.2014.12.008; Palorini R, 2013, INT J CELL BIOL, V2013, DOI DOI 10.1155/2013/243876; Park JS, 2009, HUM MOL GENET, V18, P1578, DOI 10.1093/hmg/ddp069; Park SY, 2004, J BIOL CHEM, V279, P7512, DOI 10.1074/jbc.M307677200; Pasquier J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-94; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Philley JV, 2016, J CELL PHYSIOL, V231, P1364, DOI 10.1002/jcp.25240; Porcelli AM, 2009, J BIOL CHEM, V284, P2045, DOI 10.1074/jbc.M807321200; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Rodenburg RJ, 2016, BBA-BIOENERGETICS, V1857, P938, DOI 10.1016/j.bbabio.2016.02.012; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sancho P, 2016, BRIT J CANCER, V114, P1305, DOI 10.1038/bjc.2016.152; Sancho P, 2015, CELL METAB, V22, P590, DOI 10.1016/j.cmet.2015.08.015; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Schultz N, 2003, NUCLEIC ACIDS RES, V31, P4959, DOI 10.1093/nar/gkg703; Sciacovelli M, 2014, METHOD ENZYMOL, V542, P1, DOI 10.1016/B978-0-12-416618-9.00001-7; Shanmugam MK, 2014, CANCER LETT, V346, P206, DOI 10.1016/j.canlet.2014.01.016; Sharma LK, 2011, HUM MOL GENET, V20, P4605, DOI 10.1093/hmg/ddr395; Shen J, 2016, PIGM CELL MELANOMA R, V29, P372, DOI 10.1111/pcmr.12474; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Srinivasan S, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1085120; Stockwin LH, 2010, INT J CANCER, V127, P2510, DOI 10.1002/ijc.25499; Su CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep31357; Suzuki S, 2008, CANCER LETT, V268, P31, DOI 10.1016/j.canlet.2008.03.020; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; Tanaka K, 2015, J CLIN INVEST, V125, P1591, DOI 10.1172/JCI78239; TATUM EL, 1947, J BACTERIOL, V53, P673; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326; Upadhyay M, 2013, PHARMACOL THERAPEUT, V137, P318, DOI 10.1016/j.pharmthera.2012.11.003; Vander Heiden Matthew G, 2009, Science, V324, P1029, DOI 10.1126/science.1160809; Vega-Naredo I, 2014, CELL DEATH DIFFER, V21, P1560, DOI 10.1038/cdd.2014.66; Velpula KK, 2013, CANCER RES, V73, P7277, DOI 10.1158/0008-5472.CAN-13-1868; Vernieri C, 2016, CANCER DISCOV, V6, P1315, DOI 10.1158/2159-8290.CD-16-0615; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Walsh CS, 2015, GYNECOL ONCOL, V137, P343, DOI 10.1016/j.ygyno.2015.02.017; Wanet A, 2015, STEM CELLS DEV, V24, P1957, DOI 10.1089/scd.2015.0117; Wang Q, 2014, INT J CANCER, V135, P1060, DOI 10.1002/ijc.28749; Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Xiang Y, 2015, J CLIN INVEST, V125, P2293, DOI 10.1172/JCI75836; Xie CF, 2016, ONCOTARGET, V7, P610, DOI 10.18632/oncotarget.6311; Yang G, 2010, CLIN CANCER RES, V16, P3171, DOI 10.1158/1078-0432.CCR-09-3171; Yao Z, 2013, ONCOGENE, V32, P2592, DOI 10.1038/onc.2012.259; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955; Zhang D., 2014, FRONT ONCOL, V355, P176	152	1	1	13	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	AUG	2017	1858	8			SI		686	699		10.1016/j.bbabio.2017.01.012				14	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FA9KF	WOS:000405763800014	28161329				2018-01-05	
J	Dorr, CR; Remmel, RP; Muthusamy, A; Fisher, J; Moriarity, BS; Yasuda, K; Wu, BL; Guan, WH; Schuetz, EG; Oetting, WS; Jacobson, PA; Israni, AK				Dorr, Casey R.; Remmel, Rory P.; Muthusamy, Amutha; Fisher, James; Moriarity, Branden S.; Yasuda, Kazuto; Wu, Baolin; Guan, Weihua; Schuetz, Erin G.; Oetting, William S.; Jacobson, Pamala A.; Israni, Ajay K.			CRISPR/Cas9 Genetic Modification of CYP3A5*3 in HuH-7 Human Hepatocyte Cell Line Leads to Cell Lines with Increased Midazolam and Tacrolimus Metabolisms	DRUG METABOLISM AND DISPOSITION			English	Article							CHEMICALLY-DEFINED MEDIUM; IN-VITRO; DRUG-METABOLISM; CYP3A5; EXPRESSION; CYTOCHROME-P450; CANCER; CAS9; POLYMORPHISM; MICROSOMES	Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 engineering of the CYP3A5 * 3 locus (rs776746) in human liver cell line HuH-7 (CYP3A5 * 3/* 3) has ledtothree CYP3A5 * 1 cell lines by deletion of the exon 3B splice junction or point mutation. Cell lines CYP3A5 * 1/* 3 sd (single deletion), CYP3A5 * 1/* 1 dd (double deletion), or CYP3A5 * 1/* 3pm (point mutation) expressed the CYP3A5 * 1mRNA and had elevated CYP3A5 mRNA (P < 0.0005 for all engineered cell lines) and protein expression compared with HuH-7. In metabolism assays, HuH-7 had less tacrolimus (all P < 0.05) or midazolam (MDZ) (all P < 0.005) disappearance than all engineered cell lines. HuH-7 had less 1-OH MDZ (all P < 0.0005) or 4-OH (all P < 0.005) production in metabolism assays than all bioengineered cell lines. We confirmed CYP3A5 metabolic activity with the CYP3A4 selective inhibitor CYP3CIDE. This is the first report of genomic CYP3A5 bioengineering in human cell lines with drug metabolism analysis.	[Dorr, Casey R.; Remmel, Rory P.; Muthusamy, Amutha; Fisher, James; Moriarity, Branden S.; Yasuda, Kazuto; Wu, Baolin; Guan, Weihua; Schuetz, Erin G.; Oetting, William S.; Jacobson, Pamala A.; Israni, Ajay K.] Minneapolis Med Res Fdn Inc, Mol Epidemiol Lab, Minneapolis, MN USA	Israni, AK (reprint author), Hennepin Cty Med Ctr, Nephrol Div, Dept Med, 701 Pk Ave, Minneapolis, MN 55415 USA.	isran001@umn.edu		WU, BAOLIN/0000-0001-6676-0422	Minneapolis Medical Research Foundation Postdoctoral Career Development Award; United States National institutes of Health National Institute for Allergy and Infectious Diseases [AI U19 AI070119]	This study was funded by a Minneapolis Medical Research Foundation Postdoctoral Career Development Award (to C.D.) and grant support from United States National institutes of Health National Institute for Allergy and Infectious Diseases [Grant AI U19 AI070119] (to A.I.).	Bains RK, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-34; Busi F, 2005, PHARMACOGENET GENOM, V15, P433, DOI 10.1097/01213011-200506000-00010; Busi F, 2005, MOL PHARMACOL, V68, P808, DOI 10.1124/mol.105.014225; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Choi S, 2009, XENOBIOTICA, V39, P205, DOI 10.1080/00498250802613620; Dai Y, 2006, DRUG METAB DISPOS, V34, P836, DOI 10.1124/dmd.105.008680; de Jonge H, 2013, PHARMACOGENOMICS, V14, P1467, DOI 10.2217/pgs.13.133; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Dorr C, 2015, MOL CANCER RES, V13, P1238, DOI 10.1158/1541-7786.MCR-14-0674-T; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hamel LM, 2016, CANCER CONTROL, V23, P327, DOI 10.1177/107327481602300404                                                      ; He N, 2006, CLIN EXP PHARMACOL P, V33, P813, DOI 10.1111/j.1440-1681.2006.04445.x; Jacobson PA, 2011, TRANSPLANTATION, V91, P300, DOI 10.1097/TP.0b013e318200e991; Kim Joo-Hyun, 2014, World J Hepatol, V6, P98, DOI 10.4254/wjh.v6.i2.98; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882                                                                   ; Lu J, 2017, SCI REP, V7, P1; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; NAKABAYASHI H, 1985, CANCER RES, V45, P6379; NAKABAYASHI H, 1984, GANN, V75, P151; Pelkonen O, 2008, ARCH TOXICOL, V82, P667, DOI 10.1007/s00204-008-0332-8; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roy JN, 2005, DRUG METAB DISPOS, V33, P884, DOI 10.1124/dmd.105.003822; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Schmidt R, 2004, BRIT J CANCER, V90, P911, DOI 10.1038/sj.bjc.6601492; Schuetz EG, 1996, P NATL ACAD SCI USA, V93, P4001, DOI 10.1073/pnas.93.9.4001; Sivertsson L, 2013, MOL PHARMACOL, V83, P659, DOI 10.1124/mol.112.082305; Sivertsson L, 2010, DRUG METAB DISPOS, V38, P995, DOI 10.1124/dmd.110.032367; Tseng E, 2014, DRUG METAB DISPOS, V42, P1163, DOI 10.1124/dmd.114.057000; Walsky RL, 2012, DRUG METAB DISPOS, V40, P1686, DOI 10.1124/dmd.112.045302; Wang X, 2016, BIOCHEM PHARMACOL, V105, P80, DOI 10.1016/j.bcp.2016.03.001; Yasuda SU, 2008, CLIN PHARMACOL THER, V84, P417, DOI 10.1038/clpt.2008.141	35	0	0	8	8	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0090-9556	1521-009X		DRUG METAB DISPOS	Drug Metab. Dispos.	AUG 1	2017	45	8					957	965		10.1124/dmd.117.076307				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	FA9DI	WOS:000405745800010	28533324				2018-01-05	
J	Zhang, SX; Song, Z				Zhang, Shuxian; Song, Zhan			Aio-Casilio: a robust CRISPR-Cas9-Pumilio system for chromosome labeling	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						Chromosome labeling; CRISPR technology; Mouse embryonic stem; Casilio	CRISPR/CAS SYSTEM; DNA-SEQUENCES; GENOMIC LOCI; RNA; CELLS; TRANSCRIPTION; VISUALIZATION; PROTEINS; ACTIVATION; RESISTANCE	The biological function of chromatin bases on its spatial organization and dynamic activities in different situations. Labeling and tracing of genomic sequences has been a huge challenge in studying the spatial dynamics of chromatin. We reported the development of 'all-in-one Casilio system (Aio-Casilio)', a new system that enables the labeling of endogenous genomic loci. The Aio-Casilio system consists of the dCas9 protein, mClover fused with the Pumilio and FBF proteins RNA-binding domain (PUF domain) and an U6-sgRNA appended with multiple PUF-binding site(s). Here we showed that the Aio-Casilio system is robust tool for imaging of repetitive elements in telomeres and major satellite in N2A cells. Furthermore, we developed a PBTon-Aio-Casilio System, which enables the visualization of repetitive sequences in mES cells. However, this system failed to establish a labeled ES cell line when we attempted to establish a stable labeling cell line for living cell image. This Aio-Casilio imaging tool has potential to significantly improve the capacity to study the conformation of chromosomes in living cells.	[Zhang, Shuxian; Song, Zhan] Ocean Univ China, Coll Marines Life Sci, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China	Zhang, SX (reprint author), Ocean Univ China, Coll Marines Life Sci, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China.	shuxian94@163.com; songzhan_ouc@163.com					Abil Z, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-7; Anton T, 2014, NUCLEUS-AUSTIN, V5, P163, DOI [10.4161/nucl.2848, 10.4161/nucl.28488]; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Belmont AS, 1999, METHOD CELL BIOL, V58, P203; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen Y, 2013, FEBS J, V280, P3734, DOI 10.1111/febs.12375; Cheng AW, 2016, CELL RES, V26, P254, DOI 10.1038/cr.2016.3; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui Chenghua, 2016, Front Cell Dev Biol, V4, P89, DOI 10.3389/fcell.2016.00089; Deng WL, 2015, P NATL ACAD SCI USA, V112, P11870, DOI 10.1073/pnas.1515692112; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Lindhout BI, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm618; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qin PW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14725; Wang SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26857; Yuan M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030072; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	27	0	0	6	6	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	AUG	2017	48	4					293	299		10.1007/s10735-017-9727-2				7	Cell Biology	Cell Biology	FA8VT	WOS:000405725200003	28547585				2018-01-05	
J	Zhong, GC; Wang, HM; Li, YJ; Tran, MH; Farzan, M				Zhong, Guocai; Wang, Haimin; Li, Yujun; Tran, Mai H.; Farzan, Michael			Cpf1 proteins excise CRISPR RNAs from mRNA transcripts in mammalian cells	NATURE CHEMICAL BIOLOGY			English	Article							SPECIFICITIES	Cpf1 is a CRISPR effector protein that has greater specificity than Streptococcus pyogenes Cas9 (SpCas9) in genome-editing applications. Here we show that Lachnospiraceae bacterium (Lb) and Acidaminococus sp. (As) Cpf1 orthologs have RNase activities that can excise multiple CRISPR RNAs (crRNAs) from a single RNA polymerase II-driven RNA transcript expressed in mammalian cells. This property simplifies modification of multiple genomic targets and can be used to increase the efficiency of Cpf1-mediated editing.	[Zhong, Guocai; Wang, Haimin; Li, Yujun; Tran, Mai H.; Farzan, Michael] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA; [Li, Yujun] Harbin Med Univ, Dept Microbiol, Harbin, Peoples R China; [Li, Yujun] Harbin Med Univ, Wu Lien Teh Inst, Harbin, Peoples R China	Zhong, GC (reprint author), Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA.	gzhong@scripps.edu			NIH [R37 AI091476, P01 AI100263]	This work is supported by NIH R37 AI091476 and P01 AI100263 (M.F.).	Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/NMETH.1648, 10.1038/nmeth.1648]; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Orioli A, 2011, NUCLEIC ACIDS RES, V39, P5499, DOI 10.1093/nar/gkr074; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Samulski RJ, 2014, ANNU REV VIROL, V1, P427, DOI 10.1146/annurev-virology-031413-085355; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	13	1	1	15	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2017	13	8					839	+		10.1038/nchembio.2410				5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FB0FC	WOS:000405819300009	28628097				2018-01-05	
J	Chujo, T; Yoshikawa, M; Ariga, H; Endo, M; Toki, S; Ishibashi, K				Chujo, Tetsuya; Yoshikawa, Manabu; Ariga, Hirotaka; Endo, Masaki; Toki, Seiichi; Ishibashi, Kazuhiro			A removable virus vector suitable for plant genome editing	PLANT JOURNAL			English	Article						virus vector; genome editing; tomato mosaic virus; miR398; technical advance	TARGET GENES; IDENTIFICATION; ARABIDOPSIS; MICRORNAS; TRANSFORMATION; EXPRESSION; MIR398; CELLS; TOOL; RNA	Plant genome editing is achieved by the expression of sequence-specific nucleases (SSNs). RNA virus vector-mediated expression of SSNs is a promising approach for transgene integration-free targeted mutagenesis in plants. However, the removal of virus vectors from infected plants is challenging because no antiviral drugs are available against plant viruses. Here, we developed a removable RNA virus vector that carries the target site of tobacco microRNA398 (miR398) whose expression is induced during shoot regeneration. In the inoculated leaves in which expression of miR398 is not induced, insertion of the miR398 target site did not affect the practicability of the virus vector. When shoots were regenerated from the infected leaves, miR398 was expressed and viral RNA was eliminated. The virus vector successfully expressed SSNs in inoculated leaves, from which virus-free genome-edited plants were regenerated via tissue culture.	[Chujo, Tetsuya; Yoshikawa, Manabu; Ariga, Hirotaka; Ishibashi, Kazuhiro] Natl Agr & Food Res Org, Inst Agrobiol Sci, Div Plant & Microbial Sci, Plant & Microbial Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan; [Endo, Masaki; Toki, Seiichi] Natl Agr & Food Res Org, Inst Agrobiol Sci, Div Appl Genet, Plant Genome Engn Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan; [Toki, Seiichi] Yokohama City Univ, Grad Sch Nanobiosci, 22-2 Seto, Yokohama, Kanagawa 2360027, Japan; [Toki, Seiichi] Yokohama City Univ, Kihara Inst Biol Res, 641-12 Maioka Cho, Yokohama, Kanagawa 2440813, Japan	Ishibashi, K (reprint author), Natl Agr & Food Res Org, Inst Agrobiol Sci, Div Plant & Microbial Sci, Plant & Microbial Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	bashi@affrc.go.jp		Ishibashi, Kazuhiro/0000-0002-9349-3603	Cabinet Office, Government of Japan, Cross-ministerial Strategic Innovation Promotion Program (SIP)	We thank Masayuki Ishikawa for critiquing our manuscript, Miao Shu and Rieko Iwanami for technical assistance and Shuhei Miyashita and Tetsuo Meshi for their advice on designing ToMV vectors and the I- SceI gene for expression from the ToMV vector, respectively. This work was supported by the Cabinet Office, Government of Japan, Cross-ministerial Strategic Innovation Promotion Program (SIP) to KI, ME and ST. The authors declare that a patent has been filed by National Agriculture and Food Research Organization.	Ali Z, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1044191; Ali Z, 2015, MOL PLANT, V8, P1288, DOI 10.1016/j.molp.2015.02.011; Altpeter F, 2016, PLANT CELL, V28, P1510, DOI 10.1105/tpc.16.00196; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Beauclair L, 2010, PLANT J, V62, P454, DOI 10.1111/j.1365-313X.2010.04162.x; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Dugas DV, 2008, PLANT MOL BIOL, V67, P403, DOI 10.1007/s11103-008-9329-1; Feng XM, 2010, PLANT CELL TISS ORG, V102, P53, DOI 10.1007/s11240-010-9704-x; Frazier TP, 2010, PLANTA, V232, P1289, DOI 10.1007/s00425-010-1255-1; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kaya H, 2017, PLANT CELL PHYSIOL, V58, P643, DOI 10.1093/pcp/pcx034; Kuroda M, 2010, BIOSCI BIOTECH BIOCH, V74, P2348, DOI 10.1271/bbb.100465; Liu QK, 2014, PLANT CELL, V26, P741, DOI 10.1105/tpc.113.120972; Marton I, 2010, PLANT PHYSIOL, V154, P1079, DOI 10.1104/pp.110.164806; Miyashita S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002094; Nakazono M, 2003, PLANT CELL, V15, P583, DOI 10.1105/tpc.008102; NIXON HL, 1956, VIROLOGY, V2, P126, DOI 10.1016/0042-6822(56)90081-2; Saika H, 2012, PLANT CELL PHYSIOL, V53, P1974, DOI 10.1093/pcp/pcs135; Yoshikawa M, 2016, PLANT PHYSIOL, V171, P359, DOI 10.1104/pp.16.00148; Zhu C, 2011, PHYSIOL PLANTARUM, V143, P1, DOI 10.1111/j.1399-3054.2011.01477.x	20	1	1	20	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	AUG	2017	91	3					558	561		10.1111/tpj.13581				4	Plant Sciences	Plant Sciences	FA6RX	WOS:000405572800017	28430402				2018-01-05	
J	Wang, L; Zhang, Y; Zhang, T; Zhang, L; Yan, H; Liu, X; Wang, L				Wang, L.; Zhang, Y.; Zhang, T.; Zhang, L.; Yan, H.; Liu, X.; Wang, L.			Genotyping by sequencing reveals a new locus for pig teat number	ANIMAL GENETICS			English	Article						GBS; genome-wide association analyses; sows; total teat number	GENETIC-ANALYSIS; TRAITS; POPULATION; INTERCROSS	Teat number is an extremely valuable trait for sow reproduction performance and piglet survival. Here, we used genotyping-by-sequencing and a general liner model to carry out genome-wide analysis of sow total teat number in an Erhualian population. The results indicated that eight SNPs on chromosomes 4, 5, 9 and 10 were significant genome wide (Bonferroni method, P < 2.85E-7) for sow total teat number. Validation analyses were performed in 298 Erhualian and 904 Large White sows using these significant SNPs and the general liner model procedure in SAS. Finally, only the SNP on chromosome 5 was found to be significantly associated with sow teat number in both populations. The GG genotype individuals had 2.23 and 0.82 more teat numbers respectively than did the AA genotype individuals in these two populations (P < 0.05). According to the expression and annotation analyses, we inferred the presence of a gene or lincRNA that could affect teat number by regulating other genes and ultimately affecting the mammogenesis of pigs. Further studies using methods such as Cas9 editing and gene silencing analysis are necessary for additional function analysis.	[Wang, L.; Zhang, Y.; Zhang, T.; Zhang, L.; Yan, H.; Liu, X.; Wang, L.] Chinese Acad Agr Sci, Inst Anim Sci, Key Lab Farm Anim Genet Resources & Germplasm Inn, Minist Agr, Beijing 100193, Peoples R China	Zhang, L; Wang, L (reprint author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	zhlchias@163.com; wanglixian@caas.cn			Agricultural Science and Technology Innovation Program [ASTIP-IAS02]; earmarked funds for Modern Agro-Industry Technology Research System and National Technology Program of China [2011ZX08006-003]	This research was supported by the Agricultural Science and Technology Innovation Program (ASTIP-IAS02), earmarked funds for Modern Agro-Industry Technology Research System and National Technology Program of China (No. 2011ZX08006-003).	Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chalkias H, 2013, LIVEST SCI, V152, P127, DOI 10.1016/j.livsci.2013.01.003; Chomwisarutkun K, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-13; Hernandez SC, 2014, ANIM GENET, V45, P191, DOI 10.1111/age.12123; Hu ZL, 2016, NUCLEIC ACIDS RES, V44, pD827, DOI 10.1093/nar/gkv1233; Jin S, 2013, ASIAN AUSTRAL J ANIM, V26, P1374, DOI 10.5713/ajas.2013.13140; Lee JB, 2014, MOL BIOL REP, V41, P7167, DOI 10.1007/s11033-014-3599-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundeheim N, 2013, ACTA AGR SCAND A-AN, V63, P121, DOI 10.1080/09064702.2013.841749; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Rodriguez C, 2005, ANIM GENET, V36, P490, DOI 10.1111/j.1365-2052.2005.01358.x; Scita G, 1999, NATURE, V401, P290; Tang J., 2016, ASIAN AUSTRALASIAN J, V30, P1; Verardo L. L., 2016, GENET SEL EVOL, V4, P8; Yang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19240	15	0	0	8	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0268-9146	1365-2052		ANIM GENET	Anim. Genet.	AUG	2017	48	4					470	472		10.1111/age.12547				3	Agriculture, Dairy & Animal Science; Genetics & Heredity	Agriculture; Genetics & Heredity	FA3AW	WOS:000405314400014	28370091				2018-01-05	
J	Banerjee, K; Keasey, MP; Razskazovskiy, V; Visavadiya, NP; Jia, CH; Hagg, T				Banerjee, Kalpita; Keasey, Matt P.; Razskazovskiy, Vladislav; Visavadiya, Nishant P.; Jia, Cuihong; Hagg, Theo			Reduced FAK-STAT3 signaling contributes to ER stress-induced mitochondrial dysfunction and death in endothelial cells	CELLULAR SIGNALLING			English	Article						Cell death; Endoplasmic reticulum stress; Focal adhesion kinase; Integrin; Mitochondria	ENDOPLASMIC-RETICULUM STRESS; PROTEIN-TYROSINE-PHOSPHATASE; FOCAL-ADHESION-KINASE; SPINAL-CORD-INJURY; PTP-PEST; APOPTOSIS; STAT3; PHOSPHORYLATION; AUTOPHAGY; CA2+	Excessive endoplasmic reticulum (ER) stress leads to cell loss in many diseases, e.g., contributing to endothelial cell loss after spinal cord injury. Here, we determined whether ER stress-induced mitochondrial dysfunction could be explained by interruption of the focal adhesion kinase (FAK)-mitochondrial STAT3 pathway we recently discovered. ER stress was induced in brain-derived mouse bEnd5 endothelial cells by thapsigargin or tunicamycin and caused apoptotic cell death over a 72 h period. In concert, ER stress caused mitochondrial dysfunction as shown by reduced bioenergetic function, loss of mitochondrial membrane potential and increased mitophagy. ER stress caused a reduction in mitochondrial phosphorylated S727-STAT3, known to be important for maintaining mitochondrial function. Normal activation or phosphorylation of the upstream cytoplasmic FAK was also reduced, through mechanisms that involve tyrosine phosphatases and calcium signaling, as shown by pharmacological inhibitors, bisperoxovanadium (bpV) and 2-aminoethoxydiphenylborane (APB), respectively. APB mitigated the reduction in FAK and STAT3 phosphorylation, and improved endothelial cell survival caused by ER stress. Transfection of cells rendered null for STAT3 using CRISPR technology with STAT3 mutants confirmed the specific involvement of S727-STAT3 inhibition in ER stress-mediated cell loss. These data suggest that loss of FAK signaling during ER stress causes mitochondrial dysfunction by reducing the protective effects of mitochondrial STAT3, leading to endothelial cell death. We propose that stimulation of the FAK-STAT3 pathway is a novel therapeutic approach against pathological ER stress.	[Banerjee, Kalpita; Keasey, Matt P.; Razskazovskiy, Vladislav; Visavadiya, Nishant P.; Jia, Cuihong; Hagg, Theo] East Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, POB 70582, Johnson City, TN 37614 USA	Hagg, T (reprint author), East Tennessee State Univ, Dept Biomed Sci, POB 70582, Johnson City, TN 37614 USA.	haggt1@etsu.edu			NIH [NS45734, AG029493, C06RR0306551]; Quillen College of Medicine at ETSU	We are grateful for the technical support by Richard Sante, Chiharu Lovins and Aruna Visavadiya, Dr. Gary Wright is thanked for the use of his Seahorse equipment. bEnd5 cells were a kind gift from Dr. Britta Engelhardt of the Theodor Kocher Institute. Supported by NIH Grants NS45734 and AG029493, and in part by NIH grant C06RR0306551 and by funds from the Quillen College of Medicine at ETSU.	Agouni A, 2011, BIOCHEM J, V438, P369, DOI 10.1042/BJ20110373; Alessandro R, 1998, BIOCHEM BIOPH RES CO, V248, P635, DOI 10.1006/bbrc.1998.8705; Banerjee K, 2016, NEUROCHEM INT, V96, P32, DOI 10.1016/j.neuint.2016.02.011; Boengler K, 2013, CURR PHARM DESIGN, V19, P6890, DOI 10.2174/138161281939131127115940                                                ; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Boya P, 2002, CELL DEATH DIFFER, V9, P465, DOI 10.1038/sj/cdd/4401006; Bronner DN, 2015, IMMUNITY, V43, P451, DOI 10.1016/j.immuni.2015.08.008; Cali T, 2013, BBA-MOL BASIS DIS, V1832, P495, DOI 10.1016/j.bbadis.2013.01.004; Cheshenko N, 2003, J CELL BIOL, V163, P283, DOI 10.1083/jcb.200301084; Conklin MW, 2005, DEV BIOL, V287, P201, DOI 10.1016/j.ydbio.2005.09.006; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Dricu A., CANC RES, V57; Ewan EE, 2016, J NEUROTRAUM, V33, P269, DOI 10.1089/neu.2015.4030; Fassbender JM, 2012, CURR NEUROVASC RES, V9, P274; Fassbender JM, 2011, NEUROTHERAPEUTICS, V8, P240, DOI 10.1007/s13311-011-0029-1; Flis V. V., 2013, COLD SPRING HARB PER, V5; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Giannone G, 2004, J BIOL CHEM, V279, P28715, DOI 10.1074/jbc.M404054200; Giannone G., J BIOL CHEM, V277; Gu F, 2004, J BIOL CHEM, V279, P49689, DOI 10.1074/jbc.C400261200; Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034; Hom JR, 2007, J CELL PHYSIOL, V212, P498, DOI 10.1002/jcp.21051; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Joshi A. U., 2016, CELL CALCIUM; Kaufman R.J., 2014, CURR OPIN RHEUMATOL, V1843, P2233; Keasey MP, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-35; Koo HJ, 2012, NEUROSIGNALS, V20, P265, DOI 10.1159/000333069; Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001; La Rovere RML, 2016, CELL CALCIUM, V60, P74, DOI 10.1016/j.ceca.2016.04.005; LARSSON O, 1993, J CELL SCI, V106, P299; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Lu Q, 2012, MICROVASC RES, V83, P56, DOI 10.1016/j.mvr.2011.05.003; Marchi S, 2014, BBA-BIOENERGETICS, V1837, P461, DOI 10.1016/j.bbabio.2013.10.015; Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7; Meares GP, 2014, MOL CELL BIOL, V34, P3911, DOI 10.1128/MCB.00980-14; Meier JA, 2014, SEMIN IMMUNOL, V26, P20, DOI 10.1016/j.smim.2013.12.005; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Muradov JM, 2013, EXP NEUROL, V249, P59, DOI 10.1016/j.expneurol.2013.08.009; Myers SA, 2014, EXP NEUROL, V256, P25, DOI 10.1016/j.expneurol.2014.03.016; Nakashima S, 2008, J NEUROSCI, V28, P7293, DOI 10.1523/JNEUROSCI.1826-08.2008; Natarajan V, 1998, ENVIRON HEALTH PERSP, V106, P1205, DOI 10.2307/3433987; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Placido AI, 2015, MOL NEUROBIOL, V51, P571, DOI 10.1007/s12035-014-8819-1; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Rafiq K, 2006, J BIOL CHEM, V281, P19781, DOI 10.1074/jbc.M513040200; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439                                                             ; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruff SJ, 1997, J BIOL CHEM, V272, P1263, DOI 10.1074/jbc.272.2.1263                                                          ; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7                                                    ; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Sorenson CM, 2002, AM J PHYSIOL-RENAL, V282, pF442, DOI 10.1152/ajprenal.00184.2001                                                     ; Steiner O., J CEREB BLOOD FLOW M, V31; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Tadic V, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/fnce1.2014.00147, 10.3389/fncel.2014.00147]; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Vepa S, 1999, AM J PHYSIOL-LUNG C, V277, pL150; Visavadiya NP, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0157-7; WAGNER EF, 1994, SEMIN CANCER BIOL, V5, P137; Wang Q, 2016, BIOCHEM J, V473, P397, DOI 10.1042/BJ20150907; Wang YJ, 2016, SCI REP, V6, P1, DOI DOI 10.1038/SREP21972; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wen LP, 1997, J BIOL CHEM, V272, P26056, DOI 10.1074/jbc.272.41.26056; Xu D, 2009, AM J PHYSIOL-LUNG C, V297, pL44, DOI 10.1152/ajplung.90626.2008; Yang R, 2016, INT J BIOL SCI, V12, P532, DOI 10.7150/ijbs.15153; Yang T, 2007, J PHARM SCI-US, V96, P3196, DOI 10.1002/jps.21002; Yonekawa T, 2013, ESSAYS BIOCHEM, V55, P105, DOI [10.1042/BSE0550105, 10.1042/bse0550105]; Yoon MJ, 2014, ONCOTARGET, V5, P6816; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yuan Y, 2015, NEUROSCI BULL, V31, P395, DOI 10.1007/s12264-015-1544-6; Zheng Y., MOL CELL, V35; Zheng YH, 2011, MOL CELL BIOL, V31, P4258, DOI 10.1128/MCB.05547-11	76	0	0	7	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0898-6568	1873-3913		CELL SIGNAL	Cell. Signal.	AUG	2017	36						154	162		10.1016/j.cellsig.2017.05.007				9	Cell Biology	Cell Biology	EZ9IP	WOS:000405044000016	28495589				2018-01-05	
J	Li, ZH; Li, YD; Bi, YW; Zhang, H; Yao, YF; Li, QH; Cun, W; Dong, SZ				Li, Zhihua; Li, Yadong; Bi, Yanwei; Zhang, Hui; Yao, Yufeng; Li, Qihan; Cun, Wei; Dong, Shaozhong			Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E	JOURNAL OF VIROLOGY			English	Article						CRISPR-Cas9; hepatitis C virus; infectivity; secreted apolipoprotein E; envelope protein	NONSTRUCTURAL PROTEIN 5A; AQUEOUS-SOLUTION; ADAPTER PROTEIN; INNATE IMMUNITY; PARTICLES; INFECTIVITY; BINDING; DOMAIN; HEPATOCYTES; ENHANCEMENT	Interactions between hepatitis C virus (HCV) and lipoproteins in humans play an important role in the efficient establishment of chronic infection. Apolipoprotein E (ApoE) on the HCV envelope mediates virus attachment to host cells as well as immune evasion. This interaction is thought to occur in hepatocytes, as ApoE plays dual functions in HCV assembly and maturation as well as cell attachment. In the present study, we found that secreted ApoE (sApoE) can also bind to viral particles via its C-terminal domain after HCV is released from the cell. Furthermore, the binding affinity of interactions between the sApoE N terminus and cell surface receptors affected HCV infectivity in a dose-dependent manner. The extracellular binding of sApoE to HCV is dependent on HCV envelope proteins, and recombinant HCV envelope proteins are also able to bind to sApoE. These results suggest that extracellular interactions between HCV and sApoE may potentially complicate vaccine development and studies of viral pathogenesis. IMPORTANCE End-stage liver disease caused by chronic HCV infection remains a clinical challenge, and there is an urgent need for a prophylactic method of controlling HCV infection. Because host immunity against HCV is poorly understood, additional investigations of host-virus interactions in the context of HCV are important. HCV is primarily transmitted through blood, which is rich in lipoproteins. Therefore, it is of interest to further determine how HCV interacts with lipoproteins in human blood. In this study, we found that secreted ApoE (sApoE), an exchangeable component found in lipoproteins, participates in extracellular interactions with HCV virions. More significantly, different variants of sApoE differentially affect HCV infection efficiency in a dose-dependent manner. These findings provide greater insight into HCV infection and host immunity and could help propel the development of new strategies for preventing HCV infection.	[Li, Zhihua; Li, Yadong; Bi, Yanwei; Zhang, Hui; Yao, Yufeng; Li, Qihan; Cun, Wei; Dong, Shaozhong] Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Li, Zhihua; Li, Yadong; Bi, Yanwei; Zhang, Hui; Yao, Yufeng; Li, Qihan; Cun, Wei; Dong, Shaozhong] Peking Union Med Coll, Kunming, Yunnan, Peoples R China; [Li, Zhihua; Li, Yadong; Bi, Yanwei; Zhang, Hui; Yao, Yufeng; Li, Qihan; Cun, Wei; Dong, Shaozhong] Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Yunnan, Peoples R China; [Li, Zhihua; Bi, Yanwei; Cun, Wei] Chinese Acad Med Sci, Ctr TB Res, Beijing, Peoples R China; [Li, Zhihua; Bi, Yanwei; Cun, Wei] Peking Union Med Coll, Beijing, Peoples R China	Cun, W; Dong, SZ (reprint author), Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China.; Cun, W; Dong, SZ (reprint author), Peking Union Med Coll, Kunming, Yunnan, Peoples R China.; Cun, W; Dong, SZ (reprint author), Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Yunnan, Peoples R China.; Cun, W (reprint author), Chinese Acad Med Sci, Ctr TB Res, Beijing, Peoples R China.; Cun, W (reprint author), Peking Union Med Coll, Beijing, Peoples R China.	cun@imbcams.com.cn; dsz@imbcams.com.cn			Natural Science Foundation of Yunnan Province [2013FA053, 2015BC010]; Fundamental Research Funds for the Central Universities [2015PT310001, 2016ZX310183-5]; CAMS Initiative for Innovative Medicine [2016-I2M-1-013, 2016-I2M-1-019]	This work was supported by the Natural Science Foundation of Yunnan Province (2013FA053 and 2015BC010), Fundamental Research Funds for the Central Universities (2015PT310001 and 2016ZX310183-5), and the CAMS Initiative for Innovative Medicine (2016-I2M-1-013 and 2016-I2M-1-019).	AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045; Baumert TF, 2014, J HEPATOL, V61, pS34, DOI 10.1016/j.jhep.2014.09.009; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; CARDOSA MJ, 1987, LANCET, V1, P193; Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Clayton RF, 2002, J VIROL, V76, P7672, DOI 10.1128/JVI.76.15.7672-7682.2002; Cun W, 2010, J VIROL, V84, P11532, DOI 10.1128/JVI.01021-10; DEKNIJFF P, 1994, HUM MUTAT, V4, P178, DOI 10.1002/humu.1380040303                                                         ; Ding Q, 2013, J HEPATOL, V59, P52, DOI 10.1016/j.jhep.2013.03.019; DUBUISSON J, 1994, J VIROL, V68, P6147; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Fauvelle C, 2016, GASTROENTEROLOGY, V150, P206, DOI 10.1053/j.gastro.2015.09.014; Gottwein JM, 2010, J VIROL, V84, P5277, DOI 10.1128/JVI.02667-09; Goueslain L, 2010, J VIROL, V84, P773, DOI 10.1128/JVI.01190-09; GRAKOUI A, 1993, J VIROL, V67, P1385; Halstead SB, 2014, MICROBIOL SPECTR, V2, P6, DOI DOI 10.1128/MICR0BI0LSPEC.AID-0022-2014; Halstead SB, 1988, J CHALL MOL BIO, V239, P476, DOI DOI 10.1126/SCIENCE.3277268; HAWKES RA, 1964, AUST J EXP BIOL MED, V42, P465, DOI 10.1038/icb.1964.44; HIJIKATA M, 1991, P NATL ACAD SCI USA, V88, P5547, DOI 10.1073/pnas.88.13.5547; Hishiki T, 2010, J VIROL, V84, P12048, DOI 10.1128/JVI.01063-10; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Itzhaki RF, 2003, HEPATOLOGY, V38, P1060, DOI 10.1053/jhep.2003.50354; Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; Kinge CNW, 2014, ANTIMICROB AGENTS CH, V58, P5386, DOI 10.1128/AAC.03534-14; Lee JY, 2014, J VIROL, V88, P12422, DOI 10.1128/JVI.01660-14; Lemon SM, 2007, FIELDS VIROLOGY, P1253; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Liu SF, 2012, HEPATOLOGY, V56, P484, DOI 10.1002/hep.25665; Long G, 2011, GASTROENTEROLOGY, V141, P1057, DOI 10.1053/j.gastro.2011.06.010; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MANN WA, 1989, BIOCHIM BIOPHYS ACTA, V1005, P239, DOI 10.1016/0005-2760(89)90043-X; Mazumdar B, 2011, HEPATOLOGY, V54, P1149, DOI 10.1002/hep.24523; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Negro F, 2014, J HEPATOL, V61, pS69, DOI 10.1016/j.jhep.2014.08.003; Nitta S, 2013, HEPATOLOGY, V57, P46, DOI 10.1002/hep.26017; Otsuka M, 2005, HEPATOLOGY, V41, P1004, DOI 10.1002/hep.20666; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Sundaram M, 2012, ARTERIOSCL THROM VAS, V32, P1073, DOI 10.1161/ATVBAHA.111.241455; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; Toniutto P, 2004, AM J CLIN PATHOL, V122, P428, DOI 10.1309/YLEXQA2R6R2N95JU; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WESTERLUND JA, 1993, J BIOL CHEM, V268, P15745; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Wozniak MA, 2002, HEPATOLOGY, V36, P456, DOI 10.1053/jhep.2002.34745; Xu J, 2013, ZHONG HUA WEI SHENG, V33, P161; Yamamoto M, 2011, J GEN VIROL, V92, P2082, DOI 10.1099/vir.0.032391-0; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738                                                         ; Yang ZL, 2016, J VIROL, V90, P9632, DOI 10.1128/JVI.01353-16	57	0	0	6	6	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	AUG	2017	91	15							UNSP e02227-16	10.1128/JVI.02227-16				18	Virology	Virology	FB0WV	WOS:000405866600039					2018-01-05	
J	Murakami, S; Takenaka-Uema, A; Kobayashi, T; Kato, K; Shimojima, M; Palmarini, M; Horimoto, T				Murakami, Shin; Takenaka-Uema, Akiko; Kobayashi, Tomoya; Kato, Kentaro; Shimojima, Masayuki; Palmarini, Massimo; Horimoto, Taisuke			Heparan Sulfate Proteoglycan Is an Important Attachment Factor for Cell Entry of Akabane and Schmallenberg Viruses	JOURNAL OF VIROLOGY			English	Article						Akabane virus; heparan sulfate; Schmallenberg virus; cell entry	HERPES-SIMPLEX-VIRUS; RESPIRATORY SYNCYTIAL VIRUS; ENCEPHALITIS-VIRUS; ENVELOPE PROTEIN; BINDING; INFECTION; GLYCOPROTEIN; GLYCOSAMINOGLYCANS; CULTURE; SYSTEM	Akabane virus (AKAV) and Schmallenberg virus (SBV) are members of the genus Orthobunyavirus, which are transmitted by arthropod vectors with a broad cellular tropism in vitro as well as in vivo. Both AKAV and SBV cause arthrogryposis-hydranencephaly syndrome in ruminants. The main cellular receptor and attachment factor for entry of these orthobunyaviruses are unknown. Here, we found that AKAV and SBV infections were inhibited by the addition of heparin or enzymatic removal of cell surface heparan sulfates. To confirm this finding, we prepared heparan sulfate proteoglycan (HSPG)-knockout (KO) cells by using a clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9 system and measured the quantities of binding of these viruses to cell surfaces. We observed a substantial reduction in AKAV and SBV binding to cells, limiting the infections by these viruses. These data demonstrate that HSPGs are important cellular attachment factors for AKAV and SBV, at least in vitro, to promote virus replication in susceptible cells. IMPORTANCE AKAV and SBV are the etiological agents of arthrogryposis-hydranencephaly syndrome in ruminants, which causes considerable economic losses in the livestock industry. Here, we identified heparan sulfate proteoglycan as a major cellular attachment factor for the entry of AKAV and SBV. Moreover, we found that heparin is a strong inhibitor of AKAV and SBV infections. Revealing the molecular mechanisms of virus-host interactions is critical in order to understand virus biology and develop novel live attenuated vaccines.	[Murakami, Shin; Kobayashi, Tomoya; Kato, Kentaro; Shimojima, Masayuki; Horimoto, Taisuke] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Tokyo, Japan; [Takenaka-Uema, Akiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Infect Control & Dis Prevent, Tokyo, Japan; [Kato, Kentaro] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido, Japan; [Shimojima, Masayuki] Natl Inst Infect Dis, Special Pathogens Lab, Dept Virol 1, Tokyo, Japan; [Palmarini, Massimo] Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland	Murakami, S (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Tokyo, Japan.	amurakam@mail.ecc.u-tokyo.ac.jp; ahorimo@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS), Japan [26660227, 26252048, 15K19104]	This work was supported by a Grant-in-Aid for Young Scientists (B) (grant number 15K19104), a Grant-in-Aid for Scientific Research (A) (grant number 26252048), and a Grant-in-Aid for Challenging Exploratory Research (grant number 26660227) from the Japan Society for the Promotion of Science (JSPS), Japan.	Akashi H, 1997, VIRUS RES, V47, P187, DOI 10.1016/S0168-1702(96)01415-3; Albornoz A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050143; Artpradit C, 2013, VIRUS RES, V176, P69, DOI 10.1016/j.virusres.2013.04.017; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546; Bourgeois C, 1998, J VIROL, V72, P7221; Byrnes AP, 2000, J VIROL, V74, P644, DOI 10.1128/JVI.74.2.644-651.2000; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; de Boer SM, 2012, J VIROL, V86, P13767, DOI 10.1128/JVI.01364-12; Dechecchi MC, 2000, VIROLOGY, V268, P382, DOI 10.1006/viro.1999.0171                                                          ; Elliott RM, 2014, NAT REV MICROBIOL, V12, P673, DOI 10.1038/nrmicro3332; Feldman SA, 2000, J VIROL, V74, P6442, DOI 10.1128/JVI.74.14.6442-6447.2000                                                ; Gardner CL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002719; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Hofmann H, 2013, J VIROL, V87, P4384, DOI 10.1128/JVI.02628-12; Ito N, 2003, MICROBIOL IMMUNOL, V47, P613, DOI 10.1111/j.1348-0421.2003.tb03424.x                                              ; Jackson T, 1996, J VIROL, V70, P5282; Janowicz A, 2015, J VIROL, V89, P5238, DOI 10.1128/JVI.00395-15; JENNINGS M, 1989, VET MICROBIOL, V21, P125, DOI 10.1016/0378-1135(89)90024-2; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; JUSA ER, 1995, VET MICROBIOL, V45, P251, DOI 10.1016/0378-1135(95)00040-H; Kirkland R, 2015, REV SCI TECH OIE, V34, P403; Kobayashi T, 2007, VIRUS RES, V130, P162, DOI 10.1016/j.virusres.2007.06.007; Lozach PY, 2010, CELL HOST MICROBE, V7, P488, DOI 10.1016/j.chom.2010.05.007; Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001; O'Hearn A, 2015, J VIROL, V89, P5441, DOI 10.1128/JVI.03689-14; Ogawa Y, 2007, VET MICROBIOL, V124, P16, DOI 10.1016/j.vetmic.2007.03.020; OLMSTED RA, 1984, SCIENCE, V225, P424, DOI 10.1126/science.6204381; Pietrantoni A, 2015, VIRUSES-BASEL, V7, P480, DOI 10.3390/v7020480; Riblett AM, 2016, J VIROL, V90, P1414, DOI 10.1128/JVI.02055-15; RODERIQUEZ G, 1995, J VIROL, V69, P2233; Salvador B, 2013, J VIROL, V87, P3295, DOI 10.1128/JVI.01621-12; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shimojima M, 2007, J INFECT DIS, V196, pS259, DOI 10.1086/520594; Shimojima M, 2012, J VIROL, V86, P2067, DOI 10.1128/JVI.06451-11; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6                                                   ; Smith PD, 2015, EXP NEUROL, V274, P100, DOI 10.1016/j.expneurol.2015.08.004; Suda Y, 2016, ARCH VIROL, V161, P1447, DOI 10.1007/s00705-016-2803-1; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Takenaka-Uema A, 2016, VIROL SIN, V31, P274, DOI 10.1007/s12250-015-3704-2; Takenaka-Uema A, 2015, J VIROL, V89, P9477, DOI 10.1128/JVI.00681-15; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303                                                        ; Vanlandschoot P, 2005, J GEN VIROL, V86, P75, DOI 10.1099/vir.0.80580-0; Varela M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003133; Wernike K, 2015, REV SCI TECH OIE, V34, P363, DOI 10.20506/rst.34.2.2363                                                          ; Wernike K, 2014, PREV VET MED, V116, P423, DOI 10.1016/j.prevetmed.2014.03.021; Wernike K, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-84; WUDUNN D, 1989, J VIROL, V63, P52; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314	51	0	0	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	AUG	2017	91	15							UNSP e00503	10.1128/JVI.00503-17				10	Virology	Virology	FB0WV	WOS:000405866600018					2018-01-05	
J	Yu, C; Yao, XM; Zhao, LJ; Wang, P; Zhang, Q; Zhao, CJ; Yao, SH; Wei, YQ				Yu, Chuan; Yao, Xiaomin; Zhao, Linjie; Wang, Ping; Zhang, Qian; Zhao, Chengjian; Yao, Shaohua; Wei, Yuquan			Wolf- Hirschhorn Syndrome Candidate 1 (whsc1) Functions as a Tumor Suppressor by Governing Cell Differentiation	NEOPLASIA			English	Article							SYNDROME CRITICAL REGION; EPIGENETIC MODIFICATIONS; MULTIPLE-MYELOMA; HUMAN-DISEASE; CANCER RECURRENCE; HOXC6 EXPRESSION; STEM-CELLS; HISTONE H3; DEDIFFERENTIATION; TUMORIGENESIS	Wolf-Hirschhorn syndrome candidate 1 (WHSC1) is a histone 3 lysine 36 (H3K36) specific methyltransferase that is frequently deleted in Wolf-Hirschhorn syndrome (WHS). Whsc1 is also found mutated in a subgroup of B-cell derived malignant diseases by genomic translocation or point mutation, both of which resulted in hyperactivity of WHSC1 mediated H3K36 methylation and uncontrolled cell proliferation, suggesting that whsc1 functions as an oncogene. However, here we provided evidences to show that whsc1 also has tumor suppressor functions. We used zebrafish as an in vivo model and generated homozygous whsc1 mutant lines via clustered regularly interspaced short palindromic repeats-associated protein Cas9 (CRISPR/Cas9) technology. Then western-blot (WB) and immunofluorescence (IF) were performed to analysis the expression level of H3K36Me2 and H3K36Me3, and we identified the diseased tissue via hematoxylin-eosin (HE) staining, IF staining or immunohistochemistry (IHC). Whsc1 lose-of-function led to significant decrease in di-and tri-methylation of H3K36. A series of WHS related phenotypes were found in whsc1(-/-) zebrafish, including growth retardation, neural development defects and heart failure. In addition, loss of function of whsc1 led to defects in the development of swim bladder, possibly through the dis-regulation of key genes in swim bladder organogenesis and inhibition of progenitor cell differentiation, which was correlated with its expression in this organ during embryonic development. At later stage, these whsc1(-/-) zebrafishes are inclined to grow tumors in the swim bladder. Our work suggested that whsc1 may function as a tumor suppressor by governing progenitor cell differentiation.	[Yu, Chuan; Yao, Xiaomin; Zhao, Linjie; Wang, Ping; Zhang, Qian; Zhao, Chengjian; Yao, Shaohua; Wei, Yuquan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Collaborat Innovat Ctr Biotherapy,Coll Life Sci, Chengdu 610041, Peoples R China	Yao, SH; Wei, YQ (reprint author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Collaborat Innovat Ctr Biotherapy,Coll Life Sci, Chengdu 610041, Peoples R China.	shaohuayao@scu.edu.cn			National Natural Science Foundation of China [81372143, 31000646, 81123003]	This work was supported by National Natural Science Foundation of China (No. 81372143, No. 31000646 and No. 81123003).	Bai F, 2014, CANCER RES, V74, P6161, DOI 10.1158/0008-5472.CAN-14-1119; Butler JS, 2012, EPIGENOMICS-UK, V4, P163, DOI [10.2217/EPI.12.3, 10.2217/epi.12.3]; Daley GQ, 2008, COLD SH Q B, V73, P171, DOI 10.1101/sqb.2008.73.041; du Preez Louis L, 2013, Subcell Biochem, V61, P37, DOI 10.1007/978-94-007-4525-4_2; Fujiki K, 2008, GASTROENTEROLOGY, V135, P907, DOI 10.1053/j.gastro.2008.06.034; Ginsburg DS, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.585588; Hajdu I, 2011, P NATL ACAD SCI USA, V108, P13130, DOI 10.1073/pnas.1110081108; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hewitt Z, 2007, STEM CELLS, V25, P10, DOI 10.1634/stemcells.2005-0481; HIRSCHHORN K, 1961, AM J MED, V31, P442, DOI 10.1016/0002-9343(61)90128-0                                                    ; Huang Z, 2013, CANCER RES, V73, P6277, DOI 10.1158/0008-5472.CAN-13-1000; Hudlebusch HR, 2011, CLIN CANCER RES, V17, P2919, DOI 10.1158/1078-0432.CCR-10-1302; Hudlebusch HR, 2005, BRIT J HAEMATOL, V130, P700, DOI 10.1111/j.1365-2141.2005.05664.x; Huertas D, 2009, EPIGENETICS, V4, P31, DOI 10.4161/epi.4.1.7733                                                            ; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C                                                    ; Kanwal R, 2012, CLIN GENET, V81, P303, DOI 10.1111/j.1399-0004.2011.01809.x; Kato S, 2014, CANCER SCI, V105, P281, DOI 10.1111/cas.12336; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI [10.1038/nbt.1684, 10.1038/nbt1684]; Mohamed MA, 2007, BJU INT, V99, P908, DOI 10.1111/j.1464-410X.2006.06704.x; Moritani S, 2011, PATHOL INT, V61, P143, DOI 10.1111/j.1440-1827.2010.02627.x; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Oyer JA, 2014, LEUKEMIA, V28, P198, DOI 10.1038/leu.2013.204; Park YS, 2008, ANN SURG ONCOL, V15, P1968, DOI 10.1245/s10434-008-9927-9; Piao Ying-jie, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P736; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Prusov AN, 2013, BIOCHEMISTRY-MOSCOW+, V78, P176, DOI 10.1134/S0006297913020065; Ramachandran S, 2005, ONCOGENE, V24, P188, DOI 10.1038/sj.onc.1207906; Righini A, 2007, NEUROPEDIATRICS, V38, P25, DOI 10.1055/s-2007-981685; Saloura V, 2015, MOL CANCER RES, V13, P293, DOI 10.1158/1541-7786.MCR-14-0292-T; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Simons JWIM, 1999, ANTICANCER RES, V19, P4781; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Sun D, 2014, WORLD J GASTROENTERO, V20, P6974, DOI 10.3748/wjg.v20.i22.6974; Takeshita A, 2014, INT J ONCOL, V44, P59, DOI 10.3892/ijo.2013.2172; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Ushijima T, 2014, BIOCHEM BIOPH RES CO, V455, P1, DOI 10.1016/j.bbrc.2014.11.008; Vogel T, 2014, CELL TISSUE RES, V356, P451, DOI 10.1007/s00441-014-1916-7; Wright TJ, 1997, HUM MOL GENET, V6, P317, DOI 10.1093/hmg/6.2.317; Yin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018431; Zaragosi LE, 2015, CARCINOGENESIS, V36, P32, DOI 10.1093/carcin/bgu222; Zhang J, 2014, BLOOD, V123, P2988, DOI 10.1182/blood-2013-07-517177; Zhang Q, 2013, NEOPLASMA, V60, P439, DOI 10.4149/neo_2013_057; Zhen Li, 2010, Int J Gynecol Cancer, V20, P82, DOI 10.1111/IGC.0b013e3181ae3efa; Zheng WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024019	50	0	0	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1476-5586			NEOPLASIA	Neoplasia	AUG	2017	19	8					606	616		10.1016/j.neo.2017.05.001				11	Oncology	Oncology	FB2NT	WOS:000405981200002	28654864	gold			2018-01-05	
J	Wan, SZ; Li, CF; Ma, XD; Luo, KM				Wan, Shuzhen; Li, Chaofeng; Ma, Xiaodong; Luo, Keming			PtrMYB57 contributes to the negative regulation of anthocyanin and proanthocyanidin biosynthesis in poplar	PLANT CELL REPORTS			English	Article						Poplar; PtrMYB57; Anthocyanin; Proanthoanidin; Repressor; CRISPR/Cas9	R2R3-MYB TRANSCRIPTION FACTOR; DEVELOPING GRAPE BERRIES; GENOME-WIDE ANALYSIS; ARABIDOPSIS-THALIANA; PHENYLPROPANOID BIOSYNTHESIS; FLAVONOID BIOSYNTHESIS; GENE ENCODES; DIHYDROFLAVONOL REDUCTASE; POPULUS-TRICHOCARPA; TRANSGENIC TOBACCO	R2R3-MYB transcription factors (TFs) are important regulators of secondary metabolite biosynthesis in woody species. A series of R2R3-MYB TFs involved in anthocyanin and proanthocyanidin (PA) biosynthesis have been identified in poplar. In this study, we report the identification and characterization of a subgroup 4 MYB member PtrMYB57, which contains a repressor domain (LxLxL) at the C-terminal end. PtrMYB57 encodes an R2R3 MYB protein localized in the nucleus and is predominantly expressed in mature leaves. Transgenic poplar overexpressing PtrMYB57 showed a reduction in anthocyanin and PA accumulation compared to wild-type plants. By contrast, a high anthocyanin and PA phenotype was observed in Ptrmyb57 mutants generated by the CRISPR/Cas9 system. Furthermore, transient expression assays revealed that PtrMYB57 interacted with bHLH131 (bHLH) and PtrTTG1 (WDR) to form the MBW complex and bound to the flavonoid gene promoters, leading to inhibition of these promoters. Taken together, our results suggest that PtrMYB57 plays a negative role in the regulation of anthocyanin and PA biosynthesis in poplar.	[Wan, Shuzhen; Li, Chaofeng; Ma, Xiaodong; Luo, Keming] Chinese Acad Sci, Key Lab Adaptat & Evolut Plateau Biota, Northwest Inst Plateau Biol, Xining 810008, Peoples R China; [Wan, Shuzhen; Li, Chaofeng; Ma, Xiaodong; Luo, Keming] Univ Chinese Acad Sci, 19 A Yuquan Rd, Beijing 100049, Peoples R China; [Li, Chaofeng; Luo, Keming] Southwest Univ, Sch Life Sci, 1,Tiansheng Rd, Chongqing 400715, Peoples R China; [Ma, Xiaodong] Qinghai Univ Nationalities, China Sch Chem & Chem Engn, 3 Bayi Middle Rd, Xining 810007, Qinghai, Peoples R China	Luo, KM (reprint author), Chinese Acad Sci, Key Lab Adaptat & Evolut Plateau Biota, Northwest Inst Plateau Biol, Xining 810008, Peoples R China.; Luo, KM (reprint author), Univ Chinese Acad Sci, 19 A Yuquan Rd, Beijing 100049, Peoples R China.; Luo, KM (reprint author), Southwest Univ, Sch Life Sci, 1,Tiansheng Rd, Chongqing 400715, Peoples R China.	kemingl@swu.edu.cn			National Natural Science Foundation of China [31370672, 31500216, 31500544]; "One Hundred Talents Program'' of the Chinese Academy of Sciences	This work was supported by the National Natural Science Foundation of China (31370672, 31500216, and 31500544) and the "One Hundred Talents Program'' of the Chinese Academy of Sciences.	Abrahams S, 2003, PLANT J, V35, P624, DOI 10.1046/j.1365-313X.2003.01834.x; Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Albert NW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01165; Albert NW, 2014, PLANT CELL, V26, P962, DOI 10.1105/tpc.113.122069; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An XH, 2015, PLANT CELL PHYSIOL, V56, P650, DOI 10.1093/pcp/pcu205; Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Cavallini E, 2015, PLANT PHYSIOL, V167, P1448, DOI 10.1104/pp.114.256172; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Cho JS, 2016, TREE PHYSIOL, V36, P1162, DOI 10.1093/treephys/tpw046; Colquhoun TA, 2011, J EXP BOT, V62, P1133, DOI 10.1093/jxb/erq342; CONE KC, 1986, P NATL ACAD SCI USA, V83, P9631, DOI 10.1073/pnas.83.24.9631; Cos P, 2004, CURR MED CHEM, V11, P1345, DOI 10.2174/0929867043365288                                                        ; Czemmel S, 2009, PLANT PHYSIOL, V151, P1513, DOI 10.1104/pp.109.142059; Davies KM, 2012, FUNCT PLANT BIOL, V39, P619, DOI 10.1071/FP12195; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Deluc L, 2008, PLANT PHYSIOL, V147, P2041, DOI 10.1104/pp.108.118919; Dixon RA, 1996, GENE, V179, P61, DOI 10.1016/S0378-1119(96)00327-7; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Fan D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12217; Fornale S, 2014, PLANT CELL PHYSIOL, V55, P507, DOI 10.1093/pcp/pct187; Gould KS, 2002, PLANT CELL ENVIRON, V25, P1261, DOI 10.1046/j.1365-3040.2002.00905.x; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Huang YF, 2014, NEW PHYTOL, V201, P795, DOI 10.1111/nph.12557; JEFFERSON RA, 1987, PLANT MOL BIOL REP, V5, P387; Jia ZC, 2010, TREE PHYSIOL, V30, P1599, DOI 10.1093/treephys/tpq093; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Kagale S, 2011, EPIGENETICS-US, V6, P141, DOI 10.4161/epi.6.2.13627; Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; Kraus TEC, 2003, J CHEM ECOL, V29, P703, DOI 10.1023/A:1022876804925; Landi M, 2014, PLANTA, V240, P941, DOI 10.1007/s00425-014-2087-1; Li YY, 2012, PLANT PHYSIOL, V160, P1011, DOI 10.1104/pp.112.199703; Lin-Wang K, 2010, BMC PLANT BIOL, V10, P1; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Marles MAS, 2003, PHYTOCHEMISTRY, V62, P663, DOI 10.1016/S0031-9422(02)00488-0; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4                                                   ; Nemie-Feyissa D, 2014, PHYTOCHEMISTRY, V98, P34, DOI 10.1016/j.phytochem.2013.12.006; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326; Paolocci F, 2011, J EXP BOT, V62, P1189, DOI 10.1093/jxb/erq344; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108                                                              ; Preston J, 2004, PLANT J, V40, P979, DOI 10.1111/j.1365-313X.2004.02280.x; Qin GJ, 2007, CELL RES, V17, P249, DOI 10.1038/cr.2007.7; Quattrocchio F, 2006, PLANT CELL, V18, P1274, DOI 10.1105/tpc.105.034041; RABINO I, 1986, PLANT PHYSIOL, V81, P922, DOI 10.1104/pp.81.3.922; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x                                             ; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Tamagnone L, 1998, PLANT CELL, V10, P135; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Vanderauwera S, 2005, PLANT PHYSIOL, V139, P806, DOI 10.1104/pp.105.065896; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Weisshaar B, 1998, CURR OPIN PLANT BIOL, V1, P251, DOI 10.1016/S1369-5266(98)80113-1; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Xu F, 2008, AFR J BIOTECHNOL, V7, P721; Xu WJ, 2014, NEW PHYTOL, V202, P132, DOI 10.1111/nph.12620; Yoshida K, 2015, PLANT PHYSIOL, V167, P693, DOI 10.1104/pp.114.253674; Yuan L, 2012, J EXP BOT, V63, P2513, DOI 10.1093/jxb/err425; Zaragoza MV, 2004, GENE, V330, P9, DOI 10.1016/j.gene.2004.01.017; Zhu HF, 2009, MOL PLANT, V2, P790, DOI 10.1093/mp/ssp030; Zhu QL, 2014, GENE, V548, P39, DOI 10.1016/j.gene.2014.07.004	73	0	0	36	36	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-7714	1432-203X		PLANT CELL REP	Plant Cell Reports	AUG	2017	36	8					1263	1276		10.1007/s00299-017-2151-y				14	Plant Sciences	Plant Sciences	FA8EZ	WOS:000405680300006	28523445				2018-01-05	
J	Wang, Y; Geng, LZ; Yuan, ML; Wei, J; Jin, C; Li, M; Yu, K; Zhang, Y; Jin, HB; Wang, E; Chai, ZJ; Fu, XD; Li, XG				Wang, Ying; Geng, Lizhao; Yuan, Menglong; Wei, Juan; Jin, Chen; Li, Min; Yu, Kun; Zhang, Ya; Jin, Huaibing; Wang, Eric; Chai, Zhijian; Fu, Xiangdong; Li, Xianggan			Deletion of a target gene in Indica rice via CRISPR/Cas9	PLANT CELL REPORTS			English	Article						CRISPR/Cas9; sgRNA; Target gene deletion Indica rice; DEP1	CAS SYSTEM; HUMAN-CELLS; ARABIDOPSIS-THALIANA; MODIFIED MICE; GENOME; RNA; GENERATION; PLANTS; MUTAGENESIS; EFFICIENCY	Using CRISPR/Cas9, we successfully deleted large fragments of the yield-related gene DENSE AND ERECT PANICLE1 in Indica rice at relatively high frequency and generated gain-of-function dep1 mutants. CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 is a rapidly developing technology used to produce gene-specific modifications in both mammalian and plant systems. Most CRISPR-induced modifications in plants reported to date have been small insertions or deletions. Few large target gene deletions have thus far been reported, especially for Indica rice. In this study, we designed multiple CRISPR sgRNAs and successfully deleted DNA fragments in the gene DENSE AND ERECT PANICLE1 (DEP1) in the elite Indica rice line IR58025B. We achieved deletion frequencies of up to 21% for a 430 bp target and 9% for a 10 kb target among T0 events. Constructs with four sgRNAs did not generate higher full-length deletion frequencies than constructs with two sgRNAs. The multiple mutagenesis frequency reached 93% for four targets, and the homozygous mutation frequency reached 21% at the T0 stage. Important yield-related trait characteristics, such as dense and erect panicles and reduced plant height, were observed in dep1 homozygous T0 mutant plants produced by CRISPR/Cas9. Therefore, we successfully obtained deletions in DEP1 in the Indica background using the CRISPR/Cas9 editing tool at relatively high frequency.	[Wang, Ying; Geng, Lizhao; Yuan, Menglong; Wei, Juan; Jin, Chen; Li, Min; Yu, Kun; Zhang, Ya; Jin, Huaibing; Wang, Eric; Chai, Zhijian; Li, Xianggan] Syngenta Biotechnol China, 25,Life Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China; [Fu, Xiangdong] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China	Li, XG (reprint author), Syngenta Biotechnol China, 25,Life Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	Xianggan.li@syngenta.com			BTP platform group; Biotechnology platform project of syngenta biotechnology Co. Ltd. [PI0008619]	We are indebted to our colleagues in the Transformation and Analysis Group who contributed to this study. We would especially like to acknowledge our colleagues Qiudeng Que and Zhongying Chen for their advice. Many thanks to Michael Nuccio, Qiudeng Que, and Zhongying Chen for reviewing our manuscript. We sincerely thank the BTP platform group and Liang Shi for their support. Funding was provided by Biotechnology platform project of syngenta biotechnology Co. Ltd (Grant No: PI0008619).	Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fujii W, 2014, BIOCHEM BIOPH RES CO, V445, P791, DOI 10.1016/j.bbrc.2014.01.141; Gao JP, 2015, PLANT MOL BIOL, V87, P99, DOI 10.1007/s11103-014-0263-0; Garcia-Almodovar RC, 2014, PLANT CELL TISS ORG, V116, P205, DOI 10.1007/s11240-013-0396-x; Gui HP, 2014, PLANT CELL REP, V33, P1081, DOI 10.1007/s00299-014-1596-5; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Hyun Y, 2015, PLANTA, V241, P271, DOI 10.1007/s00425-014-2180-5; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jiang WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099225; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.139, 10.1038/nplants.2016.139]; Li MR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00377; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783; Lu LZ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0652-y; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; McGlew K, 2015, PLANT CELL REP, V34, P519, DOI 10.1007/s00299-014-1710-8; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Qu F, 1996, GENE, V172, P217, DOI 10.1016/0378-1119(96)00056-X; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Srivastava V, 2017, PLANT CELL TISS ORG, V129, P153, DOI 10.1007/s11240-016-1166-3; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu R, 2014, RICE N Y, V7, P1; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806	44	0	0	30	30	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-7714	1432-203X		PLANT CELL REP	Plant Cell Reports	AUG	2017	36	8					1333	1343		10.1007/s00299-017-2158-4				11	Plant Sciences	Plant Sciences	FA8EZ	WOS:000405680300012	28584922				2018-01-05	
J	Liu, WQ; Li, KM; Bai, DD; Yin, JQ; Tang, YY; Chi, FL; Zhang, LF; Wang, Y; Pan, JP; Liang, SS; Guo, Y; Ruan, JL; Kou, XC; Zhao, YH; Wang, H; Chen, JY; Teng, XM; Gao, SR				Liu, Wenqiang; Li, Kunming; Bai, Dandan; Yin, Jiqing; Tang, Yuanyuan; Chi, Fengli; Zhang, Linfeng; Wang, Yu; Pan, Jiaping; Liang, Shanshan; Guo, Yi; Ruan, Jingling; Kou, Xiaochen; Zhao, Yanhong; Wang, Hong; Chen, Jiayu; Teng, Xiaoming; Gao, Shaorong			Dosage effects of ZP2 and ZP3 heterozygous mutations cause human infertility	HUMAN GENETICS			English	Article							ZONA-PELLUCIDA GLYCOPROTEINS; FEMALE MICE; FERTILIZATION; FOLLICULOGENESIS; PROTEINS; EGGS; MZP3; FERTILITY; LACKING; DOMAIN	The zona pellucida (ZP) is an extracellular matrix universally surrounding mammalian eggs, which is essential for oogenesis, fertilization, and pre-implantation embryo development. Here, we identified two novel heritable mutations of ZP2 and ZP3, both occurring in an infertile female patient with ZP-abnormal eggs. Mouse models with the same mutations were generated by CRISPR/Cas9 gene editing system, and oocytes obtained from female mice with either single heterozygous mutation showed approximately half of the normal ZP thickness compared to wild-type oocytes. Importantly, oocytes with both heterozygous mutations showed a much thinner or even missing ZP that could not avoid polyspermy fertilization, following the patient's pedigree. Further analysis confirmed that precursor proteins produced from either mutated ZP2 or ZP3 could not anchor to oocyte membranes. From these, we conclude that ZP mutations have dosage effects which can cause female infertility in humans. Finally, this patient was treated by intracytoplasmic sperm injection (ICSI) with an improved culture system and successfully delivered a healthy baby.	[Liu, Wenqiang; Li, Kunming; Bai, Dandan; Yin, Jiqing; Tang, Yuanyuan; Chi, Fengli; Zhang, Linfeng; Wang, Yu; Pan, Jiaping; Liang, Shanshan; Guo, Yi; Ruan, Jingling; Kou, Xiaochen; Zhao, Yanhong; Wang, Hong; Chen, Jiayu; Teng, Xiaoming; Gao, Shaorong] Tongji Univ, Clin & Translat Res Ctr, Shanghai Matern & Infant Hosp 1, Shanghai Key Lab Signaling & Dis Res,Sch Life Sci, Shanghai 200092, Peoples R China	Chen, JY; Teng, XM; Gao, SR (reprint author), Tongji Univ, Clin & Translat Res Ctr, Shanghai Matern & Infant Hosp 1, Shanghai Key Lab Signaling & Dis Res,Sch Life Sci, Shanghai 200092, Peoples R China.	chenjiayu@tongji.edu.cn; tengxiaoming@51mch.com; gaoshaorong@tongji.edu.cn			National Natural Science Foundation of China [81630035, 31401247, 31501196, 31471392, 31601177, 31401266, 31501197, 31501183, 81671521, 31430056]; Ministry of Science and Technology of China [2016YFA0100400, 2015CB964800, 2014CB964601, 2015CB964503]; Shanghai Natural Science Foundation [16ZR1427200]; Shanghai Rising-Star Program [17QA1402700]; Municipal Education Commission of Shanghai [16CG17, 16CG19]; Program for Young Excellent Talents in Tongji University [2000219115, 2000219117, 1515219023]	This project was supported by the National Natural Science Foundation of China (81630035, 31401247, 31501196, 31471392, 31601177, 31401266, 31501197, 31501183, 81671521, and 31430056), the Ministry of Science and Technology of China (Grants 2016YFA0100400, 2015CB964800, 2014CB964601, and 2015CB964503), Shanghai Natural Science Foundation (Grant 16ZR1427200), Shanghai Rising-Star Program (17QA1402700), the Municipal Education Commission of Shanghai (16CG17 and 16CG19) and the Program for Young Excellent Talents in Tongji University (Grants 2000219115, 2000219117, and 1515219023).	Avella MA, 2014, J CELL BIOL, V205, P801, DOI 10.1083/jcb.201404025; Bertrand E, 1996, FERTIL STERIL, V66, P408, DOI 10.1016/S0015-0282(16)58510-0                                                   ; Conner SJ, 2005, HUM REPROD, V20, P1148, DOI 10.1093/humrep/deh835; FAGBOHUN CF, 1990, BIOL REPROD, V42, P413, DOI 10.1095/biolreprod42.3.413; Gook DA, 2008, HUM REPROD, V23, P394, DOI 10.1093/humrep/dem373; Gupta Satish K, 2007, Soc Reprod Fertil Suppl, V63, P203; Gupta SK, 2012, CELL TISSUE RES, V349, P665, DOI 10.1007/s00441-011-1319-y; Hasegawa Akiko, 2007, Soc Reprod Fertil Suppl, V63, P229; Hoodbhoy T, 2006, MOL CELL BIOL, V26, P7991, DOI 10.1128/MCB.00904-06; Huang HL, 2014, NEW ENGL J MED, V370, P1220, DOI 10.1056/NEJMoa1308851; Jimenez-Movilla M, 2011, J CELL SCI, V124, P940, DOI 10.1242/jcs.079988; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kiefer SM, 2002, BIOL REPROD, V66, P407, DOI 10.1095/biolreprod66.2.407; Lefievre L, 2004, HUM REPROD, V19, P1580, DOI 10.1093/humrep/deh301; Liu CY, 1996, P NATL ACAD SCI USA, V93, P5431, DOI 10.1073/pnas.93.11.5431; Mannikko M, 2005, HUM REPROD, V20, P1578, DOI 10.1093/humrep/deh837; Margalit M, 2012, EUR J OBSTET GYN R B, V165, P70, DOI 10.1016/j.ejogrb.2012.07.022; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Pang PC, 2011, SCIENCE, V333, P1761, DOI 10.1126/science.1207438; Pokkyla RM, 2011, FERTIL STERIL, V95, P2669, DOI 10.1016/j.fertnstert.2011.01.168; Qi HY, 2002, MOL BIOL CELL, V13, P530, DOI 10.1091/mbc.01-09-0440; Rankin T, 1996, DEVELOPMENT, V122, P2903; Rankin T, 1999, DEVELOPMENT, V126, P3847; Rankin TL, 2001, DEVELOPMENT, V128, P1119; Sauerbrun-Cutler MT, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-014-0111-5; Wassarman PM, 2008, INT J DEV BIOL, V52, P665, DOI 10.1387/ijdb.072524pw; Wassarman PM, 2008, J BIOL CHEM, V283, P24285, DOI 10.1074/jbc.R800027200; Wassarman PM, 2012, INT J DEV BIOL, V56, P833, DOI 10.1387/ijdb.120136pw; Wassarman PM, 2004, CYTOGENET GENOME RES, V105, P228, DOI 10.1159/000078193; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Wassarman PM, 1997, P ROY SOC B-BIOL SCI, V264, P323, DOI 10.1098/rspb.1997.0046                                                          	31	2	2	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6717	1432-1203		HUM GENET	Hum. Genet.	AUG	2017	136	8					975	985		10.1007/s00439-017-1822-7				11	Genetics & Heredity	Genetics & Heredity	FA2PZ	WOS:000405284600005	28646452				2018-01-05	
J	Gill, US; Kennedy, PTF				Gill, Upkar S.; Kennedy, Patrick T. F.			Current therapeutic approaches for HBV infected patients	JOURNAL OF HEPATOLOGY			English	Article						cccDNA; Hepatitis B surface antigen; Nucleos(t)ide analogues; Pegylated interferon; Novel therapeutic agents	CHRONIC HEPATITIS-B; PEGYLATED-INTERFERON; IMMUNE-TOLERANT; CELL-FUNCTION; T-CELLS; VIRUS; ALPHA; CRISPR/CAS9; CCCDNA; LIVER		[Gill, Upkar S.; Kennedy, Patrick T. F.] Barts & London Queen Marys Sch Med & Dent, Ctr Immunobiol, Blizard Inst, London, England	Kennedy, PTF (reprint author), Barts & London Queen Marys Sch Med & Dent, Blizard Inst, 4 Newark St, London E1 2AT, England.	p.kennedy@qmul.ac.uk			Barts and The London Charity [723/1795]; NIHR [PB-PG-0614-34087]	USG is a recipient of a Wellcome Trust Clinical Research Fellowship (Grant No.: 107389/Z/15/Z). PTFK is funded by a large project grant from Barts and The London Charity (Grant No. 723/1795) and an NIHR Research for patient benefit award (Grant No. PB-PG-0614-34087).	Agarwal K, 2015, J HEPATOL, V62, P533, DOI [10.1016/j.jhep.2014.12.003, 10.1016/j.jhep.2014.10.035]; Al-Mahtab M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156667; Bengsch B, 2014, J HEPATOL, V61, P1212, DOI 10.1016/j.jhep.2014.07.005; Brouwer WP, 2015, HEPATOLOGY, V61, P1512, DOI 10.1002/hep.27586; Cho JY, 2014, GUT, V63, P1943, DOI 10.1136/gutjnl-2013-306409; EASL, 2017, J HEPATOL, V67, P370; Gill US, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005788; Gill US, 2015, J INFECT DIS, V211, P374, DOI 10.1093/infdis/jiu471; Honer Zu Siederdissenc, 2016, J INFECT DIS, V214, P1492; Isorce N, 2015, ANTIVIR RES, V122, P69, DOI 10.1016/j.antiviral.2015.08.008; Kennedy EM, 2015, ANTIVIR RES, V123, P188, DOI 10.1016/j.antiviral.2015.10.004; Kennedy PTF, 2012, GASTROENTEROLOGY, V143, P637, DOI 10.1053/j.gastro.2012.06.009; Lanford RE, 2013, GASTROENTEROLOGY, V144, P1508, DOI 10.1053/j.gastro.2013.02.003; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Mason WS, 2016, GASTROENTEROLOGY, V151, P986, DOI 10.1053/j.gastro.2016.07.012; Micco L, 2013, J HEPATOL, V58, P225, DOI 10.1016/j.jhep.2012.09.029; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Pallett LJ, 2015, NAT MED, V21, P591, DOI 10.1038/nm.3856; Peppa D, 2013, J EXP MED, V210, P99, DOI 10.1084/jem.20121172; Peppa D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001227; Qasim W, 2015, J HEPATOL, V62, P486, DOI 10.1016/j.jhep.2014.10.001; Rijckborst V., 2010, Current Hepatitis Reports, V9, P231, DOI 10.1007/s11901-010-0055-1; Schurich A, 2011, HEPATOLOGY, V53, P1494, DOI 10.1002/hep.24249; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Thimme R, 2013, J HEPATOL, V58, P205, DOI 10.1016/j.jhep.2012.11.007; Zeisel MB, 2015, GUT, V64, P1314, DOI 10.1136/gutjnl-2014-308943; Zhang EJ, 2015, ANTIVIR RES, V123, P193, DOI 10.1016/j.antiviral.2015.10.009; Zoulim F, 2012, GUT, V61, P333, DOI 10.1136/gutjnl-2011-300937	28	0	0	10	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	AUG	2017	67	2					412	414		10.1016/j.jhep.2017.04.015                                                      				3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	FA5PZ	WOS:000405497200024	28629790				2018-01-05	
J	Wu, Q; Liu, TT; Zhu, LY; Huang, H; Jiang, L				Wu, Qian; Liu, Tingting; Zhu, Liying; Huang, He; Jiang, Ling			Insights from the complete genome sequence of Clostridium tyrobutyricum provide a platform for biotechnological and industrial applications	JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY			English	Article						Complete genome sequence; Clostridium tyrobutyricum; Comparative genome analysis; Butyric acid production; Oxidative tolerance	BUTYRIC-ACID FERMENTATION; FIBROUS BED BIOREACTOR; ESCHERICHIA-COLI K-12; HYDROGEN-PRODUCTION; OXIDATIVE STRESS; TRANSPORT-SYSTEM; DELETED MUTANT; RNA GENES; TOLERANCE; ACETOBUTYLICUM	Genetic research enables the evolution of novel biochemical reactions for the production of valuable chemicals from environmentally-friendly raw materials. However, the choice of appropriate microorganisms to support these reactions, which must have strong robustness and be capable of a significant product output, is a major difficulty. In the present study, the complete genome of the Clostridium tyrobutyricum strain CCTCC W428, a hydrogen- and butyric acid-producing bacterium with increased oxidative tolerance was analyzed. A total length of 3,011,209 bp of the C. tyrobutyricum genome with a GC content of 31.04% was assembled, and 3038 genes were discovered. Furthermore, a comparative clustering of proteins from C. tyrobutyricum CCTCC W428, C. acetobutylicum ATCC 824, and C. butyricum KNU-L09 was conducted. The results of genomic analysis indicate that butyric acid is produced by CCTCC W428 from butyryl-CoA through acetate reassimilation via CoA transferase, instead of the well-established phosphotransbutyrylase-butyrate kinase pathway. In addition, we identified ten proteins putatively involved in hydrogen production and 21 proteins associated with CRISPR systems, together with 358 ORFs related to ABC transporters and transcriptional regulators. Enzymes, such as oxidoreductases, HNH endonucleases, and catalase, were also found in this species. The genome sequence illustrates that C. tyrobutyricum has several desirable traits, and is expected to be suitable as a platform for the high-level production of bulk chemicals as well as bioenergy.	[Wu, Qian; Liu, Tingting] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing 210019, Jiangsu, Peoples R China; [Wu, Qian; Liu, Tingting; Jiang, Ling] Nanjing Tech Univ, Jiangsu Natl Synerget Innovat Ctr Adv Mat, Nanjing 210019, Jiangsu, Peoples R China; [Zhu, Liying] Nanjing Tech Univ, Coll Chem & Mol Engn, Nanjing 210019, Jiangsu, Peoples R China; [Huang, He] Nanjing Tech Univ, Coll Pharmaceut Sci, Nanjing 210009, Peoples R China; [Jiang, Ling] Nanjing Tech Univ, Coll Food Sci & Light Ind, Nanjing 210009, Peoples R China	Jiang, L (reprint author), Nanjing Tech Univ, Jiangsu Natl Synerget Innovat Ctr Adv Mat, Nanjing 210019, Jiangsu, Peoples R China.; Jiang, L (reprint author), Nanjing Tech Univ, Coll Food Sci & Light Ind, Nanjing 210009, Peoples R China.	jiangling@njtech.edu.cn			National Science Foundation for Scholars of China [21506101, U1603112]; State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS [SKLBNPC15429]; Six Talent Peaks Project in Jiangsu Province [2015-JY-009]; Environmental Research Foundation of Jiangsu Province [2016053]	This work was supported by the National Science Foundation for Scholars of China (21506101, U1603112), the State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS (SKLBNPC15429), the Six Talent Peaks Project in Jiangsu Province (2015-JY-009), and the Environmental Research Foundation of Jiangsu Province (2016053).	Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI 10.1093/nar/gkv1290; Alsaker KV, 2005, J BACTERIOL, V187, P7103, DOI 10.1128/JB.187.20.7103-7118.2005; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Basak S, 2014, J BIOTECHNOL, V173, P68, DOI 10.1016/j.jbiotec.2014.01.015; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Biondi EG, 2009, APPL ENVIRON MICROB, V75, P5396, DOI 10.1128/AEM.00196-09; Blume LR, 2013, BIOENERG RES, V6, P763, DOI 10.1007/s12155-013-9295-6; Bohlin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008113; Chiaromonte F, 2002, PAC S BIOCOMPUT, V2002, P115; Choi SH, 2000, APPL ENVIRON MICROB, V66, P3911, DOI 10.1128/AEM.66.9.3911-3916.2000; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dang BJ, 2016, GENE, V591, P74, DOI 10.1016/j.gene.2016.06.060; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Friend PJ, 2006, METH MOL B, V333, P29; Gao X, 2016, J BIOTECHNOL, V224, P55, DOI 10.1016/j.jbiotec.2016.03.012; Harris R.S., 2007, THESIS; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Hillmann F, 2008, MOL MICROBIOL, V68, P848, DOI 10.1111/j.1365-2958.2008.06192.x; Hsiao WW, 2003, PLOS GENET, V1, pe62; Jiang L, 2015, GREEN CHEM, V17, P250, DOI 10.1039/c4gc01256a; Jiang L, 2013, INT J HYDROGEN ENERG, V38, P2176, DOI 10.1016/j.ijhydene.2012.11.050; Jiang L, 2012, BIOTECHNOL BIOENG, V109, P708, DOI 10.1002/bit.23346; Jiang L, 2011, APPL BIOCHEM BIOTECH, V165, P98, DOI 10.1007/s12010-011-9236-9; Jiang L, 2011, BIOTECHNOL BIOENG, V108, P31, DOI 10.1002/bit.22927; Jiang L, 2010, APPL BIOCHEM BIOTECH, V160, P350, DOI 10.1007/s12010-008-8305-1; Jiang L, 2010, BIORESOURCE TECHNOL, V101, P304, DOI 10.1016/j.biortech.2009.08.024; Jiang L, 2009, BIORESOURCE TECHNOL, V100, P3403, DOI 10.1016/j.biortech.2009.02.032; Kawasaki S, 1998, J FERMENT BIOENG, V86, P368, DOI 10.1016/S0922-338X(99)89006-0; Kirk DG, 2012, APPL ENVIRON MICROB, V78, P4590, DOI 10.1128/AEM.00304-12; Koski LB, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-151; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12                                                         ; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee J, 2016, MBIO, V7, DOI 10.1128/mBio.00743-16; Leenanon B, 2001, J FOOD PROTECT, V64, P970, DOI 10.4315/0362-028X-64.7.970                                                      ; Li M, 2013, J BACTERIOL, V195, P867, DOI 10.1128/JB.01688-12; Liu X, 2006, BIOTECHNOL PROGR, V22, P1265, DOI 10.1021/bp060082g; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo RB, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0069-2; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pommer AJ, 2001, J MOL BIOL, V314, P735, DOI 10.1006/jmbi.2001.5189; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; SAUER U, 1994, J BACTERIOL, V176, P6572; SCHULTZ JE, 1991, J MOL BIOL, V218, P129, DOI 10.1016/0022-2836(91)90879-B; Simone F, 2006, MOL ASPECTS MED, V27, P126; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Wu ZT, 2003, BIOTECHNOL BIOENG, V82, P93, DOI 10.1002/bit.10542; Xiao H, 2012, METAB ENG, V14, P569, DOI 10.1016/j.ymben.2012.05.003; Yohannes E, 2004, J BACTERIOL, V186, P192, DOI 10.1128/JB.186.1.192-199.2004; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang YL, 2012, BIOTECHNOL PROGR, V28, P52, DOI 10.1002/btpr.730; Zhu Y, 2005, BIOTECHNOL BIOENG, V90, P154, DOI 10.1002/bit.20354; ZHU Yan-zhi, 2003, THESIS	60	1	1	5	5	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1367-5435	1476-5535		J IND MICROBIOL BIOT	J. Ind. Microbiol. Biotechnol.	AUG	2017	44	8					1245	1260		10.1007/s10295-017-1956-6				16	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FA5QQ	WOS:000405498900012	28536840				2018-01-05	
J	Higashijima, Y; Hirano, S; Nangaku, M; Nureki, O				Higashijima, Yoshiki; Hirano, Seiichi; Nangaku, Masaomi; Nureki, Osamu			Applications of the CRISPR-Cas9 system in kidney research	KIDNEY INTERNATIONAL			English	Review						CRISPR-Cas9; gene expression; gene therapy; genome editing	PLURIPOTENT STEM-CELLS; STAPHYLOCOCCUS-AUREUS CAS9; SEQUENCE-SPECIFIC CONTROL; RNA-GUIDED ENDONUCLEASE; TARGET DNA RECOGNITION; IN-VIVO; GENE-EXPRESSION; DIABETIC-NEPHROPATHY; MUSCULAR-DYSTROPHY; CRISPR/CAS9 SYSTEM	The recently discovered clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR-associated protein 9 (Cas9) is an RNA-guided DNA nuclease, and has been harnessed for the development of simple, efficient, and relatively inexpensive technologies to precisely manipulate the genomic information in virtually all cell types and organisms. The CRIPSR-Cas9 systems have already been effectively used to disrupt multiple genes simultaneously, create conditional alleles, and generate reporter proteins, even in vivo. The ability of Cas9 to target a specific genomic region has also been exploited for various applications, such as transcriptional regulation, epigenetic control, and chromosome labeling. Here we first describe the molecular mechanism of the RNA-guided DNA targeting by the CRISPR-Cas9 system and then outline the current applications of this system as a genome-editing tool in mice and other species, to better model and study human diseases. We also discuss the practical and potential uses of the CRISPR-Cas9 system in kidney research and highlight the further applications of this technology beyond genome editing. Undoubtedly, the CRISPR-Cas9 system holds enormous potential for revolutionizing and accelerating kidney research and therapeutic applications in the future.	[Higashijima, Yoshiki; Nangaku, Masaomi] Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo, Japan; [Higashijima, Yoshiki] Univ Tokyo, Isotope Sci Ctr, Bunkyo Ku, Tokyo, Japan; [Hirano, Seiichi; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan	Nureki, O (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	nureki@bs.s.u-tokyo.ac.jp					Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Anderson BR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005349; Bialk P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129308; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bolar NA, 2016, AM J HUM GENET, V99, P174, DOI 10.1016/j.ajhg.2016.05.028; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Cenci MA, 2002, NAT REV NEUROSCI, V3, P574, DOI 10.1038/nrn877; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; Doggrell SA, 1998, J PHARM PHARMACOL, V50, P215, DOI 10.1111/j.2042-7158.1998.tb06179.x                                              ; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dragin N, 2008, MOL PHARMACOL, V73, P1844, DOI 10.1124/mol.108.045658; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Feng WY, 2015, INT J MOL SCI, V16, P6545, DOI 10.3390/ijms16036545; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Franzen S, 2014, AM J PHYSIOL-RENAL, V306, pF1171, DOI 10.1152/ajprenal.00595.2013; Freedman BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9715; Fujii W, 2014, J REPROD DEVELOP, V60, P324, DOI 10.1262/jrd.2013-139                                                            ; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Fujita T, 2016, GENES CELLS, V21, P370, DOI 10.1111/gtc.12341; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hara S, 2016, J REPROD DEVELOP, V62, P531, DOI 10.1262/jrd.2016-058; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; Higashijima Y, 2015, AM J PHYSIOL-RENAL, V308, pF878, DOI 10.1152/ajprenal.00590.2014; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Holmdahl R, 2001, IMMUNOL REV, V184, P184, DOI 10.1034/j.1600-065x.2001.1840117.x                                              ; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156074; Huang BN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156072; Huang GY, 2011, CURR OPIN NEPHROL HY, V20, P391, DOI 10.1097/MNH.0b013e328347768a; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Jacob HJ, 2010, TRENDS GENET, V26, P510, DOI 10.1016/j.tig.2010.08.006; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaneko T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142755; Kaneko T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06382; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Krishnaswamy JK, 2015, P NATL ACAD SCI USA, V112, P3056, DOI 10.1073/pnas.1501554112; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Lemoine A, 2016, J GENET GENOMICS, V43, P329, DOI 10.1016/j.jgg.2016.04.004; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; LI L, 1992, P NATL ACAD SCI USA, V89, P4275, DOI 10.1073/pnas.89.10.4275; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Lozic Bernarda, 2014, Med Sci Monit, V20, P1531, DOI 10.12659/MSM.890916; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandai S, 2015, HYPERTENSION, V66, P1199, DOI 10.1161/HYPERTENSIONAHA.115.05872; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marshall CB, 2006, KIDNEY INT, V70, P1962, DOI 10.1038/sj.ki.5001965; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mashimo T, 2014, DEV GROWTH DIFFER, V56, P46, DOI 10.1111/dgd.12110; Matsumoto M, 2004, J AM SOC NEPHROL, V15, P1574, DOI 10.1097/01.ASN.0000128047.13396.48; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; Menoret S, 2014, METHODS, V69, P102, DOI 10.1016/j.ymeth.2014.02.027; Miyagi A, 2016, J AM SOC NEPHROL, V27, P2940, DOI 10.1681/ASN.2016020146; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nakamura K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05635; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakurai T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20011; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Shankland SJ, 1996, KIDNEY INT, V50, P116, DOI 10.1038/ki.1996.294; Shao YJ, 2014, NAT PROTOC, V9, P2493, DOI 10.1038/nprot.2014.171; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695; Tanaka T, 2005, LAB INVEST, V85, P1292, DOI 10.1038/labinvest.3700328; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Usui JI, 2012, AM J PATHOL, V180, P2417, DOI 10.1016/j.ajpath.2012.03.007; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang BM, 2015, BIOTECHNIQUES, V59, P201, DOI 10.2144/000114339; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Williams A, 2016, COLD SPRING HARB PRO, V2016; Wuttke M, 2016, NAT REV NEPHROL, V12, P549, DOI 10.1038/nrneph.2016.107; Xu JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159597; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Zhang Z, 2011, HUM MOL GENET, V20, P4167, DOI 10.1093/hmg/ddr341; Zhou JK, 2014, INT J BIOCHEM CELL B, V46, P49, DOI 10.1016/j.biocel.2013.10.010	122	0	0	11	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	AUG	2017	92	2								10.1016/j.kint.2017.01.037				12	Urology & Nephrology	Urology & Nephrology	FA1KI	WOS:000405197800012	28433382				2018-01-05	
J	Grainger, S; Lonquich, B; Oon, CH; Nguyen, N; Willert, K; Traver, D				Grainger, Stephanie; Lonquich, Brianna; Oon, Chet Huan; Nguyen, Nicole; Willert, Karl; Traver, David			CRISPR Guide RNA Validation In Vitro	ZEBRAFISH			English	Article						Cas9; CRISPR; in vitro; validation; zebrafish; knock in	HUMAN-CELLS; ZEBRAFISH; SYSTEM; NUCLEASES	Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 has been applied to edit genomes in a wide variety of model systems. Although this process can be quite efficient, editing at precise locations in the genome remains difficult without a suitable single guide RNA (sgRNA). We have developed a method for screening sgRNA function in vitro, using reagents that most zebrafish laboratories are already using. The results from our in vitro assay correlate with function in vivo in every sgRNA that we have examined so far. When combined with endonucleases with alternative protospacer adjacent motif site specificities and alternative sgRNAs, this method will streamline genome editing at almost any locus.	[Grainger, Stephanie; Lonquich, Brianna; Oon, Chet Huan; Nguyen, Nicole; Willert, Karl; Traver, David] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Grainger, Stephanie; Lonquich, Brianna; Oon, Chet Huan; Nguyen, Nicole; Willert, Karl] Sanford Consortium Regenerat Med, La Jolla, CA USA	Willert, K; Traver, D (reprint author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	kwillert@ucsd.edu; dtraver@ucsd.edu					Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Ota S, 2014, GENES CELLS, V19, P555, DOI 10.1111/gtc.12154; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	17	0	0	4	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1545-8547	1557-8542		ZEBRAFISH	Zebrafish	AUG	2017	14	4					383	386		10.1089/zeb.2016.1358				4	Developmental Biology; Zoology	Developmental Biology; Zoology	FA5SJ	WOS:000405503600011	27829120				2018-01-05	
J	O'Brien, CL; Bringer, MA; Holt, KE; Gordon, DM; Dubois, AL; Barnich, N; Darfeuille-Michaud, A; Pavli, P				O'Brien, Claire L.; Bringer, Marie-Agnes; Holt, Kathryn E.; Gordon, David M.; Dubois, Anaelle L.; Barnich, Nicolas; Darfeuille-Michaud, Arlette; Pavli, Paul			Comparative genomics of Crohn's disease-associated adherent-invasive Escherichia coli	GUT			English	Article							INFLAMMATORY-BOWEL-DISEASE; ILEAL MUCOSA; HUMAN MACROPHAGES; HIGH PREVALENCE; STRAIN LF82; E. COLI; CANCER; MICROBIOME; DIVERSITY; VIRULENCE	Objective Adherent-invasive Escherichia coli (AIEC) are a leading candidate bacterial trigger for Crohn's disease (CD). The AIEC pathovar is defined by in vitro cell-line assays examining specific bacteria/cell interactions. No molecular marker exists for their identification. Our aim was to identify a molecular property common to the AIEC phenotype. Design 41 B2 phylogroup E. coli strains were isolated from 36 Australian subjects: 19 patients with IBD and 17 without. Adherence/invasion assays were conducted using the I-407 epithelial cell line and survival/replication assays using the THP-1 macrophage cell line. Cytokine secretion tumour necrosis factor ((TNF)-alpha, interleukin (IL) 6, IL-8 and IL-10) was measured using ELISA. The genomes were assembled and annotated, and cluster analysis performed using CD-HIT. The resulting matrices were analysed to identify genes unique/more frequent in AIEC strains compared with non-AIEC strains. Base composition differences and clustered regularly interspaced palindromic repeat (CRISPR) analyses were conducted. Results Of all B2 phylogroup strains assessed, 79% could survive and replicate in macrophages. Among them, 11/41 strains (5 CD, 2 UCs, 5 non-IBD) also adhere to and invade epithelial cells, a phenotype assigning them to the AIEC pathovar. The AIEC strains were phylogenetically heterogeneous. We did not identify a gene (or nucleic acid base composition differences) common to all, or the majority of, AIEC. Cytokine secretion and CRISPRs were not associated with the AIEC phenotype. Conclusions Comparative genomic analysis of AIEC and non-AIEC strains did not identify a molecular property exclusive to the AIEC phenotype. We recommend a broader approach to the identification of the bacteria-host interactions that are important in the pathogenesis of Crohn's disease.	[O'Brien, Claire L.; Pavli, Paul] Australian Natl Univ, Med Sch, Canberra, ACT, Australia; [O'Brien, Claire L.; Pavli, Paul] Canberra Hosp, Gastroenterol & Hepatol Unit, Canberra, ACT, Australia; [Bringer, Marie-Agnes] Univ Bourgogne Franche Comte, Ctr Sci Gout & Alimentat, CNRS, INRA,UMR1324,UMR6265, Dijon, France; [Bringer, Marie-Agnes; Dubois, Anaelle L.; Barnich, Nicolas; Darfeuille-Michaud, Arlette] Univ Auvergne, INSERM, INRA USC2018, UMR1071,M2iSH, Clermont Ferrand, France; [Holt, Kathryn E.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [Gordon, David M.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	O'Brien, CL (reprint author), Australian Natl Univ, Canberra Hosp, Med Sch, Lvl 5,Bldg 10,Yamba Dr, Garran, ACT 2605, Australia.	claire.obrien@anu.edu.au			Australian Academy of Science France-Australia Science Innovation Collaboration early career fellowship; Gastroenterological Society of Australia (GESA) Clinical Research grant; Ministere de la Recherche et de la Technologie; Inserm [UMR1071]; INRA [USC-2018]; Nouveau Chercheur EPST from Conseil Regional Auvergne	This research was supported by an Australian Academy of Science France-Australia Science Innovation Collaboration early career fellowship; a Gastroenterological Society of Australia (GESA) Clinical Research grant; and funding from the Ministere de la Recherche et de la Technologie, Inserm (UMR1071), INRA (USC-2018); and Nouveau Chercheur EPST from Conseil Regional Auvergne. Study sponsors did not influence or dictate the study design, analysis or interpretation of the data.	Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Bokil NJ, 2011, IMMUNOBIOLOGY, V216, P1164, DOI 10.1016/j.imbio.2011.05.011; Boudeau J, 1999, INFECT IMMUN, V67, P4499; Bringer MA, 2005, INFECT IMMUN, V73, P712, DOI 10.1128/IAI.73.2.712-721.2005; Bringer MA, 2007, J BACTERIOL, V189, P4860, DOI 10.1128/JB.00233-07; Carvalho FA, 2009, J EXP MED, V206, P2179, DOI 10.1084/jem.20090741; Chassaing B, 2015, J BACTERIOL, V197, P1451, DOI 10.1128/JB.02499-14; Chassaing Benoit, 2011, Med Sci (Paris), V27, P572, DOI 10.1051/medsci/2011276003; Chassaing B, 2011, J CLIN INVEST, V121, P966, DOI 10.1172/JCI44632; Clermont O, 2014, J MICROBIOL METH, V101, P24, DOI 10.1016/j.mimet.2014.03.008; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Conte Maria Pia, 2014, BMC Res Notes, V7, P748, DOI 10.1186/1756-0500-7-748; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Denizot J, 2012, INFLAMM BOWEL DIS, V18, P294, DOI 10.1002/ibd.21787; Deshpande NP, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv193; Desilets M, 2016, INFLAMM BOWEL DIS, V22, P1, DOI 10.1097/MIB.0000000000000574; Dogan B, 2014, INFLAMM BOWEL DIS, V20, P1919, DOI 10.1097/MIB.0000000000000183; Dreux N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003141; Elliott TR, 2015, J GASTROEN HEPATOL, V30, P1265, DOI 10.1111/jgh.12955; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gordon DM, 2015, ENV MICROBIOL REP, V7, P642, DOI 10.1111/1758-2229.12300; Gordon DM, 2005, MICROBIOL-SGM, V151, P15, DOI 10.1099/mic.0.27425-0; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Nguyen HTT, 2013, J INNATE IMMUN, V5, P434, DOI 10.1159/000345129; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kang S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/ibd.21319; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Martinez-Medina M, 2009, J CLIN MICROBIOL, V47, P3968, DOI 10.1128/JCM.01484-09; Martinez-Medina M, 2009, INFLAMM BOWEL DIS, V15, P872, DOI 10.1002/ibd.20860; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Miquel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012714; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mylonaki M, 2005, INFLAMM BOWEL DIS, V11, P481, DOI 10.1097/01.MIB.0000159663.62651.4f; Nishiyama K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108827; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; O'Brien CL, 2014, GUT, V63, P1596, DOI 10.1136/gutjnl-2013-305320; Prorok-Hamon M, 2014, GUT, V63, P761, DOI 10.1136/gutjnl-2013-304739; Raisch J, 2015, LAB INVEST, V95, P296, DOI 10.1038/labinvest.2014.161; Reid SD, 2000, NATURE, V406, P64; Sasaki M, 2007, LAB INVEST, V87, P1042, DOI 10.1038/labinvest.3700661; Simonsen KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016387; Simpson KW, 2006, INFECT IMMUN, V74, P4778, DOI 10.1128/IAI.00067-06; Subramanian S, 2008, ANTIMICROB AGENTS CH, V52, P427, DOI 10.1128/AAC.00375-07; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Vallenet D, 2013, NUCLEIC ACIDS RES, V41, pE636, DOI 10.1093/nar/gks1194; Vazeille E, 2016, INFLAMM BOWEL DIS, V22, P68, DOI 10.1097/MIB.0000000000000609; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	58	4	4	9	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	AUG	2017	66	8					1382	1389		10.1136/gutjnl-2015-311059				8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	FA1HW	WOS:000405191200007	27196580				2018-01-05	
J	Iyer, LM; Burroughs, AM; Anand, S; de Souza, RF; Aravind, L				Iyer, Lakshminarayan M.; Maxwell Burroughs, A.; Anand, Swadha; de Souza, Robson F.; Aravind, L.			Polyvalent Proteins, a Pervasive Theme in the Intergenomic Biological Conflicts of Bacteriophages and Conjugative Elements	JOURNAL OF BACTERIOLOGY			English	Article						DNA replication; DNA-binding proteins; RNases; antirestriction; bacteriophages; biological conflicts; effectors; metallopeptidase; plasmids; transcription	RESTRICTION-MODIFICATION SYSTEMS; NUCLEOTIDE EXCISION-REPAIR; VIRION RNA-POLYMERASE; TOXIN-ANTITOXIN SYSTEMS; STRESS-RESPONSE SYSTEMS; DNA-DAMAGE RECOGNITION; GROUP-C PROTEIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; INORGANIC PYROPHOSPHATASE	Intense biological conflicts between prokaryotic genomes and their genomic parasites have resulted in an arms race in terms of the molecular "weaponry" deployed on both sides. Using a recursive computational approach, we uncovered a remarkable class of multidomain proteins with 2 to 15 domains in the same polypeptide deployed by viruses and plasmids in such conflicts. Domain architectures and genomic contexts indicate that they are part of a widespread conflict strategy involving proteins injected into the host cell along with parasite DNA during the earliest phase of infection. Their unique feature is the combination of domains with highly disparate biochemical activities in the same polypeptide; accordingly, we term them polyvalent proteins. Of the 131 domains in polyvalent proteins, a large fraction are enzymatic domains predicted to modify proteins, target nucleic acids, alter nucleotide signaling/metabolism, and attack peptidoglycan or cytoskeletal components. They further contain nucleic acid-binding domains, virion structural domains, and 40 novel uncharacterized domains. Analysis of their architectural network reveals both pervasive common themes and specialized strategies for conjugative elements and plasmids or ( pro) phages. The themes include likely processing of multidomain polypeptides by zincin-like metallopeptidases and mechanisms to counter restriction or CRISPR/Cas systems and jump-start transcription or replication. DNAbinding domains acquired by eukaryotes from such systems have been reused in XPC/RAD4-dependent DNA repair and mitochondrial genome replication in kinetoplastids. Characterization of the novel domains discovered here, such as RNases and peptidases, are likely to aid in the development of new reagents and elucidation of the spread of antibiotic resistance. IMPORTANCE This is the first report of the widespread presence of large proteins, termed polyvalent proteins, predicted to be transmitted by genomic parasites such as conjugative elements, plasmids, and phages during the initial phase of infection along with their DNA. They are typified by the presence of multiple domains with disparate activities combined in the same protein. While some of these domains are predicted to assist the invasive element in replication, transcription, or protection of their DNA, several are likely to target various host defense systems or modify the host to favor the parasite's life cycle. Notably, DNA-binding domains from these systems have been transferred to eukaryotes, where they have been incorporated into DNA repair and mitochondrial genome replication systems.	[Iyer, Lakshminarayan M.; Maxwell Burroughs, A.; Anand, Swadha; Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [de Souza, Robson F.] Univ Sao Paulo, Biomed Sci Inst, Microbiol Dept, Cidade Univ, Sao Paulo, Brazil	Aravind, L (reprint author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	aravind@ncbi.nlm.nih.gov		Aravind, L/0000-0003-0771-253X	NIH; National Library of Medicine at the National Institutes of Health	This work was supported by an NIH postdoctoral visiting fellowship (S.A.) and intramural funds (L.M.I., A.M.B., and L.A.) from the National Library of Medicine at the National Institutes of Health.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81                                                        ; Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Anantharaman V, 2012, MOL BIOSYST, V8, P3142, DOI 10.1039/c2mb25239b; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746                                                          ; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609                                                           ; Aravind L, 2015, CURR TOP MICROBIOL, V384, P3, DOI 10.1007/82_2014_414; Aravind L, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00089; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; Aravind L, 2014, PROTEIN FAMILIES REL, P421; Attaiech L, 2008, J BACTERIOL, V190, P5729, DOI 10.1128/JB.00425-08; Bair CL, 2007, J MOL BIOL, V366, P768, DOI 10.1016/j.jmb.2006.11.051; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Beck CM, 2014, STRUCTURE, V22, P707, DOI 10.1016/j.str.2014.02.012; Belogurov AA, 2000, J MOL BIOL, V296, P969, DOI 10.1006/jmbi.1999.3493                                                          ; Bhardwaj A, 2014, CURR OPIN STRUC BIOL, V25, P1, DOI 10.1016/j.sbi.2013.10.005; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Burroughs A. M., 2007, V3, P48, DOI 10.1159/000107603; Burroughs AM, 2016, NUCLEIC ACIDS RES, V44, P8525, DOI 10.1093/nar/gkw722; Burroughs A Maxwell, 2015, Nucleic Acids Res, V43, P10633, DOI 10.1093/nar/gkv1267; Buterin T, 2005, CHEM BIOL, V12, P913, DOI 10.1016/j.chembiol.2005.06.011; Carrasco B, 2004, J BACTERIOL, V186, P5557, DOI 10.1128/JB.186.17.5557-5566.2004; Ceyssens PJ, 2010, VIROLOGY, V405, P26, DOI 10.1016/j.virol.2010.06.011; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chanto G, 2002, MICROBIOL-SGM, V148, P3671, DOI 10.1099/00221287-148-11-3671                                                    ; Chen K, 2014, BBA-PROTEINS PROTEOM, V1844, P505, DOI 10.1016/j.bbapap.2013.12.008; Chi YH, 2012, FEBS LETT, V586, P3493, DOI 10.1016/j.febslet.2012.08.002; CHILLEY PM, 1995, MICROBIOL-UK, V141, P2157, DOI 10.1099/13500872-141-9-2157                                                     ; Choi KH, 2008, J MOL BIOL, V378, P726, DOI 10.1016/j.jmb.2008.02.059; Christie PJ, 2014, BBA-MOL CELL RES, V1843, P1578, DOI 10.1016/j.bbamcr.2013.12.019; Clement FC, 2010, MUTAT RES-FUND MOL M, V685, P21, DOI 10.1016/j.mrfmmm.2009.08.005; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cooper DL, 2016, ELIFE, V5, DOI 10.7554/eLife.10807; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Craig SP, 2000, J BIOL CHEM, V275, P20231, DOI 10.1074/jbc.R000002200; Csardi G, 2006, INT J COMPLEX SYST, V1695, P1; Davidson AR, 2012, ADV EXP MED BIOL, V726, P115, DOI 10.1007/978-1-4614-0980-9_6; Davison J., 2015, BACTERIOPHAGE, V5; de Souza RF, 2012, MOL BIOSYST, V8, P1661, DOI 10.1039/c2mb05487f; Depping R, 2005, BIOCHEM BIOPH RES CO, V335, P1217, DOI 10.1016/j.bbrc.2005.08.023; Dryden DTF, 2006, BIOCHEM SOC T, V34, P317, DOI 10.1042/BST0340317                                                              ; Duan Y, 2016, J BACTERIOL, V198, P2074, DOI 10.1128/JB.00183-16; Duhagon MA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-34; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Eddy Sean R, 2009, Genome Inform, V23, P205; Epshtein V, 2015, BIOESSAYS, V37, P12, DOI 10.1002/bies.201400106; FALCO SC, 1978, P NATL ACAD SCI USA, V75, P3220, DOI 10.1073/pnas.75.7.3220; Fastrez J, 1996, EXS, V75, P35; FELZENSZWALB I, 1986, RADIAT RES, V106, P166, DOI 10.2307/3576790; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; FREEMAN LC, 1991, SOC NETWORKS, V13, P141, DOI 10.1016/0378-8733(91)90017-N                                                    ; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102                                                          ; Gaca AO, 2015, J BACTERIOL, V197, P1146, DOI 10.1128/JB.02577-14; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1016/S0378-1097(01)00326-3; Gdula DA, 1998, GENE DEV, V12, P3206, DOI 10.1101/gad.12.20.3206; GIPHARTGASSLER M, 1981, J MOL BIOL, V145, P139, DOI 10.1016/0022-2836(81)90338-7; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Gulder TAM, 2011, TOP CURR CHEM, V2011, P1; Gupta YK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8363; Hamilton SC, 2001, BIOTECHNIQUES, V31, P370; Hardies SC, 2016, VIROLOGY, V489, P116, DOI 10.1016/j.virol.2015.12.005; Hauk G, 2011, CURR OPIN STRUC BIOL, V21, P719, DOI 10.1016/j.sbi.2011.09.003; Hayes CS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a010025; Henderson-Begg SK, 2009, INT J ANTIMICROB AG, V33, P364, DOI 10.1016/j.ijantimicag.2008.10.002; Hess MT, 1997, P NATL ACAD SCI USA, V94, P6664, DOI 10.1073/pnas.94.13.6664; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hopfner KP, 2012, CURR OPIN STRUC BIOL, V22, P225, DOI 10.1016/j.sbi.2012.02.007; Horton JR, 2005, CELL, V121, P349, DOI 10.1016/j.cell.2005.02.021; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Iida S, 1998, VIROLOGY, V251, P49, DOI 10.1006/viro.1998.9405; IIDA S, 1987, VIROLOGY, V157, P156, DOI 10.1016/0042-6822(87)90324-2                                                    ; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; Iyer LM, 2016, BIOESSAYS, V38, P27, DOI 10.1002/bies.201500104; Iyer LM, 2013, NUCLEIC ACIDS RES, V41, P7635, DOI 10.1093/nar/gkt573; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI 10.1093/nar/gkr691; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-8; Iyer LM, 2006, CELL CYCLE, V5, P775, DOI 10.4161/cc.5.7.2629                                                             ; Iyer LM, 2005, NUCLEIC ACIDS RES, V33, P3875, DOI 10.1093/nar/gki702; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206                                                            ; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; Jin DJ, 2011, BBA-GENE REGUL MECH, V1809, P470, DOI 10.1016/j.bbagrm.2011.03.003; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kaufenstein M, 2011, J BACTERIOL, V193, P1633, DOI 10.1128/JB.01128-10; Kazmierczak KM, 2002, EMBO J, V21, P5815, DOI 10.1093/emboj/cdf584; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140                                                           ; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; Koch Thomas, 1995, Gene Expression, V4, P253; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Kurisu G, 2000, J INORG BIOCHEM, V82, P225, DOI 10.1016/S0162-0134(00)00136-7; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; LANKA E, 1981, J BACTERIOL, V148, P769; Lassmann T, 2009, NUCLEIC ACIDS RES, V37, P858, DOI 10.1093/nar/gkn1006; Lehours P, 2011, MBIO, V2, DOI 10.1128/mBio.00239-11; Leiman PG, 2012, ADV EXP MED BIOL, V726, P93, DOI 10.1007/978-1-4614-0980-9_5; Leipe DD, 2000, GENOME RES, V10, P5; Lenneman BR, 2015, BIOMOLECULES, V5, P647, DOI 10.3390/biom5020647; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Liu B, 2015, P NATL ACAD SCI USA, V112, P2006, DOI 10.1073/pnas.1417152112; Liu J, 2004, J BACTERIOL, V186, P4369, DOI 10.1128/JB.186.13.4369-4375.2004; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x                                                ; Lobocka MB, 2004, J BACTERIOL, V186, P7032, DOI 10.1128/JB.186.21.7032-7068.2004; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P20, DOI 10.1093/nar/gkt847; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P3, DOI 10.1093/nar/gkt990; Machnicka MA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0773-z; Maindola P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6322; Makarova KS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00102; Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Masaki H, 2002, BIOCHIMIE, V84, P433, DOI 10.1016/S0300-9084(02)01425-6                                                   ; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; McMahon SA, 2009, NUCLEIC ACIDS RES, V37, P4887, DOI 10.1093/nar/gkp478; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Morgan GJ, 2002, J MOL BIOL, V317, P337, DOI 10.1006/jmbi.2001.5437; Murakami KS, 2008, P NATL ACAD SCI USA, V105, P5046, DOI 10.1073/pnas.0712325105; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Nakasugi K, 2006, MICROBIOL-SGM, V152, P3623, DOI 10.1099/mic.0.29189-0; Narahara K, 1997, PLASMID, V38, P1, DOI 10.1006/plas.1997.1297; Neubauer C, 2009, CELL, V139, P1084, DOI 10.1016/j.cell.2009.11.015; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7                                                   ; Nocadello S, 2016, J BIOL CHEM, V291, P14915, DOI [10.1074/jbc.M116./29/49, 10.1074/jbc.M116.729749]; NODA Y, 1992, J BACTERIOL, V174, P4302; Ordonez H, 2012, NUCLEIC ACIDS RES, V40, P4604, DOI 10.1093/nar/gks046; Parker C, 2005, J BACTERIOL, V187, P3400, DOI 10.1128/JB.187.10.3400.3406.2005; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Payne JAE, 2017, MOL BIOSYST, V13, P9, DOI 10.1039/c6mb00675b; Pei JM, 2003, BIOINFORMATICS, V19, P427, DOI 10.1093/bioinformatics/btg008; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Pratt AC, 2015, J STRUCT BIOL, V192, P76, DOI 10.1016/j.jsb.2015.08.010; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price NPJ, 2007, J ANTIBIOT, V60, P485, DOI 10.1038/ja.2007.62                                                              ; REES CED, 1990, MOL MICROBIOL, V4, P1199, DOI 10.1111/j.1365-2958.1990.tb00695.x; Rifat D, 2008, J MOL BIOL, V375, P720, DOI 10.1016/j.jmb.2007.10.064; ROBERTSON ES, 1992, BIOCHEMISTRY-US, V31, P4822, DOI 10.1021/bi00135a012; ROHRER H, 1975, EUR J BIOCHEM, V60, P227, DOI 10.1111/j.1432-1033.1975.tb20995.x; Russell CW, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005317; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Schneider GF, 2012, NAT BIOTECHNOL, V30, P326, DOI 10.1038/nbt.2181; Shaw N, 2008, PROTEINS, V70, P263, DOI 10.1002/prot.21641; Shchepachev V, 2013, FEBS LETT, V587, P1858, DOI 10.1016/j.febslet.2013.05.005; Sirinakis G, 2011, EMBO J, V30, P2364, DOI 10.1038/emboj.2011.141; Sivula T, 1999, FEBS LETT, V454, P75, DOI 10.1016/S0014-5793(99)00779-6; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sugasawa K, 2002, DNA REPAIR, V1, P95, DOI 10.1016/S1568-7864(01)00008-8                                                   ; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Tan QA, 2011, MOL MICROBIOL, V79, P109, DOI 10.1111/j.1365-2958.2010.07433.x; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; TEPLYAKOV A, 1994, PROTEIN SCI, V3, P1098, DOI 10.1002/pro.5560030713                                                          ; Tomchick DR, 1998, STRUCTURE, V6, P337, DOI 10.1016/S0969-2126(98)00036-7; Tsvetkova K, 2010, J BACTERIOL, V192, P702, DOI 10.1128/JB.00680-09; Uzan M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-360; van Houte S, 2016, MICROBIOL MOL BIOL R, V80, P745, DOI 10.1128/MMBR.00011-16; Vetting MW, 2008, PROTEIN SCI, V17, P1781, DOI 10.1110/ps.035899.108; Vinga I, 2006, MOL MICROBIOL, V61, P1609, DOI 10.1111/j.1365-2958.2006.05327.x; Walker J T, 1981, Prog Clin Biol Res, V64, P69; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x; Wang LR, 2007, NAT CHEM BIOL, V3, P709, DOI 10.1038/nchembio.2007.39; WELCH AR, 1991, P NATL ACAD SCI USA, V88, P10792, DOI 10.1073/pnas.88.23.10792; Wilkins BM, 2002, ENVIRON MICROBIOL, V4, P495, DOI 10.1046/j.1462-2920.2002.00332.x                                                ; Wright GD, 1999, CURR OPIN MICROBIOL, V2, P499, DOI 10.1016/S1369-5274(99)00007-7                                                   ; Xu SY, 2012, J BACTERIOL, V194, P49, DOI 10.1128/JB.06248-11; Zhang DP, 2014, CURR OPIN STRUC BIOL, V26, P92, DOI 10.1016/j.sbi.2014.05.008; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zhang DP, 2011, NUCLEIC ACIDS RES, V39, P4532, DOI 10.1093/nar/gkr036; Zhang R, 2013, P NATL ACAD SCI USA, V110, P13114, DOI 10.1073/pnas.1306917110	168	0	0	6	6	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	AUG	2017	199	15							UNSP e00245	10.1128/JB.00245-17				31	Microbiology	Microbiology	FA1CJ	WOS:000405176200005		green_published			2018-01-05	
J	Dong, XY; Jin, YL; Ming, D; Li, BB; Dong, HS; Wang, L; Wang, TD; Wang, DC				Dong, Xiaoyun; Jin, Yingli; Ming, Di; Li, Bangbang; Dong, Haisi; Wang, Lin; Wang, Tiedong; Wang, Dacheng			CRISPR/dCas9-mediated inhibition of gene expression in Staphylococcus aureus	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						Staphylococcus aureus; Gene knockdown; CRISPR interference	ESCHERICHIA-COLI; ALLELIC REPLACEMENT; SURFACE-PROTEINS; ALPHA-HEMOLYSIN; ANTISENSE RNAS; CRISPR; INFECTIONS; RESISTANCE; BACTERIA; SYSTEM	The understanding of the genetic mechanism of Staphylococcus aureus requires efficient tools, however, genetic manipulation in S. aureus is always laborious and time-consuming. Here we proposed a novel CRISPR/dCas9 interference method for the rapid knockdown of target genes. Furthermore, multiple genes can be repressed simultaneously by using this method.	[Dong, Xiaoyun; Jin, Yingli; Li, Bangbang] Jilin Univ, Coll Basic Med Sci, Dept Pharmacol, Changchun, Peoples R China; [Ming, Di; Dong, Haisi; Wang, Tiedong; Wang, Dacheng] Jilin Univ, Coll Anim Sci, Dept Biochem & Mol Biol, Changchun, Peoples R China; [Wang, Lin] Jilin Univ, Coll Vet Med, Inst Zoonosis, Key Lab Zoonosis Res,Minist Educ, Changchun, Peoples R China	Wang, TD; Wang, DC (reprint author), Jilin Univ, Coll Anim Sci, Dept Biochem & Mol Biol, Changchun, Peoples R China.; Wang, TD; Wang, DC (reprint author), Jilin Univ, Coll Anim Sci, Changchun 130062, Peoples R China.	jinyingli@jlu.edu.cn; wanglin1020@jlu.edu.cn; wangtd@jlu.edu.cn; wangdc@jlu.edu.cn			National Key Technology R D Program [2016YFD05013]; National Natural Science Foundation of China [31502117]	We thank Stanley Qi and Chia Lee for providing us with pdCas9-bacteria and pLI50 plasmids. This work was supported by The National Key Technology R & D Program (No.2016YFD05013) and the National Natural Science Foundation of China (No.31502117).	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bayer MG, 1996, J BACTERIOL, V178, P4563, DOI 10.1128/jb.178.15.4563-4570.1996                                                ; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bolken TC, 2001, INFECT IMMUN, V69, P75, DOI 10.1128/IAI.69.1.75-80.2001; Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003; Cascioferro S, 2014, FUTURE MICROBIOL, V9, P1209, DOI [10.2217/FMB.14.56, 10.2217/fmb.14.56]; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Choudhary E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7267; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9                                                   ; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gill EE, 2015, CHEM BIOL DRUG DES, V85, P56, DOI 10.1111/cbdd.12478; GOUAUX JE, 1994, P NATL ACAD SCI USA, V91, P12828, DOI 10.1073/pnas.91.26.12828; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763                                                        ; Kong C, 2016, TOXINS, V8, DOI 10.3390/toxins8030072; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0                                                                ; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; Loeb L, 1904, J MED RES, V10, P407; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806                                                     ; Maeda Y, 2008, J CLIN PATHOL, V61, P876, DOI 10.1136/jcp.2006.046011; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; NAKANISHI N, 1986, PLASMID, V15, P217, DOI 10.1016/0147-619X(86)90040-5; Nakashima N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp498; Nekhotiaeva N, 2004, MOL THER, V10, P652, DOI 10.1016/j.ymthe.2004.07.006; Ouyang P, 2016, ANTON LEEUW INT J G, V109, P915, DOI 10.1007/s10482-016-0690-9; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ruer S, 2015, CHEM BIOL DRUG DES, V86, P379, DOI 10.1111/cbdd.12517; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Schwendener S, 2015, APPL ENVIRON MICROB, V81, P3243, DOI 10.1128/AEM.03803-14; Stead MB, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks680; Thomer L, 2016, ANNU REV PATHOL-MECH, V11, P343, DOI 10.1146/annurev-pathol-012615-044351; Thomer L, 2013, J BIOL CHEM, V288, P28283, DOI 10.1074/jbc.M113.493122; Wagner EGH, 2002, TRENDS GENET, V18, P223, DOI 10.1016/S0168-9525(02)02658-6                                                   ; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Yu KOA, 2016, J INFECT DIS, V214, P1638, DOI 10.1093/infdis/jiw441	44	1	1	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	AUG	2017	139						79	86		10.1016/j.mimet.2017.05.008				8	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	FA0VO	WOS:000405154900014	28522389				2018-01-05	
J	Huang, XR; Peng, XB; Sun, MX				Huang, Xiaorong; Peng, Xiongbo; Sun, Meng-Xiang			OsGCD1 is essential for rice fertility and required for embryo dorsal-ventral pattern formation and endosperm development	NEW PHYTOLOGIST			English	Article						dorsal-ventral axis; embryogenesis; endosperm; fertility; pattern formation; rice	CELL FATE SPECIFICATION; POLYCOMB GROUP GENES; HOMEOBOX GENE; EARLY EMBRYOGENESIS; SEED DEVELOPMENT; ORYZA-SATIVA; INDICA/JAPONICA HYBRIDS; ARABIDOPSIS-THALIANA; DOUBLE FERTILIZATION; FEMALE GAMETOPHYTE	Rice fertility is critical for rice reproduction and is thus a focus of interest. Most studies have addressed male sterility and its relation to rice production. The mechanisms of regulation of embryogenesis and endosperm development are essential for rice reproduction, but remain largely unknown. Here, we report a functional analysis of the rice gene OsGCD1, which encodes a highly conserved homolog of Arabidopsis GCD1 (GAMETE CELLS DEFECTIVE1). OsGCD1 mutants were generated using the CRISPR/Cas9 system and subjected to functional analysis. The homozygote mutants cannot be obtained, whereas heterozygotes showed altered phenotypes. In the majority of aborted seeds, the endosperm nucleus divided a limited number of times. The free nuclei were distributed only at the micropylar end of embryo sacs, and their oriented positioning was blocked. In addition, aleurone differentiation was interrupted. The embryo developed slowly, and pattern formation, particularly the dorsal-ventral pattern and symmetry establishment, of embryos was disturbed. Thus, the embryos showed various morphological and structural dysplasias. Our findings reveal that OsGCD1 is essential for rice fertility and is required for dorsal-ventral pattern formation and endosperm free nucleus positioning, suggesting a critical role in sexual reproduction of both monocotyledon and dicotyledon plants.	[Huang, Xiaorong; Peng, Xiongbo; Sun, Meng-Xiang] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China	Sun, MX (reprint author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	mxsun@whu.edu.cn			Major Research Plan of the Ministry of Science and Technology of China [2014CB943400]; NSF project of China [31430007, 31170297]	This project was supported by the Major Research Plan of the Ministry of Science and Technology of China (2014CB943400) and the NSF project of China (31430007 and 31170297).	Bai AN, 2016, CELL RES, V26, P384, DOI 10.1038/cr.2015.116; Barroco RM, 2006, PLANT PHYSIOL, V142, P1053, DOI 10.1104/pp.106.087056; Becraft PW, 2000, DEVELOPMENT, V127, P4039; Chaudhury AM, 1997, P NATL ACAD SCI USA, V94, P4223, DOI 10.1073/pnas.94.8.4223; Chettoor AM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00187; De Smet I, 2010, PLANT J, V61, P959, DOI 10.1111/j.1365-313X.2010.04143.x; Folsom JJ, 2014, PLANT PHYSIOL, V165, P238, DOI 10.1104/pp.113.232413; Gross-Hardt R, 2007, PLOS BIOL, V5, P494, DOI 10.1371/journal.pbio.0050047; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Guitton AE, 2004, DEVELOPMENT, V131, P2971, DOI 10.1242/dev.01168; Guo J, 2010, PLANTA, V231, P293, DOI 10.1007/s00425-009-1051-y; Gutierrez-Marcos JF, 2006, GENETICS, V174, P317, DOI 10.1534/genetics.106.059709; Hamamura Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5722; Hara T, 2015, PLANT J, V81, P1, DOI 10.1111/tpj.12705; Hejatko J, 2006, NAT PROTOC, V1, P1939, DOI 10.1038/nprot.2006.333; Hibara K, 2009, DEV BIOL, V334, P345, DOI 10.1016/j.ydbio.2009.07.042; HONG SK, 1995, DEV GENET, V16, P298, DOI 10.1002/dvg.1020160403; Hong SK, 1996, DEVELOPMENT, V122, P2051; Ingouff M, 2005, PLANT J, V42, P663, DOI 10.1111/j.1365-313X.2005.02404.x; Ito M, 2002, PLANT J, V29, P497, DOI 10.1046/j.1365-313x.2002.01234.x; Ito Y, 2004, GENE, V331, P9, DOI 10.1016/j.gene.2004.02.040; Jeong HJ, 2015, J INTEGR PLANT BIOL, V57, P913, DOI 10.1111/jipb.12362; Johri BM, 1984, EMBRYOLOGY ANGIOSPER; Kagi C, 2010, P NATL ACAD SCI USA, V107, P22350, DOI 10.1073/pnas.1012795108; Kamiya N, 2003, PLANT CELL PHYSIOL, V44, P875, DOI 10.1093/pcp/pcg112; Kamiya N, 2003, PLANT J, V36, P45, DOI 10.1046/j.1365-313X.2003.01856.x; Kawakatsu T, 2009, PLANT J, V59, P908, DOI 10.1111/j.1365-313X.2009.03925.x; Krohn NG, 2012, DEV CELL, V23, P219, DOI 10.1016/j.devcel.2012.05.018; Kuwano M, 2011, PLANT MOL BIOL, V76, P47, DOI 10.1007/s11103-011-9765-1; Lan Sheng Yin, 2004, Shi Yan Sheng Wu Xue Bao, V37, P34; Li CL, 2015, PLANT J, V84, P785, DOI 10.1111/tpj.13045; Li J, 2012, NEW PHYTOL, V195, P290, DOI 10.1111/j.1469-8137.2012.04182.x; Li N, 2006, PLANT CELL, V18, P2999, DOI 10.1105/tpc.106.044107; Li SS, 2014, NEW PHYTOL, V201, P66, DOI 10.1111/nph.12472; Li YB, 2014, NAT GENET, V46, P398, DOI 10.1038/ng.2923; Liu XiangDong, 1997, Journal of Tropical and Subtropical Botany, V5, P11; Liu XiangDong, 1997, Chinese Journal of Rice Science, V11, P141; Luo M, 2009, MOL PLANT, V2, P711, DOI 10.1093/mp/ssp036; MAYER U, 1993, DEVELOPMENT, V117, P149; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Mizutani M, 2010, J EXP BOT, V61, P791, DOI 10.1093/jxb/erp343; Moll C, 2008, PLANT J, V56, P913, DOI 10.1111/j.1365-313X.2008.03650.x; Nagasawa N, 2013, PLANT J, V75, P592, DOI 10.1111/tpj.12223; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Olsen OA, 2004, PLANT CELL, V16, pS214, DOI 10.1105/tpc.017111; Olsen OA, 2001, ANNU REV PLANT PHYS, V52, P233, DOI 10.1146/annurev.arplant.52.1.233; Lopez-Fernandez MP, 2015, J INTEGR PLANT BIOL, V57, P996, DOI 10.1111/jipb.12367; Phillips AR, 2011, GENETICS, V187, P1085, DOI 10.1534/genetics.110.125286; Pu CX, 2012, PLANT J, V70, P940, DOI 10.1111/j.1365-313X.2012.04925.x; Sato Y, 1996, P NATL ACAD SCI USA, V93, P8117, DOI 10.1073/pnas.93.15.8117; Sato Yutaka, 2008, V62, P149; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Shen Y, 2013, PLANT J, V74, P792, DOI 10.1111/tpj.12161; Song XY, 2014, PLANT REPROD, V27, P197, DOI 10.1007/s00497-014-0251-1; Sprunck S, 2012, SCIENCE, V338, P1093, DOI 10.1126/science.1223944; Sugimoto N, 1997, RICE GENETICS NEWSLE, V14, P148; Su'udi M, 2015, PLANT SCI, V239, P200; ten Hove CA, 2015, DEVELOPMENT, V142, P420, DOI 10.1242/dev.111500; Wu JJ, 2012, DEV CELL, V23, P1043, DOI 10.1016/j.devcel.2012.09.011; Wu XB, 2016, J INTEGR PLANT BIOL, V58, P786, DOI 10.1111/jipb.12488; Yang JY, 2002, PLANT CELL PHYSIOL, V43, P628, DOI 10.1093/pcp/pcf076; Yang WB, 2013, MOL PLANT, V6, P1945, DOI 10.1093/mp/sst107; Yi J, 2016, J EXP BOT, V67, P2425, DOI 10.1093/jxb/erw052; Yoshida S, 2014, DEV CELL, V29, P75, DOI 10.1016/j.devcel.2014.02.002; Zeng YX, 2007, PLANT BREEDING, V126, P574, DOI 10.1111/j.1439-0523.2007.01380.x; Zeng YX, 2009, J INTEGR PLANT BIOL, V51, P3, DOI 10.1111/j.1744-7909.2008.00733.x; Zhang JA, 2010, PLANT J, V64, P604, DOI 10.1111/j.1365-313X.2010.04354.x; Zhang L, 2016, J EXP BOT, V67, P633, DOI 10.1093/jxb/erv469; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30	69	0	0	20	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0028-646X	1469-8137		NEW PHYTOL	New Phytol.	AUG	2017	215	3					1039	1058		10.1111/nph.14625				20	Plant Sciences	Plant Sciences	FA1KF	WOS:000405197500013	28585692				2018-01-05	
J	Hamra, FK; Richie, CT; Harvey, BK				Hamra, F. Kent; Richie, Christopher T.; Harvey, Brandon K.			Long Evans rat spermatogonial lines are effective germline vectors for transgenic rat production	TRANSGENIC RESEARCH			English	Article						Spermatogonial stem cells; Transgenic rats; Germline editing; Allogeneic transplantation; Drug addiction; Drug abuse	SLEEPING-BEAUTY TRANSPOSON; STEM-CELLS; KNOCKOUT RATS; CONDITIONAL ALLELES; MUTAGENESIS; CRISPR/CAS9; REPORTER; MICE; TRANSPLANTATION; TRANSDUCTION	Long Evans rat strains are applied as research models in a broad spectrum of biomedical fields (> 15,800 citations, NCBI PubMed). Here, we report an approach to genetically modify the Long Evans rat germline in donor spermatogonial stem cells. Long Evans rat spermatogonial lines were derived from freshly isolated laminin-binding spermatogonia. Laminin-binding spermatogonia were cultured over multiple passages on fibroblast feeder layers in serum-free culture medium containing GDNF and FGF2. Long Evans rat spermatogonial lines were genetically modified by transposon transduction to express a germline, tdTomato reporter gene. Donor rat spermatogonial lines robustly regenerated spermatogenesis after transplantation into testes of busulfan-treated, allogenic, Long Evans rats. Donor-derived spermatogenesis largely restored testis size in the chemically sterilized, recipient Long Evans rats. Recipient Long Evans rats stably transmitted the tdTomato germline marker to subsequent generations. Overall, Long Evans rat spermatogonial lines provided effective donor germline vectors for genetically modifying Long Evans rats.	[Hamra, F. Kent] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA; [Hamra, F. Kent] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Hamra, F. Kent] Univ Texas Southwestern Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Richie, Christopher T.; Harvey, Brandon K.] NIDA, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA	Hamra, FK (reprint author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	kent.hamra@utsouthwestern.edu			NIH Intramural Research Program (IRP) of the National Institute on Drug Abuse (NIDA); NIDA-IRP, Scientific Director's Innovators Partnership Program	We thank Karen M. Chapman, Jaideep Chaudhary, Priscilla Jaichander, Gerardo Medrano and Andrew Syvyk for their help with, respective, cell culture and transfection, flow cytometry and histology, PNA-labeling techniques, recipient rat preparation and transplantation, and pSB-Dazl-tdTomato transposon construction and validation experiments. We thank Zoltan Ivics and Zsuzsanna Izsvak for providing the Sleeping Beauty transposon and transposase plasmids. This work was supported by the NIH Intramural Research Program (IRP) of the National Institute on Drug Abuse (NIDA) including the NIDA-IRP, Scientific Director's Innovators Partnership Program to BKH/FKH.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040; Chapman KM, 2015, CELL REP, V10, P1828, DOI 10.1016/j.celrep.2015.02.040; Chapman KM, 2011, TRANSGENIC TECHNOLOG, V1, DOI [10.1007/978-3-642-20792-1_12, DOI 10.1007/978-3-642-20792-1_12]; Cifani C, 2012, J NEUROSCI, V32, P8480, DOI 10.1523/JNEUROSCI.5895-11.2012; CLERMONT Y, 1957, AM J ANAT, V100, P241, DOI 10.1002/aja.1001000205; DYM M, 1976, ANAT REC, V186, P493, DOI 10.1002/ar.1091860404; Furushima K, 2012, GENETICS, V192, P1235, DOI 10.1534/genetics.112.140855; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hamra F. Kent, 2008, V450, P163, DOI 10.1007/978-1-60327-214-8_12; Hamra FK, 2002, P NATL ACAD SCI USA, V99, P14931, DOI 10.1073/pnas.222561399; Hamra FK, 2004, DEV BIOL, V269, P393, DOI 10.1016/j.ydbio.2004.01.027; Ivics Z, 2011, NAT PROTOC, V6, P1521, DOI 10.1038/nprot.2011.378; Ivics Z, 2011, METHODS, V53, P356, DOI 10.1016/j.ymeth.2010.12.014; Izsvak Z, 2010, NAT METHODS, V7, P443, DOI [10.1038/nmeth.1461, 10.1038/NMETH.1461]; Jung CJ, 2017, TRANSGENIC RES, V26, P263, DOI 10.1007/s11248-016-9998-5; Katter K, 2013, FASEB J, V27, P930, DOI 10.1096/fj.12-205526; Kitada K, 2007, NAT METHODS, V4, P131, DOI 10.1038/nmeth1002; Laulederkind SJF, 2013, BRIEF BIOINFORM, V14, P520, DOI 10.1093/bib/bbt007; Lazar J, 2005, GENOME RES, V15, P1717, DOI 10.1101/gr.3744005; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Lu BS, 2007, MAMM GENOME, V18, P338, DOI 10.1007/s00335-007-9025-5; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498                                                          ; Nicholas CR, 2009, GENESIS, V47, P74, DOI 10.1002/dvg.20460; Oatley MJ, 2011, BIOL REPROD, V84, P639, DOI 10.1095/biolreprod.110.087320; Ogawa T, 1999, TISSUE CELL, V31, P461, DOI 10.1054/tice.1999.0060                                                          ; Ohtsuka M, 2012, EXP ANIM TOKYO, V61, P489, DOI 10.1538/expanim.61.489                                                          ; Petri V, 2014, HUM GENOMICS, V8, DOI 10.1186/s40246-014-0017-8; Qiu ZW, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt258; Richie CT, 2017, J NEUROSCI METH, V284, P1, DOI 10.1016/j.jneumeth.2017.03.020; Ryu BY, 2003, DEV BIOL, V263, P253, DOI [10.1016/j.ydbio.2003.07.010, 10.1016/ydbio.2003.07.010]; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Wu ZR, 2009, BIOL REPROD, V81, P77, DOI 10.1095/biolreprod.108.072645; Yamamoto DJ, 2013, NEUROSCI BIOBEHAV R, V37, P1738, DOI 10.1016/j.neubiorev.2013.07.002; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Zhang Z, 2003, BIOL REPROD, V68, P961, DOI 10.1095/biolreprod.102.009480	38	1	1	3	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-8819	1573-9368		TRANSGENIC RES	Transgenic Res.	AUG	2017	26	4					477	489		10.1007/s11248-017-0025-2				13	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FA2UV	WOS:000405297200004	28608322				2018-01-05	
J	Zhou, M; Li, D; Huan, XL; Manthey, J; Lioutikova, E; Zhou, H				Zhou, Michael; Li, Daisy; Huan, Xiaoli; Manthey, Joseph; Lioutikova, Ekaterina; Zhou, Hong			Mathematical and computational analysis of CRISPR Cas9 sgRNA off-target homologies	INTERNATIONAL JOURNAL OF BIOMATHEMATICS			English	Article						sgRNA; CRISPR; Cas9; off-target; homology	GUIDE RNA; GENOME; SPECIFICITY; DNA; ENDONUCLEASE; NUCLEASES; SYSTEMS; CLEAVAGE; DESIGN; CELLS	Revolutionary in scope and application, the CRISPR Cas9 endonuclease system can be guided by 20-nt single guide RNA (sgRNA) to any complementary loci on the double-stranded DNA. Once the target site is located, Cas9 can then cleave the DNA and introduce mutations. Despite the power of this system, sgRNA is highly susceptible to off-target homologous attachment and can consequently cause Cas9 to cleave DNA at off-target sites. In order to better understand this flaw in the system, the human genome and Streptococcus pyogenes Cas9 (SpCas9) were used in a mathematical and computational study to analyze the probabilities of potential sgRNA off-target homologies. It has been concluded that off-target sites are nearly unavoidable for large-size genomes, such as the human genome. Backed by mathematical analysis, a viable solution is the double-nicking method which has the promise for genome editing specificity. Also applied in this study was a computational algorithm for off-target homology search that was implemented in Java to confirm the mathematical analysis.	[Zhou, Michael; Li, Daisy] Hall High Sch, 975N Main St, Hartford, CT 06117 USA; [Huan, Xiaoli] Troy Univ, Dept Comp Sci, Troy, AL 36082 USA; [Manthey, Joseph; Lioutikova, Ekaterina; Zhou, Hong] Univ St Joseph, Dept Math Sci, 1678 Asylum Ave, Hartford, CT 06117 USA	Zhou, H (reprint author), Univ St Joseph, Dept Math Sci, 1678 Asylum Ave, Hartford, CT 06117 USA.	2018michaelz226@student.whps.org; daisyli2000@hotmail.com; xhuan@troy.edu; jmanthey@usj.edu; elioutikova@usj.edu; hzhou@usj.edu					Aach J, 2014, BIORXIV; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaur K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30870; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Travis J, 2015, SCIENCE, V350, P1456, DOI 10.1126/science.350.6267.1456; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Zhou H., 2014, INFORMATICA, V38, P281; Zhou H., 2006, P INT C BIOINF COMP, P168	26	0	0	6	6	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1793-5245	1793-7159		INT J BIOMATH	Int. J. Biomath.	AUG	2017	10	6							1750085	10.1142/S1793524517500851				14	Mathematical & Computational Biology	Mathematical & Computational Biology	EZ8MN	WOS:000404980200010					2018-01-05	
J	Murovec, J; Pirc, Z; Yang, B				Murovec, Jana; Pirc, Zan; Yang, Bing			New variants of CRISPR RNA-guided genome editing enzymes	PLANT BIOTECHNOLOGY JOURNAL			English	Review						genome editing; CRISPR effector C2c2; CRISPR/Cas9; Cpf1; variants of Streptococcus pyogenes Cas9; plant biotechnology	STAPHYLOCOCCUS-AUREUS CAS9; TARGETED MUTAGENESIS; IMMUNE-SYSTEM; DNA METHYLATION; RIBONUCLEOPROTEIN COMPLEXES; TRANSCRIPTIONAL REGULATION; DIRECTED MUTAGENESIS; VIRUS-RESISTANCE; PAIRED NICKASES; PLANTS	CRISPR-mediated genome editing using the Streptococcus pyogenes Cas9 enzyme is revolutionizing life science by providing new, precise, facile and high-throughput tools for genetic modification by the specific targeting of double-strand breaks in the genome of hosts. Plant biotechnologists have extensively used the S. pyogenes Cas9-based system since its inception in 2013. However, there are still some limitations to its even broader usage in plants. Major restrictions, especially in agricultural biotechnology, are the currently unclear regulatory status of plants modified with CRISPR/Cas9 and the lack of suitable delivery methods for some plant species. Solutions to these limitations could come in the form of new variants of genome editing enzymes that have recently been discovered and have already proved comparable to or even better in performance than S. pyogenes CRISPR/Cas9 in terms of precision and ease of delivery in mammal cells. Although some of them have already been tested in plants, most of them are less well known in the plant science community. In this review, we describe the following new enzyme systems engineered for genome editing, transcriptional regulation and cellular imaging-C2c2 from L. shahii; Cas9 from F. novicida, S. aureus, S. thermophiles, N. meningitidis; Cpf1 from F. novicida, Acidaminococcus and Lachnospiraceae; nickase, split, enhanced and other Cas9 variants from S. pyogenes; catalytically inactive SpCas9 linked to various nuclease or gene-regulating domains-with an emphasis on their advantages in comparison with the broadly used SpCas9. In addition, we discuss new possibilities they offer in plant biotechnology.	[Murovec, Jana; Pirc, Zan] Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia; [Yang, Bing] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA	Murovec, J (reprint author), Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia.	jana.murovec@bf.uni-lj.si			Slovenian Research Agency [P4-0077]	This work was supported by research grant P4-0077 (Genetics and modern technologies of agricultural plants) from the Slovenian Research Agency.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Alagoz Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep30910; Ali Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep26912; Ali Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0799-6; Ali Z, 2015, MOL PLANT, V8, P1288, DOI 10.1016/j.molp.2015.02.011; Baltes NJ, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.145; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Endo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38169; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hu X., 2016, J GENET GENOMICS, V44, P2016; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Ji X, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.144, 10.1038/nplants.2015.144]; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaya H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26871; Kim H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14406; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li JY, 2017, MOL PLANT, V10, P526, DOI 10.1016/j.molp.2016.12.001; Liang Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14261; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Lu YM, 2017, MOL PLANT, V10, P523, DOI 10.1016/j.molp.2016.11.013; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malnoy M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01904; Marton I, 2010, PLANT PHYSIOL, V154, P1079, DOI 10.1104/pp.110.164806; Mei Y, 2016, J GENET GENOMICS, V43, P63, DOI 10.1016/j.jgg.2016.01.001; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Mikami M, 2016, PLANT CELL PHYSIOL, V57, P1058, DOI 10.1093/pcp/pcw049; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nishida K, 2016, SCIENCE, V353, P8729; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112; Pyott DE, 2016, MOL PLANT PATHOL, V17, P1276, DOI 10.1111/mpp.12417; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rau K, 2016, CHEMBIOCHEM, V17, P1682, DOI 10.1002/cbic.201600342; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Schiml S, 2016, P NATL ACAD SCI USA, V113, P7266, DOI 10.1073/pnas.1603823113; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Song GY, 2016, CROP J, V4, P75, DOI 10.1016/j.cj.2015.12.002; Steinert J, 2015, PLANT J, V84, P1295, DOI 10.1111/tpj.13078; Subburaj S, 2016, PLANT CELL REP, V35, P1535, DOI 10.1007/s00299-016-1937-7; Sun YW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01928; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Weeks DP, 2016, PLANT BIOTECHNOL J, V14, P483, DOI 10.1111/pbi.12448; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wolt JD, 2016, PLANT BIOTECHNOL J, V14, P510, DOI 10.1111/pbi.12444; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xu RF, 2017, PLANT BIOTECHNOL J, V15, P713, DOI 10.1111/pbi.12669; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00177	82	0	0	55	55	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1467-7644	1467-7652		PLANT BIOTECHNOL J	Plant Biotechnol. J.	AUG	2017	15	8					917	926		10.1111/pbi.12736				10	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	FA2MT	WOS:000405276200001	28371222	gold			2018-01-05	
J	Lu, D; Yuan, XH; Kim, SJ; Marques, JV; Chakravarthy, PP; Moinuddin, SGA; Luchterhand, R; Herman, B; Davin, LB; Lewis, NG				Lu, Da; Yuan, Xianghe; Kim, Sung-Jin; Marques, Joaquim V.; Chakravarthy, P. Pawan; Moinuddin, Syed G. A.; Luchterhand, Randi; Herman, Barri; Davin, Laurence B.; Lewis, Norman G.			Eugenol specialty chemical production in transgenic poplar (Populus tremula x P. alba) field trials	PLANT BIOTECHNOLOGY JOURNAL			English	Article						Eugenol; hybrid poplar; phytochemical factories; phenylpropanoid metabolism	PINORESINOL-LARICIRESINOL; SPECTROMETRY DATA; CREOSOTE BUSH; CONSTITUENTS; METABOLOMICS; GLUCOSIDES; EXPRESSION; ISOEUGENOL; GLYCOSIDES; REDUCTION	A foundational study assessed effects of biochemical pathway introduction into poplar to produce eugenol, chavicol, p-anol, isoeugenol and their sequestered storage products, from potentially available substrates, coniferyl and p-coumaryl alcohols. At the onset, it was unknown whether significant carbon flux to monolignols vs. other phenylpropanoid (acetate) pathway metabolites would be kinetically favoured. Various transgenic poplar lines generated eugenol and chavicol glucosides in ca. 0.45% (similar to 0.35 and similar to 0.1%, respectively) of dry weight foliage tissue in field trials, as well as their corresponding aglycones in trace amounts. There were only traces of any of these metabolites in branch tissues, even after similar to 4-year field trials. Levels of bioproduct accumulation in foliage plateaued, even at the lowest introduced gene expression levels, suggesting limited monolignol substrate availability. Nevertheless, this level still allows foliage collection for platform chemical production, with the remaining (stem) biomass available for wood, pulp/paper and bioenergy product purposes. Several transformed lines displayed unexpected precocious flowering after similar to 4-year field trial growth. This necessitated terminating (felling) these particular plants, as USDA APHIS prohibits the possibility of their interacting (cross-pollination, etc.) with wild-type (native plant) lines. In future, additional biotechnological approaches can be employed (e.g. gene editing) to produce sterile plant lines, to avoid such complications. While increased gene expression did not increase target bioproduct accumulation, the exciting possibility now exists of significantly increasing their amounts (e.g. 10- to 40-fold plus) in foliage and stems via systematic deployment of numerous 'omics', systems biology, synthetic biology and metabolic flux modelling approaches.	[Lu, Da; Yuan, Xianghe; Kim, Sung-Jin; Marques, Joaquim V.; Chakravarthy, P. Pawan; Moinuddin, Syed G. A.; Herman, Barri; Davin, Laurence B.; Lewis, Norman G.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Luchterhand, Randi; Herman, Barri] Washington State Univ, Puyallup Res & Extens Ctr, Puyallup, WA 98371 USA	Lewis, NG (reprint author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	lewisn@wsu.edu			U.S. Department of Agriculture National Institutes for Food and Agriculture (USDA NIFA) [683A757612]; Chemical Sciences, Geosciences and Bio-sciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy [DE-FG-0397ER20259]; USDA NIFA [2011-68005-30416]; McIntire Stennis [WNP00202]; China Scholarship Council; DOE	This work was mainly funded by U.S. Department of Agriculture National Institutes for Food and Agriculture (USDA NIFA, #683A757612), the Chemical Sciences, Geosciences and Bio-sciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy (DE-FG-0397ER20259) and, in part, by USDA NIFA (#2011-68005-30416) and McIntire Stennis (WNP00202). The DOE funding enabled development/application of all the chromatographic and metabolomics approaches used in this study. Ms. Xianghe Yuan was supported by the China Scholarship Council. Thanks are also extended to Drs. Daryl J. Petrey (Plant Health Safeguarding Specialist) and Gary W. Brown (Biotechnology Compliance Specialist) for USDA APHIS field trial inspections and compliance of same. The authors declare no conflict of interest.	Badger DA, 2002, FOOD CHEM TOXICOL, V40, P1757, DOI 10.1016/S0278-6915(02)00183-7; Caiger S, 2016, MARKET INSIDER ESSEN; Chaieb K, 2007, PHYTOTHER RES, V21, P501, DOI 10.1002/ptr.2124; Costa MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083169; DinkovaKostova AT, 1996, J BIOL CHEM, V271, P29473, DOI 10.1074/jbc.271.46.29473                                                        ; Doughton S., 2014, SEATTLE TIMES; Ferrell J., 2006, BREAKING BIOL BARRIE; JAYARAMAN K, 1999, STAT MANUAL FORESTRY; Kamatou GP, 2012, MOLECULES, V17, P6953, DOI 10.3390/molecules17066953; Kim S.-J., 2013, 52 ANN M PHYT SOC N; Kim SJ, 2014, ARCH BIOCHEM BIOPHYS, V541, P37, DOI 10.1016/j.abb.2013.10.019; Klocko AL, 2016, NAT BIOTECHNOL, V34, P918, DOI 10.1038/nbt.3636; Klocko AL, 2016, PLANT BIOTECHNOL J, V14, P808, DOI 10.1111/pbi.12431; Koeduka T, 2008, PLANT J, V54, P362, DOI 10.1111/j.1365-313X.2008.03412.x; Koeduka T, 2013, BIOCHEM BIOPH RES CO, V436, P73, DOI 10.1016/j.bbrc.2013.05.060; Koeduka T, 2006, P NATL ACAD SCI USA, V103, P10128, DOI 10.1073/pnas.0603732103; Kristensen C, 2005, P NATL ACAD SCI USA, V102, P1779, DOI 10.1073/pnas.0409233102; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Mastelic J, 2004, CROAT CHEM ACTA, V77, P491; Min TP, 2003, J BIOL CHEM, V278, P50714, DOI 10.1074/jbc.M308493200; Morant AV, 2007, METABOLOMICS, V3, P383, DOI 10.1007/s11306-007-0079-x; Morreel K, 2006, PLANT J, V47, P224, DOI 10.1111/j.1365-313X.2006.02786.x; Patten AM, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 3: DEVELOPMENT & MODIFICATION OF BIOACTIVITY, P1173; Skinner E. W., 1940, SCI DENT MAT; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Straubinger M, 1999, NAT PROD LETT, V13, P5, DOI 10.1080/10575639908048483                                                       ; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Tikunov YM, 2013, PLANT CELL, V25, P3067, DOI 10.1105/tpc.113.114231; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vassao DG, 2007, ARCH BIOCHEM BIOPHYS, V465, P209, DOI 10.1016/j.abb.2007.06.002; Vassao DG, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P815; Vassao DG, 2006, ORG BIOMOL CHEM, V4, P2733, DOI 10.1039/b605407b; Verdonk JC, 2003, PHYTOCHEMISTRY, V62, P997, DOI 10.1016/S0031-9422(02)00707-0; Voelker SL, 2010, PLANT PHYSIOL, V154, P874, DOI 10.1104/pp.110.159269; WEINBERG JE, 1972, J DENT RES, V51, P1055, DOI 10.1177/00220345720510041101                                                    ; Wolfram K, 2010, PHYTOCHEMISTRY, V71, P1076, DOI 10.1016/j.phytochem.2010.04.007; YUE JM, 1994, PHYTOCHEMISTRY, V36, P717, DOI 10.1016/S0031-9422(00)89803-9; Lewis N. G., 2015, US Patent, Patent No. [9,131,648, 9131648]; Lewis N. G, 2013, Provisional Patent Application, Patent No. [61,849,839, 61849839]	39	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1467-7644	1467-7652		PLANT BIOTECHNOL J	Plant Biotechnol. J.	AUG	2017	15	8					970	981		10.1111/pbi.12692				12	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	FA2MT	WOS:000405276200005	28064439	gold			2018-01-05	
J	Kopczynski, D; Coman, C; Zahedi, RP; Lorenz, K; Sickmann, A; Ahrends, R				Kopczynski, Dominik; Coman, Cristina; Zahedi, Rene P.; Lorenz, Kristina; Sickmann, Albert; Ahrends, Robert			Multi-OMICS: a critical technical perspective on integrative lipidomics approaches	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Article							DATA SETS; MASS-SPECTROMETRY; GENE-EXPRESSION; REVEALS; PROTEIN; GENOME; CANCER; METABOLISM; ACTIVATION; PROTEOMICS	During the past decades, high-throughput approaches for analyzing different molecular classes such as nucleic acids, proteins, metabolites, and lipids have grown rapidly. These approaches became powerful tools for getting a fundamental understanding of biological systems. Considering each approach and its results separately, relations and causal connections between these classes have no chance to be revealed, since only separate molecular snapshots are provided. Only a combined approach, not fully established yet, with the integration of the corresponding data, might yield a comprehensive and complete understanding of biological processes, such as crosstalk and interactions in signaling pathways. Taking two or more omics-methods into consideration for analysis is referred to as a multi-omics approach, which is gradually evolving. In this critical note, we briefly discuss the relevance, challenges, current state, and potential of data integration from multi-omics approaches, with a special focus on lipidomics analysis, listing the advantages and gaps in this field. This article is part of a Special Issue entitled: BBALIP_Lipidomics Opinion Articles edited by Sepp Kohlwein. (C) 2017 Elsevier B.V. All rights reserved.	[Kopczynski, Dominik; Coman, Cristina; Zahedi, Rene P.; Lorenz, Kristina; Sickmann, Albert; Ahrends, Robert] Leibniz Inst Analyt Wissensch ISAS eV, Otto Hahn Str 6b, Dortmund, Germany; [Sickmann, Albert] Ruhr Univ Bochum, MPC, Med Fak, Bochum, Germany; [Sickmann, Albert] Univ Aberdeen, Coll Phys Sci, Dept Chem, Aberdeen, Scotland; [Lorenz, Kristina] Univ Hosp Essen, West German Heart & Vasc Ctr Essen, Essen, Germany	Ahrends, R (reprint author), Leibniz Inst Analyt Wissensch ISAS eV, Otto Hahn Str 6b, Dortmund, Germany.	Robert.Ahrends@isas.de	Sickmann, Albert/A-1010-2011	Sickmann, Albert/0000-0002-2388-5265; Kopczynski, Dominik/0000-0001-5885-4568; Ahrends, Robert/0000-0003-0232-3375; Zahedi, Rene/0000-0002-4960-5460	Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; Senatsverwaltung fur Wirtschaft, Technologie und Forschung des Landes Berlin; Bundesministerium fur Bildung und Forschung [01ZX1401C, 031L0108A, 031A534B]	This work was supported by the Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen, the Senatsverwaltung fur Wirtschaft, Technologie und Forschung des Landes Berlin, and the Bundesministerium fur Bildung und Forschung, SUPR-G e:Med (Code 01ZX1401C) and de.NBI program (code 031L0108A, 031A534B). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Acharjee A., 2016, BMC BIOINFORMATICS, V17, P37; Acharjee A, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1043-4; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Akbani R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4887; Bouslimani A, 2015, P NATL ACAD SCI USA, V112, pE2120, DOI 10.1073/pnas.1424409112; Braun F, 2016, AGING-US, V8, P441, DOI 10.18632/aging.100900                                                           ; Breitkopf SB, 2015, ANAL CHEM, V87, P10995, DOI 10.1021/acs.analchem.5b03040; Casanovas A, 2015, CHEM BIOL, V22, P412, DOI 10.1016/j.chembiol.2015.02.007; Chong LC, 2014, NAT METHODS, V11, P1071, DOI [10.1038/nmeth.3094, 10.1038/NMETH.3094]; Coman C, 2016, MOL CELL PROTEOMICS, V15, P1453, DOI 10.1074/mcp.M115.053702; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Fahrmann J.F., 2017, CARCINOGENESIS; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Haag M, 2012, METABOLITES, V2, P57, DOI 10.3390/metabo2010057; Han YM, 2013, EPIGENOMICS-UK, V5, P439, DOI [10.2217/EPI.13.37, 10.2217/epi.13.37]; Hasunuma T, 2010, J EXP BOT, V61, P1041, DOI 10.1093/jxb/erp374; Hussein SMI, 2014, NATURE, V516, P198, DOI 10.1038/nature14046; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kamoun A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11263; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kershaw CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15518; Koberlin MS, 2015, CELL, V162, P170, DOI 10.1016/j.cell.2015.05.051; Kristensen VN, 2014, NAT REV CANCER, V14, P299, DOI 10.1038/nrc3721; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Muqaku B, 2017, MOL CELL PROTEOMICS, V16, P86, DOI 10.1074/mcp.M116.063313; Nakayasu E. S., 2016, MSYSTEMS, V1; Palsson B, 2010, NAT CHEM BIOL, V6, P787, DOI 10.1038/nchembio.462; N. Cancer Genome Atlas Research, 2014, NATURE, V507, P315; Ritchie MD, 2015, NAT REV GENET, V16, P85, DOI 10.1038/nrg3868; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Slatter DA, 2016, CELL METAB, V23, P930, DOI 10.1016/j.cmet.2016.04.001; Soldi M, 2013, MOL CELL PROTEOMICS, V12, P764, DOI 10.1074/mcp.M112.024307; Tanner LB, 2014, J LIPID RES, V55, P1357, DOI 10.1194/jlr.M049148; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; van Jaarsveld MT, 2015, ONCOGENE; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; Wang JR, 2014, ANAL CHEM, V86, P5688, DOI 10.1021/ac5009964; Yao QL, 2015, SCI REP-UK, V5, DOI 10.1038/srep17201; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200; Zhang ZD, 2004, GENOME RES, V14, P580, DOI 10.1101/gr.2160004; Zhou Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep06957	45	1	1	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	AUG	2017	1862	8			SI		808	811		10.1016/j.bbalip.2017.02.003				4	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	EZ5YZ	WOS:000404796900018	28193460				2018-01-05	
J	Song, HX; Yan, CH; Tian, XX; Zhu, N; Li, Y; Liu, D; Liu, YX; Liu, ML; Peng, CF; Zhang, QY; Gao, EH; Han, YL				Song, Haixu; Yan, Chenghui; Tian, Xiaoxiang; Zhu, Nan; Li, Yang; Liu, Dan; Liu, Yanxia; Liu, Meili; Peng, Chengfei; Zhang, Quanyu; Gao, Erhe; Han, Yaling			CREG protects from myocardial ischemia/reperfusion injury by regulating myocardial autophagy and apoptosis	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						CREG; Ischemia/reperfusion injury; Cardiac function; Apoptosis; Autophagy; Lysosome	CELLULAR REPRESSOR; E1A-STIMULATED GENES; REPERFUSION INJURY; CARDIAC-HYPERTROPHY; MICE; ISCHEMIA; PATHWAY; DEATH; DIFFERENTIATION; OVEREXPRESSION	Aims: Human cellular repressor of E1A-stimulated genes (CREG) is a secreted glycoprotein that regulates tissue and cell homeostasis and has been shown to antagonize heart fibrosis, which indicates a potential protective effect of CREG against cardiomyocyte chronic damage. However, little is known about the role of CREG in myocardial tissue acute injury, in this study, we aimed to investigate the role of CREG in myocardial ischemia/reperfusion (MI/R) injury and clarify the mechanism of action. Methods and results: Wild-type Creg (Creg (+)/(+)), heterozygous Creg (Creg(+)/(-)) mice and mice pretreated with infusion of recombinant 03 mg/kg.d CREG protein (reCreg(+)/(+)) were subjected to 30 min of left ascending coronary ischemia and 24 h of reperfusion. Evan's Blue-triphenyl- tetrazolium chloride (TTC) solution and echocardiography analysis were used to evaluate the effects of CREG on MI/R mice. The underlying mechanisms were further determined by cultured myocardial cells in vitro. Our findings revealed that the level of CREG protein in mouse hearts was significantly decreased after mice were subjected to MI/R. Moreover, Creg(+)/(-) mice had larger infarction size 2 h after reperfusion and worse cardiac function 28 days after Ml/R injury compared to that in Creg(+)/(+) mice. However, reCreg(+)/(+) mice could maintain CREG at a high level even after MI/R injury, and mitigated infarction size and improved cardiac function significantly. In Creg(+)/(-) mice, myocardial autophagy was dysfunctional characterized by accumulation of LOA and p62, while apoptotic cell number increase was detected by cleaved caspase-3 blotting and TUNEL staining. Conversely, decreased apoptosis and activated autophagy were detected in reCreg(+)/(+) mice. Furthermore, chloroquine, a kind of autophagy blacker, was used to demonstrate recombinant CREG protected cardiomyocytes against apoptosis mediated by activating autophagy both in vivo and in vitro. Finally, we found CREG was involved into lysosomal protein transfer and improve cellular autophagy. Conclusion: CREG protects heart against MI/R injury -induced cardiomyocytes apoptosis by activating lysosomal autophagy. This article is part of a Special Issue entitled: Genetic and epigenetic control of heart failure - edited by Jun Ren and Megan Yingmei Zhang. (C) 2016 Elsevier B.V. All rights reserved.	[Song, Haixu; Yan, Chenghui; Tian, Xiaoxiang; Zhu, Nan; Li, Yang; Liu, Dan; Liu, Yanxia; Liu, Meili; Peng, Chengfei; Zhang, Quanyu; Han, Yaling] Gen Hosp Shenyang Mil Reg, Cardiovasc Res Inst, 83 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China; [Song, Haixu; Yan, Chenghui; Tian, Xiaoxiang; Zhu, Nan; Li, Yang; Liu, Dan; Liu, Yanxia; Liu, Meili; Peng, Chengfei; Zhang, Quanyu; Han, Yaling] Gen Hosp Shenyang Mil Reg, Dept Cardiol, 83 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China; [Song, Haixu] Fourth Mil Med Univ, Xijing Hosp, Xian, Shanxi, Peoples R China; [Gao, Erhe] Temple Univ, Ctr Translat Med, Sch Med, Philadelphia, PA 19122 USA	Han, YL (reprint author), Gen Hosp Shenyang Mil Reg, Cardiovasc Res Inst, 83 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China.; Han, YL (reprint author), Gen Hosp Shenyang Mil Reg, Dept Cardiol, 83 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China.	yaling.han1953@gmail.com			National Nature Science Foundation of China [81130072, 81370243, 81570265, 81570767, 81400316, 81500329]	This work was supported by grants from the National Nature Science Foundation of China to YLH (No. 81130072 and No. 81370243), CHY (No. 81570265), XXT (No. 81570767), Y. Li (No. 81400316) and QYZ (No. 81500329).	Akhlaghi M, 2012, OXID MED CELL LONGEV, DOI 10.1155/2012/782321; Appelqvist H, 2011, AM J PATHOL, V178, P629, DOI 10.1016/j.ajpath.2010.10.030; Bian ZY, 2009, J CELL MOL MED, V13, P1302, DOI 10.1111/j.1582-4934.2008.00633.x; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Deng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060735; DORN A, 1995, NATURE, V374, P269, DOI 10.1038/374269a0; Eefting F, 2004, CARDIOVASC RES, V61, P414, DOI 10.1016/j.cardiores.2003.12.023; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Georgescu SP, 2011, AM J PHYSIOL-CELL PH, V301, pC1046, DOI 10.1152/ajpcell.00211.2011; Hamacher-Brady A, 2006, CARDIOVASC DRUG THER, V20, P445, DOI 10.1007/s10557-006-0583-7; Han YL, 2010, J MOL CELL CARDIOL, V48, P1225, DOI 10.1016/j.yjmcc.2009.12.018; Hariharan N, 2011, ANTIOXID REDOX SIGN, V14, P2179, DOI 10.1089/ars.2010.3488; Joumet A., 2002, PROTEOMICS, V2, P1026; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154861; Lopez-Neblina F, 2005, J INVEST SURG, V18, P335, DOI 10.1080/08941930500328862; LUDWIG T, 1994, EMBO J, V13, P3430; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; Minamino T, 2012, CIRC J, V76, P1074, DOI 10.1253/circj.CJ-12-0132; Moens AL, 2005, INT J CARDIOL, V100, P179, DOI 10.1016/j.ijcard.2004.04.013; Peng CF, 2015, INT J CARDIOL, V183, P232, DOI 10.1016/j.ijcard.2015.01.059; Qian MQ, 2008, MOL CELL PROTEOMICS, V7, P58, DOI 10.1074/mcp.M700217-MCP200; Sacher M, 2005, P NATL ACAD SCI USA, V102, P18326, DOI 10.1073/pnas.0505071102; Schahs P, 2008, EXP CELL RES, V314, P3036, DOI 10.1016/j.yexcr.2008.06.015; Sun MY, 2015, J MOL CELL CARDIOL, V86, P32, DOI 10.1016/j.yjmcc.2015.07.001; Tian ZW, 2012, CIRC RES, V111, P532, DOI 10.1161/CIRCRESAHA.112.270983; Troncoso R, 2012, CARDIOVASC RES, V93, P320, DOI 10.1093/cvr/cvr321; Valentim L, 2006, J MOL CELL CARDIOL, V40, P846, DOI 10.1016/j.yjmcc.2006.03.428; Veal E, 1998, MOL CELL BIOL, V18, P5032, DOI 10.1128/MCB.18.9.5032                                                           ; Veal E, 2000, ONCOGENE, V19, P2120, DOI 10.1038/sj.onc.1203529; Wang N, 2011, ATHEROSCLEROSIS, V218, P543, DOI 10.1016/j.atherosclerosis.2011.08.002; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu L, 2004, J HYPERTENS, V22, P1579, DOI 10.1097/01.hjh.0000133717.48334.cf; Yan C.H., 1852, BIOCHIM BIOPHYS ACTA, V2015, P353; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhang YQ, 2015, AM J PHYSIOL-ENDOC M, V309, pE275, DOI 10.1152/ajpendo.00577.2014	37	0	0	11	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	AUG	2017	1863	8			SI		1893	1903		10.1016/j.bbadis.2016.11.015				11	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	EZ9KB	WOS:000405048200004	27840305				2018-01-05	
J	Zhang, YM; Wang, C; Zhou, JM; Sun, AJ; Hueckstaedt, LK; Ge, JB; Ren, J				Zhang, Yingmei; Wang, Cong; Zhou, Jingmin; Sun, Aijun; Hueckstaedt, Lindsay K.; Ge, Junbo; Ren, Jun			Complex inhibition of autophagy by mitochondrial aldehyde dehydrogenase shortens lifespan and exacerbates cardiac aging	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						ALDH2; Aging; Autophagy; Cardiomyocyte; JNK; Bcl-2; IKK beta	CONTRACTILE DYSFUNCTION ROLE; HEART-FAILURE; THERAPEUTIC TARGET; SENESCENCE; ETHANOL; DAMAGE; CELLS; ACTIVATION; ASSOCIATION; DISEASES	Autophagy, a conservative degradation process for long-lived and damaged proteins, participates in a cascade of biological processes including aging. A number of autophagy regulators have been identified. Here we demonstrated that mitochondrial aldehyde dehydrogenase (ALDH2), an enzyme with the most common single point mutation in humans, governs cardiac aging through regulation of autophagy. Myocardial mechanical and autophagy properties were examined in young (4 months) and old (26-28 months) wild-type (WT) and global ALDH2 transgenic mice. ALDH2 overexpression shortened lifespan by 7.7% without affecting aging-associated changes in plasma metabolic profiles. Myocardial function was compromised with aging associated with cardiac hypertrophy, the effects were accentuated by ALDH2. Aging overtly suppressed autophagy and compromised autophagy flux, the effects were exacerbated by ALDH2. Aging dampened phosphorylation of JNK, Bcl-2, IKK beta, AMPK and TSC2 while promoting phosphorylation of mTOR, the effects of which were exaggerated by ALDH2. Co-immunoprecipitation revealed increased dissociation between Bcl-2 and Beclin-1 (result of decreased Bcl-2 phosphorylation) in aging, the effect of which was exacerbated with ALDH2. Chronic treatment of the autophagy inducer rapamycin alleviated aging-induced cardiac dysfunction in both WT and ALDH2 mice. Moreover, activation of JNK and inhibition of either Bcl-2 or IKK beta overtly attenuated ALDH2 activation-induced accentuation of cardiomyocyte aging. Examination of the otherwise elderly individuals revealed a positive correlation between cardiac function/geometry and ALDH2 gene mutation. Taken together, our data revealed that ALDH2 enzyme may suppress myocardial autophagy possibly through a complex JNK-Bcl-2 and IKK beta-AMPK-dependent mechanism en route to accentuation of myocardial remodeling and contractile dysfunction in aging. This article is part of a Special Issue entitled: Genetic and epigenetic control of heart failure - edited by Jun Ren & Megan Yingmei Zhang.	[Zhang, Yingmei; Wang, Cong; Zhou, Jingmin; Sun, Aijun; Ge, Junbo; Ren, Jun] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Dept Cardiol, Shanghai 200032, Peoples R China; [Sun, Aijun; Ge, Junbo] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Hueckstaedt, Lindsay K.; Ren, Jun] Univ Wyoming, Coll Hlth Sci, Laramie, WY 82071 USA	Ge, JB; Ren, J (reprint author), Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Dept Cardiol, Shanghai 200032, Peoples R China.	ge.junbo@zs-hospital.sh.cn; jren@uwyo.edu			National Natural Science Foundation of China [81522004, 81570225, 81370195, 81521001]	This work was supported in part by grants from the National Natural Science Foundation of China (81522004, 81570225, 81370195, and 81521001).	Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Budas GR, 2009, TRENDS CARDIOVAS MED, V19, P158, DOI 10.1016/j.tcm.2009.09.003; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen CH, 2010, CARDIOVASC RES, V88, P51, DOI 10.1093/cvr/cvq192; Cheng Z, 2013, EXP GERONTOL, V48, P341, DOI 10.1016/j.exger.2013.01.005; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017                                                           ; Daiber A, 2005, BIOCHEM BIOPH RES CO, V338, P1865, DOI 10.1016/j.bbrc.2005.10.106; Doser TA, 2009, CIRCULATION, V119, P1941, DOI 10.1161/CIRCULATIONAHA.108.823799; Duan JH, 2002, AM J PHYSIOL-HEART C, V282, pH1216, DOI 10.1152/ajpheart.00780.2001; Dutta D, 2012, CIRC RES, V110, P1125, DOI 10.1161/CIRCRESAHA.111.246108; Ge W, 2011, FREE RADICAL BIO MED, V51, P1736, DOI 10.1016/j.freeradbiomed.2011.08.002; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Guo R, 2012, AUTOPHAGY, V8, P593, DOI 10.4161/auto.18997; Guo R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008757; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hua YN, 2011, BASIC RES CARDIOL, V106, P1173, DOI 10.1007/s00395-011-0222-8; Jiang SS, 2013, AM J PHYSIOL-ENDOC M, V304, pE74, DOI 10.1152/ajpendo.00176.2012; Kandadi MR, 2014, CURR PHARM DESIGN, V20, P675, DOI 10.2174/13816128113199990019                                                    ; Kandadi MR, 2013, CURR PHARM DESIGN, V19, P4874, DOI 10.2174/1381612811319270010                                                     ; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Khoshnan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005768; Kim G, 2012, AGING CELL, V11, P617, DOI 10.1111/j.1474-9726.2012.00827.x; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Koda K, 2010, CIRCULATION, V122, P771, DOI 10.1161/CIRCULATIONAHA.110.952481; Lakatta EG, 1999, J AM GERIATR SOC, V47, P613, DOI 10.1111/j.1532-5415.1999.tb02579.x                                              ; Lee DS, 2006, NEW ENGL J MED, V355, P138, DOI 10.1056/NEJMoa052948; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li Q, 2008, REJUV RES, V11, P725, DOI 10.1089/rej.2008.0717; Ma H, 2011, EUR HEART J, V32, P1025, DOI 10.1093/eurheartj/ehq253; Ma H, 2010, J MOL CELL CARDIOL, V49, P322, DOI 10.1016/j.yjmcc.2010.03.017; Maejima Y, 2008, AGING CELL, V7, P125, DOI 10.1111/j.1474-9726.2007.00358.x; Marin TM, 2011, J CLIN INVEST, V121, P1026, DOI 10.1172/JCI44972; Marquez RT, 2012, AM J CANCER RES, V2, P214; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883                                                              ; Nakajima W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.6; Ni ZH, 2014, FREE RADICAL BIO MED, V70, P194, DOI 10.1016/j.freeradbiomed.2014.02.012; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Peng Giia-Sheun, 2009, Human Genomics, V3, P121; Piegari E, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0334-4; Ren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012520; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Sarkar S, 2011, MOL CELL, V43, P19, DOI 10.1016/j.molcel.2011.04.029; Smith NL, 2010, CIRC-CARDIOVASC GENE, V3, P256, DOI 10.1161/CIRCGENETICS.109.895763; Stice JP, 2011, ENDOCRINOLOGY, V152, P1589, DOI 10.1210/en.2010-0627; Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011; Xu XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22488; Yang XP, 2006, FASEB J, V20, P1024, DOI 10.1096/fj.05-5288fje; Yang XP, 2005, ENDOCRINE, V26, P127, DOI 10.1385/ENDO:26:2:127                                                           ; Yokoyama A, 2013, ALCOHOL CLIN EXP RES, V37, P1391, DOI 10.1111/acer.12108; Zhang B., 2013, BIOCH BIOPHYS ACTA; Zhang YM, 2014, FREE RADICAL BIO MED, V71, P208, DOI 10.1016/j.freeradbiomed.2014.03.018; Zhang YM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-40; Zhang YM, 2011, PHARMACOL THERAPEUT, V132, P86, DOI 10.1016/j.pharmthera.2011.05.008; Zhang YM, 2010, AUTOPHAGY, V6, P1212, DOI 10.1093/eurheartj/ehq253; Zhou XP, 2012, J NEURO-ONCOL, V110, P9, DOI 10.1007/s11060-012-0933-1	56	0	0	16	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	AUG	2017	1863	8			SI		1919	1932		10.1016/j.bbadis.2017.03.016				14	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	EZ9KB	WOS:000405048200007	28347844				2018-01-05	
J	Wang, HJ; Cai, J				Wang, Hongjiang; Cai, Jun			The role of microRNAs in heart failure	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Review						MicroRNA; Heart failure; Apoptosis; Fibrosis; Hypertrophy; Angiogenesis	REGULATES CARDIAC-HYPERTROPHY; ACUTE MYOCARDIAL-INFARCTION; ALDEHYDE DEHYDROGENASE 2; DOWN-REGULATION; CELL-DEATH; PROTECTS CARDIOMYOCYTES; THERAPEUTIC INHIBITION; CIRCULATING MICRORNAS; ATRIAL-FIBRILLATION; VASCULAR INTEGRITY	MicroRNAs are small non-coding RNA molecules that regulate gene expression by inhibiting mRNA translation and/or inducing mRNA degradation. In the past decade, many in vitro and in vivo studies have explored the involvement of microRNAs in various cardiovascular diseases. In this paper, studies focused upon the target genes and functionality of miRNAs in the pathophysiological processes of heart failure are reviewed. The selected miRNAs are categorized according to the biological relevance of their target genes in relation to four cardiovascular pathologies, namely angiogenesis, cardiac hypertrophy, fibrosis and apoptosis. This review illustrates the involvement of miRNAs in different biological signaling pathways and provides an overview of current understanding of the roles of miRNAs in cardiovascular health and diseases. This article is part of a Special Issue entitled: Genetic and epigenetic control of heart failure- edited by Jun Ren & Megan Yingmei Zhang. (C) 2016 Published by Elsevier B.V.	[Wang, Hongjiang] Capital Med Univ, Beijing Chaoyang Hosp, Dept Cardiol, Beijing 100020, Peoples R China; [Cai, Jun] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis China, State Key Lab Cardiovasc Dis China, North Lishi Rd 167, Beijing 100037, Peoples R China; [Cai, Jun] Fuwai Hosp, Hypertens Ctr, Peking Union Med Coll, North Lishi Rd 167, Beijing 100037, Peoples R China	Wang, HJ (reprint author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Cardiol, Beijing 100020, Peoples R China.; Cai, J (reprint author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis China, State Key Lab Cardiovasc Dis China, North Lishi Rd 167, Beijing 100037, Peoples R China.; Cai, J (reprint author), Fuwai Hosp, Hypertens Ctr, Peking Union Med Coll, North Lishi Rd 167, Beijing 100037, Peoples R China.	wanghongjiang@126.com; caijun@fuwaihospital.org			National Basic Research Program of China (973 Program) [2014CB542302]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-006]; National Natural Science Foundation of China [81470541, 81630014, 81500321]; Beijing Municipal Science and Technology Commission [Z151100002115050, Z151100004015176]; Beijing Municipal Commission of Education [KZ201610025028]; Beijing Natural Science Foundation [7154201]; Beijing Key Laboratory of Essential Hypertension	This work is supported by grants from the National Basic Research Program of China (973 Program, 2014CB542302), CAMS Innovation Fund for Medical Sciences (CIFMS, 2016-I2M-1-006), National Natural Science Foundation of China (81470541, 81630014), Beijing Municipal Science and Technology Commission (Z151100002115050, Z151100004015176), Beijing Municipal Commission of Education (KZ201610025028), the National Natural Science Foundation of China (no. 81500321), Beijing Natural Science Foundation (no. 7154201) and the Beijing Key Laboratory of Essential Hypertension. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonnenc M, 2013, CIRC RES, V113, P1138, DOI 10.1161/CIRCRESAHA.113.302400; Alla F, 2007, HEART FAIL REV, V12, P91, DOI 10.1007/s10741-007-9009-2; Angelini A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139858; Baum J, 2011, J CARDIOVASC PHARM, V57, P376, DOI 10.1097/FJC.0b013e3182116e39; Belevych AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028324; Berezin A, 2016, BBA CLIN, V6, P31, DOI 10.1016/j.bbacli.2016.05.005; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Brancho D, 2005, MOL CELL BIOL, V25, P3670, DOI 10.1128/MCB.25.9.3670-3681.2005; Briasoulis A, 2016, HEART FAIL REV, V21, P169, DOI 10.1007/s10741-016-9533-z; Bronnum H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056280; Budas GR, 2009, TRENDS CARDIOVAS MED, V19, P158, DOI 10.1016/j.tcm.2009.09.003; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Cardin S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1027, DOI 10.1161/CIRCEP.112.973214; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Castoldi G, 2012, J CELL PHYSIOL, V227, P850, DOI 10.1002/jcp.22939; Chavali V, 2012, BIOCHEM BIOPH RES CO, V425, P668, DOI 10.1016/j.bbrc.2012.07.105; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen SL, 2014, J CELL MOL MED, V18, P415, DOI 10.1111/jcmm.12218; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; Chistiakov DA, 2016, J MOL CELL CARDIOL, V97, P47, DOI 10.1016/j.yjmcc.2016.05.007; Chua SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148683; Curcio A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070158; da Costa Martins Paula A, 2010, Nat Cell Biol, V12, P1220, DOI 10.1038/ncb2126; Da Silva ND, 2012, MED SCI SPORT EXER, V44, P1453, DOI 10.1249/MSS.0b013e31824e8a36; Danowski N, 2013, CARDIOLOGY, V125, P125, DOI 10.1159/000348563; Dawson K, 2013, CIRCULATION, V127, P1466, DOI 10.1161/CIRCULATIONAHA.112.001207; Diniz GP, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0504-7; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Dong DL, 2010, HYPERTENSION, V55, P946, DOI 10.1161/HYPERTENSIONAHA.109.139519; Dong SG, 2014, INT J CLIN EXP PATHO, V7, P565; Duan QL, 2015, J CELL PHYSIOL, V230, P1964, DOI 10.1002/jcp.24942; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ecker JR, 2012, NATURE, V489, P52, DOI 10.1038/489052a; Eitel I, 2012, AM HEART J, V164, P706, DOI 10.1016/j.ahj.2012.08.004; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Ellis KL, 2013, EUR J HEART FAIL, V15, P1138, DOI 10.1093/eurjhf/hft078; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Endo K, 2013, BIOL PHARM BULL, V36, P48, DOI 10.1248/bpb.b12-00578                                                           ; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Feng BA, 2010, DIABETES-METAB RES, V26, P40, DOI 10.1002/dmrr.1054; Fiedler J, 2011, CIRCULATION, V124, P720, DOI 10.1161/CIRCULATIONAHA.111.039008; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fukushima Y, 2011, CIRC J, V75, P336, DOI 10.1253/circj.CJ-10-0457; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Ganesan J, 2013, CIRCULATION, V127, P2097, DOI 10.1161/CIRCULATIONAHA.112.000882; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gidlof O, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-12; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Harada M, 2012, CIRCULATION, V126, P2051, DOI 10.1161/CIRCULATIONAHA.112.121830; Hata A, 2013, ANNU REV PHYSIOL, V75, P69, DOI 10.1146/annurev-physiol-030212-183737; He B, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-22; He MZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145112; He SY, 2013, BIOCHEM BIOPH RES CO, V441, P763, DOI 10.1016/j.bbrc.2013.10.151; He X, 2016, HEART VESSELS; Heymans S, 2013, CIRCULATION, V128, P1420, DOI 10.1161/CIRCULATIONAHA.112.001357; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Hua YN, 2012, J CELL MOL MED, V16, P83, DOI 10.1111/j.1582-4934.2011.01307.x; Huang W, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.12; Huang XT, 2015, EXP THER MED, V10, P921, DOI 10.3892/etm.2015.2645; Huang Z., 2016, J CELL MOL MED; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Hullinger TG, 2012, CIRC RES, V110, P71, DOI 10.1161/CIRCRESAHA.111.244442; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Ito T, 2010, BIOCHEM BIOPH RES CO, V398, P735, DOI 10.1016/j.bbrc.2010.07.012; Jakob P, 2012, CIRCULATION, V126, P2962, DOI 10.1161/CIRCULATIONAHA.112.093906; Johnson FL, 2014, CARDIOL CLIN, V32, P9, DOI 10.1016/j.ccl.2013.09.015; Karakikes I, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000078; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kim JO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122509; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li JC, 2010, PLOS GENET, V6, DOI [10.1186/1746-4811-6-1, 10.1371/journal.pgen.1000795]; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Li SP, 2015, EUR REV MED PHARMACO, V19, P752; Liang HH, 2012, INT J BIOCHEM CELL B, V44, P2152, DOI 10.1016/j.biocel.2012.08.019; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Liu MF, 2014, BIOMATERIALS, V35, P3697, DOI 10.1016/j.biomaterials.2013.12.099; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Lorenzen JM, 2015, EUR HEART J, V36, P2184, DOI 10.1093/eurheartj/ehv109; Luo XB, 2008, J BIOL CHEM, V283, P20045, DOI 10.1074/jbc.M801035200; Ma H, 2011, EUR HEART J, V32, P1025, DOI 10.1093/eurheartj/ehq253; Manzoni GM, 2011, J AM COLL CARDIOL, V57, P1569, DOI 10.1016/j.jacc.2010.12.015; Matkovich SJ, 2011, CIRC RES, V108, P18, DOI 10.1161/CIRCRESAHA.110.233528; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Mayer SC, 2015, CIRC RES, V117, P622, DOI 10.1161/CIRCRESAHA.115.306721; Meloni M, 2013, MOL THER, V21, P1390, DOI 10.1038/mt.2013.89; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Nagalingam RS, 2013, J BIOL CHEM, V288, P11216, DOI 10.1074/jbc.M112.442384; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Ohyagi-Hara C, 2013, AM J PATHOL, V182, P1876, DOI 10.1016/j.ajpath.2013.01.039; Oka T, 2014, CIRC RES, V114, P565, DOI 10.1161/CIRCRESAHA.114.300507; Pan ZW, 2012, CIRCULATION, V126, P840, DOI 10.1161/CIRCULATIONAHA.112.094524; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Qi XY, 2015, CIRC RES, V116, P836, DOI 10.1161/CIRCRESAHA.116.305326; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Roca-Alonso L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.89; Romero R, 2014, J MATERN-FETAL NEO M, V27, P1397, DOI 10.3109/14767058.2013.860963; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schiattarella GG, 2015, CIRCULATION, V131, P1435, DOI 10.1161/CIRCULATIONAHA.115.013894; Seok HY, 2014, CIRC RES, V114, P1585, DOI 10.1161/CIRCRESAHA.114.303784; Shan HL, 2009, CARDIOVASC RES, V83, P465, DOI 10.1093/cvr/cvp130; SPRENKLE AB, 1995, CIRC RES, V77, P1060; Stewart S, 2001, EUR J HEART FAIL, V3, P315, DOI 10.1016/S1388-9842(00)00141-0                                                   ; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; Taniguchi K, 2007, MOL CELL BIOL, V27, P4541, DOI 10.1128/MCB.01600-06; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tijsen AJ, 2014, CARDIOVASC RES, V104, P61, DOI 10.1093/cvr/cvu184; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Trupp RJ, 2009, POL ARCH MED WEWN, V119, P436; Ucar A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2090; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Varrone F, 2013, J AM COLL CARDIOL, V61, P88, DOI 10.1016/j.jacc.2012.08.1003; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Viappiani S, 2009, BIOCHEM PHARMACOL, V77, P826, DOI 10.1016/j.bcp.2008.11.004; Villar AV, 2013, INT J CARDIOL, V167, P2875, DOI 10.1016/j.ijcard.2012.07.021; Volk N, 2014, J NEUROSCI, V34, P15070, DOI 10.1523/JNEUROSCI.0855-14.2014; Wang HR, 2011, ACS CHEM BIOL, V6, P845, DOI 10.1021/cb200146a; Wang HJ, 2015, J CELL MOL MED, V19, P2084, DOI 10.1111/jcmm.12563; Wang J, 2012, J CELL MOL MED, V16, P2150, DOI 10.1111/j.1582-4934.2012.01523.x; Wang K, 2012, J BIOL CHEM, V287, P589, DOI 10.1074/jbc.M111.266940; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wei C, 2014, FREE RADICAL RES, V48, P282, DOI 10.3109/10715762.2013.865839; Wei CY, 2013, J CELL PHYSIOL, V228, P1433, DOI 10.1002/jcp.24296; Xiong HW, 2016, EXP BIOL MED, V241, P25, DOI 10.1177/1535370215591831; Xu CQ, 2014, J MOL CELL CARDIOL, V75, P111, DOI 10.1016/j.yjmcc.2014.07.009; Xu M, 2012, CIRC RES, V111, P837, DOI 10.1161/CIRCRESAHA.112.277418; Xu QF, 2012, J AM COLL CARDIOL, V59, P2107, DOI 10.1016/j.jacc.2012.02.033; Xu XD, 2012, J CELL PHYSIOL, V227, P1391, DOI 10.1002/jcp.22852; Yancy CW, 2016, J AM COLL CARDIOL; Yang KC, 2012, J MOL CELL CARDIOL, V53, P101, DOI 10.1016/j.yjmcc.2012.04.012; Yang Q, 2014, MOL MED REP, V9, P2213, DOI 10.3892/mmr.2014.2068; Yang Y, 2016, EXP THER MED, V12, P1556, DOI 10.3892/etm.2016.3506; Zhang R, 2013, INT J CARDIOL, V166, P259, DOI 10.1016/j.ijcard.2012.09.108; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782; Zhang Y, 2014, MOL THER, V22, P974, DOI 10.1038/mt.2014.25; Zhao T, 2010, AM J PHYSIOL-ENDOC M, V299, pE110, DOI 10.1152/ajpendo.00192.2010; Zhao X, 2015, CELL PHYSIOL BIOCHEM, V35, P213, DOI 10.1159/000369689; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033766; Zhu JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075557; Zhu R.Y., 2016, IN VITRO CELL DEV BI; Zou MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24747	158	1	1	8	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	AUG	2017	1863	8			SI		2019	2030		10.1016/j.bbadis.2016.11.034				12	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	EZ9KB	WOS:000405048200017	27916680				2018-01-05	
J	Chen, YT; Wang, J; Tong, KS; Wong, LL; Liew, OW; Richards, AM				Chen, Yei-Tsung; Wang, Juan; Tong, Kai Sing; Wong, Lee Lee; Liew, Oi Wah; Richards, Arthur Mark			The association of heart failure-related microRNAs with neurohormonal signaling	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Heart failure; Neurohormone; MicroRNA	ACUTE MYOCARDIAL-INFARCTION; BRAIN NATRIURETIC PEPTIDE; REDUCED EJECTION FRACTION; RECEPTOR EXPRESSION; PREGNANCY HORMONE; GENE-EXPRESSION; ANGIOTENSIN-II; DISEASE; PREDICTION; TARGETS	Heart failure (HF) is a widely prevalent syndrome imposing a significant burden of morbidity and mortality world-wide. Differential circulating microRNA profiles observed in HF cohorts suggest the diagnostic utility of microRNAs as biomarkers. Given their function in fine tuning gene expression, alternations in microRNA landscape could reflecting the underlying mechanisms of disease and present potential therapeutic targets. Using multiple computational target predicting algorithms together with the luciferase-based reporting platform, the interactions between HF-related microRNAs and the 3' untranslated regions (3'UTRs) of neurohormone associated genes were examined and compared. Our results indicate that although in silico prediction provides an overview of possible microRNA-mRNA target pairs, less than half of the predicted interactions were experimentally confirmed by reporter assays in HeLa cells. Thus, the establishment of microRNA/3'UTR reporters is essential to systemically evaluate the roles of microRNAs for signaling cascades of interest, including cardiovascular neurohormonal signaling. The physiological relevance of HF-related microRNAs on the expression of putative gene targets was further established by using gain-of-function assays in two human cardiac-derived cells. Our findings, for the first time, provide direct evidence of the regulatory effects of HF-related microRNAs on the neurohormonal signaling in cardiac cells. More importantly, our study presents a rational approach to further exploring microRNA profiling data in deciphering the role of microRNA in complex syndromes such as HF. This article is part of a Special Issue entitled: Genetic and epigenetic control of heart failure-edited by Jun Ren & Megan Yingmei Zhang. (C) 2017 Elsevier B.V. All rights reserved.	[Chen, Yei-Tsung; Wang, Juan; Tong, Kai Sing; Wong, Lee Lee; Liew, Oi Wah; Richards, Arthur Mark] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Cardiovasc Res Inst, 08-01,MD6 Ctr Translat Med,14 Med Dr, Singapore 117599, Singapore; [Richards, Arthur Mark] Natl Univ Hlth Syst, Cardiac Dept, Tower Block Level 9,1E Kent Ridge Rd, Singapore 119228, Singapore; [Richards, Arthur Mark] Univ Otago, Dept Med, Christchurch Heart Inst, POB 4345, Christchurch 8014, New Zealand	Chen, YT (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Cardiovasc Res Inst, 08-01,MD6 Ctr Translat Med,14 Med Dr, Singapore 117599, Singapore.	mdccyt@nus.edu.sg; mdcwaju@nus.edu.sg; mdctks@nus.edu.sg; mdcwll@nus.edu.sg; mdclow@nus.edu.sg; arthur_mark_richards@nuhs.edu.sg			National University of Singapore - Cardiovascular Research Institute core fund [N-172-000-047-001]	This work was supported by the National University of Singapore - Cardiovascular Research Institute core fund, N-172-000-047-001.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Arora P, 2013, J CLIN INVEST, V123, P3378, DOI 10.1172/JCI67383; Bayes-Genis A, 2015, J AM COLL CARDIOL, V65, P657, DOI 10.1016/j.jacc.2014.11.048; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen YT, 2005, MOL CELL BIOL, V25, P2722, DOI 10.1128/MCB.25.7.2722-2732.2005; Coskunpinar E, 2016, GENE, V591, P90, DOI 10.1016/j.gene.2016.06.059; D'Uva G, 2015, NAT CELL BIOL, V17, P627, DOI 10.1038/ncb3149; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; Dschietzig T, 2003, CIRC RES, V92, P32, DOI 10.1161/01.RES.0000051884.27117.7E; Gottlieb SS, 2015, CLIN BIOCHEM, V48, P292, DOI 10.1016/j.clinbiochem.2014.12.012; Greco S, 2012, DIABETES, V61, P1633, DOI 10.2337/db11-0952; HafezQorani S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw048; Hanke S, 2001, MOL CELL BIOL, V21, P8452, DOI 10.1128/MCB.21.24.8452-8460.2001; Ishigai Y, 1997, AM J PHYSIOL-HEART C, V273, pH2659; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Khorshid M, 2013, NAT METHODS, V10, P253, DOI [10.1038/NMETH.2341, 10.1038/nmeth.2341]; Ky B, 2009, CIRCULATION, V120, P310, DOI 10.1161/CIRCULATIONAHA.109.856310; Lefkowitz RJ, 2000, CIRCULATION, V101, P1634; Leoni G, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw043; Lia D, 2010, J HYPERTENS, V28, P1646, DOI 10.1097/HJH.0b013e32833a4922; Liew OW, 2016, CLIN CHEM, V62, P856, DOI 10.1373/clinchem.2015.252932; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes LR, 2013, BBA-MOL BASIS DIS, V1832, P2451, DOI 10.1016/j.bbadis.2012.12.012; Maharjan S, 2014, PHYSIOL GENOMICS, V46, P860, DOI 10.1152/physiolgenomics.00084.2014; Marques FZ, 2016, EUR J HEART FAIL, V18, P1000, DOI 10.1002/ejhf.517; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; PEDERSEN EB, 1986, EUR J CLIN INVEST, V16, P56, DOI 10.1111/j.1365-2362.1986.tb01308.x; Quiat D, 2013, J CLIN INVEST, V123, P11, DOI 10.1172/JCI62876; Regoli D, 2012, PHARMACOL THERAPEUT, V135, P94, DOI 10.1016/j.pharmthera.2012.04.002; Richards AM, 2001, J AM COLL CARDIOL, V37, P1781, DOI 10.1016/S0735-1097(01)01269-4; Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268; Saito T, 2010, NEW BIOTECHNOL, V27, P243, DOI 10.1016/j.nbt.2010.02.016; Santhanakrishnan R, 2013, J CARD FAIL, V19, P156, DOI 10.1016/j.cardfail.2013.01.007; Santhanakrishnan R, 2012, EUR J HEART FAIL, V14, P1338, DOI 10.1093/eurjhf/hfs130; Savoia C, 1999, Cardiologia, V44 Suppl 1, P193; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806                                                     ; Seronde MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142237; Tamargo J, 2011, NAT REV DRUG DISCOV, V10, P536, DOI 10.1038/nrd3431; Thum T, 2012, CARDIOVASC RES, V93, P543, DOI 10.1093/cvr/cvs085; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; von Lueder TG, 2015, NAT REV CARDIOL, V12, P730, DOI 10.1038/nrcardio.2015.137; Wan GQ, 2010, RNA, V16, P1436, DOI 10.1261/rna.2001610; Wang JX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060798; Wang KJ, 2016, CELL PHYSIOL BIOCHEM, V38, P1015, DOI 10.1159/000443053; Wang XW, 2014, BIOINFORMATICS, V30, P1377, DOI 10.1093/bioinformatics/btu045; Wong LL, 2015, J MOL CELL CARDIOL, V82, P13, DOI 10.1016/j.yjmcc.2015.02.019; Wong L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010021; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807	51	0	0	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	AUG	2017	1863	8			SI		2031	2040		10.1016/j.bbadis.2016.12.019				10	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	EZ9KB	WOS:000405048200018	28065846				2018-01-05	
J	Mazurek, S; Kim, GH				Mazurek, Stefan; Kim, Gene H.			Genetic and epigenetic regulation of arrhythmogenic cardiomyopathy	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Arrhythmogenic cardiomyopathy; Hippo; MicroRNA; Desmosome; Single nucleotide polymorphism	RIGHT-VENTRICULAR CARDIOMYOPATHY; DISEASE-ASSOCIATED SNPS; HIPPO PATHWAY; PLAKOPHILIN-2 MUTATIONS; INTERCALATED DISC; VIRAL MYOCARDITIS; HIGH PREVALENCE; MICRORNAS; DYSPLASIA/CARDIOMYOPATHY; EXPRESSION	Arrhythmogenic cardiomyopathy (AC) is most commonly characterized as a disease of the intercalated disc that promotes abnormal cardiac conduction. Previously, arrhythmogenic cardiomyopathy was frequently referred to as arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D); however, genotype phenotype studies have defined a broader phenotypic spectrum; with the identification of left-dominant and biventricular subtypes. Molecular insight into AC has primarily focused on mutations in desmosomal proteins and the downstream signaling pathways; however, desmosomal gene mutations can only be identified in approximately 50% of patients with AC. Animal and cellular studies have shown that in addition to abnormal biomechanical properties from changes in desmosome function, crosstalk from the desmosome to the nucleus, gap junctions, and ion channels are implicated in the pathobiology of AC. In this review, we highlight some of the newly identified genetic and epigenetic mechanisms that may lead to the development of AC including the role of the Hippo pathway and microRNAs. This article is part of a Special Issue entitled: Genetic and epigenetic control of heart failure - edited by Jun Ren & Megan Yingmei Zhang.	[Mazurek, Stefan; Kim, Gene H.] Univ Chicago Med, Sect Cardiol, Chicago, IL 60637 USA	Kim, GH (reprint author), Univ Chicago Med, 5841 S Maryland Ave,MC 6080, Chicago, IL 60637 USA.	gkim1@medicine.bsd.uchicago.edu					Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anastasiadou E, 2015, INT J CANCER, V137, P1491, DOI 10.1002/ijc.29489; Asimaki A, 2009, NEW ENGL J MED, V360, P1075, DOI 10.1056/NEJMoa0808138; Awad MM, 2008, NAT CLIN PRACT CARD, V5, P258, DOI 10.1038/ncpcardio1182; Baksi A John, 2015, Card Electrophysiol Clin, V7, P269, DOI 10.1016/j.ccep.2015.03.009; Basso C, 1996, CIRCULATION, V94, P983; Basso C, 2012, NAT REV CARDIOL, V9, P223, DOI 10.1038/nrcardio.2011.173; Basso C, 2009, LANCET, V373, P1289, DOI 10.1016/S0140-6736(09)60256-7; Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005; Bowles NE, 2003, J AM COLL CARDIOL, V42, P466, DOI 10.1016/S0735-1097(03)00648-X; Bowles NE, 2002, J AM COLL CARDIOL, V39, P892, DOI 10.1016/S0735-1097(02)01688-1; Bruno AE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-44; Burke AP, 1998, CIRCULATION, V97, P1571; Calore M, 2015, CELL TISSUE RES, V360, P491, DOI 10.1007/s00441-014-2015-5; Calway T, 2015, J CARDIOVASC PHARM T, V20, P131, DOI 10.1177/1074248414552902; Chen SN, 2014, CIRC RES, V114, P454, DOI 10.1161/CIRCRESAHA.114.302810; Cioc AM, 2002, MODERN PATHOL, V15, P914, DOI 10.1097/01.MP.0000024291.37651.CD; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Corrado D, 2017, NEW ENGL J MED, V376, P61, DOI 10.1056/NEJMra1509267; Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412; Fidler LM, 2009, J CELL MOL MED, V13, P4219, DOI 10.1111/j.1582-4934.2008.00438.x; Garcia-Pavia P, 2011, HEART, V97, P1744, DOI 10.1136/hrt.2011.227967; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Gurha P, 2016, CIRC RES, V119, P731, DOI 10.1161/CIRCRESAHA.116.308422; Haas U, 2012, RNA BIOL, V9, P924, DOI 10.4161/rna.20497; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Kaplan SR, 2004, HEART RHYTHM, V1, P3, DOI 10.1016/j.hrthm.2004.01.001; Kapplinger JD, 2011, J AM COLL CARDIOL, V57, P2317, DOI 10.1016/j.jacc.2010.12.036; Kim GH, 2013, TRANSL RES, V161, P381, DOI 10.1016/j.trsl.2012.12.004; Kim W, 2013, BIOCHEM J, V450, P9, DOI 10.1042/BJ20121284; Kleber AG, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00404; Kuhl U, 2005, CIRCULATION, V111, P887, DOI 10.1161/01.CIR.0000155616.07901.35; Lyon RC, 2014, HUM MOL GENET, V23, P1134, DOI 10.1093/hmg/ddt508; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Lopez-Ayala JM, 2015, HEART RHYTHM, V12, P766, DOI 10.1016/j.hrthm.2015.01.001; Marquez RT, 2010, LAB INVEST, V90, P1727, DOI 10.1038/labinvest.2010.126; Mazurek SR, 2016, MICRORNA; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Meurs KM, 2010, HUM GENET, V128, P315, DOI 10.1007/s00439-010-0855-y; Mizusawa Y, 2016, J ARRYTHM, V32, P389, DOI 10.1016/j.joa.2015.12.009; Murray B, 2012, J GENET COUNS, V21, P494, DOI 10.1007/s10897-012-9497-7; Osboume A, 2014, J MOL CELL CARDIOL, V74, P53, DOI 10.1016/j.yjmcc.2014.04.024; Pieroni M, 2009, J AM COLL CARDIOL, V53, P681, DOI 10.1016/j.jacc.2008.11.017; Rasmussen TB, 2014, CIRC-CARDIOVASC GENE, V7, P230, DOI 10.1161/CIRCGENETICS.113.000338; Rigato I, 2013, CIRC-CARDIOVASC GENE, V6, P533, DOI 10.1161/CIRCGENETICS.113.000288; Saguner AM, 2014, WORLD J CARDIOL, V6, P154, DOI 10.4330/wjc.v6.i4.154; Sen-Chowdhry S, 2012, CIRCULATION, V125, P1563, DOI 10.1161/CIRCULATIONAHA.111.025528; Sen-Chowdhry S, 2008, J AM COLL CARDIOL, V52, P2175, DOI 10.1016/j.jacc.2008.09.019; Sheikh F, 2009, TRENDS CARDIOVAS MED, V19, P182, DOI 10.1016/j.tcm.2009.12.001; Vite A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075082; Wheeler MA, 2010, CELL MOL LIFE SCI, V67, P781, DOI 10.1007/s00018-009-0219-8; Xu HF, 2012, MOL CELL BIOCHEM, V362, P141, DOI 10.1007/s11010-011-1136-3; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6; Ye X, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004070; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhang HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep28101; Zhang QH, 2013, INTERVIROLOGY, V56, P104, DOI 10.1159/000343750	57	2	2	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	AUG	2017	1863	8			SI		2064	2069		10.1016/j.bbadis.2017.04.020				6	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	EZ9KB	WOS:000405048200021	28454914				2018-01-05	
J	Han, D; Gao, QS; Cao, F				Han, Dong; Gao, Quansheng; Cao, Feng			Long noncoding RNAs (LncRNAs) - The dawning of a new treatment for cardiac hypertrophy and heart failure	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Long noncoding RNAs; Hypertrophy; Heart failure; Genetic; Ischemic heart disease; Treatment; Biomarker	MYOCARDIAL-INFARCTION; STEM-CELLS; THERAPEUTIC-EFFICACY; DIFFERENTIATION; REGENERATION; APOPTOSIS; FIBROSIS; DISEASE; CARDIOMYOCYTES; ENGRAFTMENT	Long noncoding RNAs (lncRNAs) represent a category of noncoding RNAs with the potential for genetic and epigenetic regulations. As important regulators of gene expression, increasing evidence has proven that lncRNAs play a significant regulatory role in various cardiovascular pathologies. In particular, lncRNAs have been proved to be participating in gene regulatory mechanisms involved in heart growth and development that can be exploited to repair the injured adult heart. Furthermore, lncRNAs have been revealed as possible therapeutic targets for heart failure with different causes and in different stages. In the journey from a healthy heart to heart failure, lncRNAs have been shown to participate in almost every landmark of heart failure pathogenesis including ischemic injury, cardiac hypertrophy, and cardiac fibrosis. Furthermore, the manipulation of lncRNAs palliates the progression of heart failure by attenuating ischemic heart injury, cardiac hypertrophy and cardiac fibrosis, as well as facilitating heart regeneration and therapeutic angiogenesis. This review will highlight recent updates regarding the involvement of lncRNAs in cardiac hypertrophy and heart failure and their potential as novel therapeutic targets. This article is part of a Special Issue entitled: Genetic and epigenetic control of heart failure edited by Jun Ren & Megan Yingmei Zhang. (C) 2017 Elsevier B.V. All rights reserved.	[Han, Dong; Cao, Feng] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing 100853, Peoples R China; [Han, Dong; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Gao, Quansheng] Acad Mil Med Sci, Lab Anim Ctr, Beijing 100850, Peoples R China	Cao, F (reprint author), Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing 100853, Peoples R China.	wind8828@gmail.com	Han, Dong/B-7131-2017	Han, Dong/0000-0002-0545-3338	National Key Research Program of China [2016YFA0100903]; National Funds for Distinguished Young Scientists of China [81325009]; National Natural Science Foundation of China [81227901, 81530058]; Innovation Team Grant of Shaanxi Province [2014KCT-20]	This work was supported by the National Key Research Program of China (2016YFA0100903), National Funds for Distinguished Young Scientists of China (81325009), National Natural Science Foundation of China (81227901, 81530058), and Innovation Team Grant of Shaanxi Province (No. 2014KCT-20).	Bassett AR, 2014, ELIFE, V3, DOI 10.7554/eLife.03058; Battulin Nariman R, 2012, World J Stem Cells, V4, P87, DOI 10.4252/wjsc.v4.i8.87; Bisping E, 2014, J CARDIOVASC PHARM, V64, P293, DOI 10.1097/FJC.0000000000000126; Devaux Y, 2015, NAT REV CARDIOL, V12, P415, DOI 10.1038/nrcardio.2015.55; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Feyen DAM, 2016, ADV DRUG DELIVER REV, V106, P104, DOI 10.1016/j.addr.2016.04.023; Fiedler J, 2015, J AM COLL CARDIOL, V66, P2005, DOI 10.1016/j.jacc.2015.07.081; Greco S, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0926-5; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Han P, 2014, NATURE, V514, P102, DOI 10.1038/nature13596; He Y, 2014, BBA-MOL BASIS DIS, V1842, P2204, DOI 10.1016/j.bbadis.2014.08.015; Hou JY, 2016, EXP MOL PATHOL, V100, P493, DOI 10.1016/j.yexmp.2016.05.006; Hu SJ, 2011, CIRCULATION, V124, pS27, DOI 10.1161/CIRCULATIONAHA.111.017954; Jiang F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152767; Jiang XY, 2014, INT J CLIN EXP PATHO, V7, P1325; Johnsson P, 2014, BBA-GEN SUBJECTS, V1840, P1063, DOI 10.1016/j.bbagen.2013.10.035; Kataoka M, 2013, CIRC RES, V112, P1532, DOI 10.1161/CIRCRESAHA.113.301519; Kitow J, 2016, AM J PHYSIOL-HEART C, V311, pH707, DOI 10.1152/ajpheart.00194.2016; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kretz M, 2012, GENE DEV, V26, P338, DOI 10.1101/gad.182121.111; Kumarswamy R, 2014, CIRC RES, V114, P1569, DOI 10.1161/CIRCRESAHA.114.303915; Latronico MVG, 2015, CURR OPIN CARDIOL, V30, P213, DOI 10.1097/HCO.0000000000000162; Liu LT, 2016, CARDIOVASC RES, V111, P56, DOI 10.1093/cvr/cvw078; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Ounzain S, 2015, J MOL CELL CARDIOL, V89, P98, DOI 10.1016/j.yjmcc.2015.09.016; Ounzain S, 2015, EUR HEART J, V36, P353, DOI 10.1093/eurheartj/ehu180; Peters T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150236; Piccoli MT, 2016, J MOL CELL CARDIOL, V92, P75, DOI 10.1016/j.yjmcc.2015.12.023; Scheuermann JC, 2013, EMBO J, V32, P1805, DOI 10.1038/emboj.2013.134; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Song C, 2016, ONCOTARGET, V7, P10827, DOI 10.18632/oncotarget.7312; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Takemura G, 2013, INT J CARDIOL, V167, P2373, DOI 10.1016/j.ijcard.2013.01.163; Tanai E, 2016, COMPR PHYSIOL, V6, P187, DOI 10.1002/cphy.c140055; Tao H, 2016, CARDIOVASC PATHOL, V25, P381, DOI 10.1016/j.carpath.2016.05.005; Tao LC, 2015, ONCOTARGET, V6, P42613, DOI 10.18632/oncotarget.6073; Tham YK, 2015, ARCH TOXICOL, V89, P1401, DOI 10.1007/s00204-015-1477-x; Vausort M, 2014, CIRC RES, V115, P668, DOI 10.1161/CIRCRESAHA.115.303836; Viereck J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1475; Wang K, 2016, CELL DEATH DIFFER, V23, P1394, DOI 10.1038/cdd.2016.28; Wang K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7779; Wang K, 2014, CIRC RES, V114, P1377, DOI 10.1161/CIRCRESAHA.114.302476; Wang K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4596; Wang XH, 2015, INT J CARDIOL, V187, P365, DOI 10.1016/j.ijcard.2015.03.195; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Yan YY, 2016, BIOMED RES INT, DOI 10.1155/2016/8079372; Yang YJ, 2015, CLIN SCI, V129, P675, DOI 10.1042/CS20150121; Yin Y, 2014, CURR MOL MED, V14, P737; Zhang JY, 2016, BIOMOL THER, V24, P19, DOI 10.4062/biomolther.2015.066; Zhang Z, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0417-x; Zhang Z, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0333-5; Zhou Q, 2014, AM J PATHOL, V184, P409, DOI 10.1016/j.ajpath.2013.10.007	54	0	0	9	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	AUG	2017	1863	8			SI		2078	2084		10.1016/j.bbadis.2017.02.024				7	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	EZ9KB	WOS:000405048200023	28259753				2018-01-05	
J	Wang, N; Chen, CY; Yang, DZ; Liao, Q; Luo, H; Wang, XQ; Zhou, FY; Yang, XL; Yang, J; Zeng, CY; Wang, WE				Wang, Na; Chen, Caiyu; Yang, Dezhong; Liao, Qiao; Luo, Hao; Wang, Xinquan; Zhou, Faying; Yang, Xiaoli; Yang, Jian; Zeng, Chunyu; Wang, Wei Eric			Mesenchymal stem cells-derived extracellular vesicles, via miR-210, improve infarcted cardiac function by promotion of angiogenesis	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Myocardial infarction; Mesenchymal stem cells; Extracellular vesicles; MicroRNA; Angiogenesis	ENDOTHELIAL GROWTH-FACTOR; MYOCARDIAL-INFARCTION; RAT MODEL; CARDIOVASCULAR-DISEASES; REPERFUSION INJURY; MICROVESICLES; EXOSOMES; MICRORNA-210; ISCHEMIA; THERAPY	Mesenchymal stem cells (MSCs) exert therapeutic effect on treating acute myocardial infarction. Recent evidence showed that paracrine function rather than direct differentiation predominately contributes to the beneficial effects of MSCs, but how the paracrine factors function are not fully elucidated. In the present study, we tested if extracellular vesicles (EVs) secreted by MSC promotes angiogenesis in infracted heart via microRNAs. Immunostaining of CD31 and matrigel plug assay were performed to detect angiogenesis in a mouse myocardial infarction (MI) model. The cardiac function and structure was examined with echocardiographic analysis. Capillary like tube formation, migration and proliferation of human umbilical vein endothelial cells (HUVECs) were determined. As a result, MSC-EVs significantly improved angiogenesis and cardiac function in post-MI heart. MSC-EVs increased the proliferation, migration and tube formation capacity of HUVECs. MicroRNA (miR)-210 was found to be enriched in MSC-EVs. The EVs collected from MSCs with miR-210 silence largely lost the pro-angiogenic effect both in-vitro and in-vivo. The miR-210 target gene Efna3, which plays a role in angiogenesis, was down-regulated by MSC-EVs treatment in HUVECs. In conclusion, MSC-EVs are sufficient to improve angiogenesis and exert therapeutic effect on MI, its pro- angiogenesis effect might be associated with a miR-210-Efna3 dependent mechanism. This article is part of a Special Issue entitled: Genetic and epigenetic control of heart failure- edited by Jun Ren & Megan Yingmei Zhang. (C) 2017 Published by Elsevier B.V.	[Wang, Na; Chen, Caiyu; Yang, Dezhong; Liao, Qiao; Luo, Hao; Wang, Xinquan; Zhou, Faying; Yang, Xiaoli; Yang, Jian; Zeng, Chunyu; Wang, Wei Eric] Third Mil Med Univ, Chongqing Inst Cardiol, Daping Hosp, Dept Cardiol, Chongqing 400042, Peoples R China	Zeng, CY; Wang, WE (reprint author), Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China.	chunyuzeng01@163.com; weiericwang@163.com					Belting M, 2015, J INTERN MED, V278, P251, DOI 10.1111/joim.12393; Berchem G, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1062968; Bian SY, 2014, J MOL MED, V92, P387, DOI 10.1007/s00109-013-1110-5; Bruno S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0304; Cai J, 2013, J MOL CELL BIOL, V5, P227, DOI 10.1093/jmcb/mjt011; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Comes J., 2015, BIOMOLECULES, V5, P1741; Conforti A, 2014, STEM CELLS DEV, V23, P2591, DOI 10.1089/scd.2014.0091; Cortez-Dias N, 2016, CIRC J, V80, P2183, DOI 10.1253/circj.CJ-16-0568; Das S, 2015, CARDIOVASC PATHOL, V24, P199, DOI 10.1016/j.carpath.2015.04.007; Deng L, 2015, CIRC RES, V117, P870, DOI 10.1161/CIRCRESAHA.115.306806; Desrochers LM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11958; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fleury A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00370; Garikipati VNS, 2015, STEM CELLS, V33, P3519, DOI 10.1002/stem.2121; Heusch G, 2015, CIRC RES, V116, P674, DOI 10.1161/CIRCRESAHA.116.305348; Hu GW, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt546; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Ibrahim AGE, 2014, STEM CELL REP, V2, P606, DOI 10.1016/j.stemcr.2014.04.006; Kim GY, 2016, CELL SIGNAL, V28, P1817, DOI 10.1016/j.cellsig.2016.08.009; Kim SW, 2014, J AM COLL CARDIOL, V64, P1681, DOI 10.1016/j.jacc.2014.06.1204; Kishore R., 2016, EUR HEART J; Kohler EE, 2014, STEM CELLS, V32, P1538, DOI 10.1002/stem.1658; Dang K, 2015, INT J MOL SCI, V16, P6353, DOI 10.3390/ijms16036353; Leca J, 2016, J CLIN INVEST, V126, P4140, DOI 10.1172/JCI87734; Loyer X, 2014, CIRC RES, V114, P345, DOI 10.1161/CIRCRESAHA.113.300858; Maclntyre C. R., 2016, HEART, V102, P1953; Miao QF, 2014, J CELL MOL MED, V18, P1644, DOI 10.1111/jcmm.12351; Mocharla P, 2013, BLOOD, V121, P226, DOI 10.1182/blood-2012-01-407106; Motavaf M, 2016, CELL MOL BIOL, V62, P74, DOI 10.14715/cmb/2016.62.7.13; Pang P, 2017, KIDNEY INT, V91, P129, DOI 10.1016/j.kint.2016.07.037; Senturk T, 2014, ATHEROSCLEROSIS, V237, P760, DOI 10.1016/j.atherosclerosis.2014.10.091; Shalaby SM, 2016, IUBMB LIFE, V68, P343, DOI 10.1002/iub.1487; Teng XM, 2015, CELL PHYSIOL BIOCHEM, V37, P2415, DOI 10.1159/000438594; Vallabhaneni KC, 2015, ONCOTARGET, V6, P4953, DOI 10.18632/oncotarget.3211                                                        ; Wang WE, 2013, CIRC RES, V113, P288, DOI 10.1161/CIRCRESAHA.113.300929; Xiao F, 2013, GLYCOBIOLOGY, V23, P524, DOI 10.1093/glycob/cwt004; Yu JM, 2015, MOL MED REP, V12, P6718, DOI 10.3892/mmr.2015.4307; Yu NZ, 2016, GENE, V594, P117, DOI 10.1016/j.gene.2016.09.010; Yuan MJ, 2016, EUR J PHARMACOL, V788, P218, DOI 10.1016/j.ejphar.2016.06.032; Zhao LY, 2016, EXP CELL RES, V344, P30, DOI 10.1016/j.yexcr.2016.03.024	42	1	1	10	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	AUG	2017	1863	8			SI		2085	2092		10.1016/j.bbadis.2017.02.023				8	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	EZ9KB	WOS:000405048200024	28249798				2018-01-05	
J	Fuse, N				Fuse, Naoyuki			Genome research elucidating environmental adaptation: Dark-fly project as a case study	CURRENT OPINION IN GENETICS & DEVELOPMENT			English	Article							DROSOPHILA-MELANOGASTER; CONSTANT DARKNESS; HIGH-ALTITUDE; EVOLUTION; CAVEFISH; DISEASE; KEPT	Organisms have the capacity to adapt to diverse environments, and environmental adaptation is a substantial driving force of evolution. Recent progress of genome science has addressed the genetic mechanisms underlying environmental adaptation. Whole genome sequencing has identified adaptive genes selected under particular environments. Genome editing technology enables us to directly test the role(s) of a gene in environmental adaptation. Genome science has also shed light on a unique organism, Dark-fly, which has been reared long-term in the dark. We determined the whole genome sequence of Dark-fly and reenacted environmental selections of the Dark-fly genome to identify the genes related to dark-adaptation. Here I will give an overview of current progress in genome science and summarize our study using Dark-fly, as a case study for environmental adaptation.	[Fuse, Naoyuki] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan	Fuse, N (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan.	nfuse@m.tohoku.ac.jp			gCOE program of Kyoto University; NIG; Japan Society for the Promotion of Science	Research in my team was supported by the gCOE program of Kyoto University, NIG Collaborative Research Program, and grants from the Japan Society for the Promotion of Science.	Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Cuyvers E, 2016, LANCET NEUROL, V15, P857, DOI 10.1016/S1474-4422(16)00127-7; Fan SH, 2016, SCIENCE, V354, P54, DOI 10.1126/science.aaf5098; Fuse N, 2014, SPRINGERBRIEF BIOL, P1, DOI 10.1007/978-4-431-54147-9; Imafuku M, 2011, ZOOL SCI, V28, P195, DOI 10.2108/zsj.28.195; IMAIZUMI T, 1979, JPN J GENET, V54, P55, DOI 10.1266/jjg.54.55                                                               ; Izutsu M, 2016, G3-GENES GENOM GENET, V6, P365, DOI 10.1534/g3.115.023549; Izutsu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033288; Jeffery WR, 2008, EVOL DEV, V10, P265, DOI 10.1111/j.1525-142X.2008.00235.x; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kikuchi A, 2012, DEV NEUROSCI-BASEL, V34, P533, DOI 10.1159/000346266; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kvon EZ, 2016, CELL, V167, P633, DOI 10.1016/j.cell.2016.09.028; Lamichhaney S, 2015, NATURE, V518, P371, DOI 10.1038/nature14181; Liu SP, 2014, CELL, V157, P785, DOI 10.1016/j.cell.2014.03.054; Long A, 2015, NAT REV GENET, V16, P567, DOI 10.1038/nrg3937; McGaugh SE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6307; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; MORI S, 1983, Zoological Magazine (Tokyo), V92, P138; MORI S, 1982, Zoological Magazine (Tokyo), V91, P245; MORI S, 1986, ZOOL SCI, V3, P945; MORI SYUITI, 1959, JAPANESE JOUR GENETICS, V34, P195, DOI 10.1266/jjg.34.195; MORI SYUITI, 1959, JAPANESE JOUR GENETICS, V34, P151, DOI 10.1266/jjg.34.151; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Schlotterer C, 2014, NAT REV GENET, V15, P749, DOI 10.1038/nrg3803; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	27	0	0	6	6	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0959-437X	1879-0380		CURR OPIN GENET DEV	Curr. Opin. Genet. Dev.	AUG	2017	45						97	102		10.1016/j.gde.2017.03.004				6	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	EZ7DI	WOS:000404880400015	28419934				2018-01-05	
J	McQueen, C; Pownall, ME				McQueen, Caitlin; Pownall, Mary Elizabeth			An analysis of MyoD-dependent transcription using CRISPR/Cas9 gene targeting in Xenopus tropicalis embryos	MECHANISMS OF DEVELOPMENT			English	Article							SKELETAL-MUSCLE; NEURAL CREST; EXPRESSION; DIFFERENTIATION; MYOGENESIS; BINDING; SPECIFICATION; PROGENITORS; ACTIVATION; ZEBRAFISH	Myogenic regulatory factors (MRFs) are known to have essential roles in both the establishment and differentiation of the skeletal muscle cell lineage. MyoD is expressed early in the Xenopus mesoderm where it is present and active several hours before the activation of muscle differentiation genes. Previous studies in cultured cells and in Xenopus laevis have identified sets of genes that require MyoD prior to differentiation of skeletal muscle. Here we report results from experiments using CRISPR/Cas9 to target the MyoD gene in the diploid frog Xenopus tropicalis, that are analysed by RNA-seq at gastrula stages. We further investigate our data using cluster analysis to compare developmental expression profiles with that of MyoD and alpha-cardiac actin, reference genes for skeletal muscle determination and differentiation. Our findings provide an assessment of using founder (F0) Xenopus embryos from CRISPR/Cas9 protocols for transcriptomic analyses and we conclude that although targeted F0 embryos are genetically mosaic for MyoD, there is significant disruption in the expression of a specific set of genes. We discuss candidate target genes in context of their role in the sub-programs of MyoD regulated transcription. (C) 2017 Elsevier B.V. All rights reserved.	[McQueen, Caitlin; Pownall, Mary Elizabeth] Univ York, Dept Biol, York, N Yorkshire, England	Pownall, ME (reprint author), Univ York, Dept Biol, York, N Yorkshire, England.	betsy.pownall@york.ac.uk		Pownall, Mary Elizabeth/0000-0003-2329-5844	White Rose BBSRC DTP studentship [BB/M011151/1]	We are very grateful to Olga Moroz in the York Structural Biology labs for protein production of Cas9. We also thank the Genomics lab in University of York Biology Department technology facility especially Sally James and Katherine Newling for technical and bioinformatic support. CM is funded by a White Rose BBSRC DTP studentship (BB/M011151/1).	Aguero TH, 2012, DEV BIOL, V364, P99, DOI 10.1016/j.ydbio.2012.01.020; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6                                                   ; Berti F, 2015, J ANAT, V227, P361, DOI 10.1111/joa.12353; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Blum R, 2012, GENE DEV, V26, P2763, DOI 10.1101/gad.200113.112; Branney PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004951; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Carvajal JJ, 2010, EXP CELL RES, V316, P3014, DOI 10.1016/j.yexcr.2010.07.005; Conerly ML, 2016, DEV CELL, V36, P375, DOI 10.1016/j.devcel.2016.01.021; Emerson CP, 1993, CURR OPIN CELL BIOL, V5, P1057, DOI 10.1016/0955-0674(93)90092-5; Fisher ME, 2003, BIOL CELL, V95, P555, DOI 10.1016/j.biolcel.2003.09.002; Fisher ME, 2002, DEVELOPMENT, V129, P1307; Fong AP, 2015, CELL REP, V10, P1937, DOI 10.1016/j.celrep.2015.02.055; Gianakopoulos PJ, 2011, J BIOL CHEM, V286, P2517, DOI 10.1074/jbc.M110.163709; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805                                                          ; HOPWOOD ND, 1992, DEVELOPMENT, V114, P31; HOPWOOD ND, 1989, EMBO J, V8, P3409; Kasberg AD, 2013, DEV BIOL, V381, P312, DOI 10.1016/j.ydbio.2013.07.007; Kaul A, 2000, CELL, V102, P17, DOI 10.1016/S0092-8674(00)00006-4; Koster M, 1998, MECH DEVELOP, V76, P169, DOI 10.1016/S0925-4773(98)00123-3; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0                                                   ; Lagha M, 2009, DEV CELL, V17, P892, DOI 10.1016/j.devcel.2009.10.021; Li HY, 2010, MECH DEVELOP, V127, P281, DOI 10.1016/j.mod.2010.03.002; Li MY, 2016, TRENDS GENET, V32, P815, DOI 10.1016/j.tig.2016.10.005; Li SJ, 2013, NUCLEIC ACIDS RES, V41, P2659, DOI 10.1093/nar/gks1362; Liu ZZ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0088-4; Maguire RJ, 2012, DEV BIOL, V371, P256, DOI 10.1016/j.ydbio.2012.08.027; Maragh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105460; Maves L, 2007, DEVELOPMENT, V134, P3371, DOI 10.1242/dev.003905; Mayeuf-Louchart A, 2016, DEVELOPMENT, V143, P872, DOI 10.1242/dev.128017; Mayeuf-Louchart A, 2014, P NATL ACAD SCI USA, V111, P8844, DOI 10.1073/pnas.1407606111; Nakamura Y, 2016, DEVELOPMENT, V143, P1914, DOI 10.1242/dev.131664; Nakayama T, 2014, METHOD ENZYMOL, V546, P355, DOI 10.1016/B978-0-12-801185-0.00017-9; Papin C, 2002, MECH DEVELOP, V111, P37, DOI 10.1016/S0925-4773(01)00599-8                                                   ; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V                                                    ; Savage J, 2010, DIFFERENTIATION, V79, P31, DOI 10.1016/j.diff.2009.08.008; Shigeta M, 2016, GENES CELLS, V21, P755, DOI 10.1111/gtc.12379; Soleimani VD, 2013, NAT PROTOC, V8, P1525, DOI 10.1038/nprot.2013.088; Soleimani VD, 2012, MOL CELL, V47, P457, DOI 10.1016/j.molcel.2012.05.046; Tan MH, 2013, GENOME RES, V23, P201, DOI 10.1101/gr.141424.112; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662                                                         ; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; Topczewska JM, 2001, GENE DEV, V15, P2483, DOI 10.1101/gad.907401; Weinberg ES, 1996, DEVELOPMENT, V122, P271; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Yang JW, 2014, DEV CELL, V31, P87, DOI 10.1016/j.devcel.2014.08.025; Yao ZZ, 2013, BIOL OPEN, V2, P546, DOI 10.1242/bio.20133921	51	0	0	14	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4773	1872-6356		MECH DEVELOP	Mech. Dev.	AUG	2017	146						1	9		10.1016/j.mod.2017.05.002				9	Developmental Biology	Developmental Biology	EZ2XC	WOS:000404573400001	28536000				2018-01-05	
J	Murphy, T; Melville, H; Fradkin, E; Bistany, G; Branigan, G; Olsen, K; Comstock, CR; Hanby, H; Garbade, E; DiBenedetto, AJ				Murphy, Tami; Melville, Heather; Fradkin, Eliza; Bistany, Giana; Branigan, Gregory; Olsen, Kelly; Comstock, Catharine R.; Hanby, Hayley; Garbade, Ellie; DiBenedetto, Angela J.			Knockdown of epigenetic transcriptional co-regulator Brd2a disrupts apoptosis and proper formation of hindbrain and midbrain-hindbrain boundary (MHB) region in zebrafish	MECHANISMS OF DEVELOPMENT			English	Article						Bromodomain; Cell death; Cerebellum; Engrailed; Midbrain-hindbrain boundary; Embryonic patterning	DOUBLE-BROMODOMAIN PROTEIN; CONTAINING GENE BRD2; EMBRYONIC-DEVELOPMENT; CYCLE REGULATION; ENGRAILED GENES; HOMEOTIC GENE; IN-VIVO; EXPRESSION; DROSOPHILA; MOUSE	Brd2 is a member of the bromodomain-extraterminal domain (BET) family of proteins and functions as an acetyl-histone-directed transcriptional co-regulator and recruitment scaffold in chromatin modification complexes affecting signal-dependent transcription. While Brd2 acts as a protooncogene in mammalian blood, developmental studies link it to regulation of neuronal apoptosis and epilepsy, and complete knockout of the gene is invariably embryonic lethal. In Drosophila, the Brd2 homolog acts as a maternal effect factor necessary for segment formation and identity and proper expression of homeotic loci, including Ultrabithorax and engrailed. To test the various roles attributed to Brd2 in a single developmental system representing a non-mammalian vertebrate, we conducted a phenotypic characterization of Brd2a deficient zebrafish embryos produced bymorpholino knockdown and corroborated by Crispr-Cas9 disruption and small molecule inhibitor treatments. brd2aMO morphants exhibit reduced hindbrain with an ill-defined midbrain-hindbrain boundary (MHB) region; irregular notochord, neural tube, and somites; and abnormalities in ventral trunk and ventral nerve cord interneuron positioning. Using whole mount TUNEL and confocal microscopy, we uncover a significant decrease, then a dramatic increase, of p53-independent cell death at the start and end of segmentation, respectively. In contrast, using qualitative and quantitative analyses of BrdU incorporation, phosphohistone H3-tagging, and flow cytometry, we detect little effect of Brd2a knockdown on overall proliferation levels in embryos. RNA in situ hybridization shows reduced or absent expression of homeobox gene eng2a and paired box gene pax2a, in the hindbrain domain of the MHB region, and an overabundance of pax2a-positive kidney progenitors, in knockdowns. Together, these results suggest an evolutionarily conserved role for Brd2 in the proper formation and/or patterning of segmented tissues, including the vertebrate CNS, where it acts as a bi-modal regulator of apoptosis, and is necessary, directly or indirectly, for proper expression of genes that pattern the MHB and/or regulate differentiation in the anterior hindbrain. (C) 2017 The Authors. Published by Elsevier Ireland Ltd.	[Murphy, Tami; Melville, Heather; Fradkin, Eliza; Bistany, Giana; Branigan, Gregory; Olsen, Kelly; Comstock, Catharine R.; Hanby, Hayley; Garbade, Ellie; DiBenedetto, Angela J.] Villanova Univ, Dept Biol, Mendel Hall 147,800 Lancaster Ave, Villanova, PA 19085 USA; [Murphy, Tami] Signal Genet, W Chester, PA USA; [Murphy, Tami; Melville, Heather] Georgetown Univ, Sch Med, Washington, DC USA; [Fradkin, Eliza] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Bistany, Giana] Univ Connecticut, Sch Med, Farmington, CT USA; [Comstock, Catharine R.] George Mason Univ, Fairfax, VA 22030 USA; [Hanby, Hayley] Univ Penn, Philadelphia, PA 19104 USA; [Garbade, Ellie] SUNY Upstate Med Univ, Syracuse, NY 13210 USA	DiBenedetto, AJ (reprint author), Villanova Univ, Dept Biol, Mendel Hall 147,800 Lancaster Ave, Villanova, PA 19085 USA.	tmurphy@signalgenetics.com; hm325@georgetown.edu; Eliza.fradkin@jefferson.edu; gbistany@student.uchc.edu; gbraniga@villanova.edu; kolsen8@villanova.edu; Ccomsto2@gmu.edu; hhanby@mail.med.upenn.edu; garbadee@upstate.edu; angela.dibenedetto@villanova.edu			Villanova University; Sigma Xi; American Women in Science (AWIS)	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors, other than intramural funding from Villanova University mentioned above, and a Sigma Xi Grant-in-Aid of Research and an American Women in Science (AWIS) travel grant to H. Melville.	Belkina AC, 2014, J LEUKOCYTE BIOL, V95, P451, DOI 10.1189/jlb.1112588; Bielczyk-Maczynska E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004450; Buckles GR, 2004, MECH DEVELOP, V121, P437, DOI 10.1016/j.mod.2004.03.026; Chang YL, 2007, MOL CELL BIOL, V27, P5486, DOI 10.1128/MCB.00692-07; CHUA P, 1995, MOL CELL BIOL, V15, P3685; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Crowley TE, 2004, DEV BRAIN RES, V149, P93, DOI 10.1016/j.devbrainres.2003.12.011; Crowley TE, 2002, MOL ENDOCRINOL, V16, P1727, DOI 10.1210/me.2001-0353; Denis GV, 2000, CELL GROWTH DIFFER, V11, P417; Denis GV, 1996, GENE DEV, V10, P261, DOI 10.1101/gad.10.3.261; Denis GV, 2001, FRONT BIOSCI, V6, pD1065; Denis GV, 2001, FRONT BIOSCI, V6, pD849, DOI 10.2741/Denis; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; DiBenedetto AJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-39; DIGAN ME, 1986, DEV BIOL, V114, P161, DOI 10.1016/0012-1606(86)90392-1; Dworkin S, 2012, DEVELOPMENT, V139, P525, DOI 10.1242/dev.066522; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Florence B, 1998, GENETICS, V150, P1497; Florence B, 2001, FRONT BIOSCI, V6, pD1008, DOI 10.2741/Florence; Florence BL, 2008, DEV DYNAM, V237, P554, DOI 10.1002/dvdy.21432; Gerety SS, 2011, DEV BIOL, V350, P279, DOI 10.1016/j.ydbio.2010.11.030; Gerlach GF, 2013, WIRES DEV BIOL, V2, P559, DOI 10.1002/wdev.92; Greenwald RJ, 2004, BLOOD, V103, P1475; Gyuris A, 2009, BBA-GENE REGUL MECH, V1789, P413, DOI 10.1016/j.bbagrm.2009.03.005; Hoshino M, 2012, DEV GROWTH DIFFER, V54, P317, DOI 10.1111/j.1440-169X.2012.01330.x; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; King KL, 1998, ANNU REV PHYSIOL, V60, P601, DOI 10.1146/annurev.physiol.60.1.601                                                ; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lenburg ME, 2007, J BIOL CHEM, V282, P4803, DOI 10.1074/jbc.M605870200; Li ZY, 2005, LEUKEMIA, V19, P183, DOI 10.1038/sj.leu.2403602; McGrail M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018826; Miller FD, 2000, CELL DEATH DIFFER, V7, P880, DOI 10.1038/sj.cdd.4400736; Moens CB, 2002, DEV DYNAM, V224, P1, DOI 10.1002/dvdy.10086; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Pal DK, 2003, AM J HUM GENET, V73, P261, DOI 10.1086/377006                                                                  ; Rhee K, 1998, J CELL SCI, V111, P3541; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9                                                   ; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen; Schilling TF, 2001, PHILOS T ROY SOC B, V356, P1599, DOI 10.1098/rstb.2001.0918                                                          ; SchneiderMaunoury S, 1997, DEVELOPMENT, V124, P1215; Scholpp S, 2003, DEV DYNAM, V228, P313, DOI 10.1002/dvdy.10384; Scholpp S, 2001, GENESIS, V30, P129, DOI 10.1002/gene.1047; Schulte-Merker S., 2007, ZEBRAFISH BOOK GUIDE, P20; Shang EY, 2011, J CELL BIOCHEM, V112, P2784, DOI 10.1002/jcb.23192; Shang EY, 2009, DEV DYNAM, V238, P908, DOI 10.1002/dvdy.21911; Sinha A, 2005, BIOCHEM J, V387, P257, DOI 10.1042/BJ20041793; Solano PJ, 2003, DEVELOPMENT, V130, P1243, DOI 10.1242/dev.00348; Staehling-Hampton K, 1999, GENETICS, V153, P275; Su CY, 2014, DEV BIOL, V386, P181, DOI 10.1016/j.ydbio.2013.10.026; Tallafuss A, 2003, DEVELOPMENT, V130, P4307, DOI 10.1242/dev.00662; Trousdale RK, 2004, MOL REPROD DEV, V68, P261, DOI 10.1002/mrd.20059; Velisek L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023656; Verduzco D., 2009, ESSENTIAL ZEBRAFISH, P186; Wang SL, 1997, DEV BIOL, V188, P322, DOI 10.1006/dbio.1997.8655                                                          ; Wilson SL, 2011, CEREBELLUM, V10, P356, DOI 10.1007/s12311-011-0254-5; Wilson S.W., 2002, RESULTS PROBLEMS CEL, V2, P181; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1071/jbc.R700001200; Zheng P, 2004, BIOL REPROD, V70, P1419, DOI 10.1095/biolreprod.103.023796; Zhou M, 2006, MOL CELL BIOCHEM, V292, P205, DOI 10.1007/s11010-006-9233-4	62	0	0	12	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4773	1872-6356		MECH DEVELOP	Mech. Dev.	AUG	2017	146						10	30		10.1016/j.mod.2017.05.003				21	Developmental Biology	Developmental Biology	EZ2XC	WOS:000404573400002	28549975	gold			2018-01-05	
J	Ma, T; Tao, JL; Yang, MH; He, CJ; Tian, XZ; Zhang, XS; Zhang, JL; Deng, SL; Feng, JZ; Zhang, ZZ; Wang, J; Ji, PY; Song, YK; He, PL; Han, HB; Fu, JC; Lian, ZX; Liu, GS				Ma, Teng; Tao, Jingli; Yang, Minghui; He, Changjiu; Tian, Xiuzhi; Zhang, Xiaosheng; Zhang, Jinlong; Deng, Shoulong; Feng, Jianzhong; Zhang, Zhenzhen; Wang, Jing; Ji, Pengyun; Song, Yukun; He, Pingli; Han, Hongbing; Fu, Juncai; Lian, Zhengxing; Liu, Guoshi			An AANAT/ASMT transgenic animal model constructed with CRISPR/Cas9 system serving as the mammary gland bioreactor to produce melatonin-enriched milk in sheep	JOURNAL OF PINEAL RESEARCH			English	Article						AANAT; ASMT; CRISPR/Cas9; mammary gland bioreactor; melatonin; pronuclear microinjection; sheep	SEROTONIN N-ACETYLTRANSFERASE; ONE-STEP GENERATION; OXIDATIVE STRESS; KNOCK-IN; PRONUCLEAR MICROINJECTION; EXOGENOUS MELATONIN; SLEEP; ZEBRAFISH; CELLS; ANTIOXIDANT	Melatonin as a potent antioxidant exhibits important nutritional and medicinal values. To produce melatonin-enriched milk will benefit the consumers. In this study, a sheep bioreactor which generates melatonin-enriched milk has been successfully developed by the technology that combined CRISPR/Cas9 system and microinjection. The AANAT and ASMT were cloned from pineal gland of Dorper sheep (Ovis aries). The in vitro studies found that AANAT and ASMT were successfully transferred to the mammary epithelial cell lines and significantly increased melatonin production in the culture medium compared to the nontransgenic cell lines. In addition, the Cas9 mRNA, sgRNA, and the linearized vectors pBC1-AANAT and pBC1-ASMT were co-injected into the cytoplasm of pronuclear embryos which were implanted into ewes by oviducts transferring. Thirty-four transgenic sheep were generated with the transgenic positive rate being roughly 35% which were identified by Southern blot and sequencing. Seven carried transgenic AANAT, two carried ASMT, and 25 carried both of AANAT and ASMT genes. RT-PCR and Western blot demonstrated that the lambs expressed these genes in their mammary epithelial cells and these animals produced melatonin-enriched milk. This is the first report to show a functional AANAT and ASMT transgenic animal model which produce significantly high levels of melatonin milk compared to their wild-type counterparts. The advanced technologies used in the study laid a foundation for generating large transgenic livestock, for example, the cows, which can produce high level of melatonin milk.	[Ma, Teng; Yang, Minghui; He, Changjiu; Tian, Xiuzhi; Zhang, Zhenzhen; Wang, Jing; Ji, Pengyun; Song, Yukun; Han, Hongbing; Fu, Juncai; Lian, Zhengxing; Liu, Guoshi] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding,Minist Agr, Key Lab Anim Genet & Breeding,Beijing Key Lab Ani, Beijing, Peoples R China; [Zhang, Xiaosheng; Zhang, Jinlong; Feng, Jianzhong] Acad Agr Sci Tianjin, Inst Anim Husb & Vet, Tianjin, Peoples R China; [Deng, Shoulong] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China; [He, Pingli] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China	Liu, GS (reprint author), China Agr Univ, Coll Anim Sci & Technol, Beijing, Peoples R China.	gshliu@cau.edu.cn			Genetically Modified Organisms Breeding Major Projects of China [2014ZX08008002B, 2016ZX08008003]; National Natural Science Foundation of China [31372306]; Xinjiang Technology Support Program [2016E02037]; China Agricultural University and Xinjiang Agricultural University [2015TC050]	Genetically Modified Organisms Breeding Major Projects of China, Grant/Award Number: 2014ZX08008002B and 2016ZX08008003; National Natural Science Foundation of China, Grant/Award Number: 31372306; Xinjiang Technology Support Program, Grant/Award Number: 2016E02037; Cooperation Fund of China Agricultural University and Xinjiang Agricultural University, Grant/Award Number: 2015TC050	Acuna-Castroviejo D, 2014, CELL MOL LIFE SCI, V71, P2997, DOI 10.1007/s00018-014-1579-2; Arendt J, 2005, SLEEP MED REV, V9, P25, DOI 10.1016/j.smrv.2004.05.002; Arendt J, 1998, REV REPROD, V3, P13, DOI 10.1530/ror.0.0030013; ARENDT J, 1985, CIBA F SYMP, V117, P266; Arslanoglu S, 2012, J PERINAT MED, V40, P1, DOI 10.1515/JPM.2011.134; Auer TO, 2014, METHODS, V69, P142, DOI 10.1016/j.ymeth.2014.03.027; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bruni O, 2015, EUR J PAEDIATR NEURO, V19, P491, DOI 10.1016/j.ejpn.2015.04.007; Byeon Y, 2016, J PINEAL RES, V60, P348, DOI 10.1111/jpi.12317; Cakir ZU, 2016, INFLAMMATION, V39, P1134, DOI 10.1007/s10753-016-0347-x; Cardinali DP, 2012, J PINEAL RES, V52, P365, DOI 10.1111/j.1600-079X.2011.00962.x; Alonso-Vale MIC, 2008, J PINEAL RES, V45, P422, DOI 10.1111/j.1600-079X.2008.00610.x; Carrillo-Vico A, 2004, FASEB J, V18, P537, DOI 10.1096/fj.03-0694fje; Carrillo-Vico A, 2005, ENDOCRINE, V27, P189, DOI 10.1385/ENDO:27:2:189; Ceinos RM, 2004, NEUROSIGNALS, V13, P308, DOI 10.1159/000081966; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Currier NL, 2000, J NEUROIMMUNOL, V104, P101, DOI 10.1016/S0165-5728(99)00271-4; Dijk DJ, 1997, J BIOL RHYTHM, V12, P627, DOI 10.1177/074873049701200618; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Dong Y, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081301; Farias TSM, 2015, J PINEAL RES, V58, P251; Foulkes NS, 1997, TRENDS NEUROSCI, V20, P487, DOI 10.1016/S0166-2236(97)01109-0                                                   ; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Ganguly S, 2001, P NATL ACAD SCI USA, V98, P8083, DOI 10.1073/pnas.141118798                                                          ; GarciaMaurino S, 1997, J IMMUNOL, V159, P574; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Han HB, 2014, FRONT AGRIC SCI ENG, V1, P2, DOI 10.15302/J-FASE-2014007; Hardeland R, 2013, J PINEAL RES, V55, P325, DOI 10.1111/jpi.12090; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; JALDOALBA F, 1993, ACTA ENDOCRINOL-COP, V129, P442; Jan JE, 2007, J PINEAL RES, V42, P22, DOI 10.1111/j.1600-079X.2006.00398.x; Kim TD, 2007, GENE DEV, V21, P797, DOI 10.1101/gad.1519507; Li GC, 2014, PLASMID, V76, P47, DOI 10.1016/j.plasmid.2014.09.004; Li H, 2016, J PINEAL RES, V60, P206, DOI 10.1111/jpi.12304; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; MAESTRONI GJM, 1994, CANCER RES, V54, P4740; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manchester LC, 2015, J PINEAL RES, V59, P403, DOI 10.1111/jpi.12267; Miller SC, 2006, INT J EXP PATHOL, V87, P81, DOI 10.1111/j.0959-9673.2006.00474.x; Nagy A. G. M., 2003, MANIPULATING MOUSE E; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Pandi-Perumal SR, 2005, EXP GERONTOL, V40, P911, DOI 10.1016/j.exger.2005.08.009; Reiter RJ, 1997, ANN NY ACAD SCI, V825, P70, DOI 10.1111/j.1749-6632.1997.tb48415.x; Reiter RJ, 2016, J PINEAL RES, V61, P253, DOI 10.1111/jpi.12360; Simko F, 2013, INT J CARDIOL, V168, P2876, DOI 10.1016/j.ijcard.2013.03.139; Srinivasan V, 2005, NEUROTOX RES, V7, P293, DOI 10.1007/BF03033887                                                              ; Szewczuk LM, 2008, BIOCHEMISTRY-US, V47, P10407, DOI 10.1021/bi801189d; Uchida M, 2001, TRANSGENIC RES, V10, P577, DOI 10.1023/A:1013059917280; Valtonen M, 2005, NORD J PSYCHIAT, V59, P217, DOI 10.1080/08039480510023034; Vriend J, 2015, J PINEAL RES, V58, P1, DOI 10.1111/jpi.12189; Wang B, 2002, MOL REPROD DEV, V63, P437, DOI 10.1002/mrd.10199; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wu MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24360; Young MW, 1997, BIOPHARM-TECHNOL BUS, V10, P34; Zhang L, 2013, NEUROENDOCRINOL LETT, V34, P294; Zhao Y, 2013, J PINEAL RES, V55, P79, DOI 10.1111/jpi.12044; Zhdanova Irina V., 2003, Curr Treat Options Neurol, V5, P225, DOI 10.1007/s11940-003-0013-0; Zhdanova IV, 2005, SLEEP MED REV, V9, P51, DOI 10.1016/j.smrc.2004.04.003; Ziomek CA, 1998, THERIOGENOLOGY, V49, P139, DOI 10.1016/S0093-691X(97)00408-1	60	1	1	22	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-3098	1600-079X		J PINEAL RES	J. Pineal Res.	AUG	2017	63	1							e12406	10.1111/jpi.12406				10	Endocrinology & Metabolism; Neurosciences; Physiology	Endocrinology & Metabolism; Neurosciences & Neurology; Physiology	EZ2UC	WOS:000404565100002					2018-01-05	
J	Inniss, MC; Bandara, K; Jusiak, B; Lu, TK; Weiss, R; Wroblewska, L; Zhang, L				Inniss, Mara C.; Bandara, Kalpanie; Jusiak, Barbara; Lu, Timothy K.; Weiss, Ron; Wroblewska, Liliana; Zhang, Lin			A novel Bxb1 integrase RMCE system for high fidelity site-specific integration of mAb expression cassette in CHO Cells	BIOTECHNOLOGY AND BIOENGINEERING			English	Article						CRISPR; RMCE; site-specific integration; monoclonal antibody; cell line development	HAMSTER OVARY CELLS; MAMMALIAN-CELLS; FLUORESCENT ENRICHMENT; ANTIBODY-PRODUCTION; GENOMICS VIEWER; EXCHANGE RMCE; COPY NUMBER; STEM-CELLS; GENE; DNA	As CHO cell line development for biotherapeutic production becomes more sophisticated through the availability of the CHO genome sequence, the ability to accurately and reproducibly engineer the host cell genome has become increasingly important. Multiple well characterized systems for site-specific integration will enable more complex cell line engineering to generate cell lines with desirable attributes. We built and characterized a novel recombinase mediated cassette exchange (RMCE) system using Bxb1 integrase and compared it to the commonly used Flp/FRT RMCE system. We first integrated a DNA construct flanked by either Bxb1 attachment sites or FRT sequences (referred to as a landing pad) into the Fer1L4 genomic locus of CHO-S cells using CRISPR/Cas9 mediated homologous recombination. We characterized the resulting clones harboring either the Bxb1 or Flp/FRT landing pad using whole genome resequencing to compare their genomes with the parental host cell line. We determined that each landing pad was specifically integrated into the Fer1L4 locus in the selected clones and observed no major structural changes in the genome or variations in copy number as a result of CRISPR/Cas9 modification. We subsequently tested the ability of the Bxb1 and Flp/FRT landing pad clones to perform proper RMCE with donor vectors containing identical mAb expression cassettes flanked by either Bxb1 attachment sites or FRT sites. We demonstrated that both RMCE systems were able to generate stable pools in a similar time frame with comparable mAb expression. Through genetic characterization of up to 24 clones derived from either system, we determined that the BxB1 RMCE system yielded higher fidelity RMCE events than the Flp/FRT system as evidenced by a higher percentage of clones with expected integration of the mAb cassette into the landing pad in the respective cell lines. We conclude that Bxb1 RMCE is an excellent alternative to Flp/FRT RMCE and valuable addition to our toolbox enabling the engineering of more sophisticated cell lines for biotherapeutic production. Biotechnol. Bioeng. 2017;114: 1837-1846. (c) 2017 Wiley Periodicals, Inc.	[Inniss, Mara C.; Bandara, Kalpanie; Zhang, Lin] Pfizer Inc, Biotherapeut Pharmaceut Sci, Cell Line Dev, Andover, MA 01810 USA; [Jusiak, Barbara; Lu, Timothy K.; Weiss, Ron] MIT, Dept Biol, Synthet Biol Ctr, Cambridge, MA USA; [Wroblewska, Liliana] Pfizer Inc, BioMed Design, Cambridge, MA USA	Zhang, L (reprint author), Pfizer Inc, Biotherapeut Pharmaceut Sci, Cell Line Dev, Andover, MA 01810 USA.	lin.l.zhang@pfizer.com					Aach J., 2014, BIORXIV, DOI [DOI 10.1101/005074, 10.1101/005074]; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Coates CJ, 2005, TRENDS BIOTECHNOL, V23, P407, DOI 10.1016/j.tibtech.2005.06.099; Crawford Y, 2013, BIOTECHNOL PROGR, V29, P1307, DOI 10.1002/btpr.1783; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Duportet X, 2014, NUCLEIC ACIDS RES, V42, P13440, DOI 10.1093/nar/gku1082; Ghosh P, 2003, MOL CELL, V12, P1101, DOI 10.1016/S1097-2765(03)00444-1; Grav LM, 2015, BIOTECHNOL J, V10, P1446, DOI 10.1002/biot.201500027; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Ho SCL, 2012, J BIOTECHNOL, V157, P130, DOI 10.1016/j.jbiotec.2011.09.023; Jiang Z, 2006, BIOTECHNOL PROGR, V22, P313, DOI 10.1021/bp0501524; Kawabe Y, 2012, CYTOTECHNOLOGY, V64, P267, DOI 10.1007/s10616-011-9397-y; Keravala A, 2006, MOL GENET GENOMICS, V276, P135, DOI 10.1007/s00438-006-0129-5; Kim MS, 2008, BIOTECHNOL BIOPROC E, V13, P418, DOI 10.1007/s12257-008-0151-z; Kim MS, 2008, J MICROBIOL BIOTECHN, V18, P1342; KIMURA M, 1994, BBA-GENE STRUCT EXPR, V1219, P653, DOI 10.1016/0167-4781(94)90224-0; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Lee JS, 2016, BIOTECHNOL BIOENG, V113, P2518, DOI 10.1002/bit.26002; Lee JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08572; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YQ, 2015, NAT CHEM BIOL, V11, P207, DOI 10.1038/nchembio.1736; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mansour WY, 2008, NUCLEIC ACIDS RES, V36, P4088, DOI 10.1093/nar/gkn347; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Quinlan AR, 2014, CURR PROTOC BIOINFOR, V47, DOI DOI 10.1002/0471250953.BI1112S47; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Russell JP, 2006, BIOTECHNIQUES, V40, P460, DOI 10.2144/000112150; Sakuma T, 2015, INT J MOL SCI, V16, P23849, DOI 10.3390/ijms161023849; Schlake T, 1994, BIOCHEMISTRY-US, V33, P5; Schlatter S, 2005, BIOTECHNOL PROGR, V21, P122, DOI 10.1021/bp049780w; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Turan S, 2013, GENE, V515, P1, DOI 10.1016/j.gene.2012.11.016; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Xu ZY, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0241-5; Xu ZY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-87; Yamaguchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017267; Zhang L, 2015, BIOTECHNOL PROGR, V31, P1645, DOI 10.1002/btpr.2175; Zhu FF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1290; Zhu ZR, 2015, STEM CELL REP, V4, P1103, DOI 10.1016/j.stemcr.2015.04.016	40	0	0	8	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0006-3592	1097-0290		BIOTECHNOL BIOENG	Biotechnol. Bioeng.	AUG	2017	114	8					1837	1846		10.1002/bit.26268				10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EY6YI	WOS:000404130200020	28186334				2018-01-05	
J	Bisht, K; Grill, S; Graniel, J; Nandakumar, J				Bisht, Kamlesh; Grill, Sherilyn; Graniel, Jacqueline; Nandakumar, Jayakrishnan			A lentivirus-free inducible CRISPR-Cas9 system for efficient targeting of human genes	ANALYTICAL BIOCHEMISTRY			English	Article						CRISPR-Cas9; HeLa; Telomere; RNAi	TELOMERE PROTEIN TPP1; BACTERIAL IMMUNITY; CRYSTAL-STRUCTURE; RNA CLEAVAGE; GENOMIC LOCI; CAS SYSTEMS; HUMAN-CELLS; DNA; COMPLEX; IDENTIFICATION	CRISPR-Cas9 is a cutting-edge tool for modifying genomes. The efficacy with which Cas9 recognizes its target has revolutionized the engineering of knockouts. However this efficacy complicates the knocking out of important genes in cultured cells. Unedited cells holding a survival advantage within an edited population can confound the knockout phenotype. Here we develop a HeLa-based system that overcomes this limitation, incorporating several attractive features. First, we use Flp-recombinase to generate clones stably integrated for Cas9 and guide RNA5, eliminating the possibility of unedited cells. Second, Cas9 can be induced uniformly in the clonal cultures using doxycycline to measure the knockout phenotype. Third, two genes can be simultaneously knocked out using this approach. Finally, by not involving lentiviruses, our method is appealing to a broad research audience. Using this methodology we generated an inducible AGO2-knockout cell line showing normal RNA interference in the absence of doxycycline. Upon induction of Cas9, the AGO2 locus was cleaved, the AGO2 protein was depleted, and RNA interference was compromised. In addition to generating inducible knockouts, our technology can be adapted to improve other applications of Cas9, including transcriptional/epigenetic modulation and visualization of cellular DNA loci. (C) 2017 The Authors. Published by Elsevier Inc.	[Bisht, Kamlesh; Grill, Sherilyn; Graniel, Jacqueline; Nandakumar, Jayakrishnan] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Bisht, Kamlesh] Dana Farber Boston Childrens Canc & Blood Disorde, 300 Longwood Ave,Karp 08210, Boston, MA 02115 USA; [Graniel, Jacqueline] Univ Michigan, Med Scientist Training Program, Ann Arbor, MI 48109 USA	Nandakumar, J (reprint author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	jknanda@umich.edu		Nandakumar, Jayakrishnan/0000-0001-9146-2785	National Institutes of Health [R00CA167644, R01GM120094, NIH R01AG050509, T32GM007544]	This work was supported by the National Institutes of Health [R00CA167644 to J.N., R01GM120094 to J.N., and NIH R01AG050509 to J.N. (co-investigator)]. S.G. was supported in part by the National Institutes of Health-funded University of Michigan Genetics Training Program (T32GM007544).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bisht K, 2016, P NATL ACAD SCI USA, V113, P13021, DOI 10.1073/pnas.1605685113; Cao Jian, 2016, Nucleic Acids Res, V44, pe149; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007                                                    ; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Morita S, 2007, GENOMICS, V89, P687, DOI 10.1016/j.ygeno.2007.01.004; Nakashima M, 2013, J BIOL CHEM, V288, P33171, DOI 10.1074/jbc.M113.518175; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Seth K, 2016, BIOCHEM BIOPH RES CO, V480, P499, DOI 10.1016/j.bbrc.2016.10.130; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Weidenfeld I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp108; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Zhuang J, 2009, J BIOL CHEM, V284, P30565, DOI 10.1074/jbc.M109.059444	50	1	1	16	17	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697	1096-0309		ANAL BIOCHEM	Anal. Biochem.	AUG 1	2017	530						40	49		10.1016/j.ab.2017.05.001				10	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	EY6FF	WOS:000404077200006	28477963	gold			2018-01-05	
J	Neitemeier, S; Jelinek, A; Laino, V; Hoffmann, L; Eisenbach, I; Eying, R; Ganjam, GK; Dolga, AM; Oppermann, S; Culmsee, C				Neitemeier, Sandra; Jelinek, Anja; Laino, Vincenzo; Hoffmann, Lena; Eisenbach, Ina; Eying, Roman; Ganjam, Goutham K.; Dolga, Amalia M.; Oppermann, Sina; Culmsee, Carsten			BID links ferroptosis to mitochondrial cell death pathways	REDOX BIOLOGY			English	Article						Ferroptosis; BID; Mitochondria; CRISPR; Oxytosis; Neuronal death	FOCAL CEREBRAL-ISCHEMIA; NEURODEGENERATIVE DISORDERS; OXIDATIVE STRESS; GLUTAMATE; AIF; 12/15-LIPOXYGENASE; NEUROPROTECTION; DEPRIVATION; MECHANISMS; TOXICITY	Ferroptosis has been defined as an oxidative and iron-dependent pathway of regulated cell death that is distinct from caspase-dependent apoptosis and established pathways of death receptor-mediated regulated necrosis. While emerging evidence linked features of ferroptosis induced e.g. by erastin-mediated inhibition of the X-c(-) system or inhibition of glutathione peroxidase 4 (Gpx4) to an increasing number of oxidative cell death paradigms in cancer cells, neurons or kidney cells, the biochemical pathways of oxidative cell death remained largely unclear. In particular, the role of mitochondrial damage in paradigms of ferroptosis needs further investigation. In the present study, we find that erastin-induced ferroptosis in neuronal cells was accompanied by BID transactivation to mitochondria, loss of mitochondrial membrane potential, enhanced mitochondrial fragmentation and reduced ATP levels. These hallmarks of mitochondrial demise are also established features of oxytosis, a paradigm of cell death induced by X-c(-) inhibition by millimolar concentrations of glutamate. Bid knockout using CRISPR/Cas9 approaches preserved mitochondrial integrity and function, and mediated neuroprotective effects against both, ferroptosis and oxytosis. Furthermore, the BID-inhibitor BI-6c9 inhibited erastin-induced ferroptosis, and, in turn, the ferroptosis inhibitors ferrostatin-1 and liproxstatin-1 prevented mitochondrial dysfunction and cell death in the paradigm of oxytosis. These findings show that mitochondrial transactivation of BID links ferroptosis to mitochondrial damage as the final execution step in this paradigm of oxidative cell death.	[Neitemeier, Sandra; Jelinek, Anja; Laino, Vincenzo; Hoffmann, Lena; Eisenbach, Ina; Eying, Roman; Ganjam, Goutham K.; Dolga, Amalia M.; Oppermann, Sina; Culmsee, Carsten] Philipps Univ Marburg, Inst Pharmakol & Klin Pharm, Biochem Pharmakol Ctr Marburg, Karl von Frisch Str 1, D-35032 Marburg, Germany; [Dolga, Amalia M.] Univ Groningen, Groningen Res Inst Pharm, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands; [Oppermann, Sina] NCT, Neuenheimer Feld 460, D-69120 Heidelberg, Germany; [Oppermann, Sina] Deutsch Krebsforschungszentrum DKFZ, Neuenheimer Feld 460, D-69120 Heidelberg, Germany	Culmsee, C (reprint author), Philipps Univ Marburg, Inst Pharmakol & Klin Pharm, Fachbereich Pharm, Karl von Frisch Str 1, D-35032 Marburg, Germany.	culmsee@staff.uni-marburg.de			DFG [DFG-FOR2107]; Rosalind-Franklin fellowship; EU; University of Groningen	The authors thank Marcus Conrad for providing Liproxstatin-1 and advisory comments and discussion on the manuscript. We also thank the master students Charlotte Bold and Mirjam Montag for experimental support in the initial phase of the project and Maren Richter for additional supervision, Katharina Elsasser for her excellent technical support and Emma Esser for careful editing of the manuscript. This work was partly supported by a DFG grant to CC (DFG-FOR2107). AMD is a recipient of a Rosalind-Franklin fellowship, co-funded by EU and University of Groningen.	Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Becattini B, 2006, P NATL ACAD SCI USA, V103, P12602, DOI 10.1073/pnas.0603460103; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; Culmsee Carsten, 2006, Current Alzheimer Research, V3, P269, DOI 10.2174/156720506778249461; Diemert S, 2012, J NEUROSCI METH, V203, P69, DOI 10.1016/j.jneumeth.2011.09.012; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18; Grohm J, 2010, BRAIN BEHAV IMMUN, V24, P831, DOI 10.1016/j.bbi.2009.11.015; Kang YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4672; Krainz T, 2016, ACS CENTRAL SCI, V2, P653, DOI 10.1021/acscentsci.6b00199; Landshamer S, 2008, CELL DEATH DIFFER, V15, P1553, DOI 10.1038/cdd.2008.78; Linkermann A, 2014, P NATL ACAD SCI USA, V111, P16836, DOI 10.1073/pnas.1415518111; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Oppermann S, 2014, J PHARMACOL EXP THER, V350, P273, DOI 10.1124/jpet.114.213777; Plesnila N, 2001, P NATL ACAD SCI USA, V98, P15318, DOI 10.1073/pnas.261323298; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Speer RE, 2013, FREE RADICAL BIO MED, V62, P26, DOI 10.1016/j.freeradbiomed.2013.01.026; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423                                                          ; Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92; van Leyen K, 2006, STROKE, V37, P3014, DOI 10.1161/01.STR.0000249004.25444.a5; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yuan H, 2016, BIOCHEM BIOPH RES CO, V478, P838, DOI 10.1016/j.bbrc.2016.08.034	30	1	1	17	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2213-2317			REDOX BIOL	Redox Biol.	AUG	2017	12						558	570		10.1016/j.redox.2017.03.007				13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EX6CA	WOS:000403328700053	28384611	gold			2018-01-05	
J	Zuo, QS; Jin, K; Wang, YJ; Song, JZ; Zhang, YN; Li, BC				Zuo, Qisheng; Jin, Kai; Wang, Yingjie; Song, Jiuzhou; Zhang, Yani; Li, Bichun			CRISPR/Cas9-Mediated Deletion of C1EIS Inhibits Chicken Embryonic Stem Cell Differentiation Into Male Germ Cells (Gallus gallus)	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article						CRISPR; Cas9; C1EIS; SPERMATOGONIAL STEM CELLS; EMBRYONIC STEM CELLS	GENOME; CAS9; KNOCKOUT; SYSTEM; GENES	We previously found that C1EIS is preferentially expressed in Chicken spermatogonial stem cells (SSCs) by RNA sequencing (RNA-seq), so our current study focused on C1EIS's role in Chicken embryonic stem cells (ESCs) differentiation into male germ cells. We constructed a CRISPR/Cas9 vector targeting C1EIS. T7 endonuclease I (T7EI) digestion method and sequencing of TA cloning were used to detect the knock-out efficiency of the Single guide RNA (sgRNA) after the cas9/gRNA vector transfected into D fibroblasts 1(DF-1), ESCs, and Chicken embryos. The results showed that CRISPR/Cas9 gene knockout efficiency is about 40%. Differentiation of the targeted ESCs into SSCs was inhibited at the embryoid body stage due to C1EIS deficiency. Immunofluorescent staining revealed that the mutagenized ESCs (RA (Retinoic Acid) with C1EIS Knock out) expressed lower levels of integrin 6 and integrin 1 compared to wild type cells. Quantitative real-time PCR (QRT-PCR) revealed Oct4 and Sox2 expression significantly increased, contrarily integrin 1 and Stra8 expression significantly decreased than RA induced group and RA with C1EIS Overexpression. During retinoic acid-induced differentiation, knockout of C1EIS in ESCs inhibited formation of SSC-like cells, suggesting C1EIS plays a vital role in promoting differentiation of avian ESCs to SSCs by regulating expression of multiple pluripotency-related genes. J. Cell. Biochem. 118: 2380-2386, 2017. (c) 2017 Wiley Periodicals, Inc. During retinoic acid-induced differentiation, knockout of C1EIS in ESCs inhibited formation of SSC-like cells, suggesting C1EIS plays a vital role in promoting differentiation of avian ESCs to SSCs by regulating expression of multiple pluripotency-related genes.	[Zuo, Qisheng; Jin, Kai; Wang, Yingjie; Zhang, Yani; Li, Bichun] Yangzhou Univ, Coll Anim Sci & Technol, Key Lab Anim Breeding Reprod & Mol Design Jiangsu, Yangzhou 225009, Jiangsu, Peoples R China; [Song, Jiuzhou] Univ Maryland, Anim & Avian Sci, College Pk, MD 20741 USA	Li, BC (reprint author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China.	yubcli@yzu.edu.cn			National Natural Science Foundation [31472087, 31301959, 31272429]; Specialized Research Fund [20123250120009]; China Postdoctoral Science Foundation [2012M511326, 2014T70550]; Priority Academic Program Development	Grant sponsor: National Natural Science Foundation; Grant numbers: 31472087, 31301959, 31272429; Grant sponsor: Specialized Research Fund; Grant number: 20123250120009; Grant sponsor: China Postdoctoral Science Foundation; Grant numbers: 2012M511326, 2014T70550; Grant sponsor: Priority Academic Program Development.	Back J, 2004, BLOOD, V103, P3615, DOI 10.1182/blood-2003-11-4089; Bahena I, 2014, ZYGOTE, V22, P513, DOI 10.1017/S0967199412000743; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; [陈庭锋 Chen TingFeng], 2014, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V45, P1104; Guo T, 2013, J ANHUI AGR SCI, V29, P11605; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Liu QY, 2001, J BIOL CHEM, V276, P36961, DOI 10.1074/jbc.M105308200; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Olive V, 2007, DEVELOPMENT, V134, P3815, DOI 10.1242/dev.003467; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Simon L, 2010, EXPERT OPIN BIOL TH, V10, P519, DOI 10.1517/14712591003614731; Song HW, 2012, REPRODUCTION, V143, P611, DOI 10.1530/REP-11-0479; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Van Bragt MPA, 2008, THESIS; Willenbrock H, 2009, RNA, V15, P2028, DOI 10.1261/rna.1699809; Yang LL, 2013, GENESIS, V51, P83, DOI 10.1002/dvg.22358; Zhang YN, 2013, MOL BIOL REP, V40, P2149, DOI 10.1007/s11033-012-2274-8; Zhang ZT, 2015, J BIOL CHEM, V290, P13605, DOI 10.1074/jbc.M114.601401; Zuo QS, 2016, G3-GENES GENOM GENET, V6, P1787, DOI 10.1534/g3.116.028803	21	2	2	14	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	AUG	2017	118	8					2380	2386		10.1002/jcb.25900				7	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EX2JR	WOS:000403053000044	28106276				2018-01-05	
J	Shen, CL; Liu, YZ; Shi, S; Zhang, RY; Zhang, T; Xu, Q; Zhu, PF; Chen, XM; Lu, FM				Shen, Congle; Liu, Yongzhen; Shi, Shu; Zhang, Ruiyang; Zhang, Ting; Xu, Qiang; Zhu, Pengfei; Chen, Xiangmei; Lu, Fengmin			Long-distance interaction of the integrated HPV fragment with MYC gene and 8q24.22 region upregulating the allele-specific MYC expression in HeLa cells	INTERNATIONAL JOURNAL OF CANCER			English	Article						cervical cancer; HPV; MYC; long-distance interaction; integration	C-MYC; CERVICAL CARCINOGENESIS; CELLULAR SENESCENCE; RANGE INTERACTION; E6; GENOME; RISK; MECHANISMS; DNA	Human papillomavirus (HPV) infection is the most important risk factor for cervical cancer development. In HeLa cell line, the HPV viral genome is integrated at 8q24 in one allele of chromosome 8. It has been reported that the HPV fragment integrated in HeLa genome can cis-activate the expression of proto-oncogene MYC, which is located at 500 kb downstream of the integrated site. However, the underlying molecular mechanism of this regulation is unknown. A recent study reported that MYC was highly expressed exclusively from the HPV-integrated haplotype, and a long-range chromatin interaction between the integrated HPV fragment and MYC gene has been hypothesized. In this study, we provided the experimental evidences supporting this long-range chromatin interaction in HeLa cells by using Chromosome Conformation Capture (3C) method. We found that the integrated HPV fragment, MYC and 8q24.22 was close to each other and might form a trimer in spatial location. When knocking out the integrated HPV fragment or 8q24.22 region from chromosome 8 by CRISPR/Cas9 system, the expression of MYC reduced dramatically in HeLa cells. Interestingly, decreased expression was only observed in three from eight cell clones, when only one 8q24.22 allele was knocked out. Functionally, HPV knockout caused senescence-associated acidic -gal activity in HeLa cells. These data indicate a long-distance interaction of the integrated HPV fragment with MYC gene and 8q24.22 region, providing an alternative mechanism relevant to the carcinogenicity of HPV integration. What's new? Infection with human papillomavirus (HPV) is a well-established risk factor for cervical cancer. The mechanism by which HPV integration into the host genome influences cervical oncogenesis, however, is not fully understood. Using chromosome conformation capture, the authors of this study provide evidence for carcinogenic involvement of a long-range chromatin interaction between integrated HPV fragments, the proto-oncogene MYC, and the 8q24.22 chromosomal region in HeLa cells. Knock-out of either the integrated HPV fragment or the 8q24.22 region in HeLa cells significantly reduced MYC expression. The findings offer an alternative explanation for the carcinogenic mechanism of HPV viral genome integration.	[Shen, Congle; Liu, Yongzhen; Shi, Shu; Zhang, Ruiyang; Zhang, Ting; Xu, Qiang; Chen, Xiangmei; Lu, Fengmin] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Microbiol, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Shen, Congle; Liu, Yongzhen; Shi, Shu; Zhang, Ruiyang; Zhang, Ting; Xu, Qiang; Chen, Xiangmei; Lu, Fengmin] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Ctr Infect Dis, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Zhu, Pengfei] Zhengzhou Univ, Dept Clin Lab, Affiliated Hosp 1, Zhengzhou, Peoples R China	Chen, XM (reprint author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Microbiol, 38 Xueyuan Rd, Beijing 100191, Peoples R China.; Chen, XM (reprint author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Ctr Infect Dis, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	xm_chen6176@bjmu.edu.cn			973 Program [2012CB518900]; National Natural Science Foundation of China [81572366, 81372679]; Ministry of Education of China (111 Project) [B07001]; National Science Foundation of Henan Province [162300410289]	Grant sponsor: 973 Program; Grant number: 2012CB518900; Grant sponsor: National Natural Science Foundation of China; Grant numbers: 81572366 and 81372679; Grant sponsor: Ministry of Education of China (111 Project); Grant number: B07001; Grant sponsor: National Science Foundation of Henan Province; Grant number: 162300410289	Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Gao FH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-610; Gheldof N, 2010, NUCLEIC ACIDS RES, V38, P4325, DOI 10.1093/nar/gkq175; Gimenes F, 2016, ARCH GYNECOL OBSTET, V293, P857, DOI 10.1007/s00404-015-3870-3; Hall AHS, 2003, J VIROL, V77, P6066, DOI 10.1128/JVI.77.10.6066-6069.2003; BVS Iyer G, 2012, PHYS REV, V86; Jiang SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040363; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kennedy EM, 2014, J VIROL, V88, P11965, DOI 10.1128/JVI.01879-14; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Macville M, 1999, CANCER RES, V59, P141; Mannava S, 2012, AGING-US, V4, P917, DOI 10.18632/aging.100512                                                           ; Munger K, 2001, ONCOGENE, V20, P7888, DOI 10.1038/sj.onc.1204860; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.1145-11460.2004; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; PAN HC, 1994, GENE DEV, V8, P1285, DOI 10.1101/gad.8.11.1285; Peter M, 2006, ONCOGENE, V25, P5985, DOI 10.1038/sj.onc.1209625; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Veldman T, 2003, P NATL ACAD SCI USA, V100, P8211, DOI 10.1073/pnas.1435900100; Wang J, 2016, ONCOGENE, V35, P1692, DOI 10.1038/onc.2015.234; Wang J, 2015, WORLD J GASTROENTERO, V21, P9554, DOI 10.3748/wjg.v21.i32.9554; Wang YW, 2007, INT J BIOCHEM CELL B, V39, P402, DOI 10.1016/j.biocel.2006.09.006; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Yochum GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018966; Yugawa T, 2009, REV MED VIROL, V19, P97, DOI 10.1002/rmv.605; Zhang RY, 2016, INT J CANCER, V138, P1163, DOI 10.1002/ijc.29872; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	30	0	0	12	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-7136	1097-0215		INT J CANCER	Int. J. Cancer	AUG 1	2017	141	3					540	548		10.1002/ijc.30763				9	Oncology	Oncology	EX1XW	WOS:000403021100013	28470669	gold			2018-01-05	
J	Mittal, R; Nguyen, D; Patel, AP; Debs, LH; Mittal, J; Yan, D; Eshraghi, AA; Van De Water, TR; Liu, XZ				Mittal, Rahul; Nguyen, Desiree; Patel, Amit P.; Debs, Luca H.; Mittal, Jeenu; Yan, Denise; Eshraghi, Adrien A.; Van De Water, Thomas R.; Liu, Xue Z.			Recent Advancements in the Regeneration of Auditory Hair Cells and Hearing Restoration	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Review						auditory hair cells; hair cell regeneration; hearing loss; gene therapy; stem cell therapy	PLURIPOTENT STEM-CELLS; MOUSE INNER-EAR; VESICULAR GLUTAMATE TRANSPORTER-3; COCHLEAR SUPPORTING CELLS; EFFICIENT GENE-TRANSFER; NON-SYNDROMIC DEAFNESS; USHER-SYNDROME; IN-VIVO; NEUROTROPHIC FACTOR; ADENOASSOCIATED VIRUS	Neurosensory responses of hearing and balance are mediated by receptors in specialized neuroepithelial sensory cells. Any disruption of the biochemical and molecular pathways that facilitate these responses can result in severe deficits, including hearing loss and vestibular dysfunction. Hearing is affected by both environmental and genetic factors, with impairment of auditory function being the most common neurosensory disorder affecting 1 in 500 newborns, as well as having an impact on the majority of elderly population. Damage to auditory sensory cells is not reversible, and if sufficient damage and cell death have taken place, the resultant deficit may lead to permanent deafness. Cochlear implants are considered to be one of the most successful and consistent treatments for deaf patients, but only offer limited recovery at the expense of loss of residual hearing. Recently there has been an increased interest in the auditory research community to explore the regeneration of mammalian auditory hair cells and restoration of their function. In this review article, we examine a variety of recent therapies, including genetic, stem cell and molecular therapies as well as discussing progress being made in genome editing strategies as applied to the restoration of hearing function.	[Mittal, Rahul; Nguyen, Desiree; Patel, Amit P.; Debs, Luca H.; Mittal, Jeenu; Yan, Denise; Eshraghi, Adrien A.; Van De Water, Thomas R.; Liu, Xue Z.] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Liu, Xue Z.] Cent S Univ, Xiangya Hosp, Dept Otolaryngol, Changsha, Hunan, Peoples R China	Liu, XZ (reprint author), Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA.; Liu, XZ (reprint author), Cent S Univ, Xiangya Hosp, Dept Otolaryngol, Changsha, Hunan, Peoples R China.	xliu@med.miami.edu			National Institutes of Health/National Institute on Deafness and Other Communication Disorders [R01 DC05575, R01 DC01246, R01 DC012115]; Hearing Health Foundation (HHF); MED-EL Corporation	The research work in Prof. Liu's Laboratory is supported by grants R01 DC05575, R01 DC01246, and R01 DC012115 from the National Institutes of Health/National Institute on Deafness and Other Communication Disorders. RM is a recipient of a grant from Hearing Health Foundation (HHF). Professors AAE and TRVW have received funding from MED-EL Corporation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. We are thankful to April Mann for the critical reading of the manuscript.	Ahmed ZM, 2003, CLIN GENET, V63, P431, DOI 10.1034/j.1399-0004.2003.00109.x; Ahmed ZM, 2011, AM J HUM GENET, V88, P19, DOI 10.1016/j.ajhg.2010.11.010; Akil O, 2012, NEURON, V75, P283, DOI 10.1016/j.neuron.2012.05.019; Alagramam KN, 2016, NAT CHEM BIOL, V12, P444, DOI [10.1038/NCHEMBIO.2069, 10.1038/nchembio.2069]; An LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25199; Atkinson PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102077; Baker K, 2009, ADV OTO-RHINO-LARYNG, V66, P52, DOI 10.1159/000218207; Banjara H, 2016, INDIAN J OTOLARYNGOL, V68, P248, DOI 10.1007/s12070-015-0950-4; Barr-Gillespie PG, 2015, MOL BIOL CELL, V26, P2727, DOI 10.1091/mbc.E14-04-0940; Basch ML, 2016, J ANAT, V228, P233, DOI 10.1111/joa.12314; Ben Said M, 2016, HUM GENET, V135, P513, DOI 10.1007/s00439-016-1657-7; Ben-Rebeh I, 2016, MOL VIS, V22; Bermingham-McDonogh O, 2011, NEURON, V71, P389, DOI 10.1016/j.neuron.2011.07.015; Bolz Hanno J, 2016, Eur J Hum Genet, V24, P1650, DOI 10.1038/ejhg.2016.67; Bonnet C, 2012, CURR OPIN NEUROL, V25, P42, DOI 10.1097/WCO.0b013e32834ef8b2; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Boulet SL, 2009, ARCH PEDIAT ADOL MED, V163, P19, DOI 10.1001/archpediatrics.2008.506; Bramhall NF, 2014, STEM CELL REP, V2, P311, DOI 10.1016/j.stemcr.2014.01.008; Brigande John V., 2009, V493, P125, DOI 10.1007/978-1-59745-523-7_8; Chai RJ, 2012, P NATL ACAD SCI USA, V109, P8167, DOI 10.1073/pnas.1202774109; Chandrasegaran S, 2016, J MOL BIOL, V428, P963, DOI 10.1016/j.jmb.2015.10.014; Chen JR, 2016, CELL DEATH DIFFER, V23, P1347, DOI 10.1038/cdd.2016.16; Chen S, 2016, J BIOL CHEM, V291, P14457, DOI 10.1074/jbc.M116.733154; Chen Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02996; Chen ZY, 2006, CELL CYCLE, V5, P2609, DOI 10.4161/cc.5.22.3503; Contrera KJ, 2016, J GERONTOL B-PSYCHOL, V71, P400, DOI 10.1093/geronb/gbw005; Cox BC, 2014, DEVELOPMENT, V141, P816, DOI 10.1242/dev.103036; DeJonge RE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162508; Depreux FF, 2016, NUCLEIC ACIDS RES, V44, P9519, DOI 10.1093/nar/gkw867; Devarajan K, 2013, CELL REPROGRAM, V15, P43, DOI 10.1089/cell.2011.0097; Du YT, 2016, BIOSCI TRENDS, V10, P220, DOI 10.5582/bst.2016.01096; Eid A, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.111; El-Amraoui A, 2014, CR BIOL, V337, P167, DOI 10.1016/j.crvi.2013.12.004; Emmett SD, 2015, OTOL NEUROTOL, V36, P545, DOI 10.1097/MAO.0000000000000562; Friedman TB, 2011, ADV OTO-RHINO-LARYNG, V70, P56, DOI 10.1159/000322473; Furness DN, 2015, CELL TISSUE RES, V361, P387, DOI 10.1007/s00441-015-2113-z; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Geleoc GSG, 2014, SCIENCE, V344, P596, DOI 10.1126/science.1241062; Goman AM, 2017, JAMA OTOLARYNGOL, V143, P733, DOI 10.1001/jamaoto.2016.4642; Gomes MM, 2016, METHODS MOL BIOL, V1427, P43, DOI 10.1007/978-1-4939-3615-1_3; Goodall AF, 2015, CLIN OTOLARYNGOL, V40, P412, DOI 10.1111/coa.12432; Gopal SR, 2015, J NEUROSCI, V35, P10188, DOI 10.1523/JNEUROSCI.1096-15.2015; Goutman JD, 2015, FEBS LETT, V589, P3354, DOI 10.1016/j.febslet.2015.08.030; Govindan G, 2016, J CELL PHYSIOL, V231, P2380, DOI 10.1002/jcp.25367; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Gurumurthy CB, 2016, HUM GENET, V135, P971, DOI 10.1007/s00439-016-1704-4; Gyorgy B, 2017, MOL THER, V25, P379, DOI 10.1016/j.ymthe.2016.12.010; Hartel BP, 2017, CLIN OTOLARYNGOL, V42, P805, DOI 10.1111/coa.12775; He Y, 2014, CELL TRANSPLANT, V23, P747, DOI 10.3727/096368913X669761; Helvik AS, 2009, AM J PUBLIC HEALTH, V99, P1376, DOI 10.2105/AJPH.2007.133215; Homans NC, 2017, LARYNGOSCOPE, V127, P725, DOI 10.1002/lary.26150; Hosoya M, 2017, CELL REP, V18, P68, DOI 10.1016/j.celrep.2016.12.020; Hu ZQ, 2013, REGEN MED, V8, P309, DOI [10.2217/RME.13.32, 10.2217/rme.13.32]; Iizuka T, 2015, HUM MOL GENET, V24, P3651, DOI 10.1093/hmg/ddv109; Ishikawa M, 2017, J TISSUE ENG REGEN M, V11, P1766, DOI 10.1002/term.2072; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Jiang D, 2016, INT J MOL MED, V38, P1367, DOI 10.3892/ijmm.2016.2751; Jiang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069314; Karavitaki KD, 2010, J NEUROSCI, V30, P9051, DOI 10.1523/JNEUROSCI.4864-09.2010; Kazmierczak P, 2012, TRENDS NEUROSCI, V35, P220, DOI 10.1016/j.tins.2011.10.007; Kesser BW, 2007, GENE THER, V14, P1121, DOI 10.1038/sj.gt.3302980; Khalin I, 2015, INT J NANOMED, V10, P3245, DOI 10.2147/IJN.S77480; Kilpatrick LA, 2011, GENE THER, V18, P569, DOI 10.1038/gt.2010.175; Kim JS, 2016, NAT PROTOC, V11, P1573, DOI 10.1038/nprot.2016.104; Kim MA, 2016, ANTIOXID REDOX SIGN, V24, P590, DOI 10.1089/ars.2015.6442; Koehler KR, 2013, NATURE, V500, P217, DOI 10.1038/nature12298; Koh SB, 2017, J CELL SCI, V130, P512, DOI 10.1242/jcs.195164; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Kuo BR, 2015, J NEUROSCI, V35, P10786, DOI 10.1523/JNEUROSCI.0967-15.2015; Kwon TJ, 2014, HUM MOL GENET, V23, P1591, DOI 10.1093/hmg/ddt549; Lalwani AK, 1996, GENE THER, V3, P588; Landegger LD, 2017, NAT BIOTECHNOL, V35, P280, DOI 10.1038/nbt.3781; Leake PA, 2013, JARO-J ASSOC RES OTO, V14, P187, DOI 10.1007/s10162-013-0372-5; Lee Y, 2015, NEUROSCI LETT, V584, P320, DOI 10.1016/j.neulet.2014.10.053; Lentz JJ, 2013, NAT MED, V19, P345, DOI 10.1038/nm.3106; Li CM, 2014, JAMA OTOLARYNGOL, V140, P293, DOI 10.1001/jamaoto.2014.42; Li WY, 2015, P NATL ACAD SCI USA, V112, P166, DOI 10.1073/pnas.1415901112; Mantela J, 2005, DEVELOPMENT, V132, P2377, DOI 10.1242/dev.01834; Markossian S, 2016, J MOL ENDOCRINOL, V57, pR81, DOI 10.1530/JME-15-0305; Mathur P, 2015, BBA-MOL BASIS DIS, V1852, P406, DOI 10.1016/j.bbadis.2014.11.020; Matsuoka AJ, 2007, LARYNGOSCOPE, V117, P1629, DOI 10.1097/M1LG.0b013e3I806bf282; McLean WJ, 2016, DEVELOPMENT, V143, P4381, DOI 10.1242/dev.139840; Mei Y, 2016, J GENET GENOMICS, V43, P63, DOI 10.1016/j.jgg.2016.01.001; Mellott AJ, 2016, METHODS MOL BIOL, V1427, P319, DOI 10.1007/978-1-4939-3615-1_19; Mianne J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0273-4; Mielczarek Marzena, 2016, Otolaryngol Pol, V70, P21, DOI 10.5604/00306657.1199992; Mijovic T, 2013, RHEUMATOLOGY, V52, P780, DOI 10.1093/rheumatology/ket009; Miller JM, 2002, AUDIOL NEURO-OTOL, V7, P175, DOI 10.1159/000058306; Mittal R, 2017, J CELL PHYSIOL, V232, P743, DOI 10.1002/jcp.25631; Mittal R, 2016, J CELL PHYSIOL, V231, P1656, DOI 10.1002/jcp.25274; Mittal R, 2015, DIS MARKERS, DOI 10.1155/2015/127013; Miyasaka Y, 2016, HUM MOL GENET, V25, P2045, DOI 10.1093/hmg/ddw078; Mizutari K, 2013, NEURON, V77, P58, DOI 10.1016/j.neuron.2012.10.032; Moctar ECM, 2016, EUR ARCH OTO-RHINO-L, V273, P3693, DOI 10.1007/s00405-016-4036-z; Moser T, 2016, NAT REV NEUROL, V12, P135, DOI 10.1038/nrneurol.2016.10; Mulvaney JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep31668; Munster-Wandowski Agnieszka, 2016, Front Synaptic Neurosci, V8, P4, DOI 10.3389/fnsyn.2016.00004; Nakagawa Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27857; Nakamura T, 2008, J CELL MOL MED, V12, P391, DOI 10.1111/j.1582-4934.2007.00201.x; Niclasen J, 2016, INT J PEDIATR OTORHI, V90, P91, DOI 10.1016/j.ijporl.2016.09.002; Nishimura K, 2009, NEUROREPORT, V20, P1250, DOI 10.1097/WNR.0b013e32832ff287; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Ohnishi H, 2015, NEUROSCI LETT, V599, P49, DOI 10.1016/j.neulet.2015.05.032; Olusanya BO, 2014, B WORLD HEALTH ORGAN, V92, P367, DOI 10.2471/BLT.13.128728; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Oshima Kazuo, 2009, V493, P141, DOI 10.1007/978-1-59745-523-7_9; Pan B, 2017, NAT BIOTECHNOL, V35, P264, DOI 10.1038/nbt.3801; Qing J, 2015, GENET TEST MOL BIOMA, V19, P52, DOI 10.1089/gtmb.2014.0241; Roccio M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17886; Roland L, 2016, OTOLARYNG HEAD NECK, V155, P208, DOI 10.1177/0194599816640485; Rousset F, 2015, CURR PHARM DESIGN, V21, P5977, DOI 10.2174/1381612821666151029112421; Ruel J, 2008, AM J HUM GENET, V83, P278, DOI 10.1016/j.ajhg.2008.07.008; Sage C, 2005, SCIENCE, V307, P1114, DOI 10.1126/science.1106642; Seal RP, 2006, HANDB EXP PHARM, V175, P137; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Shen XF, 2015, INT J DEV BIOL, V59, P195, DOI 10.1387/ijdb.140200md; Shi FX, 2012, J NEUROSCI, V32, P9639, DOI 10.1523/JNEUROSCI.1064-12.2012; Shibata SB, 2012, HUM GENE THER, V23, P302, DOI 10.1089/hum.2011.086; Shinohara T, 2002, P NATL ACAD SCI USA, V99, P1657, DOI 10.1073/pnas.032677999; Shou JY, 2003, MOL CELL NEUROSCI, V23, P169, DOI 10.1016/S1044-7431(03)00066-6; Shu YL, 2016, HUM GENE THER, V27, P687, DOI 10.1089/hum.2016.053; Sienknecht UJ, 2015, CELL TISSUE RES, V361, P25, DOI 10.1007/s00441-015-2200-1; Sly DJ, 2012, JARO-J ASSOC RES OTO, V13, P1, DOI 10.1007/s10162-011-0297-9; Smith Linda S, 2015, Nursing, V45, P64, DOI 10.1097/01.NURSE.0000461842.08906.27; Stevenson J, 2015, EUR CHILD ADOLES PSY, V24, P477, DOI 10.1007/s00787-015-0697-1; Sun LW, 2016, INVEST OPHTH VIS SCI, V57, P2428, DOI 10.1167/iovs.15-18246; Suzuki M, 2000, GENE THER, V7, P1046, DOI 10.1038/sj.gt.3301180; Tang ZH, 2016, STEM CELL TRANSL MED, V5, P561, DOI 10.5966/sctm.2015-0252; Tarang S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00052; Torres-Ruiz R, 2017, BRIEF FUNCT GENOMICS, V16, P4, DOI 10.1093/bfgp/elw025; Tseng CC, 2016, J AFFECT DISORDERS, V197, P94, DOI [10.1016/j.jad.2016.02.020, 10.1016/j.jad.2016.03.020]; van As JW, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010181.pub2; Venkatesh M D, 2015, Med J Armed Forces India, V71, P363, DOI 10.1016/j.mjafi.2015.07.003; Verpy E, 2011, J COMP NEUROL, V519, P194, DOI 10.1002/cne.22509; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang LY, 2012, JOVE-J VIS EXP, DOI 10.3791/3653; Waqas M, 2016, FRONT MED-PRC, V10, P237, DOI 10.1007/s11684-016-0464-9; Wettstein Rahel, 2016, Methods Mol Biol, V1341, P321, DOI 10.1007/7651_2015_213; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Whitfield TT, 2015, CURR OPIN GENET DEV, V32, P112, DOI 10.1016/j.gde.2015.02.006; WHO, 2013, MULT ASS NAT CAP PRO; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Xia H, 2016, ACTA OTO-LARYNGOL, V136, P782, DOI 10.3109/00016489.2016.1157727; Xia WJ, 2016, FRONT MED-PRC, V10, P137, DOI 10.1007/s11684-016-0449-8; Xu YP, 2016, NEUROSCI LETT, V616, P19, DOI 10.1016/j.neulet.2016.01.016; Yamagata T, 2004, J NEUROSCI RES, V78, P75, DOI 10.1002/jnr.20239; Yan D, 2008, FRONT BIOSCI, V13, P4972, DOI 10.2741/3056; Yan D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169219; Yan D, 2016, HUM GENET, V135, P953, DOI 10.1007/s00439-016-1697-z; Yan D, 2015, GENET TEST MOL BIOMA, V19, P512, DOI 10.1089/gtmb.2015.0023; Yan D, 2010, J HUM GENET, V55, P327, DOI 10.1038/jhg.2010.29; Yang SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046355; Yu YL, 2010, J NEUROSCI, V30, P5927, DOI 10.1523/JNEUROSCI.5989-09.2010; Zak M, 2015, INT J DEV NEUROSCI, V47, P247, DOI 10.1016/j.ijdevneu.2015.09.008; Zhai SQ, 2011, J LARYNGOL OTOL, V125, P449, DOI 10.1017/S0022215110002112; Zielke N, 2015, WIRES DEV BIOL, V4, P469, DOI 10.1002/wdev.189; Zou B, 2015, HEARING RES, V327, P102, DOI 10.1016/j.heares.2015.04.016; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	159	1	1	10	10	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	JUL 31	2017	10								236	10.3389/fnmol.2017.00236				16	Neurosciences	Neurosciences & Neurology	FC1MT	WOS:000406602200001	28824370	gold			2018-01-05	
J	Park, E; Guo, JG; Shen, SH; Demirdjian, L; Wu, YN; Lin, L; Xing, Y				Park, Eddie; Guo, Jiguang; Shen, Shihao; Demirdjian, Levon; Wu, Ying Nian; Lin, Lan; Xing, Yi			Population and allelic variation of A-to-I RNA editing in human transcriptomes	GENOME BIOLOGY			English	Article						RNA editing; Transcriptome; RNA-seq; Genetic variation; GWAS	GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; ATAXIA-TELANGIECTASIA; ACCURATE IDENTIFICATION; REGULATORY VARIATION; DIABETES-MELLITUS; ALU ELEMENTS; ENZYME ADAR1; SEQ DATA; METFORMIN	Background: A-to-I RNA editing is an important step in RNA processing in which specific adenosines in some RNA molecules are post-transcriptionally modified to inosines. RNA editing has emerged as a widespread mechanism for generating transcriptome diversity. However, there remain significant knowledge gaps about the variation and function of RNA editing. Results: In order to determine the influence of genetic variation on A-to-I RNA editing, we integrate genomic and transcriptomic data from 445 human lymphoblastoid cell lines by combining an RNA editing QTL (edQTL) analysis with an allele-specific RNA editing (ASED) analysis. We identify 1054 RNA editing events associated with cis genetic polymorphisms. Additionally, we find that a subset of these polymorphisms is linked to genome-wide association study signals of complex traits or diseases. Finally, compared to random cis polymorphisms, polymorphisms associated with RNA editing variation are located closer spatially to their respective editing sites and have a more pronounced impact on RNA secondary structure. Conclusions: Our study reveals widespread cis variation in RNA editing among genetically distinct individuals and sheds light on possible phenotypic consequences of such variation on complex traits and diseases.	[Park, Eddie; Shen, Shihao; Lin, Lan; Xing, Yi] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Guo, Jiguang] Hebei Univ, Sch Med, Dept Microbiol & Parasitol, Baoding 071002, Hebei, Peoples R China; [Demirdjian, Levon; Wu, Ying Nian] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA	Xing, Y (reprint author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	yxing@ucla.edu			National Institutes of Health [R01GM088342, R01GM117624]; Alfred Sloan Research Fellowship; National Institutes of Health postdoctoral training grant [T32AR059033]	This study is supported by National Institutes of Health grants (R01GM088342 and R01GM117624 to YX). YX is supported by an Alfred Sloan Research Fellowship. EP is supported by a National Institutes of Health postdoctoral training grant T32AR059033.	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Biderman Lynn, 2012, Genes Cancer, V3, P264, DOI 10.1177/1947601912455331; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Camacho L, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0598-8; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chen CJ, 2009, MOL BIOL EVOL, V26, P327, DOI 10.1093/molbev/msn249; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Colacurcio DJ, 2013, MOL CELL NEUROSCI, V57, P54, DOI 10.1016/j.mcn.2013.10.003; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Cordaux R, 2006, GENE, V373, P134, DOI 10.1016/j.gene.2006.01.019; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Cremona CA, 2014, ONCOGENE, V33, P3351, DOI 10.1038/onc.2013.275; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Gu TJ, 2016, GENETICS, V202, P787, DOI 10.1534/genetics.115.179481; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Higuchi M, 2000, NATURE, V406, P78; Higurashi T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-118; Hofacker I. L., 2004, CURR PROTOC BIOINFOR, V12, P2, DOI [10.1002/0471250953.bi1202s04, DOI 10.1002/0471250953.BI1202S04]; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kume H, 2014, NUCLEIC ACIDS RES, V42, P10050, DOI 10.1093/nar/gku662; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lavin MF, 1996, CURR OPIN IMMUNOL, V8, P459, DOI 10.1016/S0952-7915(96)80030-6; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452                                                 ; Lehmann KA, 1999, J MOL BIOL, V291, P1, DOI 10.1006/jmbi.1999.2914                                                          ; Li G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks280; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Lin L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0876-5; Lin L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000225; Mamtani R, 2014, DIABETES CARE, V37, P1910, DOI 10.2337/dc13-1489; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Matthews MM, 2016, NAT STRUCT MOL BIOL, V23, P426, DOI 10.1038/nsmb.3203; Morita Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3273; MORRELL D, 1986, DIABETES, V35, P143, DOI 10.2337/diabetes.35.2.143                                                       ; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Park E, 2012, GENOME RES, V22, P1626, DOI 10.1101/gr.134957.111; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Ramaswami G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9194; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/nmeth.1982, 10.1038/NMETH.1982]; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992                                                                   ; Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004; Savitsky K, 1997, NUCLEIC ACIDS RES, V25, P1678, DOI 10.1093/nar/25.9.1678                                                           ; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Shen SH, 2011, P NATL ACAD SCI USA, V108, P2837, DOI 10.1073/pnas.1012834108; Shi JX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4365; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; 't Hoen PAC, 2013, NAT BIOTECHNOL, V31, P1015, DOI 10.1038/nbt.2702; Tehranchi AK, 2016, CELL, V165, P730, DOI 10.1016/j.cell.2016.03.041; Toth AM, 2009, J BIOL CHEM, V284, P29350, DOI 10.1074/jbc.M109.045146; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765                                                   ; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wong SK, 2001, RNA, V7, P846, DOI 10.1017/S135583820101007X                                                       ; Yu B, 2013, GENET EPIDEMIOL, V37, P840, DOI 10.1002/gepi.21752; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhang LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23226; Zhang Q, 2015, NAT METHODS, V12, P347, DOI [10.1038/NMETH.3314, 10.1038/nmeth.3314]; Zhao KY, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r74; Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735	77	3	3	7	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	JUL 31	2017	18								143	10.1186/s13059-017-1270-7				15	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FC0MQ	WOS:000406533000001	28754146	gold			2018-01-05	
J	Gao, SM; Wang, ZQ; Wang, WC; Hu, XL; Chen, PL; Li, JW; Feng, XH; Wong, JM; Du, JX				Gao, Shuman; Wang, Zhiqiang; Wang, Wencai; Hu, Xueli; Chen, Peilin; Li, Jiwen; Feng, Xinhua; Wong, Jiemin; Du, James X.			The lysine methyltransferase SMYD2 methylates the kinase domain of type II receptor BMPR2 and stimulates bone morphogenetic protein signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein methylation; receptor; signal transduction; SMAD transcription factor; transcription regulation	HISTONE METHYLATION; CANCER; PHOSPHORYLATION; DIFFERENTIATION; MECHANISMS; EXPRESSION; INSIGHTS; PATHWAY; ROLES; CELLS	Lysine methylation of chromosomal and nuclear proteins is a well-known mechanism of epigenetic regulation, but relatively little is known about the role of this protein modification in signal transduction. Using an RNAi-based functional screening of the SMYD family of lysine methyltransferases (KMTs), we identified SMYD2 as a KMT essential for robust bone morphogenic protein (BMP)- but not TGF-induced target gene expression in HaCaT keratinocyte cells. A role for SMYD2 in BMP-induced gene expression was confirmed by shRNA knockdown and CRISPR/Cas9-mediated knock-out of SMYD2. We further demonstrate that SMYD2 knockdown or knock-out impairs BMP-induced phosphorylation of the signal-transducing protein SMAD1/5 and SMAD1/5 nuclear localization and interaction with SMAD4. The SMYD2 KMT activity was required to facilitate BMP-mediated signal transduction, as treatment with the SMYD2 inhibitor AZ505 suppressed BMP2-induced SMAD1/5 phosphorylation. Furthermore, we present evidence that SMYD2 likely modulates the BMP response through its function in the cytosol. We show that, although SMYD2 interacted with multiple components in the BMP pathway, it specifically methylated the kinase domain of BMP type II receptor BMPR2. Taken together, our findings suggest that SMYD2 may promote BMP signaling by directly methylating BMPR2, which, in turn, stimulates BMPR2 kinase activity and activation of the BMP pathway.	[Gao, Shuman; Wang, Zhiqiang; Wang, Wencai; Hu, Xueli; Chen, Peilin; Li, Jiwen; Wong, Jiemin; Du, James X.] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Gao, Shuman; Wang, Zhiqiang; Wang, Wencai; Hu, Xueli; Chen, Peilin; Li, Jiwen; Wong, Jiemin; Du, James X.] East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Wong, Jiemin] East China Normal Univ, Joint Res Ctr Translat Med, Shanghai 201499, Peoples R China; [Wong, Jiemin] Shanghai Fengxian Dist Cent Hosp, Shanghai 201499, Peoples R China; [Feng, Xinhua] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Feng, Xinhua] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Feng, Xinhua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Feng, Xinhua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Wong, JM; Du, JX (reprint author), East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China.; Wong, JM; Du, JX (reprint author), East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China.; Wong, JM (reprint author), East China Normal Univ, Joint Res Ctr Translat Med, Shanghai 201499, Peoples R China.; Wong, JM (reprint author), Shanghai Fengxian Dist Cent Hosp, Shanghai 201499, Peoples R China.	jmweng@bio.ecnu.edu.cn; jxdu@bio.ecnu.edu.cn			Ministry of Science and Technology of China [2015CB910402]; National Natural Science Foundation of China [91419303]; Science and Technology Commission of Shanghai Municipality [14XD1401700, 11DZ2260300]	This work was supported by Ministry of Science and Technology of China Grant 2015CB910402 (to J.W.), National Natural Science Foundation of China Grant 91419303, and Science and Technology Commission of Shanghai Municipality Grants 14XD1401700 and 11DZ2260300. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed H, 2016, J PROTEOME RES, V15, P2052, DOI 10.1021/acs.jproteome.6b00220; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Cho HS, 2012, NEOPLASIA, V14, P476, DOI 10.1593/neo.12656; Donlin LT, 2012, GENE DEV, V26, P114, DOI 10.1101/gad.177758.111; ELBENDARY A, 1994, CELL GROWTH DIFFER, V5, P1301; Elkouris M, 2016, CELL REP, V15, P2733, DOI 10.1016/j.celrep.2016.05.051; Falnes PO, 2016, BIOCHEM J, V473, P1995, DOI 10.1042/BCJ20160117; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Kunizaki M, 2007, CANCER RES, V67, P10759, DOI 10.1158/0008-5472.CAN-07-1132; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; LIU F, 1995, MOL CELL BIOL, V15, P3479; Liu XH, 2013, ISRN MATH PHYS, V2013, P1, DOI DOI 10.1016/J.MICR0REL.2012.06.140; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Nakakido M, 2015, NEOPLASIA, V17, P367, DOI 10.1016/j.neo.2015.03.002; Nimura K, 2010, J MOL MED, V88, P1213, DOI 10.1007/s00109-010-0668-4; OGATA T, 1993, P NATL ACAD SCI USA, V90, P9219, DOI 10.1073/pnas.90.19.9219; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Pradhan Sriharsa, 2009, Epigenetics, V4, P383; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632                                                         ; Saddic LA, 2010, J BIOL CHEM, V285, P37733, DOI 10.1074/jbc.M110.137612; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X                                                   ; Spellmon N, 2015, INT J MOL SCI, V16, P1406, DOI 10.3390/ijms16011406; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Xu GL, 2015, J BIOL CHEM, V290, P5414, DOI 10.1074/jbc.M114.610345; Xu J, 2013, MOL CELL, V51, P5, DOI 10.1016/j.molcel.2013.05.004; Xu ST, 2011, J MOL CELL BIOL, V3, P293, DOI 10.1093/jmcb/mjr015; Zhang X, 2015, CELL MOL LIFE SCI, V72, P4257, DOI 10.1007/s00018-015-2001-4	37	0	0	4	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12702	12712		10.1074/jbc.M117.776278				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FC1ZM	WOS:000406636900033	28588028	gold			2018-01-05	
J	Finstad, KM; Probst, AJ; Thomas, BC; Andersen, GL; Demergasso, C; Echeverria, A; Amundson, RG; Banfield, JF				Finstad, Kari M.; Probst, Alexander J.; Thomas, Brian C.; Andersen, Gary L.; Demergasso, Cecilia; Echeverria, Alex; Amundson, Ronald G.; Banfield, Jillian F.			Microbial Community Structure and the Persistence of Cyanobacterial Populations in Salt Crusts of the Hyperarid Atacama Desert from Genome-Resolved Metagenomics	FRONTIERS IN MICROBIOLOGY			English	Article						metagenome; Atacama Desert; salt crust; hyperarid; hypersaline; environmental genomics; salar	CHILE; LIFE; ENVIRONMENTS; COLONIZATION; BACTERIA; VIRUSES; ARCHAEA; SHIFTS; HOT	Although once thought to be devoid of biology, recent studies have identified salt deposits as oases for life in the hyperarid Atacama Desert. To examine spatial patterns of microbial species and key nutrient sources, we genomically characterized 26 salt crusts from three sites along a fog gradient. The communities are dominated by a large variety of Halobacteriales and Bacteroidetes, plus a few algal and Cyanobacterial species. CRISPR locus analysis suggests the distribution of a single Cyanobacterial population among all sites. This is in stark contrast to the extremely high sample specificity of most other community members. Only present at the highest moisture site is a genomically characterized Thermoplasmatales archaeon (Marine Group II) and six Nanohaloarchaea, one of which is represented by a complete genome. Parcubacteria (OD1) and Saccharibacteria (TM7), not previously reported from hypersaline environments, were found at low abundances. We found no indication of a N-2 fixation pathway in the communities, suggesting acquisition of bioavailable nitrogen from atmospherically derived nitrate. Samples cluster by site based on bacterial and archaeal abundance patterns and photosynthetic capacity decreases with increasing distance from the ocean. We conclude that moisture level, controlled by coastal fog intensity, is the strongest driver of community membership.	[Finstad, Kari M.; Andersen, Gary L.; Amundson, Ronald G.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Probst, Alexander J.; Thomas, Brian C.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Andersen, Gary L.] Lawrence Berkeley Natl Lab, Earth Sci Div, Ecol Dept, Berkeley, CA USA; [Demergasso, Cecilia; Echeverria, Alex] Univ Catolic Norte, Ctr Biotecnol, Antofagasta, Chile; [Finstad, Kari M.] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA USA	Banfield, JF (reprint author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.; Banfield, JF (reprint author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	jbanfield@berkeley.edu		Demergasso, Cecilia/0000-0003-4563-3066	NASA Earth and Space Sciences Fellowship; NSF Doctoral Dissertation Improvement Grant [DEB-1406956]; German Science Foundation [DFG PR 1603/1-1]; University of California Agricultural Experiment Station; NSF [0819972]; DOE carbon cycle program [LBNL DE-AC02-05CH11231]; United States Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344, LLNL-JRNL706877]	We would like to thank Yvette Piceno for her assistance with the PhyloChip sample processing and Visjna Music for her field assistance. Funding for this work was provided to KF by the NASA Earth and Space Sciences Fellowship and NSF Doctoral Dissertation Improvement Grant (DEB-1406956). AP was supported by a scholarship from the German Science Foundation (DFG PR 1603/1-1). RA received funding through the University of California Agricultural Experiment Station and NSF grant #0819972. Support to the Banfield Lab was provided by the LBNL DE-AC02-05CH11231 program and a grant from the DOE carbon cycle program. A portion of this work was performed under the auspices of the United States Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344, LLNL-JRNL706877.	Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Cereced P, 2008, ATMOS RES, V87, P312, DOI 10.1016/j.atmosres.2007.11.012; Crits-Christoph A, 2016, ENVIRON MICROBIOL, V18, P2064, DOI 10.1111/1462-2920.13259; Davila AF, 2013, ENV MICROBIOL REP, V5, P583, DOI 10.1111/1758-2229.12050; Davila AF, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000561; De Los RA, 2010, INT MICROBIOL, V13, P79; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Finstad K, 2016, GEODERMA, V284, P57, DOI 10.1016/j.geoderma.2016.08.020; FRIEDMANN EI, 1980, MICROBIAL ECOL, V6, P95, DOI 10.1007/BF02010548; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; McKay CP, 2003, ASTROBIOLOGY, V3, P393, DOI 10.1089/153110703769016460; Michalski G, 2004, GEOCHIM COSMOCHIM AC, V68, P4023, DOI 10.1016/j.gca.2004.04.009; Navarro-Gonzalez R, 2003, SCIENCE, V302, P1018, DOI 10.1126/science.1089143; OREN A, 1994, FEMS MICROBIOL REV, V13, P415, DOI 10.1111/j.1574-6976.1994.tb00060.x; Oren A, 2015, BIODIVERS CONSERV, V24, P781, DOI 10.1007/s10531-015-0882-z; Oren Aharon, 2008, Saline Systems, V4, P2, DOI 10.1186/1746-1448-4-2; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pointing SB, 2007, ENVIRON MICROBIOL, V9, P414, DOI 10.1111/j.1462-2920.2006.01153.x; Probst AJ, 2017, ENVIRON MICROBIOL, V19, P459, DOI 10.1111/1462-2920.13362; Probst AJ, 2014, MICROARRAYS: CURRENT TECHNOLOGY, INNOVATIONS AND APPLICATIONS, P99; Pueyo JJ, 2001, SEDIMENTOLOGY, V48, P1411, DOI 10.1046/j.1365-3091.2001.00428.x                                                ; R Core Team, 2015, R LANG ENV STAT COMP; Robinson CK, 2015, ENVIRON MICROBIOL, V17, P299, DOI 10.1111/1462-2920.12364; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Stivaletta N, 2012, ORIGINS LIFE EVOL B, V42, P187, DOI 10.1007/s11084-012-9289-y; C. UniProt, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI DOI 10.1093/NAR/GKU989; Warren-Rhodes KA, 2006, MICROB ECOL, V52, P389, DOI 10.1007/s00248-006-9055-7; Weinmaier T, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0129-y; Wierzchos J, 2006, ASTROBIOLOGY, V6, P415, DOI 10.1089/ast.2006.6.415                                                          ; Wierzchos J, 2012, INT MICROBIOL, V15, P172, DOI 10.2436/20.1501.01.170; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041	39	0	0	17	17	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	JUL 28	2017	8								1435	10.3389/fmicb.2017.01435				10	Microbiology	Microbiology	FB9ML	WOS:000406463100001	28804480	gold			2018-01-05	
J	Gupta, RM; Hadaya, J; Trehan, A; Zekavat, SM; Roselli, C; Klarin, D; Emdin, CA; Hilvering, CRE; Bianchi, V; Mueller, C; Khera, AV; Ryan, RJH; Engreitz, JM; Issner, R; Shoresh, N; Epstein, CB; De Laat, W; Brown, JD; Schnabel, RB; Bernstein, BE; Kathiresan, S				Gupta, Rajat M.; Hadaya, Joseph; Trehan, Aditi; Zekavat, Seyedeh M.; Roselli, Carolina; Klarin, Derek; Emdin, Connor A.; Hilvering, Catharina R. E.; Bianchi, Valerio; Mueller, Christian; Khera, Amit V.; Ryan, Russell J. H.; Engreitz, Jesse M.; Issner, Robbyn; Shoresh, Noam; Epstein, Charles B.; De laat, Wouter; Brown, Jonathan D.; Schnabel, Renate B.; Bernstein, Bradley E.; Kathiresan, Sekar			A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression	CELL			English	Article							CORONARY-ARTERY-DISEASE; SMOOTH-MUSCLE-CELLS; GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; IDENTITY GENES; RISK-FACTORS; ATHEROSCLEROSIS; MICE; MIGRAINE	Genome-wide association studies (GWASs) implicate the PHACTR1 locus (6p24) in risk for five vascular diseases, including coronary artery disease, migraine headache, cervical artery dissection, fibromuscular dysplasia, and hypertension. Through genetic fine mapping, we prioritized rs9349379, a common SNP in the third intron of the PHACTR1 gene, as the putative causal variant. Epigenomic data from human tissue revealed an enhancer signature at rs9349379 exclusively in aorta, suggesting a regulatory function for this SNP in the vasculature. CRISPR-edited stem cell-derived endothelial cells demonstrate rs9349379 regulates expression of endothelin 1 (EDN1), a gene located 600 kb upstream of PHACTR1. The known physiologic effects of EDN1 on the vasculature may explain the pattern of risk for the five associated diseases. Overall, these data illustrate the integration of genetic, phenotypic, and epigenetic analysis to identify the biologic mechanism by which a common, non-coding variant can distally regulate a gene and contribute to the pathogenesis of multiple vascular diseases.	[Gupta, Rajat M.; Hadaya, Joseph; Trehan, Aditi; Zekavat, Seyedeh M.; Roselli, Carolina; Klarin, Derek; Emdin, Connor A.; Khera, Amit V.; Ryan, Russell J. H.; Engreitz, Jesse M.; Issner, Robbyn; Shoresh, Noam; Epstein, Charles B.; Bernstein, Bradley E.; Kathiresan, Sekar] Broad Inst MIT & Harvard Univ, Cambridge, MA 02142 USA; [Gupta, Rajat M.; Khera, Amit V.; Kathiresan, Sekar] Massachusetts Gen Hosp, Dept Med, Cardiol Div, Boston, MA 02114 USA; [Gupta, Rajat M.; Khera, Amit V.; Ryan, Russell J. H.; Bernstein, Bradley E.; Kathiresan, Sekar] Harvard Med Sch, Boston, MA 02115 USA; [Gupta, Rajat M.; Khera, Amit V.; Kathiresan, Sekar] Massachusetts Gen Hosp, Dept Med, Ctr Genom Med, Boston, MA 02114 USA; [Hilvering, Catharina R. E.; Bianchi, Valerio; De laat, Wouter] Univ Med Ctr Utrecht, Hubrecht Inst, Utrecht, Netherlands; [Ryan, Russell J. H.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mueller, Christian; Schnabel, Renate B.] Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Brown, Jonathan D.] Vanderbilt Univ, Ctr Med, Div Cardiovasc Med, Nashville, TN 37232 USA	Gupta, RM; Kathiresan, S (reprint author), Broad Inst MIT & Harvard Univ, Cambridge, MA 02142 USA.; Gupta, RM; Kathiresan, S (reprint author), Massachusetts Gen Hosp, Dept Med, Cardiol Div, Boston, MA 02114 USA.; Gupta, RM; Kathiresan, S (reprint author), Harvard Med Sch, Boston, MA 02115 USA.; Gupta, RM; Kathiresan, S (reprint author), Massachusetts Gen Hosp, Dept Med, Ctr Genom Med, Boston, MA 02114 USA.	rgupta@broadinstitute.org; skathiresan1@mgh.harvard.edu		Roselli, Carolina/0000-0001-5267-6756	Sarnoff Scholar Award; Harvard Catalyst CMERIT Award; NIH NHLBI [K08-HL128810]; NIH [T32 HL007734, R01HL127564]; NIH NHGRI [U54HG006991]; NIH NIDDK [R01 DK097768]; Fondation Leducq CVGeneF(x) Transatlantic Network of Excellence; Ofer and Shelly Nemirovsky MGH Research Scholar Award; Bayer Healthcare; Amarin; Regeneron; Novartis; Sanofi; AstraZeneca; Alnylam; Eli Lilly; Lerink Partners; Noble Insights; Merck; Quest Diagnostics; Amgen; Genentech; Corvidia; Ionis Pharmaceuticals	This work was supported by a Sarnoff Scholar Award, a Harvard Catalyst CMERIT Award, and NIH NHLBI K08-HL128810 (to R.M.G.); NIH T32 HL007734 (to D.K.); NIH NHGRI U54HG006991 to B.E.B.; and NIH NIDDK R01 DK097768, Fondation Leducq CVGeneF(x) Transatlantic Network of Excellence, NIH R01HL127564, and the Ofer and Shelly Nemirovsky MGH Research Scholar Award (to S.K.). The CHARGE endothelial function working group provided data for FMD analysis. S.K. reports receiving grants from Bayer Healthcare, Amarin, and Regeneron; serving on scientific advisory boards for Catabasis, Regeneron Genetics Center, Merck, Celera, and Genomics PLC; receiving consulting fees from Novartis, Sanofi, AstraZeneca, Alnylam, Eli Lilly, Lerink Partners, Noble Insights, Merck, Quest Diagnostics, Amgen, Genentech, Corvidia, Ionis Pharmaceuticals, and Eli Lilly; and holding equity in Catabasis and San Therapeutics.	Aguet F, 2016, BIORXIV; Amiri F, 2004, CIRCULATION, V110, P2233, DOI 10.1161/01.CIR.0000144462.08345.B9; Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Asghar MS, 2011, ANN NEUROL, V69, P635, DOI 10.1002/ana.22292; Bacon CR, 1996, CIRC RES, V79, P794; Barton M, 1998, P NATL ACAD SCI USA, V95, P14367, DOI 10.1073/pnas.95.24.14367                                                        ; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bauer RC, 2015, CIRCULATION, V131, P1202, DOI 10.1161/CIRCULATIONAHA.114.012669; Beaudoin M, 2015, ARTERIOSCL THROM VAS, V35, P1472, DOI 10.1161/ATVBAHA.115.305534; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Debette S, 2015, NAT GENET, V47, P78, DOI 10.1038/ng.3154; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Fukaya T., 2016, AM J PHYSIOL-RENAL, V288, pF912; GTEx Consortium, 2013, NAT GENET, V45, P580; HIRATA Y, 1993, J CLIN INVEST, V91, P1367, DOI 10.1172/JCI116338; HIRATA Y, 1989, ATHEROSCLEROSIS, V78, P225, DOI 10.1016/0021-9150(89)90227-X; Jarray R, 2015, BIOCHIMIE, V118, P151, DOI 10.1016/j.biochi.2015.09.008; Jarray R, 2011, BIOCHIMIE, V93, P1668, DOI 10.1016/j.biochi.2011.07.010; Kiando SR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006367; Klein FA, 2015, BIOINFORMATICS, V31, P3085, DOI 10.1093/bioinformatics/btv335; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; KOWALA MC, 1995, AM J PATHOL, V146, P819; Kreitzer FR, 2013, AM J STEM CELLS, V2, P119; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; LI JS, 1994, HYPERTENSION, V24, P183, DOI 10.1161/01.HYP.24.2.183                                                         ; Li MW, 2013, ARTERIOSCL THROM VAS, V33, P2306, DOI 10.1161/ATVBAHA.113.302028; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Voight BF, 2009, NAT GENET, V41, P334, DOI DOI 10.1038/NG.327; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Nurnberg ST, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005155; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; Olin JW, 2014, CIRCULATION, V129, P1048, DOI 10.1161/01.cir.0000442577.96802.8c; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Patsch C, 2015, NAT CELL BIOL, V17, P994, DOI 10.1038/ncb3205; Peters D. T., 2013, GENOME EDITING HUMAN; Pezzini A, 2005, CEPHALALGIA, V25, P575, DOI 10.1111/j.1468-2982.2005.00919.x; Ren Bing, 2015, Cold Spring Harb Symp Quant Biol, V80, P17, DOI 10.1101/sqb.2015.80.027219; Reschen ME, 2016, ATHEROSCLEROSIS, V250, P95, DOI 10.1016/j.atherosclerosis.2016.04.025; Kundaje A, 2015, NATURE, V518, P317, DOI DOI 10.1038/NATURE14248; Rubinstein SM, 2005, STROKE, V36, P1575, DOI 10.1161/01.STR.0000169919.73219.30; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schiffrin EL, 2005, VASC PHARMACOL, V43, P19, DOI 10.1016/j.vph.2005.03.004; Shi-wen Xu, 2001, Journal of Investigative Dermatology, V116, P417, DOI 10.1046/j.1523-1747.2001.01256.x; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; SORENSEN KE, 1995, BRIT HEART J, V74, P247; Stitziel NO, 2016, NEW ENGL J MED, V374, P1134, DOI 10.1056/NEJMoa1507652; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Surendran P, 2016, NAT GENET, V48, P1151, DOI 10.1038/ng.3654; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; Theodoris CV, 2015, CELL, V160, P1072, DOI 10.1016/j.cell.2015.02.035; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Vockley CM, 2016, CELL, V166, P1269, DOI 10.1016/j.cell.2016.07.049; Webb TR, 2017, J AM COLL CARDIOL, V69, P823, DOI 10.1016/j.jacc.2016.11.056; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Woods M, 1999, MOL PHARMACOL, V55, P902; Xu SW, 2004, J BIOL CHEM, V279, P23098, DOI 10.1074/jbc.M311430200; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; YOSHIZUMI M, 1990, BIOCHEM BIOPH RES CO, V166, P324, DOI 10.1016/0006-291X(90)91948-R; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	71	2	2	4	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					522	+		10.1016/j.cell.2017.06.049				27	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FB9ME	WOS:000406462400011	28753427				2018-01-05	
J	Koo, T; Yoon, AR; Cho, HY; Bae, S; Yun, CO; Kim, JS				Koo, Taeyoung; Yoon, A-Rum; Cho, Hee-Yeon; Bae, Sangsu; Yun, Chae-Ok; Kim, Jin-Soo			Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression	NUCLEIC ACIDS RESEARCH			English	Article							CELL LUNG-CANCER; IN-VIVO; EGFR MUTATIONS; PROSTATE-CANCER; GENE KNOCKOUT; GROWTH; CRISPR-CAS9; DISEASE; ADENOVIRUSES; RESISTANCE	Approximately 15% of non-small cell lung cancer cases are associated with a mutation in the epidermal growth factor receptor (EGFR) gene, which plays a critical role in tumor progression. With the goal of treating mutated EGFR-mediated lung cancer, we demonstrate the use of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated protein 9 (Cas9) system to discriminate between the oncogenic mutant and wild-type EGFR alleles and eliminate the carcinogenic mutant EGFR allele with high accuracy. We targeted an EGFR oncogene harboring a single-nucleotide missense mutation (CTG > CGG) that generates a protospacer-adjacent motif sequence recognized by the CRISPR/Cas9 derived from Streptococcus pyogenes. Co-delivery of Cas9 and an EGFR mutation-specific single-guide RNA via adenovirus resulted in precise disruption at the oncogenic mutation site with high specificity. Furthermore, this CRISPR/Cas9-mediated mutant allele disruption led to significantly enhanced cancer cell killing and reduced tumor size in a xenograft mouse model of human lung cancer. Taken together, these results indicate that targeting an oncogenic mutation using CRISPR/Cas9 offers a powerful surgical strategy to disrupt oncogenic mutations to treat cancers; similar strategies could be used to treat other mutation-associated diseases.	[Koo, Taeyoung; Cho, Hee-Yeon; Kim, Jin-Soo] Inst Basic Sci IBS, Ctr Genome Engn, Seoul 08826, South Korea; [Koo, Taeyoung; Kim, Jin-Soo] Univ Sci & Technol, Dept Basic Sci, Daejeon 34113, South Korea; [Yoon, A-Rum; Yun, Chae-Ok] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 04763, South Korea; [Bae, Sangsu] Hanyang Univ, Dept Chem, Seoul 04763, South Korea; [Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul 08826, South Korea	Kim, JS (reprint author), Inst Basic Sci IBS, Ctr Genome Engn, Seoul 08826, South Korea.; Kim, JS (reprint author), Univ Sci & Technol, Dept Basic Sci, Daejeon 34113, South Korea.; Yun, CO (reprint author), Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 04763, South Korea.; Kim, JS (reprint author), Seoul Natl Univ, Dept Chem, Seoul 08826, South Korea.	chaeok@hanyang.ac.kr; jskim01@snu.ac.kr			Institute for Basic Science [IBS-R021-D1]; National Research Foundation of Korea [2015R1A2A1A1 3027811, 2016M3A9B5942352]	Institute for Basic Science [IBS-R021-D1 to J.-S.K.] and National Research Foundation of Korea [2015R1A2A1A1 3027811, 2016M3A9B5942352 to C-O Yun]. Funding for open access charge: Institute for Basic Science [IBS-R021-D1].	Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Bachtarzi H, 2008, EXPERT OPIN DRUG DEL, V5, P1231, DOI [10.1517/17425240802507636, 10.1517/17425240802507636 ]; Beljanski V, 2012, CURR OPIN VIROL, V2, P629, DOI 10.1016/j.coviro.2012.07.006; Besse B, 2014, ANN ONCOL, V25, P1475, DOI 10.1093/annonc/mdu123; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Cheng RR, 2014, FEBS LETT, V588, P3954, DOI 10.1016/j.febslet.2014.09.008; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choi KJ, 2006, GENE THER, V13, P1010, DOI 10.1038/sj.gt.3302759; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Fang S, 2014, DRUG DES DEV THER, V8, P1595, DOI 10.2147/DDDT.S69690; Feng W, 2016, GENE, V587, P91, DOI 10.1016/j.gene.2016.04.046; Feng Y, 2015, J ORTHOP RES, V33, P199, DOI 10.1002/jor.22745; Fujita T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30485; Fukui T, 2010, CANCER CHEMOTH PHARM, V65, P803, DOI 10.1007/s00280-009-1212-5; Gebler C, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw183; Giaccone G, 2005, J CLIN ONCOL, V23, P3235, DOI 10.1200/JCO.2005.08.409                                                         ; Green NK, 2012, NANOMEDICINE-UK, V7, P1683, DOI [10.2217/NNM.12.50, 10.2217/nnm.12.50]; Huang K, 2017, CANCER LETT, V388, P269, DOI 10.1016/j.canlet.2016.12.011; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Inamura K, 2010, ARCH PATHOL LAB MED, V134, P66, DOI 10.1043/2008-0586-RAR1.1; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim J, 2002, CANCER GENE THER, V9, P725, DOI 10.1038/sj.cgt.7700494; Kim JH, 2006, J NATL CANCER I, V98, P1482, DOI 10.1093/jnci/djj937; Kirn D, 2000, ONCOGENE, V19, P6660, DOI 10.1038/sj.onc.1204094; Koo T, 2017, BRIEF FUNCT GENOMICS, V16, P38, DOI 10.1093/bfgp/elw032; Lee YS, 2006, CLIN CANCER RES, V12, P5859, DOI 10.1158/1078-0432.CCR-06-0935; Liu T, 2016, CANCER LETT, V373, P109, DOI 10.1016/j.canlet.2016.01.030; Liu YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6393; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Minari R, 2016, TRANSL LUNG CANCER R, V5, P695, DOI 10.21037/tlcr.2016.12.02; Monteys AM, 2017, MOL THER, V25, P12, DOI 10.1016/j.ymthe.2016.11.010; Ohsaki Y, 2000, ONCOL REP, V7, P603; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Park J, 2017, BIOINFORMATICS, V33, P286, DOI 10.1093/bioinformatics/btw561; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Sandler AB, 2004, CLIN CANCER RES, V10, p4258S, DOI 10.1158/1078-0432.CCR-040023                                                    ; Shin JW, 2016, HUM MOL GENET, V25, P4566, DOI 10.1093/hmg/ddw286; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Smith C, 2015, MOL THER, V23, P570, DOI 10.1038/mt.2014.226; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tsai MF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13574; Valletta S, 2015, ONCOTARGET, V6, P44061, DOI 10.18632/oncotarget.6392; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yi L, 2016, BBA-REV CANCER, V1866, P197, DOI 10.1016/j.bbcan.2016.09.002; Yoo JY, 2008, GENE THER, V15, P635, DOI 10.1038/gt.2008.3; Yoo JY, 2007, MOL THER, V15, P295, DOI 10.1038/sj.mt.6300023; Yoon AR, 2016, J CONTROL RELEASE, V231, P2, DOI 10.1016/j.jconrel.2016.02.046; Yoon AR, 2015, ONCOTARGET, V6, P34875, DOI 10.18632/oncotarget.5332; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Yu JY, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0086-2; Yun CO, 2005, CANCER GENE THER, V12, P61, DOI 10.1038/sj.cgt.7700769; Zhao BX, 2015, MOL MED REP, V11, P2767, DOI 10.3892/mmr.2014.3058; Zhen S, 2017, ONCOTARGET, V8, P9375, DOI 10.18632/oncotarget.14072	64	1	1	10	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	JUL 27	2017	45	13					7897	7908		10.1093/nar/gkx490				12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FC3YV	WOS:000406776400039	28575452	gold			2018-01-05	
J	Baker, O; Tsurkan, S; Fu, J; Klink, B; Rump, A; Obst, M; Kranz, A; Schrock, E; Anastassiadis, K; Stewart, AF				Baker, Oliver; Tsurkan, Sarah; Fu, Jun; Klink, Barbara; Rump, Andreas; Obst, Mandy; Kranz, Andrea; Schroeck, Evelin; Anastassiadis, Konstantinos; Stewart, A. Francis			The contribution of homology arms to nuclease-assisted genome engineering	NUCLEIC ACIDS RESEARCH			English	Article							ZINC-FINGER NUCLEASES; MEDIATED TARGETED INTEGRATION; EMBRYONIC STEM-CELLS; DOUBLE-STRAND BREAKS; BAC TRANSGENESIS; CRISPR-CAS; HPRT GENE; DNA; RECOMBINATION; ENDONUCLEASE	Designer nucleases like CRISPR/Cas9 enable fluent site-directed damage or small mutations in many genomes. Strategies for their use to achieve more complex tasks like regional exchanges for gene humanization or the establishment of conditional alleles are still emerging. To optimize Cas9-assisted targeting, we measured the relationship between targeting frequency and homology length in targeting constructs using a hypoxanthine-guanine phosphoribosyl-transferase assay in mouse embryonic stem cells. Targeting frequency with supercoiled plasmids improved steeply up to 2 kb total homology and continued to increase with even longer homology arms, thereby implying that Cas9-assisted targeting efficiencies can be improved using homology arms of 1 kb or greater. To humanize the Kmt2d gene, we built a hybrid mouse/human targeting construct in a bacterial artificial chromosome by recombineering. To simplify the possible outcomes, we employed a single Cas9 cleavage strategy and best achieved the intended 42 kb regional exchange with a targeting construct including a very long homology arm to recombine similar to 42 kb away from the cleavage site. We recommend the use of long homology arm targeting constructs for accurate and efficient complex genome engineering, particularly when combined with the simplifying advantages of using just one Cas9 cleavage at the genome target site.	[Baker, Oliver; Obst, Mandy; Anastassiadis, Konstantinos] Tech Univ Dresden, Stem Cell Engn, Ctr Biotechnol, BioInnovat Zentrum, Tatzberg 47, D-01307 Dresden, Germany; [Baker, Oliver; Tsurkan, Sarah; Fu, Jun; Obst, Mandy; Kranz, Andrea; Stewart, A. Francis] Tech Univ Dresden, Genom, Ctr Biotechnol, BioInnovat Zentrum, Tatzberg 47, D-01307 Dresden, Germany; [Fu, Jun] Shandong Univ, Shandong Univ Helmholtz Joint Inst Biotechnol, State Key Lab Microbial Technol, Shanda Nanlu 27, Jinan 250100, Shandong, Peoples R China; [Klink, Barbara; Rump, Andreas; Schroeck, Evelin] Tech Univ Dresden, Inst Clin Genet, Fac Med, Fetscherstr 74, D-01307 Dresden, Germany; [Baker, Oliver] Horizon Discovery Grp Plc, 8100 Cambridge Res Pk, Cambridge CB25 9TL, England	Anastassiadis, K (reprint author), Tech Univ Dresden, Stem Cell Engn, Ctr Biotechnol, BioInnovat Zentrum, Tatzberg 47, D-01307 Dresden, Germany.; Stewart, AF (reprint author), Tech Univ Dresden, Genom, Ctr Biotechnol, BioInnovat Zentrum, Tatzberg 47, D-01307 Dresden, Germany.	anastass@biotec.tu-dresden.de; stewart@biotec.tu-dresden.de			EU 7th Framework project, PluriMes [602423]; Deutches Krebshilfe [110560]; Else Kroner-Fresenius Stiftung [2012 A300]; DFG	EU 7th Framework project, PluriMes (602423 to K.A.); Deutches Krebshilfe (110560 to A,K and A.F.S.); Else Kroner-Fresenius Stiftung (2012 A300 to A.K and A.F.S.). Source of Open Access funding: DFG Support the Best program of TUD.	Angrand P O, 1999, Nucleic Acids Res, V27, pe16, DOI 10.1093/nar/27.17.e16; Baker O, 2016, SCI REP-UK, V6, DOI 10.1038/srep25529; Beaton BP, 2015, XENOTRANSPLANTATION, V22, P379, DOI 10.1111/xen.12194; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657                                                             ; Byrne SM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1246; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365                                                           ; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0                                                                ; Frendewey D, 2010, METHOD ENZYMOL, V476, P295, DOI 10.1016/S0076-6879(10)76017-1; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gravells P, 2015, HUM MOL GENET, V24, P7097, DOI 10.1093/hmg/ddv409; HASTY P, 1991, MOL CELL BIOL, V11, P4509, DOI 10.1128/MCB.11.9.4509                                                           ; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kantidakis T, 2016, GENE DEV, V30, P408, DOI 10.1101/gad.275453.115; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Lackner DH, 2015, NAT COMMUN, V6; Lee EC, 2014, NAT BIOTECHNOL, V32, P356, DOI 10.1038/nbt.2825; Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Maresca M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-54; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Murphy AJ, 2014, P NATL ACAD SCI USA, V111, P5153, DOI 10.1073/pnas.1324022111; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Rostovskaya M, 2013, GENESIS, V51, P135, DOI 10.1002/dvg.22362; Rostovskaya M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks643; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; STOUT JT, 1985, ANNU REV GENET, V19, P127, DOI 10.1146/annurev.genet.19.1.127; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Wallace HAC, 2007, CELL, V128, P197, DOI 10.1016/j.cell.2006.11.044; Wang HL, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1339; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	48	0	0	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	JUL 27	2017	45	13					8105	8115		10.1093/nar/gkx497				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FC3YV	WOS:000406776400053	28582546	gold			2018-01-05	
J	Hirosawa, M; Fujita, Y; Parr, CJC; Hayashi, K; Kashida, S; Hotta, A; Woltjen, K; Saito, H				Hirosawa, Moe; Fujita, Yoshihiko; Parr, Callum J. C.; Hayashi, Karin; Kashida, Shunnichi; Hotta, Akitsu; Woltjen, Knut; Saito, Hirohide			Cell-type-specific genome editing with a microRNA-responsive CRISPR-Cas9 switch	NUCLEIC ACIDS RESEARCH			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; PLURIPOTENT STEM-CELLS; CANCER-CELLS; IN-VIVO; RNA; CAS9; NUCLEASES; DELIVERY; GENE; IDENTIFICATION	The CRISPR-Cas9 system is a powerful genome-editing tool useful in a variety of biotechnology and biomedical applications. Here we developed a synthetic RNA-based, microRNA (miRNA)-responsive CRISPR-Cas9 system (miR-Cas9 switch) in which the genome editing activity of Cas9 can be modulated through endogenous miRNA signatures in mammalian cells. We created miR-Cas9 switches by using a miRNA-complementary sequence in the 5'-UTR of mRNA encoding Streptococcus pyogenes Cas9. The miR-21-Cas9 or miR-302-Cas9 switches selectively and efficiently responded to miR-21-5p in HeLa cells or miR-302a-5p in human induced pluripotent stem cells, and post-transcriptionally attenuated the Cas9 activity only in the target cells. Moreover, the miR-Cas9 switches could differentially control the genome editing by sensing endogenous miRNA activities within a heterogeneous cell population. Our miR-Cas9 switch system provides a promising framework for cell-type selective genome editing and cell engineering based on intracellular miRNA information.	[Hirosawa, Moe; Fujita, Yoshihiko; Parr, Callum J. C.; Hayashi, Karin; Kashida, Shunnichi; Hotta, Akitsu; Woltjen, Knut; Saito, Hirohide] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Dept Life Sci Frontiers, Kyoto, Japan; [Hirosawa, Moe] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Woltjen, Knut] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto, Japan	Saito, H (reprint author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Dept Life Sci Frontiers, Kyoto, Japan.	hirohide.saito@cira.kyoto-u.ac.jp			JSPS KAKENHI [15H05722, 24104002, 15H02376, 15H05581]; Naito Foundation; Canon Foundation; Nakatani Foundation; JSPS [16J10715]	JSPS KAKENHI [15H05722, 24104002, 15H02376 to H.S. and 15H05581 to A.H.]; Naito Foundation (to H.S.); Canon Foundation (to H.S.); Nakatani Foundation (to H.S.); JSPS Fellows [16J10715 to M.H.]. Funding for open access charge: JSPS KAKENHI [15H05722 to H.S.]. Conflict of interest statement. Kyoto University has filed a patent application broadly relevant to this work. M. Hirosawa and H. Saito are the investigators of record listed on the patent application.	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Feng YH, 2016, BIOMED REP, V5, P395, DOI 10.3892/br.2016.747; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hemphill J, 2015, J AM CHEM SOC, V137, P5642, DOI 10.1021/ja512664v; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Liu YC, 2016, NAT METHODS, V13, P938, DOI [10.1038/NMETH.3994, 10.1038/nmeth.3994]; Liu YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6393; Ma DC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13056; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miki K, 2015, CELL STEM CELL, V16, P699, DOI 10.1016/j.stem.2015.04.005; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/NMETH.2078, 10.1038/nmeth.2078]; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Oceguera-Yanez F, 2016, METHODS, V101, P43, DOI 10.1016/j.ymeth.2015.12.012; Parr C.J.C., 2016, NAT PUBL GR, V6, P32532; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wroblewska L, 2015, NAT BIOTECHNOL, V33, P839, DOI 10.1038/nbt.3301; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149	28	1	1	6	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	JUL 27	2017	45	13							e118	10.1093/nar/gkx309				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FC3YV	WOS:000406776400001	28525578	gold			2018-01-05	
J	Pinto, R; Hansen, L; Hintze, J; Almeida, R; Larsen, S; Coskun, M; Davidsen, J; Mitchelmore, C; David, L; Troelsen, JT; Bennett, EP				Pinto, Rita; Hansen, Lars; Hintze, John; Almeida, Raquel; Larsen, Sylvester; Coskun, Mehmet; Davidsen, Johanne; Mitchelmore, Cathy; David, Leonor; Troelsen, Jesper Thorvald; Bennett, Eric Paul			Precise integration of inducible transcriptional elements (PrIITE) enables absolute control of gene expression	NUCLEIC ACIDS RESEARCH			English	Article							TETRACYCLINE RESISTANCE DETERMINANT; MEDIATED TARGETED INTEGRATION; TET-ON SYSTEM; MAMMALIAN-CELLS; RESPONSIVE PROMOTERS; HOMEODOMAIN PROTEINS; NUCLEOTIDE-SEQUENCE; REPRESSOR GENE; COLON-CANCER; MUCIN GENE	Tetracycline-based inducible systems provide powerful methods for functional studies where gene expression can be controlled. However, the lack of tight control of the inducible system, leading to leakiness and adverse effects caused by undesirable tetracycline dosage requirements, has proven to be a limitation. Here, we report that the combined use of genome editing tools and last generation Tet-On systems can resolve these issues. Our principle is based on precise integration of inducible transcriptional elements (coined PrIITE) targeted to: (i) exons of an endogenous gene of interest (GOI) and (ii) a safe harbor locus. Using PrIITE cells harboring a GFP reporter or CDX2 transcription factor, we demonstrate discrete inducibility of gene expression with complete abrogation of leakiness. CDX2 PrIITE cells generated by this approach uncovered novel CDX2 downstream effector genes. Our results provide a strategy for characterization of dose-dependent effector functions of essential genes that require absence of endogenous gene expression.	[Pinto, Rita; Almeida, Raquel; David, Leonor] Univ Porto, i3S, Oporto, Portugal; [Pinto, Rita; Almeida, Raquel; David, Leonor] Univ Porto, Inst Mol Pathol & Immunol, Ipatimup, Oporto, Portugal; [Pinto, Rita; Almeida, Raquel; David, Leonor] Univ Porto, Fac Med, Oporto, Portugal; [Pinto, Rita; Hansen, Lars; Hintze, John; Bennett, Eric Paul] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Copenhagen, Denmark; [Pinto, Rita; Hansen, Lars; Hintze, John; Bennett, Eric Paul] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Odontol, Copenhagen, Denmark; [Almeida, Raquel] Univ Porto, Fac Sci, Dept Biol, Oporto, Portugal; [Larsen, Sylvester; Davidsen, Johanne; Mitchelmore, Cathy; Troelsen, Jesper Thorvald] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark; [Larsen, Sylvester] Naestved Hosp, Dept Clin Immunol, Naestved, Denmark; [Coskun, Mehmet] Univ Copenhagen, Herlev Hosp, Med Sect, Dept Gastroenterol, Copenhagen, Denmark; [Coskun, Mehmet] Univ Copenhagen, Bioinformat Ctr, Dept Biol, Copenhagen, Denmark; [Coskun, Mehmet] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Pinto, Rita] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway	Bennett, EP (reprint author), Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Copenhagen, Denmark.; Bennett, EP (reprint author), Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Odontol, Copenhagen, Denmark.	epb@sund.ku.dk	David, Leonor/A-4829-2008	David, Leonor/0000-0003-4207-9258; Larsen, Sylvester/0000-0002-6631-3056; Davidsen, Johanne/0000-0003-4655-1513; Bennett, Eric Paul/0000-0002-4976-0647; Larsen, Sylvester/0000-0002-5736-8055; Troelsen, Jesper Thorvald/0000-0002-4177-3267	University of Copenhagen Excellence Programme for Interdisciplinary Research [CDO2016]; Danish Council for Independent Research [4004-00140B]; Novo Nordisk Foundation; Danish National Research Foundation [DNRF107]; FEDER-Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020-Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020; Portuguese funds through FCT-Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao [POCI-01-0145-FEDER-007274, POCI-01-0145-FEDER-016390]	University of Copenhagen Excellence Programme for Interdisciplinary Research [CDO2016]; The Danish Council for Independent Research [4004-00140B], Novo Nordisk Foundation, Danish National Research Foundation [DNRF107], FEDER-Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020-Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020; Portuguese funds through FCT-Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao [POCI-01-0145-FEDER-007274, POCI-01-0145-FEDER-016390]. Funding for open access charge: Danish National Research Foundation [DNRF107].	Bahr S., 2013, BMC P, V7, pP3; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bensinger S.J., 2013, PLOS ONE, V8, P8; Boyd M, 2010, J BIOL CHEM, V285, P25115, DOI 10.1074/jbc.M109.089516; BRASELMANN S, 1993, P NATL ACAD SCI USA, V90, P1657, DOI 10.1073/pnas.90.5.1657; BROWN MS, 1974, SCIENCE, V185, P61, DOI 10.1126/science.185.4145.61; Bruning A, 2014, EXP CELL RES, V320, P281, DOI 10.1016/j.yexcr.2013.11.012; Bu XD, 2011, TISSUE CELL, V43, P201, DOI 10.1016/j.tice.2011.03.002; Cai Y., 2016, ELIFE; CAPECCHI MR, 1980, CELL, V22, P479, DOI 10.1016/0092-8674(80)90358-X; Ciprotti M, 2014, EJNMMI RES, V4, P1, DOI 10.1186/s13550-014-0022-x; Coluccio A, 2013, MOL THER, V21, P1695, DOI 10.1038/mt.2013.143; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coskun M, 2011, BBA-MOL BASIS DIS, V1812, P283, DOI 10.1016/j.bbadis.2010.11.008; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; Das AT, 2016, CURR GENE THER, V16, P156, DOI 10.2174/1566523216666160524144041; Das AT, 2016, BIOTECHNOL J, V11, P71, DOI 10.1002/biot.201500236; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Duda K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku251; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Freundlieb S, 1999, J GENE MED, V1, P4, DOI 10.1002/(SICI)1521-2254(199901/02)1:1<4::AID-JGM4>3.0.CO;2-Y                    ; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; GERARD C, 1990, J CLIN INVEST, V86, P1921, DOI 10.1172/JCI114925; Geurts A.M., 2010, SCIENCE, V325, P2009; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; GOTH R, 1972, CANCER RES, V32, P1501; Gottke MU, 1998, J EUKARYOT MICROBIOL, V45, p17S, DOI 10.1111/j.1550-7408.1998.tb04519.x; Hansen L, 2015, GLYCOBIOLOGY, V25, P211, DOI 10.1093/glycob/cwu104; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Heath JK, 1997, P NATL ACAD SCI USA, V94, P469, DOI 10.1073/pnas.94.2.469                                                           ; Heinz N, 2011, HUM GENE THER, V22, P166, DOI 10.1089/hum.2010.099; HINTON CW, 1950, P NATL ACAD SCI USA, V36, P552, DOI 10.1073/pnas.36.10.552                                                          ; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Isshiki S, 2003, J BIOL CHEM, V278, P36611, DOI 10.1074/jbc.M302681200; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kong Y., 2014, GLYCOBIOLOGY, P1; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee J.S., 2016, BIOTECHNOL BIOENG, V9999, P1; Liu J, 2014, EXP THER MED, V8, P1351, DOI 10.3892/etm.2014.1965; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Lonowski LA, 2017, NAT PROTOC, V12, P581, DOI 10.1038/nprot.2016.165; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mansour WY, 2008, NUCLEIC ACIDS RES, V36, P4088, DOI 10.1093/nar/gkn347; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Mesquita P, 2003, J BIOL CHEM, V278, P51549, DOI 10.1074/jbc.M309019200; Mitchelmore C, 2000, BIOCHEM J, V346, P529, DOI 10.1042/0264-6021:3460529; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Pinto R, 2015, LAB INVEST, V95, P718, DOI 10.1038/labinvest.2015.52; POSTLE K, 1984, NUCLEIC ACIDS RES, V12, P4849, DOI 10.1093/nar/12.12.4849                                                          ; Rizzino A, 2009, WIRES SYST BIOL MED, V1, P228, DOI 10.1002/wsbm.12; RUTZKY LP, 1980, CANCER RES, V40, P1443; Sakamoto J, 2000, CANCER CHEMOTH PHARM, V46, pS27, DOI 10.1007/PL00014045                                                              ; Sakuma K, 2012, P NATL ACAD SCI USA, V109, P7776, DOI 10.1073/pnas.1111135109; Salari K, 2012, P NATL ACAD SCI USA, V109, pE3196, DOI 10.1073/pnas.1206004109; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340                                                          ; UNGER B, 1984, NUCLEIC ACIDS RES, V12, P7693, DOI 10.1093/nar/12.20.7693; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Van Cong N., 1990, HUM GENET, V86, P167; Velcich A, 1997, J BIOL CHEM, V272, P7968, DOI 10.1074/jbc.272.12.7968                                                         ; Wandall HH, 2012, BLOOD, V120, P626, DOI 10.1182/blood-2012-02-409235; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wheeler D.a., 2012, NATURE, V487, P330; Yamamoto Y, 2015, G3-GENES GENOM GENET, V5, P1843, DOI 10.1534/g3.115.019901; Yang Z, 2015, NAT BIOTECHNOL, V33, P842, DOI 10.1038/nbt.3280; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780	74	0	0	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	JUL 27	2017	45	13							e123	10.1093/nar/gkx371				15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FC3YV	WOS:000406776400006	28472465	gold			2018-01-05	
J	Manguso, RT; Pope, HW; Zimmer, MD; Brown, FD; Yates, KB; Miller, BC; Collins, NB; Bi, K; Lafleur, MW; Juneja, VR; Weiss, SA; Lo, J; Fisher, DE; Miao, D; Van Allen, E; Root, DE; Sharpe, AH; Doench, JG; Haining, WN				Manguso, Robert T.; Pope, Hans W.; Zimmer, Margaret D.; Brown, Flavian D.; Yates, Kathleen B.; Miller, Brian C.; Collins, Natalie B.; Bi, Kevin; Lafleur, Martin W.; Juneja, Vikram R.; Weiss, Sarah A.; Lo, Jennifer; Fisher, David E.; Miao, Diana; Van Allen, Eliezer; Root, David E.; Sharpe, Arlene H.; Doench, John G.; Haining, W. Nicholas			In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; T-CELL IMMUNITY; HLA-E; GENE; MELANOMA; EXPRESSION; BLOCKADE; CD94/NKG2A; PD-1	Immunotherapy with PD-1 checkpoint blockade is effective in only a minority of patients with cancer, suggesting that additional treatment strategies are needed. Here we use a pooled in vivo genetic screening approach using CRISPR-Cas9 genome editing in transplantable tumours in mice treated with immunotherapy to discover previously undescribed immunotherapy targets. We tested 2,368 genes expressed by melanoma cells to identify those that synergize with or cause resistance to checkpoint blockade. We recovered the known immune evasion molecules PD-L1 and CD47, and confirmed that defects in interferon-gamma signalling caused resistance to immunotherapy. Tumours were sensitized to immunotherapy by deletion of genes involved in several diverse pathways, including NF-kappa B signalling, antigen presentation and the unfolded protein response. In addition, deletion of the protein tyrosine phosphatase PTPN2 in tumour cells increased the efficacy of immunotherapy by enhancing interferon-gamma-mediated effects on antigen presentation and growth suppression. In vivo genetic screens in tumour models can identify new immunotherapy targets in unanticipated pathways.	[Manguso, Robert T.; Pope, Hans W.; Zimmer, Margaret D.; Brown, Flavian D.; Yates, Kathleen B.; Miller, Brian C.; Collins, Natalie B.; Bi, Kevin; Lafleur, Martin W.; Weiss, Sarah A.; Haining, W. Nicholas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Manguso, Robert T.; Brown, Flavian D.; Lafleur, Martin W.; Miao, Diana; Van Allen, Eliezer] Harvard Med Sch, Div Med Sci, Boston, MA 02115 USA; [Manguso, Robert T.; Pope, Hans W.; Zimmer, Margaret D.; Yates, Kathleen B.; Miller, Brian C.; Collins, Natalie B.; Bi, Kevin; Miao, Diana; Van Allen, Eliezer; Root, David E.; Doench, John G.; Haining, W. Nicholas] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Miller, Brian C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Collins, Natalie B.; Sharpe, Arlene H.; Haining, W. Nicholas] Childrens Hosp, Div Pediat Hematol & Oncol, 300 Longwood Ave, Boston, MA 02115 USA; [Juneja, Vikram R.] Harvard Med Sch, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Lo, Jennifer; Fisher, David E.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Bldg 149,13th St, Charlestown, MA 02129 USA; [Lo, Jennifer; Fisher, David E.] Harvard Med Sch, Bldg 149,13th St, Charlestown, MA 02129 USA; [Sharpe, Arlene H.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA	Haining, WN (reprint author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Haining, WN (reprint author), Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA.; Haining, WN (reprint author), Childrens Hosp, Div Pediat Hematol & Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	Nicholas_Haining@dfci.harvard.edu		Miller, Brian/0000-0001-5931-4184	Broad Institute of Harvard; MIT; NIGMS [T32GM007753]	This work was supported by BroadIgnite and BroadNext10 awards from the Broad Institute of Harvard and MIT. S.A.W. was supported by award number T32GM007753 from the NIGMS. We thank members of the Haining laboratory for their spirited discussions.	Benevolo M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-184; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dranoff G, 2003, ONCOGENE, V22, P3188, DOI 10.1038/sj.onc.1206459; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Holmgaard RB, 2013, J EXP MED, V210, P1389, DOI 10.1084/jem.20130066; Howard T. P., 2016, COLD SPRING HARB SYM, V81, P237, DOI 10.1101/sqb.2016.81.031070; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; Kleppe M, 2011, BLOOD, V117, P7090, DOI 10.1182/blood-2010-10-314286; Kleppe M, 2010, NAT GENET, V42, P530, DOI 10.1038/ng.587; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Morandi F, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00394; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pike KA, 2016, CYTOKINE, V82, P52, DOI 10.1016/j.cyto.2015.12.025; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Saez-Borderias A, 2009, J IMMUNOL, V182, P829, DOI 10.4049/jimmunol.182.2.829                                                      ; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Wada H, 2004, EUR J IMMUNOL, V34, P81, DOI 10.1002/eji.200324432; Wellcome Trust Case Control Consortium, 2007, NATURE, V447, P661, DOI DOI 10.1038/NATURE05911; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yazdi MT, 2016, ONCOTARGET, V7, P3467; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	35	3	3	76	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					413	+		10.1038/nature23270				17	Multidisciplinary Sciences	Science & Technology - Other Topics	FB7ZK	WOS:000406358300027	28723893				2018-01-05	
J	Xiong, TN; Meister, GE; Workman, RE; Kato, NC; Spellberg, MJ; Turker, F; Timp, W; Ostermeier, M; Novina, CD				Xiong, Tina; Meister, Glenna E.; Workman, Rachael E.; Kato, Nathaniel C.; Spellberg, Michael J.; Turker, Fulya; Timp, Winston; Ostermeier, Marc; Novina, Carl D.			Targeted DNA methylation in human cells using engineered dCas9-methyltransferases	SCIENTIFIC REPORTS			English	Article							TUMOR-SUPPRESSOR GENE; IN-VIVO; MAMMALIAN DEVELOPMENT; CRISPR-CAS9 SYSTEM; BREAST-CANCER; CPG ISLAND; PROMOTER; EXPRESSION; METHYLTRANSFERASES; TRANSCRIPTION	Mammalian genomes exhibit complex patterns of gene expression regulated, in part, by DNA methylation. The advent of engineered DNA methyltransferases (MTases) to target DNA methylation to specific sites in the genome will accelerate many areas of biological research. However, targeted MTases require clear design rules to direct site-specific DNA methylation and minimize the unintended effects of off-target DNA methylation. Here we report a targeted MTase composed of an artificially split CpG MTase (sMTase) with one fragment fused to a catalytically-inactive Cas9 (dCas9) that directs the functional assembly of sMTase fragments at the targeted CpG site. We precisely map RNA-programmed DNA methylation to targeted CpG sites as a function of distance and orientation from the protospacer adjacent motif (PAM). Expression of the dCas9-sMTase in mammalian cells led to predictable and efficient (up to -70%) DNA methylation at targeted sites. Multiplexing sgRNAs enabled targeting methylation to multiple sites in a single promoter and to multiple sites in multiple promoters. This programmable de novo MTase tool might be used for studying mechanisms of initiation, spreading and inheritance of DNA methylation, and for therapeutic gene silencing.	[Xiong, Tina; Kato, Nathaniel C.; Ostermeier, Marc] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Meister, Glenna E.; Spellberg, Michael J.; Turker, Fulya; Novina, Carl D.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA; [Meister, Glenna E.; Spellberg, Michael J.; Turker, Fulya; Novina, Carl D.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Meister, Glenna E.; Spellberg, Michael J.; Turker, Fulya; Novina, Carl D.] Broad Inst Harvard & MIT, Cambridge, MA 02141 USA; [Workman, Rachael E.; Timp, Winston] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Turker, Fulya] Boston Univ, Boston, MA 02215 USA	Novina, CD (reprint author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA.; Novina, CD (reprint author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Novina, CD (reprint author), Broad Inst Harvard & MIT, Cambridge, MA 02141 USA.	carl_novina@dfci.harvard.edu			US National Science Foundation [CBET-1510652, CBET-1505793]; National Institute of Health Director's Pioneer award [1DP1 DK105602-01]	This work was funded by the US National Science Foundation (CBET-1510652 to MO, and CBET-1505793 to CDN) and a National Institute of Health Director's Pioneer award 1DP1 DK105602-01 (CDN).	Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Bartolomei M. S., 2011, COLD SPRING HARBOR P, V3; BENHATTAR J, 1988, GENE, V65, P219, DOI 10.1016/0378-1119(88)90458-1; Bestor TH, 2015, P NATL ACAD SCI USA, V112, P6796, DOI 10.1073/pnas.1415301111; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Carvin CD, 2003, NUCLEIC ACIDS RES, V31, P6493, DOI 10.1093/nar/gkg853; Chaikind B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096931; Chaikind B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044852; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fraga MF, 2003, NUCLEIC ACIDS RES, V31, P1765, DOI 10.1093/nar/gkg249; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536                                                        ; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gonzalgo ML, 1998, CANCER RES, V58, P1245; Jeronimo C, 2001, J NATL CANCER I, V93, P1747, DOI 10.1093/jnci/93.22.1747; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Laufer B. I., 2015, EPIGENETICS CHROMATI, V8; Lee D. S., 2014, NATURE COMMUNICATION, V5; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Mabaera R, 2007, BLOOD, V110, P1343, DOI 10.1182/blood-2007-01-068635; McDonald JI, 2016, BIOL OPEN, V5, P866, DOI 10.1242/bio.019067; McNamara AR, 2002, NUCLEIC ACIDS RES, V30, P3818, DOI 10.1093/nar/gkf501; Meister GE, 2010, NUCLEIC ACIDS RES, V38, P1749, DOI 10.1093/nar/gkp1126; Miller E. M., 1995, ELECTROPORATION PROT; Paschon DE, 2005, J MOL BIOL, V353, P26, DOI 10.1016/j.jmb.2005.08.026; Pogribny IP, 2000, CANCER RES, V60, P588; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rivenbark AG, 2012, EPIGENETICS-US, V7, P350, DOI 10.4161/epi.19507; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457                                                          ; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Sheaffer KL, 2014, GENE DEV, V28, P652, DOI 10.1101/gad.230318.113; Shieh FK, 2006, J MOL BIOL, V362, P516, DOI 10.1016/j.jmb.2006.07.030; Smith AE, 2008, J BIOL CHEM, V283, P9878, DOI 10.1074/jbc.M710393200; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Sohn BH, 2010, GASTROENTEROLOGY, V138, P1898, DOI 10.1053/j.gastro.2009.12.044; Stepper P., 2016, NUCLEIC ACIDS RES, P1; Stolzenburg S, 2015, ONCOGENE, V34, P5427, DOI 10.1038/onc.2014.470; Sung CK, 2013, MOL ONCOL, V7, P419, DOI 10.1016/j.molonc.2012.11.005; van Vlodrop IJH, 2011, CLIN CANCER RES, V17, P4225, DOI 10.1158/1078-0432.CCR-10-3394; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Vlahovicek K, 2000, BIOINFORMATICS, V16, P1044, DOI 10.1093/bioinformatics/16.11.1044; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wicki R, 1997, CELL CALCIUM, V22, P243, DOI 10.1016/S0143-4160(97)90063-4                                                   ; Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376	55	1	1	9	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 27	2017	7								6732	10.1038/s41598-017-06757-0				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FB8CH	WOS:000406366000090	28751638	gold			2018-01-05	
J	Tripathi, C; Mishra, H; Khurana, H; Dwivedi, V; Kamra, K; Negi, RK; Lal, R				Tripathi, Charu; Mishra, Harshita; Khurana, Himani; Dwivedi, Vatsala; Kamra, Komal; Negi, Ram K.; Lal, Rup			Complete Genome Analysis of Thermus parvatiensis and Comparative Genomics of Thermus spp. Provide Insights into Genetic Variability and Evolution of Natural Competence as Strategic Survival Attributes	FRONTIERS IN MICROBIOLOGY			English	Article						thermophiles; Thermus parvatiensis; CRISPR; Pilus genes; natural transformation; phage resistance	MULTIPLE SEQUENCE ALIGNMENT; THERMOSTABLE DNA-POLYMERASE; PHAGE SEARCH TOOL; SP NOV.; TRANSCRIPTIONAL REGULATORS; EXTREME THERMOPHILE; ESCHERICHIA-COLI; HIMALAYAN RANGES; CHAIN-REACTION; LOCATED ATOP	Thermophilic environments represent an interesting niche. Among thermophiles, the genus Thermus is among the most studied genera. In this study, we have sequenced the genome of Thermus parvatiensis strain RL, a thermophile isolated from Himalayan hot water springs (temperature >96 degrees C) using PacBio RSII SMRT technique. The small genome (2.01 Mbp) comprises a chromosome (1.87 Mbp) and a plasmid (143 Kbp), designated in this study as pTP143. Annotation revealed a high number of repair genes, a squeezed genome but containing highly plastic plasmid with transposases, integrases, mobile elements and hypothetical proteins (44%). We performed a comparative genomic study of the group Thermus with an aim of analysing the phylogenetic relatedness as well as niche specific attributes prevalent among the group. We compared the reference genome RL with 16 Thermus genomes to assess their phylogenetic relationships based on 16S rRNA gene sequences, average nucleotide identity (ANI), conserved marker genes (31 and 400), pan genome and tetranucleotide frequency. The core genome of the analyzed genomes contained 1,177 core genes and many singleton genes were detected in individual genomes, reflecting a conserved core but adaptive pan repertoire. We demonstrated the presence of metagenomic islands (chromosome:5, plasmid: 5) by recruiting raw metagenomic data (from the same niche) against the genomic replicons of T. parvatiensis. We also dissected the CRISPR loci wide all genomes and found widespread presence of this system across Thermus genomes. Additionally, we performed a comparative analysis of competence loci wide Thermus genomes and found evidence for recent horizontal acquisition of the locus and continued dispersal among members reflecting that natural competence is a beneficial survival trait among Thermus members and its acquisition depicts unending evolution in order to accomplish optimal fitness.	[Tripathi, Charu; Mishra, Harshita; Khurana, Himani; Dwivedi, Vatsala; Negi, Ram K.; Lal, Rup] Univ Delhi, Dept Zool, New Delhi, India; [Kamra, Komal] Univ Delhi, Sri Guru Tegh Bahadar Khalsa Coll, Ciliate Biol Lab, New Delhi, India	Lal, R (reprint author), Univ Delhi, Dept Zool, New Delhi, India.	ruplal@gmail.com			Department of Biotechnology, Government of India [BT/PR15118/BCE/8/1141/2015]; National Bureau of Agriculturally Important Microorganisms [NBAIM/AMAAS/2014-17/PF/9]	This work was supported by grants from the Department of Biotechnology (Grant no. BT/PR15118/BCE/8/1141/2015), Government of India and National Bureau of Agriculturally Important Microorganisms (Grant no. NBAIM/AMAAS/2014-17/PF/9).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson RE, 2011, FEMS MICROBIOL ECOL, V77, P120, DOI 10.1111/j.1574-6941.2011.01090.x; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Averhoff B, 2009, FEMS MICROBIOL REV, V33, P611, DOI 10.1111/j.1574-6976.2008.00160.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Blank S, 2014, JSM BIOTECHNOL BIOME, V2, P1027; BROCK TD, 1969, J BACTERIOL, V98, P289; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Bruggemann H, 2006, J BIOTECHNOL, V124, P654, DOI 10.1016/j.jbiotec.2006.03.043; Burkhardt J, 2011, J BIOL CHEM, V286, P9977, DOI 10.1074/jbc.M110.212688; CARBALLEIRA N, 1990, BIOTECHNIQUES, V9, P276; Chaudhari NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24373; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Chung AP, 2000, INT J SYST EVOL MICR, V50, P209, DOI 10.1099/00207713-50-1-209                                                       ; Collins RF, 2013, BIOCHEM J, V450, P417, DOI 10.1042/BJ20121599; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darmon E, 2014, MICROBIOL MOL BIOL R, V78, P1, DOI 10.1128/MMBR.00035-13; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.1313/1-92559-287-7:141; Dwivedi V, 2015, INDIAN J MICROBIOL, V55, P357, DOI 10.1007/s12088-015-0538-4; Dwivedi V, 2012, J BACTERIOL, V194, P3534, DOI 10.1128/JB.00604-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; ENGELKE DR, 1990, ANAL BIOCHEM, V191, P396, DOI 10.1016/0003-2697(90)90238-5                                                    ; Felsenstein J, 1993, PHYLIP PHYLOGENY INF; Friedrich A, 2002, APPL ENVIRON MICROB, V68, P745, DOI 10.1128/AEM.68.2.745-755.2002                                                   ; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gounder K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-577; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hao WL, 2010, GENETICS, V186, P411, DOI 10.1534/genetics.110.118448; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; HUDSON JA, 1987, INT J SYST BACTERIOL, V37, P431, DOI 10.1099/00207713-37-4-431                                                       ; Iqbal N, 2015, J BACTERIOL, V197, P2150, DOI 10.1128/JB.00108-15; Kelly SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0476; Kerepesi C, 2014, GENE, V533, P538, DOI 10.1016/j.gene.2013.10.015; Khorchid A, 2006, INT J BIOCHEM CELL B, V38, P307, DOI 10.1016/j.biocel.2005.08.018; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Kretza E, 2012, BIOTECHNOL BIOPROC E, V17, P512, DOI 10.1007/s12257-011-0481-0; Kumwenda B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-813; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12                                                         ; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lange SJ, 2013, NUCLEIC ACIDS RES, V41, P8034, DOI 10.1093/nar/gkt606; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LORENZ MG, 1994, MICROBIOL REV, V58, P563; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mefferd C. C., 2016, GENOME ANNOUNC, V4, DOI [10.1128/genomeA.00312-16, DOI 10.1128/GENOMEA.00312-16]; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Ming H, 2014, INT J SYST EVOL MICR, V64, P650, DOI 10.1099/ijs.0.056838-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; Murugapiran SK, 2013, STAND GENOMIC SCI, V7, P449, DOI 10.4056/sigs.3667269; Nobre MF, 1996, INT J SYST BACTERIOL, V46, P604, DOI 10.1099/00207713-46-2-604                                                       ; Ohtani N, 2012, EXTREMOPHILES, V16, P237, DOI 10.1007/s00792-011-0424-x; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Opperman DJ, 2007, J APPL MICROBIOL, V103, P1907, DOI 10.1111/j.1365-2672.2007.03429.x; Pasic L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-570; Proudfoot M, 2004, J BIOL CHEM, V279, P54687, DOI 10.1074/jbc.M411023200; RAO VB, 1992, GENE, V113, P17, DOI 10.1016/0378-1119(92)90665-C                                                    ; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rose I, 2011, EXTREMOPHILES, V15, P191, DOI 10.1007/s00792-010-0343-2; Roth C, 2007, J EXP ZOOL PART B, V308B, P58, DOI 10.1002/jez.21124; Rouli L., 2015, New Microbes and New Infections, V7, P72, DOI 10.1016/j.nmni.2015.06.005; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Sabath N, 2013, GENOME BIOL EVOL, V5, P966, DOI 10.1093/gbe/evt050; Salzer R, 2016, ENVIRON MICROBIOL, V18, P65, DOI 10.1111/1462-2920.12820; Sangwan N, 2015, ENV MICROBIOL REP, V7, P812, DOI 10.1111/1758-2229.12297; Schwarzenlander C, 2009, ENVIRON MICROBIOL, V11, P801, DOI 10.1111/j.1462-2920.2008.01801.x; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Seitz P, 2013, FEMS MICROBIOL REV, V37, P336, DOI 10.1111/j.1574-6976.2012.00353.x; SHAW JF, 1995, BOT BULL ACAD SINICA, V36, P195; Steffen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044002; Tamakoshi M., 2011, BACTERIOPHAGE, V1, P152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Teh BS, 2012, J BACTERIOL, V194, P1240, DOI 10.1128/JB.06589-11; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Touchon M, 2017, CURR OPIN MICROBIOL, V38, P66, DOI 10.1016/j.mib.2017.04.010; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Weinberger AD, 2012, MBIO, V3, DOI 10.1128/mBio.00456-12; Weinberger AD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002475; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Wheeler D., 2007, COMP GENOMICS, V1; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Yang HC, 2016, BIOMED J, V39, P5, DOI 10.1016/j.bj.2015.08.003; Yu MX, 2006, ARCH VIROL, V151, P663, DOI 10.1007/s00705-005-0667-x; Yu TT, 2015, INT J SYST EVOL MICR, V65, P2491, DOI 10.1099/ijs.0.000289; Zhang Q, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1512-4; Zhou AF, 2012, APPL ENVIRON MICROB, V78, P1168, DOI 10.1128/AEM.05666-11; Zhou EM, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0140-3; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	98	1	1	5	5	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	JUL 27	2017	8								1410	10.3389/fmicb.2017.01410				22	Microbiology	Microbiology	FB7VX	WOS:000406349200001	28798737	gold			2018-01-05	
J	Chen, TJ; Romesberg, FE				Chen, Tingjian; Romesberg, Floyd E.			Polymerase Chain Transcription: Exponential Synthesis of RNA and Modified RNA	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							IN-VITRO TRANSCRIPTION; DIRECTED EVOLUTION; DNA; CRISPR/CAS9; TEMPLATES; PCR	There is increasing demand for RNA and modified RNA oligonucleotides, but in contrast to DNA oligonucleotides, they are typically prohibitively expensive to chemically synthesize, and unlike longer RNAs, they are only inefficiently produced by in vitro transcription, especially when modified. To address these challenges, we previously reported the evolution of a thermostable DNA polymerase, SFM4-3, that more efficiently accepts substrates with 2'-substituents. We now show that SFM4-3 efficiently transcribes RNA or 2'-F-modified RNA and that it also efficiently PCR amplifies oligonucleotides of mixed RNA and DNA composition. In addition, with thermocycling and the use of a novel DNA template, we demonstrate a polymerase chain transcription (PCT) reaction that results in the exponential production of orders of magnitude more RNA or modified RNA than is available by conventional transcription. PCT is more efficient and general than conventional transcription and can produce large amounts of any RNA or modified RNA oligonucleotide at a fraction of the cost of chemical synthesis.	[Chen, Tingjian; Romesberg, Floyd E.] Scripps Res Inst, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA	Romesberg, FE (reprint author), Scripps Res Inst, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	floyd@scripps.edu	Chen, Tingjian/L-2659-2013	Chen, Tingjian/0000-0002-4458-4269; Romesberg, Floyd/0000-0001-6317-1315	DARPA [N66001-14-2-4052]	This work was supported by DARPA (Cooperative Agreement No. N66001-14-2-4052).	Brakmann S, 2001, CHEMBIOCHEM, V2, P212, DOI 10.1002/1439-7633(20010302)2:3<212::AID-CBIC212>3.0.CO;2-R; Chen T, 2016, CURR OPIN CHEM BIOL, V34, P80, DOI 10.1016/j.cbpa.2016.08.001; Chen TJ, 2016, NAT CHEM, V8, P557, DOI 10.1038/NCHEM.2493; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Cozens C, 2012, P NATL ACAD SCI USA, V109, P8067, DOI 10.1073/pnas.1120964109; Davis Robert H., 1995, Current Opinion in Biotechnology, V6, P213, DOI 10.1016/0958-1669(95)80035-2; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4                                                   ; Filonov GS, 2014, J AM CHEM SOC, V136, P16299, DOI 10.1021/ja508478x; Helm M, 1999, RNA, V5, P618, DOI 10.1017/S1355838299982328; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Huang FQ, 2008, NAT PROTOC, V3, P1848, DOI 10.1038/nprot.2008.185; Jung S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22975; Kang MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028661; Latorre A, 2016, ANGEW CHEM INT EDIT, V55, P3548, DOI 10.1002/anie.201512002; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Moll PR, 2004, ANAL BIOCHEM, V334, P164, DOI 10.1016/j.ab.2004.07.013; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Pleiss JA, 1998, RNA, V4, P1313, DOI 10.1017/S135583829800106X                                                       ; Watts JK, 2008, DRUG DISCOV TODAY, V13, P842, DOI 10.1016/j.drudi5.2008.05.007; White R, 2001, MOL THER, V4, P567, DOI 10.1006/mthe.2001.0495; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI [10.1038/nrd2016.199, 10.1038/nrd.2016.199]	22	0	0	8	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	JUL 26	2017	139	29					9949	9954		10.1021/jacs.7b03981				6	Chemistry, Multidisciplinary	Chemistry	FP1AP	WOS:000417342500011	28715205				2018-01-05	
J	Kenyon, A; Gavriouchkina, D; Zorman, J; Napolitani, G; Cerundolo, V; Sauka-Spengler, T				Kenyon, Amy; Gavriouchkina, Daria; Zorman, Jernej; Napolitani, Giorgio; Cerundolo, Vincenzo; Sauka-Spengler, Tatjana			Active nuclear transcriptome analysis reveals inflammasome-dependent mechanism for early neutrophil response to Mycobacterium marinum	SCIENTIFIC REPORTS			English	Article							TUBERCULOUS GRANULOMA; ZEBRAFISH; INFECTION; GROWTH; ACTIVATION; IL-1-BETA; SECRETION; PROTEIN; GENE; INTERLEUKIN-1	The mechanisms governing neutrophil response to Mycobacterium tuberculosis remain poorly understood. In this study we utilise biotagging, a novel genome-wide profiling approach based on cell type-specific in vivo biotinylation in zebrafish to analyse the initial response of neutrophils to Mycobacterium marinum, a close genetic relative of M. tuberculosis used to model tuberculosis. Differential expression analysis following nuclear RNA-seq of neutrophil active transcriptomes reveals a significant upregulation in both damage-sensing and effector components of the inflammasome, including caspase b, NLRC3 ortholog (wu:fb15h11) and il1 beta. Crispr/Cas9-mediated knockout of caspase b, which acts by proteolytic processing of il1 beta, results in increased bacterial burden and less infiltration of macrophages to sites of mycobacterial infection, thus impairing granuloma development. We also show that a number of immediate early response genes (IEGs) are responsible for orchestrating the initial neutrophil response to mycobacterial infection. Further perturbation of the IEGs exposes egr3 as a key transcriptional regulator controlling il1 beta transcription.	[Kenyon, Amy; Gavriouchkina, Daria; Zorman, Jernej; Sauka-Spengler, Tatjana] Univ Oxford, Weatherall Inst Mol Med, Radcliffe Dept Med, Oxford OX3 9DS, England; [Kenyon, Amy; Napolitani, Giorgio; Cerundolo, Vincenzo] Univ Oxford, Weatherall Inst Mol Med, Radcliffe Dept Med, MRC Human Immunol Unit, Oxford OX3 9DS, England	Sauka-Spengler, T (reprint author), Univ Oxford, Weatherall Inst Mol Med, Radcliffe Dept Med, Oxford OX3 9DS, England.	tatjana.sauka-spengler@imm.ox.ac.uk		Sauka-Spengler, Tatjana/0000-0001-9289-0263			Anderson L., 2016, WHO GLOBAL TUBERCULO; Andrews S, 2011, FASTQC QUALITY CONTR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556                                                                   ; Baron VT, 2015, BRIT J CANCER, V112, P755, DOI 10.1038/bjc.2014.622; Berg RD, 2012, TRENDS MOL MED, V18, P689, DOI 10.1016/j.molmed.2012.10.002; Bouttier M., 2016, NUCL ACIDS RES; Buffalo V, SCYTHE BAYESIAN ADAP; Bussmann J, 2011, DEVELOPMENT, V138, P4327, DOI 10.1242/dev.068080; Carlsson F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000895; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Gene OC, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI [10.1093/nar/gku1179, DOI 10.1093/NAR/GKU1179]; Gomez-Martin D, 2010, AUTOIMMUN REV, V9, P454, DOI 10.1016/j.autrev.2009.12.006; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Harris JE, 2007, FASEB J, V21, P356, DOI 10.1096/fj.06-6925com; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Karmakar M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10555; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Laing KJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-42; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Mortadza SAS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00407; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Nikhil J, SICKLE WINDOWED ADAP; Parant JM, 2009, DEV DYNAM, V238, P3168, DOI 10.1002/dvdy.22143; Pathak S, 2011, J IMMUNOL, V186, P1870, DOI 10.4049/jimmunol.1002275; Pio R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054096; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Suster ML, 2011, NAT PROTOC, V6, P1998, DOI 10.1038/nprot.2011.416; Takaki K, 2013, NAT PROTOC, V8, P1114, DOI 10.1038/nprot.2013.068; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6                                                   ; Trinh LA, 2017, CELL REP, V19, P425, DOI 10.1016/j.celrep.2017.03.045; Vojtech LN, 2012, INFECT IMMUN, V80, P2878, DOI 10.1128/IAI.00543-12; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wassermann R, 2015, CELL HOST MICROBE, V17, P799, DOI 10.1016/j.chom.2015.05.003; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; WESTERFIELD M, 2000, ZEBRAFISH BOOK GUIDE; Wieland GD, 2005, J CELL SCI, V118, P3203, DOI 10.1242/jcs.02445; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zoccal KF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10760	52	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 26	2017	7								6505	10.1038/s41598-017-06099-x				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FB8BU	WOS:000406364600018	28747644	gold			2018-01-05	
J	Bridgett, S; Campbell, J; Lord, CJ; Ryan, CJ				Bridgett, Stephen; Campbell, James; Lord, Christopher J.; Ryan, Colm J.			CancerGD: A Resource for Identifying and Interpreting Genetic Dependencies in Cancer	CELL SYSTEMS			English	Article							DRUG-SENSITIVITY; BREAST-CANCER; OVARIAN-CANCER; CELL LINES; VULNERABILITIES; IDENTIFICATION; INHIBITORS; LANDSCAPE; PROFILES; NETWORKS	Genes whose function is selectively essential in the presence of cancer-associated genetic aberrations represent promising targets for the development of precision therapeutics. Here, we present CancerGD, a resource that integrates genotypic profiling with large-scale loss-of-function genetic screens in tumor cell lines to identify such genetic dependencies. CancerGD provides tools for searching, visualizing, and interpreting these genetic dependencies through the integration of functional interaction networks. CancerGD includes different screen types (siRNA, shRNA, CRISPR), and we describe a simple format for submitting new datasets.	[Bridgett, Stephen; Ryan, Colm J.] Univ Coll Dublin, Syst Biol Ireland, Dublin, Ireland; [Campbell, James; Lord, Christopher J.] Inst Canc Res, CRUK Gene Funct Lab, London, England; [Campbell, James; Lord, Christopher J.] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London, England	Ryan, CJ (reprint author), Univ Coll Dublin, Syst Biol Ireland, Dublin, Ireland.	colm.ryan@ucd.ie			NHS; Irish Health Research Board [KEDS-2015-1636]; Cancer Research UK [C347/A8363]; Breast Cancer Now; Science Foundation Ireland; Health Research Board; Wellcome Trust under the SFI-HRB-Wellcome Trust Biomedical Research Partnership [103049/Z/13/Z]	We thank Lars Juhl Jensen for help with STRING integration. We also thank members of the ICR Gene Function Team and Systems Biology Ireland for providing feedback on earlier versions of this resource. We acknowledge NHS funding to the ICR/Royal Marsden Hospital Biomedical Research Center. Work on this project was supported by a grant to C.J.R. from the Irish Health Research Board (KEDS-2015-1636). C.J.L. is supported by Cancer Research UK (grant number C347/A8363) and Breast Cancer Now. C.J.R. is a Sir Henry Wellcome Fellow jointly funded by Science Foundation Ireland, the Health Research Board, and the Wellcome Trust (grant number 103049/Z/13/Z) under the SFI-HRB-Wellcome Trust Biomedical Research Partnership.	Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Brough R, 2011, CURR OPIN GENET DEV, V21, P34, DOI 10.1016/j.gde.2010.10.009; Campbell J, 2016, CELL REP, V14, P2490, DOI 10.1016/j.celrep.2016.02.023; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Daemen A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r110; Downward J, 2015, CLIN CANCER RES, V21, P1802, DOI 10.1158/1078-0432.CCR-14-2180; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Lord CJ, 2015, ANNU REV MED, V66, P455, DOI 10.1146/annurev-med-050913-022545; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Marcotte R, 2016, CELL, V164, P293, DOI 10.1016/j.cell.2015.11.062; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wagner Alex H, 2016, Nucleic Acids Res, V44, pD1036, DOI 10.1093/nar/gkv1165; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111	31	0	0	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2405-4712	2405-4720		CELL SYST	Cell Syst.	JUL 26	2017	5	1					82	+		10.1016/j.cels.2017.06.002				8	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FB7BK	WOS:000406295900009	28711281	gold			2018-01-05	
J	Kumru, S; Tekedar, HC; Gulsoy, N; Waldbieser, GC; Lawrence, ML; Karsi, A				Kumru, Salih; Tekedar, Hasan C.; Gulsoy, Nagihan; Waldbieser, Geoffrey C.; Lawrence, Mark L.; Karsi, Attila			Comparative Analysis of the Flavobacterium columnare Genomovar I and II Genomes	FRONTIERS IN MICROBIOLOGY			English	Article						Flavobacterium columnare; genomovars; comparative genomics; catfish; transposon mutagenesis; virulence; fish health	GRAM-NEGATIVE BACTERIA; VI SECRETION SYSTEM; CATFISH ICTALURUS-PUNCTATUS; ANTIBIOTIC-RESISTANCE GENES; DNA-DNA HYBRIDIZATION; PHAGE SEARCH TOOL; PROKARYOTIC GENOMES; GLIDING MOTILITY; INSERTION SEQUENCES; HIGH-THROUGHPUT	Columnaris disease caused by Gram-negative rod Flavobacterium columnare is one of the most common diseases of catfish. F. columnare is also a common problem in other cultured fish species worldwide. F. columnare has three major genomovars; we have sequenced a representative strain from genomovar I (ATCC 49512, which is avirulent in catfish) and genomovar II (94-081, which is highly pathogenic in catfish). Here, we present a comparative analysis of the two genomes. Interestingly, F. columnare ATCC 49512 and 94-081 meet criteria to be considered different species based on the Average Nucleotide Identity (90.71% similar) and DNA-DNA Hybridization (42.6% similar). Genome alignment indicated the two genomes have a large number of rearrangements. However, function-based comparative genomics analysis indicated that the two strains have similar functional capabilities with 2,263 conserved orthologous clusters; strain ATCC 49512 has 290 unique orthologous clusters while strain 94-081 has 391. Both strains carry type I secretion system, type VI secretion system, and type IX secretion system. The two genomes also have similar CRISPR capacities. The F. columnare strain ATCC 49512 genome contains a higher number of insertion sequence families and phage regions, while the F. columnare strain 94-081 genome has more genomic islands and more regulatory gene capacity. Transposon mutagenesis using Tn4351 in pathogenic strain 94-081 yielded six mutants, and experimental infections of fish showed hemolysin and glycine cleavage protein mutants had 15 and 10% mortalities, respectively, while the wild-type strain caused 100% mortalities. Our comparative and mutational analysis yielded important information on classification of genomovars I and II F. columnare as well as potential virulence genes in F. columnare strain 94-081.	[Kumru, Salih; Tekedar, Hasan C.; Lawrence, Mark L.; Karsi, Attila] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Gulsoy, Nagihan] Marmara Univ, Fac Art & Sci, Dept Biol, Istanbul, Turkey; [Waldbieser, Geoffrey C.] US ARS, Warmwater Aquaculture Res Unit, Stoneville, MS USA	Lawrence, ML; Karsi, A (reprint author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.	lawrence@cvm.msstate.edu; karsi@cvm.msstate.edu		Karsi, Attila/0000-0001-6845-3346	Ministry of National Education of Turkey; United States Department of Agriculture; National Institute of Food and Agriculture [2006-35600-16571]; USDA-ARS CRIS project [31000-012-00D]; College of Veterinary Medicine, Mississippi State University	SK is supported by a fellowship from the Ministry of National Education of Turkey. This work was supported by the United States Department of Agriculture, National Institute of Food and Agriculture (2006-35600-16571), USDA-ARS CRIS project 31000-012-00D, and the College of Veterinary Medicine, Mississippi State University.	Abby SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110726; AKATSUKA H, 1995, J BACTERIOL, V177, P6381, DOI 10.1128/jb.177.22.6381-6389.1995                                                ; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Arias CR, 2004, J APPL MICROBIOL, V97, P421, DOI 10.1111/j.1365-2672.2004.02314.x; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Aubert DF, 2015, MICROBIOL-SGM, V161, P2161, DOI 10.1099/mic.0.000174; Barakat M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-269; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bernardet JF, 1996, INT J SYST BACTERIOL, V46, P128, DOI 10.1099/00207713-46-1-128                                                       ; BERNARDET JF, 1989, DIS AQUAT ORGAN, V6, P37, DOI 10.3354/dao006037; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Braune A, 2016, J BACTERIOL, V198, P2965, DOI 10.1128/JB.00490-16; Brodt A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-65; Bullard SA, 2013, J FISH DIS, V36, P447, DOI 10.1111/jfd.12005; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; Coates ARM, 2007, BRIT J PHARMACOL, V152, P1147, DOI 10.1038/sj.bjp.0707432; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; Cuthbertson L, 2013, MICROBIOL MOL BIOL R, V77, P440, DOI 10.1128/MMBR.00018-13; Dahal N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065973; Dalbey RE, 2012, FEMS MICROBIOL REV, V36, P1023, DOI 10.1111/j.1574-6976.2012.00327.x; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darwish AM, 2005, MOL CELL PROBE, V19, P267, DOI 10.1016/j.mcp.2005.04.003; Davis H. S., 1922, B US BUR FISH, V38, P261, DOI 10.5962/bhl.title.49773; Declercq AM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-27; Decostere A, 2002, Verh K Acad Geneeskd Belg, V64, P421; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Dirix G, 2004, PEPTIDES, V25, P1425, DOI 10.1016/j.peptides.2003.10.028; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Downer R, 2002, J BIOL CHEM, V277, P243, DOI 10.1074/jbc.M107621200; Dsouza M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108009; Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ernst RK, 1999, J INFECT DIS, V179, pS326, DOI 10.1086/513850                                                                  ; Evenhuis JP, 2016, DIS AQUAT ORGAN, V120, P217, DOI 10.3354/dao03027; Farmer B., 2004, IMPROVED METHODS ISO; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Green ER, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0012-2015; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hatoum-Aslan A, 2014, CURR OPIN MICROBIOL, V17, P82, DOI 10.1016/j.mib.2013.12.001; Henikoff S, 1997, SCIENCE, V278, P609, DOI 10.1126/science.278.5338.609; Hogfors-Ronnholm E, 2010, MICROB PATHOGENESIS, V49, P369, DOI 10.1016/j.micpath.2010.08.002; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kadowaki T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23288; Kanonenberg K, 2013, RES MICROBIOL, V164, P596, DOI 10.1016/j.resmic.2013.03.011; Karlyshev AV, 2000, BIOTECHNIQUES, V28, P1078; Karsi A, 2009, APPL ENVIRON MICROB, V75, P2166, DOI 10.1128/AEM.02449-08; Kharade SS, 2015, J BACTERIOL, V197, P147, DOI 10.1128/JB.02085-14; Krushkal J, 2011, OMICS, V15, P495, DOI 10.1089/omi.2010.0117; Kumru S., 2016, GENOME ANNOUNC, V4, DOI DOI 10.1128/GENOMEA.00430-16; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Laub MT, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P45; Lawrence M. L., 2012, COMP GENOMICS TRANSC; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; McBride MJ, 1996, J BACTERIOL, V178, P583, DOI 10.1128/jb.178.3.583-590.1996                                                   ; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49                                                   ; Meier-Kolthoff JP, 2014, INT J SYST EVOL MICR, V64, P352, DOI 10.1099/ijs.0.056994-0; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Michel C, 2002, J FISH DIS, V25, P253, DOI 10.1046/j.1365-2761.2002.00364.x; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321                                                           ; Mushegian AR, 1998, GENOME RES, V8, P590, DOI 10.1101/gr.8.6.590                                                              ; Olivares-Fuster O, 2007, SYST APPL MICROBIOL, V30, P624, DOI 10.1016/j.syapm.2007.07.003; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; ROWE GE, 1994, METHOD ENZYMOL, V235, P657; Russell AB, 2014, CELL HOST MICROBE, V16, P227, DOI 10.1016/j.chom.2014.07.007; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Schmitz-Esser S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-270; Shoemaker CA, 2008, VET MICROBIOL, V127, P353, DOI 10.1016/j.vetmic.2007.09.003; Shoemaker CA, 2011, FISH SHELLFISH IMMUN, V30, P304, DOI 10.1016/j.fsi.2010.11.001; Shrivastava A, 2013, J BACTERIOL, V195, P3201, DOI 10.1128/JB.00333-13; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784                                                             ; Song H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000922; Soto E, 2008, J APPL MICROBIOL, V104, P1302, DOI 10.1111/j.1365-2672.2007.03632.x; Staroscik AM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-115; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Tan HM, 1999, APPL MICROBIOL BIOT, V51, P1, DOI 10.1007/s002530051356                                                           ; Tekedar HC, 2012, J BACTERIOL, V194, P2763, DOI 10.1128/JB.00281-12; Touchon M, 2011, APPL ENVIRON MICROB, V77, P7656, DOI 10.1128/AEM.05625-11; Triyanto, 1999, FISH PATHOL, V34, P65; Varani AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r30; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Wagner A, 2006, PLOS COMPUT BIOL, V2, P1522, DOI 10.1371/journal.pcbi.0020162; WAKABAYASHI H, 1991, J FISH DIS, V14, P279, DOI 10.1111/j.1365-2761.1991.tb00825.x                                              ; Wang Y, 2015, NUCLEIC ACIDS RES, V43, pW78, DOI 10.1093/nar/gkv487; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Whittle G, 2002, CELL MOL LIFE SCI, V59, P2044, DOI 10.1007/s000180200004                                                           ; Wilson K, 2001, CURR PROTOC MOL BIOL, V2, P2, DOI DOI 10.1002/0471142727.MB0204S56; Wu HJ, 2008, CURR OPIN CHEM BIOL, V12, P93, DOI 10.1016/j.cbpa.2008.01.023; Xu L, 2013, MICROBES INFECT, V15, P157, DOI 10.1016/j.micinf.2012.11.001; Zhang XH, 2000, J FISH DIS, V23, P93, DOI 10.1046/j.1365-2761.2000.00214.x; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Zoued A, 2014, BBA-MOL CELL RES, V1843, P1664, DOI 10.1016/j.bbamcr.2014.03.018	112	1	1	5	5	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	JUL 25	2017	8								1375	10.3389/fmicb.2017.01375				15	Microbiology	Microbiology	FB7TM	WOS:000406342900001	28790987	gold			2018-01-05	
J	Fidanza, A; Lopez-Yrigoyen, M; Romano, N; Jones, R; Taylor, AH; Forrester, LM				Fidanza, Antonella; Lopez-Yrigoyen, Martha; Romano, Nicola; Jones, Rhiannon; Taylor, A. Helen; Forrester, Lesley M.			An all-in-one UniSam vector system for efficient gene activation	SCIENTIFIC REPORTS			English	Article							CONVERTS FIBROBLASTS; STEM-CELLS; EXPRESSION; GENOME; DIFFERENTIATION; CRISPR	We have generated a drug-free, all-in-one dCAS9-SAM vector that can activate endogenous gene expression with the potential to modify cell fate. We demonstrate that this strategy can be used in a number of cell lines and avoids exceptionally high levels of gene expression that are observed in standard transgenic approaches. Compared to the multi-plasmid system, this all-in-one vector activates gene expression to a comparable level but the reduced overall DNA content results in significantly higher viability of transfected cells. This allowed us to use the RUNX1C-GFP human embryonic stem cell reporter cell line to monitor gene activation in individual cells and to show that activation could occur at all stages of the cell cycle.	[Fidanza, Antonella; Lopez-Yrigoyen, Martha; Jones, Rhiannon; Taylor, A. Helen; Forrester, Lesley M.] Univ Edinburgh, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Romano, Nicola] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	Fidanza, A; Forrester, LM (reprint author), Univ Edinburgh, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland.	afidanza@staffmail.ed.ac.uk; L.Forrester@ed.ac.uk		Romano, Nicola/0000-0002-1316-8940	Wellcome Trust [102610]; CONACYT	We thank Andrew Elefanty and Ed Stanley for the RUNX1C-GFP cell line, Keisuke Kaji for the PB-CAG-hCD2 plasmid, Miguel Foronda for the help in the plasmid design, Andrea Corsinotti for reagents and discussion and Fiona Rossi and Claire Cryer for flow cytometry. The work was funded by the Wellcome Trust (Grant No. 102610) and performed as part of the Novosang Consortium (www.novosang.co.uk). MLY received a PhD scholarship from CONACYT.	Black JB, 2016, CELL STEM CELL, V19, P406, DOI 10.1016/j.stem.2016.07.001; Chakraborty S, 2014, STEM CELL REP, V3, P940, DOI 10.1016/j.stemcr.2014.09.013; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dou DR, 2016, NAT CELL BIOL, V18, P595, DOI 10.1038/ncb3354; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Luc S, 2016, CELL REP, V16, P3181, DOI 10.1016/j.celrep.2016.08.064; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Ng ES, 2016, NAT BIOTECHNOL, V34, P1168, DOI 10.1038/nbt.3702; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108	19	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 25	2017	7								6394	10.1038/s41598-017-06468-6				7	Multidisciplinary Sciences	Science & Technology - Other Topics	FB6UZ	WOS:000406279200001	28743878	gold			2018-01-05	
J	Anderson, GR; Winter, PS; Lin, KH; Nussbaum, DP; Cakir, M; Stein, EM; Soderquist, RS; Crawford, L; Leeds, JC; Newcomb, R; Stepp, P; Yip, C; Wardell, SE; Tingley, JP; Ali, M; Xu, MM; Ryan, M; McCall, SJ; Mcree, AJ; Counter, CM; Der, CJ; Wood, KC				Anderson, Grace R.; Winter, Peter S.; Lin, Kevin H.; Nussbaum, Daniel P.; Cakir, Merve; Stein, Elizabeth M.; Soderquist, Ryan S.; Crawford, Lorin; Leeds, Jim C.; Newcomb, Rachel; Stepp, Priya; Yip, Catherine; Wardell, Suzanne E.; Tingley, Jennifer P.; Ali, Moiez; Xu, Mengmeng; Ryan, Meagan; McCall, Shannon J.; McRee, Autumn J.; Counter, Christopher M.; Der, Channing J.; Wood, Kris C.			A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution	CELL REPORTS			English	Article							MEK INHIBITION; LUNG-CANCER; FUNCTIONAL GENOMICS; ACQUIRED-RESISTANCE; COLORECTAL CANCERS; TARGETING RAS; HUMAN-CELLS; ACTIVATION; SUPPRESSION; CRISPR-CAS9	Combinatorial inhibition of effector and feedback pathways is a promising treatment strategy for KRAS mutant cancers. However, the particular pathways that should be targeted to optimize therapeutic responses are unclear. Using CRISPR/Cas9, we systematically mapped the pathways whose inhibition cooperates with drugs targeting the KRAS effectors MEK, ERK, and PI3K. By performing 70 screens in models of KRAS mutant colorectal, lung, ovarian, and pancreas cancers, we uncovered universal and tissue- specific sensitizing combinations involving inhibitors of cell cycle, metabolism, growth signaling, chromatin regulation, and transcription. Furthermore, these screens revealed secondary genetic modifiers of sensitivity, yielding a SRC inhibitorbased combination therapy for KRAS/PIK3CA double- mutant colorectal cancers (CRCs) with clinical potential. Surprisingly, acquired resistance to combinations of growth signaling pathway inhibitors develops rapidly following treatment, but by targeting signaling feedback or apoptotic priming, it is possible to construct three- drug combinations that greatly delay its emergence.	[Anderson, Grace R.; Winter, Peter S.; Lin, Kevin H.; Cakir, Merve; Stein, Elizabeth M.; Soderquist, Ryan S.; Leeds, Jim C.; Newcomb, Rachel; Stepp, Priya; Yip, Catherine; Wardell, Suzanne E.; Tingley, Jennifer P.; Ali, Moiez; Xu, Mengmeng; Counter, Christopher M.; Wood, Kris C.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Winter, Peter S.] Duke Univ, Program Genet & Genom, Durham, NC 27710 USA; [Nussbaum, Daniel P.] Duke Univ, Dept Surg, Durham, NC 27710 USA; [Crawford, Lorin] Duke Univ, Dept Stat, Durham, NC 27710 USA; [Ryan, Meagan; Der, Channing J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [McCall, Shannon J.] Duke Univ, Dept Pathol, Durham, NC 27710 USA; [McRee, Autumn J.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA	Wood, KC (reprint author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	kris.wood@duke.edu			NIGMS NIH HHS [T32 GM007171, T32 GM007754]; NCATS NIH HHS [UL1 TR001117]; NCI NIH HHS [R01 CA207083, F32 CA134171, R01 CA123031, P30 CA016086, F32 CA180569, F32 CA206234, U01 CA199235, F30 CA206348, F31 CA195967]; NICHD NIH HHS [K12 HD043446]		Ahronian LG, 2015, CANCER DISCOV, V5, P358, DOI 10.1158/2159-8290.CD-14-1518; Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Athuluri-Divakar SK, 2016, CELL, V165, P643, DOI 10.1016/j.cell.2016.03.045; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Berg M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013978; Berger AH, 2016, CANCER CELL, V30, P214, DOI 10.1016/j.ccell.2016.06.022; Bernards R, 2012, CELL, V151, P465, DOI 10.1016/j.cell.2012.10.014; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8                                                   ; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Campbell R. M., 2014, CANC THER, V13, P364; Chen SH, 2016, CANCER DISCOV, V6, P300, DOI 10.1158/2159-8290.CD-15-0896; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Costa C, 2015, CANCER CELL, V27, P97, DOI 10.1016/j.ccell.2014.11.007; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cox Adrienne D, 2010, Small GTPases, V1, P2; Downward J, 2015, CLIN CANCER RES, V21, P1802, DOI 10.1158/1078-0432.CCR-14-2180; Ebi H, 2014, CANCER SCI, V105, P499, DOI 10.1111/cas.12383; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Foster SA, 2016, CANCER CELL, V29, P477, DOI 10.1016/j.ccell.2016.02.010; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Gustavsson B, 2015, CLIN COLORECTAL CANC, V14, P1, DOI 10.1016/j.clcc.2014.11.002; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kitai H, 2016, CANCER DISCOV, V6, P754, DOI 10.1158/2159-8290.CD-15-1377; Lamba S, 2014, CELL REP, V8, P1475, DOI 10.1016/j.celrep.2014.07.033; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Lin LP, 2015, NAT GENET, V47, P250, DOI 10.1038/ng.3218; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Martz CA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa1877; Misale S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9305; Montero J, 2015, CELL, V160, P977, DOI 10.1016/j.cell.2015.01.042; Moriceau G, 2015, CANCER CELL, V27, P240, DOI 10.1016/j.ccell.2014.11.018; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ni Chonghaile T, 2011, SCIENCE, V334, P1129, DOI DOI 10.1126/SCIENCE.1206727; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarosiek KA, 2013, MOL CELL, V51, P751, DOI 10.1016/j.molcel.2013.08.048; Schwartz S, 2015, CANCER CELL, V27, P109, DOI 10.1016/j.ccell.2014.11.008; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Singh H, 2015, J CLIN ONCOL, V33, P3650, DOI 10.1200/JCO.2015.62.1052; Skoulidis F, 2015, CANCER DISCOV, V5, P860, DOI 10.1158/2159-8290.CD-14-1236; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Uronis JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038422; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Winter PS, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005301; Wood KC, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002612; Zhang H, 2007, CELL DEATH DIFFER, V14, P943, DOI 10.1038/sj.cdd.4402081	59	0	0	6	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	JUL 25	2017	20	4					999	1015		10.1016/j.celrep.2017.07.006				17	Cell Biology	Cell Biology	FB5RF	WOS:000406198900020	28746882	gold			2018-01-05	
J	Zhang, YH; Qin, W; Lu, XC; Xu, JS; Huang, HG; Bai, HP; Li, S; Lin, S				Zhang, Yihan; Qin, Wei; Lu, Xiaochan; Xu, Jason; Huang, Haigen; Bai, Haipeng; Li, Song; Lin, Shuo			Programmable base editing of zebrafish genome using a modified CRISPR-Cas9 system	NATURE COMMUNICATIONS			English	Article							CRISPR/CAS9 SYSTEM; CYTIDINE DEAMINASE; PRECISE; MUTATIONS; NUCLEASES; VARIANTS; FUSION; RICE; GENE; DNA	Precise genetic modifications in model animals are essential for biomedical research. Here, we report a programmable "base editing" system to induce precise base conversion with high efficiency in zebrafish. Using cytidine deaminase fused to Cas9 nickase, up to 28% of site-specific single-base mutations are achieved in multiple gene loci. In addition, an engineered Cas9-VQR variant with 5'-NGA PAM specificities is used to induce base conversion in zebrafish. This shows that Cas9 variants can be used to expand the utility of this technology. Collectively, the targeted base editing system represents a strategy for precise and effective genome editing in zebrafish.	[Zhang, Yihan; Qin, Wei; Lu, Xiaochan; Bai, Haipeng; Li, Song; Lin, Shuo] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Lab Chem Genom, Shenzhen 518055, Peoples R China; [Zhang, Yihan; Xu, Jason; Huang, Haigen; Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	Lin, S (reprint author), Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Lab Chem Genom, Shenzhen 518055, Peoples R China.; Lin, S (reprint author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	shuolin@ucla.edu			Science and Technology Program of Shenzhen [JCYJ20150924110425180, JCYJ20151030170755264]; NIH [R21GM109908]	We thank Zenghou Tang for zebrafish husbandry. This work was supported in part by funding from Science and Technology Program of Shenzhen (JCYJ20150924110425180 and JCYJ20151030170755264) and NIH (R21GM109908). We thank Jenny Lin for editing the manuscript.	Albadri S, 2017, METHODS, V121, P77, DOI 10.1016/j.ymeth.2017.03.005; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Basu U, 2008, MOL CELL, V32, P285, DOI 10.1016/j.molcel.2008.08.019; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bell RT, 2016, GENETICS, V202, P381, DOI 10.1534/genetics.115.185041; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Feng Y, 2016, G3-GENES GENOM GENET, V6, P2517, DOI [10.1534/g3.116.031914, 10.1534/g3.116.031914/-/DC1]; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Khordadpoor-Deilamani F, 2015, MOL VIS, V21, P730; Kim K, 2017, NAT BIOTECHNOL, V35, P435, DOI 10.1038/nbt.3816; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Marchegiani S, 2015, AM J HUM GENET, V97, P99, DOI 10.1016/j.ajhg.2015.05.017; Nishida K, 2016, SCIENCE, V353, P8729; Shimatani Z, 2017, NAT BIOTECHNOL, V35, P441, DOI 10.1038/nbt.3833; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811; Zu Y, 2013, NAT METHODS, V10, P329, DOI [10.1038/NMETH.2374, 10.1038/nmeth.2374]	23	4	4	19	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JUL 25	2017	8								118	10.1038/s41467-017-00175-6				5	Multidisciplinary Sciences	Science & Technology - Other Topics	FB6MK	WOS:000406256900001	28740134	gold			2018-01-05	
J	Wilkinson, AA; Dennis, M; Simic, N; Taylor, MJ; Morgan, BR; Frndova, H; Choong, K; Campbell, C; Fraser, D; Anderson, V; Guerguerian, AM; Schachar, R; Hutchison, J				Wilkinson, Amy A.; Dennis, Maureen; Simic, Nevena; Taylor, Margot J.; Morgan, Benjamin R.; Frndova, Helena; Choong, Karen; Campbell, Craig; Fraser, Douglas; Anderson, Vicki; Guerguerian, Anne-Marie; Schachar, Russell; Hutchison, Jamie		Canadian Critical Care Trials Grp; Canadian Critical Care Translation	Brain biomarkers and pre-injury cognition are associated with long-term cognitive outcome in children with traumatic brain injury	BMC PEDIATRICS			English	Article						Attention; Executive functions; Traumatic brain injury; Serum biomarkers	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA; II COLLAGEN; COL2A1 GENE; SPONDYLOEPIMETAPHYSEAL DYSPLASIA; PHENOTYPIC SPECTRUM; HIP-DYSPLASIA; MUTATION; DISORDERS; SEDC	Background: Children with traumatic brain injury (TBI) are frequently at risk of long-term impairments of attention and executive functioning but these problems are difficult to predict. Although deficits have been reported to vary with injury severity, age at injury and sex, prognostication of outcome remains imperfect at a patient-specific level. The objective of this proof of principle study was to evaluate a variety of patient variables, along with six brain-specific and inflammatory serum protein biomarkers, as predictors of long-term cognitive outcome following paediatric TBI. Method: Outcome was assessed in 23 patients via parent-rated questionnaires related to attention deficit hyperactivity disorder (ADHD) and executive functioning, using the Conners 3rd Edition Rating Scales (Conners-3) and Behaviour Rating Inventory of Executive Function (BRIEF) at a mean time since injury of 3.1 years. Partial least squares (PLS) analyses were performed to identify factors measured at the time of injury that were most closely associated with outcome on (1) the Conners-3 and (2) the Behavioural Regulation Index (BRI) and (3) Metacognition Index (MI) of the BRIEF. Results: Higher levels of neuron specific enolase (NSE) and lower levels of soluble neuron cell adhesion molecule (sNCAM) were associated with higher scores on the inattention, hyperactivity/impulsivity and executive functioning scales of the Conners-3, as well as working memory and initiate scales of the MI from the BRIEF. Higher levels of NSE only were associated with higher scores on the inhibit scale of the BRI. Conclusions: NSE and sNCAM show promise as reliable, early predictors of long-term attention-related and executive functioning problems following paediatric TBI.	[Wilkinson, Amy A.; Dennis, Maureen; Taylor, Margot J.] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Wilkinson, Amy A.; Dennis, Maureen; Taylor, Margot J.; Guerguerian, Anne-Marie; Schachar, Russell; Hutchison, Jamie] Hosp Sick Children, Program Neurosci Mental Hlth, Toronto, ON, Canada; [Dennis, Maureen] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Simic, Nevena] Hamilton Hlth Sci Corp, Comprehens Pediat Epilepsy Program, Hamilton, ON, Canada; [Taylor, Margot J.; Morgan, Benjamin R.] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON, Canada; [Frndova, Helena; Guerguerian, Anne-Marie; Hutchison, Jamie] Hosp Sick Children, Dept Crit Care Med, Toronto, ON, Canada; [Choong, Karen] Childrens Hosp Hamilton, Div Pediat Intens Care, Dept Pediat, Hamilton, ON, Canada; [Campbell, Craig; Fraser, Douglas] Western Univ, Schulich Sch Med, Pediat Clin Neurol Sci & Epidemiol, London, ON, Canada; [Anderson, Vicki] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Anderson, Vicki] Univ Melbourne, Psychol Sci & Pediat, Melbourne, Vic, Australia; [Schachar, Russell] Hosp Sick Children, Dept Psychiat, Toronto, ON, Canada	Wilkinson, AA (reprint author), Univ Toronto, Dept Psychol, Toronto, ON, Canada.; Wilkinson, AA; Hutchison, J (reprint author), Hosp Sick Children, Program Neurosci Mental Hlth, Toronto, ON, Canada.; Hutchison, J (reprint author), Hosp Sick Children, Dept Crit Care Med, Toronto, ON, Canada.	amy.wilkinson@sickkids.ca; jamie.hutchison@sickkids.ca			Natural Science Foundation [2015D012]; Natural Science Foundation of Fujian Province [2014D003]; Medical Innovation Foundation of Fujian Province [2014-CXB-46]; Science and Technology Project of Xiamen City [3502Z20164029]	This work was supported by the Natural Science Foundation for Distinguished Young Scholars of Fujian Province (project no. 2015D012), Natural Science Foundation of Fujian Province (project no. 2014D003), the Medical Innovation Foundation of Fujian Province (project no. 2014-CXB-46), and the Science and Technology Project of Xiamen City (project no. 3502Z20164029).	Al Kaissi A, 2013, ORTHOPADE, V42, P963, DOI 10.1007/s00132-013-2182-1; ANDERSON IJ, 1990, AM J HUM GENET, V46, P896; Barat-Houari M, 2016, EUR J HUM GENET, V24, P992, DOI 10.1038/ejhg.2015.250; BEIGHTON P, 1984, AM J MED GENET, V19, P161, DOI 10.1002/ajmg.1320190116; BOGAERT R, 1992, J BIOL CHEM, V267, P22522; Chung BHY, 2013, AM J MED GENET A, V161A, P918, DOI 10.1002/ajmg.a.35793; Deng H, 2016, MUTAT RES-REV MUTAT, V768, P1, DOI 10.1016/j.mrrev.2016.02.003; Hoornaert KP, 2006, J MED GENET, V43, P406, DOI 10.1136/jmg.2005.035717; Kaitila I, 1996, AM J MED GENET, V63, P111; Matsubayashi S, 2013, MOL SYNDROMOL, V4, P148, DOI 10.1159/000346644; Mortier GR, 2000, J MED GENET, V37, P263, DOI 10.1136/jmg.37.4.263; Nishimura G, 2005, HUM MUTAT, V26, P36, DOI 10.1002/humc.20179; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Silveira KC, 2015, AM J MED GENET A, V167, P894, DOI 10.1002/ajmg.a.36954; SPRANGER J, 1994, EUR J PEDIATR, V153, P56, DOI 10.1007/BF01959208; STICKLER GB, 1965, MAYO CLIN PROC, V40, P433; Terhal PA, 2015, AM J MED GENET A, V167, P461, DOI 10.1002/ajmg.a.36922; TILLER GE, 1995, NAT GENET, V11, P87, DOI 10.1038/ng0995-87; VIKKULA M, 1993, GENOMICS, V16, P282, DOI 10.1006/geno.1993.1179; Walter K, 2007, AM J MED GENET A, V143A, P161, DOI 10.1002/ajmg.a.31516; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Xu LL, 2014, EUR SPINE J, V23, pS271, DOI 10.1007/s00586-014-3292-0	22	1	1	7	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2431			BMC PEDIATR	BMC Pediatr.	JUL 24	2017	17								173	10.1186/s12887-017-0925-6				26	Pediatrics	Pediatrics	FB7QA	WOS:000406333900001	28738850	gold			2018-01-05	
J	Huang, XG; Zhou, GH; Wu, WY; Duan, YJ; Ma, GE; Song, JY; Xiao, R; Vandenberghe, L; Zhang, F; D'Amore, PA; Lei, HT				Huang, Xionggao; Zhou, Guohong; Wu, Wenyi; Duan, Yajian; Ma, Gaoen; Song, Jingyuan; Xiao, Ru; Vandenberghe, Luk; Zhang, Feng; D'Amore, Patricia A.; Lei, Hetian			Genome editing abrogates angiogenesis in vivo	NATURE COMMUNICATIONS			English	Article							LEBERS CONGENITAL AMAUROSIS; GENE-THERAPY; PATHOLOGICAL ANGIOGENESIS; MACULAR DEGENERATION; CELLS; RECEPTOR; MOUSE; MODEL; CARCINOGENESIS; IDENTIFICATION	Angiogenesis, in which vascular endothelial growth factor receptor (VEGFR) 2 plays an essential role, is associated with a variety of human diseases including proliferative diabetic retinopathy and wet age-related macular degeneration. Here we report that a system of adeno-associated virus (AAV)-mediated clustered regularly interspaced short palindromic repeats (CRISPR)-associated endonuclease (Cas) 9 from Streptococcus pyogenes (SpCas9) is used to deplete VEGFR2 in vascular endothelial cells (ECs), whereby the expression of SpCas9 is driven by an endothelial-specific promoter of intercellular adhesion molecule 2. We further show that recombinant AAV serotype 1 (rAAV1) transduces ECs of pathologic vessels, and that editing of genomic VEGFR2 locus using rAAV1-mediated CRISPR/Cas9 abrogates angiogenesis in the mouse models of oxygen-induced retinopathy and laser-induced choroid neovascularization. This work establishes a strong foundation for genome editing as a strategy to treat angiogenesis-associated diseases.	[Huang, Xionggao; Zhou, Guohong; Wu, Wenyi; Duan, Yajian; Ma, Gaoen; Song, Jingyuan; Xiao, Ru; Vandenberghe, Luk; D'Amore, Patricia A.; Lei, Hetian] Harvard Med Sch, Schepens Eye Res Inst, Massachusetts Eye & Ear, Boston, MA 02114 USA; [Huang, Xionggao; Zhou, Guohong; Wu, Wenyi; Duan, Yajian; Ma, Gaoen; Song, Jingyuan; Xiao, Ru; Vandenberghe, Luk; D'Amore, Patricia A.; Lei, Hetian] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02114 USA; [Huang, Xionggao] Hainan Eye Hosp, Haikou 570311, Hainan, Peoples R China; [Zhou, Guohong; Duan, Yajian] Shanxi Eye Hosp, Taiyuan 030002, Shanxi, Peoples R China; [Wu, Wenyi] Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha 410013, Hunan, Peoples R China; [Song, Jingyuan] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100193, Peoples R China; [Song, Jingyuan] Peking Union Med Coll, Beijing 100193, Peoples R China; [Zhang, Feng] Broad Inst Massachusetts Inst Technol & Harvard U, Cambridge, MA 02142 USA	Lei, HT (reprint author), Harvard Med Sch, Schepens Eye Res Inst, Massachusetts Eye & Ear, Boston, MA 02114 USA.; Lei, HT (reprint author), Harvard Med Sch, Dept Ophthalmol, Boston, MA 02114 USA.	hetian_lei@meei.harvard.edu			National Institutes of Health, National Eye Institute [R01 EY012509, P30EY003790]	This work was supported by National Institutes of Health, National Eye Institute Grants R01 EY012509 (to H.L.) and Core Grant P30EY003790.	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bergers G, 2000, NAT CELL BIOL, V2, P737; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Chitranshi N, 2015, INT J MOL SCI, V16, P21087, DOI 10.3390/ijms160921087; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Dai C, 2004, J VIROL, V78, P6209, DOI 10.1128/JVI.78.12.6209-6221.2004; Deyle DR, 2009, CURR OPIN MOL THER, V11, P442; Duan YJ, 2016, J BIOL CHEM, V291, P16339, DOI 10.1074/jbc.M116.729467; Ellis BL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-74; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27                                                               ; Fraser-Bell S, 2008, CURR OPIN OPHTHALMOL, V19, P185, DOI 10.1097/ICU.0b013e3282fb7c45; Gaudet D, 2013, GENE THER, V20, P361, DOI 10.1038/gt.2012.43; Gaudet D, 2012, CURR OPIN LIPIDOL, V23, P310, DOI 10.1097/MOL.0b013e3283555a7e; Giani A, 2011, INVEST OPHTH VIS SCI, V52, P3880, DOI 10.1167/iovs.10-6266; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Huang Xionggao, 2017, Invest Ophthalmol Vis Sci, V58, P1228, DOI 10.1167/iovs.16-20537; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kawamoto A, 2001, CIRCULATION, V103, P634; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; Lei HT, 2015, MOL CELL BIOL, V35, P1673, DOI 10.1128/MCB.01248-14; Lei HT, 2004, CIRC RES, V94, P902, DOI 10.1161/01.RES.0000124979.46214.E3; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Pillay S, 2016, NATURE, V530, P108, DOI 10.1038/nature16465; Ruan GX, 2012, EMBO J, V31, P1692, DOI 10.1038/emboj.2012.21; Saint-Geniez M, 2013, AM J PATHOL, V182, P255, DOI 10.1016/j.ajpath.2012.09.003; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SHIMA DT, 1995, MOL MED, V1, P182; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Suzuki M, 2014, BRIT J OPHTHALMOL, V98, P1186, DOI 10.1136/bjophthalmol-2013-304670; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Williams R, 2004, EYE, V18, P963, DOI 10.1038/sj.eye.6701476; Zhang F, 2015, HUM GENE THER, V26, P409, DOI 10.1089/hum.2015.29002.fzh	40	0	0	11	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JUL 24	2017	8								112	10.1038/s41467-017-00140-3				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FB5BO	WOS:000406156600011	28740073	gold			2018-01-05	
J	Laanto, E; Hoikkala, V; Ravantti, J; Sundberg, LR				Laanto, Elina; Hoikkala, Ville; Ravantti, Janne; Sundberg, Lotta-Riina			Long-term genomic coevolution of host-parasite interaction in the natural environment	NATURE COMMUNICATIONS			English	Article							CRISPR-CAS SYSTEMS; PATHOGEN FLAVOBACTERIUM-COLUMNARE; BACTERIOPHAGE RESISTANCE MECHANISMS; ANTAGONISTIC COEVOLUTION; IMMUNE-SYSTEM; PHAGE; EVOLUTION; FISH; VIRULENCE; ADAPTATION	Antagonistic coevolution of parasite infectivity and host resistance may alter the biological functionality of species, yet these dynamics in nature are still poorly understood. Here we show the molecular details of a long-term phage-bacterium arms race in the environment. Bacteria (Flavobacterium columnare) are generally resistant to phages from the past and susceptible to phages isolated in years after bacterial isolation. Bacterial resistance selects for increased phage infectivity and host range, which is also associated with expansion of phage genome size. We identified two CRISPR loci in the bacterial host: a type II-C locus and a type VI-B locus. While maintaining a core set of conserved spacers, phage-matching spacers appear in the variable ends of both loci over time. The spacers mostly target the terminal end of the phage genomes, which also exhibit the most variation across time, resulting in arms-race-like changes in the protospacers of the coevolving phage population.	[Laanto, Elina; Hoikkala, Ville; Sundberg, Lotta-Riina] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Biol Interact, POB 35, FI-40014 Jyvaskyla, Finland; [Laanto, Elina; Hoikkala, Ville; Sundberg, Lotta-Riina] Univ Jyvaskyla, Dept Biol & Environm Sci, Nanosci Ctr, POB 35, FI-40014 Jyvaskyla, Finland; [Ravantti, Janne] Univ Helsinki, Dept Biosci, Viikinkaari 9, FI-00014 Helsinki, Finland; [Ravantti, Janne] Univ Helsinki, Inst Biotechnol, Viikinkaari 9, FI-00014 Helsinki, Finland	Sundberg, LR (reprint author), Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Biol Interact, POB 35, FI-40014 Jyvaskyla, Finland.; Sundberg, LR (reprint author), Univ Jyvaskyla, Dept Biol & Environm Sci, Nanosci Ctr, POB 35, FI-40014 Jyvaskyla, Finland.	lotta-riina.sundberg@jyu.fi	Sundberg, Lotta-Riina/N-1551-2014	Sundberg, Lotta-Riina/0000-0003-3510-4398; Ravantti, Janne/0000-0002-8578-7230; Laanto, Elina/0000-0003-4172-3128	Finnish Centre of Excellence Program of the Academy of Finland; CoE in Biological Interactions [252411]; Academy of Finland [266879, 304615]; Jane and Aatos Erkko Foundation	This work was supported by the Finnish Centre of Excellence Program of the Academy of Finland; the CoE in Biological Interactions 2012-2017 (#252411), by the Academy of Finland (grants #266879 and #304615), and by the Jane and Aatos Erkko Foundation. We would like to thank MSc Jenni Marjakangas, MSc Katja Neuvonen, and Mr. Petri Papponen for skillful help in the laboratory, Dr. Heidi Kunttu for kindly donating genotyped bacterial strains, Dr. Reetta Penttinen for help in bacterial isolation, and Dr. Andres Lopez-Sepulcre for help in statistical analyses. In memory of Prof. Jaana Bamford.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Ashrafi R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0576-4; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Betts A, 2016, TRENDS PARASITOL, V32, P863, DOI 10.1016/j.pt.2016.08.003; Biswas A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2627-0; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Brockhurst MA, 2005, P ROY SOC B-BIOL SCI, V272, P1385, DOI 10.1098/rspb.2005.3086; Brockhurst MA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1382; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Burstein D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10613; Castillo D, 2015, APPL ENVIRON MICROB, V81, P1157, DOI 10.1128/AEM.03699-14; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; Declercq AM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-27; Decostere A, 1997, J CLIN MICROBIOL, V35, P322; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Gaba S, 2009, TRENDS ECOL EVOL, V24, P226, DOI 10.1016/j.tree.2008.11.005; Gomez P, 2011, SCIENCE, V332, P106, DOI 10.1126/science.1198767; Hall AR, 2011, AM NAT, V177, P44, DOI 10.1086/657441; Hamilton R, 2008, P R SOC B, V275, P937, DOI 10.1098/rspb.2007.1574; Johnson CM, 2015, ANNU REV GENET, V49, P577, DOI 10.1146/annurev-genet-112414-055018; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koskella B, 2013, CURR BIOL, V23, P1256, DOI 10.1016/j.cub.2013.05.038; Kropinski Andrew M., 2009, V501, P151, DOI 10.1007/978-1-60327-164-6_15; Kunttu HMT, 2012, ENV MICROBIOL REP, V4, P398, DOI 10.1111/j.1758-2229.2012.00342.x; Kunttu HMT, 2009, MICROB PATHOGENESIS, V46, P21, DOI 10.1016/j.micpath.2008.10.001; Laanto E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00829; Laanto E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053157; Laanto E, 2011, APPL ENVIRON MICROB, V77, P7868, DOI 10.1128/AEM.05574-11; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Leckenby A, 2015, CURR OPIN GENET DEV, V35, P86, DOI 10.1016/j.gde.2015.11.001; Leenay RT, 2017, J MOL BIOL, V429, P177, DOI 10.1016/j.jmb.2016.11.024; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Leggett HC, 2013, TRENDS ECOL EVOL, V28, P592, DOI 10.1016/j.tree.2013.07.002; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364                                                                  ; Levin BR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003312; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Lopatina A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00398; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; McGinn J, 2016, MOL CELL, V64, P616, DOI 10.1016/j.molcel.2016.08.038; Modell JW, 2017, NATURE, V544, P101, DOI 10.1038/nature21719; Molineux IJ, 2013, NAT REV MICROBIOL, V11, P194, DOI [10.1038/nrmicro2941, 10.1038/nrmicro2988]; Paez-Espino D, 2015, MBIO, V6, DOI 10.1128/mBio.00262-15; Parratt SR, 2016, ISME J, V10, P1815, DOI 10.1038/ismej.2015.247; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Richards G.P, 2014, BACTERIOPHAGE, V4, DOI DOI 10.4161/21597081.2014.975540; Romero J., 2014, HLTH ENV AQUACULTURE, P159; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; SANTOS MA, 1991, NUCLEIC ACIDS RES, V19, P5442, DOI 10.1093/nar/19.19.5442; Savitskaya E, 2017, MOL ECOL, V26, P2019, DOI 10.1111/mec.13961; Scanlan PD, 2011, MOL ECOL, V20, P981, DOI 10.1111/j.1365-294X.2010.04903.x; Scanlan P. D., 2015, BACTERIOPHAGE, V5; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; SONG YL, 1988, FISH PATHOL, V23, P91, DOI 10.3147/jsfp.23.91                                                              ; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Sun CL, 2013, ENVIRON MICROBIOL, V15, P463, DOI 10.1111/j.1462-2920.2012.02879.x; Sundberg LR, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3069; Tekedar HC, 2012, J BACTERIOL, V194, P2763, DOI 10.1128/JB.00281-12; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; Food and Agriculture Organization of the United Nations, 2014, OPP CHALL; Vale PF, 2015, P ROY SOC B-BIOL SCI, V282, P41, DOI 10.1098/rspb.2015.1270; Vale PF, 2010, P ROY SOC B-BIOL SCI, V277, P2097, DOI 10.1098/rspb.2010.0055; van Houte S, 2016, MICROBIOL MOL BIOL R, V80, P745, DOI 10.1128/MMBR.00011-16; van Houte S, 2016, NATURE, V532, P385, DOI 10.1038/nature17436; Weinberger AD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002475; Westra ER, 2015, CURR BIOL, V25, P1043, DOI 10.1016/j.cub.2015.01.065; Yasmin A, 2010, J BACTERIOL, V192, P1122, DOI 10.1128/JB.01293-09; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang J, 2014, FEMS MICROBIOL ECOL, V89, P553, DOI 10.1111/1574-6941.12356; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	77	1	1	23	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JUL 24	2017	8								111	10.1038/s41467-017-00158-7				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FB5BO	WOS:000406156600010	28740072	gold			2018-01-05	
J	Kurihara, T; Fukuhara, T; Ono, C; Yamamoto, S; Uemura, K; Okamoto, T; Sugiyama, M; Motooka, D; Nakamura, S; Ikawa, M; Mizokami, M; Maehara, Y; Matsuura, Y				Kurihara, Takeshi; Fukuhara, Takasuke; Ono, Chikako; Yamamoto, Satomi; Uemura, Kentaro; Okamoto, Toru; Sugiyama, Masaya; Motooka, Daisuke; Nakamura, Shota; Ikawa, Masato; Mizokami, Masashi; Maehara, Yoshihiko; Matsuura, Yoshiharu			Suppression of HBV replication by the expression of nickase- and nuclease dead-Cas9	SCIENTIFIC REPORTS			English	Article							HEPATITIS-B-VIRUS; GUIDED DNA ENDONUCLEASE; RNA; CRISPR; CAS9; CELLS; SPECIFICITY; RESISTANCE; SEQUENCE; CCCDNA	Complete removal of hepatitis B virus (HBV) DNA from nuclei is difficult by the current therapies. Recent reports have shown that a novel genome-editing tool using Cas9 with a single-guide RNA (sgRNA) system can cleave the HBV genome in vitro and in vivo. However, induction of a double-strand break (DSB) on the targeted genome by Cas9 risks undesirable off-target cleavage on the host genome. Nickase-Cas9 cleaves a single strand of DNA, and thereby two sgRNAs are required for inducing DSBs. To avoid Cas9-induced off-target mutagenesis, we examined the effects of the expressions of nickase-Cas9 and nuclease dead Cas9 (d-Cas9) with sgRNAs on HBV replication. The expression of nickase-Cas9 with a pair of sgRNAs cleaved the target HBV genome and suppressed the viral-protein expression and HBV replication in vitro. Moreover, nickase-Cas9 with the sgRNA pair cleaved the targeted HBV genome in mouse liver. Interestingly, d-Cas9 expression with the sgRNAs also suppressed HBV replication in vitro without cleaving the HBV genome. These results suggest the possible use of nickase-Cas9 and d-Cas9 with a pair of sgRNAs for eliminating HBV DNA from the livers of chronic hepatitis B patients with low risk of undesirable off-target mutation on the host genome.	[Kurihara, Takeshi; Fukuhara, Takasuke; Ono, Chikako; Yamamoto, Satomi; Uemura, Kentaro; Okamoto, Toru; Matsuura, Yoshiharu] Osaka Univ, Res Inst Microbial Dis, Dept Mol Virol, Osaka, Japan; [Kurihara, Takeshi; Maehara, Yoshihiko] Kyushu Univ, Dept Surg & Sci, Grad Sch Med, Fukuoka, Japan; [Sugiyama, Masaya; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Japan; [Motooka, Daisuke; Nakamura, Shota] Osaka Univ, Res Inst Microbial Dis, Dept Infect Metagen, Osaka, Japan; [Ikawa, Masato] Osaka Univ, Res Inst Microbial Dis, Ctr Genet Anal Biol Responses, Osaka, Japan; [Yamamoto, Satomi] Kitasato Univ, Sch Vet Med, Lab Vet Microbiol, Higashi 23-35-1, Towada, Aomori 0348628, Japan	Fukuhara, T; Matsuura, Y (reprint author), Osaka Univ, Res Inst Microbial Dis, Dept Mol Virol, Osaka, Japan.	fukut@biken.osaka-u.ac.jp; matsuura@biken.osaka-u.ac.jp			AMED [16fk0310510h0005]	We thank M. Tomiyama for her secretarial work and M. Ishibashi and Y. Sugiyama for their technical assistance. We also thank T. Wakita and A. Ryo for providing experimental materials. This work was supported by AMED (Grant no. 16fk0310510h0005).	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bin S., 2014, NAT METHODS, V11, P399; Cyranoski D, 2016, NATURE, V535, P476, DOI 10.1038/nature.2016.20302; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; GANEM D, 1987, ANNU REV BIOCHEM, V56, P651, DOI 10.1146/annurev.biochem.56.1.651; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karimova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13734; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Cong Le, 2013, SCIENCE, V339, P819; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Qasim W, 2015, BLOOD, V126, P2046; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reardon S., 2016, NATURE, DOI [10.1038/nature.2016.20137, DOI 10.1038/NATURE.2016.20137]; Sakuma T, 2016, GENES CELLS, V21, P1253, DOI 10.1111/gtc.12437; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Watashi K, 2014, HEPATOLOGY, V59, P1726, DOI 10.1002/hep.26982; Wursthorn K, 2006, HEPATOLOGY, V44, P675, DOI 10.1002/hep.21282; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zoulim F, 2011, LIVER INT, V31, P111, DOI 10.1111/j.1478-3231.2010.02399.x	34	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 21	2017	7								6122	10.1038/s41598-017-05905-w				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FB6XM	WOS:000406285700030	28733609	gold			2018-01-05	
J	Nagy, T; Kampmann, M				Nagy, Tamas; Kampmann, Martin			CRISPulator: a discrete simulation tool for pooled genetic screens	BMC BIOINFORMATICS			English	Article						CRISPR; CRISPRi; Functional genomics; Genome-wide screens; Simulation; Monte Carlo	HUMAN-CELLS; CRISPR-CAS9; SHRNA; IDENTIFICATION; LIBRARIES; CANCER; RNAI	Background: The rapid adoption of CRISPR technology has enabled biomedical researchers to conduct CRISPR-based genetic screens in a pooled format. The quality of results from such screens is heavily dependent on the selection of optimal screen design parameters, which also affects cost and scalability. However, the cost and effort of implementing pooled screens prohibits experimental testing of a large number of parameters. Results: We present CRISPulator, a Monte Carlo method-based computational tool that simulates the impact of screen parameters on the robustness of screen results, thereby enabling users to build intuition and insights that will inform their experimental strategy. CRISPulator enables the simulation of screens relying on either CRISPR interference (CRISPRi) or CRISPR nuclease (CRISPRn). Pooled screens based on cell growth/survival, as well as fluorescence-activated cell sorting according to fluorescent reporter phenotypes are supported. CRISPulator is freely available online (http://crispulator.ucsf.edu). Conclusions: CRISPulator facilitates the design of pooled genetic screens by enabling the exploration of a large space of experimental parameters in silico, rather than through costly experimental trial and error. We illustrate its power by deriving non-obvious rules for optimal screen design.	[Nagy, Tamas] Univ Calif San Francisco, Grad Program Bioinformat, San Francisco, CA 94158 USA; [Kampmann, Martin] Univ Calif San Francisco, Inst Neurodegenerat Dis, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Kampmann, Martin] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Kampmann, Martin] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	Kampmann, M (reprint author), Univ Calif San Francisco, Inst Neurodegenerat Dis, Dept Biochem & Biophys, San Francisco, CA 94158 USA.; Kampmann, M (reprint author), Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA.; Kampmann, M (reprint author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	Martin.Kampmann@ucsf.edu		Kampmann, Martin/0000-0002-3819-7019	National Science Foundation [1650113]; NIH/NIGMS New Innovator Award [DP2 GM119139]	TN was supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. 1650113. MK was supported by NIH/NIGMS New Innovator Award DP2 GM119139. MK is a Chan Zuckerberg Biohub investigator. The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Acosta-Alvear D, 2015, ELIFE, V4, DOI 10.7554/eLife.08153; Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Boyd Kendrick, 2013, Machine Learning and Knowledge Discovery in Databases. European Conference, ECML PKDD 2013. Proceedings: LNCS 8190, P451, DOI 10.1007/978-3-642-40994-3_29; Chan C, 2008, CYTOM PART A, V73A, P693, DOI 10.1002/cyto.a.20583; Davis J., 2006, P 23 INT C MACH LEAR, V23, P233, DOI DOI 10.1145/1143844.1143874; DeJesus R, 2016, ELIFE, V5, DOI 10.7554/elife.17290; Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Goadrich M, 2004, LECT NOTES ARTIF INT, V3194, P98; Horlbeck M. A., 2016, ELIFE, V5; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Kampmann M, 2017, TRENDS MOL MED, V23, P483, DOI 10.1016/j.molmed.2017.04.003; Kampmann M, 2015, P NATL ACAD SCI USA, V112, pE3384, DOI 10.1073/pnas.1508821112; Kampmann M, 2013, P NATL ACAD SCI USA, V110, pE2317, DOI 10.1073/pnas.1307002110; Kruth KA, 2017, BLOOD, V129, P3000, DOI 10.1182/blood-2017-02-766204; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Sims D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r104; Stombaugh J, 2015, J BIOMOL SCREEN, V20, P965, DOI 10.1177/1087057115576715; Strezoska Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042341; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	24	0	0	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	JUL 21	2017	18								347	10.1186/s12859-017-1759-9				12	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	FC1PM	WOS:000406609700001	28732459	gold			2018-01-05	
J	Huang, ZH; Nair, M				Huang, Zaohua; Nair, Madahavan			A CRISPR/Cas9 guidance RNA screen platform for HIV provirus disruption and HIV/AIDS gene therapy in astrocytes	SCIENTIFIC REPORTS			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; CENTRAL-NERVOUS-SYSTEM; ACTIVE ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; INTEGRATED HIV-1; LATENT RESERVOIR; VIRAL LOAD; TARGET DNA; IN-VIVO	HIV/AIDS remains a major health threat despite significant advances in the prevention and treatment of HIV infection. The major reason is the inability of existing treatments to eradicate the multiple HIV reservoirs in the human body, including astrocytes in the human brain. CRISPR/Cas9 system is an emerging gene-editing technique with the potential to eliminate or disrupt HIV provirus in HIV reservoir cells, which may lead to a complete cure of HIV/AIDS. The key components of CRISPR/Cas9 are guide RNAs (gRNAs) which determine specific sequence targeting of DNAs. This study established a novel, simple and quick screening method to identify gRNA candidates for targeting HIV provirus in astrocytes. Briefly, stable astrocytes clones with an integrated fluorescent HIV reporter and Cas9 expression gene were generated. Various gRNAs were screened for their efficiencies against HIV provirus in these cells. Moreover, these gRNAs and Cas9 protein were successfully tested on HIV latent astrocytes without Cas9 expression to mimic clinical conditions. HIV provirus gene-editing were confirmed by cell genomic DNA PCR and fluorescent marker expression analysis. In the future, the established transgenic cells can be used for other gene-editing studies and is well-suited for high-throughput screen application.	[Huang, Zaohua; Nair, Madahavan] Florida Int Univ, Herbert Wertheim Coll Med, Ctr Personalized Nanomed, Inst NeuroImmune Pharmacol,Dept Immunol, Miami, FL 33199 USA	Nair, M (reprint author), Florida Int Univ, Herbert Wertheim Coll Med, Ctr Personalized Nanomed, Inst NeuroImmune Pharmacol,Dept Immunol, Miami, FL 33199 USA.	nairm@fiu.edu			NIH [R01DA037838, R01DA034547, R01MH085259]	This work is supported by NIH grants R01DA037838, R01DA034547, R01MH085259. We also thank Maureen Pelham, Bryan Rivas and Dr. Andrea Raymond for their help in English editing.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Bagasra O, 1996, AIDS, V10, P573, DOI 10.1097/00002030-199606000-00002; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Brady T, 2009, AIDS, V23, P1461, DOI 10.1097/QAD.0b013e32832caf28; Chavez L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004955; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Churchill MJ, 2006, J NEUROVIROL, V12, P146, DOI 10.1080/13550280600748946; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dahabieh MS, 2013, J VIROL, V87, P4716, DOI 10.1128/JVI.03478-12; Dampier W., 2014, MOJ IMMUNOLOGY, V1; De Luca MA, 2015, INT J PHARMACEUT, V479, P129, DOI 10.1016/j.ijpharm.2014.12.057; Ding H, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/5/055101; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Gallastegui E, 2011, J VIROL, V85, P3187, DOI 10.1128/JVI.01920-10; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2015, CLIN INFECT DIS, V60, P473, DOI 10.1093/cid/ciu862; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Jayant RD, 2015, INT J NANOMED, V10, P1077, DOI 10.2147/IJN.S76517; Kaminski R, 2016, GENE THER, V23, P690, DOI 10.1038/gt.2016.41; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31527; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Kaushik A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25309; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lenasi T, 2008, CELL HOST MICROBE, V4, P123, DOI 10.1016/j.chom.2008.05.016; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; MCELRATH MJ, 1991, J CLIN INVEST, V87, P27, DOI 10.1172/JCI114981; Nair M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2717; Narasipura SD, 2014, J VIROL, V88, P3031, DOI 10.1128/JVI.03333-13; Nath A, 2015, J NEUROVIROL, V21, P227, DOI 10.1007/s13365-014-0291-1; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Patel P, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0108-6; Petito CK, 1999, J NEUROVIROL, V5, P670, DOI 10.3109/13550289909021295                                                       ; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ruelas DS, 2015, J BIOL CHEM, V290, P13736, DOI 10.1074/jbc.M115.641837; Sagar V, 2015, J BIOMED NANOTECHNOL, V11, P1722, DOI 10.1166/jbn.2015.2108; Schneider M, 2015, AIDS, V29, P1147, DOI 10.1097/QAD.0000000000000691; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Smith PD, 2003, J LEUKOCYTE BIOL, V74, P642, DOI 10.1189/jlb.0503219; Solas C, 2003, ANTIMICROB AGENTS CH, V47, P238, DOI 10.1128/AAC.47.1.238-243.2003; Sunshine S, 2016, J VIROL, V90, P4511, DOI 10.1128/JVI.01617-15; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zhu WJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0150-z	60	0	0	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 20	2017	7								5955	10.1038/s41598-017-06269-x				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FB1MN	WOS:000405907800009	28729655	gold			2018-01-05	
J	Royba, E; Miyamoto, T; Akutsu, SN; Hosoba, K; Tauchi, H; Kudo, Y; Tashiro, S; Yamamoto, T; Matsuura, S				Royba, Ekaterina; Miyamoto, Tatsuo; Akutsu, Silvia Natsuko; Hosoba, Kosuke; Tauchi, Hiroshi; Kudo, Yoshiki; Tashiro, Satoshi; Yamamoto, Takashi; Matsuura, Shinya			Evaluation of ATM heterozygous mutations underlying individual differences in radiosensitivity using genome editing in human cultured cells	SCIENTIFIC REPORTS			English	Article							CANCER SUSCEPTIBILITY; ATAXIA-TELANGIECTASIA; TARGETED INTEGRATION; IONIZING-RADIATION; IRRADIATION; SYSTEM; GENE; CRISPR-CAS9; CRISPR/CAS9; MICRONUCLEI	Ionizing radiation (IR) induces DNA double-strand breaks (DSBs), which are an initial step towards chromosomal aberrations and cell death. It has been suggested that there are individual differences in radiosensitivity within human populations, and that the variations in DNA repair genes might determine this heterogeneity. However, it is difficult to quantify the effect of genetic variants on the individual differences in radiosensitivity, since confounding factors such as smoking and the diverse genetic backgrounds within human populations affect radiosensitivity. To precisely quantify the effect of a genetic variation on radiosensitivity, we here used the CRISPR-ObLiGaRe (Obligate Ligation-Gated Recombination) method combined with the CRISPR/Cas9 system and a nonhomologous end joining (NHEJ)-mediated knock-in technique in human cultured cells with a uniform genetic background. We generated ATM heterozygous knock-out (ATM(+/-)) cell clones as a carrier model of a radiation-hypersensitive autosomal-recessive disorder, ataxia-telangiectasia (A-T). Cytokinesis-blocked micronucleus assay and chromosome aberration assay showed that the radiosensitivity of ATM(+/-)cell clones was significantly higher than that of ATM(+/+) cells, suggesting that ATM gene variants are indeed involved in determining individual radiosensitivity. Importantly, the differences in radiosensitivity among the same genotype clones were small, unlike the individual differences in fibroblasts derived from A-T-affected family members.	[Royba, Ekaterina; Miyamoto, Tatsuo; Akutsu, Silvia Natsuko; Hosoba, Kosuke; Matsuura, Shinya] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Genet & Cell Biol, Hiroshima 7348553, Japan; [Tauchi, Hiroshi] Ibaraki Univ, Fac Sci, Dept Biol Sci, Mito, Ibaraki 3108512, Japan; [Kudo, Yoshiki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, Hiroshima 7348551, Japan; [Tashiro, Satoshi] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cellular Biol, Hiroshima 7348553, Japan; [Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan	Matsuura, S (reprint author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Genet & Cell Biol, Hiroshima 7348553, Japan.	shinya@hiroshima-u.ac.jp	Yamamoto, Takashi/U-4790-2017; Matsuura, Shinya/U-4182-2017	Yamamoto, Takashi/0000-0002-6516-2903; Matsuura, Shinya/0000-0001-5294-081X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Program of the network-type Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University; Nagasaki University; Fukushima Medical University; Center of World Intelligence Projects for Nuclear S&T and Human Resource Development from the Japan Science and Technology Agency; Ministry of Health, Labor and Welfare; AMEDPRIME from the Japan Agency for Medical Research and Development, AMED; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Ono Medical Research Foundation; Takeda Science Foundation; Phoenix Leader Education Program Research Grant; Hiroshima University Program for Leading Graduate School Grant	We thank Drs Nori Nakamura, Otsura Niwa, Hiroshi Ochiai, Ken-ichi Suzuki, Yuki Kobayashi, Akihito Inoko, and Yumiko Saito for helpful discussions. We also thank Mr. Yoshinori Masatsuna, Ms. Yukiji Tonouchi and Ms. Yuka Uchikawa for technical assistance. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S.M. and T.M.),the Program of the network-type Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University, Nagasaki University and Fukushima Medical University (to S.M. and H.T.), the Center of World Intelligence Projects for Nuclear S&T and Human Resource Development from the Japan Science and Technology Agency (to S.M.), a Grant-in-Aid for Scientific Research from the Ministry of Health, Labor and Welfare (to S.M.), AMEDPRIME from the Japan Agency for Medical Research and Development, AMED (to T.M.), research grants from the Naito Foundation (to S.M. and T.M.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to T.M.), Ono Medical Research Foundation (to T.M.), Takeda Science Foundation (to T.M.), Phoenix Leader Education Program Research Grant (to E.R. and S.A.) and Hiroshima University Program for Leading Graduate School Grant (to E.R. and S.A.).	Auer TO, 2014, METHODS, V69, P142, DOI 10.1016/j.ymeth.2014.03.027; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Cao LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104279; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Deperas J, 2007, RADIAT PROT DOSIM, V124, P115, DOI 10.1093/rpd/ncm137; Distel LVR, 2006, RADIOTHER ONCOL, V81, P257, DOI 10.1016/j.radonc.2006.10.012; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Foray N, 2016, MUTAT RES-REV MUTAT, V770, P369, DOI 10.1016/j.mrrev.2016.09.001; Foray N, 2012, RADIOLOGY, V264, P627, DOI 10.1148/radiol.12112560; Guo C-X, 2016, MOL CLIN ONCOL, V4, P3, DOI DOI 10.3892/MC0.2015.666; Kato TA, 2006, RADIAT RES, V166, P443, DOI 10.1667/RR3604.1; Katoh Y, 2017, MOL BIOL CELL, V28, P898, DOI 10.1091/mbc.E17-01-0051; Koberle B, 2016, ARCH TOXICOL, V90, P2369, DOI 10.1007/s00204-016-1771-2; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Matsuura S., 2016, Annals of the ICRP, V45, P290, DOI 10.1177/0146645316633941; Miyamoto T, 2015, CELL REP, V10, P664, DOI 10.1016/j.celrep.2015.01.003; Mizutani S, 2013, INT J HEMATOL, V97, P37, DOI 10.1007/s12185-012-1240-5; O'Driscoll MC, 1998, BRIT J CANCER, V78, P1559, DOI 10.1038/bjc.1998.723; Ochiai H, 2014, P NATL ACAD SCI USA, V111, P1461, DOI 10.1073/pnas.1317008111; ONO K, 1990, RADIAT RES, V123, P345, DOI 10.2307/3577742; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Pinto P, 2016, BREAST CANCER RES TR, V159, P245, DOI 10.1007/s10549-016-3948-z; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Scott D, 1998, BRIT J CANCER, V77, P614, DOI 10.1038/bjc.1998.98; Shi L, 2012, RADIAT RES, V177, P533, DOI 10.1667/RR2849.1; Shim G, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00137; Spring K, 2002, NAT GENET, V32, P185, DOI 10.1038/ng958; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; [Anonymous], 2007, ANN ICRP, V37, P1, DOI DOI 10.1016/J.ICRP.2007.10.003	32	1	1	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 20	2017	7								5996	10.1038/s41598-017-06393-8				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FB1MN	WOS:000405907800050	28729543	gold			2018-01-05	
J	Gomes-Silva, D; Srinivasan, M; Sharma, S; Lee, CM; Wagner, DL; Davis, TH; Rouce, RH; Bao, G; Brenner, MK; Mamonkin, M				Gomes-Silva, Diogo; Srinivasan, Madhuwanti; Sharma, Sandhya; Lee, Ciaran M.; Wagner, Dimitrios L.; Davis, Timothy H.; Rouce, Rayne H.; Bao, Gang; Brenner, Malcolm K.; Mamonkin, Maksim			CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies	BLOOD			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHIMERIC ANTIGEN RECEPTOR; MONOCLONAL-ANTIBODY; PHOSPHATIDYLINOSITOL 3-KINASE; CRISPR/CAS9 SYSTEMS; CHAIN IMMUNOTOXIN; K12 SECTM1; CD7; GENE; PROTEIN	Extending the success of chimeric antigen receptor (CAR) T cells to T-cell malignancies is problematic because most target antigens are shared between normal and malignant cells, leading to CART-cell fratricide. CD7 is a transmembrane protein highly expressed in acute T-cell leukemia (T-ALL) and in a subset of peripheral T-cell lymphomas. Normal expression of CD7 is largely confined to T cells and natural killer (NK) cells, reducing the risk of off-target-organ toxicity. Here, we show that the expression of a CD7-specific CAR impaired expansion of transduced T cells because of residual CD7 expression and the ensuing fratricide. We demonstrate that targeted genomic disruption of the CD7 gene prevented this fratricide and enabled expansion of CD7 CAR T cells without compromising their cytotoxic function. CD7 CAR T cells produced robust cytotoxicity against malignant T-cell lines and primary tumors and were protective in a mouse xenograft model of T-ALL. Although CD7 CAR T cells were also toxic against unedited (CD7 1) T and NK lymphocytes, we show that the CD7-edited T cells themselves can respond to viral peptides and therefore could be protective against pathogens. Hence, genomic disruption of a target antigen overcomes fratricide of CAR T cells and establishes the feasibility of using CD7 CAR T cells for the targeted therapy of T-cell malignancies.	[Gomes-Silva, Diogo; Srinivasan, Madhuwanti; Sharma, Sandhya; Wagner, Dimitrios L.; Rouce, Rayne H.; Brenner, Malcolm K.; Mamonkin, Maksim] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Gomes-Silva, Diogo; Srinivasan, Madhuwanti; Sharma, Sandhya; Wagner, Dimitrios L.; Rouce, Rayne H.; Brenner, Malcolm K.; Mamonkin, Maksim] Texas Childrens Hosp, Houston, TX 77030 USA; [Gomes-Silva, Diogo; Srinivasan, Madhuwanti; Sharma, Sandhya; Wagner, Dimitrios L.; Rouce, Rayne H.; Brenner, Malcolm K.; Mamonkin, Maksim] Houston Methodist Hosp, 1102 Bates St,Suite FC1770, Houston, TX 77030 USA; [Gomes-Silva, Diogo] Univ Lisbon, Inst Super Tecn, Dept Bioengn, Lisbon, Portugal; [Gomes-Silva, Diogo] Univ Lisbon, Inst Super Tecn, Inst Bioengn & Biosci, Lisbon, Portugal; [Lee, Ciaran M.; Davis, Timothy H.; Bao, Gang] Rice Univ, Dept Bioengn, Houston, TX USA; [Mamonkin, Maksim] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Mamonkin, M (reprint author), Houston Methodist Hosp, 1102 Bates St,Suite FC1770, Houston, TX 77030 USA.; Mamonkin, M (reprint author), Texas Childrens Hosp, Baylor Coll Med, 1102 Bates St,Suite FC1770, Houston, TX 77030 USA.	mamonkin@bcm.edu		Wagner, Dimitrios L./0000-0002-2189-3579; Mamonkin, Maksim/0000-0001-7178-8163; Gomes-Silva, Diogo/0000-0002-9615-3735; Lee, Ciaran/0000-0002-0789-9149	American Society of Hematology Scholar Award; National Institutes of Health, National Cancer Institute [P50 CA126752]; Cancer Prevention and Research Institute of Texas [RR140081]; Fundacao para a Ciencia e Tecnologia (Portugal) [SFRH/BD/52479/2014];  [P30CA125123]	This work was supported by an American Society of Hematology Scholar Award (M.M.) and by the National Institutes of Health, National Cancer Institute (P50 CA126752), as well as by the Cancer Prevention and Research Institute of Texas (RR140081) (G.B.). D.G.-S. acknowledges Fundacao para a Ciencia e Tecnologia (Portugal) for financial support (SFRH/BD/52479/2014). The authors also appreciate the support of shared resources from the Cancer Center (support grant P30CA125123).	Baum W, 1996, BRIT J HAEMATOL, V95, P327, DOI 10.1046/j.1365-2141.1996.d01-1900.x; Bonilla FA, 1997, INT IMMUNOL, V9, P1875, DOI 10.1093/intimm/9.12.1875; Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674                                                   ; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; CAMPANA D, 1991, BLOOD, V77, P1546; Chan ASH, 1997, J IMMUNOL, V159, P934; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Frankel AE, 1997, LEUKEMIA LYMPHOMA, V26, P287, DOI 10.3109/10428199709051778                                                       ; Gorczyca W., 2014, ATLAS DIFFERENTIAL D; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314                                                     ; HAYNES BF, 1979, P NATL ACAD SCI USA, V76, P5829, DOI 10.1073/pnas.76.11.5829; KERNAN NA, 1984, J IMMUNOL, V133, P137; Lam GK, 2005, J CLIN IMMUNOL, V25, P41, DOI 10.1007/s10875-005-0356-5; Lee CM, 2017, METHODS MOL BIOL, V1498, P3, DOI 10.1007/978-1-4939-6472-7_1; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Lee DM, 1996, INT IMMUNOL, V8, P1195, DOI 10.1093/intimm/8.8.1195; Lee DM, 1998, J IMMUNOL, V160, P5749; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Lyman SD, 2000, J BIOL CHEM, V275, P3431, DOI 10.1074/jbc.275.5.3431; Mamonkin M, 2015, BLOOD, V126, P983, DOI 10.1182/blood-2015-02-629527; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Pace KE, 2000, J IMMUNOL, V165, P2331, DOI 10.4049/jimmunol.165.5.2331                                                     ; Papadopoulou A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008825; Pauza ME, 1997, J IMMUNOL, V158, P3259; PREIJERS FWMB, 1988, BRIT J HAEMATOL, V70, P289, DOI 10.1111/j.1365-2141.1988.tb02484.x; Qasim W, 2015, BLOOD, V126, P2046; RABINOWICH H, 1994, J IMMUNOL, V152, P517; Rapoport AP, 2015, NAT MED, V21, P914, DOI 10.1038/nm.3910; Recchia A, 2006, P NATL ACAD SCI USA, V103, P1457, DOI 10.1073/pnas.0507496103; Reinhold U, 1996, IMMUNOLOGY, V89, P391, DOI 10.1046/j.1365-2567.1996.d01-744.x; REINHOLD U, 1993, J IMMUNOL, V150, P2081; Slentz-Kesler KA, 1998, GENOMICS, V47, P327, DOI 10.1006/geno.1997.5151; Sotillo E, 2015, CANCER DISCOV, V5, P1282, DOI 10.1158/2159-8290.CD-15-1020; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; Wang T, 2012, J LEUKOCYTE BIOL, V91, P449, DOI 10.1189/jlb.1011498; WARD SG, 1995, EUR J IMMUNOL, V25, P502, DOI 10.1002/eji.1830250229	43	4	4	5	5	AMER SOC HEMATOLOGY	WASHINGTON	2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA	0006-4971	1528-0020		BLOOD	Blood	JUL 20	2017	130	3					285	296		10.1182/blood-2017-01-761320				12	Hematology	Hematology	FB1HL	WOS:000405894300013	28539325				2018-01-05	
J	Erard, N; Knott, SRV; Hannon, GJ				Erard, Nicolas; Knott, Simon R. V.; Hannon, Gregory J.			A CRISPR Resource for Individual, Combinatorial, or Multiplexed Gene Knockout	MOLECULAR CELL			English	Article							LIBRARIES; ALGORITHM; DESIGN	We have combined a machine-learning approach with other strategies to optimize knockout efficiency with the CRISPR/Cas9 system. In addition, we have developed a multiplexed sgRNA expression strategy that promotes the functional ablation of single genes and allows for combinatorial targeting. These strategies have been combined to design and construct a genome-wide, sequence-verified, arrayed CRISPR library. This resource allows single-target or combinatorial genetic screens to be carried out at scale in a multiplexed or arrayed format. By conducting parallel loss-of-function screens, we compare our approach to existing sgRNA design and expression strategies.	[Erard, Nicolas; Knott, Simon R. V.; Hannon, Gregory J.] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England; [Knott, Simon R. V.; Hannon, Gregory J.] Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA; [Knott, Simon R. V.] Cedars Sinai Med Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Hannon, Gregory J.] New York Genome Ctr, 101 6th Ave, New York, NY 10013 USA	Knott, SRV; Hannon, GJ (reprint author), Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.; Knott, SRV; Hannon, GJ (reprint author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.; Knott, SRV (reprint author), Cedars Sinai Med Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.; Hannon, GJ (reprint author), New York Genome Ctr, 101 6th Ave, New York, NY 10013 USA.	simon.knott@cshs.org; greg.hannon@cruk.cam.ac.uk			CRUK	This work was supported in part by funding from CRUK. We thank the CRUK Genomics facility for providing sequencing services and members of the Hannon and Knott labs for helpful discussions. S.R.V.K. and G.H. are associated with Transomic Technologies, which has commercialized libraries constructed using the CRoatan design strategy.	Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Knott SRV, 2014, MOL CELL, V56, P796, DOI 10.1016/j.molcel.2014.10.025; Kudo T, 2005, J REPROD DEVELOP, V51, P411, DOI 10.1262/jrd.16094; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Pelossof R, 2017, NAT BIOTECHNOL, V35, P350, DOI 10.1038/nbt.3807; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Vidigal JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9083; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737	17	1	1	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	JUL 20	2017	67	2					348	+		10.1016/j.molcel.2017.06.030				10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FB1MQ	WOS:000405908100017	28732207	gold			2018-01-05	
J	Shipman, SL; Nivala, J; Macklis, JD; Church, GM				Shipman, Seth L. .; Nivala, Jeff; Macklis, Jeffrey D.; Church, George M.			CRISPR-Cas encoding of a digital movie into the genomes of a population of living bacteria	NATURE			English	Article							INFORMATION-STORAGE; ESCHERICHIA-COLI; DNA; ADAPTATION; IMMUNITY; GENERATION; RESISTANCE; SEQUENCE; ELEMENTS; SYSTEMS	DNA is an excellent medium for archiving data. Recent efforts have illustrated the potential for information storage in DNA using synthesized oligonucleotides assembled in vitro(1-6). A relatively unexplored avenue of information storage in DNA is the ability to write information into the genome of a living cell by the addition of nucleotides over time. Using the Cas1-Cas2 integrase, the CRISPR-Cas microbial immune system stores the nucleotide content of invading viruses to confer adaptive immunity(7). When harnessed, this system has the potential to write arbitrary information into the genome(8). Here we use the CRISPR-Cas system to encode the pixel values of black and white images and a short movie into the genomes of a population of living bacteria. In doing so, we push the technical limits of this information storage system and optimize strategies to minimize those limitations. We also uncover underlying principles of the CRISPR-Cas adaptation system, including sequence determinants of spacer acquisition that are relevant for understanding both the basic biology of bacterial adaptation and its technological applications. This work demonstrates that this system can capture and stably store practical amounts of real data within the genomes of populations of living cells.	[Shipman, Seth L. .; Nivala, Jeff; Church, George M.] Harvard Med Sch, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA; [Shipman, Seth L. .; Macklis, Jeffrey D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Shipman, Seth L. .; Macklis, Jeffrey D.] Harvard Univ, Harvard Stem Cell Inst, Bauer Lab 103, Cambridge, MA 02138 USA; [Shipman, Seth L. .; Nivala, Jeff; Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Church, GM (reprint author), Harvard Med Sch, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.; Church, GM (reprint author), Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	gchurch@genetics.med.harvard.edu		church, george/0000-0001-6232-9969	National Institute of Mental Health [5R01MH103910]; National Human Genome Research Institute [5RM1HG008525]; Simons Foundation Autism Research Initiative [368485]; National Institute of Neurological Disorders and Stroke [5R01NS045523]; Paul G. Allen Frontiers Group	S.L.S. is a Shurl and Kay Curci Foundation Fellow of the Life Sciences Research Foundation. The project was supported by grants from the National Institute of Mental Health (5R01MH103910), National Human Genome Research Institute (5RM1HG008525), and Simons Foundation Autism Research Initiative (368485) to G.M.C., the National Institute of Neurological Disorders and Stroke (5R01NS045523) to J.D.M and an Allen Distinguished Investigator Award from the Paul G. Allen Frontiers Group to J.D.M. We thank G. Kuznetsov for comments on the manuscript.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Clelland CT, 1999, NATURE, V399, P533, DOI 10.1038/21092; Davis J, 1996, ART J, V55, P70, DOI 10.2307/777811                                                                  ; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diez-Villasenor C, 2010, MICROBIOL-SGM, V156, P1351, DOI 10.1099/mic.0.036046-0; Erlich Y, 2017, SCIENCE, V355, P950, DOI 10.1126/science.aaj2038; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Goldman N, 2013, NATURE, V494, P77, DOI 10.1038/nature11875; Held NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012988; Hsiao V, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156663; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; O'Shea JP, 2013, NAT METHODS, V10, P1211, DOI [10.1038/NMETH.2646, 10.1038/nmeth.2646]; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Weinberger AD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002475; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Yosef I, 2013, P NATL ACAD SCI USA, V110, P14396, DOI 10.1073/pnas.1300108110; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zhirnov V, 2016, NAT MATER, V15, P366, DOI 10.1038/nmat4594	30	4	4	50	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					345	+		10.1038/nature23017				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FB0OR	WOS:000405844900033	28700573				2018-01-05	
J	Silva, SR; Alvarenga, DO; Aranguren, Y; Penha, HA; Fernandes, CC; Pinheiro, DG; Oliveira, MT; Michael, TP; Miranda, VFO; Varani, AM				Silva, Saura R.; Alvarenga, Danillo O.; Aranguren, Yani; Penha, Helen A.; Fernandes, Camila C.; Pinheiro, Daniel G.; Oliveira, Marcos T.; Michael, Todd P.; Miranda, Vitor F. O.; Varani, Alessandro M.			The mitochondrial genome of the terrestrial carnivorous plant Utricularia reniformis (Lentibulariaceae): Structure, comparative analysis and evolutionary landmarks	PLOS ONE			English	Article							GROUP-I INTRON; BLADDERWORT UTRICULARIA; HORIZONTAL TRANSFER; DNA; SEQUENCES; GENES; MODEL; IDENTIFICATION; VISUALIZATION; ARCHITECTURE	The carnivorous plants of the family Lentibulariaceae have attained recent attention not only because of their interesting lifestyle, but also because of their dynamic nuclear genome size. Lentibulariaceae genomes span an order of magnitude and include species with the smallest genomes in angiosperms, making them a powerful system to study the mechanisms of genome expansion and contraction. However, little is known about mitochondrial DNA (mtDNA) sequences of this family, and the evolutionary forces that shape this organellar genome. Here we report the sequencing and assembly of the complete mtDNA from the endemic terrestrial Brazilian species Utricularia reniformis. The 857,234bp master circle mitochondrial genome encodes 70 transcriptionaly active genes (42 protein-coding, 25 tRNAs and 3 rRNAs), covering up to 7% of the mtDNA. A ltrA-like protein related to splicing and mobility and a LAGLIDADG homing endonuclease have been identified in intronic regions, suggesting particular mechanisms of genome maintenance. RNA-seq analysis identified properties with putative diverse and important roles in genome regulation and evolution: 1) 672kbp (78%) of the mtDNA is covered by full-length reads; 2) most of the 243kbp intergenic regions exhibit transcripts; and 3) at least 69 novel RNA editing sites in the protein-coding genes. Additional genomic features are hypothetical ORFs (48%), chloroplast insertions, including truncated plastid genes that have been lost from the chloroplast DNA (5%), repeats (5%), relics of transposable elements mostly related to LTR retrotransposons (5%), and truncated mitovirus sequences (0.4%). Phylogenetic analysis based on 32 different Lamiales mitochondrial genomes corroborate that Lentibulariaceae is a monophyletic group. In summary, the U. reniformis mtDNA represents the eighth largest plant mtDNA described to date, shedding light on the genomic trends and evolutionary characteristics and phylogenetic history of the family Lentibulariaceae.	[Silva, Saura R.] Univ Estadual Paulista UNESP, Inst Biociencias, Dept Bot, Botucatu, SP, Brazil; [Alvarenga, Danillo O.; Penha, Helen A.; Fernandes, Camila C.; Pinheiro, Daniel G.; Oliveira, Marcos T.; Varani, Alessandro M.] Univ Estadual Paulista Unesp, Dept Tecnol, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil; [Aranguren, Yani; Miranda, Vitor F. O.] Univ Estadual Paulista Unesp, Dept Biol Aplicada Agr, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil; [Michael, Todd P.] Ibis Biosci, Computat Genom, Carlsbad, CA USA; [Aranguren, Yani] Univ Simon Bolivar, Barranquilla, Colombia; [Michael, Todd P.] J Craig Venter Inst, La Jolla, CA USA	Varani, AM (reprint author), Univ Estadual Paulista Unesp, Dept Tecnol, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil.; Miranda, VFO (reprint author), Univ Estadual Paulista Unesp, Dept Biol Aplicada Agr, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil.	vmiranda@fcav.unesp.br; amvarani@fcav.unesp.br	Miranda, Vitor/B-2800-2011; Varani, Alessandro/Q-1637-2016; Silva, Saura/I-1953-2015; de Mello Varani, Alessandro/F-6887-2011	Miranda, Vitor/0000-0003-0574-9865; Varani, Alessandro/0000-0002-8876-3269; Silva, Saura/0000-0002-6333-5268; de Mello Varani, Alessandro/0000-0002-8876-3269; Oliveira, Marcos Tulio/0000-0003-4779-5755; Alvarenga, Danillo/0000-0002-3666-2220; Aranguren-Diaz, Yani/0000-0001-6475-2787	Fundacao de Amparo do Estado de Sao Paulo, FAPESP [13/25164-6]; Ibis Biosciences, an Abbott Laboratories company	This study was funded by Fundacao de Amparo do Estado de Sao Paulo, FAPESP (13/25164-6). Ibis Biosciences, an Abbott Laboratories company, provided support to TM in the form of salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Adamec L, 1997, BOT REV, V63, P273, DOI 10.1007/BF02857953; Adlassnig W, 2005, PLANT SOIL, V274, P127, DOI 10.1007/s11104-004-2754-2; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert VA, 2010, J EXP BOT, V61, P5, DOI 10.1093/jxb/erp349; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Bremer B, 2009, BOT J LINN SOC, V161, P105; Bruenn JA, 2015, PEERJ, V3, DOI 10.7717/peerj.876; Bruhs A, 2011, ADVAN PL BIO, V1, P157; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caravieri FA, 2014, AQUAT BOT, V116, P8, DOI 10.1016/j.aquabot.2013.12.008; Carlsson J, 2011, ADVAN PL BIO, V1, P469; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Cheong WH, 2015, BIOINFORMATICS, V31, P3685, DOI 10.1093/bioinformatics/btv433; Christenhusz MJM, 2015, BOT J LINN SOC, V178, P501, DOI 10.1111/boj.12285; Clivati D, 2014, PLANT BIOLOGY, V16, P677, DOI 10.1111/plb.12091; Clivati D, 2012, AM J BOT, V99, pE375, DOI 10.3732/ajb.1200080; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Alcaraz LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148979; Dierckxsens N, 2016, NUCLEIC ACIDS RES; Ellison AM, 2011, OIKOS, V120, P1721, DOI 10.1111/j.1600-0706.2011.19604.x; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fujii S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-279; Grimes BT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-31; Gualberto JM, 2014, BIOCHIMIE, V100, P107, DOI 10.1016/j.biochi.2013.09.016; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hillman BI, 2013, ADV VIRUS RES, V86, P149, DOI 10.1016/B978-0-12-394315-6.00006-4; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ibarra-Laclette E, 2013, NATURE, V498, P94, DOI 10.1038/nature12132; Ibarra-Laclette E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-101; Iorizzo M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-61; Jackman SD, 2015, GENOME BIOL EVOL; Jobson RW, 2004, P NATL ACAD SCI USA, V101, P18064, DOI 10.1073/pnas.0408092101; Jobson RW, 2002, CLADISTICS, V18, P127, DOI 10.1006/clad.2001.0187; Juniper B, 1989, CARNIVIROROUS PLANTS; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Knoop V, 2004, CURR GENET, V46, P123, DOI 10.1007/s00294-004-0522-8; Koopman MM, 2011, MICROB ECOL, V61, P750, DOI 10.1007/s00248-011-9832-9; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lan TY, 2017, P NATL ACAD SCI USA, V114, pE4435, DOI 10.1073/pnas.1702072114; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin CS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09040; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mills DA, 1996, J BACTERIOL, V178, P3531, DOI 10.1128/jb.178.12.3531-3538.1996                                                ; Mower JP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-96; Mower JP, 2012, PLANT GENOME DIVERSI, V1, P123, DOI DOI 10.1007/978-3-7091-1130-7_; Oldenburg DJ, 1996, PLANT CELL, V8, P447; Palmer JD, 1992, MOL SYSTEMATICS PLAN, P36; Park S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-405; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817                                                 ; Rutishauser R, 2016, ANN BOT-LONDON, V117, P811, DOI 10.1093/aob/mcv172; Sanchez-Puerta MV, 2008, MOL BIOL EVOL, V25, P1762, DOI 10.1093/molbev/msn129; Sanchez-Puerta MV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-277; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Silva SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165176; Sirova D, 2009, AQUAT BOT, V90, P129, DOI 10.1016/j.aquabot.2008.07.007; Sloan DB, 2013, NEW PHYTOL, V200, P978, DOI 10.1111/nph.12395; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Stone JD, 2015, MOL GENET GENOMICS, V290, P1, DOI 10.1007/s00438-014-0905-6; Takeuchi Y, 2015, SYST APPL MICROBIOL, V38, P330, DOI 10.1016/j.syapm.2015.05.006; Taylor P., 1989, GENUS UTRICULARIA TA; Treangen TJ, 2011, CURR PROTOC BIOINFOR; VAUGHN JC, 1995, J MOL EVOL, V41, P563; Wang D, 2012, MOL BIOL EVOL, V29, P1707, DOI 10.1093/molbev/mss016; Wick Ryan R, 2015, Bioinformatics, V31, P3350, DOI 10.1093/bioinformatics/btv383; Wu ZQ, 2015, P NATL ACAD SCI USA, V112, P10185, DOI 10.1073/pnas.1421397112; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xi ZX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003265; Yoshihisa T, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00213	82	0	0	17	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e180484	10.1371/journal.pone.0180484				26	Multidisciplinary Sciences	Science & Technology - Other Topics	FB3UH	WOS:000406067800015	28723946	gold			2018-01-05	
J	Xie, C; Chen, YL; Wang, DF; Wang, YL; Zhang, TP; Li, H; Liang, F; Zhao, Y; Zhang, GY				Xie, Chen; Chen, Yan-Lian; Wang, Dong-Fang; Wang, Yi-Lin; Zhang, Tian-Peng; Li, Hui; Liang, Fu; Zhao, Yong; Zhang, Guang-Ya			SgRNA Expression of CRIPSR-Cas9 System Based on MiRNA Polycistrons as a Versatile Tool to Manipulate Multiple and Tissue-Specific Genome Editing	SCIENTIFIC REPORTS			English	Article							INTERFERING RNAS; CAS9; MICRORNAS; VECTOR; CAMKII; MEMORY; VIRUS	CRISPR/Cas9-mediated genome editing is a next-generation strategy for genetic modifications. Typically, sgRNA is constitutively expressed relying on RNA polymerase III promoters. Polymerase II promoters initiate transcription in a flexible manner, but sgRNAs generated by RNA polymerase II promoter lost their nuclease activity. To express sgRNAs in a tissue-specific fashion and endow CRISPR with more versatile function, a novel system was established in a polycistron, where miRNAs (or shRNAs) and sgRNAs alternately emerged and co-expressed under the control of a single polymerase II promoter. Effective expression and further processing of functional miRNAs and sgRNAs were achieved. The redundant nucleotides adjacent to sgRNA were degraded, and 5'-cap structure was responsible for the compromised nuclease capacity of sgRNA: Cas9 complex. Furthermore, this strategy fulfilled conducting multiplex genome editing, as well as executing neural-specific genome editing and enhancing the proportion of homologous recombination via inhibiting NHEJ pathway by shRNA. In summary, we designed a new construction for efficient expression of sgRNAs with miRNAs (shRNAs) by virtue of RNA polymerase II promoters, which will spur the development of safer, more controllable/regulable and powerful CRISPR/Cas9 system-mediated genome editing in a wide variety of further biomedical applications.	[Xie, Chen; Zhang, Guang-Ya] Huaqiao Univ, Coll Chem Engn, Xiamen 361021, Fujian, Peoples R China; [Chen, Yan-Lian; Zhang, Tian-Peng; Zhao, Yong] Sun Yat Sen Univ, Sch Life Sci, Cooperat Innovat Ctr High Performance Comp, Key Lab Gene Engn,Minist Educ, Guangzhou 510006, Guangdong, Peoples R China; [Xie, Chen; Li, Hui; Liang, Fu] Shenzhen Weiguang Biol Prod Co Ltd, Shenzhen 518107, Guangdong, Peoples R China; [Wang, Dong-Fang] Jinan Univ, Sch Med, Dept Spine Surg, Shenzhen Peoples Hosp, Shenzhen 518020, Guangdong, Peoples R China; [Wang, Yi-Lin] Qingdao Univ, Biochip Lab, Yantai Yuhuangding Hosp, Yantai 264000, Shandong, Peoples R China	Zhang, GY (reprint author), Huaqiao Univ, Coll Chem Engn, Xiamen 361021, Fujian, Peoples R China.; Zhao, Y (reprint author), Sun Yat Sen Univ, Sch Life Sci, Cooperat Innovat Ctr High Performance Comp, Key Lab Gene Engn,Minist Educ, Guangzhou 510006, Guangdong, Peoples R China.	zhaoy82@mail.sysu.edu.cn; zhgyghh@hqu.edu.cn			Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University [ZQN-YX105]; Program of Innovative Research Team of Huaqiao University [Z14X0047]; Scientific Research Foundation of Yantai Yuhuangding Hospital for Youth [201510]	This work was supported by the Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University (ZQN-YX105), the Program of Innovative Research Team of Huaqiao University (Z14X0047) and the Scientific Research Foundation of Yantai Yuhuangding Hospital for Youth (201510).	Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Bolukbasi MF, 2015, NAT METHODS, V12, P1150, DOI 10.1038/nmeth.3624; Brake Olivier Ter, 2008, Mol Ther, V16, P557, DOI 10.1038/sj.mt.6300382; Bui JD, 2000, CELL, V100, P457, DOI 10.1016/S0092-8674(00)80681-9; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/NMETH.1648, 10.1038/nmeth.1648]; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Evergren E, 2007, J NEUROSCI RES, V85, P2648, DOI 10.1002/jnr.21176; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057                                                        ; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kohlhaas M, 2006, CIRC RES, V98, P235, DOI 10.1161/01.RES.0000200739.90811.9f; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/NMETH.2078, 10.1038/nmeth.2078]; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Snyder LL, 2008, ANTIVIR RES, V80, P36, DOI 10.1016/j.antiviral.2008.04.001; Vasileva A, 2005, NAT REV MICROBIOL, V3, P837, DOI 10.1038/nrmicro1266; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Xu L, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1048; Yan Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep38970; Zhou N, 2004, GENE THER, V11, P1703, DOI 10.1038/sj.gt.3302339	30	0	0	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 19	2017	7								5795	10.1038/s41598-017-06216-w				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FB1HK	WOS:000405894200013	28724960	gold			2018-01-05	
J	Jia, GX; Wang, XL; Xiao, GH				Jia, Gaoxiang; Wang, Xinlei; Xiao, Guanghua			A permutation-based non-parametric analysis of CRISPR screen data	BMC GENOMICS			English	Article						Functional genomics; False discovery rate; RNA interference; Negative selection; Next generation sequencing; Positive selection	IDENTIFYING DIFFERENTIAL EXPRESSION; FALSE DISCOVERY RATE; RNA-SEQ DATA; ESSENTIAL GENES; OFF-TARGET; HUMAN-CELLS; GENOME; IDENTIFICATION; METAANALYSIS; MICROARRAY	Background: Clustered regularly-interspaced short palindromic repeats (CRISPR) screens are usually implemented in cultured cells to identify genes with critical functions. Although several methods have been developed or adapted to analyze CRISPR screening data, no single specific algorithm has gained popularity. Thus, rigorous procedures are needed to overcome the shortcomings of existing algorithms. Methods: We developed a Permutation-Based Non-Parametric Analysis (PBNPA) algorithm, which computes p-values at the gene level by permuting sgRNA labels, and thus it avoids restrictive distributional assumptions. Although PBNPA is designed to analyze CRISPR data, it can also be applied to analyze genetic screens implemented with siRNAs or shRNAs and drug screens. Results: We compared the performance of PBNPA with competing methods on simulated data as well as on real data. PBNPA outperformed recent methods designed for CRISPR screen analysis, as well as methods used for analyzing other functional genomics screens, in terms of Receiver Operating Characteristics (ROC) curves and False Discovery Rate (FDR) control for simulated data under various settings. Remarkably, the PBNPA algorithm showed better consistency and FDR control on published real data as well. Conclusions: PBNPA yields more consistent and reliable results than its competitors, especially when the data quality is low. R package of PBNPA is available at: https://cran.r-project.org/web/packages/PBNPA/.	[Jia, Gaoxiang; Wang, Xinlei] Southern Methodist Univ, Dept Stat Sci, Dallas, TX 75205 USA; [Jia, Gaoxiang; Xiao, Guanghua] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA; [Xiao, Guanghua] Univ Texas Southwestern Med Ctr Dallas, Dept Bioinformat, Dallas, TX 75390 USA; [Xiao, Guanghua] Univ Texas Southwestern Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	Wang, XL (reprint author), Southern Methodist Univ, Dept Stat Sci, Dallas, TX 75205 USA.; Xiao, GH (reprint author), Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA.	swang@smu.edu; guanghua.xiao@utsouthwestern.edu			National Institutes of Health grants [1R01CA17221, R15GM113157]	This work was supported by the National Institutes of Health grants (1R01CA17221, R15GM113157).	Anders S., 2012, DIFFERENTIAL EXPRESS; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Bonafede E, 2016, BIOMETRICS, V72, P804, DOI 10.1111/biom.12458; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Chen J., 2013, DISCRETE DYN NAT SOC, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0071543; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Diaz AA, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1197; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Hart T, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1015-8; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mebane WR, 2009, MULTINOMROB ROBUST E; Miles LA, 2016, FEBS J, V283, P3170, DOI 10.1111/febs.13770; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Pawitan Y, 2005, BIOINFORMATICS, V21, P3017, DOI 10.1093/bioinformatics/bti448; Rau A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-91; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Seyednasrollah F, 2015, BRIEF BIOINFORM, V16, P59, DOI 10.1093/bib/bbt086; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarazona S, 2012, EMBNET J, V17, P18, DOI DOI 10.14806/EJ.17.B.265; Tu S., 2014, DIRICHLET MULTINOMIA; Tvedebrink T, 2010, THEOR POPUL BIOL, V78, P200, DOI 10.1016/j.tpb.2010.07.002; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu Xuebing, 2014, Quant Biol, V2, P59; Xie Y, 2005, BIOINFORMATICS, V21, P4280, DOI 10.1093/bioinformatics/bti685; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Yu JY, 2016, BIOINFORMATICS, V32, P260, DOI 10.1093/bioinformatics/btv556; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37	39	0	0	3	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	JUL 19	2017	18								545	10.1186/s12864-017-3938-5				11	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FB1FR	WOS:000405889600006	28724352	gold			2018-01-05	
J	Najafov, J; Najafov, A				Najafov, Jamil; Najafov, Ayaz			CrossCheck: an open-source web tool for high-throughput screen data analysis	SCIENTIFIC REPORTS			English	Article							REPOSITORY; MUTATIONS; MOTIFS	Modern high-throughput screening methods allow researchers to generate large datasets that potentially contain important biological information. However, oftentimes, picking relevant hits from such screens and generating testable hypotheses requires training in bioinformatics and the skills to efficiently perform database mining. There are currently no tools available to general public that allow users to cross-reference their screen datasets with published screen datasets. To this end, we developed CrossCheck, an online platform for high-throughput screen data analysis. CrossCheck is a centralized database that allows effortless comparison of the user-entered list of gene symbols with 16,231 published datasets. These datasets include published data from genome-wide RNAi and CRISPR screens, interactome proteomics and phosphoproteomics screens, cancer mutation databases, low-throughput studies of major cell signaling mediators, such as kinases, E3 ubiquitin ligases and phosphatases, and gene ontological information. Moreover, CrossCheck includes a novel database of predicted protein kinase substrates, which was developed using proteome-wide consensus motif searches. CrossCheck dramatically simplifies high-throughput screen data analysis and enables researchers to dig deep into the published literature and streamline data-driven hypothesis generation. CrossCheck is freely accessible as a web-based application at http://proteinguru.com/crosscheck.	[Najafov, Jamil] Gazi Univ, Fac Engn, Dept Comp Engn, Ankara, Turkey; [Najafov, Ayaz] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA	Najafov, A (reprint author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	ayaz_najafov@hms.harvard.edu		Najafov, Ayaz/0000-0002-1350-2056			Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285                                                             ; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Dai XP, 2014, ONCOTARGET, V5, P3307, DOI 10.18632/oncotarget.1939                                                        ; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hu JF, 2014, BIOINFORMATICS, V30, P141, DOI 10.1093/bioinformatics/btt627; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; C. UniProt, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI DOI 10.1093/NAR/GKU989; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041	12	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 19	2017	7								5855	10.1038/s41598-017-05960-3				4	Multidisciplinary Sciences	Science & Technology - Other Topics	FB1HR	WOS:000405895000007	28724888	gold			2018-01-05	
J	Obara, Y; Imai, T; Sato, H; Takeda, Y; Kato, T; Ishii, K				Obara, Yutaro; Imai, Toru; Sato, Hidenori; Takeda, Yuji; Kato, Takeo; Ishii, Kuniaki			Midnolin is a novel regulator of parkin expression and is associated with Parkinson's Disease	SCIENTIFIC REPORTS			English	Article							ENDOPLASMIC-RETICULUM STRESS; NERVE GROWTH-FACTOR; OXIDATIVE STRESS; PC12 CELLS; ACTIVATION; RAP1; PROTEIN; GENE; CAMP; ATF4	Midnolin (MIDN) was first discovered in embryonic stem cells, but its physiological and pathological roles are, to date, poorly understood. In the present study, we therefore examined the role of MIDN in detail. We found that in PC12 cells, a model of neuronal cells, MIDN localized primarily to the nucleus and intracellular membranes. Nerve growth factor promoted MIDN gene expression, which was attenuated by specific inhibitors of extracellular signal-regulated kinases 1/2 and 5. MIDN-deficient PC12 cells created using CRISPR/Cas9 technology displayed significantly impaired neurite outgrowth. Interestingly, a genetic approach revealed that 10.5% of patients with sporadic Parkinson's disease (PD) had a lower MIDN gene copy number whereas no copy number variation was observed in healthy people, suggesting that MIDN is involved in PD pathogenesis. Furthermore, the expression of parkin, a major causative gene in PD, was significantly reduced by CRISPR/Cas9 knockout and siRNA knockdown of MIDN. Activating transcription factor 4 (ATF4) was also down-regulated, which binds to the cAMP response element (CRE) in the parkin core promoter region. The activity of CRE was reduced following MIDN loss. Overall, our data suggests that MIDN promotes the expression of parkin E3 ubiquitin ligase, and that MIDN loss can trigger PD-related pathogenic mechanisms.	[Obara, Yutaro; Imai, Toru; Ishii, Kuniaki] Yamagata Univ, Sch Med, Dept Pharmacol, 2-2-2 Iida Nishi, Yamagata 9909585, Japan; [Sato, Hidenori] Yamagata Univ, Sch Med, Inst Promot Med Sci Res, Genome Informat Unit, 2-2-2 Iida Nishi, Yamagata 9909585, Japan; [Takeda, Yuji] Yamagata Univ, Sch Med, Dept Immunol, 2-2-2 Iida Nishi, Yamagata 9909585, Japan; [Kato, Takeo] Yamagata Univ, Sch Med, Dept Neurol Hematol Metab Endocrinol & Diabetol, 2-2-2 Iida Nishi, Yamagata 9909585, Japan	Obara, Y (reprint author), Yamagata Univ, Sch Med, Dept Pharmacol, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	obaray@med.id.yamagata-u.ac.jp			Japan Society for the Promotion of Science [15K07963]; 21st Century Center of Elegance Program [F03]; Takeda Science Foundation	This work was supported in part by Grants-in-Aid from the Japan Society for the Promotion of Science (No. 15K07963 to Y.O), the 21st Century Center of Elegance Program (No. F03 to T.K), and the Takeda Science Foundation (Y.O). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Ryusuke Kuwai, Takuya Koyano, and Hiroki Nakashima (Yamagata University) for technical assistance. We thank Yoshishiro Koyama (ThermoFisher Scientific KK, Tokyo, Japan) for collaboration for analysis of neurite outgrowth. We thank Boehringer Ingelheim (Ridgefield, CT) for providing BIX02189, and Dr. Konstanze F. Winklhofer (Ruhr University Bochum, Germany) for providing the DNA plasmid encoding parkin-CRE/luciferase.	Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Arawaka S, 2006, J NEUROSCI, V26, P9227, DOI 10.1523/JNEUROSCI.0341-06.2006; Ariga H, 2015, BIOL PHARM BULL, V38, P795, DOI 10.1248/bpb.b15-00125; Asakawa S, 2001, BIOCHEM BIOPH RES CO, V286, P863, DOI 10.1006/bbrc.2001.5490; Bouman L, 2011, CELL DEATH DIFFER, V18, P769, DOI 10.1038/cdd.2010.142; Cieri D, 2017, BIOCHEM BIOPH RES CO, V483, P1020, DOI 10.1016/j.bbrc.2016.08.153; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Hofmeister-Brix A, 2013, J BIOL CHEM, V288, P35824, DOI 10.1074/jbc.M113.526632; Honda T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117914; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X                                                   ; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Lewerenz J, 2012, CELL DEATH DIFFER, V19, P847, DOI 10.1038/cdd.2011.165; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0                                                   ; Matsuda N, 2010, J ALZHEIMERS DIS, V19, P1, DOI 10.3233/JAD-2010-1231; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5                                                   ; Obara Y, 2004, J CELL SCI, V117, P6085, DOI 10.1242/jcs.01527; Obara Y, 2007, J NEUROCHEM, V101, P470, DOI 10.1111/j.1471-4159.2006.04390.x; Obara Y, 2016, CELL SIGNAL, V28, P177, DOI 10.1016/j.cellsig.2015.12.016; Obara Y, 2011, CELL SIGNAL, V23, P666, DOI 10.1016/j.cellsig.2010.11.020; Obara Y, 2010, MOL PHARMACOL, V77, P10, DOI 10.1124/mol.109.060236; Obara Y, 2009, J BIOL CHEM, V284, P23564, DOI 10.1074/jbc.M109.027821; Sato H, 2011, J NEUROSCI, V31, P16884, DOI 10.1523/JNEUROSCI.3967-11.2011; Sun XT, 2013, J NEUROSCI, V33, P2398, DOI 10.1523/JNEUROSCI.2292-12.2013; Tsukahara M, 2000, GENE, V254, P45, DOI 10.1016/S0378-1119(00)00259-6; Wang HQ, 2008, J NEUROCHEM, V107, P171, DOI 10.1111/j.1471-4159.2008.05607.x; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; West AB, 2003, J MOL BIOL, V326, P11, DOI 10.1016/S0022-2836(02)01376-1; York RD, 1998, NATURE, V392, P622; Zielak AE, 2008, MOL REPROD DEV, V75, P904, DOI 10.1002/mrd.20819	32	0	0	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 19	2017	7								5885	10.1038/s41598-017-05456-0				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FB1HR	WOS:000405895000037	28724963	gold			2018-01-05	
J	Fernando, TR; Contreras, JR; Zampini, M; Rodriguez-Malave, NI; Alberti, MO; Anguiano, J; Tran, TM; Palanichamy, JK; Gajeton, J; Ung, NM; Aros, CJ; Waters, EV; Casero, D; Basso, G; Pigazzi, M; Rao, DS				Fernando, Thilini R.; Contreras, Jorge R.; Zampini, Matteo; Rodriguez-Malave, Norma I.; Alberti, Michael O.; Anguiano, Jaime; Tran, Tiffany M.; Palanichamy, Jayanth K.; Gajeton, Jasmine; Ung, Nolan M.; Aros, Cody J.; Waters, Ella V.; Casero, David; Basso, Giuseppe; Pigazzi, Martina; Rao, Dinesh S.			The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia	MOLECULAR CANCER			English	Article						Non-coding RNA; CASC15; ETV6-RUNX1; SOX4; B-all	ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; MOUSE BONE-MARROW; NONCODING RNAS; EMBRYONIC-DEVELOPMENT; CRISPR-CAS9 SYSTEM; INITIATE LEUKEMIA; CELL-GROWTH; PRO-B; PROTEIN	Background: Long non-coding RNAs (lncRNAs) play a variety of cellular roles, including regulation of transcription and translation, leading to alterations in gene expression. Some lncRNAs modulate the expression of chromosomally adjacent genes. Here, we assess the roles of the lncRNA CASC15 in regulation of a chromosomally nearby gene, SOX4, and its function in RUNX1/AML translocated leukemia. Results: CASC15 is a conserved lncRNA that was upregulated in pediatric B-acute lymphoblastic leukemia (B-ALL) with t (12; 21) as well as pediatric acute myeloid leukemia (AML) with t (8; 21), both of which are associated with relatively better prognosis. Enforced expression of CASC15 led to a myeloid bias in development, and overall, decreased engraftment and colony formation. At the cellular level, CASC15 regulated cellular survival, proliferation, and the expression of its chromosomally adjacent gene, SOX4. Differentially regulated genes following CASC15 knockdown were enriched for predicted transcriptional targets of the Yin and Yang-1 (YY1) transcription factor. Interestingly, we found that CASC15 enhances YY1-mediated regulation of the SOX4 promoter. Conclusions: Our findings represent the first characterization of this CASC15 in RUNX1-translocated leukemia, and point towards a mechanistic basis for its action.	[Fernando, Thilini R.; Contreras, Jorge R.; Rodriguez-Malave, Norma I.; Alberti, Michael O.; Anguiano, Jaime; Tran, Tiffany M.; Palanichamy, Jayanth K.; Ung, Nolan M.; Waters, Ella V.; Casero, David; Rao, Dinesh S.] UCLA, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Contreras, Jorge R.; Rodriguez-Malave, Norma I.] UCLA, Cellular & Mol Pathol PhD Program, Los Angeles, CA 90095 USA; [Zampini, Matteo; Basso, Giuseppe; Pigazzi, Martina] Univ Padua, Women & Child Hlth Dept, Hematol Oncol Lab, Padua, Italy; [Tran, Tiffany M.] UCLA, Mol Cellular & Integrat Physiol PhD program, Los Angeles, CA 90095 USA; [Gajeton, Jasmine] UCLA, Microbiol Immunol & Mol Genet Program, Los Angeles, CA 90095 USA; [Aros, Cody J.] Univ Calif Los Angeles, David Geffen Sch Med, Med Scientist Training Program, Los Angeles, CA 90095 USA; [Rao, Dinesh S.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Rao, Dinesh S.] UCLA, Broad Stem Cell Res Ctr, 650 Charles E Young Dr,Factor 12-272, Los Angeles, CA 90095 USA; [Fernando, Thilini R.; Rodriguez-Malave, Norma I.] Cedars Sinai Med Ctr, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Alberti, Michael O.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Anguiano, Jaime] Univ San Francisco, 2130 Fulton St, San Francisco, CA 94117 USA; [Palanichamy, Jayanth K.] All India Inst Med Sci, New Delhi, India; [Gajeton, Jasmine] Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Waters, Ella V.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA USA	Rao, DS (reprint author), UCLA, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.; Rao, DS (reprint author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.; Rao, DS (reprint author), UCLA, Broad Stem Cell Res Ctr, 650 Charles E Young Dr,Factor 12-272, Los Angeles, CA 90095 USA.	drao@mednet.ucla.edu			NIH [T32 CA009056, T32 CA009120, T32 HL086345, R03CA175426]; National Science Foundation [DGE-1144087]; UCLA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA Training Program; Irving Feintech Family Foundation/Tower Cancer Research Foundation; University of California Cancer Research Coordinating Committee; Stein-Oppenheimer Endowment Award	This research was supported by the NIH T32 CA009056 (T.R.F. and T.M.T.), NIH T32 CA009120 (J.R.C.), NIH T32 HL086345 (N.M.U), National Science Foundation DGE-1144087 (N.I.R.M.), Eugene V. Cota-Robles Fellowship from UCLA (J.R.C. and N.I.R.M.), Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA Training Program (M.O.A.), NIH Small Research Grant Program R03CA175426 (D.S.R.), the Irving Feintech Family Foundation/Tower Cancer Research Foundation Research Grant (D.S.R.), the University of California Cancer Research Coordinating Committee (D.S.R.) and the Stein-Oppenheimer Endowment Award (D.S.R.).	Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Ahn SG, 2002, EXP MOL MED, V34, P243, DOI 10.1038/emm.2002.34                                                             ; Alachkar H, 2014, J CLIN INVEST, V124, P1512, DOI 10.1172/JCI70921; Aue G, 2011, BLOOD, V118, P4674, DOI 10.1182/blood-2011-04-351528; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Campana D, 2009, SEMIN HEMATOL, V46, P100, DOI 10.1053/j.seminhematol.2008.09.001; Chari R, 2017, SGRNA SCORER 2 0 SPE; Contreras JR, 2015, ONCOTARGET, V6, P11023, DOI 10.18632/oncotarget.3433                                                        ; Fernando TR, 2015, MOL CANCER RES, V13, P839, DOI 10.1158/1541-7786.MCR-15-0006-T; Fischer M, 2005, ONCOGENE, V24, P7579, DOI 10.1038/sj.onc.1208931; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Han JX, 2014, RNA BIOL, V11, P829, DOI 10.4161/rna.29624; Hardy Richard R, 2004, Methods Mol Biol, V271, P1; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595                                                ; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hertzberg L, 2010, BLOOD, V115, P1006, DOI 10.1182/blood-2009-08-235408; Jafarnejad SM, 2010, AM J PATHOL, V177, P2741, DOI 10.2353/ajpath.2010.100377; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kayala M. A., 2012, NUCL ACIDS RES; King Jennifer K, 2016, Front Immunol, V7, P670, DOI 10.3389/fimmu.2016.00670; Lessard L, 2015, J INVEST DERMATOL, V135, P2464, DOI 10.1038/jid.2015.200; Li M, 2013, LEUKEMIA, V27, P1570, DOI 10.1038/leu.2013.15; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Linka Y, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.48; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma HQ, 2014, HAEMATOLOGICA, V99, P1591, DOI 10.3324/haematol.2014.104695; Mullighan CG, 2012, J CLIN INVEST, V122, P3407, DOI 10.1172/JCI61203; Palanichamy JK, 2016, J CLIN INVEST, V126, P1495, DOI 10.1172/JCI80046; Perry C, 2002, LEUKEMIA RES, V26, P221, DOI 10.1016/S0145-2126(01)00128-X; Pession A, 2013, BLOOD, V122, P170, DOI 10.1182/blood-2013-03-491621; Pramoonjago P, 2006, ONCOGENE, V25, P5626, DOI 10.1038/sj.onc.1209566; Ramezani-Rad P, 2013, BLOOD, V121, P148, DOI 10.1182/blood-2012-05-428938; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao DS, 2010, IMMUNITY, V33, P48, DOI 10.1016/j.immuni.2010.06.013; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rodriguez-Malave NI, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0485-z; Russell MR, 2015, CANCER RES, V75, P3155, DOI 10.1158/0008-5472.CAN-14-3613; Sandoval S, 2012, BLOOD, V120, P155, DOI 10.1182/blood-2011-05-357418; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0                                                                ; Schindler JW, 2009, CELL STEM CELL, V5, P43, DOI 10.1016/j.stem.2009.04.019; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10066; Shechner DM, 2015, NAT METHODS, V12, P664, DOI [10.1038/NMETH.3433, 10.1038/nmeth.3433]; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Tregnago C, 2016, LEUKEMIA, V30, P1887, DOI 10.1038/leu.2016.98; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; VANDEWETERING M, 1993, EMBO J, V12, P3847; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang H, 2013, CANCER CELL, V24, P575, DOI 10.1016/j.ccr.2013.09.018; Zhou L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10026	59	0	0	3	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1476-4598			MOL CANCER	Mol. Cancer	JUL 19	2017	16								126	10.1186/s12943-017-0692-x				15	Biochemistry & Molecular Biology; Oncology	Biochemistry & Molecular Biology; Oncology	FB1HO	WOS:000405894700002	28724437	gold			2018-01-05	
J	Ryu, YS; Chandran, SP; Kim, K; Lee, SK				Ryu, Young Shin; Chandran, Sathesh-Prabu; Kim, Kyungchul; Lee, Sung Kuk			Oligo- and dsDNA-mediated genome editing using a tetA dual selection system in Escherichia coli	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE; GENE REPLACEMENT; RECOMBINATION; EFFICIENT; SCARLESS; CELLS; K-12; TRANSCRIPTION; MECHANISMS; CHROMOSOME	The ability to precisely and seamlessly modify a target genome is needed for metabolic engineering and synthetic biology techniques aimed at creating potent biosystems. Herein, we report on a promising method in Escherichia coli that relies on the insertion of an optimized tetA dual selection cassette followed by replacement of the same cassette with short, single-stranded DNA (oligos) or long, double-stranded DNA and the isolation of recombinant strains by negative selection using NiCl2. This method could be rapidly and successfully used for genome engineering, including deletions, insertions, replacements, and point mutations, without inactivation of the methyl-directed mismatch repair (MMR) system and plasmid cloning. The method we describe here facilitates positive genome-edited recombinants with selection efficiencies ranging from 57 to 92%. Using our method, we increased lycopene production (3.4-fold) by replacing the ribosome binding site (RBS) of the rate-limiting gene (dxs) in the 1-deoxy-D-xylulose-5-phosphate (DXP) biosynthesis pathway with a strong RBS. Thus, this method could be used to achieve scarless, proficient, and targeted genome editing for engineering E. coli strains.	[Ryu, Young Shin; Chandran, Sathesh-Prabu; Lee, Sung Kuk] UNIST, Sch Energy & Chem Engn, Ulsan, South Korea; [Kim, Kyungchul; Lee, Sung Kuk] UNIST, Sch Life Sci, Ulsan, South Korea	Lee, SK (reprint author), UNIST, Sch Energy & Chem Engn, Ulsan, South Korea.; Lee, SK (reprint author), UNIST, Sch Life Sci, Ulsan, South Korea.	sklee@unist.ac.kr	Lee, Sung/E-6525-2010		National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2058667]; Next-Generation Bio Green 21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ011181]	This work was supported by the National Research Foundation of Korea (NRF) through grants funded by the Ministry of Education (2013R1A1A2058667) and by a grant from the Next-Generation Bio Green 21 Program (SSAC, PJ011181), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOCHNER BR, 1980, J BACTERIOL, V143, P926; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; DeVito JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1084; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898                                                          ; Esvelt KM, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.66; GRIFFITH JK, 1982, PLASMID, V8, P86, DOI 10.1016/0147-619X(82)90044-0; Gupta RM, 2014, J CLIN INVEST, V124, P4154, DOI 10.1172/JCI72992; Heermann R, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-14; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879                                                         ; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; Jeong J, 2013, BIOTECHNOL ADV, V31, P804, DOI 10.1016/j.biotechadv.2013.04.003; Kang MJ, 2005, BIOTECHNOL BIOENG, V91, P636, DOI 10.1002/bit.20539; Kim J, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-84; Kim SM, 2015, METAB ENG, V30, P141, DOI [10.1016/j.ymben.2015.05.002, 10.1016/j.ymben.201.5.05.002]; Kim SW, 2001, BIOTECHNOL BIOENG, V72, P408, DOI 10.1002/1097-0290(20000220)72:4<408::AID-BIT1003>3.0.CO;2-H; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Li XT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt1075; Liang RB, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-209; Madyagol M, 2011, FOLIA MICROBIOL, V56, P253, DOI 10.1007/s12223-011-0035-z; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; MALOY SR, 1981, J BACTERIOL, V145, P1110; Mizoguchi H, 2007, BIOSCI BIOTECH BIOCH, V71, P2905, DOI 10.1271/bbb.70274; Muranaka N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp039; Murphy KC, 1998, J BACTERIOL, V180, P2063; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Ng CY, 2015, METAB ENG, V29, P86, DOI 10.1016/j.ymben.2015.03.001; Nomura Y, 2007, BIOSYSTEMS, V90, P115, DOI 10.1016/j.biosystems.2006.07.006; Pines G, 2015, ACS SYNTH BIOL, V4, P1176, DOI 10.1021/acssynbio.5b00009; Podolsky T, 1996, PLASMID, V36, P112, DOI 10.1006/plas.1996.0038; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; Ryu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108335; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; Schnappinger D, 1996, ARCH MICROBIOL, V165, P359, DOI 10.1007/s002030050339; Seo SW, 2013, METAB ENG, V15, P67, DOI 10.1016/j.ymben.2012.10.006; Tas H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136963; Thomason L., 2007, CURR PROTOC MOL BIOL, V16, DOI DOI 10.1002/0471142727.MB0116S78; Vinuselvi P, 2012, ENZYME MICROB TECH, V50, P1, DOI 10.1016/j.enzmictec.2011.10.001; Vinuselvi P, 2011, BIOFUELS-UK, V2, P153, DOI [10.4155/bfs.11.4, 10.4155/BFS.11.4]; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wong QNY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni059; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	47	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181501	10.1371/journal.pone.0181501				16	Multidisciplinary Sciences	Science & Technology - Other Topics	FB3RW	WOS:000406061400051	28719630	gold			2018-01-05	
J	van Raaphorst, R; Kjos, M; Veening, JW				van Raaphorst, Renske; Kjos, Morten; Veening, Jan-Willem			Chromosome segregation drives division site selection in Streptococcus pneumoniae	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						cell division; Streptococcus pneumoniae; SMC; chromosome organization; FtsZ	PENICILLIN-BINDING PROTEINS; CELL-DIVISION; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; IMAGE-ANALYSIS; RING FORMATION; 2 DISTINCT; E. COLI; REPLICATION; DNA	Accurate spatial and temporal positioning of the tubulin-like protein FtsZ is key for proper bacterial cell division. Streptococcus pneumoniae (pneumococcus) is an oval-shaped, symmetrically dividing opportunistic human pathogen lacking the canonical systems for division site control (nucleoid occlusion and the Min-system). Recently, the early division protein MapZ was identified and implicated in pneumococcal division site selection. We show that MapZ is important for proper division plane selection; thus, the question remains as to what drives pneumococcal division site selection. By mapping the cell cycle in detail, we show that directly after replication both chromosomal origin regions localize to the future cell division sites, before FtsZ. Interestingly, Z-ring formation occurs coincidently with initiation of DNA replication. Perturbing the longitudinal chromosomal organization by mutating the condensin SMC, by CRISPR/Cas9-mediated chromosome cutting, or by poisoning DNA decatenation resulted in mistiming of MapZ and FtsZ positioning and subsequent cell elongation. Together, we demonstrate an intimate relationship between DNA replication, chromosome segregation, and division site selection in the pneumococcus, providing a simple way to ensure equally sized daughter cells.	[van Raaphorst, Renske; Kjos, Morten; Veening, Jan-Willem] Univ Groningen, Ctr Synthet Biol, Groningen Biomol Sci & Biotechnol Inst, Mol Genet Grp, NL-9747 AG Groningen, Netherlands; [van Raaphorst, Renske; Veening, Jan-Willem] Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, CH-1015 Lausanne, Switzerland; [Kjos, Morten] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, N-1432 As, Norway	Veening, JW (reprint author), Univ Groningen, Ctr Synthet Biol, Groningen Biomol Sci & Biotechnol Inst, Mol Genet Grp, NL-9747 AG Groningen, Netherlands.; Veening, JW (reprint author), Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, CH-1015 Lausanne, Switzerland.	Jan-Willem.Veening@unil.ch		Veening, Jan-Willem/0000-0002-3162-6634; van Raaphorst, Renske/0000-0001-7778-5289; Kjos, Morten/0000-0003-4448-9082	European Molecular Biology Organization Young Investigator Program; VIDI fellowship from the Netherlands Organization for Scientific Research [864.12.001]; European Research Council [337399-PneumoCell]; Research Council of Norway [250976/F20]	We thank Jeroen Siebring for initial work on parB<INF>p</INF>; Lieke van Gijtenbeek for providing m(sf)gfp; Oliver Gericke and Katrin Beilharz for technical assistance; GeneCore, EMBL, Heidelberg for sequencing; Jelle Slager and Rieza Aprianto for help with analysis; Dirk-Jan Scheffers for stimulating discussions; and Sophie Martin and Stephan Gruber for constructive feedback on our manuscript. Work in the J.-W.V. laboratory is supported by the European Molecular Biology Organization Young Investigator Program, a VIDI fellowship from the Netherlands Organization for Scientific Research (864.12.001), and European Research Council Starting Grant 337399-PneumoCell. M.K. is supported by The Research Council of Norway Grant 250976/F20.	Adams DW, 2014, CURR OPIN MICROBIOL, V22, P94, DOI 10.1016/j.mib.2014.09.020; Alberts B, 2015, MOLECULAR BIOLOGY OF THE CELL, SIXTH EDITION, P963; Bailey MW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004504; Beilharz K, 2015, APPL ENVIRON MICROB, V81, P7244, DOI 10.1128/AEM.02033-15; Beilharz K, 2012, P NATL ACAD SCI USA, V109, pE905, DOI 10.1073/pnas.1119172109; Berg KH, 2013, J BACTERIOL, V195, P4342, DOI 10.1128/JB.00184-13; Boersma MJ, 2015, J BACTERIOL, V197, P3472, DOI 10.1128/JB.00541-15; Bouet JY, 2014, CURR OPIN MICROBIOL, V22, P60, DOI 10.1016/j.mib.2014.09.013; Bramkamp M, 2015, TRENDS MICROBIOL, V23, P121, DOI 10.1016/j.tim.2015.02.001; Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5                                                   ; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Donovan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055078; Elowitz MB, 1999, J BACTERIOL, V181, P197; Espeli O, 2012, EMBO J, V31, P3198, DOI 10.1038/emboj.2012.128; Fadda D, 2007, J BACTERIOL, V189, P1288, DOI 10.1128/JB.01168-06; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Fernandez-Moreira E, 2000, MICROB DRUG RESIST, V6, P259, DOI 10.1089/mdr.2000.6.259                                                          ; Fleurie A, 2014, NATURE, V516, P259, DOI 10.1038/nature13966; Fleurie A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004275; FUNNELL BE, 1994, BIOCHIMIE, V76, P924, DOI 10.1016/0300-9084(94)90017-5                                                    ; Grangeasse C, 2016, TRENDS MICROBIOL, V24, P713, DOI 10.1016/j.tim.2016.04.004; Gruber S, 2014, CURR OPIN MICROBIOL, V22, P102, DOI 10.1016/j.mib.2014.09.018; Gruber S, 2014, CURR BIOL, V24, P293, DOI 10.1016/j.cub.2013.12.049; Hajduka IV, 2016, SEMIN CELL DEV BIOL, V53, P2, DOI 10.1016/j.semcdb.2015.11.012; Hole ckova N, 2014, MBIO, V6, DOI [10.1128/MBIO.01700-14, DOI 10.1128/MBIO.01700-14]; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kjos M, 2014, MOL MICROBIOL, V91, P1088, DOI 10.1111/mmi.12517; Land AD, 2013, MOL MICROBIOL, V90, P939, DOI 10.1111/mmi.12408; Lemon KP, 2000, MOL CELL, V6, P1321, DOI 10.1016/S1097-2765(00)00130-1; Li YF, 2002, MOL MICROBIOL, V46, P985, DOI 10.1046/j.1365-2958.2002.03234.x                                                ; Libby EA, 2012, P NATL ACAD SCI USA, V109, P7445, DOI 10.1073/pnas.1109479109; Mannik J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00306; Manuse S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12071; Marbouty M, 2015, MOL CELL, V59, P588, DOI 10.1016/j.molcel.2015.07.020; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038//nrm1745; MARTIN B, 1995, MOL MICROBIOL, V15, P367, DOI 10.1111/j.1365-2958.1995.tb02250.x; Minnen A, 2011, MOL MICROBIOL, V81, P676, DOI 10.1111/j.1365-2958.2011.07722.x; Monahan LG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00019; Paintdakhi A, 2016, MOL MICROBIOL, V99, P767, DOI 10.1111/mmi.13264; Parry BR, 2014, CELL, V156, P183, DOI 10.1016/j.cell.2013.11.028; Pinho MG, 2013, NAT REV MICROBIOL, V11, P601, DOI 10.1038/nrmicro3088; Popham DL, 2003, CURR OPIN MICROBIOL, V6, P594, DOI 10.1016/j.mib.2003.10.002; Potluri LP, 2012, MOL MICROBIOL, V84, P203, DOI 10.1111/j.1365-2958.2012.08023.x; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Rowlett VW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00478; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Slager J, 2014, CELL, V157, P395, DOI 10.1016/j.cell.2014.01.068; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Treuner-Lange A, 2013, MOL MICROBIOL, V87, P235, DOI 10.1111/mmi.12094; Tsui HCT, 2014, MOL MICROBIOL, V94, P21, DOI 10.1111/mmi.12745; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wallden M, 2016, CELL, V166, P729, DOI 10.1016/j.cell.2016.06.052; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Wang XD, 2014, CURR OPIN MICROBIOL, V22, P66, DOI 10.1016/j.mib.2014.09.016; Wang XD, 2014, P NATL ACAD SCI USA, V111, P12877, DOI 10.1073/pnas.1407461111; Wang XD, 2014, CURR BIOL, V24, P287, DOI 10.1016/j.cub.2013.11.050; Wegmann U, 2012, MICROBIOL-SGM, V158, P2936, DOI 10.1099/mic.0.062554-0; Willemse J, 2011, GENE DEV, V25, P89, DOI 10.1101/gad.600211; Willet AH, 2015, CURR OPIN MICROBIOL, V28, P46, DOI 10.1016/j.mib.2015.08.001; Woldringh CL, 2002, MOL MICROBIOL, V45, P17, DOI 10.1046/j.1365-2958.2002.02993.x                                                ; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002                                                      ; Zaritsky A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00756	64	1	1	3	3	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUL 18	2017	114	29					E5959	E5968		10.1073/pnas.1620608114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FA7YC	WOS:000405662300025	28674002	green_published			2018-01-05	
J	Norris, AD; Gracida, X; Calarco, JA				Norris, Adam D.; Gracida, Xicotencatl; Calarco, John A.			CRISPR-mediated genetic interaction profiling identifies RNA binding proteins controlling metazoan fitness	ELIFE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PRE-MESSENGER-RNA; CAENORHABDITIS-ELEGANS; C. ELEGANS; SPLICING REGULATION; LONGEVITY; NEURONS; DISEASE; RESTRICTION; MECHANISMS	Genetic interaction screens have aided our understanding of complex genetic traits, diseases, and biological pathways. However, approaches for synthetic genetic analysis with null-alleles in metazoans have not been feasible. Here, we present a CRISPR/Cas9-based Synthetic Genetic Interaction (CRISPR-SGI) approach enabling systematic double-mutant generation. Applying this technique in Caenorhabditis elegans, we comprehensively screened interactions within a set of 14 conserved RNA binding protein genes, generating all possible single and double mutants. Many double mutants displayed fitness defects, revealing synthetic interactions. For one interaction between the MBNL1/2 ortholog mbl-1 and the ELAVL ortholog exc-7, double mutants displayed a severely shortened lifespan. Both genes are required for regulating hundreds of transcripts and isoforms, and both may play a critical role in lifespan extension through insulin signaling. Thus, CRISPR-SGI reveals a rich genetic interaction landscape between RNA binding proteins in maintaining organismal health, and will serve as a paradigm applicable to other biological questions.	[Norris, Adam D.; Gracida, Xicotencatl; Calarco, John A.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Norris, Adam D.] Southern Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA; [Calarco, John A.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	Calarco, JA (reprint author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.; Calarco, JA (reprint author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	calarco@utoronto.ca			NIH Office of the Director NIH Early Independence Award [DP5OD009153]; Harvard University Bauer Fellows Program; University of Toronto; Charles King postdoctoral fellowship; Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-06573]	NIH Office of the Director NIH Early Independence Award DP5OD009153 John A Calarco; Harvard University Bauer Fellows Program John A Calarco; University of Toronto John A Calarco; Charles King postdoctoral fellowship Adam D Norris; Natural Sciences and Engineering Research Council of Canada Discovery Grant RGPIN-2017-06573 John A Calarco	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anyanful A, 2004, J CELL BIOL, V167, P639, DOI 10.1083/jcb.200407085; Asikainen S, 2005, NEUROREPORT, V16, P1995, DOI 10.1097/00001756-200512190-00005; Barberan-Soler S, 2011, NUCLEIC ACIDS RES, V39, P666, DOI 10.1093/nar/gkq767; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Baugh LR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r45; BRENNER S, 1974, GENETICS, V77, P71; Brooks AN, 2015, GENOME RES, V25, P1771, DOI 10.1101/gr.192518.115; Butland G, 2008, NAT METHODS, V5, P789, DOI [10.1038/nmeth.1239, 10.1038/NMETH.1239]; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/nmeth.1463, 10.1038/NMETH.1463]; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Castello A, 2013, TRENDS GENET, V29, P318, DOI 10.1016/j.tig.2013.01.004; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dickinson DJ, 2016, GENETICS, V202, P885, DOI 10.1534/genetics.115.182162; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Firnhaber C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003921; Fujita M, 2003, DEV BIOL, V256, P290, DOI 10.1016/S0012-1606(03)00040-X; Gehman LT, 2012, GENE DEV, V26, P445, DOI 10.1101/gad.182477.111; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Gerstberger S, 2014, ADV EXP MED BIOL, V825, P1, DOI 10.1007/978-1-4939-1221-6_1; Heintz C, 2017, NATURE, V541, P102, DOI 10.1038/nature20789; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; LUNDQUIST EA, 1994, GENETICS, V138, P83; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Munoz MJ, 2003, GENETICS, V163, P171; Norris AD, 2015, GENETICS, V201, P449, DOI 10.1534/genetics.115.180679; Norris AD, 2014, MOL CELL, V54, P946, DOI 10.1016/j.molcel.2014.05.004; Nussbacher JK, 2015, TRENDS NEUROSCI, V38, P226, DOI 10.1016/j.tins.2015.02.003; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ramani AK, 2011, GENOME RES, V21, P342, DOI 10.1101/gr.114645.110; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Simone LE, 2013, CURR OPIN GENET DEV, V23, P35, DOI 10.1016/j.gde.2012.12.006; Spilker KA, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-7; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Van Nostrand EL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003325; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang ET, 2015, GENOME RES, V25, P858, DOI 10.1101/gr.184390.114; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041	54	0	0	0	0	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	JUL 18	2017	6								e28129	10.7554/eLife.28129				18	Biology	Life Sciences & Biomedicine - Other Topics	FC5YR	WOS:000406918100001		gold			2018-01-05	
J	Luo, MJ; Cai, MJ; Zhang, JH; Li, YR; Zhang, RY; Song, W; Zhang, K; Xiao, HL; Yue, B; Zheng, YL; Zhao, YX; Zhao, JR; Qiu, FZ				Luo, Meijie; Cai, Manjun; Zhang, Jianhua; Li, Yurong; Zhang, Ruyang; Song, Wei; Zhang, Ke; Xiao, Hailin; Yue, Bing; Zheng, Yonglian; Zhao, Yanxin; Zhao, Jiuran; Qiu, Fazhan			Functional divergence and origin of the DAG-like gene family in plants	SCIENTIFIC REPORTS			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; MOTIF-CONTAINING PROTEIN; EDITING SITE; CHLOROPLAST DIFFERENTIATION; RNA; MITOCHONDRIA; ARABIDOPSIS; GENOME; EVOLUTION; DIVERSITY	The nuclear-encoded DAG-like (DAL) gene family plays critical roles in organelle C-to-U RNA editing in Arabidopsis thaliana. However, the origin, diversification and functional divergence of DAL genes remain unclear. Here, we analyzed the genomes of diverse plant species and found that: DAL genes are specific to spermatophytes, all DAL genes share a conserved gene structure and protein similarity with the inhibitor I9 domain of subtilisin genes found in ferns and mosses, suggesting that DAL genes likely arose from I9-containing proproteases via exon shuffling. Based on phylogenetic inference, DAL genes can be divided into five subfamilies, each composed of putatively orthologous and paralogous genes from different species, suggesting that all DAL genes originated from a common ancestor in early seed plants. Significant type I functional divergence was observed in 6 of 10 pairwise comparisons, indicating that shifting functional constraints have contributed to the evolution of DAL genes. This inference is supported by the finding that functionally divergent amino acids between subfamilies are predominantly located in the DAL domain, a critical part of the RNA editosome. Overall, these findings shed light on the origin of DAL genes in spermatophytes and outline functionally important residues involved in the complexity of the RNA editosome.	[Luo, Meijie; Zhang, Ruyang; Song, Wei; Zhao, Yanxin; Zhao, Jiuran] Beijing Acad Agr & Forestry Sci, Maize Res Ctr, Beijing Key Lab Maize DNA Fingerprinting & Mol Br, Beijing 100097, Peoples R China; [Cai, Manjun; Zhang, Jianhua; Li, Yurong; Zhang, Ke; Xiao, Hailin; Yue, Bing; Zheng, Yonglian; Zhao, Yanxin; Qiu, Fazhan] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Xiao, Hailin] China Natl Seed Grp Co Ltd, Life Sci & Technol Ctr, Wuhan 430075, Peoples R China	Zhao, YX; Zhao, JR (reprint author), Beijing Acad Agr & Forestry Sci, Maize Res Ctr, Beijing Key Lab Maize DNA Fingerprinting & Mol Br, Beijing 100097, Peoples R China.; Zhao, YX; Qiu, FZ (reprint author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China.	rentlang2003@163.com; maizezhao@126.com; qiufazhan@mail.hzau.edu.cn			National Natural Science Foundation of China [31571675, 91335205, 31171565, 31500253]; BAAFS Innovation Team of Corn Germplasm Innovation and Breeding of New Varieties [JNKYT201603]	This work was supported by the National Natural Science Foundation of China (31571675, 91335205, 31171565 and 31500253) and by the BAAFS Innovation Team of Corn Germplasm Innovation and Breeding of New Varieties (JNKYT201603). We are grateful to Dr. Jingqi Zhou (Fudan University) for helpful assistance to functional divergence analysis with DIVERGE v3.0.	Babiychuk E, 1997, P NATL ACAD SCI USA, V94, P12722, DOI 10.1073/pnas.94.23.12722; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Bisanz C, 2003, PLANT MOL BIOL, V51, P651, DOI 10.1023/A:1022557825768; Bock R, 1996, EMBO J, V15, P5052; Bock R, 2000, BIOCHIMIE, V82, P549, DOI 10.1016/S0300-9084(00)00610-6                                                   ; Chateigner-Boutin A. L, 2001, RNA BIOL, V7, P213; Chatterjee M, 1996, EMBO J, V15, P4194; Chaudhuri S, 1996, EMBO J, V15, P5958; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863                                                        ; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Farre JC, 2001, MOL CELL BIOL, V21, P6731, DOI 10.1128/MCB.21.20.6731-6737.2001; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Grewe F, 2009, NUCLEIC ACIDS RES, V37, P5093, DOI 10.1093/nar/gkp532; Gruntman E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-371; Gu X, 2013, MOL BIOL EVOL, V30, P1713, DOI 10.1093/molbev/mst069; Hayes ML, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-66; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584                                                                ; Kugita M, 2003, NUCLEIC ACIDS RES, V31, P2417, DOI 10.1093/nar/gkg327; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427                                               ; LI YY, 1995, J BIOL CHEM, V270, P25127, DOI 10.1074/jbc.270.42.25127                                                        ; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Mackenzie S, 1999, PLANT CELL, V11, P571; Marchfelder A, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P261, DOI 10.1007/978-1-4020-3166-3_10; Neuwirt J, 2005, RNA, V11, P1563, DOI 10.1261/rna.2740905; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; Oldenkott B, 2014, RNA, V20, P1499, DOI 10.1261/rna.045575.114; Rudinger M, 2008, MOL BIOL EVOL, V25, P1405, DOI 10.1093/molbev/msn084; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Schallenberg-Rudinger M, 2013, PLANT J, V76, P420, DOI 10.1111/tpj.12304; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Shi XW, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1167299; Shi XW, 2016, PLANT PHYSIOL, V170, P294, DOI 10.1104/pp.15.01280; Shi XW, 2015, NUCLEIC ACIDS RES, V43, P3814, DOI 10.1093/nar/gkv245; Singh R, 2016, TROP PLANT BIOL, V9, P136, DOI 10.1007/s12042-016-9165-4; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Smarda P, 2012, PLANT GENOME DIVERSI, V1, P209, DOI DOI 10.1007/978-3-7091-1130-7_; Smarda P, 2014, P NATL ACAD SCI USA, V111, pE4096, DOI 10.1073/pnas.1321152111; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Sun T., 2016, PLOS GENET, V11; Sun T, 2016, TRENDS PLANT SCI, V21, P962, DOI 10.1016/j.tplants.2016.07.005; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Takenaka M, 2004, NUCLEIC ACIDS RES, V32, P4137, DOI 10.1093/nar/gkh763; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsudzuki T, 2001, J MOL EVOL, V53, P327, DOI 10.1007/s002390010222; Wang Y, 2013, NUCLEIC ACIDS RES, V41, pD1159, DOI 10.1093/nar/gks1109; Zhang F, 2014, P NATL ACAD SCI USA, V111, P2023, DOI 10.1073/pnas.1316183111	56	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 18	2017	7								5688	10.1038/s41598-017-05961-2				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FA9DJ	WOS:000405745900039	28720816	gold			2018-01-05	
J	Mukherjee, N; Lu, Y; Almeida, A; Lambert, K; Shiau, CW; Su, JC; Luo, YC; Fujita, M; Robinson, WA; Robinson, SE; Norris, DA; Shellman, YG				Mukherjee, Nabanita; Lu, Yan; Almeida, Adam; Lambert, Karoline; Shiau, Chung-Wai; Su, Jung-Chen; Luo, Yuchun; Fujita, Mayumi; Robinson, William A.; Robinson, Steven E.; Norris, David A.; Shellman, Yiqun G.			Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells	ONCOTARGET			English	Article						melanoma stem cells; cancer stem cells; drug-induced cell death; melanoma; SC-2001	CANCER STEM-CELLS; HEPATOCELLULAR-CARCINOMA CELLS; ACUTE MYELOID-LEUKEMIA; BCL-2 FAMILY PROTEINS; BH3 MIMETIC ABT-737; BREAST-CANCER; METASTATIC MELANOMA; BH3-MIMETIC ABT-737; INDUCED APOPTOSIS; NOXA DETERMINES	MCL-1 (BCL-2 family anti-apoptotic protein) is responsible for melanoma's resistance to therapy. Cancer initiating cells also contribute to resistance and relapse from treatments. Here we examined the effects of the MCL-1 inhibitor SC-2001 in killing non melanoma-initiating-cells (bulk of melanoma), and melanoma-initiatingcells (MICs). By itself, SC-2001 significantly kills melanoma cells under monolayer conditions in vitro and in a conventional mouse xenograft model. However, even at high doses (10 mu M), SC-2001 does not effectively eliminate MICs. In contrast, the combination of SC-2001 with ABT-737 (a BCL-2/BCL-XL/BCL-W inhibitor) significantly decreases ALDH(+) cells, disrupts primary spheres, and inhibits the self-renewability of MICs. These results were observed in multiple melanomas, including short term cultures of relapsed tumors from current treatments, independent of the mutation status of BRAF or NRAS. Using a low-cell-number mouse xenograft model, we examined the effects of these treatments on the tumor initiating ability of MIC-enriched cultures. The combination therapy reduces tumor formation significantly compared to either drug alone. Mechanistic studies using shRNA and the CRISPR-Cas9 technology demonstrated that the upregulation of pro-apoptotic proteins NOXA and BIM contribute to the combination-induced cell death. These results indicate that the MCL-1 inhibitor SC-2001 combined with ABT-737 is a promising treatment strategy for targeting melanoma.	[Mukherjee, Nabanita; Lu, Yan; Almeida, Adam; Lambert, Karoline; Luo, Yuchun; Fujita, Mayumi; Norris, David A.; Shellman, Yiqun G.] Univ Colorado, Sch Med, Dept Dermatol, Anschutz Med Campus, Aurora, CO 80045 USA; [Shiau, Chung-Wai; Su, Jung-Chen] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan; [Robinson, William A.; Robinson, Steven E.] Univ Colorado, Div Med Oncol, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Norris, David A.] Dept Vet Affairs Med Ctr, Dermatol Sect, Denver, CO 80220 USA	Norris, DA; Shellman, YG (reprint author), Univ Colorado, Sch Med, Dept Dermatol, Anschutz Med Campus, Aurora, CO 80045 USA.; Norris, DA (reprint author), Dept Vet Affairs Med Ctr, Dermatol Sect, Denver, CO 80220 USA.	David.Norris@ucdenver.edu; Yiqun.Shellman@ucdenver.edu		Shellman, Yiqun/0000-0003-0598-5753	Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development); Southwestern Skin Cancer SPORE Pilot project; Cancer Center [P30CA046934]; NIAMS Skin Disease Research Core Center [P30 AR 057212]	This work was supported in part by a Veterans Administration merit grant from the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development) to DAN; and by a Southwestern Skin Cancer SPORE Pilot project to YGS. We would like to thank the Functional Genomics Facility at UC Boulder and Dr. Feng Zhang lab from the Broad Institute and the McGovern Institute of Brain Research at the Massachusetts Institute of Technology for providing CRISPR reagents [56]. We thank the University of Colorado Skin Cancer Biorepository for providing human melanoma samples and melanoma cell lines. We are grateful to Karen Helm, Christine Childs, and Erin Erdahl of the CU Cancer Center Flow Cytometry Core facility (supported by Cancer Center Support Grant P30CA046934 and NIAMS Skin Disease Research Core Center grant P30 AR 057212) for their expert technical assistance.	Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Andersson Y, 2004, INT J CANCER, V112, P475, DOI 10.1002/ijc.20371; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Barrangou R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0816-9; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Beekman AM, 2015, CHEMMEDCHEM; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Besbes S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.168; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Bolesta E, 2012, MOL CELL BIOL, V32, P1879, DOI 10.1128/MCB.06214-11; Cancer Genome Atlas Network, 2015, CELL, V161, P1681, DOI DOI 10.1016/J.CELL.2015.05.044; Cheli Y, 2012, ONCOGENE, V31, P2461, DOI 10.1038/onc.2011.425; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Chen KF, 2012, BIOCHEM PHARMACOL, V84, P268, DOI 10.1016/j.bcp.2012.04.023; Chen KF, 2012, CANCER LETT, V321, P27, DOI 10.1016/j.canlet.2012.03.023; Chetoui N, 2008, MOL CANCER RES, V6, P42, DOI 10.1158/1541-7786.MCR-07-0080; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Elgendy M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6637; Fofaria NM, 2015, ONCOTARGET, DOI 10.18632/oncotarget.5755; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Glaser SP, 2012, GENE DEV, V26, P120, DOI 10.1101/gad.182980.111; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; Haschka MD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7891; Hauck P, 2009, MOL CANCER THER, V8, P883, DOI 10.1158/1535-7163.MCT-08-1118; Hirata N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5806; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huelsemann MF, 2015, LEUKEMIA, V29, P981, DOI 10.1038/leu.2014.320; Iwanaga R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3219; Jokinen E, 2014, ONCOTARGET, V5, P9295, DOI 10.18632/oncotarget.2424                                                        ; Lee N, 2014, LAB INVEST, V94, P13, DOI 10.1038/labinvest.2013.116; LePoole IC, 1997, IN VITRO CELL DEV-AN, V33, P42, DOI 10.1007/s11626-997-0021-6                                                       ; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Lucas KM, 2012, CLIN CANCER RES, V18, P783, DOI 10.1158/1078-0432.CCR-11-1166; Luo Y., 2013, CURR PROTOC STEM CEL, V26; Luo YC, 2012, STEM CELLS, V30, P2100, DOI 10.1002/stem.1193; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; McKee CS, 2013, EXP DERMATOL, V22, P767, DOI 10.1111/exd.12254; Miller LA, 2009, J INVEST DERMATOL, V129, P964, DOI 10.1038/jid.2008.327; Mohana-Kumaran N, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12242; Mukherjee N, 2015, J INVEST DERMATOL, V135, P2155, DOI 10.1038/jid.2015.145; Mukherjee N, 2015, J INVEST DERMATOL, V135, P842, DOI 10.1038/jid.2014.464; Murphy AC, 2014, APOPTOSIS, V19, P629, DOI 10.1007/s10495-013-0935-2; Nakajima W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.6; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nguyen N, 2015, MELANOMA MA IN PRESS; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pan RQ, 2015, BLOOD, V126, P363, DOI 10.1182/blood-2014-10-604975; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Perciavalle RM, 2013, TRENDS CELL BIOL, V23, P22, DOI 10.1016/j.tcb.2012.08.011; Perez-Galan P, 2007, BLOOD, V109, P4441, DOI 10.1182/blood-2006-07-034173; Radvanyi L, 2013, MOL THER, V21, P1471, DOI 10.1038/mt.2013.160; Rameshwar P, 2014, ENLIVEN CHALLENGES C, V1; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026                                                                 ; Reuland SN, 2012, BIOL OPEN, V1, P92, DOI 10.1242/bio.2011035; Reuland SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024294; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Ruth MC, 2006, J INVEST DERMATOL, V126, P862, DOI 10.1038/sj.jid.5700211; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Santini R, 2012, STEM CELLS, V30, P1808, DOI 10.1002/stem.1160; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Schadendorf D, 2015, EUR J CANCER, V51, P833, DOI 10.1016/j.ejca.2015.03.004; Shakhova O, 2013, CANCER LETT, V338, P74, DOI 10.1016/j.canlet.2012.10.009; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sheridan C, 2010, ONCOGENE, V29, P6428, DOI 10.1038/onc.2010.380; Singh SK, 2003, CANCER RES, V63, P5821; Smith SM, 2012, METHOD CELL BIOL, V112, P361, DOI 10.1016/B978-0-12-405914-6.00020-2; Stecca B, 2013, CURR PROTOC STEM CEL; Su JC, 2014, NEOPLASIA, V16, P595, DOI 10.1016/j.neo.2014.06.005; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Thomas S, 2013, EXPERT OPIN THER TAR, V17, P61, DOI 10.1517/14728222.2013.733001; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Weber A, 2009, TRANSL ONCOL, V2, P73, DOI 10.1593/tlo.08223; Wei SH, 2008, CANCER CHEMOTH PHARM, V62, P1055, DOI 10.1007/s00280-008-0697-7; White MK, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7104; Williams MM, 2015, ONCOTARGET, V6, P3519, DOI 10.18632/oncotarget.2792                                                        ; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zhou Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05382; Zhu P, 2014, CANCER PREV RES, V7, P199, DOI 10.1158/1940-6207.CAPR-13-0181	94	1	1	1	1	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	JUL 18	2017	8	29					46801	46817		10.18632/oncotarget.8695				17	Oncology; Cell Biology	Oncology; Cell Biology	FA8KD	WOS:000405694000010	27086916	green_published			2018-01-05	
J	Yan, F; Ying, L; Li, XF; Qiao, B; Meng, QH; Yu, L; Yuan, XL; Ren, ST; Chan, DW; Shi, LY; Ni, PH; Wang, XF; Xu, DK; Hu, YQ				Yan, Feng; Ying, Le; Li, Xiaofang; Qiao, Bin; Meng, Qiaohong; Yu, Liang; Yuan, Xiangliang; Ren, Shu-Ting; Chan, David W.; Shi, Liyun; Ni, Peihua; Wang, Xuefeng; Xu, Dakang; Hu, Yiqun			Overexpression of the transcription factor ATF3 with a regulatory molecular signature associates with the pathogenic development of colorectal cancer	ONCOTARGET			English	Article						colorectal cancer; ATF3; genes signature; prognosis	COLON-CANCER; PROMOTES INFLAMMATION; TUMOR-SUPPRESSOR; CELLS; METASTASIS; GENE; INHIBITOR; CARCINOMA; APOPTOSIS; PATHWAY	The identification of novel biomarkers of cancer is important for improved diagnosis and prognosis. With an abundant amount of resources in the publicly available database, such as the Cancer Genome Atlas (TCGA) database, an integrative strategy is used to systematically characterize the aberrant patterns of colorectal cancer (CRC) based on RNA-Seq, chromatin immunoprecipitation sequencing (ChIP-Seq), tissue microarray (TMA), gene profiling and molecular signatures. The expression of the transcription factor ATF3 was elevated in human CRC specimens in a TMA by immunochemistry analysis compared to the adjacent normal tissues. In addition, ATF3 overexpression associated with a regulatory molecular signature, and its functions are related to the pathogenic development of CRC. Furthermore, putative ATF3 regulatory elements were identified within the promoters of ATF3 target genes and were confirmed by ChIP-Seq. Critically, in higher ATF3 expression cell lines (HCT116 and RKO) with CRISPR/Cas9 mediated ATF3 knock out, we are able to show that ATF3 target genes such as CEACAM1, DUSP14, HDC, HLF and ULBP2, are required for invasion and proliferation, and they are robustly linked with poor prognosis in CRC. Our findings have important implications for CRC tumorigenesis and may be exploited for diagnostic and therapeutic purposes.	[Yan, Feng; Ying, Le; Li, Xiaofang; Qiao, Bin; Yuan, Xiangliang; Ni, Peihua; Xu, Dakang; Hu, Yiqun] Shanghai Jiao Tong Univ, Ruijin Hosp, Fac Med Lab Sci, Sch Med, Shanghai, Peoples R China; [Yan, Feng; Li, Xiaofang; Meng, Qiaohong; Xu, Dakang] Hangzhou Normal Univ, Inst Ageing Res, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Ying, Le] Zhejiang Univ, Dept Tea Sci, Hangzhou, Zhejiang, Peoples R China; [Qiao, Bin] Zhengzhou Univ, Affiliated Hosp 1, Dept Stomatol, Zhengzhou, Henan, Peoples R China; [Yu, Liang] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Gen Surg, Shanghai, Peoples R China; [Ren, Shu-Ting] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Xian, Peoples R China; [Chan, David W.] Univ Hong Kong, LKS Fac Med, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Shi, Liyun] Nanjing Univ Chinese Med, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Wang, Xuefeng; Hu, Yiqun] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Lab Med, Shanghai, Peoples R China; [Xu, Dakang] Hudson Inst Med Res, Clayton, Vic, Australia; [Xu, Dakang] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia	Xu, DK; Hu, YQ (reprint author), Shanghai Jiao Tong Univ, Ruijin Hosp, Fac Med Lab Sci, Sch Med, Shanghai, Peoples R China.; Xu, DK (reprint author), Hangzhou Normal Univ, Inst Ageing Res, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Hu, YQ (reprint author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Lab Med, Shanghai, Peoples R China.; Xu, DK (reprint author), Hudson Inst Med Res, Clayton, Vic, Australia.; Xu, DK (reprint author), Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia.	dakang.xu@monash.edu; ichunhu@126.com	YAN, FENG/T-6084-2017	YAN, FENG/0000-0002-8848-1739	National Natural Science Foundation of China [81273247, 81472655, 31670905]; Shanghai Municipal Education Commission key discipline support project [2015-10101001-1]; National Health and Medical Research Council of Australia Grants [1066665]	This work was supported by grants from the National Natural Science Foundation of China (81273247, 81472655 and 31670905) and the Shanghai Municipal Education Commission key discipline support project 2015-10101001-1. National Health and Medical Research Council of Australia Grants (1066665).	Arabzadeh A, 2013, ONCOGENE, V32, P849, DOI 10.1038/onc.2012.112; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Banchereau R, 2016, CELL, V165, P1548, DOI 10.1016/j.cell.2016.05.057; Bottone FG, 2003, J BIOL CHEM, V278, P25790, DOI 10.1074/jbc.M301002200; Bottone FG, 2005, MOL CANCER THER, V4, P693, DOI 10.1158/1535-7163.MCT-04-0337                                                   ; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Colussi D, 2013, INT J MOL SCI, V14, P16365, DOI 10.3390/ijms140816365; Garcia-Faroldi G, 2009, CURR OPIN CLIN NUTR, V12, P59, DOI 10.1097/MCO.0b013e328314b9ac; Hackl C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-668; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0                                                   ; Hardcastle TJ, 2016, BIOINFORMATICS, V32, P195, DOI 10.1093/bioinformatics/btv569; Hua F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8951; Ishiguro T, 2000, ONCOL RES, V12, P343; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Pan XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034662; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Ritchie A, 2009, CELL DEATH DIFFER, V16, P838, DOI 10.1038/cdd.2009.13; Sadler AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7795; Sadler AJ, 2015, P NATL ACAD SCI USA, V112, P1535, DOI 10.1073/pnas.1409728112; Sankaranarayanan R, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-3; Simon R, 2011, EMBO MOL MED, V3, P429, DOI 10.1002/emmm.201100153; Smyth G. K., 2004, APPL GENET MOL BIOL, V3, DOI DOI 10.2202/1544-6115.1027; Sooraj D, 2016, MOL CANCER THER, V15, P1726, DOI 10.1158/1535-7163.MCT-15-0890; Thompson MR, 2009, J MOL MED-JMM, V87, P1053, DOI 10.1007/s00109-009-0520-x; van de Velde CJ, 2014, EUR J CANCER, V50, pe34; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Wu ZY, 2014, TUMOR BIOL, V35, P8329, DOI 10.1007/s13277-014-2044-4; Xie JJ, 2014, ONCOTARGET, V5, P8569, DOI 10.18632/oncotarget.2322                                                        ; Yang CY, 2016, CELL SIGNAL, V28, P145, DOI 10.1016/j.cellsig.2015.10.017; Yang XD, 2011, NAT MED, V17, P87, DOI 10.1038/nm.2278; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhao J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2664-8; Zheng YX, 2012, EUR J IMMUNOL, V42, P2803, DOI 10.1002/eji.201242475; Zhou X, 2016, ONCOTARGET, V7, P69616, DOI 10.18632/oncotarget.11903	37	1	1	5	5	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	JUL 18	2017	8	29					47020	47036		10.18632/oncotarget.16638				17	Oncology; Cell Biology	Oncology; Cell Biology	FA8KD	WOS:000405694000027	28402947	green_published			2018-01-05	
J	Bak, RO; Porteus, MH				Bak, Rasmus O.; Porteus, Matthew H.			CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors	CELL REPORTS			English	Article							HEMATOPOIETIC STEM-CELLS; MESSENGER-RNA; IN-VIVO; GENOME; DNA; RECOMBINATION; SIZE; EXPRESSION; NUCLEASES; FRAGMENT	The CRISPR/Cas9 system has recently been shown to facilitate high levels of precise genome editing using adeno-associated viral (AAV) vectors to serve as donor template DNA during homologous recombination (HR). However, the maximum AAV packaging capacity of similar to 4.5 kb limits the donor size. Here, we overcome this constraint by showing that two cotransduced AAV vectors can serve as donors during consecutive HR events for the integration of large transgenes. Importantly, the method involves a single-step procedure applicable to primary cells with relevance to therapeutic genome editing. We use the methodology in primary human T cells and CD34(+) hematopoietic stem and progenitor cells to site-specifically integrate an expression cassette that, as a single donor vector, would otherwise amount to a total of 6.5 kb. This approach now provides an efficient way to integrate large transgene cassettes into the genomes of primary human cells using HR-mediated genome editing with AAV vectors.	[Bak, Rasmus O.; Porteus, Matthew H.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Bak, RO; Porteus, MH (reprint author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	rbak@stanford.edu; mporteus@stanford.edu		Bak, Rasmus/0000-0002-7383-0297	Individual Postdoctoral grant [DFF-133300106B]; Sapere Aude, Research Talent grant [DFF-1331-00735B]; Danish Council for Independent Research, Medical Sciences; Amon Carter Foundation; Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research; NIH [R01-AI120766]	R.O.B. was supported through an Individual Postdoctoral grant (DFF-133300106B) and a Sapere Aude, Research Talent grant (DFF-1331-00735B), both from the Danish Council for Independent Research, Medical Sciences. M.H.P. gratefully acknowledges the support of the Amon Carter Foundation, the Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research, and NIH grant R01-AI120766. We thank David Russell (University of Washington) for the pDGM6 plasmid, the Binns Program for Cord Blood Research (Stanford University) for cord-blood-derived CD34+ HSPCs, and Sruthi Mantri (Stanford University) for isolation of CD34+ HSPCs from cord blood. We also thank Daniel Dever and other members of the Porteus lab for helpful input, comments, and discussion. M.H.P. is a consultant and has equity interest in CRISPR Tx, but CRISPR Tx had no input into the design, execution, interpretation, or publication of the results herein.	Aurnhammer C, 2012, HUM GENE THER METHOD, V23, P18, DOI 10.1089/hgtb.2011.034; Barzel A, 2015, NATURE, V517, P360, DOI 10.1038/nature13864; Basiri M, 2017, CELL J, V18, P532; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Chamberlain K, 2016, HUM GENE THER METHOD, V27, P1, DOI 10.1089/hgtb.2015.140; Chicaybam L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060298; De Ravin SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3480; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Grieger JC, 2005, J VIROL, V79, P9933, DOI 10.1128/JVI.79.15.9933-9944.2005; Halbert CL, 2002, NAT BIOTECHNOL, V20, P697, DOI 10.1038/nbt0702-697; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hendel A, 2014, CELL REP, V7, P293, DOI 10.1016/j.celrep.2014.02.040; Hoban MD, 2016, MOL THER, V24, P1561, DOI 10.1038/mt.2016.148; Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/nmeth.3075, 10.1038/NMETH.3075]; Knipping F, 2017, MOL THER-METH CLIN D, V4, P213, DOI 10.1016/j.omtm.2017.01.005; Kung SH, 2013, APPL ENVIRON MICROB, V79, P1712, DOI 10.1128/AEM.03525-12; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Nakai H, 2000, NAT BIOTECHNOL, V18, P527; Perez C, 2005, BIOTECHNIQUES, V39, P109, DOI 10.2144/05391GT01; Ryan MA, 2010, NAT MED, V16, P1141, DOI 10.1038/nm.2217; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Sun LW, 2000, NAT MED, V6, P599; Takahashi T, 1998, BLOOD, V91, P4509; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272                                                         ; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Zhang W, 2014, GENE THER, V21, P282, DOI 10.1038/gt.2013.83; Zhang WF, 2014, J BIOTECHNOL, V188, P1, DOI 10.1016/j.jbiotec.2014.08.003	32	3	3	7	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	JUL 18	2017	20	3					750	756		10.1016/j.celrep.2017.06.064				7	Cell Biology	Cell Biology	FA8IR	WOS:000405690100019	28723575	gold			2018-01-05	
J	Sui, HY; Zhou, M; Imamichi, H; Jiao, XL; Sherman, BT; Lane, HC; Imamichi, T				Sui, Hongyan; Zhou, Ming; Imamichi, Hiromi; Jiao, Xiaoli; Sherman, Brad T.; Lane, H. Clifford; Imamichi, Tomozumi			STING is an essential mediator of the Ku70-mediated production of IFN-gimel 1 in response to exogenous DNA	SCIENCE SIGNALING			English	Article							PATTERN-RECOGNITION RECEPTORS; DEPENDENT PROTEIN-KINASE; INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTORS; IFN-LAMBDA-S; DENDRITIC CELLS; I INTERFERON; PATHOGEN RECOGNITION; INTRACELLULAR DNA; V(D)J RECOMBINATION	We previously identified Ku70, a subunit of a DNA repair protein complex, as a cytosolic DNA sensor that induces the production of interferon-gimel 1 (IFN-gimel 1) by human primary cells and cell lines. IFN-gimel 1 is a type III IFN and has similar antiviral activity to that of the type I IFNs (IFN-alpha and IFN-beta). We observed that human embryonic kidney (HEK) 293T cells, which are deficient in the innate immune adaptor protein STING (stimulator of IFN genes), did not produce IFN-gimel 1 in response to DNA unless they were reconstituted with STING. Conversely, parental HEK 293 cells produced IFN-gimel 1 after they were exposed to exogenous DNA; however, when STING was knocked out in the HEK 293 cells through the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 genome editing system, they lost this response. Through confocal microscopy, we demonstrated that endogenous Ku70 was located in the nucleus and then translocated to the cytoplasm upon DNA exposure to form a complex with STING. Additionally, the DNA binding domain of Ku70 was essential for formation of the Ku70-STING complex. Knocking down STING in primary human macrophages inhibited their ability to produce IFN-gimel 1 in response to transfection with DNA or infection with the DNA virus HSV-2 (herpes simplex virus-2). Together, these data suggest that STING mediates the Ku70 mediated IFN-gimel 1 innate immune response to exogenous DNA or DNA virus infection.	[Sui, Hongyan; Jiao, Xiaoli; Sherman, Brad T.; Imamichi, Tomozumi] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Lab Human Retrovirol & Immunoinformat, Appl & Dev Res Directorate, Frederick, MD 21702 USA; [Zhou, Ming] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Canc Res Technol Program, Lab Prote & Analyt Technol, Frederick, MD 21702 USA; [Imamichi, Hiromi; Lane, H. Clifford] NIAID, Immunoregulat Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Zhou, Ming] Inova Hlth Syst, Inova Schar Canc Inst, Annandale, VA 22003 USA	Imamichi, T (reprint author), Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Lab Human Retrovirol & Immunoinformat, Appl & Dev Res Directorate, Frederick, MD 21702 USA.	timamichi@mail.nih.gov			National Cancer Institute, NIH [HHSN261200800001E]	This project was funded in whole or in part with federal funds from the National Cancer Institute, NIH under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the reviews or policies of the U. S. Department of Health and Human Services nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. government.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andrei G., 2000, ANTIVIRAL METHODS PR, P151; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2009, BIOFACTORS, V35, P82, DOI 10.1002/biof.19; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Booth D, 2013, NAT GENET, V45, P119, DOI 10.1038/ng.2537; Bowie AG, 2005, MOL IMMUNOL, V42, P859, DOI 10.1016/j.molimm.2004.11.007; Bowie A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002919; Cavlar T, 2012, IMMUNOL CELL BIOL, V90, P474, DOI 10.1038/icb.2012.11; Chanput W, 2014, INT IMMUNOPHARMACOL, V23, P37, DOI 10.1016/j.intimp.2014.08.002; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Fakruddin JM, 2007, BLOOD, V109, P1841, DOI 10.1182/blood-2006-02-001578; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Kondo T, 2013, P NATL ACAD SCI USA, V110, P2969, DOI 10.1073/pnas.1222694110; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lee MN, 2013, NAT IMMUNOL, V14, P179, DOI 10.1038/ni.2509; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Levy DE, 2003, CURR OPIN IMMUNOL, V15, P52, DOI 10.1016/S0952-7915(02)00011-0; Lu YF, 2015, VIROLOGY, V476, P334, DOI 10.1016/j.virol.2014.12.020; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506                                                     ; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Rivera-Calzada A, 2007, EMBO REP, V8, P56, DOI 10.1038/sj.embor.7400847; Sharma S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001310; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4396.2004; Sui HY, 2014, NUCLEIC ACIDS RES, V42, P583, DOI 10.1093/nar/gkt844; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009; Zhang X, 2011, J IMMUNOL, V186, P4541, DOI 10.4049/jimmunol.1003389; Zhang ZQ, 2011, J IMMUNOL, V187, P4501, DOI 10.4049/jimmunol.1101307; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	51	2	2	3	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	1945-0877	1937-9145		SCI SIGNAL	Sci. Signal.	JUL 18	2017	10	488							eaah5054	10.1126/scisignal.aah5054				11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FA8DM	WOS:000405676400002					2018-01-05	
J	Larsson, C; Ali, MA; Pandzic, T; Lindroth, AM; He, LQ; Sjoblom, T				Larsson, Chatarina; Ali, Muhammad Akhtar; Pandzic, Tatjana; Lindroth, Anders M.; He, Liqun; Sjoblom, Tobias			Loss of DIP2C in RKO cells stimulates changes in DNA methylation and epithelial-mesenchymal transition	BMC CANCER			English	Article						Cancer; DIP2C; Gene knockout; rAAV-mediated gene targeting; Tumour cell biology; DNA methylation; Epithelial-mesenchymal transition (EMT)	LARGE GENE LISTS; HUMAN BREAST; EXPRESSION ANALYSIS; COLORECTAL CANCERS; IDENTIFICATION; SENESCENCE; RECEPTOR; DIFFERENTIATION; P16(INK4A); DROSOPHILA	Background: The disco-interacting protein 2 homolog C (DIP2C) gene is an uncharacterized gene found mutated in a subset of breast and lung cancers. To understand the role of DIP2C in tumour development we studied the gene in human cancer cells. Methods: We engineered human DIP2C knockout cells by genome editing in cancer cells. The growth properties of the engineered cells were characterised and transcriptome and methylation analyses were carried out to identify pathways deregulated by inactivation of DIP2C. Effects on cell death pathways and epithelial-mesenchymal transition traits were studied based on the results from expression profiling. Results: Knockout of DIP2C in RKO cells resulted in cell enlargement and growth retardation. Expression profiling revealed 780 genes for which the expression level was affected by the loss of DIP2C, including the tumour-suppressor encoding CDKN2A gene, the epithelial-mesenchymal transition (EMT) regulator-encoding ZEB1, and CD44 and CD24 that encode breast cancer stem cell markers. Analysis of DNA methylation showed more than 30,000 sites affected by differential methylation, the majority of which were hypomethylated following loss of DIP2C. Changes in DNA methylation at promoter regions were strongly correlated to changes in gene expression, and genes involved with EMT and cell death were enriched among the differentially regulated genes. The DIP2C knockout cells had higher wound closing capacity and showed an increase in the proportion of cells positive for cellular senescence markers. Conclusions: Loss of DIP2C triggers substantial DNA methylation and gene expression changes, cellular senescence and epithelial-mesenchymal transition in cancer cells.	[Larsson, Chatarina; Ali, Muhammad Akhtar; Pandzic, Tatjana; He, Liqun; Sjoblom, Tobias] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Dag Hammarskjolds Vag 20, SE-75185 Uppsala, Sweden; [Ali, Muhammad Akhtar] Uppsala Univ, Dept Med Biochem & Microbiol, BMC, Husargatan 3, SE-75123 Uppsala, Sweden; [Lindroth, Anders M.] Natl Canc Ctr, Dept Syst Canc Sci, Grad Sch Canc Sci & Policy, 323 Ilsan Ro, Goyang Si 10408, South Korea; [He, Liqun] Tianjin Med Univ, Gen Hosp, Dept Neurosurg,Minist Educ & Tianjin City, Tianjin Neurol Inst,Key Lab Postneuroinjury Neuro, Tianjin 300052, Peoples R China	Sjoblom, T (reprint author), Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Dag Hammarskjolds Vag 20, SE-75185 Uppsala, Sweden.	tobias.sjoblom@igp.uu.se		Sjoblom, Tobias/0000-0001-6668-4140	Swedish Cancer Society, and Research [2006/2154, 2007/775, 2012/834]; Swedish Foundation for Strategic Research [F06-0050, RBa08-0114]; Swedish Cancer Society [2012/1235]; Swedish Society for Medical Research	This work was supported by Research grants 2006/2154, 2007/775, and 2012/834 from the Swedish Cancer Society, and Research grants F06-0050 and RBa08-0114 from the Swedish Foundation for Strategic Research to TS, and Postdoctoral grant 2012/1235 from the Swedish Cancer Society and a postdoctoral stipend from the Swedish Society for Medical Research to CL. There was no role of the funding bodies in the design of the study, in collection, analysis, and interpretation of data or in writing the manuscript.	Bakshi S, 2008, ENVIRON HEALTH PERSP, V116, P769, DOI 10.1289/ehp.11215; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Closa A, 2014, CARCINOGENESIS, V35, P2039, DOI 10.1093/carcin/bgu092; DeScipio C, 2012, AM J MED GENET A, V158A, P2152, DOI 10.1002/ajmg.a.35574; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egger G, 2014, NEUROGENETICS, V15, P117, DOI 10.1007/s10048-014-0394-0; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Girault I, 2003, CLIN CANCER RES, V9, P4415; Halvey PJ, 2014, CANCER RES, V74, P387, DOI 10.1158/0008-5472.CAN-13-2488; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiao X, 2012, GENE CHROMOSOME CANC, V51, P480, DOI 10.1002/gcc.21935; Kanellou P, 2008, CANCER LETT, V264, P145, DOI 10.1016/j.canlet.2008.01.042; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kulis M, 2013, BBA-GENE REGUL MECH, V1829, P1161, DOI 10.1016/j.bbagrm.2013.08.001; Kumari R., 2014, MOL CELL ONCOL, V1; Lee GE, 2010, J BIOL CHEM, V285, P37630, DOI 10.1074/jbc.M110.148536; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liesenfeld M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-507; Marabita F, 2013, EPIGENETICS-US, V8, P333, DOI 10.4161/epi.24008; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Mukhopadhyay M, 2002, GENE, V293, P59, DOI 10.1016/S0378-1119(02)00694-7; Negishi M, 2009, GENES CELLS, V14, P1347, DOI 10.1111/j.1365-2443.2009.01352.x; Newman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064991; Ouchi N, 2010, J BIOL CHEM, V285, P7127, DOI 10.1074/jbc.M109.069468; Parson W, 2005, FASEB J, V19, P434, DOI 10.1096/fj.04-3062fje; Poelmans G, 2009, AM J MED GENET B, V150B, P140, DOI 10.1002/ajmg.b.30787; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Qin WH, 2011, NUCLEUS-AUSTIN, V2, P392, DOI 10.4161/nucl.2.5.17928; R Core Team, 2014, R LANG ENV STAT COMP; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stoimenov I, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1286; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tanaka M, 2010, FEBS J, V277, P4278, DOI 10.1111/j.1742-4658.2010.07816.x; Topaloglu O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni160; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Triche TJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt090; Winnepenninckx B, 2007, AM J HUM GENET, V80, P221, DOI 10.1086/510800; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2	50	0	0	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2407			BMC CANCER	BMC Cancer	JUL 17	2017	17								487	10.1186/s12885-017-3472-5				12	Oncology	Oncology	FB0WI	WOS:000405865300001	28716088	gold			2018-01-05	
J	Lin, CY; Tsai, MY; Liu, YH; Lu, YF; Chen, YC; Lai, YR; Liao, HC; Lien, HW; Yang, CH; Huang, CJ; Hwang, SPL				Lin, Che-Yi; Tsai, Ming-Yuan; Liu, Yu-Hsiu; Lu, Yu-Fen; Chen, Yi-Chung; Lai, Yun-Ren; Liao, Hsin-Chi; Lien, Huang-Wei; Yang, Chung-Hsiang; Huang, Chang-Jen; Hwang, Sheng-Ping L.			Klf8 regulates left-right asymmetric patterning through modulation of Kupffer's vesicle morphogenesis and spaw expression	JOURNAL OF BIOMEDICAL SCIENCE			English	Article						Zebrafish; Klf8; Spaw; L-R patterning; Kupffer's vesicle	LEFT-RIGHT AXIS; KRUPPEL-LIKE FACTOR-8; LATERAL PLATE MESODERM; TRANSCRIPTION FACTORS; ZEBRAFISH EMBRYO; GENE SOUTHPAW; GLOBIN GENE; CILIA; ESTABLISHMENT; PROTEIN	Background: Although vertebrates are bilaterally symmetric organisms, their internal organs are distributed asymmetrically along a left-right axis. Disruption of left-right axis asymmetric patterning often occurs in human genetic disorders. In zebrafish embryos, Kupffer's vesicle, like the mouse node, breaks symmetry by inducing asymmetric expression of the Nodal-related gene, spaw, in the left lateral plate mesoderm (LPM). Spaw then stimulates transcription of itself and downstream genes, including lft1, lft2, and pitx2, specifically in the left side of the diencephalon, heart and LPM. This developmental step is essential to establish subsequent asymmetric organ positioning. In this study, we evaluated the role of kruppel-like factor 8 (klf8) in regulating left-right asymmetric patterning in zebrafish embryos. Methods: Zebrafish klf8 expression was disrupted by both morpholino antisense oligomer-mediated knockdown and a CRISPR-Cas9 system. Whole-mount in situ hybridization was conducted to evaluate gene expression patterns of Nodal signalling components and the positions of heart and visceral organs. Dorsal forerunner cell number was evaluated in Tg(sox17:gfp) embryos and the length and number of cilia in Kupffer's vesicle were analyzed by immunocytochemistry using an acetylated tubulin antibody. Results: Heart jogging, looping and visceral organ positioning were all defective in zebrafish klf8 morphants. At the 1822 s stages, klf8 morphants showed reduced expression of genes encoding Nodal signalling components (spaw, lft1, lft2, and pitx2) in the left LPM, diencephalon, and heart. Co-injection of klf8 mRNA with klf8 morpholino partially rescued spaw expression. Furthermore, klf8 but not klf8(Delta)zf overexpressing embryos showed dysregulated bilateral expression of Nodal signalling components at late somite stages. At the 10s stage, klf8 morphants exhibited reductions in length and number of cilia in Kupffer's vesicle, while at 75% epiboly, fewer dorsal forerunner cells were observed. Interestingly, klf8 mutant embryos, generated by a CRISPR-Cas9 system, showed bilateral spaw expression in the LPM at late somite stages. This observation may be partly attributed to compensatory upregulation of klf12b, because klf12b knockdown reduced the percentage of klf8 mutants exhibiting bilateral spaw expression. Conclusions: Our results demonstrate that zebrafish Klf8 regulates left-right asymmetric patterning by modulating both Kupffer's vesicle morphogenesis and spaw expression in the left LPM.	[Lin, Che-Yi; Lai, Yun-Ren; Liao, Hsin-Chi; Hwang, Sheng-Ping L.] Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan; [Tsai, Ming-Yuan] Natl Def Univ, Grad Inst Life Sci, Natl Def Med Ctr, Taipei, Taiwan; [Liu, Yu-Hsiu; Hwang, Sheng-Ping L.] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan; [Lu, Yu-Fen; Chen, Yi-Chung; Hwang, Sheng-Ping L.] Acad Sinica, Inst Cellular & Organism Biol, Taipei 11529, Taiwan; [Lien, Huang-Wei; Yang, Chung-Hsiang; Huang, Chang-Jen] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lin, Che-Yi; Tsai, Ming-Yuan] Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan	Hwang, SPL (reprint author), Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan.; Hwang, SPL (reprint author), Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan.; Hwang, SPL (reprint author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 11529, Taiwan.	zoslh@gate.sinica.edu.tw			Academia Sinica Innovative Translational Agricultural Research Program [542300]; Ministry of Science and Technology, Taiwan [MOST 105-2313-B-001-005-MY3]	This work was supported by Academia Sinica Innovative Translational Agricultural Research Program [542300 to S.P.L.H.] and the Ministry of Science and Technology, Taiwan [MOST 105-2313-B-001-005-MY3 to S.P.L.H.].	Ahmad N, 2004, TRENDS CARDIOVAS MED, V14, P43, DOI 10.1016/j.tcm.2003.11.001                                                       ; Amack JD, 2007, DEV BIOL, V310, P196, DOI 10.1016/j.ydbio.2007.05.039; Amack Jeffrey D, 2014, Bioarchitecture, V4, P6, DOI 10.4161/bioa.28014; Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.041; Bisgrove BW, 2003, ANNU REV GENOM HUM G, V4, P1, DOI 10.1146/annurev.genom.4.070802.110428; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chocron S, 2007, DEV BIOL, V305, P577, DOI 10.1016/j.ydbio.2007.03.001; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fujiwara T, 2002, DEVELOPMENT, V129, P4685; Funnell APW, 2013, MOL CELL BIOL, V33, P2976, DOI 10.1128/MCB.00074-13; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hashimoto H, 2004, DEVELOPMENT, V131, P1741, DOI 10.1242/dev.01070; Hirokawa N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000802; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206                                                         ; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kosaki K, 1998, SEMIN CELL DEV BIOL, V9, P89, DOI 10.1006/scdb.1997.0187; Lahiri SK, 2012, AM J TRANSL RES, V4, P357; Lenhart KF, 2011, DEVELOPMENT, V138, P4405, DOI 10.1242/dev.071092; Lin MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36188; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Matsui Takaaki, 2015, Front Cell Dev Biol, V3, P27, DOI 10.3389/fcell.2015.00027; Matsui T, 2011, P NATL ACAD SCI USA, V108, P9881, DOI 10.1073/pnas.1017248108; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Mine N, 2008, DEVELOPMENT, V135, P2425, DOI 10.1242/dev.018986; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Neugebauer JM, 2009, NATURE, V458, P651, DOI 10.1038/nature07753; Noel ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3754; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5                                                   ; Oteiza P, 2008, DEVELOPMENT, V135, P2807, DOI 10.1242/dev.022228; Oteiza P, 2010, DEVELOPMENT, V137, P3459, DOI 10.1242/dev.049981; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Peterson AG, 2013, DEV BIOL, V382, P198, DOI 10.1016/j.ydbio.2013.06.011; Raya A, 2004, MECH DEVELOP, V121, P1043, DOI 10.1016/j.mod.2004.05.005; Ryan AK, 1998, NATURE, V394, P545; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Sampaio P, 2014, DEV CELL, V29, P716, DOI 10.1016/j.devcel.2014.04.030; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schlange T, BMP2 IS POSITIVE REG; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9                                                   ; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Smith D J, 2014, Bioarchitecture, V4, P119, DOI 10.4161/19490992.2014.956593; Smith KA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002289; Thomas J, 2010, BIOL CELL, V102, P499, DOI 10.1042/BC20100035; Tsai MY, 2015, DEV NEUROBIOL, V75, P908, DOI 10.1002/dneu.22258; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wang GL, 2012, DEV BIOL, V370, P52, DOI 10.1016/j.ydbio.2012.07.019; Wang GL, 2011, DEVELOPMENT, V138, P45, DOI 10.1242/dev.052985; Wang XH, 2008, DEV DYNAM, V237, P3640, DOI 10.1002/dvdy.21771; Zhang P, 2005, BLOOD CELL MOL DIS, V35, P227, DOI 10.1016/j.bcmd.2005.04.009; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5	54	0	0	2	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1021-7770	1423-0127		J BIOMED SCI	J. Biomed. Sci.	JUL 17	2017	24								45	10.1186/s12929-017-0351-y				14	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	FA9EY	WOS:000405750000001	28716076	gold			2018-01-05	
J	Ware, RE; de Montalembert, M; Tshilolo, L; Abboud, MR				Ware, Russell E.; de Montalembert, Mariane; Tshilolo, Leon; Abboud, Miguel R.			Sickle cell disease	LANCET			English	Article							SUB-SAHARAN AFRICA; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; TRANSFUSION-TRANSMITTED INFECTIONS; EARLY-CHILDHOOD MORTALITY; PULMONARY-HYPERTENSION; CLINICAL-TRIAL; FETAL-HEMOGLOBIN; YOUNG-CHILDREN; IRON OVERLOAD; RISK-FACTORS	Sickle cell disease is a common and life-threatening haematological disorder that affects millions of people worldwide. Abnormal sickle-shaped erythrocytes disrupt blood flow in small vessels, and this vaso-occlusion leads to distal tissue ischaemia and inflammation, with symptoms defining the acute painful sickle-cell crisis. Repeated sickling and ongoing haemolytic anaemia, even when subclinical, lead to parenchymal injury and chronic organ damage, causing substantial morbidity and early mortality. Currently available treatments are limited to transfusions and hydroxycarbamide, although stem cell transplantation might be a potentially curative therapy. Several new therapeutic options are in development, including gene therapy and gene editing. Recent advances include systematic universal screening for stroke risk, improved management of iron overload using oral chelators and non-invasive MRI measurements, and point-of-care diagnostic devices. Controversies include the role of haemolysis in sickle cell disease pathophysiology, optimal management of pregnancy, and strategies to prevent cerebrovascular disease.	[Ware, Russell E.] Cincinnati Childrens Hosp Med Ctr, Div Hematol, Dept Pediat, Cincinnati, OH 45229 USA; [de Montalembert, Mariane] Hop Necker Enfants Malad, Dept Pediat, LABEX GR Ex, Paris, France; [Tshilolo, Leon] Ctr Hosp Monkole, Kinshasa, DEM REP CONGO; [Abboud, Miguel R.] Amer Univ Beirut, Dept Pediat, Beirut, Lebanon	Ware, RE (reprint author), Cincinnati Childrens Hosp Med Ctr, Div Hematol, Dept Pediat, Cincinnati, OH 45229 USA.	russell.ware@cchmc.org			Bristol-Meyers Squibb; Biomedomics; Global Blood Therapeutics; NovaLaboratories; Bayer Pharmaceuticals; Addmedica; Novartis; AFD, a French Cooperative Agency for international projects on sickle cell disease in four African countries; France Expertise/Initiative; Pfizer	REW reports grants and non-financial support from Bristol-Meyers Squibb, non-financial support and material donation from Addmedica, Grants from Biomedomics, and personal fees from Global Blood Therapeutics, NovaLaboratories, and Bayer Pharmaceuticals, outside the submitted work. MdM reports grants from Addmedica during the study, grants and personal fees from Novartis and grants from Pfizer outside the submitted work. LT is a member of the advisory board of SEBIA and Pierre Fabre Foundations. He has financial support from AFD, a French Cooperative Agency for international projects on sickle cell disease in four African countries. Other financial support was received from France Expertise/Initiative that concerns a study on malaria resistance. MRA reports grants from Eli Lilly, Pfizer, MAST therapeutics, Hemaquest, Shire, Astra Zeneca, outside the submitted work. He also reports personal fees from Pfizer and Novartis, and has participated on steering committees and advisory boards for Eli Lilly, Pfizer, and Novartis.	Adam SS, 2013, PEDIATR BLOOD CANCER, V60, P550, DOI 10.1002/pbc.24443; ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; Adams RJ, 2005, NEW ENGL J MED, V353, P2769; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102                                                     ; Aguilar MP, 2014, ORPHANET J RARE DIS, V9, P97, DOI DOI 10.1186/1750-1172-9-97; Angelucci E, 2014, HAEMATOLOGICA, V99, P811, DOI 10.3324/haematol.2013.099747; Anyanwu JN, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.5599; Ataga KI, 2017, NEW ENGL J MED, V376, P429, DOI 10.1056/NEJMoa1611770; Ataga KI, 2011, BRIT J HAEMATOL, V153, P92, DOI 10.1111/j.1365-2141.2010.08520.x; BALKARAN B, 1992, J PEDIATR-US, V120, P360, DOI 10.1016/S0022-3476(05)80897-2; Bartolucci P, 2016, J AM SOC NEPHROL, V27, P1847, DOI 10.1681/ASN.2014111126; Bernaudin F, 2007, BLOOD, V110, P2749, DOI 10.1182/blood-2007-03-079665; Bernaudin F, 2015, BLOOD, V125, P1653, DOI 10.1182/blood-2014-09-599852; Bolanos-Meade J, 2012, BLOOD, V120, P4285, DOI 10.1182/blood-2012-07-438408; Breda L, 2016, BLOOD, V128, P1139, DOI 10.1182/blood-2016-01-691089; Brousse V, 2015, BRIT J HAEMATOL, V170, P615, DOI 10.1111/bjh.13477; Brousse V, 2012, BRIT J HAEMATOL, V156, P643, DOI 10.1111/j.1365-2141.2011.08999.x; Bunn HF, 2010, BLOOD, V116, P687, DOI 10.1182/blood-2010-02-268193; Canver MC, 2016, BLOOD, V127, P2536, DOI 10.1182/blood-2016-01-678128; Casas J, 2015, TRANSFUSION, V55, P1388, DOI 10.1111/trf.12987; Cataldo G, 2015, PAIN, V156, P722, DOI 10.1097/j.pain.0000000000000104; Caughey MC, 2015, BRIT J HAEMATOL, V170, P416, DOI 10.1111/bjh.13447; Cavazzana M, 2015, AM SOC HEM 57 ANN M; CHARACHE S, 1992, BLOOD, V79, P2555; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Chou ST, 2016, HEMATOL ONCOL CLIN N, V30, P591, DOI 10.1016/j.hoc.2016.01.011; Chou ST, 2013, HEMATOL-AM SOC HEMAT, P439; Chou ST, 2013, BLOOD, V122, P1062, DOI 10.1182/blood-2013-03-490623; Cokic VP, 2008, BLOOD, V111, P1117, DOI 10.1182/blood-2007-05-088732; Colah R, 2014, CURR OPIN HEMATOL, V21, P215, DOI 10.1097/MOH.0000000000000029; Couque N, 2016, BRIT J HAEMATOL, V173, P927, DOI 10.1111/bjh.14015; Dallas MH, 2013, BIOL BLOOD MARROW TR, V19, P820, DOI 10.1016/j.bbmt.2013.02.010; Darbari DS, 2006, AM J HEMATOL, V81, P858, DOI 10.1002/ajh.20685; de Montalembert M, 2006, HAEMATOL-HEMATOL J, V91, P125; de Montalembert M, 2011, HAEMATOL-HEMATOL J, V96, P801, DOI 10.3324/haematol.2010.038307; de Montalembert M, 2010, HAEMATOL-HEMATOL J, V95, P4, DOI 10.3324/haematol.2009.020172; Deane CR, 2010, HAEMATOL-HEMATOL J, V95, P1287, DOI 10.3324/haematol.2010.022624; DeBaun MR, 2014, NEW ENGL J MED, V371, P699, DOI 10.1056/NEJMoa1401731; Drawz P, 2016, CLIN J AM SOC NEPHRO, V11, P207, DOI 10.2215/CJN.03940415; Dulmovits BM, 2016, BLOOD, V127, P1481, DOI 10.1182/blood-2015-09-667923; Dwyre DM, 2011, VOX SANG, V100, P92, DOI 10.1111/j.1423-0410.2010.01426.x; Elmariah H, 2014, AM J HEMATOL, V89, P530, DOI 10.1002/ajh.23683; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; FALK RJ, 1992, NEW ENGL J MED, V326, P910, DOI 10.1056/NEJM199204023261402; Van Zuuren EJ, 2013, COCHRANE DB SYST REV, V6; Ferster A, 1996, BLOOD, V88, P1960; Field JJ, 2013, BLOOD, V121, P3329, DOI 10.1182/blood-2012-11-465963; Fitzhugh CD, 2005, PEDIATR BLOOD CANCER, V45, P982, DOI 10.1002/pbc.20296; Fitzhugh CD, 2010, AM J HEMATOL, V85, P36, DOI 10.1002/ajh.21569; Galadanci NA, 2015, PEDIATR BLOOD CANCER, V62, P395, DOI 10.1002/pbc.25289; GAO WY, 1995, P NATL ACAD SCI USA, V92, P8333, DOI 10.1073/pnas.92.18.8333; GBD, 2016, LANCET, V388, P1459, DOI DOI 10.1016/S0140-6736(16)31012-1; Geyer HL, 2014, BLOOD, V124, P3529, DOI 10.1182/blood-2014-05-577635; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Gladwin MT, 2016, LANCET, V387, P2565, DOI 10.1016/S0140-6736(16)00647-4; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gluckman E, 2017, BLOOD, V129, P1548, DOI 10.1182/blood-2016-10-745711; Gordeuk VR, 2016, BLOOD, V127, P820, DOI 10.1182/blood-2015-08-618561; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Gulbis B, 2005, BLOOD, V105, P2685, DOI 10.1182/blood-2004-07-2704; Hamideh D, 2013, PEDIATR BLOOD CANCER, V60, P1482, DOI 10.1002/pbc.24557; Hankins JS, 2015, AM J HEMATOL, V90, P1099, DOI 10.1002/ajh.24198; Hankins JS, 2009, BLOOD, V113, P4853, DOI 10.1182/blood-2008-12-191643; Hebbel RP, 2011, AM J HEMATOL, V86, P123, DOI 10.1002/ajh.21952; Heeney MM, 2016, NEW ENGL J MED, V374, P625, DOI 10.1056/NEJMoa1512021; Heeney MM, 2015, NATHAN OSKIS HEMATOL, P675; Hoban MD, 2016, BLOOD, V127, P839, DOI 10.1182/blood-2015-09-618587; Hoffbrand AV, 2012, BLOOD, V120, P3657, DOI 10.1182/blood-2012-05-370098; Howard J, 2013, LANCET, V381, P930, DOI 10.1016/S0140-6736(12)61726-7; Hsieh MM, 2014, JAMA-J AM MED ASSOC, V312, P48, DOI 10.1001/jama.2014.7192; IHME, 2013, GLOB BURD DIS GEN EV; Jayaraman S, 2010, TRANSFUSION, V50, P433, DOI 10.1111/j.1537-2995.2009.002402.x; Kamani NR, 2012, BIOL BLOOD MARROW TR, V18, P1265, DOI 10.1016/j.bbmt.2012.01.019; Karafin MS, 2015, BLOOD CELL MOL DIS, V55, P304, DOI 10.1016/j.bcmd.2015.07.010; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; King LGC, 2015, J PEDIATR-US, V167, P702, DOI 10.1016/j.jpeds.2015.06.028; Kinney TR, 1999, BLOOD, V94, P1550; Kumar AA, 2014, P NATL ACAD SCI USA, V111, P14864, DOI 10.1073/pnas.1414739111; Kutlar A, 2012, AM J HEMATOL, V87, P536, DOI 10.1002/ajh.23147; Lanzkron S, 2013, PUBLIC HEALTH REP, V128, P110, DOI 10.1177/003335491312800206                                                      ; Laurin LP, 2014, NEPHROL DIAL TRANSPL, V29, P1211, DOI 10.1093/ndt/gft295; Le PQ, 2015, PEDIATR BLOOD CANCER, V62, P1956, DOI 10.1002/pbc.25608; Lesage N, 2015, EUR J OBSTET GYN R B, V194, P183, DOI 10.1016/j.ejogrb.2015.09.016; Lettre G, 2016, LANCET, V387, P2554, DOI 10.1016/S0140-6736(15)01341-0; Mabaera R, 2008, EXP HEMATOL, V36, P1057, DOI 10.1016/j.exphem.2008.06.014; Malinowski AK, 2015, BLOOD, V126, P2424, DOI 10.1182/blood-2015-06-649319; McCavit TL, 2011, J PEDIATR-US, V158, P505, DOI 10.1016/j.jpeds.2010.11.025; McGann PT, 2016, AM J HEMATOL, V91, P205, DOI 10.1002/ajh.24232; McGann PT, 2016, PEDIATR BLOOD CANCER, V63, P98, DOI 10.1002/pbc.25705; McGann PT, 2015, J PEDIATR-US, V167, P1314, DOI 10.1016/j.jpeds.2015.08.068; McLaughlin JF, 2016, TRANSFUSION, V56, P1014, DOI 10.1111/trf.13418; Nath KA, 2015, NAT REV NEPHROL, V11, P161, DOI 10.1038/nrneph.2015.8; Ndeezi G, 2016, LANCET GLOB HEALTH, V4, pE195, DOI 10.1016/S2214-109X(15)00288-0; Nickel RS, 2014, BLOOD, V124, P861, DOI 10.1182/blood-2014-05-575209; Niss O, 2016, JACC-CARDIOVASC IMAG, V9, P243, DOI 10.1016/j.jcmg.2015.05.013; Novelli EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114309; Ohene-Frempong K, 1998, BLOOD, V91, P288; Okam MM, 2015, BLOOD, V125, P3668, DOI 10.1182/blood-2015-03-635391; Oksenberg D, 2016, BRIT J HAEMATOL, V175, P141, DOI 10.1111/bjh.14214; Oteng-Ntim E, 2015, BLOOD, V125, P3316, DOI 10.1182/blood-2014-11-607317; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; Piel FB, 2013, PLOS MED, V10, DOI DOI 10.1371/JOURNAL.PMED.1001484; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; PLATT OS, 1984, J CLIN INVEST, V74, P652, DOI 10.1172/JCI111464; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POWARS D, 1978, AM J MED, V65, P461, DOI 10.1016/0002-9343(78)90772-6; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; Quinn CT, 2016, AM J HEMATOL, V91, P1195, DOI 10.1002/ajh.24562; Ranque B, 2014, LANCET HAEMATOL, V1, pE64, DOI 10.1016/S2352-3026(14)00007-6; Reardon DA, 2009, BRIT J CANCER, V101, P1995, DOI 10.1038/sj.bjc.6605411; Reeves SL, 2016, JAMA PEDIATR, V170, P550, DOI 10.1001/jamapediatrics.2015.4859; Reid ME, 2014, AM J HEMATOL, V89, P709, DOI 10.1002/ajh.23725; Sachdev V, 2007, J AM COLL CARDIOL, V49, P472, DOI 10.1016/j.jacc.2006.09.038; Saraf SL, 2014, BRIT J HAEMATOL, V164, P729, DOI 10.1111/bjh.12690; Savage WJ, 2015, AM J HEMATOL, V90, P273, DOI 10.1002/ajh.23945; Seck M, 2016, TRANSFUS CLIN BIOL, V23, P98, DOI 10.1016/j.tracli.2015.11.001; Serjeant GR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011783; Sharpe CC, 2014, BLOOD, V123, P3720, DOI 10.1182/blood-2014-02-557439; Shenoy S, 2016, BLOOD, V128, P2561, DOI 10.1182/blood-2016-05-715870; Silva GS, 2006, CEREBROVASC DIS, V21, P38, DOI 10.1159/000089592; Telen MJ, 2016, BLOOD, V127, P810, DOI 10.1182/blood-2015-09-618553; Telen MJ, 2015, BLOOD, V125, P2656, DOI 10.1182/blood-2014-06-583351; Thornburg CD, 2009, PEDIATR BLOOD CANCER, V52, P609, DOI 10.1002/pbc.21738; Tshilolo L, 2008, PUBLIC HEALTH, V122, P933, DOI 10.1016/j.puhe.2007.12.005; Tshilolo L, 2012, ANEMIA, DOI 10.1155/2012/105349; Valadi N, 2006, NEUROLOGY, V67, P572, DOI 10.1212/01.wnl.0000230150.39429.8e; Verlhac S, 2014, PEDIATR RADIOL, V44, P587, DOI 10.1007/s00247-014-2880-9; Vichinsky E, 2013, AM J HEMATOL, V88, P1068, DOI 10.1002/ajh.23569; Vincent L, 2013, BLOOD, V122, P1853, DOI 10.1182/blood-2013-04-498105; Vinchinsky EP, 1995, NEW ENGL J MED, V333, P206; Walters MC, 2016, BIOL BLOOD MARROW TR, V22, P207, DOI 10.1016/j.bbmt.2015.10.017; Wang WC, 2001, J PEDIATR-US, V139, P790, DOI 10.1067/mpd.2001.119590; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Ware RE, 2004, J PEDIATR-US, V145, P346, DOI 10.1016/j.jpeds.2004.04.058; Ware RE, 2016, LANCET, V387, P661, DOI 10.1016/S0140-6736(15)01041-7; Ware RE, 2012, BLOOD, V119, P3925, DOI 10.1182/blood-2011-11-392340; Wood JC, 2005, BLOOD, V106, P1460, DOI 10.1182/blood-2004-10-3982; Wood JC, 2016, BRIT J HAEMATOL, V172, P122, DOI 10.1111/bjh.13791; Wood JC, 2015, AM J HEMATOL, V90, P806, DOI 10.1002/ajh.24089; World Health Organization Regional Office for Africa, 2010, AFRFC608 WHO; Yang XX, 2013, LAB CHIP, V13, P1464, DOI 10.1039/c3lc41302k; Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517; Yee MM, 2011, CLIN J AM SOC NEPHRO, V6, P2628, DOI 10.2215/CJN.01600211; Zhu JQ, 2014, BLOOD, V124, P1146, DOI 10.1182/blood-2013-10-534842; Zimmerman SA, 2004, BLOOD, V103, P2039, DOI 10.1182/blood-2003-07-2475	145	9	9	35	35	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2017	390	10091					311	323		10.1016/S0140-6736(17)30193-9				13	Medicine, General & Internal	General & Internal Medicine	FA5IZ	WOS:000405477900031	28159390				2018-01-05	
J	Baysal, BE; Sharma, S; Hashemikhabir, S; Janga, SC				Baysal, Bora E.; Sharma, Shraddha; Hashemikhabir, Seyedsasan; Janga, Sarath Chandra			RNA Editing in Pathogenesis of Cancer	CANCER RESEARCH			English	Review							B MESSENGER-RNA; GENOME-WIDE IDENTIFICATION; AICARDI-GOUTIERES SYNDROME; SQUAMOUS-CELL CARCINOMA; TO-INOSINE RNA; HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; TUMOR-SUPPRESSOR; ENZYME; GENE	Several adenosine or cytidine deaminase enzymes deaminate transcript sequences in a cell type or environment-dependent manner by a programmed process called RNA editing. RNA editing enzymes catalyze A>I or C>U transcript alterations and have the potential to change protein coding sequences. In this brief review, we highlight some recent work that shows aberrant patterns of RNA editing in cancer. Transcrip-tome sequencing studies reveal increased or decreased global RNA editing levels depending on the tumor type. Altered RNA editing in cancer cells may provide a selective advantage for tumor growth and resistance to apoptosis. RNA editing may promote cancer by dynamically recoding oncogenic genes, regulating oncogenic gene expression by noncoding RNA and miRNA editing, or by transcriptome scale changes in RNA editing levels that may affect innate immune signaling. Although RNA editing markedly increases complexity of the cancer cell transcriptomes, cancer-specific recoding RNA editing events have yet to be discovered. Epitranscriptomic changes by RNA editing in cancer represent a novel mechanism contributing to sequence diversity independently of DNA mutations. Therefore, RNA editing studies should complement genome sequence data to understand the full impact of nucleic acid sequence alterations in cancer.	[Baysal, Bora E.; Sharma, Shraddha] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Hashemikhabir, Seyedsasan; Janga, Sarath Chandra] Indiana Univ Purdue Univ, Sch Informat & Comp, Indianapolis, IN 46202 USA; [Janga, Sarath Chandra] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Janga, Sarath Chandra] Indiana Univ Sch Med, Dept Med & Mol Genet, Med Res & Lib Bldg, Indianapolis, IN 46202 USA	Baysal, BE (reprint author), Roswell Pk Canc Inst, Elm & Carlton St, Buffalo, NY 14261 USA.	bora.baysal@roswellpark.org			Roswell Park Cancer Institute; School of Informatics and Computing at Indiana University Purdue University	This work was supported by funds from Roswell Park Cancer Institute (B.E. Baysal) and the School of Informatics and Computing at Indiana University Purdue University (S.C. Janga).	Anadon C, 2016, ONCOGENE, V35, P4407, DOI 10.1038/onc.2015.469; Beghini A, 2000, HUM MOL GENET, V9, P2297, DOI 10.1093/oxfordjournals.hmg.a018921                                              ; Blanc V, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r79; Cappione AJ, 1997, AM J HUM GENET, V60, P305; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Chan THM, 2016, GASTROENTEROLOGY, V151, P637, DOI 10.1053/j.gastro.2016.06.043; Chan THM, 2014, GUT, V63, P832, DOI 10.1136/gutjnl-2012-304037; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chen YB, 2017, INT J ONCOL, V50, P622, DOI 10.3892/ijo.2016.3823; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Daniel C, 2015, BIOCHIMIE, V117, P22, DOI 10.1016/j.biochi.2015.05.020; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gumireddy K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10715; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Han SW, 2014, J EXP MED, V211, P613, DOI 10.1084/jem.20132209; Higuchi M, 2000, NATURE, V406, P78; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kang L, 2015, GENOMICS, V105, P76, DOI 10.1016/j.ygeno.2014.11.005; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Licht K, 2016, J CELL BIOL, V213, P15, DOI 10.1083/jcb.201511041; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Mukhopadhyay D, 2002, AM J HUM GENET, V70, P38, DOI 10.1086/337952                                                                  ; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Ohlson J, 2007, RNA, V13, P698, DOI 10.1261/rna.349107; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Qin YR, 2014, CANCER RES, V74, P840, DOI 10.1158/0008-5472.CAN-13-2545; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; Sharma S, 2017, RNA BIOL, V14, P603, DOI 10.1080/15476286.2016.1184387; Sharma S, 2017, HUM MOL GENET, V26, P1328, DOI 10.1093/hmg/ddx041; Sharma S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39100; Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7881; Shimokawa T, 2013, RNA BIOL, V10, P321, DOI 10.4161/rna.23343; Shoshan E, 2015, NAT CELL BIOL, V17, P311, DOI 10.1038/ncb3110; Skuse GR, 1996, NUCLEIC ACIDS RES, V24, P478, DOI 10.1093/nar/24.3.478                                                            ; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Takahashi M, 2006, NEOPLASIA, V8, P1003, DOI 10.1593/neo.06595; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765                                                   ; Yeo JC, 2010, P NATL ACAD SCI USA, V107, P20715, DOI 10.1073/pnas.1009231107; Zhang LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23226; Zipeto MA, 2016, CELL STEM CELL, V19, P177, DOI 10.1016/j.stem.2016.05.004	51	0	0	4	4	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	JUL 15	2017	77	14					3733	3739		10.1158/0008-5472.CAN-17-0520				7	Oncology	Oncology	FA8DX	WOS:000405677500002	28667076				2018-01-05	
J	Wang, SH; Tang, NH; Lara-Gonzalez, P; Zhao, ZL; Cheerambathur, DK; Prevo, B; Chisholm, AD; Desai, A; Oegema, K				Wang, Shaohe; Tang, Ngang Heok; Lara-Gonzalez, Pablo; Zhao, Zhiling; Cheerambathur, Dhanya K.; Prevo, Bram; Chisholm, Andrew D.; Desai, Arshad; Oegema, Karen			A toolkit for GFP-mediated tissue-specific protein degradation in C. elegans	DEVELOPMENT			English	Article						Protein degradation; C. elegans; ZIF-1; GFP nanobody; vhhGFP4	CAENORHABDITIS-ELEGANS; AXON REGENERATION; GAMMA-TUBULIN; GATA-FACTOR; SYSTEM; CELLS; RECOMBINATION; INTESTINE; DEPLETION; LINEAGES	Proteins that are essential for embryo production, cell division and early embryonic events are frequently reused later in embryogenesis, during organismal development or in the adult. Examining protein function across these different biological contexts requires tissue-specific perturbation. Here, we describe a method that uses expression of a fusion between a GFP-targeting nanobody and a SOCS-box containing ubiquitin ligase adaptor to target GFP-tagged proteins for degradation. When combined with endogenous locus GFP tagging by CRISPR-Cas9 or with rescue of a null mutant with a GFP fusion, this approach enables routine and efficient tissue-specific protein ablation. We show that this approach works in multiple tissues - the epidermis, intestine, body wall muscle, ciliated sensory neurons and touch receptor neurons - where it recapitulates expected loss-of-function mutant phenotypes. The transgene toolkit and the strain set described here will complement existing approaches to enable routine analysis of the tissue-specific roles of C. elegans proteins.	[Wang, Shaohe; Lara-Gonzalez, Pablo; Zhao, Zhiling; Cheerambathur, Dhanya K.; Prevo, Bram; Desai, Arshad; Oegema, Karen] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Tang, Ngang Heok; Chisholm, Andrew D.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Wang, Shaohe] Natl Inst Dent & Craniofacial Res, Cell Biol Sect, NIH, Bethesda, MD 20892 USA	Oegema, K (reprint author), Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	koegema@ucsd.edu		Tang, Ngang Heok/0000-0002-0977-0816; Oegema, Karen/0000-0001-8515-7514	National Institutes of Health [GM074207, NS093588]; Ludwig Institute for Cancer Research	This work was supported by grants from the National Institutes of Health to K.O. (GM074207) and A.D.C. (NS093588). A.D. and K.O. receive salary and other support from the Ludwig Institute for Cancer Research. Deposited in PMC for release after 12 months.	Armenti ST, 2014, DEVELOPMENT, V141, P4640, DOI 10.1242/dev.115048; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Chen LZ, 2011, NEURON, V71, P1043, DOI 10.1016/j.neuron.2011.07.009; Collet J, 1998, GENETICS, V148, P187; DEPPE U, 1978, P NATL ACAD SCI USA, V75, P376, DOI 10.1073/pnas.75.1.376                                                           ; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; Dickinson DJ, 2015, GENETICS, V200, P1035, DOI 10.1534/genetics.115.178335; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Feldman JL, 2012, CURR BIOL, V22, P575, DOI 10.1016/j.cub.2012.02.044; FIRE A, 1989, EMBO J, V8, P3419; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7                                                   ; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Huang T, 2001, MOL CELL BIOL, V21, P1111, DOI 10.1128/MCB.21.4.1111-1120.2001; Hubbard EJA, 2014, METHODS, V68, P417, DOI 10.1016/j.ymeth.2014.05.007; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Paix A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw502; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Shen ZF, 2014, DEV CELL, V30, P625, DOI 10.1016/j.devcel.2014.07.017; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751                                                           ; Wang S., 2015, COMPUT MATH METHOD M, V2015, P1, DOI DOI 10.1016/J.EC0C0M.2015.04.004; Wu Q, 2017, ACS CHEM BIOL, V12, P664, DOI 10.1021/acschembio.6b00998; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Zhang LY, 2015, DEVELOPMENT, V142, P4374, DOI 10.1242/dev.129635	31	0	0	11	11	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	JUL 15	2017	144	14					2694	2701		10.1242/dev.150094				8	Developmental Biology	Developmental Biology	FA8MV	WOS:000405701000016	28619826				2018-01-05	
J	Wang, JK; Pan, Y; Shen, SH; Lin, L; Xing, Y				Wang, Jinkai; Pan, Yang; Shen, Shihao; Lin, Lan; Xing, Yi			rMATS- DVR: rMATS discovery of differential variants in RNA	BIOINFORMATICS			English	Article							SEQ DATA; DATABASE	Motivation: RNA sequences of a gene can have single nucleotide variants (SNVs) due to single nucleotide polymorphisms (SNPs) in the genome, or RNA editing events within the RNA. By comparing RNA-seq data of a given cell type before and after a specific perturbation, we can detect and quantify SNVs in the RNA and discover SNVs with altered frequencies between distinct cellular states. Such differential variants in RNA (DVRs) may reflect allele-specific changes in gene expression or RNA processing, as well as changes in RNA editing in response to cellular perturbations or stimuli. Results: We have developed rMATS-DVR, a convenient and user-friendly software program to streamline the discovery of DVRs between two RNA-seq sample groups with replicates. rMATSDVR combines a stringent GATK-based pipeline for calling SNVs including SNPs and RNA editing events in RNA-seq reads, with our rigorous rMATS statistical model for identifying differential isoform ratios using RNA-seq sequence count data with replicates. We applied rMATS-DVR to RNAseq data of the human chronic myeloid leukemia cell line K562 in response to shRNA knockdown of the RNA editing enzyme ADAR1. rMATS-DVR discovered 1372 significant DVRs between knockdown and control. These DVRs encompassed known SNPs and RNA editing sites as well as novel SNVs, with the majority of DVRs corresponding to known RNA editing sites repressed after ADAR1 knockdown. Availability and Implementation: rMATS-DVR is at https://github. com/Xinglab/rMATS-DVR. Contact: yxing@ ucla. edu Supplementary information: Supplementary data are available at Bioinformatics online.	[Wang, Jinkai; Pan, Yang; Shen, Shihao; Lin, Lan; Xing, Yi] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	Xing, Y (reprint author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	yxing@ucla.edu			National Institutes of Health [R01GM088342, R01GM117624]	National Institutes of Health (R01GM088342 & R01GM117624 to Y. X.).	Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; Lee JH, 2013, RNA, V19, P725, DOI 10.1261/rna.037903.112; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Piskol R, 2013, AM J HUM GENET, V93, P641, DOI 10.1016/j.ajhg.2013.08.008; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002	10	0	0	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	JUL 15	2017	33	14					2216	2217		10.1093/bioinformatics/btx128				2	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	FA2RS	WOS:000405289100073	28334241				2018-01-05	
J	Bahceci, I; Dogrusoz, U; La, KC; Babur, O; Gao, JJ; Schultz, N				Bahceci, Istemi; Dogrusoz, Ugur; La, Konnor C.; Babur, Ozgun; Gao, Jianjiong; Schultz, Nikolaus			PathwayMapper: a collaborative visual web editor for cancer pathways and genomic data	BIOINFORMATICS			English	Article								Motivation: While existing network visualization tools enable the exploration of cancer genomics data, most biologists prefer simplified, curated pathway diagrams, such as those featured in many manuscripts from The Cancer Genome Atlas (TCGA). These pathway diagrams typically summarize how a pathway is altered in individual cancer types, including alteration frequencies for each gene. Results: To address this need, we developed the web-based tool PathwayMapper, which runs in most common web browsers. It can be used for viewing pre-curated cancer pathways, or as a graphical editor for creating new pathways, with the ability to overlay genomic alteration data from cBioPortal. In addition, a collaborative mode is available that allows scientists to co-operate interactively on constructing pathways, with support for concurrent modifications and built-in conflict resolution.	[Bahceci, Istemi; Dogrusoz, Ugur] Bilkent Univ, Dept Comp Engn, TR-06800 Ankara, Turkey; [La, Konnor C.] Triinst Program Computat Biol & Med, New York, NY 10065 USA; [Babur, Ozgun] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97239 USA; [Gao, Jianjiong; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Marie Jose & Henry R Kravis Ctr Mol Oncol, New York, NY 10065 USA; [Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA	Dogrusoz, U (reprint author), Bilkent Univ, Dept Comp Engn, TR-06800 Ankara, Turkey.	ivis@cs.bilkent.edu.tr			Marie-Josee and Henry R. Kravis Center for Molecular Oncology; National Cancer Institute Cancer Center Core Grant [P30CA008748]; Robertson Foundation; Prostate Cancer Foundation; Google Summer of Code program	This work was supported by the Marie-Josee and Henry R. Kravis Center for Molecular Oncology, a National Cancer Institute Cancer Center Core Grant (P30CA008748), the Robertson Foundation, and the Prostate Cancer Foundation. We are also grateful for the support of the Google Summer of Code program.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Dogrusoz U, 2009, INFORM SCIENCES, V179, P980, DOI 10.1016/j.ins.2008.11.017; Franz M, 2016, BIOINFORMATICS, V32, P309, DOI 10.1093/bioinformatics/btv557; Gao, 2013, SCI SIGNAL, V6, ppl1; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; [Anonymous], 2008, NATURE, V455, P1061, DOI DOI 10.1038/NATURE07385; The Cancer Genome Atlas Research Network, 2012, NATURE, V487, P330, DOI DOI 10.1038/NATURE11252; Villaveces Jose M, 2015, Adv Appl Bioinform Chem, V8, P11, DOI 10.2147/AABC.S63534	16	0	0	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	JUL 15	2017	33	14					2238	2240		10.1093/bioinformatics/btx149				3	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	FA2RS	WOS:000405289100081	28334343				2018-01-05	
J	Agrawal, SA; Burgoyne, T; Eblimit, A; Bellingham, J; Parfitt, DA; Lane, A; Nichols, R; Asomugha, C; Hayes, MJ; Munro, PM; Xu, MC; Wang, KQ; Futter, CE; Li, YM; Chen, R; Cheetham, ME				Agrawal, Smriti A.; Burgoyne, Thomas; Eblimit, Aiden; Bellingham, James; Parfitt, David A.; Lane, Amelia; Nichols, Ralph; Asomugha, Chinwe; Hayes, Matthew J.; Munro, Peter M.; Xu, Mingchu; Wang, Keqing; Futter, Clare E.; Li, Yumei; Chen, Rui; Cheetham, Michael E.			REEP6 deficiency leads to retinal degeneration through disruption of ER homeostasis and protein trafficking	HUMAN MOLECULAR GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; RETINITIS-PIGMENTOSA; PHOTORECEPTOR CELLS; MOUSE MODEL; MUTATIONS; LOCALIZATION; RHODOPSIN; DISEASES; DYSFUNCTION; ACTIVATION	Retinitis pigmentosa (RP) is the most common form of inherited retinal dystrophy. We recently identified mutations in REEP6, which encodes the receptor expression enhancing protein 6, in several families with autosomal recessive RP. REEP6 is related to the REEP and Yop1p family of ER shaping proteins and potential receptor accessory proteins, but the role of REEP6 in the retina is unknown. Here we characterize the disease mechanisms associated with loss of REEP6 function using a Reep6 knockout mouse generated by CRISPR/Cas9 gene editing. In control mice REEP6 was localized to the inner segment and outer plexiform layer of rod photoreceptors. The Reep6(-/-)mice exhibited progressive photoreceptor degeneration from P20 onwards. Ultrastructural analyses at P20 by transmission electron microscopy and 3Viewserial block face scanning EM revealed an expansion of the distal ER in the Reep(6-/-)rods and an increase in their number of mitochondria. Electroretinograms revealed photoreceptor dysfunction preceded degeneration, suggesting potential defects in phototransduction. There was no effect on the traffic of rhodopsin, Rom1 or peripherin/rds; however, the retinal guanylate cyclases GC1 and GC2were severely affected in the Reep6 knockout animals, with almost undetectable expression. These changes correlated with an increase in C/EBP homologous protein (CHOP) expression and the activation of caspase 12, suggesting that ER stress contributes to cell death. Collectively, these data suggest that REEP6 plays an essential role inmaintaining cGMP homeostasis though facilitating the stability and/or trafficking of guanylate cyclases and maintaining ER and mitochondrial homeostasis.	[Agrawal, Smriti A.; Eblimit, Aiden; Xu, Mingchu; Wang, Keqing; Li, Yumei; Chen, Rui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Agrawal, Smriti A.; Eblimit, Aiden; Xu, Mingchu; Wang, Keqing; Li, Yumei; Chen, Rui] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Burgoyne, Thomas; Bellingham, James; Parfitt, David A.; Lane, Amelia; Hayes, Matthew J.; Munro, Peter M.; Futter, Clare E.; Cheetham, Michael E.] UCL Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England; [Nichols, Ralph] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Asomugha, Chinwe] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Chen, R (reprint author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Chen, R (reprint author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.; Cheetham, ME (reprint author), UCL Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England.	ruichen@bcm.edu; michael.cheetham@ucl.ac.uk		Futter, Clare/0000-0001-5559-9389	Foundation Fighting Blindness [BR-GE-0613-0618-BCM]; National Eye Institute [R01EY022356, R01EY020540, 5T32EY007102]; Baylor College of Medicine Ophthalmology Core [5P30EY002520-32]; Wellcome Trust [092621, 093445]; Fight for Sight; UCL; Wellcome Trust	Foundation Fighting Blindness (BR-GE-0613-0618-BCM) and National Eye Institute (R01EY022356, R01EY020540) to R.C.; 5T32EY007102-23 to S.A. (PI: Dr Graeme Mardon); Baylor College of Medicine Ophthalmology Core (5P30EY002520-32) for TEM imaging; Wellcome Trust (092621 to M.E.C. and 093445 to C.E.F.); Fight for Sight to M.E.C. Funding to pay the Open Access publication charges for this article was provided by UCL with funds from the Wellcome Trust.	Arno G, 2016, AM J HUM GENET, V99, P1305, DOI 10.1016/j.ajhg.2016.10.008; Athanasiou D, 2013, FEBS LETT, V587, P2008, DOI 10.1016/j.febslet.2013.05.020; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Bales KL, 2016, EXP EYE RES, V150, P71, DOI 10.1016/j.exer.2015.11.007; Beetz C, 2013, J CLIN INVEST, V123, P4273, DOI 10.1172/JCI65665; Beetz C, 2012, AM J HUM GENET, V91, P139, DOI 10.1016/j.ajhg.2012.05.007; Bjork S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076366; Bok D, 2007, ARCH OPHTHALMOL-CHIC, V125, P160, DOI 10.1001/archopht.125.2.160; Boye S.E., 2014, COLD SPRING HARB PER, V5; Broillet MC, 1999, ANN NY ACAD SCI, V868, P730, DOI 10.1111/j.1749-6632.1999.tb11352.x; Chan P, 2016, BRAIN RES, V1648, P538, DOI 10.1016/j.brainres.2016.04.021; Chiang WC, 2016, ADV EXP MED BIOL, V854, P185, DOI 10.1007/978-3-319-17121-0_25; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151                                                      ; de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575; Eblimit A, 2015, HUM MOL GENET, V24, P1584, DOI 10.1093/hmg/ddu573; Ferrari S., 2011, GENOMICS, V12, P238, DOI DOI 10.2174/138920211795860107; Fu Y, 2007, EUR J PHYSL, V454, P805; Gorbatyuk M.S., 2013, J GENET SYNDR GENE T, V4; Gross OP, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00006; Hao H, 2014, HUM MOL GENET, V23, P4260, DOI 10.1093/hmg/ddu143; Hunt DM, 2010, MOL CELL BIOCHEM, V334, P157, DOI 10.1007/s11010-009-0331-y; Hurt CM, 2014, BRAIN RES, V1545, P12, DOI 10.1016/j.brainres.2013.12.008; Kaden T.R., 2013, ASIA PAC J OPHTHALMO, V2; Koch KW, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00067; Kohl S, 2015, NAT GENET, V47, P757, DOI 10.1038/ng.3319; Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721; Lim YS, 2015, ANN NEUROL, V78, P679, DOI 10.1002/ana.24488; Lobo GP, 2016, ADV EXP MED BIOL, V854, P223, DOI 10.1007/978-3-319-17121-0_30; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Ma HW, 2015, J BIOL CHEM, V290, P20880, DOI 10.1074/jbc.M115.641159; Molday LL, 2013, HUM MOL GENET, V22, P3894, DOI 10.1093/hmg/ddt244; Molday RS, 2015, J CELL SCI, V128, P4039, DOI 10.1242/jcs.175687; Nash BM, 2015, TRANSL PEDIATR, V4, P139, DOI 10.3978/j.issn.2224-4336.2015.04.03; Nemet Ina, 2015, Prog Mol Biol Transl Sci, V132, P39, DOI 10.1016/bs.pmbts.2015.02.007; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Pearring JN, 2015, ELIFE, V4, DOI 10.7554/eLife.12058; Pearring JN, 2013, PROG RETIN EYE RES, V36, P24, DOI 10.1016/j.preteyeres.2013.03.002; Riaz M, 2016, DEV OPHTHALMOL, V55, P57, DOI 10.1159/000431142; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348; Sato H, 2005, INVEST OPHTH VIS SCI, V46, P791, DOI 10.1167/iovs.04-0867; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Tsang SH, 2008, AM J OPHTHALMOL, V146, P780, DOI 10.1016/j.ajo.2008.06.017; Tucker CL, 2004, MOL VIS, V10, P297; West JB, 2010, RESP PHYSIOL NEUROBI, V170, P202, DOI 10.1016/j.resp.2009.12.010; Xu MC, 2015, INVEST OPHTH VIS SCI, V56, P3889, DOI 10.1167/iovs.15-16778; Zhang SX, 2014, EXP EYE RES, V125, P30, DOI 10.1016/j.exer.2014.04.015	50	0	0	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	JUL 15	2017	26	14					2667	2677		10.1093/hmg/ddx149				11	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FA0DT	WOS:000405102100007	28475715				2018-01-05	
J	Midic, U; Hung, PH; Vincent, KA; Goheen, B; Schupp, PG; Chen, DD; Bauer, DE; VandeVoort, CA; Latham, KE				Midic, Uros; Hung, Pei-Hsuan; Vincent, Kailey A.; Goheen, Benjamin; Schupp, Patrick G.; Chen, Diane D.; Bauer, Daniel E.; VandeVoort, Catherine A.; Latham, Keith E.			Quantitative assessment of timing, efficiency, specificity and genetic mosaicism of CRISPR/Cas9-mediated gene editing of hemoglobin beta gene in rhesus monkey embryos	HUMAN MOLECULAR GENETICS			English	Article							SICKLE-CELL-DISEASE; CYNOMOLGUS MONKEY; MOUSE ZYGOTES; CAS9; GENERATION; SYSTEM; DNA	Gene editing technologies offer new options for developing novel biomedical research models and for gene and stem cell based therapies. However, applications in many species demand high efficiencies, specificity, and a thorough understanding of likely editing outcomes. To date, overall efficiencies, rates of off-targeting and degree of genetic mosaicism have not been well-characterized for most species, limiting our ability to optimize methods. As a model gene for measuring these parameters of the CRISPR/Cas9 application in a primate species (rhesus monkey), we selected the beta-hemoglobin gene (HBB), which also has high relevance to the potential application of gene editing and stem-cell technologies for treating human disease. Our data demonstrate an ability to achieve a high efficiency of gene editing in rhesus monkey zygotes, with no detected off-target effects at selected off-target loci. Considerable genetic mosaicism and variation in the fraction of embryonic cells bearing targeted alleles are observed, and the timing of editing events is revealed using a new model. The uses of Cas9-WT protein combined with optimized concentrations of sgRNAs are two likely areas for further refinement to enhance efficiency while limiting unfavorable outcomes that can be exceedingly costly for application of gene editing in primate species.	[Midic, Uros; Vincent, Kailey A.; Goheen, Benjamin; Latham, Keith E.] Michigan State Univ, Dept Anim Sci, 474 S Shaw Lane,Room 1230E, E Lansing, MI 48824 USA; [Midic, Uros; Vincent, Kailey A.; Goheen, Benjamin; Latham, Keith E.] Michigan State Univ, Reprod & Dev Sci Program, 474 S Shaw Lane,Room 1230E, E Lansing, MI 48824 USA; [Hung, Pei-Hsuan; VandeVoort, Catherine A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Hung, Pei-Hsuan; VandeVoort, Catherine A.] Univ Calif Davis, Dept Obstet & Gynecol, Davis, CA 95616 USA; [Schupp, Patrick G.; Chen, Diane D.; Bauer, Daniel E.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Bauer, Daniel E.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Bauer, Daniel E.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Bauer, Daniel E.] Harvard Univ, Harvard Stem Cell Inst, Boston, MA 02115 USA	Latham, KE (reprint author), Michigan State Univ, Dept Anim Sci, 474 S Shaw Lane,Room 1230E, E Lansing, MI 48824 USA.; Latham, KE (reprint author), Michigan State Univ, Reprod & Dev Sci Program, 474 S Shaw Lane,Room 1230E, E Lansing, MI 48824 USA.	lathamk1@msu.edu			National Institutes of Health, Office of Research Infrastructure Programs, Division of Comparative Medicine [R24 OD-012221, OD011107, OD010967]; MSU AgBioResearch; National Institute of Diabetes and Digestive and Kidney Disease [K08-DK093705]; Burroughs Wellcome Fund; American Society of Hematology; Charles H. Hood Foundation; Cooley's Anemia Foundation; Michigan State University	Grants from the National Institutes of Health, Office of Director, Office of Research Infrastructure Programs, Division of Comparative Medicine Grants R24 OD-012221 (to K.E.L.), and OD011107 (California National Primate Research Center) and OD010967 (to C.A.V.), by MSU AgBioResearch and Michigan State University (K.E.L), by a grant from the National Institute of Diabetes and Digestive and Kidney Disease K08-DK093705 (to D.E.B.), and by grants from the Burroughs Wellcome Fund, American Society of Hematology, Charles H. Hood Foundation, and Cooley's Anemia Foundation (D.E.B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen YC, 2015, HUM MOL GENET, V24, P3764, DOI 10.1093/hmg/ddv120; Chen YC, 2015, CELL RES, V25, P262, DOI 10.1038/cr.2014.167; de Prada JKN, 2008, J ASSIST REPROD GEN, V25, P145, DOI 10.1007/s10815-008-9208-3; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; Hoban MD, 2016, BLOOD, V127, P839, DOI 10.1182/blood-2015-09-618587; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jung CJ, 2017, TRANSGENIC RES, V26, P263, DOI 10.1007/s11248-016-9998-5; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Kang Y, 2015, HUM MOL GENET, V24, P7255, DOI 10.1093/hmg/ddv425; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mashiko D, 2014, DEV GROWTH DIFFER, V56, P122, DOI 10.1111/dgd.12113; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mizuno S, 2014, MAMM GENOME, V25, P327, DOI 10.1007/s00335-014-9524-0; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2                                                   ; Tu ZC, 2017, SCI REP-UK, V7, DOI 10.1038/srep42081; VandeVoort CA, 2011, FERTIL STERIL, V96, P203, DOI 10.1016/j.fertnstert.2011.05.016; Wan HF, 2015, CELL RES, V25, P258, DOI 10.1038/cr.2014.158; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017	25	0	0	31	31	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	JUL 15	2017	26	14					2678	2689		10.1093/hmg/ddx154				12	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FA0DT	WOS:000405102100008	28444193				2018-01-05	
J	Li, HQ; Pei, WH; Vergarajauregui, S; Zerfas, PM; Raben, N; Burgess, SM; Puertollano, R				Li, Huiqing; Pei, Wuhong; Vergarajauregui, Sivia; Zerfas, Patricia M.; Raben, Nina; Burgess, Shawn M.; Puertollano, Rosa			Novel degenerative and developmental defects in a zebrafish model of mucolipidosis type IV	HUMAN MOLECULAR GENETICS			English	Article							ZINC-FINGER TARGETER; MOUSE MODEL; LYSOSOMAL EXOCYTOSIS; NATURAL-HISTORY; MOTOR DEFICIT; HAIR-CELLS; CHANNEL; TRPML1; VULNERABILITY; CLEARANCE	Mucolipidosis type IV (MLIV) is a lysosomal storage disease characterized by neurologic and ophthalmologic abnormalities. There is currently no effective treatment. MLIV is caused by mutations in MCOLN1, a lysosomal cation channel from the transient receptor potential (TRP) family. In this study, we used genome editing to knockout the two mcoln1 genes present in Danio rerio (zebrafish). Our model successfully reproduced the retinal and neuromuscular defects observed in MLIV patients, indicating that this model is suitable for studying the disease pathogenesis. Importantly, our model revealed novel insights into the origins and progression of the MLIV pathology, including the contribution of autophagosome accumulation to muscle dystrophy and the role of mcoln1 in embryonic development, hair cell viability and cellular maintenance. The generation of a MLIV model in zebrafish is particularly relevant given the suitability of this organism for large-scale in vivo drug screening, thus providing unprecedented opportunities for therapeutic discovery.	[Li, Huiqing; Vergarajauregui, Sivia; Puertollano, Rosa] NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Pei, Wuhong; Burgess, Shawn M.] NHGRI, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA; [Vergarajauregui, Sivia] Friedrich Alexander Univ Erlangen Nurnberg, Expt Renal & Cardiovasc Res, Dept Nephropathol, Inst Pathol, Erlangen, Germany; [Zerfas, Patricia M.] NIH, Off Res Serv, Div Vet Resources, Bldg 10, Bethesda, MD 20892 USA; [Raben, Nina] NIAMSD, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA	Puertollano, R (reprint author), NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	puertolr@mail.nih.gov			National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI)	Intramural Research Program of the National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI).	Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306                                                            ; AMIR N, 1987, PEDIATRICS, V79, P953; Anderson JE, 2012, METHODS MOL BIOL, V798, P85, DOI 10.1007/978-1-61779-343-1_6; Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; Behra M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000455; Benini A, 2013, INT J DEV BIOL, V57, P85, DOI 10.1387/ijdb.120033gb; BERMAN ER, 1974, J PEDIATR-US, V84, P519, DOI 10.1016/S0022-3476(74)80671-2; Bottger EC, 2013, HEARING RES, V303, P12, DOI 10.1016/j.heares.2013.01.006; Bonavita S, 2003, J CHILD NEUROL, V18, P443, DOI 10.1177/08830738030180070701; Cheng XP, 2014, NAT MED, V20, P1187, DOI 10.1038/nm.3611; CHITAYAT D, 1991, AM J MED GENET, V41, P313, DOI 10.1002/ajmg.1320410310; Coblentz J, 2014, BIOCHEM J, V457, P361, DOI 10.1042/BJ20130647; Cuajungco MP, 2014, TRAFFIC, V15, P1247, DOI 10.1111/tra.12205; Curcio-Morelli C, 2010, NEUROBIOL DIS, V40, P370, DOI 10.1016/j.nbd.2010.06.010; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Eichelsdoerfer JL, 2010, J BIOL CHEM, V285, P34304, DOI 10.1074/jbc.C110.165480; Esterberg R, 2014, J NEUROSCI, V34, P9703, DOI 10.1523/JNEUROSCI.0281-14.2014; Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/88281; Frei KP, 1998, NEUROLOGY, V51, P565, DOI 10.1212/WNL.51.2.565                                                            ; Froehlicher M, 2009, AQUAT TOXICOL, V95, P307, DOI 10.1016/j.aquatox.2009.04.007; Grishchuk Y, 2016, AM J PATHOL, V186, P199, DOI 10.1016/j.ajpath.2015.09.017; Grishchuk Y, 2015, DIS MODEL MECH, V8, P1591, DOI 10.1242/dmm.021154; Grishchuk Y, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0133-7; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; King KA, 2014, EAR HEARING, V35, P110, DOI 10.1097/AUD.0b013e3182a362b8; Kukic I, 2013, BIOCHEM J, V451, P155, DOI [10.1042/BJ20121506, 10.1042/5J20121506]; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Miragoli M, 2016, CELL REP, V14, P140, DOI 10.1016/j.celrep.2015.12.014; Owens KN, 2007, J COMP NEUROL, V502, P522, DOI 10.1002/cne.21345; Pei Wuhong, 2016, Cell Regen (Lond), V5, P3; Piotrowski T, 2014, DEV BIOL, V389, P68, DOI 10.1016/j.ydbio.2014.02.016; Puertollano R, 2009, AM J PHYSIOL-RENAL, V296, pF1245, DOI 10.1152/ajprenal.90522.2008; Raben N, 2016, ANNU REV CELL DEV BI, V32, P255, DOI 10.1146/annurev-cellbio-111315-125407; Raben N, 2009, METHOD ENZYMOL, V453, P417, DOI 10.1016/S0076-6879(08)04021-4; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Schiffmann R, 1998, P NATL ACAD SCI USA, V95, P1207, DOI 10.1073/pnas.95.3.1207; Sha SH, 2001, HEARING RES, V155, P1, DOI 10.1016/S0378-5955(01)00224-6                                                   ; Shea L, 2009, INT J CLIN PHARM TH, V47, pS42; Smith JA, 2002, OPHTHALMOLOGY, V109, P588, DOI 10.1016/S0161-6420(01)00968-X                                                   ; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; TELLEZNAGEL I, 1976, ARCH NEUROL-CHICAGO, V33, P828, DOI 10.1001/archneur.1976.00500120032005                                            ; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Vergarajauregui S, 2008, HUM MOL GENET, V17, P2723, DOI 10.1093/hmg/ddn174; Wada H, 2015, DEV GROWTH DIFFER, V57, P169, DOI 10.1111/dgd.12196; Wakabayashi K, 2011, MOL GENET METAB, V104, P206, DOI 10.1016/j.ymgme.2011.06.006; Walker MT, 2016, HUM MOL GENET, V25, P2752, DOI 10.1093/hmg/ddw132; Whitfield TT, 2002, J NEUROBIOL, V53, P157, DOI 10.1002/neu.10123; Wold SM, 2010, INT J PEDIATR OTORHI, V74, P27, DOI 10.1016/j.ijporl.2009.09.042; Zhang XZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10938	60	0	0	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	JUL 15	2017	26	14					2701	2718		10.1093/hmg/ddx158				18	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FA0DT	WOS:000405102100010	28449103				2018-01-05	
J	Guo, HD; Chu, YJ; Wang, L; Chen, X; Chen, YP; Cheng, H; Zhang, L; Zhou, Y; Yang, FC; Cheng, T; Xu, MJ; Zhang, XB; Zhou, JF; Yuan, WP				Guo, Huidong; Chu, Yajing; Wang, Le; Chen, Xing; Chen, Yangpeng; Cheng, Hui; Zhang, Lei; Zhou, Yuan; Yang, Feng-Chun; Cheng, Tao; Xu, Mingjiang; Zhang, Xiaobing; Zhou, Jianfeng; Yuan, Weiping			PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia	INTERNATIONAL JOURNAL OF CANCER			English	Article						PBX3; leukemia stem cell; epigenetic modification; MLL	ACUTE MYELOID-LEUKEMIA; H3K79 METHYLATION; DOT1L INHIBITOR; MEIS1 COOPERATE; HOMEOBOX GENES; MLL-AF9; HOXA9; IDENTIFICATION; PROLIFERATION; TRANSCRIPTION	Interaction of HOXA9/MEIS1/PBX3 is responsible for hematopoietic system transformation in MLL-rearranged (MLL-r) leukemia. Of these genes, HOXA9 has been shown to be critical for leukemia cell survival, while MEIS1 has been identified as an essential regulator for leukemia stem cell (LSC) maintenance. Although significantly high expression of PBX3 was observed in clinical acute myeloid leukemia (AML) samples, the individual role of PBX3 in leukemia development is still largely unknown. In this study, we explored the specific role of PBX3 and its associated regulatory network in leukemia progression. By analyzing the clinical database, we found that the high expression of PBX3 is significantly correlated with a poor prognosis in AML patients. ChIP-Seq/qPCR analysis in MLL-r mouse models revealed aberrant epigenetic modifications with increased H3K79me2, and decreased H3K9me3 and H3K27me3 levels in LSCs, which may account for the high expression levels of Pbx3. To further examine the role of Pbx3 in AML maintenance and progression, we used the CRISPR/Cas9 system to delete Pbx3 in leukemic cells in the MLL-AF9 induced AML mouse model. We found that Pbx3 deletion significantly prolonged the survival of leukemic mice and decreased the leukemia burden by decreasing the capacity of LSCs and promoting LSC apoptosis. In conclusion, we found that PBX3 is epigenetically aberrant in the LSCs of MLL-r AML and is essential for leukemia development. Significantly, the differential expression of PBX3 in normal and malignant hematopoietic cells suggests PBX3 as a potential prognostic marker and therapeutic target for MLL-r leukemia.	[Guo, Huidong; Chu, Yajing; Wang, Le; Chen, Yangpeng; Cheng, Hui; Zhang, Lei; Zhou, Yuan; Yang, Feng-Chun; Cheng, Tao; Xu, Mingjiang; Zhang, Xiaobing; Zhou, Jianfeng; Yuan, Weiping] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Guo, Huidong; Chu, Yajing; Wang, Le; Chen, Yangpeng; Cheng, Hui; Zhang, Lei; Zhou, Yuan; Yang, Feng-Chun; Cheng, Tao; Xu, Mingjiang; Zhang, Xiaobing; Zhou, Jianfeng; Yuan, Weiping] Chinese Acad Med Sci, Blood Dis Hosp, Dept Stem Cell & Regenerat Med, Tianjin, Peoples R China; [Guo, Huidong; Chu, Yajing; Wang, Le; Chen, Yangpeng; Cheng, Hui; Zhang, Lei; Zhou, Yuan; Yang, Feng-Chun; Cheng, Tao; Xu, Mingjiang; Zhang, Xiaobing; Zhou, Jianfeng; Yuan, Weiping] Peking Union Med Coll, Tianjin, Peoples R China; [Chen, Xing; Zhou, Jianfeng] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hematol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Yang, Feng-Chun; Xu, Mingjiang] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Zhang, Xiaobing] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA	Zhou, JF (reprint author), Tongji Hosp, Dept Hematol, Tongji Med Coll, Wuhan, Hubei, Peoples R China.; Yuan, WP (reprint author), Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China.; Yuan, WP (reprint author), Blood Dis Hosp, Tianjin, Peoples R China.	wpyuan@ihcams.ac.cn; wpyuan@ihcams.ac.cn			Ministry of Science and Technology of China [2016YFA0100600]; CAMS Initiative for Innovative Medicine CAMS-I2M [2016-I2M-1-017, 2016GH3100001]; National Nature Science Foundation of China [81629001, 81600136, 81421002, 81470280, 81090414]	Grant sponsor: Ministry of Science and Technology of China; Grant number: 2016YFA0100600; Grant sponsor: CAMS Initiative for Innovative Medicine CAMS-I2M; Grant numbers: 2016-I2M-1-017 and 2016GH3100001; Grant sponsor: National Nature Science Foundation of China; Grant numbers: 81629001, 81600136, 81421002, 81470280 and 81090414	Albert M, 2010, SEMIN CELL DEV BIOL, V21, P209, DOI 10.1016/j.semcdb.2009.10.007; Ballabio Erica, 2012, Cancers (Basel), V4, P904, DOI 10.3390/cancers4030904; Bates S, 1999, CELL MOL LIFE SCI, V55, P28, DOI 10.1007/s000180050267; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Chen L, 2013, LEUKEMIA, V27, P813, DOI 10.1038/leu.2012.327; Cheng H, 2015, BLOOD, V126, P1302, DOI 10.1182/blood-2015-01-623645; Chu YJ, 2014, CELL RES, V24, P1250, DOI 10.1038/cr.2014.120; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Dick JE, 2005, INT J HEMATOL, V82, P389, DOI 10.1532/IJH97.05144; Dickson GJ, 2013, HAEMATOLOGICA, V98, P1216, DOI 10.3324/haematol.2012.079012; Faber J, 2009, BLOOD, V113, P2375, DOI [10.1182/blood-2007-09-113597, 10.1182/blood-2007-09113597]; Garcia-Cuellar MP, 2015, HAEMATOLOGICA, V100, P905, DOI 10.3324/haematol.2015.124032; Green DR, 2015, COLD SPRING HARB PER, V7; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Heidel FH, 2013, J EXP MED, V210, P15, DOI 10.1084/jem.20120596; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kumar AR, 2009, BLOOD, V113, P1756, DOI 10.1182/blood-2008-06-163287; Li ZJ, 2016, CANCER RES, V76, P619, DOI 10.1158/0008-5472.CAN-15-1566; Li ZJ, 2013, BLOOD, V121, P1422, DOI 10.1182/blood-2012-07-442004; Liu Y, 2014, LEUKEMIA, V28, P1071, DOI 10.1038/leu.2013.304; MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Mukherjee K, 2007, J MOL EVOL, V65, P137, DOI 10.1007/s00239-006-0023-0; Orlovsky K, 2011, P NATL ACAD SCI USA, V108, P7956, DOI 10.1073/pnas.1103154108; Pan MM, 2016, LEUKEMIA, V30, P1590, DOI 10.1038/leu.2015.347; Raponi M, 2008, BLOOD, V111, P2589, DOI 10.1182/blood-2007-09-112730; Raponi M, 2007, CLIN CANCER RES, V13, P2254, DOI 10.1158/1078-0432.CCR-06-2609; Sarkaria SM, 2014, LEUKEMIA, V28, P2403, DOI 10.1038/leu.2014.235; Slany RK, 2005, HEMATOL ONCOL, V23, P1, DOI 10.1002/hon.739; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Thorne RMW, 2015, HAEMATOLOGICA, V100, P850, DOI 10.3324/haematol.2015.129932; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Willer A, 2015, LEUKEMIA, V29, P1018, DOI 10.1038/leu.2014.307; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Wong SHK, 2015, CANCER CELL, V28, P198, DOI 10.1016/j.ccell.2015.06.003; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zheng Y, 2016, LEUKEMIA, V30, P2373, DOI 10.1038/leu.2016.112; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894	45	1	1	5	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-7136	1097-0215		INT J CANCER	Int. J. Cancer	JUL 15	2017	141	2					324	335		10.1002/ijc.30739				12	Oncology	Oncology	EV4NJ	WOS:000401737200011	28411381				2018-01-05	
J	Nishio, M; Matsumoto, D; Kato, Y; Abe, K; Lee, J; Tsukakoshi, K; Yamagishi, A; Nakamura, C; Ikebukuro, K				Nishio, Maui; Matsumoto, Daisuke; Kato, Yoshio; Abe, Koichi; Lee, Jinhee; Tsukakoshi, Kaori; Yamagishi, Ayana; Nakamura, Chikashi; Ikebukuro, Kazunori			DNA aptamers against FokI nuclease domain for genome editing applications	BIOSENSORS & BIOELECTRONICS			English	Article; Proceedings Paper	26th Anniversary World Congress on Biosensors (Biosensors)	MAY 24-28, 2016	Gothenburg, SWEDEN	Ercon Inc		Aptamer; Genome editing; FokI; Protein delivery	SILICON NANONEEDLE ARRAY; ZINC-FINGER NUCLEASES; ENZYME SUBUNIT; G-QUADRUPLEX; SELECTION; POTASSIUM; DELIVERY; LIGANDS; PROTEIN; CELLS	Genome editing with site-specific nucleases (SSNs) can modify only the target gene and may be effective for gene therapy. The main limitation of genome editing for clinical use is off-target effects; excess SSN5 in the cells and their longevity can contribute to off-target effects. Therefore, a controlled delivery system for SSN5 is necessary. Fold nuclease domain (FokI) is a common DNA cleavage domain in zinc finger nuclease (ZFN) and transcription activator-like effector nuclease. Previously, we reported a zinc finger protein delivery system that combined aptamer-fused, double-strand oligonucleotides and nanoneedles. Here, we report the development of DNA aptamers that bind to the target molecules, with high affinity and specificity to the FokI. DNA aptamers were selected in six rounds of systematic evolution of ligands by exponential enrichment. Aptamers F6#8 and #71, which showed high binding affinity to Fokl (K-d=82 nM, 74 nM each), showed resistance to nuclease activity itself and did not inhibit nuclease activity. We immobilized the ZFN-fused GFP to nanoneedles through these aptamers and inserted the nanoneedles into HEK293 cells. We observed the release of ZFN-fused GFP from the nanoneedles in the presence of cells. Therefore, these aptamers are useful for genome editing applications such as controlled delivery of SSNs.	[Nishio, Maui; Matsumoto, Daisuke; Abe, Koichi; Lee, Jinhee; Tsukakoshi, Kaori; Nakamura, Chikashi; Ikebukuro, Kazunori] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan; [Kato, Yoshio; Yamagishi, Ayana; Nakamura, Chikashi] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Cent 5 1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan	Ikebukuro, K (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	ikebu@cc.tuat.ac.jp	Tsukakoshi, Kaori/I-4285-2016; Nakamura, Chikashi/G-9732-2013	Nakamura, Chikashi/0000-0002-8012-2192	Japan Society for the Promotion of Science (JSPS, Japan) [JP26249127]	This work was supported by a Grant-in-Aid for Scientific Research (A) (JP26249127) from the Japan Society for the Promotion of Science (JSPS, Japan).	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; CENTURY TJ, 1970, J CELL SCI, V7, P5; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0                                                                ; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Li J, 2005, NUCLEIC ACIDS RES, V33, P4649, DOI 10.1093/nar/gki782; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085755; LIVOLANT F, 1991, PHYSICA A, V176, P117, DOI 10.1016/0378-4371(91)90436-G                                                    ; Matsumoto D, 2016, ELECTROCHEMISTRY, V84, P305, DOI 10.5796/electrochemistry.84.305; Matsumoto D, 2015, SCI REP-UK, V5, DOI 10.1038/srep15325; Miyoshi D, 2006, J AM CHEM SOC, V128, P7957, DOI 10.1021/ja061267m; Nakano S, 2014, CHEM REV, V114, P2733, DOI 10.1021/cr400113m; Obataya I, 2005, NANO LETT, V5, P27, DOI 10.1021/nl0485399; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Tsukakoshi K, 2012, ANAL CHEM, V84, P5542, DOI 10.1021/ac300330g; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wu Xuebing, 2014, Quant Biol, V2, P59; Yoshida W, 2006, ANAL CHEM, V78, P3296, DOI 10.1021/ac060254o; Yoshida W, 2008, BIOTECHNOL LETT, V30, P421, DOI 10.1007/s10529-007-9575-3; Yoshida W, 2009, BIOSENS BIOELECTRON, V24, P1116, DOI 10.1016/j.bios.2008.06.016; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	27	1	1	7	62	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-5663	1873-4235		BIOSENS BIOELECTRON	Biosens. Bioelectron.	JUL 15	2017	93						26	31		10.1016/j.bios.2016.11.042				6	Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical; Electrochemistry; Nanoscience & Nanotechnology	Biophysics; Biotechnology & Applied Microbiology; Chemistry; Electrochemistry; Science & Technology - Other Topics	ES0ZZ	WOS:000399259000005	27899266				2018-01-05	
J	Dabiri, Y; Kalman, S; Gurth, CM; Kim, JY; Mayer, V; Cheng, XL				Dabiri, Yasamin; Kalman, Sara; Guerth, Clara-Marie; Kim, Jee Young; Mayer, Viola; Cheng, Xinlai			The essential role of TAp73 in bortezomib-induced apoptosis in p53-deficient colorectal cancer cells	SCIENTIFIC REPORTS			English	Article							PROTEASOME INHIBITOR BORTEZOMIB; MOLECULAR-BASIS; FEEDBACK LOOP; IN-VITRO; P53; P73; DERIVATIVES; EXPRESSION; POTENT; P63	Mutations in the tumor suppressor p53 are among the most highly occurring events in colorectal cancer (CRC). Such mutations have been shown to influence the sensitivity of cancer cells to chemotherapeutic agents. However their impact on the efficacy of the proteasomal inhibitor bortezomib remains controversial. We thus re-evaluated the toxicity of bortezomib in the CRC cell lines HCT116 wt (wildtype) and its p53-/-clone. Transient resistance to bortezomib treatment was observed in p53-null cells that was later accompanied by an increase in levels and nuclear translocation of TAp73, an isoform of the p53-homologue p73, as well as induction of apoptosis. Knockdown of p73 in p53-/-cells using CRISPR/Cas9 significantly prolonged the duration of resistance. Moreover, similar results were observed in HT-29 cells carrying mutated p53, but not human fibroblasts with expression of functional p53. Thus, our results clearly demonstrated that TAp73 served as a substitute for p53 in bortezomib-induced apoptosis in p53-deficient or mutated cells, implicating that TAp73 could be a potential therapeutic target for treatment of CRCs, in particular those lacking functional p53.	[Dabiri, Yasamin; Kalman, Sara; Guerth, Clara-Marie; Kim, Jee Young; Mayer, Viola; Cheng, Xinlai] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Pharmaceut Biol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany	Cheng, XL (reprint author), Heidelberg Univ, Inst Pharm & Mol Biotechnol, Pharmaceut Biol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	x.cheng@uni-heidelberg.de		Gurth, Clara-Marie/0000-0002-9644-5762; Cheng, Xinlai/0000-0001-6441-3742	BMBF grant program SysToxChip [031A303E]; DGF [CH 1690/2-1]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	We thank Prof. Dr. Stefan Wolfl (Heidelberg, Germany) for his valuable suggestions and corrections. We thank Dr. Thomas G. Hofmann (DKFZ, Germany) for supporting us with HCT116 wt and p53-/- cell lines. This work was supported by the BMBF grant program SysToxChip 031A303E and DGF CH 1690/2-1. We are thankful for the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing.	Adams J, 1999, CANCER RES, V59, P2615; Adams J, 2002, ONCOLOGIST, V7, P9, DOI 10.1634/theoncologist.7-1-9; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Aklilu M, 2011, NAT REV CLIN ONCOL, V8, P649, DOI 10.1038/nrclinonc.2011.118; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Bychkov ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109756; Chen SQ, 2010, CANCER RES, V70, P4318, DOI 10.1158/0008-5472.CAN-09-4428; Cheng XL, 2016, MOL ONCOL, V10, P806, DOI 10.1016/j.molonc.2016.01.008; Cheng XL, 2015, J MED CHEM, V58, P5742, DOI 10.1021/acs.jmedchem.5b00226; Cheng X, 2015, J MED CHEM, V58, P4976, DOI 10.1021/acs.jmedchem.5b00144; Cheng XL, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-221; Cheng XL, 2014, BIOORGAN MED CHEM, V22, P247, DOI 10.1016/j.bmc.2013.11.031; Cheng XL, 2012, CHEM BIOL, V19, P1423, DOI 10.1016/j.chembiol.2012.09.008; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; Dullo I, 2015, NAT CELL BIOL, V17, P511, DOI 10.1038/ncb3130; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Gong JG, 1999, NATURE, V399, P806; Han S, 1999, EUR J SURG ONCOL, V25, P194, DOI 10.1053/ejso.1998.0626                                                          ; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Iacopetta B, 2003, HUM MUTAT, V21, P271, DOI 10.1002/humu.10175; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3                                                   ; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; Kartasheva NN, 2002, ONCOGENE, V21, P4715, DOI 10.1038/sj.onc.1205584; Khoo KH, 2014, NAT REV DRUG DISCOV, V13, DOI 10.1038/nrd4288; Kurita T, 2005, MECH DEVELOP, V122, P1043, DOI 10.1016/j.mod.2005.04.008; Lenz HJ, 2003, CANCER TREAT REV, V29, P41, DOI 10.1016/S0305-7372(03)00082-3; Liu YH, 2015, NATURE, V520, P697, DOI 10.1038/nature14418; MacLaren AP, 2001, CELL DEATH DIFFER, V8, P210, DOI 10.1038/sj.cdd.4400801; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Mitsiades CS, 2006, J CLIN ENDOCR METAB, V91, P4013, DOI 10.1210/jc.2005-2472; Montero J, 2013, CELL DEATH DIFFER, V20, P1465, DOI 10.1038/cdd.2013.52; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Niewerth D, 2015, DRUG RESIST UPDATE, V18, P18, DOI 10.1016/j.drup.2014.12.001; Oliver TG, 2011, MOL CELL, V43, P57, DOI 10.1016/j.molcel.2011.06.012; Pandit B, 2011, AM J PATHOL, V178, P355, DOI 10.1016/j.ajpath.2010.11.010; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Roger L, 2010, J CELL SCI, V123, P1295, DOI 10.1242/jcs.061002; Strauss SJ, 2007, CANCER RES, V67, P2783, DOI 10.1158/0008-5472.CAN-06-3254; Su XH, 2013, NAT REV CANCER, V13, P136, DOI 10.1038/nrc3446; Tannapfel A, 2008, CARCINOGENESIS, V29, P211, DOI 10.1093/carcin/bgm236; Vayssade M, 2005, INT J CANCER, V116, P860, DOI 10.1002/ijc.21033; Vaziri SAJ, 2009, ANTICANCER RES, V29, P2961; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675                                                                ; Wang WG, 2006, P NATL ACAD SCI USA, V103, P11003, DOI 10.1073/pnas.0604507103; Williams SA, 2003, CANCER RES, V63, P7338; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127                                                                ; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhu ZY, 2005, J BIOL CHEM, V280, P34473, DOI 10.1074/jbc.M503736200	50	1	1	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 14	2017	7								5423	10.1038/s41598-017-05813-z				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FA5EA	WOS:000405464200060	28710427	gold			2018-01-05	
J	Shankar, S; Prasad, D; Sanawar, R; Das, AV; Pillai, MR				Shankar, Sumitra; Prasad, Deepti; Sanawar, Rahul; Das, Ani V.; Pillai, M. Radhakrishna			TALEN based HPV-E7 editing triggers necrotic cell death in cervical cancer cells	SCIENTIFIC REPORTS			English	Article							ZINC-FINGER NUCLEASES; TRANSFORMED PHENOTYPE; EFFECTOR NUCLEASES; CARCINOMA CELLS; IN-VIVO; E7 GENE; E6; DNA; KERATINOCYTES; INACTIVATION	Human Papillomavirus E7 and E6 oncoproteins have been considered as suitable candidate anti-viral targets since they cause malignant conversion in cervical cancers. Transcription Activator-Like Effector Nucleases (TALENs) are recent editing tools to knockout genes by inducing double stranded breaks at specific sites in the genome. In here, we have designed specific TALENs to target E7 and analyzed their efficiency in inducing cell death in cervical cancer cells. We found that designed TALENs could yield about 10-12% editing activity as observed from T7E1 and nuclease resistance assays. Down-regulation of E7 and E6 was further evident at the transcript as well as proteins levels indicating that the selected TALENs were effective. TALEN-mediated E7 editing led to cell death as ascertained by cell cycle and Annexin V assays. Annexin profiling suggested that cell death could be due to necrosis as observed by upregulation of necrotic markers such as LDH A, Rip-1, and Cyclophilin A. Necrosis appears to be a better therapeutic response as it could further activate pro-inflammatory cytokines to attract immune cells to eliminate HPV-integrated cells and therefore TALEN editing strategy has the potential to be a promising tool as an adjuvant therapy in cervical cancer along with surgery.	[Shankar, Sumitra; Prasad, Deepti; Sanawar, Rahul; Das, Ani V.; Pillai, M. Radhakrishna] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thycaud PO, Thiruvananthapuram 14, Kerala, India	Pillai, MR (reprint author), Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thycaud PO, Thiruvananthapuram 14, Kerala, India.	mrpillai@rgcb.res.in			Department of Biotechnology, Government of India; Rajiv Gandhi Centre for Biotechnology, Kerala, India; Senior Research Fellowship from the Council for Scientific and Industrial Research [10-2(5)/2007]; Junior Research Fellowships from the University Grants Commission [F.2-12/2003, 23/06/2013]	We would like to thank Prof. P.N. Rangarajan, Indian Institute of Science, Bangalore, India for his critical suggestions. This work was supported by the Department of Biotechnology, Government of India and intramural funding from Rajiv Gandhi Centre for Biotechnology, Kerala, India. S.S. was supported by a Senior Research Fellowship from the Council for Scientific and Industrial Research (10-2(5)/2007 (ii)-E.U.II) while D.P. and R.S. were supported by Junior Research Fellowships from the University Grants Commission [Order no. F.2-12/2003 (SA-I) & 23/06/2013 (i) EU-V, respectively].	Ahn WS, 2004, INT J GYNECOL CANCER, V14, P475, DOI 10.1111/j.1048-891x.2004.14308.x                                                ; Alvarez-Salas LM, 1998, P NATL ACAD SCI USA, V95, P1189, DOI 10.1073/pnas.95.3.1189; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001                                                   ; Bloom K, 2013, MOL THER, V21, P1889, DOI 10.1038/mt.2013.170; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Booher NJ, 2014, METHODS, V69, P121, DOI 10.1016/j.ymeth.2014.06.006; Bruni L., 2016, 20160225 ICO HPV; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; Byrne SM, 2014, METHOD ENZYMOL, V546, P119, DOI 10.1016/B978-0-12-801185-0.00006-4; Chen JL, 2014, MOL THER, V22, P303, DOI 10.1038/mt.2013.212; Chuah MK, 2013, J THROMB HAEMOST, V11, P99, DOI 10.1111/jth.12215; Ding WC, 2014, CLIN CANCER RES, V20, P6495, DOI 10.1158/1078-0432.CCR-14-0250; Dupuy A, 2015, MUTAT RES-FUND MOL M, V776, P2, DOI 10.1016/j.mrfmmm.2014.08.007; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Giarre M, 2001, J VIROL, V75, P4705, DOI 10.1128/JVI.75.10.4705-4712.2001; Holkers M, 2014, METHODS, V69, P179, DOI 10.1016/j.ymeth.2014.02.017; Horner SM, 2007, J VIROL, V81, P6254, DOI 10.1128/JVI.00232-07; Hu Z, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/612823; Hu Z, 2015, J CLIN INVEST, V125, P425, DOI 10.1172/JCI78206; Jia JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091547; Jiang Ming, 2005, Methods Mol Biol, V292, P401; Kennedy EM, 2014, J VIROL, V88, P11965, DOI 10.1128/JVI.01879-14; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim Kidong, 2008, J Gynecol Oncol, V19, P209, DOI 10.3802/jgo.2008.19.4.209; Lin YN, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1363; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085755; Liu YC, 2016, ASIAN J ANDROL, V18, P475, DOI 10.4103/1008-682X.157399; Molano M, 2003, AM J EPIDEMIOL, V158, P486, DOI 10.1093/aje/kwg171; Rampias T, 2009, J NATL CANCER I, V101, P412, DOI 10.1093/jnci/djp017; Sano T, 2002, PATHOL INT, V52, P375, DOI 10.1046/j.1440-1827.2002.01359.x; Schornack S, 2006, J PLANT PHYSIOL, V163, P256, DOI 10.1016/j.jplph.2005.12.001; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Singh R. N., 2013, CANC NANOTECHNOLOGY, P205; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Strong CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125652; Sun N, 2014, BIOTECHNOL BIOENG, V111, P1048, DOI 10.1002/bit.25018; Sung PS, 2014, J VIROL, V88, P9233, DOI 10.1128/JVI.01428-14; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Yu L, 2015, ONCOTARGETS THER, V8, P37, DOI 10.2147/OTT.S64092; Zhen S, 2014, BIOCHEM BIOPH RES CO, V450, P1422, DOI 10.1016/j.bbrc.2014.07.014; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	42	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 14	2017	7								5500	10.1038/s41598-017-05696-0				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FA5EA	WOS:000405464200137	28710417	gold			2018-01-05	
J	Kwarteng, A; Ahuno, ST; Kwakye-Nuako, G				Kwarteng, Alexander; Ahuno, Samuel Terkper; Kwakye-Nuako, Godwin			The therapeutic landscape of HIV-1 via genome editing	AIDS RESEARCH AND THERAPY			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; CELL-PENETRATING PEPTIDES; CD4(+) T-CELLS; BROADLY NEUTRALIZING ANTIBODIES; HISTONE DEACETYLASE INHIBITORS; HEMATOPOIETIC STEM-CELLS; BLOOD MONONUCLEAR-CELLS; SMALL INTERFERING RNAS; ZINC-FINGER NUCLEASES; DOUBLE-STRANDED-RNA	Current treatment for HIV-1 largely relies on chemotherapy through the administration of antiretroviral drugs. While the search for anti-HIV-1 vaccine remain elusive, the use of highly active antiretroviral therapies (HAART) have been far-reaching and has changed HIV-1 into a manageable chronic infection. There is compelling evidence, including several side-effects of ARTs, suggesting that eradication of HIV-1 cannot depend solely on antiretrovirals. Gene therapy, an expanding treatment strategy, using RNA interference (RNAi) and programmable nucleases such as meganuclease, zinc finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN), and clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins (CRISPR-Cas9) are transforming the therapeutic landscape of HIV-1. TALENS and ZFNS are structurally similar modular systems, which consist of a FokI endonuclease fused to custom-designed effector proteins but have been largely limited, particularly ZFNs, due to their complexity and cost of protein engineering. However, the newly developed CRISPR-Cas9 system, consists of a single guide RNA (sgRNA), which directs a Cas9 endonuclease to complementary target sites, and serves as a superior alternative to the previous protein-based systems. The techniques have been successfully applied to the development of better HIV-1 models, generation of protective mutations in endogenous/host cells, disruption of HIV-1 genomes and even reactivating latent viruses for better detection and clearance by host immune response. Here, we focus on gene editing-based HIV-1 treatment and research in addition to providing perspectives for refining these techniques.	[Kwarteng, Alexander; Ahuno, Samuel Terkper] KNUST, Dept Biochem & Biotechnol, PMB, Kumasi, Ghana; [Kwarteng, Alexander] Kumasi Ctr Collaborat Res Trop Med KCCR, Kumasi, Ghana; [Kwakye-Nuako, Godwin] Univ Cape Coast, Sch Allied Hlth Sci, Dept Biomed Sci, Coll Hlth & Allied Sci, Cape Coast, Ghana	Kwarteng, A (reprint author), KNUST, Dept Biochem & Biotechnol, PMB, Kumasi, Ghana.; Kwarteng, A (reprint author), Kumasi Ctr Collaborat Res Trop Med KCCR, Kumasi, Ghana.	akwarteng@knust.edu.gh		KWARTENG, ALEXANDER/0000-0002-0893-2908; Ahuno, Samuel/0000-0002-1327-0195			Abreu CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097257; Adesina SK, 2015, MOL PHARMACEUT, V12, P4175, DOI 10.1021/acs.molpharmaceut.5b00335; Al-Mawsawi LQ, 2007, TRENDS PHARMACOL SCI, V28, P526, DOI 10.1016/j.tips.2007.09.005; Anderson J, 2003, OLIGONUCLEOTIDES, V13, P303, DOI 10.1089/154545703322616989; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Chong H, 2017, J VIROL, V91; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112; Bhaskar S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-3; Bilal MY, 2015, IMMUNOL CELL BIOL, V93, P896, DOI 10.1038/icb.2015.59; Blake SJ, 2012, CURR DRUG TARGETS, V13, P1411; Blazkova J, 2012, J INFECT DIS, V206, P765, DOI 10.1093/infdis/jis412; Bobbin ML, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0174-y; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Boisguerin P, 2015, ADV DRUG DELIVER REV, V87, P52, DOI 10.1016/j.addr.2015.02.008; Bolhassani A, 2017, PEPTIDES, V87, P50, DOI 10.1016/j.peptides.2016.11.011; [Anonymous], 2009, GENE THER; Cary DC, 2016, J CLIN INVEST, V126, P448, DOI 10.1172/JCI80565; Cary DC, 2016, F1000RESEARCH, P5; Cave E, 2006, AIDS RES HUM RETROV, V22, P401, DOI 10.1089/aid.2006.22.401; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cerrato CP, 2017, EXPERT OPIN DRUG DEL, V14, P245, DOI 10.1080/17425247.2016.1213237; Chiu YL, 2004, J VIROL, V78, P2517, DOI 10.1128/JVI.78.5.2517-2529.2004; Choi JG, 2016, GENE THER, V23, P627, DOI 10.1038/gt.2016.27; Chong H, 2017, J VIROL, V91; Christ F, 2013, VIROLOGY, V435, P102, DOI 10.1016/j.virol.2012.09.033; Christensen HS, 2007, J VIROL, V81, P5121, DOI 10.1128/JVI.01511-06; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 2015, NAT IMMUNOL, V16, P584, DOI 10.1038/ni.3152; Chun TW, 2014, P NATL ACAD SCI USA, V111, P13151, DOI 10.1073/pnas.1414148111; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cullen BR, 2005, AIDS REV, V7, P22; Cyranoski D, 2016, NATURE, V536, P136, DOI 10.1038/536136a; Darcis G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005063; DeChristopher BA, 2012, NAT CHEM, V4, P705, DOI [10.1038/NCHEM.1395, 10.1038/nchem.1395]; Deeks SG, 2016, NAT MED, V22, P839, DOI 10.1038/nm.4108; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; DiGiusto DL, 2013, VIRUSES-BASEL, V5, P2898, DOI 10.3390/v5112898; Dissanayake S, 2017, J CONTROL RELEASE, V250, P62, DOI 10.1016/j.jconrel.2017.02.006; Djupedal I, 2009, CELL RES, V19, P282, DOI 10.1038/cr.2009.13; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Drake MJ, 2015, CURR OPIN HIV AIDS, V10, P123, DOI 10.1097/COH.0000000000000139; Edagwa BJ, 2014, CURR MED CHEM, V21, P4186, DOI 10.2174/0929867321666140826114135                                               ; Eekels JJM, 2011, ANTIVIR RES, V89, P43, DOI 10.1016/j.antiviral.2010.11.005; [Anonymous], 2015, J CLIN INVEST; Fadel HJ, 2014, J VIROL, V88, P9704, DOI 10.1128/JVI.01397-14; Feelixge HSD, 2016, ANTIVIR RES, V126, P90, DOI 10.1016/j.antiviral.2015.12.007; Flynn MN, 2005, J INFECT DIS, V191, P654; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Gavegnano C, 2014, ANTIMICROB AGENTS CH, V58, P1977, DOI 10.1128/AAC.02496-13; Gomes MJ, 2014, INT J NANOMED, V9, P1757, DOI 10.2147/IJN.S45886; Green VA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-272; Guidotti G, 2017, TRENDS PHARMACOL SCI, V38, P406, DOI 10.1016/j.tips.2017.01.003; Guo XY, 2015, CELL RES, V25, P767, DOI 10.1038/cr.2015.64; [Anonymous], 2016, J CLIN INVEST; Halper-Stromberg A, 2016, J CLIN INVEST, V126, P415, DOI 10.1172/JCI80561; Hammond SM, 2000, NATURE, V404, P293; [Anonymous], 2016, ZHONGGUO YI CHUAN XU; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hoffer P, 2011, P NATL ACAD SCI USA, V108, P409, DOI 10.1073/pnas.1009805108; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Hon T, 2015, BIOCHEM BIOPH RES CO, V459, P288, DOI 10.1016/j.bbrc.2015.02.102; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ishaq M, 2008, MOL BIOTECHNOL, V39, P231, DOI 10.1007/s12033-008-9040-0; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Jekimovs C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00086; Jiang GC, 2014, AIDS, V28, P1555, DOI 10.1097/QAD.0000000000000289; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jose DP, 2014, VIROLOGY, V462, P328, DOI 10.1016/j.virol.2014.05.033; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Juks C, 2017, FASEB J, V31, P975, DOI 10.1096/fj.201600811R; Jung U, 2015, HUM GENE THER, V26, P664, DOI 10.1089/hum.2015.059; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Kaushik A, 2016, INT J NANOMED, V11, P4317, DOI 10.2147/IJN.S109943; Kishida T, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01001; Kitabwalla M, 2002, NEW ENGL J MED, V347, P1364, DOI 10.1056/NEJMcibr022294; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Kovalskyy DB, 2014, BIOCHEMISTRY-US, V53, P1466, DOI 10.1021/bi4014962; Krebs MD, 2011, CHEM-EUR J, V17, P3054, DOI 10.1002/chem.201003144; Lau TS, 2007, FEBS LETT, V581, P3253, DOI 10.1016/j.febslet.2007.06.011; Lemons D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00223; Lessells RJ, 2014, JAIDS-J ACQ IMM DEF, V65, pE17, DOI 10.1097/QAI.0b013e31829ceb14; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Li MJ, 2005, MOL THER, V12, P900, DOI 10.1016/j.ymthe.2005.07.524; Liang C, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0270-0; Liu HL, 2014, CELL STEM CELL, V14, P323, DOI 10.1016/j.stem.2014.01.018; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Manjunath N, 2013, VIRUSES-BASEL, V5, P2748, DOI 10.3390/v5112748; Margolis David M, 2010, Curr HIV/AIDS Rep, V7, P37, DOI 10.1007/s11904-009-0033-9; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; Martinez MA, 2002, AIDS, V16, P2385, DOI 10.1097/00002030-200212060-00002; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mock U, 2015, NUCLEIC ACIDS RES, V43, P5560, DOI 10.1093/nar/gkv469; Mock U, 2014, SCI REP-UK, V4, DOI 10.1038/srep06409; Morris Kevin V, 2005, RNA Biol, V2, P17, DOI 10.4161/rna.2.1.1198; Moss DM, 2014, BRIT J PHARMACOL, V171, P3963, DOI 10.1111/bph.12604; Neagu MR, 2009, J CLIN INVEST, V119, P3035, DOI 10.1172/JCI39354; Nishitsuji H, 2006, J VIROL, V80, P7658, DOI 10.1128/JVI.00078-06; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Omoto Shinya, 2004, Retrovirology, V1, P44, DOI 10.1186/1742-4690-1-44; [Anonymous], 2015, HIV AIDS RES TREAT O; Park WS, 2003, GENE THER, V10, P2046, DOI 10.1038/sj.gt.3302099; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Perez M, 2010, CURR HIV RES, V8, P418, DOI 10.2174/157016210793499312                                                      ; Pillai AB, 2017, INSECT MOL BIOL, V26, P127, DOI 10.1111/imb.12282; Ping YH, 2004, RETROVIROLOGY, V1, P46, DOI 10.1186/1742-4690-1-46; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; [Anonymous], 2014, J CLIN INVEST; Richardson MW, 2014, MOL THER, V22, P1084, DOI 10.1038/mt.2014.52; Robert F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0215-6; Rossi JJ, 2006, BIOTECHNIQUES, V40, P25, DOI 10.2144/000112167; Ru Renli, 2013, Cell Regen (Lond), V2, P5, DOI 10.1186/2045-9769-2-5; [Anonymous], 2016, INSECT MOL BIOL; Sanz-Ramos M, 2013, J GEN VIROL, V94, P2587, DOI 10.1099/vir.0.058180-0; Saydaminova Kamola, 2015, Mol Ther Methods Clin Dev, V1, P14057, DOI 10.1038/mtm.2014.57; Scarborough RJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.31; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shi BJ, 2017, JAIDS-J ACQ IMM DEF, V74, P229, DOI 10.1097/QAI.0000000000001190; Singh A, 2014, J ANTIMICROB CHEMOTH, V69, P404, DOI 10.1093/jac/dkt348; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Stone D, 2016, HUM GENET, V135, P1071, DOI 10.1007/s00439-016-1686-2; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Strong CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125652; Subramanya S, 2010, MOL THER, V18, P2028, DOI 10.1038/mt.2010.148; Subramanya S, 2010, EXPERT OPIN BIOL TH, V10, P201, DOI 10.1517/14712590903448158; Suzuki K, 2011, RNA BIOL, V8, P1035, DOI 10.4161/rna.8.6.16264; Tashima T, 2017, BIOORG MED CHEM LETT, V27, P121, DOI 10.1016/j.bmcl.2016.11.083; ter Brake O, 2006, MOL THER, V14, P883, DOI 10.1016/j.ymthe.2006.07.007; [Anonymous], 2016, J CLIN INVESTIG; Vartak SV, 2015, FEBS J, V282, P4289, DOI 10.1111/febs.13416; Volberding PA, 2010, LANCET, V376, P49, DOI 10.1016/S0140-6736(10)60676-9; Walker JE, 2012, J VIROL, V86, P5719, DOI 10.1128/JVI.06300-11; Wang C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142739; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang HJ, 2005, J VIROL, V79, P10999, DOI 10.1128/JVI.79.17.10999-11013.2005; Wang HJ, 2008, EXP HEMATOL, V36, P823, DOI 10.1016/j.exphem.2008.01.014; Wang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083908; Wang XL, 2017, ARCH VIROL, V162, P793, DOI 10.1007/s00705-016-3169-0; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; Weinberg MS, 2016, NUCLEIC ACIDS RES, V44, P6505, DOI 10.1093/nar/gkw139; Wender PA, 2014, ORG LETT, V16, P5136, DOI 10.1021/ol502491f; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yamamoto T, 2006, BLOOD, V108, P3305, DOI 10.1182/blood-2006-04-014829; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yu WD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003146; Zaitseva L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-11; Zeller Skye J., 2011, Yale Journal of Biology and Medicine, V84, P301; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhao JL, 2016, MOL CELLS, V39, P687, DOI 10.14348/molcells.2016.0140; Zhou J, 2011, GENE THER, V18, P1134, DOI 10.1038/gt.2011.149; Zhou JH, 2013, MOL THER, V21, P192, DOI 10.1038/mt.2012.226; Zhou JH, 2011, MOL THER, V19, P2228, DOI 10.1038/mt.2011.207	164	0	0	9	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-6405			AIDS RES THER	Aids Res. Ther.	JUL 14	2017	14								32	10.1186/s12981-017-0157-8				16	Infectious Diseases	Infectious Diseases	FB0RF	WOS:000405851500001	28705213	gold			2018-01-05	
J	Zeng, BS; Huang, YP; Xu, J; Shiotsuki, T; Bai, H; Palli, SR; Huang, YP; Tan, AJ				Zeng, Baosheng; Huang, Yuping; Xu, Jun; Shiotsuki, Takahiro; Bai, Hua; Palli, Subba Reddy; Huang, Yongping; Tan, Anjiang			The FOXO transcription factor controls insect growth and development by regulating juvenile hormone degradation in the silkworm, Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; INSULIN-RECEPTOR; LIFE-SPAN; FAT-BODY; METAMORPHOSIS; PATHWAY; CELLS; SIZE; BIOSYNTHESIS; ESTERASE	Forkhead box O (FOXO) functions as the terminal transcription factor of the insulin signaling pathway and regulates multiple physiological processes in many organisms, including life-span in insects. However, how FOXO interacts with hormone signaling to modulate insect growth and development is largely unknown. Here, using the transgene-based CRISPR/Cas9 system, we generated and characterized mutants of the silkworm Bombyx mori FOXO (BmFOXO) to elucidate its physiological functions during development of this lepidopteran insect. The BmFOXO mutant (FOXO-M) exhibited growth delays from the first larval stage and showed precocious metamorphosis, pupating at the end of the fourth instar (trimolter) rather than at the end of the fifth instar as in the wild-type (WT) animals. However, different from previous reports on precocious metamorphosis caused by juvenile hormone (JH) deficiency in silkworm mutants, the total developmental time of the larval period in the FOXO-M was comparable with that of the WT. Exogenous application of 20-hydroxyecdysone (20E) or of the JH analog rescued the trimolter phenotype. RNA-seq and gene expression analyses indicated that genes involved in JH degradation but not in JH biosynthesis were up-regulated in the FOXO-M compared with the WT animals. Moreover, we identified several FOXO-binding sites in the promoter of genes coding for JH-degradation enzymes. These results suggest that FOXO regulates JH degradation rather than its biosynthesis, which further modulates hormone homeostasis to control growth and development in B. mori. In conclusion, we have uncovered a pivotal role for FOXO in regulating JH signaling to control insect development.	[Zeng, Baosheng; Huang, Yuping; Xu, Jun; Huang, Yongping; Tan, Anjiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [Zeng, Baosheng; Xu, Jun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Shiotsuki, Takahiro] Natl Agr & Food Res Org, Inst Agrobiol Sci, Div Insect Sci, 1-2 Owashi, Tsukuba, Ibaraki 3058634, Japan; [Bai, Hua] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Palli, Subba Reddy] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Tan, AJ (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China.	ajtan01@sibs.ac.cn			Strategic Priority Research Program of Chinese Academy of Sciences [XDB11010600]; National Basic Research Program of China [2015CB755703]; National Science Foundation of China [31420103918, 31530072]; Chinese Academy of Sciences [KJZD-EW-L12-02]	This work was supported by Strategic Priority Research Program of Chinese Academy of Sciences Grant XDB11010600, National Basic Research Program of China Grant 2015CB755703, National Science Foundation of China Grants 31420103918 and 31530072, and Chinese Academy of Sciences Grant KJZD-EW-L12-02. The authors declare that they have no conflicts of interest with the contents of this article.	Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9                                                   ; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carter ME, 2007, CURR BIOL, V17, pR113, DOI 10.1016/j.cub.2007.01.008; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Daimon T, 2015, P NATL ACAD SCI USA, V112, pE4226, DOI 10.1073/pnas.1506645112; Daimon T, 2014, DEV GROWTH DIFFER, V56, P14, DOI 10.1111/dgd.12096; Daimon T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002486; Delanoue R, 2010, DEV CELL, V18, P1012, DOI 10.1016/j.devcel.2010.05.007; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Furuta K, 2013, BIOSCI BIOTECH BIOCH, V77, P988, DOI 10.1271/bbb.120883; Gelman DB, 2002, J INSECT PHYSIOL, V48, P63, DOI 10.1016/S0022-1910(01)00146-9; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Herold MJ, 2013, EMBO REP, V14, P992, DOI 10.1038/embor.2013.152; Hossain MS, 2013, INSECT BIOCHEM MOLEC, V43, P829, DOI 10.1016/j.ibmb.2013.06.007; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kingan TG, 2000, J EXP BIOL, V203, P3011; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Kramer Jamie M, 2003, BMC Dev Biol, V3, P5, DOI 10.1186/1471-213X-3-5; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Li ZQ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0513; Li ZQ, 2015, INT J BIOL SCI, V11, P176, DOI 10.7150/ijbs.10235; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Ling L, 2014, INSECT BIOCHEM MOLEC, V53, P13, DOI 10.1016/j.ibmb.2014.06.011; MCCUTCHEN BF, 1995, INSECT BIOCHEM MOLEC, V25, P119, DOI 10.1016/0965-1748(94)00036-H; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Mirth CK, 2014, P NATL ACAD SCI USA, V111, P7018, DOI 10.1073/pnas.1313058111; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rauschenbach I Yu, 2015, Genetika, V51, P1083; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Slack C, 2011, AGING CELL, V10, P735, DOI 10.1111/j.1474-9726.2011.00707.x; Suren-Castillo S, 2012, INSECT BIOCHEM MOLEC, V42, P491, DOI 10.1016/j.ibmb.2012.03.006; Tan A, 2005, P NATL ACAD SCI USA, V102, P11751, DOI 10.1073/pnas.0500954102; Tsubota T, 2010, BIOSCI BIOTECH BIOCH, V74, P2259, DOI 10.1271/bbb.100480; Tu MP, 2005, GEN COMP ENDOCR, V142, P347, DOI 10.1016/j.ygcen.2005.02.009; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293                                                                   ; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Xu J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006576; Zeng BS, 2016, INSECT BIOCHEM MOLEC, V72, P31, DOI 10.1016/j.ibmb.2016.03.006; Zhang L, 2014, J BACTERIOL, V196, P3949, DOI 10.1128/JB.02037-14	43	2	2	23	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11659	11669		10.1074/jbc.M117.777797				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FA5LU	WOS:000405485600007	28490635				2018-01-05	
J	Morgan, SL; Mariano, NC; Bermudez, A; Arruda, NL; Wu, FT; Luo, YH; Shankar, G; Jia, L; Chen, HL; Hu, JF; Hoffman, AR; Huang, CC; Pitteri, SJ; Wang, KC				Morgan, Stefanie L.; Mariano, Natasha C.; Bermudez, Abel; Arruda, Nicole L.; Wu, Fangting; Luo, Yunhai; Shankar, Gautam; Jia, Lin; Chen, Huiling; Hu, Ji-Fan; Hoffman, Andrew R.; Huang, Chiao-Chain; Pitteri, Sharon J.; Wang, Kevin C.			Manipulation of nuclear architecture through CRISPR-mediated chromosomal looping	NATURE COMMUNICATIONS			English	Article							PLURIPOTENCY; ACTIVATION; ENHANCER; GENES	Chromatin looping is key to gene regulation, yet no broadly applicable methods to selectively modify chromatin loops have been described. We have engineered a method for chromatin loop reorganization using CRISPR-dCas9 (CLOuD9) to selectively and reversibly establish chromatin loops. We demonstrate the power of this technology to selectively modulate gene expression at targeted loci.	[Morgan, Stefanie L.; Mariano, Natasha C.; Luo, Yunhai; Shankar, Gautam; Wang, Kevin C.] Stanford Univ, Sch Med, Dept Dermatol, Program Epithelial Biol, Stanford, CA 94305 USA; [Morgan, Stefanie L.; Mariano, Natasha C.; Luo, Yunhai; Shankar, Gautam; Wang, Kevin C.] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA; [Bermudez, Abel; Pitteri, Sharon J.] Stanford Univ, Sch Med, Canary Ctr Canc Early Detect, Dept Radiol, Palo Alto, CA 94304 USA; [Arruda, Nicole L.] Bridgewater State Univ, Dept Biol, Bridgewater, MA 02325 USA; [Wu, Fangting; Huang, Chiao-Chain] Syst Biosci, Palo Alto, CA 94303 USA; [Jia, Lin; Chen, Huiling; Hu, Ji-Fan; Hoffman, Andrew R.; Wang, Kevin C.] Vet Affairs Healthcare Syst, Palo Alto, CA 94304 USA; [Jia, Lin; Hu, Ji-Fan] Jilin Univ, Affiliated Hosp 1, Stem Cell & Canc Ctr, Changchun 130021, Peoples R China; [Chen, Huiling] Cent S Univ, Dept Endocrinol, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China	Wang, KC (reprint author), Stanford Univ, Sch Med, Dept Dermatol, Program Epithelial Biol, Stanford, CA 94305 USA.; Wang, KC (reprint author), Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA.; Wang, KC (reprint author), Vet Affairs Healthcare Syst, Palo Alto, CA 94304 USA.	kevwang@stanford.edu			Burroughs Wellcome Fund	We thank H. Chang, T. Oro, S. Tavazoie, R. Flynn, P. Batista, E. Calo and the entire Wang laboratory for technical support and critical reading of the manuscript. S.L.M. is an NSF and NDSEG fellow. K.C.W. is supported by a Career Award for Medical Scientists from the Burroughs Wellcome Fund, and is a Donald E. and Delia B. Baxter Foundation Faculty Scholar.	Ameres SL, 2005, EMBO J, V24, P358, DOI 10.1038/sj.emboj.7600531; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Drier Y, 2016, NAT GENET, V48, P265, DOI 10.1038/ng.3502; Kim A, 2012, MOL CELLS, V34, P1, DOI 10.1007/s10059-012-0048-8; Krivega I, 2016, ANN NY ACAD SCI, V1368, P31, DOI 10.1111/nyas.13012; Liang FS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001449; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Matharu N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005640; Mokry M, 2012, NUCL ACIDS RES, V40, P148; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Petrascheck M., 2005, NUCL ACIDS RES, V33, P3743; Ryan RJH, 2015, CANCER DISCOV, V5, P1058, DOI 10.1158/2159-8290.CD-15-0370; Stadhouders Ralph, 2012, Transcription, V3, P181, DOI 10.4161/trns.20720; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; Zhang H, 2013, CELL STEM CELL, V13, P30, DOI 10.1016/j.stem.2013.05.012	18	2	2	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JUL 13	2017	8								15993	10.1038/ncomms15993				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FA4GH	WOS:000405401300001	28703221				2018-01-05	
J	Petersen, R; Lambourne, JJ; Javierre, BM; Grassi, L; Kreuzhuber, R; Ruklisa, D; Rosa, IM; Tome, AR; Elding, H; van Geffen, JP; Jiang, T; Farrow, S; Cairns, J; Al-Subaie, AM; Ashford, S; Attwood, A; Batista, J; Bouman, H; Burden, F; Choudry, FA; Clarke, L; Flicek, P; Garner, SF; Haimel, M; Kempster, C; Ladopoulos, V; Lenaerts, AS; Materek, PM; McKinney, H; Meacham, S; Mead, D; Nagy, M; Penkett, CJ; Rendon, A; Seyres, D; Sun, B; Tuna, S; van der Weide, ME; Wingett, SW; Martens, JH; Stegle, O; Richardson, S; Vallier, L; Roberts, DJ; Freson, K; Wernisch, L; Stunnenberg, HG; Danesh, J; Fraser, P; Soranzo, N; Butterworth, AS; Heemskerk, JW; Turro, E; Spivakov, M; Ouwehand, WH; Astle, WJ; Downes, K; Kostadima, M; Frontini, M				Petersen, Romina; Lambourne, John J.; Javierre, Biola M.; Grassi, Luigi; Kreuzhuber, Roman; Ruklisa, Dace; Rosa, Isabel M.; Tome, Ana R.; Elding, Heather; van Geffen, Johanna P.; Jiang, Tao; Farrow, Samantha; Cairns, Jonathan; Al-Subaie, Abeer M.; Ashford, Sofie; Attwood, Antony; Batista, Joana; Bouman, Heleen; Burden, Frances; Choudry, Fizzah A.; Clarke, Laura; Flicek, Paul; Garner, Stephen F.; Haimel, Matthias; Kempster, Carly; Ladopoulos, Vasileios; Lenaerts, An-Sofie; Materek, Paulina M.; McKinney, Harriet; Meacham, Stuart; Mead, Daniel; Nagy, Magdolna; Penkett, Christopher J.; Rendon, Augusto; Seyres, Denis; Sun, Benjamin; Tuna, Salih; van der Weide, Marie-Elise; Wingett, Steven W.; Martens, Joost H.; Stegle, Oliver; Richardson, Sylvia; Vallier, Ludovic; Roberts, David J.; Freson, Kathleen; Wernisch, Lorenz; Stunnenberg, Hendrik G.; Danesh, John; Fraser, Peter; Soranzo, Nicole; Butterworth, Adam S.; Heemskerk, Johan W.; Turro, Ernest; Spivakov, Mikhail; Ouwehand, Willem H.; Astle, William J.; Downes, Kate; Kostadima, Myrto; Frontini, Mattia			Platelet function is modified by common sequence variation in megakaryocyte super enhancers	NATURE COMMUNICATIONS			English	Article							DNA-BINDING PROTEINS; HUMAN CELL-TYPES; THROMBUS FORMATION; GENE-REGULATION; OPEN CHROMATIN; TRAIT LOCI; DISEASE; SEQ; GENOME; BLOOD	Linking non-coding genetic variants associated with the risk of diseases or disease-relevant traits to target genes is a crucial step to realize GWAS potential in the introduction of precision medicine. Here we set out to determine the mechanisms underpinning variant association with platelet quantitative traits using cell type-matched epigenomic data and promoter long-range interactions. We identify potential regulatory functions for 423 of 565 (75%) non-coding variants associated with platelet traits and we demonstrate, through ex vivo and proof of principle genome editing validation, that variants in super enhancers play an important role in controlling archetypical platelet functions.	[Petersen, Romina; Lambourne, John J.; Grassi, Luigi; Kreuzhuber, Roman; Ruklisa, Dace; Rosa, Isabel M.; Tome, Ana R.; Farrow, Samantha; Al-Subaie, Abeer M.; Ashford, Sofie; Attwood, Antony; Batista, Joana; Burden, Frances; Choudry, Fizzah A.; Kempster, Carly; Ladopoulos, Vasileios; McKinney, Harriet; Meacham, Stuart; Penkett, Christopher J.; Rendon, Augusto; Seyres, Denis; Tuna, Salih; van der Weide, Marie-Elise; Soranzo, Nicole; Turro, Ernest; Ouwehand, Willem H.; Astle, William J.; Downes, Kate; Kostadima, Myrto; Frontini, Mattia] Univ Cambridge, Dept Haematol, Cambridge Biomed Campus, Cambridge CB2 0PT, England; [Petersen, Romina; Lambourne, John J.; Grassi, Luigi; Kreuzhuber, Roman; Ruklisa, Dace; Rosa, Isabel M.; Tome, Ana R.; Farrow, Samantha; Al-Subaie, Abeer M.; Ashford, Sofie; Attwood, Antony; Batista, Joana; Burden, Frances; Choudry, Fizzah A.; Garner, Stephen F.; Kempster, Carly; McKinney, Harriet; Meacham, Stuart; Penkett, Christopher J.; Rendon, Augusto; Seyres, Denis; Tuna, Salih; van der Weide, Marie-Elise; Turro, Ernest; Spivakov, Mikhail; Ouwehand, Willem H.; Downes, Kate; Kostadima, Myrto; Frontini, Mattia] NHSBT, Cambridge Biomed Campus, Cambridge CB2 0PT, England; [Javierre, Biola M.; Cairns, Jonathan; Wingett, Steven W.; Fraser, Peter; Spivakov, Mikhail] Babraham Inst, Nucl Dynam Programme, Babraham Res Campus, Cambridge CB22 3AT, England; [Grassi, Luigi; Ashford, Sofie; Attwood, Antony; Haimel, Matthias; Meacham, Stuart; Penkett, Christopher J.; Seyres, Denis; Tuna, Salih; Turro, Ernest] Univ Cambridge, NIHR BioResource Rare Dis, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Kreuzhuber, Roman; Clarke, Laura; Flicek, Paul; Stegle, Oliver; Kostadima, Myrto] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge CB10 1SD, England; [Ruklisa, Dace; Richardson, Sylvia; Wernisch, Lorenz; Turro, Ernest; Astle, William J.] Univ Cambridge, Med Res Council Biostat Unit, Forvie Site,Cambridge Biomed Campus, Cambridge CB2 0SR, England; [Elding, Heather; Bouman, Heleen; Mead, Daniel; Danesh, John; Soranzo, Nicole; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Dept Human Genet, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Elding, Heather; Danesh, John; Soranzo, Nicole; Butterworth, Adam S.; Ouwehand, Willem H.] Univ Cambridge, Donor Hlth & Genom, Blood & Transplant Unit, NIHR,Strangeways Res Lab, Cambridge CB1 8RN, England; [van Geffen, Johanna P.; Nagy, Magdolna; Heemskerk, Johan W.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, POB 616, NL-6200 MD Maastricht, Netherlands; [Jiang, Tao; Sun, Benjamin; Danesh, John; Butterworth, Adam S.; Astle, William J.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, MRC,BHF,Strangeways Res Lab, Cambridge CB1 8RN, England; [Al-Subaie, Abeer M.] Univ Dammam, Coll Appl Med Sci, Dept Clin Lab Sci, POB 1982, Dammam 31441, Saudi Arabia; [Haimel, Matthias] Univ Cambridge, Dept Med, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Lenaerts, An-Sofie; Materek, Paulina M.] Univ Cambridge, Dept Surg, NIHR Cambridge Biomed Res Ctr hIPSC Core Facil, Cambridge Biomed Campus, Cambridge CB2 0SZ, England; [Lenaerts, An-Sofie; Materek, Paulina M.; Vallier, Ludovic] Univ Cambridge, Dept Surg, Wellcome Trust & MRC Cambridge Stem Cell Inst, Cambridge Biomed Campus, Cambridge CB2 0SZ, England; [Rendon, Augusto] Queen Mary Univ London, Genom England Ltd, Dawson Hall, London EC1M 6BQ, England; [Martens, Joost H.; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, NL-6525 GA Nijmegen, Netherlands; [Vallier, Ludovic] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Roberts, David J.] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford OX9 3DU, England; [Roberts, David J.] Churchill Hosp, Dept Haematol, Oxford OX3 7LE, England; [Roberts, David J.] John Radcliffe Hosp, NHSBT, Oxford OX3 9BQ, England; [Freson, Kathleen] Univ Leuven, Ctr Mol & Vasc Biol, Dept Cardiovasc Sci, B-3000 Louvain, Belgium; [Danesh, John; Soranzo, Nicole; Butterworth, Adam S.; Ouwehand, Willem H.; Astle, William J.; Frontini, Mattia] Addenbrookes Hosp, Div Cardiovasc Med, BHF Ctr Excellence, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Fraser, Peter] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32303 USA	Kostadima, M; Frontini, M (reprint author), Univ Cambridge, Dept Haematol, Cambridge Biomed Campus, Cambridge CB2 0PT, England.; Spivakov, M; Kostadima, M; Frontini, M (reprint author), NHSBT, Cambridge Biomed Campus, Cambridge CB2 0PT, England.; Spivakov, M (reprint author), Babraham Inst, Nucl Dynam Programme, Babraham Res Campus, Cambridge CB22 3AT, England.; Frontini, M (reprint author), Addenbrookes Hosp, Div Cardiovasc Med, BHF Ctr Excellence, Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	Mikhail.Spivakov@babraham.ac.uk; kostadim@ebi.ac.uk; mf471@cam.ac.uk		Meacham, Stuart/0000-0002-3667-6059; Butterworth, Adam/0000-0002-6915-9015; Cairns, Jonathan/0000-0002-9982-1401; Grassi, Luigi/0000-0002-6308-7540; Clarke, Laura/0000-0002-5989-6898; freson, kathleen/0000-0002-4381-2442	European Commission 7th Framework Program (FP7) [282510]; NHS Health Education England; British Heart Foundation (BHF) Cambridge Centre of Excellence [RE/13/6/30180]; Isaac Newton fellowship; Bristol Myers-Squibb; BHF; European Commission; MRC; NIHR; NHS Blood and Transplant (NHSBT); European Union's Horizon research and innovation programme [692041]; ERC grant Relieve IMDs [ERC-2011-StG]; NIHR Cambridge Biomedical Research Centre (BRC) hIPSCs core facility; MRC [MR/L007150/1, G0800270]; Biotechnology and Biological Sciences Research Council [BB/J004480/1]; FWO-Vlaanderen [G.0B17.13N]; BOF KULeuven [OT/14/098]; Wellcome Trust [WT095908]; European Molecular Biology Laboratory; BHF [SP/09/002]; NIHR Cambridge BRC; European Research Council [268834]; European Commission FP7 [HEALTH-F2-2012-279233]; Merck; Pfizer; NHSBT	We gratefully acknowledge the participation of National Institute of Health Research (NIHR) Cambridge BioResource volunteers and thank the NIHR Cambridge BioResource staff for their support for the recall study of genotyped subjects. The work was funded by a grant from the European Commission 7th Framework Program (FP7/2007-2013, grant 282510, BLUEPRINT). F.A.C. is a Medical Research Council (MRC) clinical fellow (MR/K024043/1); K.D. is a HTSS trainee supported by NHS Health Education England; M.F. is supported by the British Heart Foundation (BHF) Cambridge Centre of Excellence (RE/13/6/30180); D.S. is funded by an Isaac Newton fellowship to M.F.; research in the W.H.O. laboratory is also supported by grants from Bristol Myers-Squibb, BHF, European Commission, MRC, NIHR (W.H.O. is NIHR Senior Investigator) and NHS Blood and Transplant (NHSBT). R.P. is supported by the European Union's Horizon 2020 research and innovation programme under grant agreement number 692041 (TrainMALTA, H2020-TWINN-2015). L.V. is funded by the ERC grant Relieve IMDs (ERC-2011-StG). P.M. and A.-S.L. are funded by the NIHR Cambridge Biomedical Research Centre (BRC) hIPSCs core facility. B.M.J., P. Fraser and M.S. are supported by the MRC (MR/L007150/1) and Biotechnology and Biological Sciences Research Council (BB/J004480/1). K.F. is funded by FWO-Vlaanderen (G.0B17.13N) and BOF KULeuven (OT/14/098). Work at EMBL-EBI received additional support from the Wellcome Trust (WT095908) to P. Flicek and from the European Molecular Biology Laboratory to L.C., M.K., P. Flicek and O.S. The MRC/BHF Cardiovascular Epidemiology receives core support from the MRC (G0800270), the BHF (SP/09/002), the NIHR and NIHR Cambridge BRC, as well as grants from the European Research Council (268834), the European Commission FP7 (HEALTH-F2-2012-279233), Merck and Pfizer. J.D. is a BHF Professor, European Research Council Senior Investigator, and NIHR Senior Investigator. The NIHR Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge is funded by NIHR and NHSBT. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health of England or NHSBT.	Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Barutcu AR, 2016, J CELL PHYSIOL, V231, P31, DOI 10.1002/jcp.25062; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Cabrera C. P., G3 BETHESDA, V2, P1067; Cairns J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0992-2; Chen L, 2014, SCIENCE, V345, P1580, DOI 10.1126/science.1251033; Cvejic A, 2013, NAT GENET, V45, P542, DOI 10.1038/ng.2603; D'Andrea D, 2013, NUCLEIC ACIDS RES, V41, pW84, DOI 10.1093/nar/gkt516; de Witt SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5257; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Ghirlando R, 2016, GENE DEV, V30, P881, DOI 10.1101/gad.277863.116; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Jones CI, 2009, BLOOD, V114, P1405, DOI 10.1182/blood-2009-02-202614; Kaushansky K, 2006, NEW ENGL J MED, V354, P2034, DOI 10.1056/NEJMra052706                                                            ; Kautz L, 2014, BLOOD, V124, P479, DOI 10.1182/blood-2014-05-516252; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Moreau T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11208; Nurnberg ST, 2012, BLOOD, V120, P4859, DOI 10.1182/blood-2012-01-401893; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Paul DS, 2013, GENOME RES, V23, P1130, DOI 10.1101/gr.155127.113; Paul DS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002139; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stunnenberg HG, 2016, CELL, V167, P1897, DOI 10.1016/j.cell.2016.12.002; Turro E, 2014, BIOINFORMATICS, V30, P180, DOI 10.1093/bioinformatics/btt624; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Van Kruchten R, 2012, PLATELETS, V23, P229, DOI 10.3109/09537104.2011.630848; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zerbino DR, 2014, BIOINFORMATICS, V30, P1008, DOI 10.1093/bioinformatics/btt737; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2016, NUCLEIC ACIDS RES, V44, P6721, DOI 10.1093/nar/gkw278	51	0	0	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JUL 13	2017	8								16058	10.1038/ncomms16058				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FA4GK	WOS:000405401600001	28703137				2018-01-05	
J	Parmar, N; Singh, KH; Sharma, D; Singh, L; Kumar, P; Nanjundan, J; Khan, YJ; Chauhan, DK; Thakur, AK				Parmar, Nehanjali; Singh, Kunwar Harendra; Sharma, Deepika; Singh, Lal; Kumar, Pankaj; Nanjundan, J.; Khan, Yasin Jeshima; Chauhan, Devendra Kumar; Thakur, Ajay Kumar			Genetic engineering strategies for biotic and abiotic stress tolerance and quality enhancement in horticultural crops: a comprehensive review	3 BIOTECH			English	Review						Genetic engineering; Horticultural crops; Abiotic and biotic stresses; Quality improvement; Genome editing	TRANSGENIC POTATO PLANTS; AGROBACTERIUM-MEDIATED TRANSFORMATION; TRICHODERMA-HARZIANUM ENDOCHITINASE; ISOPENTENYL TRANSFERASE GENE; SELECTABLE MARKER GENES; IN-VITRO ORGANOGENESIS; CAPSICUM-ANNUUM L.; CV KANDHARI KABULI; VITIS-VINIFERA L.; TOMATO PLANTS	Genetic engineering technique offers myriads of applications in improvement of horticultural crops for biotic and abiotic stress tolerance, and produce quality enhancement. During last two decades, a large number of transgenic horticultural crops has been developed and more are underway. A number of genes including natural and synthetic Cry genes, protease inhibitors, trypsin inhibitors and cystatin genes have been used to incorporate insect and nematode resistance. For providing protection against fungal and bacterial diseases, various genes like chitinase, glucanase, osmotin, defensin and pathogenesis-related genes are being transferred to many horticultural crops world over. RNAi technique has been found quite successful in inducing virus resistance in horticultural crops in addition to coat protein genes. Abiotic stresses such as drought, heat and salinity adversely affect production and productivity of horticultural crops and a number of genes encoding for biosynthesis of stress protecting compounds including mannitol, glycine betaine and heat shock proteins have been employed for abiotic stress tolerance besides various transcription factors like DREB1, MAPK, WRKY, etc. Antisense gene and RNAi technologies have revolutionized the pace of improvement of horticultural crops, particularly ornamentals for color modification, increasing shelf-life and reducing post-harvest losses. Precise genome editing tools, particularly CRISPR/Cas9, have been efficiently applied in tomato, petunia, citrus, grape, potato and apple for gene mutation, repression, activation and epigenome editing. This review provides comprehensive overview to draw the attention of researchers for better understanding of genetic engineering advancements in imparting biotic and abiotic stress tolerance as well as on improving various traits related to quality, texture, plant architecture modification, increasing shelf-life, etc. in different horticultural crops.	[Parmar, Nehanjali] Dr Yashwant Singh Parmar Univ Hort & Forestry, Solan 173230, HP, India; [Singh, Kunwar Harendra; Sharma, Deepika; Singh, Lal; Thakur, Ajay Kumar] ICAR Directorate Rapeseed Mustard Res, Bharatpur 321303, Rajasthan, India; [Kumar, Pankaj] Natl Inst Plant Genome Res, New Delhi 110067, India; [Nanjundan, J.] ICAR Indian Agr Res Inst, The Nilgiris 643231, Tamil Nadu, India; [Khan, Yasin Jeshima] ICAR Natl Bur Plant Genet Resources, Div Genom Resources, PUSA Campus, New Delhi 110012, India; [Chauhan, Devendra Kumar] Sher E Kashmir Univ Agr Sci & Technol Jammu, Div Plant Breeding & Genet, Jammu 180009, J&K, India	Parmar, N (reprint author), Dr Yashwant Singh Parmar Univ Hort & Forestry, Solan 173230, HP, India.	nehanjalibtc@gmail.com					Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Aida R, 2008, PLANT BIOTECHNOL, V25, P55, DOI 10.5511/plantbiotechnology.25.55; AKAMA K, 1995, PLANT CELL REP, V14, P450, DOI 10.1007/BF00234053; Ali Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0799-6; ARAKI H, 1985, J MOL BIOL, V182, P191, DOI 10.1016/0022-2836(85)90338-9                                                    ; Asao H., 1997, PLANT BIOTECHNOL-NAR, V14, P145; Aslam J., 2015, Plant Science Today, V2, P93, DOI 10.14719/pst.2015.2.3.119; Atkinson HJ, 2004, TRANSGENIC RES, V13, P135, DOI 10.1023/B:TRAG.0000026070.15253.88; Azadi P, 2011, BIOTECHNOL LETT, V33, P1249, DOI 10.1007/s10529-011-0550-7; Ballester A, 2007, PLANT CELL REP, V26, P39, DOI 10.1007/s00299-006-0197-3; Baltes NJ, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.145; Baranski R, 2008, J PHYTOPATHOL, V156, P513, DOI 10.1111/j.1439-0434.2008.01417.x; BARRY GF, 1984, P NATL ACAD SCI-BIOL, V81, P4776, DOI 10.1073/pnas.81.15.4776; Behboodian B, 2012, SCI WORLD J, DOI 10.1100/2012/439870; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; BEVAN MW, 1983, NATURE, V304, P184, DOI 10.1038/304184a0                                                                ; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; Bojorquez-Quintal E, 2014, FRONT PLANT SCI, V5, P10; Bolar JP, 2001, TRANSGENIC RES, V10, P533, DOI 10.1023/A:1013036732691; Borkowska M, 1998, Z NATURFORSCH C, V53, P1012; Borth W., 2011, Acta Horticulturae, P449; Boston RS, 1996, MOL CHAPERONES PROTE, P191; Bovy AG, 1999, MOL BREEDING, V5, P301, DOI 10.1023/A:1009617804359                                                         ; Bulle M, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0451-5; Cardi T, 2016, PLANT CELL REP, V35, P1401, DOI 10.1007/s00299-016-1975-1; Ceasar SA, 2012, BIOTECHNOL LETT, V34, P995, DOI 10.1007/s10529-012-0871-1; Cervera M, 2000, J HORTIC SCI BIOTECH, V75, P26, DOI 10.1080/14620316.2000.11511195                                                  ; Chaitanya KV, 2002, PLANT GROWTH REGUL, V36, P175, DOI 10.1023/A:1015092628374; Chakrabarty R, 2002, J BIOSCIENCES, V27, P495, DOI 10.1007/BF02705046; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Checker VG, 2012, TRANSGENIC RES, V21, P939, DOI 10.1007/s11248-011-9577-8; Chen JR, 2016, J PLANT GROWTH REGUL, V35, P586, DOI 10.1007/s00344-015-9564-z; Chen XK, 2012, MOL BIOL REP, V39, P8083, DOI 10.1007/s11033-012-1655-3; Cheng L, 2009, J INTEGR PLANT BIOL, V51, P489, DOI 10.1111/j.1744-7909.2009.00816.x; Cheng SY, 2016, PLANTA, V243, P1041, DOI 10.1007/s00425-015-2459-1; Cheng YJ, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-30; Clark DG, 2003, PLANT BIOTECHNOLOGY 2002 AND BEYOND, P337; Clarke JL, 2008, PLANT CELL REP, V27, P1027, DOI 10.1007/s00299-008-0526-9; Collinge DB, 2010, ANNU REV PHYTOPATHOL, V48, P269, DOI 10.1146/annurev-phyto-073009-114430; DALE EC, 1991, P NATL ACAD SCI USA, V88, P10558, DOI 10.1073/pnas.88.23.10558; Das DK, 2010, CURR TRENDS BIOTENOL, V41, P820; Das M, 2011, TRANSGENIC RES, V20, P231, DOI 10.1007/s11248-010-9405-6; Das MP, 2012, J CHEM PHARM RES, V4, P969; Davuluri GR, 2005, NAT BIOTECHNOL, V23, P890, DOI 10.1038/nbt1108; de Carvalho K, 2013, MOL BIOL REP, V40, P3269, DOI 10.1007/s11033-012-2402-5; de Vetten N, 2003, NAT BIOTECHNOL, V21, P439, DOI 10.1038/nbt801; Degenhardt J, 2007, ACTA HORTIC, P287, DOI 10.17660/ActaHortic.2007.738.31                                                 ; Degenhardt J, 2006, ACTA HORTIC, P811, DOI 10.17660/ActaHortic.2006.725.113                                                ; Dhekney SA, 2011, IN VITRO CELL DEV-PL, V47, P458, DOI 10.1007/s11627-011-9358-3; Ding LC, 1998, PLANT CELL REP, V17, P854, DOI 10.1007/s002990050497                                                           ; Distefano G, 2008, TRANSGENIC RES, V17, P873, DOI 10.1007/s11248-008-9172-9; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Dutt M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137134; Ebinuma H, 1997, P NATL ACAD SCI USA, V94, P2117, DOI 10.1073/pnas.94.6.2117; Escobar MA, 2001, P NATL ACAD SCI USA, V98, P13437, DOI 10.1073/pnas.241276898; Fagoaga C, 2001, MOL BREEDING, V7, P175, DOI 10.1023/A:1011358005054; Fan QQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150572; Fan WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037344; Finstad K, 1995, ACTA HORTIC, V385, P6; FISCHHOFF DA, 1987, BIO-TECHNOL, V5, P807, DOI 10.1038/nbt0887-807; Flachowsky H, 2010, PLANTA, V231, P623, DOI 10.1007/s00425-009-1074-4; de Campos MKF, 2011, ENVIRON EXP BOT, V72, P242, DOI 10.1016/j.envexpbot.2011.03.009; Galambos A, 2013, PLANT CELL REP, V32, P1751, DOI 10.1007/s00299-013-1488-0; Gangadhar BH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01228; Gao H, 2012, PLANT CELL REP, V28, P223; Gessler C, 2007, ADV BIOCHEM ENG BIOT, V107, P113, DOI 10.1007/10_2007_053; Ghag SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039557; Girhepuje PV, 2011, PLANT CELL TISS ORG, V105, P243, DOI 10.1007/s11240-010-9859-5; Gleave AP, 1999, PLANT MOL BIOL, V40, P223, DOI 10.1023/A:1006184221051; Graham J, 2002, J HORTIC SCI BIOTECH, V77, P33, DOI 10.1080/14620316.2002.11511453                                                  ; Han BH, 2007, SCI HORTIC-AMSTERDAM, V115, P70, DOI 10.1016/j.scienta.2007.07.012; Han JS, 2015, PLANT BREEDING, V134, P233, DOI 10.1111/pbr.12253; Hare PD, 2002, NAT BIOTECHNOL, V20, P575, DOI 10.1038/nbt0602-575; Hazarika Pranjal, 2011, Physiology and Molecular Biology of Plants, V17, P115, DOI 10.1007/s12298-011-0053-y; HE H, 2013, PLOS ONE, V0008; HOLTON TA, 1993, PLANT J, V4, P1003, DOI 10.1046/j.1365-313X.1993.04061003.x; Husaini AM, 2008, INDIAN J BIOTECHNOL, V7, P465; Islam Aparna, 2006, Plant Tissue Culture & Biotechnology, V16, P117; James C., 1996, GLOBAL REV FIELD TES, P1; Jiang BB, 2010, PLANT MOL BIOL REP, V28, P144, DOI 10.1007/s11105-009-0130-3; Jin WM, 2009, HORTSCIENCE, V44, P35; Jiwan D, 2013, TRANSGENIC RES, V22, P1119, DOI 10.1007/s11248-013-9715-6; Jones HD, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2014.11, 10.1038/nplants.2014.11]; Joshi SG, 2009, ACTA HORTIC, V839, P403; Josine T. L., 2015, International Journal of Agriculture and Crop Sciences (IJACS), V8, P463; Kathryn KK, 2008, NELLIE WHITE HORTIC, V43, P1864; Katsumoto Y, 2007, PLANT CELL PHYSIOL, V48, P1589, DOI 10.1093/pcp/pcm131; Kaur P, 2010, J PLANT BIOCHEM BIOT, V19, P177, DOI 10.1007/BF03263338                                                              ; Keen NT, 1993, PLANT PHYSIOL, V71, P460; Khan H, 2011, J PLANT BIOCHEM BIOT, V20, P84, DOI 10.1007/s13562-010-0029-y; Khan RS, 2010, BIOL PLANTARUM, V54, P265, DOI 10.1007/s10535-010-0046-7; Khan RS, 2008, PLANT BIOTECHNOL REP, V2, P13, DOI 10.1007/s11816-008-0043-x; Khan RS, 2011, PLANT CELL REP, V30, P1041, DOI 10.1007/s00299-011-1011-4; Khare N, 2010, PLANT CELL TISS ORG, V103, P267, DOI 10.1007/s11240-010-9776-7; Khodakovskaya M, 2009, PLANT CELL REP, V28, P1351, DOI 10.1007/s00299-009-0735-x; Khurana Paramjit, 2008, Physiol Mol Biol Plants, V14, P277, DOI 10.1007/s12298-008-0026-y; Kishi-Kaboshi M, 2017, PLANT CELL PHYSIOL, V58, P216, DOI 10.1093/pcp/pcw222; Ko M, 2016, PLANTA, V244, P379, DOI 10.1007/s00425-016-2514-6; Kothari SL, 2010, BIOTECHNOL ADV, V28, P35, DOI 10.1016/j.biotechadv.2009.08.005; Kumar PA, 1998, MOL BREEDING, V4, P33, DOI 10.1023/A:1009694016179; Kumar P, 2015, PHYSIOL MOL BIOL PLA, V21, P279, DOI 10.1007/s12298-015-0282-6; Le HG, 2011, PLANTA, V234, P405; Lee YH, 2009, PLANT CELL REP, V28, P223, DOI 10.1007/s00299-008-0637-3; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li PL, 2015, PLANT PHYSIOL BIOCH, V95, P26, DOI 10.1016/j.plaphy.2015.07.002; Li YH, 2010, PLANT CELL TISS ORG, V102, P337, DOI 10.1007/s11240-010-9738-0; Lilley CJ, 2004, PLANT BIOTECHNOL J, V2, P3, DOI 10.1046/j.1467-7652.2003.00037.x; Lim MY, 2016, PLANT BIOTECHNOL REP, V10, P105, DOI 10.1007/s11816-016-0392-9; Lin WC, 2004, TRANSGENIC RES, V13, P567, DOI 10.1007/s11248-004-2375-9                                                       ; Lindow S, 2014, MOL PLANT MICROBE IN, V27, P244, DOI 10.1094/MPMI-07-13-0197-FI; Lorito M, 1998, P NATL ACAD SCI USA, V95, P7860, DOI 10.1073/pnas.95.14.7860; Lu CY, 2003, PLANT BIOTECHNOLOGY 2002 AND BEYOND, P333; Lurquin P, 2002, HIGH TECH HARVEST UN; Malnoy M., 2007, Plant Breeding Reviews, V29, P315, DOI 10.1002/9780470168035.ch6; Malnoy M, 2007, MOL PLANT MICROBE IN, V20, P1568, DOI 10.1094/MPMI-20-12-1568; Malnoy M, 2008, MOL PLANT MICROBE IN, V21, P448, DOI 10.1094/MPMI-21-4-0448; Malnoy M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01904; Markwick NP, 2003, TRANSGENIC RES, V12, P671, DOI 10.1023/B:TRAG.0000005103.83019.51; Martinelli A, 1997, ACTA HORTIC, V439, P169; Martinez-Estevez M, 2014, FRONT PLANT SCI, V5, P10; Mercado J.A., 2007, ACTA HORTIC, V738, P383; Mercado JA, 2015, TRANSGENIC RES, V24, P979, DOI 10.1007/s11248-015-9895-3; MEYER P, 1987, NATURE, V330, P677, DOI 10.1038/330677a0; Minlong Cui, 2000, Plant Science (Shannon), V159, P273, DOI 10.1016/S0168-9452(00)00351-4; Mishra M, 2016, CZECH J GENET PLANT, V52, P6, DOI 10.17221/74/2015-CJGPB; Missiou A, 2004, MOL BREEDING, V14, P185, DOI 10.1023/B:MOLB.0000038006.32812.52; Mondal SN, 2012, EUR J PLANT PATHOL, V133, P391, DOI 10.1007/s10658-011-9912-1; Mora AA, 2001, MOL BREEDING, V8, P1, DOI 10.1023/A:1011913100783; Moravcikova J, 2004, PLANT CELL TISS ORG, V79, P161, DOI 10.1007/s11240-004-0656-x; Naing AH, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-015-2059-5; Najar A. G., 2011, Journal of Phytology, V3, P31; Nakamura Y, 1999, PLANT CELL REP, V18, P527, DOI 10.1007/s002990050616; Nambeesan S, 2010, PLANT J, V63, P836, DOI 10.1111/j.1365-313X.2010.04286.x; Namukwaya B, 2012, TRANSGENIC RES, V21, P855, DOI 10.1007/s11248-011-9574-y; Narendran M, 2013, PLANT CELL REP, V32, P1191, DOI 10.1007/s00299-013-1415-4; Nehanjali Parmar, 2015, Vegetos, V28, P160, DOI 10.5958/2229-4473.2015.00051.8; Nishitani C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31481; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Pandolfini T, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-7                                                           ; Papolu PK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01122; Park S, 2005, PLANT PHYSIOL, V139, P1194, DOI 10.1104/pp.105.066266; Parmar N, 2013, P NATL A SCI INDIA B, V83, P569, DOI 10.1007/s40011-013-0178-6; Parmar N, 2012, NATL ACAD SCI LETT, V35, P215, DOI 10.1007/s40009-012-0041-y; Pasquali G, 2008, PLANT CELL REP, V27, P1677, DOI 10.1007/s00299-008-0587-9; Paul Anderson, 2005, Indian Journal of Biotechnology, V4, P72; Pessina S, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.16; Petty LM, 2003, PLANT SCI, V164, P175, DOI 10.1016/S0168-9452(02)00380-1; Praveen S, 2010, TRANSGENIC RES, V19, P45, DOI 10.1007/s11248-009-9291-y; Puchta H, 2000, TRENDS PLANT SCI, V5, P273, DOI 10.1016/S1360-1385(00)01684-8                                                   ; Punja ZK, 1996, PLANT DIS, V80, P999, DOI 10.1094/PD-80-0999                                                              ; Qu SC, 2009, J AGR SCI TECHNOL, V11, P36; Rai MK, 2011, ENVIRON EXP BOT, V71, P89, DOI 10.1016/j.envexpbot.2010.10.021; Ren C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32289; Rengasamy P, 2006, J EXP BOT, V57, P1017, DOI 10.1093/jxb/erj108; Rivera Domínguez Marisela, 2011, Rev. mex. fitopatol, V29, P78; Robson PRH, 1996, NAT BIOTECHNOL, V14, P995, DOI 10.1038/nbt0896-995; Roderick H, 2012, MOL PLANT PATHOL, V13, P842, DOI 10.1111/j.1364-3703.2012.00792.x; Rustaee M., 2007, International Journal of Agriculture and Biology, V9, P775; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Sajeevan RS, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00418; SAVIN KW, 1995, HORTSCIENCE, V30, P970; Schestibratov KA, 2005, SCI HORTIC-AMSTERDAM, V106, P177, DOI 10.1016/j.scienta.2005.03.016; SHAH DM, 1986, SCIENCE, V233, P478, DOI 10.1126/science.233.4762.478                                                    ; Sharma Sarita, 2006, Crop Improvement, V33, P1; Shekhawat UKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075506; Shekhawat UKS, 2012, J GEN VIROL, V93, P1804, DOI 10.1099/vir.0.041871-0; Shekhawat UKS, 2011, PLANTA, V234, P915, DOI 10.1007/s00425-011-1455-3; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Shin R, 2002, MOL PLANT MICROBE IN, V15, P983, DOI 10.1094/MPMI.2002.15.10.983; Shingles J, 2007, EXP PARASITOL, V115, P114, DOI 10.1016/j.exppara.2006.07.008; Singh D, 2014, PHYSIOL MOL BIOL PLA, V20, P143, DOI 10.1007/s12298-014-0225-7; Singh S, 2010, J PLANT BIOCHEM BIOT, V19, P195, DOI 10.1007/BF03263340                                                              ; SMITH CJS, 1988, NATURE, V334, P724, DOI 10.1038/334724a0; Song AP, 2014, INT J MOL SCI, V15, P5063, DOI 10.3390/ijms15035063; Song GY, 2016, CROP J, V4, P75, DOI 10.1016/j.cj.2015.12.002; Sreedharan S, 2012, PLANT MOL BIOL, V80, P503, DOI 10.1007/s11103-012-9964-4; Sripaoraya S, 2006, PLANT BREEDING, V125, P411, DOI 10.1111/j.1439-0523.2006.01229.x; Stewart RJ, 2001, AUST J PLANT PHYSIOL, V28, P181, DOI 10.1071/PP00094; Subramanyam K, 2011, PLANT CELL TISS ORG, V105, P181, DOI 10.1007/s11240-010-9850-1; Sugita K, 1999, PLANT CELL REP, V18, P941, DOI 10.1007/s002990050688; Sun L, 2009, PLANT MOL BIOL REP, V27, P102, DOI 10.1007/s11105-008-0062-3; Suzuki JY, 2008, 2 INT S PAP 9 12 DEC, P56; Szankowski I, 2009, TREE GENET GENOMES, V5, P349, DOI 10.1007/s11295-008-0191-8; Tanaka Y, 2005, PLANT CELL TISS ORG, V80, P1, DOI 10.1007/s11240-004-0739-8; Tang L, 2006, PLANT CELL REP, V25, P1380, DOI 10.1007/s00299-006-0199-1; Tao R, 1997, J AM SOC HORTIC SCI, V122, P764; Thirukkumaran G, 2009, PLANT CELL TISS ORG, V97, P237, DOI 10.1007/s11240-009-9519-9; Tian SW, 2017, PLANT CELL REP, V36, P399, DOI 10.1007/s00299-016-2089-5; Tripathi L, 2009, PLANT DIS, V93, P440, DOI 10.1094/PDIS-93-5-0440; Tsai-Hung H, 2002, PLANT PHYSIOL, V130, P618; Ueta R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00501-4; Valizadeh M., 2013, African Journal of Biotechnology, V12, P6922; Vanblaere T, 2011, J BIOTECHNOL, V154, P304, DOI 10.1016/j.jbiotec.2011.05.013; VANDERKROL AR, 1988, NATURE, V333, P866, DOI 10.1038/333866a0                                                                ; Vasudevan A., 2007, American Journal of Biochemistry and Biotechnology, V3, P24; Vellicce GR, 2006, TRANSGENIC RES, V15, P57, DOI 10.1007/s11248-005-2543-6; Vieira P, 2015, TRANSGENIC RES, V24, P421, DOI 10.1007/s11248-014-9848-2; Wally O, 2009, PLANTA, V231, P131, DOI 10.1007/s00425-009-1031-2; Wang RK, 2012, PLANT MOL BIOL, V79, P123, DOI 10.1007/s11103-012-9899-9; Wang Y. J., 2006, Journal of Applied Horticulture (Lucknow), V8, P87; Wang YJ, 2005, J AM SOC HORTIC SCI, V130, P167; Wen XP, 2010, TRANSGENIC RES, V19, P91, DOI 10.1007/s11248-009-9296-6; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wisniewski M, 2002, 36 INT HORT C EXH, P147; Xiangdong W., 2007, FRONT BIOL CHINA, V2, P284; Yamamoto T, 2000, PLANT CELL REP, V19, P639, DOI 10.1007/s002999900174; Yarra R, 2012, PLANT CELL TISS ORG, V111, P49, DOI 10.1007/s11240-012-0169-y; YOSHIKAWA M, 1993, NATURWISSENSCHAFTEN, V80, P417, DOI 10.1007/BF01168337; Yu TA, 2011, PLANT CELL REP, V30, P359, DOI 10.1007/s00299-010-0951-4; Zainal Z., 2009, American Journal of Plant Physiology, V4, P70, DOI 10.3923/ajpp.2009.70.79; Zhang HY, 2015, GENET MOL RES, V14, P8483, DOI 10.4238/2015.July.28.16; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhang Y, 2011, SCI HORTIC, V129, P222; Zheng ZL, 2001, J AM SOC HORTIC SCI, V126, P19	214	1	2	69	69	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2190-572X	2190-5738		3 BIOTECH	3 Biotech	JUL 12	2017	7								239	10.1007/s13205-017-0870-y				35	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FA2AE	WOS:000405242100001	28702937				2018-01-05	
J	Chakraborty, AA; Nakamura, E; Qi, J; Creech, A; Jaffe, JD; Paulk, J; Novak, JS; Nagulapalli, K; McBrayer, SK; Cowley, GS; Pineda, J; Song, JX; Wang, YYE; Carr, SA; Root, DE; Signoretti, S; Bradner, JE; Kaelin, WG				Chakraborty, Abhishek A.; Nakamura, Eijiro; Qi, Jun; Creech, Amanda; Jaffe, Jacob D.; Paulk, Joshiawa; Novak, Jesse S.; Nagulapalli, Kshithija; McBrayer, Samuel K.; Cowley, Glenn S.; Pineda, Javier; Song, Jiaxi; Wang, Yaoyu E.; Carr, Steven A.; Root, David E.; Signoretti, Sabina; Bradner, James E.; Kaelin, William G., Jr.			HIF activation causes synthetic lethality between the VHL tumor suppressor and the EZH1 histone methyltransferase	SCIENCE TRANSLATIONAL MEDICINE			English	Article							RENAL-CELL CARCINOMA; ACUTE LYMPHOBLASTIC-LEUKEMIA; EXPRESSION PROFILES; GENE-EXPRESSION; KIDNEY CANCER; BCR-ABL; DEMETHYLASE; HYPOXIA; CHROMATIN; REVEALS	Inactivation of the von Hippel-Lindau tumor suppressor protein (pVHL) is the signature lesion in the most common form of kidney cancer, clear cell renal cell carcinoma (ccRCC). pVHL loss causes the transcriptional activation of hypoxia-inducible factor (HIF) target genes, including many genes that encode histone lysine demethylases. Moreover, chromatin regulators are frequently mutated in this disease. We found that ccRCC displays increased H3K27 acetylation and a shift toward mono-or unmethylated H3K27 caused by an HIF-dependent increase in H3K27 demethylase activity. Using a focused short hairpin RNA library, as well as CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated protein 9) and a pharmacological inhibitor, we discovered that pVHL-defective ccRCC cells are hyperdependent on the H3K27 methyltransferase EZH1 for survival. Therefore, targeting EZH1 could be therapeutically useful in ccRCC.	[Chakraborty, Abhishek A.; Nakamura, Eijiro; Qi, Jun; Paulk, Joshiawa; Novak, Jesse S.; McBrayer, Samuel K.; Pineda, Javier; Song, Jiaxi; Signoretti, Sabina; Bradner, James E.; Kaelin, William G., Jr.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Chakraborty, Abhishek A.; Nakamura, Eijiro; Qi, Jun; Paulk, Joshiawa; McBrayer, Samuel K.; Pineda, Javier; Song, Jiaxi; Signoretti, Sabina; Bradner, James E.; Kaelin, William G., Jr.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02215 USA; [Creech, Amanda; Jaffe, Jacob D.; Cowley, Glenn S.; Carr, Steven A.; Root, David E.; Kaelin, William G., Jr.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Novak, Jesse S.; Song, Jiaxi; Signoretti, Sabina] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Nagulapalli, Kshithija; Wang, Yaoyu E.] Harvard Med Sch, Dana Farber Canc Inst, Ctr Canc Computat Biol, Boston, MA 02215 USA; [Kaelin, William G., Jr.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Nakamura, Eijiro] Kyoto Univ, Med Innovat Ctr, DSK Project, Grad Sch Med, Kyoto 6068397, Japan; [Pineda, Javier] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA	Kaelin, WG (reprint author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Kaelin, WG (reprint author), Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02215 USA.; Kaelin, WG (reprint author), Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA.; Kaelin, WG (reprint author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.; Kaelin, WG (reprint author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	william_kaelin@dfci.harvard.edu			NIH [R01CA068490, P50CA101942]; Friends of Dana-Farber; NIH [Cancer Biology Training grant] [T32CA009361]; NIH [DF/HCC (Dana-Farber/Harvard Cancer Center) Kidney SPORE (Specialized Programs of Research Excellence) Career Enhancement Program award)] [P50CA101942]; American Cancer Society Postdoctoral Fellowship [PF-14-144-01-TBE]	W.G.K. was supported by grants from the NIH (R01CA068490 and P50CA101942). A.A.C. was supported by grants from the "Friends of Dana-Farber" and the NIH [Cancer Biology Training grant T32CA009361 and the DF/HCC (Dana-Farber/Harvard Cancer Center) Kidney SPORE (Specialized Programs of Research Excellence) Career Enhancement Program award P50CA101942]. W.G.K. is a Howard Hughes Medical Institute investigator. S.K.M. was supported by the American Cancer Society Postdoctoral Fellowship award PF-14-144-01-TBE.	Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9                                                   ; Balbas MD, 2013, ELIFE, V2, DOI 10.7554/eLife.00499; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Black JC, 2013, CELL, V154, P541, DOI 10.1016/j.cell.2013.06.051; Burgess MR, 2005, P NATL ACAD SCI USA, V102, P3395, DOI 10.1073/pnas.0409770102; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020                                                    ; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Creech AL, 2015, METHODS, V72, P57, DOI 10.1016/j.ymeth.2014.10.033; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Duns G, 2012, HUM MUTAT, V33, P1059, DOI 10.1002/humu.22090; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Fisher R, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0433-z; Cancer Genome Atlas Research Network, 2013, NATURE, V499, P43; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Hashizume R, 2014, NAT MED, V20, P1394, DOI 10.1038/nm.3716; Henriquez B, 2013, MOL CELL NEUROSCI, V57, P130, DOI 10.1016/j.mcn.2013.07.012; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; Jerby-Arnon L, 2014, CELL, V158, P1199, DOI 10.1016/j.cell.2014.07.027; Kaelin W. G., 2005, KIDNEY CANC PRINCIPL, P31; Kaelin WG, 2017, NAT REV CANCER, V17, P441, DOI 10.1038/nrc.2017.32; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kokura Kenji, 2009, V523, P249, DOI 10.1007/978-1-59745-190-1_17; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Lee HY, 2014, MOL CELLS, V37, P43, DOI 10.14348/molcells.2014.2250; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LJ, 2013, CANCER CELL, V24, P738, DOI 10.1016/j.ccr.2013.10.025; Liu L, 2016, BJU INT, V117, P351, DOI 10.1111/bju.12702; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mousavi K, 2012, MOL CELL, V45, P255, DOI 10.1016/j.molcel.2011.11.019; Hirsila M., 2003, J BIOL CHEM, V278, P30772; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Sanchez-Fernandez EM, 2013, BIOCHEM J, V449, P491, DOI 10.1042/BJ20121155; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Srigley JR, 2013, AM J SURG PATHOL, V37, P1469, DOI 10.1097/PAS.0b013e318299f2d1; Stojic L, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-16; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tausendschon M, 2011, CYTOKINE, V53, P256, DOI 10.1016/j.cyto.2010.11.002; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wagener N, 2008, INT J CANCER, V123, P1545, DOI 10.1002/ijc.23683; Watson JA, 2009, HUM MOL GENET, V18, P3594, DOI 10.1093/hmg/ddp307; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Xu J, 2015, MOL CELL, V57, P304, DOI 10.1016/j.molcel.2014.12.009; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413; Zhou X, 2010, CANCER RES, V70, P4214, DOI 10.1158/0008-5472.CAN-09-2942	60	0	0	5	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	1946-6234	1946-6242		SCI TRANSL MED	Sci. Transl. Med.	JUL 12	2017	9	398							eaal5272	10.1126/scitranslmed.aal5272				14	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	FA2WH	WOS:000405301500004					2018-01-05	
J	Li, J; Liang, C; Zhang, ZK; Pan, XH; Peng, SL; Lee, WS; Lu, AP; Lin, ZX; Zhang, G; Leung, WN; Zhang, BT				Li, Jie; Liang, Chao; Zhang, Zong-Kang; Pan, Xiaohua; Peng, Songlin; Lee, Wing-Sze; Lu, Aiping; Lin, Zhixiu; Zhang, Ge; Leung, Wing-Nang; Zhang, Bao-Ting			TAK1 inhibition attenuates both inflammation and fibrosis in experimental pneumoconiosis	CELL DISCOVERY			English	Article						TAK1; inflammation; fibrosis; pneumoconiosis	NF-KAPPA-B; ALLERGIC AIRWAY INFLAMMATION; COAL-WORKERS PNEUMOCONIOSIS; BETA-ACTIVATED KINASE-1; SILICA INHALATION; LUNG-DISEASE; TGF-BETA; IN-VITRO; ALVEOLAR MACROPHAGES; GENE-EXPRESSION	Pneumoconiosis, caused by inhalation of mineral dusts, is a major occupational disease worldwide. Currently, there are no effective drugs owing to a lack of potential therapeutic targets during either the inflammation or fibrosis molecular events in pneumoconiosis. Here, we performed microarrays to identify aberrantly expressed genes in the above molecular events in vitro and found a hub gene transforming growth factor-beta-activated kinase 1 (TAK1), which was highly expressed and activated in pneumoconiosis patients as well as silica-exposed rats with experimental pneumoconiosis. Genetic modulation of TAK1 by CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9, RNA interference and overexpression indicated the important role of TAK1 in both inflammation and fibrosis in experimental pneumoconiosis. To achieve pharmacological TAK1 inhibition, we virtually screened out a natural product resveratrol, which targeted TAK1 at both N161 and A107 residues, and significantly inhibited TAK1 activation to attenuate inflammation and fibrosis in vitro. Consistently, in vivo prevention and intervention studies showed that resveratrol could inhibit pulmonary inflammation and fibrosis in silica-exposed rats.	[Li, Jie; Zhang, Zong-Kang; Lee, Wing-Sze; Lin, Zhixiu; Leung, Wing-Nang; Zhang, Bao-Ting] Chinese Univ Hong Kong, Fac Med, Sch Chinese Med, Sha Tin, Hong Kong, Peoples R China; [Liang, Chao; Lu, Aiping; Zhang, Ge] Hong Kong Baptist Univ, Sch Chinese Med, Inst Integrated Bioinformed & Translat Sci IBTS, Kowloon Tong, Hong Kong, Peoples R China; [Liang, Chao; Lu, Aiping; Zhang, Ge] Hong Kong Baptist Univ, Sch Chinese Med, Law Sau Fai Inst Adv Translat Med Bone & Joint Di, Kowloon Tong, Hong Kong, Peoples R China; [Pan, Xiaohua] Shenzhen Baoan Dist Peoples Hosp, Dept Surg, Shenzhen, Peoples R China; [Peng, Songlin] Jinan Univ, Sch Med, Shenzhen Peoples Hosp, Dept Surg, Shenzhen, Peoples R China	Leung, WN; Zhang, BT (reprint author), Chinese Univ Hong Kong, Fac Med, Sch Chinese Med, Sha Tin, Hong Kong, Peoples R China.; Zhang, G (reprint author), Hong Kong Baptist Univ, Sch Chinese Med, Inst Integrated Bioinformed & Translat Sci IBTS, Kowloon Tong, Hong Kong, Peoples R China.; Zhang, G (reprint author), Hong Kong Baptist Univ, Sch Chinese Med, Law Sau Fai Inst Adv Translat Med Bone & Joint Di, Kowloon Tong, Hong Kong, Peoples R China.	zhangge@hkbu.edu.hk; awnleung@cuhk.edu.hk; zhangbaoting@cuhk.edu.hk	Lin, Zhi-Xiu/H-2807-2016; Zhang, Baoting/B-6273-2015	ZHANG, Ge/0000-0002-7807-7695	Pneumoconiosis Compensation Fund Board of Hong Kong [MK/AL/extgrant/PCFB//0325/11sh]; Hong Kong Research Grant Council Early Career Scheme [489213]; Direct Grant for Research from the Chinese University of Hong Kong [4054138]	This study was supported by the Pneumoconiosis Compensation Fund Board of Hong Kong (MK/AL/extgrant/PCFB//0325/11sh), the Hong Kong Research Grant Council Early Career Scheme (489213) and the Direct Grant for Research from the Chinese University of Hong Kong (4054138). The statistical analysis was performed by a contract service from Bioinformedicine (http://www.bioinformedicine.com/index.php).	Ajibade AA, 2013, TRENDS IMMUNOL, V34, P307, DOI 10.1016/j.it.2013.03.007; Boehme JD, 2015, LUNG, V193, P947, DOI 10.1007/s00408-015-9797-4; Brichet A, 2002, SARCOIDOSIS VASC DIF, V19, P211; Britton RG, 2015, ANN NY ACAD SCI, V1348, P124, DOI 10.1111/nyas.12796; Cao H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14593; Castranova V, 2002, MOL CELL BIOCHEM, V234, P177, DOI 10.1023/A:1015967017103; Castranova V, 2000, ENVIRON HEALTH PERSP, V108, P675, DOI 10.2307/3454404; Chang CK, 2008, J CELL MOL MED, V12, P2781, DOI 10.1111/j.1582-4934.2008.00215.x; Chen F, 1997, AM J PHYSIOL-LUNG C, V272, pL779; Chiva-Blanch G, 2011, J CHROMATOGR A, V1218, P698, DOI 10.1016/j.chroma.2010.12.012; Cho HY, 2003, TOXICOL LETT, V143, P323, DOI 10.1016/S0378-4274(03)00193-0; Choi ME, 2012, SEMIN NEPHROL, V32, P244, DOI 10.1016/j.semnephrol.2012.04.003; Cortez-Retamozo V, 2008, J CLIN INVEST, V118, P4058, DOI 10.1172/JCI36335; Ding X, 2014, J PHARMACEUT BIOMED, V100, P150, DOI 10.1016/j.jpba.2014.08.001; DOI T, 1989, J NUTR SCI VITAMINOL, V35, P1; Dvashi Z, 2014, INVEST OPHTH VIS SCI, V55, P5679, DOI 10.1167/iovs.14-14349; Fan YH, 2013, APOPTOSIS, V18, P1224, DOI 10.1007/s10495-013-0864-0; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Gilmer J, 2016, AM J PHYSIOL-LUNG C, V310, pL1071, DOI 10.1152/ajplung.00462.2015; Greenberg MI, 2007, DM-DIS MON, V53, P394, DOI 10.1016/j.disamonth.2007.09.020; Guida N, 2015, TOXICOL APPL PHARM, V288, P387, DOI 10.1016/j.taap.2015.08.010; Gulumian M, 2006, J TOXICOL ENV HEAL B, V9, P357, DOI 10.1080/15287390500196537; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang XZ, 2014, J CELL BIOCHEM, V115, P996, DOI 10.1002/jcb.24748; Huaux F, 2007, CURR OPIN ALLERGY CL, V7, P168, DOI 10.1097/ACI.0b013e32802bf8a5                                                    ; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Kilic A, 2011, J ALLERGY CLIN IMMUN, V128, P1058, DOI 10.1016/j.jaci.2011.06.017; Kilty I, 2015, FUTURE MED CHEM, V7, P23, DOI [10.4155/FMC.14.138, 10.4155/fmc.14.138]; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Kim SI, 2012, KIDNEY RES CLIN PRAC, V31, P94, DOI 10.1016/j.krcp.2012.04.322; Kitamura K, 2014, J CHEM INF MODEL, V54, P1653, DOI 10.1021/ci400719v; Kono Y, 2007, AM J RESP CELL MOL, V37, P395, DOI 10.1165/rcmb.2007-0065OC; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Liu HL, 2007, AM J RESP CELL MOL, V36, P594, DOI 10.1165/rcmb.2006-02970C; Lu Y, 2014, CHEM BIOL, V21, P246, DOI 10.1016/j.chembiol.2013.12.009; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; McKeever T, 2013, CHEST, V144, P1788, DOI 10.1378/chest.13-0871; Mihaly SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094982; Moitra S, 2015, CURR OPIN PULM MED, V21, P114, DOI 10.1097/MCP.0000000000000136; Okada M, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.579961; Painter RC, 2012, BIRTH DEFECTS RES C, V96, P315, DOI 10.1002/bdrc.21021; Peeters PM, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0058-0; Petyaev IM, 2012, HYBRIDOMA, V31, P449, DOI 10.1089/hyb.2012.0007; Pirola L, 2008, IUBMB LIFE, V60, P323, DOI 10.1002/iub.47; Poole JA, 2011, AM J PHYSIOL-LUNG C, V301, pL296, DOI 10.1152/ajplung.00086.2011; Porter DW, 2006, TOXICOL SCI, V90, P188, DOI 10.1093/toxsci/kfj075; Porter DW, 2004, TOXICOL SCI, V79, P370, DOI 10.1093/toxsci/kfh110; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scabilloni JF, 2005, AM J PHYSIOL-LUNG C, V288, pL709, DOI 10.1152/ajplung.00034.2004; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Schreiber MP, 2014, CRIT CARE MED, V42, P1480, DOI 10.1097/CCM.0000000000000247; Seaman DM, 2015, CLIN CHEST MED, V36, P249, DOI 10.1016/j.ccm.2015.02.008; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Sirajuddin A, 2009, J THORAC IMAG, V24, P310, DOI 10.1097/RTI.0b013e3181c1a9b3; Suarthana E, 2007, OCCUP ENVIRON MED, V64, P595, DOI 10.1136/oem.2006.027904; Tajima T, 2005, J ORTHOP RES, V23, P891, DOI 10.1016/j.orthres.2005.01.003; Tse LA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11059; Wendling D, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-10; Wilson AA, 2010, J CLIN INVEST, V120, P379, DOI 10.1172/JCI36666; Wu JQ, 2013, ACS CHEM BIOL, V8, P643, DOI 10.1021/cb3005897; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yacoub R, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00166; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200; Zhang H, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/208349	70	0	0	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2056-5968			CELL DISCOV	Cell Discov.	JUL 11	2017	3								UNSP 17023	10.1038/celldisc.2017.23				21	Cell Biology	Cell Biology	FM3OV	WOS:000414917400001	28698801	gold			2018-01-05	
J	Martin, TD; Cook, DR; Choi, MY; Li, MZ; Haigis, KM; Elledge, SJ				Martin, Timothy D.; Cook, Danielle R.; Choi, Mei Yuk; Li, Mamie Z.; Haigis, Kevin M.; Elledge, Stephen J.			A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells	CELL REPORTS			English	Article							THERAPEUTIC STRATEGY; ESSENTIAL GENES; CANCER-CELLS; LUNG-CANCER; KRAS; INHIBITION; VULNERABILITIES; GENOME; TUMORS; IDENTIFICATION	Activating mutations in the KRAS oncogene are highly prevalent in tumors, especially those of the colon, lung, and pancreas. To better understand the genetic dependencies that K-Ras mutant cells rely upon for their growth, we employed whole-genome CRISPR loss-of-function screens in two isogenic pairs of cell lines. Since loss of essential genes is uniformly toxic in CRISPR-based screens, we also developed a small hairpin RNA (shRNA) library targeting essential genes. These approaches uncovered a large set of proteins whose loss results in the selective reduction of K-Ras mutant cell growth. Pathway analysis revealed that many of these genes function in the mitochondria. For validation, we generated isogenic pairs of cell lines using CRISPR-based genome engineering, which confirmed the dependency of K-Ras mutant cells on these mitochondrial pathways. Finally, we found that mitochondrial inhibitors reduce the growth of K-Ras mutant tumors in vivo, aiding in the advancement of strategies to target K-Ras-driven malignancy.	[Martin, Timothy D.; Choi, Mei Yuk; Li, Mamie Z.; Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; [Martin, Timothy D.; Choi, Mei Yuk; Li, Mamie Z.; Elledge, Stephen J.] Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Cook, Danielle R.; Haigis, Kevin M.] Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02215 USA; [Cook, Danielle R.; Haigis, Kevin M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Elledge, Stephen J.] Harvard Univ, Sch Med, Program Virol, Boston, MA 02215 USA	Elledge, SJ (reprint author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA.; Elledge, SJ (reprint author), Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA.; Elledge, SJ (reprint author), Harvard Univ, Sch Med, Program Virol, Boston, MA 02215 USA.	selledge@genetics.med.harvard.edu			Damon Runyon Cancer Research Foundation [DRC 2199-14]; National Cancer Institute (NCI) [U01CA199252]	We thank Eric Wooten for help with sequence alignment and bioinformatics analysis, Sneha Menon for help with the mouse work, and members of the Elledge lab for helpful discussions. T.D.M. is supported by a Damon Runyon Cancer Research Foundation fellowship (DRC 2199-14). This work was supported by the National Cancer Institute (NCI) U01CA199252 (K.M.H. and S.J.E.). S.J.E. is an investigator with the Howard Hughes Medical Institute.	Ambrogio C, 2016, NAT MED, V22, P270, DOI 10.1038/nm.4041; Baracca A, 2010, BBA-BIOENERGETICS, V1797, P314, DOI 10.1016/j.bbabio.2009.11.006; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Burns MC, 2014, P NATL ACAD SCI USA, V111, P3401, DOI 10.1073/pnas.1315798111; Castle JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-190; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cullis J, 2014, CANCER CELL, V25, P181, DOI 10.1016/j.ccr.2014.01.025; Davoli T, 2016, GENE DEV, V30, P2684, DOI 10.1101/gad.290122.116; De Raedt T, 2011, CANCER CELL, V20, P400, DOI 10.1016/j.ccr.2011.08.014; Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gao BC, 2015, BBA-GENE REGUL MECH, V1849, P753, DOI 10.1016/j.bbagrm.2014.11.006; GRISWOLD DP, 1975, CANCER, V36, P2441, DOI 10.1002/1097-0142(197512)36:6<2441::AID-CNCR2820360627>3.0.CO;2-P; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hernandez-Valladares M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17307; Kim HS, 2013, CELL, V155, P552, DOI 10.1016/j.cell.2013.09.041; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Melki R, 1997, BIOCHEMISTRY-US, V36, P5817, DOI 10.1021/bi962830o; Nielsen CH, 2015, ONCOTARGET, V6, P37495; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203                                                         ; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Smakman N, 2005, ONCOGENE, V24, P8338, DOI 10.1038/sj.onc.1208995; Spencer-Smith R, 2017, NAT CHEM BIOL, V13, P62, DOI [10.1038/NCHEMBIO.2231, 10.1038/nchembio.2231]; Stein GE, 2006, CLIN INFECT DIS, V43, P518, DOI 10.1086/505494; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Young JH, 2016, BIOINFORMATICS, V32, P1373, DOI 10.1093/bioinformatics/btw010; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004; Zhang XN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4295; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	39	0	0	5	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	JUL 11	2017	20	2					427	438		10.1016/j.celrep.2017.06.061				12	Cell Biology	Cell Biology	FA1KL	WOS:000405198100013	28700943	gold			2018-01-05	
J	Evivie, SE; Li, BL; Ding, XY; Meng, YY; Yu, SF; Du, JC; Xu, M; Li, W; Jin, D; Huo, GC; Liu, F				Evivie, Smith E.; Li, Bailiang; Ding, Xiuyun; Meng, Yueyue; Yu, Shangfu; Du, Jincheng; Xu, Min; Li, Wan; Jin, Da; Huo, Guicheng; Liu, Fei			Complete Genome Sequence of Streptococcus thermophilus KLDS 3.1003, A Strain with High Antimicrobial Potential against Foodborne and Vaginal Pathogens	FRONTIERS IN MICROBIOLOGY			English	Article						Streptococcus thermophilus; genome sequence; EPS; antimicrobial activity; dairy industry	LACTIC-ACID; BACTERIOPHAGE; TOLERANCE; CRISPR	Lactic acid bacteria play increasingly important roles in the food industry. Streptococcus thermophilus KLDS 3.1003 strain was isolated from traditional yogurt in Inner Mongolia, China. It has shown high antimicrobial activity against selected foodborne and vaginal pathogens. In this study, we investigated and analyzed its complete genome sequence. The S. thermophilus KLDS 3.1003 genome comprise of a 1,899,956 bp chromosome with a G+C content of 38.92%, 1,995 genes, and 6 rRNAs. With the exception of S. thermophilus M17TZA496, S. thermophilus KLDS 3.1003 has more tRNAs (amino acid coding genes) compared to some S. thermophilus strains available on the National Centre for Biotechnology Information database. MG-RAST annotation showed that this strain has 317 subsystems with most genes associated with amino acid and carbohydrate metabolism. This strain also has a unique EPS gene cluster containing 23 genes, and may be a mixed dairy starter culture. This information provides more insight into the molecular basis of its potentials for further applications in the dairy and allied industries.	[Evivie, Smith E.; Li, Bailiang; Ding, Xiuyun; Meng, Yueyue; Yu, Shangfu; Du, Jincheng; Xu, Min; Li, Wan; Jin, Da; Huo, Guicheng; Liu, Fei] Northeast Agr Univ, Coll Food Sci, Minist Educ, Key Lab Dairy Sci, Harbin, Peoples R China; [Evivie, Smith E.] Univ Benin, Fac Agr, Dept Anim Sci, Food Sci & Nutr Unit, Benin, Nigeria	Huo, GC; Liu, F (reprint author), Northeast Agr Univ, Coll Food Sci, Minist Educ, Key Lab Dairy Sci, Harbin, Peoples R China.	gchuo58@126.com; david.as@163.com		Evivie, Smith/0000-0002-4209-0978	National Key Research and Development Program of China [2017YFD0400303]; National Natural Science Foundation of China [31401512]; Delta State Government of Nigeria	This study was funded by grants from the National Key Research and Development Program of China (No: 2017YFD0400303) and the National Natural Science Foundation of China (No: 31401512). The Delta State Government of Nigeria is also appreciated for financially supporting SE.	Ankolekar C. R., 2013, THESIS; Bai Y, 2016, J BIOTECHNOL, V224, P45, DOI 10.1016/j.jbiotec.2016.03.003; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Caggianiello G, 2016, APPL MICROBIOL BIOT, V100, P3877, DOI 10.1007/s00253-016-7471-2; Canani RB, 2016, ISME J, V10, P742, DOI 10.1038/ismej.2015.151; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Duboc P, 2001, NETH MILK DAIRY J, V11, P759, DOI DOI 10.1016/S0958-6946(01)00119-4; Enujiugha V. N., 2015, CRIT REV FOOD SCI NU, V57, P790, DOI 10.1080/10408398.2014.930018; Evivie SE, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1318034; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gezginc Y, 2015, J DAIRY SCI, V98, P1426, DOI 10.3168/jds.2014-8447; Iyer R, 2010, INT DAIRY J, V20, P133, DOI 10.1016/j.idairyj.2009.10.005; Jolly L, 2001, INT DAIRY J, V11, P733, DOI 10.1016/S0958-6946(01)00117-0; Kang XH, 2012, J BACTERIOL, V194, P4428, DOI 10.1128/JB.00740-12; Kebouchi M, 2016, APPL MICROBIOL BIOT, V100, P3667, DOI 10.1007/s00253-016-7322-1; Kleanthous C, 1999, NAT STRUCT BIOL, V6, P243, DOI 10.1038/6683                                                                    ; Kort R, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0370-x; Labrie S. J., 2015, GENOME ANNOUNC, V3, DOI [10.1128/genomeA.00480-15, DOI 10.1128/GENOMEA.00480-15]; Ledeboer A., 2011, 10 LAB S 30 YEARS RE; Lee M, 2015, FOOD SCI BIOTECHNOL, V24, P537, DOI 10.1007/s10068-015-0070-7; Li P, 2016, J BIOTECHNOL, V238, P52, DOI 10.1016/j.jbiotec.2016.09.012; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li SQ, 2016, J FOOD SCI, V81, pM1167, DOI 10.1111/1750-3841.13276; Li W, 2016, CURR MICROBIOL, V73, P393, DOI 10.1007/s00284-016-1076-y; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Patras KA, 2015, INFECT IMMUN, V83, P3438, DOI 10.1128/IAI.00409-15; Renye JA, 2016, BIOTECHNOL LETT, V38, P1947, DOI 10.1007/s10529-016-2184-2; Sah BNP, 2016, J DAIRY SCI, V99, P4233, DOI 10.3168/jds.2015-10499; Shi Y., 2015, GENOME ANNOUNC, V3, P2, DOI DOI 10.1128/GEN0MEA.00979-15; Sun ZG, 2011, STRUCTURAL INTEGRITY IN NUCLEAR ENGINEERING, P193; Wu QL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04974	33	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	JUL 11	2017	8								1238	10.3389/fmicb.2017.01238				4	Microbiology	Microbiology	FA1WX	WOS:000405233300001	28744258	gold			2018-01-05	
J	Palermo, G; Miao, YL; Walker, RC; Jinek, M; McCammon, JA				Palermo, Giulia; Miao, Yinglong; Walker, Ross C.; Jinek, Martin; McCammon, J. Andrew			CRISPR-Cas9 conformational activation as elucidated from enhanced molecular simulations	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						protein-nucleic acid interactions; gene regulation; RNA dynamics; enhanced sampling; free energy	GUIDED ENDONUCLEASE CAS9; TARGET DNA RECOGNITION; DYNAMICS SIMULATIONS; CRYSTAL-STRUCTURE; FORCE-FIELD; RNA; CLEAVAGE; COMPLEX; BIOMOLECULES; NUCLEASES	CRISPR-Cas9 has become a facile genome editing technology, yet the structural and mechanistic features underlying its function are unclear. Here, we perform extensive molecular simulations in an enhanced sampling regime, using a Gaussian-accelerated molecular dynamics (GaMD) methodology, which probes displacements over hundreds of microseconds to milliseconds, to reveal the conformational dynamics of the endonuclease Cas9 during its activation toward catalysis. We disclose the conformational transition of Cas9 from its apo form to the RNA-bound form, suggesting a mechanism for RNA recruitment in which the domain relocations cause the formation of a positively charged cavity for nucleic acid binding. GaMD also reveals the conformation of a catalytically competent Cas9, which is prone for catalysis and whose experimental characterization is still limited. We show that, upon DNA binding, the conformational dynamics of the HNH domain triggers the formation of the active state, explaining how the HNH domain exerts a conformational control domain over DNA cleavage [Sternberg SH et al. (2015) Nature, 527, 110-113]. These results provide atomic-level information on the molecular mechanism of CRISPR-Cas9 that will inspire future experimental investigations aimed at fully clarifying the biophysics of this unique genome editing machinery and at developing new tools for nucleic acid manipulation based on CRISPR-Cas9.	[Palermo, Giulia; Miao, Yinglong; McCammon, J. Andrew] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Palermo, Giulia; McCammon, J. Andrew] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Miao, Yinglong; McCammon, J. Andrew] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Miao, Yinglong; McCammon, J. Andrew] Univ Calif San Diego, Natl Biomed Computat Resource, La Jolla, CA 92093 USA; [Walker, Ross C.; McCammon, J. Andrew] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Jinek, Martin] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Walker, Ross C.] GlaxoSmithKline, Collegeville, PA 19426 USA	Palermo, G; McCammon, JA (reprint author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.; Palermo, G; McCammon, JA (reprint author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; McCammon, JA (reprint author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.; McCammon, JA (reprint author), Univ Calif San Diego, Natl Biomed Computat Resource, La Jolla, CA 92093 USA.; McCammon, JA (reprint author), Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA.	gpalermo@ucsd.edu; jmccammon@ucsd.edu		Jinek, Martin/0000-0002-7601-210X; Palermo, Giulia/0000-0003-1404-8737	Swiss National Science Foundation [P300PA_164698]; NIH; National Science Foundation; Howard Hughes Medical Institute; National Biomedical Computation Resource; San Diego Supercomputer Center; Intel; NVIDIA; Extreme Science and Engineering Discovery Environment [MCB160059]	G.P. thanks the J.A.M. group, Prof. Rommie E. Amaro, and Dr. Kendra Hailey for useful discussions. The Swiss National Science Foundation supports this work with Advanced Postdoctoral Grant P300PA_164698 (to G.P.). Work in the J.A.M. group is supported by NIH, National Science Foundation, Howard Hughes Medical Institute, National Biomedical Computation Resource, and San Diego Supercomputer Center. R.C.W. thanks Intel and NVIDIA for research fellowships. Computing time was provided by the Extreme Science and Engineering Discovery Environment with Grant MCB160059.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021; Banas P, 2010, J CHEM THEORY COMPUT, V6, P3836, DOI 10.1021/ct100481h; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Casalino L, 2017, J CHEM THEORY COMPUT, V13, P340, DOI 10.1021/acs.jctc.6b00905; Case D. A., 2016, AMBER 2016; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Dagdas Y., 2017, BIORXIV; De Vivo M, 2008, J AM CHEM SOC, V130, P10955, DOI 10.1021/ja8005786; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Jiang FG, 2017, ANNU REV BIOPHYS, V46, P505, DOI 10.1146/annurev-biophys-062215-010822; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Miao YL, 2016, P NATL ACAD SCI USA, V113, P12162, DOI 10.1073/pnas.1614538113; Miao YL, 2016, MOL SIMULAT, V42, P1046, DOI 10.1080/08927022.2015.1121541; Miao YL, 2015, J CHEM THEORY COMPUT, V11, P3584, DOI 10.1021/acs.jctc.5b00436; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Palermo G, 2016, ACS CENTRAL SCI, V2, P756, DOI 10.1021/acscentsci.6b00218; Palermo G, 2015, ACCOUNTS CHEM RES, V48, P220, DOI 10.1021/ar500314j; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; Singh D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12778; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Trzesniak D, 2007, CHEMPHYSCHEM, V8, P162, DOI 10.1002/cphc.200600527; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x; Zheng WJ, 2017, PROTEINS, V85, P342, DOI 10.1002/prot.25229; Zuo ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37584	37	7	7	24	24	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUL 11	2017	114	28					7260	7265		10.1073/pnas.1707645114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FA1CR	WOS:000405177100054	28652374				2018-01-05	
J	Gocheva, V; Naba, A; Bhutkar, A; Guardia, T; Miller, KM; Li, CMC; Dayton, TL; Sanchez-Rivera, FJ; Kim-Kiselak, C; Jailkhani, N; Winslow, MM; Del Rosario, A; Hynes, RO; Jacks, T				Gocheva, Vasilena; Naba, Alexandra; Bhutkar, Arjun; Guardia, Talia; Miller, Kathryn M.; Li, Carman Man-Chung; Dayton, Talya L.; Sanchez-Rivera, Francisco J.; Kim-Kiselak, Caroline; Jailkhani, Noor; Winslow, Monte M.; Del Rosario, Amanda; Hynes, Richard O.; Jacks, Tyler			Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						extracellular matrix; Tenascin-C; lung cancer; quantitative proteomics; tumor microenvironment	IDIOPATHIC PULMONARY-FIBROSIS; EXTRACELLULAR-MATRIX; ADENOCARCINOMA PROGRESSION; METASTASIS; TUMORIGENESIS; EXPRESSION; PROTEINS; INJURY; NKX2-1; NICHE	The extracellular microenvironment is an integral component of normal and diseased tissues that is poorly understood owing to its complexity. To investigate the contribution of the microenvironment to lung fibrosis and adenocarcinoma progression, two pathologies characterized by excessive stromal expansion, we used mouse models to characterize the extracellular matrix (ECM) composition of normal lung, fibrotic lung, lung tumors, and metastases. Using quantitative proteomics, we identified and assayed the abundance of 113 ECM proteins, which revealed robust ECM protein signatures unique to fibrosis, primary tumors, or metastases. These analyses indicated significantly increased abundance of several S100 proteins, including Fibronectin and Tenascin-C (Tnc), in primary lung tumors and associated lymph node metastases compared with normal tissue. We further showed that Tnc expression is repressed by the transcription factor Nkx2-1, a well-established suppressor of metastatic progression. We found that increasing the levels of Tnc, via CRISPR-mediated transcriptional activation of the endogenous gene, enhanced the metastatic dissemination of lung adenocarcinoma cells. Interrogation of human cancer gene expression data revealed that high TNC expression correlates with worse prognosis for lung adenocarcinoma, and that a three-gene expression signature comprising TNC, S100A10, and S100A11 is a robust predictor of patient survival independent of age, sex, smoking history, and mutational load. Our findings suggest that the poorly understood ECM composition of the fibrotic and tumor microenvironment is an underexplored source of diagnostic markers and potential therapeutic targets for cancer patients.	[Gocheva, Vasilena; Naba, Alexandra; Bhutkar, Arjun; Guardia, Talia; Miller, Kathryn M.; Li, Carman Man-Chung; Dayton, Talya L.; Sanchez-Rivera, Francisco J.; Kim-Kiselak, Caroline; Jailkhani, Noor; Winslow, Monte M.; Del Rosario, Amanda; Hynes, Richard O.; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Gocheva, Vasilena; Naba, Alexandra; Guardia, Talia; Miller, Kathryn M.; Li, Carman Man-Chung; Dayton, Talya L.; Sanchez-Rivera, Francisco J.; Kim-Kiselak, Caroline; Jailkhani, Noor; Winslow, Monte M.; Hynes, Richard O.; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Hynes, Richard O.; Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Naba, Alexandra] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Winslow, Monte M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Naba, A; Jacks, T (reprint author), MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Naba, A; Jacks, T (reprint author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Jacks, T (reprint author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.; Naba, A (reprint author), Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA.	anaba@uic.edu; tjacks@mit.edu		Naba, Alexandra/0000-0002-4796-5614; Li, Carman Man-Chung/0000-0002-0577-7797; Sanchez-Rivera, Francisco J./0000-0002-8466-8563	National Cancer Institute's Tumor Microenvironment Network [U54 CA126515, U54 CA163109]; Howard Hughes Medical Institute; Ludwig Center for Molecular Oncology at MIT; National Cancer Institute (Koch Institute Cancer Center Support Grant) [P30-CA14051]; Jane Coffin Childs Memorial Fund Postdoctoral Fellowship; Mazumdar-Shaw International Oncology Fellowship	We thank Nadya Dimitrova for a critical review of the manuscript; the Koch Institute Swanson Biotechnology Center for technical support, specifically Kathleen Cormier at the Hope Babette Tang (1983) Histology Facility; and Roderick Bronson for pathological analysis. This work was supported by the National Cancer Institute's Tumor Microenvironment Network (Grants U54 CA126515 and U54 CA163109), by the Howard Hughes Medical Institute (at which R.O.H. and T.J. are investigators), the Ludwig Center for Molecular Oncology at MIT, and the National Cancer Institute (Koch Institute Cancer Center Support Grant P30-CA14051). V.G. was supported by a Jane Coffin Childs Memorial Fund Postdoctoral Fellowship. N.J. is supported by a Mazumdar-Shaw International Oncology Fellowship. R.O.H. is a Daniel K. Ludwig Professor for Cancer Research. T.J. is a David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar at MIT.	American Cancer Society, 2016, CANC FACTS FIG 2016; Bakalarski CE, 2016, MOL CELL PROTEOMICS, V15, P1489, DOI 10.1074/mcp.O115.056986; Biton A, 2014, CELL REP, V9, P1235, DOI 10.1016/j.celrep.2014.10.035; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Carey WA, 2010, AM J PHYSIOL-LUNG C, V299, pL785, DOI 10.1152/ajplung.00385.2009; Decaris ML, 2014, MOL CELL PROTEOMICS, V13, P1741, DOI 10.1074/mcp.M113.037267; Dimitrova N, 2016, CANCER DISCOV, V6, P188, DOI 10.1158/2159-8290.CD-15-0854; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Estany S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-120; Hao JT, 2012, MOL CELL BIOCHEM, V359, P323, DOI 10.1007/s11010-011-1026-8; HERNNAS J, 1992, EUR RESPIR J, V5, P404; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Ishii A, 2009, PATHOL INT, V59, P623, DOI 10.1111/j.1440-1827.2009.02417.x; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Katono Ken, 2016, Asian Pac J Cancer Prev, V17, P289; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; KUHN C, 1995, AM J PATHOL, V147, P1759; Langlois B, 2014, ONCOTARGET, V5, P10529, DOI 10.18632/oncotarget.2470; Li CMC, 2015, GENE DEV, V29, P1850, DOI 10.1101/gad.267393.115; Lowy CM, 2015, CELL ADHES MIGR, V9, P112, DOI 10.1080/19336918.2015.1008331; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Malik R, 2015, TRENDS BIOTECHNOL, V33, P230, DOI 10.1016/j.tibtech.2015.01.004; Midwood KS, 2016, J CELL SCI, V129, P4321, DOI 10.1242/jcs.190546; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Miettinen J, 2017, J STAT SOFTW; Naba A, 2016, OMICS, V49, P10; Naba A, 2015, JOVE-J VIS EXP, DOI 10.3791/53057; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; O'Connell JT, 2011, P NATL ACAD SCI USA, V108, P16002, DOI 10.1073/pnas.1109493108; Orend G, 2005, INT J BIOCHEM CELL B, V37, P1066, DOI 10.1016/j.biocel.2004.12.002; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; Pirinen R, 2005, HUM PATHOL, V36, P44, DOI 10.1016/j.humpath.2004.10.010; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rutledge DN, 2013, TRAC-TREND ANAL CHEM, V50, P22, DOI 10.1016/j.trac.2013.03.013; Saupe F, 2013, CELL REP, V5, P482, DOI 10.1016/j.celrep.2013.09.014; Schiller HB, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156123; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; Spenle C, 2015, CELL ADHES MIGR, V9, P141, DOI 10.1080/19336918.2014.1000074; Talts JF, 1999, J CELL SCI, V112, P1855; Thannickal VJ, 2014, AM J PATHOL, V184, P1643, DOI 10.1016/j.ajpath.2014.02.003; Tian T, 2007, CANCER SCI, V98, P1265, DOI 10.1111/j.1349-7006.2007.00514.x; Vancheri C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0478-1; Walters D. M., 2008, CURR PROTOC PHARM, V5, P1; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Woo T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142642	48	0	0	6	6	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUL 11	2017	114	28					E5625	E5634		10.1073/pnas.1707054114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FA1CR	WOS:000405177100019	28652369				2018-01-05	
J	Cai, LL; Cao, YY; Xu, ZY; Ma, WX; Zakria, M; Zou, LF; Cheng, ZQ; Chen, GY				Cai, Lulu; Cao, Yanyan; Xu, Zhengyin; Ma, Wenxiu; Zakria, Muhammad; Zou, Lifang; Cheng, Zaiquan; Chen, Gongyou			A Transcription Activator-Like Effector Tal7 of Xanthomonas oryzae pv. oryzicola Activates Rice Gene Os09g29100 to Suppress Rice Immunity	SCIENTIFIC REPORTS			English	Article							DISEASE-SUSCEPTIBILITY GENE; BACTERIAL LEAF STREAK; RESISTANCE GENE; AVIRULENCE GENES; III EFFECTORS; BINDING; BLIGHT; HOST; SPECIFICITY; EXPRESSION	Xanthomonas oryzae pv. oryzicola (Xoc) and X. oryzae pv. oryzae (Xoo) cause bacterial leaf streak (BLS) and bacterial leaf blight (BLB) in rice, respectively. Unlike Xoo, endogenous avirulence-resistance (avrR) gene interactions have not been identified in the Xoc-rice pathosystem; however, both pathogens possess transcription activator-like effectors (TALEs) that are known to modulate R or S genes in rice. The transfer of individual tal genes from Xoc RS105 (hypervirulent) into Xoc YNB0-17 (hypovirulent) led to the identification of tal7, which suppressed avrXa7-Xa7 mediated defense in rice containing an Xa7 R gene. Mobility shift and microscale thermophoresis assays showed that Tal7 bound two EBE sites in the promoters of two rice genes, Os09g29100 and Os12g42970, which encode predicted Cyclin-D4-1 and GATA zinc finger family protein, respectively. Assays using designer TALEs and a TALE-free strain of Xoo revealed that Os09g29100 was the biologically relevant target of Tal7. Tal7 activates the expression of rice gene Os09g29100 that suppresses avrXa7-Xa7 mediated defense in Rice. TALEN editing of the Tal7binding site in the Os09g29100 gene promoter further enhanced resistance to the pathogen Xoc RS105. The suppression of effector-trigger immunity (ETI) is a phenomenon that may contribute to the scarcity of BLS resistant cultivars.	[Cai, Lulu; Cao, Yanyan; Xu, Zhengyin; Ma, Wenxiu; Zakria, Muhammad; Zou, Lifang; Chen, Gongyou] Shanghai Jiao Tong Univ, Sch Agr & Biol, Key Lab Urban South, Minist Agr, Shanghai 200240, Peoples R China; [Cai, Lulu; Cao, Yanyan; Xu, Zhengyin; Ma, Wenxiu; Zou, Lifang; Chen, Gongyou] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Cheng, Zaiquan] Yunnan Acad Agr Sci, Biotechnol & Genet Resource Res Inst, Kunming 650223, Peoples R China	Chen, GY (reprint author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Key Lab Urban South, Minist Agr, Shanghai 200240, Peoples R China.; Chen, GY (reprint author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China.; Cheng, ZQ (reprint author), Yunnan Acad Agr Sci, Biotechnol & Genet Resource Res Inst, Kunming 650223, Peoples R China.	czquan-99@163.com; gyouchen@sjtu.edu.cn			National Key Research and Development Program of China [2016YFD0100601]; National Natural Science Foundation of China [U1302265, 31471742]	We thank Dr. Bing Yang, Iowa State University, for providing pHZWavrXa7 and pHZWavrXa27, Dr. Chaozu He, Chinese Academy of Sciences, for providing a rice cultivar 87- 15 that contains Xa27, and Dr. Carol L. Bender, Oklahoma State University, for critically reading the manuscript. This study is sported by the National Key Research and Development Program of China (2016YFD0100601) and the National Natural Science Foundation of China (U1302265, 31471742).	Ackerveken G. V., 1996, CELL, V87, P1307; Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Bai JF, 2000, MOL PLANT MICROBE IN, V13, P1322, DOI 10.1094/MPMI.2000.13.12.1322; Bing Y, 2004, MOL PLANT MICROBE IN, V17, P1192, DOI 10.1094/MPMI.2004.17.11.1192; Blanvillain-Baufume S, 2017, PLANT BIOTECHNOL J, V15, P306, DOI 10.1111/pbi.12613; Boch J, 2014, NEW PHYTOL, V204, P823, DOI 10.1111/nph.13015; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; Cernadas RA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003972; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Dou DL, 2012, CELL HOST MICROBE, V12, P484, DOI 10.1016/j.chom.2012.09.003; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; FANG C. -T., 1957, Acta phytopath. sinica, V3, P99; Furutani A, 2006, FEMS MICROBIOL LETT, V259, P133, DOI 10.1111/j.1574-6968.2006.00265.x; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; [贺文爱 HE Wen-ai], 2010, [植物遗传资源学报, Journal of Plant Genetic Resources], V11, P116; Hiei Y, 2008, NAT PROTOC, V3, P824, DOI 10.1038/nprot.2008.46; HOPKINS CM, 1992, MOL PLANT MICROBE IN, V5, P451, DOI 10.1094/MPMI-5-451                                                              ; Hummel AW, 2017, MOL PLANT PATHOL, V18, P55, DOI 10.1111/mpp.12377; Hummel AW, 2012, NEW PHYTOL, V195, P883, DOI 10.1111/j.1469-8137.2012.04216.x; Hutin M, 2015, PLANT J, V84, P694, DOI 10.1111/tpj.13042; Ji ZY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13435; Kim JG, 2009, PLANT CELL, V21, P1305, DOI 10.1105/tpc.108.063123; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li T, 2014, METHODS, V69, P9, DOI 10.1016/j.ymeth.2014.03.019; Li T, 2013, MOL PLANT, V6, P781, DOI 10.1093/mp/sst034; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Li YR, 2011, MOL PLANT MICROBE IN, V24, P1086, DOI 10.1094/MPMI-09-10-0205; Lu H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003828; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Makino S, 2006, MOL PLANT MICROBE IN, V19, P240, DOI 10.1094/MPMI-19-0240; Moscou MJ, 2009, CHINESE J BIOCH MOL, V326, P1501, DOI DOI 10.1126/SCIENCE.1178817; Nio-Liu D. O., 2006, MOL PLANT PATHOL, V7, P303, DOI DOI 10.1111/J.1364-3703.2006.00344.X; Ou S. H, 1985, RICE DISEASE; Richter A, 2016, METHODS MOL BIOL, V1338, P9, DOI 10.1007/978-1-4939-2932-0_2; Romer P, 2009, P NATL ACAD SCI USA, V106, P20526, DOI 10.1073/pnas.0908812106; Romer P, 2009, PLANT PHYSIOL, V150, P1697, DOI 10.1104/pp.109.139931; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Sambrook J, 1989, MOL CLONING LAB MANU; Song CF, 2010, MOL PLANT MICROBE IN, V23, P893, DOI 10.1094/MPMI-23-7-0893; Streubel J, 2013, NEW PHYTOL, V200, P808, DOI 10.1111/nph.12411; SWINGS J, 1990, INT J SYST BACTERIOL, V40, P309, DOI 10.1099/00207713-40-3-309                                                       ; Tamirisa S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00165; Tang XY, 2006, MOL PLANT MICROBE IN, V19, P1159, DOI 10.1094/MPMI-19-1159; Tian DS, 2014, PLANT CELL, V26, P497, DOI 10.1105/tpc.113.119255; Tian DS, 2009, MOL PLANT PATHOL, V10, P29, DOI 10.1111/j.1364-3703.2008.00509.x; Triplett LR, 2016, PLANT J, V87, P472, DOI 10.1111/tpj.13212; Verdier V, 2012, NEW PHYTOL, V196, P1197, DOI 10.1111/j.1469-8137.2012.04367.x; Verdier V, 2012, J BIOTECHNOL, V159, P320, DOI 10.1016/j.jbiotec.2011.09.020; White FF, 2009, MOL PLANT PATHOL, V10, P749, DOI 10.1111/j.1364-3703.2009.00590.x; White FF, 2009, PLANT PHYSIOL, V150, P1677, DOI 10.1104/pp.109.139360; Wu XM, 2007, PLANT PATHOL, V56, P26, DOI 10.1111/j.1365-3059.2006.01495.x; [肖友伦 XIAO Youlun], 2007, [微生物学报, Acta Microbiologica Sinica], V47, P396; Yang B, 2000, P NATL ACAD SCI USA, V97, P9807, DOI 10.1073/pnas.170286897; Yang B, 2005, MOL PLANT MICROBE IN, V18, P142, DOI 10.1094/MPMI-18-0142; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Zhang HT, 2013, CURR OPIN PLANT BIOL, V16, P188, DOI 10.1016/j.pbi.2013.02.008; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102; Zhao J., 2016, MOL CELLS IN PRESS; Zhu WG, 1998, MOL PLANT MICROBE IN, V11, P824, DOI 10.1094/MPMI.1998.11.8.824; Zou HS, 2012, MICROBIOL-SGM, V158, P2372, DOI 10.1099/mic.0.059964-0; Zou LF, 2006, APPL ENVIRON MICROB, V72, P6212, DOI 10.1128/AEM.00511-06; ROMER P, 2007, Patent No. 318645	66	1	1	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 11	2017	7								5089	10.1038/s41598-017-04800-8				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FA1BI	WOS:000405172600056	28698641	gold			2018-01-05	
J	Cook, PJ; Thomas, R; Kannan, R; de Leon, ES; Drilon, A; Rosenblum, MK; Scaltriti, M; Benezra, R; Ventura, A				Cook, Peter J.; Thomas, Rozario; Kannan, Ram; de Leon, Esther Sanchez; Drilon, Alexander; Rosenblum, Marc K.; Scaltriti, Maurizio; Benezra, Robert; Ventura, Andrea			Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target	NATURE COMMUNICATIONS			English	Article							CHRONIC MYELOID-LEUKEMIA; ABL TYROSINE KINASE; IN-VIVO; NERVOUS-SYSTEM; ALK INHIBITOR; GLIOBLASTOMA; REARRANGEMENTS; LANDSCAPE; ENTRECTINIB; CRISPR/CAS9	The widespread application of high-throughput sequencing methods is resulting in the identification of a rapidly growing number of novel gene fusions caused by tumour-specific chromosomal rearrangements, whose oncogenic potential remains unknown. Here we describe a strategy that builds upon recent advances in genome editing and combines ex vivo and in vivo chromosomal engineering to rapidly and effectively interrogate the oncogenic potential of genomic rearrangements identified in human brain cancers. We show that one such rearrangement, an microdeletion resulting in a fusion between Brevican (BCAN) and Neurotrophic Receptor Tyrosine Kinase 1 (NTRK1), is a potent oncogenic driver of high-grade gliomas and confers sensitivity to the experimental TRK inhibitor entrectinib. This work demonstrates that BCAN-NTRK1 is a bona fide human glioma driver and describes a general strategy to define the oncogenic potential of novel glioma-associated genomic rearrangements and to generate accurate preclinical models of this lethal human cancer.	[Cook, Peter J.; Thomas, Rozario; Kannan, Ram; Benezra, Robert; Ventura, Andrea] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Thomas, Rozario; de Leon, Esther Sanchez] Cornell Univ, Weill Cornell Grad Sch Med Sci, Dept Mol Biol, New York, NY 10065 USA; [Drilon, Alexander] Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, New York, NY 10065 USA; [Rosenblum, Marc K.; Scaltriti, Maurizio] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Scaltriti, Maurizio] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA	Benezra, R; Ventura, A (reprint author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	benezrar@mskcc.org; venturaa@mskcc.org			Pershing Square-Sohn Cancer Research Foundation; MSKCC Brain Tumor Center; Geoffrey Beene Cancer Research Foundation; Cancer Center Support Grant [P30 CA008748]; MSKCC NIH TROT fellowship [T32 CA 160001]	We would like to thank Jason Huse for technical assistance and advise regarding glioma tumour histology. We thank Riddhi Shah and Paul Ogrodowski for animal husbandry assistance. This work was funded in part by grants from the Pershing Square-Sohn Cancer Research Foundation (to A.V.), the MSKCC Brain Tumor Center (to A.V. and R.B.), the Geoffrey Beene Cancer Research Foundation (to A.V.) and Cancer Center Support Grant P30 CA008748 (to M.S.). R.K. is funded by the T32 CA 160001 MSKCC NIH TROT fellowship.	Ardini E, 2016, MOL CANCER THER, V15, P628, DOI 10.1158/1535-7163.MCT-15-0758; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Cook PJ, 2016, NEURO-ONCOLOGY, V18, P1379, DOI 10.1093/neuonc/now049; Dow LE, 2015, TRENDS MOL MED, V21, P609, DOI 10.1016/j.molmed.2015.07.006; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401                                                     ; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Iyer R, 2016, CANCER LETT, V372, P179, DOI 10.1016/j.canlet.2016.01.018; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kim JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085445; Kraft K, 2015, CELL REP, V10, P833, DOI 10.1016/j.celrep.2015.01.016; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Maddalo D, 2016, CANCER RES, V76, P4918, DOI 10.1158/0008-5472.CAN-16-0726; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Marino S, 2000, GENE DEV, V14, P994; Mertens F., 2015, NAT REV CANC, V15, P371; Network TCGAR, 2008, NATURE, V455, P1061, DOI DOI 10.1038/NATURE07385; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; PANTELOURIS EM, 1968, NATURE, V217, P370, DOI 10.1038/217370a0; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rolfo C, 2015, EXPERT OPIN INV DRUG, V24, P1493, DOI 10.1517/13543784.2015.1096344; Shah N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-818; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Vaishnavi A, 2015, CANCER DISCOV, V5, P25, DOI 10.1158/2159-8290.CD-14-0765; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vidigal JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9083; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	37	2	2	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JUL 11	2017	8								15987	10.1038/ncomms15987				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FA1CA	WOS:000405175100001	28695888	gold			2018-01-05	
J	Mawphlang, OIL; Kharshiing, EV				Mawphlang, Ophilia I. L.; Kharshiing, Eros V.			Photoreceptor Mediated Plant Growth Responses: Implications for Photoreceptor Engineering toward Improved Performance in Crops	FRONTIERS IN PLANT SCIENCE			English	Review						plant growth and development; light signaling; plant photoreceptors; photoreceptor engineering; crop productivity	FLUORESCENT PROTEIN ILOV; ULTRAVIOLET-B RADIATION; PHYTOCHROME-B; BLUE-LIGHT; UV-B; SEED-GERMINATION; ARABIDOPSIS-THALIANA; SHADE-AVOIDANCE; CRYPTOCHROME 2; CIRCADIAN CLOCK	Rising temperatures during growing seasons coupled with altered precipitation rates presents a challenging task of improving crop productivity for overcoming such altered weather patterns and cater to a growing population. Light is a critical environmental factor that exerts a powerful influence on plant growth and development ranging from seed germination to flowering and fruiting. Higher plants utilize a suite of complex photoreceptor proteins to perceive surrounding red/far-red (phytochromes), blue/UV-A (cryptochromes, phototropins, ZTL/FKF1/LKP2), and UV-B light (UVR8). While genomic studies have also shown that light induces extensive reprogramming of gene expression patterns in plants, molecular genetic studies have shown that manipulation of one or more photoreceptors can result in modification of agronomically beneficial traits. Such information can assist researchers to engineer photoreceptors via genome editing technologies to alter expression or even sensitivity thresholds of native photoreceptors for targeting aspects of plant growth that can confer superior agronomic value to the engineered crops. Here we summarize the agronomically important plant growth processes influenced by photoreceptors in crop species, alongwith the functional interactions between different photoreceptors and phytohormones in regulating these responses. We also discuss the potential utility of synthetic biology approaches in photobiology for improving agronomically beneficial traits of crop plants by engineering designer photoreceptors.	[Mawphlang, Ophilia I. L.; Kharshiing, Eros V.] St Edmunds Coll, Dept Bot, Shillong, Meghalaya, India	Kharshiing, EV (reprint author), St Edmunds Coll, Dept Bot, Shillong, Meghalaya, India.	eros.kharshiing@gmail.com			Science and Engineering Research Board (Department of Science and Technology), New Delhi, India [SB/EMEQ152/2014, SR/FT/LS-82/2011]	EK is grateful to the Science and Engineering Research Board (Department of Science and Technology), New Delhi, India for supporting research in his laboratory vide grants no. SB/EMEQ152/2014 and SR/FT/LS-82/2011.	Ahloowalia BS, 2004, EUPHYTICA, V135, P187, DOI 10.1023/B:EUPH.0000014914.85465.4f; Ainley WM, 2013, PLANT BIOTECHNOL J, V11, P1126, DOI 10.1111/pbi.12107; Al-Hammadi ASA, 2003, PLANT PHYSIOL, V133, P113, DOI 10.1104/pp.103.025478; Alabadi D, 2008, PLANT J, V53, P324, DOI 10.1111/j.1365-313X.2007.03346.x; Appenroth KJ, 2006, PLANT CELL ENVIRON, V29, P701, DOI 10.1111/j.1365-3040.2005.01455.x; Araki M, 2015, TRENDS PLANT SCI, V20, P145, DOI 10.1016/j.tplants.2015.01.010; Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; Ballare CL, 2017, PLANT CELL ENVIRON, V40, P2530, DOI 10.1111/pce.12914; Ballare CL, 2014, ANNU REV PLANT BIOL, V65, P335, DOI 10.1146/annurev-arplant-050213-040145; Ballare CL, 2012, PLANT PHYSIOL, V160, P145, DOI 10.1104/pp.112.200733; BALLARE CL, 1992, PHOTOCHEM PHOTOBIOL, V56, P777, DOI 10.1111/j.1751-1097.1992.tb02234.x; Barrero JM, 2014, PLANT CELL, V26, P1094, DOI 10.1105/tpc.113.121830; Baudry A, 2010, PLANT CELL, V22, P606, DOI 10.1105/tpc.109.072843; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Bertram L., 2004, Advances in Horticultural Science, V18, P3; Boccalandro HE, 2003, PLANT PHYSIOL, V133, P1539, DOI 10.1104/pp.103.029579; Boccalandro HE, 2012, PLANT PHYSIOL, V158, P1475, DOI 10.1104/pp.111.187237; Bodanapu R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01714; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Botto JF, 2003, PLANT PHYSIOL, V133, P1547, DOI 10.1104/pp.103.029546; Boxall SF, 2005, PLANT PHYSIOL, V137, P969, DOI 10.1104/pp.104.054577; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Cardi T, 2016, PLANT BREEDING, V135, P139, DOI 10.1111/pbr.12345; Casal Jorge J, 2012, Arabidopsis Book, V10, pe0157, DOI 10.1199/tab.0157; Causse M., 2006, GENETIC IMPROVEMENT, V2, P153, DOI 10.1201/b10744-6; Cecchetti V, 2008, PLANT CELL, V20, P1760, DOI 10.1105/tpc.107.057570; Cecchetti V, 2015, J INTEGR PLANT BIOL, V57, P1089, DOI 10.1111/jipb.12332; Chapman S, 2008, P NATL ACAD SCI USA, V105, P20038, DOI 10.1073/pnas.0807551105; Chen A, 2014, P NATL ACAD SCI USA, V111, P10037, DOI 10.1073/pnas.1409795111; Chen H, 2008, P NATL ACAD SCI USA, V105, P4495, DOI 10.1073/pnas.0710778105; Chen M, 2011, TRENDS CELL BIOL, V21, P664, DOI 10.1016/j.tcb.2011.07.002; Christie JM, 2015, PLANT CELL PHYSIOL, V56, P401, DOI 10.1093/pcp/pcu196; Christie JM, 2012, J BIOL CHEM, V287, P22295, DOI 10.1074/jbc.M111.318881; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Chung NJ, 2003, AGRON J, V95, P184, DOI 10.2134/agronj2003.0184                                                         ; Cinelli RAG, 2000, PHOTOCHEM PHOTOBIOL, V71, P771, DOI 10.1562/0031-8655(2000)071<0771:TEGFPA>2.0.CO;2                                 ; Clasen BM, 2016, PLANT BIOTECHNOL J, V14, P169, DOI 10.1111/pbi.12370; Cluis CP, 2004, PLANT J, V38, P332, DOI 10.1111/j.1365-313X.2004.02052.x; D'Halluin K, 2013, PLANT BIOTECHNOL J, V11, P933, DOI 10.1111/pbi.12085; Dahmani-Mardas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015776; Davey MP, 2012, PHOTOSYNTH RES, V114, P121, DOI 10.1007/s11120-012-9785-y; de Wit M, 2016, ANNU REV PLANT BIOL, V67, P513, DOI 10.1146/annurev-arplant-043015-112252; Dechaine JM, 2009, PLANT CELL ENVIRON, V32, P1297, DOI 10.1111/j.1365-3040.2009.01998.x; Demkura PV, 2012, MOL PLANT, V5, P642, DOI 10.1093/mp/sss025; Devlin PF, 2003, PLANT PHYSIOL, V133, P1617, DOI 10.1104/pp.103.034397; Djukanovic V, 2013, PLANT J, V76, P888, DOI 10.1111/tpj.12335; D'Souza S. F., 2009, P INT JOINT FAO IAEA, P55; Eckstein A, 2016, PLANT PHYSIOL BIOCH, V105, P271, DOI 10.1016/j.plaphy.2016.05.008; Endo M, 2016, CELL MOL LIFE SCI, V73, P829, DOI 10.1007/s00018-015-2095-8; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; Facella P, 2017, FEBS OPEN BIO, V7, P456, DOI 10.1002/2211-5463.12082; Facella P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002798; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Galvao VC, 2014, ADV BOT RES, V72, P63, DOI 10.1016/B978-0-12-417162-6.00003-1; Garg AK, 2006, PLANTA, V223, P627, DOI 10.1007/s00425-005-0101-3; Giliberto L, 2005, PLANT PHYSIOL, V137, P199, DOI 10.1104/pp.104.051987; Gommers CMM, 2017, PLANT CELL, V29, P331, DOI 10.1105/tpc.16.00790; Graf A, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160333; Griebel T, 2008, PLANT PHYSIOL, V147, P790, DOI 10.1104/pp.108.119503; Gupta SK, 2014, PLANT CELL ENVIRON, V37, P1688, DOI 10.1111/pce.12279; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Hirose F, 2006, PLANT CELL PHYSIOL, V47, P915, DOI 10.1093/pcp/pcj064; Hisamatsu T, 2008, J EXP BOT, V59, P3821, DOI 10.1093/jxb/ern232; Hudson M., 2008, ANN PLANT REV LIGHT, V30, P267; Ito S, 2012, MOL PLANT, V5, P573, DOI 10.1093/mp/sss013; Jacobsen JV, 2002, PHYSIOL PLANTARUM, V115, P428, DOI 10.1034/j.1399-3054.2002.1150313.x; Jansen MAK, 2002, PHYSIOL PLANTARUM, V116, P423, DOI 10.1034/j.1399-3054.2002.1160319.x; Jenkins GI, 2014, PLANT CELL, V26, P21, DOI 10.1105/tpc.113.119446; Jeong RD, 2010, P NATL ACAD SCI USA, V107, P13538, DOI 10.1073/pnas.1004529107; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kang CY, 2009, PLANT CELL, V21, P2624, DOI 10.1105/tpc.109.069765; Kasahara M, 2004, PLANT PHYSIOL, V135, P1388, DOI 10.1104/pp.104.042705; Kendrick RE, 1997, PLANT CELL ENVIRON, V20, P746, DOI 10.1046/j.1365-3040.1997.d01-109.x; Kharshiing EV, 2010, PLANT BIOLOGY, V12, P224, DOI 10.1111/j.1438-8677.2009.00267.x; Kharshiing E, 2016, J PHOTOCH PHOTOBIO B, V165, P157, DOI 10.1016/j.jphotobiol.2016.10.026; Kharshiing E, 2015, J PLANT GROWTH REGUL, V34, P206, DOI 10.1007/s00344-014-9454-9; Kharshiing EV, 2010, PLANT SIGNAL BEHAV, V5, P1379, DOI 10.4161/psb.5.11.13035; Kimura S., 2008, COLD SPRING HARB PRO; Kliebenstein DJ, 2002, PLANT PHYSIOL, V130, P234, DOI 10.1104/pp.005041; Koepfli J. B., 1938, BIOL I CHEM J, V122, P763; Kozuka T, 2013, PLANT CELL PHYSIOL, V54, P69, DOI 10.1093/pcp/pcs134; Kurowska M, 2011, J APPL GENET, V52, P371, DOI 10.1007/s13353-011-0061-1; Lee KP, 2012, CELL CYCLE, V11, P4489, DOI 10.4161/cc.22667; Li JG, 2012, PROTEIN CELL, V3, P106, DOI 10.1007/s13238-012-2016-7; Li L, 2012, GENE DEV, V26, P785, DOI 10.1101/gad.187849.112; Li QF, 2016, MOL PLANT, V9, P113, DOI 10.1016/j.molp.2015.08.014; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Lidon F. J. C., 2012, Emirates Journal of Food and Agriculture, V24, P546, DOI 10.9755/ejfa.v24i6.546556; Lidon F. C., 2011, PHOTOCHEM PHOTOBIO B, V104, P457, DOI [10.1016/j.jphotobiol.2011.05.004, DOI 10.1016/J.JPHOTOBIOL.2011.05.004]; Lin CT, 2002, PLANT CELL, V14, pS207, DOI 10.1105/tpc.000646; Liu J, 2012, PLANT MOL BIOL, V78, P289, DOI 10.1007/s11103-011-9860-3; Lopez L, 2012, PLANT CELL ENVIRON, V35, P994, DOI 10.1111/j.1365-3040.2011.02467.x; Lucas M, 2014, NEW PHYTOL, V202, P1126, DOI [10.1111/nph.12725, DOI 10.1111/NPH.12725]; Manova V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00885; Markelz NH, 2003, PLANT PHYSIOL, V133, P1578, DOI 10.1104/pp.103.029694; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; Mazza CA, 2015, NEW PHYTOL, V207, P4, DOI 10.1111/nph.13332; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Meng YY, 2013, PLANT CELL, V25, P4405, DOI 10.1105/tpc.113.116590; Millar AJ, 2003, J BIOL RHYTHM, V18, P217, DOI 10.1177/0748730403253383; Mockler T, 2003, P NATL ACAD SCI USA, V100, P2140, DOI 10.1073/pnas.0437826100; Moreno JE, 2014, J CHEM ECOL, V40, P848, DOI 10.1007/s10886-014-0471-8; Neff MM, 1998, PLANT PHYSIOL, V118, P27, DOI 10.1104/pp.118.1.27; Negi S, 2010, MOL PLANT, V3, P854, DOI 10.1093/mp/ssq033; Oh E, 2007, PLANT CELL, V19, P1192, DOI 10.1105/tpc.107.050153; Oh E, 2009, PLANT CELL, V21, P403, DOI 10.1105/tpc.108.064691; Osakabe K, 2012, PLANT MUTATION BREEDING AND BIOTECHNOLOGY, P523, DOI 10.1079/9781780640853.0523; Osakabe Y, 2015, PLANT CELL PHYSIOL, V56, P389, DOI 10.1093/pcp/pcu170; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Pathirana R., 2011, PLANT SCI REV, P107; Pearce S, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0831-3; Pedmale UV, 2016, CELL, V164, P233, DOI 10.1016/j.cell.2015.12.018; Perrella G, 2016, NEW PHYTOL, V212, P908, DOI 10.1111/nph.14269; Petrillo E, 2014, RNA BIOL, V11, P1215, DOI 10.4161/15476286.2014.972852; Petroutsos D, 2016, NATURE, V537, P563, DOI 10.1038/nature19358; Prasad BRV, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-37; Gutierrez C, 2015, PLANT J, V83, P1, DOI [10.1111/tpj.12909, 10.1111/tpj.13100]; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Robson PRH, 1996, NAT BIOTECHNOL, V14, P995, DOI 10.1038/nbt0896-995; Robson TM, 2015, PLANT CELL ENVIRON, V38, P856, DOI 10.1111/pce.12374; Sawers RJH, 2005, TRENDS PLANT SCI, V10, P138, DOI 10.1016/j.tplants.2005.01.004; Schaeffer SM, 2015, PLANT SCI, V240, P130, DOI 10.1016/j.plantsci.2015.09.011; Schmidt D, 2015, TRENDS BIOTECHNOL, V33, P80, DOI 10.1016/j.tibtech.2014.10.007; Schmitt J, 2003, INTEGR COMP BIOL, V43, P459, DOI 10.1093/icb/43.3.459; Seo M, 2006, PLANT J, V48, P354, DOI 10.1111/j.1365-313X.2006.02881.x; Seo M, 2009, PLANT MOL BIOL, V69, P463, DOI 10.1007/s11103-008-9429-y; Sharma P, 2014, PLANT CELL ENVIRON, V37, P961, DOI 10.1111/pce.12212; Sharma S, 2014, PLANT PHYSIOL, V164, P2030, DOI 10.1104/pp.113.232306; Sheehan MJ, 2007, PLANT J, V49, P338, DOI 10.1111/j.1365-313X.2006.02962.x; Shih PM, 2016, PLANT J, V87, P103, DOI 10.1111/tpj.13176; Shinkle JR, 2004, PHYSIOL PLANTARUM, V120, P240, DOI 10.1111/j.0031-9317.2004.0237.x; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Slade AJ, 2012, PLANT MUTATION BREEDING AND BIOTECHNOLOGY, P359, DOI 10.1079/9781780640853.0359; Somers DE, 2004, PLANT CELL, V16, P769, DOI 10.1105/tpc.016808; Song GY, 2016, CROP J, V4, P75, DOI 10.1016/j.cj.2015.12.002; Song YH, 2014, P NATL ACAD SCI USA, V111, P17672, DOI 10.1073/pnas.1415375111; Soyk S, 2017, NAT GENET, V49, P162, DOI 10.1038/ng.3733; Suesslin C, 2003, PLANT J, V33, P591, DOI 10.1046/j.1365-313X.2003.01649.x; Suetsugu N, 2013, PLANT CELL PHYSIOL, V54, P8, DOI 10.1093/pcp/pcs165; Suprasanna P, 2012, PLANT MUTATION BREEDING AND BIOTECHNOLOGY, P347, DOI 10.1079/9781780640853.0347; Takano M, 2005, PLANT CELL, V17, P3311, DOI 10.1105/tpc.105.035899; Takemiya A, 2005, PLANT CELL, V17, P1120, DOI 10.1105/tpc.104.030049; Taylor A, 2010, PLANT CELL PHYSIOL, V51, P1638, DOI 10.1093/pcp/pcq120; de Toledo Thomazella D. P., 2016, BIORXIV, DOI [10.1101/064824, DOI 10.1101/064824]; Tilbrook Kimberley, 2013, Arabidopsis Book, V11, pe0164, DOI 10.1199/tab.0164; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Tsormpatsidis E, 2010, ANN APPL BIOL, V156, P357, DOI 10.1111/j.1744-7348.2010.00393.x; Ukai Y, 2012, PLANT MUTATION BREEDING AND BIOTECHNOLOGY, P209, DOI 10.1079/9781780640853.0209; Gonzalez CV, 2015, PHYTOCHEMISTRY, V110, P46, DOI 10.1016/j.phytochem.2014.11.018; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Wang Q, 2013, MOL PLANT, V6, P5, DOI 10.1093/mp/sss102; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wargent JJ, 2013, NEW PHYTOL, V197, P1058, DOI 10.1111/nph.12132; Wargent JJ, 2011, PLANT CELL ENVIRON, V34, P1401, DOI 10.1111/j.1365-3040.2011.02342.x; Wargent JJ, 2009, NEW PHYTOL, V183, P315, DOI 10.1111/j.1469-8137.2009.02855.x; Warnasooriya SN, 2014, J EXP BOT, V65, P2825, DOI 10.1093/jxb/eru221; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Weeks DP, 2016, PLANT BIOTECHNOL J, V14, P483, DOI 10.1111/pbi.12448; Weijschede J, 2006, NEW PHYTOL, V172, P655, DOI 10.1111/j.1469-8137.2006.01885.x; Weinig C, 2006, AM NAT, V167, P826, DOI 10.1086/503530; Weller JL, 2004, PLANT PHYSIOL, V135, P2186, DOI 10.1104/pp.103.036103; Weller JL, 2001, PLANT J, V26, P283, DOI 10.1046/j.1365-313X.2001.01027.x; Xie XZ, 2011, MOL PLANT, V4, P688, DOI 10.1093/mp/ssr005; Xue ZG, 2012, MOL BIOL REP, V39, P1411, DOI 10.1007/s11033-011-0875-2; Yang DY, 2016, P NATL ACAD SCI USA, V113, P7667, DOI 10.1073/pnas.1601309113; Yang JC, 2013, AM J BOT, V100, P1860, DOI 10.3732/ajb.1200574; Yanovsky MJ, 2000, PLANT J, V23, P223, DOI 10.1046/j.1365-313x.2000.00775.x; Yon F, 2016, NEW PHYTOL, V209, P1058, DOI 10.1111/nph.13681; Yu XH, 2005, Light Sensing in Plants, P325, DOI 10.1007/4-431-27092-2_38; Yu Xuhong, 2010, Arabidopsis Book, V8, pe0135; Yu YW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004025; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zhang QZ, 2008, P NATL ACAD SCI USA, V105, P21028, DOI 10.1073/pnas.0810585105; Zoltowski BD, 2014, ENZYMES, V35, P213, DOI 10.1016/B978-0-12-801922-1.00009-9	175	0	0	20	20	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	JUL 11	2017	8									10.3389/fpls.2017.01181				14	Plant Sciences	Plant Sciences	FA0ZI	WOS:000405164900001	28744290	gold			2018-01-05	
J	Lei, Y; Zhang, XT; Su, JZ; Jeong, M; Gundry, MC; Huang, YH; Zhou, YB; Li, W; Goodell, MA				Lei, Yong; Zhang, Xiaotian; Su, Jianzhong; Jeong, Mira; Gundry, Michael C.; Huang, Yung-Hsin; Zhou, Yubin; Li, Wei; Goodell, Margaret A.			Targeted DNA methylation in vivo using an engineered dCas9-MQ1 fusion protein	NATURE COMMUNICATIONS			English	Article							SEQUENCE-SPECIFIC CONTROL; ENDOGENOUS GENES; GENOME; METHYLTRANSFERASE; EXPRESSION; CANCER; CRISPR; ACTIVATION; ENHANCERS; BINDING	Comprehensive studies have shown that DNA methylation plays vital roles in both loss of pluripotency and governance of the transcriptome during embryogenesis and subsequent developmental processes. Aberrant DNA methylation patterns have been widely observed in tumorigenesis, ageing and neurodegenerative diseases, highlighting the importance of a systematic understanding of DNA methylation and the dynamic changes of methylomes during disease onset and progression. Here we describe a facile and convenient approach for efficient targeted DNA methylation by fusing inactive Cas9 (dCas9) with an engineered prokaryotic DNA methyltransferase MQ1. Our study presents a rapid and efficient strategy to achieve locus-specific cytosine modifications in the genome without obvious impact on global methylation in 24 h. Finally, we demonstrate our tool can induce targeted CpG methylation in mice by zygote microinjection, thereby demonstrating its potential utility in early development.	[Lei, Yong; Zhang, Xiaotian; Jeong, Mira; Gundry, Michael C.; Goodell, Margaret A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lei, Yong; Zhang, Xiaotian; Jeong, Mira; Gundry, Michael C.; Huang, Yung-Hsin; Li, Wei; Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Su, Jianzhong; Goodell, Margaret A.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Su, Jianzhong; Goodell, Margaret A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Huang, Yung-Hsin] Baylor Coll Med, Dept Dev Biol, Houston, TX 77030 USA; [Zhou, Yubin] Texas A&M Univ, Ctr Translat Canc Res, Inst Biosci & Technol, Dept Med Physiol,Coll Med, Houston, TX 77030 USA; [Zhang, Xiaotian] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA	Goodell, MA (reprint author), Baylor Coll Med, Ctr Cell & Gene Therapy, Dept Mol & Human Genet, Houston, TX 77030 USA.; Goodell, MA (reprint author), Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA.; Goodell, MA (reprint author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.; Goodell, MA (reprint author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	Goodell@bcm.edu		ZHOU, YUBIN/0000-0001-7962-0517; Zhang, Xiaotian/0000-0002-9533-4761	NIH [DK092883, CA183252, CA125123, P50CA126752, HG007538, CA193466, GM112003]; Edward P. Evans Foundation; Adrienne Helis Malvin Medical Research Foundation; Robert A. Welch Foundation [BE-1913]; CPRIT	This work was supported by the NIH (DK092883, CA183252, CA125123, P50CA126752, HG007538, CA193466 and GM112003), the Edward P. Evans Foundation, the Adrienne Helis Malvin Medical Research Foundation, Robert A. Welch Foundation (BE-1913) and by CPRIT.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Bell AC, 2000, NATURE, V405, P482; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bernstein DL, 2015, J CLIN INVEST, V125, P1998, DOI 10.1172/JCI77321; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r92, 10.1186/gb-2012-13-10-R92]; Brena RM, 2007, HUM MOL GENET, V16, pR96, DOI 10.1093/hmg/ddm073; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Choi SH, 2011, NUCLEIC ACIDS RES, V39, P104, DOI 10.1093/nar/gkq774; Cui CH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0819-6; Darii MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1654, DOI 10.1016/j.bbapap.2009.07.016; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Heerboth S, 2014, GENET EPIGENETICS, V6, P9, DOI 10.4137/GEG.S12270; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782                                                        ; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; McDonald JI, 2016, BIOL OPEN, V5, P866, DOI 10.1242/bio.019067; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Ordonez-Moran P, 2015, CANCER CELL, V28, P815, DOI 10.1016/j.ccell.2015.11.001; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; RENBAUM P, 1990, NUCLEIC ACIDS RES, V18, P1145, DOI 10.1093/nar/18.5.1145; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Singh Purnima, 2012, Frontiers in Genetics, V3, P214, DOI 10.3389/fgene.2012.00214; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stepper P, 2017, NUCLEIC ACIDS RES, V45, P1703, DOI 10.1093/nar/gkw1112; Valton J, 2012, J BIOL CHEM, V287, P30139, DOI 10.1074/jbc.M112.379966; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wojciechowski M, 2013, P NATL ACAD SCI USA, V110, P105, DOI 10.1073/pnas.1207986110; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003	40	2	2	20	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JUL 11	2017	8								16026	10.1038/ncomms16026				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FA1CG	WOS:000405175900001	28695892	gold			2018-01-05	
J	McKerrow, WH; Savva, YA; Rezaei, A; Reenan, RA; Lawrence, CE				McKerrow, Wilson H.; Savva, Yiannis A.; Rezaei, Ali; Reenan, Robert A.; Lawrence, Charles E.			Predicting RNA hyper-editing with a novel tool when unambiguous alignment is impossible	BMC GENOMICS			English	Article						RNA editing; Hyper-editing; Alignment; Repetitive element; Transposable element; dsRNA	DOUBLE-STRANDED-RNA; SYNAPTIC GROWTH; SEQUENCING DATA; DROSOPHILA; PROTEIN; GENOME; ADAR1; SITES; INTERFERENCE; RECEPTOR	Background: Repetitive elements are now known to have relevant cellular functions, including self-complementary sequences that form double stranded (ds) RNA. There are numerous pathways that determine the fate of endogenous dsRNA, and misregulation of endogenous dsRNA is a driver of autoimmune disease, particularly in the brain. Unfortunately, the alignment of high-throughput, short-read sequences to repeat elements poses a dilemma: Such sequences may align equally well to multiple genomic locations. In order to differentiate repeat elements, current alignment methods depend on sequence variation in the reference genome. Reads are discarded when no such variations are present. However, RNA hyper-editing, a possible fate for dsRNA, introduces enough variation to distinguish between repeats that are otherwise identical. Results: To take advantage of this variation, we developed a new algorithm, RepProfile, that simultaneously aligns reads and predicts novel variations. RepProfile accurately aligns hyper-edited reads that other methods discard. In particular we predict hyper-editing of Drosophila melanogaster repeat elements in vivo at levels previously described only in vitro, and provide validation by Sanger sequencing sixty-two individual cloned sequences. We find that hyper-editing is concentrated in genes involved in cell-cell communication at the synapse, including some that are associated with neurodegeneration. We also find that hyper-editing tends to occur in short runs. Conclusions: Previous studies of RNA hyper-editing discarded ambiguously aligned reads, ignoring hyper-editing in long, perfect dsRNA - the perfect substrate for hyper-editing. We provide a method that simulation and Sanger validation show accurately predicts such RNA editing, yielding a superior picture of hyper-editing.	[McKerrow, Wilson H.; Lawrence, Charles E.] Brown Univ, Div Appl Math, Providence, RI 02912 USA; [Savva, Yiannis A.; Rezaei, Ali; Reenan, Robert A.] Brown Univ, Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	McKerrow, WH (reprint author), Brown Univ, Div Appl Math, Providence, RI 02912 USA.	willmckerrow@gmail.com					Attrill H., 2015, NUCLEIC ACIDS RES, V44, pD786, DOI DOI 10.1093/NAR/GKV1046; Benjamini Y, 2001, ANN STAT, V29, P1165; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110                                                                ; Carrillo RA, 2015, CELL, V163, P1770, DOI 10.1016/j.cell.2015.11.022; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Jin Y, 2015, BIOINFORMATICS, V31, P3593, DOI 10.1093/bioinformatics/btv422; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.285504; Kim M, 2015, AUTOPHAGY, V11, P1358, DOI 10.1080/15548627.2015.1063766; Kumar JP, 2003, DEVELOPMENT, V130, P3703, DOI 10.1242/dev.00556                                                               ; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Lee HK, 2013, NEURON, V78, P813, DOI 10.1016/j.neuron.2013.04.001; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Lehmann KA, 1999, J MOL BIOL, V291, P1, DOI 10.1006/jmbi.1999.2914                                                          ; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu ZJ, 2009, RNA, V15, P1805, DOI 10.1261/rna.1643609; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; Merino C, 2009, J CELL BIOL, V185, P713, DOI 10.1083/jcb.200809127; Meyer S, 2014, MECH DEVELOP, V133, P105, DOI 10.1016/j.mod.2014.05.003; Nahm M, 2010, J NEUROSCI, V30, P8138, DOI 10.1523/JNEUROSCI.0256-10.2010; NISHIKURA K, 1991, EMBO J, V10, P3523; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrn2061; O'Connell MA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005687; Parks MM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0633-1; POLSON AG, 1994, EMBO J, V13, P5701; Porath HT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5726; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]; Rodriguez J, 2012, MOL CELL, V47, P27, DOI 10.1016/j.molcel.2012.05.002; Saldi TK, 2014, EMBO J, V33, P2947, DOI 10.15252/embj.201488740; Savva YA, 2016, FRONT GENET, V7, DOI [10.3389/fgene.2016.00100, 10.3389/fgene.2015.00100]; Savva YA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3745; Sjolander K, 1996, COMPUT APPL BIOSCI, V12, P327; Smith KR, 2010, MOL CELL NEUROSCI, V44, P330, DOI 10.1016/j.mcn.2010.04.004; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; St Laurent G, 2013, NAT STRUCT MOL BIOL, V20, P1333, DOI 10.1038/nsmb.2675; Stevenson KR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-536; Wang J, 2006, DEVELOPMENT, V133, P1231, DOI 10.1242/dev.02299; Wang J, 2010, BIOINFORMATICS, V26, P2501, DOI 10.1093/bioinformatics/btq460; Whipple JM, 2015, RNA, V21, P786, DOI 10.1261/rna.048801.114; Yu WH, 2011, MOL CELL NEUROSCI, V47, P19, DOI 10.1016/j.mcn.2011.02.002	47	0	0	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	JUL 10	2017	18								522	10.1186/s12864-017-3898-9				16	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FB1FF	WOS:000405888400003	28693467	gold			2018-01-05	
J	Zhang, W; Wang, G; Wang, Y; Jin, Y; Zhao, LH; Xiong, Q; Zhang, LN; Mou, LS; Li, RF; Yang, HY; Dai, YF				Zhang, Wei; Wang, Guan; Wang, Ying; Jin, Yong; Zhao, Lihua; Xiong, Qiang; Zhang, Lining; Mou, Lisha; Li, Rongfeng; Yang, Haiyuan; Dai, Yifan			Generation of complement protein C3 deficient pigs by CRISPR/Cas9-mediated gene targeting	SCIENTIFIC REPORTS			English	Article							ONE-STEP GENERATION; 3RD COMPONENT; CELLS; BIOSYNTHESIS; EXPRESSION; SYSTEM; MICE; CAS9; ALPHA-1,3-GALACTOSYLTRANSFERASE; HYPOCOMPLEMENTEMIA	Complement protein C3 is the pivotal component of the complement system. Previous studies have demonstrated that C3 has implications in various human diseases and exerts profound functions under certain conditions. However, the delineation of pathological and physiological roles of C3 has been hampered by the insufficiency of suitable animal models. In the present study, we applied the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system to target the C3 gene in porcine fetal fibroblasts. Our results indicated that CRISPR/Cas9 targeting efficiency was as high as 84.7%, and the biallelic mutation efficiency reached at 45.7%. The biallelic modified colonies were used as donor for somatic cell nuclear transfer (SCNT) technology to generate C3 targeted piglets. A total of 19 C3 knockout (KO) piglets were produced and their plasma C3 protein was undetectable by western blot analysis and ELISA. The hemolytic complement activity and complement-dependent cytotoxicity assay further confirmed that C3 was disrupted in these piglets. These C3 KO pigs could be utilized as a valuable large animal model for the elucidation of the roles of C3.	[Zhang, Wei; Wang, Guan; Wang, Ying; Jin, Yong; Zhao, Lihua; Xiong, Qiang; Zhang, Lining; Li, Rongfeng; Yang, Haiyuan; Dai, Yifan] Nanjing Med Univ, Jiangsu Key Lab Xenotransplantat, Nanjing 211166, Jiangsu, Peoples R China; [Mou, Lisha] Shenzhen Univ, Shenzhen Peoples Hosp 2, Affiliated Hosp 1,Inst Translat Med, Shenzhen Xenotransplantat Med Engn Res & Dev Ctr, Shenzhen 518035, Guangdong, Peoples R China	Yang, HY; Dai, YF (reprint author), Nanjing Med Univ, Jiangsu Key Lab Xenotransplantat, Nanjing 211166, Jiangsu, Peoples R China.	hyyang@njmu.edu.cn; daiyifan@njmu.edu.cn		Yang, Haiyuan/0000-0001-5253-0079	National Natural Science Foundation of China [81570402]; Jiangsu Key Laboratory of Xenotransplantation [BM2012116]; Sanming Project of Medicine in Shenzhen; Fund for High Level Medical Discipline Construction of Shenzhen [2016031638]; Shenzhen Foundation of Science and Technology [JCYJ20160229204849975, GCZX2015043017281705]	This work was supported by a grant from the National Natural Science Foundation of China (No. 81570402), a grant from the Jiangsu Key Laboratory of Xenotransplantation (BM2012116), grants from the Sanming Project of Medicine in Shenzhen, the Fund for High Level Medical Discipline Construction of Shenzhen (No. 2016031638), and the Shenzhen Foundation of Science and Technology (No. JCYJ20160229204849975 and GCZX2015043017281705). Y.D., R.L. and Y.W. are Fellows at the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University.	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Al-Mashhadi RH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004853; ALPER CA, 1972, LANCET, V2, P1179; ALPER CA, 1969, SCIENCE, V163, P286, DOI 10.1126/science.163.3864.286                                                    ; Botto M, 1993, Int Rev Immunol, V10, P37, DOI 10.3109/08830189309051170; BOTTO M, 1992, J IMMUNOL, V149, P1348; BROOIMANS RA, 1991, J CLIN INVEST, V88, P379, DOI 10.1172/JCI115314; BURGER R, 1986, EUR J IMMUNOL, V16, P7, DOI 10.1002/eji.1830160103; CHARLESWORTH JA, 1974, J CLIN INVEST, V53, P1578, DOI 10.1172/JCI107708; Colten H R, 1979, Ann N Y Acad Sci, V332, P482, DOI 10.1111/j.1749-6632.1979.tb47142.x; COLTEN HR, 1981, NEW ENGL J MED, V304, P653, DOI 10.1056/NEJM198103123041107                                                     ; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gao HC, 2017, J REPROD DEVELOP, V63, P17, DOI 10.1262/jrd.2016-079; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; KATZ Y, 1988, ARTHRITIS RHEUM, V31, P1365, DOI 10.1002/art.1780311104; KOMATSU M, 1988, IMMUNOLOGY, V64, P363; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Miles EL, 2013, P NATL ACAD SCI USA, V110, P6334, DOI 10.1073/pnas.1220910110; Niemann H, 2016, THERIOGENOLOGY, V86, P80, DOI 10.1016/j.theriogenology.2016.04.021; PANTAZIS P, 1990, MOL IMMUNOL, V27, P283, DOI 10.1016/0161-5890(90)90141-L                                                    ; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Peng Q, 2006, J IMMUNOL, V176, P3330, DOI 10.4049/jimmunol.176.6.3330                                                     ; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; ROODHOOFT AM, 1990, PEDIATR NEPHROL, V4, P597, DOI 10.1007/BF00858631                                                              ; ROTHMAN BL, 1990, J IMMUNOL, V145, P592; Sheerin NS, 1997, KIDNEY INT, V51, P703, DOI 10.1038/ki.1997.101; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; SINGER L, 1994, PATHOBIOLOGY, V62, P14, DOI 10.1159/000163873; Smerup M, 2004, HEART SURG FORUM, V7, pE259, DOI 10.1532/HSF98.20041015; SUNDSTROM SA, 1989, J BIOL CHEM, V264, P16941; THEODOROPOULOS G, 1992, HUM HERED, V42, P168, DOI 10.1159/000154061; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JX, 2016, CLIN IMMUNOL, V162, P37, DOI 10.1016/j.clim.2015.11.002; WELCH TR, 1993, J CLIN INVEST, V92, P1451, DOI 10.1172/JCI116722; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; WINKELSTEIN JA, 1981, SCIENCE, V212, P1169, DOI 10.1126/science.7233211; Yuan L, 2016, SCI REP-UK, V6, DOI 10.1038/srep22024; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7	45	0	0	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 10	2017	7								5009	10.1038/s41598-017-05400-2				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FA1EA	WOS:000405180900082	28694465	gold			2018-01-05	
J	Lim, YW; Lo, HP; Ferguson, C; Martel, N; Giacomotto, J; Gomez, GA; Yap, AS; Hall, TE; Parton, RG				Lim, Ye-Wheen; Lo, Harriet P.; Ferguson, Charles; Martel, Nick; Giacomotto, Jean; Gomez, Guillermo A.; Yap, Alpha S.; Hall, Thomas E.; Parton, Robert G.			Caveolae Protect Notochord Cells against Catastrophic Mechanical Failure during Development	CURRENT BIOLOGY			English	Article							LARVAL ZEBRAFISH; MUSCLE-FIBERS; MEMBRANE; CAVIN; MORPHOGENESIS; ORGANIZATION; DYSTROPHIN; ONTOGENY; INSIGHTS; COMPLEX	The embryonic notochord is a flexible structure present during development that serves as scaffold for formation of the vertebrate spine. This rod-like organ is thought to have evolved in non-vertebrate chordates to facilitate locomotion by providing a rigid but flexible midline structure against which the axial muscles can contract. This hydrostatic "skeleton'' is exposed to a variety of mechanical forces during oscillation of the body. There is evidence that caveolae, submicroscopic cup-shaped plasma membrane pits, can buffer tension in cells that undergo high levels of mechanical stress. Indeed, caveolae are particularly abundant in the embryonic notochord. In this study, we used the CRISPR/Cas9 system to generate a mutant zebrafish line lacking Cavin1b, a coat protein required for caveola formation. Our cavin1b(-/-) zebrafish line exhibits reduced locomotor capacity and prominent notochord lesions characterized by necrotic, damaged, and membrane-permeable cells. Notochord diameter and body length are reduced, but remarkably, the mutants recover and are homozygous viable. By manipulating mechanical stress using a number of different assays, we show that progression of lesion severity in the mutant notochord is directly dependent on locomotion. We also demonstrate changes in caveola morphology in vivo in response to mechanical stress. Finally, induction of a catastrophic collapse of live cavin1b(-/-) mutant notochord cells provides the first real-time observation of caveolae mediating cellular mechano-protection.	[Lim, Ye-Wheen; Lo, Harriet P.; Ferguson, Charles; Martel, Nick; Gomez, Guillermo A.; Yap, Alpha S.; Hall, Thomas E.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Ferguson, Charles; Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; [Giacomotto, Jean] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Giacomotto, Jean] Univ Claude Bernard Lyon 1, INSERM, CNRS, Inst NeuroMyoGene,UMR5310,U1217, F-69622 Villeurbanne, France; [Gomez, Guillermo A.] SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Gomez, Guillermo A.] Univ South Australia, Adelaide, SA 5000, Australia	Hall, TE; Parton, RG (reprint author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.; Parton, RG (reprint author), Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia.	thomas.hall@imb.uq.edu.au; r.parton@imb.uq.edu.au		Giacomotto, Jean/0000-0002-2918-4689	National Health and Medical Research Council of Australia [569542, 1045092, APP1037320, APP1044041, APP1099251]; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology [CE140100036]; ACRF	We thank the labs of Ben Hogan and Kelly Smith for their help with the CRISPR/ Cas9 system setup. We thank Susan Nixon for designing cavin1b and cav1 qRT-PCR primers. This work was supported by fellowships and grants from the National Health and Medical Research Council of Australia (to R.G.P., grant numbers 569542 and 1045092; to R.G.P. and A.S.Y., grant number APP1037320; to A.S.Y., grant number APP1044041; and to T.E.H. and R.G.P., grant number APP1099251) as well as by the Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology (to R.G.P., grant number CE140100036). Confocal microscopy was performed at the Australian Cancer Research Foundation (ACRF)/Institute for Molecular Bioscience (IMB) Dynamic Imaging Facility for Cancer Biology, established with funding from the ACRF. The authors acknowledge the facilities, and the scientific and technical assistance, of the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy and Microanalysis, The University of Queensland.	ADAMS DS, 1990, DEVELOPMENT, V110, P115; Annona G, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0025-3; Ariotti N, 2015, DEV CELL, V35, P513, DOI 10.1016/j.devcel.2015.10.016; Attili S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103751; Bassett DI, 2003, DEVELOPMENT, V130, P5851, DOI 10.1242/dev.00799; Bensimon-Brito A, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-28; Budick SA, 2000, J EXP BIOL, V203, P2565; Cheng JPX, 2015, J CELL BIOL, V211, P53, DOI 10.1083/jcb.201504042; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; DE BK, 1991, BIOCHEM BIOPH RES CO, V178, P830, DOI 10.1016/0006-291X(91)90966-B; Deerinck TJ, 2010, NCMIR METHODS 3D EM; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Du SJ, 2001, DEV BIOL, V238, P239, DOI 10.1006/dbio.2001.0390; Ellis K, 2013, J CELL BIOL, V200, P667, DOI 10.1083/jcb.201212095; Esterberg R, 2008, DEVELOPMENT, V135, P3891, DOI 10.1242/dev.029264; Fiaz AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034072; Fleming A, 2004, DEVELOPMENT, V131, P873, DOI 10.1242/dev.00952; Fontaine E, 2008, J EXP BIOL, V211, P1305, DOI 10.1242/jeb.010272; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; Gray RS, 2014, DEV BIOL, V386, P72, DOI 10.1016/j.ydbio.2013.11.028; Haga Y, 2009, TRANSGENIC RES, V18, P669, DOI 10.1007/s11248-009-9259-y; Hall TE, 2007, P NATL ACAD SCI USA, V104, P7092, DOI 10.1073/pnas.0700942104; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hapuarachchige S, 2011, J AM CHEM SOC, V133, P6780, DOI 10.1021/ja2005175; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Jiang D, 2007, DEV DYNAM, V236, P1748, DOI 10.1002/dvdy.21184; Koehl MAR, 2000, AM ZOOL, V40, P28, DOI 10.1668/0003-1569(2000)040[0028:MDOFWH]2.0.CO;2; Kovtun O, 2015, J CELL SCI, V128, P1269, DOI 10.1242/jcs.167866; Kovtun O, 2014, DEV CELL, V31, P405, DOI 10.1016/j.devcel.2014.10.002; Laird AS, 2016, HUM MOL GENET, V25, P1728, DOI 10.1093/hmg/ddw044; Liang X., 2016, BIOL PROTOC, V6, pe2068; Liew WC, 2014, BRIEF FUNCT GENOMICS, V13, P172, DOI 10.1093/bfgp/elt041; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Lo HP, 2015, J CELL BIOL, V210, P833, DOI 10.1083/jcb.201501046; LONG JH, 1995, ENVIRON BIOL FISH, V44, P199, DOI 10.1007/BF00005916; MATSUDA R, 1995, J BIOCHEM-TOKYO, V118, P959, DOI 10.1093/jb/118.5.959                                                            ; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; Nixon SJ, 2005, HUM MOL GENET, V14, P1727, DOI 10.1093/hmg/ddi179; Nixon SJ, 2007, J CELL SCI, V120, P2151, DOI 10.1242/jcs.003830; Pearen MA, 2012, MOL ENDOCRINOL, V26, P372, DOI 10.1210/me.2011-1274; Satoh N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1729; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Smolders LA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4157; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; Stoeber M, 2012, EMBO J, V31, P2350, DOI 10.1038/emboj.2012.98; Thorsen DH, 2004, J EXP BIOL, V207, P4175, DOI 10.1242/jeb.01285; Walser PJ, 2012, CELL, V150, P752, DOI 10.1016/j.cell.2012.06.042; WESTERFIELD M, 2000, ZEBRAFISH BOOK GUIDE; Williams RJ, 2011, BIOMATERIALS, V32, P5304, DOI 10.1016/j.biomaterials.2011.03.078; Wilson JM, 2009, J AM ASSOC LAB ANIM, V48, P785; Yamamoto M, 2010, DEVELOPMENT, V137, P2527, DOI 10.1242/dev.051011	56	1	1	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0960-9822	1879-0445		CURR BIOL	Curr. Biol.	JUL 10	2017	27	13					1968	+		10.1016/j.cub.2017.05.067				21	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FA0HZ	WOS:000405114300027	28648821				2018-01-05	
J	Huang, JG; Chen, M; Whitley, MJ; Kuo, HC; Xu, ES; Walens, A; Mowery, YM; Van Mater, D; Eward, WC; Cardona, DM; Luo, LX; Ma, Y; Lopez, OM; Nelson, CE; Robinson-Hamm, JN; Reddy, A; Dave, SS; Gersbach, CA; Dodd, RD; Kirsch, DG				Huang, Jianguo; Chen, Mark; Whitley, Melodi Javid; Kuo, Hsuan-Cheng; Xu, Eric S.; Walens, Andrea; Mowery, Yvonne M.; Van Mater, David; Eward, William C.; Cardona, Diana M.; Luo, Lixia; Ma, Yan; Lopez, Omar M.; Nelson, Christopher E.; Robinson-Hamm, Jacqueline N.; Reddy, Anupama; Dave, Sandeep S.; Gersbach, Charles A.; Dodd, Rebecca D.; Kirsch, David G.			Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma	NATURE COMMUNICATIONS			English	Article							SOFT-TISSUE SARCOMA; ONCOGENIC K-RAS; IN-VIVO; PANCREATIC-CANCER; GENOME; MICE; CELLS; CRISPR/CAS9; DELETION; MUSCLE	Genetically engineered mouse models that employ site-specific recombinase technology are important tools for cancer research but can be costly and time-consuming. The CRISPR-Cas9 system has been adapted to generate autochthonous tumours in mice, but how these tumours compare to tumours generated by conventional recombinase technology remains to be fully explored. Here we use CRISPR-Cas9 to generate multiple subtypes of primary sarcomas efficiently in wild type and genetically engineered mice. These data demonstrate that CRISPR-Cas9 can be used to generate multiple subtypes of soft tissue sarcomas in mice. Primary sarcomas generated with CRISPR-Cas9 and Cre recombinase technology had similar histology, growth kinetics, copy number variation and mutational load as assessed by whole exome sequencing. These results show that sarcomas generated with CRISPR-Cas9 technology are similar to sarcomas generated with conventional modelling techniques and suggest that CRISPR-Cas9 can be used to more rapidly generate genotypically and phenotypically similar cancers.	[Huang, Jianguo; Xu, Eric S.; Mowery, Yvonne M.; Luo, Lixia; Ma, Yan; Dodd, Rebecca D.; Kirsch, David G.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA; [Chen, Mark; Whitley, Melodi Javid; Kuo, Hsuan-Cheng; Walens, Andrea; Lopez, Omar M.; Kirsch, David G.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Chen, Mark; Whitley, Melodi Javid] Duke Univ, Med Ctr, Med Scientist Training Program, Durham, NC 27710 USA; [Van Mater, David] Duke Univ, Med Ctr, Dept Pediat, Div Hematol Oncol, Durham, NC 27710 USA; [Eward, William C.] Duke Univ, Dept Orthoped Surg, Durham, NC 27710 USA; [Cardona, Diana M.] Duke Univ, Dept Pathol, Durham, NC 27710 USA; [Nelson, Christopher E.; Robinson-Hamm, Jacqueline N.; Gersbach, Charles A.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Nelson, Christopher E.; Robinson-Hamm, Jacqueline N.; Reddy, Anupama; Dave, Sandeep S.; Gersbach, Charles A.] Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC 27708 USA; [Dave, Sandeep S.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Dodd, Rebecca D.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	Kirsch, DG (reprint author), Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA.; Kirsch, DG (reprint author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	david.kirsch@duke.edu	Chen, Mark/U-3905-2017	Chen, Mark/0000-0001-5616-9321; Mowery, Yvonne/0000-0002-9839-2414	National Cancer Institute of the US NIH [F30CA206424, T32GM007171, R35CA197616]; Department of Defense [W81XWH-14-1-0067]	We thank David Ousterout for suggestions on designing the sgRNA to Trp53. We also thank Andrea Ventura and Danilo Maddalo for sharing plasmids and helpful advice to generate vectors to utilize the CRISPR-Cas9 system. This work was supported by the National Cancer Institute of the US NIH under award numbers F30CA206424 (M.C.), T32GM007171 (M.C. and M.J.W.) and R35CA197616 (D.G.K.), and by the Department of Defense under award number W81XWH-14-1-0067 (D.G.K.).	Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867                                                             ; Annunziato S, 2016, GENE DEV, V30, P1470, DOI 10.1101/gad.279190.116; Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026; Blum JM, 2013, CELL REP, V5, P933, DOI 10.1016/j.celrep.2013.10.020; Carroll KJ, 2016, P NATL ACAD SCI USA, V113, P338, DOI 10.1073/pnas.1523918113; Chiou SH, 2015, GENE DEV, V29, P1576, DOI 10.1101/gad.264861.115; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dodd RD, 2013, MOL CANCER THER, V12, P1906, DOI 10.1158/1535-7163.MCT-13-0189; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Hanahan D, 2007, GENE DEV, V21, P2258, DOI 10.1101/gad.1583307; Hatley ME, 2012, CANCER CELL, V22, P536, DOI 10.1016/j.ccr.2012.09.004; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; HEGI ME, 1994, CANCER RES, V54, P6257; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kerr EM, 2016, NATURE, V531, P110, DOI 10.1038/nature16967; Kim Suzy, 2012, Sarcoma, P680708, DOI 10.1155/2012/680708; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Lee W, 2014, NAT GENET, V46, P1227, DOI 10.1038/ng.3095; LEVINE DS, 1991, P NATL ACAD SCI USA, V88, P6427, DOI 10.1073/pnas.88.15.6427; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maresch R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10770; Margolis RL, 2003, J CELL BIOCHEM, V88, P673, DOI 10.1002/jcb.10411; McFadden DG, 2016, P NATL ACAD SCI USA, V113, pE6409, DOI 10.1073/pnas.1613601113; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Minas TZ, 2017, ONCOTARGET, V8, P34141, DOI 10.18632/oncotarget.9388; Mito JK, 2013, J PATHOL, V229, P132, DOI 10.1002/path.4099; Mito JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008075; Moding EJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4214; Moding EJ, 2014, J CLIN INVEST, V124, P3325, DOI 10.1172/JCI73932; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Politi K, 2011, J CLIN ONCOL, V29, P2273, DOI 10.1200/JCO.2010.30.8304; Post SM, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-20; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodriguez R, 2012, CELL RES, V22, P62, DOI 10.1038/cr.2011.157; Sachdeva M, 2014, J CLIN INVEST, V124, P4305, DOI 10.1172/JCI77116; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Tsumura H, 2006, ONCOGENE, V25, P7673, DOI 10.1038/sj.onc.1209749; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Van der Auwera GA, 2013, CURR PROTOC BIOINFOR, V11, DOI DOI 10.1002/0471250953.BI1110S43; Weber J, 2015, P NATL ACAD SCI USA, V112, P13982, DOI 10.1073/pnas.1512392112; Whitley MJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0293; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	56	0	0	14	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JUL 10	2017	8								15999	10.1038/ncomms15999				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FA0IA	WOS:000405114400001	28691711	gold			2018-01-05	
J	Xie, QQ; Lin, Q; Li, DZ; Chen, JM				Xie, Qingqing; Lin, Qj; Li, Dezhi; Chen, Jianming			Imatinib induces autophagy via upregulating XIAP in GIST882 cells	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						XIAP; Autophagy; GIST; Imatinib	GASTROINTESTINAL STROMAL TUMORS; TYROSINE KINASE INHIBITOR; DOWN-REGULATION; CANCER-CELLS; KAPPA-B; CLINICAL MANAGEMENT; INDUCED APOPTOSIS; STRUCTURAL BASIS; RESISTANCE; OVEREXPRESSION	Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms originating from the gastrointestinal tract with gain of function mutations in receptor tyrosine kinases KIT or platelet derived growth factor receptor A (PDGFRA). The main effective treatment for GISTs is tyrosine kinase inhibitors, such as imatinib mesylate. However, GISTs respond to imatinib treatment eventually develop acquired resistance, which is a main obstacle for GISTs therapy. Therefore, it's urgent to have a better understanding of the mechanisms underlying the imatinib resistance in GISTs to develop novel therapeutic strategies. X-linked inhibitor of apoptosis (XIAP) is the most potent apoptosis inhibitor among the inhibitor of apoptosis protein (IAP) family members. Increased cellular expression of XIAP often leads to drug resistance in cancers. Here we report that XIAP is induced upon imatinb treatment in GIST882 cells, leading to imatinib-induced autophagy. Imatinib-induced autophagy was impaired in XIAP-knockout cells generated by CRISPR/Cas9 system demonstrated by the decreasing of LC3 lipidation. XIAP knockout sensitizes GIST882 cells to imatinib-induced apoptotic cell death, suggesting that XIAP protects GIST882 cells from imatinib-induced cell death by inducing autophagy. Thus, the resistance of the GIST882 cells to imatinib appears to be, in part, due to the increasing of XIAP and subsequent induction of autophagy. (C) 2017 Elsevier Inc. All rights reserved.	[Xie, Qingqing; Lin, Qj; Li, Dezhi] Xiamen Univ, Sch Life Sci, Xiamen 361102, Fujian, Peoples R China; [Chen, Jianming] Third Inst Oceanog, Fujian Collaborat Innovat Ctr Exploitat & Utiliza, Key Lab Marine Genet Resources, Xiamen 361005, Fujian, Peoples R China	Chen, JM (reprint author), State Ocean Admn, Third Inst Oceanog, Xiamen 361005, Fujian, Peoples R China.	chenjm@xmu.edu.cn			International Science & Technology Cooperation Program of China [2015DFA20500]	This work was supported by the International Science & Technology Cooperation Program of China (2015DFA20500).	Airiau K, 2012, EXP HEMATOL, V40, P367, DOI 10.1016/j.exphem.2012.01.004; Bauer S, 2007, ONCOGENE, V26, P7560, DOI 10.1038/sj.onc.1210558; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Cheng SM, 2015, BRIT J PHARMACOL, V172, P214, DOI 10.1111/bph.12935; Dan HC, 2016, J BIOL CHEM, V291, P22846, DOI 10.1074/jbc.A116.312044; DeMatteo RP, 2002, HUM PATHOL, V33, P466, DOI 10.1053/hupa.2002.124123; Dewar AL, 2005, CELL CYCLE, V4, P851, DOI 10.4161/cc.4.7.1788                                                             ; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Ertmer A, 2007, LEUKEMIA, V21, P936, DOI 10.1038/sj.leu.2404606; Falkenhorst J, 2016, ONCOTARGET, V7, P41390, DOI 10.18632/oncotarget.9159; Farhadi E, 2017, ANTI-CANCER DRUG, V28, P51, DOI 10.1097/CAD.0000000000000426; Gupta A, 2010, P NATL ACAD SCI USA, V107, P14333, DOI 10.1073/pnas.1000248107; Heinrich MC, 2000, BLOOD, V96, P925; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Henze J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037776; Hornle M, 2011, ONCOGENE, V30, P575, DOI 10.1038/onc.2010.434; Huang X, 2013, EMBO J, V32, P2204, DOI 10.1038/emboj.2013.133; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(02)02075-5; Li J, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0554-6; Li S., 2013, MOL CLIN ONCOL, V1, P305; Lin F, 2015, HUM MOL GENET, V24, P2899, DOI 10.1093/hmg/ddv052; Maki RG, 2015, ONCOLOGIST, V20, P823, DOI 10.1634/theoncologist.2014-0471; Mizutani Y, 2007, INT J ONCOL, V30, P919; Ravegnini G., 2017, AUTOPHAGY, P1; Rubin BP, 2007, LANCET, V369, P1731, DOI 10.1016/S0140-6736(07)60780-6                                                   ; Rubin BP, 2010, AUTOPHAGY, V6, P1190, DOI 10.4161/auto.6.8.13430; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Shi Z, 2007, ONCOL REP, V17, P969; Sun CH, 1999, NATURE, V401, P818; Zhang X, 2013, ACTA BIOCH BIOPH SIN, V45, P995, DOI 10.1093/abbs/gmt113; Zhou SN, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-288	31	0	0	2	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	JUL 8	2017	488	4					584	589		10.1016/j.bbrc.2017.05.096				6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EY4VB	WOS:000403974600003	28528977				2018-01-05	
J	Larsen, ISB; Narimatsu, Y; Joshi, HJ; Yang, Z; Harrison, OJ; Brasch, J; Shapiro, L; Honig, B; Vakhrushev, SY; Clausen, H; Halim, A				Larsen, Ida Signe Bohse; Narimatsu, Yoshiki; Joshi, Hiren Jitendra; Yang, Zhang; Harrison, Oliver J.; Brasch, Julia; Shapiro, Lawrence; Honig, Barry; Vakhrushev, Sergey Y.; Clausen, Henrik; Halim, Adnan			Mammalian O-mannosylation of cadherins and plexins is independent of protein O-mannosyltransferases 1 and 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WALKER-WARBURG-SYNDROME; CHONDROITIN SULFATE PROTEOGLYCAN; EYE-BRAIN DISEASE; ALPHA-DYSTROGLYCAN; MUSCULAR-DYSTROPHY; GLYCAN STRUCTURES; MANNOSE GLYCOPROTEOME; ENZYMATIC-ACTIVITY; RIBITOL-PHOSPHATE; SKELETAL-MUSCLE	Protein O-mannosylation is found in yeast and metazoans, and a family of conserved orthologous protein O-mannosyltransferases is believed to initiate this important post-translational modification. We recently discovered that the cadherin superfamily carries O-linked mannose (O-Man) glycans at highly conserved residues in specific extracellular cadherin domains, and it was suggested that the function of E-cadherin was dependent on the O-Man glycans. Deficiencies in enzymes catalyzing O-Man biosynthesis, including the two human protein O-mannosyltransferases, POMT1 and POMT2, underlie a subgroup of congenital muscular dystrophies designated alpha-dystroglycanopathies, because deficient O-Man glycosylation of alpha-dystroglycan disrupts laminin interaction with alpha-dystroglycan and the extracellular matrix. To explore the functions of O-Man glycans on cadherins and protocadherins, we used a combinatorial gene-editing strategy in multiple cell lines to evaluate the role of the two POMTs initiating O-Man glycosylation and the major enzyme elongating O-Man glycans, the protein O-mannose alpha-1,2-N-acetylglucosaminyltransferase, POMGnT1. Surprisingly, O-mannosylation of cadherins and protocadherins does not require POMT1 and/or POMT2 in contrast to alpha-dystroglycan, and moreover, the O-Man glycans on cadherins are not elongated. Thus, the classical and evolutionarily conserved POMT O-mannosylation pathway is essentially dedicated to alpha-dystroglycan and a few other proteins, whereas a novel O-mannosylation process in mammalian cells is predicted to serve the large cadherin superfamily and other proteins.	[Larsen, Ida Signe Bohse; Narimatsu, Yoshiki; Joshi, Hiren Jitendra; Yang, Zhang; Vakhrushev, Sergey Y.; Clausen, Henrik; Halim, Adnan] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Harrison, Oliver J.; Brasch, Julia; Shapiro, Lawrence; Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Shapiro, Lawrence; Honig, Barry] Columbia Univ, Dept Syst Biol, Zuckerman Mind Brain Behav Inst, New York, NY 10032 USA; [Honig, Barry] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Halim, A (reprint author), Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA.	halim@sund.ku.dk		Halim, Adnan/0000-0003-1629-187X	A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene For-maal; Kirsten og Freddy Johansen Fonden; Carlsberg Foundation; Novo Nordisk Foundation; European Union [704228]; Danish Research Councils; National Science Foundation (NSF) [MCB-1412472]; National Institutes of Health [R01-GM10751, R01GM118584]; University of Copenhagen Program of Excellence; Danish National Research Foundation [DNRF107]	This work was supported by A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene For-maal, Kirsten og Freddy Johansen Fonden, The Carlsberg Foundation, The Novo Nordisk Foundation, The European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Grant 704228, The Danish Research Councils, National Science Foundation (NSF) Grant MCB-1412472 (to B. H.), National Institutes of Health Grants R01-GM10751 and R01GM118584 (to L. S.), the University of Copenhagen Program of Excellence, and the Danish National Research Foundation Grant DNRF107. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akasaka-Manya K, 2011, BIOCHEM BIOPH RES CO, V411, P721, DOI 10.1016/j.bbrc.2011.07.012; Amano K, 2008, P NATL ACAD SCI USA, V105, P3232, DOI 10.1073/pnas.0710412105; Avsar-Ban E, 2010, GLYCOBIOLOGY, V20, P1089, DOI 10.1093/glycob/cwq069; Balci B, 2005, NEUROMUSCULAR DISORD, V15, P271, DOI 10.1016/j.nmd.2005.01.013; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bartels MF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166119; Bausewein D, 2016, J BIOL CHEM, V291, P18006, DOI 10.1074/jbc.M116.739128; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bleckmann C, 2009, BIOL CHEM, V390, P627, DOI 10.1515/BC.2009.044; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Breloy I, 2008, J BIOL CHEM, V283, P18832, DOI 10.1074/jbc.M802834200; Breloy I, 2012, BIOL CHEM, V393, P709, DOI 10.1515/hsz-2012-0214; Carvalho S, 2016, ONCOTARGET, V7, P65231, DOI 10.18632/oncotarget.11245; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x                                                ; Dwyer CA, 2012, NEUROSCIENCE, V220, P47, DOI 10.1016/j.neuroscience.2012.06.026; FINNE J, 1979, J BIOL CHEM, V254, P295; Gerin I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11534; Gill DJ, 2013, P NATL ACAD SCI USA, V110, pE3152, DOI 10.1073/pnas.1305269110; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Halim A, 2015, P NATL ACAD SCI USA, V112, P15648, DOI 10.1073/pnas.1511743112; Halmo SM, 2017, J BIOL CHEM, V292, P2101, DOI 10.1074/jbc.M116.764712; Harrison R, 2012, GLYCOBIOLOGY, V22, P662, DOI 10.1093/glycob/cws002; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; KRUSIUS T, 1986, J BIOL CHEM, V261, P8237; Kuwabara N, 2016, P NATL ACAD SCI USA, V113, P9280, DOI 10.1073/pnas.1525545113; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Lommel M, 2011, J BIOL CHEM, V286, P39768, DOI 10.1074/jbc.M111.281196; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2003, BIOCHEM BIOPH RES CO, V306, P93, DOI 10.1016/S0006-291X(03)00924-0; Martinez T, 2007, J CHROMATOGR A, V1156, P183, DOI 10.1016/j.chroma.2007.04.050; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; Mercuri E, 2006, NEUROMUSCULAR DISORD, V16, P446, DOI 10.1016/j.nmd.2006.03.016; Nakamura N, 2010, GLYCOBIOLOGY, V20, P381, DOI 10.1093/glycob/cwp189; Neubert P, 2016, CURR OPIN CELL BIOL, V41, P100, DOI 10.1016/j.ceb.2016.04.010; Neubert P, 2016, MOL CELL PROTEOMICS, V15, P1323, DOI 10.1074/mcp.M115.057505; Nilsson J, 2010, GLYCOBIOLOGY, V20, P1160, DOI 10.1093/glycob/cwq082; Pacharra S, 2013, J PROTEOME RES, V12, P1764, DOI 10.1021/pr3011028; Pacharra S, 2012, J PROTEOME RES, V11, P3955, DOI 10.1021/pr200996y; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Praissman JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14473; Praissman JL, 2014, BIOCHEMISTRY-US, V53, P3066, DOI 10.1021/bi500153y; Rubinstein R, 2015, CELL, V163, P629, DOI 10.1016/j.cell.2015.09.026; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; SMITH PL, 1990, P NATL ACAD SCI USA, V87, P7275, DOI 10.1073/pnas.87.18.7275; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/NMETH.1731, 10.1038/nmeth.1731]; Toledo AG, 2012, GLYCOBIOLOGY, V22, P1413, DOI 10.1093/glycob/cws109; Tran DT, 2012, J BIOL CHEM, V287, P20967, DOI 10.1074/jbc.M112.370387; van Meel E, 2014, P NATL ACAD SCI USA, V111, P3532, DOI 10.1073/pnas.1401417111; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3                                                   ; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	62	2	2	6	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11586	11598		10.1074/jbc.M117.794487				13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FA0JN	WOS:000405119600037	28512129	green_published			2018-01-05	
J	Fin, L; Bergamin, G; Steiner, RA; Hughes, SM				Fin, Laura; Bergamin, Giorgia; Steiner, Roberto A.; Hughes, Simon M.			The Cannabinoid Receptor Interacting Proteins 1 of zebrafish are not required for morphological development, viability or fertility	SCIENTIFIC REPORTS			English	Article							ENDOCANNABINOID SYSTEM; COLORECTAL-CANCER; GENE-EXPRESSION; DOWN-REGULATION; MESSENGER-RNA; RAT-BRAIN; CB1; LOCALIZATION; EVOLUTION; CRIP1A	The Cannabinoid Receptor Interacting Protein 1 (Cnrip1) was discovered as an interactor with the intracellular region of Cannabinoid Receptor 1 (CB1R, also known as Cnr1 or CB1). Functional assays in mouse show cannabinoid sensitivity changes and Cnrip1 has recently been suggested to control eye development in Xenopus laevis. Two Cnrip1 genes are described in zebrafish, cnrip1a and cnrip1b. In situ mRNA hybridisation revealed accumulation of mRNA encoding each gene primarily in brain and spinal cord, but also elsewhere. For example, cnrip1b is expressed in forming skeletal muscle. CRISPR/Cas9 genome editing generated predicted null mutations in cnrip1a and cnrip1b. Each mutation triggered nonsense-mediated decay of the respective mRNA transcript. No morphological or behavioural phenotype was observed in either mutant. Moreover, fish lacking both Cnrip1a and Cnrip1b both maternally and zygotically are viable and fertile and no phenotype has so far been detected despite strong evolutionary conservation over at least 400 Myr.	[Fin, Laura; Bergamin, Giorgia; Steiner, Roberto A.; Hughes, Simon M.] Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England	Steiner, RA; Hughes, SM (reprint author), Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England.	roberto.steiner@kcl.ac.uk; simon.hughes@kcl.ac.uk		Hughes, Simon/0000-0001-8227-9225; Bergamin, Giorgia/0000-0002-2519-5524	Biotechnology and Biological Sciences Research Council [BB/K0101151]; Medical Research Council (MRC) [G1001029, MR/N021231/1]	We thank Vikki Williams for genotyping, Pat Doherty, Anthony Graham, Yaniv Hinits and members of the Hughes lab for advice and Bruno Correia da Silva and his staff for care of the fish. LF had an EPSRC PhD studentship in the laboratory of RAS. GB was funded by the Biotechnology and Biological Sciences Research Council (BB/K0101151) to SMH. SMH is a Medical Research Council (MRC) Scientist with Programme Grant G1001029 and MR/N021231/1 support.	Anavi-Goffer S, 2007, J BIOL CHEM, V282, P25100, DOI 10.1074/jbc.M703388200; Andresen K, 2015, HEPATOLOGY, V61, P1651, DOI 10.1002/hep.27707; Bethge N, 2014, EPIGENETICS-US, V9, P428, DOI 10.4161/epi.27554; Blume LC, 2017, MOL PHARMACOL, V91, P75, DOI 10.1124/mol.116.104638; Blume LC, 2016, J NEUROCHEM, V139, P396, DOI 10.1111/jnc.13767; Blume LC, 2015, CELL SIGNAL, V27, P716, DOI 10.1016/j.cellsig.2014.11.006; Blume LC, 2013, J NEUROCHEM, V124, P808, DOI 10.1111/jnc.12139; Boehm V, 2016, TRENDS GENET, V32, P724, DOI 10.1016/j.tig.2016.09.003; Bojnik E, 2012, EPILEPSY RES, V99, P64, DOI 10.1016/j.eplepsyres.2011.10.020; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1                 ; Elphick MR, 2012, PHILOS T R SOC B, V367, P3201, DOI 10.1098/rstb.2011.0394; Fernandez-Ruiz Javier, 2015, Handb Exp Pharmacol, V231, P233, DOI 10.1007/978-3-319-20825-1_8; Flores A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00256; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046                                                             ; Guggenhuber S., 2015, BRAIN STRUCTURE FUNC, DOI [10.1007/s00429-015-1027-6, DOI 10.1007/S00429-015-1027-6(2015)]; Hu SSJ, 2010, J COMP NEUROL, V518, P3848, DOI 10.1002/cne.22429; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jin L, 1997, J CLIN LAB ANAL, V11, P2, DOI 10.1002/(SICI)1098-2825(1997)11:1<2::AID-JCLA2>3.3.CO;2-U; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lind GE, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-85; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Maccarrone M, 2015, TRENDS PHARMACOL SCI, V36, P277, DOI 10.1016/j.tips.2015.02.008; Maida V, 2016, CURR ONCOL, V23, P398, DOI 10.3747/co.23.3487; MAILLEUX P, 1992, NEUROSCI LETT, V143, P200, DOI 10.1016/0304-3940(92)90265-9                                                    ; Martini L, 2007, FASEB J, V21, P802, DOI 10.1096/fj.06-7132com; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Nie JJ, 2001, J NEUROSCI, V21, P8758; Niehaus JL, 2007, MOL PHARMACOL, V72, P1557, DOI 10.1124/mol.107.039263; Oltrabella F., 2017, DEV GROWTH DIFFER, DOI [10.1111/dgd.12351, DOI 10.1111/DGD.12351[EPUBAHEADOFPRINT](2017)]; Oster B, 2011, INT J CANCER, V129, P2855, DOI 10.1002/ijc.25951; Pasquier J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2709-z; PERTWEE RG, 1992, BRIT J PHARMACOL, V105, P980, DOI 10.1111/j.1476-5381.1992.tb09088.x                                              ; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Sanchez C, 2001, MOL PHARMACOL, V59, P955; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Sharma C, 2015, EVID-BASED COMPL ALT, DOI 10.1155/2015/238482; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Smith TH, 2015, MOL PHARMACOL, V87, P747, DOI 10.1124/mol.114.096495; Thisse B, 2004, FAST RELEASE CLONES; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tiburu EK, 2011, AAPS J, V13, P92, DOI 10.1208/s12248-010-9244-7; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3                                                   ; WESTERFIELD M, 2000, ZEBRAFISH BOOK GUIDE; Zheng XN, 2015, GENES CELLS, V20, P324, DOI 10.1111/gtc.12225	47	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 7	2017	7								4858	10.1038/s41598-017-05017-5				9	Multidisciplinary Sciences	Science & Technology - Other Topics	EZ8JI	WOS:000404970900020	28687732	gold			2018-01-05	
J	Wu, J; Wang, PC; Li, L; Williams, NL; Ji, DB; Zahurancik, WJ; You, CJ; Wang, JS; Suo, ZC; Wang, YS				Wu, Jun; Wang, Pengcheng; Li, Lin; Williams, Nicole L.; Ji, Debin; Zahurancik, Walter J.; You, Changjun; Wang, Jianshuang; Suo, Zucai; Wang, Yinsheng			Replication studies of carboxymethylated DNA lesions in human cells	NUCLEIC ACIDS RESEARCH			English	Article							N-NITROSO COMPOUNDS; MASS-SPECTROMETRY; RED MEAT; BIOLOGICAL CONSEQUENCES; TRANSLESION SYNTHESIS; ENDOGENOUS FORMATION; GLYCINE DERIVATIVES; COLORECTAL-CANCER; POLYMERASE ETA; ADDUCTS	Metabolic activation of some N-nitroso compounds (NOCs), an important class of DNA damaging agents, can induce the carboxymethylation of nucleobases in DNA. Very little was previously known about how the carboxymethylated DNA lesions perturb DNA replication in human cells. Here, we investigated the effects of five carboxymethylated DNA lesions, i.e. O-6-CMdG, N-6-CMdA, N-4-CMdC, N3-CMdT and O-4-CMdT on the efficiency and fidelity of DNA replication in HEK293T human embryonic kidney cells. We found that, while neither N-6-CMdA nor N-4-CMdC blocked DNA replication or induced mutations, N3-CMdT, O-4-CMdT and O-6-CMdG moderately blocked DNA replication and induced substantial frequencies of T -> A (81%), T -> C (68%) and G -> A (6.4%) mutations, respectively. In addition, our results revealed that CRISPR-Cas9-mediated depletion of Pol eta resulted in significant drops in bypass efficiencies of N-4-CMdC and N3-CMdT. Diminution in bypass efficiencies was also observed for N-6-CMdA and O-6-CMdG upon depletion of Pol kappa, and for O-6-CMdG upon removal of Pol zeta. Together, our study provided molecular-level insights into the impacts of the carboxymethylated DNA lesions on DNA replication in human cells, revealed the roles of individual translesion synthesis DNA polymerases in bypassing these lesions, and suggested the contributions of O-6-CMdG, N3-CMdT and O-4-CMdT to the mutations found in p53 gene of human gastrointestinal cancers.	[Wu, Jun; Li, Lin; Ji, Debin; You, Changjun; Wang, Jianshuang; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Wang, Pengcheng; Williams, Nicole L.; Wang, Yinsheng] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA; [Zahurancik, Walter J.; Suo, Zucai] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	Wang, YS (reprint author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.; Wang, YS (reprint author), Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu			National Institutes of Health [R01 DK082779]	National Institutes of Health [R01 DK082779]. Funding for open access charge: National Institutes of Health [R01 DK082779].	Bingham SA, 2002, J NUTR, V132, p3522S; Bingham SA, 1996, CARCINOGENESIS, V17, P515, DOI 10.1093/carcin/17.3.515; BURNS PA, 1988, CARCINOGENESIS, V9, P1607, DOI 10.1093/carcin/9.9.1607                                                         ; BUSBY WF, 1985, CANCER RES, V45, P1367; Cupid BC, 2004, CHEM RES TOXICOL, V17, P294, DOI 10.1021/tx0340706; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Gottschalg E, 2007, CARCINOGENESIS, V28, P356, DOI 10.1093/carcin/bgl150; Harrison KL, 1999, CHEM RES TOXICOL, V12, P106, DOI 10.1021/tx980057n; Harrison KL, 1997, CHEM RES TOXICOL, V10, P652, DOI 10.1021/tx960203u; Jakszyn P, 2006, CARCINOGENESIS, V27, P1497, DOI 10.1093/carcin/bcl019; Joosen AMCP, 2009, CARCINOGENESIS, V30, P1402, DOI 10.1093/carcin/bgp130; Lewin MH, 2006, CANCER RES, V66, P1859, DOI 10.1158/0008-5472.CAN-05-2237; Liu S, 2015, CHEM SOC REV, V44, P7829, DOI 10.1039/c5cs00316d; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; MIRVISH SS, 1995, CANCER LETT, V93, P17, DOI 10.1016/0304-3835(95)03786-V; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; O'Driscoll M, 1999, CARCINOGENESIS, V20, P1855, DOI 10.1093/carcin/20.9.1855; Ohmori H, 2009, ADV PROTEIN CHEM STR, V78, P99, DOI 10.1016/S1876-1623(09)78004-0; Raz MH, 2016, CHEM RES TOXICOL, V29, P1493, DOI 10.1021/acs.chemrestox.6b00168; Senthong P, 2013, NUCLEIC ACIDS RES, V41, P3047, DOI 10.1093/nar/gks1476; Swanson AL, 2011, BIOCHEMISTRY-US, V50, P7666, DOI 10.1021/bi2007417; Tricker AR, 1997, EUR J CANCER PREV, V6, P226, DOI 10.1097/00008469-199706000-00003; Wang J., 2010, NUCL ACIDS RES, V38; Wang JS, 2009, NUCLEIC ACIDS RES, V37, P336, DOI 10.1093/nar/gkn946; Wang P, 2015, NUCLEIC ACIDS RES, V43, P7207, DOI 10.1093/nar/gkv757; Williams NL, 2016, CHEM RES TOXICOL, V29, P669, DOI 10.1021/acs.chemrestox.5b00509; Wu J, 2016, NUCLEIC ACIDS RES, V44, P9256, DOI 10.1093/nar/gkw662; You CJ, 2016, ACS CHEM BIOL, V11, P1332, DOI 10.1021/acschembio.6b00085; You CJ, 2016, ACCOUNTS CHEM RES, V49, P205, DOI 10.1021/acs.accounts.5b00437; You CJ, 2015, NUCLEIC ACIDS RES, V43, P1012, DOI 10.1093/nar/gku1391; You CJ, 2013, J BIOL CHEM, V288, P28548, DOI 10.1074/jbc.M113.480459; Yu Y, 2016, ANAL CHEM, V88, P8036, DOI 10.1021/acs.analchem.6b01349; Yuan BF, 2011, NUCLEIC ACIDS RES, V39, P5945, DOI 10.1093/nar/gkr159; Zahurancik WJ, 2013, BIOCHEMISTRY-US, V52, P7041, DOI [10.1021/bi400803y, 10.1021/bi400803v]; Zhang F, 2013, NUCLEIC ACIDS RES, V41, P5524, DOI 10.1093/nar/gkt198; Ziegler K, 2004, J VIROL METHODS, V122, P123, DOI 10.1016/j.jviromet.2004.08.012	36	0	0	8	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	JUL 7	2017	45	12					7276	7284		10.1093/nar/gkx442				9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EZ7CX	WOS:000404879000031	28531304	gold			2018-01-05	
J	Kampmann, M				Kampmann, Martin			Elucidating drug targets and mechanisms of action by genetic screens in mammalian cells	CHEMICAL COMMUNICATIONS			English	Article							DISCOVERY	Phenotypic screening is a powerful approach to discover small molecules with desired effects on biological systems, which can then be developed into therapeutic drugs. The identification of the target and mechanism of action of compounds discovered in phenotypic screens remains a major challenge. This feature article describes the use of genetic tools to reveal drug targets and mechanisms in mammalian cells. Until recently, RNA interference was the method of choice for such studies. Here, we highlight very recent additions to the genetic toolkit in mammalian cells, including CRISPR, CRISPR interference, and CRISPR activation, and illustrate their usefulness for drug target identification.	[Kampmann, Martin] Univ Calif San Francisco, Dept Biochem & Biophys, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Kampmann, Martin] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	Kampmann, M (reprint author), Univ Calif San Francisco, Dept Biochem & Biophys, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA.; Kampmann, M (reprint author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	martin.kampmann@ucsf.edu		Kampmann, Martin/0000-0002-3819-7019	NIH/NCI [K99/R00 CA181494]; NIH/NIGMS [DP2 GM119139]; Stand Up to Cancer/American Association for Cancer Research Innovative Research Grant	We thank our collaborators on the studies summarized here. Research on gene-drug interaction in the Kampmann lab was supported by NIH/NCI grant K99/R00 CA181494, NIH/NIGMS New Innovator Award DP2 GM119139, and a Stand Up to Cancer/American Association for Cancer Research Innovative Research Grant.	Acosta-Alvear D, 2015, ELIFE, V4, DOI 10.7554/eLife.08153; Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791                                                                    ; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Julien O, 2014, NAT CHEM BIOL, V10, P969, DOI [10.1038/nchembio.1639, 10.1038/NCHEMBIO.1639]; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Kampmann M, 2015, P NATL ACAD SCI USA, V112, pE3384, DOI 10.1073/pnas.1508821112; Kampmann M, 2013, P NATL ACAD SCI USA, V110, pE2317, DOI 10.1073/pnas.1307002110; Kruth K., 2017, BLOOD, DOI [10.1182/blood-2017-02-766204, DOI 10.1182/BLOOD-2017-02-766204]; Matheny CJ, 2013, CHEM BIOL, V20, P1352, DOI 10.1016/j.chembiol.2013.09.014; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Schenone M, 2013, NAT CHEM BIOL, V9, P232, DOI [10.1038/NCHEMBIO.1199, 10.1038/nchembio.1199]; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	22	1	1	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.	JUL 7	2017	53	53					7162	7167		10.1039/c7cc02349a				6	Chemistry, Multidisciplinary	Chemistry	EZ3IQ	WOS:000404605000003	28487920				2018-01-05	
J	Ren, BJ; Gupta, N				Ren, Bingjian; Gupta, Nishith			Taming Parasites by Tailoring Them	FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY			English	Article						parasite manipulation; CRISPR; genetic engineering; protozoan infections; genome editing	PLASMODIUM-FALCIPARUM; GENETIC MANIPULATION; CRISPR; TRANSFECTION; MALARIA; SYSTEM; APICOMPLEXA; INFECTIONS; EXPRESSION; EIMERIA	The next-generation gene editing based on CRISPR (clustered regularly interspaced short palindromic repeats) has been successfully implemented in a wide range of organisms including some protozoan parasites. However, application of such a versatile game-changing technology in molecular parasitology remains fairly underexplored. Here, we briefly introduce state-of-the-art in human and mouse research and usher new directions to drive the parasitology research in the years to come. In precise, we outline contemporary ways to embolden existing apicomplexan and kinetoplastid parasite models by commissioning front-line gene-tailoring methods, and illustrate how we can break the enduring gridlock of gene manipulation in non-model parasitic protists to tackle intriguing questions that remain long unresolved otherwise. We show how a judicious solicitation of the CRISPR technology can eventually balance out the two facets of pathogen-host interplay.	[Ren, Bingjian; Gupta, Nishith] Humboldt Univ, Fac Life Sci, Inst Biol, Berlin, Germany	Gupta, N (reprint author), Humboldt Univ, Fac Life Sci, Inst Biol, Berlin, Germany.	Gupta.Nishith@hu-berlin.de			German Research Foundation (DFG) [GU1100/7-1, GU1100/8-1]	The work was funded by a research grant (GU1100/7-1) and Heisenberg fellowship (GU1100/8-1) awarded to NG by German Research Foundation (DFG). The funder had no role in designing or editing this work.	Adl SM, 2007, SYSTEMATIC BIOL, V56, P684, DOI 10.1080/10635150701494127; Blow N, 2016, BIOTECHNIQUES, V61, P172, DOI 10.2144/000114462; Burle-Caldas GD, 2015, MOL BIOCHEM PARASIT, V203, P25, DOI 10.1016/j.molbiopara.2015.10.004; Cable J, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0088; Chen XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07581; Clark JD, 2008, MOL BIOCHEM PARASIT, V162, P77, DOI 10.1016/j.molbiopara.2008.07.006; Cox FEG, 2002, CLIN MICROBIOL REV, V15, P595, DOI 10.1128/CMR.15.4.595-612.2002; Cui YB, 2016, PARASITOL INT, V65, P641, DOI 10.1016/j.parint.2016.08.011; Dangoudoubiyam S, 2014, PARASITOLOGY, V141, P1399, DOI 10.1017/S0031182014000687; De Goeyse I, 2015, VET PARASITOL, V208, P238, DOI 10.1016/j.vetpar.2015.01.013; de Koning-Ward TF, 2015, NAT REV MICROBIOL, V13, P373, DOI 10.1038/nrmicro3450; Fayer R, 2004, CLIN MICROBIOL REV, V17, P894, DOI 10.1128/CMR.17.4.894-902.2004; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Koonin EV, 2013, RNA BIOL, V10, P679, DOI 10.4161/rna.24022; Krause PJ, 2007, TRENDS PARASITOL, V23, P605, DOI 10.1016/j.pt.2007.09.005; Lane N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0344; Lee MCS, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0063-9; Lendner M, 2014, PARASITOLOGY, V141, P1511, DOI 10.1017/S0031182014000237; Levine ND, 1961, PROTOZOAN PARASITES; Limenitakis J, 2011, FEBS LETT, V585, P1579, DOI 10.1016/j.febslet.2011.05.002; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Peng D, 2014, MBIO, V6, DOI DOI 10.1128/MBIO.02097-14; Plattner F, 2008, ANNU REV MICROBIOL, V62, P471, DOI 10.1146/annurev.micro.62.081307.162802; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Reinke AW, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005283; Richter F, 2016, NUCLEIC ACIDS RES, V44, P10003, DOI 10.1093/nar/gkw930; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Smith KA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00068; Smith TG, 2002, TRENDS PARASITOL, V18, P315, DOI 10.1016/S1471-4922(02)02292-4; Sollelis L, 2015, CELL MICROBIOL, V17, P1405, DOI 10.1111/cmi.12456; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; Suarez CE, 2010, VET PARASITOL, V167, P205, DOI 10.1016/j.vetpar.2009.09.022; Teixeira Santuza M R, 2003, Genet Mol Res, V2, P148; Torgerson PR, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001920; Tretina K, 2015, TRENDS PARASITOL, V31, P306, DOI 10.1016/j.pt.2015.04.001; Vinayak S, 2015, NATURE, V523, P477, DOI 10.1038/nature14651; Wagner JC, 2014, NAT METHODS, V11, P915, DOI [10.1038/NMETH.3063, 10.1038/nmeth.3063]; Walker RA, 2013, PARASITOLOGY, V140, P1701, DOI 10.1017/S0031182013000838; Wang JL, 2016, TRENDS PARASITOL, V32, P542, DOI 10.1016/j.pt.2016.04.013; Wang MG, 2017, MOL PLANT, V10, P1011, DOI 10.1016/j.molp.2017.03.001; WOO PTK, 1987, ADV PARASIT, V26, P199, DOI 10.1016/S0065-308X(08)60297-3; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang W, 2015, MATH PROBL ENG, V2015, P9, DOI DOI 10.1128/MBI0.00861-15	49	0	0	9	9	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	2235-2988			FRONT CELL INFECT MI	Front. Cell. Infect. Microbiol.	JUL 6	2017	7								292	10.3389/fcimb.2017.00292				7	Immunology; Microbiology	Immunology; Microbiology	FA0PQ	WOS:000405138200001	28730142				2018-01-05	
J	Lau, HY; Tang, J; Casey, PJ; Wang, M				Lau, H. Y.; Tang, J.; Casey, P. J.; Wang, M.			Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms	ONCOGENE			English	Article							SMALL-MOLECULE INHIBITOR; CARBOXYL METHYLTRANSFERASE; CANCER-CELLS; PROTEIN PRENYLATION; EPITHELIAL-CELLS; K-RAS; DISEASE; ONCOGENESIS; APOPTOSIS; GROWTH	Despite extensive effort, there has been limited progress in the development of direct RAS inhibitors. Targeting isoprenylcysteine carboxylmethyltransferase (ICMT), a unique enzyme of RAS post-translational modification, represents a promising strategy to inhibit RAS function. However, there lacks direct genetic evidence on the role of ICMT in RAS-driven human cancer initiation and maintenance. Using CRISPR/Cas9 genome editing, we have created Icmt loss-of-function isogenic cell lines for both RAS-transformed human mammary epithelial cells (HME1) and human cancer cell lines MiaPaca-2 and MDA-MB-231 containing naturally occurring mutant KRAS. In both in vitro and in vivo tumorigenesis studies, Icmt loss-of-function abolishes the tumor initiation ability of all major isoforms of mutant RAS in HME1 cells, and the tumor maintenance capacity of MiaPaca-2 and MDA-MB-231 cells, establishing the critical role of ICMT in RAS-driven cancers.	[Lau, H. Y.; Tang, J.; Casey, P. J.; Wang, M.] Duke NUS Med Sch, Canc & Stem Cell Biol Program, 8 Coll Rd, Singapore 169857, Singapore; [Wang, M.] Natl Univ Singapore, Dept Biochem, Singapore, Singapore	Wang, M (reprint author), Duke NUS Med Sch, Canc & Stem Cell Biol Program, 8 Coll Rd, Singapore 169857, Singapore.	mei.wang@duke-nus.edu.sg			National Medical Research Council of Singapore	We would like to thank Dr Shang Li and Muhammad Khairul Ramlee for their invaluable technical assistance and advice, as well as Dr Mathijs Voorhoeve and Dr Shi Yun Yeo for the gift of retroviral expression vectors. This work was supported by the National Medical Research Council of Singapore.	Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Court H, 2013, J CLIN INVEST, V123, P4681, DOI 10.1172/BCI65764; Cox AD, 2015, CLIN CANCER RES, V21, P1819, DOI 10.1158/1078-0432.CCR-14-3214; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; Dimri G, 2005, BREAST CANCER RES, V7, P171, DOI 10.1186/bcr1275; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901                                                              ; Ibrahim MX, 2013, SCIENCE, V340, P1330, DOI 10.1126/science.1238880; Lampson BL, 2013, CURR BIOL, V23, P70, DOI 10.1016/j.cub.2012.11.031; Lau HY, 2014, CANCER BIOL THER, V15, P1280, DOI 10.4161/cbt.29692; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; Ramlee MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15587; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Sun WT, 2016, EXP HEMATOL, V44, P189, DOI 10.1016/j.exphem.2015.12.002; Teh JT, 2015, ONCOGENE, V34, P3296, DOI 10.1038/onc.2014.260; Tsai FD, 2015, P NATL ACAD SCI USA, V112, P779, DOI 10.1073/pnas.1412811112; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Wahlstrom AM, 2008, BLOOD, V112, P1357, DOI 10.1182/blood-2007-06-094060; Wang LX, 2011, P NATL ACAD SCI USA, V108, pE803, DOI 10.1073/pnas.1103423108; Wang M, 2010, ONCOGENE, V29, P4959, DOI 10.1038/onc.2010.247; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Winter-Vann AM, 2005, P NATL ACAD SCI USA, V102, P4336, DOI 10.1073/pnas.0408107102; Wright LP, 2009, MOL CELL BIOL, V29, P1826, DOI 10.1128/MCB.01719-08	32	2	2	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 6	2017	36	27					3934	3942		10.1038/onc.2016.508				9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EZ6SM	WOS:000404848200013	28192404	green_published			2018-01-05	
J	Lema, I; Amazit, L; Lamribet, K; Fagart, J; Blanchard, A; Lombes, M; Cherradi, N; Viengchareun, S				Lema, Ingrid; Amazit, Larbi; Lamribet, Khadija; Fagart, Jerome; Blanchard, Anne; Lombes, Marc; Cherradi, Nadia; Viengchareun, Say			HuR-Dependent Editing of a New Mineralocorticoid Receptor Splice Variant Reveals an Osmoregulatory Loop for Sodium Homeostasis	SCIENTIFIC REPORTS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MESSENGER-RNA STABILITY; BINDING PROTEIN HUR; ANTIGEN-R HUR; POSTTRANSCRIPTIONAL CONTROL; SUBCELLULAR-LOCALIZATION; INCREASED EXPRESSION; KIDNEY-DISEASE; LIVING CELLS; GENE	Aldosterone and the Mineralocorticoid Receptor (MR) control hydroelectrolytic homeostasis and alterations of mineralocorticoid signaling pathway are involved in the pathogenesis of numerous human diseases, justifying the need to decipher molecular events controlling MR expression level. Here, we show in renal cells that the RNA-Binding Protein, Human antigen R (HuR), plays a central role in the editing of MR transcript as revealed by a RNA interference strategy. We identify a novel Delta 6 MR splice variant, which lacks the entire exon 6, following a HuR-dependent exon skipping event. Using isoform-specific TaqMan probes, we show that Delta 6 MR variant is expressed in all MR-expressing tissues and cells and demonstrate that extracelullar tonicity regulates its renal expression. More importantly, this splice variant exerts dominant-negative effects on transcriptional activity of the full-ength MR protein. Collectively, our data highlight a crucial role of HuR as a master posttranscriptional regulator of MR expression in response to osmotic stress. We demonstrate that hypotonicity, not only enhances MR mRNA stability, but also decreases expression of the Delta 6 MR variant, thus potentiating renal MR signaling. These findings provide compelling evidence for an autoregulatory feedback loop for the control of sodium homeostasis through posttranscriptional events, likely relevant in renal pathophysiological situations.	[Lema, Ingrid; Amazit, Larbi; Lamribet, Khadija; Fagart, Jerome; Lombes, Marc; Viengchareun, Say] Univ Paris Saclay, Fac Med Paris Sud, INSERM, U1185, F-94276 Le Kremlin Bicetre, France; [Amazit, Larbi] UMS 32, F-94276 Le Kremlin Bicetre, France; [Blanchard, Anne] INSERM, Ctr Invest Clin 9201, F-75015 Paris, France; [Lombes, Marc] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, F-94275 Le Kremlin Bicetre, France; [Cherradi, Nadia] INSERM, U1036, Inst Natl Sante & Rech Med, F-38000 Grenoble, France; [Cherradi, Nadia] Commissariat Energie Atom & Energies Alternat, Inst Biosci & Biotechnol Grenoble, Lab Biol Canc & Infect, F-38000 Grenoble, France; [Cherradi, Nadia] Univ Grenoble Alpes, Unite Mixte Rech S1036, F-38000 Grenoble, France	Lombes, M; Viengchareun, S (reprint author), Univ Paris Saclay, Fac Med Paris Sud, INSERM, U1185, F-94276 Le Kremlin Bicetre, France.; Lombes, M (reprint author), Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, F-94275 Le Kremlin Bicetre, France.; Cherradi, N (reprint author), INSERM, U1036, Inst Natl Sante & Rech Med, F-38000 Grenoble, France.; Cherradi, N (reprint author), Commissariat Energie Atom & Energies Alternat, Inst Biosci & Biotechnol Grenoble, Lab Biol Canc & Infect, F-38000 Grenoble, France.; Cherradi, N (reprint author), Univ Grenoble Alpes, Unite Mixte Rech S1036, F-38000 Grenoble, France.	marc.lombes@u-psud.fr; nadia.cherradi@cea.fr; viengchareun@u-psud.fr	Viengchareun, Say/M-6612-2017	viengchareun, say/0000-0003-4280-3250; Fagart, Jerome/0000-0002-7965-0553; BLANCHARD, Anne/0000-0002-0815-0586	Institut National de la Sante et de la Recherche Medicale; Universite Paris-Sud; Cardiovasculaire-Obesite-Rein-Diabete-Domaine d'Interet Majeur (Region Ile-de-France); HAC Pharma & SFE (Societe Francaise d'Endocrinologie); Agence Nationale de la Recherche [11-BSV1-028-01]	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale, the Universite Paris-Sud and Agence Nationale de la Recherche (Grant 11-BSV1-028-01). Ingrid Lema held a fellowship from the Cardiovasculaire-Obesite-Rein-Diabete-Domaine d'Interet Majeur (Region Ile-de-France) and HAC Pharma & SFE (Societe Francaise d'Endocrinologie). The authors are indebted to Julie Sappa for English editing.	Amazit L, 2015, J BIOL CHEM, V290, P21876, DOI 10.1074/jbc.M115.657957; Amazit L, 2011, MOL ENDOCRINOL, V25, P394, DOI 10.1210/me.2010-0458; Baou M., 2009, J BIOMED BIOTECHNOL, V2009, DOI DOI 10.1155/2009/634520; Berger S, 1998, P NATL ACAD SCI USA, V95, P9424, DOI 10.1073/pnas.95.16.9424; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; BLOEM LJ, 1995, J STEROID BIOCHEM, V55, P159, DOI 10.1016/0960-0760(95)00162-S; Chang SH, 2014, P NATL ACAD SCI USA, V111, P18309, DOI 10.1073/pnas.1412172111; Dutertre M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4395; Eswar N, 2006, CURR PROTOC BIOINFOR, V5, P6, DOI [10.1002/0471250953.bi0506s15, DOI 10.1002/0471250953.BI0506S15]; Feigerlova E, 2017, FASEB J, V31, P457, DOI 10.1096/fj.201601087RR; Fejes-Toth G, 1998, P NATL ACAD SCI USA, V95, P2973, DOI 10.1073/pnas.95.6.2973; Fernandes-Rosa FL, 2011, J CLIN ENDOCR METAB, V96, pE519, DOI 10.1210/jc.2010-1486; Geller DS, 1998, NAT GENET, V19, P279; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Izquierdo JM, 2008, J BIOL CHEM, V283, P19077, DOI 10.1074/jbc.M800017200; Izquierdo JM, 2010, NUCLEIC ACIDS RES, V38, P8001, DOI 10.1093/nar/gkq698; Jaisser F, 2016, PHARMACOL REV, V68, P49, DOI 10.1124/pr.115.011106; Kanda K, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-37; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Leung DYM, 1997, J EXP MED, V186, P1567, DOI 10.1084/jem.186.9.1567; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lu L, 2014, J BIOL CHEM, V289, P31792, DOI 10.1074/jbc.M114.573246; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144                                                         ; Martinerie L, 2009, ENDOCRINOLOGY, V150, P4414, DOI 10.1210/en.2008-1498; McManus CJ, 2011, CURR OPIN GENET DEV, V21, P373, DOI 10.1016/j.gde.2011.04.001; Mukherjee N, 2011, MOL CELL, V43, P327, DOI [10.1016/j.molcel.2011.06.007, 10.1016/j.molce1.2011.06.007]; Munier M, 2010, ENDOCRINOLOGY, V151, P2244, DOI 10.1210/en.2009-0753; Nishi M, 2001, MOL ENDOCRINOL, V15, P1077, DOI 10.1210/me.15.7.1077; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Quinkler M, 2005, CIRCULATION, V112, P1435, DOI 10.1161/CIRULATIONHA.105.539122; Sartorato P, 2003, J CLIN ENDOCR METAB, V88, P2508, DOI 10.1210/jc.2002-021932; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Suzuki M, 2016, J EXP BIOL, V219, P1249, DOI 10.1242/jeb.132811; van der Vaart Michiel, 2009, Nucl Recept Signal, V7, pe007, DOI 10.1621/nrs.07007; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Viengchareun S, 2014, J AM SOC NEPHROL, V25, P2213, DOI 10.1681/ASN.2013091023; Viengchareun S, 2009, MOL ENDOCRINOL, V23, P1948, DOI 10.1210/me.2009-0095; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wickert L, 2000, J NEUROENDOCRINOL, V12, P867, DOI 10.1046/j.1365-2826.2000.00535.x                                                ; Xiao SX, 2015, ACTA NEUROPATHOL, V130, P49, DOI 10.1007/s00401-015-1412-5; Zennaro MC, 1998, J CLIN INVEST, V101, P1254, DOI 10.1172/JCI1915; Zennaro MC, 2001, MOL ENDOCRINOL, V15, P1586, DOI 10.1210/me.15.9.1586; Zhou MY, 2000, MOL CELL ENDOCRINOL, V159, P125, DOI 10.1016/S0303-7207(99)00198-7	46	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 6	2017	7								4835	10.1038/s41598-017-04838-8				13	Multidisciplinary Sciences	Science & Technology - Other Topics	EZ6QC	WOS:000404841500001	28684740	gold			2018-01-05	
J	Van De Weghe, JC; Rusterholz, TDS; Latour, B; Grout, ME; Aldinger, KA; Shaheen, R; Dempsey, JC; Maddirevula, S; Cheng, YHH; Phelps, IG; Gesemann, M; Goel, H; Birk, OS; Alanzi, T; Rawashdeh, R; Khan, AO; Bamshad, MJ; Nickerson, DA; Neuhauss, SCF; Dobyns, WB; Alkuraya, FS; Roepman, R; Bachmann-Gagescu, R; Doherty, D				Van De Weghe, Julie C.; Rusterholz, Tamara D. S.; Latour, Brooke; Grout, Megan E.; Aldinger, Kimberly A.; Shaheen, Ranad; Dempsey, Jennifer C.; Maddirevula, Sateesh; Cheng, Yong-Han H.; Phelps, Ian G.; Gesemann, Matthias; Goel, Himanshu; Birk, Ohad S.; Alanzi, Talal; Rawashdeh, Rifaat; Khan, Arif O.; Bamshad, Michael J.; Nickerson, Deborah A.; Neuhauss, Stephan C. F.; Dobyns, William B.; Alkuraya, Fowzan S.; Roepman, Ronald; Bachmann-Gagescu, Ruxandra; Doherty, Dan		Univ Washington Ctr Mendelian Geno	Mutations in ARMC9, which Encodes a Basal Body Protein, Cause Joubert Syndrome in Humans and Ciliopathy Phenotypes in Zebrafish	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CILIARY-DISEASE GENES; TRANSITION ZONE; INTRAFLAGELLAR TRANSPORT; PRIMARY CILIUM; FLAGELLAR REGENERATION; CENTROSOMAL PROTEIN; PROTEOMIC ANALYSIS; LISH MOTIF; CHLAMYDOMONAS; DISORDERS	Joubert syndrome (JS) is a recessive neurodevelopmental disorder characterized by hypotonia, ataxia, abnormal eye movements, and variable cognitive impairment. It is defined by a distinctive brain malformation known as the "molar tooth sign" on axial MRI. Subsets of affected individuals have malformations such as coloboma, polydactyly, and encephalocele, as well as progressive retinal dystrophy, fibrocystic kidney disease, and liver fibrosis. More than 35 genes have been associated with JS, but in a subset of families the genetic cause remains unknown. All of the gene products localize in and around the primary cilium, making JS a canonical ciliopathy. Ciliopathies are unified by their overlapping clinical features and underlying mechanisms involving ciliary dysfunction. In this work, we identify biallelic rare, predicted-deleterious ARMC9 variants (stop-gain, missense, splice-site, and single-exon deletion) in 11 individuals with JS from 8 families, accounting for approximately 1% of the disorder. The associated phenotypes range from isolated neurological involvement to JS with retinal dystrophy, additional brain abnormalities (e.g., heterotopia, Dandy-Walker malformation), pituitary insufficiency, and/or synpolydactyly. We show that ARMC9 localizes to the basal body of the cilium and is upregulated during ciliogenesis. Typical ciliopathy phenotypes (curved body shape, retinal dystrophy, coloboma, and decreased cilia) in a CRISPR/Cas9-engineered zebrafish mutant model provide additional support for ARMC9 as a ciliopathy-associated gene. Identifying ARMC9 mutations as a cause of JS takes us one step closer to a full genetic understanding of this important disorder and enables future functional work to define the central biological mechanisms underlying JS and other ciliopathies.	[Van De Weghe, Julie C.; Grout, Megan E.; Aldinger, Kimberly A.; Dempsey, Jennifer C.; Cheng, Yong-Han H.; Phelps, Ian G.; Bamshad, Michael J.; Dobyns, William B.; Doherty, Dan] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rusterholz, Tamara D. S.; Gesemann, Matthias; Neuhauss, Stephan C. F.; Bachmann-Gagescu, Ruxandra] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Latour, Brooke; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Latour, Brooke; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Aldinger, Kimberly A.; Dobyns, William B.; Doherty, Dan] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Shaheen, Ranad; Maddirevula, Sateesh; Alanzi, Talal; Rawashdeh, Rifaat; Khan, Arif O.; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 12713, Saudi Arabia; [Goel, Himanshu] Hunter Genet, Waratah, NSW 2298, Australia; [Goel, Himanshu] Univ Newcastle, Callaghan, NSW 2308, Australia; [Birk, Ohad S.] Ben Gurion Univ Negev, Soroka Med Ctr, Genet Inst, IL-8499000 Beer Sheva, Israel; [Birk, Ohad S.] Ben Gurion Univ Negev, NIBN, IL-8499000 Beer Sheva, Israel; [Khan, Arif O.] Cleveland Clin Abu Dhabi, Eye Inst, Abu Dhabi, U Arab Emirates; [Bamshad, Michael J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Alkuraya, Fowzan S.] Alfaisal Univ, Dept Anat & Cell Biol, Coll Med, Riyadh 11533, Saudi Arabia; [Alkuraya, Fowzan S.] King Abdulaziz City Sci & Technol, Saudi Human Genome Program, Riyadh 12371, Saudi Arabia; [Bachmann-Gagescu, Ruxandra; Doherty, Dan] Univ Zurich, Inst Med Genet, CH-8952 Schlieren, Switzerland	Doherty, D (reprint author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Bachmann-Gagescu, R (reprint author), Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.	ruxandra.bachmann@imls.uzh.ch; ddoher@uw.edu		Bachmann-Gagescu, Ruxandra/0000-0002-3571-5271	NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54HD083091, 6849]; NIH National Institute of Neurological Diseases and Stroke [R01NS064077, R01NS050375]; Swiss National Science Foundation [PZ00P3_163979]; Netherlands Organization for Scientific Research [NWO Vici-865.12.005]; King Salman Center for Disability Research; Dandy-Walker Alliance; NIH National Human Genome Research Institute [U54HG006493]; Saudi Human Genome Program	We deeply thank the families who participated in this study. We also thank the Joubert syndrome and Related Disorder Foundation for referring families, Heather Mefford and her laboratory for help with arrays, the Center for Microscopy and Image Analysis, University of Zurich (ZMB), for their assistance with Scanning Electron Microscopy, in particular Gery Barmettler, the Genotyping and Sequencing Core Facilities at King Faisal Specialist Hospital & Research Centre for their technical help, and Darren Gilmour for the Cas9 protein. This work was supported by the following: NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development U54HD083091 (Genetics Core and Sub-project 6849) to D. D., NIH National Institute of Neurological Diseases and Stroke (R01NS064077 to D. D. and R01NS050375 to W.B.D.), private donations from families to D. D., the Swiss National Science Foundation (PZ00P3_163979) to R.B.-G., the Netherlands Organization for Scientific Research (NWO Vici-865.12.005) to R.R., the King Salman Center for Disability Research to F.S.A., Dandy-Walker Alliance to W.B.D., and NIH National Human Genome Research Institute (U54HG006493) to M.B. and D.N. We acknowledge the support of the Saudi Human Genome Program (F.S.A.).	Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4; Alkuraya F. S., 2012, CURR PROTOC HUM GENE; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499                                                                  ; Bachmann-Gagescu R, 2015, J MED GENET, V52, P514, DOI 10.1136/jmedgenet-2015-103087; Bachmann-Gagescu R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005575; Bachmann-Gagescu R, 2011, HUM MOL GENET, V20, P4041, DOI 10.1093/hmg/ddr332; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bae YK, 2008, FRONT BIOSCI, V13, P5959, DOI 10.2741/3129; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Chavez M, 2015, DEV CELL, V34, P338, DOI 10.1016/j.devcel.2015.06.016; Chhin B, 2008, EUR RESPIR J, V32, P121, DOI 10.1183/09031936.00172107; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Clement DL, 2013, J CELL SCI, V126, P953, DOI 10.1242/jcs.116426; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; Coordinators N. R.; and NCBI Resource Coordinators, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI DOI 10.1093/NAR/GKV1290; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Delto CF, 2015, STRUCTURE, V23, P364, DOI 10.1016/j.str.2014.11.016; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985                                                                  ; Doherty D, 2009, SEMIN PEDIATR NEUROL, V16, P143, DOI 10.1016/j.spen.2009.06.002; Dyson JM, 2017, J CELL BIOL, V216, P247, DOI 10.1083/jcb.201511055; Edvardson S, 2010, AM J HUM GENET, V86, P93, DOI 10.1016/j.ajhg.2009.12.007; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; FRIEDE RL, 1978, DEV MED CHILD NEUROL, V20, P758; Garcia-Gonzalo FR, 2015, DEV CELL, V34, P400, DOI 10.1016/j.devcel.2015.08.001; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Grimes DT, 2016, SCIENCE, V352, P1341, DOI 10.1126/science.aaf6419; Halbritter J, 2013, AM J HUM GENET, V93, P915, DOI 10.1016/j.ajhg.2013.09.012; Hartmann C, 2015, EPILEPSIA, V56, pE26, DOI 10.1111/epi.12920; He M, 2014, NAT CELL BIOL, V16, P663, DOI 10.1038/ncb2988; Hoover AN, 2008, DEVELOPMENT, V135, P4049, DOI 10.1242/dev.029835; Huang LJ, 2011, AM J HUM GENET, V89, P713, DOI 10.1016/j.ajhg.2011.11.005; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; Juric-Sekhar G, 2012, ACTA NEUROPATHOL, V123, P695, DOI 10.1007/s00401-012-0951-2; Kane M. S., 2017, CILIA, V10; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024                                                       ; Kim YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072549; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Ko HW, 2010, DEV CELL, V18, P237, DOI 10.1016/j.devcel.2009.12.014; Kobayashi T, 2014, J CELL BIOL, V204, P215, DOI 10.1083/jcb.201304153; Krock BL, 2008, J CELL SCI, V121, P1907, DOI 10.1242/jcs.029397; Kunitomo H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r17; Lancaster MA, 2011, NAT MED, V17, P726, DOI 10.1038/nm.2380; Lee JH, 2012, SCIENCE, V335, P966, DOI 10.1126/science.1213506; Lee JE, 2012, NAT GENET, V44, P193, DOI 10.1038/ng.1078; LEFEBVRE PA, 1978, J CELL BIOL, V78, P8, DOI 10.1083/jcb.78.1.8                                                              ; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lessieur EM, 2017, INVEST OPHTH VIS SCI, V58, P448, DOI 10.1167/iovs.16-20326; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lih CJ, 1996, P NATL ACAD SCI USA, V93, P4617, DOI 10.1073/pnas.93.10.4617; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mariani L. E., 2016, MOL BIOL CELL MBC; Mateja A, 2006, J MOL BIOL, V357, P621, DOI 10.1016/j.jmb.2006.01.002; Mefford HC, 2011, ANN NEUROL, V70, P974, DOI 10.1002/ana.22645; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Mick DU, 2015, DEV CELL, V35, P497, DOI 10.1016/j.devcel.2015.10.015; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Plotnikova OV, 2015, J CELL SCI, V128, P364, DOI 10.1242/jcs.161323; Poretti A, 2008, AM J NEURORADIOL, V29, P1090, DOI 10.3174/ajnr.A1038; Poretti A, 2011, AM J NEURORADIOL, V32, P1459, DOI 10.3174/ajnr.A2517; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Romani M, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-72; Romio L, 2004, J AM SOC NEPHROL, V15, P2556, DOI 10.1097/01.ASN.0000140220.46477.SC; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Saudi Mendeliome Group, 2015, GENOME BIOL, V16, P134; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Shaheen R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1099-5; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Slaats GG, 2016, J MED GENET, V53, P62, DOI 10.1136/jmedgenet-2015-103250; Slaats GG, 2015, J CLIN INVEST, V125, P3657, DOI 10.1172/JCI80657; Srour M, 2012, J MED GENET, V49, P636, DOI 10.1136/jmedgenet-2012-101132; Srour M, 2012, AM J HUM GENET, V90, P693, DOI 10.1016/j.ajhg.2012.02.011; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Stratigopoulos G, 2014, CELL METAB, V19, P767, DOI 10.1016/j.cmet.2014.04.009; Sukumaran S, 2009, VISION RES, V49, P479, DOI 10.1016/j.visres.2008.12.009; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; TAMM SL, 1969, J CELL SCI, V4, P171; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thomas S, 2012, AM J HUM GENET, V91, P372, DOI 10.1016/j.ajhg.2012.06.017; Tuz K, 2014, AM J HUM GENET, V94, P62, DOI 10.1016/j.ajhg.2013.11.019; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Vazquez-Manrique RP, 2007, GENOMICS, V89, P392, DOI 10.1016/j.ygeno.2006.10.007; Vilboux T., 2017, GENET MED; WESTERFIELD M, 1993, ZEBRAFISH BOOK GUIDE; Yachnis AT, 1999, J CHILD NEUROL, V14, P655, DOI 10.1177/088307389901401006; Ye X, 2014, P NATL ACAD SCI USA, V111, P2164, DOI 10.1073/pnas.1318737111; Yeh SD, 2002, J BIOL CHEM, V277, P6311, DOI 10.1074/jbc.M106941200; Yin YL, 2009, DEVELOPMENT, V136, P655, DOI 10.1242/dev.028464; Zou J, 2008, J NEUROSCI, V28, P13684, DOI 10.1523/JNEUROSCI.4333-08.2008	100	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 6	2017	101	1					23	36		10.1016/j.ajhg.2017.05.010				14	Genetics & Heredity	Genetics & Heredity	EZ7FK	WOS:000404886800002	28625504				2018-01-05	
J	Marczenke, M; Piccini, I; Mengarelli, I; Fell, J; Ropke, A; Seebohm, G; Verkerk, AO; Greber, B				Marczenke, Maike; Piccini, Ilaria; Mengarelli, Isabella; Fell, Jakob; Roepke, Albrecht; Seebohm, Guiscard; Verkerk, Arie O.; Greber, Boris			Cardiac Subtype-Specific Modeling of K(v)1.5 Ion Channel Deficiency Using Human Pluripotent StemCells	FRONTIERS IN PHYSIOLOGY			English	Article						induced pluripotent stem cells; disease modeling; cardiac differentiation; K(v)1.5; atrial fibrillation	CELL-DERIVED CARDIOMYOCYTES; ONSET ATRIAL-FIBRILLATION; IN-VITRO MATURATION; LONG QT SYNDROME; STEM-CELLS; HUMAN HEART; RISK; ASSOCIATION; MECHANISMS; ARRHYTHMIA	The ultrarapid delayed rectifier K+ current (I-Kur), mediated by K(v)1.5 channels, constitutes a key component of the atrial action potential. Functional mutations in the underlying KCNA5 gene have been shown to cause hereditary forms of atrial fibrillation (AF). Here, we combine targeted genetic engineering with cardiac subtype-specific differentiation of human induced pluripotent stem cells (hiPSCs) to explore the role of K(v)1.5 in atrial hiPSC-cardiomyocytes. CRISPR/Cas9-mediated mutagenesis of integration-free hiPSCs was employed to generate a functional KCNA5 knockout. This model as well as isogenic wild-type control hiPSCs could selectively be differentiated into ventricular or atrial cardiomyocytes at high efficiency, based on the specific manipulation of retinoic acid signaling. Investigation of electrophysiological properties in K(v)1.5-deficient cardiomyocytes compared to isogenic controls revealed a strictly atrial-specific disease phentoype, characterized by cardiac subtype-specific field and action potential prolongation and loss of 4-aminopyridine sensitivity. Atrial Kv1.5-deficient cardiomyocytes did not show signs of arrhythmia under adrenergic stress conditions or upon inhibiting additional types of K+ current. Exposure of bulk cultures to carbachol lowered beating frequencies and promoted chaotic spontaneous beating in a stochastic manner. Low-frequency, electrical stimulation in single cells caused atrial and mutant-specific early afterdepolarizations, linking the loss of KCNA5 function to a putative trigger mechanism in familial AF. These results clarify for the first time the role of K(v)1.5 in atrial hiPSC-cardiomyocytes and demonstrate the feasibility of cardiac subtype-specific disease modeling using engineered hiPSCs.	[Marczenke, Maike; Piccini, Ilaria; Fell, Jakob; Greber, Boris] Max Planck Inst Mol Biomed, Human Stem Cell Pluripotency Lab, Munster, Germany; [Marczenke, Maike; Fell, Jakob; Greber, Boris] Max Planck Gesell, Chem Genom Ctr, Dortmund, Germany; [Piccini, Ilaria; Seebohm, Guiscard] Univ Munster, Inst Genet Heart Dis, Dept Cardiovasc Med, Sch Med, Munster, Germany; [Mengarelli, Isabella; Verkerk, Arie O.] Univ Amsterdam, Acad Med Ctr, Dept Clin & Expt Cardiol, Amsterdam, Netherlands; [Roepke, Albrecht] Univ Munster, Inst Human Genet, Munster, Germany; [Verkerk, Arie O.] Univ Amsterdam, Acad Med Ctr, Dept Med Biol, Amsterdam, Netherlands	Greber, B (reprint author), Max Planck Inst Mol Biomed, Human Stem Cell Pluripotency Lab, Munster, Germany.; Greber, B (reprint author), Max Planck Gesell, Chem Genom Ctr, Dortmund, Germany.; Verkerk, AO (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Clin & Expt Cardiol, Amsterdam, Netherlands.; Verkerk, AO (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Med Biol, Amsterdam, Netherlands.	a.o.verkerk@amc.uva.nl; boris.greber@mpi-muenster.mpg.de			Chemical Genomics Centre of the Max Planck Society; Bundesinstitut fur Risikobewertung [1328-539]	This work was supported by the Chemical Genomics Centre of the Max Planck Society and the Bundesinstitut fur Risikobewertung, grant 1328-539 (BG).	BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Bezzerides VJ, 2017, CIRC J, V81, P12, DOI 10.1253/circj.CJ-16-1113; Bingen BO, 2014, CARDIOVASC RES, V104, P194, DOI 10.1093/cvr/cvu179; Christophersen IE, 2016, J HUM GENET, V61, P61, DOI 10.1038/jhg.2015.44; Christophersen IE, 2013, EUR HEART J, V34, P1517, DOI 10.1093/eurheartj/ehs442; Devalla HD, 2015, EMBO MOL MED, V7, P394, DOI 10.15252/emmm.201404757; Fabritz L, 2016, NAT REV CARDIOL, V13, P230, DOI 10.1038/nrcardio.2015.194; Frank S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041958; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Giles WR, 2016, BIOPHYS J, V110, P278, DOI 10.1016/j.bpj.2015.06.070; Goedel A, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0828-z; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; HAMMER R, 1986, LIFE SCI, V38, P1653, DOI 10.1016/0024-3205(86)90409-1; Hayashi K, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1095, DOI 10.1161/CIRCEP.114.002519; Hoekstra M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00346; Hucker WJ, 2016, CAN J CARDIOL, V32, P1300, DOI 10.1016/j.cjca.2016.02.032; Johnson JN, 2008, HEART RHYTHM, V5, P704, DOI 10.1016/j.hrthm.2008.02.007; Kannel WB, 2008, MED CLIN N AM, V92, P17, DOI 10.1016/j.mcna.2007.09.002; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Kovoor P, 2001, J AM COLL CARDIOL, V37, P2136, DOI 10.1016/S0735-1097(01)01304-3; Lubitz SA, 2010, JAMA-J AM MED ASSOC, V304, P2263, DOI 10.1001/jama.2010.1690; Malan D, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0530-0; Nielsen JB, 2013, J AM COLL CARDIOL, V61, P2557, DOI 10.1016/j.jacc.2013.03.032; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Piccini I, 2015, GENOM DATA, V4, P69, DOI 10.1016/j.gdata.2015.03.008; Rampe D, 1997, FEBS LETT, V417, P28, DOI 10.1016/S0014-5793(97)01249-0; Schmitt N, 2014, PHYSIOL REV, V94, P609, DOI 10.1152/physrev.00022.2013; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Stallmeyer B, 2017, CIRC RES, V120, pE33, DOI 10.1161/CIRCRESAHA.116.310112; Umapathy K, 2010, CIRC-ARRHYTHMIA ELEC, V3, P105, DOI 10.1161/CIRCEP.110.853804; van Putten RMEM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00007; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983                                                         ; Yang YQ, 2009, J HUM GENET, V54, P277, DOI 10.1038/jhg.2009.26; Yoshioka N, 2013, CELL STEM CELL, V13, P246, DOI 10.1016/j.stem.2013.06.001; Zaffran S, 2014, J DEV BIOL, V2, P50, DOI 10.3390/jdb2010050; Zhang M, 2015, STEM CELLS, V33, P1456, DOI 10.1002/stem.1964; Zhang M, 2014, P NATL ACAD SCI USA, V111, pE5383, DOI 10.1073/pnas.1419553111	38	1	1	4	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-042X			FRONT PHYSIOL	Front. Physiol.	JUL 6	2017	8								469	10.3389/fphys.2017.00469				11	Physiology	Physiology	EZ7DL	WOS:000404880800001	28729840	gold			2018-01-05	
J	Yang, H; Patel, DJ				Yang, Hui; Patel, Dinshaw J.			Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9	MOLECULAR CELL			English	Article							RNA-GUIDED ENDONUCLEASE; BACTERIAL IMMUNE-SYSTEM; CAS SYSTEMS; STRUCTURAL BASIS; DNA RECOGNITION; BACTERIOPHAGE; COMPLEX; RESISTANCE; PROTEINS; CLEAVAGE	Prokaryotic CRISPR-Cas adaptive immune systems utilize sequence-specific RNA-guided endonucleases to defend against infection by viruses, bacteriophages, and mobile elements, while these foreign genetic elements evolve diverse anti-CRISPR proteins to overcome the CRISPR-Cas-mediated defense of the host. Recently, AcrIIA2 and AcrIIA4, encoded by Listeria monocytogene prophages, were shown to block the endonuclease activity of type II-A Streptococcus pyogene Cas9 (SpyCas9). We now report the crystal structure of AcrIIA4 in complex with single-guide RNA-bound SpyCas9, thereby establishing that AcrIIA4 preferentially targets critical residues essential for PAM duplex recognition, as well as blocks target DNA access to key catalytic residues lining the RuvC pocket. These structural insights, validated by biochemical assays on key mutants, demonstrate that AcrIIA4 competitively occupies both PAM-interacting and non-target DNA strand cleavage catalytic pockets. Our studies provide insights into anti-CRISPR-mediated suppression mechanisms for inactivating SpyCas9, thereby broadening the applicability of CRISPR-Cas regulatory tools for genome editing.	[Yang, Hui; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Yang, H; Patel, DJ (reprint author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	yangh3@mskcc.org; pateld@mskcc.org			NIGMS [P41GM103403]; U.S. Department of Energy [DE-AC02-06CH11357]; NIHORIP HEI [S10 RR029205]; NIH [GM104962]; Memorial Sloan Kettering Cancer Center Core Grant [P30CA008748]	X-ray diffraction studies were conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by NIGMS grant P41GM103403 and U.S. Department of Energy grant DE-AC02-06CH11357. The Pilatus 6M detector on 24-ID-C beam line is funded by a NIHORIP HEI grant (S10 RR029205). The research was supported by NIH grant GM104962 to D.J.P. and by the Memorial Sloan Kettering Cancer Center Core Grant (P30CA008748).	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dong D., 2017, NATURE; Dupuis ME, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3087; East-Seletsky A, 2017, MOL CELL, V66, P373, DOI 10.1016/j.molcel.2017.04.008; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Fmsley P., 2010, ACTA CRYSTALLOGR D, V66, P486; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Hine F., 2016, PHILOS T R SOC LON B, V371, P371; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nishimasu H, 2017, CURR OPIN STRUC BIOL, V43, P68, DOI 10.1016/j.sbi.2016.11.013; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Smargon A.A., 2017, CELL, V65; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang JY, 2016, CELL RES, V26, P1165, DOI 10.1038/cr.2016.103; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	53	1	1	11	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	JUL 6	2017	67	1					117	+		10.1016/j.molcel.2017.05.024				16	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EZ7IT	WOS:000404897300012	28602637				2018-01-05	
J	Nishimasu, H; Yamano, T; Gao, LY; Zhang, F; Ishitani, R; Nureki, O				Nishimasu, Hiroshi; Yamano, Takashi; Gao, Linyi; Zhang, Feng; Ishitani, Ryuichiro; Nureki, Osamu			Structural Basis for the Altered PAM Recognition by Engineered CRISPR-Cpf1	MOLECULAR CELL			English	Article							STAPHYLOCOCCUS-AUREUS CAS9; RNA-GUIDED ENDONUCLEASE; HUMAN-CELLS; CPF1; SPECIFICITIES; NUCLEASES; IMMUNITY; SYSTEMS	The RNA-guided Cpf1 nuclease cleaves double-stranded DNA targets complementary to the CRISPR RNA (crRNA), and it has been harnessed for genome editing technologies. Recently, Acidaminococcus sp. BV3L6 (AsCpf1) was engineered to recognize altered DNA sequences as the protospacer adjacent motif (PAM), thereby expanding the target range of Cpf1-mediated genome editing. Whereas wildtype AsCpf1 recognizes the TTTV PAM, the RVR (S542R/K548V/N552R) and RR (S542R/K607R) variants can efficiently recognize the TATV and TYCV PAMs, respectively. However, their PAM recognition mechanisms remained unknown. Here we present the 2.0 angstrom resolution crystal structures of the RVR and RR variants bound to a crRNA and its target DNA. The structures revealed that the RVR and RR variants primarily recognize the PAM-complementary nucleotides via the substituted residues. Our high-resolution structures delineated the altered PAM recognition mechanisms of the AsCpf1 variants, providing a basis for the further engineering of CRISPR-Cpf1.	[Nishimasu, Hiroshi; Yamano, Takashi; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan; [Nishimasu, Hiroshi] JST, PRESTO, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan; [Gao, Linyi; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Gao, Linyi; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA	Nishimasu, H; Nureki, O (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.; Nishimasu, H (reprint author), JST, PRESTO, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	nisimasu@bs.s.u-tokyo.ac.jp; nureki@bs.s.u-tokyo.ac.jp		Gao, Linyi/0000-0002-3579-0327	JST, PRESTO [JPMJPR13L8]; JSPS KAKENHI [26291010, 15H01463]; NIH through the National Institute of Mental Health (NIMH) [5DP1-MH100706, 1R01-MH110049]; NSF; Howard Hughes Medical Institute; New York Stem Cell Foundation; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation; Japan Agency for Medical Research and Development (AMED)	We thank Hisato Hirano and the beamline scientists at BL41XU at SPring-8 for assistance with data collection, Dr. Takanori Nakane for assistance with data processing, and Hisato Hirano and Seiichi Hirano for comments on the manuscript. H.N. is supported by JST, PRESTO (JPMJPR13L8), and JSPS KAKENHI (grants 26291010 and 15H01463). F.Z. is supported by the NIH through the National Institute of Mental Health (NIMH) (5DP1-MH100706 and 1R01-MH110049); the NSF; Howard Hughes Medical Institute; the New York Stem Cell, Simons, Paul G. Allen Family, and Vallee Foundations; and James and Patricia Poitras, Robert Metcalfe, and David Cheng. O.N. is supported by the Basic Science and Platform Technology Program for Innovative Biological Medicine from the Japan Agency for Medical Research and Development (AMED).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anders C, 2016, MOL CELL, V61, P895, DOI 10.1016/j.molcel.2016.02.020; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Cony L, 2013, SCIENCE, V339, P819; Dung D., 2016, NATURE, V532, P577; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gao L., 2017, NAT BIOTECHNOL; Gao P, 2016, CELL RES, V26, P901, DOI 10.1038/cr.2016.88; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hirano S, 2016, MOL CELL, V61, P886, DOI 10.1016/j.molcel.2016.02.018; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim HK, 2017, NAT METHODS, V14, P153, DOI [10.1038/NMETH.4104, 10.1038/nmeth.4104]; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mchanraju P., 2016, SCIENCE, V353; Nishimasu H, 2017, CURR OPIN STRUC BIOL, V43, P68, DOI 10.1016/j.sbi.2016.11.013; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Waterman D. G., 2013, CCP4 NEWSL PROTEIN C, V49, P16; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	33	4	4	12	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	JUL 6	2017	67	1					139	+		10.1016/j.molcel.2017.04.019				11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EZ7IT	WOS:000404897300014	28595896				2018-01-05	
J	Rodriguez, ML; Kaminska, D; Lappalainen, K; Pihlajamaki, J; Kaikkonen, MU; Laakso, M				Rodriguez, Maykel Lopez; Kaminska, Dorota; Lappalainen, Kati; Pihlajamaki, Jussi; Kaikkonen, Minna U.; Laakso, Markku			Identification and characterization of a FOXA2-regulated transcriptional enhancer at a type 2 diabetes intronic locus that controls GCKR expression in liver cells	GENOME MEDICINE			English	Article						rs780094; rs780095; rs780096; GCKR; Transcriptional enhancer; FOXA2; Type 2 diabetes	GLUCOKINASE REGULATORY PROTEIN; INTEGRATIVE GENOMICS VIEWER; FASTING PLASMA-GLUCOSE; RS780094 POLYMORPHISM; TRIGLYCERIDE LEVELS; INSULIN-RESISTANCE; WIDE ASSOCIATION; P446L VARIANT; HEPG2 CELLS; GENE	Background: Genome-wide association studies (GWAS) have identified more than 100 genetic loci associated with type 2 diabetes (T2D). However, the underlying biological mechanisms for many of these associations remain unknown. GWAS signals close to the glucokinase regulatory protein gene (GCKR) have been reported for lipid and glucose metabolism traits and the risk of T2D. We investigated the regulatory function of an intronic locus at GCKR represented by the lead single nucleotide polymorphism (SNP) rs780094. Methods: We used ENCODE project histone modification and transcription factor binding data to determine the regulatory features of a GCKR intronic locus formed by the high linkage disequilibrium rs780094(C/T), rs780095(G/A), and rs780096(G/C) SNPs. Characterization of the transcriptional activity of this region was assessed by luciferase reporter assays in HepG2 cells and mouse primary hepatocytes. ChIP-qPCR was used to determine the levels of haplotype specific transcription factor binding and histone marks. A CRISPR-dCas9 transcriptional activator system and qPCR were used to activate the locus and measure GCKR expression, respectively. Differential haplotype expression was measured from human liver biopsies. Results: The ENCODE data suggest the existence of a liver-specific intragenic enhancer at the locus represented by s780094. We observed that FOXA2 increased the transcriptional activity of this region in a haplotype specific way (CGG > TAC; rs780094, rs780095, and rs780096). In addition, the CGG haplotype showed higher binding to FOXA2 and higher levels of the H3K27Ac histone mark. The epigenetic activation of this locus increased the expression of endogenous GCKR in HepG2 cells, confirming that GCKR is the direct target gene of the enhancer. Finally, we confirmed that the CGG haplotype exhibits higher levels of transcription in human liver. Conclusions: Our results demonstrate the existence of a liver-specific FOXA2-regulated transcriptional enhancer at an intronic T2D locus represented by rs780094, rs780095, and rs780096 SNPs that increases GCKR expression. Differential haplotype regulation suggests the existence of cis regulatory effects that may contribute to the associated traits at this locus.	[Rodriguez, Maykel Lopez; Laakso, Markku] Univ Eastern Finland, Inst Clin Med, Internal Med, Yliopistonranta 1 C, Kuopio 70211, Finland; [Kaminska, Dorota; Pihlajamaki, Jussi] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio Campus,POB 1627, FI-70211 Kuopio, Finland; [Kaminska, Dorota] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Lappalainen, Kati; Kaikkonen, Minna U.] Univ Eastern Finland, Dept Biotechnol & Mol Med, AI Virtanen Inst Mol Sci, POB 1627, Kuopio 70211, Finland; [Pihlajamaki, Jussi] Kuopio Univ Hosp, Clin Nutr & Obes Ctr, POB 100, FI-70029 Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, Dept Med, POB 100, FI-70029 Kuopio, Finland	Laakso, M (reprint author), Univ Eastern Finland, Inst Clin Med, Internal Med, Yliopistonranta 1 C, Kuopio 70211, Finland.; Laakso, M (reprint author), Kuopio Univ Hosp, Dept Med, POB 100, FI-70029 Kuopio, Finland.	markku.laakso@uef.fi		Kaikkonen, Minna/0000-0001-6294-0979; Pihlajamaki, Jussi/0000-0002-6241-6859	Academy of Finland; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation; Post Doc Pool Foundation; Finnish Ministry of Education	This study was supported in part by grants from the Academy of Finland, Sigrid Juselius Foundation, Jane and Aatos Erkko Foundation, Finnish Foundation for Cardiovascular Research, Finnish Ministry of Education, Finnish Cultural Foundation, and the Post Doc Pool Foundation.	Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Allister EM, 2008, J LIPID RES, V49, P2218, DOI 10.1194/jlr.M800297-JLR200; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Arden C, 2011, DIABETES, V60, P3110, DOI 10.2337/db11-0061; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074; Brouwers MCGJ, 2015, TRENDS MOL MED, V21, P583, DOI 10.1016/j.molmed.2015.08.004; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; de la Iglesia N, 2000, J BIOL CHEM, V275, P10597, DOI 10.1074/jbc.275.14.10597                                                        ; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Gao F, 2015, MOL MED REP, V12, P6555, DOI 10.3892/mmr.2015.4298; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Howell JJ, 2009, J BIOL CHEM, V284, P24816, DOI 10.1074/jbc.M109.042135; Huang D, 2015, NUCLEIC ACIDS RES, V43, P225, DOI 10.1093/nar/gku1318; Kaminska D, 2012, DIABETES, V61, P2807, DOI 10.2337/db12-0239; Kannan MB, 2012, BBA-MOL CELL RES, V1823, P1841, DOI 10.1016/j.bbamcr.2012.06.012; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Levo M, 2014, NAT REV GENET, V15, P453, DOI 10.1038/nrg3684; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Locke JM, 2015, DIABETES, V64, P1484, DOI 10.2337/db14-0957; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Onuma H, 2010, J HUM GENET, V55, P600, DOI 10.1038/jhg.2010.75; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Paakinaho V, 2014, NUCLEIC ACIDS RES, V42, P1575, DOI 10.1093/nar/gkt1033; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Rees MG, 2012, DIABETOLOGIA, V55, P114, DOI 10.1007/s00125-011-2348-5; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SALONPAA P, 1994, BIOCHEM BIOPH RES CO, V205, P631, DOI 10.1006/bbrc.1994.2712; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sekiya T, 2009, GENE DEV, V23, P804, DOI 10.1101/gad.1775509; Slosberg ED, 2001, DIABETES, V50, P1813, DOI 10.2337/diabetes.50.8.1813; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Tam CHT, 2009, DIABETES, V58, P765, DOI 10.2337/db08-1277; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414; von Meyenn F, 2013, CELL METAB, V17, P436, DOI 10.1016/j.cmet.2013.01.014; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Wong N, 2000, HEPATOLOGY, V32, P1060, DOI 10.1053/jhep.2000.19349; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zhang WY, 2010, HORM METAB RES, V42, P930, DOI 10.1055/s-0030-1265219; Zhang WY, 2010, BIOL PHARM BULL, V33, P1494, DOI 10.1248/bpb.33.1494	54	1	1	5	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-994X			GENOME MED	Genome Med.	JUL 6	2017	9								63	10.1186/s13073-017-0453-x				14	Genetics & Heredity	Genetics & Heredity	EZ6VR	WOS:000404857800001		gold			2018-01-05	
J	Liu, DG; Mewalal, R; Hu, RB; Tuskan, GA; Yang, XH				Liu, Degao; Mewalal, Ritesh; Hu, Rongbin; Tuskan, Gerald A.; Yang, Xiaohan			New technologies accelerate the exploration of non-coding RNAs in horticultural plants	HORTICULTURE RESEARCH			English	Review							SMALL-INTERFERING RNAS; COGNATE MESSENGER-RNA; CIRCULAR RNAS; ARABIDOPSIS-THALIANA; TARGET GENES; MICRORNA TRANSCRIPTOME; PHOSPHATE HOMEOSTASIS; CONSERVED MICRORNAS; MEDICAGO-TRUNCATULA; STRESS RESPONSES	Non-coding RNAs (ncRNAs), that is, RNAs not translated into proteins, are crucial regulators of a variety of biological processes in plants. While protein-encoding genes have been relatively well-annotated in sequenced genomes, accounting for a small portion of the genome space in plants, the universe of plant ncRNAs is rapidly expanding. Recent advances in experimental and computational technologies have generated a great momentum for discovery and functional characterization of ncRNAs. Here we summarize the classification and known biological functions of plant ncRNAs, review the application of next-generation sequencing (NGS) technology and ribosome profiling technology to ncRNA discovery in horticultural plants and discuss the application of new technologies, especially the new genome-editing tool clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9) systems, to functional characterization of plant ncRNAs.	[Liu, Degao; Mewalal, Ritesh; Hu, Rongbin; Tuskan, Gerald A.; Yang, Xiaohan] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA	Yang, XH (reprint author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	yangx@ornl.gov			Department of Energy (DOE), Office of Science, Genomic Science Program [DE-SC0008834]; US DOE [DE-AC05-00OR22725]; U.S. Department of Energy [DE-AC05-00OR22725]	We thank Dr Zong-Ming Cheng (University of Tennessee) and the reviewers for their critical review and instructive comments on our manuscript. This research is supported by the Department of Energy (DOE), Office of Science, Genomic Science Program under Award Number DE-SC0008834. Oak Ridge National Laboratory is managed by UT-Battelle, LLC for the US DOE under Contract Number DE-AC05-00OR22725. This manuscript has been authored by UT-Battelle, LLC under Contract No. DE-AC05-00OR22725 with the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a non-exclusive, paid-up, irrevocable, world-wide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan).	Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Amor B. B., 2009, Genome Research, V19, P57, DOI 10.1101/gr.080275.108; Arikit S, 2013, CURR OPIN PLANT BIOL, V16, P170, DOI 10.1016/j.pbi.2013.01.006; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Bardou F, 2014, DEV CELL, V30, P166, DOI 10.1016/j.devcel.2014.06.017; Bazzini AA, 2014, EMBO J, V33, P981, DOI 10.1002/embj.201488411; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Boccara M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003883; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Butler NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144591; Buxdorf K, 2010, PLANTA, V232, P1009, DOI 10.1007/s00425-010-1231-9; Byrne SL, 2015, PLANT J, V84, P816, DOI 10.1111/tpj.13037; Campalans A, 2004, PLANT CELL, V16, P1047, DOI 10.1105/tpc.019406; Campo S, 2013, NEW PHYTOL, V199, P212, DOI 10.1111/nph.12292; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chao YT, 2014, PLANT MOL BIOL, V84, P529, DOI 10.1007/s11103-013-0150-0; Cheng X, 2015, FASEB J, V29; Chitwood DH, 2007, DEVELOPMENT, V134, P813, DOI 10.1242/dev.000497; Chu C, 2015, NAT STRUCT MOL BIOL, V22, P29, DOI 10.1038/nsmb.2921; Conn VM, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.53; Contreras-Cubas C, 2012, PLANTA, V236, P943, DOI 10.1007/s00425-012-1693-z; Costa LM, 2014, SCIENCE, V344, P168, DOI 10.1126/science.1243005; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Debernardi JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002419; Dey M, 2004, PHYSIOL PLANTARUM, V120, P132, DOI 10.1111/j.0031-9317.2004.0208.x; Ding JH, 2012, P NATL ACAD SCI USA, V109, P2654, DOI 10.1073/pnas.1121374109; Eddy Sean R, 2009, Genome Inform, V23, P205; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Fu XD, 2014, NATL SCI REV, V1, P190, DOI 10.1093/nsr/nwu008; Gao Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0571-3; Ge AJ, 2013, PHYSIOL PLANTARUM, V148, P387, DOI 10.1111/j.1399-3054.2012.01713.x; Giacomelli JI, 2012, NEW PHYTOL, V195, P766, DOI 10.1111/j.1469-8137.2012.04259.x; Guan XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4050; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Guo SY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2542; Hanada K, 2013, P NATL ACAD SCI USA, V110, P2395, DOI 10.1073/pnas.1213958110; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hao ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121800; Held MA, 2008, P NATL ACAD SCI USA, V105, P20534, DOI 10.1073/pnas.0809408105; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Ho TT, 2014, NUCLEIC ACIDS RES, V43, pe17, DOI DOI 10.1093/NAR/GKU1198; HOLLEY RW, 1965, SCIENCE, V147, P1462, DOI 10.1126/science.147.3664.1462; Hoshino A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13295; Hsu PY, 2016, P NATL ACAD SCI USA, V113, pE7126, DOI 10.1073/pnas.1614788113; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jabnoune M, 2013, PLANT CELL, V25, P4166, DOI 10.1105/tpc.113.116251; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jia F, 2013, PLANT MOL BIOL, V81, P447, DOI 10.1007/s11103-013-0015-6; Jiao WB, 2017, CURR OPIN PLANT BIOL, V36, P64, DOI 10.1016/j.pbi.2017.02.002; Jones-Rhoades MW, 2012, PLANT MOL BIOL, V80, P3, DOI 10.1007/s11103-011-9829-2; Joshi RK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158784; Juntawong P, 2014, P NATL ACAD SCI USA, V111, pE203, DOI 10.1073/pnas.1317811111; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Kim J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-657; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kutter C, 2007, PLANT CELL, V19, P2417, DOI 10.1105/tpc.107.050377; Lauressergues D, 2015, NATURE, V520, P90, DOI 10.1038/nature14346; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee SM, 2017, TRENDS PLANT SCI, V22, P357, DOI 10.1016/j.tplants.2017.03.007; Lei JK, 2014, BIOINFORMATICS, V30, P2837, DOI 10.1093/bioinformatics/btu380; Li AM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-311; Li F, 2015, ONCOTARGET, V6, P6001, DOI 10.18632/oncotarget.3469                                                        ; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li JY, 2014, TRENDS PLANT SCI, V19, P750, DOI 10.1016/j.tplants.2014.08.006; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Liu DG, 2016, CURR OPIN PLANT BIOL, V30, P70, DOI 10.1016/j.pbi.2016.01.007; Liu J, 2015, PLANT BIOTECHNOL J, V13, P319, DOI 10.1111/pbi.12336; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Luo QJ, 2012, PLANT MOL BIOL, V80, P117, DOI 10.1007/s11103-011-9778-9; Marquardt S, 2014, MOL CELL, V54, P156, DOI 10.1016/j.molcel.2014.03.026; Matsui A, PLANT STRESS TOLERAN, P141; Matsui A, 2013, INT J MOL SCI, V14, P22642, DOI 10.3390/ijms141122642; Mecchia MA, 2013, MECH DEVELOP, V130, P2, DOI 10.1016/j.mod.2012.07.005; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Montgomery TA, 2008, P NATL ACAD SCI USA, V105, P20055, DOI 10.1073/pnas.0810241105; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Ng DWK, 2011, PLANT CELL, V23, P1729, DOI 10.1105/tpc.111.083915; Ng SY, 2013, TRENDS GENET, V29, P461, DOI 10.1016/j.tig.2013.03.002; Nishitani C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31481; Nosaka M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002953; Nowak MD, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0567-z; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pamudurti NR, 2017, MOL CELL, V66, P9, DOI 10.1016/j.molcel.2017.02.021; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; Pauli A, 2015, BIOESSAYS, V37, P103, DOI 10.1002/bies.201400103; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Pefanis E, 2015, CELL, V161, P774, DOI 10.1016/j.cell.2015.04.034; Perkel JM, 2013, BIOTECHNIQUES, V54, P301, DOI 10.2144/000114037; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Rehrauer H, 2010, PLANT PHYSIOL, V152, P487, DOI 10.1104/pp.109.150185; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; Rubio-Somoza I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003374; Sakaguchi J, 2012, DEV GROWTH DIFFER, V54, P93, DOI 10.1111/j.1440-169X.2011.01318.x; Santosh B, 2015, CELL BIOCHEM FUNCT, V33, P14, DOI 10.1002/cbf.3079; Scarano D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171504; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shechner DM, 2015, NAT METHODS, V12, P664, DOI [10.1038/NMETH.3433, 10.1038/nmeth.3433]; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Shin SY, 2016, PLANT BIOTECHNOL REP, V10, P35, DOI 10.1007/s11816-016-0389-4; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Sousa C, 2001, MOL CELL BIOL, V21, P354, DOI 10.1128/MCB.21.1.354-366.2001; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-122; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Wang L, 2013, PLANT MOL BIOL, V83, P365, DOI 10.1007/s11103-013-0093-5; Wang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090859; Wang Y, 2011, PLANT CELL, V23, P3185, DOI 10.1105/tpc.111.088013; Wang YQ, 2014, P NATL ACAD SCI USA, V111, P10359, DOI 10.1073/pnas.1409457111; Wang Z, 2015, GENE, V571, P178, DOI 10.1016/j.gene.2015.06.047; Wang ZP, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00413; Wu G, 2013, J GENET GENOMICS, V40, P217, DOI 10.1016/j.jgg.2013.04.002; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Wunderlich M, 2014, PLANT MOL BIOL, V85, P541, DOI 10.1007/s11103-014-0202-0; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Xie JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127412; Xiong JS, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2015.19; Yan K, 2012, MOL CELL, V48, P521, DOI 10.1016/j.molcel.2012.08.032; YANG WC, 1993, PLANT J, V3, P573, DOI 10.1046/j.1365-313X.1993.03040573.x; Yang XH, 2011, GENOME RES, V21, P634, DOI 10.1101/gr.109280.110; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Ye CY, 2015, NEW PHYTOL, V208, P88, DOI 10.1111/nph.13585; Yoon EK, 2010, NUCLEIC ACIDS RES, V38, P1382, DOI 10.1093/nar/gkp1128; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang RX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057233; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zhang YC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0512-1; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhu QH, 2012, GENES-BASEL, V3, P176, DOI 10.3390/genes3010176; Zuo JH, 2016, BIOCHEM BIOPH RES CO, V479, P132, DOI 10.1016/j.bbrc.2016.07.032	146	2	2	13	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2052-7276			HORTIC RES-ENGLAND	Hortic. Res.-England	JUL 5	2017	4						1	8		10.1038/hortres.2017.31				8	Plant Sciences; Horticulture	Plant Sciences; Agriculture	FB5KQ	WOS:000406180800001	28698797	gold			2018-01-05	
J	Cullis, PR; Hope, MJ				Cullis, Pieter R.; Hope, Michael J.			Lipid Nanoparticle Systems for Enabling Gene Therapies	MOLECULAR THERAPY			English	Article; Proceedings Paper	20th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)	MAY 10-13, 2017	Washington, DC	Amer Soc Gene & Cell Therapy			IN-VIVO; SIRNA DELIVERY; CATIONIC LIPIDS; MEMBRANE-FUSION; MESSENGER-RNA; POTENCY; SIZE; ENCAPSULATION; THERAPEUTICS; FORMULATIONS	Genetic drugs such as small interfering RNA (siRNA), mRNA, or plasmid DNA provide potential gene therapies to treat most diseases by silencing pathological genes, expressing therapeutic proteins, or through gene-editing applications. In order for genetic drugs to be used clinically, however, sophisticated delivery systems are required. Lipid nanoparticle (LNP) systems are currently the lead non-viral delivery systems for enabling the clinical potential of genetic drugs. Application will be made to the Food and Drug Administration (FDA) in 2017 for approval of an LNP siRNA drug to treat transthyretin-induced amyloidosis, presently an untreatable disease. Here, we first review research leading to the development of LNP siRNA systems capable of silencing target genes in hepatocytes following systemic administration. Subsequently, progress made to extend LNP technology to mRNA and plasmids for protein replacement, vaccine, and gene-editing applications is summarized. Finally, we address current limitations of LNP technology as applied to genetic drugs and ways in which such limitations may be overcome. It is concluded that LNP technology, by virtue of robust and efficient formulation processes, as well as advantages in potency, payload, and design flexibility, will be a dominant non-viral technology to enable the enormous potential of gene therapy.	[Cullis, Pieter R.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Hope, Michael J.] Acuitas Therapeut, Vancouver, BC V6T 1Z3, Canada	Cullis, PR (reprint author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	pieterc@mail.ubc.ca			Canadian Institutes for Health Research; Canadian Medical Research Council; National Science and Engineering Research Council (NSERC); Genome BC	The authors wish to acknowledge collaborations extending over many years with colleagues based at Alnylam Pharmaceuticals, Arbutus Biopharma, Precision Nanosystems, Acuitas Therapeutics, and the University of BC. Continuous funding for this work has been provided through the Canadian Institutes for Health Research and its precursor, the Canadian Medical Research Council, for the past 39 years. Additional funding has been provided by the National Science and Engineering Research Council (NSERC) and Genome BC.	Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; BAILEY AL, 1994, BIOCHEMISTRY-US, V33, P12573, DOI 10.1021/bi00208a007; Basha G, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.68; Basha G, 2011, MOL THER, V19, P2186, DOI 10.1038/mt.2011.190; Belliveau NM, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.28; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Chen S, 2016, J CONTROL RELEASE, V235, P236, DOI 10.1016/j.jconrel.2016.05.059; CHONN A, 1992, J BIOL CHEM, V267, P18759; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; CULLIS P R, 1989, Advanced Drug Delivery Reviews, V3, P267, DOI 10.1016/0169-409X(89)90024-0; CULLIS PR, 1978, NATURE, V271, P672, DOI 10.1038/271672a0; CULLIS PR, 1978, BIOCHIM BIOPHYS ACTA, V513, P31, DOI 10.1016/0005-2736(78)90109-8; CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V559, P399, DOI 10.1016/0304-4157(79)90012-1                                                    ; FEIGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI DOI 10.1073/PNAS.84.21.7413; Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612; Hafez IM, 2001, GENE THER, V8, P1188, DOI 10.1038/sj.gt.3301506; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8                                                    ; Jayaraman M, 2012, ANGEW CHEM INT EDIT, V51, P8529, DOI 10.1002/anie.201203263; Jeffs LB, 2005, PHARM RES, V22, P362, DOI 10.1007/s11095-004-1873-z; Kariko K, 2007, CURR OPIN DRUG DISC, V10, P523; Kulkarni J.A., 2016, NANOMEDICINE; Lee JB, 2012, INT J CANCER, V131, pE781, DOI 10.1002/ijc.27361; Leung AKK, 2015, J PHYS CHEM B, V119, P8698, DOI 10.1021/acs.jpcb.5b02891; Leung AKK, 2012, J PHYS CHEM C, V116, P18440, DOI 10.1021/jp303267y; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Maeda H, 2012, J CONTROL RELEASE, V164, P138, DOI 10.1016/j.jconrel.2012.04.038; Mui BL, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.66; Pardi N., 2017, NAT COMM, V8; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Rungta RL, 2015, CELL, V161, P610, DOI 10.1016/j.cell.2015.03.029; Rungta RL, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.65; Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614; Semple SC, 2001, BBA-BIOMEMBRANES, V1510, P152, DOI 10.1016/S0005-2736(00)00343-6; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Szebeni J, 2014, MOL IMMUNOL, V61, P163, DOI 10.1016/j.molimm.2014.06.038; Thess A, 2015, MOL THER, V23, P1456, DOI 10.1038/mt.2015.103; Vance JE, 2010, BBA-MOL CELL BIOL L, V1801, P806, DOI 10.1016/j.bbalip.2010.02.007; Wang HT, 2016, MOL THER, V24, P2100, DOI 10.1038/mt.2016.179; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Williams KJ, 2010, CURR OPIN LIPIDOL, V21, P218, DOI 10.1097/MOL.0b013e328338cabc; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	42	8	8	23	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	JUL 5	2017	25	7					1467	1475		10.1016/j.ymthe.2017.03.013				9	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FA4WZ	WOS:000405445500002	28412170				2018-01-05	
J	Bridge, KS; Shah, KM; Li, YG; Foxler, DE; Wong, SCK; Miller, DC; Davidson, KM; Foster, JG; Rose, R; Hodgkinson, MR; Ribeiro, PS; Aboobaker, AA; Yashiro, K; Wang, XZ; Graves, PR; Plevin, MJ; Lagos, D; Sharp, TV				Bridge, Katherine S.; Shah, Kunal M.; Li, Yigen; Foxler, Daniel E.; Wong, Sybil C. K.; Miller, Duncan C.; Davidson, Kathryn M.; Foster, John G.; Rose, Ruth; Hodgkinson, Michael R.; Ribeiro, Paulo S.; Aboobaker, A. Aziz; Yashiro, Kenta; Wang, Xiaozhong; Graves, Paul R.; Plevin, Michael J.; Lagos, Dimitris; Sharp, Tyson V.			Argonaute Utilization for miRNA Silencing Is Determined by Phosphorylation-Dependent Recruitment of LIM-Domain-Containing Proteins	CELL REPORTS			English	Article							MESSENGER-RNA DECAY; TRANSLATIONAL REPRESSION; IN-VIVO; MICRORNAS; GW182; COMPLEXES; BINDING; CCR4-NOT; CELLS; AGO2	As core components of the microRNA-induced silencing complex (miRISC), Argonaute (AGO) proteins interact with TNRC6 proteins, recruiting other effectors of translational repression/mRNA destabilization. Here, we show that LIMD1 coordinates the assembly of an AGO-TNRC6 containing miRISC complex by binding both proteins simultaneously at distinct interfaces. Phosphorylation of AGO2 at Ser 387 by Akt3 induces LIMD1 binding, which in turn enables AGO2 to interact with TNRC6A and downstream effector DDX6. Conservation of this serine in AGO1 and 4 indicates this mechanism may be a fundamental requirement for AGO function and miRISC assembly. Upon CRISPR-Cas9-mediated knockout of LIMD1, AGO2 miRNA-silencing function is lost and miRNA silencing becomes dependent on a complex formed by AGO3 and the LIMD1 family member WTIP. The switch to AGO3 utilization occurs due to the presence of a glutamic acid residue (E390) on the interaction interface, which allows AGO3 to bind to LIMD1, AJUBA, and WTIP irrespective of Akt signaling.	[Bridge, Katherine S.; Shah, Kunal M.; Li, Yigen; Foxler, Daniel E.; Wong, Sybil C. K.; Miller, Duncan C.; Davidson, Kathryn M.; Foster, John G.; Sharp, Tyson V.] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, John Vane Sci Ctr, Charterhouse Sq, London EC1M 6BQ, England; [Rose, Ruth] Queen Mary Univ London, Sch Biol & Chem Sci, Fogg Bldg,Mile End Rd, London E1 4NS, England; [Hodgkinson, Michael R.; Plevin, Michael J.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Ribeiro, Paulo S.] Queen Mary Univ London, Barts Canc Inst, Ctr Tumour Biol, John Vane Sci Ctr, Charterhouse Sq, London EC1M 6BQ, England; [Aboobaker, A. Aziz] Univ Oxford, Dept Zool, Tinbergen Bldg,South Parks Rd, Oxford OX1 3PS, England; [Yashiro, Kenta; Graves, Paul R.] New York Presbyterian Brooklyn Methodist Hosp, Dept Radiat Oncol, 506 6th St, Brooklyn, NY 11215 USA; [Wang, Xiaozhong] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Lagos, Dimitris] Univ York, Hull York Med Sch, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Lagos, Dimitris] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	Sharp, TV (reprint author), Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, John Vane Sci Ctr, Charterhouse Sq, London EC1M 6BQ, England.	t.sharp@qmul.ac.uk		Plevin, Michael/0000-0003-2057-8291; Foster, John/0000-0002-8591-0833	BBSRC [BB/L027755/1, BB/I007571/1]; CRUK [C8932/A12733]; BBSRC New Investigator [BB/N018818/1]; Medical Research Council New Investigator Research Grant holder [MR/L008505/1]; Wellcome Trust through the Centre for Chronic Diseases and Disorders at the University of York [097829]	We thank Prof Ian MacRae and Jessica Sheu-Gruttadauria from The Scripps Research Institute, San Diego for providing purified recombinant AGO2 protein. We also thank Dr. Incheol Shin from Hanyang University in South Korea for providing the Myristoylated-Akt3 construct. K.S.B. is supported by funds from the BBSRC (Grant Code BB/L027755/1). K.M.S. was supported by funds from the BBSRC (Grant Code BB/I007571/1). J.G.F. was supported by funds from CRUK (C8932/A12733). M.J.P. is a BBSRC New Investigator (BB/N018818/1). D.L. is a Medical Research Council New Investigator Research Grant holder (MR/L008505/1) with further funding from The Wellcome Trust through the Centre for Chronic Diseases and Disorders at the University of York (097829). This work was supported by funds awarded to T.V.S. from the BBSRC (Grant Code BB/I007571/1).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5                                                   ; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Chen Y, 2014, MOL CELL, V54, P737, DOI 10.1016/j.molcel.2014.03.034; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; De N, 2011, METHODS MOL BIOL, V725, P107, DOI 10.1007/978-1-61779-046-1_8; Dueck A, 2012, NUCLEIC ACIDS RES, V40, P9850, DOI 10.1093/nar/gks705; Editorial, 2009, NAT PHOTONICS, V3, P361; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2009, RNA, V15, P1433, DOI 10.1261/rna.1703809; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Golden RJ, 2017, NATURE, V542, P197, DOI 10.1038/nature21025; Horman SR, 2013, MOL CELL, V50, P356, DOI [10.1016/j.molce1.2013.03.015, 10.1016/j.molcel.2013.03.015]; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; James V, 2010, P NATL ACAD SCI USA, V107, P12499, DOI 10.1073/pnas.0914987107; Jee D, 2014, TRENDS CELL BIOL, V24, P546, DOI 10.1016/j.tcb.2014.04.008; Koch BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033261; La Rocca G, 2015, P NATL ACAD SCI USA, V112, P767, DOI 10.1073/pnas.1424217112; Lian SL, 2009, RNA, V15, P804, DOI 10.1261/rna.1229409; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Lopez-Orozco J, 2015, RNA, V21, P2030, DOI 10.1261/rna.053207.115; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; McKenzie AJ, 2016, CELL REP, V15, P978, DOI 10.1016/j.celrep.2016.03.085; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Patranabis S, 2016, MOL CELL BIOL, V36, P1260, DOI 10.1128/MCB.00054-16; Petri S, 2011, RNA, V17, P737, DOI 10.1261/rna.2348111; Pfaff J, 2013, P NATL ACAD SCI USA, V110, pE3770, DOI 10.1073/pnas.1308510110; Rouya C, 2014, RNA, V20, P1398, DOI 10.1261/rna.045302.114; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Sahin U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102957; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song J, 2008, FEBS LETT, V582, P1693, DOI 10.1016/j.febslet.2008.04.024; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Takimoto K, 2009, RNA, V15, P1078, DOI 10.1261/rna.1363109; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Valdmanis PN, 2012, NUCLEIC ACIDS RES, V40, P3704, DOI 10.1093/nar/gkr1274; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Warner MJ, 2016, NUCLEIC ACIDS RES, V44, P9942, DOI 10.1093/nar/gkw631; Yang M, 2014, MOL CELL, V55, P782, DOI 10.1016/j.molcel.2014.07.018; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599	47	0	0	6	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	JUL 5	2017	20	1					173	187		10.1016/j.celrep.2017.06.027				15	Cell Biology	Cell Biology	EZ7JM	WOS:000404899700016	28683311	gold			2018-01-05	
J	Sahraeian, SME; Mohiyuddin, M; Sebra, R; Tilgner, H; Afshar, PT; Au, KF; Asadi, NB; Gerstein, MB; Wong, WH; Snyder, MP; Schadt, E; Lam, HYK				Sahraeian, Sayed Mohammad Ebrahim; Mohiyuddin, Marghoob; Sebra, Robert; Tilgner, Hagen; Afshar, Pegah T.; Au, Kin Fai; Asadi, Narges Bani; Gerstein, Mark B.; Wong, Wing Hung; Snyder, Michael P.; Schadt, Eric; Lam, Hugo Y. K.			Gaining comprehensive biological insight into the transcriptome by performing a broad-spectrum RNA-seq analysis	NATURE COMMUNICATIONS			English	Article							EXPRESSION ANALYSIS; ACCURATE IDENTIFICATION; FUSION TRANSCRIPTS; ERROR-CORRECTION; GENE-EXPRESSION; SEQUENCING DATA; MESSENGER-RNA; EDITING SITES; LARGE GENOMES; READS	RNA-sequencing (RNA-seq) is an essential technique for transcriptome studies, hundreds of analysis tools have been developed since it was debuted. Although recent efforts have attempted to assess the latest available tools, they have not evaluated the analysis workflows comprehensively to unleash the power within RNA-seq. Here we conduct an extensive study analysing a broad spectrum of RNA-seq workflows. Surpassing the expression analysis scope, our work also includes assessment of RNA variant-calling, RNA editing and RNA fusion detection techniques. Specifically, we examine both short-and long-read RNA-seq technologies, 39 analysis tools resulting in similar to 120 combinations, and similar to 490 analyses involving 15 samples with a variety of germline, cancer and stem cell data sets. We report the performance and propose a comprehensive RNA-seq analysis protocol, named RNACocktail, along with a computational pipeline achieving high accuracy. Validation on different samples reveals that our proposed protocol could help researchers extract more biologically relevant predictions by broad analysis of the transcriptome.	[Sahraeian, Sayed Mohammad Ebrahim; Mohiyuddin, Marghoob; Asadi, Narges Bani; Lam, Hugo Y. K.] Roche Sequencing Solut, Belmont, CA 94002 USA; [Sebra, Robert; Schadt, Eric] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Tilgner, Hagen; Snyder, Michael P.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Afshar, Pegah T.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Au, Kin Fai] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Gerstein, Mark B.] Yale Univ, Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Wong, Wing Hung] Stanford Univ, Stat Hlth Res & Policy, Stanford, CA 94305 USA	Lam, HYK (reprint author), Roche Sequencing Solut, Belmont, CA 94002 USA.	hugo.lam@roche.com			NIH [R01HG007834]	We thank Tom Wu from Genentech for contribution of GMAP, John Mu, Jian Li, Bayo Lau, Anoop Grewal, and Michael Braverman from Roche Sequencing Solutions for fruitful discussions and useful insights. The works of P.T.A. and W.H.W. were partially supported by NIH grant R01HG007834.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Ahn J, 2015, BIOINFORMATICS, V31, P3906, DOI 10.1093/bioinformatics/btv505; Au KF, 2013, P NATL ACAD SCI USA, V110, pE4821, DOI 10.1073/pnas.1320101110; Au KF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046679; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Brorsson C, 2009, DIABETES OBES METAB, V11, P60, DOI 10.1111/j.1463-1326.2008.01004.x; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Consortium SM-I, 2014, NAT BIOTECHNOL, V32, P903, DOI [10.1038/nbt.2957, DOI 10.1038/NBT.2957]; Davidson NM, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0167-x; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/nmeth.2722, 10.1038/NMETH.2722]; Fonseca NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107026; Frazee AC, 2015, NAT BIOTECHNOL, V33, P243, DOI 10.1038/nbt.3172; Gordon SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132628; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hackl T, 2014, BIOINFORMATICS, V30, P3004, DOI 10.1093/bioinformatics/btu392; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hayer KE, 2015, BIOINFORMATICS, V31, P3938, DOI 10.1093/bioinformatics/btv488; Jia WL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r12; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/nmeth.3317, 10.1038/NMETH.3317]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Knowles DG, 2013, BIOINFORMATICS, V29, P614, DOI 10.1093/bioinformatics/btt016; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1234; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mu JC, 2015, BIOINFORMATICS, V31, P1469, DOI 10.1093/bioinformatics/btu828; Nicorici D., 2014, FUSIONCATCHERA TOOL; Parker BC, 2013, CHIN J CANCER, V32, P594, DOI 10.5732/cjc.013.10178; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pimentel H. J., 2016, DIFFERENTIAL ANAL RN; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salmela L, 2014, BIOINFORMATICS, V30, P3506, DOI 10.1093/bioinformatics/btu538; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Srivastava A, 2016, BIOINFORMATICS, V32, P192, DOI 10.1093/bioinformatics/btw277; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/NMETH.2714, 10.1038/nmeth.2714]; Teng MX, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0940-1; Tilgner H, 2015, NAT BIOTECHNOL, V33, P736, DOI 10.1038/nbt.3242; Tilgner H, 2014, P NATL ACAD SCI USA, V111, P9869, DOI 10.1073/pnas.1400447111; Tilgner H, 2013, G3-GENES GENOM GENET, V3, P387, DOI 10.1534/g3.112.004812; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Weirather JL, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv562; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Q, 2015, NAT METHODS, V12, P347, DOI [10.1038/NMETH.3314, 10.1038/nmeth.3314]; Zook JM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.25	73	0	0	24	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JUL 5	2017	8								59	10.1038/s41467-017-00050-4				15	Multidisciplinary Sciences	Science & Technology - Other Topics	EZ5SP	WOS:000404778800003	28680106	gold			2018-01-05	
J	Denbow, CJ; Lapins, S; Dietz, N; Scherer, R; Nimchuk, ZL; Okumoto, S				Denbow, Cynthia J.; Lapins, Samantha; Dietz, Nick; Scherer, Raelynn; Nimchuk, Zachary L.; Okumoto, Sakiko			Gateway-Compatible CRISPR-Cas9 Vectors and a Rapid Detection by High-Resolution Melting Curve Analysis	FRONTIERS IN PLANT SCIENCE			English	Article						CRISPR/Cas9; high-resolution melting curve analysis; gene editing; indel detection; genome editing	ARABIDOPSIS-THALIANA; CRISPR/CAS9 SYSTEM; FLORAL DIP; DNA; PLANT; NUCLEASES; TRANSFORMATION; SPECIFICITY; MUTAGENESIS; EFFICIENCY	CRISPR-Cas9 system rapidly became an indispensable tool in plant biology to perform targeted mutagenesis. A CRISPR-Cas9-mediated double strand break followed by non-homologous end joining (NHEJ) repair most frequently results in a single base pair deletion or insertions (indels), which is hard to detect using methods based on enzymes that detect heteroduplex DNA. In addition, somatic tissues of the T1 generation inevitably contain a mosaic population, in which the portion of cells carrying the mutation can be too small to be detected by the enzyme-based methods. Here we report an optimized experimental protocol for detecting Arabidopsis mutants carrying a CRISPR-Cas9 mediated mutation, using high-resolution melting (HRM) curve analysis. Single-base pair insertion or deletion (indel) can be easily detected using this method. We have also examined the detection limit for the template containing a one bp indel compared to the WT genome. Our results show that< 5% ofmutant DNA containing one bp indel can be detected using this method. The vector developed in this study can be used with a Gateway technology-compatible derivative of pCUT vectors, with which off-target mutations could not be detected even by a whole genome sequencing.	[Denbow, Cynthia J.; Lapins, Samantha; Dietz, Nick; Scherer, Raelynn; Okumoto, Sakiko] Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Nimchuk, Zachary L.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Okumoto, Sakiko] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA	Okumoto, S (reprint author), Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA.; Okumoto, S (reprint author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.	sokumoto@tamu.edu			National Science Foundation [MCB 1052048, IOS-1455607]; Virginia Agricultural Experiment Station; Hatch Program of the National Institute of Food and Agriculture, U.S. Department of Agriculture [VA-160037, VA-135882]	This work was supported by The National Science Foundation MCB 1052048, the Virginia Agricultural Experiment Station and the Hatch Program of the National Institute of Food and Agriculture, U.S. Department of Agriculture, projects VA-160037 and VA-135882 (SO). This work was supported by grants to ZN from the National Science Foundation (IOS-1455607).	Baltes NJ, 2015, TRENDS BIOTECHNOL, V33, P120, DOI 10.1016/j.tibtech.2014.11.008; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Declais AC, 2008, CURR OPIN STRUC BIOL, V18, P86, DOI 10.1016/j.sbi.2007.11.001; Dufresne SD, 2006, ARCH PATHOL LAB MED, V130, P185; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Ghedira R, 2013, MOL PLANT MICROBE IN, V26, P823, DOI 10.1094/MPMI-11-12-0267-R; GOHLKE C, 1994, P NATL ACAD SCI USA, V91, P11660, DOI 10.1073/pnas.91.24.11660; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang MC, 2012, ELECTROPHORESIS, V33, P788, DOI 10.1002/elps.201100460; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488                                                           ; Lalonde S, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00024; Laurie AD, 2009, CLIN BIOCHEM, V42, P528, DOI 10.1016/j.clinbiochem.2008.11.015; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321                                                           ; Palais R, 2009, METHOD ENZYMOL, V454, P323, DOI [10.1016/S0076-6879(08)03913-5, 10.1016/S0076-6879(08)03813-5]; Pan C., 2016, NAT SCI REP, V6, P24765, DOI DOI 10.1038/SREP24765; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Peterson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162169; Ren C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32289; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Simko I, 2016, TRENDS PLANT SCI, V21, P528, DOI 10.1016/j.tplants.2016.01.004; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Yeung A, 2005, BIOTECHNIQUES, V38, P749, DOI 10.2144/05385RV01; Zhu XX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06420; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003	31	0	0	13	13	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	JUL 5	2017	8								1171	10.3389/fpls.2017.01171				8	Plant Sciences	Plant Sciences	EZ4XQ	WOS:000404716200001	28725235				2018-01-05	
J	Han, T; Schatoff, EM; Murphy, C; Zafra, MP; Wilkinson, JE; Elemento, O; Dow, LE				Han, Teng; Schatoff, Emma M.; Murphy, Charles; Zafra, Maria Paz; Wilkinson, John E.; Elemento, Olivier; Dow, Lukas E.			R-Spondin chromosome rearrangements drive Wnt-dependent tumour initiation and maintenance in the intestine	NATURE COMMUNICATIONS			English	Article							STEM-CELL NICHE; IN-VIVO; COLORECTAL-CANCER; TRANSGENIC MICE; SELF-RENEWAL; DIFFERENTIATION; COLON; ADENOMA; MOUSE; VITRO	Defining the genetic drivers of cancer progression is a key in understanding disease biology and developing effective targeted therapies. Chromosome rearrangements are a common feature of human malignancies, but whether they represent bona fide cancer drivers and therapeutically actionable targets, requires functional testing. Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon cancer-associated EIF3E-RSPO2 and PTPRK-RSPO3 chromosome rearrangements in vivo. We show that both Rspo2 and Rspo3 fusion events are sufficient to initiate hyperplasia and tumour development in vivo, without additional cooperating genetic events. Rspo-fusion tumours are entirely Wnt-dependent, as treatment with an inhibitor of Wnt secretion, LGK974, drives rapid tumour clearance from the intestinal mucosa without effects on normal intestinal crypts. Altogether, our study provides direct evidence that endogenous Rspo2 and Rspo3 chromosome rearrangements can initiate and maintain tumour development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion cancers.	[Han, Teng; Schatoff, Emma M.; Murphy, Charles; Zafra, Maria Paz; Elemento, Olivier; Dow, Lukas E.] Weill Cornell Med, Dept Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10021 USA; [Han, Teng; Murphy, Charles; Dow, Lukas E.] Weill Cornell Grad Sch Med Sci, Weill Cornell Med, New York, NY 10021 USA; [Schatoff, Emma M.] Weill Cornell Rockefeller Sloan Kettering Tri MD, New York, NY 10021 USA; [Murphy, Charles] Tri Inst Training Program Computat Biol & Med, New York, NY 10021 USA; [Wilkinson, John E.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Dow, Lukas E.] Weill Cornell Med, Dept Biochem, New York, NY 10021 USA	Dow, LE (reprint author), Weill Cornell Med, Dept Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10021 USA.; Dow, LE (reprint author), Weill Cornell Grad Sch Med Sci, Weill Cornell Med, New York, NY 10021 USA.; Dow, LE (reprint author), Weill Cornell Med, Dept Biochem, New York, NY 10021 USA.	lud2005@med.cornell.edu			NIH Cancer Center support grant [P30 CA008748]; Center for Advanced Digestive Care (CADC) at Weill Cornell Medicine; NIH/NCI [CA195787-01]; Starr Cancer Consortium [I10-0095]; National Institute of General Medical Sciences of the National Institutes of Health [T32GM07739]; K22 Career Development Award from the NCI/NIH [CA 181280-01]	We thank Ashlesha Muley and Sukanya Goswami for technical assistance with animal colonies, Arun Unni and Miguel Foronda for critical reading of the manuscript, and other members of the Dow laboratory for advice and discussions. We thank Cameron Nowell, Research Facilities Manager, Monash Institute of Pharmaceutical Science, Melbourne, Australia, for the development of a computational script for exporting whole-slide scans. Whole-slide scans were performed in collaboration with Institute for Precision Medicine and Meyer Cancer Center. Microscopy was performed at the Weill Cornell Medicine Optical Microscopy Core Facility, and RNAseq was conducted at the Weill Cornell Medicine Genomics Core Facility. DNA FISH analysis was performed by the Memorial Sloan Kettering Cancer Center (MSKCC) Molecular Cytogenetics Core, with support from an NIH Cancer Center support grant (P30 CA008748). This work was supported by a pilot grant from the Center for Advanced Digestive Care (CADC) at Weill Cornell Medicine, and a project grant from the NIH/NCI (CA195787-01) and a project grant from the Starr Cancer Consortium (I10-0095). E.M.S. was supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health under Award Number T32GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program. L.E.D. was supported by a K22 Career Development Award from the NCI/NIH (CA 181280-01).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bin-Nun N, 2014, DEVELOPMENT, V141, P410, DOI 10.1242/dev.095984; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dow LE, 2015, CELL, V161, P1539, DOI 10.1016/j.cell.2015.05.033; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Hilkens J, 2017, GUT, V66, P1095, DOI 10.1136/gutjnl-2016-311606; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784                                                   ; Larraguibel J, 2015, MOL BIOL CELL, V26, P2375, DOI 10.1091/mbc.E14-12-1648; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madan B, 2016, ONCOGENE, V35, P2197, DOI 10.1038/onc.2015.280; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; O'Rourke K. P., 2016, BIO PROTOC, V6, pe1733; O'Rourke K. P., 2016, BIO PROTOC, V6, pe1732; Perna D, 2015, P NATL ACAD SCI USA, V112, pE536, DOI 10.1073/pnas.1418163112; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sekine S, 2016, J PATHOL, V239, P133, DOI 10.1002/path.4709; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Storm EE, 2016, NATURE, V529, P97, DOI 10.1038/nature16466; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Yeung TM, 2011, CELL MOL LIFE SCI, V68, P2513, DOI 10.1007/s00018-011-0687-5	42	1	1	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JUL 4	2017	8						1	12	15945	10.1038/ncomms15945				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FA1BV	WOS:000405174500001	28695896	gold			2018-01-05	
J	Gupta, SK; Shukla, P				Gupta, Sanjeev K.; Shukla, Pratyoosh			Sophisticated Cloning, Fermentation, and Purification Technologies for an Enhanced Therapeutic Protein Production: A Review	FRONTIERS IN PHARMACOLOGY			English	Review						monoclonal antibody (mAb); cloning; therapeutic protein; drug development; quality by design (QbD); gene editing	PROCESS DESIGN SPACE; HYDROPHOBIC INTERACTION CHROMATOGRAPHY; MONOCLONAL-ANTIBODY PRODUCTION; YEAST PICHIA-PASTORIS; ALCOHOL OXIDASE GENES; HAMSTER OVARY CELLS; ESCHERICHIA-COLI; FED-BATCH; A CHROMATOGRAPHY; BIOPHARMACEUTICAL PRODUCTION	The protein productions strategies are crucial towards the development of application based research and elucidating the novel purification strategies for industrial production. Currently, there are few innovative avenues are studies for cloning, upstream, and purification through efficient bioprocess development. Such strategies are beneficial for industries as well as proven to be vital for effectual therapeutic protein development. Though, these techniques are well documented, but, there is scope of addition to current knowledge with novel and new approaches and it will pave new avenues in production of recombinant microbial and non-microbial proteins including secondary metabolites. In this review, we have focussed on the recent development in clone selection, various modern fermentation and purification technologies and future directions in these emerging areas. Moreover, we have also highlighted notable perspectives and challenges involved in the bioengineering of such proteins, including quality by design, gene editing and pioneering ideas. The biopharmaceutical industries continue to shift towards more flexible, automated platforms and economical product development, which in turn can help in developing the cost effective processes and affordable drug development for a large community.	[Gupta, Sanjeev K.] Ipca Labs Ltd, Adv Biotech Lab, Bombay, Maharashtra, India; [Gupta, Sanjeev K.; Shukla, Pratyoosh] Maharshi Dayanand Univ, Dept Microbiol, Enzyme Technol & Prot Bioinformat Lab, Rohtak, Haryana, India	Shukla, P (reprint author), Maharshi Dayanand Univ, Dept Microbiol, Enzyme Technol & Prot Bioinformat Lab, Rohtak, Haryana, India.	pratyoosh.shukla@gmail.com					Abu-Absi SF, 2010, BIOTECHNOL BIOENG, V106, P894, DOI 10.1002/bit.22764; Ahamed T, 2007, J CHROMATOGR A, V1164, P181, DOI 10.1016/j.chroma.2007.07.010; Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5; Akesson M, 2001, CONTROL ENG PRACT, V9, P709, DOI 10.1016/S0967-0661(01)00020-X                                                   ; Amanullah A, 2010, BIOTECHNOL BIOENG, V106, P57, DOI 10.1002/bit.22664; Angarita M, 2015, J CHROMATOGR A, V1389, P85, DOI 10.1016/j.chroma.2015.02.046; Basu A, 2011, APPL MICROBIOL BIOT, V92, P241, DOI 10.1007/s00253-011-3513-y; Bhambure R, 2011, TRENDS BIOTECHNOL, V29, P127, DOI 10.1016/j.tibtech.2010.12.001; Bhuvanesh S, 2010, J IND MICROBIOL BIOT, V37, P1053, DOI 10.1007/s10295-010-0753-2; Birch JR, 2006, ADV DRUG DELIVER REV, V58, P671, DOI 10.1016/j.addr.2005.12.006; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bonham-Carter J., 2011, BIOPROCESS INT, V9; Butler M, 2012, APPL MICROBIOL BIOT, V96, P885, DOI 10.1007/s00253-012-4451-z; Challener CA, 2015, BIOPHARM INT, V28, P17; Chon JH, 2011, NEW BIOTECHNOL, V28, P458, DOI 10.1016/j.nbt.2011.03.015; Chung ME, 2017, BIOTECHNOL BIOENG, V114, P172, DOI 10.1002/bit.26056; Collins M., 2016, BIOPROCESS INT, V14, P30; Cost GJ, 2010, BIOTECHNOL BIOENG, V105, P330, DOI 10.1002/bit.22541; Costa AR, 2010, EUR J PHARM BIOPHARM, V74, P127, DOI 10.1016/j.ejpb.2009.10.002; Cramer SM, 2011, CURR OPIN CHEM ENG, V1, P27, DOI 10.1016/j.coche.2011.08.008; CREGG JM, 1985, MOL CELL BIOL, V5, P3376, DOI 10.1128/MCB.5.12.3376                                                           ; CREGG JM, 1989, MOL CELL BIOL, V9, P1316, DOI 10.1128/MCB.9.3.1316                                                            ; Cregg J. M., 2010, CURR PROTOC ESSENT L, V13, P1; Curran KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5002; Dalton AC, 2014, PROTEIN SCI, V23, P517, DOI 10.1002/pro.2439; De Jesus M, 2011, EUR J PHARM BIOPHARM, V78, P184, DOI 10.1016/j.ejpb.2011.01.005; del Val IJ, 2010, BIOTECHNOL PROGR, V26, P1505, DOI 10.1002/btpr.470; Dhanasekharan K., 2016, BIOPROCESS INT, V14, P32; Drioli E, 2011, J MEMBRANE SCI, V380, P1, DOI 10.1016/j.memsci.2011.06.043; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; ELLIS SB, 1985, MOL CELL BIOL, V5, P1111, DOI 10.1128/MCB.5.5.1111                                                            ; Elvin JG, 2013, INT J PHARMACEUT, V440, P83, DOI 10.1016/j.ijpharm.2011.12.039; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; Fakruddin M., 2013, ISRN BIOTECHNOL, V2013, DOI 10.5402/2013/590587; Fisher AC, 2011, APPL ENVIRON MICROB, V77, P871, DOI 10.1128/AEM.01901-10; Frohlich H, 2012, CHEM-ING-TECH, V84, P905, DOI 10.1002/cite.201200025; Gagnon P., 2010, BIOPROCESS INT, V8, P22; Gagnon P, 2012, J CHROMATOGR A, V1221, P57, DOI 10.1016/j.chroma.2011.10.034; Ghose S, 2006, J CHROMATOGR A, V1122, P144, DOI 10.1016/j.chroma.2006.04.083; Gottschalk U, 2009, PROCESS SCALE PURIFI; Grav LM, 2015, BIOTECHNOL J, V10, P1446, DOI 10.1002/biot.201500027; Green M.R., 2012, MOL CLONING LAB MANU; Gupta SK, 2016, CRIT REV BIOTECHNOL, V36, P1089, DOI 10.3109/07388551.2015.1084264; Gupta SK, 2017, CRIT REV MICROBIOL, V43, P31, DOI 10.3109/1040841X.2016.1150959; Gwinn W, 2006, PROTEIN EXPRES PURIF, V45, P30, DOI 10.1016/j.pep.2005.04.009; Harms J, 2008, BIOTECHNOL PROGR, V24, P655, DOI 10.1021/bp070338y; Hasslacher M, 1997, PROTEIN EXPRES PURIF, V11, P61, DOI 10.1006/prep.1997.0765; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.chromb.2006.09.030; Horvath B, 2010, MOL BIOTECHNOL, V45, P203, DOI 10.1007/s12033-010-9267-4; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Huang CJ, 2012, J IND MICROBIOL BIOT, V39, P383, DOI 10.1007/s10295-011-1082-9; Huang YM, 2010, BIOTECHNOL PROGR, V26, P1400, DOI 10.1002/btpr.436; Idiris A, 2010, APPL MICROBIOL BIOT, V86, P403, DOI 10.1007/s00253-010-2447-0; Inan M, 2001, J BIOSCI BIOENG, V92, P585, DOI 10.1263/jbb.92.585; Jackewitz A., 2008, BIOPROCESS INT, V6, P108; Jacquemart R, 2016, COMPUT STRUCT BIOTEC, V14, P309, DOI 10.1016/j.csbj.2016.06.007; Jain E, 2008, BIOTECHNOL ADV, V26, P46, DOI 10.1016/j.biotechadv.2007.09.004; Jana S, 2005, APPL MICROBIOL BIOT, V67, P289, DOI 10.1007/s00253-004-1814-0; Jayapal KR, 2007, CHEM ENG PROG, V103, P40; Jiang CP, 2010, BIOTECHNOL BIOENG, V107, P985, DOI 10.1002/bit.22894; Jin M, 2010, BIOTECHNOL BIOENG, V105, P306, DOI 10.1002/bit.22532; Kaltenbrunner O, 2016, BIOTECHNOL PROGR, V32, P938, DOI 10.1002/btpr.2291; Kelley B, 2007, BIOTECHNOL PROGR, V23, P995, DOI 10.1021/bp070117s; Kelley B, 2009, MABS, V1, P443, DOI 10.4161/mabs.1.5.9448                                                           ; Klutz S, 2015, J BIOTECHNOL, V213, P120, DOI [10.1016/j.jbiotec.2015.08.388, 10.1016/j.jbiotec.2015.06.388]; KOUTZ P, 1989, YEAST, V5, P167, DOI 10.1002/yea.320050306; Krivoruchko A, 2015, CURR OPIN BIOTECH, V35, P7, DOI 10.1016/j.copbio.2014.12.004; Kurtzman CP, 2009, J IND MICROBIOL BIOT, V36, P1435, DOI 10.1007/s10295-009-0638-4; Lain B, 2009, BIOPROCESS INT, V7, P26; Lain B., 2013, BIOPROCESS INT, V11, P29; Langer ES, 2014, ENG LIFE SCI, V14, P238, DOI 10.1002/elsc.201300090; Ledung E, 2009, J BIOTECHNOL, V141, P64, DOI 10.1016/j.jbiotec.2009.02.016; Lee CJ, 2009, BIOTECHNOL BIOENG, V102, P1107, DOI 10.1002/bit.22126; Levin M, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0150-z; Levine H. L., 2012, BIOPROCESS INT, V10; Levine H. L., 2013, BUS REV WEBINAR; Li F., 2010, PHARM SCI ENCY, V2, P466, DOI [10.4161/mabs.2.5.12720, DOI 10.4161/MABS.2.5.12720]; Lim J, 2011, BIOPHARM INT, V24, P54; Lim SF, 2006, METAB ENG, V8, P509, DOI 10.1016/j.ymben.2006.05.005; Liu HF, 2010, MABS-AUSTIN, V2, P480, DOI 10.4161/mabs.2.5.12645; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Loffelholz C, 2013, CHEM-ING-TECH, V85, P40, DOI 10.1002/cite.201200125; Low D, 2007, J CHROMATOGR B, V848, P48, DOI 10.1016/j.jchromb.2006.10.033; Mamat U., 2015, MICROB CELL FACT, V14, P1; Mane P, 2015, INT J CURR MICROBIOL, V4, P17; Martin-Moe S, 2011, J PHARM SCI-US, V100, P3031, DOI 10.1002/jps.22545; Michels DA, 2012, ELECTROPHORESIS, V33, P815, DOI 10.1002/elps.201100528; Minow B, 2014, ENG LIFE SCI, V14, P272, DOI 10.1002/elsc.201300130; Mori K, 2004, BIOTECHNOL BIOENG, V88, P901, DOI 10.1002/bit.20326; Morrison C., 2015, NAT BIOTECHNOL, V32, P129; Mothes B, 2016, BIOPROCESS INT, V14, P34; Muhl M., 2010, BIOPROCESS INT, P86; Nasab FP, 2013, APPL ENVIRON MICROB, V79, P997, DOI 10.1128/AEM.02817-12; Nema S., 2007, PROCESS CEM PHARM IN, V2, P427; Noh SM, 2013, CURR OPIN CHEM ENG, V2, P391, DOI 10.1016/j.coche.2013.08.002; Olempska-Beer ZS, 2006, REGUL TOXICOL PHARM, V45, P144, DOI 10.1016/j.yrtph.2006.05.001; PARDEE AB, 1959, J MOL BIOL, V1, P165, DOI 10.1016/S0022-2836(59)80045-0                                                   ; Pathak M, 2014, ELECTROPHORESIS, V35, P2163, DOI 10.1002/elps.201400055; Pegel A, 2011, BIOPROCESS INT, V9, P52; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085                                                   ; Pralong A, 2014, ENG LIFE SCI, V14, P244, DOI 10.1002/elsc.201400027; Prasad N. K., 2010, DOWNSTREAM PROCESS T; Rathore AS, 2013, J CHEM TECHNOL BIOT, V88, P1794, DOI 10.1002/jctb.4152; Rathore AS, 2009, TRENDS BIOTECHNOL, V27, P546, DOI 10.1016/j.tibtech.2009.06.006; RAZZELL WE, 1958, BIOCHIM BIOPHYS ACTA, V28, P562, DOI 10.1016/0006-3002(58)90519-5; Reclari M, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4874612; Robinson MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9072; ROETTGER BF, 1989, BIOTECHNOL ADV, V7, P15, DOI 10.1016/0734-9750(89)90901-4; Rose S., 2003, HDB IND CELL CULTURE; Royce J., 2014, BIOPROCESS INT, V12, P40; Salunkhe S. S., 2009, J MICROBIAL BIOCH TE, V1, DOI 10.4172/1948-5948.1000002; SAMBROOK J, 1989, MOL CLONING; Saraswat M., 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/312709; Savic N, 2016, TRANSL RES, V168, P15, DOI 10.1016/j.trsl.2015.09.008; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Schlegel S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-24; Schreffler J, 2015, BIOPROCESS INT, V13, P36; Seyis I, 2005, INT BIODETER BIODEGR, V55, P115, DOI 10.1016/j.ibiod.2004.09.001; Shimoni Y, 2013, BIOPROCESS INT, V11, P26; Shrivastava S, 2013, WORLD J MICROB BIOT, V29, P2407, DOI 10.1007/s11274-013-1409-y; Shukla AA, 2008, BIOTECHNOL PROGR, V24, P1115, DOI [10.1002/btpr.50, 10.1021/bp.50]; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Shukla AA, 2013, TRENDS BIOTECHNOL, V31, P147, DOI 10.1016/j.tibtech.2012.10.004; Shukla AA, 2010, TRENDS BIOTECHNOL, V28, P253, DOI 10.1016/j.tibtech.2010.02.001; Shuler M. L, 2002, BIOPROCESS ENG; Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Sockolosky JT, 2013, PROTEIN EXPRES PURIF, V87, P129, DOI 10.1016/j.pep.2012.11.002; Sommerfeld S, 2005, CHEM ENG PROCESS, V44, P1123, DOI 10.1016/j.cep.2005.03.006; Spadiut O, 2014, TRENDS BIOTECHNOL, V32, P54, DOI 10.1016/j.tibtech.2013.10.002; Strube J, 2014, CHEM-ING-TECH, V86, P687, DOI 10.1002/cite.201300081; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Szymanski CM, 2003, TRENDS MICROBIOL, V11, P233, DOI 10.1016/S0966-842X(03)00079-9; Tang HT, 2015, BIOTECHNOL BIOENG, V112, P1872, DOI 10.1002/bit.25596; Tarrant RDR, 2012, BIOTECHNOL PROGR, V28, P1037, DOI 10.1002/btpr.1581; Tomic S, 2015, SEP PURIF TECHNOL, V141, P269, DOI 10.1016/j.seppur.2014.12.002; Tscheliessnig AL, 2013, BIOTECHNOL J, V8, P655, DOI 10.1002/biot.201200018; TSCHOPP JF, 1987, NUCLEIC ACIDS RES, V15, P3859, DOI 10.1093/nar/15.9.3859                                                           ; Tyo KEJ, 2014, APPL MICROBIOL BIOT, V98, P7149, DOI 10.1007/s00253-014-5783-7; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wang CZ, 2008, BIOTECHNOL PROGR, V24, P209, DOI 10.1021/bp070263y; Wang F, 2014, APPL MICROBIOL BIOT, V98, P7491, DOI 10.1007/s00253-014-5710-y; Warikoo V, 2012, BIOTECHNOL BIOENG, V109, P3018, DOI 10.1002/bit.24584; Wells EA, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600105; Whitford WG, 2010, BIOPROCESS INT, V8, P34; Wildt S, 2005, NAT REV MICROBIOL, V3, P119, DOI 10.1038/nrmicro1087; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yang ST, 2013, PHARM BIOPROCESS, V1, P133, DOI 10.4155/PBP.13.15; YANOFSKY C, 1959, VIROLOGY, V8, P425, DOI 10.1016/0042-6822(59)90046-7; Zerbs S, 2014, METHOD ENZYMOL, V536, P117, DOI 10.1016/B978-0-12-420070-8.00011-8; Zhao M., 2015, POSTER IBC BIOPHARMA; Zhu JW, 2012, BIOTECHNOL ADV, V30, P1158, DOI 10.1016/j.biotechadv.2011.08.022	154	0	0	30	30	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	JUL 4	2017	8								419	10.3389/fphar.2017.00419				17	Pharmacology & Pharmacy	Pharmacology & Pharmacy	EZ4IO	WOS:000404677000001	28725194				2018-01-05	
J	Mehboob-ur-Rahman; Khan, AQ; Rahmat, Z; Iqbal, MA; Zafar, Y				Mehboob-ur-Rahman; Khan, Ali Q.; Rahmat, Zainab; Iqbal, Muhammad A.; Zafar, Yusuf			Genetics and Genomics of Cotton Leaf Curl Disease, Its Viral Causal Agents and Whitefly Vector: A Way Forward to Sustain Cotton Fiber Security	FRONTIERS IN PLANT SCIENCE			English	Review						begomoviruses; CLCuD; genome editing; introgression breeding; marker-assisted breeding	GOSSYPIUM-HIRSUTUM L.; BEMISIA-TABACI; PLANT-VIRUSES; INSECTICIDE RESISTANCE; TRANSCRIPTOME ANALYSIS; MULTAN BETASATELLITE; RNA INTERFERENCE; IMMUNE-SYSTEM; KOKHRAN-VIRUS; CRUMPLE-VIRUS	Cotton leaf curl disease (CLCuD) after its first epidemic in 1912 in Nigeria, has spread to different cotton growing countries including United States, Pakistan, India, and China. The disease is of viral origin-transmitted by the whitefly Bemisia tabaci, which is difficult to control because of the prevalence of multiple virulent viral strains or related species. The problem is further complicated as the CLCuD causing virus complex has a higher recombination rate. The availability of alternate host crops like tomato, okra, etc., and practicing mixed type farming system have further exaggerated the situation by adding synergy to the evolution of new viral strains and vectors. Efforts to control this disease using host plant resistance remained successful using two gene based-resistance that was broken by the evolution of new resistance breaking strain called Burewala virus. Development of transgenic cotton using both pathogen and non-pathogenic derived approaches are in progress. In future, screening for new forms of host resistance, use of DNA markers for the rapid incorporation of resistance into adapted cultivars overlaid with transgenics and using genome editing by CRISPR/Cas system would be instrumental in adding multiple layers of defense to control the disease-thus cotton fiber production will be sustained.	[Mehboob-ur-Rahman; Khan, Ali Q.; Rahmat, Zainab; Iqbal, Muhammad A.] Natl Inst Biotechnol & Genet Engn, Faisalabad, Pakistan; [Zafar, Yusuf] Pakistan Agr Res Council, Islamabad, Pakistan	Mehboob-ur-Rahman (reprint author), Natl Inst Biotechnol & Genet Engn, Faisalabad, Pakistan.	mehboob_pbd@yahoo.com			United States Department of Agriculture, Agricultural Research Service [58-6402-0-178F, ICARDA-ID-1198-5, ICARDA-ID-1198-6]	This work is supported by the United States Department of Agriculture, Agricultural Research Service; under agreement No. 58-6402-0-178F through two subprojects entitled "Germplasm Evaluation (ICARDA-ID-1198-5 and Gene Mapping (ICARDA-ID-1198-6)." Any opinions, findings, conclusions, or recommendations expressed in this manuscript are those of the author(s) and do not necessarily reflect the views of the United States Department of Agriculture.	Abbas A, 2015, TURK J BOT, V39, P1033, DOI 10.3906/bot-1505-22; Adkins S, 2009, PLANT DIS, V93, DOI 10.1094/PDIS-93-3-0320B; Ahmad S, 2011, GENET MOL RES, V10, P2404, DOI 10.4238/2011.October.7.2; Ahuja SL, 2007, J HERED, V98, P79, DOI 10.1093/jhered/esl049; Akad F, 2008, PLANT DIS, V92, P648, DOI 10.1094/PDIS-92-4-0648C; Akad F, 2007, ARCH VIROL, V152, P1323, DOI 10.1007/s00705-007-0942-0; Akhtar S, 2014, VIRUSES-BASEL, V6, P2186, DOI 10.3390/v6052186; Ali I, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-231; Ali Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0799-6; Amrao L, 2010, VIRUS RES, V153, P161, DOI 10.1016/j.virusres.2010.07.003; Amudha J, 2011, CURR SCI INDIA, V101, P300; Amudha J., 2010, ELECT J PLANT BREED, V4, P360; Arimura GI, 2011, INT J MOL SCI, V12, P3723, DOI 10.3390/ijms12063723; Arshad M, 2009, J PLANT REGIST, V3, P231, DOI 10.3198/jpr2009.04.0169crc; Ashfaq M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104485; Aslam M., 1999, PAK J BIOL SCI, V2, P124, DOI 10.3923/pjbs.1999.124.126; Azhar MT, 2011, AUSTRALAS PLANT DIS, V6, P7, DOI 10.1007/s13314-011-0003-0; BACHMAIR A, 1990, EMBO J, V9, P4543; Baltes NJ, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.145; Baluch Z. A., 2007, P WORLD COTT RES C 4, V4; Basit M, 2013, J ECON ENTOMOL, V106, P1414, DOI 10.1603/EC12414; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Briddon RW, 2014, VIRUS RES, V186, P114, DOI 10.1016/j.virusres.2013.12.008; Briddon RW, 2002, MOL BIOTECHNOL, V20, P315, DOI 10.1385/MB:20:3:315; Briddon RW, 2000, VIRUS RES, V71, P151, DOI 10.1016/S0168-1702(00)00195-7; Briddon RW, 2001, VIROLOGY, V285, P234, DOI 10.1006/viro.2001.0949; Brown J. K., 1992, P275; Brown J. K., 2002, PLANT VIRUS MYCOPLAS; Brown J. K., 2001, COMPENDIUM COTTON DI, P52; Cai JH, 2010, PLANT PATHOL, V59, P794, DOI 10.1111/j.1365-3059.2010.02266.x; Carvalho MG, 2017, ENTOMOL EXP APPL, V162, P86, DOI 10.1111/eea.12534; Castellano MM, 1999, J MOL BIOL, V290, P639, DOI 10.1006/jmbi.1999.2916; Chaparro-Garcia A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0829-4; Chellappan P, 2004, PLANT MOL BIOL, V56, P601, DOI 10.1007/s11103-004-0147-9; COHEN S, 1988, PHYTOPARASITICA, V16, P259, DOI 10.1007/BF02979527; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cook D, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10024; Cuthbertson AGS, 2011, INSECT SCI, V18, P1, DOI 10.1111/j.1744-7917.2010.01383.x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; DICKSON RC, 1954, PHYTOPATHOLOGY, V44, P479; Dubey NK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-241; Edelbaum D, 2009, ARCH VIROL, V154, P399, DOI 10.1007/s00705-009-0317-9; Eini O, 2009, MOL PLANT MICROBE IN, V22, P737, DOI 10.1094/MPMI-22-6-0737; Ellsworth P., 2006, WHITEFLY MANAGEMENT; Follett PA, 2017, ENTOMOL EXP APPL, V162, P1, DOI 10.1111/eea.12524; FONTES EPB, 1992, PLANT CELL, V4, P597; Furstenberg-Hagg J, 2013, INT J MOL SCI, V14, P10242, DOI 10.3390/ijms140510242; Gatehouse JA, 2002, NEW PHYTOL, V156, P145, DOI 10.1046/j.1469-8137.2002.00519.x; Ghanim M, 2014, VIRUS RES, V186, P47, DOI 10.1016/j.virusres.2014.01.022; Goldbach R, 2003, VIRUS RES, V92, P207, DOI 10.1016/S0168-1702(02)00353-2; Golding F. D., 1930, EMPIRE COTTON GROWIN, V7, P120; Gorovits R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070280; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Gupta M, 2012, PLANT BIOTECHNOL J, V10, P783, DOI 10.1111/j.1467-7652.2012.00695.x; Haible D, 2006, J VIROL METHODS, V135, P9, DOI 10.1016/j.jviromet.2006.01.017; Hameed U, 2014, PLANT DIS, V98, P1447, DOI 10.1094/PDIS-04-14-0345-PDN; Hashmi JA, 2011, VIRUS GENES, V42, P286, DOI 10.1007/s11262-011-0569-9; Hollis P., 2015, COTTON GROWERS SAW T; Horowitz AR, 2014, PEST MANAG SCI, V70, P1568, DOI 10.1002/ps.3752; Huseth AS, 2016, PEST MANAG SCI, V72, P1934, DOI 10.1002/ps.4232; Hussain T., 1991, Pakistan Journal of Phytopathology, V3, P57; HUTCHINSON JB, 1950, J GENET, V50, P100, DOI 10.1007/BF02986798; IDRIS A M, 1990, Mededelingen van de Faculteit Landbouwwetenschappen Universiteit Gent, V55, P263; Idris AM, 2011, J GEN VIROL, V92, P706, DOI 10.1099/vir.0.025288-0; Idris AM, 2002, VIRUS GENES, V24, P249, DOI 10.1023/A:1015380600089; Incubar M., 2008, ANNU REV ENTOMOL, V53, P431, DOI [10.1146/annurev.ento.53.032107.122456, DOI 10.1146/ANNUREV.ENTO.53.032107.122456]; Inoue-Nagata AK, 2004, J VIROL METHODS, V116, P209, DOI 10.1016/j.jviromet.2003.11.015; Iqbal MJ, 1997, THEOR APPL GENET, V94, P139, DOI 10.1007/s001220050392; Iqbal Z, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00475; Iqbal Z, 2012, VIRUS RES, V169, P107, DOI 10.1016/j.virusres.2012.07.016; Javaid S, 2016, SCI REP-UK, V6, DOI 10.1038/srep34706; Ji X, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.144, 10.1038/nplants.2015.144]; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Jones GH, 1926, ANN BOT-LONDON, V40, P759, DOI 10.1093/oxfordjournals.aob.a090049                                              ; Kafkafi U. G., 2001, HDB POTASSIUM CHLORI, P220; Khalid Annum, 2017, Front Microbiol, V8, P43, DOI 10.3389/fmicb.2017.00043; Khan Z, 2017, PLANT MOL BIOL REP, V35, P1, DOI 10.1007/s11105-016-0997-8; KIRKPATRICK T. W., 1931, BULL ENT RES [LONDON], V22, P323; Kliot A, 2013, VIRUSES-BASEL, V5, P1516, DOI 10.3390/v5061516; Knight IA, 2017, ENTOMOL EXP APPL, V162, P19, DOI 10.1111/eea.12523; KNIGHT RL, 1948, J GENET, V48, P370, DOI 10.1007/BF02986637                                                              ; Legg JP, 2014, VIRUS RES, V186, P61, DOI 10.1016/j.virusres.2013.11.018; Li JY, 2016, PLANT BIOTECHNOL J, V14, P1956, DOI 10.1111/pbi.12554; Lomonossoff G. P., 1995, PLANT VIRUSES PHARM, P7; Malik HJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38469; Mao YB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13925; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Morin S, 2000, VIROLOGY, V276, P404, DOI 10.1006/viro.2000.0549; Moulherat Christophe, 2002, Journal of Archaeological Science, V29, P1393, DOI 10.1006/jasc.2001.0779; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Mumtaz AS, 2010, PAK J BOT, V42, P3949; Narula AM, 1999, J COTTON RES DEV, V13, P129; Nazeer W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111861; Niaz A., 2005, THESIS QUAID I AZAM; Nour M. A., 1964, EMPIRE COTTON GROWIN, V41, P27; Polston JE, 2014, PEST MANAG SCI, V70, P1547, DOI 10.1002/ps.3738; Pooggin M, 2003, NAT BIOTECHNOL, V21, P131, DOI 10.1038/nbt0203-131b; Rafiq Muhammad, 2008, International Journal of Agriculture and Biology, V10, P577; Rahman M, 2005, PLANT PATHOL, V54, P764, DOI 10.1111/j.1365-3059.2005.01280.x; Rahman M, 2002, CROP SCI, V42, P2137, DOI 10.2135/cropsci2002.2137                                                        ; Rahman M, 2007, J PLANT REGIST, V1, P51, DOI DOI 10.3198/JPR2006.12.0778CRG; Rahman M., 2014, P INT COTT GEN IN C; Rahman M, 2012, J PLANT REGIST, V6, P342, DOI DOI 10.3198/JPR2011.09.0510CRG; Rahman M., 2014, WORLD COTTON GERMPLA, P138, DOI [10.5772/58620.ch6, DOI 10.5772/58620.CH6]; Rajagopalan PA, 2012, ARCH VIROL, V157, P855, DOI 10.1007/s00705-012-1225-y; Rana VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042168; Reddy RVC, 2005, PLANT PATHOL, V54, P570, DOI 10.1111/j.1365-3059.2005.01214.x; Roditakis E, 2017, PEST MANAG SCI, V73, P1574, DOI 10.1002/ps.4577; Saleem H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151161; Sanjaya V, 2005, PLANT CELL TISS ORG, V81, P55; Sartaj S., 2014, SAUDI J BIOL SCI, V21, P626, DOI [10.1016/j.sjbs.2014.11.006, DOI 10.1016/J.SJBS.2014.11.006]; Sarwar M, 2016, PAK J ZOOL, V48, P131; Saunders K, 2000, P NATL ACAD SCI USA, V97, P6890, DOI 10.1073/pnas.97.12.6890; Sera T, 2002, BIOCHEMISTRY-US, V41, P7074, DOI 10.1021/bi020095c; Shukla AK, 2016, NAT BIOTECHNOL, V34, P1046, DOI 10.1038/nbt.3665; Singh D., 2002, J COTTON RES, V16, P40; Smalling KL, 2013, MAR POLLUT BULL, V73, P144, DOI 10.1016/j.marpolbul.2013.05.028; Sohrab SS, 2016, SAUDI J BIOL SCI, V23, P358, DOI 10.1016/j.sjbs.2014.11.013; Stewart SD, 2013, J COTTON SCI, V17, P263; Tenllado F, 2004, VIRUS RES, V102, P85, DOI 10.1016/j.virusres.2004.01.019; Vanderschuren H, 2007, PLANT BIOTECHNOL J, V5, P207, DOI 10.1111/j.1467-7652.2006.00217.x; Vyas M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168921; Wang JY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01162; Wang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-529; Williams M. R., 2014, P BELTW COTT C, P494; WILSON FD, 1991, J HERED, V82, P508, DOI 10.1093/oxfordjournals.jhered.a111140                                           ; Xie Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-178; Yasmeen A, 2016, MOL BIOTECHNOL, V58, P807, DOI 10.1007/s12033-016-9980-8; Ye XD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-370; Yuan LZ, 2012, CROP PROT, V31, P67, DOI 10.1016/j.cropro.2011.09.017; Zaidi SSEA, 2017, TRENDS PLANT SCI, V22, P6, DOI 10.1016/j.tplants.2016.11.005; Zaidi SSEA, 2016, TRENDS PLANT SCI, V21, P279, DOI 10.1016/j.tplants.2016.01.023; Zhu DT, 2016, INSECT SCI, V23, P531, DOI 10.1111/1744-7917.12367	133	0	0	13	13	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	JUL 4	2017	8								1157	10.3389/fpls.2017.01157				14	Plant Sciences	Plant Sciences	EZ4WI	WOS:000404712800001		gold			2018-01-05	
J	Cao, SL; He, Y; Hao, CF; Xu, Y; Zhang, HC; Wang, CF; Liu, HQ; Xu, JR				Cao, Shulin; He, Yi; Hao, Chaofeng; Xu, Yan; Zhang, Hongchang; Wang, Chenfang; Liu, Huiquan; Xu, Jin-Rong			RNA editing of the AMD1 gene is important for ascus maturation and ascospore discharge in Fusarium graminearum	SCIENTIFIC REPORTS			English	Article							GIBBERELLA-ZEAE; PATHOGENESIS; KINASE; MORPHOGENESIS; INFECTION; FUNGI; WHEAT; LOCALIZATION; VIRULENCE; SEQUENCE	Ascospores are the primary inoculum in the wheat scab fungus Fusarium graminearum that was recently shown to have sexual stage-specific A-to-I RNA editing. One of the genes with premature-stop-codons requiring A-to-I editing to encode full-length functional proteins is AMD1 that encodes a protein with a major facilitator superfamily (MFS) domain. Here, we characterized the functions of AMD1 and its UAG to UGG editing event. The amd1 deletion mutant was normal in growth and conidiation but defective in ascospore discharge due to the premature breakdown of its ascus wall in older perithecia, which is consistent with the specific expression of AMD1 at later stages of sexual development. Expression of the wild-type or edited allele of AMD1 but not un-editable allele rescued the defects of amd1 in ascospore discharge. Furthermore, Amd1-GFP localized to the ascus membrane and Amd1 orthologs are only present in ascocarp-forming fungi that physically discharge ascospores. Interestingly, deletion of AMD1 results in the up-regulation of a number of genes related to transporter activity and membrane functions. Overall, these results indicated that Amd1 may play a critical role in maintaining ascus wall integrity during ascus maturation, and A-to-I editing of its transcripts is important for ascospore discharge in F. graminearum.	[Cao, Shulin; Hao, Chaofeng; Xu, Yan; Wang, Chenfang; Liu, Huiquan; Xu, Jin-Rong] Northwest A&F Univ, Coll Plant Protect, Purdue NWAFU Joint Res Ctr, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [He, Yi; Zhang, Hongchang] Northwest A&F Univ, Coll Life Sci, Yangling, Peoples R China; [Xu, Jin-Rong] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Liu, HQ; Xu, JR (reprint author), Northwest A&F Univ, Coll Plant Protect, Purdue NWAFU Joint Res Ctr, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.; Xu, JR (reprint author), Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA.	liuhuiquan@nwsuaf.edu.cn; jinrong@purdue.edu		Liu, Huiquan/0000-0002-4723-845X	US Wheat and Barley Scab Initiative; National Science Fund for Excellent Young Scholars [31622045]	We thank Chaohui Li and Dr. Qinhu Wang for assistance with drawing ascocarp diagrams and GO enrichment figure. We also thank Dr. Cong Jiang for fruitful discussions. This work was supported by grants from the US Wheat and Barley Scab Initiative and National Science Fund for Excellent Young Scholars (no. 31622045).	Bai GH, 2002, MYCOPATHOLOGIA, V153, P91, DOI 10.1023/A:1014419323550; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bennett RJ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.FUNK-0005-2016; Bruno KS, 2004, EUKARYOT CELL, V3, P1525, DOI 10.1128/EC.3.6.1525-1532.2004; Cao SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22333; Cavinder B., 2012, JOVE-J VIS EXP, V61, pe3895, DOI DOI 10.3791/3895:; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Dimont E, 2015, BIOINFORMATICS, V31, P2589, DOI 10.1093/bioinformatics/btv209; Ding SL, 2009, EUKARYOT CELL, V8, P867, DOI 10.1128/EC.00048-09; Gao XL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005973; Geiser DM, 2006, MYCOLOGIA, V98, P1053, DOI 10.3852/mycologia.98.6.1053                                                     ; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Howlett B. J., 2012, PLOS PATHOG, V8; Jiang C, 2016, ENVIRON MICROBIOL, V18, P3689, DOI 10.1111/1462-2920.13279; Jiang C, 2015, ENVIRON MICROBIOL, V17, P1245, DOI 10.1111/1462-2920.12561; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/nmeth.3317, 10.1038/NMETH.3317]; Kim HK, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005486; Kim HK, 2012, FEMS MICROBIOL LETT, V337, P89, DOI 10.1111/1574-6968.12012; King R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1756-1; Li CH, 2015, MOL MICROBIOL, V98, P770, DOI 10.1111/mmi.13157; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu HQ, 2016, GENOME RES, V26, P499, DOI 10.1101/gr.199877.115; Liu HQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004913; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo YP, 2014, NEW PHYTOL, V204, P943, DOI 10.1111/nph.12953; Lysoe E, 2011, MOL PLANT MICROBE IN, V24, P995, DOI 10.1094/MPMI-02-11-0038; Min K, 2010, EUKARYOT CELL, V9, P1495, DOI 10.1128/EC.00083-10; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Read ND, 1996, MYCOL RES, V100, P1281, DOI 10.1016/S0953-7562(96)80057-8                                                   ; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; Son H, 2013, MICROBIOL-SGM, V159, P1077, DOI 10.1099/mic.0.064287-0; Son H, 2012, MICROBIOL RES, V167, P608, DOI 10.1016/j.micres.2012.04.001; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Tassan JP, 2004, BIOL CELL, V96, P193, DOI 10.1016/j.biolcel.2003.10.009; Trail F, 2005, FUNGAL GENET BIOL, V42, P528, DOI 10.1016/j.fgb.2005.03.008; Trail F, 2002, MYCOLOGIA, V94, P181, DOI 10.2307/3761794; Trail F, 2000, MYCOLOGIA, V92, P130, DOI 10.2307/3761457; Wang CF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002460; Yun YZ, 2015, NEW PHYTOL, V207, P119, DOI 10.1111/nph.13374; Zhao ZT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06746; Zheng Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131623; Zhou XY, 2011, METHODS MOL BIOL, V722, P199, DOI 10.1007/978-1-61779-040-9_15; Zhou XY, 2010, FUNGAL GENET BIOL, V47, P143, DOI 10.1016/j.fgb.2009.11.001	44	0	0	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 4	2017	7								4617	10.1038/s41598-017-04960-7				11	Multidisciplinary Sciences	Science & Technology - Other Topics	EZ4CI	WOS:000404658300001	28676631	gold			2018-01-05	
J	Leisegang, MS; Fork, C; Josipovic, I; Richter, FM; Preussner, J; Hu, J; Miller, MJ; Epah, J; Hofmann, P; Gunther, S; Moll, F; Valasarajan, C; Heidler, J; Ponomareva, Y; Freiman, TM; Maegdefessel, L; Plate, KH; Mittelbronn, M; Uchida, S; Kunne, C; Stellos, K; Schermuly, RT; Weissmann, N; Devraj, K; Wittig, I; Boon, RA; Dimmeler, S; Pullamsetti, SS; Looso, M; Miller, FJ; Brandes, RP				Leisegang, Matthias S.; Fork, Christian; Josipovic, Ivana; Richter, Florian Martin; Preussner, Jens; Hu, Jiong; Miller, Matthew J.; Epah, Jeremy; Hofmann, Patrick; Guenther, Stefan; Moll, Franziska; Valasarajan, Chanil; Heidler, Juliana; Ponomareva, Yuliya; Freiman, Thomas M.; Maegdefessel, Lars; Plate, Karl H.; Mittelbronn, Michel; Uchida, Shizuka; Kuenne, Carsten; Stellos, Konstantinos; Schermuly, Ralph T.; Weissmann, Norbert; Devraj, Kavi; Wittig, Ilka; Boon, Reinier A.; Dimmeler, Stefanie; Pullamsetti, Soni Savai; Looso, Mario; Miller, Francis J., Jr.; Brandes, Ralf P.			Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function	CIRCULATION			English	Article						epigenomics; glioblastoma; hypertension,pulmonary; neovascularization; physiologic; RNA, long noncoding	CHROMATIN REMODELING COMPLEX; PULMONARY-HYPERTENSION; VASCULAR DEVELOPMENT; EPIGENETIC REGULATION; ILLUMINA MICROARRAY; BINDING PROTEINS; COUP-TFII; IN-VIVO; EXPRESSION; BRG1	BACKGROUND: The angiogenic function of endothelial cells is regulated by numerous mechanisms, but the impact of long noncoding RNAs (lncRNAs) has hardly been studied. We set out to identify novel and functionally important endothelial lncRNAs. METHODS: Epigenetically controlled lncRNAs in human umbilical vein endothelial cells were searched by exon-array analysis after knockdown of the histone demethylase JARID1B. Molecular mechanisms were investigated by RNA pulldown and immunoprecipitation, mass spectrometry, microarray, several knockdown approaches, CRISPR-Cas9, assay for transposase-accessible chromatin sequencing, and chromatin immunoprecipitation in human umbilical vein endothelial cells. Patient samples from lung and tumors were studied for MANTIS expression. RESULTS: A search for epigenetically controlled endothelial lncRNAs yielded lncRNA n342419, here termed MANTIS, as the most strongly regulated lncRNA. Controlled by the histone demethylase JARID1B, MANTIS was downregulated in patients with idiopathic pulmonary arterial hypertension and in rats treated with monocrotaline, whereas it was upregulated in carotid arteries of Macaca fascicularis subjected to atherosclerosis regression diet, and in endothelial cells isolated from human glioblastoma patients. CRISPR/Cas9-mediated deletion or silencing of MANTIS with small interfering RNAs or GapmeRs inhibited angiogenic sprouting and alignment of endothelial cells in response to shear stress. Mechanistically, the nuclear-localized MANTIS lncRNA interacted with BRG1, the catalytic subunit of the switch/sucrose nonfermentable chromatin-remodeling complex. This interaction was required for nucleosome remodeling by keeping the ATPase function of BRG1 active. Thereby, the transcription of key endothelial genes such as SOX18, SMAD6, and COUP-TFII was regulated by ensuring efficient RNA polymerase II machinery binding. CONCLUSION: MANTIS is a differentially regulated novel lncRNA facilitating endothelial angiogenic function.	[Leisegang, Matthias S.; Fork, Christian; Josipovic, Ivana; Miller, Matthew J.; Epah, Jeremy; Moll, Franziska; Brandes, Ralf P.] Goethe Univ, Inst Cardiovasc Physiol, Frankfurt, Germany; [Richter, Florian Martin; Heidler, Juliana; Wittig, Ilka] Goethe Univ, Fac Med, Funct Prote, Core Unit SFB 815, Frankfurt, Germany; [Preussner, Jens; Guenther, Stefan; Kuenne, Carsten; Looso, Mario] Max Planck Inst Heart & Lung Res, ECCPS Bioinformat & Sequencing Facil, Bad Nauheim, Germany; [Hu, Jiong] Goethe Univ, Inst Vasc Signalling, Frankfurt, Germany; [Hofmann, Patrick; Ponomareva, Yuliya; Uchida, Shizuka; Stellos, Konstantinos; Boon, Reinier A.; Dimmeler, Stefanie] Goethe Univ, Inst Cardiovasc Regenerat, Frankfurt, Germany; [Freiman, Thomas M.] Goethe Univ, Dept Neurosurg, Frankfurt, Germany; [Maegdefessel, Lars] Tech Univ Munich, Dept Vasc & Endovasc Surg, Klinikum Rechts Isar, Munich, Germany; [Plate, Karl H.; Mittelbronn, Michel; Devraj, Kavi] Goethe Univ, Inst Neurol, Edinger Inst, Frankfurt, Germany; [Mittelbronn, Michel] Luxembourg Ctr Neuropathol LCNP, Luxembourg, Luxembourg; [Mittelbronn, Michel] Lab Natl Sante, Dudelange, Luxembourg; [Mittelbronn, Michel] Univ Luxembourg, LCSB, Esch Sur Alzette, Luxembourg; [Mittelbronn, Michel] LIH, Dept Oncol, NORLUX Neurooncol Lab, Luxembourg, Luxembourg; [Uchida, Shizuka] Univ Louisville, Cardiovasc Innovat Inst, Louisville, KY 40292 USA; [Schermuly, Ralph T.; Weissmann, Norbert; Pullamsetti, Soni Savai] Justus Liebig Univ, Dept Internal Med, German Ctr Lung Res DZL, Giessen, Germany; [Devraj, Kavi] Goethe Univ, Inst Gen Pharmacol & Toxicol, Pharmazentrum Frankfurt, Frankfurt, Germany; [Valasarajan, Chanil; Pullamsetti, Soni Savai] Max Planck Inst Heart & Lung Res, German Ctr Lung Res DZL, Dept Lung Dev & Remodeling, Bad Nauheim, Germany; [Miller, Francis J., Jr.] Duke Univ, Dept Med, Durham, NC USA; [Miller, Francis J., Jr.] Durham VA Med Ctr, Durham, NC USA; [Leisegang, Matthias S.; Fork, Christian; Josipovic, Ivana; Hu, Jiong; Epah, Jeremy; Hofmann, Patrick; Moll, Franziska; Ponomareva, Yuliya; Plate, Karl H.; Stellos, Konstantinos; Wittig, Ilka; Boon, Reinier A.; Dimmeler, Stefanie; Brandes, Ralf P.] German Ctr Cardiovasc Res DZHK, Partner Site RheinMain, Frankfurt, Germany	Brandes, RP (reprint author), Goethe Univ, Fachbereich Med, Inst Kardiovaskulare Physiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	brandes@vrc.uni-frankfurt.de	Boon, Reinier/E-8423-2011; Leisegang, Matthias/P-6006-2017	Boon, Reinier/0000-0001-7944-9748; Leisegang, Matthias/0000-0002-6084-6484; Looso, Mario/0000-0003-1495-9530; Dimmeler, Stefanie/0000-0002-1045-2436; Stellos, Konstantinos/0000-0002-0194-0825; Devraj, Kavi/0000-0002-5005-3413; Pullamsetti, Soni/0000-0003-0440-8831; Uchida, Shizuka/0000-0003-4787-8067; Hu, Jiong/0000-0001-8266-0886; Schermuly, Ralph/0000-0002-5167-6970	German Research Foundation [DFG SFB 834 TP A1, TP B9, SFB 1039 TP A1, SFB 815 TP Z1, EX147]; German Center of Cardiovascular Research (DZHK); Goethe-University	This work was supported by the German Research Foundation (DFG SFB 834 TP A1, TP B9, and SFB 1039 TP A1, SFB 815 TP Z1, EX147 "ECCPS"), the German Center of Cardiovascular Research (DZHK), and Goethe-University.	Albert M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003461; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2005, GENE DEV, V19, P2849, DOI 10.1101/gad.1364105; Cajigas I, 2015, DEVELOPMENT, V142, P2641, DOI 10.1242/dev.126318; Calviello L, 2016, NAT METHODS, V13, P165, DOI [10.1038/NMETH.3688, 10.1038/nmeth.3688]; Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4; Chen DW, 2013, CARDIOVASC RES, V100, P363, DOI 10.1093/cvr/cvt214; Chereji RV, 2016, NUCLEIC ACIDS RES, V44, P1036, DOI 10.1093/nar/gkv978; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Curtis CD, 2012, MOL CELL BIOL, V32, P1312, DOI 10.1128/MCB.06222-11; Davis RB, 2013, DEVELOPMENT, V140, P1272, DOI 10.1242/dev.087379; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Edelstein LC, 2005, J BIOL CHEM, V280, P11192, DOI 10.1074/jbc.M412997200; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Fan HY, 2005, MOL CELL, V17, P805, DOI 10.1016/j.molcel.2005.02.024; Fish JE, 2010, J BIOL CHEM, V285, P810, DOI 10.1074/jbc.M109.067868; Fontijn RD, 2014, STEM CELL RES, V13, P367, DOI 10.1016/j.scr.2014.09.004; Fork C, 2015, ARTERIOSCL THROM VAS, V35, P1645, DOI 10.1161/ATVBAHA.115.305561; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Gellert P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks877; Gomez-Arroyo JG, 2012, AM J PHYSIOL-LUNG C, V302, pL363, DOI 10.1152/ajplung.00212.2011; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; Gu LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146645; Gurnik S, 2016, ACTA NEUROPATHOL, V131, P753, DOI 10.1007/s00401-016-1551-3; Han D, 2008, DEV BIOL, V315, P136, DOI 10.1016/j.ydbio.2007.12.024; Han P, 2014, NATURE, V514, P102, DOI 10.1038/nature13596; Harmanci A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0474-3; Hathaway CA, 2002, CIRC RES, V90, P277, DOI 10.1161/hh0302.104724; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Josipovic I, 2016, ACTA PHYSIOL, V218, P13, DOI 10.1111/apha.12700; Kidder BL, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r32; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341                                                          ; Kramer K, 2014, NAT METHODS, V11, P1064, DOI [10.1038/nmeth.3092, 10.1038/NMETH.3092]; Laib AM, 2009, NAT PROTOC, V4, P1202, DOI 10.1038/nprot.2009.96; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Marino F, 2014, ANALYST, V139, P6520, DOI 10.1039/c4an01568a; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; Mattick JS, 2015, NAT STRUCT MOL BIOL, V22, P5, DOI 10.1038/nsmb.2942; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Meyer CA, 2014, NAT REV GENET, V15, P709, DOI 10.1038/nrg3788; Mysliwiec MR, 2011, J BIOL CHEM, V286, P17193, DOI 10.1074/jbc.M110.205146; Nakagawa S, 2014, BBA-GENE REGUL MECH, V1839, P215, DOI 10.1016/j.bbagrm.2013.10.009; Neri F, 2015, NUCLEIC ACIDS RES, V43, P6814, DOI 10.1093/nar/gkv392; Nilsen TW, 2012, COLD SPRING HARB PRO, V12, P1302, DOI [10.1101/pdb.prot072322, DOI 10.1101/PDB.PROT072322]; Park C, 2013, CIRC RES, V112, P1380, DOI 10.1161/CIRCRESAHA.113.301078; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Pullamsetti SS, 2012, ARTERIOSCL THROM VAS, V32, P1354, DOI 10.1161/ATVBAHA.112.248500; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Uchida S, 2015, CIRC RES, V116, P737, DOI 10.1161/CIRCRESAHA.116.302521; Varga-Weisz PD, 2014, NAT STRUCT MOL BIOL, V21, P14, DOI 10.1038/nsmb.2748; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang SW, 2015, EUR J CARDIO-THORAC, V47, P439, DOI 10.1093/ejcts/ezu215; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wong MSK, 2014, CIRCULATION, V130, P976, DOI 10.1161/CIRCULATIONAHA.114.010650; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229	74	4	4	6	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-7322	1524-4539		CIRCULATION	Circulation	JUL 4	2017	136	1					65	+		10.1161/CIRCULATIONAHA.116.026991				44	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	EZ2RV	WOS:000404558500009	28351900	green_published			2018-01-05	
J	Kleinberger, G; Brendel, M; Mracsko, E; Wefers, B; Groeneweg, L; Xiang, XY; Focke, C; Deussing, M; Suarez-Calvet, M; Mazaheri, F; Parhizkar, S; Pettkus, N; Wurst, W; Feederle, R; Bartenstein, P; Mueggler, T; Arzberger, T; Knuesel, I; Rominger, A; Haass, C				Kleinberger, Gernot; Brendel, Matthias; Mracsko, Eva; Wefers, Benedikt; Groeneweg, Linda; Xiang, Xianyuan; Focke, Carola; Deussing, Maximilian; Suarez-Calvet, Marc; Mazaheri, Fargol; Parhizkar, Samira; Pettkus, Nadine; Wurst, Wolfgang; Feederle, Regina; Bartenstein, Peter; Mueggler, Thomas; Arzberger, Thomas; Knuesel, Irene; Rominger, Axel; Haass, Christian			The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism	EMBO JOURNAL			English	Article						frontotemporal dementia; neurodegeneration; neuroinflammation; regulated intramembrane proteolysis; TREM2	MYELOID CELLS-2 TREM2; FLUID SOLUBLE TREM2; NASU-HAKOLA-DISEASE; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; FRONTOTEMPORAL DEMENTIA; GAMMA-SECRETASE; IN-VIVO; TRANSLOCATOR PROTEIN; APOLIPOPROTEIN-E	Genetic variants in the triggering receptor expressed on myeloid cells 2 (TREM2) increase the risk for several neurodegenerative diseases including Alzheimer's disease and frontotemporal dementia (FTD). Homozygous TREM2 missense mutations, such as p.T66M, lead to the FTD-like syndrome, but how they cause pathology is unknown. Using CRISPR/Cas9 genome editing, we generated a knock-in mouse model for the disease-associated Trem2 p.T66M mutation. Consistent with a loss-of-function mutation, we observe an intracellular accumulation of immature mutant Trem2 and reduced generation of soluble Trem2 similar to patients with the homozygous p.T66M mutation. Trem2 p.T66M knock-in mice show delayed resolution of inflammation upon in vivo lipopolysaccharide stimulation and cultured macrophages display significantly reduced phagocytic activity. Immunohistochemistry together with in vivo TSPO small animal positron emission tomography (mu PET) demonstrates an age-dependent reduction in microglial activity. Surprisingly, perfusion magnetic resonance imaging and FDG-mu PET imaging reveal a significant reduction in cerebral blood flow and brain glucose metabolism. Thus, we demonstrate that a TREM2 loss-of-function mutation causes brain-wide metabolic alterations pointing toward a possible function of microglia in regulating brain glucose metabolism.	[Kleinberger, Gernot; Xiang, Xianyuan; Suarez-Calvet, Marc; Parhizkar, Samira; Pettkus, Nadine; Haass, Christian] Ludwig Maximilians Univ Munchen, Biomed Ctr BMC, Biochem, Munich, Germany; [Kleinberger, Gernot; Wurst, Wolfgang; Feederle, Regina; Bartenstein, Peter; Rominger, Axel; Haass, Christian] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Brendel, Matthias; Focke, Carola; Deussing, Maximilian; Bartenstein, Peter; Rominger, Axel] Ludwig Maximilians Univ Munchen, Dept Nucl Med, Munich, Germany; [Mracsko, Eva; Groeneweg, Linda; Mueggler, Thomas; Knuesel, Irene] Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, NORD Discovery & Translat Area, Basel, Switzerland; [Wefers, Benedikt; Suarez-Calvet, Marc; Mazaheri, Fargol; Wurst, Wolfgang; Feederle, Regina; Arzberger, Thomas; Haass, Christian] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Wefers, Benedikt; Wurst, Wolfgang] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Wurst, Wolfgang] Tech Univ Munich, Freising Weihenstephan, Germany; [Feederle, Regina] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Diabet & Obes, Core Facil Monoclonal Antibody Dev, Munich, Germany; [Arzberger, Thomas] Ludwig Maximilians Univ Munchen, Ctr Neuropathol & Prion Res, Munich, Germany; [Arzberger, Thomas] Ludwig Maximilians Univ Munchen, Dept Psychiat & Psychotherapy, Munich, Germany	Haass, C (reprint author), Ludwig Maximilians Univ Munchen, Biomed Ctr BMC, Biochem, Munich, Germany.; Haass, C (reprint author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.; Haass, C (reprint author), German Ctr Neurodegenerat Dis DZNE, Munich, Germany.	christian.haass@mail03.med.uni-muenchen.de			Deutsche Forschungsgemeinschaft (DFG) [EXC 1010 SyNergy, FOR2290]; European Research Council under the European Union's Seventh Framework Program (FP7)/ERC [321366]; MetLife award; Cure Alzheimer's Fund;  [SFB870]	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) within the framework of the Munich Cluster for Systems Neurology (EXC 1010 SyNergy) and FOR2290, the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC Grant Agreement No. 321366-Amyloid, the general legacy of Mrs. Ammer, the MetLife award, and the Cure Alzheimer's Fund. W.W was further supported by SFB870. We would like to thank Dr. Marco Colonna (Washington University, School of Medicine) for kindly providing the Trem2 knockout mouse line and Mrs. Brigitte Kraft for technical assistance with immunohistochemistry. We thank Dr. Mikael Simons for critically reading the manuscript.	Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bailey CC, 2015, J BIOL CHEM, V290, P26033, DOI 10.1074/jbc.M115.677286; Borroni B, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.017; Brandl C, 2015, FEBS OPEN BIO, V5, P26, DOI 10.1016/j.fob.2014.11.009; Brendel M, 2015, MOL PSYCHIATR, V20, P1179, DOI 10.1038/mp.2015.74; Brendel M, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00008; Brendel M, 2016, J NUCL MED, V57, P954, DOI 10.2967/jnumed.115.167858; Bruns A, 2009, MAGN RESON MED, V61, P1451, DOI 10.1002/mrm.21779; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Cuyvers E, 2016, LANCET NEUROL, V15, P857, DOI 10.1016/S1474-4422(16)00127-7; Cuyvers E, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.009; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594                                                      ; Dickens AM, 2014, J NUCL MED, V55, P466, DOI 10.2967/jnumed.113.125625; Dorr A, 2007, NEUROIMAGE, V35, P1409, DOI 10.1016/j.neuroimage.2006.12.040; Glebov K, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0479-9; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; HAASE A, 1986, RADIOLOGY, V160, P787, DOI 10.1148/radiology.160.3.3737918                                                 ; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051                                                     ; Henjum K, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0182-1; Herholz K, 2011, INT PSYCHOGERIATR, V23, pS25, DOI 10.1017/S1041610211000937; Heslegrave A, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0071-x; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Ito H, 2012, EUR J IMMUNOL, V42, P176, DOI 10.1002/eji.201141679; Jonsson T, N ENGL J MED, V368, P107; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Klunemann HH, 2005, NEUROLOGY, V64, P1502, DOI 10.1212/01.WNL.0000160304.00003.CA; Kober DL, 2016, ELIFE, V5, DOI 10.7554/eLife.20391; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2                                                    ; Liu B, 2015, J NEUROSCI, V35, P15716, DOI 10.1523/JNEUROSCI.0996-15.2015; Liu GJ, 2014, BRAIN PATHOL, V24, P631, DOI 10.1111/bpa.12196; Lourbopoulos A, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fnce1.2015.00054, 10.3389/fncel.2015.00054]; Mazaheri F, 2017, EMBO REP, V18, P1186, DOI 10.15252/embr.201743922; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Montalbetti L, 2005, FUNCT NEUROL, V20, P71; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Otero K, 2012, J IMMUNOL, V188, P2612, DOI 10.4049/jimmunol.1102836; Overhoff F, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00045; Paloneva J, 2001, NEUROLOGY, V56, P1552, DOI 10.1212/WNL.56.11.1552                                                          ; Park JS, 2015, TRAFFIC, V16, P510, DOI 10.1111/tra.12264; PAXINOS G, 1998, RAT BRAIN STEREOTAXI; Paxinos G, 2001, MOUSE BRAIN STEREOTA; Piccio L, 2008, BRAIN, V131, P3081, DOI 10.1093/brain/awn217; Piccio L, 2016, ACTA NEUROPATHOL, V131, P925, DOI 10.1007/s00401-016-1533-5; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Schelle J, 2017, ALZHEIMERS DEMENT, V13, P701, DOI 10.1016/j.jalz.2016.09.005; Singh S, 2013, ACTA NEUROPATHOL, V125, P595, DOI 10.1007/s00401-013-1082-0; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Sokoloff L, 1999, NEUROCHEM RES, V24, P321, DOI 10.1023/A:1022534709672; SOKOLOFF L, 1977, J NEUROCHEM, V29, P13, DOI 10.1111/j.1471-4159.1977.tb03919.x; Suarez-Calvet M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1767; Suarez-Calvet M, 2016, EMBO MOL MED, V8, P466, DOI 10.15252/emmm.201506123; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takeshita T, 2005, ANN NUCL MED, V19, P309, DOI 10.1007/BF02984623; Tosun D, 2016, ANN CLIN TRANSL NEUR, V3, P740, DOI 10.1002/acn3.330; Tremblay Marie-Eve, 2011, Commun Integr Biol, V4, P220, DOI 10.4161/cib.4.2.14506; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520                                                     ; Ueki Y, 2000, ACTA NEUROL SCAND, V102, P60, DOI 10.1034/j.1600-0404.2000.102001060.x                                            ; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Varrone A, 2009, EUR J NUCL MED MOL I, V36, P2103, DOI 10.1007/s00259-009-1264-0; Verfaillie SCJ, 2015, EUR RADIOL, V25, P3050, DOI 10.1007/s00330-015-3696-1; Villegas-Llerena C, 2016, CURR OPIN NEUROBIOL, V36, P74, DOI 10.1016/j.conb.2015.10.004; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wefers B, 2013, NAT PROTOC, V8, P2355, DOI 10.1038/nprot.2013.142; Wickstrom T, 2014, J LABELLED COMPD RAD, V57, P42, DOI 10.1002/jlcr.3112; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wu K, 2015, J EXP MED, V212, P681, DOI 10.1084/jem.20141732; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Xiang XY, 2016, EMBO MOL MED, V8, P992, DOI 10.15252/emmm.201606370; Yang WL, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00030; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Zhong L, 2017, J EXP MED, V214, P597, DOI 10.1084/jem.20160844; Zhong L, 2015, J BIOL CHEM, V290, P15866, DOI 10.1074/jbc.M115.645986	78	5	5	8	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0261-4189	1460-2075		EMBO J	Embo J.	JUL 3	2017	36	13					1837	1853		10.15252/embj.201796516				17	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EZ2UQ	WOS:000404566600005	28559417				2018-01-05	
J	Wang, QZ; Timberlake, MA; Prall, K; Dwivedi, Y				Wang, Qingzhong; Timberlake, Matthew A., II; Prall, Kevin; Dwivedi, Yogesh			The recent progress in animal models of depression	PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY			English	Review						Rodents; Depression; Model; Behavior; Review	CHRONIC ANTIDEPRESSANT TREATMENT; NEONATAL MATERNAL SEPARATION; OLFACTORY-BULBECTOMIZED RAT; MAJOR PSYCHIATRIC-DISORDERS; MEDIAL PREFRONTAL CORTEX; CA3 PYRAMIDAL NEURONS; OPEN-FIELD BEHAVIOR; EARLY-LIFE STRESS; LEARNED HELPLESSNESS; NEUROTROPHIC-FACTOR	Major depression disorder (MDD) is a debilitating mental illness with significant morbidity and mortality. Despite the growing number of studies that have emerged, the precise underlying mechanisms of MDD remain unknown. When studying MDD, tissue samples like peripheral blood or post-mortem brain samples are used to elucidate underlying mechanisms. Unfortunately, there are many uncontrollable factors with such samples such as medication history, age, time after death before post-mortem tissue was collected, age, sex, race, and living conditions. Although these factors are critical, they introduce confounding variables that can influence the outcome profoundly. In this regard, animal models provide a crucial approach to examine neural circuitry and molecular and cellular pathways in a controlled environment. Further, manipulations with pharmacological agents and gene editing are accepted methods of studying depression in animal models, which is impossible to employ in human patient studies. Here, we have reviewed the most widely used animal models of depression and delineated the salient features of each model in terms of behavioral and neurobiological outcomes. We have also illustrated the current challenges in using these models and have suggested strategies to delineate the underlying mechanism associated with vulnerability or resilience to developing depression.	[Wang, Qingzhong; Timberlake, Matthew A., II; Prall, Kevin; Dwivedi, Yogesh] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, SC711 Sparks Ctr,1720 7th Ave South, Birmingham, AL 35294 USA	Dwivedi, Y (reprint author), Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, UAB Mood Disorder Program, Translat Res, SC711 Sparks Ctr,1720 7th Ave South, Birmingham, AL 35294 USA.	ydwivedi@uab.edu			National Institute of Mental Health [R01MH082802, R21MH081099, 1R01MH101890, R01MH100616, 1R01MH107183]; American Foundation for Suicide Prevention [SRG-XXXX-001778-1209]	The research was supported by grants from National Institute of Mental Health (R01MH082802; R21MH081099; 1R01MH101890; R01MH100616; 1R01MH107183), and American Foundation for Suicide Prevention (SRG-XXXX-001778-1209) to Dr. Dwivedi.	Abdolmaleky HM, 2005, AM J PHARMACOGENOMIC, V5, P149, DOI 10.2165/00129785-200505030-00002                                                ; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Agid O, 2000, BIOMED PHARMACOTHER, V54, P135, DOI 10.1016/S0753-3322(00)89046-0; Alvarez C, 2002, NEUROSCIENCE, V115, P753, DOI 10.1016/S0306-4522(02)00484-0; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Anisman H, 2005, NEUROSCI BIOBEHAV R, V29, P525, DOI 10.1016/j.neubiorev.2005.03.007; Aznar S, 2010, SYNAPSE, V64, P561, DOI 10.1002/syn.20773; Bahi A, 2014, PSYCHONEUROENDOCRINO, V46, P78, DOI 10.1016/j.psyneuen.2014.04.009; Bai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046921; Baudry A, 2010, SCIENCE, V329, P1537, DOI 10.1126/science.1193692; Belzung C, 2011, BIOL MOOD ANXIETY DI, V1, P1; Bjorkqvist K, 2001, PHYSIOL BEHAV, V73, P435, DOI 10.1016/S0031-9384(01)00490-5; Bland ST, 2007, NEUROSCIENCE, V144, P1219, DOI 10.1016/j.neuroscience.2006.11.026; BOHUS B, 1993, NEUROPSYCHOBIOLOGY, V28, P95, DOI 10.1159/000119008; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Brandao ML, 2008, BEHAV BRAIN RES, V188, P1, DOI 10.1016/j.bbr.2007.10.018; Brunello N, 2002, EUR NEUROPSYCHOPHARM, V12, P461, DOI 10.1016/S0924-977X(02)00057-3; Bunney WE, 2003, AM J PSYCHIAT, V160, P657, DOI 10.1176/appi.ajp.160.4.657                                                      ; BUTLER LD, 1989, J NEUROIMMUNOL, V24, P143, DOI 10.1016/0165-5728(89)90108-2; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cao Mei-Qun, 2013, Zhongguo Zhong Yao Za Zhi, V38, P1585; Carney RM, 2002, J PSYCHOSOM RES, V53, P897, DOI 10.1016/S0022-3999(02)00311-2; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Champagne F, 2001, P NATL ACAD SCI USA, V98, P12736, DOI 10.1073/pnas.221224598; Chertkow-Deutsher Y, 2010, INT J NEUROPSYCHOPH, V13, P347, DOI 10.1017/S146114570999071X; Chourbaji S, 2005, BRAIN RES PROTOC, V16, P70, DOI 10.1016/j.brainresprot.2005.09.002; Chourbaji S, 2012, NEUROSCIENCE, V220, P267, DOI 10.1016/j.neuroscience.2012.06.016; Conrad CD, 1999, BEHAV NEUROSCI, V113, P902, DOI 10.1037//0735-7044.113.5.902; CORUM CR, 1977, PSYCHOSOM MED, V39, P436; Crema L, 2010, NEUROCHEM RES, V35, P1787, DOI 10.1007/s11064-010-0245-9; Cryan JF, 2003, PSYCHOPHARMACOLOGY, V168, P347, DOI 10.1007/s00213-003-1445-7; Daniels WMU, 2004, METAB BRAIN DIS, V19, P3, DOI 10.1023/B:MEBR.0000027412.19664.b3; Delgado PL, 2000, J CLIN PSYCHIAT, V61, P7; DENENBERG VH, 1969, ANN NY ACAD SCI, V159, P852, DOI 10.1111/j.1749-6632.1969.tb12983.x                                              ; Dibbets P, 2015, MEMORY, V23, P350, DOI 10.1080/09658211.2014.886704; Dwivedi Y, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.175; Dwivedi Y, 2004, BIOL PSYCHIAT, V56, P30, DOI 10.1016/j.biopsych.2004.03.018; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Ellenbroek BA, 1998, NEUROSCI RES COMMUN, V22, P127; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Enthoven L, 2008, ENDOCRINOLOGY, V149, P6366, DOI 10.1210/en.2008-0238; Etzersdorfer E, 2015, WIEN KLIN WOCHENSCHR, V127, P308, DOI 10.1007/s00508-015-0729-3; Felger JC, 2013, NEUROSCIENCE, V246, P199, DOI 10.1016/j.neuroscience.2013.04.060; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Fukui M, 2007, J NEUROSCI, V27, P10520, DOI 10.1523/JNEUROSCI.4388-06.2007; Galvão Bruno de Oliveira, 2011, Psychol. Neurosci., V4, P205, DOI 10.3922/j.psns.2011.2.005; GOLD PW, 1988, NEW ENGL J MED, V319, P348, DOI 10.1056/NEJM198808113190606; Golden SA, 2013, NAT MED, V19, P337, DOI 10.1038/nm.3090; Gregus A, 2005, BEHAV BRAIN RES, V156, P105, DOI 10.1016/j.bbr.2004.05.013; Gutknecht L, 2015, PSYCHOPHARMACOLOGY, V232, P2429, DOI 10.1007/s00213-015-3879-0; Halasz N., 1990, VERTEBRATE OLFACTORY; HALL RD, 1983, PHYSIOL BEHAV, V30, P797, DOI 10.1016/0031-9384(83)90180-4; Harkin A, 2003, CLIN NEUROSCI RES, V3, P253, DOI 10.1016/S1566-2772(03)00087-2; Hedden S. L., 2015, BEHAV HLTH TRENDS US; Hellweg R, 2007, NEUROBIOL DIS, V25, P1, DOI 10.1016/j.nbd.2006.07.017; HELMSTETTER FJ, 1994, BEHAV NEUROSCI, V108, P1005, DOI 10.1037//0735-7044.108.5.1005; HENINGER GR, 1984, ARCH GEN PSYCHIAT, V41, P398; Higuchi F, 2016, J NEUROSCI, V36, P7253, DOI 10.1523/JNEUROSCI.0319-16.2016; Huhman KL, 2006, HORM BEHAV, V50, P640, DOI 10.1016/j.yhbeh.2006.06.022; Ilango Anton, 2012, Front Neurosci, V6, P132, DOI 10.3389/fnins.2012.00132; JANCSAR SM, 1984, NEUROPHARMACOLOGY, V23, P1065, DOI 10.1016/0028-3908(84)90130-8; Jarosik J, 2007, EXP NEUROL, V204, P20, DOI 10.1016/j.expneurol.2006.09.008; Jiao L, 2011, NEUROSCIENCE, V182, P177, DOI 10.1016/j.neuroscience.2011.01.017; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Kelly JP, 1997, PHARMACOL THERAPEUT, V74, P299, DOI 10.1016/S0163-7258(97)00004-1; Kember RL, 2012, BRAIN BEHAV, V2, P455, DOI 10.1002/brb3.69; Kendler KS, 2002, AM J PSYCHIAT, V159, P1133, DOI 10.1176/appi.ajp.159.7.1133                                                     ; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kim H, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-24; KLEIN DF, 1974, ARCH GEN PSYCHIAT, V31, P447; Kohen R, 2005, PHARMACOGENOMICS J, V5, P278, DOI 10.1038/sj.tpj.6500322; Koolhaas JM, 1997, NEUROSCI BIOBEHAV R, V21, P775, DOI 10.1016/S0149-7634(96)00057-7; Garrison B., 1985, AM J PSYCHIAT, V1, P559, DOI DOI 10.1176/AJP.142.5.559; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; LEDOUX JE, 1983, SCIENCE, V221, P576, DOI 10.1126/science.6867731; Lee JH, 2007, NEUROSCI RES, V58, P32, DOI 10.1016/j.neures.2007.01.008; Leonard B E, 1981, Int Rev Neurobiol, V22, P251, DOI 10.1016/S0074-7742(08)60295-0; LEVINE S, 1967, SCIENCE, V156, P258, DOI 10.1126/science.156.3772.258; Levine S, 2005, PSYCHONEUROENDOCRINO, V30, P939, DOI 10.1016/j.psyneuen.2005.03.013; Lewis DA, 2002, NEUROPSYCHOPHARMACOL, V26, P143, DOI 10.1016/S0893-133X(01)00393-1                                                   ; Li K, 2013, SCIENCE, V341, P1016, DOI 10.1126/science.1240729; LLOYD C, 1980, ARCH GEN PSYCHIAT, V37, P541; Lotrich F, 2012, CURR PHARM DESIGN, V18, P5920, DOI 10.2174/138161212803523680                                                      ; LUMIA AR, 1992, BRAIN RES, V587, P181, DOI 10.1016/0006-8993(92)90995-L                                                    ; Lyons DM, 1998, DEV PSYCHOBIOL, V32, P285, DOI 10.1002/(SICI)1098-2302(199805)32:4<285::AID-DEV3>3.3.CO;2-N; MacQueen GM, 2001, BEHAV NEUROSCI, V115, P1145, DOI 10.1037//0735-7044.115.5.1145; Magarinos AM, 1999, EUR J PHARMACOL, V371, P113, DOI 10.1016/S0014-2999(99)00163-6                                                   ; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L                                                    ; MAHATA SK, 1993, NEUROSCI LETT, V156, P70, DOI 10.1016/0304-3940(93)90442-N; MAIER SF, 1976, J EXP PSYCHOL GEN, V105, P3, DOI 10.1037/0096-3445.105.1.3; Martinez M, 1998, EUR J NEUROSCI, V10, P20, DOI 10.1046/j.1460-9568.1998.00011.x; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; MCGONAGLE KA, 1990, AM J COMMUN PSYCHOL, V18, P681, DOI 10.1007/BF00931237                                                              ; McKernan DP, 2009, PROG NEUROBIOL, V88, P246, DOI 10.1016/j.pneurobio.2009.04.006; Meaney MJ, 2005, TRENDS NEUROSCI, V28, P456, DOI 10.1016/j.tins.2005.07.006; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161                                                 ; Meerlo P, 1996, STRESS, V1, P21, DOI DOI 10.3109/10253899609001093; Morgan C, 2007, PSYCHOL MED, V37, P495, DOI 10.1017/S0033291706009330; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Nam H, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00109; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Newport DJ, 2002, AM J PSYCHIAT, V159, P1265, DOI 10.1176/appi.ajp.159.8.1265; Nishi K, 2009, NEUROCHEM INT, V54, P205, DOI 10.1016/j.neuint.2008.10.010; Nishi M, 2013, GEN COMP ENDOCR, V181, P306, DOI 10.1016/j.ygcen.2012.09.024; Ohadi M, 2012, PROG NEURO-PSYCHOPH, V37, P276, DOI 10.1016/j.pnpbp.2012.02.007; OVERSTREET DH, 1982, PSYCHOPHARMACOLOGY, V78, P150, DOI 10.1007/BF00432254; Overstreet DH, 2005, NEUROSCI BIOBEHAV R, V29, P739, DOI 10.1016/j.neubiorev.2005.03.015; Padilla E, 2010, PHYSIOL BEHAV, V101, P746, DOI 10.1016/j.physbeh.2010.08.017; Padilla E, 2009, BEHAV BRAIN RES, V201, P257, DOI 10.1016/j.bbr.2009.02.019; Pause BM, 2001, J PSYCHIAT RES, V35, P271, DOI 10.1016/S0022-3956(01)00029-2; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7                                                    ; Pena CJ, 2013, ENDOCRINOLOGY, V154, P4340, DOI 10.1210/en.2013-1595; PETERS JE, 1961, PSYCHOSOM MED, V23, P138, DOI 10.1097/00006842-196103000-00005                                                ; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Plotsky PM, 2005, NEUROPSYCHOPHARMACOL, V30, P2192, DOI 10.1038/sj.npp.1300769                                                          ; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Pryce CR, 2005, NEUROSCI BIOBEHAV R, V29, P649, DOI 10.1016/j.neubiorev.2005.03.011; PUCILOWSKI O, 1993, BRAIN RES BULL, V32, P471, DOI 10.1016/0361-9230(93)90293-K; Quesseveur G, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00490; Rao T S Sathyanarayana, 2008, Indian J Psychiatry, V50, P77, DOI 10.4103/0019-5545.42391; RITTER RC, 1978, AM J PHYSIOL, V234, pE20; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Ryu V, 2009, BRAIN RES, V1295, P127, DOI 10.1016/j.brainres.2009.08.006; Schmidt MV, 2011, PSYCHONEUROENDOCRINO, V36, P330, DOI 10.1016/j.psyneuen.2010.07.001; Schulte-Herbruggen O, 2006, PSYCHONEUROENDOCRINO, V31, P1266, DOI 10.1016/j.psyneuen.2006.09.008; SELIGMAN ME, 1972, ANNU REV MED, V23, P407, DOI 10.1146/annurev.me.23.020172.002203                                             ; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514                                                                ; SHERMAN AD, 1982, BEHAV NEURAL BIOL, V35, P344, DOI 10.1016/S0163-1047(82)90978-5; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Shumake J, 2010, BRAIN RES, V1343, P218, DOI 10.1016/j.brainres.2010.05.015; Smalheiser NR, 2011, INT J NEUROPSYCHOPH, V14, P1315, DOI 10.1017/S1461145710001628; SONG C, 1995, HUM PSYCHOPHARM CLIN, V10, P7, DOI 10.1002/hup.470100103                                                           ; Song C, 2005, NEUROSCI BIOBEHAV R, V29, P627, DOI 10.1016/j.neubiorev.2005.03.010; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Sun HS, 2013, NEUROPSYCHOPHARMACOL, V38, P124, DOI 10.1038/npp.2012.73; Suns A., 2010, ANN CLIN PSYCHIATRY, V22, P274; Timberlake M. A, 2015, FRONT PHARM, V6; Tran PV, 2003, J CLIN PSYCHOPHARM, V23, P78, DOI 10.1097/00004714-200302000-00011                                                ; Uher R, 2010, MOL PSYCHIATR, V15, P18, DOI 10.1038/mp.2009.123; Vollmayr B, 2001, MOL PSYCHIATR, V6, P471, DOI 10.1038/sj.mp.4000907; Vollmayr B, 2007, EUR ARCH PSY CLIN N, V257, P300, DOI 10.1007/s00406-007-0734-2; WALKER CD, 1991, ENDOCRINOLOGY, V128, P1385, DOI 10.1210/endo-128-3-1385                                                         ; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; WATANABE Y, 1992, HIPPOCAMPUS, V2, P431, DOI 10.1002/hipo.450020410                                                          ; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WEISS JM, 1980, NEUROCHEM RES, V5, P9, DOI 10.1007/BF00964456; WEISS JM, 1986, CIBA F SYMP, V123, P191; Weiss J., 1982, BEHAVIORAL MODELS AN, P195; Weiss J. M., 1985, ADV BEHAVIORAL MED, V1, P233; [Anonymous], 2003, INV MENT HLTH; Will CC, 2003, MOL PSYCHIATR, V8, P925, DOI 10.1038/sj.mp.4001345; Willner P, 2002, BEHAV PHARMACOL, V13, P169, DOI 10.1097/00008877-200205000-00001                                                ; WILLNER P, 1991, TRENDS PHARMACOL SCI, V12, P131, DOI 10.1016/0165-6147(91)90529-2                                                    ; Willner P, 2015, PSYCHOPHARMACOLOGY, V232, P3473, DOI 10.1007/s00213-015-4034-7; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566; Wood GE, 2003, HORM BEHAV, V43, P205, DOI 10.1016/S0018-506X(02)00026-0; Yohannes A. M, 2008, PSYCHIAT TIMES, V25, P52; You ZL, 2011, BEHAV BRAIN RES, V225, P135, DOI 10.1016/j.bbr.2011.07.006; ZACHARKO RM, 1983, BEHAV BRAIN RES, V9, P129, DOI 10.1016/0166-4328(83)90123-7; Zangen A, 1997, J NEUROCHEM, V69, P2477; Zhang L, 2014, INT J NEUROPSYCHOPH, V17, P793, DOI 10.1017/S1461145713001661	167	0	0	15	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-5846	1878-4216		PROG NEURO-PSYCHOPH	Prog. Neuro-Psychopharmacol. Biol. Psychiatry	JUL 3	2017	77						99	109		10.1016/j.pnpbp.2017.04.008				11	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	EY9GW	WOS:000404308100012	28396255				2018-01-05	
J	Liu, X; Zhang, M; Ying, SM; Zhang, C; Lin, RH; Zheng, JX; Zhang, GH; Tian, DP; Guo, Y; Du, CW; Chen, YP; Chen, SB; Su, X; Ji, J; Deng, WT; Li, X; Qiu, SY; Yan, RJ; Xu, ZX; Wang, Y; Guo, YN; Cui, JC; Zhuang, SS; Yu, H; Zheng, Q; Marom, MS; Sheng, ST; Zhang, GQ; Hu, SN; Li, RQ; Su, M				Liu, Xi; Zhang, Min; Ying, Songmin; Zhang, Chong; Lin, Runhua; Zheng, Jiaxuan; Zhang, Guohong; Tian, Dongping; Guo, Yi; Du, Caiwen; Chen, Yuping; Chen, Shaobin; Su, Xue; Ji, Juan; Deng, Wanting; Li, Xiang; Qiu, Shiyue; Yan, Ruijing; Xu, Zexin; Wang, Yuan; Guo, Yuanning; Cui, Jiancheng; Zhuang, Shanshan; Yu, Huan; Zheng, Qi; Marom, Moshe; Sheng, Sitong; Zhang, Guoqiang; Hu, Songnian; Li, Ruiqiang; Su, Min			Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma	GASTROENTEROLOGY			English	Article						Esophagus; Sequencing; Carcinogenesis; Driver Mutation	HELICOBACTER-PYLORI INFECTION; CELL CARCINOMA; PRECANCEROUS LESIONS; MUTATIONAL PROCESSES; BARRETTS-ESOPHAGUS; CANCER DEVELOPMENT; SOMATIC MUTATIONS; DNA; ADENOCARCINOMA; POPULATION	BACKGROUND & AIMS: Esophageal squamous cell carcinoma (ESCC) is the most common subtype of esophageal cancer. Little is known about the genetic changes that occur in esophageal cells during the development of ESCC. We performed next-generation sequence analyses of esophageal nontumor, intra-epithelial neoplasia (IEN), and ESCC tissues from the same patients to track genetic changes during tumor development. METHODS: We performed whole-genome, whole-exome, or targeted sequence analyses of 227 esophageal tissue samples from 70 patients with ESCC undergoing resection at Shantou University Medical College in China from 2012 through 2015 (no patients had received chemotherapy or radiation therapy); we analyzed normal tissues, tissues with simple hyperplasia, dysplastic tissues (IEN), and ESCC tissues collected from different regions of the esophagus at the same time. We also obtained 1191 nontumor esophageal biopsy specimens from the Chaoshan region (a high-risk region for ESCC) of China (a high-risk region for ESCC) and performed immunohistochemical and histologic analyses to detect inflammation. RESULTS: IEN and ESCC tissues had similar mutations and copy number alterations, at similar frequencies; these differed from mutations detected in tissues with simple hyperplasia. IEN tissues had mutations associated with apolipoprotein B messenger RNA editing enzyme, catalytic polypeptide-like-mediated mutagenesis (a DNA damage mutational signature). Genetic analyses indicated that most ESCCs were formed from early stage IEN clones. Trunk mutations (mutations shared by > 10% of paired IEN and ESCC tissues) were in genes that regulate DNA repair and cell apoptosis, proliferation and adhesion. Mutations in TP53 and CDKN2A and copy number alterations in 11q (contains CCND1), 3q (contains SOX2), 2q (contains NFE2L2), and 9p (contains CDKN2A) were considered to be trunk variants; these were dominant mutations detected at high frequencies in clones of paired IEN and ESCC samples. In the esophageal biopsy samples from high-risk individuals (residing in the Chaoshan region), 68.9% had an evidence of chronic inflammation; the level of inflammation was correlated with atypical cell structures and markers of DNA damage. CONCLUSIONS: We analyzed mutations and gene copy number changes in nontumor, IEN, and ESCC samples, collected from 70 patients. IEN and ESCCs each had similar mutations and markers of genomic instability, including apolipoprotein B messenger RNA editing enzyme, catalytic polypeptide-like. Genomic changes observed in precancerous lesions might be used to identify patients at risk for ESCC.	[Liu, Xi; Ying, Songmin; Zhang, Chong; Lin, Runhua; Zheng, Jiaxuan; Zhang, Guohong; Tian, Dongping; Su, Xue; Ji, Juan; Deng, Wanting; Li, Xiang; Qiu, Shiyue; Yan, Ruijing; Xu, Zexin; Wang, Yuan; Guo, Yuanning; Su, Min] Shantou Univ, Coll Med, Dept Pathol, Inst Clin Pathol, 22 Xinling Rd, Shantou, Guangdong, Peoples R China; [Guo, Yi; Du, Caiwen; Chen, Yuping; Chen, Shaobin; Zhuang, Shanshan] Shantou Univ, Coll Med, Canc Hosp, Shantou, Guangdong, Peoples R China; [Zhang, Min; Cui, Jiancheng; Yu, Huan; Zheng, Qi; Li, Ruiqiang] Novogene Co Ltd, Beijing, Peoples R China; [Ying, Songmin] Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou, Zhejiang, Peoples R China; [Marom, Moshe] Guangdong Technion Israel Inst Technol, Shantou, Guangdong, Peoples R China; [Sheng, Sitong] HYK High Throughput Biotechnol Inst, Software Pk, Shenzhen, Peoples R China; [Zhang, Guoqiang; Hu, Songnian] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China	Su, M (reprint author), Shantou Univ, Coll Med, Dept Pathol, Inst Clin Pathol, 22 Xinling Rd, Shantou, Guangdong, Peoples R China.	minsu@stu.edu.cn			National Natural Science Foundation of China (NSFC)-Guangdong joint fund key project [U1132004]; NSFC [31171226, 81572684]; Guangdong International Cooperative Technical Innovation Platform [Certificate gihz1106]; Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases, Molecular Diagnosis, and Personalized Medicine Center of Shantou University	Supported by the National Natural Science Foundation of China (NSFC)-Guangdong joint fund key project (U1132004), NSFC (31171226, 81572684), Guangdong International Cooperative Technical Innovation Platform (Certificate gihz1106), Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases, Molecular Diagnosis, and Personalized Medicine Center of Shantou University.	Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chelico L, 2009, NAT STRUCT MOL BIOL, V16, P454, DOI 10.1038/nsmb0509-454; Chen Yuguo, 2015, Southern Power System Technology, V9, P32, DOI 10.13648/j.cnki.issn1674-0629.2015.08.006; Chiba T, 2012, GASTROENTEROLOGY, V143, P550, DOI 10.1053/j.gastro.2012.07.009; Chudnovsky Y, 2014, CELL REP, V6, P313, DOI 10.1016/j.celrep.2013.12.032; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DAWSEY SM, 1994, CANCER, V74, P1686, DOI 10.1002/1097-0142(19940915)74:6<1686::AID-CNCR2820740608>3.0.CO;2-V; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010                                                            ; GAO HK, 1994, CANCER RES, V54, P4342; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Li WS, 2014, INT J CANCER, V134, P2626, DOI 10.1002/ijc.28588; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Lin RH, 2016, ONCOTARGET, V7, P24564, DOI 10.18632/oncotarget.8356; Liu M, 2011, EXP THER MED, V2, P997, DOI 10.3892/etm.2011.297; Ma N, 2006, NITRIC OXIDE-BIOL CH, V14, P137, DOI 10.1016/j.niox.2005.09.012; Nasrollahzadeh D, 2015, SCI REP-UK, V5, DOI 10.1038/srep08820; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pennathur A, 2009, ANN THORAC SURG, V87, P1048, DOI 10.1016/j.athoracsur.2008.12.060; Rebhandl Stefan, 2015, Oncoscience, V2, P320; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Ross-Innes CS, 2015, NAT GENET, V47, P1038, DOI 10.1038/ng.3357; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/NMETH.2883, 10.1038/nmeth.2883]; Roth MJ, 2001, CANCER RES, V61, P4098; Rustgi AK, 2014, NEW ENGL J MED, V371, P2499, DOI 10.1056/NEJMra1314530; Sawada G, 2016, GASTROENTEROLOGY, V150, P1171, DOI 10.1053/j.gastro.2016.01.035; Shimada M, 1996, GENE CHROMOSOME CANC, V15, P165, DOI 10.1002/(SICI)1098-2264(199603)15:3<165::AID-GCC3>3.0.CO;2-0; Shimizu T, 2014, GASTROENTEROLOGY, V147, P407, DOI 10.1053/j.gastro.2014.04.036; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Stachler MD, 2015, NAT GENET, V47, P1047, DOI 10.1038/ng.3343; Wang CL, 2014, J MOL NEUROSCI, V52, P250, DOI 10.1007/s12031-013-0133-2; Wang GQ, 2005, GUT, V54, P187, DOI 10.1136/gut.2004.046631; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wang YS, 2014, MICROBES INFECT, V16, P840, DOI 10.1016/j.micinf.2014.06.009; Zhang L, 2015, AM J HUM GENET, V96, P597, DOI 10.1016/j.ajhg.2015.02.017	45	1	1	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	JUL	2017	153	1					166	177		10.1053/j.gastro.2017.03.033				12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	EY4AL	WOS:000403918300034	28365443				2018-01-05	
J	Song, MJ				Song, Minjung			The CRISPR/Cas9 System: Their Delivery, In Vivo and Ex Vivo Applications and Clinical Development by Startups	BIOTECHNOLOGY PROGRESS			English	Review						CRISPR/Cas9; gene delivery; nonviral delivery; in vivo therapeutics; ex vivo application	HUMAN HEMATOPOIETIC STEM; RNA-GUIDED ENDONUCLEASE; LIPID-DNA COMPLEXES; HEPATITIS-B-VIRUS; T-CELLS; LENTIVIRAL VECTORS; MUSCULAR-DYSTROPHY; GENE-THERAPY; CAS9 RIBONUCLEOPROTEINS; EFFICIENT DELIVERY	The CRISPR/Cas9 gene editing system was originally derived from the prokaryotic adaptive immune system mediated by Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated proteins (Cas). The system has been successfully applied to genome editing in eukaryotes and has contributed to remarkable advances in the life sciences, in areas ranging from agriculture to genetic disease therapies. For efficient editing and extending the influence of this system, proper delivery of its components is crucial. Both viral and nonviral delivery methods are reviewed here, along with the advantages and disadvantages of each. In addition, we review ex vivo and in vivo CRISPR/Cas9 applications for disease therapies. Related remarkable studies are highlighted and relevant startup companies and their drug development pipelines are described. (C) 2017 American Institute of Chemical Engineers	[Song, Minjung] Silla Univ, Dept Food Biotechnol, Baekyangdaero 700, Busan, South Korea	Song, MJ (reprint author), Silla Univ, Dept Food Biotechnol, Baekyangdaero 700, Busan, South Korea.	songmj@silla.ac.kr			National Research Foundation of Korea [2013R1A1A1075992]	This study was supported by the National Research Foundation of Korea (2013R1A1A1075992). The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.	Baek K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30620; Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Black JB, 2016, CELL STEM CELL, V19, P406, DOI 10.1016/j.stem.2016.07.001; Cai YJ, 2014, ELIFE, V3, DOI 10.7554/eLife.01911; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Chen S, 2016, J BIOL CHEM, V291, P14457, DOI 10.1074/jbc.M116.733154; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Cyranoski D, 2016, NATURE, V539, P479, DOI 10.1038/nature.2016.20988; Cyranoski D, 2016, NATURE, V535, P476, DOI 10.1038/nature.2016.20302; D'Astolfo DS, 2015, CELL, V161, P674, DOI 10.1016/j.cell.2015.03.028; de Lima MCP, 2001, ADV DRUG DELIVER REV, V47, P277; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Han X, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500454; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/nmeth.3075, 10.1038/NMETH.3075]; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jacobsen F, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/26060; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joglekar AV, 2013, MOL THER, V21, P1705, DOI 10.1038/mt.2013.106; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Liu XJ, 2017, CELL RES, V27, P154, DOI 10.1038/cr.2016.142; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Maresch R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10770; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Mikuni T, 2016, CELL, V165, P1803, DOI 10.1016/j.cell.2016.04.044; Miller JB, 2017, ANGEW CHEM INT EDIT, V56, P1059, DOI 10.1002/anie.201610209; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Naldini L, 2016, SCIENCE, V353, P1101, DOI 10.1126/science.aah6192; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Pankowicz FP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12642; Product Pipeline of Sangamo Therapeutics, SANG THER; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rapoport AP, 2015, NAT MED, V21, P914, DOI 10.1038/nm.3910; Ren J, 2016, CLIN CANC RES; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Sessa M, 2016, LANCET, V388, P476, DOI 10.1016/S0140-6736(16)30374-9; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Travis J, 2015, SCIENCE, V350, P1456, DOI 10.1126/science.350.6267.1456; Travis J, 2015, SCIENCE, V350, P1299, DOI 10.1126/science.350.6266.1299; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Wang W, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1016/J.GR.2014.02.002; Wanisch K, 2009, MOL THER, V17, P1316, DOI 10.1038/mt.2009.122; Wong M, 2001, BBA-GEN SUBJECTS, V1527, P61, DOI 10.1016/S0304-4165(01)00149-0; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Yu WH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14716; Zhou S, 2016, MOL THER, V24, P1090, DOI 10.1038/mt.2016.55; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	96	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8756-7938	1520-6033		BIOTECHNOL PROGR	Biotechnol. Prog.	JUL-AUG	2017	33	4					1035	1045		10.1002/btpr.2484				11	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	FO3GF	WOS:000416710400017	28440027				2018-01-05	
J	Lamy, JB				Lamy, Jean-Baptiste			Owlready: Ontology-oriented programming in Python with automatic classification and high level constructs for biomedical ontologies	ARTIFICIAL INTELLIGENCE IN MEDICINE			English	Article						Semantic web; Ontology-oriented programming; Automatic classification; Local closed world reasoning; Biomedical ontology; OWL	OWL ONTOLOGIES; FOUNDATIONAL MODEL; DESCRIPTION LOGICS; FUZZY ONTOLOGY; INFORMATICS; ANATOMY; DRUGS	Objective: Ontologies are widely used in the biomedical domain. While many tools exist for the edition, alignment or evaluation of ontologies, few solutions have been proposed for ontology programming interface, i.e. for accessing and modifying an ontology within a programming language. Existing query languages (such as SPARQL) and APIs (such as OWLAPI) are not as easy-to-use as object programming languages are. Moreover, they provide few solutions to difficulties encountered with biomedical ontologies. Our objective was to design a tool for accessing easily the entities of an OWL ontology, with high-level constructs helping with biomedical ontologies. Methods: From our experience on medical ontologies, we identified two difficulties: (1) many entities are represented by classes (rather than individuals), but the existing tools do not permit manipulating classes as easily as individuals, (2) ontologies rely on the open-world assumption, whereas the medical reasoning must consider only evidence-based medical knowledge as true. We designed a Python module for ontology-oriented programming. It allows access to the entities of an OWL ontology as if they were objects in the programming language. We propose a simple high-level syntax for managing classes and the associated "role-filler" constraints. We also propose an algorithm for performing local closed world reasoning in simple situations. Results: We developed Owlready, a Python module for a high-level access to OWL ontologies. The paper describes the architecture and the syntax of the module version 2. It details how we integrated the OWL ontology model with the Python object model. The paper provides examples based on Gene Ontology (GO). We also demonstrate the interest of Owlready in a use case focused on the automatic comparison of the contraindications of several drugs. This use case illustrates the use of the specific syntax proposed for manipulating classes and for performing local closed world reasoning. Conclusion: Owlready has been successfully used in a medical research project. It has been published as Open-Source software and then used by many other researchers. Future developments will focus on the support of vagueness and additional non -monotonic reasoning feature, and automatic dialog box generation. (C) 2017 Elsevier B.V. All rights reserved.	[Lamy, Jean-Baptiste] Univ Paris 13, Sorbonne Paris Cite, LIMICS, F-93017 Bobigny, France; [Lamy, Jean-Baptiste] UPMC Univ Paris 6, Sorbonne Univ, INSERM UMRS 1142, Paris, France	Lamy, JB (reprint author), Univ Paris 13, UFR SMBH, LIMICS Bur 149, 74 Rue Marcel Cachin, F-93017 Bobigny, France.	jibalamy@free.fr			French drug agency (ANSM, Agence Nationale de Securite du Medicament et des produits de sante) through the VIIIP project [AAP-2012-013]	This work was supported by the French drug agency (ANSM, Agence Nationale de Securite du Medicament et des produits de sante) through the VIIIP project [grant number AAP-2012-013].	Babik M, 2006, PROBABILITY MEASURES, P1; Bobillo F, 2011, INT J APPROX REASON, V52, P1073, DOI [10.1016/j.ijar.2011.05.003, 10.1016/j.jaac.2011.05.003]; Bock C, 2012, OWL 2 WEB ONTOLOGY L; Bonatti PA, 2009, J ARTIF INTELL RES, V35, P717; Burgun Anita, 2005, AMIA Annu Symp Proc, P91; Calegari S, 2007, LECT NOTES ARTIF INT, V4578, P118; Clark KL, 2006, APPL INTELL, V24, P189, DOI 10.1007/s10489-006-8511-x; Cure O., 2012, J DATA INF QUAL, V4, P20; Denecker M, 2010, ACM T DATABASE SYST, V35, DOI 10.1145/1806907.1806914; Detwiler LT, 2016, ARTIF INTELL MED, V69, P12, DOI 10.1016/j.artmed.2016.04.003; Doherty P, 2000, LECT NOTES ARTIF INT, V1904, P49; Goldman NM, 2003, LECT NOTES COMPUT SC, V2870, P850; Grasso Clare T., 2016, 2016 IEEE Tenth International Conference on Semantic Computing (ICSC). Proceedings, P321, DOI 10.1109/ICSC.2016.53; Grimm S, 2006, EUR SEM WEB C BERL H, V575-589; Grimm S, 2005, P OWLED 2005 WORKSH; Guarino N., 2009, HDB ONTOLOGIES, V2009, P1, DOI [10.1007/978-3-540-92673-3_0, DOI 10.1007/978-3-540-92673-3_0]; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Heja G, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-S1-S8; Horridge M, 2011, SEMANT WEB, V2, P11, DOI 10.3233/SW-2011-0025; Hustadt U., 1994, KI 1994 WORKSH REAS, VD-94-11, P24; ICoide S, 2005, 4 INT SEM WEB C ISWC, P1; Krishnadhi A, 2011, P 2011 INT WORKSH DE, V745-756; Kalyanpur A, 2004, P 16 INT C SOFTW ENG, P98; Keet C. Maria, 2017, Language, Data and Knowledge. First International Conference, LDK 2017. Proceedings: LNAI 10318, P58, DOI 10.1007/978-3-319-59888-8_5; Keet CM, 2017, DEM 14 EXT SEM WEB C; Knorr M, 2011, ARTIF INTELL, V175, P1528, DOI 10.1016/j.artint.2011.01.007; Knublauch H, 2006, SEMANTIC WEB PRIMER; Koide S, 2006, LECT NOTES COMPUT SC, V4185, P263; Kollia I, 2013, J ARTIF INTELL RES, V48, P253; Lamy JB, 2017, J BIOMED INFORM, V71, P58, DOI 10.1016/j.jbi.2017.04.019; Lamy JB, 2016, STUD HEALTH TECHNOL, V221, P64, DOI 10.3233/978-1-61499-633-0-64; Lamy Jean-Baptiste, 2015, Stud Health Technol Inform, V210, P924; Lassila O, 1999, RESOURCE DESCRIPTION; Levin MK, 2015, J BIOMED SEMANT, V6, DOI 10.1186/s13326-015-0035-z; McGettigan P, 2001, BRIT J CLIN PHARMACO, V51, P184; Motik B, 2007, P OWLED 2007 WORKSH; Motik B, 2010, J ACM, V57, DOI 10.1145/1754399.1754403; Motik B, 2009, J ARTIF INTELL RES, V36, P165; Patel C, 2007, SEMANTIC WEB, V816-829; Prosser H, 2003, FAM PRACT, V20, P61, DOI 10.1093/fampra/20.1.61                                                          ; Rector A, 2008, 4 INT WORKSH SEM WEB; Rector AL, 1996, 14 INT C EUR FED MED; Ren Yuan, 2010, Tsinghua Science and Technology, V15, P692, DOI 10.1016/S1007-0214(10)70117-6; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; Rudolph S, 2008, TECHNICAL REPORT; Schulz S, 2013, Yearb Med Inform, V8, P132; Sheridan DJ, 2016, J AM COLL CARDIOL, V68, P204, DOI 10.1016/j.jacc.2016.03.600; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; SPARQL query language for RDF, 2008, W3C RECOMMENDATION; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Stevenson G, 2011, LECT NOTES BUS INF P, V83, P425; Yu AC, 2006, J BIOMED INFORM, V39, P252, DOI 10.1016/j.jbi.2005.11.006; Zhao JC, 2017, P 2017 INT C MAN ENG, V321-325; Zhu XX, 2009, J BIOMED INFORM, V42, P413, DOI 10.1016/j.jbi.2009.03.003; Zimmermann M., 2009, OWL2JAVA JAVA CODE G	55	0	0	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0933-3657	1873-2860		ARTIF INTELL MED	Artif. Intell. Med.	JUL	2017	80						11	28		10.1016/j.artmed.2017.07.002				18	Computer Science, Artificial Intelligence; Engineering, Biomedical; Medical Informatics	Computer Science; Engineering; Medical Informatics	FJ3DD	WOS:000412609800002	28818520				2018-01-05	
J	Zong, HF; Han, L; Ding, K; Wang, JX; Sun, T; Zhang, XY; Cagliero, C; Jiang, H; Xie, YQ; Xu, JR; Zhang, BH; Zhu, JW				Zong, Huifang; Han, Lei; Ding, Kai; Wang, Jiaxian; Sun, Tao; Zhang, Xinyu; Cagliero, Cedric; Jiang, Hua; Xie, Yueqing; Xu, Jianrong; Zhang, Baohong; Zhu, Jianwei			Producing defucosylated antibodies with enhanced in vitro antibody-dependent cellular cytotoxicity via FUT8 knockout CHO-S cells	ENGINEERING IN LIFE SCIENCES			English	Article						alpha-1,6 fucosyltransferase (FUT8); Antibody-dependent cellular cytotoxicity (ADCC); CRISPR; Cas9; Defucosylated antibodies; Gene knockout	MONOCLONAL-ANTIBODIES; MEDIATED CYTOTOXICITY; MAMMALIAN-CELLS; CANCER; TRASTUZUMAB; BINDING; FUCOSE; ALPHA-1,6-FUCOSYL-TRANSFERASE; CHROMATOGRAPHY; MOGAMULIZUMAB	To engineer a host cell line that produces defucosylated mAbs with superior antibody dependent cellular cytotoxicity, we disrupted alpha-1,6 fucosyltransferase (FUT8) gene in CHO-S (CHO is Chinese hamster ovary) cells by clustered regularly interspaced short palindromic repeats-CRISPR associated nuclease 9. The gene knockout cell line was evaluated for growth, stability, and product quality. The growth profile of FUT8 gene knockout CHO-S (FUT8(-/-)) cells was comparable with wild type CHO-S cells. FUT8 catalyzes the transfer of a fucose residue from GDP-fucose to N-glycans residue. Defucosylated IgG1 antibodies produced by FUT8(-/-) cells showed increased binding affinities to human Fc gamma RIIIa and higher activities in mediating antibody-dependent cellular cytotoxicity, comparing with conventional fucosylated IgG1. Our results demonstrated the potential of using the clustered regularly interspaced short palindromic repeats-CRISPR associated nuclease 9 technology in cell line engineering for biopharmaceutical industrial applications.	[Zong, Huifang; Han, Lei; Ding, Kai; Wang, Jiaxian; Sun, Tao; Zhang, Xinyu; Zhang, Baohong; Zhu, Jianwei] Shanghai Jiao Tong Univ, Minist Educ, Sch Pharm, Engn Res Ctr Cell & Therapeut Antibody, Shanghai, Peoples R China; [Cagliero, Cedric; Jiang, Hua; Xie, Yueqing; Zhu, Jianwei] Jecho Labs, Frederick, MD USA; [Xu, Jianrong] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China	Zhang, BH (reprint author), Shanghai Jiao Tong Univ, Sch Pharm, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	bhzhang@sjtu.edu.cn			National Science Foundation of China [81502969]	This project was supported by National Science Foundation of China (grant number: 81502969). All the authors reviewed and agree to submit this study. The study does not contain experiments using animals and human studies.	Almhanna K, 2013, CANCER CONTROL, V20, P111, DOI 10.1177/107327481302000204                                                      ; Bachu R, 2015, BIOTECHNOL BIOENG, V112, P2154, DOI 10.1002/bit.25629; Barok M, 2007, MOL CANCER THER, V6, P2065, DOI 10.1158/1535-7163.MCT-06-0766; Beck A, 2012, MABS-AUSTIN, V4, P419, DOI 10.4161/mabs.20996; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Carter P, 2001, NAT REV CANCER, V1, P118, DOI 10.1038/35101072; Clynes RA, 2000, NAT MED, V6, P443; Collins DM, 2012, ANN ONCOL, V23, P1788, DOI 10.1093/annonc/mdr484; Damen CWN, 2009, J PHARMACEUT BIOMED, V50, P861, DOI 10.1016/j.jpba.2009.04.031; Ding K, 2017, APPL MICROBIOL BIOT, V101, P1889, DOI 10.1007/s00253-016-7973-y; Drake AW, 2012, ANAL BIOCHEM, V429, P58, DOI 10.1016/j.ab.2012.06.024; Duvic M, 2015, BLOOD, V125, P1883, DOI 10.1182/blood-2014-09-600924; Elvin JG, 2013, INT J PHARMACEUT, V440, P83, DOI 10.1016/j.ijpharm.2011.12.039; Gupta RM, 2014, J CLIN INVEST, V124, P4154, DOI 10.1172/JCI72992; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.chromb.2006.09.030; Iannello A, 2005, CANCER METAST REV, V24, P487, DOI 10.1007/s10555-005-6192-2; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Iqbal N, 2014, MOL BIOL INT, V2014, P1, DOI DOI 10.1155/2014/852748; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9                                                    ; Kotzler MP, 2012, BBA-GEN SUBJECTS, V1820, P1915, DOI 10.1016/j.bbagen.2012.08.018; Lee JS, 2015, BIOTECHNOL J, V10, P979, DOI 10.1002/biot.201500082; Li WZ, 2015, J IMMUNOL, V194, P2596, DOI 10.4049/jimmunol.1402678; Malphettes L, 2010, BIOTECHNOL BIOENG, V106, P774, DOI 10.1002/bit.22751; Mimura K, 2005, CLIN CANCER RES, V11, P4898, DOI 10.1158/1078-0432.CCR-04-2476                                                   ; Niwa R, 2005, CLIN CANCER RES, V11, P2327, DOI 10.1158/1078-0432.CCR-04-2263                                                   ; Omasa T, 2010, CURR PHARM BIOTECHNO, V11, P233, DOI 10.2174/138920110791111960                                                      ; Ronda C, 2014, BIOTECHNOL BIOENG, V111, P1604, DOI 10.1002/bit.25233; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Sun T, 2015, ENG LIFE SCI, V15, P660, DOI 10.1002/elsc.201400218; Tschui J, 2015, VIRCHOWS ARCH, V466, P703, DOI 10.1007/s00428-015-1729-4; Weitzman J, 2009, LEUKEMIA LYMPHOMA, V50, P1361, DOI 10.1080/10428190903026500; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Zhu JW, 2012, BIOTECHNOL ADV, V30, P1158, DOI 10.1016/j.biotechadv.2011.08.022	35	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1618-0240	1618-2863		ENG LIFE SCI	Eng. Life Sci.	JUL	2017	17	7					801	808		10.1002/elsc.201600255				8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FI8YE	WOS:000412288400011					2018-01-05	
J	Niu, YY; Li, TQ; Ji, WZ				Niu, Yuyu; Li, Tianqing; Ji, Weizhi			Paving the road for biomedicine: genome editing and stem cells in primates	NATIONAL SCIENCE REVIEW			English	Review						genome editing; stem cells; non-human primate	MARMOSET CALLITHRIX-JACCHUS; MPTP-TREATED MONKEYS; CYNOMOLGUS MONKEY; NONHUMAN PRIMATE; PARKINSONS-DISEASE; TRANSGENIC MONKEYS; NUCLEAR TRANSFER; RHESUS-MONKEYS; GENE-TRANSFER; GERMLINE TRANSMISSION	Non-human primates (NHPs) are similar with humans in their anatomy, physiology, genetics and neural functions, and in their cognition, emotions and social behavior. The NHP model has played an important role in the biomedical research, development of vaccines and drugs and new therapies for many diseases. Recent advances in genome editing have generated NHP models for human diseases. Genome editing integrated with derivation of NHP pluripotent stem cells now provides an optimal resource to regenerate medicine.	[Niu, Yuyu; Li, Tianqing; Ji, Weizhi] Kunming Univ Sci & Technol, Yunnan Key Lab Primate Biomed Res, Inst Primate Translat Med, Kunming 650500, Yunnan, Peoples R China	Ji, WZ (reprint author), Kunming Univ Sci & Technol, Yunnan Key Lab Primate Biomed Res, Inst Primate Translat Med, Kunming 650500, Yunnan, Peoples R China.	wji@lpbr.cn			National Key Research and Development Program of China [2016YFA0101401]; National Natural Science Foundation of China [U1302227, U1602224]	This work was supported by the National Key Research and Development Program of China (2016YFA0101401), the National Natural Science Foundation of China (U1302227 and U1602224).	Bjugstad KB, 2005, CELL TRANSPLANT, V14, P183, DOI 10.3727/000000005783983098; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Chan AWS, 2001, SCIENCE, V291, P309, DOI 10.1126/science.291.5502.309; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen YC, 2017, CELL, V169, P945, DOI 10.1016/j.cell.2017.04.035; Chen YC, 2015, CELL STEM CELL, V17, P116, DOI 10.1016/j.stem.2015.06.004; Chen YC, 2015, HUM MOL GENET, V24, P3764, DOI 10.1093/hmg/ddv120; Chen YC, 2015, CELL RES, V25, P262, DOI 10.1038/cr.2014.167; Chung YG, 2014, CELL STEM CELL, V14, P777, DOI 10.1016/j.stem.2014.03.015; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Daadi MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041120; Emborg ME, 2008, CELL TRANSPLANT, V17, P383; Emborg ME, 2013, CELL REP, V3, P646, DOI 10.1016/j.celrep.2013.02.016; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Hallett PJ, 2015, CELL STEM CELL, V16, P269, DOI 10.1016/j.stem.2015.01.018; Hong SG, 2014, CELL REP, V7, P1298, DOI 10.1016/j.celrep.2014.04.019; Huang K, 2014, CELL STEM CELL, V15, P410, DOI 10.1016/j.stem.2014.09.014; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kang Y, 2015, HUM MOL GENET, V24, P7255, DOI 10.1093/hmg/ddv425; Ke Q, 2016, CELL RES, V26, P1048, DOI 10.1038/cr.2016.93; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Liu HL, 2014, CELL STEM CELL, V14, P323, DOI 10.1016/j.stem.2014.01.018; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Liu Z, 2016, NATURE, V530, P98, DOI 10.1038/nature16533; Liu Z, 2014, NEUROSCI BULL, V30, P381, DOI 10.1007/s12264-014-1434-8; Meng L, 1997, BIOL REPROD, V57, P454, DOI 10.1095/biolreprod57.2.454; Mitalipov S, 2006, STEM CELLS, V24, P2177, DOI 10.1634/stemcells.2006-0125; Nasir J, 2001, CLIN GENET, V59, P302, DOI 10.1034/j.1399-0004.2001.590502.x; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niu YY, 2015, HUM MOL GENET, V24, P2308, DOI 10.1093/hmg/ddu748; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Niu YY, 2010, P NATL ACAD SCI USA, V107, P17663, DOI 10.1073/pnas.1006563107; Park JE, 2016, SCI REP-UK, V6, DOI 10.1038/srep34931; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Sasaki E, 2005, STEM CELLS, V23, P1304, DOI 10.1634/stemcells.2004-0366; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Sasaki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026577; Sato K, 2016, CELL STEM CELL, V19, P127, DOI 10.1016/j.stem.2016.06.003; Senior K, 2001, LANCET, V357, P450, DOI 10.1016/S0140-6736(05)71263-0                                                   ; Shiozawa S, 2011, STEM CELLS DEV, V20, P1588, DOI 10.1089/scd.2010.0351; Simerly CR, 2009, STEM CELL RES, V2, P178, DOI 10.1016/j.scr.2009.02.004; Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191                                                               ; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; Takagi Y, 2005, J CLIN INVEST, V115, P102, DOI 10.1172/JCI200521137; Takahashi Jun, 2009, V482, P199, DOI 10.1007/978-1-59745-060-7_13; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Thomson JA, 1996, BIOL REPROD, V55, P254, DOI 10.1095/biolreprod55.2.254; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Wan HF, 2015, CELL RES, V25, P258, DOI 10.1038/cr.2014.158; Wang SY, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.12; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Wolfgang MJ, 2001, P NATL ACAD SCI USA, V98, P10728, DOI 10.1073/pnas.181336098; Xiong X, 2016, ANNU REV GENOM HUM G, V17, P131, DOI 10.1146/annurev-genom-083115-022258; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Yang Y, 2017, CELL, V169, P243, DOI 10.1016/j.cell.2017.02.005; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	60	0	0	7	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2095-5138	2053-714X		NATL SCI REV	Natl. Sci. Rev.	JUL	2017	4	4					543	549		10.1093/nsr/nwx094				7	Multidisciplinary Sciences	Science & Technology - Other Topics	FI8RT	WOS:000412270500013					2018-01-05	
J	Shin, J; Jiang, FG; Liu, JJ; Bray, NL; Rauch, BJ; Baik, SH; Nogales, E; Bondy-Denomy, J; Corn, JE; Doudna, JA				Shin, Jiyung; Jiang, Fuguo; Liu, Jun-Jie; Bray, Nicolas L.; Rauch, Benjamin J.; Baik, Seung Hyun; Nogales, Eva; Bondy-Denomy, Joseph; Corn, Jacob E.; Doudna, Jennifer A.			Disabling Cas9 by an anti-CRISPR DNA mimic	SCIENCE ADVANCES			English	Article							TARGET DNA; ENDONUCLEASE CAS9; RNA; SPECIFICITY; NUCLEASES; CLEAVAGE; COMPLEX; MICROSCOPY; SYSTEM; GENES	CRISPR (clustered regularly interspaced short palindromic repeats)-Cas9 gene editing technology is derived from a microbial adaptive immune system, where bacteriophages are often the intended target. Natural inhibitors of CRISPR-Cas9 enable phages to evade immunity and show promise in controlling Cas9-mediated gene editing in human cells. However, the mechanism of CRISPR-Cas9 inhibition is not known, and the potential applications for Cas9 inhibitor proteins in mammalian cells have not been fully established. We show that the anti-CRISPR protein AcrIIA4 binds only to assembled Cas9-single-guide RNA (sgRNA) complexes and not to Cas9 protein alone. A 3.9 angstrom resolution cryo-electron microscopy structure of the Cas9-sgRNA-AcrIIA4 complex revealed that the surface of AcrIIA4 is highly acidic and binds with a 1:1 stoichiometry to a region of Cas9 that normally engages the DNA protospacer adjacent motif. Consistent with this binding mode, order-of-addition experiments showed that AcrIIA4 interferes with DNA recognition but has no effect on preformed Cas9-sgRNA-DNA complexes. Timed delivery of AcrIIA4 into human cells as either protein or expression plasmid allows on-target Cas9-mediated gene editing while reducing off-target edits. These results provide a mechanistic understanding of AcrIIA4 function and demonstrate that inhibitors can modulate the extent and outcomes of Cas9-mediated gene editing.	[Shin, Jiyung; Bray, Nicolas L.; Baik, Seung Hyun; Corn, Jacob E.; Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Shin, Jiyung; Jiang, Fuguo; Liu, Jun-Jie; Bray, Nicolas L.; Baik, Seung Hyun; Nogales, Eva; Corn, Jacob E.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Jiang, Fuguo; Doudna, Jennifer A.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Liu, Jun-Jie; Nogales, Eva; Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Rauch, Benjamin J.; Nogales, Eva; Bondy-Denomy, Joseph] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Rauch, Benjamin J.; Nogales, Eva; Bondy-Denomy, Joseph; Doudna, Jennifer A.] Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94158 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Corn, JE; Doudna, JA (reprint author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Corn, JE; Doudna, JA (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	jcorn@berkeley.edu; doudna@berkeley.edu		Corn, Jacob/0000-0002-7798-5309	Li Ka Shing Foundation; Heritage Medical Research Institute; AstraZeneca; Pfizer; National Institute on Aging of the NIH [T32 AG000266]; University of California, San Francisco Program for Breakthrough in Biomedical Research; Sandler Foundation; NIH Office of the Director Early Independence Award [DP5-0D021344]; HHMI; NIH; NSF; Roche; Paul Allen Foundation; Keck Foundation	F.J. is a Merck Fellow of the Damon Runyon Cancer Research (DRG-2201-14). J.E.C. is supported by the Li Ka Shing Foundation and the Heritage Medical Research Institute. J.E.C. receives funding from AstraZeneca, Pfizer, the Li Ka Shing Foundation, and the Heritage Medical Research Institute. J.S. is supported by the National Institute on Aging of the NIH under award number T32 AG000266. J.B.-D. and BJ.R. are supported by the University of California, San Francisco Program for Breakthrough in Biomedical Research, funded in part by the Sandler Foundation, and an NIH Office of the Director Early Independence Award (DP5-0D021344). J.A.D, receives funding from HHMI, the NIH, the NSF, Roche, Pfizer, the Paul Allen Foundation, and the Keck Foundation. J.A.D. and E.N. are Investigators of the Howard Hughes Medical Institute (HHMI). This work was supported in part by HHMI.	Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Walkinshaw MD, 2002, MOL CELL, V9, P187, DOI 10.1016/S1097-2765(02)00435-5                                                   ; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	31	3	3	5	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	JUL	2017	3	7							e1701620	10.1126/sciadv.1701620				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FI0CH	WOS:000411588000029	28706995	gold			2018-01-05	
J	Miller, WG; Yee, E; Lopes, BS; Chapman, MH; Huynh, S; Bono, JL; Parker, CT; Strachan, NJC; Forbes, KJ				Miller, William G.; Yee, Emma; Lopes, Bruno S.; Chapman, Mary H.; Huynh, Steven; Bono, James L.; Parker, Craig T.; Strachan, Norval J. C.; Forbes, Ken J.			Comparative Genomic Analysis Identifies a Campylobacter Clade Deficient in SeleniumMetabolism	GENOME BIOLOGY AND EVOLUTION			English	Article						Campylobacter; C. lanienae; C. fetus; selenium; flagella	CRISPR-CAS SYSTEMS; ESCHERICHIA-COLI; ANTIMICROBIAL SUSCEPTIBILITY; FORMATE DEHYDROGENASE; BEEF-CATTLE; SUS-SCROFA; UGA CODON; FETUS; HYOINTESTINALIS; PROKARYOTES	The nonthermotolerant Campylobacter species C. fetus, C. hyointestinalis, C. iguaniorum, and C. lanienae form a distinct phylogenetic cluster within the genus. These species are primarily isolated from foraging (swine) or grazing (e. g., cattle, sheep) animals and cause sporadic and infrequent human illness. Previous typing studies identified three putative novel C. lanienae-related taxa, based on either MLST or atpA sequence data. To further characterize these putative novel taxa and the C. fetus group as a whole, 76 genomeswere sequenced, either tocompletionor to draft level. These genomes represent26 C. lanienae strains and 50strainsof the three novel taxa. C. fetus, C. hyointestinalis and C. iguaniorum genomes were previously sequenced to completion; therefore, a comparative genomic analysis across the entire C. fetus group was conducted (including average nucleotide identity analysis) that supports the initial identification of these three novel Campylobacter species. Furthermore, C. lanienae and the three putative novel species form a discrete cladewithin the C. fetus group, whichwe have termed the C. lanienae clade. This clade is distinguished from othermembers of the C. fetus group by a reduced genome size and distinct CRISPR/ Cas systems. Moreover, there are two signature characteristics of the C. lanienae clade. C. lanienae clade genomes carry four to ten unlinked and similar, but nonidentical, flagellin genes. Additionally, all 76 C. lanienae clade genomes sequenced demonstrate a complete absence of genes related to selenium metabolism, including genes encoding the selenocysteine insertion machinery, selenoproteins, and the selenocysteinyl tRNA.	[Miller, William G.; Yee, Emma; Chapman, Mary H.; Huynh, Steven; Parker, Craig T.] ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA; [Lopes, Bruno S.; Strachan, Norval J. C.; Forbes, Ken J.] Univ Aberdeen, Sch Med Med Sci & Nutr, Aberdeen, Scotland; [Bono, James L.] ARS, Meat Safety & Qual Res Unit, USDA, Clay Ctr, NE USA	Miller, WG (reprint author), ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA.	william.miller@ars.usda.gov			United States Department of Agriculture, Agricultural Research Service, CRIS projects [2030-42000-230-047, 2030-42000-230-051]; United States Department of Agriculture, Agricultural Research Service, Food Standards Scotland project [S14054]	This work was funded by the United States Department of Agriculture, Agricultural Research Service, CRIS projects 2030-42000-230-047 and 2030-42000-230-051, and Food Standards Scotland project S14054.	Ali A, 2012, GENE, V508, P145, DOI 10.1016/j.gene.2012.07.070; Baumler A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010041; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Blaser MJ, 2008, CAMPYLOBACTER, 3RD EDITION, P401; Carbonero A, 2014, COMP IMMUNOL MICROB, V37, P115, DOI 10.1016/j.cimid.2014.01.001; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cooley MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065716; Cravedi P, 2015, GENOME BIOL EVOL, V7, P2692, DOI 10.1093/gbe/evv177; Debruyne L, 2008, CAMPYLOBACTER, 3RD EDITION, P3; Deshpande NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022170; Fitzgerald C, 2014, INT J SYST EVOL MICR, V64, P2944, DOI 10.1099/ijs.0.057778-0; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; FORCHHAMMER K, 1991, BIOCHIMIE, V73, P1481, DOI 10.1016/0300-9084(91)90181-Y; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; GEBHART CJ, 1985, J CLIN MICROBIOL, V21, P715; Gilbert MJ, 2015, INT J SYST EVOL MICR, V65, P975, DOI 10.1099/ijs.0.000048; Gilbert M.J., 2013, GENOME ANNOUNC, V1, P3; Gilbert MJ, 2014, GENOME ANNOUNC, V2; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Gorkiewicz G, 2002, J CLIN MICROBIOL, V40, P2601, DOI 10.1128/JCM.40.7.2601-2605.2002; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guevremont E, 2014, FOODBORNE PATHOG DIS, V11, P388, DOI 10.1089/fpd.2013.1706; Hakkinen M, 2007, APPL ENVIRON MICROB, V73, P3232, DOI 10.1128/AEM.02579-06; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hille F, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0496; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Inglis GD, 2004, J APPL MICROBIOL, V97, P410, DOI 10.1111/j.1365-2672.2004.02313.x; Inglis GD, 2003, CAN J MICROBIOL, V49, P655, DOI [10.1139/w03-087, 10.1139/W03-087]; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jay-Russell MT, 2012, ZOONOSES PUBLIC HLTH, V59, P314, DOI 10.1111/j.1863-2378.2012.01465.x; Kim DK, 2015, ANN LAB MED, V35, P657, DOI 10.3343/alm.2015.35.6.657; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lin J, 2015, GENOME BIOL EVOL, V7, P664, DOI 10.1093/gbe/evv022; Logan JMJ, 2000, INT J SYST EVOL MICR, V50, P865, DOI 10.1099/00207713-50-2-865                                                       ; Logan SM, 2008, CAMPYLOBACTER, 3RD EDITION, P471; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Merga JY, 2013, GENOME ANNOUNC, V1; Miller WG, 2014, LETT APPL MICROBIOL, V58, P582, DOI 10.1111/lam.12228; Miller WG, 2016, GENOME ANNOUNC, V4, P646; Miller WG, 2016, GENOME ANNOUNC, V4; Miller WG, 2015, GENOME ANNOUNC, V3; Miller WG, 2014, GENOME BIOL EVOL, V6, P3252, DOI 10.1093/gbe/evu249; Miller WG, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00045; Navarro-Gonzalez N, 2014, ECOHEALTH, V11, P333, DOI 10.1007/s10393-014-0921-3; Oliveira L. M., 2016, GENOME ANNOUNC, V4; On SLW, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P13; ON SLW, 1995, INT J SYST BACTERIOL, V45, P767, DOI 10.1099/00207713-45-4-767                                                       ; Oporto B, 2011, FOODBORNE PATHOG DIS, V8, P807, DOI 10.1089/fpd.2010.0803; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Patrick ME, 2013, EMERG INFECT DIS, V19, P1678, DOI 10.3201/eid1910.130883; Pearson BM, 2015, GENOME BIOL EVOL, V7, P2663, DOI 10.1093/gbe/evv174; Stynen APR, 2011, J BACTERIOL, V193, P5871, DOI 10.1128/JB.05854-11; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Salihu MD, 2009, VET ITAL, V45, P501; Samosornsuk W, 2015, JPN J INFECT DIS, V68, P209, DOI 10.7883/yoken.JJID.2014.229; Sasaki Y, 2013, FOODBORNE PATHOG DIS, V10, P985, DOI 10.1089/fpd.2013.1548; Schoenhofen IC, 2009, GLYCOBIOLOGY, V19, P715, DOI 10.1093/glycob/cwp039; Schweitzer N, 2011, FOODBORNE PATHOG DIS, V8, P615, DOI 10.1089/fpd.2010.0754; Serraino A, 2013, J DAIRY SCI, V96, P2801, DOI 10.3168/jds.2012-6249; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Tasaki E, 2012, WORLD J MICROB BIOT, V28, P713, DOI 10.1007/s11274-011-0867-3; Turowski EE, 2014, ZOONOSES PUBLIC HLTH, V61, P571, DOI 10.1111/zph.12107; van Bergen MAP, 2005, J CLIN MICROBIOL, V43, P5888, DOI 10.1128/JCM.43.12.5888-5898.2005; van der Graaf-van Bloois L, 2014, J CLIN MICROBIOL, V52, P4183, DOI 10.1128/JCM.01837-14; vander Graaf-van Bloois L, 2014, GENOME ANNOUNC, V2, DOI DOI 10.1128/GENOMEA.01246-13; WITTWER AJ, 1983, J BIOL CHEM, V258, P8637; Wolfe MD, 2004, J BIOL CHEM, V279, P1801, DOI 10.1074/jbc.M310442200; ZINONI F, 1987, P NATL ACAD SCI USA, V84, P3156, DOI 10.1073/pnas.84.10.3156; ZINONI F, 1990, P NATL ACAD SCI USA, V87, P4660, DOI 10.1073/pnas.87.12.4660                                                         	70	0	0	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1759-6653			GENOME BIOL EVOL	Genome Biol. Evol.	JUL	2017	9	7					1843	1858		10.1093/gbe/evx093				16	Evolutionary Biology; Genetics & Heredity	Evolutionary Biology; Genetics & Heredity	FG8JD	WOS:000410676100001	28854596	gold			2018-01-05	
J	Bernardo, R				Bernardo, Rex			Prospective Targeted Recombination and Genetic Gains for Quantitative Traits in Maize	PLANT GENOME			English	Article							GENOMEWIDE SELECTION; GENOMIC SELECTION; CELLULOSIC ETHANOL; GRAIN-YIELD; PREDICTION; POPULATIONS; INBREDS; PLANTS; CROSS; MAP	Advances in clustered regularly interspaced short palindromic repeats (CRISPR) technology have allowed targeted recombination in specific DNA sequences in yeast (Saccharomyces cerevisiae). My objective was to determine if the selection gains from targeted recombination are large enough to warrant the development of targeted recombination technology in plants. Genomewide marker effects for quantitative traits in two maize (Zea mays L.) experiments were used to identify targeted recombination points that would maximize the per-chromosome genetic gains in a given cross. With nontargeted recombination in the intermated B73 x Mo17 population, selecting the best out of 180 recombinant inbreds led to a 7.1% gain for testcross yield. Having one targeted recombination on each of the 10 maize chromosomes led to a predicted gain of 15.3% for yield. Targeted recombination therefore led to a predicted relative efficiency (RETargeted) of (0.153 divided by 0.071) = 212% of targeted recombination compared with nontargeted recombination. For the five other traits in the intermated B73 x Mo17 population and for four traits in 45 other maize crosses, the RETargeted values ranged from 105 to 600%. The targeted recombination points differed among traits and crosses. Predicted gains increased when the number of targeted recombinations per chromosome increased from one to two. Overall, the results suggested that targeted recombination could double the selection gains for quantitative traits in maize and that the development of targeted recombination technology is worthwhile. Empirical experiments with current marker-assisted breeding procedures are needed to validate the per-chromosome predicted gains.	[Bernardo, Rex] Univ Minnesota, Dept Agron & Plant Genet, 411 Borlaug Hall,1991 Upper Buford Circle, St Paul, MN 55108 USA	Bernardo, R (reprint author), Univ Minnesota, Dept Agron & Plant Genet, 411 Borlaug Hall,1991 Upper Buford Circle, St Paul, MN 55108 USA.	bernando@umn.edu					Albrecht T, 2011, THEOR APPL GENET, V123, P339, DOI 10.1007/s00122-011-1587-7; Asoro FG, 2013, CROP SCI, V53, P1894, DOI 10.2135/cropsci2012.09.0526; Bastianelli G., 2015, PLANT AN GEN C SAN D; BECKER WA, 1984, MANUAL QUANTITATIVE; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; BERNARDO R, 1991, CROP SCI, V31, P1174, DOI 10.2135/cropsci1991.0011183X003100050020x                                       ; Bernardo R., 2010, BREEDING QUANTITATIV; Bernardo R, 2014, ESSENTIALS PLANT BRE; Bernardo R., 2015, CROP SCI, V55, P2586; Bernardo R, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2016.03.0028; Bernardo R, 2014, CROP SCI, V54, P68, DOI 10.2135/cropsci2013.05.0315; Beyene Y, 2015, CROP SCI, V55, P154, DOI 10.2135/cropsci2014.07.0460; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Combs E, 2013, CROP SCI, V53, P1427, DOI 10.2135/cropsci2012.11.0666; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; Dekkers JCM, 2007, J ANIM BREED GENET, V124, P331, DOI 10.1111/j.1439-0388.2007.00701.x                                                ; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Food and Agriculture Organization, 2009, HIGH LEV EXP FOR FEE; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Hallauer A. R., 1988, Corn and corn improvement. Third edition., P463; Hallauer A. R., 1989, QUANTITATIVE GENETIC; Jacobson A, 2014, CROP SCI, V54, P895, DOI 10.2135/cropsci2013.11.0774; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Lewis MF, 2010, CROP SCI, V50, P516, DOI 10.2135/cropsci2009.03.0148; Lian L, 2014, CROP SCI, V54, P1514, DOI 10.2135/cropsci2013.12.0856; Liu SZ, 2010, GENETICS, V184, P19, DOI 10.1534/genetics.109.107557; Lorenzana RE, 2010, CROP SCI, V50, P541, DOI 10.2135/cropsci2009.04.0182; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Massman JM, 2013, CROP SCI, V53, P58, DOI 10.2135/cropsci2012.02.0112; Massman JM, 2013, THEOR APPL GENET, V126, P13, DOI 10.1007/s00122-012-1955-y; Meuwissen THE, 2001, GENETICS, V157, P1819; Offord C., 2016, SCIENTIST; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Puchta H, 2014, PLANT J, V78, P727, DOI 10.1111/tpj.12338; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Resende Jr M.F.R., 2012, GENETICS, V188, P695; Rutkoski J, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.10.0074; Sadhu MJ, 2016, SCIENCE, V352, P1113, DOI 10.1126/science.aaf5124; Schaefer CM, 2013, CROP SCI, V53, P2518, DOI 10.2135/cropsci2013.02.0121; Schuermann D, 2005, TRENDS GENET, V21, P172, DOI 10.1016/j.tig.2005.01.002; Senior ML, 1996, CROP SCI, V36, P1676, DOI 10.2135/cropsci1996.0011183X003600060043x                                       ; Sleper JA, 2016, THEOR APPL GENET, V129, P2429, DOI 10.1007/s00122-016-2781-4; Smith JSC, 2008, MOL BREEDING, V22, P51, DOI 10.1007/s11032-007-9155-1	44	0	0	6	6	CROP SCIENCE SOC AMER	MADISON	677 S SEGOE ROAD, MADISON, WI 53711 USA	1940-3372			PLANT GENOME-US	Plant Genome	JUL	2017	10	2								10.3835/plantgenome2016.11.0118				9	Plant Sciences; Genetics & Heredity	Plant Sciences; Genetics & Heredity	FH0HF	WOS:000410819500016		gold			2018-01-05	
J	Dardouri, S; Chehimi, S; Murillo, J; Hajlaoui, MR				Dardouri, S.; Chehimi, S.; Murillo, J.; Hajlaoui, M. R.			MOLECULAR CHARACTERIZATION OF TUNISIAN STRAINS OF ERWINIA AMYLOVORA	JOURNAL OF PLANT PATHOLOGY			English	Article						fire blight; Erwinia amylovora; PCR; CRIS-PR; VNTR primers; fingerprinting; epidemiology	FRAGMENT-LENGTH-POLYMORPHISM; VARIABLE-NUMBER; FIRE BLIGHT; TANDEM REPEATS; MYCOBACTERIUM-TUBERCULOSIS; DNA; DIFFERENTIATION; DIVERSITY; GENOME; CRISPR	The present study focused on the molecular characterization of a collection of Erwinia amylovora isolates recovered from different outbreaks in Tunisia between 2012 and 2014. Analysis of 54 isolates, including the reference type strain CFBP 1430, revealed that all Tunisian isolates produced the expected amplicons with diverse primer pairs routinely used for molecular diagnostics of E. amylovora. We also evaluated the genetic variability of these isolates by PCR fingerprinting, using specific primers for clustered regularly interspaced short palindromic repeats (CRISPRs) and for variable number of tandem repeats (VNTR) sequences. For the first method, our results revealed that all the primers used, except those for CRISPR3, which produced an identical amplicon for all isolates, showed some variability among Tunisian isolates. For the second method, forty-nine isolates showed the same fingerprint patterns as the reference type strain CFBP 1430 with all the primers used, whereas four of the isolates showed very divergent patterns. These results suggest that there has been a main introduction of European-type isolates in Tunisia, and possibly a few mutations or other independent introductions of the pathogen. Additionally, these results indicate that PCR fingerprinting using VNTR markers is a most useful tool for discriminating among E. amylovora strains and for their identification in epidemiological studies.	[Dardouri, S.; Chehimi, S.; Hajlaoui, M. R.] INRA Tunisie, Lab Biotechnol Appl Agr, Tunis 1004, Tunisia; [Dardouri, S.] Fac Sci Math Phys & Nat Tunis, Campus Univ, Tunis 2092, Tunisia; [Murillo, J.] Univ Publ Navarra, Dept Prod Agr, Lab Patol Vegetal, Pamplona 31006, Spain	Dardouri, S (reprint author), INRA Tunisie, Lab Biotechnol Appl Agr, Tunis 1004, Tunisia.; Dardouri, S (reprint author), Fac Sci Math Phys & Nat Tunis, Campus Univ, Tunis 2092, Tunisia.	sanadardouri@gmail.com	Murillo, Jesus/D-2901-2009	Murillo, Jesus/0000-0001-6585-2421	Ministry of Higher Education and Scientific Research of Tunisia	We would like to express our appreciation to staff of the Laboratorio de Patologia Vegetal, Departamento de Produccion Agraria (Universidad Publica de Navarra, Pamplona, Spain) for their invaluable help during the course of this work. This research was supported in part by the Ministry of Higher Education and Scientific Research of Tunisia.	Barionovi D, 2006, J APPL MICROBIOL, V100, P1084, DOI 10.1111/j.1365-2672.2006.02813.x; Bonn WG, 2000, FIRE BLIGHT, P37, DOI 10.1079/9780851992945.003; BOWDITCH BM, 1993, METHOD ENZYMOL, V224, P294, DOI 10.1016/0076-6879(93)24022-M; Buhlmann A, 2014, ENVIRON MICROBIOL, V16, P2112, DOI 10.1111/1462-2920.12289; Donat V, 2007, J APPL MICROBIOL, V103, P1639, DOI 10.1111/j.1365-2672.2007.03399.x; Drenova N., 2016, PROGR 1 INT S FIR BL, V10; Dreo T, 2011, ACTA HORTIC, V896, P115; Fabre L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036995; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; Hannou N, 2013, EUR J PLANT PATHOL, V136, P665, DOI 10.1007/s10658-013-0197-4; ISHIMARU C, 1984, PHYTOPATHOLOGY, V74, P1342, DOI 10.1094/Phyto-74-1342; Jock S, 2002, ENVIRON MICROBIOL, V4, P106, DOI 10.1046/j.1462-2920.2002.00277.x                                                ; Jock S, 2004, ENVIRON MICROBIOL, V6, P480, DOI 10.1111/j.1462-2920.2004.00583.x; Jones A. L., 2001, LAB GUIDE IDENTIFICA, P40; Klevytska AM, 2001, J CLIN MICROBIOL, V39, P3179, DOI 10.1128/JCM.39.9.3179-3185.2001; Malachowa N, 2005, J CLIN MICROBIOL, V43, P3095, DOI 10.1128/JCM.43.7.3095-3100.2005; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901                                                          ; McGhee C. G., 2012, PLOS ONE, V7; McManus PS, 1995, PHYTOPATHOLOGY, V85, P1547, DOI 10.1094/Phyto-85-1547; Momol EA, 1999, ACTA HORTIC, V489, P55; Momol MT, 2000, FIRE BLIGHT, P55, DOI 10.1079/9780851992945.0055; Momol MT, 1997, J APPL MICROBIOL, V82, P389, DOI 10.1046/j.1365-2672.1997.00377.x; Obradovic D, 2007, MICROBIOLOGY+, V76, P748, DOI 10.1134/S002626170706015X; Onteniente L, 2003, J CLIN MICROBIOL, V41, P4991, DOI 10.1128/JCM.41.11.4991-4997.2003; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Powney R, 2011, AUSTRALAS PLANT PATH, V40, P87, DOI 10.1007/s13313-010-0017-7; Pulawska J, 2012, TREES-STRUCT FUNCT, V26, P3, DOI 10.1007/s00468-011-0643-x; Rezzonico F, 2012, MOL PLANT PATHOL, V13, P975, DOI 10.1111/j.1364-3703.2012.00807.x; Rezzonico F, 2011, APPL ENVIRON MICROB, V77, P3819, DOI 10.1128/AEM.00177-11; Rhouma A, 2014, PLANT DIS, V98, P158, DOI 10.1094/PDIS-05-13-0542-PDN; Rico A, 2004, J APPL MICROBIOL, V96, P302, DOI 10.1046/j.1365-2672.2003.02156.x; Rico A, 2008, PHYTOPATHOLOGY, V98, P260, DOI 10.1094/PHYTO-98-3-0260; Shariat N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Taylor RK, 2001, NEW ZEAL J CROP HORT, V29, P35, DOI 10.1080/01140671.2001.9514158                                                   ; Vanneste J. L., 1995, PATHOGENESIS HOST SP, P21; Wensing A, 2012, J APPL MICROBIOL, V112, P147, DOI 10.1111/j.1365-2672.2011.05165.x; Yazdankhah Siamak P., 2007, V396, P395; [Anonymous], 2013, OEPP EPPO B, V43, P21	39	0	0	0	0	EDIZIONI ETS	PISA	PIAZZA CARRARA 16-19, 56126 PISA, ITALY	1125-4653			J PLANT PATHOL	J. Plant Pathol.	JUL	2017	99	2					331	337						7	Plant Sciences	Plant Sciences	FG8PN	WOS:000410696900003					2018-01-05	
J	Escobar-Suarez, S; Huanca-Mamani, W; Vargas, HA				Escobar-Suarez, Scott; Huanca-Mamani, Wilson; Vargas, Hector A.			Genetic divergence of a newly documented population of the cecidogenous micromoth Eugnosta azapaensis Vargas & Moreira (Lepidoptera: Tortricidae) in the Atacama Desert of northern Chile	REVISTA BRASILEIRA DE ENTOMOLOGIA			English	Article						Asteraceae; Baccharis salicifolia; Chile; DNA barcodes	INTEGRATIVE TAXONOMY; LIFE-HISTORY; DNA BARCODES; 1ST REMARKS; GRACILLARIIDAE; VALLEY; OLETHREUTINAE; MITOCHONDRIAL; BIODIVERSITY; FABACEAE	Eugnosta azapaensis Vargas and Moreira, 2015 (Lepidoptera: Tortricidae) is a micromoth native to the Atacama Desert whose larvae induce fusiform galls in shoots of Baccharis salicifolia (Ruiz & Pay.) Pers. (Asteraceae). The presence of this cecidogenous tortricid was previously recorded only from the type locality, the Azapa Valley, Arica Province, northern Chile. However, fusiform galls on shoots of B. salicifolia were recently found in Chaca, another coastal valley of the Atacama Desert. The adults obtained from these galls were preliminarily identified as E. azapaensis based on morphology. Subsequently, to assess an additional source of evidence for the taxonomic identification of E. azapaensis in this new locality, sequences of the DNA barcode fragment of the cytochrome oxidase subunit I mitochondrial gene from the two localities were analyzed. Four haplotypes were detected, two restricted to Azapa and two restricted to Chaca. The genetic divergence (K2P) between haplotypes of each locality was 0.2-0.8%, while it was 1.1-1.4% between haplotypes of different localities, and 8.7-13.5% between the Chilean haplotypes and other species of Eugnosta Hubner, 1825. In addition, all the sequences of Azapa and Chaca were clustered in a well-supported group in a Maximum Likelihood (ML) analysis. Accordingly, divergence and ML analyses support the morphological identification of E. azapaensis in the Chaca Valley. Furthermore, although preliminary, the analyses suggest that the genetic variation of the populations of this insect could be geographically structured, a pattern that must be assessed in further studies. (C) 2017 Sociedade Brasileira de Entomologia. Published by Elsevier Editora Ltda.	[Escobar-Suarez, Scott; Vargas, Hector A.] Univ Tarapaca, Fac Ciencias Agron, Dept Recursos Ambientales, Arica, Chile; [Huanca-Mamani, Wilson] Univ Tarapaca, Fac Ciencias Agron, Dept Prod Agr, Arica, Chile	Vargas, HA (reprint author), Univ Tarapaca, Fac Ciencias Agron, Dept Recursos Ambientales, Arica, Chile.	havargas@uta.cl			Universidad de Tarapaca [9715-16]	The authors thank John W. Brown, Lucas A. Kaminski and two anonymous reviewers for valuable comments that substantially improved the final version of the manuscript, to Paula Escobar for providing Fig, 1 and Lafayette Eaton for checking the English. The study was supported by Project 9715-16 from Universidad de Tarapaca.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036                                           ; Bobadilla D, 2015, J LEPID SOC, V69, P331, DOI 10.18473/lepi.69i4.a1; Brown JW, 2007, P ENTOMOL SOC WASH, V109, P265; Brown JW, 2014, J LEPID SOC, V68, P248; Brown John W., 2003, Journal of the Lepidopterists' Society, V57, P113; CLARKE J F G, 1987, Acta Entomologica Chilena, V14, P7; Clarke JDA, 2006, GEOMORPHOLOGY, V73, P101, DOI 10.1016/j.geomorph.2005.06.008; [Anonymous], 2017, DNA BARCODING REVEAL; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x                                                ; Estades CF, 2007, BIRD CONSERV INT, V17, P163, DOI 10.1017/S0959270907000676; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gilligan T.M., 2014, TRTS ONLINEWORLD CAT; Gilligan T, 2016, ZOOTAXA, V4178, P347, DOI 10.11646/zootaxa.4178.3.3; GOEDEN RD, 1981, PAN-PAC ENTOMOL, V57, P402; Haghani Atousa Farahpour, 2014, Nota Lepidopterologica, V37, P113, DOI 10.3897/nl.37.7708; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Harper GL, 2008, J INSECT CONSERV, V12, P147, DOI 10.1007/s10841-007-9072-y; Hausmann A, 2011, ZOOTAXA, P60; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Howden AT, 2008, ZOOTAXA, P55; Huanca-Mamani W., 2015, GENET MOL RES, V14, P7990; Huemer P, 2014, ZOOKEYS, P91, DOI 10.3897/zookeys.404.7234; Jaeger CM, 2013, J LEPID SOC, V67, P253; Kirichenko N, 2015, ZOOKEYS, P157, DOI 10.3897/zookeys.473.8543; Landry JF, 2013, ZOOKEYS, P43, DOI 10.3897/zookeys.327.5831; Luebert F., 2006, SINOPSIS BIOCLIMATIC; Luz FA, 2015, J NAT HIST, V49, P1849, DOI 10.1080/00222933.2015.1006284; Maia AVP, 2016, REV BRAS ENTOMOL, V60, P206, DOI 10.1016/j.rbe.2016.03.004; Maita-Maita J, 2015, J LEPID SOC, V69, P192; Mendez-Abarca F, 2012, REV BRAS ENTOMOL, V56, P240, DOI 10.1590/S0085-56262012005000033; Ossa Gonzalo, 2016, Check List, V12, P1850; Pereira CM, 2017, REV BRAS ENTOMOL, V61, P6, DOI [10.1016/j.rbe.2016.10.003, 10.1016/j.rbe.2016.11.003]; PORTER C C, 1985, Psyche (Cambridge), V92, P513, DOI 10.1155/1985/12672; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2006.01678.x; Razowski J, 2014, AFR ENTOMOL, V22, P796, DOI 10.4001/003.022.0424; Razowski J, 2010, SHILAP-REV. LEPIDOPT, V38, P5; Razowski J, 2017, ZOOTAXA, V4250, P541, DOI 10.11646/zootaxa.4250.6.3; REGIER J. C., 2012, PLOS ONE; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Seraphim N, 2016, CONSERV GENET, V17, P533, DOI 10.1007/s10592-015-0802-5; Taft WH, 2016, J LEPID SOC, V70, P211, DOI 10.18473/107.070.0307; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Valade R, 2009, MOL ECOL, V18, P3458, DOI 10.1111/j.1365-294X.2009.04290.x; Vargas HA, 2015, ZOOTAXA, V3920, P265, DOI 10.11646/zootaxa.3920.2.3; Vargas HA, 2009, REV BRAS ENTOMOL, V53, P291, DOI 10.1590/S0085-56262009000200012; Velasco-Cuervo SM, 2016, ENTOMOL EXP APPL, V158, P217, DOI 10.1111/eea.12397; Warren AD, 2017, ZOOKEYS, P155, DOI 10.3897/zookeys.667.6080; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8	49	1	1	4	4	SOC BRASILEIRA ENTOMOLOGIA	CURITIBA	CAIXA POSTAL 19030, CURITIBA, PR 81531-980, BRAZIL	0085-5626	1806-9665		REV BRAS ENTOMOL	Rev. Bras. Entomol.	JUL-SEP	2017	61	3					266	270		10.1016/j.rbe.2017.05.004				5	Entomology	Entomology	FG7GK	WOS:000410583100010		gold			2018-01-05	
J	Binothman, N; Hachim, IY; Lebrun, JJ; Ali, S				Binothman, Najat; Hachim, Ibrahim Y.; Lebrun, Jean-Jacques; Ali, Suhad			CPSF6 is a Clinically Relevant Breast Cancer Vulnerability Target Role of CPSF6 in Breast Cancer	EBIOMEDICINE			English	Article						Paraspeckles; A-to-I RNA editing; Long non-coding RNA; Prolactin; Differentiation; Mammary	FACTOR-I-M; NON-ONCOGENE ADDICTION; LONG NONCODING RNA; PROLACTIN RECEPTOR; GENE-EXPRESSION; DIFFERENTIATION; THERAPY; PROTEIN; CELLS; PATHWAY	Breast cancer represents a major health challenge. The majority of breast cancer deaths are due to cancer progression/recurrence for which no efficient therapies exist. Aggressive breast cancers are characterized by loss of cellular differentiation. Defining molecular mechanisms/targets contributing to cancer aggressiveness is needed to guide the design of new screening and targeted treatments. Here, we describe a novel tumor promoting function for the Cleavage and Polyadenylation Factor-6 (CPSF6). Importantly, aggressive breast cancer cells of luminal B, HER2-overexpressing and triple negative subtypes show dependency on CPSF6 for viability and tumorigenic capacity. Mechanistically, we found CPSF6 to interact with components of the A-to-I RNA editing machinery, paraspeckles and ADAR1 enzyme, and to be required for their physical integrity. Clinically, we found CPSF6 and all core paraspeckles proteins to be overexpressed in human breast cancer cases and their expression to correlate with poor patient outcomes. Finally, we found prolactin, a key mammary differentiation factor, to suppress CPSF6/RNA editing activity. Together, this study revealed CPSF6 as a molecular target with clinical relevance for prognosis and therapy in breast cancer. (C) 2017 The Authors. Published by Elsevier B.V.	[Binothman, Najat; Hachim, Ibrahim Y.; Lebrun, Jean-Jacques; Ali, Suhad] McGill Univ, Ctr Hlth, Ctr Translat Biol, Dept Med,Canc Res Program, Montreal, PQ, Canada	Ali, S (reprint author), MUHC RI, Off E 02 6232, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada.	Najat.Binothman@mail.mcgill.ca; ibrahim.hachim@mail.mcgill.ca; jj.lebrun@mcgill.ca; suhad.ali@mcgill.ca			Canadian Institutes of Health Research [233437, 233438]	J.J. Lebrun is the recipient of the McGill Sir William Dawson Research Chair. This work was supported by the Canadian Institutes of Health Research (operating grants #233437 and 233438) granted to Suhad Ali.	Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Bonuccelli G, 2012, CELL CYCLE, V11, P3972, DOI 10.4161/cc.22227; Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2                                                   ; Choudhry H, 2015, ONCOGENE, V34, P4482, DOI 10.1038/onc.2014.378; Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Goffin V, 2015, EXPERT OPIN THER TAR, V19, P1229, DOI 10.1517/14728222.2015.1053209; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hachim IY, 2016, HUM PATHOL, V53, P142, DOI 10.1016/j.humpath.2016.02.010; Hachim IY, 2016, APPL IMMUNOHISTO M M, V24, P238, DOI 10.1097/PAI.0000000000000178; Haines E, 2009, MOL CELL BIOL, V29, P2505, DOI 10.1128/MCB.00034-09; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Liu FM, 2015, STEM CELL RES, V15, P376, DOI 10.1016/j.scr.2015.08.001; Lopez-Ozuna VM, 2016, SCI REP-UK, V6, DOI 10.1038/srep30934; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; MIELE A, 1995, ANTIMICROB AGENTS CH, V39, P1772, DOI 10.1128/AAC.39.8.1772                                                           ; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Murakami K, 2015, J VET MED SCI, V77, P1715, DOI 10.1292/jvms.15-0263; Murayama MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9483; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Nouhi Z, 2006, CANCER RES, V66, P1824, DOI 10.1158/0008-5472-CAN-05-2292; Nukumi N, 2007, CANCER LETT, V252, P65, DOI 10.1016/j.canlet.2006.12.005; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Peck AR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3328; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093                                                                ; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2                                                   ; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Ruegsegger U, 1996, J BIOL CHEM, V271, P6107; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Sonnenblick A, 2014, CANCER TREAT REV, V40, P1089, DOI 10.1016/j.ctrv.2014.07.005; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Yamashita H, 2006, ENDOCR-RELAT CANCER, V13, P885, DOI 10.1677/erc.1.01095; Yang Q, 2011, STRUCTURE, V19, P368, DOI 10.1016/j.str.2010.12.021	36	0	0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2352-3964			EBIOMEDICINE	EBioMedicine	JUL	2017	21						65	78		10.1016/j.ebiom.2017.06.023				14	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	FG0LB	WOS:000409430700015	28673861	gold			2018-01-05	
J	Bootorabi, F; Manouchehri, H; Changizi, R; Barker, H; Palazzo, E; Saltari, A; Parikka, M; Pincelli, C; Aspatwar, A				Bootorabi, Fatemeh; Manouchehri, Hamed; Changizi, Reza; Barker, Harlan; Palazzo, Elisabetta; Saltari, Annalisa; Parikka, Mataleena; Pincelli, Carlo; Aspatwar, Ashok			Zebrafish as a Model Organism for the Development of Drugs for Skin Cancer	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review						melanoma; squamous cell carcinoma; inhibitor screening; transgenic zebrafish; skin cancer; drug development	SQUAMOUS-CELL CARCINOMA; BLOOD-BRAIN-BARRIER; IN-VIVO; MELANOCYTE DEVELOPMENT; MELANIN SYNTHESIS; LINEAGE SURVIVAL; MASTER REGULATOR; ADULT ZEBRAFISH; NEURAL CREST; ML-IAP	Skin cancer, which includes melanoma and squamous cell carcinoma, represents the most common type of cutaneous malignancy worldwide, and its incidence is expected to rise in the near future. This condition derives from acquired genetic dysregulation of signaling pathways involved in the proliferation and apoptosis of skin cells. The development of animal models has allowed a better understanding of these pathomechanisms, with the possibility of carrying out toxicological screening and drug development. In particular, the zebrafish (Danio rerio) has been established as one of the most important model organisms for cancer research. This model is particularly suitable for live cell imaging and high-throughput drug screening in a large-scale fashion. Thanks to the recent advances in genome editing, such as the clustered regularly-interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) methodologies, the mechanisms associated with cancer development and progression, as well as drug resistance can be investigated and comprehended. With these unique tools, the zebrafish represents a powerful platform for skin cancer research in the development of target therapies. Here, we will review the advantages of using the zebrafish model for drug discovery and toxicological and phenotypical screening. We will focus in detail on the most recent progress in the field of zebrafish model generation for the study of melanoma and squamous cell carcinoma (SCC), including cancer cell injection and transgenic animal development. Moreover, we will report the latest compounds and small molecules under investigation in melanoma zebrafish models.	[Bootorabi, Fatemeh] Univ Tehran Med Sci, Biosensor Res Ctr, Endocrinol & Metab Mol Cellular Sci Inst, Tehran 14114, Iran; [Manouchehri, Hamed; Changizi, Reza] Islamic Azad Univ, Babol Branch, Dept Aquaculture, Babol Sar 47134, Iran; [Barker, Harlan; Aspatwar, Ashok] Univ Tampere, Fac Med & Life Sci, Tampere 33014, Finland; [Palazzo, Elisabetta; Saltari, Annalisa; Pincelli, Carlo] Univ Modena & Reggio Emilia, Lab Cutaneous Biol, Dept Surg Med Dent & Morphol Sci, I-41100 Modena, Italy; [Parikka, Mataleena] Univ Tampere, Fac Med & Life Sci, Oral & Maxillofacial Unit, Tampere Univ Hosp, Tampere 33014, Finland	Aspatwar, A (reprint author), Univ Tampere, Fac Med & Life Sci, Tampere 33014, Finland.	fatemeh.bootorabi@gmail.com; hd_manuchehri@yahoo.com; rech76ir@gmail.com; harlan.barker@uta.fi; elisabetta.palazzo1@gmail.com; annalisax85@alice.it; mataleena.parikka@uta.fi; carlo.pincelli@unimore.it; ashok.aspatwar@staff.uta.fi		/0000-0002-6938-7835			Ablain J, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026260; Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Ali S, 2011, BIRTH DEFECTS RES C, V93, P115, DOI 10.1002/bdrc.20206; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Berghmans Stephane, 2008, Journal of Pharmacological and Toxicological Methods, V58, P59, DOI 10.1016/j.vascn.2008.05.130; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chapman A, 2014, CELL REP, V8, P688, DOI 10.1016/j.celrep.2014.06.045; Chen L, 2012, PIGM CELL MELANOMA R, V25, P446, DOI 10.1111/j.1755-148X.2012.01007.x; Cheng C, 2016, MELANOMA RES, V26, P117, DOI 10.1097/CMR.0000000000000229; Cichon MA, 2014, ONCOGENE, V33, P4185, DOI 10.1038/onc.2013.388; Dahm R, 2006, MAR BIOTECHNOL, V8, P329, DOI 10.1007/s10126-006-5139-0; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766                                                             ; del Ama LF, 2016, ONCOTARGET, V7, P40348, DOI 10.18632/oncotarget.9613; Drabsch Y, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3573; Ekedahl H, 2013, BRIT J DERMATOL, V169, P1049, DOI 10.1111/bjd.12504; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gibney GT, 2013, EXPERT OPIN DRUG MET, V9, P893, DOI 10.1517/17425255.2013.794220; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Guo JN, 2013, CHEM REV, V113, P8583, DOI 10.1021/cr400105n; Haq R, 2011, J CLIN ONCOL, V29, P3474, DOI 10.1200/JCO.2010.32.6223; Hartman ML, 2015, J INVEST DERMATOL, V135, P352, DOI 10.1038/jid.2014.319; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jeong JY, 2008, BRAIN RES BULL, V75, P619, DOI 10.1016/j.brainresbull.2007.10.043; Jung DW, 2011, CHEM BIOL, V18, P1581, DOI 10.1016/j.chembiol.2011.10.001; Kaufman CK, 2016, SCIENCE, V351, DOI 10.1126/science.aad2197; Kim MK, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1209-7; Koludrovic D, 2013, FUTURE ONCOL, V9, P235, DOI [10.2217/fon.12.177, 10.2217/FON.12.177]; Krauss J, 2014, BIOL OPEN, V3, P503, DOI 10.1242/bio.20148441; Langheinrich U, 2003, TOXICOL APPL PHARM, V193, P370, DOI 10.1016/10.1016/j.taap.2003.07.012; Lasithiotakis KG, 2008, J INVEST DERMATOL, V128, P2013, DOI 10.1038/jid.2008.44; Le XN, 2013, DEVELOPMENT, V140, P2354, DOI 10.1242/dev.088427; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Levesque M, 2013, DIS MODEL MECH, V6, P508, DOI 10.1242/dmm.010371; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li MY, 2016, TRENDS GENET, V32, P815, DOI 10.1016/j.tig.2016.10.005; Li ZH, 2011, MOL BIOSYST, V7, P2128, DOI 10.1039/c1mb00001b; Lister JA, 2014, J INVEST DERMATOL, V134, P133, DOI 10.1038/jid.2013.293; Liu CJ, 2016, J NEUROCHEM, V139, P187, DOI 10.1111/jnc.13707; MacRae CA, 2015, NAT REV DRUG DISCOV, V14, P721, DOI 10.1038/nrd4627; Martins V. L., 2015, JNCI-J NATL CANCER I, P108; McGill GG, 2006, J BIOL CHEM, V281, P10365, DOI 10.1074/jbc.M513094200; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Michailidou C, 2009, DIS MODEL MECH, V2, P399, DOI 10.1242/dmm.001149; Mirbahai L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-3; Moshal Karni S, 2011, Cancers (Basel), V3, P4102, DOI 10.3390/cancers3044102; Mouti MA, 2016, ONCOTARGET, V7, P39654, DOI 10.18632/oncotarget.9207; Oberoi-Khanuja TK, 2012, J BIOL CHEM, V287, P28445, DOI 10.1074/jbc.M112.341297; Ochoa-Alvarez JA, 2015, ONCOTARGET, V6, P9045, DOI 10.18632/oncotarget.3515                                                        ; Opdecamp K, 1997, DEVELOPMENT, V124, P2377; Parng C, 2005, CURR OPIN DRUG DISC, V8, P100; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031                                                       ; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Perles Z, 2015, J MED GENET, V52, P840, DOI 10.1136/jmedgenet-2015-103336; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; Rennekamp AJ, 2015, CURR OPIN CHEM BIOL, V24, P58, DOI 10.1016/j.cbpa.2014.10.025; Rubinstein AL, 2003, CURR OPIN DRUG DI DE, V6, P218; Saltari A, 2016, J INVEST DERMATOL, V136, P2049, DOI 10.1016/j.jid.2016.05.116; Santoriello C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015170; Schroder U, 1996, BRAIN RES, V710, P121, DOI 10.1016/0006-8993(95)01375-X                                                    ; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sheu JJC, 2009, CANCER RES, V69, P2568, DOI 10.1158/0008-5472.CAN-08-3199; Shin YS, 2016, CANCER RES TREAT, V48, P738, DOI 10.4143/crt.2015.102; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q                 ; Spitsbergen Jan M., 2003, Toxicologic Pathology, V31, P62, DOI 10.1080/01926230390174959; Tan JL, 2016, MOL CELL, V62, P34, DOI 10.1016/j.molcel.2016.03.013; Tang Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10358; Taylor KL, 2011, DEVELOPMENT, V138, P3579, DOI 10.1242/dev.064014; Teraoka Hiroki, 2003, Congenital Anomalies, V43, P123, DOI 10.1111/j.1741-4520.2003.tb01036.x; Thomas HE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003923; van der Weyden L, 2016, J PATHOL, V238, P152, DOI 10.1002/path.4632; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; Verkman AS, 2004, AM J PHYSIOL-CELL PH, V286, pC465, DOI 10.1152/ajpcell.00397.2003; von Massenhausen A, 2016, INT J CANCER, V139, P2359, DOI 10.1002/ijc.30279; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; Weiss FU, 2009, GASTROENTEROLOGY, V137, P2136, DOI 10.1053/j.gastro.2009.08.065; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Widmer DS, 2013, J INVEST DERMATOL, V133, P2436, DOI 10.1038/jid.2013.115; Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762; Wu SYS, 2015, INT J MOL SCI, V16, P20240, DOI 10.3390/ijms160920240; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Xiong P, 2013, NEOPLASMA, V60, P395, DOI 10.4149/neo_2013_051; Xiong P, 2011, PROTEIN J, V30, P499, DOI 10.1007/s10930-011-9354-9; Yajima I., 2011, J SKIN CANC, V2011, DOI [10.1155/2011/730170, DOI 10.1155/2011/730170]; Yang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061801; Yen J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r113; Zeng ZQ, 2015, PIGM CELL MELANOMA R, V28, P229, DOI 10.1111/pcmr.12336; Zhang BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085439; Zhao S, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0196-8; Zon J, 2005, CHEM BIODIVERS, V2, P1187, DOI 10.1002/cbdv.200590089; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606; Zonfrillo Mark R, 2005, Psychiatry (Edgmont), V2, P14	98	0	0	3	3	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	JUL	2017	18	7							1550	10.3390/ijms18071550				15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	FF2SJ	WOS:000408746800217		gold			2018-01-05	
J	Han, WY; Feng, X; She, QX				Han, Wenyuan; Feng, Xu; She, Qunxin			Reverse Gyrase Functions in Genome Integrity Maintenance by Protecting DNA Breaks In Vivo	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						reverse gyrase; Sulfolobus; MMS; genomic DNA breakage; genomic DNA degradation; CRISPRi approach	ARCHAEON SULFOLOBUS-SOLFATARICUS; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; METHYLATING AGENTS; PROTEIN; HYPERTHERMOPHILES; TOPOISOMERASES; INTERFERENCE; CRENARCHAEA; ISLANDICUS	Reverse gyrase introduces positive supercoils to circular DNA and is implicated in genome stability maintenance in thermophiles. The extremely thermophilic crenarchaeon Sulfolobus encodes two reverse gyrase proteins, TopR1 (topoisomerase reverse gyrase 1) and TopR2, whose functions in thermophilic life remain to be demonstrated. Here, we investigated the roles of TopR1 in genome stability maintenance in S. islandicus in response to the treatment of methyl methanesulfonate (MMS), a DNA alkylation agent. Lethal MMS treatment induced two successive events: massive chromosomal DNA backbone breakage and subsequent DNA degradation. The former occurred immediately after drug treatment, leading to chromosomal DNA degradation that concurred with TopR1 degradation, followed by chromatin protein degradation and DNA-less cell formation. To gain a further insight into TopR1 function, the expression of the enzyme was reduced in S. islandicus cells using a CRISPR-mediated mRNA interference approach (CRISPRi) in which topR1 mRNAs were targeted for degradation by endogenous III-B CRISPR-Cas systems. We found that the TopR1 level was reduced in the S. islandicus CRISPRi cells and that the cells underwent accelerated genomic DNA degradation during MMS treatment, accompanied by a higher rate of cell death. Taken together, these results indicate that TopR1 probably facilitates genome integrity maintenance by protecting DNA breaks from thermo-degradation in vivo.	[Han, Wenyuan; Feng, Xu; She, Qunxin] Univ Copenhagen, Dept Biol, Archaeal Ctr, Copenhagen Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark	Han, WY; She, QX (reprint author), Univ Copenhagen, Dept Biol, Archaeal Ctr, Copenhagen Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	wenyuan.han@bio.ku.dk; xu.feng@bio.ku.dk; qunxin@bio.ku.dk			Danish Council for Independent Research [DFF-0602-02196, DFF-1323-00330]; China Scholarship Council	This research was supported by the Danish Council for Independent Research (grant No. DFF-0602-02196, DFF-1323-00330). Wenyuan Han and Xu Feng are recipients of a PhD studentship from the China Scholarship Council.	Atomi H, 2004, J BACTERIOL, V186, P4829, DOI 10.1128/JB.186.14.4829-4833.2004; Cejka P, 2005, CURR BIOL, V15, P1395, DOI 10.1016/j.cub.2005.07.032; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369                                                ; Couturier M, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-18; D'Amaro Anna, 2007, Ital J Biochem, V56, P103; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Deng L, 2009, EXTREMOPHILES, V13, P735, DOI 10.1007/s00792-009-0254-2; Frols S, 2007, J BACTERIOL, V189, P8708, DOI 10.1128/JB.01016-07; Guo L, 2008, NUCLEIC ACIDS RES, V36, P1129, DOI 10.1093/nar/gkm1128; Guo R, 2003, MOL MICROBIOL, V50, P1605, DOI 10.1046/j.1365-2958.2003.03793.x; Heine M, 2009, J MICROBIOL, V47, P229, DOI 10.1007/s12275-009-0019-8; Kampmann M, 2004, NUCLEIC ACIDS RES, V32, P3537, DOI 10.1093/nar/gkh683; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; MARGUET E, 1994, NUCLEIC ACIDS RES, V22, P1681, DOI 10.1093/nar/22.9.1681                                                           ; Napoli A, 2004, J BIOL CHEM, V279, P33192, DOI 10.1074/jbc.M402619200; Nowosielska A, 2006, NUCLEIC ACIDS RES, V34, P2258, DOI 10.1093/nar/gkl222; Peng N, 2017, SCI CHINA LIFE SCI, V60, P370, DOI 10.1007/s11427-016-0355-8; Peng N, 2012, APPL ENVIRON MICROB, V78, P5630, DOI 10.1128/AEM.00855-12; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Quaiser A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-25; Samson RY, 2013, CELL REP, V3, P485, DOI 10.1016/j.celrep.2013.01.002; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Valenti A, 2006, NUCLEIC ACIDS RES, V34, P2098, DOI 10.1093/nar/gkl115; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Zhang CY, 2013, BIOCHEM SOC T, V41, P405, DOI 10.1042/BST20120285; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	29	2	2	0	0	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	JUL	2017	18	7							1340	10.3390/ijms18071340				13	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	FF2SJ	WOS:000408746800012					2018-01-05	
J	Castle, KD; Chen, M; Wisdom, AJ; Kirsch, DG				Castle, Katherine D.; Chen, Mark; Wisdom, Amy J.; Kirsch, David G.			Genetically engineered mouse models for studying radiation biology	TRANSLATIONAL CANCER RESEARCH			English	Review						RCAS-TVA; Cre-loxP; CRISPR; genetically engineered mouse models (GEMMs); radiation biology	IN-VIVO; DNA-DAMAGE; CHROMOSOMAL REARRANGEMENTS; CRISPR-CAS9 NUCLEASES; TUMOR-DEVELOPMENT; DRUG DEVELOPMENT; CAS9 NUCLEASES; HEART-DISEASE; STEM-CELLS; GENOME	Genetically engineered mouse models (GEMMs) are valuable research tools that have transformed our understanding of cancer. The first GEMMs generated in the 1980s and 1990s were knock- in and knock-out models of single oncogenes or tumor suppressors. The advances that made these models possible catalyzed both technological and conceptual shifts in the way cancer research was conducted. As a result, dozens of mouse models of cancer exist today, covering nearly every tissue type. The advantages inherent to GEMMs compared to in vitro and in vivo transplant models are compounded in preclinical radiobiology research for several reasons. First, they accurately and robustly recapitulate primary cancers anatomically, histopathologically, and genetically. Reliable models are a prerequisite for predictive preclinical studies. Second, they preserve the tumor microenvironment, including the immune, vascular, and stromal compartments, which enables the study of radiobiology at a systems biology level. Third, they provide exquisite control over the genetics and kinetics of tumor initiation, which enables the study of specific gene mutations on radiation response and functional genomics in vivo. Taken together, these facets allow researchers to utilize GEMMs for rigorous and reproducible preclinical research. In the three decades since the generation of the first GEMMs of cancer, advancements in modeling approaches have rapidly progressed and expanded the mouse modeling toolbox with techniques such as in vivo short hairpin RNA (shRNA) knockdown, inducible gene expression, site-specific recombinases, and dual recombinase systems. Our lab and many others have utilized these tools to study cancer and radiobiology. Recent advances in genome engineering with CRISPR/Cas9 technology have made GEMMs even more accessible to researchers. Here, we review current and future approaches to mouse modeling with a focus on applications in preclinical radiobiology research.	[Castle, Katherine D.; Chen, Mark; Wisdom, Amy J.; Kirsch, David G.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Chen, Mark; Wisdom, Amy J.] Duke Univ, Med Ctr, Med Scientist Training Program, Durham, NC USA; [Kirsch, David G.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	Kirsch, DG (reprint author), Duke Univ, Med Ctr, DUMC Box 91006, Durham, NC 27708 USA.	david.kirsch@duke.edu	Chen, Mark/U-3905-2017	Chen, Mark/0000-0001-5616-9321; Wisdom, Amy/0000-0002-6098-5353	National Institutes of Health [R35 CA197616, F30CA206424, T32GM007171]	We acknowledge support from National Institutes of Health award R35 CA197616 to DG Kirsch, F30CA206424 to M Chen, and T32GM007171 to M Chen and AJ Wisdom.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Annunziato S, 2016, GENE DEV, V30, P1470, DOI 10.1101/gad.279190.116; Barton KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077639; Becher OJ, 2006, CANCER RES, V66, P3355, DOI 10.1158/0008-5472.CAN-05-3827; Becher O. J., 2006, CANCER RES, V66, P3358; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Bortfeld T, 2011, BRIT J RADIOL, V84, P485, DOI 10.1259/bjr/86221320; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chiou SH, 2015, GENE DEV, V29, P1576, DOI 10.1101/gad.264861.115; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Darby SC, 2010, INT J RADIAT ONCOL, V76, P656, DOI 10.1016/j.ijrobp.2009.09.064; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Farin AM, 2015, RADIAT RES, V183, P124, DOI 10.1667/RR13878.1; Fenton BM, 2001, INT J CANCER, V93, P693, DOI 10.1002/ijc.1401; FIELD SB, 1991, BRIT J CANCER, V63, P723, DOI 10.1038/bjc.1991.163                                                            ; Floyd SR, 2013, NATURE, V498, P246, DOI 10.1038/nature12147; Formenti SC, 2009, LANCET ONCOL, V10, P718, DOI 10.1016/S1470-2045(09)70082-8; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Galban S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035857; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Gudkov AV, 2005, BIOCHEM BIOPH RES CO, V331, P726, DOI 10.1016/j.bbrc.2005.03.153; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Halliday J, 2014, P NATL ACAD SCI USA, V111, P5248, DOI 10.1073/pnas.1321014111; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hinkal G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006654; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Holland EC, BASIC FIBROBLAST GRO; Howlader N, 2013, SEER CANC STAT REV 1; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; HUGHES SH, 1987, J VIROL, V61, P3004; Jasin M, 2016, DNA REPAIR, V44, P6, DOI 10.1016/j.dnarep.2016.05.001; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kirsch DG, 2010, INT J RADIAT ONCOL, V76, P973, DOI 10.1016/j.ijrobp.2009.11.038; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kondo S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001350; Lee CL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9477; Lee CL, 2014, INT J RADIAT ONCOL, V88, P686, DOI 10.1016/j.ijrobp.2013.11.238; Lee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002918; Lee CL, 2012, DIS MODEL MECH, V5, P397, DOI 10.1242/dmm.009084; LEE JM, 1994, ONCOGENE, V9, P3731; Lemasson B, 2016, NEOPLASIA, V18, P82, DOI 10.1016/j.neo.2015.11.014; Leonova KI, 2010, CELL CYCLE, V9, P1434, DOI 10.4161/cc.9.7.11508                                                            ; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maresch R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10770; Mezzaroma E, 2012, INT J CARDIOL, V156, P231, DOI 10.1016/j.ijcard.2012.01.038; Moding EJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4214; Moding EJ, 2014, J CLIN INVEST, V124, P3325, DOI 10.1172/JCI73932; Moding EJ, 2013, NAT REV DRUG DISCOV, V12, P526, DOI 10.1038/nrd4003; Pant V, 2012, BLOOD, V120, P5118, DOI 10.1182/blood-2012-05-356014; Perez BA, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00072; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ringborg U, 2003, ACTA ONCOL, V42, P357, DOI 10.1080/02841860310010826; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; SCHULTZHECTOR S, 1992, INT J RADIAT BIOL, V61, P149, DOI 10.1080/09553009214550761; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Singh M, 2006, CLIN CANCER RES, V12, P5312, DOI 10.1158/1078-0432.CCR-06-0437; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Squatrito M, 2010, CANCER CELL, V18, P619, DOI 10.1016/j.ccr.2010.10.034; Su H, 2015, INT J RADIAT ONCOL, V92, P1116, DOI 10.1016/j.ijrobp.2015.04.003; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004; von Werder A, 2012, NAT PROTOC, V7, P1167, DOI 10.1038/nprot.2012.060; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang MS, 2015, RADIAT RES, V183, P594, DOI 10.1667/RR14016.1; Zuckermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8391	88	0	0	6	6	AME PUBL CO	SHEUNG WAN	ROOM 604 6-F HOLLYWOOD CENTER, 77-91, QUEENS ROAD, SHEUNG WAN, HONG KONG 00000, PEOPLES R CHINA	2218-676X	2219-6803		TRANSL CANCER RES	Transl. Cancer Res.	JUL	2017	6			5	SI		S900	S913		10.21037/tcr.2017.06.19				14	Oncology	Oncology	FF9NJ	WOS:000409342900013					2018-01-05	
J	Bryant, JM; Regnault, C; Scheidig-Benatar, C; Baumgarten, S; Guizetti, J; Scherf, A				Bryant, Jessica M.; Regnault, Clement; Scheidig-Benatar, Christine; Baumgarten, Sebastian; Guizetti, Julien; Scherf, Artur			CRISPR/Cas9 Genome Editing Reveals That the Intron Is Not Essential for var2csa Gene Activation or Silencing in Plasmodium falciparum	MBIO			English	Article						CRISPR/Cas9; Plasmodium falciparum; antigenic variation; transcriptional regulation; var genes	MUTUALLY EXCLUSIVE EXPRESSION; PREGNANCY-ASSOCIATED MALARIA; CHONDROITIN SULFATE-A; ANTIGENIC VARIATION; VIRULENCE GENES; INFECTED ERYTHROCYTES; NONCODING RNAS; PARASITES; CYTOADHESION; MECHANISMS	Plasmodium falciparum relies on monoallelic expression of 1 of 60 var virulence genes for antigenic variation and host immune evasion. Each var gene contains a conserved intron which has been implicated in previous studies in both activation and repression of transcription via several epigenetic mechanisms, including interaction with the var promoter, production of long noncoding RNAs (lncRNAs), and localization to repressive perinuclear sites. However, functional studies have relied primarily on artificial expression constructs. Using the recently developed P. falciparum clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system, we directly deleted the var2csa P. falciparum 3D7_1200600 (Pf3D7_1200600) endogenous intron, resulting in an intronless var gene in a natural, marker-free chromosomal context. Deletion of the var2csa intron resulted in an upregulation of transcription of the var2csa gene in ring-stage parasites and subsequent expression of the PfEMP1 protein in late-stage parasites. Intron deletion did not affect the normal temporal regulation and subsequent transcriptional silencing of the var gene in trophozoites but did result in increased rates of var gene switching in some mutant clones. Transcriptional repression of the intronless var2csa gene could be achieved via long-term culture or panning with the CD36 receptor, after which reactivation was possible with chondroitin sulfate A (CSA) panning. These data suggest that the var2csa intron is not required for silencing or activation in ring-stage parasites but point to a subtle role in regulation of switching within the var gene family. IMPORTANCE Plasmodium falciparum is the most virulent species of malaria parasite, causing high rates of morbidity and mortality in those infected. Chronic infection depends on an immune evasion mechanism termed antigenic variation, which in turn relies on monoallelic expression of 1 of similar to 60 var genes. Understanding antigenic variation and the transcriptional regulation of monoallelic expression is important for developing drugs and/or vaccines. The var gene family encodes the antigenic surface proteins that decorate infected erythrocytes. Until recently, studying the underlying genetic elements that regulate monoallelic expression in P. falciparum was difficult, and most studies relied on artificial systems such as episomal reporter genes. Our study was the first to use CRISPR/Cas9 genome editing for the functional study of an important, conserved genetic element of var genes-the in-tron-in an endogenous, episome-free manner. Our findings shed light on the role of the var gene intron in transcriptional regulation of monoallelic expression.	[Bryant, Jessica M.; Regnault, Clement; Scheidig-Benatar, Christine; Baumgarten, Sebastian; Guizetti, Julien; Scherf, Artur] Inst Pasteur, Unite Biol Interact Hote Parasite, Paris, France; [Bryant, Jessica M.; Scheidig-Benatar, Christine; Baumgarten, Sebastian; Guizetti, Julien; Scherf, Artur] INSERM, U1201, Paris, France; [Bryant, Jessica M.; Scheidig-Benatar, Christine; Baumgarten, Sebastian; Guizetti, Julien; Scherf, Artur] CNRS, ERL9195, Paris, France; [Regnault, Clement] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Wellcome Ctr Mol Parasitol, Glasgow, Lanark, Scotland	Bryant, JM; Guizetti, J (reprint author), Inst Pasteur, Unite Biol Interact Hote Parasite, Paris, France.; Bryant, JM; Guizetti, J (reprint author), INSERM, U1201, Paris, France.; Bryant, JM; Guizetti, J (reprint author), CNRS, ERL9195, Paris, France.	jessica.bryant@pasteur.fr; julien.guizetti@gmail.com		Guizetti, Julien/0000-0002-8762-4259	European Research Council [670301]; Agence Nationale de la Recherche [ANR-11-LABEX-0024-01, ANR-13-ISV3-0003-01]; European Molecular Biology Organization [EMBO ALTF 180-2015]; Institut Pasteur Roux-Cantarini postdoctoral fellowship; Human Frontier Science Program [LT000620/2012-L]	This work was supported by a European Research Council Advanced grant (PlasmoSilencing 670301) and grants from the Agence Nationale de la Recherche (ANR-11-LABEX-0024-01 ParaFrap, ANR-13-ISV3-0003-01 NSFC MalVir) to A.S. J.M.B. was supported by a European Molecular Biology Organization long-term postdoctoral fellowship (EMBO ALTF 180-2015) and the Institut Pasteur Roux-Cantarini postdoctoral fellowship. J.G. was supported by a Human Frontier Science Program fellowship (LT000620/2012-L). The funders had no role in the study design, data collection and interpretation, or the decision to submit the work for publication.	Amit-Avraham I, 2015, P NATL ACAD SCI USA, V112, pE982, DOI 10.1073/pnas.1420855112; Amulic B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000256; Avril M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016622; Bancells C, 2013, MOL MICROBIOL, V90, P472, DOI 10.1111/mmi.12379; Bottius E, 1998, MOL CELL BIOL, V18, P919, DOI 10.1128/MCB.18.2.919                                                            ; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Duffy MF, 2014, BRIEF FUNCT GENOMICS, V13, P203, DOI 10.1093/bfgp/elt047; Dzikowski R, 2007, EMBO REP, V8, P959, DOI 10.1038/sj.embor.7401063; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Dzikowski R, 2009, CURR GENET, V55, P103, DOI 10.1007/s00294-009-0233-2; Epp C, 2009, RNA, V15, P116, DOI 10.1261/rna.1080109; Frank M, 2006, J BIOL CHEM, V281, P9942, DOI 10.1074/jbc.M513067200; Frank M, 2007, MOL MICROBIOL, V64, P1486, DOI 10.1111/j.1365-2958.2007.05736.x; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gannoun-Zaki L, 2005, EUKARYOT CELL, V4, P490, DOI 10.1128/EC.4.2.490-492.2005; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Guizetti J, 2013, CELL MICROBIOL, V15, P718, DOI 10.1111/cmi.12115; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Kyes SA, 2003, MOL MICROBIOL, V48, P1339, DOI 10.1046/j.1365-2958.2003.03505.x; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; MacPherson CR, 2015, NAT BIOTECHNOL, V33, P805, DOI 10.1038/nbt.3291; Mok BW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001982; Ralph SA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r93; Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Siegel TN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-150; Smith JD, 2013, CELL MICROBIOL, V15, P1976, DOI 10.1111/cmi.12183; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1                                                    ; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Ukaegbu UE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005234; Vembar SS, 2014, CURR OPIN MICROBIOL, V20, P153, DOI 10.1016/j.mib.2014.06.013; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407; Wickert H, 2003, EUR J CELL BIOL, V82, P271, DOI 10.1078/0171-9335-00319; Zhang QF, 2014, NATURE, V513, P431, DOI 10.1038/nature13468; Zhang QF, 2011, CELL HOST MICROBE, V10, P451, DOI 10.1016/j.chom.2011.09.013	47	0	0	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2150-7511			MBIO	mBio	JUL-AUG	2017	8	4							e00729-17	10.1128/mBio.00729-17				13	Microbiology	Microbiology	FG0BP	WOS:000409384300008		gold			2018-01-05	
J	Kim, K				Kim, Kami			AID-ing Signaling in Toxoplasma gondii	MBIO			English	Article						Toxoplasma; cell signaling; gene regulation; genetics; kinases	DEPENDENT PROTEIN-KINASE; MOLECULAR CHARACTERIZATION; PLASMODIUM; TARGET	The cyclic GMP-dependent protein kinase (PKG) of apicomplexan parasites is essential for secretion of micronemes and host cell invasion and egress. Both kinase specificity and localization can determine which substrates are phosphorylated. The functions of plasma membrane and cytosolic PKG isoforms of Toxoplasma gondii were unknown because of difficulties precisely manipulating expression of essential genes. Brown et al. (K. M. Brown, S. Long, and L. D. Sibley, mBio 8: e00375-17, https://doi.org/10.1128/mBio.00375-17) adapted the auxin-inducible degron (AID) system for conditional expression of T. gondii proteins. AID, in combination with clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9 gene editing, facilitated creation of a panel of PKG mutants to demonstrate that the membrane association via acylation of PKG is critical for its essential functions in tachyzoites. The cytosolic form of PKG is not sufficient for viability and is dispensable. These studies illuminate a critical role for targeting of kinase complexes for parasite viability. The AID system enables rapid, conditional regulation of protein expression that expands the molecular toolbox of T. gondii.	[Kim, Kami] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Kim, Kami] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Kim, Kami] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Kim, K (reprint author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.; Kim, K (reprint author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.; Kim, K (reprint author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	kami.kim@einstein.yu.edu					Brown KM, 2017, MBIO, V8, DOI 10.1128/mBio.00375-17; de Monerri NCS, 2015, CELL HOST MICROBE, V18, P621, DOI 10.1016/j.chom.2015.10.014; Donald RGK, 2002, EUKARYOT CELL, V1, P317, DOI 10.1128/EC.1.3.317-328.2002; Donald RGK, 2002, MOL BIOCHEM PARASIT, V120, P165, DOI 10.1016/S0166-6851(01)00451-0; Goldston AM, 2014, TRENDS PARASITOL, V30, P350, DOI 10.1016/j.pt.2014.05.003; Gurnett AM, 2002, J BIOL CHEM, V277, P15913, DOI 10.1074/jbc.M108393200; Hopp CS, 2012, MICROBES INFECT, V14, P831, DOI 10.1016/j.micinf.2012.04.011; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Philip N, 2015, CELL HOST MICROBE, V18, P122, DOI 10.1016/j.chom.2015.05.018; Vinayak S, 2015, NATURE, V523, P477, DOI 10.1038/nature14651; Wiersma HI, 2004, INT J PARASITOL, V34, P369, DOI 10.1016/j.ijpara.2003.11.019	11	0	0	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2150-7511			MBIO	mBio	JUL-AUG	2017	8	4							e01076-17	10.1128/mBio.00375-17				3	Microbiology	Microbiology	FG0BP	WOS:000409384300047		gold			2018-01-05	
J	Lin, DL; Cherepanova, NA; Bozzacco, L; MacDonald, MR; Gilmore, R; Tai, AW				Lin, David L.; Cherepanova, Natalia A.; Bozzacco, Leonia; MacDonald, Margaret R.; Gilmore, Reid; Tai, Andrew W.			Dengue Virus Hijacks a Noncanonical Oxidoreductase Function of a Cellular Oligosaccharyltransferase Complex	MBIO			English	Article						dengue fever; endoplasmic reticulum; glycosylation; host-pathogen interactions; oxidoreductases	PROTEIN-DISULFIDE-ISOMERASE; N-GLYCOSYLATION; LINKED GLYCOSYLATION; VIRAL REPLICATION; CELLS LACKING; HOST FACTORS; ZIKA VIRUS; SITES; INFECTION; CYSTEINE	Dengue virus (DENV) is the most common arboviral infection globally, infecting an estimated 390 million people each year. We employed a genome-wide clustered regularly interspaced short palindromic repeat (CRISPR) screen to identify host dependency factors required for DENV propagation and identified the oligosaccharyltransferase (OST) complex as an essential host factor for DENV infection. Mammalian cells express two OSTs containing either STT3A or STT3B. We found that the canonical catalytic function of the OSTs as oligosaccharyltransferases is not necessary for DENV infection, as cells expressing catalytically inactive STT3A or STT3B are able to support DENV propagation. However, the OST subunit MAGT1, which associates with STT3B, is also required for DENV propagation. MAGT1 expression requires STT3B, and a catalytically inactive STT3B also rescues MAGT1 expression, supporting the hypothesis that STT3B serves to stabilize MAGT1 in the context of DENV infection. We found that the oxidoreductase CXXC active site motif of MAGT1 was necessary for DENV propagation, as cells expressing an AXXA MAGT1 mutant were unable to support DENV infection. Interestingly, cells expressing single-cysteine CXXA or AXXC mutants of MAGT1 were able to support DENV propagation. Utilizing the engineered peroxidase APEX2, we demonstrate the close proximity between MAGT1 and NS1 or NS4B during DENV infection. These results reveal that the oxidoreductase activity of the STT3B-containing OST is necessary for DENV infection, which may guide the development of antiviral agents targeting DENV. IMPORTANCE The host oligosaccharyltransferase (OST) complexes have been identified as essential host factors for dengue virus (DENV) replication; however, their functions during DENV infection are unclear. A previous study showed that the canonical OST activity was dispensable for DENV replication, suggesting that the OST complexes serve as scaffolds for DENV replication. However, our work demonstrates that one function of the OST complex during DENV infection is to provide oxidoreductase activity via the OST subunit MAGT1. We also show that MAGT1 associates with DENV NS1 and NS4B during viral infection, suggesting that these nonstructural proteins may be targets of MAGT1 oxidoreductase activity. These results provide insight into the cell biology of DENV infection, which may guide the development of antivirals against DENV.	[Lin, David L.; Tai, Andrew W.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Cherepanova, Natalia A.; Gilmore, Reid] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Bozzacco, Leonia; MacDonald, Margaret R.] Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Tai, Andrew W.] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI USA; [Tai, Andrew W.] Ann Arbor Vet Adm Hlth Syst, Med Serv, Ann Arbor, MI 48105 USA	Tai, AW (reprint author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.; Tai, AW (reprint author), Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI USA.; Tai, AW (reprint author), Ann Arbor Vet Adm Hlth Syst, Med Serv, Ann Arbor, MI 48105 USA.	andrewwt@umich.edu		Tai, Andrew/0000-0002-6877-450X	National Institutes of Health [R01DK097374]; Molecular Mechanisms of Microbial Pathogenesis Training Program [5T32AI007528, R01AI124690, R01GM043768]; University of Michigan Center for Gastrointestinal Research (National Institutes of Health) [P30DK034933]	This work was supported by National Institutes of Health grants R01DK097374 (A.W.T.), the Molecular Mechanisms of Microbial Pathogenesis Training Program 5T32AI007528 (D.L.L.), R01AI124690 (M.R.M.) and R01GM043768 (R.G.). Microscopy was performed at the University of Michigan Microscopy & Image Analysis Laboratory with support from the University of Michigan Center for Gastrointestinal Research (National Institutes of Health P30DK034933).	Atasheva S, 2010, J VIROL, V84, P10004, DOI 10.1128/JVI.01151-10; Bagchi P, 2016, ELIFE, V5, DOI 10.7554/eLife.21470; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BOCCHINFUSO WP, 1992, ENDOCRINOLOGY, V131, P2331, DOI 10.1210/en.131.5.2331; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; Cherepanova NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20946; Cherepanova NA, 2014, J CELL BIOL, V206, P525, DOI 10.1083/jcb.201404083; Frolova EI, 2002, J VIROL, V76, P11254, DOI 10.1128/JVI.76.22.11254-11264.2002; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Houzet L, 2011, EXP BIOL MED, V236, P962, DOI 10.1258/ebm.2010.010272; Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027; Hung V, 2016, NAT PROTOC, V11, P456, DOI 10.1038/nprot.2016.018; LABOISSIERE MCA, 1995, J BIOL CHEM, V270, P28006; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; McGee CE, 2010, VECTOR-BORNE ZOONOT, V10, P267, DOI 10.1089/vbz.2009.0067; Mohorko E, 2014, STRUCTURE, V22, P590, DOI 10.1016/j.str.2014.02.013; Naik NG, 2015, J VIROL, V89, P6746, DOI 10.1128/JVI.00423-15; Roboti P, 2012, J CELL SCI, V125, P3474, DOI 10.1242/jcs.103952; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Salloum S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003513; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Satoh T, 2015, ELIFE, V4, DOI 10.7554/eLife.06306; Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028; Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109; Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916; Shrimal S, 2015, GLYCOBIOLOGY, V25, P774, DOI 10.1093/glycob/cwv018; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; Wang HL, 2014, GASTROENTEROLOGY, V146, P1373, DOI 10.1053/j.gastro.2014.02.002; Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; Yi ZG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001255; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106	38	1	1	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2150-7511			MBIO	mBio	JUL-AUG	2017	8	4							e00939-17	10.1128/mBio.00939-17				16	Microbiology	Microbiology	FG0BP	WOS:000409384300052		gold			2018-01-05	
J	Silas, S; Makarova, KS; Shmakov, S; Paez-Espino, D; Mohr, G; Liu, Y; Davison, M; Roux, S; Krishnamurthy, SR; Fu, BXH; Hansen, LL; Wang, D; Sullivan, MB; Millard, A; Clokie, MR; Bhaya, D; Lambowitz, AM; Kyrpides, NC; Koonin, EV; Fire, AZ				Silas, Sukrit; Makarova, Kira S.; Shmakov, Sergey; Paez-Espino, David; Mohr, Georg; Liu, Yi; Davison, Michelle; Roux, Simon; Krishnamurthy, Siddharth R.; Fu, Becky Xu Hua; Hansen, Loren L.; Wang, David; Sullivan, Matthew B.; Millard, Andrew; Clokie, Martha R.; Bhaya, Devaki; Lambowitz, Alan M.; Kyrpides, Nikos C.; Koonin, Eugene V.; Fire, Andrew Z.			On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires	MBIO			English	Article						CRISPR; RNA spacer acquisition; cyanobacteria; deep sequencing; horizontal gene transfer; host-parasite relationship; phylogeny; reverse transcriptase	STREPTOCOCCUS-THERMOPHILUS; RNA CLEAVAGE; DNA; IMMUNITY; INTERFERENCE; RESISTANCE; VIRUSES; PROKARYOTES; POPULATION; PREDICTION	Cas1 integrase is the key enzyme of the clustered regularly interspaced short palindromic repeat (CRISPR)-Cas adaptation module that mediates acquisition of spacers derived from foreign DNA by CRISPR arrays. In diverse bacteria, the cas1 gene is fused (or adjacent) to a gene encoding a reverse transcriptase (RT) related to group II intron RTs. An RT-Cas1 fusion protein has been recently shown to enable acquisition of CRISPR spacers from RNA. Phylogenetic analysis of the CRISPR-associated RTs demonstrates monophyly of the RT-Cas1 fusion, and coevolution of the RT and Cas1 domains. Nearly all such RTs are present within type III CRISPR-Cas loci, but their phylogeny does not parallel the CRISPR-Cas type classification, indicating that RT-Cas1 is an autonomous functional module that is disseminated by horizontal gene transfer and can function with diverse type III systems. To compare the sequence pools sampled by RT-Cas1-associated and RT-lacking CRISPR-Cas systems, we obtained samples of a commercially grown cyanobacterium-Arthrospira platensis. Sequencing of the CRISPR arrays uncovered a highly diverse population of spacers. Spacer diversity was particularly striking for the RT-Cas1-containing type III-B system, where no saturation was evident even with millions of sequences analyzed. In contrast, analysis of the RT-lacking type III-D system yielded a highly diverse pool but reached a point where fewer novel spacers were recovered as sequencing depth was increased. Matches could be identified for a small fraction of the non-RT-Cas1-associated spacers, and for only a single RT-Cas1-associated spacer. Thus, the principal source(s) of the spacers, particularly the hypervariable spacer repertoire of the RT-associated arrays, remains unknown. IMPORTANCE While the majority of CRISPR-Cas immune systems adapt to foreign genetic elements by capturing segments of invasive DNA, some systems carry reverse transcriptases (RTs) that enable adaptation to RNA molecules. From analysis of available bacterial sequence data, we find evidence that RT-based RNA adaptation machinery has been able to join with CRISPR-Cas immune systems in many, diverse bacterial species. To investigate whether the abilities to adapt to DNA and RNA molecules are utilized for defense against distinct classes of invaders in nature, we sequenced CRISPR arrays from samples of commercial-scale open-air cultures of Arthrospira platensis, a cyanobacterium that contains both RT-lacking and RT-containing CRISPR-Cas systems. We uncovered a diverse pool of naturally occurring immune memories, with the RT-lacking locus acquiring a number of segments matching known viral or bacterial genes, while the RT-containing locus has acquired spacers from a distinct sequence pool for which the source remains enigmatic.	[Silas, Sukrit; Fu, Becky Xu Hua; Hansen, Loren L.; Fire, Andrew Z.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Silas, Sukrit; Fu, Becky Xu Hua; Hansen, Loren L.; Fire, Andrew Z.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Silas, Sukrit] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Makarova, Kira S.; Shmakov, Sergey; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [Shmakov, Sergey] Skolkovo Inst Sci & Technol, Skolkovo, Russia; [Paez-Espino, David; Kyrpides, Nikos C.] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Mohr, Georg; Lambowitz, Alan M.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Liu, Yi] Stanford Univ, Dept Biomed Informat, Stanford, CA 94305 USA; [Davison, Michelle; Bhaya, Devaki] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA; [Roux, Simon; Sullivan, Matthew B.] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA; [Krishnamurthy, Siddharth R.; Wang, David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Krishnamurthy, Siddharth R.; Wang, David] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Sullivan, Matthew B.] Ohio State Univ, Dept Civil Environm & Geodet Engn, Columbus, OH 43210 USA; [Clokie, Martha R.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Millard, Andrew] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Warwick, England	Fire, AZ (reprint author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.; Fire, AZ (reprint author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	afire@stanford.edu	Kyrpides, Nikos/A-6305-2014	Kyrpides, Nikos/0000-0002-6131-0462	Stanford Graduate Fellowship; HHMI; U.S. Department of Health and Human Services; U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility [DE-AC02-05CH11231];  [NIH R01-GM37706];  [NIH R01-GM37949]	S. Silas was supported by a Stanford Graduate Fellowship and an HHMI International Student Research Fellowship. K. S. Makarova, S. Shmakov, and E. V. Koonin are supported by the Intramural Program of the U.S. Department of Health and Human Services (via funds provided to the National Library of Medicine). D. Paez-Espino and N. C. Kyrpides were supported by the U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, under contract number DE-AC02-05CH11231.; This research was supported by grant NIH R01-GM37706 to A. Z. Fire and grant NIH R01-GM37949 to A. M. Lambowitz. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Bryson AL, 2015, MBIO, V6, DOI 10.1128/mBio.00648-15; CHAO A, 1984, SCAND J STAT, V11, P265; Chen IMA, 2017, NUCLEIC ACIDS RES, V45, pD507, DOI 10.1093/nar/gkw929; Davison M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160574; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-18; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; GRUNBERGMANAGO M, 1956, BIOCHIM BIOPHYS ACTA, V20, P269, DOI 10.1016/0006-3002(56)90286-4; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Held NL, 2013, ENVIRON MICROBIOL, V15, P3065, DOI 10.1111/1462-2920.12146; Jackson SA, 2017, SCIENCE, V356, P40, DOI 10.1126/science.aal5056; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Kojima KK, 2008, MOL BIOL EVOL, V25, P1395, DOI 10.1093/molbev/msn081; KONARSKA MM, 1989, CELL, V57, P423, DOI 10.1016/0092-8674(89)90917-3; Krishnamurthy SR, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002409; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600                                          ; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11; Maniv I, 2016, J BACTERIOL, V198, P941, DOI 10.1128/JB.00897-15; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mihara T, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030066; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Morin N, 2010, J MICROBIOL METH, V80, P148, DOI 10.1016/j.mimet.2009.11.012; Paez-Espino D, 2017, NUCLEIC ACIDS RES, V45, pD457, DOI 10.1093/nar/gkw1030; Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094; Parameswaran P, 2013, CELL HOST MICROBE, V13, P691, DOI 10.1016/j.chom.2013.05.008; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Plagens A, 2015, FEMS MICROBIOL REV, V39, P442, DOI 10.1093/femsre/fuv019; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Roux S, 2016, NATURE, V537, P689, DOI 10.1038/nature19366; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Shmakov SA, 2017, BIORXIV; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Simon DM, 2008, NUCLEIC ACIDS RES, V36, P7219, DOI 10.1093/nar/gkn867; Sun CL, 2016, ISME J, V10, P858, DOI 10.1038/ismej.2015.162; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Toro N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114083; Wang C, 2014, J IMMUNOL, V192, P603, DOI 10.4049/jimmunol.1301384; Weinberger AD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002475; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	57	0	0	3	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2150-7511			MBIO	mBio	JUL-AUG	2017	8	4							e00897-17	10.1128/mBio.00897-17				16	Microbiology	Microbiology	FG0BP	WOS:000409384300083		gold			2018-01-05	
J	Sugi, T; Tu, V; Ma, YF; Tomita, T; Weiss, LM				Sugi, Tatsuki; Tu, Vincent; Ma, Yanfen; Tomita, Tadakimi; Weiss, Louis M.			Toxoplasma gondii Requires Glycogen Phosphorylase for Balancing Amylopectin Storage and for Efficient Production of Brain Cysts	MBIO			English	Article						amylopectin; bradyzoite; latency; metabolism; Toxoplasma gondii; energy utilization; glycogen metabolism; glycogen phosphorylase; posttranslational modification; protein phosphorylation	PROTEIN-KINASE; INFECTION; PARASITES; GENES	In immunocompromised hosts, latent infection with Toxoplasma gondii can reactivate from tissue cysts, leading to encephalitis. A characteristic of T. gondii bradyzoites in tissue cysts is the presence of amylopectin granules. The regulatory mechanisms and role of amylopectin accumulation in this organism are not fully understood. The T. gondii genome encodes a putative glycogen phosphorylase (TgGP), and mutants were constructed to manipulate the activity of TgGP and to evaluate the function of TgGP in amylopectin storage. Both a stop codon mutant (Pru/TgGP(S25stop) [expressing a Ser-to-stop codon change at position 25 in TgGP]) and a phosphorylation null mutant (Pru/TgGP(S25A) [expressing a Ser-to-Ala change at position 25 in TgGp]) mutated at Ser25 displayed amylopectin accumulation, while the phosphorylation-mimetic mutant (Pru/TgGP(S25E) [expressing a Ser-to-Glu change at position 25 in TgGp]) had minimal amylopectin accumulation under both tachyzoite and bradyzoite growth conditions. The expression of active TgGP(S25S) or TgGP(S25E) restored amylopectin catabolism in Pru/TgGP(S25A). To understand the relation between GP and calcium-dependent protein kinase 2 (CDPK2), which was recently reported to regulate amylopectin consumption, we knocked out CDPK2 in these mutants. Pru Delta cdpk2/TgGP(S25E) had minimal amylopectin accumulation, whereas the Delta cdpk2 phenotype in the other GP mutants and parental lines displayed amylopectin accumulation. Both the inactive S25A and hyperactive S25E mutant produced brain cysts in infected mice, but the numbers of cysts produced were significantly less than the number produced by the S25S wild-type GP parasite. Complementation that restored amylopectin regulation restored brain cyst production to the control levels seen in infected mice. These data suggest that T. gondii requires tight regulation of amylopectin expression for efficient production of cysts and persistent infections and that GP phosphorylation is a regulatory mechanism involved in amylopectin storage and utilization. IMPORTANCE Toxoplasma gondii is an obligate intracellular parasite that causes disease in immune-suppressed individuals, as well as a fetopathy in pregnant women who acquire infection for the first time during pregnancy. This parasite can differentiate between tachyzoites (seen in acute infection) and bradyzoites (seen in latent infection), and this differentiation is associated with disease relapse. A characteristic of bradyzoites is that they contain cytoplasmic amylopectin granules. The regulatory mechanisms and the roles of amylopectin granules during latent infection remain to be elucidated. We have identified a role of T. gondii glycogen phosphorylase (TgGP) in the regulation of starch digestion and a role of posttranslational modification of TgGP, i.e., phosphorylation of Ser25, in the regulation of amylopectin digestion. By manipulating TgGP activity in the parasite with genome editing, we found that the digestion and storage of amylopectin due to TgGP activity are both important for latency in the brain.	[Sugi, Tatsuki; Tu, Vincent; Ma, Yanfen; Tomita, Tadakimi; Weiss, Louis M.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Weiss, Louis M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Weiss, LM (reprint author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.; Weiss, LM (reprint author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	louis.weiss@einstein.yu.edu			HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID) [R01AI095094]; Japan Society for the Promotion of Science (JSPS) [JSPS 26-7030]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [K12GM102779, T32GM007491]	This work, including the efforts of L.M.W., was funded by HHS vertical bar NIH vertical bar National Institute of Allergy and Infectious Diseases (NIAID) R01AI095094 (principal investigator [PI], L.M.W.). The efforts of T.S. were funded by Japan Society for the Promotion of Science (JSPS) (JSPS 26-7030). The efforts of T. T. were funded by HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS) grant number K12GM102779 (PI, Dianne Cox). The efforts of V.T. were funded by HHS vertical bar NIH vertical bar National Institute of General Medical Sciences ( NIGMS) grant number T32GM007491 (PI, Margaret Kielian). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Brushia Robert J., 1999, Frontiers in Bioscience, V4, pd618, DOI 10.2741/Brushia; Coppin A, 2005, J MOL EVOL, V60, P257, DOI 10.1007/s00239-004-0185-6; Dzierszinski F, 2004, EUKARYOT CELL, V3, P992, DOI 10.1128/EC.3.4.992-1003.2004; Ferguson DJP, 2014, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN - PERSPECTIVES AND METHODS, 2ND EDITION, P19, DOI 10.1016/B978-0-12-396481-6.00002-7; Fox BA, 2011, EUKARYOT CELL, V10, P1193, DOI 10.1128/EC.00297-10; Guerardel Y, 2005, MICROBES INFECT, V7, P41, DOI 10.1016/j.micinf.2004.09.007; Hjerrild M, 2004, J PROTEOME RES, V3, P426, DOI 10.1021/pr0341033; Jenkins M, 2003, PARASITOL RES, V89, P1, DOI 10.1007/s00436-002-0720-6; JOHNSON LN, 1992, FASEB J, V6, P2274; JOHNSON LN, 1994, PROTEIN SCI, V3, P1726, DOI 10.1002/pro.5560031011                                                          ; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li ZL, 2006, ARCH HISTOL CYTOL, V69, P147, DOI 10.1679/aohc.69.147; Lin H., 2002, TECHNOMETRICS, V44, P85, DOI http://dx.doi.org/10.1198/tech.2002.s656; LIN K, 1995, J BIOL CHEM, V270, P26833, DOI 10.1074/jbc.270.45.26833                                                        ; Mahlow S, 2016, CELL MOL LIFE SCI, V73, P2753, DOI 10.1007/s00018-016-2248-4; NAKAI Y, 1987, JPN J VET SCI, V49, P447; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Sakikawa M, 2012, CLIN VACCINE IMMUNOL, V19, P365, DOI 10.1128/CVI.05486-11; Schaeffer M, 2009, J IMMUNOL, V182, P6379, DOI 10.4049/jimmunol.0804307; Shanmugasundram A, 2013, NUCLEIC ACIDS RES, V41, pD706, DOI 10.1093/nar/gks1139; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Silver DM, 2014, TRENDS PLANT SCI, V19, P471, DOI 10.1016/j.tplants.2014.01.008; Sugi T, 2016, PARASITOL INT, V65, P1; Sugi T, 2016, MBIO, V7, DOI 10.1128/mBio.00755-16; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Tomita T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003823; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Uboldi AD, 2015, CELL HOST MICROBE, V18, P670, DOI 10.1016/j.chom.2015.11.004; Watts E, 2015, MBIO, V6, DOI 10.1128/mBio.01155-15; Weiss LM, 2014, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN - PERSPECTIVES AND METHODS, 2ND EDITION, P1	31	0	0	4	4	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2150-7511			MBIO	mBio	JUL-AUG	2017	8	4							e01289-17	10.1128/mBio.01289-17				13	Microbiology	Microbiology	FG0BP	WOS:000409384300086		gold			2018-01-05	
J	Merenda, A; Andersson-Rolf, A; Mustata, RC; Li, TB; Kim, H; Koo, BK				Merenda, Alessandra; Andersson-Rolf, Amanda; Mustata, Roxana C.; Li, Taibo; Kim, Hyunki; Koo, Bon-Kyoung			A Protocol for Multiple Gene Knockout in Mouse Small Intestinal Organoids Using a CRISPR-concatemer	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Bioengineering; Issue 125; CRISPR/Cas9; knockout; organoid; intestine; electroporation; paralogues; Wnt	CAS9	CRISPR/Cas9 technology has greatly improved the feasibility and speed of loss-of-function studies that are essential in understanding gene function. In higher eukaryotes, paralogous genes can mask a potential phenotype by compensating the loss of a gene, thus limiting the information that can be obtained from genetic studies relying on single gene knockouts. We have developed a novel, rapid cloning method for guide RNA (gRNA) concatemers in order to create multi-gene knockouts following a single round of transfection in mouse small intestinal organoids. Our strategy allows for the concatemerization of up to four individual gRNAs into a single vector by performing a single Golden Gate shuffling reaction with annealed gRNA oligos and a pre-designed retroviral vector. This allows either the simultaneous knockout of up to four different genes, or increased knockout efficiency following the targeting of one gene by multiple gRNAs. In this protocol, we show in detail how to efficiently clone multiple gRNAs into the retroviral CRISPR-concatemer vector and how to achieve highly efficient electroporation in intestinal organoids. As an example, we show that simultaneous knockout of two pairs of genes encoding negative regulators of the Wnt signaling pathway (Axin1/2 and Rnf43/Znrf3) renders intestinal organoids resistant to the withdrawal of key growth factors.	[Merenda, Alessandra; Andersson-Rolf, Amanda; Mustata, Roxana C.; Li, Taibo; Koo, Bon-Kyoung] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England; [Merenda, Alessandra; Andersson-Rolf, Amanda; Koo, Bon-Kyoung] Univ Cambridge, Dept Genet, Cambridge, England; [Kim, Hyunki] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea	Koo, BK (reprint author), Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England.; Koo, BK (reprint author), Univ Cambridge, Dept Genet, Cambridge, England.	bkk25@cam.ac.uk	Koo, Bon-Kyoung/V-5219-2017	Koo, Bon-Kyoung/0000-0002-4134-8033	Wntsapp (Marie Curie ITN); Medical Research Council (MRC); Sir Henry Dale Fellowship from Wellcome Trust; Royal Society [101241/Z/13/Z]; Wellcome Trust; MRC	We thank Christopher Hindley for the critical reading of the manuscript. A.M. is supported by Wntsapp (Marie Curie ITN), A. A-R. is supported by the Medical Research Council (MRC), and B-K.K. and R.M. are supported by a Sir Henry Dale Fellowship from the Wellcome Trust and the Royal Society [101241/Z/13/Z] and receive support through a core grant from the Wellcome Trust and MRC to the Wellcome Trust - MRC Cambridge Stem Cell Institute.	Andersson-Rolf A, 2016, DEV BIOL, V420, P271, DOI 10.1016/j.ydbio.2016.10.016; Andersson-Rolf A, 2014, JOVE-J VIS EXP, DOI 10.3791/51765; Bassett AR, 2015, J GENET GENOMICS, V42, P301, DOI 10.1016/j.jgg.2015.03.011; Cress BF, 2015, ACS SYNTH BIOL, V4, P987, DOI 10.1021/acssynbio.5b00012; Diss G, 2014, J EXP ZOOL PART B, V322, P488, DOI 10.1002/jez.b.22555; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Froger A., 2007, JOVE-J VIS EXP, P253, DOI DOI 10.3791/253; Fujii M, 2015, NAT PROTOC, V10, P1474, DOI 10.1038/nprot.2015.088; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Yin LL, 2015, GENETICS, V200, P431, DOI 10.1534/genetics.115.176917; ZIMMERMANN J, 1988, FEBS LETT, V233, P432, DOI 10.1016/0014-5793(88)80477-0	15	0	0	0	0	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JUL	2017		125							e55916	10.3791/55916				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FD3TS	WOS:000407455900051		green_published			2018-01-05	
J	Ishag, HZA; Liu, MJ; Yang, RS; Xiong, QY; Feng, ZX; Shao, GQ				Ishag, Hassan Z. A.; Liu, Maojun; Yang, Ruosong; Xiong, Qiyan; Feng, Zhixin; Shao, Guoqing			Inactivation of eGFP DNA in PK-15 cells via CRISPR/Cas9 system	ROMANIAN BIOTECHNOLOGICAL LETTERS			English	Article						eGFP; PK-15 Cells; NHEJ; HDR; CRISPR/Cas9		The aim of this study is to outline a simple method to efficiently disrupt eGFP gene in PK-15 cells using RNA-guided Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system. We co-transfected a plasmid encoding both eGFP and it is sgRNA with a plasmid encoding Cas9 into PK-15 cells using Lipofectamine. After 24 hrs of culture, an about 65% of the cells had lost eGFP expression via non-homologous end joining (NHEJ), examined under the fluorescence microscope. When a donor plasmid carrying a blue fluorescence protein (BFP) with arms homologous to eGFP was introduced along with CRISPR plasmids, a BFP fluorescence replacing the green fluorescence of eGFP was observed, possibly induced by homology-directed repair (HDR). In conclusion, CRISPR/Cas9 system was successfully utilized in PK-15 cells to inactivate eGFP. This might be a useful technique to be developed to inactivate foreign genes, including invaders such as viruses and internal parasites reducing their burden.	[Ishag, Hassan Z. A.; Liu, Maojun; Yang, Ruosong; Xiong, Qiyan; Feng, Zhixin; Shao, Guoqing] Jiangsu Acad Agr Sci, Inst Vet Med, Natl Res Ctr Engn & Technol Vet Bioprod, Key Lab Vet Biol Engn & Technol,Minist Agr, Nanjing 210014, Peoples R China; [Liu, Maojun] Univ Nyala, Coll Vet Sci, Nyala, Sudan	Shao, GQ (reprint author), Jiangsu Acad Agr Sci, Inst Vet Med, Natl Res Ctr Engn & Technol Vet Bioprod, Key Lab Vet Biol Engn & Technol,Minist Agr, Nanjing 210014, Peoples R China.	gqshaojaas@163.com			Jiangsu Academy of Agricultural Sciences, China [6511318]; National Natural Sciences Foundation of China [31100136, 31550110211]	This work was supported by Postdoctoral Fund of Jiangsu Academy of Agricultural Sciences, China (6511318) National Natural Sciences Foundation of China (31100136, 31550110211).	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Chen A, 2014, P NATL ACAD SCI USA, V111, P10037, DOI 10.1073/pnas.1409795111; Choi W, 2015, ZYGOTE, V23, P916, DOI 10.1017/S096719941400063X; CHU V. T., 2015, NAT BIOTECHNOL, V33, P5; DING Q., 2013, STEM CELLS, V12, P4; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huppert J, 2010, FASEB J, V24, P1023, DOI 10.1096/fj.09-141978; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; RAN F. A., 2013, NAT PROTOC, V8, P11; WANG H., 2013, CELL, V153, P4; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang X.-C., 2015, NAT COMMUN, V6, P1; WU Y., 2013, STEM CELLS, V13, P6; Zhang GQ, 2014, MICRO NANO LETT, V9, P141, DOI 10.1049/mnl.2013.0596; ZUKER M., 2003, NUCLEIC ACIDS RES, V31, P13	17	0	0	0	0	ARS DOCENDI	BUCHAREST	SOS PANDURI 90, SECT 5, BUCHAREST, RO-050663, ROMANIA	1224-5984			ROM BIOTECH LETT	Rom. Biotech. Lett.	JUL-AUG	2017	22	4					12767	12774						8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FE7YU	WOS:000408423600011					2018-01-05	
J	Pillai, AB; Kumar, AJ; Thulasi, K; Kumarapillai, H				Pillai, Aneesh Balakrishna; Kumar, Arjun Jaya; Thulasi, Kavitha; Kumarapillai, Harikrishnan			Evaluation of short-chain-length polyhydroxyalkanoate accumulation in Bacillus aryabhattai	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Bacillus aryabhattai PHB10; Polyhydroxybutyrate; Domestic sewerage; Polymer characterization; 16S rRNA	RECOMBINANT ESCHERICHIA-COLI; POLY(BETA-HYDROXYBUTYRIC ACID); MOLECULAR CHARACTERIZATION; ALCALIGENES-EUTROPHUS; BIOSYNTHESIS; BACTERIAL; POLY(3-HYDROXYBUTYRATE); GENES; SOIL; OPTIMIZATION	This study was focused on the polyhydroxybutyrate (PHB) accumulation property of Bacillus aryabhattai isolated from environment. Twenty-four polyhydroxyalkanoate (PHA) producers were screened out from sixty-two environmental bacterial isolates based on Sudan Black B colony staining. Based on their PHA accumulation property, six promising isolates were further screened out. The most productive isolate PHB10 was identified as B. aryabhattai PHB10. The polymer production maxima were 3.264 g/L, 2.181 g/L, 1.47 g/L, 1.742 g/L and 1.786 g/L in glucose, fructose, maltose, starch and glycerol respectively. The bacterial culture reached its stationary and declining phases at 18 h and 21 h respectively and indicated growth-associated PHB production. Nuclear Magnetic Resonance (NMR) spectra confirmed the material as PHB. The material has thermal stability between 30 and 140 degrees C, melting point at 170 degrees C and maximum thermal degradation at 287 degrees C. The molecular weight and poly dispersion index of the polymer were found as 199.7 kDa and 2.67 respectively. The bacterium B. aryabhattai accumulating PHB up to 75% of cell dry mass utilizing various carbon sources is a potential candidate for large scale production of bacterial polyhydroxybutyrate. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Pillai, Aneesh Balakrishna; Kumar, Arjun Jaya; Thulasi, Kavitha; Kumarapillai, Harikrishnan] RGCB, Environm Biol Lab, Thycaud PO, Thiruvananthapuram 14, Kerala, India	Kumarapillai, H (reprint author), RGCB, Environm Biol Lab, Thycaud PO, Thiruvananthapuram 14, Kerala, India.	harikrishnan@rgcb.res.in			Department of Biotechnology, Govt. of India; Council of Scientific and Industrial Research (CSIR), India (SRF) [09/716(0149)/2012-EMR-I]	The authors are grateful to Prof. M. Radhakrishna Pillai, Director, RGCB for the facilities provided. This work was supported by Department of Biotechnology, Govt. of India. Aneesh B would like to acknowledge Council of Scientific and Industrial Research (CSIR), India for awarding research fellowship (SRF; 09/716(0149)/2012-EMR-I).	Alvarez HM, 1997, FETT-LIPID, V99, P239, DOI 10.1002/lipi.19970990704                                                        ; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450; Andreessen B, 2010, APPL ENVIRON MICROB, V76, P622, DOI 10.1128/AEM.02097-09; Aneesh BP, 2016, INT J CURR MICROBIOL, V5, P816; BONTHRONE KM, 1992, FEMS MICROBIOL LETT, V103, P269; BURDON KL, 1946, J BACTERIOL, V52, P665; Cappuccino J. G., 2011, MICROBIOLOGY LAB MAN; Chen GQ, 2010, MICROBIOL MONOGR, V14, P17, DOI 10.1007/978-3-642-03287_5_2; Doan VT, 2012, MICROBIOLOGYOPEN, V1, P395, DOI 10.1002/mbo3.44; FERNANDEZCASTILLO R, 1986, APPL ENVIRON MICROB, V51, P214; Gouda MK, 2001, MICROBIOL RES, V156, P201, DOI 10.1078/0944-5013-00104; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Grothe E, 1999, ENZYME MICROB TECH, V25, P132, DOI 10.1016/S0141-0229(99)00023-X; Gunaratne LMWK, 2004, THERMOCHIM ACTA, V423, P127, DOI 10.1016/j.tca.2004.05.003; HAHN SK, 1995, APPL ENVIRON MICROB, V61, P34; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Han J, 2007, APPL ENVIRON MICROB, V73, P6058, DOI 10.1128/AEM.00953-07; Hocking J, 1994, CHEM TECHNOLOGY BIOD, P48; Holt JG, 1994, BERGEYS MANUAL DETER; Jendrossek D, 2007, APPL ENVIRON MICROB, V73, P586, DOI 10.1128/AEM.01839-06; Jo SJ, 2007, J BIOSCI BIOENG, V104, P457, DOI 10.1263/jbb.104.457; 김수환, 2011, [Korean Journal of Microbiology and Biotechnology, 한국미생물Â·생명공학회지], V39, P77; Kourmentza C, 2015, INT J BIOL MACROMOL, V74, P202, DOI 10.1016/j.ijbiomac.2014.12.032; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054; Labuzek S, 2001, J APPL MICROBIOL, V90, P353, DOI 10.1046/j.1365-2672.2001.01253.x                                                ; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115; Legault BA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-171; Lemoigne M., 1926, B SOC CHIM BIOL, V8, P770; LILLO JG, 1990, APPL ENVIRON MICROB, V56, P2517; Liu CL, 2013, APPL MICROBIOL BIOT, V97, P9377, DOI 10.1007/s00253-013-5165-6; Liu MH, 1998, APPL ENVIRON MICROB, V64, P4600; Mizuno K, 2010, POLYM DEGRAD STABIL, V95, P1335, DOI 10.1016/j.polymdegradstab.2010.01.033; MULLER HM, 1993, ANGEW CHEM INT EDIT, V32, P477, DOI 10.1002/anie.199304771; Philip S, 2007, J CHEM TECHNOL BIOT, V82, P233, DOI 10.1002/jctb.1667; Poil A, 2011, ARCHAEA, P1; Poirier Y, 2002, PROG LIPID RES, V41, P131, DOI 10.1016/S0163-7827(01)00018-2; Qi QS, 2001, MICROBIOL-SGM, V147, P3353, DOI 10.1099/00221287-147-12-3353                                                    ; Reinecke F, 2009, J MOL MICROB BIOTECH, V16, P91, DOI 10.1159/000142897; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Salgaonkar BB, 2013, J APPL MICROBIOL, V114, P1347, DOI 10.1111/jam.12135; Sangkharak K, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue3-fulltext-2; Shamala TR, 2003, J APPL MICROBIOL, V94, P369, DOI 10.1046/j.1365-2672.2003.01838.x; Shi HD, 1997, J FERMENT BIOENG, V84, P579, DOI 10.1016/S0922-338X(97)81915-0; Shivaji S, 2009, INT J SYST EVOL MICR, V59, P2977, DOI 10.1099/ijs.0.002527-0; Shrivastav A, 2010, INT J BIOL MACROMOL, V47, P283, DOI 10.1016/j.ijbiomac.2010.04.007; Singh M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-38; Singh P, 2015, ANTON LEEUW INT J G, V107, P749, DOI 10.1007/s10482-014-0369-z; Steinbuchel A, 2003, BIOCHEM ENG J, V16, P81, DOI 10.1016/S1369-703X(03)00036-6; Steinbuchel A, 1998, TRENDS BIOTECHNOL, V16, P419, DOI 10.1016/S0167-7799(98)01194-9; Su W.-F., 2013, PRINCIPLES POLYM DES, P9; Tanamool V, 2013, TURK J BIOL, V37, P259, DOI 10.3906/biy-1205-62; Valappil SP, 2007, ANTON LEEUW INT J G, V91, P1, DOI 10.1007/s10482-006-9095-5; Valentin HE, 1997, J BIOTECHNOL, V58, P33, DOI 10.1016/S0168-1656(97)00127-2; Volova T.G., 2004, POLYHYDROXYALKANOATE; Wong PAL, 2004, E-POLYMERS, V4, P324; Yao ZZ, 2012, P NATL ACAD SCI USA, V109, pE2561, DOI 10.1073/pnas.1209742109; Yoshihiro A, 2002, POLYM DEGRAD STABIL, V76, P53	57	0	0	5	5	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	JUL-SEP	2017	48	3					451	460		10.1016/j.bjm.2017.01.005				10	Microbiology	Microbiology	FD2PN	WOS:000407377400010	28359856	gold			2018-01-05	
J	Techaparin, A; Thanonkeo, P; Klanrit, P				Techaparin, Atiya; Thanonkeo, Pornthap; Klanrit, Preekamol			High-temperature ethanol production using thermotolerant yeast newly isolated from Greater Mekong Subregion	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Thermotolerant yeast; Box-Behnken experimental design; Response surface method; Ethanol production; Sweet sorghum juice(SSJ)	SWEET SORGHUM JUICE; RESPONSE-SURFACE METHODOLOGY; SACCHAROMYCES-CEREVISIAE; BIOETHANOL PRODUCTION; KLUYVEROMYCES-MARXIANUS; SIMULTANEOUS SACCHARIFICATION; CANDIDA-ALBICANS; GENE-EXPRESSION; CASSAVA STARCH; FUEL ETHANOL	The application of high-potential thermotolerant yeasts is a key factor for successful ethanol production at high temperatures. Two hundred and thirty-four yeast isolates from Greater Mekong Subregion (GMS) countries, i.e., Thailand, The Lao People's Democratic Republic (Lao PDR) and Vietnam were obtained. Five thermotolerant yeasts, designated Saccharomyces cerevisiae KKU-VN8, KKU-VN20, and KKU-VN27, Pichia kudriavzevii KKU-TH33 and P. kudriavzevii KKU-TH43, demonstrated high temperature and ethanol tolerance levels up to 45 degrees C and 13% (v/v), respectively. All five strains produced higher ethanol concentrations and exhibited greater productivities and yields than the industrial strain S. cerevisiae TISTR5606 during high-temperature fermentation at 40 degrees C and 43 degrees C. S. cerevisiae KKU-VN8 demonstrated the best performance for ethanol production from glucose at 37 degrees C with an ethanol concentration of 72.69g/L, a productivity of 1.59g/L/h and a theoretical ethanol yield of 86.27%. The optimal conditions for ethanol production of S. cerevisiae KKU-VN8 from sweet sorghum juice (SSJ) at 40 degrees C were achieved using the Box-Behnken experimental design (BBD). The maximal ethanol concentration obtained during fermentation was 89.32g/L, with a productivity of 2.48g/L/h and a theoretical ethanol yield of 96.32%. Thus, the newly isolated thermotolerant S. cerevisiae KKU-VN8 exhibits a great potential for commercial-scale ethanol production in the future. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. All rights reserved.	[Techaparin, Atiya] Khon Kaen Univ, Grad Sch, Khon Kaen 40002, Thailand; [Techaparin, Atiya; Thanonkeo, Pornthap; Klanrit, Preekamol] Khon Kaen Univ, Fac Technol, Dept Biotechnol, Khon Kaen 40002, Thailand; [Thanonkeo, Pornthap; Klanrit, Preekamol] Khon Kaen Univ, Fermentat Res Ctr Value Added Agr Prod FerVAAP, Khon Kaen 40002, Thailand	Klanrit, P (reprint author), Khon Kaen Univ, Fac Technol, Dept Biotechnol, Khon Kaen 40002, Thailand.	kpreek@kku.ac.th			National Research University Project of Thailand through the Biofuel Research Cluster of Khon Kaen University, Thailand [NRU 543042, NRU-KKU-Ph.D 54310]	The research was financially supported by the National Research University Project of Thailand through the Biofuel Research Cluster of Khon Kaen University, Thailand (NRU 543042 and NRU-KKU-Ph.D 54310). We are grateful to the Fermentation Research Center for Value Added Agricultural Products (FerVAAP) and the Department of Biotechnology, Faculty of Technology, Khon Kaen University for supporting the equipment and facilities for this research.	Abdel-Banat BMA, 2010, APPL MICROBIOL BIOT, V85, P861, DOI 10.1007/s00253-009-2248-5; Aguilera F, 2006, INT J FOOD MICROBIOL, V110, P34, DOI 10.1016/j.ijfoodmicro.2006.02.002; Alexandre H, 2001, FEBS LETT, V498, P98, DOI 10.1016/S0014-5793(01)02503-0; Auesukaree C, 2012, J BIOSCI BIOENG, V114, P144, DOI 10.1016/j.jbiosc.2012.03.012; Balat M, 2009, APPL ENERG, V86, P2273, DOI 10.1016/j.apenergy.2009.03.015; Banat IM, 1998, WORLD J MICROB BIOT, V14, P809, DOI 10.1023/A:1008802704374; Barnnett J, 1978, GUIDE IDENTIFYING CL; Bhima B, 2010, IIOAB J, V1, P32; Brito EHS, 2009, VET MICROBIOL, V139, P318, DOI 10.1016/j.vetmic.2009.06.031; Cao WX, 2013, BIOMASS BIOENERG, V50, P45, DOI 10.1016/j.biombioe.2012.10.016; Charoensopharat K, 2015, ANTON LEEUW INT J G, V108, P173, DOI 10.1007/s10482-015-0476-5; Chen YC, 2001, J CLIN MICROBIOL, V39, P4042, DOI 10.1128/JCM.39.11.4042-4051.2001; Choi GW, 2010, BIOMASS BIOENERG, V34, P1223, DOI 10.1016/j.biombioe.2010.03.019; Deesuth O, 2012, ENERGIES, V5, P3178, DOI 10.3390/en5093178; Dhaliwal SS, 2011, BIORESOURCE TECHNOL, V102, P5968, DOI 10.1016/j.biortech.2011.02.015; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017                                                             ; Edgardo A, 2008, ENZYME MICROB TECH, V43, P120, DOI 10.1016/j.enzmictec.2008.02.007; Ferreira SLC, 2007, ANAL CHIM ACTA, V597, P179, DOI 10.1016/j.aca.2007.07.011; Martin JFG, 2010, RENEW ENERG, V35, P1602, DOI 10.1016/j.renene.2009.12.015; Guigou M, 2011, BIOMASS BIOENERG, V35, P3058, DOI 10.1016/j.biombioe.2011.04.028; Harju S, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-8; Hohmann S., 2003, YEAST STRESS RESPONS; Jutakanoke R., 2014, Journal of Applied Pharmaceutical Science, V4, P52; Kaewkrajay C, 2014, SCIENCEASIA, V40, P268, DOI 10.2306/scienceasia1513-1874.2014.40.268; Katiyar S, 2006, ANTIMICROB AGENTS CH, V50, P2892, DOI 10.1128/AAC.00349-06; Kitagawa T, 2010, APPL MICROBIOL BIOT, V87, P1841, DOI 10.1007/s00253-010-2629-9; Kwon YJ, 2011, BIORESOURCE TECHNOL, V102, P8099, DOI 10.1016/j.biortech.2011.06.035; Laopaiboon L, 2007, WORLD J MICROB BIOT, V23, P1497, DOI 10.1007/s11274-007-9383-x; Laopaiboon L, 2009, BIORESOURCE TECHNOL, V100, P4176, DOI 10.1016/j.biortech.2009.03.046; Leesing R, 2011, WASET, V76, P799; Limtong S, 2007, BIORESOURCE TECHNOL, V98, P3367, DOI 10.1016/j.biortech.2006.10.044; Lin Y, 2006, APPL MICROBIOL BIOT, V69, P627, DOI 10.1007/s00253-005-0229-x; Lindquist S, 1996, P NATL ACAD SCI USA, V93, P5301, DOI 10.1073/pnas.93.11.5301; Matsushika A, 2010, APPL BIOCHEM BIOTECH, V162, P1952, DOI 10.1007/s12010-010-8972-6; MCCRACKEN LD, 1982, BIOTECHNOL BIOENG, P91; Mei XY, 2009, ENERG FUEL, V23, P487, DOI 10.1021/ef800429u; Mussatto SI, 2010, BIOTECHNOL ADV, V28, P817, DOI 10.1016/j.biotechadv.2010.07.001; Negi B., 2013, International Food Research Journal, V20, P975; Nitayavardhana S, 2010, BIORESOURCE TECHNOL, V101, P2741, DOI 10.1016/j.biortech.2009.10.075; Nuanpeng S, 2016, ENERGIES, V9, DOI 10.3390/en9040253; Oberoi HS, 2010, PROCESS BIOCHEM, V45, P1299, DOI 10.1016/j.procbio.2010.04.017; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Ogbonna JC, 2001, BIORESOURCE TECHNOL, V76, P1, DOI 10.1016/S0960-8524(00)00084-5; Onyewu C, 2003, ANTIMICROB AGENTS CH, V47, P956, DOI 10.1128/AAC.47.3.956-964.2003; Papone T, 2012, WORLD ACAD SCI ENG T, V64, P1127; Patrascu E., 2009, Innovative Romanian Food Biotechnology, V4, P1; Pereira FB, 2010, BIORESOURCE TECHNOL, V101, P7856, DOI 10.1016/j.biortech.2010.04.082; Phutela UG, 2014, SUGAR TECH, V16, P411, DOI 10.1007/s12355-013-0283-0; PIPER PW, 1995, FEMS MICROBIOL LETT, V134, P121, DOI 10.1016/0378-1097(95)00431-9; Pratt PL, 2003, J I BREWING, V109, P218, DOI 10.1002/j.2050-0416.2003.tb00162.x                                              ; Roehr M., 2001, BIOTECHNOLOGY ETHANO; Rosa MM, 2010, WORLD J MICROB BIOT, V26, P1491, DOI 10.1007/s11274-010-0324-8; Singh A, 2013, IND CROP PROD, V41, P221, DOI 10.1016/j.indcrop.2012.04.036; Sree NK, 1999, PROCESS BIOCHEM, V34, P115, DOI 10.1016/S0032-9592(98)00074-0; Sree NK, 2000, BIORESOURCE TECHNOL, V72, P43, DOI 10.1016/S0960-8524(99)90097-4; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thammasittirong SN-R, 2013, SPRINGERPLUS, V2, P1; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; Tikka Chiranjeevi, 2013, Bioinformation, V9, P421, DOI 10.6026/97320630009421; Tofighi A, 2014, J ENVIRON HEALTH SCI, V12, DOI 10.1186/2052-336X-12-107; Tomas-Pejo E, 2009, FUEL, V88, P2142, DOI 10.1016/j.fuel.2009.01.014; Watanabe T, 2010, BIORESOURCE TECHNOL, V101, P9710, DOI 10.1016/j.biortech.2010.07.079; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1139/B07-071; Wu XR, 2010, IND CROP PROD, V31, P164, DOI 10.1016/j.indcrop.2009.10.006; Yu JL, 2008, FUEL PROCESS TECHNOL, V89, P1056, DOI 10.1016/j.fuproc.2008.04.008; Yu JL, 2009, BIOMASS BIOENERG, V33, P521, DOI 10.1016/j.biombioe.2008.08.020; Yuangsaard N, 2013, ANTON LEEUW INT J G, V103, P577, DOI 10.1007/s10482-012-9842-8; Zhao ShiHao, 2012, African Journal of Biotechnology, V11, P6117; Zoecklien B.W., 1995, WINE ANAL PRODUCTION	70	1	1	8	8	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	JUL-SEP	2017	48	3					461	475		10.1016/j.bjm.2017.01.006				15	Microbiology	Microbiology	FD2PN	WOS:000407377400011	28365094	gold			2018-01-05	
J	Ozsoy, S; Ilki, A				Ozsoy, Sevim; Ilki, Arzu			Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Clostridium difficile; Enterococci; Vancomycin resistance (VRE); Colonizationa	RISK-FACTORS; COLONIZATION; FAECIUM; EPIDEMIOLOGY; INFECTION; CARRIAGE; FAECALIS; SPREAD; AGAR	The aim of this study was to determine the association between Clostridium difficile (C. difficile) and vancomycin-resistant Enterococcus (VRE) and efficacy of screening stools submitted for C. difficile toxin assay for prevalence of VRE. Between April 2012 and February 2014, 158 stool samples submitted for C. difficile toxin to the Marmara University Microbiology Laboratory, were included in the study. Stool samples were analyzed by enzyme immuno assay test; VIDAS (bioMerieux, France) for Toxin A&B. Samples were inoculated on chromID VRE (bioMerieux, France) and incubated 24 h at 37 degrees C. Manuel tests and API20 STREP (bioMerieux, France) test were used to identify the Enterococci species. After the species identification, vancomycin and teicoplanin MIC's were performed by E test and molecular resistance genes for vanA vs vanB were detected by polymerase chain reaction (PCR). Of the 158 stool samples, 88 were toxin positive. The prevalence of VRE was 17%(n:19) in toxin positives however, 11.4% in toxin negatives(n:70). All VRE isolates were identified as Enterococcus faecium. These results were evaluated according to Fischer's exact chi-square test and p value between VRE colonization and C. difficile toxin positivity was detected 0.047 (p < 0.05). PPV and NPV were 79% and 47% respectively. In our study, the presence of VRE in C. difficile toxin positives is statistically significant compared with toxin negatives (p < 0.05). Screening for VRE is both additional cost and work load for the laboratories. Therefore VRE screening among C. difficile toxin positive samples, will be cost effective for determination of high risk patients in the hospitals especially for developing countries (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Ozsoy, Sevim; Ilki, Arzu] Marmara Univ, Med Fac, Dept Med Microbiol, Maltepe Basibuyuk Sok 9-1, TR-34854 Istanbul, Turkey	Ilki, A (reprint author), Marmara Univ, Med Fac, Dept Med Microbiol, Maltepe Basibuyuk Sok 9-1, TR-34854 Istanbul, Turkey.	ailki@marmara.edu.tr			Marmara University Scientific Research Commission [SAG-C-YLP-130213-0025]	The study was supported by a grant from Marmara University Scientific Research Commission, with a grant number of SAG-C-YLP-130213-0025.	Anderson NW, 2013, J CLIN MICROBIOL, V51, P2758, DOI 10.1128/JCM.00979-13; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; D'Agata EMC, 2002, CLIN INFECT DIS, V34, P167, DOI 10.1086/338234; DUTKAMALEN S, 1995, J CLIN MICROBIOL, V33, P24; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; French GL, 1998, CLIN INFECT DIS, V27, pS75, DOI 10.1086/514910                                                                  ; Fujitani S, 2011, AM J INFECT CONTROL, V39, P188, DOI 10.1016/j.ajic.2010.10.024; Garbutt JM, 1999, INFECT CONT HOSP EP, V20, P664, DOI 10.1086/501562                                                                  ; Gerding DN, 1997, CLIN INFECT DIS   S2, V25, pS206; Humphreys H, 2014, J HOSP INFECT, V88, P191, DOI 10.1016/j.jhin.2014.09.002; JORDENS JZ, 1994, J ANTIMICROB CHEMOTH, V34, P515, DOI 10.1093/jac/34.4.515                                                            ; Kim H, 2012, J MED MICROBIOL, V61, P274, DOI 10.1099/jmm.0.035618-0; Koneman EW, 2005, DIAG MICROBIOL, P431; Lawrence SJ, 2007, INFECT CONT HOSP EP, V28, P123, DOI 10.1086/511793; Leber AL, 2001, INFECT CONT HOSP EP, V22, P160, DOI 10.1086/501884; Ledeboer NA, 2007, DIAGN MICR INFEC DIS, V59, P477, DOI 10.1016/j.diagmicrobio.2007.06.018; Rafferty ME, 1997, CONTROL HOSP EPIDEMI, V18, P342; Safdar N, 2002, ANN INTERN MED, V136, P834, DOI 10.7326/0003-4819-136-11-200206040-00013; SHAY DK, 1995, J INFECT DIS, V172, P993, DOI 10.1093/infdis/172.4.993                                                        ; Ulu-Kilic A, 2016, AM J INFECT CONTROL; Zaas AK, 2002, CLIN INFECT DIS, V35, P1139, DOI 10.1086/342904                                                                  	21	0	0	2	2	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	JUL-SEP	2017	48	3					489	492		10.1016/j.bjm.2016.12.012				4	Microbiology	Microbiology	FD2PN	WOS:000407377400014	28389190	gold			2018-01-05	
J	Dalmolin, TV; Bianchini, BV; Rossi, GG; Ramos, AC; Gales, AC; Trindade, PD; de Campos, MMA				Dalmolin, Tanise Vendruscolo; Bianchini, Bianca Vendruscolo; Rossi, Grazielle Guidolin; Ramos, Ana Carolina; Gales, Ana Cristina; Trindade, Priscila de Arruda; Anraku de Campos, Marli Matiko			Detection and analysis of different interactions between resistance mechanisms and carbapenems in clinical isolates of Klebsiella pneumoniae	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Klebsiella pneumoniae; Carbapenemases; Loss of porins; Efflux pumpa	METALLO-BETA-LACTAMASES; PSEUDOMONAS-AERUGINOSA; MASS-SPECTROMETRY; RAPID DETECTION; ENTEROBACTERIACEAE; PORIN; IDENTIFICATION; SPREAD; PCR; PRODUCERS	Carbapenems are considered last-line agents for the treatment of serious infections caused by Klebsiella pneumoniae, and this microorganism may exhibit resistance to beta-lactam antibiotics due to different mechanisms of resistance. We evaluated 27 isolates of K. pneumoniae resistant to carbapenems recovered from inpatients at the University Hospital of Santa Maria-RS from July 2013 to August 2014. We carried out antimicrobial susceptibility, carbapenemase detection, testing for the presence of efflux pump by broth microdilution and loss of porin by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Genetic similarity was evaluated by ERIC-PCR. High levels of resistance were verified by the minimum inhibitory concentration for the antimicrobials tested. The blaKPC gene was present in 89% of the clinical isolates. Blue-Carba and combined disk with AFB tests showed 100% concordance, while the combined disk test with EDTA showed a high number of false-positives (48%) compared with the gold-standard genotypic test. Four isolates showed a phenotypic resistance profile consistent with the overexpression of the efflux pump, and all clinical isolates had lost one or both porins. The ERIC-PCR dendrogram demonstrated the presence of nine clusters. The main mechanism of resistance to carbapenems found in the assessed isolates was the presence of the blaKPC gene. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Dalmolin, Tanise Vendruscolo; Bianchini, Bianca Vendruscolo; Rossi, Grazielle Guidolin; Trindade, Priscila de Arruda; Anraku de Campos, Marli Matiko] Univ Fed Santa Maria, Lab Micobacteriol, Santa Maria, RS, Brazil; [Ramos, Ana Carolina; Gales, Ana Cristina] Univ Fed Sao Paulo UNIFESP, Lab ALERTA, Sao Paulo, SP, Brazil	Trindade, PD (reprint author), Ave Roraima 1000, Santa Maria, RS, Brazil.	priscila.trindade@gmail.com		Matiko, Marli/0000-0002-8717-0576; Campos, MARLI/0000-0001-9851-7793; Trindade, Priscila/0000-0002-3454-9654	AstraZeneca; MSD; Novartis	Ana Cristina Gales has recently received research funding and/or consultation fees from AstraZeneca, MSD and Novartis. All the other authors declare no conflicts of interest.	Andrade LN, 2011, ANTIMICROB AGENTS CH, V55, P3579, DOI 10.1128/AAC.01783-10; Cai JC, 2012, J CLIN MICROBIOL, V50, P2179, DOI 10.1128/JCM.00503-12; Castanheira M, 2012, ANTIMICROB AGENTS CH, V56, P1668, DOI 10.1128/AAC.05942-11; Chu YW, 2005, INT J ANTIMICROB AG, V26, P340, DOI 10.1016/j.ijantimicag.2005.07.004; Standard-Tenth Approved, 2015, M07A10 CLSI; Domenech-Sanchez A, 2003, ANTIMICROB AGENTS CH, V47, P3332, DOI 10.1128/AAC.47.10.3332-3335.2003; Findlay J, 2012, CLIN MICROBIOL INFEC, V18, P140, DOI 10.1111/j.1469-0691.2011.03515.x; Franklin C, 2006, J CLIN MICROBIOL, V44, P3139, DOI 10.1128/JCM.00879-06; Garcia-Sureda L, 2014, ANTIMICROB AGENTS CH, P4742; Franco MRG, 2010, CLINICS, V65, P825, DOI 10.1590/S1807-59322010000900002; Hernandez-Alles S, 1999, MICROBIOL-UK, V145, P673, DOI 10.1099/13500872-145-3-673                                                      ; Khosravi Y, 2012, SCI WORLD J, DOI 10.1100/2012/654939; Kim SY, 2007, DIAGN MICR INFEC DIS, V57, P85, DOI 10.1016/j.diagmicrobio.2006.05.008; Lomaestro BM, 2006, CLIN INFECT DIS, V43, pE26, DOI 10.1086/505598; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Mendes RE, 2007, J CLIN MICROBIOL, V45, P544, DOI 10.1128/JCM.01728-06; National Health Surveillance Agency (ANVISA), 2013, 012013 ANVISA; Nordmann P, 2014, CLIN MICROBIOL INFEC, V20, P821, DOI 10.1111/1469-0691.12719; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; Nordmann P, 2011, J CLIN MICROBIOL, V49, P718, DOI 10.1128/JCM.01773-10; Panda A, 2014, INDIAN J MED RES, V140, P770; Pereira PS, 2013, J ANTIMICROB CHEMOTH, V68, P312, DOI 10.1093/jac/dks396; Pires J, 2013, J CLIN MICROBIOL, V51, P4281, DOI [10.1128/JCM.01634-13, 10.1128/JCM.0163-13]; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; RIVERA IG, 1995, APPL ENVIRON MICROB, V61, P2898; Shanmugam P, 2013, J CLIN DIAGN RES, V7, P2736, DOI 10.7860/JCDR/2013/7759.3747; Shi WF, 2013, BRAZ J MICROBIOL, V44, P435, DOI 10.1590/S1517-83822013000200015; Song W, 2015, ANN LAB MED, V35, P212, DOI 10.3343/alm.2015.35.2.212; Speijer H, 1999, J CLIN MICROBIOL, V37, P3654; Tsai YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079640; Tsakris A, 2010, J ANTIMICROB CHEMOTH, V65, P1664, DOI 10.1093/jac/dkq210	31	0	0	4	4	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	JUL-SEP	2017	48	3					493	498		10.1016/j.bjm.2017.01.003				6	Microbiology	Microbiology	FD2PN	WOS:000407377400015	28291698	gold			2018-01-05	
J	El-Tayeb, MA; Ibrahim, ASS; Al-Salamah, AA; Almaary, KS; Elbadawi, YB				El-Tayeb, Mohamed A.; Ibrahim, Abdelnasser S. S.; Al-Salamah, Ali A.; Almaary, Khalid S.; Elbadawi, Yahya B.			Prevalence, serotyping and antimicrobials resistance mechanism of Salmonella enterica isolated from clinical and environmental samples in Saudi Arabia	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Salmonella; Serotyping; Antibiotic resistance; Antimicrobials resistance determinants	FOOD; SUSCEPTIBILITY; SEROVARS; HUMANS; GENES; DETERMINANTS; INTEGRON; BACTERIA; DIARRHEA; ANIMALS	Salmonella is recognized as a common foodborne pathogen, causing major health problems in Saudi Arabia. Herein, we report epidemiology, antimicrobial susceptibility and the genetic basis of resistance among S. enterica strains isolated in Saudi Arabia. Isolation of Salmonella spp. from clinical and environmental samples resulted in isolation of 33 strains identified as S. enterica based on their biochemical characteristics and 16S-rDNA sequences. S. enterica serovar Enteritidis showed highest prevalence (39.4%), followed by S. Paratyphi (21.2%), S. Typhimurium (15.2%), S. Typhi and S. Arizona (12.1%), respectively. Most isolates were resistant to 1st and 2nd generation cephalosporin; and aminoglycosides. Moreover, several S. enterica isolates exhibited resistance to the first-line antibiotics used for Salmonellosis treatment including ampicillin, trimethoprimsulfamethoxazole and chloramphenicol. In addition, the results revealed the emergence of two S. enterica isolates showing resistance to third-generation cephalosporin. Analysis of resistance determinants in S. enterica strains (n = 33) revealed that the resistance to beta-lactam antibiotics, trimethoprimsulfamethoxazole, chloramphenicol, and tetracycline, was attributed to the presence of carb-like, dfrA1, floR, tetA gene, respectively. On the other hand, fluoroquinolone resistance was related to the presence of mutations in gyrA and parC genes. These findings improve the information about foodborne Salmonella in Saudi Arabia, alarming the emergence of multi-drug resistant S. enterica strains, and provide useful data about the resistance mechanisms. (C) 2017 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Microbiologia.	[El-Tayeb, Mohamed A.; Ibrahim, Abdelnasser S. S.; Al-Salamah, Ali A.; Almaary, Khalid S.; Elbadawi, Yahya B.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh, Saudi Arabia; [Ibrahim, Abdelnasser S. S.] Natl Res Ctr, Pharmaceut Ind Res Div, Dept Chem Nat & Microbial Prod, Cairo, Egypt	Ibrahim, ASS (reprint author), King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh, Saudi Arabia.; Ibrahim, ASS (reprint author), Natl Res Ctr, Pharmaceut Ind Res Div, Dept Chem Nat & Microbial Prod, Cairo, Egypt.	ashebl@ksu.edu.sa	Elbadawi, Yahya/U-5749-2017	Elbadawi, Yahya/0000-0001-5126-2308	Research Center at College of Science, Deanship of Scientific Research at King Saud University	The authors extend their appreciation to the Research Center at College of Science, Deanship of Scientific Research at King Saud University for funding this work.	Aarestrup FM, 2007, EMERG INFECT DIS, V13, P726, DOI 10.3201/eid1305.061489                                                          ; Abakpa G. O., 2015, Environmental Nanotechnology, Monitoring and Management, V3, P38, DOI 10.1016/j.enmm.2014.11.004; Andrews JR, 2015, VACCINE, V33, pC8, DOI 10.1016/j.vaccine.2015.02.030; Antunes P, 2006, CLIN MICROBIOL INFEC, V12, P1047, DOI 10.1111/j.1469-0691.2006.01539.x; Bailey JK, 2010, J MED MICROBIOL, V59, P1331, DOI 10.1099/jmm.0.022475-0; Brolund A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009233; Burke L, 2014, J ANTIMICROB CHEMOTH, V69, P977, DOI 10.1093/jac/dkt469; Cabrera R, 2004, ANTIMICROB AGENTS CH, V48, P3934, DOI 10.1128/AAC.48.10.3934-3939.2004; Ceyssens PJ, 2015, ANTIMICROB AGENTS CH, V59, P544, DOI 10.1128/AAC.04203-14; Choudhary A, 2013, INDIAN J MED RES, V137, P800; CLSI, 2012, M02A11 CLSI; Cummings KJ, 2012, EMERG INFECT DIS, V18, P1929, DOI 10.3201/eid1812.110831; Demczuk W, 2003, J CLIN MICROBIOL, V41, P4279, DOI 10.1128/JCM.41.9.4279-4284.2003; Farmer JJ, 1999, MANUAL CLIN MICROBIO; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Ferrari R, 2013, BRAZ J MICROBIOL, V44, P657, DOI 10.1590/S1517-83822013000200046; Giguere S, 2013, ANTIMICROBIAL THERAPY IN VETERINARY MEDICINE, 5TH EDITION, P1; Grimont P.A.D., 2007, ANTIGENIC FORMULAE S; Hassing RJ, 2011, INT J ANTIMICROB AG, V37, P240, DOI 10.1016/j.ijantimicag.2010.10.026; Hsu YM, 2013, COMP IMMUNOL MICROB, V36, P9, DOI 10.1016/j.cimid.2012.08.004; Khan AA, 2006, J ANTIMICROB CHEMOTH, V58, P1308, DOI 10.1093/jac/dkl416; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115; Literak I, 2010, APPL ENVIRON MICROB, V76, P8126, DOI 10.1128/AEM.01446-10; Mandomando I, 2009, ANTIMICROB AGENTS CH, V53, P2450, DOI 10.1128/AAC.01282-08; Manning J, 2015, PREV VET MED, V120, P241, DOI 10.1016/j.prevetmed.2015.03.019; Masarikova M, 2016, SCI TOTAL ENVIRON, V542, P102, DOI 10.1016/j.scitotenv.2015.10.069; Morpeth SC, 2009, CLIN INFECT DIS, V49, P606, DOI 10.1086/603553; Murgia M, 2015, INT J FOOD MICROBIOL, V215, P31, DOI 10.1016/j.ijfoodmicro.2015.08.003; Neupane GP, 2010, ANTIMICROB AGENTS CH, V54, P3696, DOI 10.1128/AAC.00988-09; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Seputiene V, 2010, J MED MICROBIOL, V59, P315, DOI 10.1099/jmm.0.015008-0; Somily AM, 2011, J INFECT DEV COUNTR, V6, P478; SZU, 2015, INF CZECH REP EPIDAT; Wachino J, 2012, DRUG RESIST UPDATE, V15, P133, DOI 10.1016/j.drup.2012.05.001; Wei LS, 2011, PHARM ONLINE, V2, P996	35	0	0	12	12	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	JUL-SEP	2017	48	3					499	508		10.1016/j.bjm.2016.09.021				10	Microbiology	Microbiology	FD2PN	WOS:000407377400016	28245965	gold			2018-01-05	
J	Ansarypour, Z; Shahpiri, A				Ansarypour, Zahra; Shahpiri, Azar			Heterologous expression of a rice metallothionein isoform (OsMTI-1b) in Saccharomyces cerevisiae enhances cadmium, hydrogen peroxide and ethanol tolerance	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Cadmium; Ethanol; Hydrogen peroxide; Rice metallothionein; S. cerevisiae	OXIDATIVE STRESS-RESPONSE; GENE-EXPRESSION; HEAT-SHOCK; YEAST; PROTEIN; ARABIDOPSIS; RESISTANCE; SYSTEMS; TYPE-1	Metallothioneins are a superfamily of low-molecular-weight, cysteine (Cys)-rich proteins that are believed to play important roles in protection against metal toxicity and oxidative stress. The main purpose of this study was to investigate the effect of heterologous expression of a rice metallothionein isoform (OsMTI-1b) on the tolerance of Saccharomyces cerevisiae to Cd2+, H2O2 and ethanol stress. The gene encoding OsMTI-lb was cloned into p426GPD as a yeast expression vector. The new construct was transformed to competent cells of S. cerevisiae. After verification of heterologous expression of OsMTI-lb, the new strain and control were grown under stress conditions. In comparison to control strain, the transformed S. cerevisiae cells expressing OsMTI-lb showed more tolerance to Cd2+ and accumulated more Cd2+ ions when they were grown in the medium containing CdCI2. In addition, the heterologous expression of GST-OsMTI-lb conferred H2O2 and ethanol tolerance to S. cerevisiae cells. The results indicate that heterologous expression of plant MT isoforms can enhance the tolerance of S. cerevisiae to multiple stresses. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Ansarypour, Zahra; Shahpiri, Azar] Isfahan Univ Technol, Dept Biotechnol, Coll Agr, Esfahan 8415683111, Iran	Shahpiri, A (reprint author), Isfahan Univ Technol, Dept Biotechnol, Coll Agr, Esfahan 8415683111, Iran.	a.shahpiri@cc.iut.ac.ir			Iran National Science Foundation [91001342]	Iran National Science Foundation is thanked for financial support (grant No. 91001342).	Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; BAUMAN JW, 1991, TOXICOL APPL PHARM, V110, P347, DOI 10.1016/S0041-008X(05)80017-1; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Freisinger E, 2011, J BIOL INORG CHEM, V16, P1035, DOI 10.1007/s00775-011-0801-z; Garcia-Hernandez M, 1998, PLANT PHYSIOL, V118, P387, DOI 10.1104/pp.118.2.387                                                            ; Gellissen G, 1997, GENE, V190, P87, DOI 10.1016/S0378-1119(97)00020-6; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gomez-Pastor R, 2012, MICROB CELL FACT, V11, P1; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9                                                   ; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; HIDALGO J, 1988, AM J PHYSIOL, V255, pE518; Hong ME, 2010, J BIOTECHNOL, V149, P52, DOI 10.1016/j.jbiotec.2010.06.006; Inoue Y, 1999, J BIOL CHEM, V274, P27002, DOI 10.1074/jbc.274.38.27002; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.0.CO;2-S; KAGI JHR, 1991, METHOD ENZYMOL, V205, P613, DOI 10.1016/0076-6879(91)05145-L; Khan KH, 2013, ADV PHARM BULL, V3, P257, DOI 10.5681/apb.2013.042; KUGE S, 1994, EMBO J, V13, P655; Lee J, 2004, PLANT MOL BIOL, V54, P805, DOI 10.1007/s11103-004-0190-6; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; Miller JD, 1999, PLANT PHYSIOL, V120, P1015, DOI 10.1104/pp.120.4.1015; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Morgan BA, 1997, EMBO J, V16, P1035, DOI 10.1093/emboj/16.5.1035                                                         ; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nasser M. W., 2003, Indian Journal of Biotechnology, V2, P477; Nezhad RM, 2013, BIOTECHNOL APPL BIOC, V60, P275, DOI 10.1002/bab.1078; Nezhad RM, 2013, PROTEIN J, V32, P131, DOI 10.1007/s10930-013-9469-2; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428                                                         ; Pina C, 2004, BIOTECHNOL LETT, V26, P1521, DOI 10.1023/B:BILE.0000044456.72347.9f; ROBINSON NJ, 1993, BIOCHEM J, V295, P1; Sambrook J, 1989, MANIATIS MOL CLONING; Schmidt FR, 2004, APPL MICROBIOL BIOT, V65, P363, DOI 10.1007/s00253-004-1656-9; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Sugiyama K, 2000, J BIOL CHEM, V275, P15535, DOI 10.1074/jbc.275.20.15535; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Toone WM, 1999, CURR OPIN GENET DEV, V9, P55, DOI 10.1016/S0959-437X(99)80008-2; Watanabe M, 2009, J BIOSCI BIOENG, V107, P516, DOI 10.1016/j.jbiosc.2009.01.006; Wong CKC, 2000, ARCH ENVIRON CON TOX, V38, P486, DOI 10.1007/s002449910064                                                           ; Xue TT, 2009, J EXP BOT, V60, P339, DOI 10.1093/jxb/ern291; Yang JL, 2011, MOL BIOL REP, V38, P1567, DOI 10.1007/s11033-010-0265-1; Yazawa H, 2007, YEAST, V24, P551, DOI 10.1002/yea.1492; Yoshikawa K, 2009, FEMS YEAST RES, V9, P32, DOI 10.1111/j.1567-1364.2008.00456.x; Zhang TT, 2011, YEAST, V28, P795, DOI 10.1002/yea.1905	45	1	1	9	9	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	JUL-SEP	2017	48	3					537	543		10.1016/j.bjm.2016.10.024				7	Microbiology	Microbiology	FD2PN	WOS:000407377400021	28223030	gold			2018-01-05	
J	Carvalho-Castro, GA; Silva, JR; Paiva, LV; Custodioa, DAC; Moreira, RO; Mian, GF; Prado, IA; Chalfun, A; Costa, GM				Carvalho-Castro, Glei A.; Silva, Juliana R.; Paiva, Luciano V.; Custodioa, Dirceia A. C.; Moreira, Rafael O.; Mian, Glaucia F.; Prado, Ingrid A.; Chalfun-Junior, Antonio; Costa, Geraldo M.			Molecular epidemiology of Streptococcus agalactiae isolated from mastitis in Brazilian dairy herds	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Group B Streptococcus; Multilocus sequence typing; Genotypic capsular typing; Virulence genes; Bovine disease	GROUP-B STREPTOCOCCI; FIELD GEL-ELECTROPHORESIS; MULTIPLEX PCR ASSAY; ANTIMICROBIAL SUSCEPTIBILITY; VIRULENCE DETERMINANTS; GENETIC DIVERSITY; BOVINE MASTITIS; SEROTYPE IDENTIFICATION; EVOLUTIONARY; RESISTANCE	Streptococcus agalactiae is one of the most common pathogens leading to mastitis in dairy herds worldwide; consequently, the pathogen causes major economic losses for affected farmers. In this study, multilocus sequence typing (MLST), genotypic capsular typing by multiplex polymerase chain reaction (PCR), and virulence gene detection were performed to address the molecular epidemiology of 59 bovine (mastitis) S. agalactiae isolates from 36 dairy farms located in the largest milk-producing mesoregions in Brazil (Minas Gerais, Sao Paulo, Parana, and Pernambuco). We screened for the virulence genes bac, bca, bibA, cfb, hylB, fbsA, fbsB, PI-1, PI-2a, and PI-2b, which are associated with adhesion, invasion, tissue damage, and/or immune evasion. Furthermore, five capsular types were identified (Ia, Ib, II, III, and IV), and a few isolates were classified as non-typeable (NT). MLST revealed the following eight sequence types (STs): ST-61, ST-67, ST-103, ST-146, ST-226, ST-314, and ST-570, which were clustered in five clonal complexes (CC64, CC67, CC103, CC17, and CC314), and one singleton, ST-91. Among the virulence genes screened in this study, PI-2b,fbsB, cfb, and hylB appear to be the most important during mastitis development in cattle. Collectively, these results establish the molecular epidemiology of S. agalactiae isolated from cows in Brazilian herds. We believe that the data presented here provide a foundation for future research aimed at developing and implementing new preventative and treatment options for mastitis caused by S. agalactiae. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Carvalho-Castro, Glei A.; Silva, Juliana R.; Custodioa, Dirceia A. C.; Mian, Glaucia F.; Prado, Ingrid A.; Costa, Geraldo M.] Univ Fed Lavras, Lab Bacteriol, Lavras, Brazil; [Paiva, Luciano V.; Moreira, Rafael O.; Chalfun-Junior, Antonio] Univ Fed Lavras, Cent Lab Mol Biol, Lavras, Brazil	Costa, GM (reprint author), Univ Fed Lavras, Dept Vet Med, Lab Bacteriol, BR-37200000 Lavras, MG, Brazil.	gleicarv@yahoo.com.br		Chalfun-Junior, Antonio/0000-0002-1794-9429	FAPEMIG [APQ 02025/13, BPD-00261-14]; CAPES	This work was supported by grants FAPEMIG APQ 02025/13. We thank FAPEMIG (BPD-00261-14) and CAPES for the student fellowship.	Pinto TCA, 2013, BRAZ J INFECT DIS, V17, P131, DOI 10.1016/j.bjid.2012.09.006; Nakib M, 2011, J MICROBIOL METH, V85, P137, DOI 10.1016/j.mimet.2011.02.010; Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; Braga PAC, 2013, RSC ADV, V3, P994, DOI 10.1039/c2ra22063f; Chattopadhyay D, 2011, MICROBES INFECT, V13, P369, DOI 10.1016/j.micinf.2010.12.009; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; Correa ABD, 2009, MEM I OSWALDO CRUZ, V104, P599, DOI 10.1590/S0074-02762009000400011; Correa ABD, 2011, MEM I OSWALDO CRUZ, V106, P1002, DOI 10.1590/S0074-02762011000800017; De Vliegher S, 2012, J DAIRY SCI, V95, P1025, DOI 10.3168/jds.2010-4074; Devi AS, 2010, PROTEIN EXPRES PURIF, V74, P148, DOI 10.1016/j.pep.2010.07.004; Dore N, 2003, EPIDEMIOL INFECT, V131, P823, DOI 10.1017/S0950268803008847; Duarte RS, 2005, ANTIMICROB AGENTS CH, V49, P97, DOI 10.1128/ACC.49.1.97-103.2005; Duarte RS, 2004, J CLIN MICROBIOL, V42, P4214, DOI 10.1128/JCM.42.9.4214-4222.2004; Dutra VG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-323; Evans JJ, 2008, J MED MICROBIOL, V57, P1369, DOI 10.1099/jmm.0.47815-0; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175                                                              ; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Godoy DT, 2013, LETT APPL MICROBIOL, V57, P476, DOI 10.1111/lam.12138; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Keefe G, 2012, VET CLIN N AM-FOOD A, V28, P203, DOI 10.1016/j.cvfa.2012.03.010; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581                                                              ; Kong F, 2008, J CLIN MICROBIOL, V46, P2745, DOI 10.1128/JCM.00189-08; Kong FR, 2002, J CLIN MICROBIOL, V40, P216, DOI 10.1128/JCM.40.1.216-226.2002; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Macfaddin J.F., 2000, BIOCH TESTS IDENTIFI; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Martins ER, 2010, J BACTERIOL, V192, P1361, DOI 10.1128/JB.01130-09; Mata AI, 2004, APPL ENVIRON MICROB, V70, P3183, DOI 10.1128/AEM.70.5.3183-3187.2004; Merl K, 2003, FEMS MICROBIOL LETT, V226, P87, DOI 10.1016/S0378-1097(03)00564-0; Morozumi M, 2014, EPIDEMIOL INFECT, V142, P812, DOI 10.1017/S0950268813001647; Oliveira ICM, 2006, CLIN MICROBIOL INFEC, V12, P887, DOI 10.1111/j.1469-0691.2006.01508.x; Otaguiri ES, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-297; Palmeiro JK, 2010, J CLIN MICROBIOL, V48, P4397, DOI 10.1128/JCM.00419-10; Perez-Losada M, 2013, INFECT GENET EVOL, V16, P38, DOI 10.1016/j.meegid.2013.01.009; Poyart C, 2007, J CLIN MICROBIOL, V45, P1985, DOI 10.1128/JCM.00159-07; Rajagopal L, 2009, FUTURE MICROBIOL, V4, P201, DOI 10.2217/17460913.4.2.201; Rato MG, 2013, VET MICROBIOL, V161, P286, DOI 10.1016/j.vetmic.2012.07.043; Richards VP, 2014, GENOME BIOL EVOL, V6, P741, DOI 10.1093/gbe/evu048; Rinaudo CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009216; Rosenau A, 2007, INFECT IMMUN, V75, P1310, DOI 10.1128/IAI.00996-06; Rosinski-Chupin I, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-252; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Santi I, 2009, J INFECT DIS, V200, P564, DOI 10.1086/603540; Sharma P, 2013, J BIOL CHEM, V288, P4023, DOI 10.1074/jbc.M112.425728; Slotved HC, 2007, J CLIN MICROBIOL, V45, P2929, DOI 10.1128/JCM.00117-07; Sorensen UBS, 2010, MBIO, V1, DOI 10.1128/mBio.00178-10; Springman AC, 2009, J BACTERIOL, V191, P5419, DOI 10.1128/JB.00369-09; Springman AC, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-159; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673                                                          ; Yang YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054736; Yao KH, 2013, J CLIN MICROBIOL, V51, P503, DOI 10.1128/JCM.02417-12; Zadoks RN, 2011, J MAMMARY GLAND BIOL, V16, P357, DOI 10.1007/s10911-011-9236-y	55	1	1	4	4	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	JUL-SEP	2017	48	3					551	559		10.1016/j.bjm.2017.02.004				9	Microbiology	Microbiology	FD2PN	WOS:000407377400023	28256391	gold			2018-01-05	
J	Oliveira, RC; Yamaguti, M; Marques, LM; Buzinhani, M; Rizzo, H; Meira, EBD; Guimaraesa, AMS; Gregory, L; Timenetsky, J				Oliveira, Rosangela C.; Yamaguti, Mauricio; Marques, Lucas M.; Buzinhani, Melissa; Rizzo, Huber; de Souza Meira-Junior, Enoch Brandao; Guimaraesa, Ana Marcia S.; Gregory, Lilian; Timenetsky, Jorge			Molecular characterization of ureaplasmas isolated from reproductive tract of goats and sheep from Brazil	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Ureaplasma; Ovine; Caprine; Molecular characterizationa	EWES; ELECTROPHORESIS; VULVITIS; DIVERSUM	Ovine/caprine ureaplasmas have not yet been assigned a species designation, but they have been classified into nine serotypes. Herein ureaplasmas were searched for in 120 samples of vulvo vaginal mucous from sheep and 98 samples from goats at 17 farms. In addition, semen samples were collected from 11 sheep and 23 goats. The recovered ureaplasma were from sheep and goats from animals without any reproductive disorder symptoms, but not all animals presented positive cultures. In sheep, 17 (68%) cultures of vulvovaginal mucous were positive for ureaplasma and 11 (27%) samples of semen presented positive cultures in animals with clinical signs of orchitis, balanoposthitis or low sperm motility. In goats four ureaplasma isolates were obtained from vulvovaginal mucus, but the semen samples were all negative. The isolates were submitted to Pulsed-field gel electrophoresis methodology and their 16S rRNA genes were sequenced. Fifty percent of ureaplasma recovered from sheep allowed for PFGE typing. Eleven isolates showed eight profiles genetically close to the bovine ureaplasmas. The 16S rRNA gene sequencing showed differences or similarities of isolates from sheep and goats, and the reference strains of bovine and human ureaplasma. Four clinical isolates from sheep were grouped separately. The studied ureaplasma isolates showed to be a diverse group of mollicutes. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Oliveira, Rosangela C.; Yamaguti, Mauricio; Marques, Lucas M.; Buzinhani, Melissa; Guimaraesa, Ana Marcia S.; Timenetsky, Jorge] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, SP, Brazil; [Marques, Lucas M.] Univ Fed Bahia, Inst Multidisciplinar Saude, Nucleo Tecnol Saude, Salvador, BA, Brazil; [Rizzo, Huber; de Souza Meira-Junior, Enoch Brandao; Gregory, Lilian] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Clin Med, Sao Paulo, SP, Brazil	Marques, LM (reprint author), Inst Ciencias Biomed, Av Prof Lineu Prestes 1374, BR-05508900 Sao Paulo, SP, Brazil.	lucasm@usp.br			Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [06/56855-0]	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant 06/56855-0). We thank Aricelma P. Franca for valuable technical assistance, as well as AcademicEnglishSolutions.com for revising the English.	BALL HJ, 1982, VET REC, V110, P581, DOI 10.1136/vr.110.25.581                                                           ; BOOM R, 1990, J CLIN MICROBIOL, V28, P495; Buzinhani M, 2007, VET J, V173, P688, DOI 10.1016/j.tvjl.2006.02.001; DOIG PA, 1977, VET REC, V100, P179, DOI 10.1136/vr.100.9.179                                                            ; dos Santos SB, 2013, BRAZ J MICROBIOL, V44, P911, DOI 10.1590/S1517-83822013000300040; Dybvig K, 1996, ANNU REV MICROBIOL, V50, P25, DOI 10.1146/annurev.micro.50.1.25                                                   ; Harasawa R, 1996, INT J SYST BACTERIOL, V46, P827, DOI 10.1099/00207713-46-3-827                                                       ; HOWARD CJ, 1978, INT J SYST BACTERIOL, V28, P599, DOI 10.1099/00207713-28-4-599                                                       ; HOWARD CJ, 1983, J GEN MICROBIOL, V129, P3197; KOTANI H, 1980, JPN J VET SCI, V42, P31; LIVINGSTON CW, 1982, AM J VET RES, V43, P1190; Marois C, 2001, VET MICROBIOL, V79, P1, DOI 10.1016/S0378-1135(00)00342-4; MCCAUGHEY WJ, 1981, VET REC, V109, P472, DOI 10.1136/vr.109.21.472                                                           ; MCCAUGHEY WJ, 1979, VET REC, V105, P576; Paralanov V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-88; Razin S, 2010, BIOLOGICALS, V38, P183, DOI 10.1016/j.biologicals.2009.11.008; Ruffin DC, 2001, VET CLIN N AM-FOOD A, V17, P315, DOI 10.1016/S0749-0720(15)30031-1                                                   ; Ruhnke HL, 1994, USEFUL PROTOCOLS DIA; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TULLY JG, 1993, CLIN INFECT DIS, V17, pS2, DOI 10.1093/clinids/17.Supplement_1.S2                                              	20	0	0	1	1	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	JUL-SEP	2017	48	3					560	565		10.1016/j.bjm.2016.09.020				6	Microbiology	Microbiology	FD2PN	WOS:000407377400024	28320598	gold			2018-01-05	
J	Todorov, SD; Stojanovski, S; Iliev, I; Moncheva, P; Nero, LA; Ivanova, IV				Todorov, Svetoslav Dimitrov; Stojanovski, Saso; Iliev, Ilia; Moncheva, Penka; Nero, Luis Augusto; Ivanova, Iskra Vitanova			Technology and safety assessment for lactic acid bacteria isolated from traditional Bulgarian fermented meat product "lukanka"	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Lukanka; Antibiotic resistance; Virulence factors; Lactic acid bacteria; Bacteriocins	ENTEROCOCCUS-FAECIUM; BACTERIOCINOGENIC STRAIN; VIRULENCE DETERMINANTS; LACTOBACILLUS STRAINS; STARTER CULTURES; STRUCTURAL GENES; SUBSP-LACTIS; SAUSAGES; IDENTIFICATION; PCR	The present work discusses the technological and new selection criteria that should be included for selecting lactic acid bacteria for production of fermented meat. Lactic acid bacteria isolated from Bulgarian traditional fermented "lulanka" salami was studied regarding some positive technological parameters (growth at different temperature, pH, and proteolytic activity). The presence of genes related to the virulence factors, production of biogenic amines, and vancomycin resistance were presented in low frequency in the studied lactic acid bacteria. On the other hand, production of antimicrobial peptides and high spread of bacteriocin genes were broadly presented. Very strong activity against L. monocytogenes was detected in some of the studied lactic acid bacteria. In addition, the studied strains did not present any antimicrobial activity against tested closely related bacteria such as Lacto-bacillus spp., Enterococcus spp. or Pediococcus spp. To our knowledge this is the first study on the safety and antimicrobial properties of lactic acid bacteria isolated from Bulgarian lukanka obtained by spontaneous fermentation. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Todorov, Svetoslav Dimitrov; Nero, Luis Augusto; Ivanova, Iskra Vitanova] Univ Fed Vicosa, Dept Vet, Campus UFV, Vicosa, MG, Brazil; [Stojanovski, Saso; Moncheva, Penka; Ivanova, Iskra Vitanova] Sofia Univ St Kliment Ohridski, Fac Biol, Dept Gen & Ind Microbiol, Sofia, Bulgaria; [Iliev, Ilia] Plovdiv Univ Paisii Hilendarski, Fac Biol, Dept Biochem & Microbiol, Plovdiv, Bulgaria; [Stojanovski, Saso] Bitola Univ St Kliment Ohridski, Fac Vet Med, Bitola, Macedonia	Todorov, SD (reprint author), Univ Fed Vicosa, Dept Vet, Campus UFV, Vicosa, MG, Brazil.	slavi310570@abv.bg	Moncheva, Penka/L-7778-2017		CNPq [313852/2013-8, 401140/2014-8]; CAPES; FAPEMIG	The authors would like to acknowledge CNPq 313852/2013-8 and CNPq 401140/2014-8 projects for providing financial support in addition to support from CAPES and FAPEMIG.	Albano H, 2007, INT J FOOD MICROBIOL, V116, P239, DOI 10.1016/j.ijfoodmicro.2007.01.011; Andrighetto C, 2001, LETT APPL MICROBIOL, V33, P26, DOI 10.1046/j.1472-765X.2001.00939.x; Capita R, 2006, J FOOD PROTECT, V69, P1183, DOI 10.4315/0362-028X-69.5.1183                                                     ; Claeys E, 2004, MEAT SCI, V67, P281, DOI 10.1016/j.meatsci.2003.11.001; de Kwaadsteniet M, 2008, APPL ENVIRON MICROB, V74, P547, DOI 10.1128/AEM.01862-07; De Kwaadsteniet M, 2006, APPL ENVIRON MICROB, V72, P4761, DOI 10.1128/AEM.00436-06; Demeyer D, 2000, FOOD RES INT, V33, P171, DOI 10.1016/S0963-9969(00)00031-4; Eaton TJ, 2001, APPL ENVIRON MICROB, V67, P1628, DOI 10.1128/AEM.67.4.1628-1635.2001; Erkkila S, 2001, MEAT SCI, V58, P111, DOI 10.1016/S0309-1740(00)00135-2; Hugas M, 1997, FOOD CHEM, V59, P547, DOI 10.1016/S0308-8146(97)00005-8; Kilic A, 2004, ANN MICROBIOL, V54, P543; Kjos M, 2014, MOL MICROBIOL, V92, P1177, DOI 10.1111/mmi.12632; Kruger MF, 2013, FOOD CONTROL, V33, P467, DOI 10.1016/j.foodcont.2013.03.043; Leroy F, 2006, INT J FOOD MICROBIOL, V106, P270, DOI 10.1016/j.ijfoodmicro.2005.06.027; Macwana SJ, 2012, J MICROBIOL METH, V88, P197, DOI 10.1016/j.mimet.2011.11.008; Martin-Platero AM, 2009, INT J FOOD MICROBIOL, V132, P24, DOI 10.1016/j.ijfoodmicro.2009.03.010; Montel MC, 1998, MEAT SCI, V49, pS111; Moore JE, 2004, MEAT SCI, V67, P565, DOI 10.1016/j.meatsci.2003.12.009; Murua A, 2013, J APPL MICROBIOL, V114, P1793, DOI 10.1111/jam.12190; Papamanoli E, 2003, MEAT SCI, V65, P859, DOI 10.1016/S0309-1740(02)00292-9; Pennacchia C, 2004, MEAT SCI, V67, P309, DOI 10.1016/j.meatsci.2003.11.003; Poeta P, 2007, MICROBIOL RES, V162, P257, DOI 10.1016/j.micres.2006.06.003; Ravyts F, 2012, ENG LIFE SCI, V12, P356, DOI 10.1002/elsc.201100119; Remiger A, 1996, SYST APPL MICROBIOL, V19, P28, DOI 10.1016/S0723-2020(96)80005-1                                                   ; Rivas P, 2005, CHEST, V128, P764, DOI 10.1378/chest.128.2.764; Rodali VP, 2013, J PURE APPL MICROBIO, V7, P2933; Sanz Y, 1999, INT J FOOD MICROBIOL, V53, P115, DOI 10.1016/S0168-1605(99)00134-8; Stojanovski S, 2010, BIOTECHNOL BIOTEC EQ, V24, P708, DOI 10.1080/13102818.2010.10817927                                                  ; Todorov SD, 2014, BENEF MICROBES, V5, P351, DOI 10.3920/BM2013.0030; Todorov SD, 2008, BRAZ J MICROBIOL, V39, P178, DOI [10.1590/S1517-83822008000100035, 10.1590/S1517-838220080001000035]; Todorov SD, 2011, ANAEROBE, V17, P23, DOI 10.1016/j.anaerobe.2010.01.004; Todorov SD, 2010, FOOD MICROBIOL, V27, P869, DOI 10.1016/j.fm.2010.05.001; Vankerckhoven V, 2004, J CLIN MICROBIOL, V42, P4473, DOI 10.1128/JCM.42.10.4473-4479.2004; Vestergaard CS, 2000, MEAT SCI, V55, P1, DOI 10.1016/S0309-1740(99)00095-9; Vignolo G, 2010, HDB MEAT PROC, V5, P379; Zendo T, 2008, J APPL MICROBIOL, V104, P499, DOI 10.1111/j.1365-2672.2007.03575.x; Zhang Y, 2010, J BIOTECHNOL, V148, P139, DOI 10.1016/j.jbiotec.2010.05.008	37	0	0	19	19	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	JUL-SEP	2017	48	3					576	586		10.1016/j.bjm.2017.02.005				11	Microbiology	Microbiology	FD2PN	WOS:000407377400027	28552660	gold			2018-01-05	
J	Lima, JO; Pereira, JF; de Araujo, EF; de Queiroz, MV				Lima, Juliana Oliveira; Pereira, Jorge Fernando; de Araujo, Elza Fernandes; de Queiroz, Marisa Vieira			Pectin lyase overproduction by Penicillium griseoroseum mutants resistant to catabolite repression	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						2-Deoxy-D-glucose; Ultraviolet mutagenesis; Pectinolytic complex; Spontaneous mutant	SOLID-STATE FERMENTATION; ASPERGILLUS-NIGER; MOLECULAR CHARACTERIZATION; NEUROSPORA-CRASSA; ENZYMES; GENE; 2-DEOXYGLUCOSE; EXPRESSION; FUNGI	Expression of pectinolytic genes is regulated by catabolic repression limiting the production of pectin lyase (PL) if the natural inducer, pectin, is missing from the growth medium. Here, we report the isolation of Penicillium griseoroseum mutants resistant to 2-deoxy-D-glucose (DG) that show resistance to catabolite repression and overproduce PL. Three spontaneous and nine UV-induced mutants were obtained. Some mutants produced sectors (segments morphologically different) that were also studied. The mutants were analyzed for pectinases production on pectinase-agar plates and five mutants and two sectors showing larger clearing zones than the wild type were selected for quantitative assay. Although PL production higher than the wild type has been found, phenotype instability was observed for most of the mutants and, after transfers to nonselective medium, the DG resistance was no longer present. Only mutants M03 and M04 were stable maintaining the DG-resistance phenotype. When growing for 120 h in liquid medium containing glucose with or without pectin, both mutants showed higher PL production. In the presence of glucose as sole carbon source, the mutant M03 produced 7.8-fold more PL than the wild type. Due its phenotypic stability and PL overproduction, the mutant M03 presents potential for industrial applications. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Lima, Juliana Oliveira; Pereira, Jorge Fernando; de Araujo, Elza Fernandes; de Queiroz, Marisa Vieira] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil; [Pereira, Jorge Fernando] Embrapa Trigo, Passo Fundo, RS, Brazil; [Pereira, Jorge Fernando] Embrapa Gado Leite, Juiz De Fora, MG, Brazil	de Queiroz, MV (reprint author), Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil.	mvqueiro@ufv.br			Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos (FINEP); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	The authors gratefully acknowledge the financial support of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Financiadora de Estudos e Projetos (FINEP) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG).	Adsul MG, 2007, BIORESOURCE TECHNOL, V98, P1467, DOI 10.1016/j.biortech.2006.02.036; ALANA A, 1989, APPL ENVIRON MICROB, V55, P1612; ALBERSHEIM P, 1962, ARCH BIOCHEM BIOPHYS, V97, P107, DOI 10.1016/0003-9861(62)90050-4; ALLEN KE, 1989, J BACTERIOL, V171, P53, DOI 10.1128/jb.171.1.53-58.1989                                                     ; ANTIER P, 1993, ENZYME MICROB TECH, V15, P254, DOI 10.1016/0141-0229(93)90146-S; Anwar MN, 1996, APPL MICROBIOL BIOT, V45, P684, DOI 10.1007/s002530050748; Baracat-Pereira MC, 1999, APPL BIOCHEM BIOTECH, V76, P129, DOI 10.1385/ABAB:76:2:129; Bazzolli DS, 2006, CAN J MICROBIOL, V52, P1070, DOI 10.1139/W06-070; D'Souza CA, 2001, FEMS MICROBIOL REV, V25, P349, DOI 10.1111/j.1574-6976.2001.tb00582.x                                              ; Ebbole DJ, 1998, FUNGAL GENET BIOL, V25, P15, DOI 10.1006/fgbi.1998.1088                                                          ; Fawole OB, 2003, INT BIODETER BIODEGR, V52, P223, DOI 10.1016/S0964-8305(03)00094-5; Cardoso PG, 2008, J IND MICROBIOL BIOT, V35, P159, DOI 10.1007/s10295-007-0277-6; Iwakuma H, 2016, BIOSCI BIOTECH BIOCH, V80, P486, DOI 10.1080/09168451.2015.1104236; Jayani RS, 2005, PROCESS BIOCHEM, V40, P2931, DOI 10.1016/j.procbio.2005.03.026; Kiesenhofer D, 2016, FUNG BIOL-US, P275, DOI 10.1007/978-3-319-27951-0_12; Kumar P, 2009, APPL BIOCHEM BIOTECH, V158, P113, DOI 10.1007/s12010-008-8342-9; Lara-Marquez A, 2011, BIOTECHNOL LETT, V33, P859, DOI 10.1007/s10529-011-0520-0; Loera O, 1999, ENZYME MICROB TECH, V25, P103, DOI 10.1016/S0141-0229(99)00015-0; McCartney RR, 2014, GENETICS, V198, P635, DOI 10.1534/genetics.114.169060; MinjaresCarranco A, 1997, ENZYME MICROB TECH, V21, P25, DOI 10.1016/S0141-0229(96)00212-8; MOORE D, 1981, NEW PHYTOL, V87, P487, DOI 10.1111/j.1469-8137.1981.tb03221.x; Mukherjee S, 2016, FRONT MICROBIOL, V7, DOI [10.3359/fmicb.2016.00596, 10.3389/fmicb.2016.00596]; Panda T, 2004, ENZYME MICROB TECH, V34, P466, DOI 10.1016/j.enzmictec.2003.12.004; Pereira JF, 2004, CAN J MICROBIOL, V50, P891, DOI 10.1139/W04-081; Pereira JF, 2002, BIOTECHNOL LETT, V24, P831, DOI 10.1023/A:1015502721909; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Raiser M, 2008, P NATL ACAD SCI USA, V105, P17807; Bazzolli DMS, 2015, ANN MICROBIOL, V65, P1145, DOI 10.1007/s13213-014-0873-4; Teixeira JA, 2011, J APPL MICROBIOL, V111, P818, DOI 10.1111/j.1365-2672.2011.05099.x; Varavallo MA, 2007, BRAZ J MICROBIOL, V38, P52, DOI 10.1590/S1517-83822007000100011; Yadav S, 2009, PROCESS BIOCHEM, V44, P1, DOI 10.1016/j.procbio.2008.09.012; Youderian P, 1999, J BACTERIOL, V181, P2225; [Anonymous], 2008, J APPL MICROBIOL, V105, P1595	33	1	1	2	2	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	JUL-SEP	2017	48	3					602	606		10.1016/j.bjm.016.12.009				5	Microbiology	Microbiology	FD2PN	WOS:000407377400030	28237679				2018-01-05	
J	Sun, LC; He, T; Zhang, LL; Pang, MD; Zhang, QY; Zhou, Y; Bao, HD; Wang, R				Sun, Lichang; He, Tao; Zhang, Lili; Pang, Maoda; Zhang, Qiaoyan; Zhou, Yan; Bao, Hongduo; Wang, Ran			Generation of Newly Discovered Resistance Gene mcr-1 Knockout in Escherichia coli Using the CRISPR/Cas9 System	JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						mcr-1; knockout; E. coli; CRISPR/Cas9 system; BMAP-27	KLEBSIELLA-PNEUMONIAE; PLASMID; RNA; NUCLEASES	The mcr-1 gene is a new "superbug" gene discoverd in China in 2016 that makes bacteria highly resistant to the last-resort class of antibiotics. The mcr-1 gene raised serious concern about its possible global dissemination and spread. Here, we report a potential anti-resistant strategy using the CRISPR/Cas9-mediated approach that can efficiently induce mcr-1 gene knockout in Escherichia coli. Our findings suggested that using the CRISPR/Cas9 system to knock out the resistance gene mcr-1 might be a potential anti-resistant strategy. Bovine myeloid antimicrobial peptide-27 could help deliver plasmid pCas:: mcr targeting specific DNA sequences of the mcr-1 gene into microbial populations.	[Sun, Lichang; He, Tao; Zhang, Lili; Pang, Maoda; Zhou, Yan; Bao, Hongduo; Wang, Ran] Jiangsu Acad Agr Sci, Key Lab Control Technol & Standard Agroprod Safet, Minist Agr,Key Lab Food Qual & Safety Jiangsu Pro, State Key Lab Breeding Base,Inst Food Qual & Safe, Nanjing 210014, Jiangsu, Peoples R China; [Zhang, Qiaoyan] Zhejiang Acad Agr Sci, Zhejiang Prov Key Lab Food Safety, Inst Qual & Standard Agroprod, Hangzhou 310021, Zhejiang, Peoples R China	Wang, R (reprint author), Jiangsu Acad Agr Sci, Key Lab Control Technol & Standard Agroprod Safet, Minist Agr,Key Lab Food Qual & Safety Jiangsu Pro, State Key Lab Breeding Base,Inst Food Qual & Safe, Nanjing 210014, Jiangsu, Peoples R China.	ranwang@jaas.ac.cn			National Natural Science Foundation of China [31302009]; Natural Science Foundation of Jiangsu Province [BK20160585]; Jiangsu Agricultural Science and Technology Innovation Fund [CX(16)1060]; Key Laboratory of Food Quality and Safety of Jiangsu Province-State Key Laboratory Breeding Base Self-determined Project [3201614]; Zhejiang Province Major Program [2015C02041]; National Agricultural Product Quality and Safety Risk Assessment [GJGP201701203]	This work was funded by the National Natural Science Foundation of China (No. 31302009), the Natural Science Foundation of Jiangsu Province (No. BK20160585) and Jiangsu Agricultural Science and Technology Innovation Fund (No. CX(16)1060), Key Laboratory of Food Quality and Safety of Jiangsu Province-State Key Laboratory Breeding Base Self-determined Project (NO. 3201614), Zhejiang Province Major Program (2015C02041), and National Agricultural Product Quality and Safety Risk Assessment (GJGP201701203). We thank Lucas Ferguson (Mississippi State University) for manuscript editing and revising assistance.	Cannatelli A, 2013, ANTIMICROB AGENTS CH, V57, P5521, DOI 10.1128/AAC.01480-13; CDC, 2016, DISC 1 MCR 1 GEN E C; Chu HY, 2016, J PEDIATR INFECT DIS, V5, P29, DOI 10.1093/jpids/piu099; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Hasman H, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.49.30085; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; LaFountaine JS, 2015, INT J PHARMACEUT, V494, P180, DOI 10.1016/j.ijpharm.2015.08.029; Lee EK, 2011, PEPTIDES, V32, P1123, DOI 10.1016/j.peptides.2011.03.024; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Malhotra-Kumar S, 2016, LANCET INFECT DIS, V16, P283, DOI 10.1016/S1473-3099(16)00012-8; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Morrill HJ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02236-16, 10.1128/aac.02236-16]; Olaitan AO, 2016, LANCET INFECT DIS, V16, P147, DOI 10.1016/S1473-3099(15)00540-X; Stoesser N, 2016, LANCET INFECT DIS, V16, P285, DOI 10.1016/S1473-3099(16)00010-4; Suzuki S, 2016, LANCET INFECT DIS, V16, P284, DOI 10.1016/S1473-3099(16)00008-6; Tse H, 2016, LANCET INFECT DIS, V16, P145, DOI 10.1016/S1473-3099(15)00532-0	18	0	0	17	17	KOREAN SOC MICROBIOLOGY & BIOTECHNOLOGY	SEOUL	KOREA SCI TECHNOL CENTER #507,  635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL 135-703, SOUTH KOREA	1017-7825	1738-8872		J MICROBIOL BIOTECHN	J. Microbiol. Biotechnol.	JUL	2017	27	7					1276	1280		10.4014/jmb.1611.11021				5	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	FE5DL	WOS:000408232100010	28535607				2018-01-05	
J	Wang, PL; Zou, JX; Wu, JN; Zhang, CY; Ma, CX; Yu, J; Zhou, Y; Li, BZ; Wang, K				Wang, Pingli; Zou, Jixia; Wu, Jingni; Zhang, Chengyan; Ma, Chengxi; Yu, Juan; Zhou, You; Li, Baizhou; Wang, Kai			Clinical profiles and trend analysis of newly diagnosed lung cancer in a tertiary care hospital of East China during 2011-2015	JOURNAL OF THORACIC DISEASE			English	Article						Lung cancer; China; profiles	HONG-KONG CHINESE; HISTOLOGICAL TYPES; ADENOCARCINOMA; MORTALITY; STAGE	Background: More than one-third of lung cancer worldwide occurring in China. However, the clinical profiles of lung cancer patients in the mainland of China are rarely reported and largely unknown. The objective of this study is to analyze the characteristics and time trends of newly diagnosed lung cancer cases during the past 5 years in East China. Methods: The data came from an academic tertiary care hospital of East China. Patients who were newly diagnosed as lung cancer from 2011 to 2015 were enrolled. All new cases got pathological supports by lung biopsy or surgery. Tumor staging was performed according to the seventh edition of the tumor node metastasis (TNM) classification of malignant tumors. The patients' disease information was collected from the database of the hospital information system (HIS). Results: From 2011 to 2015, aggregately 5,779 patients, including 3,719 males and 2,060 females, were diagnosed as lung cancer. The major histologic subtypes of lung cancer were adenocarcinoma (ADC, 60.0%), squamous cell carcinoma (SCC, 25.6%), small cell lung cancer (SCLC, 8.5%), large cell carcinoma (0.6%), adenosquamous carcinoma (1%), other non-small cell carcinoma (1.6%) and unclassified or rare carcinoma (2.8%). ADC proportion of female was much higher than that of male. A higher proportion of advanced stage (stage IIIB, IV) of lung cancer existed in patients who were admitted to hospital due to respiratory or cancer related symptoms (RCRS) than those without RCRS. Smoking rate in male patients reached 80.2%, while it was only 2.7% in females. EGFR mutation existed in 66% of female and 37% of male patients with ADC. Conclusions: This study demonstrates the clinicopathologic characteristics of lung cancer patients from East China, including histologic composition, staging proportion, smoking prevalence and gene mutation status. During the past 5 years, the proportion of ADC has increased gradually whereas SCC decreased.	[Wang, Pingli; Zou, Jixia; Wu, Jingni; Zhang, Chengyan; Ma, Chengxi; Yu, Juan; Zhou, You; Wang, Kai] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Resp & Crit Care Med, Hangzhou 310009, Zhejiang, Peoples R China; [Li, Baizhou] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Pathol, Hangzhou 310009, Zhejiang, Peoples R China	Wang, K (reprint author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Resp & Crit Care Med, Hangzhou 310009, Zhejiang, Peoples R China.	kaiw@zju.edu.cn			National Natural Science Foundation of China [81470212, U1609220]; Distinguished Young Investigator Award [LR14H010001]; Natural Science Foundation of Zhejiang Province [2015C03043]	This work was supported by the General Project (81470212 and U1609220) from the National Natural Science Foundation of China, the Distinguished Young Investigator Award (LR14H010001) and Key Science Project (2015C03043) from Natural Science Foundation of Zhejiang Province.	CHAN WC, 1977, BRIT J CANCER, V35, P226, DOI 10.1038/bjc.1977.30                                                             ; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Gao Y, 2015, PATIENT PREFER ADHER, V9, P1189, DOI 10.2147/PPA.S87069; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Herceg Z, 2011, EPIGENETICS-US, V6, P804, DOI 10.4161/epi.6.7.16262; Hong QY, 2015, CANCER-AM CANCER SOC, V121, P3080, DOI 10.1002/cncr.29584; Howlader N, 2013, SEER CANC STAT REV 1; Jiang XH, 2012, LUNG CANCER, V78, P16, DOI 10.1016/j.lungcan.2012.06.002; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; KUNG ITM, 1984, BRIT J CANCER, V50, P381, DOI 10.1038/bjc.1984.187; LEE SH, 1963, BRIT J CANCER, V17, P37, DOI 10.1038/bjc.1963.4; Reck M, 2016, J THORAC ONCOL, V11, P1682, DOI 10.1016/j.jtho.2016.05.036; Ringer G, 2005, CLIN LUNG CANCER, V7, P180, DOI 10.3816/CLC.2005.n.033                                                          ; She J, 2013, CHEST, V143, P1117, DOI 10.1378/chest.11-2948; Shi YK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143515; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Toyoda Y, 2008, JPN J CLIN ONCOL, V38, P534, DOI 10.1093/jjco/hyn072; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136727; Zhao SJ, 2015, THORAC CANCER, V6, P385, DOI 10.1111/1759-7714.12253; Zou XN, 2014, THORAC CANCER, V5, P447, DOI 10.1111/1759-7714.12121	20	0	0	3	3	PIONEER BIOSCIENCE PUBL CO	HONG KONG	9A GOLD SHINE TOWER, 346-348 QUEEN'S RD CENTRAL, SHEUNG WAN, HONG KONG, 00000, PEOPLES R CHINA	2072-1439	2077-6624		J THORAC DIS	J. Thorac. Dis.	JUL	2017	9	7					1973	1979		10.21037/jtd.2017.06.102				7	Respiratory System	Respiratory System	FE2AD	WOS:000408017800062	28839996	green_published			2018-01-05	
J	Bannikov, AV; Lavrov, AV				Bannikov, A. V.; Lavrov, A. V.			CRISPR/CAS9, the King of Genome Editing Tools	MOLECULAR BIOLOGY			English	Review						CRISPR/Cas9; genome editing; sgRNA	HOMOLOGY-DIRECTED REPAIR; CRISPR-CAS9 NUCLEASES; HUMAN-CELLS; GENETIC ELEMENTS; CAS9 PROTEIN; SGRNA DESIGN; TARGET DNA; IN-VIVO; RNA; ENDONUCLEASE	The discovery of CRISPR/Cas9 brought a hope for having an efficient, reliable, and readily available tool for genome editing. CRISPR/Cas9 is certainly easy to use, while its efficiency and reliability remain the focus of studies. The review describes the general principles of the organization and function of Cas nucleases and a number of important issues to be considered while planning genome editing experiments with CRISPR/Cas9. The issues include evaluation of the efficiency and specificity for Cas9, sgRNA selection, Cas9 variants designed artificially, and use of homologous recombination and nonhomologous end joining in DNA editing.	[Bannikov, A. V.; Lavrov, A. V.] Med Genet Res Ctr, Moscow 115478, Russia; [Lavrov, A. V.] Pirogov Russian Natl Res Med Univ, Moscow 117997, Russia	Bannikov, AV (reprint author), Med Genet Res Ctr, Moscow 115478, Russia.	broyler3@mail.ru					Barkal AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152683; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Elleuche S, 2010, APPL MICROBIOL BIOT, V87, P479, DOI 10.1007/s00253-010-2628-x; Fagerlund RD, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0824-9; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Hinz JM, 2015, BIOCHEMISTRY-US, V54, P7063, DOI 10.1021/acs.biochem.5b01108; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Hu JZ, 2016, NAT PROTOC, V11, P853, DOI 10.1038/nprot.2016.043; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Koonin EV, 2015, NAT REV GENET, V16, P184, DOI 10.1038/nrg3859; Kouranova E, 2016, HUM GENE THER, V27, P464, DOI 10.1089/hum.2016.009; Lander ES, 2016, CELL, V164, P18, DOI 10.1016/j.cell.2015.12.041; Ma YW, 2016, RNA BIOL, V13, P605, DOI 10.1080/15476286.2016.1185591; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miyaoka Y., 2016, SCI REP, V6, P235; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Oakes BL, 2016, NAT BIOTECHNOL, V34, P646, DOI 10.1038/nbt.3528; Periwal V, 2017, BRIEF BIOINFORM, V18, P698, DOI 10.1093/bib/bbw052; Pougach KS, 2012, MOL BIOL+, V46, P175, DOI 10.1134/S0026893312020136; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Truong DJJ, 2015, NUCLEIC ACIDS RES, V43, P6450, DOI 10.1093/nar/gkv601; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsui TKM, 2015, ANNU REV BIOPHYS, V44, P229, DOI 10.1146/annurev-biophys-060414-033939; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vasil'eva E A, 2015, Tsitologiia, V57, P19; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang X, 2016, ARTERIOSCL THROM VAS, V36, P783, DOI 10.1161/ATVBAHA.116.307227; Wong N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0784-0; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149	58	0	0	17	17	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0026-8933	1608-3245		MOL BIOL+	Mol. Biol.	JUL	2017	51	4					514	525		10.1134/S0026893317040033				12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FE4XU	WOS:000408217400004					2018-01-05	
J	Cunningham, TJ; Yu, MS; McKeithan, WL; Spiering, S; Carrette, F; Huang, CT; Bushway, PJ; Tierney, M; Albini, S; Giacca, M; Mano, M; Puri, PL; Sacco, A; Ruiz-Lozano, P; Riou, JF; Umbhauer, M; Duester, G; Mercola, M; Colas, AR				Cunningham, Thomas J.; Yu, Michael S.; McKeithan, Wesley L.; Spiering, Sean; Carrette, Florent; Huang, Chun-Teng; Bushway, Paul J.; Tierney, Matthew; Albini, Sonia; Giacca, Mauro; Mano, Miguel; Puri, Pier Lorenzo; Sacco, Alessandra; Ruiz-Lozano, Pilar; Riou, Jean-Francois; Umbhauer, Muriel; Duester, Gregg; Mercola, Mark; Colas, Alexandre R.			Id genes are essential for early heart formation	GENES & DEVELOPMENT			English	Article						cardiac progenitors; cardiac mesoderm specification; heartless; Id proteins; CRISPR/Cas9-mediated quadruple knockout; platform for cardiac disease modeling and drug discovery	EMBRYONIC STEM-CELLS; CARDIOVASCULAR PROGENITOR CELLS; MOUSE GASTRULATION; MYOCARDIAL-CELLS; MAMMALIAN HEART; XENOPUS-LAEVIS; MESP1; PROTEINS; WNT; MESODERM	Deciphering the fundamental mechanisms controlling cardiac specification is critical for our understanding of how heart formation is initiated during embryonic development and for applying stem cell biology to regenerative medicine and disease modeling. Using systematic and unbiased functional screening approaches, we discovered that the Id family of helix-loop-helix proteins is both necessary and sufficient to direct cardiac mesoderm formation in frog embryos and human embryonic stem cells. Mechanistically, Id proteins specify cardiac cell fate by repressing two inhibitors of cardiogenic mesoderm formation-Tcf3 and Foxa2-and activating inducers Evx1, Grrp1, and Mesp1. Most importantly, CRISPR/Cas9-mediated ablation of the entire Id (Id1-4) family in mouse embryos leads to failure of anterior cardiac progenitor specification and the development of heartless embryos. Thus, Id proteins play a central and evolutionarily conserved role during heart formation and provide a novel means to efficiently produce cardiovascular progenitors for regenerative medicine and drug discovery applications.	[Cunningham, Thomas J.; Yu, Michael S.; McKeithan, Wesley L.; Spiering, Sean; Carrette, Florent; Huang, Chun-Teng; Tierney, Matthew; Albini, Sonia; Puri, Pier Lorenzo; Sacco, Alessandra; Ruiz-Lozano, Pilar; Duester, Gregg; Mercola, Mark; Colas, Alexandre R.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Yu, Michael S.; Bushway, Paul J.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92037 USA; [McKeithan, Wesley L.] Sanford Burnham Prebys Med Discovery Inst, Grad Sch Biomed Sci, La Jolla, CA USA; [McKeithan, Wesley L.; Mercola, Mark] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [McKeithan, Wesley L.; Mercola, Mark] Stanford Univ, Cardiovasc Inst, Stanford, CA 94305 USA; [Giacca, Mauro] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy; [Mano, Miguel] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, P-3004504 Coimbra, Portugal; [Puri, Pier Lorenzo] Fdn Santa Lucia, Ist Ricovero & Cura Carattere Sci, I-00179 Rome, Italy; [Riou, Jean-Francois] Regencor Inc, Los Altos, CA 94022 USA; [Riou, Jean-Francois; Umbhauer, Muriel] Univ Paris 06, Sorbonne Univ, UMR 7622, Dev Biol, F-75005 Paris, France	Colas, AR (reprint author), Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.	acolas@sbpdiscovery.org		Mano, Miguel/0000-0003-1922-4824; Duester, Gregg/0000-0003-4335-3650	National Institutes of Health [R01HL113601, R01HL128072, R01HL130840, R44ES023521, P30 AR06130303, R01AR056712, R01AR052779, F31 AR065923-01]; Muscular Dystrophy Association [200845]; Fondation Leducq Transatlantic Alliance; California Institute for Regenerative Medicine (CIRM) [RC1-000132]; CIRM post-doctoral training program [TG2-01162];  [P30 CA030199-30]	We gratefully acknowledge Pedro Aza-Blanc and the Sanford Burnham Prebys Medical Discovery Institute Functional Genomics core (supported by P30 CA030199-30) for screening support. This research was funded by grants from the National Institutes of Health (R01HL113601, R01HL128072, and R01HL130840 to M. Mercola; R44ES023521 to A.C.; P30 AR06130303 to M. Mercola, A.S., and P.L.P.; R01AR056712 and R01AR052779 to P.L.P.; and F31 AR065923-01 to M.T.), the Muscular Dystrophy Association (200845 to A.S.), the Fondation Leducq Transatlantic Alliance (Shapeheart), and the California Institute for Regenerative Medicine (CIRM; RC1-000132 to M. Mercola). S.A. was supported by the CIRM post-doctoral training program (TG2-01162).	Bardot E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14428; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Birket MJ, 2015, NAT BIOTECHNOL, V33, P970, DOI 10.1038/nbt.3271; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Bruneau BG, 2013, COLD SPRING HARB PER, V5; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chan SSK, 2013, CELL STEM CELL, V12, P587, DOI 10.1016/j.stem.2013.03.004; Chiapparo G, 2016, J CELL BIOL, V213, P463, DOI 10.1083/jcb.201505082; Colas A, 2008, DEV BIOL, V320, P351, DOI 10.1016/j.ydbio.2008.05.547; Colas AR, 2012, GENE DEV, V26, P2567, DOI 10.1101/gad.200758.112; Collop AH, 2006, DEV BIOL, V291, P96, DOI 10.1016/j.ydbio.2005.12.018; Costello I, 2011, NAT CELL BIOL, V13, P1084, DOI 10.1038/ncb2304; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Devine WP, 2014, ELIFE, V3, DOI 10.7554/eLife.03848; Djiane A, 2000, DEVELOPMENT, V127, P3091; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Foley AC, 2007, DEV BIOL, V303, P57, DOI 10.1016/j.ydbio.2006.10.033; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Galvin KE, 2010, J BIOL CHEM, V285, P19747, DOI 10.1074/jbc.M109.077347; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Kee Y, 2005, GENE DEV, V19, P744, DOI 10.1101/gad.1257405; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kelly RG, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015750; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lescroart F, 2014, NAT CELL BIOL, V16, P829, DOI 10.1038/ncb3024; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; McKeithan WL, 2012, CURR PROTOC STEM CEL, V23; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Meilhac SM, 2015, COLD SPRING HARB PER, V5; Menasche P, 2015, EUR HEART J, V36, P743, DOI 10.1093/eurheartj/ehu192; Mercola M, 2013, CIRC RES, V112, P534, DOI 10.1161/CIRCRESAHA.111.250266; Miller EW, 2012, P NATL ACAD SCI USA, V109, P2114, DOI 10.1073/pnas.1120694109; Moretti A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014027; Nieuwkoop P D, 1967, Acta Biotheor, V17, P178, DOI 10.1007/BF01601987; Niola F, 2013, J CLIN INVEST, V123, P405, DOI 10.1172/JCI63811; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; PENG HB, 1991, METHOD CELL BIOL, V36, P657; Roschger C, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-016-0161-y; Saga Y, 1996, DEVELOPMENT, V122, P2769; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X                                                   ; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451                                                            ; Stainier DYR, 2002, GENE DEV, V16, P893, DOI 10.1101/gad.974902; Vincent SD, 2003, GENE DEV, V17, P1646, DOI 10.1101/gad.1100503; Viotti M, 2014, NAT CELL BIOL, V16, P1146, DOI 10.1038/ncb3070; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Wills AE, 2015, DEV CELL, V32, P345, DOI 10.1016/j.devcel.2014.11.034; Yang J, 2014, CARDIOVASC RES, V104, P388, DOI 10.1093/cvr/cvu215; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yoon SJ, 2011, GENE DEV, V25, P1654, DOI 10.1101/gad.16800511; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013	66	2	2	7	7	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	0890-9369	1549-5477		GENE DEV	Genes Dev.	JUL 1	2017	31	13					1325	1338		10.1101/gad.300400.117				14	Cell Biology; Developmental Biology; Genetics & Heredity	Cell Biology; Developmental Biology; Genetics & Heredity	FD6AP	WOS:000407611300004		green_published			2018-01-05	
J	Mitra, A; Sarin, YK				Mitra, Aparajita; Sarin, Yogesh Kumar			Use of Hormones, Tissue Factors and Bioengineering in the Management of Hypospadias	INDIAN JOURNAL OF PEDIATRICS			English	Review						Hypospadias; Hormone therapy; Genetics; Tissue engineering	EXTERNAL GENITALIA DEVELOPMENT; URETHRAL RECONSTRUCTION; PROXIMAL HYPOSPADIAS; GROWTH-FACTOR; THERAPY; SURGERY; MATRIX; REPAIR	Hypospadiology is a rapidly evolving field. Progress in the understanding of how hormonal therapy affects the growth of the phallus has allowed surgeons to optimize the tissues for surgery. But conflicting data from a number of studies and a lack of consensus on drugs, their dosing, mode of delivery and timing of use means that the creation of protocols is unlikely to happen in the near future. Nonetheless, there is a hope and the standardization of scientific reporting will make it easier to compare data at the global level. There are reports of the increasing incidence of hypospadias and the etiology is thought to be multifactorial. Although complex interactions between genetic polymorphisms and the environment make it difficult to identify the exact factors responsible for hypospadias, the advent of massively parallel gene sequencing, large scale epigenetic screens and CRISPR technology will definitely ease the process. The knowledge of culprit genes will not only broaden our understanding of embryology and growth but will also enable us to predict and/or modify tissue healing. Advances in tissue engineering are also expected to provide a plethora of biomaterials for urethral reconstruction. The development of this field is directly linked with the elucidation of the processes of proliferation and vascularization coupled with the cataloguing of the growth factors involved. One can safely conclude that the exciting new advances in the field will have far reaching consequences on patient care and counselling.	[Mitra, Aparajita; Sarin, Yogesh Kumar] Maulana Azad Med Coll, Dept Pediat Surg, New Delhi 110002, India; [Mitra, Aparajita; Sarin, Yogesh Kumar] Associated Lok Nayak Hosp, New Delhi 110002, India	Sarin, YK (reprint author), Maulana Azad Med Coll, Dept Pediat Surg, New Delhi 110002, India.; Sarin, YK (reprint author), Associated Lok Nayak Hosp, New Delhi 110002, India.	yksarin@hotmail.com					Albers N, 1997, J PEDIATR-US, V131, P386, DOI 10.1016/S0022-3476(97)80063-7                                                   ; Bahadir GG, 2016, TURK J MED SCI, V46, P1624, DOI 10.3906/sag-1507-72; Baskin LS, 2001, ENVIRON HEALTH PERSP, V109, P1175, DOI 10.1289/ehp.011091175; Bastos AN, 2011, J UROLOGY, V185, P2474, DOI 10.1016/j.juro.2011.01.035; Bouty A, 2015, SEX DEV, V9, P239, DOI 10.1159/000441988; Chalapathi G, 2003, J PEDIATR SURG, V38, P221, DOI 10.1053/jpsu.2003.50047; de Kemp V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118653; Dubey D, 2007, J UROLOGY, V178, P2466, DOI 10.1016/j.juro.2007.08.010; El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8; ElGalley RES, 1997, BRIT J UROL, V79, P116, DOI 10.1046/j.1464-410X.1997.22624.x; Feng C, 2010, J BIOMED MATER RES A, V94A, P317, DOI 10.1002/jbm.a.32729; Fossum M, 2012, ACTA PAEDIATR, V101, P755, DOI 10.1111/j.1651-2227.2012.02659.x; Gilliver SC, 2007, CLIN DERMATOL, V25, P56, DOI 10.1016/j.clindermatol.2006.09.012; Gorduza DB, 2011, J PEDIATR UROL, V7, P158, DOI 10.1016/j.jpurol.2010.05.003; Haraguchi R, 2001, DEVELOPMENT, V128, P4241; Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154                                                       ; Jorgez CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107028; Klonisch T, 2004, DEV BIOL, V270, P1, DOI 10.1016/j.ydbio.2004.02.018; Koff SA, 1999, J UROLOGY, V162, P1435, DOI 10.1016/S0022-5347(05)68333-4                                                   ; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529                                                         ; Mangera A, 2013, ASIAN J ANDROL, V15, P89, DOI 10.1038/aja.2012.91; Marrocco G, 2015, J PEDIATR UROL, V11, P12, DOI 10.1016/j.jpurol.2014.10.003; Netto JMB, 2013, J PEDIATR UROL, V9, P971, DOI 10.1016/j.jpurol.2013.03.009; Ratan Simmi K, 2014, Indian J Endocrinol Metab, V18, P558, DOI 10.4103/2230-8210.137519; Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9; Snodgrass WT, 2014, J PEDIATR UROL, V10, P118, DOI 10.1016/j.jpurol.2013.07.006	26	1	1	0	0	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0019-5456	0973-7693		INDIAN J PEDIATR	Indian J. Pediatr.	JUL	2017	84	7					564	569		10.1007/s12098-017-2347-8				6	Pediatrics	Pediatrics	FD2VD	WOS:000407392000012	28429283				2018-01-05	
J	Champer, J; Reeves, R; Oh, SY; Liu, C; Liu, JX; Clark, AG; Messer, PW				Champer, Jackson; Reeves, Riona; Oh, Suh Yeon; Liu, Chen; Liu, Jingxian; Clark, Andrew G.; Messer, Philipp W.			Novel CRISPR/Cas9 gene drive constructs reveal insights into mechanisms of resistance allele formation and drive efficiency in genetically diverse populations	PLOS GENETICS			English	Article							HOMING ENDONUCLEASE GENES; HOMOLOGY-DIRECTED REPAIR; DROSOPHILA-MELANOGASTER; ERADICATING MOSQUITOS; INSECT PESTS; MALARIA; TRANSLOCATIONS; TRANSMISSION; ELIMINATION; DISTORTER	A functioning gene drive system could fundamentally change our strategies for the control of vector-borne diseases by facilitating rapid dissemination of transgenes that prevent pathogen transmission or reduce vector capacity. CRISPR/Cas9 gene drive promises such a mechanism, which works by converting cells that are heterozygous for the drive construct into homozygotes, thereby enabling super-Mendelian inheritance. Although CRISPR gene drive activity has already been demonstrated, a key obstacle for current systems is their propensity to generate resistance alleles, which cannot be converted to drive alleles. In this study, we developed two CRISPR gene drive constructs based on the nanos and vasa promoters that allowed us to illuminate the different mechanisms by which resistance alleles are formed in the model organism Drosophila melanogaster. We observed resistance allele formation at high rates both prior to fertilization in the germline and post-fertilization in the embryo due to maternally deposited Cas9. Assessment of drive activity in genetically diverse backgrounds further revealed substantial differences in conversion efficiency and resistance rates. Our results demonstrate that the evolution of resistance will likely impose a severe limitation to the effectiveness of current CRISPR gene drive approaches, especially when applied to diverse natural populations.	[Champer, Jackson; Reeves, Riona; Oh, Suh Yeon; Liu, Chen; Liu, Jingxian; Clark, Andrew G.; Messer, Philipp W.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA; [Champer, Jackson; Reeves, Riona; Oh, Suh Yeon; Liu, Chen; Liu, Jingxian; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Champer, J; Messer, PW (reprint author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA.; Champer, J (reprint author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	jc3248@cornell.edu; messer@cornell.edu		Messer, Philipp/0000-0001-8453-9377	College of Agriculture and Life Sciences at Cornell University; Meinig Family Investigator award	This research was supported by startup funds from the College of Agriculture and Life Sciences at Cornell University to PWM and the Meinig Family Investigator award to AGC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002; Alphey N, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1071; Beaghton A, 2016, THEOR POPUL BIOL, V108, P51, DOI 10.1016/j.tpb.2015.11.005; Burt A., 2014, PHILOS T R SOC LON B, V369; Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34; Chan YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074254; Chan YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054130; Chan YS, 2011, GENETICS, V188, P33, DOI 10.1534/genetics.111.127506; Chen CH, 2007, SCIENCE, V316, P597, DOI 10.1126/science.1138595; Committee on Gene Drive Research in Non-Human Organisms: Recommendations for Responsible Conduct, 2016, GEN DRIV HOR ADV SCI; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001003; CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108; DiCarlo JE, 2015, NAT BIOTECHNOL; Drapeau MD, 2006, GENETICS, V172, P1009, DOI 10.1534/genetics.105.045666; Drury DW, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601910; Eckhoff PA, 2017, P NATL ACAD SCI USA, V114, pE255, DOI 10.1073/pnas.1611064114; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; FOSTER GG, 1972, SCIENCE, V176, P875, DOI 10.1126/science.176.4037.875; Franz AWE, 2015, CURR OPIN INSECT SCI, V8, P88, DOI 10.1016/j.cois.2014.12.009; Fuchs Silke, 2013, Methods Mol Biol, V923, P601; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Gantz VM, 2015, BIOESSAYS; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Grenier JK, 2015, G3-GENES GENOM GENET, V5, P593, DOI 10.1534/g3.114.015883; Hammond A., 2015, NAT BIOTECHNOL; KAISER PE, 1982, CAN J GENET CYTOL, V24, P177, DOI 10.1139/g82-017                                                                 ; Kokoza V, 2010, P NATL ACAD SCI USA, V107, P8111, DOI 10.1073/pnas.1003056107; LAVEN H, 1972, NATURE, V236, P456, DOI 10.1038/236456a0; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; LEWONTIN RC, 1960, GENETICS, V45, P705; Lin CC, 2016, G3 BETHESDA; LYTTLE TW, 1979, GENETICS, V91, P339; LYTTLE TW, 1981, GENETICS, V98, P317; Lyttle TW, 1977, GENETICS 1, V86; Miles A, 2016, BIORXIV; Noble C, 2016, SCI ADV, V3; North A, 2013, J APPL ECOL, V50, P1216, DOI 10.1111/1365-2664.12133; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Pugh J, 2016, J MED ETHICS, V42, P578, DOI 10.1136/medethics-2016-103462; Reed FA, 2017, GENETICS, V205, P1037, DOI 10.1534/genetics.116.198887; Reeves RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097557; ROBINSON AS, 1976, BIOL REV, V51, P1, DOI 10.1111/j.1469-185X.1976.tb01118.x; Simoni A, 2014, NUCLEIC ACIDS RES, V42, P7461, DOI 10.1093/nar/gku387; Sinha S, 2014, PARASITE, V21, DOI 10.1051/parasite/2014059; Unckless RL, 2015, GENETICS; Unckless RL, 2017, GENETICS, V205, P827, DOI 10.1534/genetics.116.197285; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Webber BL, 2015, P NATL ACAD SCI USA, V112, P10565, DOI 10.1073/pnas.1514258112; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; [Anonymous], 2015, MALARIA; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937	55	6	6	17	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	JUL	2017	13	7							e1006796	10.1371/journal.pgen.1006796				18	Genetics & Heredity	Genetics & Heredity	FC1RO	WOS:000406615300003	28727785	gold			2018-01-05	
J	Santos-Ledo, A; Garcia-Macia, M; Campbell, PD; Gronska, M; Marlow, FL				Santos-Ledo, Adrian; Garcia-Macia, Marina; Campbell, Philip D.; Gronska, Marta; Marlow, Florence L.			Kinesin-1 promotes chondrocyte maintenance during skeletal morphogenesis	PLOS GENETICS			English	Article							PROGRAMMED CELL-DEATH; HYPERTROPHIC CHONDROCYTES; GENE-EXPRESSION; GROWTH-PLATE; EMBRYONIC-DEVELOPMENT; TAIL FORMATION; HEAVY-CHAIN; BUCKY BALL; IN-VIVO; ZEBRAFISH	During skeletal morphogenesis diverse mechanisms are used to support bone formation. This can be seen in the bones that require a cartilage template for their development. In mammals the cartilage template is removed, but in zebrafish the cartilage template persists and the bone mineralizes around the cartilage scaffold. Remodeling of unmineralized cartilage occurs via planar cell polarity (PCP) mediated cell rearrangements that contribute to lengthening of elements; however, the mechanisms that maintain the chondrocyte template that supports perichondral ossification remain unclear. We report double mutants disrupting two zebrafish kinesin-I genes (hereafter kif5Blof) that we generated using CRISPR/Cas9 mutagenesis. We show that zygotic Kif5Bs have a conserved function in maintaining muscle integrity, and are required for cartilage remodeling and maintenance during craniofacial morphogenesis by a PCP-distinct mechanism. Further, kif5Blof does not activate ER stress response genes, but instead disrupts lysosomal function, matrix secretion, and causes deregulated autophagic markers and eventual chondrocyte apoptosis. Ultrastructural and transplantation analysis reveal neighboring cells engulfing extruded kif5Blof chondrocytes. Initial cartilage specification is intact; however, during remodeling, kif5Blof chondrocytes die and the cartilage matrix devoid of hypertrophic chondrocytes remains and impedes normal ossification. Chimeric and mosaic analyses indicate that Kif5B functions cell-autonomously in secretion, nuclear position, cell elongation and maintenance of hypertrophic chondrocytes. Interestingly, large groups of wild-type cells can support elongation of neighboring mutant cells. Finally, mosaic expression of kif5Ba, but not kif5Aa in cartilage rescues the chondrocyte phenotype, further supporting a specific requirement for Kif5B. Cumulatively, we show essential Kif5B functions in promoting cartilage remodeling and chondrocyte maintenance during zebrafish craniofacial morphogenesis.	[Santos-Ledo, Adrian; Campbell, Philip D.; Marlow, Florence L.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Santos-Ledo, Adrian] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England; [Garcia-Macia, Marina] Newcastle Univ, Inst Cellular & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England; [Garcia-Macia, Marina] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Gronska, Marta; Marlow, Florence L.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Marlow, Florence L.] Icahn Sch Med Mt Sinai, Cell Dev & Regenerat Biol Dept, New York, NY 10029 USA	Marlow, FL (reprint author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA.; Marlow, FL (reprint author), Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA.; Marlow, FL (reprint author), Icahn Sch Med Mt Sinai, Cell Dev & Regenerat Biol Dept, New York, NY 10029 USA.	florence.marlow@mssm.edu			NIH [R01GM089979];  [T32-GM007288];  [F31NS083258]	Work in the Marlow lab is supported by NIH R01GM089979 and PDC was supported by T32-GM007288 and F31NS083258. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CS, 2002, CRIT REV ORAL BIOL M, V13, P465, DOI 10.1177/154411130201300604                                                      ; Ahmed YA, 2007, OSTEOARTHR CARTILAGE, V15, P575, DOI 10.1016/j.joca.2006.10.016; Almonte-Becerril M, 2010, APOPTOSIS, V15, P631, DOI 10.1007/s10495-010-0458-z; Apschner A, 2011, METHOD CELL BIOL, V105, P239, DOI 10.1016/B978-0-12-381320-6.00010-2; Bastow ER, 2012, BIOL OPEN, V1, P318, DOI 10.1242/bio.2012547; Behonick DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001150; Ben-Aderet L, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0586-5; Boglev Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003279; Campbell PD, 2015, DEVELOPMENT, V142, P2996, DOI 10.1242/dev.124586; Campbell PD, 2014, J NEUROSCI, V34, P14717, DOI 10.1523/JNEUROSCI.2770-14.2014; Campbell PD, 2013, GENE EXPR PATTERNS, V13, P271, DOI 10.1016/j.gep.2013.05.002; Cardoso CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004424; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Conradt B, 2009, ANNU REV GENET, V43, P493, DOI 10.1146/annurev.genet.42.110807.091533; Crimella C, 2012, CLIN GENET, V82, P157, DOI 10.1111/j.1399-0004.2011.01717.x; DeLaurier A, 2010, GENESIS, V48, P505, DOI 10.1002/dvg.20639; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Feng L, 2014, DEV BIOL, V395, P268, DOI 10.1016/j.ydbio.2014.09.010; Flanagan-Steet H, 2009, AM J PATHOL, V175, P2063, DOI 10.2353/ajpath.2009.090210; Flanagan-Steet H, 2015, J BONE MINER RES; Follo C, 2013, BIOSCIENCE REP, V33, P371, DOI 10.1042/BSR20120100; Fukuda T, 1999, NEUROSCI RES, V33, P49, DOI 10.1016/S0168-0102(98)00111-4; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; GIBSON GJ, 1995, DEV DYNAM, V203, P468, DOI 10.1002/aja.1002030409                                                          ; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Hayes AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075787; Heim AE, 2014, DEVELOPMENT, V141, P842, DOI 10.1242/dev.090449; Hewett K, 2009, J PSYCHOPHARMACOL, V23, P531, DOI 10.1177/0269881108089602; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Holmbeck K, 2003, J CELL BIOL, V163, P661, DOI 10.1083/jcb.200307061; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jamuar SS, 2014, NEW ENGL J MED, V371, P733, DOI 10.1056/NEJMoa1314432; Janssens E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052915; Kai M, 2008, DEVELOPMENT, V135, P3043, DOI 10.1242/dev.020396; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kosaki N, 2007, BIOCHEM BIOPH RES CO, V354, P846, DOI 10.1016/j.bbrc.2006.12.234; Krane SM, 2008, BONE, V43, P7, DOI 10.1016/j.bone.2008.03.020; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kuhn S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8088; Kuss P, 2014, DEV BIOL, V385, P83, DOI 10.1016/j.ydbio.2013.10.013; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Langdon YG, 2016, DEVELOPMENT, V143, P1016, DOI 10.1242/dev.128900; Le Pabic P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004726; LeClair EE, 2009, DEV DYNAM, V238, P2550, DOI 10.1002/dvdy.22086; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Melville DB, 2011, DIS MODEL MECH, V4, P763, DOI 10.1242/dmm.007625; Merkes C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116627; Metzger T, 2012, NATURE, V484, P120, DOI 10.1038/nature10914; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Monk KR, 2013, DIS MODEL MECH, V6, P135, DOI 10.1242/dmm.009217; MUNDLOS S, 1994, PROG HISTOCHEM CYTOC, V28, P1; Ostrander GK, 2000, LAB FISH2000; Pandruvada SNM, 2016, MOL CELL BIOL, V36, P507, DOI 10.1128/MCB.00656-15; Paul S, 2016, DEVELOPMENT, V143, P2066, DOI 10.1242/dev.131292; Petrey AC, 2012, DIS MODEL MECH, V5, P177, DOI 10.1242/dmm.008219; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227; Roach HI, 1999, J BONE MINER RES, V14, P1367, DOI 10.1359/jbmr.1999.14.8.1367                                                     ; ROACH HI, 1995, J CELL BIOL, V131, P483, DOI 10.1083/jcb.131.2.483; Roach HI, 2004, APOPTOSIS, V9, P265, DOI 10.1023/B:APPT.0000025803.17498.26                                              ; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Santos-Ledo A, 2013, NEUROSCIENCE, V250, P493, DOI 10.1016/j.neuroscience.2013.07.036; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; Sisson BE, 2015, MECH DEVELOP, V138, P279, DOI 10.1016/j.mod.2015.10.001; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Vacaru AM, 2014, J CELL SCI, V127, P485, DOI 10.1242/jcs.140194; Varga M, 2014, CELL DEATH DIFFER, V21, P547, DOI 10.1038/cdd.2013.175; Varga M, 2015, METHODS, V75, P172, DOI 10.1016/j.ymeth.2014.12.004; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1                                                   ; Wakayama Y, 2015, DEV CELL, V32, P109, DOI 10.1016/j.devcel.2014.11.024; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Wang Z, 2013, DEVELOPMENT, V140, P617, DOI 10.1242/dev.085969; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wiesner C, 2010, BLOOD, V116, P1559, DOI 10.1182/blood-2009-12-257089; Wilson MH, 2015, DEVELOPMENT, V142, P218, DOI 10.1242/dev.114769; Wiweger MI, 2011, J PATHOL, V223, P531, DOI 10.1002/path.2824; Wu BT, 2015, J CELL SCI, V128, P2328, DOI 10.1242/jcs.167403; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Zamli Z, 2011, INT J RHEUM DIS, V14, P159, DOI 10.1111/j.1756-185X.2011.01618.x; Berendsen AD, 2015, BONE, V80, P14; Zhang H, 2016, OSTEOARTHRITIS CARTI; Zuzarte-Luis V, 2007, DEV DYNAM, V236, P880, DOI 10.1002/dvdy.21076	90	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	JUL	2017	13	7							e1006918	10.1371/journal.pgen.1006918				28	Genetics & Heredity	Genetics & Heredity	FC1RO	WOS:000406615300050	28715414	gold			2018-01-05	
J	Xia, ZD; Wei, JY; Li, YN; Wang, J; Li, WW; Wang, K; Hong, XL; Zhao, L; Chen, CY; Min, JX; Wang, F				Xia, Zhidan; Wei, Jiayu; Li, Yingniang; Wang, Jia; Li, Wenwen; Wang, Kai; Hong, Xiaoli; Zhao, Lu; Chen, Caiyong; Min, Junxia; Wang, Fudi			Zebrafish slc30a10 deficiency revealed a novel compensatory mechanism of Atp2c1 in maintaining manganese homeostasis	PLOS GENETICS			English	Article							HAILEY-HAILEY-DISEASE; INTRACELLULAR TRAFFICKING; INDUCED NEUROTOXICITY; TYROSINE-HYDROXYLASE; TRANSPORTER SLC30A10; EFFLUX TRANSPORTER; ONSET PARKINSONISM; HEPATIC CIRRHOSIS; FOLLOW-UP; MUTATIONS	Recent studies found that mutations in the human SLC30A10 gene, which encodes a manganese (Mn) efflux transporter, are associated with hypermanganesemia with dystonia, polycythemia, and cirrhosis (HMDPC). However, the relationship between Mn metabolism and HMDPC is poorly understood, and no specific treatments are available for this disorder. Here, we generated two zebrafish slc30a10 mutant lines using the CRISPR/Cas9 system. Compared to wild-type animals, mutant adult animals developed significantly higher systemic Mn levels, and Mn accumulated in the brain and liver of mutant embryos in response to exogenous Mn. Interestingly, slc30a10 mutants developed neurological deficits in adulthood, as well as environmental Mn-induced manganism in the embryonic stage; moreover, mutant animals had impaired dopaminergic and GABAergic signaling. Finally, mutant animals developed steatosis, liver fibrosis, and polycythemia accompanied by increased epo expression. This phenotype was rescued partially by EDTA-CaNa2 chelation therapy and iron supplementation. Interestingly, prior to the onset of slc30a10 expression, expressing ATP2C1 (ATPase secretory pathway Ca2+ transporting 1) protected mutant embryos from Mn exposure, suggesting a compensatory role for Atp2c1 in the absence of Slc30a10. Notably, expressing either wild-type or mutant forms of SLC30A10 was sufficient to inhibit the effect of ATP2C1 in response to Mn challenge in both zebrafish embryos and HeLa cells. These findings suggest that either activating ATP2C1 or restoring the Mn-induced trafficking of ATP2C1 can reduce Mn accumulation, providing a possible target for treating HMDPC.	[Xia, Zhidan; Wei, Jiayu; Li, Yingniang; Hong, Xiaoli; Zhao, Lu; Min, Junxia; Wang, Fudi] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Med,Sch Publ Hlth,Affiliated Hosp 1,Inst Nutr, Childrens Hosp,Inst Translational Med,Nutr Discov, Hangzhou, Zhejiang, Peoples R China; [Wang, Jia; Li, Wenwen; Wang, Fudi] Zhengzhou Univ, Sch Publ Hlth, Dept Nutr, Precis Nutr Innovat Ctr, Zhengzhou, Henan, Peoples R China; [Wang, Kai; Chen, Caiyong] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Min, JX; Wang, F (reprint author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Med,Sch Publ Hlth,Affiliated Hosp 1,Inst Nutr, Childrens Hosp,Inst Translational Med,Nutr Discov, Hangzhou, Zhejiang, Peoples R China.; Wang, F (reprint author), Zhengzhou Univ, Sch Publ Hlth, Dept Nutr, Precis Nutr Innovat Ctr, Zhengzhou, Henan, Peoples R China.	junxiamin@zju.edu.cn; fwang@zju.edu.cn			National Natural Science Foundation of China [31501181, 31330036, 31225013, 31530034, 31570791, 91542205, 31401016]; Natural Science Foundation of Zhejiang Province [LQ15C110001]	This work was supported by research grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (31501181 to ZX; 31330036, 31225013 and 31530034 to FW; 31570791 and 91542205 to JM and 31401016 to LZ), the Natural Science Foundation of Zhejiang Province (http://www.zjnsf.gov.cn/)(LQ15C110001 to ZX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Au C, 2008, NEUROTOXICOLOGY, V29, P569, DOI 10.1016/j.neuro.2008.04.022; Bakthavatsalam S, 2014, DIS MODEL MECH, V7, P1239, DOI 10.1242/dmm.016683; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; Bouabid S, 2016, J NEUROCHEM, V136, P677, DOI 10.1111/jnc.13442; Boycott KM, 2015, AM J HUM GENET, V97, P886, DOI 10.1016/j.ajhg.2015.11.002; Burkhard PR, 2003, ARCH NEUROL-CHICAGO, V60, P521, DOI 10.1001/archneur.60.4.521; Butterworth RF, 2013, METAB BRAIN DIS, V28, P261, DOI 10.1007/s11011-012-9341-7; Butterworth RF, 2010, NEUROTOX RES, V18, P100, DOI 10.1007/s12640-010-9185-z; Carvalho L, 2010, TRENDS CELL BIOL, V20, P586, DOI 10.1016/j.tcb.2010.06.009; Chalela JA, 2011, NEUROCRIT CARE, V14, P456, DOI 10.1007/s12028-010-9476-5; Chen P, 2015, J NEUROCHEM, V134, P601, DOI 10.1111/jnc.13170; Chen P, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00265; da Silva TC, 2016, J STEROID BIOCHEM, V163, P77, DOI 10.1016/j.jsbmb.2016.04.006; Donovan A, 2000, NATURE, V403, P776; Ebert BL, 1999, BLOOD, V94, P1864; Erikson KM, 2005, ENVIRON TOXICOL PHAR, V20, P390, DOI 10.1016/j.etap.2005.03.009; Fairclough RJ, 2003, J BIOL CHEM, V278, P24721, DOI 10.1074/jbc.M300509200; Fitsanakis VA, 2010, NEUROTOX RES, V18, P124, DOI 10.1007/s12640-009-9130-1; Ganis JJ, 2012, DEV BIOL, V366, P185, DOI 10.1016/j.ydbio.2012.03.021; Gospe SM, 2000, ARCH DIS CHILD, V83, P439, DOI 10.1136/adc.83.5.439; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; Hernandez EH, 2006, NEUROTOXICOLOGY, V27, P333, DOI 10.1016/j.neuro.2005.09.003; Horning KJ, 2015, ANNU REV NUTR, V35, P71, DOI 10.1146/annurev-nutr-071714-034419; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Hutchens S, 2017, J BIOL CHEM, V292, P9760, DOI 10.1074/jbc.M117.783605; Kalasekar SM, 2015, REPROD TOXICOL, V55, P20, DOI 10.1016/j.reprotox.2014.10.022; Lechpammer M, 2014, ANN NEUROL, V75, P608, DOI 10.1002/ana.24131; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Lin W, 2017, J CLIN INVEST, V127, P2407, DOI 10.1172/JCI90896; Liu D, 2014, J GENET GENOMICS, V41, P43, DOI 10.1016/j.jgg.2013.11.004; Lucchini RG, 2012, NEUROTOXICOLOGY, V33, P687, DOI 10.1016/j.neuro.2012.01.005; Mammarella LD, 2014, J NEUROL, V261, P227, DOI 10.1007/s00415-013-7187-5; McLean DL, 2004, J COMP NEUROL, V480, P57, DOI 10.1002/cne.20281; Milatovic D, 2009, TOXICOL APPL PHARM, V240, P219, DOI 10.1016/j.taap.2009.07.004; Mu Y, 2012, NEURON, V75, P688, DOI 10.1016/j.neuron.2012.05.035; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Mukhtiar K, 2016, BRAIN DEV-JPN, V38, P862, DOI 10.1016/j.braindev.2016.04.005; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Patrushev N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033211; Quadri M, 2015, MOVEMENT DISORD, V30, P996, DOI 10.1002/mds.26202; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Racette BA, 2012, NEUROTOXICOLOGY, V33, P1356, DOI 10.1016/j.neuro.2012.08.011; Ren GQ, 2013, J BIOL CHEM, V288, P22451, DOI 10.1074/jbc.M113.485227; Rivera-Mancia S, 2011, BIOMETALS, V24, P811, DOI 10.1007/s10534-011-9454-1; Roth JA, 2014, NEUROTOXICOLOGY, V44, P314, DOI 10.1016/j.neuro.2014.08.006; Sheng DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000914; Sikk K, 2011, PARKINSONS DIS, V2011; Stamelou M, 2012, MOVEMENT DISORD, V27, P1317, DOI 10.1002/mds.25138; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; Tuschl K, 2008, J INHERIT METAB DIS, V31, P151, DOI 10.1007/s10545-008-0813-1; Tuschl K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11601; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Wager K, 2013, AUTOPHAGY, V9, P1693, DOI 10.4161/auto.25082; Wahlberg K, 2016, TOXICOL SCI, V149, P473, DOI 10.1093/toxsci/kfv252; Xia ZD, 2013, DEV BIOL, V381, P83, DOI 10.1016/j.ydbio.2013.06.009; Zhao L, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00033; Zhao YT, 2016, TRAFFIC, V17, P267, DOI 10.1111/tra.12371; Zogzas CE, 2016, J BIOL CHEM, V291, P15940, DOI 10.1074/jbc.M116.726935	60	1	1	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	JUL	2017	13	7							e1006892	10.1371/journal.pgen.1006892				29	Genetics & Heredity	Genetics & Heredity	FC1RO	WOS:000406615300031	28692648	gold			2018-01-05	
J	Huang, WH; Wang, GQ; Sebra, R; Zhuge, J; Yin, CH; Aguero-Rosenfeld, ME; Schuetz, AN; Dimitrova, N; Fallon, JT				Huang, Weihua; Wang, Guiqing; Sebra, Robert; Zhuge, Jian; Yin, Changhong; Aguero-Rosenfeld, Maria E.; Schuetz, Audrey N.; Dimitrova, Nevenka; Fallon, John T.			Emergence and Evolution of Multidrug-Resistant Klebsiella pneumoniae with both bla(KPC) and bla(CTX-M) Integrated in the Chromosome	ANTIMICROBIAL AGENTS AND CHEMOTHERAPY			English	Article						CRISPR-Cas; CTX-M; carbapenem-resistance; chromosomal beta-lactamases; Klebsiella pneumoniae; bla(KPC)	SPECTRUM BETA-LACTAMASES; SEQUENCE-SPECIFIC ANTIMICROBIALS; CRISPR-CAS SYSTEMS; MOLECULAR EPIDEMIOLOGY; GENOMICS VIEWER; READ ALIGNMENT; BACTERIA; ENTEROBACTERIACEAE; CLASSIFICATION; IDENTIFICATION	The extended-spectrum-beta-lactamase (ESBL)- and Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae represent serious and urgent threats to public health. In a retrospective study of multidrug-resistant K. pneumoniae, we identified three clinical isolates, CN1, CR14, and NY9, carrying both bla(CTX-M) and bla(KPC) genes. The complete genomes of these three K. pneumoniae isolates were de novo assembled by using both short-and long-read whole-genome sequencing. In CR14 and NY9, bla(CTX-M) and bla(KPC) were carried on two different plasmids. In contrast, CN1 had one copy of bla(KPC-2) and three copies of bla(CTX-M-15) integrated in the chromosome, for which the bla(CTX-M-15) genes were linked to an insertion sequence, ISEcp1, whereas the bla(KPC-2) gene was in the context of a Tn4401a transposition unit conjugated with a PsP3-like prophage. Intriguingly, downstream of the Tn4401a-bla(KPC-2)-prophage genomic island, CN1 also carried a clustered regularly interspaced short palindromic repeat (CRISPR)-cas array with four spacers targeting a variety of K. pneumoniae plasmids harboring antimicrobial resistance genes. Comparative genomic analysis revealed that there were two subtypes of type I-E CRISPR-cas in K. pneumoniae strains and suggested that the evolving CRISPR-cas, with its acquired novel spacer, induced the mobilization of antimicrobial resistance genes from plasmids into the chromosome. The integration and dissemination of multiple copies of bla(CTX-M) and bla(KPC) from plasmids to chromosome depicts the complex pandemic scenario of multidrug-resistant K. pneumoniae. Additionally, the implications from this study also raise concerns for the application of a CRISPR-cas strategy against antimicrobial resistance.	[Huang, Weihua; Wang, Guiqing; Yin, Changhong; Fallon, John T.] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; [Wang, Guiqing; Zhuge, Jian; Fallon, John T.] Westchester Med Ctr, Dept Pathol & Clin Labs, Valhalla, NY 10595 USA; [Sebra, Robert] Icahn Sch Med Mt Sinai, Icahn Inst, New York, NY 10029 USA; [Sebra, Robert] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Aguero-Rosenfeld, Maria E.] NYU, Dept Pathol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Schuetz, Audrey N.] Weill Cornell Med Ctr, Dept Pathol & Lab Med, New York, NY USA; [Dimitrova, Nevenka] Philips Res North Amer, Cambridge, MA USA; [Schuetz, Audrey N.] Mayo Clin, Coll Med & Sci, Div Lab Med & Pathol, Rochester, MN USA	Huang, WH; Wang, GQ (reprint author), New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA.; Wang, GQ (reprint author), Westchester Med Ctr, Dept Pathol & Clin Labs, Valhalla, NY 10595 USA.	weihua_huang@nymc.edu; guiqing_wang@nymc.edu			Department of Pathology at New York Medical College and Philips Research North America	This study was supported in part by research funds from the Department of Pathology at New York Medical College and Philips Research North America.	Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Bush K, 2008, CLIN MICROBIOL INFEC, V14, P134, DOI 10.1111/j.1469-0691.2007.01848.x; Canton R, 2008, CLIN MICROBIOL INFEC, V14, P144, DOI 10.1111/j.1469-0691.2007.01850.x                                                ; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; Clinical and Laboratory Standards Institute, 2015, M100S25 CLIN LAB STA; Coelho A, 2010, INT J ANTIMICROB AG, V36, P73, DOI 10.1016/j.ijantimicag.2010.03.005; Conlan S., 2014, GENOME ANNOUNC, V2; Conlan S, 2016, GENOME ANNOUNCEMENTS, V4, DOI DOI 10.1128/GENOMEA.00664-16; Conlan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009845; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Di Pilato V, 2016, GENOME ANNOUNC, V4; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hawkey PM, 2008, CLIN MICROBIOL INFEC, V14, P159, DOI 10.1111/j.1469-0691.2007.01855.x; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Kopacz J, 2013, ANTIMICROB AGENTS CH, V57, P5166, DOI 10.1128/AAC.00043-13; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mshana SE, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0460-2; Naas T, 2008, ANTIMICROB AGENTS CH, V52, P1257, DOI 10.1128/AAC.01451-07; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang GQ, 2013, EMERG INFECT DIS, V19, P1803, DOI [10.3201/1911.121470, 10.3201/eid1911.121470]; Yosef I, 2015, P NATL ACAD SCI USA, V112, P7267, DOI 10.1073/pnas.1500107112; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao WH, 2013, CRIT REV MICROBIOL, V39, P79, DOI 10.3109/1040841X.2012.691460; Zowawi HM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15082	42	0	0	4	4	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0066-4804	1098-6596		ANTIMICROB AGENTS CH	Antimicrob. Agents Chemother.	JUL	2017	61	7							e00076-17	10.1128/AAC.00076-17				11	Microbiology; Pharmacology & Pharmacy	Microbiology; Pharmacology & Pharmacy	FB6MR	WOS:000406257600005					2018-01-05	
J	Yang, YM; Lei, H; Qiang, YW; Wang, B				Yang, Yanmei; Lei, Hong; Qiang, Ya-wei; Wang, Bin			Ixazomib enhances parathyroid hormone-induced beta-catenin/T-cell factor signaling by dissociating beta-catenin from the parathyroid hormone receptor	MOLECULAR BIOLOGY OF THE CELL			English	Article							PROTEASOME INHIBITOR MLN9708; AIRWAY SMOOTH-MUSCLE; MULTIPLE-MYELOMA; OSTEOBLAST DIFFERENTIATION; TERMINAL REGION; BONE-FORMATION; IN-VIVO; PTH; WNT; PROTEIN	The anabolic action of PTH in bone is mostly mediated by cAMP/PKA and Wnt-independent activation of beta-catenin/T-cell factor (TCF) signaling. beta-Catenin switches the PTH receptor (PTHR) signaling from cAMP/PKA to PLC/PKC activation by binding to the PTHR. Ixazomib (Izb) was recently approved as the first orally administered proteasome inhibitor for the treatment of multiple myeloma; it acts in part by inhibition of pathological bone destruction. Proteasome inhibitors were reported to stabilize beta-catenin by the ubiquitin-proteasome pathway. However, how Izb affects PTHR activation to regulate beta-catenin/TCF signaling is poorly understood. In the present study, using CRISPR/Cas9 genome-editing technology, we show that Izb reverses beta-catenin-mediated PTHR signaling switch and enhances PTH-induced cAMP generation and cAMP response element-luciferase activity in osteoblasts. Izb increases active forms of beta-catenin and promotes beta-catenin translocation, thereby dissociating beta-catenin from the PTHR at the plasma membrane. Furthermore, Izb facilitates PTH-stimulated GSK3 beta phosphorylation and beta-catenin phosphorylation. Thus Izb enhances PTH stimulation of beta-catenin/TCF signaling via cAMP-dependent activation, and this effect is due to its separating beta-catenin from the PTHR. These findings provide evidence that Izb may be used to improve the therapeutic efficacy of PTH for the treatment of osteoporosis and other resorptive bone diseases.	[Yang, Yanmei; Lei, Hong; Wang, Bin] Thomas Jefferson Univ, Dept Med, Sidney Kimmel Med Coll, Ctr Translat Med, Philadelphia, PA 19107 USA; [Lei, Hong] Nanjing Univ Finance & Econ, Coll Food Sci & Engn, Nanjing 210023, Jiangsu, Peoples R China; [Qiang, Ya-wei] Univ Arkansas Med Sci, Myeloma Inst, Little Rock, AR 72205 USA	Wang, B (reprint author), Thomas Jefferson Univ, Dept Med, Sidney Kimmel Med Coll, Ctr Translat Med, Philadelphia, PA 19107 USA.	bin.wang@jefferson.edu			National Institutes of Health [AR062705, AR063289]; Department of Defense [PR152096]	We thank Raymond B. Penn for help in the completion of this work. This work was supported, in whole or in part, by National Institutes of Health Grants AR062705 and AR063289 and Department of Defense Grant PR152096 to B.W.	Alonso V, 2011, J BONE MINER RES, V26, P2923, DOI 10.1002/jbmr.494; Bauer W, 1929, J EXP MED, V49, P145, DOI 10.1084/jem.49.1.145; Berenson JR, 2014, LEUKEMIA, V28, P1529, DOI 10.1038/leu.2014.27; Bienz M, 2003, NAT CELL BIOL, V5, P179, DOI 10.1038/mcb0303-179; Boissy P, 2008, LEUKEMIA RES, V32, P1661, DOI 10.1016/j.leukres.2008.02.019; Carter PH, 2015, MOL ENDOCRINOL, V29, P307, DOI 10.1210/me.2014-1129; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cheloha RW, 2015, NAT REV ENDOCRINOL, V11, P712, DOI 10.1038/nrendo.2015.139; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Deshpande DA, 2014, FASEB J, V28, P956, DOI 10.1096/fj.13-240226; Garcia-Gomez A, 2014, CLIN CANCER RES, V20, P1542, DOI 10.1158/1078-0432.CCR-13-1657; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gidon A, 2014, NAT CHEM BIOL, V10, P707, DOI [10.1038/NCHEMBIO.1589, 10.1038/nchembio.1589]; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Herndon TM, 2013, CLIN CANCER RES, V19, P4559, DOI 10.1158/1078-0432.CCR-13-0755; Hu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074191; IIDAKLEIN A, 1995, J BIOL CHEM, V270, P8458, DOI 10.1074/jbc.270.15.8458                                                         ; Kulkarni NH, 2005, J CELL BIOCHEM, V95, P1178, DOI 10.1002/jcb.20506; Kupperman E, 2010, CANCER RES, V70, P1970, DOI 10.1158/0008-5472.CAN-09-2766; Liu B, 2015, INT J MOL MED, V36, P1572, DOI 10.3892/ijmm.2015.2382; Long FX, 2001, DEVELOPMENT, V128, P541; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Marie PJ, 2014, CALCIFIED TISSUE INT, V94, P46, DOI 10.1007/s00223-013-9733-7; Murray EJB, 1998, EXP CELL RES, V242, P460, DOI 10.1006/excr.1998.4090; Muz B, 2016, DRUG DES DEV THER, V10, P217, DOI 10.2147/DDDT.S93602; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291                                                         ; Ogata N, 2011, J BIOL CHEM, V286, P13733, DOI 10.1074/jbc.M110.200196; Pearman AT, 1996, J BIOL CHEM, V271, P25715, DOI 10.1074/jbc.271.41.25715                                                        ; Pennisi A, 2009, AM J HEMATOL, V84, P6, DOI 10.1002/ajh.21310; Qiang YW, 2009, BLOOD, V113, P4319, DOI 10.1182/blood-2008-08-174300; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; Revollo L, 2015, J BONE MINER RES, V30, P274, DOI 10.1002/jbmr.2323; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Romero G, 2010, J BIOL CHEM, V285, P14756, DOI 10.1074/jbc.M110.102970; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Vilardaga JP, 2011, CELL MOL LIFE SCI, V68, P1, DOI 10.1007/s00018-010-0465-9; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2013, BONE, V52, P268, DOI 10.1016/j.bone.2012.10.001; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Wheeler D, 2008, MOL ENDOCRINOL, V22, P1163, DOI 10.1210/me.2007-0461; Yan HD, 2011, FASEB J, V25, P389, DOI 10.1096/fj.10-164798; Yang HL, 2016, ANN NY ACAD SCI, V1385, P41, DOI 10.1111/nyas.13221; Yang YM, 2015, BIOCHEM BIOPH RES CO, V464, P27, DOI 10.1016/j.bbrc.2015.05.082; Yang YM, 2015, J BIOL CHEM, V290, P16918, DOI 10.1074/jbc.M115.663963; Yano F, 2013, ARTHRITIS RHEUM-US, V65, P429, DOI 10.1002/art.37779; Zhou FF, 2016, J BONE MINER RES, V31, P1888, DOI 10.1002/jbmr.2863	53	0	0	5	5	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	JUL 1	2017	28	13					1792	1803		10.1091/mbc.E17-02-0096				12	Cell Biology	Cell Biology	FB9PI	WOS:000406470900009	28495797	green_published			2018-01-05	
J	Jee, B; Sharma, P; Katoch, K; Joshi, B; Awasthi, SK				Jee, Babban; Sharma, Pawan; Katoch, Kiran; Joshi, Beenu; Awasthi, Sudhir Kumar			IL-10 down-regulates the expression of survival associated gene hspX of Mycobacterium tuberculosis in murine macrophage	BRAZILIAN JOURNAL OF INFECTIOUS DISEASES			English	Article						Mycobacterium tuberculosis; hspX; rmIFN-gamma; rmIL-10; Murine macrophage	ALPHA-CRYSTALLIN; IN-VITRO; PROTEIN; TRANSCRIPTION; INFECTION; HSP16.3; GROWTH	Mycobacterium tuberculosis (MTB) adopts a special survival strategy to overcome the killing mechanism(s) of host immune system. Amongst the many known factors, small heat shock protein 16.3 (sHSP16.3) of MTB encoded by gene hspX has been reported to be critical for the survival of MTB. In the present study, the effect of recombinant murine interferon-gamma (rmIFN-y) and recombinant murine interleukin-10 (rmIL-10) on the expression of gene hspX of MTB in murine macrophage RAW264.7 has been investigated. By real-time RT-PCR, it was observed that three increasing concentrations (5, 25 and 50 ng/ml) of rmIFN-y significantly up-regulated the expression of hspX whereas similar concentrations of rmIL-10 (5, 25 and 50 ng/ml) significantly down-regulated the hspX expression. This effect was not only dependent on the concentration of the stimulus but this was time-dependent as well. A contrasting pattern of hspX expression was observed against combinations of two different concentrations of rmIFN-gamma and rmIL-10. The study results suggest that rIL-10 mediated down-regulation of hspX expression, in the presence of low concentration of rIFN-gamma, could be used as an important strategy to decrease the dormancy of MTB in its host and thus making MTB susceptible to the standard anti-mycobacterial therapy used for treating tuberculosis. However, as these are only preliminary results in the murine cell line model, this hypothesis needs to be first validated in human cell lines and subsequently in animal models mimicking the latent infection using clinical isolates of MTB before considering the development of modified regimens for humans. (C) 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.	[Jee, Babban] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Dept Microbiol & Mol Biol, Agra, Uttar Pradesh, India; [Jee, Babban; Awasthi, Sudhir Kumar] Chhatrapati Shahu Ji Maharaj Univ, Inst Life Sci, Kanpur, Uttar Pradesh, India; [Sharma, Pawan] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India; [Katoch, Kiran] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Agra, Uttar Pradesh, India; [Joshi, Beenu] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Dept Immunol, Agra, Uttar Pradesh, India	Awasthi, SK (reprint author), Chhatrapati Shahu Ji Maharaj Univ, Inst Life Sci, Kanpur, Uttar Pradesh, India.	sudhir200211@rediffmail.com			Department of Science and Technology, New Delhi [SR/SO/HS-66/2007]	The financial support from Department of Science and Technology, New Delhi in the form of Project No. SR/SO/HS-66/2007 is duly acknowledged. Authors are highly thankful to Director, International Center for Genetic Engineering and Biotechnology, New Delhi for providing essential research facilities; Arvind Pandey, Director, National Institute of Medical Statistics, New Delhi for statistical analysis; Santosh Kumar and Zaved Siddiqui, International Center for Genetic Engineering and Biotechnology, New Delhi for their technical support.	Chang ZY, 1996, J BIOL CHEM, V271, P7218, DOI 10.1074/jbc.271.12.7218                                                         ; COATES ARM, 1981, LANCET, V2, P167; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159                                                                   ; Cunningham AF, 1998, J BACTERIOL, V180, P801; Curfs JHAJ, 1997, CLIN MICROBIOL REV, V10, P742; DICKINSON JM, 1981, AM REV RESPIR DIS, V123, P367; Dirt S, 2015, IMMUNOL REV, V764, P319; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Flentie K, 2016, J BACTERIOL, V198, P1360, DOI 10.1128/JB.00935-15; Fu XM, 2004, BIOCHEM BIOPH RES CO, V316, P291, DOI 10.1016/j.bbrc.2004.02.053; Garbe TR, 1999, INFECT IMMUN, V67, P460; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Haile Y, 2002, MICROBIOL-SGM, V148, P3881, DOI 10.1099/00221287-148-12-3881                                                    ; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Hu YM, 1999, J BACTERIOL, V181, P1380; LEE BY, 1992, INFECT IMMUN, V60, P2066; Meng QL, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-37; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Rook GAW, 1996, ANNU REV MICROBIOL, V50, P259, DOI 10.1146/annurev.micro.50.1.259; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498                                                          ; Stewart GC, 2005, MOL MICROBIOL, V57, P1177, DOI 10.1111/j.1365-2958.2005.04760.x; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129                                                    ; Verhon A, 1992, J BACTERIOL, V174, P1357; Wang J, 2012, CELL MOL BIOL, V58, P1688, DOI 10.1170/196; Wayne LG, 1996, INFECT IMMUN, V64, P2062; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578                                                         ; Yuan Ying, 1996, Journal of Bacteriology, V178, P4484; [Anonymous], 1986, INFECT IMMUN, V51, P718	29	0	0	3	3	ELSEVIER BRAZIL	RIO DE JANEIRO	R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL	1413-8670	1678-4391		BRAZ J INFECT DIS	Braz. J. Infect. Dis.	JUL-AUG	2017	21	4					386	390		10.1016/j.bjid.2017.03.009				5	Infectious Diseases	Infectious Diseases	FB2TG	WOS:000405995500003	28435012	gold			2018-01-05	
J	Rani, A; Nawaz, SK; Irfan, S; Arshad, M; Bashir, R; Shaheen, N				Rani, Asima; Nawaz, Syed Kashif; Irfan, Shazia; Arshad, Muhammad; Bashir, Razia; Shaheen, Najma			Role of MyD88-adaptor-like gene polymorphism rs8177374 in modulation of malaria severity in the Pakistani population	BRAZILIAN JOURNAL OF INFECTIOUS DISEASES			English	Article						Malaria; Plasmodium; rs8177374; MAL; Pakistani population	TOLL-LIKE RECEPTORS; SIGNAL-TRANSDUCTION; TIRAP; TUBERCULOSIS; SUSCEPTIBILITY; FALCIPARUM; CHILDREN; IMMUNITY; DISEASE	Introduction: The present study was designed to investigate the association between rs8177374 polymorphism and malaria symptoms due to exposure of Plasmodium vivax and Plasmodium falciparum. Materials and methods: A total of 454 samples were included in the study (228 malaria patients and 226 healthy individuals). Malaria patients, divided into P. vivax and P. falciparum groups on the basis of the causative species of Plasmodium, were categorized into mild and severe on the basis of clinical outcomes according to WHO criteria. Healthy individuals were used as controls. Allele specific PCR based strategy was used for the identification of rs8177374 SNP. Results: MyD88-adaptor-like gene polymorphism was associated with susceptibility to malaria (p <0.001). C allele frequency (0.74) was higher in the population compared to T allele frequency (0.26). CT genotype increased the susceptibility of malaria (OR: 2.661; 95% CI: 1.722-4.113) and was positively associated with mild malaria (OR: 5.609; 95% CI: 3.479-9.044, p = 0.00). On the other hand, CC genotype was associated with severe malaria (OR: 3.116; 95% CI: 1.560-6.224, p = 0.00). P. vivax infection rate was higher in CT genotype carriers compared to other genotypes (OR: 3.616; 95% CI: 2.219-5.894, p < 0.001). Conclusion: MyD88-adaptor-like/TIR domain containing adaptor protein polymorphism for single nucleotide polymorphism rs8177374 is related with the susceptibility of malaria. (C) 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.	[Rani, Asima; Nawaz, Syed Kashif; Irfan, Shazia; Bashir, Razia] Univ Sargodha, Dept Zool, Sargodha, Pakistan; [Arshad, Muhammad] Univ Educ, Lower Mall Campus, Lahore, Pakistan; [Shaheen, Najma] Univ Punjab, Dept Zool, Lahore, Pakistan	Rani, A (reprint author), Univ Sargodha, Dept Zool, Sargodha, Pakistan.	primer.snp@gmail.com			Higher Education Commission (HEC) Pakistan [S180L]	This research was completed using funds from Higher Education Commission (HEC) Pakistan, for project entitled "Role of MAL/TIRAP polymorphism (S180L) on inflammatory and anti-inflammatory cytokines in severe malarial manifestations".	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Al-Yaman FM, 1998, T ROY SOC TROP MED H, V92, P417, DOI 10.1016/S0035-9203(98)91073-2; Antinori S, 2012, MEDITERR J HEMATOL I, V4; Armant MA, 2002, GENOME BIOL, V3; Bannerman DD, 2002, BIOCHEM BIOPH RES CO, V295, P157, DOI 10.1016/S0006-291X(02)00638-1                                                   ; Beg MA, 2002, AM J TROP MED HYG, V67, P230, DOI 10.4269/ajtmh.2002.67.230                                                       ; Bland JM, 2000, BMJ-BRIT MED J, V320, P8; Castiblanco J, 2008, INFECT GENET EVOL, V8, P541, DOI 10.1016/j.meegid.2008.03.001; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; Eriksson EM, 2013, J INFECT DIS, V7, P126; Esposito S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-196; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Hamann L, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-65; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835                                                              ; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Khattak AA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-297; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Maitland K, 1997, T ROY SOC TROP MED H, V91, P562, DOI 10.1016/S0035-9203(97)90026-2; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97                                                        ; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Naderi M, 2014, ASIAN PAC J TROP MED, V7, P451, DOI 10.1016/S1995-7645(14)60073-0; Nejentsev S, 2008, NAT GENET, V40, P261, DOI 10.1038/ng0308-261; O'Neill LAJ, 2003, J ENDOTOXIN RES, V9, P55, DOI 10.1179/096805103125001351; Ramasawmy R, 2009, J INFECT DIS, P1838; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Selvaraj P, 2010, TUBERCULOSIS, V90, P306, DOI 10.1016/j.tube.2010.08.001; Sun T, 2012, P NATL ACAD SCI USA, V109, pE2117, DOI 10.1073/pnas.1206573109; SVENSON JE, 1995, ARCH INTERN MED, V155, P861, DOI 10.1001/archinte.155.8.861; Wu J, 2014, P NATL ACAD SCI USA, V111, pE511, DOI 10.1073/pnas.1316467111; Yamamoto M, 2002, NATURE, P420; Zakeri S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-77	35	0	0	3	3	ELSEVIER BRAZIL	RIO DE JANEIRO	R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL	1413-8670	1678-4391		BRAZ J INFECT DIS	Braz. J. Infect. Dis.	JUL-AUG	2017	21	4					418	423		10.1016/j.bjid.2017.04.002				6	Infectious Diseases	Infectious Diseases	FB2TG	WOS:000405995500008	28482182	gold			2018-01-05	
J	de Carvalho, SP; de Almeida, JB; Andrade, YMFS; da Silva, LSC; de Oliveira, AC; Nascimento, FS; Campos, GB; Oliveira, MV; Timenetsky, J; Marques, LM				de Carvalho, Suzi P.; de Almeida, JeSsica B.; Andrade, Yasmin M. F. S.; da Silva, Lucas S. C.; de Oliveira, Arianne C.; Nascimento, Flavia S.; Campos, Guilherme B.; Oliveira, Marcio V.; Timenetsky, Jorge; Marques, Lucas M.			Community-acquired methicillin-resistant Staphylococcus aureus carrying SCCmec type IV and V isolated from healthy children attending public daycares in northeastern Brazil	BRAZILIAN JOURNAL OF INFECTIOUS DISEASES			English	Article						CA-MRSA; Antibiotic resistance; SCCmec; MLST	MOLECULAR EPIDEMIOLOGY; NASAL CARRIAGE	Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) have increasingly been reported in healthy communities. This study aimed to assess the rate of S. aureus in general and MRSA in particular from nasal secretion of children in daycare centers in Vitoria da Conquista, Brazil. The isolates were identified based on morphology, biochemical tests and by PCR. Detection of virulence genes, biofilm production, and susceptibility test by disk diffusion agar were performed. MRSA isolates were characterized by spa, SCCmec, and multilocus sequence typing (MLST). S. aureus were recovered from 70 (47.3%) of 148 children. Among the 11 MRSA strains (15.7%), two SCCmec types (IV and V) were detected. MLST identified four STs related to three clonal complexes (CC): 5, 45, and 398. Four spa types were found circulating in this setting. Resistance of S. aureus isolates to ampicillin, erythromycin, ciprofloxacin, clindamycin, and tetracycline was 80%, 32.8%, 7.1%, 7.1% and 4.3%, respectively. One isolate presented intermediate resistance to vancomycin detected by Etest methodology. All strains were biofilm producers. The virulence genes seb, sec, spa, and pul were detected in some isolates. This study revealed a high rate of children carrying MRSA among healthy attendees in daycare centers in Vitoria da Conquista, Brazil. (C) 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.	[de Carvalho, Suzi P.; de Almeida, JeSsica B.; Marques, Lucas M.] Univ Estadual Santa Cruz, Dept Microbiol, Ilheus, BA, Brazil; [de Carvalho, Suzi P.; de Almeida, JeSsica B.; Andrade, Yasmin M. F. S.; da Silva, Lucas S. C.; de Oliveira, Arianne C.; Nascimento, Flavia S.; Oliveira, Marcio V.; Marques, Lucas M.] Univ Fed Bahia, Inst Multidisciplinar Saude, Nucleo Tecnol Saude, Vitoria Da Conquista, BA, Brazil; [Campos, Guilherme B.; Timenetsky, Jorge; Marques, Lucas M.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, SP, Brazil	Marques, LM (reprint author), Univ Estadual Santa Cruz, Dept Microbiol, Ilheus, BA, Brazil.; Marques, LM (reprint author), Univ Fed Bahia, Inst Multidisciplinar Saude, Nucleo Tecnol Saude, Vitoria Da Conquista, BA, Brazil.; Marques, LM (reprint author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, SP, Brazil.	lucasm@ufba.br			CAPES	This study was supported by CAPES. We thank the DCCs, children and parents/guardians for allowing this research to be conducted, and AcademicEnglishSolutions.com for proofreading.	Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Casagrande Proietti P, 2010, J VET MED SCI, V72, P1443, DOI 10.1292/jvms.10-0158; Cassat James E., 2007, V391, P127; Dagi HT, 2015, BALK MED J, V32, P171, DOI 10.5152/balkanmedj.2015.150186; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Sousa MA, 2005, J CLIN MICROBIOL, V43, P5150, DOI 10.1128/JCM.43.10.5150-5157.2005; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008; Gelatti LC, 2013, REV SOC BRAS MED TRO, V46, P34, DOI 10.1590/0037-868213022013; GLSI, 2012, M100S22 CLSI; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ho PL, 2012, J INFECTION, V64, P500, DOI 10.1016/j.jinf.2012.02.018; Hu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073300; Krziwanek K, 2009, EMERG INFECT DIS, V15, P766, DOI 10.3201/eid1505.080326; Lamaro-Cardoso J, 2009, J CLIN MICROBIOL, V47, P3991, DOI 10.1128/JCM.01322-09; Lo WT, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-51; Miller MB, 2011, J CLIN MICROBIOL, V49, P1041, DOI 10.1128/JCM.02235-10; Pillai SK, 2009, CLIN INFECT DIS, V49, P1169, DOI 10.1086/605636; Shopsin B, 2000, J INFECT DIS, V182, P359, DOI 10.1086/315695; Tavares DA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-110; Watkins RR, 2012, J MED MICROBIOL, V61, P1179, DOI 10.1099/jmm.0.043513-0; Xie XY, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1684-y; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	22	0	0	4	4	ELSEVIER BRAZIL	RIO DE JANEIRO	R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL	1413-8670	1678-4391		BRAZ J INFECT DIS	Braz. J. Infect. Dis.	JUL-AUG	2017	21	4					464	467		10.1016/j.bjid.2017.04.001				4	Infectious Diseases	Infectious Diseases	FB2TG	WOS:000405995500014	28482183	gold			2018-01-05	
J	Frazao, MR; Andrade, LN; Darini, ALC; Falcao, JP				Frazao, Miliane R.; Andrade, Leonardo N.; Darini, Ana L. C.; Falcao, Juliana P.			Antimicrobial resistance and plasmid replicons in Yersinia enterocolitica strains isolated in Brazil in 30 years	BRAZILIAN JOURNAL OF INFECTIOUS DISEASES			English	Article						Yersinia enterocolitica; Resistance profile; Plasmid replicon	SPECTRUM BETA-LACTAMASES; SUSCEPTIBILITY PATTERNS; QUINOLONE RESISTANCE; VIRULENCE; ENTEROBACTERIACEAE; DETERMINANTS; AMPC; FOOD; EPIDEMIOLOGY; PREVALENCE	Some studies evaluated the resistance profile of the Y. enterocolitica strains isolated in diverse countries. However, in Brazil the isolation and the study of Y enterocolitica are not common and therefore information about the antimicrobial resistance profile of this species in this country is scarce. Therefore, the aim of this study was to evaluate the antimicrobial resistance of Y enterocolitica of biotypes 1A, 2 and 4 isolated from clinical and non-clinical sources between 1979 and 2012, in Brazil. This study showed that some Yersinia enterocolitica of different biotypes remain susceptible to antimicrobials used for gastroenteritis treatment. Moreover, neither acquired resistance genes nor diversity of plasmids replicons were found; however, variation in the in vitro intrinsic resistant pattern was detected, except the nonresistance to cefoxitin in all strains. Notwithstanding, due to epidemiological link between Y enterocolitica and the pork production chain, monitoring plasmid acquired resistance in Y enterocolitica could also be considered for antimicrobial resistance control purposes and food safety measures. (C) 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.	[Frazao, Miliane R.; Andrade, Leonardo N.; Darini, Ana L. C.; Falcao, Juliana P.] Univ Sao Paulo, FCFRP, DACTB, Ribeirao Preto, SP, Brazil	Falcao, JP (reprint author), Univ Sao Paulo, FCFRP, DACTB, Ribeirao Preto, SP, Brazil.	jufalcao@fcfrp.usp.br	Darini, Ana Lucia/C-8127-2012; Falcao, Juliana/E-9652-2012		Sao Paulo Research Foundation [FAPESP-2012/19132-1]; Coordination for the Improvement of the Higher Education Personnel (CAPES); Programa Nacional de Pos Doutorado (PNPD)/CAPES	We thank Sao Paulo Research Foundation (FAPESP-2012/19132-1) for financial support. During the course of this work, Frazao, M.R. was supported by a scholarship granted by Coordination for the Improvement of the Higher Education Personnel (CAPES). Andrade, L.N. was supported by a postdoctoral fellowship from Programa Nacional de Pos Doutorado (PNPD)/CAPES 2015.	Andrade LN, 2010, CAN J MICROBIOL, V56, P399, DOI [10.1139/W10-020, 10.1139/w10-020]; Bent ZW, ANTIMICROB AGENTS CH; Brauer A, 2016, ANTIMICROB AGENTS CH; Campioni F, 2014, APMIS, V122, P215, DOI 10.1111/apm.12126; Capilla S, 2004, J ANTIMICROB CHEMOTH, V53, P1068, DOI 10.1093/jac/dkh225; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; [CLSI] Clinical and Laboratorial Standards Institute, 2016, PERF STAND ANT SUSC; CLSI CaLSI, 2016, PERF STAND ANT DISK; Drummond N, 2013, FOODBORNE PATHOG DIS, V10, P744, DOI 10.1089/fpd.2012.1468; Drummond N, 2012, FOODBORNE PATHOG DIS, V9, P179, DOI 10.1089/fpd.2011.0938; EUCAST ECoAST, BREAKP TABL INT MICS; Fabrega A, 2012, ENFERM INFEC MICR CL, V30, P24, DOI 10.1016/j.eimc.2011.07.017; Fabrega A, 2010, INT J MED MICROBIOL, V300, P457, DOI 10.1016/j.ijmm.2010.02.003; Falcao JP, 2004, J APPL MICROBIOL, V96, P1230, DOI 10.1111/j.1365-2672.2004.02268.x; Falcao JP, 2006, J MED MICROBIOL, V55, P1539, DOI 10.1099/jmm.0.46733-0; Frazao MR, 2015, J APPL MICROBIOL, V118, P1058, DOI 10.1111/jam.12751; Funk JA, 2000, J FOOD PROTECT, V63, P395, DOI 10.4315/0362-028X-63.3.395                                                      ; Gousia P, FOODBORNE PATHOG DIS; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; JARLIER V, 1988, REV INFECT DIS, V10, P867; Kim HB, 2009, ANTIMICROB AGENTS CH, V53, P3582; Liebana E, 2013, CLIN INFECT DIS, V56, P1030, DOI 10.1093/cid/cis1043; Liu C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01282; Ng LK, 2001, MOL CELL PROBE, V15, P209, DOI 10.1006/mcpr.2001.0363; Rusak LA, 2014, J INFECT DEV COUNTR, V8, P1533, DOI [10.3855/jidc.4533, 10.3855/jidc.4553]; Sihvonen LM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-42; Tamang MD, 2012, FOODBORNE PATHOG DIS, V9, P1057, DOI 10.1089/fpd.2012.1225; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347	29	1	1	1	1	ELSEVIER BRAZIL	RIO DE JANEIRO	R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL	1413-8670	1678-4391		BRAZ J INFECT DIS	Braz. J. Infect. Dis.	JUL-AUG	2017	21	4					477	480		10.1016/j.bjid.2017.04.006				4	Infectious Diseases	Infectious Diseases	FB2TG	WOS:000405995500017	28558260	gold			2018-01-05	
J	Barrangou, R; Horvath, P				Barrangou, Rodolphe; Horvath, Philippe			A decade of discovery: CRISPR functions and applications	NATURE MICROBIOLOGY			English	Article							BACTERIAL IMMUNE-SYSTEM; RNA-GUIDED ENDONUCLEASE; SEQUENCE-SPECIFIC ANTIMICROBIALS; TARGET DNA RECOGNITION; CAS ADAPTIVE IMMUNITY; LACTIC-ACID BACTERIA; STREPTOCOCCUS-THERMOPHILUS; ESCHERICHIA-COLI; GENE-EXPRESSION; ACQUIRED-RESISTANCE	This year marks the tenth anniversary of the identification of the biological function of CRISPR-Cas as adaptive immune systems in bacteria. In just a decade, the characterization of CRISPR-Cas systems has established a novel means of adaptive immunity in bacteria and archaea and deepened our understanding of the interplay between prokaryotes and their environment, and CRISPR-based molecular machines have been repurposed to enable a genome editing revolution. Here, we look back on the historical milestones that have paved the way for the discovery of CRISPR and its function, and discuss the related technological applications that have emerged, with a focus on microbiology. Lastly, we provide a perspective on the impacts the field has had on science and beyond.	[Barrangou, Rodolphe] North Carolina State Univ, Dept Food Bioproc & Nutr Sci, 400 Dan Allen Dr,Campus Box 7624, Raleigh, NC 27695 USA; [Horvath, Philippe] DuPont Nutr & Hlth, BP10, F-86220 Dange St Romain, France	Barrangou, R (reprint author), North Carolina State Univ, Dept Food Bioproc & Nutr Sci, 400 Dan Allen Dr,Campus Box 7624, Raleigh, NC 27695 USA.	rbarran@ncsu.edu		HORVATH, Philippe/0000-0003-2015-8123; Barrangou, Rodolphe/0000-0002-0648-3504	North Carolina State University; North Carolina Ag. Foundation	R.B. is supported by funds from North Carolina State University and the North Carolina Ag. Foundation. The authors would like to thank their colleagues and collaborators for their contributions and insights, and for having the privilege to share the CRISPR journey.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; Anders C, 2016, MOL CELL, V61, P895, DOI 10.1016/j.molcel.2016.02.020; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Barrangou R, 2016, ANNU REV FOOD SCI T, V7, P395, DOI 10.1146/annurev-food-022814-015729; Barrangou R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0816-9; Barrangou R, 2015, NUCLEIC ACIDS RES, V43, P3407, DOI 10.1093/nar/gkv226; Barrangou R, 2015, EXPERT OPIN BIOL TH, V15, P311, DOI 10.1517/14712598.2015.994501; Barrangou R, 2013, BIOCHEM SOC T, V41, P1383, DOI 10.1042/BST20130160; Barrangou R, 2012, ANNU REV FOOD SCI T, V3, P143, DOI 10.1146/annurev-food-022811-101134; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Box AM, 2016, J BACTERIOL, V198, P578, DOI 10.1128/JB.00747-15; Briner AE, 2016, CURR OPIN MICROBIOL, V31, P101, DOI 10.1016/j.mib.2016.03.006; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Carte J, 2014, MOL MICROBIOL, V93, P98, DOI 10.1111/mmi.12644; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Edgar R, 2010, J BACTERIOL, V192, P6291, DOI 10.1128/JB.00644-10; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Gong B, 2014, P NATL ACAD SCI USA, V111, P16359, DOI 10.1073/pnas.1410806111; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Haurwitz RE, 2012, EMBO J, V31, P2824, DOI 10.1038/emboj.2012.107; Heidelberg JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004169; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Heler R, 2014, MOL MICROBIOL, V93, P1, DOI 10.1111/mmi.12640; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Hoe N, 1999, EMERG INFECT DIS, V5, P254, DOI 10.3201/eid0502.990210                                                          ; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jansen Rund, 2002, OMICS A Journal of Integrative Biology, V6, P23, DOI 10.1089/15362310252780816; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kapitonov VV, 2016, J BACTERIOL, V198, P797, DOI 10.1128/JB.00783-15; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Klaenhammer T, 2002, ANTON LEEUW INT J G, V82, P29, DOI 10.1023/A:1020638309912; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Koonin EV, 2015, NAT REV GENET, V16, P184, DOI 10.1038/nrg3859; Krupovic M, 2016, GENOME BIOL EVOL, V8, P375, DOI 10.1093/gbe/evw006; Krupovic M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-36; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lander ES, 2016, CELL, V164, P18, DOI 10.1016/j.cell.2015.12.041; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Lewis KM, 2017, MOL CELL, V65, P377, DOI 10.1016/j.molcel.2017.01.024; Liu L, 2017, MOL CELL, V65, P310, DOI 10.1016/j.molcel.2016.11.040; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P3, DOI 10.1093/nar/gkt990; Louwen R, 2013, EUR J CLIN MICROBIOL, V32, P207, DOI 10.1007/s10096-012-1733-4; Louwen R, 2014, MICROBIOL MOL BIOL R, V78, P74, DOI 10.1128/MMBR.00039-13; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2017, CELL, V168, P946, DOI 10.1016/j.cell.2017.02.018; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Makarova KS, 2013, BIOCHEM SOC T, V41, P1392, DOI 10.1042/BST20130038; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Martel B, 2014, NUCLEIC ACIDS RES, V42, P9504, DOI 10.1093/nar/gku628; Masepohl B, 1996, BBA-GENE STRUCT EXPR, V1307, P26, DOI 10.1016/0167-4781(96)00040-1; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; Mougiakos I, 2016, TRENDS BIOTECHNOL, V34, P575, DOI 10.1016/j.tibtech.2016.02.004; NAKATA A, 1989, J BACTERIOL, V171, P3553, DOI 10.1128/jb.171.6.3553-3556.1989                                                 ; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Paez-Espino D, 2015, MBIO, V6, DOI 10.1128/mBio.00262-15; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pride DT, 2011, GENOME RES, V21, P126, DOI 10.1101/gr.111732.110; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sampson TR, 2014, P NATL ACAD SCI USA, V111, P11163, DOI 10.1073/pnas.1323025111; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927; Selle K, 2015, J FOOD SCI, V80, pR2367, DOI 10.1111/1750-3841.13094; Selle K, 2015, P NATL ACAD SCI USA, V112, P8076, DOI 10.1073/pnas.1508525112; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shariat N, 2013, J CLIN MICROBIOL, V51, P2328, DOI 10.1128/JCM.00608-13; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sontheimer EJ, 2015, HUM GENE THER, V26, P413, DOI 10.1089/hum.2015.091; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Sun CL, 2016, ISME J, V10, P858, DOI 10.1038/ismej.2015.162; Sun CL, 2013, ENVIRON MICROBIOL, V15, P463, DOI 10.1111/j.1462-2920.2012.02879.x; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van Houte S, 2016, NATURE, V532, P385, DOI 10.1038/nature17436; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Weinberger AD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002475; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yang H, 2016, CELL, V167, P1814, DOI 10.1016/j.cell.2016.11.053; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	147	8	8	39	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2058-5276			NAT MICROBIOL	NAT. MICROBIOL	JUL	2017	2	7							17092	10.1038/nmicrobiol.2017.92				9	Microbiology	Microbiology	FC6BL	WOS:000406925300016	28581505				2018-01-05	
J	Vazquez-Rosas-Landa, M; Ponce-Soto, GY; Eguiarte, LE; Souza, V				Vazquez-Rosas-Landa, Mirna; Ponce-Soto, Gabriel Yaxal; Eguiarte, Luis E.; Souza, V.			Comparative genomics of free-living Gammaproteobacteria: pathogenesis-related genes or interaction-related genes?	PATHOGENS AND DISEASE			English	Article						comparative genomics; evolution; Gammaproteobacteria; one health; pathogenesis; secretion systems	CUATRO CIENEGAS BASIN; GRAM-NEGATIVE BACTERIA; III SECRETION SYSTEM; ANTIBIOTIC-RESISTANCE GENES; 2 MICROBIAL MATS; ESCHERICHIA-COLI; ENTEROCYTE EFFACEMENT; COMPARATIVE METAGENOMICS; GAMMA-PROTEOBACTERIA; NATURAL-POPULATIONS	Bacteria have numerous strategies to interact with themselves and with their environment, but genes associated with these interactions are usually cataloged as pathogenic. To understand the role that these genes have not only in pathogenesis but also in bacterial interactions, we compared the genomes of eight bacteria from human-impacted environments with those of free-living bacteria from the Cuatro Cienegas Basin (CCB), a relatively pristine oligotrophic site. Fifty-one genomes from CCB bacteria, including Pseudomonas, Vibrio, Photobacterium and Aeromonas, were analyzed. We found that the CCB strains had several virulence-related genes, 15 of which were common to all strains and were related to flagella and chemotaxis. We also identified the presence of Type III and VI secretion systems, which leads us to propose that these systems play an important role in interactions among bacterial communities beyond pathogenesis. None of the CCB strains had pathogenicity islands, despite having genes associated with antibiotics. Integrons were rare, while CRISPR elements were common. The idea that pathogenicity-related genes in many cases form part of a wider strategy used by bacteria to interact with other organisms could help us to understand the role of pathogenicity-related elements in an ecological and evolutionary framework leading toward a more inclusive One Health concept.	[Vazquez-Rosas-Landa, Mirna; Ponce-Soto, Gabriel Yaxal; Eguiarte, Luis E.; Souza, V.] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, AP 70-275, Mexico City 04510, DF, Mexico	Souza, V (reprint author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Lab Ecol Mol & Expt, AP 70-275, Mexico City 04510, DF, Mexico.	souza@unam.mx		souza, valeria/0000-0002-2992-4229	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IG200215]	This study was conducted with financial support from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) project IG200215.	Aguirre-von-Wobeser E, 2014, ENVIRON MICROBIOL, V16, P1366, DOI 10.1111/1462-2920.12305; Alcaraz LD, 2008, P NATL ACAD SCI USA, V105, P5803, DOI 10.1073/pnas.0800981105; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Austin B, 2010, VET MICROBIOL, V140, P310, DOI 10.1016/j.vetmic.2009.03.015; Avitia M, 2014, PEERJ, V2, DOI 10.7717/peerj.696; Bik Elisabeth M., 2016, Yale Journal of Biology and Medicine, V89, P363; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bonilla-Rosso G, 2012, ASTROBIOLOGY, V12, P659, DOI 10.1089/ast.2011.0724; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Carson EW, 2012, MOL ECOL, V21, P1209, DOI 10.1111/j.1365-294X.2011.05433.x; Castillo A, 2005, P NATL ACAD SCI USA, V102, P1542, DOI 10.1073/pnas.0408633102; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Chen LH, 2016, NUCLEIC ACIDS RES, V44, pD694, DOI 10.1093/nar/gkv1239; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; Cristobal-Azkarate J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107719; Cury J, 2016, NUCLEIC ACIDS RES, V44, P4539, DOI 10.1093/nar/gkw319; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Diaz-Mejia JJ, 2008, MICROBIOL-SGM, V154, P94, DOI 10.1099/mic.0.2007/008649-0; Diggle SP, 2007, PHILOS T R SOC B, V362, P1241, DOI 10.1098/rstb.2007.2049; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Rodriguez-Torres MD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00029; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elser JJ, 2005, FRESHWATER BIOL, V50, P1808, DOI 10.1111/j.1365-2427.2005.01451.x; Epstein SS, 2003, ELS; Escalante AE, 2008, FEMS MICROBIOL ECOL, V65, P50, DOI 10.1111/j.1574-6941.2008.00496.x; Escalante AE, 2009, INT J SYST EVOL MICR, V59, P1416, DOI 10.1099/ijs.0.006189-0; Espinosa-Asuar L, 2015, INT MICROBIOL, V18, P105, DOI 10.2436/20.1501.01.240; Fajardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001619; Fancello L, 2011, J ANTIMICROB CHEMOTH, V66, P2448, DOI 10.1093/jac/dkr315; Feugeas JP, 2016, MOL BIOL EVOL, V33, P2515, DOI 10.1093/molbev/msw105; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI 10.1093/nar/gkt1223; Garcia-Gutierrez E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131935; Gazi AD, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-188; Grosso-Becerra MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-318; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hazen TH, 2010, FEMS MICROBIOL ECOL, V74, P485, DOI 10.1111/j.1574-6941.2010.00937.x; Hershler R, 1984, Journal of the Arizona-Nevada Academy of Science, V19, P61; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Jiang SC, 1998, APPL ENVIRON MICROB, V64, P2780; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80; Kapitein N, 2013, CURR OPIN MICROBIOL, V16, P52, DOI 10.1016/j.mib.2012.11.009; Koster M, 2000, INT J MED MICROBIOL, V290, P325; Krumins JA, 2009, FOREST ECOL MANAG, V258, P1383, DOI 10.1016/j.foreco.2009.06.046; Lee ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123949; Lee ZMP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00949; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li YX, 2011, J BACTERIOL, V193, P3389, DOI 10.1128/JB.00347-11; Lopez-Lozano NE, 2013, PEERJ, V1, DOI 10.7717/peerj.47; Lopez-Lozano NE, 2012, ASTROBIOLOGY, V12, P699, DOI 10.1089/ast.2012.0840; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1                                                   ; Makino W, 2004, AQUAT MICROB ECOL, V34, P33, DOI 10.3354/ame034033; Manyahi J, 2017, MICROB DRUG RESIST, V23, P37, DOI 10.1089/mdr.2016.0074; Marie C, 2003, MOL PLANT MICROBE IN, V16, P743, DOI 10.1094/MPMI.2003.16.9.743; Marie C, 2001, CURR OPIN PLANT BIOL, V4, P336, DOI 10.1016/S1369-5266(00)00182-5; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605                                                    ; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664                                                          ; Methot PO, 2014, VIRULENCE, V5, P775, DOI 10.4161/21505594.2014.960726; Minckley W.L., 1984, Journal of the Arizona-Nevada Academy of Science, V19, P13; Modi SR, 2013, NATURE, V499, P219, DOI 10.1038/nature12212; Moon BY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151409; Moreno-Letelier A., 2011, INT J EVOL BIOL, V2011, DOI DOI 10.4061/2011/781642; Morris BE, 2013, FEMS MICROBIOL REV, V37, P384, DOI 10.1111/1574-6976.12019; Nadalin F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S8; OCHMAN H, 1984, J BACTERIOL, V157, P690; Okada N, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-302; Okazaki S, 2013, P NATL ACAD SCI USA, V110, P17131, DOI 10.1073/pnas.1302360110; Pajares S, 2016, PEERJ, V4, DOI 10.7717/peerj.2459; Parret AHA, 2002, TRENDS MICROBIOL, V10, P107, DOI 10.1016/S0966-842X(02)02307-7                                                   ; Peek AS, 2001, J MOL EVOL, V52, P193, DOI 10.1007/s002390010148                                                           ; Peimbert M, 2012, ASTROBIOLOGY, V12, P648, DOI 10.1089/ast.2011.0694; Perez-Gutierrez RA, 2013, ISME J, V7, P487, DOI 10.1038/ismej.2012.119; Ponce-Soto GY, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00246; Power ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063017; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Riley MA, 1999, TRENDS MICROBIOL, V7, P129, DOI 10.1016/S0966-842X(99)01459-6; Rodriguez-Verdugo A, 2012, INT J MICROBIOL, V2012, DOI DOI 10.1155/2012/201389; Salyers AA, 1997, ANTIMICROB AGENTS CH, V41, P2321; Sandner L, 2001, MICROBIOL-SGM, V147, P3149, DOI 10.1099/00221287-147-11-3149                                                    ; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Scully EP, 2016, NEW ENGL J MED, V375, P1780, DOI 10.1056/NEJMcps1512793; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sheludchenko MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124090; Souza V, 1999, APPL ENVIRON MICROB, V65, P3373; Souza V, 2006, P NATL ACAD SCI USA, V103, P6565, DOI 10.1073/pnas.0601434103; Souza V, 2008, NAT REV MICROBIOL, V6, P559, DOI 10.1038/nrmicro1917; Souza V, 2012, ASTROBIOLOGY, V12, P634, DOI 10.1089/ast.2011.0768; Souza V, 2012, ASTROBIOLOGY, V12, P641, DOI 10.1089/ast.2011.0675; Stalder T., 2016, NPJ BIOFILMS MICROBI, V2, P16022; Subirats J, 2016, INT J ANTIMICROB AG, V48, P163, DOI 10.1016/j.ijantimicag.2016.04.028; Tampakaki AP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00114; Tapia-Torres Y, 2016, APPL ENVIRON MICROB, V82, P4652, DOI 10.1128/AEM.00160-16; The UniProt Consortium, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI [DOI 10.1093/NAR/GKW1099, 10.1093/nar/gkw1099]; Velez P, 2016, PEERJ, V4, DOI 10.7717/peerj.2064; Viprey V, 1998, MOL MICROBIOL, V28, P1381, DOI 10.1046/j.1365-2958.1998.00920.x; Weinbauer MG, 2004, ENVIRON MICROBIOL, V6, P1, DOI 10.1046/j.1462-2920.2003.00539.x; Werner GDA, 2014, P NATL ACAD SCI USA, V111, P1237, DOI 10.1073/pnas.1315980111; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107	110	0	0	6	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2049-632X			PATHOG DIS	Pathog. Dis.	JUL	2017	75	5							ftx059	10.1093/femspd/ftx059				12	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	FD0RB	WOS:000407245300015					2018-01-05	
J	Pagotto, A; Pilotto, G; Mazzoldi, EL; Nicoletto, MO; Frezzini, S; Pasto, A; Amadori, A				Pagotto, Anna; Pilotto, Giorgia; Mazzoldi, Elena Laura; Nicoletto, Maria Ornella; Frezzini, Simona; Pasto, Anna; Amadori, Alberto			Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells	CELL DEATH & DISEASE			English	Article							CHEMOTHERAPY; APOPTOSIS; DEGRADATION; POPULATION; RESISTANCE; DEFINES	Epithelial ovarian cancer (EOC) is one of the most malignant gynecological tumors with a high mortality rate owing to tumor relapse after anticancer therapies. It is widely accepted that a rare tumor cell population, known as cancer stem cells (CSC), is responsible for tumor progression and relapse; intriguingly, these cells are able to survive nutrient starvation (such as in vitro culture in the absence of glucose) and chemotherapy treatment. Recent data also indicated that chemotherapy resistance is associated with autophagy activation. We thus decided to investigate both in vitro and in vivo the autophagic activity and the effects of the perturbation of this pathway in CSC isolated from EOC ascitic effusions. Ovarian CSC, identified according to their CD44/CD117 co-expression, presented a higher basal autophagy compared with the non-stem counterpart. Inhibition of this pathway, by in vitro chloroquine treatment or CRISPR/Cas9 ATG5 knockout, impaired canonical CSC properties, such as viability, the ability to form spheroidal structures in vitro, and in vivo tumorigenic potential. In addition, autophagy inhibition showed a synergistic effect with carboplatin administration on both in vitro CSC properties and in vivo tumorigenic activity. On the whole, these results indicate that the autophagy process has a key role in CSC maintenance; inhibition of this pathway in combination with other chemotherapeutic approaches could represent a novel effective strategy to overcome drug resistance and tumor recurrence.	[Pagotto, Anna; Pilotto, Giorgia; Mazzoldi, Elena Laura; Amadori, Alberto] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Nicoletto, Maria Ornella; Frezzini, Simona; Pasto, Anna; Amadori, Alberto] IRCCS, Ist Oncol Veneto, Via Gattamelata 64, I-35128 Padua, Italy	Pasto, A (reprint author), IRCCS, Ist Oncol Veneto, Via Gattamelata 64, I-35128 Padua, Italy.	annapasto.phd@gmail.com			European Commission [600376]; Italian Association for Cancer Research (AIRC) [N14032]; IOV 5 per mille	The research leading to these results has received funding from the European Commission, Seventh Framework Program (FP7/2007-2013) under Grant Agreement no. 600376. This work was also supported in part by grants from the Italian Association for Cancer Research (AIRC) (grants #N14032) and in part by IOV 5 per mille. A Pagotto was a Marie Curie Fellow at the University of Padova. Current affiliation: Innate Pharma, 117 Avenue de Luminy, Marseille, France.	Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931                                                   ; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Bhoola S, 2006, OBSTET GYNECOL, V107, P1399, DOI 10.1097/01.AOG.0000220516.34053.48; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Clarke-Pearson DL, 2009, NEW ENGL J MED, V361, P170, DOI 10.1056/NEJMcp0901926; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Domen J, 1998, BLOOD, V91, P2272; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Galavotti S, 2013, ONCOGENE, V32, P699, DOI 10.1038/onc.2012.111; Gao M, 2016, J LIPOSOME RES, V27, P1; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Gong C, 2013, ONCOGENE, V32, P2261, DOI 10.1038/onc.2012.252; Guo XL, 2012, CANCER LETT, V320, P171, DOI 10.1016/j.canlet.2012.03.002; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Indraccolo S, 2006, EUR J CANCER, V42, P1475, DOI 10.1016/j.ejca.2006.01.057; Jacobs IJ, 2004, MOL CELL PROTEOMICS, V3, P355, DOI 10.1074/mcp.R400006-MCP200; Kim EL, 2010, NEURO-ONCOLOGY, V12, P389, DOI 10.1093/neuonc/nop046; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Lakhter AJ, 2013, J INVEST DERMATOL, V133, P2247, DOI 10.1038/jid.2013.56; Li J, 2010, EUR J CANCER, V46, P1900, DOI 10.1016/j.ejca.2010.02.021; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Ozols RF, 2005, INT J GYNECOL CANCER, V15, P3, DOI 10.1111/j.1525-1438.2005.15351.x                                                ; Pasto A, 2017, ONCOTARGET, V8, P6433, DOI 10.18632/oncotarget.14118; Pasto A, 2014, ONCOTARGET, V5, P4305, DOI 10.18632/oncotarget.2010                                                        ; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sharrow AC, 2016, GYNECOL ONCOL, V142, P341, DOI 10.1016/j.ygyno.2016.03.022; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Tomao F, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-48; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; YANG MC, 2015, MOL CANCER, V14; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yue W, 2013, AUTOPHAGY, V9, P714, DOI 10.4161/auto.23997; Zhang Y, 2012, ONCOGENE, V31, P1055, DOI 10.1038/onc.2011.290	39	1	1	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	JUL	2017	8								e2943	10.1038/cddis.2017.327				10	Cell Biology	Cell Biology	FC5GR	WOS:000406870400032	28726781	gold			2018-01-05	
J	Xia, D; Ji, WL; Xu, CT; Lin, X; Wang, XK; Xia, Y; Lv, P; Song, QS; Ma, DL; Chen, YY				Xia, Dan; Ji, Wanli; Xu, Chentong; Lin, Xin; Wang, Xiaokun; Xia, Yan; Lv, Ping; Song, Quansheng; Ma, Dalong; Chen, Yingyu			Knockout of MARCH2 inhibits the growth of HCT116 colon cancer cells by inducing endoplasmic reticulum stress	CELL DEATH & DISEASE			English	Article							UNFOLDED PROTEIN RESPONSE; ER STRESS; SIGNALING PATHWAY; PROSTATE-CANCER; GRP78; AUTOPHAGY; INVOLVEMENT; RECURRENCE; ACTIVATION; MECHANISMS	Membrane-associated RING-CH protein 2 (MARCH2), a member of the MARCH family, functions in vesicle trafficking and autophagy regulation. In this study, we established MARCH2 knockout HCT116 cell lines using CRISPR/Cas9-mediated genome editing to evaluate the role of MARCH2 in colon cancer in vitro and in vivo. Knockout of MARCH2 suppressed cell proliferation, and promoted autophagy, apoptosis and G2/M phase cell cycle arrest. These effects were associated with activation of endoplasmic reticulum (ER) stress. In addition, loss of MARCH2 sensitized HCT116 cells to the chemotherapy drugs etoposide and cisplatin. Moreover, we analyzed the clinical significance of MARCH2 in human colon carcinoma (n=100). High MARCH2 expression was significantly associated with advanced clinicopathological features and poorer overall survival in colon carcinoma. MARCH2 expression correlated negatively with expression of the unfolded protein response molecule p-PERK in colon cancer. Collectively, these data reveal a relationship between MARCH2, ER stress and colon cancer, and indicates MARCH2 may have an important role in the development and progression of colon cancer.	[Xia, Dan; Xu, Chentong; Lin, Xin; Wang, Xiaokun; Xia, Yan; Lv, Ping; Song, Quansheng; Ma, Dalong; Chen, Yingyu] Peking Univ, Sch Basic Med Sci, Key Lab Med Immunol, Dept Immunol,Minist Hlth,Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Xia, Dan] Shandong Med Coll, Dept Pathol, 6 Jucai Rd, Linyi 276000, Peoples R China; [Xia, Dan; Xu, Chentong; Lin, Xin; Wang, Xiaokun; Xia, Yan; Lv, Ping; Song, Quansheng; Ma, Dalong; Chen, Yingyu] Peking Univ, Ctr Human Dis Genom, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Ji, Wanli] Shandong Med Coll, Affiliated Hosp, Dept Pathol, 80 Jintan Rd, Linyi 276000, Peoples R China	Chen, YY (reprint author), Peking Univ, Sch Basic Med Sci, Dept Immunol, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	yingyu_chen@bjmu.edu.cn			National Natural Science Foundation of China [3137089, 814201080028, 91430101]; Projects of medical and health technology development program in Shandong province [2016WS0569]; The science and technology plan project of Shandong higher education institutions [J17KA238]	This work was supported by grants from the National Natural Science Foundation of China (31370898, 81420108002, 91430101), Projects of medical and health technology development program in Shandong province (2016WS0569), The science and technology plan project of Shandong higher education institutions (J17KA238).	Ando T, 2001, J BIOL CHEM, V276, P42971, DOI 10.1074/jbc.M106460200; Ariyasu D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020382; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Boutell C, 2002, J VIROL, V76, P841, DOI 10.1128/JVI.76.2.841-850.2002; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Burdelski C, 2015, CLIN CANCER RES, V21, P3471, DOI 10.1158/1078-0432.CCR-14-0620; Cai Y, 2016, J CELL BIOL, V215, P245, DOI 10.1083/jcb.201605065; Cao ZF, 2008, CELL SIGNAL, V20, P73, DOI 10.1016/j.cellsig.2007.08.019; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chen L, 2016, LEUKEMIA RES, V49, P7, DOI 10.1016/j.leukres.2016.07.006; Cheng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cubillos-Ruiz JR, 2017, CELL, V168, P692, DOI 10.1016/j.cell.2016.12.004; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guo ML, 2015, AUTOPHAGY, V11, P995, DOI 10.1080/15548627.2015.1052205; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; Hiramatsu N, 2015, AM J PATHOL, V185, P1800, DOI 10.1016/j.ajpath.2015.03.009; Kang BR, 2016, SCI REP-UK, V6, DOI 10.1038/srep34922; Kugimiya N, 2015, J CELL MOL MED, V19, P1569, DOI 10.1111/jcmm.12531; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Moscat J, 2016, CELL, V167, P606, DOI 10.1016/j.cell.2016.09.030; Nakamura N, 2005, MOL BIOL CELL, V16, P1696, DOI 10.1091/mbc.E04-03-0216; Nishimura T, 2017, EMBO J, V36, P1719, DOI 10.15252/embj.201695189; Oakes SA, 2017, AM J PHYSIOL-CELL PH, V312, pC93, DOI 10.1152/ajpcell.00266.2016; Pytel D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006518; Rani S, 2017, MOL CELLS, V40, P66, DOI 10.14348/molcells.2017.2259; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rozpedek W, 2016, CURR MOL MED, V16, P533, DOI 10.2174/1566524016666160523143937; Schlafli AM, 2016, ONCOTARGET, V7, P39544, DOI 10.18632/oncotarget.9647; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Tameire F, 2015, SEMIN CANCER BIOL, V33, P3, DOI 10.1016/j.semcancer.2015.04.002; Wu HM, 2014, HUM PATHOL, V45, P1936, DOI 10.1016/j.humpath.2014.04.023; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xia D, 2016, AUTOPHAGY, V12, P1614, DOI 10.1080/15548627.2016.1192752; Xie YX, 2016, SCI REP-UK, V6, DOI 10.1038/srep38832; Xue Z, 2011, J BIOL CHEM, V286, P30859, DOI 10.1074/jbc.M111.273714; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200; Zheng HC, 2008, HUM PATHOL, V39, P1042, DOI 10.1016/j.humpath.2007.11.009	41	0	0	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	JUL	2017	8								e2957	10.1038/cddis.2017.347				11	Cell Biology	Cell Biology	FC5GR	WOS:000406870400046	28749466	gold			2018-01-05	
J	McGee, LJ; Jiang, AL; Lan, Y				McGee, Lynessa J.; Jiang, Alex L.; Lan, Yu			Golga5 is dispensable for mouse embryonic development and postnatal survival	GENESIS			English	Article						cleft palate; CRISPR; golgi; golgb1; golgin-84; mouse	MEMBRANE-PROTEIN; RIBBON FORMATION; SONIC-HEDGEHOG; GOLGIN-84; GMAP-210; GM130; GENE; MICE; MSX1; OSR2	Golgins are a family of coiled-coil proteins located at the cytoplasmic surface of the Golgi apparatus and have been implicated in maintaining Golgi structural integrity through acting as tethering factors for retrograde vesicle transport. Whereas knockdown of several individual golgins in cultured cells caused Golgi fragmentation and disruption of vesicle trafficking, analysis of mutant mouse models lacking individual golgins have discovered tissue-specific developmental functions. Recently, homozygous loss of function of GOLGA2, of which previous in vitro studies suggested an essential role in maintenance of Golgi structure and in mitosis, has been associated with a neuromuscular disorder in human patients, which highlights the need for understanding the developmental roles of the golgins in vivo. We report here generation of Golga5-deficient mice using CRISPR/Cas9-mediated genome editing. Although knockdown studies in cultured cells have implicated Golga5 in maintenance of Golgi organization, we show that Golga5 is not required for mouse embryonic development, postnatal survival, or fertility. Moreover, whereas Golga5 is structurally closely related to Golgb1, we show that inactivation of Golga5 does not enhance the severity of developmental defects in Golgb1-deficient mice. The Golga5-deficient mice enable further investigation of the roles and functional specificity of golgins in development and diseases.	[McGee, Lynessa J.; Jiang, Alex L.; Lan, Yu] Cincinnati Childrens Hosp Med Ctr, Div Plast Surg, 3333 Burnet Ave,MLC 7007, Cincinnati, OH 45229 USA; [Lan, Yu] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, 3333 Burnet Ave,MLC 7007, Cincinnati, OH 45229 USA	Lan, Y (reprint author), Cincinnati Childrens Hosp Med Ctr, Div Plast Surg, 3333 Burnet Ave,MLC 7007, Cincinnati, OH 45229 USA.	Yu.Lan@cchmc.org			NIH [R03 DE023864]	Grant Support: NIH R03 DE023864	Bascom RA, 1999, J BIOL CHEM, V274, P2953, DOI 10.1074/jbc.274.5.2953                                                          ; Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Follit JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000315; Gillingham AK, 2016, TRENDS CELL BIOL, V26, P399, DOI 10.1016/j.tcb.2016.02.005; Han F., CELL DEATH DIS, V8, pe2532; Katayama K, 2011, BONE, V49, P1027, DOI 10.1016/j.bone.2011.08.001; Lan Y, 2001, MECH DEVELOP, V107, P175, DOI 10.1016/S0925-4773(01)00457-9; Lan Y, 2016, DEVELOPMENT, V143, P2344, DOI 10.1242/dev.134577; Lan Y, 2009, DEVELOPMENT, V136, P1387, DOI 10.1242/dev.028167; Liu CY, 2017, P NATL ACAD SCI USA, V114, P346, DOI 10.1073/pnas.1608576114; Liu H, 2013, P NATL ACAD SCI USA, V110, P18555, DOI 10.1073/pnas.1306495110; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nozawa K, 2005, AUTOIMMUN REV, V4, P35, DOI 10.1016/j.autrev.2004.06.002; Ramirez IBR, 2009, SEMIN CELL DEV BIOL, V20, P770, DOI 10.1016/j.semcdb.2009.03.011; Rios RM, 2004, CELL, V118, P323; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Smits P, 2010, NEW ENGL J MED, V362, P206, DOI 10.1056/NEJMoa0900158; Sutterlin C, 2010, J CELL BIOL, V188, P621, DOI 10.1083/jcb.200910001; Witkos Tomasz M, 2015, Front Cell Dev Biol, V3, P86, DOI 10.3389/fcell.2015.00086; Wong M, 2017, BMC BIOL, V15, DOI 10.1186/s12915-016-0345-3; Wong M, 2014, SCIENCE, V346, P601, DOI 10.1126/science.1256898; Xu JY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005769; Zhang Xiaoyan, 2015, Front Cell Dev Biol, V3, P84, DOI 10.3389/fcell.2015.00084; Zhang YD, 1999, DEV DYNAM, V215, P45, DOI 10.1002/(SICI)1097-0177(199905)215:1<45::AID-DVDY5>3.3.CO;2-X; Zhou J, 2011, DEV BIOL, V353, P344, DOI 10.1016/j.ydbio.2011.03.012	27	1	1	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-954X	1526-968X		GENESIS	Genesis	JUL	2017	55	7							e23039	10.1002/dvg.23039				8	Developmental Biology; Genetics & Heredity	Developmental Biology; Genetics & Heredity	FC8FI	WOS:000407076800004					2018-01-05	
J	Labiak, PH; Karol, KG				Labiak, Paulo H.; Karol, Kenneth G.			Plastome sequences of an ancient fern lineage reveal remarkable changes in gene content and architecture	AMERICAN JOURNAL OF BOTANY			English	Article						ctinostachys; Chloroplast genome; ndh genes; phylogenomics; plastome evolution; RNA editing; Schizaea; Schizaeaceae	COMPLETE CHLOROPLAST GENOME; ADIANTUM-CAPILLUS-VENERIS; C-TO-U; ANEMIA SCHIZAEACEAE; CUSCUTA CONVOLVULACEAE; LYGODIUM-JAPONICUM; INVERTED REPEAT; NUCLEAR GENES; LAND PLANTS; INTRON LOSS	PREMISE OF THE STUDY: Comparative analyses of plastid genomes have suggested that gene order and content are relatively stable across the main groups of land plants, with significant changes rarely reported. We examine plastome organization and RNA editing in ferns and report changes that add valuable information on plastome evolution in land plants. METHODS: Using next-generation sequencing methods, we fully sequenced plastomes from three species of Schizaeaceae, and compared their plastomes with other groups of land plants to study changes in gene composition, plastome architecture, and putative RNA editing sites. We also performed maximum likelihood and Bayesian inference phylogenetic analyses using 46 plastid-encoded genes, including 26 ferns, two gymnosperms, and five angiosperms. KEY RESULTS: Within Schizaeaceae, plastomes were similar to each other in gene content and architecture. Striking changes compared with other ferns include the complete loss of ndh genes and reduction of the small single copy. Putative RNA editing was identified in all three plastomes, a characteristic that is shared with other fern groups. The monophyly of Schizaeales and Schizaeaceae was confirmed. CONCLUSIONS: The plastomes of Schizaea are the smallest reported for a fern so far. The loss of the ndh gene suite is associated with the reduction of the small single copy, instead of the inverted repeat as noted for other groups of plants. Putative C-to-U and U-to-C transitions were observed in several instances in the three plastomes, suggesting that posttranscriptional modification of RNA is likely a common phenomenon in this clade as well.	[Labiak, Paulo H.] Univ Fed Parana, Dept Bot, Caixa Postal 19031, BR-81531980 Curitiba, PR, Brazil; [Labiak, Paulo H.; Karol, Kenneth G.] New York Bot Garden, Lewis B & Dorothy Cullman Program Mol Systemat, Bronx, NY 10458 USA	Labiak, PH (reprint author), Univ Fed Parana, Dept Bot, Caixa Postal 19031, BR-81531980 Curitiba, PR, Brazil.; Labiak, PH (reprint author), New York Bot Garden, Lewis B & Dorothy Cullman Program Mol Systemat, Bronx, NY 10458 USA.	plabiak@ufpr.br			Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [304835/2013-7, 232662/2014-2]; National Science Foundation [DEB-1020660, DEB-1036466]	The authors thank the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (304835/2013-7 and 232662/2014-2) for a grant to P.H.L., and the National Science Foundation (DEB-1020660 and DEB-1036466) for a grant to K.G.K. The authors thank J. D. Hall, J. T. Mickel, and R. C. Moran for helpful discussions, and P. O. Lewis, K. Fucikova, S. Neupane, and L. A. Lewis for sharing scripts and invaluable discussions. We also thank two reviewers for improving the manuscript. Phylogenetic analyses were performed through the Biotechnology and Bioservices Center of the University of Connecticut.	Aya K, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu184; BIERHORST DW, 1975, AM J BOT, V62, P319, DOI 10.2307/2442086; Braukmann T, 2013, J EXP BOT, V64, P977, DOI 10.1093/jxb/ers391; BROWNLIE G., 1965, PACIFIC SCI, V19, P493; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; DETTMANN ME, 1992, ALCHERINGA, V16, P269, DOI 10.1080/03115519208619111                                                       ; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fucikova K, 2016, MOL PHYLOGENET EVOL, V98, P176, DOI 10.1016/j.ympev.2016.01.022; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; Gao L, 2013, GENOME BIOL EVOL, V5, P1403, DOI 10.1093/gbe/evt099; Gao L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-130; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Graham SW, 2017, NEW PHYTOL, V214, P48, DOI 10.1111/nph.14398; Grewe F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-8; Guo WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117075; Hecht J, 2011, GENOME BIOL EVOL, V3, P344, DOI 10.1093/gbe/evr027; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Karol KG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-321; Kim HT, 2014, MOL CELLS, V37, P372, DOI 10.14348/molcells.2014.2296; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; Kugita M, 2003, NUCLEIC ACIDS RES, V31, P2417, DOI 10.1093/nar/gkg327; Kuo LY, 2011, MOL PHYLOGENET EVOL, V59, P556, DOI 10.1016/j.ympev.2011.03.010; Labiak PH, 2015, TAXON, V64, P1141, DOI 10.12705/646.3                                                                  ; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lehtonen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024851; Lenz H, 2013, BIOINFORM BIOL INSIG, V7, P1, DOI 10.4137/BBI.S11059; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058747; Lin CP, 2010, GENOME BIOL EVOL, V2, P504, DOI 10.1093/gbe/evq036; LOVIS JD, 1958, NATURE, V181, P1085, DOI 10.1038/1811085a0                                                               ; Lu JM, 2015, J SYST EVOL, V53, P448, DOI 10.1111/jse.12180; Luo JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108185; Mccoy SR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-130; McNeal JR, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-55; Oldenkott B, 2014, RNA, V20, P1499, DOI 10.1261/rna.045575.114; PALMER JD, 1987, CURR GENET, V11, P275, DOI 10.1007/BF00355401; Peredo EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068591; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; Pryer KM, 2001, NATURE, V409, P618, DOI 10.1038/35054555; Qiu YL, 2007, INT J PLANT SCI, V168, P691, DOI 10.1086/513474; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Rai HS, 2010, AM J BOT, V97, P1444, DOI 10.3732/ajb.0900305; RAMBAUT A., 2013, TRACER VERSION 1 6; Rice A, 2015, NEW PHYTOL, V206, P19, DOI 10.1111/nph.13191; Rothfels CJ, 2015, AM J BOT, V102, P1089, DOI 10.3732/ajb.1500089; Ruhlman TA, 2014, METHODS MOL BIOL, V1132, P3, DOI 10.1007/978-1-62703-995-6_1; Sanderson MJ, 2015, AM J BOT, V102, P1115, DOI 10.3732/ajb.1500184; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schelkunov MI, 2015, GENOME BIOL EVOL, V7, P1179, DOI 10.1093/gbe/evv019; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903                                                                ; Schuettpelz E, 2006, TAXON, V55, P897, DOI 10.2307/25065684                                                                ; SKOG JE, 1992, REV PALAEOBOT PALYNO, V70, P279, DOI 10.1016/0034-6667(92)90068-R; Skog JE, 2002, AM FERN J, V92, P119, DOI 10.1640/0002-8444(2002)092[0119:ASFTSO]2.0.CO;2                                 ; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646                                                                ; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swatzell LJ, 1996, INT J PLANT SCI, V157, P53, DOI 10.1086/297320; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Thiede J, 2007, BIOCHEM SYST ECOL, V35, P372, DOI 10.1016/j.bse.2006.12.010; Van Konijnenburg J. H. A., 1991, POLLEN SPORES PATTER; WAGNER W. H., 1963, AMER FERN JOUR, V53, P1, DOI 10.2307/1546805; Walker T.G., 1985, B BRIT MUS NAT HIST, V13, P149; Wallace RS, 1996, CURR GENET, V29, P275; Wicke S, 2013, PLANT CELL, V25, P3711, DOI 10.1105/tpc.113.113373; Wicke S, 2014, MOL BIOL EVOL, V31, P529, DOI 10.1093/molbev/mst261; Wickett NJ, 2008, MOL BIOL EVOL, V25, P393, DOI 10.1093/molbev/msm267; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Wikstrom N, 2005, MOL PHYLOGENET EVOL, V36, P484, DOI 10.1016/j.ympev.2005.04.008; Wikstrom N, 2002, REV PALAEOBOT PALYNO, V119, P35, DOI 10.1016/S0034-6667(01)00128-2; Wilgenbusch J. C., 2004, AWTY SYSTEM GRAPHICA; Wolf PG, 2015, GENOME BIOL EVOL, V7, P2533, DOI 10.1093/gbe/evv163; Wolf PG, 2011, PLANT MOL BIOL, V76, P251, DOI 10.1007/s11103-010-9706-4; Wolf PG, 2010, GENOME, V53, P731, DOI [10.1139/g10-061, 10.1139/G10-061]; Wolf PG, 2005, GENE, V350, P117, DOI 10.1016/j.gene.2005.01.018; Wolf PG, 2004, GENE, V339, P89, DOI 10.1016/j.gene.2004.06.018; Wolf PG, 2003, DNA RES, V10, P59, DOI 10.1093/dnares/10.2.59; Wu F. H., 2011, GENOME BIOL EVOL, V3, P309; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang JB, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-84; Zhong BJ, 2014, GENOME BIOL EVOL, V6, P1166, DOI 10.1093/gbe/evu087	81	0	0	5	5	BOTANICAL SOC AMER INC	ST LOUIS	PO BOX 299, ST LOUIS, MO 63166-0299 USA	0002-9122	1537-2197		AM J BOT	Am. J. Bot.	JUL	2017	104	7					1008	1018		10.3732/ajb.1700135				11	Plant Sciences	Plant Sciences	FC2TR	WOS:000406691800007					2018-01-05	
J	Kim, SW; Lee, JH; Park, BC; Park, TS				Kim, Si Won; Lee, Jeong Hyo; Park, Byung-Chul; Park, Tae Sub			Myotube differentiation in clustered regularly interspaced short palindromic repeat/Cas9-mediated MyoD knockout quail myoblast cells	ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES			English	Article						Myoblast; CRISPR-Cas9; Knockout; Muscle Differentiation; MyoD	PRIMORDIAL GERM-CELLS; ONE-STEP GENERATION; GENETIC-MODIFICATION; CHICKENS; MYOGENESIS; PROTEINS; MUSCLE; INACTIVATION; PIGGYBAC; REVEALS	Objective: In the livestock industry, the regulatory mechanisms of muscle proliferation and differentiation can be applied to improve traits such as growth and meat production. We investigated the regulatory pathway of MyoD and its role in muscle differentiation in quail myoblast cells. Methods: The MyoD gene was mutated by the clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 technology and single cell-derived MyoD mutant sublines were identified to investigate the global regulatory mechanism responsible for muscle differentiation. Results: The mutation efficiency was 73.3% in the mixed population, and from this population we were able to establish two QM7 MyoD knockout subline (MyoD KO QM7#4) through single cell pick-up and expansion. In the undifferentiated condition, paired box 7 expression in MyoD KO QM7#4 cells was not significantly different from regular QM7 (rQM7) cells. During differentiation, however, myotube formation was dramatically repressed in MyoD KO QM7#4 cells. Moreover, myogenic differentiation-specific transcripts and proteins were not expressed in MyoD KO QM7#4 cells even after an extended differentiation period. These results indicate that MyoD is critical for muscle differentiation. Furthermore, we analyzed the global regulatory interactions by RNA sequencing during muscle differentiation. Conclusion: With CRISPR/Cas9-mediated genomic editing, single cell-derived sublines with a specific knockout gene can be adapted to various aspects of basic research as well as in functional genomics studies.	[Kim, Si Won; Lee, Jeong Hyo; Park, Byung-Chul; Park, Tae Sub] Seoul Natl Univ, Grad Sch Int Agr Technol, Pyeongchang 25354, South Korea; [Kim, Si Won; Lee, Jeong Hyo; Park, Byung-Chul; Park, Tae Sub] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang 25354, South Korea	Park, BC; Park, TS (reprint author), Seoul Natl Univ, Grad Sch Int Agr Technol, Pyeongchang 25354, South Korea.; Park, BC; Park, TS (reprint author), Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang 25354, South Korea.	bcpark@snu.ac.kr; taesubpark@snu.ac.kr			Cooperative Research Program for Agriculture Science & Technology Development Rural Development Administration, Republic of Korea [PJ01111401]; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Agri-Bio Industry Technology Development Program - Ministry of Agriculture, Food and Rural Affairs (MAFRA) [316005-5]	This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ01111401)" Rural Development Administration, Republic of Korea. This work was also supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Agri-Bio Industry Technology Development Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (316005-5).	Al-Musawi SL, 2011, DIFFERENTIATION, V82, P127, DOI 10.1016/j.diff.2011.05.012; Arnold HH, 1996, INT J DEV BIOL, V40, P345; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dimitrov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154303; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868; Love J., 1994, NAT BIOTECHNOL, V12, P60; Macdonald J, 2012, P NATL ACAD SCI USA, V109, pE1466, DOI 10.1073/pnas.1118715109; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Park TS, 2012, ANN NY ACAD SCI, V1271, P104, DOI 10.1111/j.1749-6632.2012.06744.x; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V                                                    ; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; SALTER DW, 1986, POULTRY SCI, V65, P1445, DOI 10.3382/ps.0651445                                                              ; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; Shin S, 2015, AM J PHYSIOL-CELL PH, V309, pC650, DOI 10.1152/ajpcell.00187.2015; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Weber D, 2014, CURR TOP DEV BIOL, V110, P285, DOI 10.1016/B978-0-12-405943-6.00008-7	28	0	0	5	5	ASIAN-AUSTRALASIAN ASSOC ANIMAL PRODUCTION SOC	SEOUL	ROOM 708 SAMMO SPOREX, 1638-32, SEOWON-DONG, GWANAK-GU, SEOUL 151-730, SOUTH KOREA	1011-2367	1976-5517		ASIAN AUSTRAL J ANIM	Asian Australas. J. Anim. Sci.	JUL	2017	30	7					1029	1036		10.5713/ajas.16.0749				8	Agriculture, Dairy & Animal Science	Agriculture	FC3NC	WOS:000406745000018	27809462	green_published			2018-01-05	
J	Wright, G; Golubeva, V; Rix, LLR; Bemdt, N; Luo, Y; Ward, GA; Gray, JE; Schonbrunn, E; Lawrence, HR; Monteiro, ANA; Rix, U				Wright, Gabriela; Golubeva, Volha; Rix, Lily L. Remsing; Bemdt, Norbert; Luo, Yunting; Ward, Grace A.; Gray, Jhanelle E.; Schonbrunn, Ernst; Lawrence, Harshani R.; Monteiro, Alvaro N. A.; Rix, Uwe			Dual Targeting of WEE1 and PLK1 by AZD1775 Elicits Single Agent Cellular Anticancer Activity	ACS CHEMICAL BIOLOGY			English	Article							DNA-DAMAGING AGENTS; POLO-LIKE KINASES; CHEMICAL PROTEOMICS; INHIBITOR AZD1775; AURORA KINASES; CANCER-THERAPY; SOMATIC WEE1; SOLID TUMORS; PHASE-I; CELLS	Inhibition of the WEE1 tyrosine kinase enhances anticancer chemotherapy efficacy. Accordingly, the WEE1 inhibitor AZD1775 (previously MK-1775) is currently under evaluation in clinical trials for cancer in combination with Chemotherapy. AZD1775 has been reported to display high selectivity and is therefore used in many studies as a probe to interrogate WEE1 biology. However, AZD1775 also exhibits anticancer activity as a single agent although the underlying mechanism not fully understood. Using a chemical proteomics approach, we here describe a proteome-wide survey of AZD1775 targets in lung cancer cells and identify several previously unknown targets in addition to WEE1. In particular, we observed polo-like kinase 1 (PLK1) as a new target of AZD1775. Importantly, in vitro kinase assays showed PLK1 and WEE1 to be inhibited by AZD1775 with similar potency. Subsequent loss-of-function experiments using RNAi for WEE1 and PLK1 suggested that targeting PLK1 enhances the pro-apoptotic and antiproliferative effects observed with WEE1 knockdown. Combination of RNAi with AZD1775 treatment suggested WEE1 and PLK1 to be the most relevant targets for mediating AZD1775's anticancer effects. Furthermore, disruption of WEE1 by CRISPR-Cas9 sensitized H322 lung cancer cells to AZD1775 to a similar extent as the potent PLK1 inhibitor BI-2536 suggesting a complex crosstalk between PLK1 and WEE1. In summary, we show that AZD1775 is a potent dual WEE1 and PLK1 inhibitor, which limits its use as a specific molecular probe for WEE1. However, PLK1 inhibition makes important contributions to the single agent mechanism of action of AZD1775 and enhances its anticancer effects.	[Wright, Gabriela; Rix, Lily L. Remsing; Bemdt, Norbert; Ward, Grace A.; Schonbrunn, Ernst; Lawrence, Harshani R.; Rix, Uwe] H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, Tampa, FL 33612 USA; [Monteiro, Alvaro N. A.] H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol, Tampa, FL 33612 USA; [Luo, Yunting; Schonbrunn, Ernst; Lawrence, Harshani R.] H Lee Moffitt Canc Ctr & Res Inst, Chem Biol Core, Tampa, FL 33612 USA; [Ward, Grace A.] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33620 USA; [Gray, Jhanelle E.] H Lee Moffitt Canc Ctr & Res Inst, Thorac Oncol Dept, Tampa, FL 33612 USA	Rix, U (reprint author), H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, Tampa, FL 33612 USA.; Monteiro, ANA (reprint author), H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol, Tampa, FL 33612 USA.	Alvaro.Monteiro@moffitt.org; Uwe.Rix@moffitt.org			National Cancer Institute [R01 CA181746, P30-CA076292]; H. Lee Moffitt Cancer Center and Research Institute; Moffitt Lung Cancer Center of Excellence	This work was supported by the National Cancer Institute R01 CA181746 (to U.R.), by the H. Lee Moffitt Cancer Center and Research Institute as a Team Science Grant, and the Moffitt Lung Cancer Center of Excellence. We furthermore acknowledge the Moffitt Chemical Biology (Chemistry Unit), Proteomics and Molecular Genomics Core Facilities, which are supported by the National Cancer Institute (Award No. P30-CA076292) as a Cancer Center Support Grant.	Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Brehmer D, 2005, CANCER RES, V65, P379; Bridges KA, 2016, ONCOTARGET, V7, P71660, DOI 10.18632/oncotarget.12311; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Do K, 2015, J CLIN ONCOL, V33, P3409, DOI 10.1200/JCO.2014.60.4009; Do K, 2013, CELL CYCLE, V12, P3159, DOI 10.4161/cc.26062; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Guertin AD, 2013, MOL CANCER THER, V12, P1442, DOI 10.1158/1535-7163.MCT-13-0025; Gutteridge REA, 2016, MOL CANCER THER, V15, P1427, DOI 10.1158/1535-7163.MCT-15-0897; Hirai H, 2010, CANCER BIOL THER, V9, P514, DOI 10.4161/cbt.9.7.11115                                                           ; Hirai H, 2009, MOL CANCER THER, V8, P2992, DOI 10.1158/1535-7163.MCT-09-0463; Jhuraney A, 2016, MOL CANCER THER, V15, P1669, DOI 10.1158/1535-7163.MCT-15-0182; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Knezevic CE, 2016, CELL CHEM BIOL, V23, P1490, DOI 10.1016/j.chembiol.2016.10.011; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Kreahling JM, 2012, MOL CANCER THER, V11, P174, DOI 10.1158/1535-7163.MCT-11-0529; Kuenzi BM, 2016, J PROTEOME RES, V15, P4747, DOI 10.1021/acs.jproteome.6b00660; Leijen S, 2016, J CLIN ONCOL, V34, P4371, DOI 10.1200/JCO.2016.67.5991; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Lera RF, 2016, NAT CHEM BIOL, V12, P411, DOI 10.1038/nchembio.2060; Lescarbeau RS, 2016, MOL CANCER THER, V15, P1332, DOI [10.1158/1535-7163.MCT-15-0692-T, 10.1158/1535-7163.MCT-15-0692]; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Matheson CJ, 2016, ACS CHEM BIOL, V11, P921, DOI [10.1021/acschembio5b00725, 10.1021/acschembio.5b00725]; Moser R, 2014, CLIN CANCER RES, V20, P4274, DOI 10.1158/1078-0432.CCR-13-2858; Oppermann FS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.012351; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Rajeshkumar NV, 2011, CLIN CANCER RES, V17, P2799, DOI 10.1158/1078-0432.CCR-10-2580; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Sillaber C, 2009, EUR J CLIN INVEST, V39, P1098, DOI 10.1111/j.1365-2362.2009.02206.x; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Sumi NJ, 2015, ACS CHEM BIOL, V10, P2680, DOI 10.1021/acschembio.5b00368; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Wachowicz P, 2016, BIOESSAYS, V38, pS96, DOI 10.1002/bies.201670908; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Winter GE, 2012, NAT CHEM BIOL, V8, P905, DOI [10.1038/NCHEMBIO.1085, 10.1038/nchembio.1085]; Winter GE, 2011, MOL CANCER THER, V10, P1846, DOI 10.1158/1535-7163.MCT-11-0100; Zybailov BL, 2007, MOL BIOSYST, V3, P354, DOI 10.1039/b701483j	44	1	1	6	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1554-8929	1554-8937		ACS CHEM BIOL	ACS Chem. Biol.	JUL	2017	12	7					1883	1892		10.1021/acschembio.7b00147				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FB7YQ	WOS:000406356300021	28557434				2018-01-05	
J	Rainey, MD; Quachthithu, H; Gaboriau, D; Santocanale, C				Rainey, Michael D.; Quachthithu, Huong; Gaboriau, David; Santocanale, Corrado			DNA Replication Dynamics and Cellular Responses to ATP Competitive CDC7 Kinase Inhibitors	ACS CHEMICAL BIOLOGY			English	Article							PROTEIN PHOSPHATASE 1; CYCLIN-DEPENDENT KINASES; S-PHASE; HUMAN-CELLS; CHEMICAL GENETICS; ORIGIN ACTIVATION; DORMANT ORIGINS; PHOSPHORYLATION; CHECKPOINT; STRESS	The CDC7 kinase, by phosphorylating the MCM DNA helicase, is a key switch for DNA replication initiation. ATP competitive CDC7 inhibitors are being developed as potential anticancer agents; however how human cells respond to the selective pharmacological inhibition of this kinase is controversial and not understood. Here we have characterized the mode of action of the two widely used CDC7 inhibitors, PHA-767491 and XL-413, which have become important tool compounds to explore the kinase's cellular functions. We have used a chemical genetics approach to further characterize pharmacological CDC7 inhibition and CRISPR/CAS9 technology to assess the requirement for kinase activity for cell proliferation. We show that, in human breast cells, CDC7 is essential and that CDC7 kinase activity is formally required for proliferation. However, full and sustained inhibition of the kinase, which is required to block the cell-cycle progression with ATP competitor compounds, is problematic to achieve. We establish that MCM2 phosphorylation is highly sensitive to CDC7 inhibition and, as a biomarker, it lacks in dynamic range since it is easily lost at concentrations of inhibitors that only mildly affect DNA synthesis. Furthermore, we find that the cellular effects of selective CDC7 inhibitors can be altered by the concomitant inhibition of cell-cycle and transcriptional CDKs. This work shows that DNA replication and cell proliferation can occur with reduced CDC7 activity for at least 5 days and that the bulk of DNA synthesis is not tightly coupled to MCM2 phosphorylation end provides guidance for the development of next generation CDC7 inhibitors.	[Rainey, Michael D.; Quachthithu, Huong; Gaboriau, David; Santocanale, Corrado] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway H91 TK33, Ireland; [Gaboriau, David] Imperial Coll London, Natl Heart & Lung Inst, FILM, London SW7 2AZ, England	Santocanale, C (reprint author), Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway H91 TK33, Ireland.	corrado.santocanale@nuigalway.ie	Gaboriau, David/O-3197-2017	Gaboriau, David/0000-0003-4047-6487; Rainey, Michael/0000-0001-9777-873X; Santocanale, Corrado/0000-0003-1337-5656	Breast Cancer Now [2015MayPR506]; Molecular Medicine Ireland fellowship	This work was supported by Breast Cancer Now [2015MayPR506] and H.Q., by a Molecular Medicine Ireland fellowship.	Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; Alver RC, 2017, CELL REP, V18, P2508, DOI 10.1016/j.celrep.2017.02.042; Alver RC, 2014, DNA REPAIR, V19, P182, DOI 10.1016/j.dnarep.2014.03.012; Barbero J. L., 2003, NAT GENET, V35, P25; Bishop AC, 2000, NATURE, V407, P395; Conti C, 2007, MOL BIOL CELL, V18, P3059, DOI 10.1091/mbc.E06-08-0689; Dave A, 2014, CELL REP, V7, P53, DOI 10.1016/j.celrep.2014.02.019; FitzGerald J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098891; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gribble FM, 2000, J BIOL CHEM, V275, P30046, DOI 10.1074/jbc.M001010200; Hiraga S, 2017, EMBO REP, V18, P403, DOI 10.15252/embr.201641983; Hiraga S, 2014, GENE DEV, V28, P372, DOI 10.1101/gad.231258.113; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Hochegger H, 2007, J CELL BIOL, V178, P257, DOI 10.1083/jcb.200702034; Hughes S, 2012, NAT STRUCT MOL BIOL, V19, P1101, DOI 10.1038/nsmb.2404; Kim JM, 2008, ONCOGENE, V27, P3475, DOI 10.1038/sj.onc.1210994; Koltun ES, 2012, BIOORG MED CHEM LETT, V22, P3727, DOI 10.1016/j.bmcl.2012.04.024; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Liachko NF, 2013, ANN NEUROL, V74, P39, DOI 10.1002/ana.23870; Lopez MS, 2013, J AM CHEM SOC, V135, P18153, DOI 10.1021/ja408704u; Marella NV, 2009, CANCER RES, V69, P5946, DOI 10.1158/0008-5472.CAN-09-0420; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; McGarry E, 2016, CANCER RES, V76, P2384, DOI 10.1158/0008-5472.CAN-15-2890; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Montagnoli A, 2004, CANCER RES, V64, P7110, DOI 10.1158/0008-5472.CAN-04-1547; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Natoni A, 2011, MOL CANCER THER, V10, P1624, DOI 10.1158/1535-7163.MCT-10-1119; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Rainey MD, 2013, CELL CYCLE, V12, P1560, DOI 10.4161/cc.24675; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Rodriguez-Acebes S, 2010, AM J PATHOL, V177, P2034, DOI 10.2353/ajpath.2010.100421; Sasi NK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113300; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; SOULE HD, 1990, CANCER RES, V50, P6075; Suzuki T, 2012, J BIOL CHEM, V287, P40256, DOI 10.1074/jbc.M112.353805; Tudzarova S, 2010, EMBO J, V29, P3381, DOI 10.1038/emboj.2010.201; Poh WT, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130138; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Wu KZL, 2016, NUCLEIC ACIDS RES, V44, P8786, DOI 10.1093/nar/gkw626; Yamada M, 2014, CELL CYCLE, V13, P1859, DOI 10.4161/cc.29251; Yamada M, 2013, GENE DEV, V27, P2459, DOI 10.1101/gad.224568.113; Yu DS, 2010, EMBO REP, V11, P876, DOI 10.1038/embor.2010.153; Yung-Chi C., 1973, BIOCHEM PHARMACOL, V22, P3099; Zhang C, 2013, ACS CHEM BIOL, V8, P1931, DOI 10.1021/cb400376p	46	0	0	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1554-8929	1554-8937		ACS CHEM BIOL	ACS Chem. Biol.	JUL	2017	12	7					1893	1902		10.1021/acschembio.7b00117				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FB7YQ	WOS:000406356300022	28560864				2018-01-05	
J	Schneider, C; Bronstein, L; Diemer, J; Koeppl, H; Suess, B				Schneider, Christopher; Bronstein, Leo; Diemer, Jascha; Koeppl, Heinz; Suess, Beatrix			ROC'n'Ribo: Characterizing a Riboswitching Expression System by Modeling Single-Cell Data	ACS SYNTHETIC BIOLOGY			English	Article							GENE-EXPRESSION; SYNTHETIC BIOLOGY; SACCHAROMYCES-CEREVISIAE; RNA APTAMERS; DESIGN; YEAST; PROTEIN; CRISPR; TRANSLATION; INFORMATION	RNA-engineered systems offer simple and versatile control over gene expression in many organisms. In particular, the design and implementation of riboswitches presents a unique opportunity to manipulate any reporter device in cis, executing tight temporal and spatial control at low metabolic costs. Assembled to higher order genetic circuits, such riboswitch-regulated devices may efficiently process logical operations. Here, we propose a hierarchical stochastic modeling approach to characterize an in silico repressor gate based on neomycin and tetracycline-sensitive riboswitches. The model was calibrated on rich, transient in vivo single-cell data to account for cell-to-cell variability. To capture the effect of this variability on gate performance we employed the well-known ROC-analysis and derived a novel performance indicator for logic gates. Introduction of such a performance measure is necessary, since we aimed to assess the correct functionality of the gate at the single-cell level-a prerequisite for its further adaption to a genetic circuitry. Our results may be applied to other genetic devices to analyze their efficiency and ensure their correct performance in the light of cell-to-cell variability.	[Schneider, Christopher; Suess, Beatrix] Tech Univ Darmstadt, Dept Biol, Synthet Genet Circuits, Schnittspahnstr 10, D-64287 Darmstadt, Germany; [Bronstein, Leo; Diemer, Jascha; Koeppl, Heinz] Tech Univ Darmstadt, Dept Elect Engn & Informat Technol, Bioinspired Commun, Rundeturmstr 12, D-64283 Darmstadt, Germany	Suess, B (reprint author), Tech Univ Darmstadt, Dept Biol, Synthet Genet Circuits, Schnittspahnstr 10, D-64287 Darmstadt, Germany.; Koeppl, H (reprint author), Tech Univ Darmstadt, Dept Elect Engn & Informat Technol, Bioinspired Commun, Rundeturmstr 12, D-64283 Darmstadt, Germany.	heinz.koeppl@bcs.tu-darmstadt.de; bsuess@bio.tu-darmstadt.de			Landesoffensive fiir wissenschaftliche Exzellenz (LOEWE; initiative to increase research excellence in the state of Hessen, Germany) as part of the LOEWE Schwerpunkt CompuGene; European Union (FP7 Promys); DFG [SFB902]	This work was supported by the Landesoffensive fiir wissenschaftliche Exzellenz (LOEWE; initiative to increase research excellence in the state of Hessen, Germany) as part of the LOEWE Schwerpunkt CompuGene, the European Union (FP7 Promys) and DFG SFB902 A2.	Auslander S, 2014, NAT METHODS, V11, P1154, DOI [10.1038/NMETH.3136, 10.1038/nmeth.3136]; Beisel CL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000363; Berens C, 2015, BIOTECHNOL J, V10, P246, DOI 10.1002/biot.201300498; Borujeni AE, 2016, NUCLEIC ACIDS RES, V44, P1, DOI 10.1093/nar/gkv1289; Bowsher CG, 2012, P NATL ACAD SCI USA, V109, pE1320, DOI 10.1073/pnas.1119407109; Breaker R. R., 2012, BIOL, V4; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/nmeth.2926, 10.1038/NMETH.2926]; Callura JM, 2012, P NATL ACAD SCI USA, V109, P5850, DOI 10.1073/pnas.1203808109; Cameron DE, 2014, NAT REV MICROBIOL, V12, P381, DOI 10.1038/nrmicro3239; Cardinale S, 2012, BIOTECHNOL J, V7, P856, DOI 10.1002/biot.201200085; Chappell J, 2015, CURR OPIN CHEM BIOL, V28, P47, DOI 10.1016/j.cbpa.2015.05.018; Chin JW, 2014, ANNU REV BIOCHEM, V83, P379, DOI 10.1146/annurev-biochem-060713-035737; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Crane MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100042; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dvir S, 2013, P NATL ACAD SCI USA, V110, pE2792, DOI 10.1073/pnas.1222534110; Etzel M, 2017, BIOCHEMISTRY-US, V56, P1181, DOI 10.1021/acs.biochem.6b01218; Felletti M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12834; Finkenstadt B, 2013, ANN APPL STAT, V7, P1960, DOI 10.1214/13-AOAS669; Frohlich F, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005030; Grate D, 2001, BIOORGAN MED CHEM, V9, P2565, DOI 10.1016/S0968-0896(01)00031-1                                                   ; Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002; Groher F, 2014, BBA-GENE REGUL MECH, V1839, P964, DOI 10.1016/j.bbagrm.2014.05.005; Hanson S, 2003, MOL MICROBIOL, V49, P1627, DOI 10.1046/j.1365-2958.2003.03656.x; Jakociunas T, 2015, ACS SYNTH BIOL, V4, P1226, DOI 10.1021/acssynbio.5b00007; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kay S. M., 1998, FUNDAMENTALS STAT SI; Klauser B, 2015, ACS SYNTH BIOL, V4, P516, DOI 10.1021/sb500062p; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Lee JW, 2016, MOL CELL, V63, P329, DOI 10.1016/j.molcel.2016.06.006; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067902; Liang JC, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks636; Macmillan N. A., 2004, DETECTION THEORY USE; McKeague M, 2016, NUCLEIC ACIDS RES, V44, P2987, DOI 10.1093/nar/gkw151; Mclsaac R. S., 2011, MOL BIOL CELL, V22, P4447; Munsky B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.75; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Nielsen AAK, 2016, SCIENCE, V352, DOI 10.1126/science.aac7341; Peselis A, 2014, BBA-GENE REGUL MECH, V1839, P908, DOI 10.1016/j.bbagrm.2014.02.012; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Redden H, 2015, FEMS YEAST RES, V15, DOI 10.1111/1567-1364.12188; Schneider C, 2016, METHODS, V97, P44, DOI 10.1016/j.ymeth.2015.12.001; Scholz O, 2000, EUR J BIOCHEM, V267, P1565, DOI 10.1046/j.1432-1327.2000.01170.x; Serganov A, 2012, CURR OPIN STRUC BIOL, V22, P279, DOI 10.1016/j.sbi.2012.04.005; Stovicek Vratislav, 2015, Metabolic Engineering Communications, V2, P13, DOI 10.1016/j.meteno.2015.03.001; van Kampen N.G., 1992, STOCHASTIC PROCESSES; Wachsmuth M, 2013, NUCLEIC ACIDS RES, V41, P2541, DOI 10.1093/nar/gks1330; Weigand JE, 2008, RNA, V14, P89, DOI 10.1261/rna.772408; Wieland M, 2008, ANGEW CHEM INT EDIT, V47, P2604, DOI 10.1002/anie.200703700; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Wittmann A, 2012, FEBS LETT, V586, P2076, DOI 10.1016/j.febslet.2012.02.038; Zechner C, 2014, NAT METHODS, V11, P197, DOI [10.1038/NMETH.2794, 10.1038/nmeth.2794]; Zechner C, 2012, P NATL ACAD SCI USA, V109, P8340, DOI 10.1073/pnas.1200161109	58	0	0	6	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	JUL	2017	6	7					1211	1224		10.1021/acssynbio.6b00322				14	Biochemical Research Methods	Biochemistry & Molecular Biology	FB7YO	WOS:000406356100012	28591515				2018-01-05	
J	Kim, SK; Kim, H; Ahn, WC; Park, KH; Woo, EJ; Lee, DH; Lee, SG				Kim, Seong Keun; Kim, Haseong; Ahn, Woo-Chan; Park, Kwang-Hyun; Woo, Eui-Jeon; Lee, Dae-Hee; Lee, Seung-Goo			Efficient Transcriptional Gene Repression by Type V-A CRISPR-Cpf1 from Eubacterium eligens	ACS SYNTHETIC BIOLOGY			English	Article						CRISPRi; deactivated Cpf1; deactivated Cas9; Eubacterium eligens; protospacer adjacent motif Streptococcus pyogenes	RNA-GUIDED ENDONUCLEASE; MALTOSE-BINDING PROTEIN; ESCHERICHIA-COLI; CAS SYSTEM; HUMAN-CELLS; SCREENING SYSTEM; EXPRESSION; CPF1; SPECIFICITIES; INTERFERENCE	Clustered regularly interspaced short palindromic repeats interference (CRISPRi) is an emerging technology for artificial gene regulation. Type II CRISPR-Cas endonuclease Cas9 is the most widely used protein for gene regulation with CRISPRi. Here, we present type V-A CRISPR-Cas endonuclease Cpf1-based CRISPRi. We constructed an L-rhamnose-inducible CRISPRi system with DNase-deactivated Cpf1 from Eubacterium eligens (EedCpf1) and compared its performance with catalytically deactivated Cas9 from Streptococcus pyogenes (SpdCas9). In contrast to SpdCas9, EedCpf1 showed stronger gene repression when it was targeted to the template strand than when it was targeted to the nontemplate strand of the 5' untranslated region or coding DNA sequences. EedCpf1 exhibited no strand bias when targeted to the promoter, and preferentially used the 5'-TTTV-3' (V = A, G, or C) protospacer adjacent motif. Multiplex repression of the EedCpf1-based CRISPRi system was demonstrated using episomal and chromosomal gene targets. Our findings will guide an efficient EedCpf1-mediated CRISPRi genetic control	[Kim, Seong Keun; Kim, Haseong; Lee, Dae-Hee; Lee, Seung-Goo] KRIBB, Synthet Biol & Bioengn Res Ctr, Daejeon 34141, South Korea; [Kim, Seong Keun; Kim, Haseong; Lee, Dae-Hee; Lee, Seung-Goo] Univ Sci & Technol, Biosyst & Bioengn Program, Daejeon 34113, South Korea; [Ahn, Woo-Chan; Park, Kwang-Hyun; Woo, Eui-Jeon] KRIBB, Dis Target Struct Res Ctr, Daejeon 34141, South Korea; [Woo, Eui-Jeon] Univ Sci & Technol, Bioanalyt Sci Program, Daejeon 34113, South Korea	Lee, DH; Lee, SG (reprint author), KRIBB, Synthet Biol & Bioengn Res Ctr, Daejeon 34141, South Korea.; Lee, DH; Lee, SG (reprint author), Univ Sci & Technol, Biosyst & Bioengn Program, Daejeon 34113, South Korea.	dhlee@kribb.re.kr; sglee@kribb.re.kr			Korea Institute of Energy Technology Evaluation and Planning (KETEP) - Ministry of Trade, Industry and Energy (MOTE) arid C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) [20163030091540, NRF-2015M3D3A1A01064875]; Ministry of Science, ICT & Future Planning (MSIP) of the Republic of Korea; KRIBB Research Initiative Program	The authors would like to thank Dr. Victor D. Lorenzo for the kind donation of the pSEVA plasmids and members of the Synthetic Biology Laboratory in the Synthetic Biology and Bioengineering Center at KRIBB for their valuable comments and helpful discussions. This work was supported by the Korea Institute of Energy Technology Evaluation and Planning (KETEP) (Grant numbers: 20163030091540) funded by the Ministry of Trade, Industry and Energy (MOTE) arid C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) (Grant number: NRF-2015M3D3A1A01064875) funded by the Ministry of Science, ICT & Future Planning (MSIP) of the Republic of Korea. This work is also supported by the KRIBB Research Initiative Program.	Afroz T, 2014, MOL MICROBIOL, V93, P1093, DOI 10.1111/mmi.12695; BETTON JM, 1994, EMBO J, V13, P1226; BETTON JM, 1993, FEBS LETT, V325, P34, DOI 10.1016/0014-5793(93)81409-S; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Cencic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109213; Chang YZ, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0594-4; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choi SL, 2014, ACS SYNTH BIOL, V3, P163, DOI 10.1021/sb400112u; Choudhary E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7267; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cress BF, 2015, ACS SYNTH BIOL, V4, P987, DOI 10.1021/acssynbio.5b00012; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Giacalone MJ, 2006, BIOTECHNIQUES, V40, P355, DOI 10.2144/000112112; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim H, 2016, ACS SYNTH BIOL, V5, P1231, DOI 10.1021/acssynbio.5b00287; Kim HK, 2017, NAT METHODS, V14, P153, DOI [10.1038/NMETH.4104, 10.1038/nmeth.4104]; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim SK, 2016, METAB ENG, V38, P228, DOI 10.1016/j.ymben.2016.08.006; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Liu D, 2015, ACS SYNTH BIOL, V4, P132, DOI 10.1021/sb400158w; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nielsen AAK, 2016, SCIENCE, V352, DOI 10.1126/science.aac7341; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rath D, 2015, NUCLEIC ACIDS RES, V43, P237, DOI 10.1093/nar/gku1257; Rogers JK, 2016, CURR OPIN BIOTECH, V42, P84, DOI 10.1016/j.copbio.2016.03.005; Wegerer A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-2; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yoo SM, 2013, NAT PROTOC, V8, P1694, DOI 10.1038/nprot.2013.105; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	38	3	3	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	JUL	2017	6	7					1273	1282		10.1021/acssynbio.6b00368				10	Biochemical Research Methods	Biochemistry & Molecular Biology	FB7YO	WOS:000406356100018	28375596				2018-01-05	
J	Lemay, ML; Tremblay, DM; Moineau, S				Lemay, Marie-Laurence; Tremblay, Denise M.; Moineau, Sylvain			Genome Engineering of Virulent Lactococcal Phages Using CRISPR-Cas9	ACS SYNTHETIC BIOLOGY			English	Article						virulent bacteriophages; lactic acid bacteria; genome engineering; CRISPR-Cas9; homologous recombination; double-strand DNA break repair	CAS SYSTEMS; RNA; DNA; BACTERIOPHAGE; EVOLUTION; REPEATS; CLASSIFICATION; EXPRESSION; DIVERSITY; MECHANISM	Phages are biological entities found in every ecosystem. Although much has been learned about them in past decades, significant knowledge gaps remain. Manipulating virulent phage genomes is challenging. To date, no efficient gene-editing tools exist for engineering virulent lactococcal phages. Lactococcus lactis is a bacterium extensively used as a starter culture in various milk fermentation processes, and its phage sensitivity poses a constant risk to the cheese industry. The lactococcal phage p2 is one of the best-studied models for these virulent phages. Despite its importance, almost half of its genes have no functional assignment. CRISPR-Cas9 genome editing technology, which is derived from a natural prokaryotic defense mechanism, offers new strategies for phage research. Here, the well-known Streptococcus pyogenes CRISPR-Cas9 was used in a heterologous host to modify the genome of a strictly lytic phage. Implementation of our adapted CRISPR-Cas9 tool in the prototype phage-sensitive host L. lactis MG1363 allowed us to modify the genome of phage p2. A simple, reproducible technique to generate precise mutations that allow the study of lytic phage genes and their encoded proteins in vivo is described.	[Lemay, Marie-Laurence; Tremblay, Denise M.; Moineau, Sylvain] Univ Laval, Dept Biochim Microbiol & Bioinformat, Fac Sci & Genie, Felix Herelle Reference Ctr Bacterial Viruses, Quebec City, PQ G1V 0A6, Canada; [Lemay, Marie-Laurence; Tremblay, Denise M.; Moineau, Sylvain] Univ Laval, Grp Rech Ecol Buccale, Fac Med Dent, Quebec City, PQ G1V 0A6, Canada	Moineau, S (reprint author), Univ Laval, Dept Biochim Microbiol & Bioinformat, Fac Sci & Genie, Felix Herelle Reference Ctr Bacterial Viruses, Quebec City, PQ G1V 0A6, Canada.; Moineau, S (reprint author), Univ Laval, Grp Rech Ecol Buccale, Fac Med Dent, Quebec City, PQ G1V 0A6, Canada.	Sylvain.Moineau@bcm.ulaval.ca		Moineau, Sylvain/0000-0002-2832-5101	FRQNT; Natural Sciences and Engineering Research Council of Canada (Discovery Program); Fonds de Recherche du Quebec-Nature et Technologies (FRQNT); Novalait; Op +Lait	We thank Luciano Marraffini for plasmid pCas9. We would like to thank Barbara-Ann Conway (Medical Writer & Editor) for editorial assistance. This work was funded by a team grant from the FRQNT and the Natural Sciences and Engineering Research Council of Canada (Discovery Program). M.-L.L. is supported by scholarships from the Fonds de Recherche du Quebec-Nature et Technologies (FRQNT), Novalait and Op +Lait. S.M. holds a T1 Canada Research Chair in Bacteriophages.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bebeacua C, 2013, J VIROL, V87, P12302, DOI 10.1128/JVI.02033-13; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Box AM, 2016, J BACTERIOL, V198, P578, DOI 10.1128/JB.00747-15; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2006, APPL ENVIRON MICROB, V72, P4338, DOI 10.1128/AEM.02517-05; DEVOS WM, 1987, FEMS MICROBIOL LETT, V46, P281, DOI 10.1016/0378-1097(87)90113-3                                                    ; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicrol163; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fokine A, 2014, BACTERIOPHAGE, V4, DOI DOI 10.4161/BACT.28281; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hurwitz BL, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw077; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kiro R, 2014, RNA BIOL, V11, P42, DOI 10.4161/rna.27766; Kropinski Andrew M., 2009, V501, P69, DOI 10.1007/978-1-60327-164-6_7; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Mahony J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00335; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Martel B, 2014, NUCLEIC ACIDS RES, V42, P9504, DOI 10.1093/nar/gku628; Millen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051663; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; OSULLIVAN DJ, 1993, GENE, V137, P227, DOI 10.1016/0378-1119(93)90011-Q; Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094; Pires DP, 2016, MICROBIOL MOL BIOL R, V80, P523, DOI 10.1128/MMBR.00069-15; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rousseau GM, 2009, APPL ENVIRON MICROB, V75, P5336, DOI 10.1128/AEM.00761-09; Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160	41	4	4	8	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	JUL	2017	6	7					1351	1358		10.1021/acssynbio.6b00388				8	Biochemical Research Methods	Biochemistry & Molecular Biology	FB7YO	WOS:000406356100027	28324650				2018-01-05	
J	Greely, HT				Greely, Henry T.			Is De-extinction Special?	HASTINGS CENTER REPORT			English	Article								I have been involved with the current interest in de-extinction since early 2012, nearly its beginning. I have given a lot of thought to the potential risks and benefits of de-extinction. But only recently, after deep immersion in discussions around CRISPR-Cas9, the hottest new tool in bioscience since polymerase chain reaction, have I thought about a more fundamental question: how, if at all, is de-extinction special? Are revived species just another kind of genetically modified organism, raising essentially the same general concerns? I answer, for the most part, yes. De-extinction is not (very) special. New biotechnologies are giving humans even more power to change the biosphere but more directly, more quickly, and more utterly than ever before. De-extinction is just one possible, and probably small, use of those technologies. Our attention, for the most part, should be on the bigger issues of regulating this power, rather than focusing specifically on their application to de-extinction.	[Greely, Henry T.] Stanford Univ, Law, Stanford, CA 94305 USA; [Greely, Henry T.] Stanford Univ, Courtesy Genet, Stanford, CA 94305 USA; [Greely, Henry T.] Stanford Univ, Ctr Law & Biosci, Stanford, CA 94305 USA	Greely, HT (reprint author), Stanford Univ, Law, Stanford, CA 94305 USA.; Greely, HT (reprint author), Stanford Univ, Courtesy Genet, Stanford, CA 94305 USA.; Greely, HT (reprint author), Stanford Univ, Ctr Law & Biosci, Stanford, CA 94305 USA.						Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Charo RA, 2015, AM J BIOETHICS, V15, P11, DOI 10.1080/15265161.2015.1104138; Committee on Gene Drive Research in Non-Human Organisms: Recommendations for Responsible Conduct, 2016, GEN DRIV HOR ADV SCI; Cook LM, 2012, BIOL LETTERS, V8, P609, DOI 10.1098/rsbl.2011.1136; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Sherkow JS, 2013, SCIENCE, V340, P32, DOI 10.1126/science.1236965; Thurber J., 1940, FABLES FOR OUR TIME, p[65, 65]; van't Hof AE, 2016, NATURE, V534, P102, DOI 10.1038/nature17951; [Anonymous], 2000, STANFORD TECHNOLOGY, V1, P1	9	0	0	19	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0093-0334	1552-146X		HASTINGS CENT REP	Hastings Cent. Rep.	JUL-AUG	2017	47			2			S30	S36		10.1002/hast.749				7	Ethics; Health Care Sciences & Services; Medical Ethics; Social Sciences, Biomedical	Social Sciences - Other Topics; Health Care Sciences & Services; Medical Ethics; Biomedical Social Sciences	FB7KQ	WOS:000406319900008	28746759				2018-01-05	
J	Kohl, P				Kohl, Patrice			Reclaiming Hope in Extinction Storytelling	HASTINGS CENTER REPORT			English	Article							DE-EXTINCTION	Critics often take conservationists to task for delivering a constant barrage of bad news without offering a compelling vision of the future. Could recent advances in synthetic biologyan optimistic, forward-looking field with a can-do attitudelet conservationists develop a new vision and generate some better news? Synthetic biology and related gene-editing applications could be used to address threats to species. Genetic interventions might also be used in plants to better protect biodiversity in U.S. rangelands and forests. One possibility has stood out in its ability to capture media attention and the public imaginationrecreating extinct species. And perhaps a de-extinction story could counter the seemingly relentless negativity in biodiversity talk. De-extinction proponent Stewart Brand writes that resurrecting species could shift the conservation story ... from negative to positive, from constant whining and guilt-tripping to high fives and new excitement. So, why do many people in conservation oppose the de-extinction narrative? This essay is an inquiry into whether there are intrinsic social reactions to these types of conservation solutions that might offset their potential benefits. If genetic tools are to be applied to address conservation issues in a realistic and responsible way, their broader social-cultural implications deserve far more attention than they have so far received.	[Kohl, Patrice] Univ Wisconsin, Dept Life Sci Commun, Madison, WI 53706 USA	Kohl, P (reprint author), Univ Wisconsin, Dept Life Sci Commun, Madison, WI 53706 USA.						Banks P. B., 2016, AUSTR ZOOLOGIST; Barrow MV, 2011, ENVIRON HIST-US, V16, P428, DOI 10.1093/envhis/emr042; Brand S., 2014, YALE ENV, V360; Carolan M., 2006, ORG ENV, V19, p[153, 158]; Carroll L., 1917, LOOKING GLASS WHAT A, P39; COX JR, 1982, Q J SPEECH, V68, P227, DOI 10.1080/00335638209383609                                                       ; D'Angelo C., 2016, HUFFINGTON POST; Darwin C., 1896, ORIGIN SPECIES, V2, p[97, 287]; Ehrenfield D., 2013, GUARDIAN; Gould S. J., 1987, URCHIN STORM ESSAYS, P21; Greely H., 2017, 47 HAST CTR, V47, p[S30, S35]; International Union for Conservation of Nature, IUCN RED LIST CAT CR; International Union for Conservation of Nature Species Survival Commission, 2016, IUCN SSC GUID PRINC; KELLERT SR, 1985, J WILDLIFE MANAGE, V49, P528, DOI 10.2307/3801568; Kohler R., 2002, LANDSCAPES LABSCAPES; Ladle RJ, 2008, CONSERV LETT, V1, P111, DOI 10.1111/j.1755-263X.2008.00016.x; Lezak SB, 2016, J ENVIRON PSYCHOL, V46, P143, DOI 10.1016/j.jenvp.2016.04.005; Lin AC, 2013, ECOL LAW QUART, V40, P673; Martinelli L, 2014, CROAT MED J, V55, P423, DOI 10.3325/cmj.2014.55.423; McCauley DJ, 2017, FUNCT ECOL, V31, P1003, DOI 10.1111/1365-2435.12728; Moser C, 2013, J ENVIRON PSYCHOL, V35, P121, DOI 10.1016/j.jenvp.2013.06.003; National Academies of Sciences, 2016, ENG MED GEN DRIV HOR; Norton B. G., 2010, PRES COMM BIOETH M S; Orr DW, 2007, CONSERV BIOL, V21, P1392, DOI 10.1111/j.1523-1739.2007.00836.x; Orr D. W, 1992, ECOLOGICAL LITERACY; Pimm S., 2014, EDGE; Regnier C, 2015, P NATL ACAD SCI USA, V112, P7761, DOI 10.1073/pnas.1502350112; Revive & Restore, WHAT WE DO; Rolston Holmes, 1994, ROYAL I PHILOS S, V36, P13; Ryder OA, 1997, ZOO BIOL, V16, P295, DOI 10.1002/(SICI)1098-2361(1997)16:4<295::AID-ZOO1>3.0.CO;2-5; Smith-Patten BD, 2015, PUBLIC UNDERST SCI, V24, P481, DOI 10.1177/0963662515571489; Smithsonian Insider, 2011, EXT BIRDS REAPP RAIN; Tenner E., 1997, WHY THINGS BITE BACK, P6; Thibodeau P. H., 2015, P 37 ANN M COGN SCI; Weingertner P, 2010, PROCEEDINGS OF THE 4TH INTERNATIONAL YELLOW RIVER FORUM ON ECOLOGICAL CIVILIZATION AND RIVER ETHICS, VOL II, P3	35	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0093-0334	1552-146X		HASTINGS CENT REP	Hastings Cent. Rep.	JUL-AUG	2017	47			2			S24	S29		10.1002/hast.748				6	Ethics; Health Care Sciences & Services; Medical Ethics; Social Sciences, Biomedical	Social Sciences - Other Topics; Health Care Sciences & Services; Medical Ethics; Biomedical Social Sciences	FB7KQ	WOS:000406319900007	28746763				2018-01-05	
J	Poddar, U; Yachha, SK; Borkar, V; Srivastava, A				Poddar, Ujjal; Yachha, Surender K.; Borkar, Vibhor; Srivastava, Anshu			Is acute recurrent pancreatitis in children a precursor of chronic pancreatitis? A long-term follow-up study of 93 cases	DIGESTIVE AND LIVER DISEASE			English	Article						Biliopancreatic obstruction; Chronic pancreatitis; Genetic predisposition; Idiopathic	IDIOPATHIC CHRONIC-PANCREATITIS; TROPICAL CALCIFIC PANCREATITIS; TRYPSIN-INHIBITOR MUTATIONS; CHANGING INCIDENCE; GENETIC MUTATIONS; SPINK1 GENE; ASSOCIATION; DISEASE; POLYMORPHISMS; CHILDHOOD	Background/aims: In view of paucity of literature we analyzed our experience of acute recurrent pancreatitis (ARP) to study clinical profile and long-term outcome. Methods: Over 13 years, 93 consecutive children (<= 18 years) diagnosed to have ARP were included in this study. Magnetic resonance cholangiopancreatography was done at baseline and on follow-up. Common mutations for serine-protease-inhibitor (SPINKI N34S), protease inhibitor (PRSS1 R122S) and cystic fibrosis transmembrane conductance regulator (CFTR deltaF508, 5T) were studied in 22 idiopathic cases. Results: The median age of the children with ARP was 13 (10-14.5) years, 53 were males. Etiology included biliary in 14 (15%), pancreas divisum in 6 (7%), others in 3 (3.5%) and idiopathic in the remaining 70 (75%). SPINKI mutation was found in 10/22 (45%) cases. Over a median follow-up of 25.5 (8.25-48) months, 37 (42%) of 88 (5 lost to follow-up) developed chronic pancreatitis (CP). On multivariate analysis idiopathic etiology (p < 0.03), presence of SPINKI mutation (p = 0.01), longer follow-up (p < 0.001) were associated with progression to CP. Conclusions: Biliopancreatic structural/obstructive causes should always be looked for. It seems ARP is a precursor of CP and progression is associated with idiopathic etiology and presence of genetic mutations. Hence, patients with ARP should be kept on regular follow-up to detect CP. (C) 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.	[Poddar, Ujjal; Yachha, Surender K.; Borkar, Vibhor; Srivastava, Anshu] Sanjay Gandhi Postgrad Inst Med Sci, Dept Pediat Gastroenterol, Lucknow, Uttar Pradesh, India	Poddar, U (reprint author), SGPGIMS, Dept Pediat Gastroenterol, Lucknow 226014, Uttar Pradesh, India.	ujjalpoddar@hotmail.com					Aoun E, 2010, AM J GASTROENTEROL, V105, P446, DOI 10.1038/ajg.2009.630; Balci Numan Cem, 2009, Top Magn Reson Imaging, V20, P25, DOI 10.1097/RMR.0b013e3181b483c2; Benifla M, 2003, J CLIN GASTROENTEROL, V37, P169, DOI 10.1097/00004836-200308000-00015                                                ; Bertin C, 2012, AM J GASTROENTEROL, V107, P311, DOI 10.1038/ajg.2011.424; Bhatia E, 2002, GASTROENTEROLOGY, V123, P1020, DOI 10.1053/gast.2002.36028; Bhatia E, 2000, AM J GASTROENTEROL, V95, P3658; Chandak GR, 2004, GUT, V53, P723, DOI 10.1136/gut.2003.026526; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002                                                     ; Garg PK, 2007, CLIN GASTROENTEROL H, V5, P75, DOI 10.1016/j.cgh.2006.06.023; Garg PK, 2009, J CLIN GASTROENTEROL, V43, P848, DOI 10.1097/MCG.0b013e3181a4e772; Keim V, 2008, WORLD J GASTROENTERO, V14, P1011, DOI 10.3748/wjg.14.1011; KLOPPEL G, 1993, PANCREAS, V8, P659; Kumar S, 2016, JAMA PEDIATR, V170, P562, DOI 10.1001/jamapediatrics.2015.4955; Lopez MJ, 2002, J PEDIATR-US, V140, P622, DOI 10.1067/mpd.2002.123880; Lucidi V, 2011, PANCREAS, V40, P517, DOI 10.1097/MPA.0b013e318214fe42; MACCARTY RL, 1975, AM J ROENTGENOL, V123, P359, DOI 10.2214/ajr.123.2.359                                                           ; Mariani A, 2008, WORLD J GASTROENTERO, V14, P995, DOI 10.3748/wjg.14.995; Midha S, 2010, GUT, V59, P800, DOI 10.1136/gut.2009.191239; Mora J, 2009, PANCREATOLOGY, V9, P644, DOI 10.1159/000181177; Morinville VD, 2012, J PEDIATR GASTR NUTR, V55, P261, DOI 10.1097/MPG.0b013e31824f1516; Morinville VD, 2010, PANCREAS, V39, P5, DOI 10.1097/MPA.0b013e3181baac47; Nydegger A, 2007, J GASTROEN HEPATOL, V22, P1313, DOI 10.1111/j.1440-1746.2007.04936.x; Park A, 2009, J PEDIATR GASTR NUTR, V49, P316, DOI 10.1097/MPG.0b013e31818d7db3; Pfutzer RH, 2000, GASTROENTEROLOGY, V119, P615, DOI 10.1053/gast.2000.18017; Plendl H, 2001, AM J MED GENET, V100, P252, DOI 10.1002/ajmg.1287; Poddar U, 2015, DIGEST LIVER DIS, V47, P709, DOI 10.1016/j.dld.2015.04.012; Sanchez-Ramirez CA, 2007, ACTA PAEDIATR, V96, P534, DOI 10.1111/j.1651-2227.2007.00225.x; Somogyi L, 2001, GASTROENTEROLOGY, V120, P708, DOI 10.1053/gast.2001.22333; Su WJ, 2007, J FORMOS MED ASSOC, V106, P119, DOI 10.1016/S0929-6646(09)60227-8                                                   ; Werlin SL, 2003, J PEDIATR GASTR NUTR, V37, P591, DOI 10.1097/00005176-200311000-00017; Whitcomb DC, 2004, NAT CLIN PRACT GASTR, V1, P46, DOI 10.1038/ncpgasthep0025; Whitcomb DC, 2004, GUT, V53, P1710, DOI 10.1136/gut.2003.015511	32	0	0	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	JUL	2017	49	7					796	801		10.1016/j.dld.2017.02.019				6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	FB5ZP	WOS:000406221200012	28320629				2018-01-05	
J	d'Espaux, L; Ghosh, A; Runguphan, W; Wehrs, M; Xu, F; Konzock, O; Dev, I; Nhan, M; Gin, J; Apel, AR; Petzold, CJ; Singh, S; Simmons, BA; Mukhopadhyay, A; Martin, HG; Keasling, JD				d'Espaux, Leo; Ghosh, Amit; Runguphan, Weerawat; Wehrs, Maren; Xu, Feng; Konzock, Oliver; Dev, Ishaan; Nhan, Melissa; Gin, Jennifer; Apel, Amanda Reider; Petzold, Christopher J.; Singh, Seema; Simmons, Blake A.; Mukhopadhyay, Aindrila; Martin, Hector Garcia; Keasling, Jay D.			Engineering high-level production of fatty alcohols by Saccharomyces cerevisiae from lignocellulosic feedstocks	METABOLIC ENGINEERING			English	Article							MARINOBACTER-AQUAEOLEI VT8; ESCHERICHIA-COLI; YARROWIA-LIPOLYTICA; CELLULOSIC ETHANOL; OLEAGINOUS YEAST; ACID SYNTHESIS; IONIC LIQUIDS; ACYL-COA; OLEOCHEMICALS; BIOFUELS	Fatty alcohols in the C12-C18 range are used in personal care products, lubricants, and potentially biofuels. These compounds can be produced from the fatty acid pathway by a fatty acid reductase (FAR), yet yields from the preferred industrial host Saccharomyces cerevisiae remain under 2% of the theoretical maximum from glucose. Here we improved titer and yield of fatty alcohols using an approach involving quantitative analysis of protein levels and metabolic flux, engineering enzyme level and localization, pull-push-block engineering of carbon flux, and cofactor balancing. We compared four heterologous FARs, finding highest activity and endoplasmic reticulum localization from a Mus musculus FAR. After screening an additional twenty-one single-gene edits, we identified increasing FAR expression; deleting competing reactions encoded by DGA1, HFD1, and ADH6; overexpressing a mutant acetyl-CoA carboxylase; limiting NADPH and carbon usage by the glutamate dehydrogenase encoded by GDH1; and overexpressing the.9-desaturase encoded by OLE1 as successful strategies to improve titer. Our final strain produced 1.2 g/L fatty alcohols in shake flasks, and 6.0 g/L in fed-batch fermentation, corresponding to similar to 20% of the maximum theoretical yield from glucose, the highest titers and yields reported to date in S. cerevisiae. We further demonstrate high-level production from lignocellulosic feedstocks derived from ionic-liquid treated switchgrass and sorghum, reaching 0.7 g/L in shake flasks. Altogether, our work represents progress towards efficient and renewable microbial production of fatty acidderived products.	[d'Espaux, Leo; Ghosh, Amit; Runguphan, Weerawat; Wehrs, Maren; Xu, Feng; Konzock, Oliver; Dev, Ishaan; Nhan, Melissa; Gin, Jennifer; Apel, Amanda Reider; Petzold, Christopher J.; Singh, Seema; Simmons, Blake A.; Mukhopadhyay, Aindrila; Martin, Hector Garcia; Keasling, Jay D.] US DOE, Joint BioEnergy Inst, Oakland, CA 94608 USA; [d'Espaux, Leo; Ghosh, Amit; Runguphan, Weerawat; Wehrs, Maren; Xu, Feng; Konzock, Oliver; Dev, Ishaan; Nhan, Melissa; Gin, Jennifer; Apel, Amanda Reider; Petzold, Christopher J.; Singh, Seema; Simmons, Blake A.; Mukhopadhyay, Aindrila; Martin, Hector Garcia; Keasling, Jay D.] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA; [Xu, Feng; Singh, Seema; Simmons, Blake A.] Sandia Natl Labs, Biomass Sci & Convers Technol Dept, Livermore, CA 94551 USA; [Xu, Feng; Singh, Seema; Simmons, Blake A.] Sandia Natl Labs, Biol & Mat Sci Ctr, Livermore, CA 94551 USA; [Dev, Ishaan; Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Sustainabil, Lyngby, Denmark; [Ghosh, Amit] Indian Inst Technol, Sch Energy Sci & Engn, Kharagpur 721302, W Bengal, India; [Runguphan, Weerawat] Natl Sci & Technol Dev Agcy, Microbial Cell Factory Lab, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Nhan, Melissa] Calysta Energy, Menlo Pk, CA 94025 USA	Keasling, JD (reprint author), Joint BioEnergy Inst, 5885 Hollis St, Emeryville, CA 94608 USA.	jdkeasling@lbl.gov		Garcia Martin, Hector/0000-0002-4556-9685	United States Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; DOE	This work was part of the DOE Joint BioEnergy Institute (www.jbei.org) supported by the United States Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the DOE. The US Government retains and the publisher, by accepting the article for publication, acknowledges that the US Government retains a non-exclusive, paid-up, irrevocable, worldwide license to publish or reproduce the published form of this manuscript, or allow others to do so, for US Government purposes. The DOE will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (energy.gov/downloads/doe-public-access-plan). We thank Eric Sundstrom, Mona Misriaghi, and Fabrice Masson at the DOE ABPDU for technical assistance with bioreactor experiments.	Apel A.Reider, 2016, NUCLEIC ACIDS RES, P1; Avalos JL, 2013, NAT BIOTECHNOL, V31, P335, DOI 10.1038/nbt.2509; Batth T. S., 2012, METHOD MOL BIOL, V944, P47; Brachmann CB, 1998, YEAST, V14, P115; Caspeta L, 2013, NAT BIOTECHNOL, V31, P789, DOI 10.1038/nbt.2683; Clomburg JM, 2015, METAB ENG, V28, P202, DOI 10.1016/j.ymben.2015.01.007; Connor R., 2016, UN WORLD WATER DEV R; Degreif D, 2017, METAB ENG, V41, P46, DOI 10.1016/j.ymben.2017.03.002; Feng XY, 2015, METAB ENG, V27, P10, DOI 10.1016/j.ymben.2014.10.001; Fillet S, 2015, J IND MICROBIOL BIOT, V42, P1463, DOI 10.1007/s10295-015-1674-x; Gaikwad S., 2016, FATTY ALCOHOL MARKET; Ghosh Amit, 2016, Frontiers in Bioengineering and Biotechnology, V4, DOI 10.3389/fbioe.2016.00076; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goh EB, 2012, APPL ENVIRON MICROB, V78, P70, DOI 10.1128/AEM.06785-11; Guo ZP, 2011, METAB ENG, V13, P49, DOI 10.1016/j.ymben.2010.11.003; Haushalter RW, 2014, METAB ENG, V26, P111, DOI 10.1016/j.ymben.2014.09.002; Hoja U, 2004, J BIOL CHEM, V279, P21779, DOI 10.1074/jbc.M401071200; Kalscheuer R, 2006, MICROBIOL-SGM, V152, P2529, DOI 10.1099/mic.0.29028-0; Kildegaard KR, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0451-5; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Liu AQ, 2013, APPL MICROBIOL BIOT, V97, P7061, DOI 10.1007/s00253-013-5027-2; Liu YL, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0524-5; Martin HG, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004363; Mazzoleni S, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0295-4; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Petkovic M, 2010, GREEN CHEM, V12, P643, DOI 10.1039/b922247b; Pfleger BF, 2015, METAB ENG, V29, P1, DOI 10.1016/j.ymben.2015.01.009; Qiao K, 2015, METAB ENG, V29, P56, DOI 10.1016/j.ymben.2015.02.005; Runguphan W, 2014, METAB ENG, V21, P103, DOI 10.1016/j.ymben.2013.07.003; Sheng JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26884; Shi SB, 2014, MBIO, V5, DOI 10.1128/mBio.01130-14; Stryer L., 1988, BIOCHEMISTRY; Sun J, 2016, ENERG ENVIRON SCI, V9, P2822, DOI 10.1039/c6ee00913a; Tai M, 2013, METAB ENG, V15, P1, DOI 10.1016/j.ymben.2012.08.007; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Teixeira PG, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0663-3; THOMAS D, 1991, EMBO J, V10, P547; Verho R, 2002, BIOCHEMISTRY-US, V41, P13833, DOI 10.1021/bi0265325; Wahlen BD, 2009, APPL ENVIRON MICROB, V75, P2758, DOI 10.1128/AEM.02578-08; Wang G, 2016, SCI PROGRAMMING-NETH, DOI 10.1155/2016/3676149; Willis RM, 2011, BIOCHEMISTRY-US, V50, P10550, DOI 10.1021/bi2008646; Xu F, 2016, ENERG ENVIRON SCI, V9, P1042, DOI 10.1039/c5ee02940f; Xu P, 2016, P NATL ACAD SCI USA, V113, P10848, DOI 10.1073/pnas.1607295113; Zampar GG, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.11; Zhang FZ, 2012, METAB ENG, V14, P653, DOI 10.1016/j.ymben.2012.08.009; Zhang L, 2011, BIOTECHNOL LETT, V33, P1375, DOI 10.1007/s10529-011-0588-6; Zhou YJJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11709; Zhu SD, 2006, GREEN CHEM, V8, P325, DOI 10.1039/b601395c	50	1	1	20	20	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7176	1096-7184		METAB ENG	Metab. Eng.	JUL	2017	42						115	125		10.1016/j.ymben.2017.06.004				11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FB0SI	WOS:000405854400014	28606738				2018-01-05	
J	Cho, JS; Choi, KR; Prabowo, CPS; Shin, JH; Yang, D; Jang, J; Lee, SY				Cho, Jae Sung; Choi, Kyeong Rok; Prabowo, Cindy Pricilia Surya; Shin, Jae Ho; Yang, Dongsoo; Jang, Jaedong; Lee, Sang Yup			CRISPR/Cas9-coupled recombineering for metabolic engineering of Corynebacterium glutamicum	METABOLIC ENGINEERING			English	Article						Corynebacterium glutamicum; CRISPR/Cas9; Recombineering; Metabolic engineering; CoPaR; Curable plasmids	ESCHERICHIA-COLI; CRISPR INTERFERENCE; ENHANCED PRODUCTION; GENOME; CLONING; ACID; CHROMOSOME; PRODUCTS; SYSTEMS; MAGE	Genome engineering of Corynebacterium glutamicum, an important industrial microorganism for amino acids production, currently relies on random mutagenesis and inefficient double crossover events. Here we report a rapid genome engineering strategy to scarlessly knock out one or more genes in C. glutamicum in sequential and iterative manner. Recombinase RecT is used to incorporate synthetic single-stranded oligodeoxyribonucleotides into the genome and CRISPR/Cas9 to counter-select negative mutants. We completed the system by engineering the respective plasmids harboring CRISPR/Cas9 and RecT for efficient curing such that multiple gene targets can be done iteratively and final strains will be free of plasmids. To demonstrate the system, seven different mutants were constructed within two weeks to study the combinatorial deletion effects of three different genes on the production of.-aminobutyric acid, an industrially relevant chemical of much interest. This genome engineering strategy will expedite metabolic engineering of C. glutamicum.	[Cho, Jae Sung; Choi, Kyeong Rok; Prabowo, Cindy Pricilia Surya; Shin, Jae Ho; Yang, Dongsoo; Jang, Jaedong; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Metab & Biomol Engn Natl Res Lab, Plus Program BK21, 291 Daehak Ro, Daejeon 34141, South Korea; [Cho, Jae Sung; Choi, Kyeong Rok; Prabowo, Cindy Pricilia Surya; Shin, Jae Ho; Yang, Dongsoo; Jang, Jaedong; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Inst BioCentury, 291 Daehak Ro, Daejeon 34141, South Korea; [Lee, Sang Yup] Korea Adv Inst Sci & Technol, BioInformat Res Ctr, 291 Daehak Ro, Daejeon 34141, South Korea; [Lee, Sang Yup] Korea Adv Inst Sci & Technol, BioProc Engn Res Ctr, 291 Daehak Ro, Daejeon 34141, South Korea	Lee, SY (reprint author), Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Metab & Biomol Engn Natl Res Lab, Plus Program BK21, 291 Daehak Ro, Daejeon 34141, South Korea.; Lee, SY (reprint author), Korea Adv Inst Sci & Technol, Inst BioCentury, 291 Daehak Ro, Daejeon 34141, South Korea.; Lee, SY (reprint author), Korea Adv Inst Sci & Technol, BioInformat Res Ctr, 291 Daehak Ro, Daejeon 34141, South Korea.; Lee, SY (reprint author), Korea Adv Inst Sci & Technol, BioProc Engn Res Ctr, 291 Daehak Ro, Daejeon 34141, South Korea.	leesy@kaist.ac.kr	Lee, Sang Yup/C-1526-2011	Lee, Sang Yup/0000-0003-0599-3091; shin, Jaeho/0000-0002-5874-9765	Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries from Ministry of Science, ICT and Future Planning (MSIP) through National Research Foundation of Korea [NRF-2012M1A2A2026556, NRF-2012M1A2A2026557]; Hanwha Chemical through KAIST-Hanwha Chemical Future Technology Institute	This work was supported by the Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries from the Ministry of Science, ICT and Future Planning (MSIP) through the National Research Foundation of Korea [NRF-2012M1A2A2026556 and NRF-2012M1A2A2026557]. This work was further supported by Hanwha Chemical through KAIST-Hanwha Chemical Future Technology Institute.	Bassalo MC, 2016, ACS SYNTH BIOL, V5, P561, DOI 10.1021/acssynbio.5b00187; Becker J, 2015, ANGEW CHEM INT EDIT, V54, P3328, DOI 10.1002/anie.201409033; Becker J, 2011, METAB ENG, V13, P159, DOI 10.1016/j.ymben.2011.01.003; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Binder S, 2013, NUCLEIC ACIDS RES, V41, P6360, DOI 10.1093/nar/gkt312; Blin K., 2016, SYNTH SYST BIOTECHNO, V1, P118, DOI 10.1016/j.synbio.2016.01.003; Choi JW, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0205-9; Choi KR, 2016, BIOTECHNOL ADV, V34, P1180, DOI 10.1016/j.biotechadv.2016.08.002; Cleto S, 2016, ACS SYNTH BIOL, V5, P375, DOI 10.1021/acssynbio.5b00216; Cui L, 2016, NUCLEIC ACIDS RES, V44, P4243, DOI 10.1093/nar/gkw223; Eggeling L, 2015, APPL MICROBIOL BIOT, V99, P3387, DOI 10.1007/s00253-015-6508-2; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Heider SAE, 2015, BIOTECHNOL J, V10, P1170, DOI 10.1002/biot.201400590; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KATSUMATA R, 1993, BIO-TECHNOL, V11, P921, DOI 10.1038/nbt0893-921; Kind S, 2014, METAB ENG, V25, P113, DOI 10.1016/j.ymben.2014.05.007; Nakamura J, 2006, PLASMID, V56, P179, DOI 10.1016/j.plasmid.2006.05.003; Nesvera J, 2011, APPL MICROBIOL BIOT, V90, P1641, DOI 10.1007/s00253-011-3272-9; Ni YL, 2015, BIOTECHNOL LETT, V37, P2219, DOI 10.1007/s10529-015-1897-y; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Park SH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5618; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; Resende BC, 2011, GENE, V482, P1, DOI 10.1016/j.gene.2011.03.008; Ronda C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19452; Ruan YL, 2015, BIOTECHNOL LETT, V37, P2445, DOI 10.1007/s10529-015-1934-x; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHWARZER A, 1991, BIO-TECHNOL, V9, P84, DOI 10.1038/nbt0191-84; Shi F, 2013, J IND MICROBIOL BIOT, V40, P1285, DOI 10.1007/s10295-013-1316-0; Shin JH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0566-8; Thomason L. C., 2014, CURR PROTOC MOL BIOL, V106; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/nmeth.1971, 10.1038/NMETH.1971]; Yim SS, 2013, BIOTECHNOL BIOENG, V110, P2959, DOI 10.1002/bit.24954; Zelder O., 2015, PCT patent, Patent No. 2014066633	42	1	1	21	21	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7176	1096-7184		METAB ENG	Metab. Eng.	JUL	2017	42						157	167		10.1016/j.ymben.2017.06.010				11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FB0SI	WOS:000405854400018	28649005				2018-01-05	
J	D'Agostino, Y; D'Aniello, S				D'Agostino, Ylenia; D'Aniello, Salvatore			Molecular basis, applications and challenges of CRISPR/Cas9: a continuously evolving tool for genome editing	BRIEFINGS IN FUNCTIONAL GENOMICS			English	Article						genome editing; CRISPR; Cas9; guide RNA (gRNA); knock-in; Conditional knock-out	ONE-STEP GENERATION; CRISPR-CAS9 SYSTEM; KNOCK-IN; CONDITIONAL ALLELES; ADAPTIVE IMMUNITY; CAS NUCLEASES; HUMAN-CELLS; C. ELEGANS; ZEBRAFISH; ENDONUCLEASE	The clustered regularly interspaced short palindromic repeats (CRISPR/Cas9) system is a recently discovered tool for genome editing that has quickly revolutionized the ability to generate site-specific mutations in a wide range of animal models, including nonhuman primates. Indeed, a significant number of scientific reports describing single or multiplex guide RNA microinjection, double-nicking strategies, site-specific knock-in and conditional knock-out have been published in less than three years. However, despite the great potential of this new technology, there are some limitations because of the presence of off-target genomic sites, which must be taken into consideration. To address this issue, various research teams have tried to improve the efficiency of the system through enzymatic modifications of the Cas9 protein or by the introduction of alternative strategies. Although several review articles are available that singly describe the molecular mechanism(s), applications and challenges of each of these strategies, a concise compilation of approaches is lacking. In the current review, we describe and evaluate most CRISPR/Cas9 approaches available at present, describing both mechanism of action, in addition to advantages or disadvantages. The primary goal of this work is to serve as a guide for not skilled researchers, facilitating the selection of the best strategy to target their gene of interest and allowing optimization of particular applications to the specific aims of the study. The present article also offers a unique perspective, focusing on the fact that CRISPR technology is opening a new genomic era, providing the means to manipulate specific genes in a targeted manner in all animal models, an endeavor previously considered to be difficult.	[D'Agostino, Ylenia] Univ Naples Federico II, Naples, Italy; [D'Agostino, Ylenia; D'Aniello, Salvatore] Stn Zool Anton Dohrn, Naples, Italy	D'Aniello, S (reprint author), Stn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, I-80121 Naples, Italy.	salvatore.daniello@szn.it			FIRB grant from the Italian Ministry of Education, University and Research (MIUR) [RBFR12QW4I]	This work was supported by a FIRB grant (RBFR12QW4I) from the Italian Ministry of Education, University and Research (MIUR) to S.D.	Arakawa H, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600699; Auer TO, 2014, METHODS, V69, P142, DOI 10.1016/j.ymeth.2014.03.027; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Carrington B, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv802; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cheng JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11178; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; D'Agostino Y, 2016, MOL BIOTECHNOL, V58, P73, DOI 10.1007/s12033-015-9905-y; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Flecknell P, 2002, ALTEX-ALTERN TIEREXP, V19, P73; Flemr M, 2015, CELL REP, V12, P709, DOI 10.1016/j.celrep.2015.06.051; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Giovannangeli C, 2014, METHODS, V69, P119, DOI 10.1016/j.ymeth.2014.08.013; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang MC, 2012, ELECTROPHORESIS, V33, P788, DOI 10.1002/elps.201100460; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jiang Q, 2014, RNA BIOL, V11, P1243, DOI 10.1080/15476286.2014.996067; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kungulovski G, 2016, TRENDS GENET, V32, P101, DOI 10.1016/j.tig.2015.12.001; Li J, 2015, CELL RES, V25, P634, DOI 10.1038/cr.2015.43; Lin CY, 2016, DEV BIOL, V409, P420, DOI 10.1016/j.ydbio.2015.11.018; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Mou HW, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0178-7; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Peng Y, 2014, DEVELOPMENT, V141, P4042, DOI 10.1242/dev.102186; Prykhozhij SV, 2016, ZEBRAFISH, V13, P70, DOI 10.1089/zeb.2015.1158; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rath D, 2015, BIOCHIMIE, V117, P119, DOI 10.1016/j.biochi.2015.03.025; Ruan JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep14253; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Sasaki H, 2014, DEV GROWTH DIFFER, V56, P499, DOI 10.1111/dgd.12149; Shen ZF, 2014, DEV CELL, V30, P625, DOI 10.1016/j.devcel.2014.07.017; Singh R, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv575; Sontheimer EJ, 2015, HUM GENE THER, V26, P413, DOI 10.1089/hum.2015.091; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Stolfi A, 2014, DEVELOPMENT, V141, P4115, DOI 10.1242/dev.114488; Thomas HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114632; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wen D, 2015, J CONTROL RELEASE, V219, P237, DOI 10.1016/j.jconrel.2015.08.011; Wu Xuebing, 2014, Quant Biol, V2, P59; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhou JK, 2014, INT J BIOCHEM CELL B, V46, P49, DOI 10.1016/j.biocel.2013.10.010; Zhu XX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06420	64	2	2	9	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2041-2649	2041-2657		BRIEF FUNCT GENOMICS	Brief. Funct. Genomics	JUL	2017	16	4					211	216		10.1093/bfgp/elw038				6	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FB2AH	WOS:000405944900004	28057617				2018-01-05	
J	Powell, SK; Gregory, J; Akbarian, S; Brennand, KJ				Powell, S. K.; Gregory, J.; Akbarian, S.; Brennand, K. J.			Application of CRISPR/Cas9 to the study of brain development and neuropsychiatric disease	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article							PLURIPOTENT STEM-CELLS; FRAGILE-X-SYNDROME; CHROMATIN ASSEMBLY FACTOR-1; AUTISM SPECTRUM DISORDERS; IPSC-DERIVED NEURONS; DE-NOVO MUTATIONS; GENE-EXPRESSION; CRISPR-CAS9 SYSTEM; DNA METHYLATION; NONCODING RNA	CRISPR/Cas9 technology has transformed our ability to manipulate the genome and epigenome, from efficient genomic editing to targeted localization of effectors to specific loci. Through the manipulation of DNA-and histone-modifying enzyme activities, activation or repression of gene expression, and targeting of transcriptional regulators, the role of gene-regulatory and epigenetic pathways in basic biology and disease processes can be directly queried. Here, we discuss emerging CRISPR-based methodologies, with specific consideration of neurobiological applications of human induced pluripotent stem cell (hiPSC)-based models. (C) 2017 Elsevier Inc. All rights reserved.	[Powell, S. K.] Icahn Sch Med Mt Sinai, Med Scientist Training Program, New York, NY 10029 USA; [Powell, S. K.; Akbarian, S.; Brennand, K. J.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Powell, S. K.; Akbarian, S.; Brennand, K. J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Gregory, J.] Icahn Sch Med Mt Sinai, Instruct Technol Grp, New York, NY 10029 USA; [Brennand, K. J.] Icahn Sch Med Mt Sinai, Dept Genet & Gen, New York, NY 10029 USA	Brennand, KJ (reprint author), Icahn Sch Med Mt Sinai, Dept Genet & Gen & Neurosci, New York, NY 10029 USA.	kristen.brennand@mssm.edu		Brennand, Kristen/0000-0003-0993-5956	National Institutes of Health (NIH) grants [R01 MH101454, R01 MH106056, P50 MH096890]; New York Stem Cell Foundation; Brain & Behavior Research Foundation	Kristen Brennand is a New York Stem Cell Foundation - Robertson Investigator. This work was partially supported by National Institutes of Health (NIH) grants R01 MH101454 (KJB) and R01 MH106056 (SA) and P50 MH096890 (SA), as well as the New York Stem Cell Foundation and the Brain & Behavior Research Foundation.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Avitzour M, 2014, STEM CELL REP, V3, P699, DOI 10.1016/j.stemcr.2014.09.001; Balachandar Vellingiri, 2016, Stem Cell Investig, V3, P52; Barbieri E, 2014, CANCER RES, V74, P765, DOI 10.1158/0008-5472.CAN-13-1315; Barbieri E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079843; Bardy C, 2016, MOL PSYCHIATR, V21, P1573, DOI 10.1038/mp.2016.158; Bharadwaj R, 2014, NEURON, V84, P997, DOI 10.1016/j.neuron.2014.10.032; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bradshaw NJ, 2012, NEUROPHARMACOLOGY, V62, P1230, DOI 10.1016/j.neuropharm.2010.12.027; Brennand KJ, 2015, STEM CELL REP, V5, P933, DOI 10.1016/j.stemcr.2015.10.011; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Chailangkarn T, 2016, NATURE, V536, P338, DOI 10.1038/nature19067; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Coffee B, 1999, NAT GENET, V22, P98; Cotter DR, 2001, BRAIN RES BULL, V55, P585, DOI 10.1016/S0361-9230(01)00527-5; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dong H, 2001, GENE, V264, P187, DOI 10.1016/S0378-1119(01)00335-3; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Egan CM, 2013, DEV CELL, V26, P223, DOI 10.1016/j.devcel.2013.07.008; Emdad L, 2012, STEM CELLS DEV, V21, P404, DOI 10.1089/scd.2010.0560; Erwin JA, 2016, NAT NEUROSCI, V19, P1583, DOI 10.1038/nn.4388; Espinosa-Jeffrey A., 2016, CURR PROTOC STEM CEL, V38, DOI [10.1002/cpsc.11, DOI 10.1002/CPSC.11]; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; FOLSTEIN SE, 1991, PEDIATRICS, V87, P767; Frank CL, 2015, NAT NEUROSCI, V18, P647, DOI 10.1038/nn.3995; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Fujii H, 2015, INT J MOL SCI, V16, P21802, DOI 10.3390/ijms160921802; Fujita T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103084; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Goffin A, 2001, AM J MED GENET, V105, P521, DOI 10.1002/ajmg.1477                                                               ; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Hartley B.J., 2016, NEUROCHEM INT; Hayashi M, 2016, J CELL BIOCHEM, V117, P780, DOI 10.1002/jcb.25368; Ho SM, 2016, METHODS, V101, P113, DOI 10.1016/j.ymeth.2015.11.019; Ho SM, 2015, BIOMARK INSIGHTS, V10, P31, DOI [10.4137/BMIMI.S20066, 10.4137/BMI.S20066]; Hu JX, 2015, DEVELOPMENT, V142, P2775, DOI 10.1242/dev.126391; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Le-Niculescu H, 2013, MOL PSYCHIATR, V18, P1249, DOI 10.1038/mp.2013.95; Lee I.S., 2015, NPJ SCHIZOPHR, V1; Li QY, 2015, G3-GENES GENOM GENET, V5, P2809, DOI 10.1534/g3.115.021857; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Liu ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093388; Lu JF, 2016, NAT BIOTECHNOL, V34, P89, DOI 10.1038/nbt.3435; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Ma HH, 2013, P NATL ACAD SCI USA, V110, P21048, DOI 10.1073/pnas.1319097110; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Marchetto M.C., 2016, MOL PSYCHIAT; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; McDonald JI, 2016, BIOL OPEN, V5, P866, DOI 10.1242/bio.019067; McGill Zoghbi, 2014, NEUROBIOLOGY MENTAL; Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Millar JK, 2000, GENOMICS, V67, P69, DOI 10.1006/geno.2000.6239; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park CY, 2015, CELL REP, V13, P234, DOI 10.1016/j.celrep.2015.08.084; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Pena CJ, 2014, J MOL BIOL, V426, P3389, DOI 10.1016/j.jmb.2014.03.016; Peng HH, 2016, BIOCHEM BIOPH RES CO, V469, P1111, DOI 10.1016/j.bbrc.2015.12.111; Pla P, 2003, INT J DEV BIOL, V47, P315; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Quivy JP, 2001, EMBO J, V20, P2015, DOI 10.1093/emboj/20.8.2015                                                         ; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Rajarajan P, 2016, NAT REV NEUROSCI, V17, P681, DOI 10.1038/nrn.2016.124; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rannals MD, 2016, NEURON, V90, P43, DOI 10.1016/j.neuron.2016.02.021; Ridgway P, 2000, J CELL SCI, V113, P2647; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Roussos P, 2014, CELL REP, V9, P1417, DOI 10.1016/j.celrep.2014.10.015; Ruest LB, 2004, DEVELOPMENT, V131, P4413, DOI 10.1242/dev.01291; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sartor Gregory C., 2012, Frontiers in Genetics, V3, P106, DOI 10.3389/fgene.2012.00106; Savic D, 2015, GENOME RES, V25, P1581, DOI 10.1101/gr.193540.115; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shechner DM, 2015, NAT METHODS, V12, P664, DOI [10.1038/NMETH.3433, 10.1038/nmeth.3433]; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shinmyo Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20611; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Spadaro PA, 2015, BIOL PSYCHIAT, V78, P848, DOI 10.1016/j.biopsych.2015.02.004; Srikanth P, 2015, CELL REP, V12, P1414, DOI 10.1016/j.celrep.2015.07.061; Sun AX, 2016, CELL REP, V16, P1942, DOI 10.1016/j.celrep.2016.07.035; Szafranskil K, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00087; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Taylor SM, 2015, INVEST OPHTH VIS SCI, V56, P7496, DOI 10.1167/iovs.15-17616; Thanisch K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1348; Theka I, 2013, STEM CELL TRANSL MED, V2, P473, DOI 10.5966/sctm.2012-0133; Thiruvalluvan A, 2016, STEM CELL TRANSL MED, V5, P1550, DOI 10.5966/sctm.2016-0024; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; van de Vondervoort IIGM, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00053; Vera E, 2015, DEVELOPMENT, V142, P3085, DOI 10.1242/dev.120667; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H                                                    ; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Vora S, 2016, FEBS J, V283, P3181, DOI 10.1111/febs.13768; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang P, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0048-6; Wang S, 2014, DEV CELL, V30, P513, DOI 10.1016/j.devcel.2014.07.018; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Williams MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25611; Wu ZH, 2014, BIOCHEM BIOPH RES CO, V449, P208, DOI 10.1016/j.bbrc.2014.05.006; Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184; Yang R, 2016, NUCLEIC ACIDS RES, V44, P3082, DOI 10.1093/nar/gkv1358; Yu JY, 2007, SCIENCE, V318, P1917, DOI [10.1126/science.1151526, 10.1126/science.1172482]; Zhang Y.D., 2016, ONCOTARGET; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715	140	0	0	12	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	JUL	2017	82						157	166		10.1016/j.mcn.2017.05.007				10	Neurosciences	Neurosciences & Neurology	FB2MH	WOS:000405977400016	28549865				2018-01-05	
J	Tang, JY; Chu, CC				Tang, Jiuyou; Chu, Chengcai			MicroRNAs in crop improvement: fine-tuners for complex traits	NATURE PLANTS			English	Review							LATERAL ROOT DEVELOPMENT; RICE ORYZA-SATIVA; MODIFIED CRISPR/CAS9 SYSTEM; MESSENGER-RNA CLEAVAGE; CONTROLS GRAIN-SIZE; TRANSCRIPTION FACTOR; MIRNA GENES; STARVATION RESPONSES; PHOSPHATE STARVATION; PLANT ARCHITECTURE	One of the most common challenges for both conventional and modern crop improvement is that the appearance of one desirable trait in a new crop variety is always balanced by the impairment of one or more other beneficial characteristics. The best way to overcome this problem is the flexible utilization of regulatory genes, especially genes that provide more efficient and precise regulation in a targeted manner. MicroRNAs (miRNAs), a type of short non-coding RNA, are promising candidates in this area due to their role as master modulators of gene expression at the post-transcriptional level, targeting messenger RNAs for cleavage or directing translational inhibition in eukaryotes. We herein highlight the current understanding of the biological role of miRNAs in orchestrating distinct agriculturally important traits by summarizing recent functional analyses of 65 miRNAs in 9 major crops worldwide. The integration of current miRNA knowledge with conventional and modern crop improvement strategies is also discussed.	[Tang, Jiuyou; Chu, Chengcai] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, Beijing 100101, Peoples R China	Tang, JY; Chu, CC (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China.	jytang@genetics.ac.cn; ccchu@genetics.ac.cn		Chu, Chengcai/0000-0001-8097-6115	Chinese Academy of Sciences [XDA08010400]; National Key Research and Development Program of China [2016YFD0101801]; National Natural Science Foundation of China [31571248, 31201182]	This work was supported by the grants from the Chinese Academy of Sciences (XDA08010400), the National Key Research and Development Program of China (2016YFD0101801), and the National Natural Science Foundation of China (31571248 and 31201182). We apologize to our colleagues whose work was not included or sufficiently discussed in this article because of space restrictions.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Barrangou R, 2015, NUCLEIC ACIDS RES, V43, P3407, DOI 10.1093/nar/gkv226; Berger Y, 2009, DEVELOPMENT, V136, P823, DOI 10.1242/dev.031625; Bhogale S, 2014, PLANT PHYSIOL, V164, P1011, DOI 10.1104/pp.113.230714; Bian HW, 2012, NEW PHYTOL, V196, P149, DOI 10.1111/j.1469-8137.2012.04248.x; Brown ME, 2008, SCIENCE, V319, P580, DOI 10.1126/science.1154102; Budak H, 2015, FUNCT INTEGR GENOMIC, V15, P523, DOI 10.1007/s10142-015-0451-2; Buxdorf K, 2010, PLANTA, V232, P1009, DOI 10.1007/s00425-010-1231-9; Campo S, 2013, NEW PHYTOL, V199, P212, DOI 10.1111/nph.12292; Che RH, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.195, 10.1038/nplants.2015.195]; Chen WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep07852; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Chuck G, 2010, DEVELOPMENT, V137, P1243, DOI 10.1242/dev.048348; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Curaba J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-6; Damodharan S, 2016, PLANT J, V86, P458, DOI 10.1111/tpj.13127; de Vries S, 2015, GENOME BIOL EVOL, V7, P3307, DOI 10.1093/gbe/evv225; Du H, 2012, J EXP BOT, V63, P6467, DOI 10.1093/jxb/ers300; Duan PG, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2015.203, 10.1038/NPLANTS.2015.203]; Fan YR, 2016, P NATL ACAD SCI USA, V113, P15144, DOI 10.1073/pnas.1619159114; Fang RQ, 2013, PLANTA, V238, P259, DOI 10.1007/s00425-013-1881-5; Fang YJ, 2014, J EXP BOT, V65, P2119, DOI 10.1093/jxb/eru072; Fedoroff NV, 2010, NEW BIOTECHNOL, V27, P461, DOI 10.1016/j.nbt.2009.12.004; Feng H, 2013, BIOCHIM BIOPHYS ACTA, V1839, P1; Feng H, 2014, MOL PLANT PATHOL, V15, P284, DOI 10.1111/mpp.12089; Feng H, 2013, PLANT MOL BIOL, V83, P433, DOI 10.1007/s11103-013-0101-9; Silva GFFE, 2014, PLANT J, V78, P604, DOI 10.1111/tpj.12493; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Gao F, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.196, 10.1038/nplants.2015.196]; Gao S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19736; Gratten J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0332-x; Guan XY, 2014, TRENDS PLANT SCI, V19, P516, DOI 10.1016/j.tplants.2014.04.007; Guan XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4050; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Guo SY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2542; Hewezi T, 2012, PLANT PHYSIOL, V159, P321, DOI 10.1104/pp.112.193649; Houston K, 2013, P NATL ACAD SCI USA, V110, P16675, DOI 10.1073/pnas.1311681110; Hu B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00188; Hu B, 2011, PLANT PHYSIOL, V156, P1101, DOI 10.1104/pp.110.170209; Hu J, 2015, MOL PLANT, V8, P1455, DOI 10.1016/j.molp.2015.07.002; Huang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29938; Iwamoto M, 2016, PLANT J, V85, P466, DOI 10.1111/tpj.13117; Jia XY, 2015, PLANTA, V242, P283, DOI 10.1007/s00425-015-2305-5; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Lee YS, 2014, RICE, V7, DOI 10.1186/s12284-014-0031-4; Li AL, 2014, PLANT CELL, V26, P1878, DOI 10.1105/tpc.114.124388; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-220; Li JY, 2017, MOL PLANT, V10, P526, DOI 10.1016/j.molp.2016.12.001; Li J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.139, 10.1038/nplants.2016.139]; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li X, 2016, SCI REP-UK, V6, DOI 10.1038/srep32158; Li Y, 2014, PLANT PHYSIOL, V164, P1077, DOI 10.1104/pp.113.230052; Lin SI, 2010, PLANT CELL PHYSIOL, V51, P2119, DOI 10.1093/pcp/pcq170; Liu HH, 2014, PLANT PHYSIOL, V165, P160, DOI 10.1104/pp.114.235564; Liu J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004755; Liu N, 2014, J EXP BOT, V65, P2507, DOI 10.1093/jxb/eru141; Liu Qing, 2012, Methods Mol Biol, V877, P303, DOI 10.1007/978-1-61779-818-4_23; Liu QP, 2015, MOL GENET GENOMICS, V290, P593, DOI 10.1007/s00438-014-0943-0; Liu TF, 2016, PLANT J, V85, P396, DOI 10.1111/tpj.13113; Lombardo L, 2016, TRENDS BIOTECHNOL, V34, P49, DOI 10.1016/j.tibtech.2015.10.006; Lu YM, 2017, MOL PLANT, V10, P523, DOI 10.1016/j.molp.2016.11.013; Martin A, 2009, DEVELOPMENT, V136, P2873, DOI 10.1242/dev.031658; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Nair SK, 2010, P NATL ACAD SCI USA, V107, P490, DOI 10.1073/pnas.0909097107; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Nizampatnam NR, 2015, PLANT J, V84, P140, DOI 10.1111/tpj.12965; Nosaka M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002953; Nozawa M, 2012, GENOME BIOL EVOL, V4, P230, DOI 10.1093/gbe/evs002; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Ouyang SQ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004464; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shen Y, 2011, FUNCT INTEGR GENOMIC, V11, P179, DOI 10.1007/s10142-010-0202-3; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Shivaprasad PV, 2012, EMBO J, V31, P257, DOI 10.1038/emboj.2011.458; Si LZ, 2016, NAT GENET, V48, P447, DOI 10.1038/ng.3518; Sun GL, 2012, PLANT MOL BIOL, V80, P17, DOI 10.1007/s11103-011-9817-6; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; Tang JY, 2011, PLANT J, V66, P996, DOI 10.1111/j.1365-313X.2011.04557.x; Taylor RS, 2014, TRENDS PLANT SCI, V19, P175, DOI 10.1016/j.tplants.2013.11.008; Tian CJ, 2015, J GENET GENOMICS, V42, P393, DOI 10.1016/j.jgg.2015.04.008; Tsuji H, 2006, PLANT J, V47, P427, DOI 10.1111/j.1365-313X.2006.02795.x; Varallyay E, 2010, EMBO J, V29, P3507, DOI 10.1038/emboj.2010.215; Varshney RK, 2006, TRENDS BIOTECHNOL, V24, P490, DOI 10.1016/j.tibtech.2006.08.006; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang CM, 2013, INT J BIOL SCI, V9, P578, DOI 10.7150/ijbs.6357; Wang HC, 2016, PLANT PHYSIOL, V170, P2365, DOI 10.1104/pp.15.01283; Wang L, 2015, P NATL ACAD SCI USA, V112, P15504, DOI 10.1073/pnas.1521949112; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang YM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01722; Wang Y, 2011, PLANT CELL, V23, P3185, DOI 10.1105/tpc.111.088013; Wang YN, 2015, PLANT PHYSIOL, V168, P101, DOI 10.1104/pp.15.00265; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048445; Wei CH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-743; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705; Wu JG, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.203; Wu JG, 2015, ELIFE, V4, DOI 10.7554/eLife.05733; Xia KF, 2015, PLANT CELL ENVIRON, V38, P2662, DOI 10.1111/pce.12576; Xia KF, 2015, NEW PHYTOL, V208, P790, DOI 10.1111/nph.13513; Xia KF, 2012, PLOS ONE, V7, P364, DOI 10.1371/journal.pone.0030039; Xian ZQ, 2014, J EXP BOT, V65, P6655, DOI 10.1093/jxb/eru387; Xu WH, 2014, NEW PHYTOL, V201, P1396, DOI 10.1111/nph.12598; Yan JJ, 2015, PLANTA, V241, P109, DOI 10.1007/s00425-014-2167-2; Yan YS, 2014, PLANT J, V78, P44, DOI 10.1111/tpj.12446; Yan Z, 2013, MOL PLANT MICROBE IN, V26, P1371, DOI 10.1094/MPMI-04-13-0111-R; Yang CH, 2013, PLANT CELL ENVIRON, V36, P2207, DOI 10.1111/pce.12130; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; Yang L, 2015, J INTEGR PLANT BIOL, V57, P1078, DOI 10.1111/jipb.12348; Yuan N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28791; Zhang C, 2016, MOL PLANT, V9, P1302, DOI 10.1016/j.molp.2016.06.014; Zhang T, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.153, 10.1038/nplants.2016.153]; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhang XH, 2011, FEBS LETT, V585, P435, DOI 10.1016/j.febslet.2010.12.036; Zhang YC, 2013, NAT BIOTECHNOL, V31, P848, DOI 10.1038/nbt.2646; Zhao M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126154; Zhao P, 2015, FUNCT INTEGR GENOMIC, V15, P261, DOI 10.1007/s10142-014-0411-2; Zhao WC, 2015, J EXP BOT, V66, P4653, DOI 10.1093/jxb/erv238; Zhao XY, 2016, PLANT PHYSIOL, V170, P1578, DOI 10.1104/pp.15.01216; Zheng LL, 2015, PLANT BIOTECHNOL J, V13, P329, DOI 10.1111/pbi.12321; Zhou M, 2013, PLANT MOL BIOL, V83, P59, DOI 10.1007/s11103-013-0089-1; Zhu QH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084390; Zhu QH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-149; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811	128	2	2	14	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2055-026X	2055-0278		NAT PLANTS	Nat. Plants	JUL	2017	3	7							17077	10.1038/nplants.2017.77				11	Plant Sciences	Plant Sciences	FB3IW	WOS:000406037200009	28665396				2018-01-05	
J	Venkatratnam, A; Furuya, S; Kosyk, O; Gold, A; Bodnar, W; Konganti, K; Threadgill, DW; Gillespie, KM; Aylor, DL; Wright, FA; Chiu, WA; Rusyn, I				Venkatratnam, Abhishek; Furuya, Shinji; Kosyk, Oksana; Gold, Avram; Bodnar, Wanda; Konganti, Kranti; Threadgill, David W.; Gillespie, Kevin M.; Aylor, David L.; Wright, Fred A.; Chiu, Weihsueh A.; Rusyn, Ivan			Editor's Highlight: Collaborative Cross Mouse Population Enables Refinements to Characterization of the Variability in Toxicokinetics of Trichloroethylene and Provides Genetic Evidence for the Role of PPAR Pathway in Its Oxidative Metabolism	TOXICOLOGICAL SCIENCES			English	Article						population; trichloroethylene; mouse	DIVERSITY OUTBRED MICE; ACTIVATED RECEPTOR-ALPHA; TISSUE-SPECIFIC TOXICITY; LIVER-TUMOR-INDUCTION; ENVIRONMENTAL CHEMICALS; INTERSTRAIN VARIABILITY; B6C3F1 MICE; TRICHLOROACETATE; HEPATOTOXICITY; MECHANISMS	Background: Trichloroethylene (TCE) is a known carcinogen in humans and rodents. Previous studies of inter-strain variability in TCE metabolism were conducted in multi-strain panels of classical inbred mice with limited genetic diversity to identify gene-environment interactions associated with chemical exposure. Objectives: To evaluate inter-strain variability in TCE metabolism and identify genetic determinants that are associated with TCE metabolism and effects using Collaborative Cross (CC), a large panel of genetically diverse strains of mice. Methods: We administered a single oral dose of 0, 24, 80, 240, or 800 mg/kg of TCE to mice from 50 CC strains, and collected organs 24 h post-dosing. Levels of trichloroacetic acid (TCA), a major oxidative metabolite of TCE were measured in multiple tissues. Protein expression and activity levels of TCE-metabolizing enzymes were evaluated in the liver. Liver transcript levels of known genes perturbed by TCE exposure were also quantified. Genetic association mapping was performed on the acquired phenotypes. Results: TCA levels varied in a dose- and strain-dependent manner in liver, kidney, and serum. The variability in TCA levels among strains did not correlate with expression or activity of a number of enzymes known to be involved in TCE oxidation. Peroxisome proliferator-activated receptor alpha (PPAR alpha)-responsive genes were found to be associated with strain-specific differences in TCE metabolism. Conclusions: This study shows that CC mouse population is a valuable tool to quantitatively evaluate inter-individual variability in chemical metabolism and to identify genes and pathways that may underpin population differences.	[Venkatratnam, Abhishek; Furuya, Shinji; Chiu, Weihsueh A.; Rusyn, Ivan] Texas A&M Univ, Dept Vet Integrat Biosci, 4458 TAMU, College Stn, TX 77843 USA; [Venkatratnam, Abhishek; Kosyk, Oksana; Gold, Avram; Bodnar, Wanda] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA; [Konganti, Kranti; Threadgill, David W.] Texas A&M Univ, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Gillespie, Kevin M.; Aylor, David L.; Wright, Fred A.] North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Gillespie, Kevin M.; Aylor, David L.; Wright, Fred A.] North Carolina State Univ, Dept Stat Sci, Raleigh, NC 27695 USA; [Gillespie, Kevin M.; Aylor, David L.; Wright, Fred A.] North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA	Rusyn, I (reprint author), Texas A&M Univ, Dept Vet Integrat Biosci, 4458 TAMU, College Stn, TX 77843 USA.	irusyn@cvm.tamu.edu			U.S. Environmental Protection Agency [STAR RD83561202]; National Institute of Environmental Health Sciences [P42 ES005948]	U.S. Environmental Protection Agency (STAR RD83561202); National Institute of Environmental Health Sciences (P42 ES005948).	Aylor DL, 2011, GENOME RES, V21, P1213, DOI 10.1101/gr.111310.110; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018                                            ; Bogue MA, 2015, MAMM GENOME, V26, P511, DOI 10.1007/s00335-015-9595-6; Bradford BU, 2011, TOXICOL SCI, V120, P206, DOI 10.1093/toxsci/kfq362; Bronley-DeLancey A, 2006, ENVIRON HEALTH PERSP, V114, P1237, DOI 10.1289/ehp.9047; BULL RJ, 1990, TOXICOLOGY, V63, P341, DOI 10.1016/0300-483X(90)90195-M; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chiu WA, 2014, ENVIRON HEALTH PERSP, V122, P456, DOI 10.1289/ehp.1307623; Chiu WHA, 2013, ENVIRON HEALTH PERSP, V121, P303, DOI 10.1289/ehp.1205879; Church RJ, 2015, FOOD CHEM TOXICOL, V76, P19, DOI 10.1016/j.fct.2014.11.008; Cichocki JA, 2016, J PHARMACOL EXP THER, V359, P110, DOI 10.1124/jpet.116.232629; Corton JC, 2008, CRIT REV TOXICOL, V38, P857, DOI [10.1080/10408440802209796, 10.1080/10408440802209796 ]; Domino M. M., 2003, 5523 US EPA; Durrant C, 2011, GENOME RES, V21, P1239, DOI 10.1101/gr.118786.110; Fang ZZ, 2013, ARCH TOXICOL, V87, P1975, DOI 10.1007/s00204-013-1053-1; Ferris MT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003196; FESTING MFW, 1995, ENVIRON HEALTH PERSP, V103, P44, DOI 10.2307/3432255                                                                 ; French JE, 2015, ENVIRON HEALTH PERSP, V123, P237, DOI 10.1289/ehp.1408202; Gatti DM, 2014, G3-GENES GENOM GENET, V4, P1623, DOI 10.1534/g3.114.013748; Harrill AH, 2012, TOXICOL SCI, V130, P416, DOI 10.1093/toxsci/kfs238; Harrill AH, 2009, GENOME RES, V19, P1507, DOI 10.1101/gr.090241.108; Harrill AH, 2009, TOXICOL SCI, V110, P235, DOI 10.1093/toxsci/kfp096; Ito Y, 2007, ARCH TOXICOL, V81, P219, DOI 10.1007/s00204-006-0141-x; Kaeppler SM, 1997, THEOR APPL GENET, V95, P384, DOI 10.1007/s001220050574; Kim S, 2009, TOXICOL APPL PHARM, V238, P90, DOI 10.1016/j.taap.2009.04.019; Koturbash I, 2011, TOXICOL SCI, V122, P448, DOI 10.1093/toxsci/kfr133; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Lash LH, 2014, MUTAT RES-REV MUTAT, V762, P22, DOI 10.1016/j.mrrev.2014.04.003; Lash LH, 2006, J TOXICOL ENV HEAL A, V69, P1285, DOI 10.1080/15287390500360133; Lash LH, 2000, ENVIRON HEALTH PERSP, V108, P177, DOI 10.1289/ehp.00108s2177                                                          ; Li R, 2016, LIFE SCI, V147, P59, DOI 10.1016/j.lfs.2016.01.028; Liu CX, 2000, GENOMICS, V69, P271, DOI 10.1006/geno.2000.6331; Maloney EK, 1999, TOXICOL APPL PHARM, V161, P209, DOI 10.1006/taap.1999.8809; MULLER G, 1974, ARCH TOXICOL, V32, P283, DOI 10.1007/BF00330110; MULLER G, 1975, ARCH TOXICOL, V33, P173, DOI 10.1007/BF00311271; National Toxicology Program, 1990, NATL TOXICOL PROGRAM, V243, P1; Pastino GM, 2000, ENVIRON HEALTH PERSP, V108, P201, DOI 10.1289/ehp.00108s2201                                                          ; PROUT MS, 1985, TOXICOL APPL PHARM, V79, P389, DOI 10.1016/0041-008X(85)90137-1                                                    ; Ramdhan DH, 2008, TOXICOL APPL PHARM, V231, P300, DOI 10.1016/j.taap.2008.04.020; Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595; Rogala AR, 2014, MAMM GENOME, V25, P95, DOI 10.1007/s00335-013-9499-2; Rusyn I, 2014, PHARMACOL THERAPEUT, V141, P55, DOI 10.1016/j.pharmthera.2013.08.004; Threadgill DW, 2012, GENETICS, V190, P291, DOI 10.1534/genetics.111.138032; Yan Z., 2004, OPTIMIZATION DRUG DI; Yoo HS, 2015, TOXICOL SCI, V147, P339, DOI 10.1093/toxsci/kfv134; Yoo HS, 2015, J TOXICOL ENV HEAL A, V78, P15, DOI 10.1080/15287394.2015.958417; Yoo HS, 2015, J TOXICOL ENV HEAL A, V78, P32, DOI 10.1080/15287394.2015.958418; Zeise L, 2013, ENVIRON HEALTH PERSP, V121, P23, DOI 10.1289/ehp.1205687; Zhou YC, 1998, ENVIRON HEALTH PERSP, V106, P983, DOI 10.2307/3434141                                                                 	49	2	2	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	JUL	2017	158	1					48	62		10.1093/toxsci/kfx065				15	Toxicology	Toxicology	FA8LZ	WOS:000405698800005	28369613				2018-01-05	
J	Kania-Korwel, I; Lukasiewicz, T; Barnhart, CD; Stamou, M; Chung, H; Kelly, KM; Bandiera, S; Lein, PJ; Lehmler, HJ				Kania-Korwel, Izabela; Lukasiewicz, Tracy; Barnhart, Christopher D.; Stamou, Marianna; Chung, Haeun; Kelly, Kevin M.; Bandiera, Stelvio; Lein, Pamela J.; Lehmler, Hans-Joachim			Editor's Highlight: Congener-Specific Disposition of Chiral Polychlorinated Biphenyls in Lactating Mice and Their Offspring: Implications for PCB Developmental Neurotoxicity	TOXICOLOGICAL SCIENCES			English	Article						atropisomer; chiral; cytochrome P450 enzymes; metabolites; persistent organic pollutants; polychlorinated biphenyls; plasticity	CEREBELLAR GRANULE CELLS; RECEPTOR-DEPENDENT MECHANISMS; HYDROXYLATED METABOLITES; 4-HYDROXY-2,3,3',4',5-PENTACHLOROBIPHENYL 4-OH-CB107; HIPPOCAMPAL-NEURONS; DENDRITIC GROWTH; LIVER-MICROSOMES; RAT CEREBELLUM; MOTOR-ACTIVITY; ESTER BINDING	Chiral polychlorinated biphenyl (PCB) congeners have been implicated by laboratory and epidemiological studies in PCB developmental neurotoxicity. These congeners are metabolized by cytochrome P450 (P450) enzymes to potentially neurotoxic hydroxylated metabolites (OH-PCBs). The present study explores the enantioselective disposition and toxicity of 2 environmentally relevant, neurotoxic PCB congeners and their OH-PCB metabolites in lactating mice and their offspring following dietary exposure of the dam. Female C57BL/6N mice (8-weeks old) were fed daily, beginning 2 weeks prior to conception and continuing throughout gestation and lactation, with 3.1 A mu mol/kg bw/d of racemic 2,2',3,5',6-pentachlorobiphenyl (PCB 95) or 2,2',3,3',6,6'-hexachlorobiphenyl (PCB 136) in peanut butter; controls received vehicle (peanut oil) in peanut butter. PCB 95 levels were higher than PCB 136 levels in both dams and pups, consistent with the more rapid metabolism of PCB 136 compared with PCB 95. In pups and dams, both congeners were enriched for the enantiomer eluting second on enantioselective gas chromatography columns. OH-PCB profiles in lactating mice and their offspring were complex and varied according to congener, tissue and age. Developmental exposure to PCB 95 versus PCB 136 differentially affected the expression of P450 enzymes as well as neural plasticity (arc and ppp1r9b) and thyroid hormone-responsive genes (nrgn and mbp). The results suggest that the enantioselective metabolism of PCBs to OH-PCBs may influence neurotoxic outcomes following developmental exposures, a hypothesis that warrants further investigation.	[Kania-Korwel, Izabela; Lukasiewicz, Tracy; Kelly, Kevin M.; Lehmler, Hans-Joachim] Univ Iowa, Coll Publ Hlth, Dept Occupat & Environm Hlth, Iowa City, IA USA; [Barnhart, Christopher D.; Stamou, Marianna; Lein, Pamela J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Chung, Haeun; Bandiera, Stelvio] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada; [Kania-Korwel, Izabela; Lehmler, Hans-Joachim] Hlth Res Inst Labs, Fairfield, IA USA; [Barnhart, Christopher D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Stamou, Marianna] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland	Lehmler, HJ (reprint author), Univ Iowa, Dept Occupat & Environm Hlth, Univ Iowa Res Pk,221 IREH, Iowa City, IA 52242 USA.	hans-joachim-lehmler@uiowa.edu	Kelly, Kevin/E-2716-2013	Kelly, Kevin/0000-0002-9177-1454; Lein, Pamela/0000-0001-7665-7584	National Institute of Environmental Health Science at the National Institute of Health [ES005605, ES013661, ES014901, ES023513, ES011269, ES017425, ES007059]; U.S. Environmental Protection Agency [RD83543201]; Natural Sciences and Engineering Research Council of Canada; Advancing Science in America (ARCS) Fellowship; National Institutes of Health [ES06694]	This work was supported by the National Institute of Environmental Health Science at the National Institute of Health (ES005605 and ES013661 to H-J.L., ES014901, ES023513 and ES011269 to P.J.L., ES017425 to H-J.L. and P.J.L., ES007059 to C.B.); U.S. Environmental Protection Agency (RD83543201 to P.J.L.); Natural Sciences and Engineering Research Council of Canada (14 April 2017 to S.M.B.); and Advancing Science in America (ARCS) Fellowship (to C.B.). The synthesis of metabolites of PCB 136 was supported by the National Institutes of Health (ES06694 to EA Mash and SC Waller of the Synthetic Chemistry Facility Core of the Southwest Environmental Health Sciences Center). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Bal-Price A, 2017, NEUROTOXICOLOGY, V59, P240, DOI 10.1016/j.neuro.2016.05.010; Boix J, 2011, NEUROCHEM INT, V58, P69, DOI 10.1016/j.neuint.2010.10.014; Cauli O, 2013, TOXICOLOGY, V311, P61, DOI 10.1016/j.tox.2012.11.016; Dreiem A, 2009, TOXICOL APPL PHARM, V240, P306, DOI 10.1016/j.taap.2009.07.016; Dziennis S, 2008, ENVIRON HEALTH PERSP, V116, P474, DOI [10.1289/ehp.10828, 10.1289/chp.10828]; Grimm FA, 2015, CRIT REV TOXICOL, V45, P245, DOI 10.3109/10408444.2014.999365; Guvenius DM, 2003, ENVIRON HEALTH PERSP, V111, P1235, DOI 10.1289/ehp.5946; Hrycay E, 2014, MOL CELL BIOCHEM, V389, P119, DOI 10.1007/s11010-013-1933-y; Jacobson JL, 1996, NEW ENGL J MED, V335, P783, DOI 10.1056/NEJM199609123351104; Jamshidi A, 2007, ENVIRON SCI TECHNOL, V41, P2153, DOI 10.1021/es062218c; Joshi SN, 2011, SYNTHESIS-STUTTGART, P1045, DOI 10.1055/s-0030-1258454; Kania-Korwel I, 2008, J CHROMATOGR A, V1207, P146, DOI 10.1016/j.chroma.2008.08.044; Kania-Korwel I, 2008, CHEM RES TOXICOL, V21, P1295, DOI 10.1021/tx800059j; Kania-Korwel I, 2016, ENVIRON SCI POLLUT R, V23, P2042, DOI 10.1007/s11356-015-4150-2; Kania-Korwel I, 2016, ENVIRON SCI POLLUT R, V23, P2058, DOI 10.1007/s11356-015-4383-0; Kania-Korwel I, 2015, CHEM RES TOXICOL, V28, P1774, DOI 10.1021/acs.chemrestox.5b00241; Kania-Korwel I, 2007, CHIRALITY, V19, P56, DOI 10.1002/chir.20342; Kania-Korwel I, 2012, ENVIRON SCI TECHNOL, V46, P11393, DOI 10.1021/es302810t; Kania-Korwel I, 2011, ENVIRON SCI TECHNOL, V45, P9590, DOI 10.1021/es2014727; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; Kodavanti PRS, 2010, FRONT NEUROENDOCRIN, V31, P479, DOI 10.1016/j.yfrne.2010.06.005; Kodavanti PRS, 2003, NEUROTOXICOLOGY, V24, P187, DOI 10.1016/S0161-813X(02)00215-2; Korrick SA, 2008, CURR OPIN PEDIATR, V20, P198, DOI 10.1097/MOP.0b013e3282f6a4e9; Krucker T, 2002, J NEUROSCI, V22, P5525; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehmler HJ, 2010, ENVIRON SCI TECHNOL, V44, P2757, DOI 10.1021/es902208u; Lehmler HJ, 2005, TOXICOL LETT, V156, P391, DOI 10.1016/j.toxlet.2004.12.011; Lein P. J., 2007, ENV HLTH PERSPECT, P556; Lesiak A, 2014, J NEUROSCI, V34, P717, DOI 10.1523/JNEUROSCI.2884-13.2014; Lu Z, 2013, ENVIRON SCI TECHNOL, V47, P12184, DOI 10.1021/es402838f; LUCIER GW, 1978, DRUG METAB DISPOS, V6, P584; Meerts IATM, 2004, TOXICOL SCI, V82, P259, DOI 10.1093/toxsci/kfh251; Meerts IATM, 2004, TOXICOL SCI, V82, P207, DOI 10.1093/toxsci/kfh252; Meerts IATM, 2002, TOXICOL SCI, V68, P361, DOI 10.1093/toxsci/68.2.361; Megson D, 2013, SCI TOTAL ENVIRON, V461, P99, DOI 10.1016/j.scitotenv.2013.04.082; Mitchell MM, 2012, ENVIRON MOL MUTAGEN, V53, P589, DOI 10.1002/em.21722; MORSE DC, 1995, CHEM-BIOL INTERACT, V95, P41, DOI 10.1016/0009-2797(94)03347-1; Ngui JS, 1999, TOXICOL APPL PHARM, V161, P160, DOI 10.1006/taap.1999.8787; Niknam Y, 2013, TOXICOL SCI, V136, P500, DOI 10.1093/toxsci/kft202; Nowack N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129906; Park JS, 2007, ENVIRON HEALTH PERSP, V115, P20, DOI 10.1289/ehp.8913; Pessah IN, 2006, CHEM RES TOXICOL, V19, P92, DOI 10.1021/tx050196m; Pessah IN, 2010, PHARMACOL THERAPEUT, V125, P260, DOI 10.1016/j.pharmthera.2009.10.009; Pessah IN, 2009, CHEM RES TOXICOL, V22, P201, DOI 10.1021/tx800328u; Santos ARA, 2008, J NEUROSCI RES, V86, P3684, DOI 10.1002/jnr.21796; SAS Institute, 2013, BAS SAS 9 4 PORC GUI; SCHANTZ SL, 1995, FUND APPL TOXICOL, V26, P117, DOI 10.1006/faat.1995.1081                                                          ; Schantz SL, 1997, NEUROTOXICOLOGY, V18, P457; Schecter A, 2010, ENVIRON HEALTH PERSP, V118, P796, DOI 10.1289/ehp.0901347; Segal M, 2001, NEURON, V31, P169, DOI 10.1016/S0896-6273(01)00368-3                                                   ; Shin ES, 2015, ENVIRON POLLUT, V207, P403, DOI 10.1016/j.envpol.2015.08.051; Soechitram SD, 2004, ENVIRON HEALTH PERSP, V112, P1208, DOI 10.1289/ehp.6424; Stamou M, 2015, TOXICOLOGY, V338, P59, DOI 10.1016/j.tox.2015.10.002; Stamou M, 2014, DRUG METAB DISPOS, V42, P239, DOI 10.1124/dmd.113.054239; Thomas K., 2012, POLYCHLORINATED BIPH; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Uwimana E, 2016, CHEM RES TOXICOL, V29, P2108, DOI 10.1021/acs.chemrestox.6b00371; Waller SC, 1999, CHEM RES TOXICOL, V12, P690, DOI 10.1021/tx990030j; Wang A., 1996, BIOCHEM PHARMACOL, V52, P735; Warner NA, 2009, ENVIRON SCI TECHNOL, V43, P114, DOI 10.1021/es802237u; Wayman GA, 2012, ENVIRON HEALTH PERSP, V120, P997, DOI 10.1289/ehp.1104832; Wayman GA, 2012, ENVIRON HEALTH PERSP, V120, P1003, DOI 10.1289/ehp.1104833; Whitcomb BW, 2005, ENVIRON TOXICOL PHAR, V19, P203, DOI 10.1016/j.etap.2004.04.009; Wingfors H, 2006, ANN OCCUP HYG, V50, P65, DOI 10.1093/annhyg/mei063; WOLFF MS, 1992, ENVIRON RES, V59, P202, DOI 10.1016/S0013-9351(05)80240-3; Wu XN, 2015, ENVIRON SCI TECHNOL, V49, P616, DOI 10.1021/es504766p; Wu XN, 2013, CHEM RES TOXICOL, V26, P1642, DOI 10.1021/tx400229e; Yang DR, 2014, TOXICOL SCI, V138, P379, DOI 10.1093/toxsci/kft334; Yang D, 2009, ENVIRON HEALTH PERSP, V117, P426, DOI 10.1289/ehp.11771; Yang H, 2014, PROTEIN CELL, V5, P113, DOI 10.1007/s13238-013-0013-0; Zoeller RT, 2000, ENDOCRINOLOGY, V141, P181, DOI 10.1210/endo.141.1.7273	71	0	0	10	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	JUL	2017	158	1					101	115		10.1093/toxsci/kfx071				15	Toxicology	Toxicology	FA8LZ	WOS:000405698800009	28431184				2018-01-05	
J	Nwanaji-Enwerem, JC; Bind, MA; Dai, LZ; Oulhote, Y; Colicino, E; Di, Q; Just, AC; Hou, LF; Vokonas, P; Coull, BA; Weisskopf, MG; Baccarelli, AA; Schwartz, JD				Nwanaji-Enwerem, Jamaji C.; Bind, Marie-Abele; Dai, Lingzhen; Oulhote, Youssef; Colicino, Elena; Di, Qian; Just, Allan C.; Hou, Lifang; Vokonas, Pantel; Coull, Brent A.; Weisskopf, Marc G.; Baccarelli, Andrea A.; Schwartz, Joel D.			Editor's Highlight: Modifying Role of Endothelial Function Gene Variants on the Association of Long-Term PM2.5 Exposure With Blood DNA Methylation Age: The VA Normative Aging Study	TOXICOLOGICAL SCIENCES			English	Article						DNA methylation age; particulate matter 2; 5; endothelial function	PARTICULATE AIR-POLLUTION; OXIDE SYNTHASE GENE; LUNG-CANCER; PROGENITOR CELLS; ELDERLY COHORT; FINE PARTICLES; DISEASE; REGULARIZATION; DYSFUNCTION; COMPONENTS	Recent studies have reported robust associations of long-term PM2.5 exposure with DNA methylation-based measures of aging; yet, the molecular implications of these relationships remain poorly understood. We evaluated if genetic variation in 3 biological pathways implicated in PM2.5-related disease-oxidative stress, endothelial function, and metal processing-could modify the effect of PM2.5 on DNAm-age, one prominent DNA methylation-based measure of biological age. This analysis was based on 552 individuals from the Normative Aging Study with at least one visit between 2000 and 2011 (n = 940 visits). A genetic-score approach was used to calculate aging-risk variant scores for endothelial function, oxidative stress, and metal processing pathways. One-year PM2.5 and PM2.5 component (sulfate and ammonium) levels at participants' addresses were estimated using the GEOS-chem transport model. Blood DNAm-age was calculated using CpG sites on the Illumina HumanMethylation450 BeadChip. In fully-adjusted linear mixed-effects models, the effects of sulfate on DNAm-age (in years) were greater in individuals with high aging-risk endothelial function variant scores when compared with individuals with low aging-risk endothelial function variant scores Similar trends were observed in fully adjusted models of ammonium and total alone. No effect modification was observed by oxidative stress and metal processing variant scores. Secondary analyses revealed significant associations of serum endothelial markers, intercellular adhesion molecule-1 (beta = 0.01, 95% CI: 0.002, 0.012) and vascular cell adhesion molecule-1 (beta = 0.002, 95% CI: 0.0005, 0.0026), with DNAm-age. Our results add novel evidence that endothelial physiology may be important to DNAm-age relationships, but further research is required to establish their generalizability.	[Nwanaji-Enwerem, Jamaji C.; Dai, Lingzhen; Oulhote, Youssef; Di, Qian; Weisskopf, Marc G.; Schwartz, Joel D.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Bind, Marie-Abele] Harvard Univ, Dept Stat, Fac Arts & Sci, Cambridge, MA 02138 USA; [Colicino, Elena; Baccarelli, Andrea A.] Columbia Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [Just, Allan C.] Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA; [Hou, Lifang] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Vokonas, Pantel] Vet Affairs Boston Healthcare Syst, Dept Med, Boston, MA USA; [Vokonas, Pantel] Boston Univ, Sch Med, VA Normat Aging Study, Boston, MA 02118 USA; [Coull, Brent A.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA	Nwanaji-Enwerem, JC (reprint author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Biol Sci Publ Hlth, Bldg 1,Room G7,665 Huntington Ave, Boston, MA 02115 USA.	jnwanajienwerem@g.harvard.edu	Chem, GEOS/C-5595-2014		National Institute of Environmental Health Sciences (NIEHS) [R01ES021733, R01ES025225]; NIEHS [ES015172, ES014663, ES020010, P30ES009089]; Environmental Protection Agency (EPA) [RD832416, RD83587201]; National Heart, Lung, and Blood Institute (NHLBI) [2T32HL007118-41]; Office of the Director, National Institutes of Health of the National Institutes of Health [DP5OD021412]; Cooperative Studies Program/ERIC, U.S. Department of VA; U.S. Department of Agriculture, Agricultural Research Service [53-K06-510]	This work was supported by grants from the National Institute of Environmental Health Sciences (NIEHS) (R01ES021733 and R01ES025225). Other support comes from NIEHS grants (ES015172, ES014663, ES020010, P30ES009089); Environmental Protection Agency (EPA) grants RD832416 and RD83587201; and National Heart, Lung, and Blood Institute (NHLBI) grant (2T32HL007118-41). Research reported in this publication was also supported by the Office of the Director, National Institutes of Health of the National Institutes of Health under Award Number (DP5OD021412). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The U.S. Department of VA Normative Aging Study (NAS) is supported by the Cooperative Studies Program/ERIC, U.S. Department of VA, and is a research component of the Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC). The views expressed in this article are those of the authors and do not necessarily represent the views of the U.S. Department of VA. Additional support was provided by the U.S. Department of Agriculture, Agricultural Research Service (contract 53-K06-510).	Abbas M, 2017, CIRCULATION, V135, P280, DOI 10.1161/CIRCULATIONAHA.116.017513; Alexeeff SE, 2011, ENVIRON HEALTH PERSP, V119, P481, DOI 10.1289/ehp.1002560; ANDO K, 1994, HYPERTENSION, V24, P189, DOI 10.1161/01.HYP.24.2.189                                                         ; Apte JS, 2015, ENVIRON SCI TECHNOL, V49, P8057, DOI 10.1021/acs.est.5b01236; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Ayala-Haedo JA, 2010, ANN HUM GENET, V74, P195, DOI 10.1111/j.1469-1809.2010.00570.x; BELL B, 1966, GERONTOLOGIST, V6, P179, DOI 10.1093/geront/6.4.179                                                          ; Bind MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096000; Chen BH, 2016, AGING-US, V8, P1844, DOI 10.18632/aging.101020; Chen SJ, 2017, ENVIRON SCI TECHNOL, V51, P1687, DOI 10.1021/acs.est.6b03901; Dadvand P, 2014, OCCUP ENVIRON MED, V71, P570, DOI 10.1136/oemed-2013-101693; Dai LZ, 2016, J EXPO SCI ENV EPID, V26, P415, DOI 10.1038/jes.2015.83; Di Q, 2016, ATMOS ENVIRON, V131, P390, DOI 10.1016/j.atmosenv.2016.02.002; Fan A. M., 2015, TOXICOLOGY RISK ASSE; Friedman J, 2010, J STAT SOFTW, V33, P1; Glad JA, 2012, ARCH ENVIRON OCCUP H, V67, P103, DOI 10.1080/19338244.2011.598888; Hancock DB, 2008, NEUROGENETICS, V9, P249, DOI 10.1007/s10048-008-0137-1; Horvath S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1030-0; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019; Kang JH, 2010, INVEST OPHTH VIS SCI, V51, P971, DOI 10.1167/iovs.09-4266; Kioumourtzoglou MA, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-2; Lane-Cordova AD, 2016, J HYPERTENS, V34, P2402, DOI 10.1097/HJH.0000000000001103; Lenters V, 2016, ENVIRON HEALTH PERSP, V124, P365, DOI 10.1289/ehp.1408933; Lepeule J, 2012, ENVIRON HEALTH PERSP, V120, P965, DOI 10.1289/ehp.1104660; Lever J, 2016, NAT METHODS, V13, P803, DOI 10.1038/nmeth.4014; Levine ME, 2015, AGING-US, V7, P690, DOI 10.18632/aging.100809                                                           ; Lin CJ, 2016, KIDNEY BLOOD PRESS R, V41, P1025, DOI 10.1159/000452604; Lowe D, 2016, ONCOTARGET, V7, P8524, DOI 10.18632/oncotarget.7383; Martinelli N, 2013, EUR J INTERN MED, V24, P295, DOI 10.1016/j.ejim.2013.04.001; Mayor S, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5244; Mendonca GV, 2017, SPORTS MED, V47, P583, DOI 10.1007/s40279-016-0596-8; Mordukhovich I, 2016, EPIDEMIOLOGY, V27, P284, DOI 10.1097/EDE.0000000000000424; Mordukhovich I, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0074-z; Nwanaji-Enwerem J. C., 2017, ENV INT IN PRESS; Nwanaji-Enwerem J. C., 2016, ENV EPIGENET, V2; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Power MC, 2011, ENVIRON HEALTH PERSP, V119, P682, DOI 10.1289/ehp.1002767; Raaschou-Nielsen O, 2016, ENVIRON INT, V87, P66, DOI 10.1016/j.envint.2015.11.007; Reinders J, 2010, EPIGENOMICS-UK, V2, P209, DOI 10.2217/EPI.10.6; Ren C, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-78; Ren CZ, 2010, EPIDEMIOLOGY, V21, P198, DOI 10.1097/EDE.0b013e3181cc8bfc; Ricottini E, 2016, AM J CARDIOL, V117, P165, DOI 10.1016/j.amjcard.2015.10.043; Rowe JW, 2015, J GERONTOL B-PSYCHOL, V70, P593, DOI 10.1093/geronb/gbv025; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Schikowski T, 2015, ENVIRON RES, V142, P10, DOI 10.1016/j.envres.2015.06.009; Schnoor M, 2015, MEDIAT INFLAMM, DOI 10.1155/2015/946509; Tchalla AE, 2017, J GERONTOL A-BIOL, V72, P560, DOI 10.1093/gerona/glw099; Toth P., 2016, AM J PHYSIOL-HEART C, V312, pH1; Velez DR, 2009, HUM GENET, V126, P643, DOI 10.1007/s00439-009-0713-y; Ward-Caviness CK, 2016, ONCOTARGET, V7, P74510, DOI 10.18632/oncotarget.12903; Weisskopf M. G., 2017, TRADE OFFS SONAL VS; Wolf EJ, 2016, PSYCHONEUROENDOCRINO, V63, P155, DOI 10.1016/j.psyneuen.2015.09.020; Wu SW, 2016, SCI TOTAL ENVIRON, V560, P141, DOI 10.1016/j.scitotenv.2016.03.228; Xiao X, 2016, ENVIRON POLLUT, V218, P487, DOI 10.1016/j.envpol.2016.07.028; Zanobetti A, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-58; Zhang J, 2014, RADIOTHER ONCOL, V111, P194, DOI 10.1016/j.radonc.2014.03.001; Zhong J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001423; Zou H, 2005, J ROY STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x                                                	60	1	1	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	JUL	2017	158	1					116	126		10.1093/toxsci/kfx077				11	Toxicology	Toxicology	FA8LZ	WOS:000405698800010	28486674				2018-01-05	
J	Sanders, LH; Paul, KC; Howlett, EH; Lawal, H; Boppana, S; Bronstein, JM; Ritz, B; Greenamyre, JT				Sanders, Laurie H.; Paul, Kimberly C.; Howlett, Evan H.; Lawal, Hakeem; Boppana, Sridhar; Bronstein, Jeff M.; Ritz, Beate; Greenamyre, J. Timothy			Editor's Highlight: Base Excision Repair Variants and Pesticide Exposure Increase Parkinson's Disease Risk	TOXICOLOGICAL SCIENCES			English	Article						Parkinson's disease; base excision repair; pesticides; gene-environment interaction; mitochondrial DNA; paraquat	MITOCHONDRIAL-DNA DAMAGE; GENE-ENVIRONMENT INTERACTIONS; OXIDATIVE-STRESS; DROSOPHILA-MELANOGASTER; PARAQUAT EXPOSURE; NIGRAL NEURONS; DYSFUNCTION; MODEL; CANCER; NEURODEGENERATION	Exposure to certain pesticides induces oxidative stress and increases Parkinson's disease (PD) risk. Mitochondrial DNA (mtDNA) damage is found in dopaminergic neurons in idiopathic PD and following pesticide exposure in experimental models thereof. Base excision repair (BER) is the major pathway responsible for repairing oxidative DNA damage in cells. Whether single nucleotide polymorphisms (SNPs) in BER genes alone or in combination with pesticide exposure influence PD risk is unknown. We investigated the contributions of functional SNPs in 2 BER genes (APEX1 and OGG1) and mitochondrial dysfunction- or oxidative stress-related pesticide exposure, including paraquat, to PD risk. We also studied the effect of paraquat on levels of mtDNA damage and mitochondrial bioenergetics. 619 PD patients and 854 population-based controls were analyzed for the 2 SNPs, APEX1 rs1130409 and OGG1 rs1052133. Ambient pesticide exposures were assessed with a geographic information system. Individually, or in combination, the BER SNPs did not influence PD risk. Mitochondrial-inhibiting (OR = 1.79, 95% CI [1.32, 2.42]), oxidative stress-inducing pesticides (OR = 1.61, 95% CI [1.22, 2.11]), and paraquat (OR = 1.54, 95% CI [1.23, 1.93]) were associated with PD. Statistical interactions were detected, including for a genetic risk score based on rs1130409 and rs1052133 and oxidative stress inducing pesticides, where highly exposed carriers of both risk genotypes were at the highest risk of PD (OR = 2.21, 95% CI [1.25, 3.86]); similar interactions were estimated for mitochondrial-inhibiting pesticides and paraquat alone. Additionally, paraquat exposure was found to impair mitochondrial respiration and increase mtDNA damage in in vivo and in vitro systems. Our findings provide insight into possible mechanisms involved in increased PD risk due to pesticide exposure in the context of BER genotype variants.	[Sanders, Laurie H.; Howlett, Evan H.; Greenamyre, J. Timothy] Univ Pittsburgh, Dept Neurol, Pittsburgh Inst Neurodegenerat Dis, 3501 Fifth Ave,Suite 7039, Pittsburgh, PA 15260 USA; [Paul, Kimberly C.; Ritz, Beate] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, POB 951772, Los Angeles, CA 90095 USA; [Lawal, Hakeem; Boppana, Sridhar] Delaware State Univ, Dept Biol Sci, Neurosci Program, Delaware, OH 19901 USA; [Bronstein, Jeff M.; Ritz, Beate] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	Greenamyre, JT (reprint author), Univ Pittsburgh, Dept Neurol, Pittsburgh Inst Neurodegenerat Dis, 3501 Fifth Ave,Suite 7039, Pittsburgh, PA 15260 USA.; Ritz, B (reprint author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, POB 951772, Los Angeles, CA 90095 USA.	britz@ucla.edu; jgreena@pitt.edu		Paul, Kimberly/0000-0002-4476-2352	National Institute of Environmental Health Sciences at the National Institutes of Health [R01ES010544, P01ES016732, U54ES12078, R01ES020718]; SCEHSC [5P30 ES07048]; American Parkinson Disease Association; Burroughs Wellcome Fund Population and Laboratory Based Sciences Award; Pittsburgh Claude D. Pepper OAIC; William N. and Bernice E. Bumpus Foundation Innovation Award	National Institute of Environmental Health Sciences at the National Institutes of Health (grant number R01ES010544, P01ES016732, U54ES12078), pilot funding from SCEHSC No. 5P30 ES07048 and The American Parkinson Disease Association (B.R. and J.T.G.); Burroughs Wellcome Fund Population and Laboratory Based Sciences Award (K.C.P.); Pittsburgh Claude D. Pepper OAIC (L.H.S.); William N. and Bernice E. Bumpus Foundation Innovation Award (L.H.S.); National Institute of Environmental Health Sciences at the National Institutes of Health (grant number R01ES020718) (J.T.G.).	Arai T, 2006, ACTA NEUROPATHOL, V112, P139, DOI 10.1007/s00401-006-0081-9; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; BAUD FJ, 1988, J TOXICOL-CLIN TOXIC, V26, P35, DOI 10.3109/15563658808995396                                                       ; Bettencourt C, 2016, ANN NEUROL, V79, P983, DOI 10.1002/ana.24656; Biernacka JM, 2016, PARKINSONISM RELAT D, V32, P25, DOI 10.1016/j.parkreldis.2016.08.002; Breton CV, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-39; Bronstein J, 2009, ENVIRON HEALTH PERSP, V117, P117, DOI 10.1289/ehp.11702; Chaudhuri A, 2007, J NEUROSCI, V27, P2457, DOI 10.1523/JNEUROSCI.4239-06.2007; Cockburn M, 2011, AM J EPIDEMIOL, V173, P1280, DOI 10.1093/aje/kwr003; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Czerniczyniec A, 2011, FREE RADICAL BIO MED, V51, P1428, DOI 10.1016/j.freeradbiomed.2011.06.034; de Oliveira MR, 2017, MOL NEUROBIOL, V54, P6018, DOI 10.1007/s12035-016-0135-5; De Miranda B. R., 2016, MITOCHONDRIAL MECH D, DOI [10.1007/978-3-319-42139-1, DOI 10.1007/978-3-319-42139-1]; Dhillon Amanpreet S, 2008, J Agromedicine, V13, P37, DOI 10.1080/10599240801986215; Dick FD, 2007, OCCUP ENVIRON MED, V64, P673, DOI 10.1136/oem.2006.032078; Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012; Elbaz A, 2007, J NEUROL SCI, V262, P37, DOI 10.1016/j.jns.2007.06.024; Erlich PM, 2006, HUM MOL GENET, V15, P77, DOI 10.1093/hmg/ddi428; Fitzmaurice AG, 2013, P NATL ACAD SCI USA, V110, P636, DOI 10.1073/pnas.1220399110; Freire C, 2012, NEUROTOXICOLOGY, V33, P947, DOI 10.1016/j.neuro.2012.05.011; Fukae J, 2005, ACTA NEUROPATHOL, V109, P256, DOI 10.1007/s00401-004-0937-9; Furda A, 2014, METHODS MOL BIOL, V1105, P419, DOI 10.1007/978-1-62703-739-6_31; Gao HM, 2011, PROG NEUROBIOL, V94, P1, DOI 10.1016/j.pneurobio.2011.03.005; Gencer M, 2012, GENET TEST MOL BIOMA, V16, P504, DOI 10.1089/gtmb.2011.0252; Genetic Modifiers of Huntington's Disease (GeM-HD) Consortium, 2015, CELL, V162, P516, DOI DOI 10.1016/J.CELL.2015.07.003; Gonzalez-Hunt CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114459; Hancock DB, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-6; Hosamani R, 2013, ARCH INSECT BIOCHEM, V83, P25, DOI 10.1002/arch.21094; Jeppesen DK, 2011, PROG NEUROBIOL, V94, P166, DOI 10.1016/j.pneurobio.2011.04.013; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Karahalil B, 2012, HUM EXP TOXICOL, V31, P981, DOI 10.1177/0960327112444476; Kowal SL, 2013, MOVEMENT DISORD, V28, P311, DOI 10.1002/mds.25292; Krokan HE, 2013, COLD SPRING HARB PER, V5, DOI DOI 10.1101/CSHPERSPECT.A012583; Kuter K, 2010, NEUROCHEM RES, V35, P1121, DOI 10.1007/s11064-010-0163-x; Kwakye GF, 2017, NEUROCHEM RES, V42, P1772, DOI 10.1007/s11064-016-2052-4; Lauritzen KH, 2011, DNA REPAIR, V10, P639, DOI 10.1016/j.dnarep.2011.04.011; Martinez TN, 2012, ANTIOXID REDOX SIGN, V16, P920, DOI 10.1089/ars.2011.4033; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Meara J, 1999, AGE AGEING, V28, P99, DOI 10.1093/ageing/28.2.99; Mehdi SH, 2013, TOXICOL SCI, V134, P355, DOI 10.1093/toxsci/kft116; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Ossowska K, 2005, EUR J NEUROSCI, V22, P1294, DOI 10.1111/j.1460-9568.2005.04301.x; Peng J, 2007, J NEUROSCI, V27, P6914, DOI 10.1523/JNEUROSCI.1569-07.2007; Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197                                                   ; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045                                                   ; Richardson JR, 2009, ARCH NEUROL-CHICAGO, V66, P870, DOI 10.1001/archneurol.2009.89; Ritz Beate R, 2016, Curr Environ Health Rep, V3, P40, DOI 10.1007/s40572-016-0083-2; Ritz BR, 2009, ENVIRON HEALTH PERSP, V117, P964, DOI 10.1289/ehp.0800277; Ritz B. R., 2007, ARCH NEUROL-CHICAGO, V64, P960; Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3; Ryan BJ, 2015, TRENDS BIOCHEM SCI, V40, P200, DOI 10.1016/j.tibs.2015.02.003; Saki M, 2017, FREE RADICAL BIO MED, V107, P216, DOI 10.1016/j.freeradbiomed.2016.11.050; Sanders LH, 2014, TOXICOL SCI, V142, P395, DOI 10.1093/toxsci/kfu185; Sanders LH, 2014, NEUROBIOL DIS, V70, P214, DOI 10.1016/j.nbd.2014.06.014; Sanders LH, 2014, NEUROBIOL DIS, V62, P381, DOI 10.1016/j.nbd.2013.10.013; Sanders LH, 2013, FREE RADICAL BIO MED, V62, P111, DOI 10.1016/j.freeradbiomed.2013.01.003; Shimura-Miura H, 1999, ANN NEUROL, V46, P920, DOI 10.1002/1531-8249(199912)46:6<920::AID-ANA17>3.0.CO;2-R; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tummala H, 2014, AM J HUM GENET, V94, P246, DOI 10.1016/j.ajhg.2014.01.007; Vance JM, 2010, NEUROTOXICOLOGY, V31, P598, DOI 10.1016/j.neuro.2010.04.007; Verstraeten A, 2015, TRENDS GENET, V31, P140, DOI 10.1016/j.tig.2015.01.004; Wang A, 2011, EUR J EPIDEMIOL, V26, P547, DOI 10.1007/s10654-011-9574-5; Weiss JM, 2005, MOL CARCINOGEN, V42, P127, DOI 10.1002/mc.20067; Wermuth L, 2012, DAN MED J, V59; Wirdefeldt K, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.02.017; Wunnapuk K, 2014, BRIT J CLIN PHARMACO, V78, P855, DOI 10.1111/bcp.12389	66	2	2	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	JUL	2017	158	1					188	198		10.1093/toxsci/kfx086				11	Toxicology	Toxicology	FA8LZ	WOS:000405698800016	28460087				2018-01-05	
J	Sweeney, CL; Choi, U; Liu, CY; Koontz, S; Ha, SK; Malech, HL				Sweeney, Colin L.; Choi, Uimook; Liu, Chengyu; Koontz, Sherry; Ha, Seung-Kwon; Malech, Harry L.			CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants	HUMAN GENE THERAPY			English	Article						chronic granulomatous disease; CRISPR/Cas9; Cybb; knockout; NSG mouse	NADPH OXIDASE ACTIVITY; HEMATOPOIETIC-CELLS; LENTIVIRAL VECTORS; MOUSE; INFECTIONS; DEFECT; BLOOD; CAS9	Chronic granulomatous disease (CGD) is characterized by defects in the production of microbicidal reactive oxygen species (ROS) by phagocytes. Testing of gene and cell therapies for the treatment of CGD in human hematopoietic cells requires preclinical transplant models. The use of the lymphocyte-deficient NOD. Cg-Prkdc(scid) Il2rg(tm1Wjl/)SzJ (NSG) mouse strain for human hematopoietic cell xenografts to test CGD therapies is complicated by the presence of functional mouse granulocytes capable of producing ROS for subsequent bacterial and fungal killing. To establish a phagocyte-defective mouse model of X-linked CGD (X-CGD) in NSG mice, clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 was utilized for targeted knockout of mouse Cybb on the X-chromosome by microinjection of NSG mouse zygotes with Cas9 mRNA and CRISPR single-guide RNA targeting Cybb exon 1 or exon 3. This resulted in a high incidence of indel formation at the CRISPR target site, with all mice exhibiting deletions in at least one Cybb allele based on sequence analysis of tail snip DNA. A female mouse heterozygous for a 235-bp deletion in Cybb exon 1 was bred to an NSG male to establish the X-CGD NSG mouse strain, NSG. Cybb[KO]. Resulting male offspring with the 235 bp deletion were found to be defective for production of ROS by neutrophils and other phagocytes, and demonstrated increased susceptibility to spontaneous bacterial and fungal infections with granulomatous inflammation. The establishment of the phagocyte-defective NSG. Cybb[KO] mouse model enables the in vivo assessment of gene and cell therapy strategies for treating CGD in human hematopoietic cell transplants without obfuscation by functional mouse phagocytes, and may also be useful for modeling other phagocyte disorders in humanized NSG mouse xenografts.	[Sweeney, Colin L.; Choi, Uimook; Koontz, Sherry; Malech, Harry L.] NIAID, Host Def Lab, NIH, Bldg 10,Rm 5-3750,10 Ctr Dr,MSC 1456, Bethesda, MD 20892 USA; [Liu, Chengyu] NHLBI, Transgen Core, NIH, Bldg 10, Bethesda, MD 20892 USA; [Ha, Seung-Kwon] NINDS, Neuroimmunol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	Malech, HL (reprint author), NIAID, Host Def Lab, NIH, Bldg 10,Rm 5-3750,10 Ctr Dr,MSC 1456, Bethesda, MD 20892 USA.	hmalech@nih.gov	zhang, hongling/R-3737-2017		Intramural Research Program of NIAID [Z01-Al-00644, Z01-Al-00988]	This research was supported by the Intramural Research Program of NIAID under intramural project numbers Z01-Al-00644 and Z01-Al-00988. The authors thank the Diagnostic and Research Services Branch of the Division of Veterinary Resources of NIH for pathology and bacteriology analysis, the Department of Laboratory Medicine of the NIH Clinical Center for additional bacteriology analysis, and Crystal Thomas of the Laboratory of Animal Medicine Section of NIAID for advice and assistance in maintaining the health of NSG.Cybb[KO] mice.	Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Barde I, 2011, GENE THER, V18, P1087, DOI 10.1038/gt.2011.65; Brenner S, 2003, BLOOD, V102, P2789, DOI 10.1182/blood-2002-05-1482; Choi U, 2010, MOL THER, V18, pS137; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dagnaes-Hansen F, 2004, LAB ANIM-UK, V38, P321, DOI 10.1258/002367704323133718; De Ravin SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3480; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; Dinauer MC, 1999, BLOOD, V94, P914; Dinauer MC, 2001, BLOOD, V97, P3738, DOI 10.1182/blood.V97.12.3738; Foreman O, 2011, VET PATHOL, V48, P495, DOI 10.1177/0300985810378282; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Li F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05290; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marciano BE, 2015, CLIN INFECT DIS, V60, P1176, DOI 10.1093/cid/ciu1154; Merling RK, 2017, BLOOD ADV, V1, P270, DOI 10.1182/bloodadvances.2016001214; Naumann N, 2007, GENE THER, V14, P1513, DOI 10.1038/sj.gt.3303010; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317                                                                 ; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Sadat MA, 2003, HUM GENE THER, V14, P651, DOI 10.1089/104303403321618164; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477                                                    ; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Sweeney CL, 2014, METHODS MOL BIOL, V1124, P189, DOI 10.1007/978-1-62703-845-4_12; Takeuchi Y, 2015, INT J HEMATOL, V102, P111, DOI 10.1007/s12185-015-1799-8; Ulrich S, 2015, CURR GENE THER, V15, P416; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025	29	1	1	4	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	JUL	2017	28	7					565	575		10.1089/hum.2017.005				11	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FA8AS	WOS:000405669200005	28264583				2018-01-05	
J	Yao, XM; Liu, XW; Zhang, YG; Li, YH; Zhao, CJ; Yao, SH; Wei, YQ				Yao, Xiaomin; Liu, Xiaowei; Zhang, Yaguang; Li, Yuhao; Zhao, Chenjian; Yao, Shaohua; Wei, Yuquan			Gene Therapy of Adult Neuronal Ceroid Lipofuscinoses with CRISPR/Cas9 in Zebrafish	HUMAN GENE THERAPY			English	Article						ANCL; gene therapy; CRISPR/Cas9	HOMOLOGOUS RECOMBINATION; TALE NUCLEASES; HUMAN-DISEASE; CAS SYSTEM; GENOME; MUTATIONS; MUTAGENESIS; ALPHA; DEGENERATION; CRISPR-CAS9	Adult-onset neuronal ceroid lipofuscinosis (ANCL), one of the neuronal ceroid lipofuscinosis (NCLs), is an inherited neurodegenerative disorder with progressive neuronal dysfunction. Recently, mutations in the DNAJC5 gene that encodes cysteine-string protein alpha (CSP alpha) have been reported to be associated with familial autosomal-dominant ANCL (AD-ANCL). This study constructed an ANCL transgenic zebrafish model expressing the human mutant DNAJC5 (mDNAJC5) gene under the control of a zebrafish neuron-specific promoter. To investigate whether gene therapy based on genome-editing technology could treat ANCL, a panel of TALEN and Cas9 nucleases was designed to disrupt the mDNAJC5 gene in this transgenic animal model. By screening these nucleases, it was found that one nuclease that targeted the 5' coding region efficiently alleviated mDNAJC5 protein aggregates in the affected neurons. Therefore, this study provides a gene therapy strategy via the use of the CRISPR/Cas9 system to treat neural genetic diseases.	[Yao, Xiaomin; Liu, Xiaowei; Zhang, Yaguang; Zhao, Chenjian; Yao, Shaohua; Wei, Yuquan] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu, Peoples R China; [Li, Yuhao] Nankai Univ, Sch Med, Key Lab Tumor Microenvironm & Neurovasc Regulat, Tianjin, Peoples R China	Yao, SH (reprint author), Sichuan Univ, 17 South Sect Renmin Rd, Chengdu 610041, Peoples R China.; Zhao, CJ (reprint author), Sichuan Univ, West China Med Ctr, Chengu, Sichuan, Peoples R China.	chjianzhao@scu.edu.cn; chjianzhao@scu.edu.cn			Hi-Tech Research and Development (863) Program of China [2015AA020309]; National Natural Science Foundation of China [81372143, 31000646, 81123003]	This work was supported by the Hi-Tech Research and Development (863) Program of China 2015AA020309 and the National Natural Science Foundation of China (No. 81372143, No. 31000646, and No. 81123003).	Ansai S, 2013, GENETICS, V193, P739, DOI 10.1534/genetics.112.147645; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Benitez BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026741; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Cadieux-Dion M, 2013, CLIN GENET, V83, P571, DOI 10.1111/cge.12020; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Haltia M, 2003, J NEUROPATH EXP NEUR, V62, P1; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2                                                    ; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; Katsuyama T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt638; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Klein C, 2011, DEVELOPMENT, V138, P1935, DOI 10.1242/dev.056861; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; Paterna JC, 2004, J VIROL, V78, P6808, DOI 10.1128/JVI.78.13.6806-6817.2004; Penberthy WT, 2002, FRONT BIOSCI, V7, pD1439, DOI 10.2741/penber; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rider J A, 1988, Am J Med Genet Suppl, V5, P21; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Tan BJ, 2013, INT J ONCOL, V42, P1605, DOI 10.3892/ijo.2013.1843; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; van den Bosch M, 2002, BIOL CHEM, V383, P873; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Warrier V, 2013, BBA-MOL BASIS DIS, V1832, P1827, DOI 10.1016/j.bbadis.2013.03.017; Wu YX, 2015, CELL RES, V25, P67, DOI 10.1038/cr.2014.160; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	43	0	0	5	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	JUL	2017	28	7					588	597		10.1089/hum.2016.190				10	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FA8AS	WOS:000405669200007	28478735				2018-01-05	
J	Maroofi, N; Azarkeivan, A; Banihashemi, S; Mohammadparast, S; Aghajanirefah, A; Banan, M				Maroofi, Nahal; Azarkeivan, Azita; Banihashemi, Soosan; Mohammadparast, Saeid; Aghajanirefah, Ali; Banan, Mehdi			An enhancer haplotype may influence BCL11A expression levels and the response to hydroxyurea in beta-thalassemia patients	PHARMACOGENOMICS			English	Article						beta-thalassemia; BCL11A enhancer; CRISPR/Cas9; hydroxyurea	FETAL-HEMOGLOBIN INDUCTION; RED-BLOOD-CELLS; ERYTHROID-CELLS; CRISPR/CAS9 SYSTEM; GENE-EXPRESSION; GLOBIN GENE; GENOME; ADAPTATION; DELETION; VARIANTS	Aim: To identify the BCL11A intron-2 enhancer linkage disequilibrium (LD) block, harboring two previously identified SNPs, associating with the hydroxyurea response in beta-thalassemia patients and the functional significance of this region. Materials & methods: Several neighboring SNPs were genotyped in our cohort. The associating LD block was identified, and its function studied in K562 erythroid cells via CRISPR/Cas9 genome editing. Results: A haplotype harboring three tag SNPs correlated significantly with the HU-response and BCL11A transcript levels in the patients' reticulocytes. Two deletions encompassing this LD block significantly reduced BCL11A transcript levels in K562 cells. Conclusion: Our data suggest an essential role for this LD block in BCL11A expression levels and the response to hydroxyurea in beta-thalassemia patients.	[Maroofi, Nahal; Banihashemi, Soosan; Mohammadparast, Saeid; Aghajanirefah, Ali; Banan, Mehdi] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran, Iran; [Azarkeivan, Azita] Thalassemia Clin, Blood Transfus Res Ctr, High Inst Res & Educ Transfus Med, Pediat Hematol Oncol, Tehran, Iran; [Aghajanirefah, Ali] UCSF, Sch Med, Lab Med, San Francisco, CA 94115 USA	Banan, M (reprint author), Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran, Iran.	mbbanan@yahoo.com	Banan, Mehdi/L-9762-2017		University of Social Welfare and Rehabilitation Sciences [64032]; Iranian National Research Foundation [4376-4385]	This work was supported by a grant from the University of Social Welfare and Rehabilitation Sciences (grant no. 64032), and in part by a grant from the Iranian National Research Foundation (grant no. 4376-4385). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials - discussed in the manuscript apart from those disclosed.	Banan M, 2013, HEMOGLOBIN, V37, P413, DOI 10.3109/03630269.2013.805418; Banan M, 2013, ANN HEMATOL, V92, P289, DOI 10.1007/s00277-012-1671-3; Banan M, 2012, HEMOGLOBIN, V36, P371, DOI 10.3109/03630269.2012.691147; Banan M, 2012, CLIN EXP PHARMACOL P, V39, P510, DOI 10.1111/j.1440-1681.2012.05702.x; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bauer DE, 2012, BLOOD, V120, P2945, DOI [10.1182/blood2012-06-292078, 10.1182/blood-2012-06-292078]; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Chaisue C, 2007, CLIN BIOCHEM, V40, P1373, DOI 10.1016/j.clinbiochem.2007.08.005; Charpentier E, 2013, NATURE, V495, P50, DOI 10.1038/495050a; Chen ZY, 2009, BLOOD CELL MOL DIS, V42, P144, DOI 10.1016/j.bcmd.2008.12.003; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Chou YC, 2015, MOL CELL BIOL, V35, P2541, DOI 10.1128/MCB.00035-15; Cokic VP, 2008, RED CELL DEV, P169; Corradin O, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0085-3; Drexler HG, 2004, LEUKEMIA RES, V28, P1243, DOI 10.1016/j.leukres.2004.03.022; Duda K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku251; Finotti A, 2015, EXP HEMATOL, V43, P1062, DOI 10.1016/j.exphem.2015.08.011; Grieco AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129431; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Higgs DR, 2008, P NATL ACAD SCI USA, V105, P11595, DOI 10.1073/pnas.0806633105; Higgs DR, 2012, LANCET, V379, P373, DOI 10.1016/S0140-6736(11)60283-3; Iolascon A, 2015, HAEMATOLOGICA, V100, P3, DOI 10.3324/haematol.2014.120733; Jawaid K, 2010, BLOOD CELL MOL DIS, V45, P140, DOI 10.1016/j.bcmd.2010.05.006; Kabanova S, 2009, INT J MED SCI, V6, P156; Kolovos P, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-1; Liu H, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-18; Mabaera R, 2008, EXP HEMATOL, V36, P1057, DOI 10.1016/j.exphem.2008.06.014; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Musallam KM, 2013, BLOOD, V121, P2199, DOI 10.1182/blood-2012-10-408021; Naumann S, 2001, LEUKEMIA RES, V25, P313, DOI 10.1016/S0145-2126(00)00125-9; Nienhuis AW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011726; Pourfarzad F, 2013, HAEMATOLOGICA, V98, P696, DOI 10.3324/haematol.2012.074492; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Ronchi A, 2013, HAEMATOLOGICA, V98, P657, DOI 10.3324/haematol.2013.084392; Rupon JW, 2011, BLOOD CELL MOL DIS, V46, P212, DOI 10.1016/j.bcmd.2011.01.001; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Saunthararajah Y, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P745; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Stamatoyannopoulos G, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P86; Tak YG, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0050-4; Thein SL, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P323; Thein SL, 2009, HUM MOL GENET, V18, pR216, DOI 10.1093/hmg/ddp401; Trakarnsanga K, 2014, HAEMATOLOGICA, V99, P1677, DOI 10.3324/haematol.2014.110155; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Zheng QP, 2014, BIOTECHNIQUES, V57, P115, DOI 10.2144/000114196; Zhu XX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06420	49	0	0	2	2	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1462-2416	1744-8042		PHARMACOGENOMICS	Pharmacogenomics	JUL	2017	18	10					955	967		10.2217/pgs-2017-0019				13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	FA8LK	WOS:000405697300004	28639471				2018-01-05	
J	Periwal, V				Periwal, Vinita			A comprehensive overview of computational resources to aid in precision genome editing with engineered nucleases	BRIEFINGS IN BIOINFORMATICS			English	Article						ZFN; TALEN; CRISPR/Cas; genome editing; engineered nucleases; computational resources	ZINC-FINGER-NUCLEASES; OFF-TARGET SITES; HOMOLOGY-DIRECTED REPAIR; GUIDE-RNA DESIGN; CAS ADAPTIVE IMMUNITY; CRISPR-CAS9 NUCLEASES; CRISPR/CAS9 SYSTEM; WEB TOOL; PROGRAMMABLE NUCLEASES; NUCLEOTIDE COMPOSITION	Genome editing with engineered nucleases (zinc finger nucleases, TAL effector nucleases s and Clustered regularly interspaced short palindromic repeats/CRISPR-associated) has recently been shown to have great promise in a variety of therapeutic and biotechnological applications. However, their exploitation in genetic analysis and clinical settings largely depends on their specificity for the intended genomic target. Large and complex genomes often contain highly homologous/repetitive sequences, which limits the specificity of genome editing tools and could result in off-target activity. Over the past few years, various computational approaches have been developed to assist the design process and predict/reduce the off-target activity of these nucleases. These tools could be efficiently used to guide the design of constructs for engineered nucleases and evaluate results after genome editing. This review provides a comprehensive overview of various databases, tools, web servers and resources for genome editing and compares their features and functionalities. Additionally, it also describes tools that have been developed to analyse post-genome editing results. The article also discusses important design parameters that could be considered while designing these nucleases. This review is intended to be a quick reference guide for experimentalists as well as computational biologists working in the field of genome editing with engineered nucleases.	[Periwal, Vinita] CSIR, Inst Genom & Integrat Biol, Delhi, India	Periwal, V (reprint author), CSIR, Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India.	vin.peri04@gmail.com			Council for Scientific and Industrial Research (CSIR), India [BSC0123]	Author acknowledges funding from Council for Scientific and Industrial Research (CSIR), India through Grant BSC0123 (GENCODE-C).	Aouida M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133373; Aryan A, 2014, METHODS, V69, P38, DOI 10.1016/j.ymeth.2014.02.008; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bao L, 2014, SCI CHINA LIFE SCI, V57, P263, DOI 10.1007/s11427-013-4601-2; Bender S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005264; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Bolukbasi MF, 2015, NAT METHODS, V12, P1150, DOI 10.1038/nmeth.3624; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Chen PB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21802; Chen W, 2015, MOL BIOSYST, V11, P2620, DOI 10.1039/c5mb00155b; Chen W, 2014, ANAL BIOCHEM, V456, P53, DOI 10.1016/j.ab.2014.04.001; Cherepanova NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20946; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Cradick TJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-152; Dai Zhiyin, 2014, F1000Res, V3, P95, DOI 10.12688/f1000research.3928.2; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326; Frank S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-773; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fujita T, 2016, JOVE-J VIS EXP, V107; Gaj T, 2014, BIOTECHNOL BIOENG, V111, P1, DOI 10.1002/bit.25096; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Grau J, 2013, BIOINFORMATICS, V29, P2931, DOI 10.1093/bioinformatics/btt501; Guell M, 2014, BIOINFORMATICS, V30, P2968, DOI 10.1093/bioinformatics/btu427; Guo XY, 2015, CELL RES, V25, P767, DOI 10.1038/cr.2015.64; Gymrek M, 2014, BIOINFORMATICS, V30, P3405, DOI 10.1093/bioinformatics/btu565; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Heigwer F, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt789; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Hofsteen P, 2016, P NATL ACAD SCI USA, V113, P1002, DOI 10.1073/pnas.1523930113; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu JH, 2016, CELL CHEM BIOL, V23, P57, DOI 10.1016/j.chembiol.2015.12.009; Jayakanthan M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-421; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Juarez-Moreno K, 2013, EPIGENETICS-US, V8, P164, DOI 10.4161/epi.23503; Kaur K, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav055; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kleinkauf R, 2015, BIOINFORMATICS, V31, P3114, DOI 10.1093/bioinformatics/btv319; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lange SJ, 2013, NUCLEIC ACIDS RES, V41, P8034, DOI 10.1093/nar/gkt606; Lee HB, 2015, CELL LOGIST, V5; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li J, 2015, P NATL ACAD SCI USA, V112, P14876, DOI 10.1073/pnas.1520490112; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Li QY, 2015, G3-GENES GENOM GENET, V5, P2809, DOI 10.1534/g3.115.021857; Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6; Li XY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9212; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Liesche C, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0250-4; Lin YN, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1363; Liu B, 2016, MOL GENET GENOMICS, V291, P473, DOI 10.1007/s00438-015-1078-7; Liu B, 2015, BIOINFORMATICS, V31, P1307, DOI 10.1093/bioinformatics/btu820; Liu HL, 2014, CELL STEM CELL, V14, P323, DOI 10.1016/j.stem.2014.01.018; Liu HL, 2015, BIOINFORMATICS, V31, P3676, DOI 10.1093/bioinformatics/btv423; Liu YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084893; Luo Y, 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/514709; Ma M, 2013, BIOMED RES INT, DOI 10.1155/2013/270805; MacPherson CR, 2015, NAT BIOTECHNOL, V33, P805, DOI 10.1038/nbt.3291; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Maggio I, 2016, NUCLEIC ACIDS RES, V44, P1449, DOI 10.1093/nar/gkv1540; Mahata B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134425; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Mangericao TC, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-015-0248-x; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mashimo T, 2014, DEV GROWTH DIFFER, V56, P46, DOI 10.1111/dgd.12110; Matsubara Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05043; Menon T, 2015, CELL STEM CELL, V16, P367, DOI 10.1016/j.stem.2015.02.005; Mianne J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0273-4; Mitchell NC, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-28; Miura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12799; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Neff KL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-1; Nowak DG, 2015, CANCER DISCOV, V5, P636, DOI 10.1158/2159-8290.CD-14-1113; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; O'Brien A, 2014, BIOINFORMATICS, V30, P2673, DOI 10.1093/bioinformatics/btu354; Ousterout DG, 2015, MOL THER, V23, P523, DOI [10.1038/mt.2074.234, 10.1038/mt.2014.234]; Parikh BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116484; Park J, 2015, BIOINFORMATICS, V31, P4014, DOI 10.1093/bioinformatics/btv537; Periwal V, 2015, BIOINFORMATICS, V31, P1, DOI 10.1093/bioinformatics/btu600; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; PINELLO MCC, 2016, BIORXIV; Pliatsika V, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0035-z; Preissler S, 2015, ELIFE, V4, DOI 10.7554/eLife.12621; Prykhozhij SV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119372; Qu XY, 2013, NUCLEIC ACIDS RES, V41, P7771, DOI 10.1093/nar/gkt571; Rakheja D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5802; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Reyon D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-83; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Ronda C, 2014, BIOTECHNOL BIOENG, V111, P1604, DOI 10.1002/bit.25233; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Singh R, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv575; Sluch VM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16595; Smith JD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0900-9; Stein LD, 2013, BRIEF BIOINFORM, V14, P162, DOI 10.1093/bib/bbt001; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Takahashi G, 2015, SCI REP-UK, V5, DOI 10.1038/srep11406; Tattini Lorenzo, 2015, Front Bioeng Biotechnol, V3, P92, DOI 10.3389/fbioe.2015.00092; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tong C, 2011, NAT PROTOC, V6, P827, DOI 10.1038/nprot.2011.338; Ul Ain Q, 2015, J CONTROL RELEASE, V205, P120, DOI 10.1016/j.jconrel.2014.12.036; Camarasa MV, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0275-6; Wang J, 2013, BRIEF BIOINFORM, V14, P131, DOI 10.1093/bib/bbs029; WANG K, 2010, NUCLEIC ACIDS RES, V38, DOI DOI 10.1093/NAR/GKQ603; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep20620; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Winter J, 2016, BIOINFORMATICS, V32, P632, DOI 10.1093/bioinformatics/btv617; Wong ASL, 2016, P NATL ACAD SCI USA, V113, P2544, DOI 10.1073/pnas.1517883113; Wong N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0784-0; Wu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep18865; Xiao A, 2014, BIOINFORMATICS, V30, P1180, DOI 10.1093/bioinformatics/btt764; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Xiao A, 2013, NUCLEIC ACIDS RES, V41, pD415, DOI 10.1093/nar/gks1144; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xiong JS, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2015.19; Xu P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12065; Yao J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06926; Yu JY, 2016, BIOINFORMATICS, V32, P260, DOI 10.1093/bioinformatics/btv556; Zhang C, 2015, BIOINFORMATICS, V31, P2324, DOI 10.1093/bioinformatics/btv134; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424	151	2	2	8	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1467-5463	1477-4054		BRIEF BIOINFORM	Brief. Bioinform.	JUL	2017	18	4					698	711		10.1093/bib/bbw052				14	Biochemical Research Methods; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Mathematical & Computational Biology	FA8SX	WOS:000405717400012	27373734				2018-01-05	
J	Lu, HJ; Cui, Y; Jiang, LW; Ge, W				Lu, Huijie; Cui, Yong; Jiang, Liwen; Ge, Wei			Functional Analysis of Nuclear Estrogen Receptors in Zebrafish Reproduction by Genome Editing Approach	ENDOCRINOLOGY			English	Article							ER-BETA-A; DANIO-RERIO; NULL MICE; SEX-DIFFERENTIATION; AROMATASE GENE; EXPRESSION; ALPHA; PHENOTYPES; MECHANISMS; KNOCKOUT	Estrogens signal through both nuclear and membrane receptors with most reported effects being mediated via the nuclear estrogen receptors (nERs). Although much work has been reported on nERs in the zebrafish, there is a lack of direct genetic evidence for their functional roles and importance in reproduction. To address this issue, we undertook this study to disrupt all three nERs in the zebrafish, namely esr1 (ER alpha), esr2a (ER beta II), and esr2b (ER beta I), by the genome-editing technology clustered regularly interspaced short palindromic repeats and its associated nuclease (CRISPR/Cas9). Using this loss-of-function genetic approach, we successfully created three mutant zebrafish lines with each nER knocked out. In addition, we also generated all possible double and triple knockouts of the three nERs. The phenotypes of these mutants in reproduction were analyzed in all single, double, and triple nER knockouts in both females and males. Surprisingly, all three single nER mutant fish lines display normal reproductive development and function in both females and males, suggesting functional redundancy among these nERs. Further analysis of double and triple knockouts showed that nERs, especially Esr2a and Esr2b, were essential for female reproduction, and loss of these two nERs led to an arrest of folliculogenesis at previtellogenic stage II followed by sex reversal from female to male. In addition, the current study also revealed a unique role for Esr2a in follicle cell proliferation and transdifferentiation, follicle growth, and chorion formation. Taken together, this study provides the most comprehensive genetic analysis for differential functions of esr1, esr2a, and esr2b in fish reproduction.	[Lu, Huijie; Ge, Wei] Univ Macau, Fac Hlth Sci, CRDA, Taipa, Macau, Peoples R China; [Cui, Yong; Jiang, Liwen] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China	Ge, W (reprint author), Univ Macau, Fac Hlth Sci, Ave Univ, Taipa, Macau, Peoples R China.	weige@umac.mo			University of Macau [MYRG2014-00062-FHS, MYRG2015-00227-FHS, MYRG2016-00072-FHS, CPG2014-00014-FHS]; The Macau Fund for Development of Science and Technology [FDCT114/2013/A3, FDCT/089/2014/A2]	This work was supported by the University of Macau (Grants MYRG2014-00062-FHS, MYRG2015-00227-FHS, MYRG2016-00072-FHS, and CPG2014-00014-FHS) and The Macau Fund for Development of Science and Technology (Grants FDCT114/2013/A3 and FDCT/089/2014/A2) (to W.G).	Bardet PL, 2004, DEV GENES EVOL, V214, P240, DOI 10.1007/s00427-004-0404-6; Bardet PL, 2002, J MOL ENDOCRINOL, V28, P153, DOI 10.1677/jme.0.0280153; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Britt KL, 2002, FASEB J, V16, P1389, DOI 10.1096/fj.01-0992com; Celeghin A, 2011, GEN COMP ENDOCR, V172, P120, DOI 10.1016/j.ygcen.2010.12.020; Chen WT, 2013, MOL REPROD DEV, V80, P384, DOI 10.1002/mrd.22172; Cotter KA, 2013, GEN COMP ENDOCR, V194, P217, DOI 10.1016/j.ygcen.2013.09.014; Couse JF, 2001, ANN NY ACAD SCI, V948, P1; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Couse JF, 2000, J STEROID BIOCHEM, V74, P287, DOI 10.1016/S0960-0760(00)00105-9; CURTIS HS, 2000, BREAST CANCER RES, V2, P345; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Dupont S, 2000, DEVELOPMENT, V127, P4277; Emmen JMA, 2003, GYNECOL ENDOCRINOL, V17, P169; Fernandez SV, 2006, INT J CANCER, V118, P1862, DOI 10.1002/ijc.21590; Froehlicher M, 2009, DEV BIOL, V330, P32, DOI 10.1016/j.ydbio.2009.03.005; Griffin LB, 2013, ENDOCRINOLOGY, V154, P4158, DOI 10.1210/en.2013-1446; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; Hewitt Sylvia Curtis, 2002, Rev Endocr Metab Disord, V3, P193, DOI 10.1023/A:1020068224909; Jia TR, 2013, J EXP BOT, V64, P2817, DOI 10.1093/jxb/ert125; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Korach KS, 2003, J STEROID BIOCHEM, V86, P387, DOI 10.1016/S0960-0760(03)00348-0; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Lassiter CS, 2002, GENE, V299, P141, DOI 10.1016/S0378-1119(02)01050-8; Lau ESW, 2016, SCI REP-UK, V6, DOI 10.1038/srep37357; Le Page Y, 2006, ENVIRON HEALTH PERSP, V114, P752, DOI 10.1289/ehp.8141; Leanos-Castaneda O, 2007, TOXICOL APPL PHARM, V224, P116, DOI 10.1016/j.taap.2007.06.017; Liu KC, 2017, GEN COMP ENDOCR, V246, P218, DOI 10.1016/j.ygcen.2016.12.011; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Maack G, 2003, J FISH BIOL, V62, P895, DOI 10.1046/j.1095-8649.2003.00074.x; Menuet A, 2004, J MOL ENDOCRINOL, V32, P975, DOI 10.1677/jme.0.0320975; Menuet A, 2002, BIOL REPROD, V66, P1881, DOI 10.1095/biolreprod66.6.1881; Mold DE, 2009, BIOL REPROD, V81, P101, DOI 10.1095/biolreprod.108.071720; Mueller Stefan O., 2001, Current Opinion in Pharmacology, V1, P613, DOI 10.1016/S1471-4892(01)00105-9; Muth-Kohne E, 2016, AQUAT TOXICOL, V176, P116, DOI 10.1016/j.aquatox.2016.04.018; Nelson ER, 2013, GEN COMP ENDOCR, V192, P15, DOI 10.1016/j.ygcen.2013.03.032; Nelson ER, 2010, ENDOCRINOLOGY, V151, P1668, DOI 10.1210/en.2009-1447; Pang Y, 2008, ENDOCRINOLOGY, V149, P3410, DOI 10.1210/en.2007-1663; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Simpson ER, 2005, ENDOCR REV, V26, P322, DOI 10.1210/er.2004-0020; TAKAHASHI H, 1977, Bulletin of the Faculty of Fisheries Hokkaido University, V28, P57; Tingaud-Sequeira A, 2004, GENE EXPR PATTERNS, V4, P561, DOI 10.1016/j.medgep.2004.02.002; Tohme M, 2014, FASEB J, V28, P3124, DOI 10.1096/fj.13-240465; Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270                                                        ; Vrtacnik P, 2014, BIOCHEM MEDICA, V24, P329, DOI 10.11613/BM.2014.035; Wang Y, 2004, BIOL REPROD, V71, P2056, DOI 10.1095/biolreprod.104.032649; Woodruff TK, 2005, ENDOCRINOLOGY, V146, P3244, DOI 10.1210/en.2005-0630; Yue W, 2010, INT J CANCER, V127, P1748, DOI 10.1002/ijc.25207; Zhang ZW, 2015, ENDOCRINOLOGY, V156, P3747, DOI 10.1210/en.2015-1039; Zhang ZW, 2015, MOL ENDOCRINOL, V29, P76, DOI 10.1210/me.2014-1256	53	3	3	15	15	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	JUL	2017	158	7					2292	2308		10.1210/en.2017-00215				17	Endocrinology & Metabolism	Endocrinology & Metabolism	FA0EW	WOS:000405105100031	28398516				2018-01-05	
J	Adikusuma, F; Pederick, D; McAninch, D; Hughes, J; Thomas, P				Adikusuma, Fatwa; Pederick, Daniel; McAninch, Dale; Hughes, James; Thomas, Paul			Functional Equivalence of the SOX2 and SOX3 Transcription Factors in the Developing Mouse Brain and Testes	GENETICS			English	Article						SOXB1 genes; CRISPR/CAS9 mutagenesis; gene swap	ONE-STEP GENERATION; DUPLICATE GENES; EXPRESSION; MICE; MUTATIONS; NEUROGENESIS; REPLACEMENT; REDUNDANCY; AXIS	Gene duplication provides spare genetic material that evolution can craft into new functions. Sox2 and Sox3 are evolutionarily related genes with overlapping and unique sites of expression during embryogenesis. It is currently unclear whether SOX2 and SOX3 have identical or different functions. Here, we use CRISPR/Cas9-assisted mutagenesis to perform a gene-swap, replacing the Sox3 ORF with the Sox2 ORF to investigate their functional equivalence in the brain and testes. We show that increased expression of SOX2 can functionally replace SOX3 in the development of the infundibular recess/ventral diencephalon, and largely rescues pituitary gland defects that occur in Sox3 null mice. We also show that ectopic expression of SOX2 in the testes functionally rescues the spermatogenic defect of Sox3 null mice, and restores gene expression to near normal levels. Together, these in vivo data provide strong evidence that SOX2 and SOX3 proteins are functionally equivalent.	[Adikusuma, Fatwa; Pederick, Daniel; McAninch, Dale; Hughes, James; Thomas, Paul] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia; [Adikusuma, Fatwa; Pederick, Daniel; McAninch, Dale; Hughes, James; Thomas, Paul] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5005, Australia; [Adikusuma, Fatwa] Diponegoro Univ, Fac Med, Ctr Biomed Res CEBIOR, Semarang 50271, Indonesia; [Thomas, Paul] South Australian Hlth & Med Res Inst, Adelaide, SA 5000, Australia	Thomas, P (reprint author), Univ Adelaide, South Australian Hlth & Med Res Inst, Adelaide, SA 5000, Australia.	paul.thomas@adelaide.edu.au			Beasiswa Unggulan DIKTI (Directorate General of Higher Education, Indonesian Government); Australian Research Council	We thank Robin Lovell-Badge for the Sox3 gene targeting plasmid, Todd Norton for technical assistance, Sandra Piltz for technical expertise in the generation of KI and KO mice, and Eileen McLaughlin for provision of the spermatogonia RNA. F.A. was supported by a scholarship from Beasiswa Unggulan DIKTI (Directorate General of Higher Education, Indonesian Government). Funding from the Australian Research Council supported this study. The authors declare no competing financial interests. All of the experiments involving animal use have been approved by the University of Adelaide Animal Ethics Committee. All studies were conducted in accordance with the principles of animal replacement and reduction and experimental refinement.	Acampora D, 2003, GENE EXPR PATTERNS, V3, P497, DOI 10.1016/S1567-133X(03)00056-5; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Carl SH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1495-3; Cheah PS, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1194-1; Coppola E, 2005, EMBO J, V24, P4392, DOI 10.1038/sj.emboj.7600897; Force A, 1999, GENETICS, V151, P1531; Gao Y, 2009, DEV BIOL, V328, P200, DOI 10.1016/j.ydbio.2009.01.008; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5                                                   ; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077                                                                ; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Hughes J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003290; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kellerer S, 2006, DEVELOPMENT, V133, P2875, DOI 10.1242/dev.02477; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Raverot G, 2005, DEV BIOL, V283, P215, DOI 10.1016/j.ydbio.2005.04.013; Rizzoti K, 2004, NAT GENET, V36, P247, DOI 10.1038/ng1309; Rogers N, 2013, GENE EXPR PATTERNS, V13, P240, DOI 10.1016/j.gep.2013.04.004; Ruff JS, 2015, GENETICS, V201, P727, DOI 10.1534/genetics.115.178079; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bias.20170; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhao L, 2012, DEV CELL, V22, P585, DOI 10.1016/j.devcel.2011.12.023	28	1	1	4	4	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	JUL	2017	206	3					1495	1503		10.1534/genetics.117.202549				9	Genetics & Heredity	Genetics & Heredity	EZ8MZ	WOS:000404981600023	28515211				2018-01-05	
